PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dagbay, KB; Bolik-Coulon, N; Savinov, SN; Hardy, JA				Dagbay, Kevin B.; Bolik-Coulon, Nicolas; Savinov, Sergey N.; Hardy, Jeanne A.			Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; AMYLOID PRECURSOR PROTEIN; C-TERMINAL CLEAVAGE; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN; AXONAL DEGENERATION; CRYSTAL-STRUCTURES; HYDROGEN-EXCHANGE; TRANSGENIC MICE; SELF-ACTIVATION	Caspases are cysteine aspartate proteases that are major players in key cellular processes, including apoptosis and inflammation. Specifically, caspase-6 has also been implicated in playing a unique and critical role in neurodegeneration; however, structural similarities between caspase-6 and other caspase active sites have hampered precise targeting of caspase-6. All caspases can exist in a canonical conformation, in which the substrate binds atop a beta-strand platform in the 130' s region. This caspase-6 region can also adopt a helical conformation that has not been seen in any other caspases. Understanding the dynamics and interconversion between the helical and strand conformations in caspase-6 is critical to fully assess its unique function and regulation. Here, hydrogen/deuterium exchange mass spec-trometry indicated that caspase-6 is inherently and dramatically more conformationally dynamic than closely related caspase-7. In contrast to caspase-7, which rests constitutively in the strand conformation before and after substrate binding, the hydrogen/deuterium exchange data in the L2 ' and 130' s regions suggested that before substrate binding, caspase-6 exists in a dynamic equilibrium between the helix and strand conformations. Caspase-6 transitions exclusively to the canonical strand conformation only upon substrate binding. Glu-135, which showed noticeably different calculated pK(a) values in the helix and strand conformations, appears to play a key role in the interconversion between the helix and strand conformations. Because caspase-6 has roles in several neurodegenerative diseases, exploiting the unique structural features and conformational changes identified here may provide new avenues for regulating specific caspase-6 functions for therapeutic purposes.	[Dagbay, Kevin B.; Bolik-Coulon, Nicolas; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, 745A Lederle Grad Res Tower,710 N Pleasant, Amherst, MA 01003 USA; [Savinov, Sergey N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 745A Lederle Grad Res Tower,710 N Pleasant, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Bolik-Coulon, Nicolas/0000-0002-2759-5767; Kevin, Dagbay/0000-0001-7002-7207; Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM080532]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080532. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Aharony I, 2015, HUM MOL GENET, V24, P2604, DOI 10.1093/hmg/ddv023; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Cao Q, 2014, ACTA CRYSTALLOGR D, V70, P58, DOI 10.1107/S1399004713024218; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Ding ZM, 2012, INT J MOL SCI, V13, P6089, DOI 10.3390/ijms13056089; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Galvan V, 2002, J NEUROCHEM, V82, P283, DOI 10.1046/j.1471-4159.2002.00970.x; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hill ME, 2016, ACS CHEM BIOL, V11, P1603, DOI 10.1021/acschembio.5b00971; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Landgraf RR, 2013, STRUCTURE, V21, P1942, DOI 10.1016/j.str.2013.08.023; LeBlanc AC, 2013, EUR J NEUROSCI, V37, P2005, DOI 10.1111/ejn.12250; Liao SY, 2013, PROTEIN SCI, V22, P1623, DOI 10.1002/pro.2368; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024227; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Majdi A, 2016, J NEUROSCI RES, V94, P879, DOI 10.1002/jnr.23757; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Muller I, 2011, BIOORG MED CHEM LETT, V21, P5244, DOI 10.1016/j.bmcl.2011.07.041; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan LY, 2014, ANAL CHEM, V86, P2657, DOI 10.1021/ac404003q; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Riechers SP, 2016, HUM MOL GENET, V25, P1600, DOI 10.1093/hmg/ddw036; Saganich MJ, 2006, J NEUROSCI, V26, P13428, DOI 10.1523/JNEUROSCI.4180-06.2006; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Snijder J, 2014, J MOL BIOL, V426, P1971, DOI 10.1016/j.jmb.2014.02.022; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Strajbl M, 2001, J PHYS CHEM B, V105, P4471, DOI 10.1021/jp010279l; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Witkowski WA, 2011, PROTEIN SCI, V20, P1421, DOI 10.1002/pro.673; Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030; Yassine W, 2009, BBA-BIOMEMBRANES, V1788, P1722, DOI 10.1016/j.bbamem.2009.05.014; Zhao H, 2014, CELL MOL NEUROBIOL, V34, P369, DOI 10.1007/s10571-013-0021-x; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006	80	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4885	4897		10.1074/jbc.M116.773499	http://dx.doi.org/10.1074/jbc.M116.773499			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154009	Green Published, hybrid			2022-12-26	WOS:000397590400012
J	Wang, L; Chakravarthy, S; Verdine, GL				Wang, Lan; Chakravarthy, Srinivas; Verdine, Gregory L.			Structural Basis for the Lesion-scanning Mechanism of the MutY DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; REPAIR; EXCISION; 8-OXOGUANINE; RECOGNITION; SPECIFICITY; PROTEINS; VALIDATION; MUTATIONS; REMOVAL	The highly mutagenic A: 8-oxoguanine (oxoG) base pair is generated mainly by misreplication of the C: oxoG base pair, the oxidation product of the C: G base pair. The A: oxoG base pair is particularly insidious because neither base in it carries faithful information to direct the repair of the other. The bacterial MutY (MUTYHin humans) adenine DNA glycosylase is able to initiate the repair of A: oxoG by selectively cleaving the A base from the A: oxoG base pair. The difference between faithful repair and wreaking mutagenic havoc on the genome lies in the accurate discrimination between two structurally similar base pairs: A: oxoG and A:T. Here we present two crystal structures of the MutY N-terminal domain in complex with either undamaged DNA or DNA containing an intrahelical lesion. These structures have captured for the first time a DNA glycosylase scanning the genome for a damaged base in the very first stage of lesion recognition and the base extrusion pathway. The mode of interaction observed here has suggested a common lesion-scanning mechanism across the entire helix-hairpin-helix superfamily to which MutY belongs. In addition, small angle X-ray scattering studies together with accompanying biochemical assays have suggested a possible role played by the C-terminal oxoG-recognition domain of MutY in lesion scanning.	[Wang, Lan; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Med Sch, 12 Oxford St, Cambridge, MA 02138 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Biophys Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA	Harvard University; Harvard University; Harvard University; United States Department of Energy (DOE); Argonne National Laboratory	Verdine, GL (corresponding author), Harvard Med Sch, 12 Oxford St, Cambridge, MA 02138 USA.; Verdine, GL (corresponding author), Harvard Univ, 12 Oxford St, Cambridge, MA 02138 USA.	Gregory_verdine@harvard.edu			National Institutes of Health [CA100742, P41 GM103622, 1S10OD018090-01]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants CA100742,P41 GM103622 (to BioCAT), and 1S10OD018090-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2010, J BIOL CHEM, V285, P35783, DOI 10.1074/jbc.M110.155663; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; Li XH, 2000, J BIOL CHEM, V275, P8448, DOI 10.1074/jbc.275.12.8448; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lipton L, 2003, CANCER RES, V63, P7595; LU AL, 1995, J BIOL CHEM, V270, P23582, DOI 10.1074/jbc.270.40.23582; Manuel RC, 1997, BIOCHEMISTRY-US, V36, P11140, DOI 10.1021/bi9709708; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Volk DE, 2000, BIOCHEMISTRY-US, V39, P7331, DOI 10.1021/bi000416p; Wang L, 2015, J BIOL CHEM, V290, P17096, DOI 10.1074/jbc.M115.657866; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	42	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5007	5017		10.1074/jbc.M116.757039	http://dx.doi.org/10.1074/jbc.M116.757039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130451	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000397590400022
J	Honda-Ogawa, M; Sumitomo, T; Mori, Y; Hamd, DT; Ogawa, T; Yamaguchi, M; Nakata, M; Kawabata, S				Honda-Ogawa, Mariko; Sumitomo, Tomoko; Mori, Yasushi; Hamd, Dalia Talat; Ogawa, Taiji; Yamaguchi, Masaya; Nakata, Masanobu; Kawabata, Shigetada			Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; INNATE IMMUNITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-ENOLASE; M-PROTEIN; PNEUMONIAE; SYSTEM; FIBRONECTIN; PLASMINOGEN; ACTIVATION	Streptococcus pyogenes secretes various virulence factors for evasion from complement-mediated bacteriolysis. However, full understanding of the molecules possessed by this organism that interact with complement C1q, an initiator of the classical complement pathway, remains elusive. In this study, we identified an endopeptidase of S. pyogenes, PepO, as an interacting molecule, and investigated its effects on complement immunity and pathogenesis. Enzyme-linked immunosorbent assay and surface plasmon resonance analysis findings revealed that S. pyogenes recombinant PepO bound to human C1q in a con-centration-dependent manner under physiological conditions. Sites of inflammation are known to have decreased pH levels, thus the effects of PepO on bacterial evasion from complement immunity was analyzed in a low pH condition. Notably, under low pH conditions, PepO exhibited a higher affinity for C1q as compared with IgG, and PepO inhibited the binding of IgG to C1q. In addition, pepO deletion rendered S. pyogenes more susceptible to the bacteriocidal activity of human serum. Also, observations of the morphological features of the pepO mutant strain (Delta pepO) showed damaged irregular surfaces as compared with the wild-type strain (WT). WT-infected tissues exhibited greater severity and lower complement activity as compared with those infected by Delta pepO in a mouse skin infection model. Furthermore, WT infection resulted in a larger accumulation of C1q than that with Delta pepO. Our results suggest that interaction of S. pyogenes PepO with C1q interferes with the complement pathway, which enables S. pyogenes to evade complement-mediated bacteriolysis under acidic conditions, such as seen in inflammatory sites.	[Honda-Ogawa, Mariko; Sumitomo, Tomoko; Mori, Yasushi; Hamd, Dalia Talat; Yamaguchi, Masaya; Nakata, Masanobu; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Mori, Yasushi] Osaka Univ, Dent Hosp, Div Special Care Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Ogawa, Taiji] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science (JSPS) [A15H06380]; Naito Foundation;  [A15H05012];  [A16H058470];  [T266708000]; Grants-in-Aid for Scientific Research [26463112, 16K15787, 15H05012, 26462780] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) A15H05012, Grant-in-aid for Scientific Research (B) A16H058470, Grant-in-Aid for challenging Exploratory Research T266708000, and Grant-in-Aid for Young Scientists (Start-up) A15H06380 from the Japan Society for the Promotion of Science (JSPS), and the Naito Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castelli R, 2013, IMMUNOPHARM IMMUNOT, V35, P181, DOI 10.3109/08923973.2012.726627; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Emeis M, 1998, MEDIAT INFLAMM, V7, P417, DOI 10.1080/09629359890802; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; FISHELSON Z, 1987, J IMMUNOL, V138, P3392; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; HAANES EJ, 1989, J BACTERIOL, V171, P6397, DOI 10.1128/jb.171.12.6397-6408.1989; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Igonin AA, 2012, CRIT CARE MED, V40, P770, DOI 10.1097/CCM.0b013e318236edb8; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kaul M, 1997, J BIOL CHEM, V272, P33234, DOI 10.1074/jbc.272.52.33234; Kawabata S, 1999, MICROB PATHOGENESIS, V27, P71, DOI 10.1006/mpat.1999.0283; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Koroleva IV, 1998, FEMS IMMUNOL MED MIC, V20, P11, DOI 10.1016/S0928-8244(97)00101-6; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; LIN TY, 1978, IMMUNOCHEMISTRY, V15, P107; Liu D, 2007, J IMMUNOL, V179, P3966, DOI 10.4049/jimmunol.179.6.3966; MENKIN V, 1956, SCIENCE, V123, P527, DOI 10.1126/science.123.3196.527; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; Murakami J, 2002, EPIDEMIOL INFECT, V128, P397, DOI 10.1017/S0950268802006854; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Oetjen J, 2001, INFECT IMMUN, V69, P58, DOI 10.1128/IAI.69.1.58-64.2001; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Sakamoto M, 1998, NUTRITION, V14, P391, DOI 10.1016/S0899-9007(97)00473-5; SJOHOLM AG, 1991, APMIS, V99, P1120; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Sonntag J, 1998, MEDIAT INFLAMM, V7, P49, DOI 10.1080/09629359891388; STEEN KH, 1995, J NEUROSCI, V15, P3982; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sumitomo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20069; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; THERN A, 1995, J IMMUNOL, V154, P375; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Zhang H, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00023	60	15	15	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4244	4254		10.1074/jbc.M116.749275	http://dx.doi.org/10.1074/jbc.M116.749275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154192	hybrid, Green Published			2022-12-26	WOS:000395837100022
J	Elschot, K; Vermeulen, A; Vandenbruwaene, W; Bakker, JP; Bouma, TJ; Stahl, J; Castelijns, H; Temmerman, S				Elschot, Kelly; Vermeulen, Anke; Vandenbruwaene, Wouter; Bakker, Jan P.; Bouma, Tjeerd J.; Stahl, Julia; Castelijns, Henk; Temmerman, Stijn			Top-down vs. bottom-up control on vegetation composition in a tidal marsh depends on scale	PLOS ONE			English	Article							GEESE ANSER ANSER; LONG-TERM CHANGES; SEA-LEVEL RISE; SALT-MARSH; DIVERSITY DEPENDS; SPECIES RICHNESS; RESOURCE CONTROL; COASTAL MARSHES; PLANT-GROWTH; SNOW GEESE	The relative impact of top-down control by herbivores and bottom-up control by environmental conditions on vegetation is a subject of debate in ecology. In this study, we hypothesize that top-down control by goose foraging and bottom-up control by sediment accretion on vegetation composition within an ecosystem can co-occur but operate at different spatial and temporal scales. We used a highly dynamic marsh system with a large population of the Greylag goose (Anser anser) to investigate the potential importance of spatial and temporal scales on these processes. At the local scale, Greylag geese grub for below-ground storage organs of the vegetation, thereby creating bare patches of a few square metres within the marsh vegetation. In our study, such activities by Greylag geese allowed them to exert top-down control by setting back vegetation succession. However, we found that the patches reverted back to the initial vegetation type within 12 years. At large spatial (i.e. several square kilometres) and temporal scales (i.e. decades), high rates of sediment accretion surpassing the rate of local sea-level rise were found to drive long-term vegetation succession and increased cover of several climax vegetation types. In summary, we conclude that the vegetation composition within this tidal marsh was primarily controlled by the bottom-up factor of sediment accretion, which operates at large spatial as well as temporal scales. Top-down control exerted by herbivores was found to be a secondary process and operated at much smaller spatial and temporal scales.	[Elschot, Kelly; Bakker, Jan P.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Cc Groningen, Netherlands; [Vermeulen, Anke; Temmerman, Stijn] Univ Antwerp, Ecosyst Management Res Grp, Univ Pl, Antwerp, Belgium; [Vandenbruwaene, Wouter] Flemish Govt, Flanders Hydraul Res, Antwerp, Belgium; [Bouma, Tjeerd J.] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Ac Yerseke, Netherlands; [Bouma, Tjeerd J.] Univ Utrecht, Ac Yerseke, Netherlands; [Stahl, Julia] Sovon, Dutch Ctr Field Ornithol, Ga Nijmegen, Netherlands; [Castelijns, Henk] Nat Beschermingsvereniging Steltkluut, Ah Terneuzen, Netherlands; [Elschot, Kelly] Wageningen Univ & Res, Wageningen Marine Res, Ab Den Helder, Netherlands; [Vermeulen, Anke] Univ Antwerp, Ethol Res Grp, Univ Pl, Antwerp, Belgium	University of Groningen; University of Antwerp; Flanders Hydraulics Research (FHR); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Wageningen University & Research; University of Antwerp	Bakker, JP (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Cc Groningen, Netherlands.	j.p.bakker@rug.nl	Temmerman, Stijn/C-5521-2009	Temmerman, Stijn/0000-0003-3346-9115; Bouma, Tjeerd/0000-0001-7824-7546; Vandenbruwaene, Wouter/0000-0003-3779-6076	Netherlands Organization for Scientific Research (NWOZKO) [83908320]; Netherlands Organisation for Scientific Research (NWO) [850.13.011]; Deltares; Boskalis; Van Oord; Rijkswaterstaat; World Wildlife Fund; HZ University of Applied Science	Netherlands Organization for Scientific Research (NWOZKO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deltares; Boskalis; Van Oord; Rijkswaterstaat; World Wildlife Fund; HZ University of Applied Science	This work was funded by the Netherlands Organization for Scientific Research (NWOZKO, project 83908320). It forms part of the research programme BE SAFE, which is financed by the Netherlands Organisation for Scientific Research (NWO; grant #850.13.011), Deltares, Boskalis, Van Oord, Rijkswaterstaat, World Wildlife Fund and HZ University of Applied Science, of which T.J. Bouma is a principal investigator. This work is part of the UA-BOF DOCPRO awarded to S. Temmerman. There was no additional external funding received for this study. The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Alberti J, 2010, OECOLOGIA, V163, P181, DOI 10.1007/s00442-009-1504-9; AMAT JA, 1986, BIRD STUDY, V33, P74, DOI 10.1080/00063658609476899; AMAT JA, 1995, ECOGRAPHY, V18, P155, DOI 10.1111/j.1600-0587.1995.tb00336.x; Amat JA, 2008, WATERBIRDS, V31, P133, DOI 10.1675/1524-4695(2008)31[133:GIASCO]2.0.CO;2; ANDRESEN H, 1990, VEGETATIO, V89, P137, DOI 10.1007/BF00032166; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Bockelmann AC, 1999, J ECOL, V87, P503, DOI 10.1046/j.1365-2745.1999.00368.x; Bockelmann AC, 2002, AQUAT BOT, V73, P211, DOI 10.1016/S0304-3770(02)00022-0; Bos D, 2002, APPL VEG SCI, V5, P45, DOI 10.1658/1402-2001(2002)005[0045:LTVCIE]2.0.CO;2; Calle P, 2015, LEVENDE NATUUR, V116, P215; Castelijns H, 2010, LEVENDE NATUUR, P45; Castelijns Henk, 1998, Oriolus, V64, P90; Daleo P, 2015, ECOLOGY, V96, P2147, DOI 10.1890/14-1776.1; Davy AJ, 2011, J ECOL, V99, P1350, DOI 10.1111/j.1365-2745.2011.01870.x; de Groot AV, 2011, GEOMORPHOLOGY, V134, P280, DOI 10.1016/j.geomorph.2011.07.005; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; DIJKEMA KS, 1990, BIOL CONSERV, V51, P191, DOI 10.1016/0006-3207(90)90151-E; Elschot K, 2015, MAR ECOL PROG SER, V537, P9, DOI 10.3354/meps11447; Elschot K, 2013, ESTUAR COAST SHELF S, V133, P109, DOI 10.1016/j.ecss.2013.08.021; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Esselink P, 1997, AQUAT BOT, V55, P261, DOI 10.1016/S0304-3770(96)01076-5; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Gauthier G, 2005, GLOBAL CHANGE BIOL, V11, P856, DOI 10.1111/j.1365-2486.2005.00944.x; Gough L, 2012, ECOLOGY, V93, P1683, DOI 10.1890/11-1631.1; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hansen BB, 2007, POLAR BIOL, V30, P549, DOI 10.1007/s00300-006-0212-8; He YL, 2011, WETL ECOL MANAG, V19, P341, DOI 10.1007/s11273-011-9220-8; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; HUNTER MD, 1992, ECOLOGY, V73, P724; IACOBELLI A, 1991, J ECOL, V79, P61, DOI 10.2307/2260784; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; KERBES RH, 1990, J APPL ECOL, V27, P242, DOI 10.2307/2403582; Kerimoglu O, 2013, OIKOS, V122, P223, DOI 10.1111/j.1600-0706.2012.20603.x; Kirwan ML, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001400; Klok C, 2010, ANIM BIOL, V60, P373, DOI 10.1163/157075610X523260; Knochel DG, 2010, ECOL APPL, V20, P1903, DOI 10.1890/09-1944.1; Kuijper DPJ, 2005, ECOLOGY, V86, P914, DOI 10.1890/04-0693; Leemans J, 1980, SAEFTINGHE VEGETATIE; Leendertse PC, 1997, PLANT ECOL, V132, P49, DOI 10.1023/A:1009795002076; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Lovelock CE, 2011, ECOSYSTEMS, V14, P745, DOI 10.1007/s10021-011-9443-9; MADSEN J, 1991, ARDEA, V79, P113; Madsen J., 1999, GOOSE POPULATIONS W; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; McLaren JR, 2004, J ECOL, V92, P648, DOI 10.1111/j.0022-0477.2004.00897.x; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001591; Nilsson Leif, 2006, P514; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olff H, 1997, J ECOL, V85, P799, DOI 10.2307/2960603; Peterson SL, 2013, ARCT ANTARCT ALP RES, V45, P575, DOI 10.1657/1938-4246.45.4.575; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; Piernik A, 2005, PHYTOCOENOLOGIA, V35, P19, DOI 10.1127/0340-269X/2005/0035-0019; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140181; Reitsma JM, 2006, TOELICHTING BIJ VEGE; Russell BD, 2005, MAR ECOL PROG SER, V289, P5, DOI 10.3354/meps289005; Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381; Schrama M, 2015, ECOSCIENCE, V22, P71, DOI 10.1080/11956860.2015.1079409; SHUMWAY SW, 1992, OECOLOGIA, V92, P490, DOI 10.1007/BF00317840; SHUMWAY SW, 1994, ECOLOGY, V75, P564, DOI 10.2307/1939559; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Souza L, 2016, OIKOS, V125, P566, DOI 10.1111/oik.02579; Srivastava DS, 1996, J ECOL, V84, P31, DOI 10.2307/2261697; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tessier M, 2003, ACTA OECOL, V24, P103, DOI 10.1016/S1146-609X(03)00049-3; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van der Wal R, 2000, ECOGRAPHY, V23, P60, DOI 10.1034/j.1600-0587.2000.230107.x; Van Eerden MR, 2005, GLOBAL CHANGE BIOL, V11, P894, DOI 10.1111/j.1365-2486.2005.00940.x; van Oene H, 1999, ECOSYSTEMS, V2, P122, DOI 10.1007/s100219900064; Vandenbruwaene W, 2015, GEOMORPHOLOGY, V231, P40, DOI 10.1016/j.geomorph.2014.11.020; Vandenbruwaene W, 2013, EARTH SURF PROC LAND, V38, P122, DOI 10.1002/esp.3265; Veeneklaas RM, 2013, APPL VEG SCI, V16, P205, DOI 10.1111/j.1654-109X.2012.01228.x; Wang C, 2013, J GEOPHYS RES-EARTH, V118, P229, DOI 10.1029/2012JF002474; Wanner A, 2014, AGR ECOSYST ENVIRON, V182, P69, DOI 10.1016/j.agee.2013.08.014; Zimmerman RC, 1996, OECOLOGIA, V107, P560, DOI 10.1007/BF00333949	80	7	7	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169960	10.1371/journal.pone.0169960	http://dx.doi.org/10.1371/journal.pone.0169960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158218	Green Published, gold			2022-12-26	WOS:000396161700007
J	Kawazoe, H; Yano, A; Ishida, Y; Takechi, K; Katayama, H; Ito, R; Yakushijin, Y; Moriguchi, T; Tanaka, M; Tanaka, A; Araki, H				Kawazoe, Hitoshi; Yano, Akiko; Ishida, Yuri; Takechi, Kenshi; Katayama, Hitoshi; Ito, Ryoji; Yakushijin, Yoshihiro; Moriguchi, Toshihide; Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki			Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; RANDOMIZED PHASE-III; RENAL-FUNCTION; MAINTENANCE BEVACIZUMAB; JAPANESE PATIENTS; RISK-FACTORS; CISPLATIN; CHEMOTHERAPY; NEPHROPATHY; METHOTREXATE	Purpose As the major toxicity induced by pemetrexed plus carboplatin is severe hematologic toxicities, the aim of this study was to determine the risk factors for severe hematologic toxicities in lung cancer patients. Methods We retrospectively investigated data from lung cancer patients who had received pemetrexed plus carboplatin, with or without bevacizumab. This observational study was carried out at Ehime University Hospital using electronic medical records dating from July 2009 to March 2015. Severe hematologic toxicities were defined as grade 3 or 4, according to the Common Terminology Criteria for Adverse Events, version 4.0. Results Forty-two patients were included in the study. The incidence of grade 3 or 4 hematologic toxicities during the first cycle of chemotherapy and during all cycles was 19.0% and 16.1%, respectively. Multivariate time-depend generalized estimating equations logistic regression analysis revealed that regular use of non- steroidal anti-inflammatory drugs (NSAIDs) was significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted odds ratio (OR): 8.32, 95% confidence interval (CI): 1.27-54.38; p = 0.03), whereas creatinine clearance of <45 mL/min was not significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted OR: 0.91, 95% CI: 0.25-3.34; p = 0.88). Conclusions The results suggest that severe hematologic toxicities in patients receiving carboplatin-based pemetrexed may be significantly induced by the inhibition of renal tubular pemetrexed secretion through drug-drug interactions between NSAIDs and pemetrexed rather than through glomerular filtration of pemetrexed, even with moderate to sufficient renal function.	[Kawazoe, Hitoshi; Yano, Akiko; Takechi, Kenshi; Moriguchi, Toshihide; Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan; [Ishida, Yuri] Komazawa Hosp, Div Pharm, Setagaya Ku, Tokyo, Japan; [Katayama, Hitoshi] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan; [Ito, Ryoji] Natl Hosp Org, Ehime Med Ctr, Dept Resp Med, Toon, Ehime, Japan; [Yakushijin, Yoshihiro] Ehime Univ Hosp, Ctr Canc, Toon, Ehime, Japan; [Takechi, Kenshi] Tokushima Univ Hosp, Clin Trial Ctr Dev Therapeut, Tokushima, Japan; [Moriguchi, Toshihide] Saiseikai Imabari Hosp, Div Pharm, Imabari, Ehime, Japan	Ehime University; Ehime University; Ehime University; Tokushima University	Tanaka, A (corresponding author), Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan.	akiki@m.ehime-u.ac.jp		Kawazoe, Hitoshi/0000-0002-0626-7908				Barlesi F, 2013, J CLIN ONCOL, V31, P3004, DOI 10.1200/JCO.2012.42.3749; Bezabeh S, 2012, ONCOLOGIST, V17, P550, DOI 10.1634/theoncologist.2011-0431; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Hesketh PJ, 2016, J CLIN ONCOL, V34, P381, DOI 10.1200/JCO.2015.64.3635; Ikesue H, 2015, BIOL PHARM BULL, V38, P1192, DOI 10.1248/bpb.b15-00162; Kurata T, 2014, DRUG METAB PHARMACOK, V29, P148, DOI 10.2133/dmpk.DMPK-13-RG-042; Latz JE, 2006, CANCER CHEMOTH PHARM, V57, P401, DOI 10.1007/s00280-005-0036-1; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; MAICHE AG, 1986, LANCET, V1, P1390; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mita AC, 2006, J CLIN ONCOL, V24, P552, DOI 10.1200/JCO.2004.00.9720; Nakagawa K, 2008, JPN J CLIN ONCOL, V38, P339, DOI 10.1093/jjco/hyn024; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Posada MM, 2015, DRUG METAB DISPOS, V43, P325, DOI 10.1124/dmd.114.059618; Reeves DJ, 2014, BRIT J CLIN PHARMACO, V78, P565, DOI 10.1111/bcp.12384; Sakata Y, 2013, YAKUGAKU ZASSHI, V133, P1209, DOI 10.1248/yakushi.13-00180; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shimokata T, 2010, CANCER SCI, V101, P2601, DOI 10.1111/j.1349-7006.2010.01729.x; Suzuki K, 2009, BRIT J CLIN PHARMACO, V67, P44, DOI 10.1111/j.1365-2125.2008.03303.x; Sweeney CJ, 2006, CLIN CANCER RES, V12, P536, DOI 10.1158/1078-0432.CCR-05-1834; THYSS A, 1986, LANCET, V1, P256; Tiseo M, 2007, TUMORI, V93, P138; Tomita K, 2007, DIABETES CARE, V30, P1581, DOI 10.2337/dc06-2493; Uwai Yuichi, 2004, Drug Metab Pharmacokinet, V19, P369, DOI 10.2133/dmpk.19.369	28	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171066	10.1371/journal.pone.0171066	http://dx.doi.org/10.1371/journal.pone.0171066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158216	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700027
J	Kwon, RJ; Kim, YH; Jeong, DC; Han, ME; Kim, JY; Liu, L; Jung, JS; Oh, SO				Kwon, Ryuk-Jun; Kim, Yun Hak; Jeong, Dae Cheon; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Jung, Jin-Sup; Oh, Sae-Ock			Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SURVIVAL; CANCER; GENE; PROLIFERATION; GROWTH; ROLES; ZHX1	Zinc fingers and homeoboxes (ZHX) is a transcription repressor family that contains three members; ZHX1, ZHX2, and ZHX3. Although ZHX family members have been associated with the progression of cancer, their values as prognostic factors in cancer patients have been poorly examined. Renal cell carcinoma (RCC) is a highly heterogeneous, aggressive cancer that responds variably to treatment. Thus, prognostic molecular markers are required to evaluate disease progression and to improve the survival. In clear cell RCC (ccRCC), ZHX1 and ZHX3 expression were found to be down-regulated but ZHX2 was up-regulated, and the expressions of ZHX1 and ZHX3 were significantly associated with pathological stage. Furthermore, Kaplan-Meier and multivariate regression analysis showed that reduction in the mRNA expression of ZHX1 was associated with poorer survival. Taken together, the present study shows loss of ZHX1 is correlated with ccRCC progression and suggests it is an independent prognostic marker in ccRCC.	[Kwon, Ryuk-Jun; Kim, Yun Hak; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan, South Korea; [Kwon, Ryuk-Jun; Kim, Yun Hak; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Oh, Sae-Ock] Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Yangsan, South Korea; [Jeong, Dae Cheon] Korea Univ, Dept Stat, Seoul, South Korea; [Jung, Jin-Sup] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Korea University; Pusan National University; Pusan National University Hospital	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan, South Korea.; Oh, SO (corresponding author), Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Yangsan, South Korea.	hedgehog@pusan.ac.kr		Liu, Liangwen/0000-0003-2918-8142; Kim, Yun Hak/0000-0002-9796-8266	National Research Foundation of Korea(NRF) grant - Korea government(MSIP) [NRF-2016R1A2B4014593]; Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015R1A5A2009656]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	National Research Foundation of Korea(NRF) grant - Korea government(MSIP); Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (NRF-2016R1A2B4014593), the Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A5A2009656) and a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0920050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATURE, V499, P43, DOI DOI 10.1038/NATURE12222; Belldegrun AS, 2007, EUR UROL SUPPL, V6, P477, DOI 10.1016/j.eursup.2007.01.016; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Gunningham SP, 2001, CANCER RES, V61, P3206; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kucuk U, 2015, ACTA CHIR BELG, V115, P202; Liu Y, 2015, CANCER GENE THER, V22, P223, DOI 10.1038/cgt.2015.16; Ma XJ, 2016, J CANCER, V7, P60, DOI 10.7150/jca.12973; Mignogna C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-293; Minardi D, 2015, ANTICANCER RES, V35, P433; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; Protzel C, 2012, EUR UROL SUPPL, V11, P52, DOI 10.1016/j.eursup.2012.05.002; Pruitt HC, 2016, INT J CANCER, V139, P491, DOI 10.1002/ijc.30043; Vermassen T, 2016, ACTA CLIN BELG, P1; Wang JP, 2013, MOL MED REP, V8, P1531, DOI 10.3892/mmr.2013.1700; Xing TY, 2016, CHINESE J CANCER RES, V28, P80, DOI 10.3978/j.issn.1000-9604.2016.02.09; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	21	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171036	10.1371/journal.pone.0171036	http://dx.doi.org/10.1371/journal.pone.0171036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152006	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200077
J	Shinozaki, A; Misawa, K; Ikeda, Y; Haraguchi, A; Kamagata, M; Tahara, Y; Shibata, S				Shinozaki, Ayako; Misawa, Kenichiro; Ikeda, Yuko; Haraguchi, Atsushi; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu			Potent Effects of Flavonoid Nobiletin on Amplitude, Period, and Phase of the Circadian Clock Rhythm in PER2::LUCIFERASE Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PERIPHERAL CLOCKS; IN-VIVO; REV-ERB; LIGHT; ENTRAINMENT; RESVERATROL; ACTIVATION; IMPAIRMENT	Flavonoids are natural polyphenols that are widely found in plants. The effects of flavonoids on obesity and numerous diseases such as cancer, diabetes, and Alzheimer's have been well studied. However, little is known about the relationships between flavonoids and the circadian clock. In this study, we show that continuous or transient application of flavonoids to the culture medium of embryonic fibroblasts from PER2::LUCIFERASE (PER2::LUC) mice induced various modifications in the circadian clock amplitude, period, and phase. Transient application of some of the tested flavonoids to cultured cells induced a phase delay of the PER2::LUC rhythm at the down slope phase. In addition, continuous application of the polymethoxy flavonoids nobiletin and tangeretin increased the amplitude and lengthened the period of the PER2:: LUC rhythm. The nobiletin-induced phase delay was blocked by co-treatment with U0126, an ERK inhibitor. In summary, among the tested flavonoids, polymethoxy flavones increased the amplitude, lengthened the period, and delayed the phase of the PER2::LUC circadian rhythm. Therefore, foods that contain polymethoxy flavones may have beneficial effects on circadian rhythm disorders and jet lag.	[Shinozaki, Ayako; Misawa, Kenichiro; Ikeda, Yuko; Haraguchi, Atsushi; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Waseda University	Shibata, S (corresponding author), Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.	shibatas@waseda.jp	Haraguchi, Atsushi/ABC-6337-2020; Tahara, Yu/Q-4324-2018	Tahara, Yu/0000-0002-3015-8883; Haraguchi, Atsushi/0000-0003-4162-2474	Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (Bio-oriented Technology Research Advancement Institution, NARO)	Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (Bio-oriented Technology Research Advancement Institution, NARO)	This work was partially supported by the Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); and Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO).	Antoun G, 2012, J NEUROSCI, V32, P4867, DOI 10.1523/JNEUROSCI.5650-11.2012; Brito R, 2016, J NEUROCHEMISTRY; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chen Z, 2013, CELL MOL LIFE SCI, V70, P2985, DOI 10.1007/s00018-012-1207-y; Coogan AN, 2003, J NEUROSCI, V23, P3085; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Eini H, 2015, BIOCHEM PHARMACOL, V98, P110, DOI 10.1016/j.bcp.2015.08.092; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Hamaguchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14207; Hao Y, 2015, CELL PHYSIOL BIOCHEM, V37, P306, DOI 10.1159/000430355; Hayasaka N, 2007, ENDOCRINOLOGY, V148, P3316, DOI 10.1210/en.2007-0010; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kawahata I, 2013, J NEURAL TRANSM, V120, P1397, DOI 10.1007/s00702-013-1025-x; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Liu M, 2007, ENDOCRINOLOGY, V148, P5348, DOI 10.1210/en.2007-0073; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lu MF, 2013, BIOCHEM BIOPH RES CO, V434, P701, DOI 10.1016/j.bbrc.2013.04.035; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Miranda J, 2013, BRIT J NUTR, V110, P1421, DOI 10.1017/S0007114513000755; Moriya S, 2014, J PHARMACOL SCI, V125, P329, DOI 10.1254/jphs.14071SC; Nagase H, 2005, BIOCHEMISTRY-US, V44, P13683, DOI 10.1021/bi050643x; Nakajima A, 2007, J PHARMACOL EXP THER, V321, P784, DOI 10.1124/jpet.106.117010; Narishige S, 2014, BRIT J PHARMACOL, V171, P5858, DOI 10.1111/bph.12890; O'Neill John S, 2013, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-25950-0_4; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; Oike H, 2008, BIOSCI BIOTECH BIOCH, V72, P3038, DOI 10.1271/bbb.80426; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; Poletini Maristela O, 2015, Temperature (Austin), V2, P522, DOI 10.1080/23328940.2015.1115803; Qiao LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087766; Ribas-Latre A, 2015, J NUTR BIOCHEM, V26, P112, DOI 10.1016/j.jnutbio.2014.09.006; Ribas-Latre A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10954; Ribas-Latre A, 2015, MOL NUTR FOOD RES, V59, P865, DOI 10.1002/mnfr.201400571; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schroeder AM, 2013, TRENDS PHARMACOL SCI, V34, P605, DOI 10.1016/j.tips.2013.09.002; Tahara Yu, 2016, Journal of Circadian Rhythms, V14, P4, DOI 10.5334/jcr.136; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Takito J, 2016, CANADIAN J PHYSL PHA, P1; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wu X, 2015, J FUNCT FOODS, V19, P278, DOI 10.1016/j.jff.2015.09.035; Yanagihara N, 2014, J PHARMACOL SCI, V124, P123, DOI 10.1254/jphs.13R17CP; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang L, 2016, BRAIN RES, V1636, P130, DOI 10.1016/j.brainres.2016.02.013; Zhang N, 2016, MOL CELL BIOCHEM, V417, P87, DOI 10.1007/s11010-016-2716-z; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	54	56	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170904	10.1371/journal.pone.0170904	http://dx.doi.org/10.1371/journal.pone.0170904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152057	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200057
J	Ullah, R; Rehman, A; Zafeer, MF; Rehman, L; Khan, YA; Khan, MAH; Khan, SN; Khan, AU; Abidi, SMA				Ullah, Rizwan; Rehman, Abdur; Zafeer, Mohd Faraz; Rehman, Lubna; Khan, Yasir A.; Khan, M. A. Hannan; Khan, Shahper N.; Khan, Asad U.; Abidi, S. M. A.			Anthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica	PLOS ONE			English	Article							NIGELLA-SATIVA OIL; TEGUMENTAL SURFACE CHANGES; IN-VITRO EFFICACY; SCHISTOSOMA-MANSONI; HEPATICA; TRICLABENDAZOLE; GLUTATHIONE; LIVER; RESISTANCE; PROTEINS	Fasciolosis an economically important global disease of ruminants in the temperate and tropical regions, caused by Fasciola hepatica and F. gigantica, respectively, also poses a potential zoonotic threat. In India alone it causes huge losses to stakeholders. Anthelmintics including triclabendazole have been used to control this menace but the emerging resistance against the available compounds necessitates identification of novel and alternative therapeutic measures involving plant derived natural compounds for their anthelmintic potential. Thymoquinone (T) and curcumin (C), the active ingredients of Nigella sativa and Curcuma longa respectively have been used as antiparasitic agents but the information on their flukicidal effect is very limited. Adult flukes of F. gigantica were in vitro exposed to different concentrations of thymoquinone and curcumin separately for 3h at 37 +/- 1 degrees C. A significant (p<0.05) reduction in the worm motility at 60 mu M concentration of both T and C was observed though all the worms remained alive after 3h exposure, whereas the effect on egg shedding was statistically insignificant. Pronounced tegumental disruptions and erosion of spines in the posterior region and around the acetabulum was evident. A significant (p<0.05) decrease in glutathione-S-transferase and superoxide dismutase activity and reduced glutathione (GSH) level was observed, while protein carbonylation increased differentially. A significant inhibition of CathepsinL (CatL) gene expression in thymoquinone treated worms was also evident. Further, in silico molecular docking of T and C with CatL revealed a stronger interaction of curcumin with the involvement of higher number of amino acids as compared to thymoquinone that could be more effective in inhibiting the antioxidant enzymes of F. gigantica. It is concluded that both the compounds understudy will decrease the detoxification ability of F. gigantica, while inhibition of CatL will significantly affect their virulence potential. Thus, both thymoquinone and curcumin appeared to be promising anthelmintic compounds for further investigations.	[Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Khan, Yasir A.; Khan, M. A. Hannan; Abidi, S. M. A.] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India; [Zafeer, Mohd Faraz] Aligarh Muslim Univ, JN Med Coll, IBRC, Aligarh, Uttar Pradesh, India; [Khan, Shahper N.; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Khan, Yasir A.] Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ullah, R (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India.	rizwanullah1987@gmail.com	Khan, Asad U/K-8157-2013; Khan, M. A. Hannan/AAE-7567-2019	Khan, Asad U/0000-0001-9191-9423; Khan, M. A. Hannan/0000-0002-0742-1372; Khan, Shahper N./0000-0002-3931-6702; Zafeer, Mohd faraz/0000-0001-9595-0452	Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme [BT/PR4872/INF/22/150/2012]	Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme	The financial assistance in the form of fellowships by the Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme (Grant No. BT/PR4872/INF/22/150/2012) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Ela EI, 2002, MUTAT RES-GEN TOX EN, V516, P11, DOI 10.1016/S1383-5718(01)00333-3; AGARWAL R, 1979, INDIAN J EXP BIOL, V17, P1264; AHMAD M, 1983, ANN NY ACAD SCI, V411, P347, DOI 10.1111/j.1749-6632.1983.tb47322.x; AHMAD M, 1988, ZOOL ANZ, V220, P59; Aljabre SHM, 2015, J DERMATOL DERMATOL, V19, P92, DOI 10.1016/j.jdds.2015.04.002; Allam G, 2009, IMMUNOBIOLOGY, V214, P712, DOI 10.1016/j.imbio.2008.11.017; [Anonymous], 2004, WATERBORNE ZOONOSES; Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004; Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Ayaz E, 2007, SAUDI MED J, V28, P1654; Bero J, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P455; Bhambal S S, 1980, Indian Pediatr, V17, P469; Brennan GP, 2007, EXP MOL PATHOL, V82, P104, DOI 10.1016/j.yexmp.2007.01.009; CHENSUE SW, 1984, BIOCHEM BIOPH RES CO, V122, P184, DOI 10.1016/0006-291X(84)90457-1; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Das K, 2007, Indian J Gastroenterol, V26, P92; El-Baba C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-201; Elhence V, 2001, Indian J Gastroenterol, V20, P164; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; FELDMAN GM, 1990, J LEUKOCYTE BIOL, V47, P344, DOI 10.1002/jlb.47.4.344; Gandhi V, 2010, BMJ CASE REP, V29, P2010, DOI DOI 10.1007/S12664-010-0029-9; Gharib B, 1999, J HEPATOL, V30, P594, DOI 10.1016/S0168-8278(99)80189-5; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001; Hanna REB, 2015, VET PARASITOL, V207, P34, DOI 10.1016/j.vetpar.2014.11.016; Haq A, 1999, INT J IMMUNOPHARMACO, V21, P283, DOI 10.1016/S0192-0561(99)00010-7; Jefferies JR, 2001, PROTEOMICS, V1, P1128, DOI 10.1002/1615-9861(200109)1:9<1128::AID-PROT1128>3.0.CO;2-0; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Keiser J, 2008, EXP PARASITOL, V119, P87, DOI 10.1016/j.exppara.2007.12.015; Keiser J, 2006, J ANTIMICROB CHEMOTH, V57, P1139, DOI 10.1093/jac/dkl125; Kelley JM, 2016, TRENDS PARASITOL, V32, P458, DOI 10.1016/j.pt.2016.03.002; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; LaCourse EJ, 2012, PLOS NEGLECT TROP D, V6, P5; Laouer H, 2009, NAT PROD COM, V4, P1; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Rondon FCM, 2012, REV BRAS PARASITOL V, V21, P185, DOI 10.1590/S1984-29612012000300002; Mahmoud MR, 2002, J ETHNOPHARMACOL, V79, P1, DOI 10.1016/S0378-8741(01)00310-5; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; McCormick ML, 1996, J IMMUNOL, V157, P5009; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; McKinstry B, 2003, PARASITOL RES, V91, P251, DOI 10.1007/s00436-003-0930-6; McVeigh P, 2014, PLOS NEGLECT TROP D, V8, P9; Mehlhorn H, 2008, ENCY PARASITOLOGY; Mohamed AM, 2005, MEM I OSWALDO CRUZ, V100, P205, DOI 10.1590/S0074-02762005000200016; Morphew RM, 2007, MOL CELL PROTEOMICS, V6, P963, DOI 10.1074/mcp.M600375-MCP200; Morphew RM, 2012, J PROTEOME RES, V11, P5876, DOI 10.1021/pr300654w; Narain Kanwar, 1997, Journal of Communicable Diseases, V29, P161; Nayak A, 2012, PARASITOL RES, V111, P1173, DOI 10.1007/s00436-012-2948-0; Novobilsky A, 2016, INT J PARASITOL-DRUG, V6, P141, DOI 10.1016/j.ijpddr.2016.06.004; Ramachandran J, 2012, J POSTGRAD MED, V58, P150, DOI 10.4103/0022-3859.97180; Sanmartin-Suarez C, 2011, J PHARMACOL TOX MET, V63, P209, DOI 10.1016/j.vascn.2010.10.004; Saowakon N, 2009, EXP PARASITOL, V122, P289, DOI 10.1016/j.exppara.2009.04.011; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shalaby H. A., 2012, Global Veterinaria, V9, P465; Shalaby HA, 2009, VET PARASITOL, V160, P76, DOI 10.1016/j.vetpar.2008.10.027; Shareef PAA, 2014, ACTA TROP, V136, P108, DOI 10.1016/j.actatropica.2014.04.011; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Spithill TW, 1999, FASCIOLOSIS, P465; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stepek G, 2005, PARASITOLOGY, V130, P203, DOI 10.1017/S0031182004006225; STITT AW, 1993, PARASITOL RES, V79, P529, DOI 10.1007/BF00932235; Tu X, 2013, PARASITOL RES, V112, P2839, DOI 10.1007/s00436-013-3455-7; Umar S, 2016, POULTRY SCI, V95, P1513, DOI 10.3382/ps/pew069; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; van Vuuren SF, 2006, S AFR J BOT, V72, P287, DOI 10.1016/j.sajb.2005.07.007; Vibanco-Perez N, 2002, PARASITOL RES, V88, P398, DOI 10.1007/s00436-001-0580-5; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Winkelhagen AJS, 2012, EMERG INFECT DIS, V18, P1028, DOI 10.3201/eid1806.120302	74	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171267	10.1371/journal.pone.0171267	http://dx.doi.org/10.1371/journal.pone.0171267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152102	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200121
J	Zhang, Z; Ordonez, AA; Smith-Jones, P; Wang, H; Gogarty, KR; Daryaee, F; Bambarger, LE; Chang, YS; Jain, SK; Tonge, PJ				Zhang, Zhuo; Ordonez, Alvaro A.; Smith-Jones, Peter; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.; Tonge, Peter J.			The biodistribution of 5-[F-18] fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography	PLOS ONE			English	Article							PYRAZINAMIDE SUSCEPTIBILITY; MOUSE MODEL; RESISTANCE; PHARMACOKINETICS; GENE; PNCA	5-[F-18]F-pyrazinamide (5-[18 F]F-PZA), a radiotracer analog of the first-line tuberculosis drug pyrazinamide (PZA), was employed to determine the biodistribution of PZA using PET imaging and ex vivo analysis. 5-[F-18]F-PZA was synthesized in 60 min using a halide exchange reaction. The overall decay-corrected yield of the reaction was 25% and average specific activity was 2.6 x 10(6) kBq (70 mCi)/mu mol. The biodistribution of 5-[F-18]F-PZA was examined in a pulmonary Mycobacterium tuberculosis mouse model, where rapid distribution of the tracer to the lung, heart, liver, kidney, muscle, and brain was observed. The concentration of 5-[F-18]F-PZA was not significantly different between infected and uninfected lung tissue. Biochemical and microbiological studies revealed substantial differences between 5-F-PZA and PZA. 5-F-PZA was not a substrate for pyrazinamidase, the bacterial enzyme that activates PZA, and the minimum inhibitory concentration for 5-F-PZA against M. tuberculosis was more than 100-fold higher than that for PZA.	[Zhang, Zhuo; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Zhang, Zhuo; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Tonge, Peter J.] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Ordonez, Alvaro A.; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Ctr TB Res, Baltimore, MD 21205 USA; [Ordonez, Alvaro A.; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Smith-Jones, Peter] SUNY Stony Brook, Dept Psychiat, Facil Expt Radiopharmaceut Mfg, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Johns Hopkins University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.; Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Ctr TB Res, Baltimore, MD 21205 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	sjain5@jhmi.edu; peter.tonge@stonybrook.edu	Tonge, Peter J/A-7443-2009; Ordonez, Alvaro/AAC-9996-2022	Tonge, Peter J/0000-0003-1606-3471; Ordonez, Alvaro/0000-0002-8571-0655; Jain, Sanjay/0000-0001-9620-7070	NIH [GM102864]; NIH Director's Transformative Research Award [R01-EB020539]; NIH New Innovator Award [DP2-OD006492]; DAIDS ACTG Novel Formulations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative Research Award; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DAIDS ACTG Novel Formulations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant GM102864 (PJT), a NIH Directors Transformative Research Award R01-EB020539 (SKJ), a NIH New Innovator Award DP2-OD006492 (SKJ) (https://www.nih.gov/) and a DAIDS ACTG Novel Formulations subcontract from Brigham and Womens Hospital (SKJ and PJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2012, INDIAN J MED RES, V136, P808; [Anonymous], 1986, AM REV RESPIR DIS, V134, P355; [Anonymous], 2008, Tuberculosis (Edinb), V88, P141, DOI 10.1016/S1472-9792(08)70021-0; Baughn AD, 2010, ANTIMICROB AGENTS CH, V54, P5323, DOI 10.1128/AAC.00529-10; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Cynamon MH, 1998, ANTIMICROB AGENTS CH, V42, P462; CYNAMON MH, 1995, J MED CHEM, V38, P3902, DOI 10.1021/jm00020a003; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Dawson R, 2011, P 931A PYRAZINAMIDE; DeMarco VP, 2015, ANTIMICROB AGENTS CH, V59, P5768, DOI 10.1128/AAC.01146-15; Furuya T, 2008, CURR OPIN DRUG DISC, V11, P803; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Heifets L, 2000, J CLIN MICROBIOL, V38, P1498, DOI 10.1128/JCM.38.4.1498-1501.2000; Irwin SM, 2016, ACS INFECT DIS, V2, P251, DOI 10.1021/acsinfecdis.5b00127; Manca C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074082; Ordonez AA, 2016, J NUCL MED; Ordonez AA, 2016, DIS MODEL MECH, V9, P779, DOI 10.1242/dmm.025643; Ordonez AA, 2015, MOL IMAGING BIOL, V17, P609, DOI 10.1007/s11307-015-0836-6; Preshlock S, 2016, CHEM REV, V116, P719, DOI 10.1021/acs.chemrev.5b00493; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Singh Pushpendra, 2006, J Commun Dis, V38, P288; Singh P, 2007, J CLIN MICROBIOL, V45, P76, DOI 10.1128/JCM.00951-06; Sun ZH, 1997, MICROBIOL-SGM, V143, P3367, DOI 10.1099/00221287-143-10-3367; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147; Weinstein EA, 2012, ANTIMICROB AGENTS CH, V56, P6284, DOI 10.1128/AAC.01644-12; Weinstein EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009815; Zhang S, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.38; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	34	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170871	10.1371/journal.pone.0170871	http://dx.doi.org/10.1371/journal.pone.0170871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151985	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200052
J	Englebert, N; Bongaerts, P; Muir, PR; Hay, KB; Pichon, M; Hoegh-Guldberg, O				Englebert, Norbert; Bongaerts, Pim; Muir, Paul R.; Hay, Kyra B.; Pichon, Michel; Hoegh-Guldberg, Ove			Lower Mesophotic Coral Communities ( 60-125mDepth) of the Northern Great Barrier Reef and Coral Sea	PLOS ONE			English	Article							JOHNSTON ATOLL; DEEP; ZONATION; DIVERSITY; SLOPES; COVER; GENUS	Mesophotic coral ecosystems in the Indo-Pacific remain relatively unexplored, particularly at lower mesophotic depths ( >= 60m), despite their potentially large spatial extent. Here, we used a remotely operated vehicle to conduct a qualitative assessment of the zooxanthellate coral community at lower mesophotic depths ( 60-125 m) at 10 different locations in the Great Barrier Reef Marine Park and the Coral Sea Commonwealth Marine Reserve. Lower mesophotic coral communities were present at all 10 locations, with zooxanthellate scleractinian corals extending down to similar to 100 metres on walls and similar to 125 m on steep slopes. Lower mesophotic coral communities were most diverse in the 60-80 m zone, while at depths of >= 100 m the coral community consisted almost exclusively of the genus Leptoseris. Collections of coral specimens ( n = 213) between 60 and 125 m depth confirmed the presence of at least 29 different species belonging to 18 genera, including several potential new species and geographic/depth range extensions. Overall, this study highlights that lower mesophotic coral ecosystems are likely to be ubiquitous features on the outer reefs of the Great Barrier Reef and atolls of the Coral Sea, and harbour a generic and species richness of corals that is much higher than thus far reported. Further research efforts are urgently required to better understand and manage these ecosystems as part of the Great Barrier Reef Marine Park and Coral Sea Commonwealth Marine Reserve.	[Englebert, Norbert; Bongaerts, Pim; Hay, Kyra B.; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Englebert, Norbert; Bongaerts, Pim; Hoegh-Guldberg, Ove] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Englebert, Norbert] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Muir, Paul R.; Pichon, Michel] Queensland Museum, Townsville, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland Museum	Englebert, N (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.; Englebert, N (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia.; Englebert, N (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	n.englebert@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Bongaerts, Pim/0000-0001-6747-6044	Catlin Group Limited; Global Change Institute	Catlin Group Limited; Global Change Institute	This work was supported by the Catlin Group Limited and the Global Change Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; Bare AY, 2010, CORAL REEFS, V29, P369, DOI 10.1007/s00338-010-0600-y; Benzoni F, 2012, SYST BIODIVERS, V10, P417, DOI 10.1080/14772000.2012.744369; Bongaerts P, 2011, CORAL REEFS, V30, P335, DOI 10.1007/s00338-011-0725-7; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2013, CORAL REEFS; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; BRAKEL WH, 1979, B MAR SCI, V29, P406; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2012, CORAL REEFS, P1; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; COLIN PL, 1986, B MAR SCI, V38, P111; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Englebert N, 2014, MAR BIODIV; FRICKE H W, 1983, Marine Ecology, V4, P163, DOI 10.1111/j.1439-0485.1983.tb00294.x; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; FRICKE HW, 1986, OECOLOGIA, V71, P29, DOI 10.1007/BF00377316; Harris PT, 2012, ICES J MAR SCI; HEAD SM, 1983, J NAT HIST, V17, P419, DOI 10.1080/00222938300770281; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoeksema BW, 2017, MAR BIODIVERS, V47, P67, DOI 10.1007/s12526-015-0431-8; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hopley D., 1989, J AUST GEOGR STUD, V27, P47, DOI 10.1111/j.1467-8470.1989.tb00591.x; Hopley D.H., 1982, GEOMORPHOLOGY GREAT; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2012, MAR ECOL PROG SER, V455, P65, DOI 10.3354/meps09657; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Liddell W.D., 1988, PALAIOS, V3, P413, DOI DOI 10.2307/3514787; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; Menza C, 2008, REV BIOL TROP, V56, P11; Muir P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117933; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Sarano F, 1988, P 6 INT COR REEF S T, V2, P607; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; SHEPPARD CRC, 1980, MAR ECOL PROG SER, V2, P193, DOI 10.3354/meps002193; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Sheppard CRC, 1998, BIODIVERS CONSERV, V7, P847, DOI 10.1023/A:1008830222860; Sherman C, 2010, CORAL REEFS, V29, P347, DOI 10.1007/s00338-010-0607-4; Smith TB, 2010, CORAL REEFS, V29, P289, DOI 10.1007/s00338-009-0575-8; Steinberg C., 2007, CLIMATE CHANGE GREAT, P51; VERON JEN, 1978, PHILOS T R SOC B, V284, P3, DOI 10.1098/rstb.1978.0050; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Yamazato K, 1972, P S COR COR REEFS	48	25	26	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170336	10.1371/journal.pone.0170336	http://dx.doi.org/10.1371/journal.pone.0170336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146574	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700021
J	Einarsson, R; Persson, UM				Einarsson, Rasmus; Persson, U. Martin			Analyzing key constraints to biogas production from crop residues and manure in the EU-A spatially explicit model	PLOS ONE			English	Article							ANAEROBIC CO-DIGESTION; ENVIRONMENTAL CONSEQUENCES; LIGNOCELLULOSIC BIOMASS; LIVESTOCK MANURES; RECIRCULATION	This paper presents a spatially explicit method for making regional estimates of the potential for biogas production from crop residues and manure, accounting for key technical, biochemical, environmental and economic constraints. Methods for making such estimates are important as biofuels from agricultural residues are receiving increasing policy support from the EU and major biogas producers, such as Germany and Italy, in response to concerns over unintended negative environmental and social impacts of conventional biofuels. This analysis comprises a spatially explicit estimate of crop residue and manure production for the EU at 250 m resolution, and a biogas production model accounting for local constraints such as the sustainable removal of residues, transportation of substrates, and the substrates' biochemical suitability for anaerobic digestion. In our base scenario, the EU biogas production potential from crop residues and manure is about 0.7 EJ/year, nearly double the current EU production of biogas from agricultural substrates, most of which does not come from residues or manure. An extensive sensitivity analysis of the model shows that the potential could easily be 50% higher or lower, depending on the stringency of economic, technical and biochemical constraints. We find that the potential is particularly sensitive to constraints on the substrate mixtures' carbon-to-nitrogen ratio and dry matter concentration. Hence, the potential to produce biogas from crop residues and manure in the EU depends to large extent on the possibility to overcome the challenges associated with these substrates, either by complementing them with suitable co-substrates (e.g. household waste and energy crops), or through further development of biogas technology (e.g. pretreatment of substrates and recirculation of effluent).	[Einarsson, Rasmus; Persson, U. Martin] Chalmers Univ Technol, Div Phys Resource Theory, Environm & Energy Dept, Gothenburg, Sweden	Chalmers University of Technology	Einarsson, R (corresponding author), Chalmers Univ Technol, Div Phys Resource Theory, Environm & Energy Dept, Gothenburg, Sweden.	rasmus.einarsson@chalmers.se	Einarsson, Rasmus/GXG-3568-2022	Einarsson, Rasmus/0000-0002-7587-6280; Persson, U. Martin/0000-0001-7069-6734	Swedish Knowledge Centre for Renewable Transportation Fuels, f3; Swedish Energy Agency; Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR); Goteborgs Handelskompanis deposition	Swedish Knowledge Centre for Renewable Transportation Fuels, f3; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR); Goteborgs Handelskompanis deposition	Funding was provided by The Swedish Knowledge Centre for Renewable Transportation Fuels, f3 (http://www.f3centre.se/); The Swedish Energy Agency (http://www.energimyndigheten.se/en); The Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through the Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR) (no website); and Goteborgs Handelskompanis deposition (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzias FA, 2005, RENEW ENERG, V30, P1161, DOI 10.1016/j.renene.2004.10.001; Bauer A, 2010, CLEAN TECHNOL ENVIR, V12, P153, DOI 10.1007/s10098-009-0236-1; Bauer F, 2013, BIOFUEL BIOPROD BIOR, V7, P499, DOI 10.1002/bbb.1423; Bentsen NS, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-25; Berglund M, 2006, BIOMASS BIOENERG, V30, P254, DOI 10.1016/j.biombioe.2005.11.011; Bidart C, 2014, RENEW SUST ENERG REV, V38, P537, DOI 10.1016/j.rser.2014.06.005; Bossard M., 2000, 40 EUR ENV AG; Dagnall S, 2000, BIORESOURCE TECHNOL, V71, P225, DOI 10.1016/S0960-8524(99)00076-0; De Vries JW, 2012, J ENVIRON MANAGE, V102, P173, DOI 10.1016/j.jenvman.2012.02.032; EEA, 2007, EUROPEAN ENV; Estevez MM, 2014, J ENVIRON MANAGE, V136, P9, DOI 10.1016/j.jenvman.2014.01.028; Eur'Observer Biogas Barometer, 2014, BIOG BAR; European Commission, 2012, COM 2012 595 FINAL; European Commission, 2014, EUR COMM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Hamelin L, 2014, APPL ENERG, V114, P774, DOI 10.1016/j.apenergy.2013.09.033; Hamelin L, 2011, ENVIRON SCI TECHNOL, V45, P5869, DOI 10.1021/es200273j; Hertel TW, 2013, GLOB FOOD SECUR-AGR, V2, P131, DOI 10.1016/j.gfs.2013.05.003; Hohn J, 2014, APPL ENERG, V113, P1, DOI 10.1016/j.apenergy.2013.07.005; IPCC, 2014, 2013 SUPPLEMENT 2006; Koch P., 2015, AGRIBALYSE RAPPORT M; Kreuger E, 2014, BIOGAS FRAN SKANSK B, P93; Lantz M, 2012, APPL ENERG, V98, P502, DOI 10.1016/j.apenergy.2012.04.015; Leip A., 2010, EVALUATION LIVESTOCK; Litorell O., 2005, FJADERFAGODSEL VARDE; Lugato E, 2014, GLOBAL CHANGE BIOL, V20, P313, DOI 10.1111/gcb.12292; Menzi H., 2002, P 10 INT C RAM NETW; Menzi H., 1998, SOLID MANURE EUROPE; Miranda ND, 2016, BIOMASS BIOENERG, V86, P65, DOI 10.1016/j.biombioe.2016.01.012; Moller HB, 2004, BIOMASS BIOENERG, V26, P485, DOI 10.1016/j.biombioe.2003.08.008; Monforti F, 2015, RENEW SUST ENERG REV, V44, P519, DOI 10.1016/j.rser.2014.12.033; Monforti F, 2013, RENEW SUST ENERG REV, V19, P666, DOI 10.1016/j.rser.2012.11.060; Nahm K. H., 2003, World's Poultry Science Journal, V59, P77, DOI 10.1079/WPS20030004; Nilsson D, 2009, HALM SOM BRANSLE; Nordberg A, 2007, BIORESOURCE TECHNOL, V98, P104, DOI 10.1016/j.biortech.2005.11.027; NRC, NUTR REQ DAIR CATTL; Perpina C, 2013, LAND USE POLICY, V31, P326, DOI 10.1016/j.landusepol.2012.07.014; Persson UM, 2015, WIRES ENERGY ENVIRON, V4, P410, DOI 10.1002/wene.155; Petersson A, 2009, IEA BIOENERGY TASK, V37; Petersson A, 2007, BIOMASS BIOENERG, V31, P812, DOI 10.1016/j.biombioe.2007.06.001; Rajagopal R, 2013, BIORESOURCE TECHNOL, V143, P632, DOI 10.1016/j.biortech.2013.06.030; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Scarlat N, 2010, WASTE MANAGE, V30, P1889, DOI 10.1016/j.wasman.2010.04.016; Scheftelowitz M., 2015, STROMERZEUGUNG BIOMA; Shanmugam P, 2009, BIORESOURCE TECHNOL, V100, P4117, DOI 10.1016/j.biortech.2009.03.052; Sommer SG, 2001, EUR J AGRON, V15, P1, DOI 10.1016/S1161-0301(01)00112-5; Van THV, 2009, ANIM FEED SCI TECH, V151, P97, DOI 10.1016/j.anifeedsci.2008.10.008; Walla C, 2008, BIOMASS BIOENERG, V32, P551, DOI 10.1016/j.biombioe.2007.11.009; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097265; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Zheng Y, 2014, PROG ENERG COMBUST, V42, P35, DOI 10.1016/j.pecs.2014.01.001; Zubaryeva A, 2012, RENEW ENERG, V39, P261, DOI 10.1016/j.renene.2011.08.021	51	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171001	10.1371/journal.pone.0171001	http://dx.doi.org/10.1371/journal.pone.0171001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141827	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129500032
J	Hong, Y; Luo, Y; Gao, Q; Ren, C; Yuan, Q; Yang, QE				Hong, Yu; Luo, Yan; Gao, Qi; Ren, Chen; Yuan, Qiong; Yang, Qin-Er			Phylogeny and reclassification of Aconitum subgenus Lycoctonum (Ranunculaceae)	PLOS ONE			English	Article							HYBRIDIZATION; MODEL; GENUS; HIMALAYAS; EVOLUTION; INFERENCE; SEQUENCE; CHINA	Phylogenetic analyses were performed using multiple nuclear (ITS and ETS) and chloroplast regions (ndhF-trnL, psbA-trnH, psbD-trnT, and trnT-trnL) to test the monophyly of Aconitum subgen. Lycoctonum (Ranunculaceae) and reconstruct the phylogenetic relationships within the subgenus. The subgenus as currently circumscribed is revealed to be polyphyletic. To achieve its monophyly, sect. Galeata and sect. Fletcherum, both being unispecific and each having a unique array of characters (the latter even having the aberrant base chromosome number of x= 6), must be removed from the subgenus. The subgenus Lycoctonum should thus be redefined to include only two sections, the unispecific sect. Alatospermum and the relatively species -rich sect. Lycoctonum. The section Alatospermum, which is both morphologically and karyologically in the primitive condition, is resolved as the first diverging lineage of the subgenus Lycoctonum Glade. The monophyly of sect. Lycoctonum is strongly supported, but all the ten series currently recognized within the section are revealed to be para- or poly-phyletic. Five major clades are recovered within the section. We propose to treat them as five series: ser. Crassiflora, ser. Scaposa, ser. Volubilia, ser. Longicassidata, and ser. Lycoctonia. Thus, a formal reclassification of subgen. Lycoctonum is presented, which involves segregating both sect. Galeata and sect. Fletcherum from the subgenus as two independent subgenera within the genus Aconitum, reinstating one series (ser. Crassiflora) and abolishing six series (ser. Laevia, ser. Longibracteolata, ser. Micrantha, ser. Ranunculoidea, ser. Reclinata, and ser. Umbrosa) within sect. Lycoctonum. The series affiliation of some species within the section is adjusted accordingly.	[Hong, Yu; Ren, Chen; Yuan, Qiong; Yang, Qin-Er] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hong, Yu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Yan] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China; [Gao, Qi] Guangxi Zhuangzu Autonomous Reg, Guangxi Inst Bot, Guilin, Peoples R China; [Gao, Qi] Chinese Acad Sci, Guilin, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences	Yang, QE (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	qeyang@scib.ac.cn			National Natural Science Foundation of China [31470303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [www.nsfc.gov.cn/] grant no 31470303.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Borodina-Grabovskaya A. E, 2007, PLANTS CENTRAL ASIA, P22; Chaudhary L. B., 1998, Feddes Repertorium, V109, P527; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Gao Q, 2012, NORD J BOT, V30, P426, DOI 10.1111/j.1756-1051.2012.01506.x; GREGORY W. C., 1941, Phylogenetic and cytological studies in the Ranunculaceae Juss., V31, P443, DOI 10.2307/1005611; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handel-Mazzetti H., 1939, ACTA HORTI GOTOB, V13, P39; Hong Y, 2016, NORD J BOT, V34, P442, DOI 10.1111/njb.00957; Iwatsuki K, 2006, FLORA OF JAPAN A, VIIa, P267; Jabbour F, 2012, MOL PHYLOGENET EVOL, V62, P928, DOI 10.1016/j.ympev.2011.12.005; Jee V, 1983, TAXON, VLXXIX, p[32, 320]; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kadota Yuichi, 2001, Journal of Japanese Botany, V76, P183; Kadota Yuichi, 1999, Journal of Japanese Botany, V74, P282; Kadota Yuichi, 2010, Journal of Japanese Botany, V86, P8; Kadota Yuichi, 2012, Journal of Japanese Botany, V87, P1; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kita Y, 1995, J PLANT RES, V108, P429, DOI 10.1007/BF02344231; Kong Hang-Hui, 2013, Plant Diversity and Resources, V35, P241; KRASNIKOV A A, 1986, Botanicheskii Zhurnal (St. Petersburg), V71, P116; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Kurita M, 1957, REP BIOL I EHIME U, V3, P1; LANGLET OLOF, 1932, SVENSK BOT TIDSKR, V26, P381; LANGLET OLOF F. I., 1927, SVENSK BOT TIDSKR, V21, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUENER L A, 1978, Notes from the Royal Botanic Garden Edinburgh, V37, P113; LEWITSKY G. A., 1931, Bull. Appl. Bot. Genet. and Plant-Breed., V27, P187; Li LQ., 2001, FLORA CHINA, V6, P149; Luo Y, 2005, ACTA PHYTOTAXON SIN, V43, P289, DOI 10.1360/aps040102; Luo Y, 2005, PLANT SYST EVOL, V252, P11, DOI 10.1007/s00606-004-0257-5; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schafer B, 1934, ANN BOT-LONDON, V48, P693, DOI 10.1093/oxfordjournals.aob.a090470; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; Shang X-M., 1984, J SYS EVO, V22, P378; Shankar U, 2003, CURR SCI INDIA, V84, P148; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Steinberg EI, 1937, FLORA SSSR, VVII, P183; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Swofford David L., 1996, P407; TAMURA M, 1979, Notes from the Royal Botanic Garden Edinburgh, V37, P431; Tamura M., 1995, NATURLICHEN PFLANZEN; TAMURA MICHIO, 1966, SCI REP OSAKA UNIV, V15, P13; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Than C, 2007, J COMPUT BIOL, V14, P517, DOI 10.1089/cmb.2007.A010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; Utelli AB, 2000, PLANT SYST EVOL, V224, P195, DOI 10.1007/BF00986343; Wang W. T., 1965, OBSERVATIONES FLORUL, P113; Wang W.T., 1965, ATA PHYTOTAXONOMICA, V1, P49; Wang W, 2013, TAXON, V62, P713, DOI 10.12705/624.10; WANG WT, 1979, FLORA REIPUBLICAE PO, V27, P113; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiao PG, 2006, ACTA PHYTOTAXON SIN, V44, P1, DOI 10.1360/aps050046; Yang Q. E., 1993, Cathaya, V5, P89; Yang Q.E., 1999, J SYST EVOL, V37, P545; Yuan Q, 2006, BOT J LINN SOC, V150, P343, DOI 10.1111/j.1095-8339.2006.00468.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP; 杨亲二, 2001, 植物分类学报, V39, P502	68	13	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171038	10.1371/journal.pone.0171038	http://dx.doi.org/10.1371/journal.pone.0171038			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141851	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129500034
J	Yahata, I; Kawase, T; Kanno, A; Hidaka, H; Sakamoto, S; Nakasato, N; Kawashima, R; Katori, Y				Yahata, Izumi; Kawase, Tetsuaki; Kanno, Akitake; Hidaka, Hiroshi; Sakamoto, Shuichi; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Effects of Visual Speech on Early Auditory Evoked Fields - From the Viewpoint of Individual Variance	PLOS ONE			English	Article							AUDIOVISUAL SPEECH; INTERINDIVIDUAL DIFFERENCES; MULTISENSORY INTEGRATION; CROSSMODAL BINDING; PERCEPTION; CORTEX; LANGUAGE; HEARING; IMPACT; SITES	The effects of visual speech (the moving image of the speaker's face uttering speech sound) on early auditory evoked fields (AEFs) were examined using a helmet-shaped magnetoencephalography system in 12 healthy volunteers (9 males, mean age 35.5 years). AEFs (N100m) in response to the monosyllabic sound/be/were recorded and analyzed under three different visual stimulus conditions, the moving image of the same speaker's face uttering/be/(congruent visual stimuli) or uttering/ge/(incongruent visual stimuli), and visual noise (still image processed from speaker's face using a strong Gaussian filter: control condition). On average, latency of N100m was significantly shortened in the bilateral hemispheres for both congruent and incongruent auditory/visual (A/V) stimuli, compared to the control A/V condition. However, the degree of N100m shortening was not significantly different between the congruent and incongruent A/V conditions, despite the significant differences in psychophysical responses between these two A/V conditions. Moreover, analysis of the magnitudes of these visual effects on AEFs in individuals showed that the lipreading effects on AEFs tended to be well correlated between the two different audio-visual conditions (congruent vs. incongruent visual stimuli) in the bilateral hemispheres but were not significantly correlated between right and left hemisphere. On the other hand, no significant correlation was observed between the magnitudes of visual speech effects and psychophysical responses. These results may indicate that the auditory-visual interaction observed on the N100m is a fundamental process which does not depend on the congruency of the visual information.	[Yahata, Izumi; Kawase, Tetsuaki; Hidaka, Hiroshi; Katori, Yukio] Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabilitat Auditory Sci, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Dept Audiol, Grad Sch Med, Sendai, Miyagi, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Sakamoto, Shuichi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Nakasato, Nobukazu] Tohoku Univ, Dept Epileptol, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019; Hidala, Hiroshi/N-2957-2016	Hidala, Hiroshi/0000-0001-5214-3159	Ministry of Education, Culture, Sports, Science and Technology Japan [24390386]; Grants-in-Aid for Scientific Research [16H05435] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology Japan (Grant-in-Aid for Scientific Research (B), 24390386); https://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Mallick D, 2015, PSYCHON B REV, V22, P1299, DOI 10.3758/s13423-015-0817-4; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Davis C, 2008, BRAIN RES, V1242, P151, DOI 10.1016/j.brainres.2008.04.077; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Jaaskelainen LP, 2008, NEUROREPORT, V19, P93, DOI 10.1097/WNR.0b013e3282f36f7a; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; MacSweeney M, 2002, NEUROPSYCHOLOGIA, V40, P801, DOI 10.1016/S0028-3932(01)00180-4; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Molloy K, 2015, J NEUROSCI, V35, P16046, DOI 10.1523/JNEUROSCI.2931-15.2015; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Nath AR, 2011, J NEUROSCI, V31, P13963, DOI 10.1523/JNEUROSCI.2605-11.2011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Sekiyama K, 2008, DEVELOPMENTAL SCI, V11, P306, DOI 10.1111/j.1467-7687.2008.00677.x; Shinozaki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31388; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Usubuchi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099457; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	31	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170166	10.1371/journal.pone.0170166	http://dx.doi.org/10.1371/journal.pone.0170166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141836	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500007
J	Alba-Tercedor, J; Sainz-Bariain, M; Poquet, JM; Rodriguez-Lopez, R				Alba-Tercedor, Javier; Sainz-Bariain, Marta; Manuel Poquet, Jose; Rodriguez-Lopez, Roberto			Predicting River Macroinvertebrate Communities Distributional Shifts under Future Global Change Scenarios in the Spanish Mediterranean Area	PLOS ONE			English	Article							FRESH-WATER ECOSYSTEMS; RECENT CLIMATE-CHANGE; STREAM MACROINVERTEBRATES; SPECIES RICHNESS; UNITED-STATES; BIODIVERSITY; IMPACTS; EXTINCTIONS; INSECTS; VULNERABILITY	Several studies on global change over the next century predict increases in mean air tem-peratures of between 1 degrees C to 5 degrees C that would affect not only water temperature but also river flow. Climate is the predominant environmental driver of thermal and flow regimes of fresh-water ecosystems, determining survival, growth, metabolism, phenology and behaviour as well as biotic interactions of aquatic fauna. Thus, these changes would also have consequences for species phenology, their distribution range, and the composition and dynamics of communities. These effects are expected to be especially severe in the Mediterranean basin due its particular climate conditions, seriously threatening Southern European ecosys-tems. In addition, species with restricted distributions and narrow ecological requirements, such as those living in the headwaters of rivers, will be severely affected. The study area corresponds to the Spanish Mediterranean and Balearic Islands, delimited by the Koppen climate boundary. With the application of the MEDPACS (MEDiterranean Pre-diction And Classification System) predictive approach, the macroinvertebrate community was pre-dicted for current conditions and compared with three posible scenarios of watertempera-ture increase and its associated water flow reductions. The results indicate that the aquatic macroinvertebrate communities will undergo a drastic impact, with reductions in taxa richness for each scenario in relation to simulated current conditions, accompanied by changes in the taxa distribution pattern. Accordingly, the distribution area of most of the taxa (65.96%) inhabiting the mid-high elevations would contract and rise in altitude. Thus, fami-lies containing a great number of generalist species will move upstream to colonize new zones with lower water temperatures. By contrast, more vulnerable taxa will undergo reduc-tions in their distribution area.	[Alba-Tercedor, Javier; Sainz-Bariain, Marta; Manuel Poquet, Jose; Rodriguez-Lopez, Roberto] Univ Granada, Dept Zool, Granada, Spain	University of Granada	Alba-Tercedor, J; Sainz-Bariain, M (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	jalba@ugr.es; msainzb@ugr.es	Sáinz-Bariáin, Marta/B-4770-2018; Alba-Tercedor, Javier/C-3679-2015	Sáinz-Bariáin, Marta/0000-0001-9427-3680; Alba-Tercedor, Javier/0000-0002-3461-5340	GUADALMED-II [REN2001-3438-007-06/HID]; Junta de Andalucia [RNM-02654/FEDER]; Spanish "Ministerio de Ciencia e Innovacion" [CGL2007-61856/BOS]; Spanish Ministerio de Medio Am biente, Medio Rural y Marino [21.8120062/8511]; University of Granada [21.8120062/8511]	GUADALMED-II; Junta de Andalucia(Junta de Andalucia); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Medio Am biente, Medio Rural y Marino; University of Granada	This work was funded by GUADALMED-II (REN2001-3438-007-06/HID), a project of excellence from "Junta de Andalucia" (RNM-02654/FEDER), the Spanish "Ministerio de Ciencia e Innovacion" (CGL2007-61856/BOS), projects and a collaboration agreement between the "Spanish Ministerio de Medio Am biente, Medio Rural y Marino" and the University of Granada (21.8120062/8511). The preparation of the manuscript benefited by NIFA grant 'Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease', 2015, Lead Dr. S. Brown, Kansas State University & USDA.; This research was funded by the GUADALMED-II (REN2001-3438-007-06/HID), a project of excellence from "Junta de Andalucia" (RNM-02654/FEDER), the Spanish "Ministerio de Ciencia e Innovacion" (CGL2007-61856/BOS), projects and a collaboration agreement between the "Spanish Ministerio de Medio Ambiente, Medio Rural y Marino" and the University of Granada (21.812-0062/8511). Collection authorisations in protected areas were provided by: Direccion General de Gestion del Medio Natural, Consejeria de Medio Ambiente, Junta de Andalucia; Direccion General de Desarrollo Sostenible y Biodiversidad, Gobierno de Aragon; Consejeria de Industria, Energia y Medio Ambiente, Junta de Castilla-La Mancha; Direccion General del Medio Natural, Junta de Castilla y Leon; Departament de Medi Ambient i Habitatge, Direccio General del Medi Natural, Generalitat de Catalunya; Direccion General del Medio natural, Junta de Extremadura; Direccion General de Medio Ambiente, Consejeria de Medio Ambiente de la Comunidad de Madrid. The preparation of the manuscript benefited by NIFA grant 'Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease', 2015. Lead Dr. S. Brown, Kansas State University & USDA. The authors wish to thank Hydraena S.L.L personal and Marta Fernandez Plaza for field and laboratory assistance, and David Nesbitt for checking the English.	Abdul Malak D, 2008, 2008 REV IUCN RED LI, P1; Alba-Tercedor J, 2009, GEN MANUAL UTILIZACI; Alba-Tercedor J., 2002, LIMNETICA, V21, P175; ALBATERCEDOR J, 1988, LIMNETICA, V4, P51; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Bates B.C., 2008, CLIMATE CHANGE WATER; Bhowmik AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130025; Blondel J, 2010, MEDITERRANEAN REGION; Bonada N, 2013, HYDROBIOLOGIA, V719, P1, DOI 10.1007/s10750-013-1634-2; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Climate Change, 2012, CLIM CHANG IMP VULN, DOI DOI 10.2800/66071; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Domisch S, 2011, FRESHWATER BIOL, V56, P2009, DOI 10.1111/j.1365-2427.2011.02631.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; EEA, 2008, 42008 EEA JRC WHO EE; Fajardo-Merlo MC, 2015, HUELLA CAMBIO GLOBAL, P70; Filipe AF, 2013, HYDROBIOLOGIA, V719, P331, DOI 10.1007/s10750-012-1244-4; Floury M, 2012, SCI TOTAL ENVIRON, V441, P220, DOI 10.1016/j.scitotenv.2012.09.051; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Garcia-Ruiz JM, 2011, EARTH-SCI REV, V105, P121, DOI 10.1016/j.earscirev.2011.01.006; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Graf W, 2006, EUROLIMPACS PROJECT; Haidekker A, 2008, AQUAT ECOL, V42, P463, DOI 10.1007/s10452-007-9097-z; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HYNES HBN, 1970, ANNU REV ENTOMOL, V15, P25, DOI 10.1146/annurev.en.15.010170.000325; IPCC, 2002, CLIMATE CHANGE BIODI; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Koppen W, 1923, DE KLIMATE DER ERDE; Kovats RS, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1267; Kullman L, 2001, AMBIO, V30, P72, DOI 10.1639/0044-7447(2001)030[0072:CCWATL]2.0.CO;2; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Poquet JM, 2009, HYDROBIOLOGIA, V623, P153, DOI 10.1007/s10750-008-9655-y; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Mulholland PJ, 1997, HYDROL PROCESS, V11, P949; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Poff NL, 2006, GEOMORPHOLOGY, V79, P264, DOI 10.1016/j.geomorph.2006.06.032; Poff NL, 2010, J N AM BENTHOL SOC, V29, P1441, DOI 10.1899/10-030.1; Roudier P, 2016, CLIMATIC CHANGE, V135, P341, DOI 10.1007/s10584-015-1570-4; Sainz-Bariain M, 2015, HUELLA CAMBIO GLOBAL, P73; Sainz-Bariain M, 2015, AQUAT SCI, P1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schwartz P., 1996, ART LONG VIEW PLANNI; Solheim AL, 2010, EUR ENV, P1; Solomon S, 2007, CLIMATE CHANGE 2007; Sweeney B.W., 1984, P56; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Vannote R, 2007, AM NAT, V115, P667; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD J.V., 1992, AQUATIC INSECT ECOLO, V1, P1; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Wilson RJ, 2005, ECOL LETT, V8, P1346, DOI 10.1111/j.1461-0248.2005.00865.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x	65	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0167904	10.1371/journal.pone.0167904	http://dx.doi.org/10.1371/journal.pone.0167904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135280	Green Submitted, gold, Green Published			2022-12-26	WOS:000396124700002
J	Zilverstand, A; Sorger, B; Slaats-Willemse, D; Kan, CC; Goebel, R; Buitelaar, JK				Zilverstand, Anna; Sorger, Bettina; Slaats-Willemse, Dorine; Kan, Cornelis C.; Goebel, Rainer; Buitelaar, Jan K.			fMRI Neurofeedback Training for Increasing Anterior Cingulate Cortex Activation in Adult Attention Deficit Hyperactivity Disorder. An Exploratory Randomized, Single-Blinded Study	PLOS ONE			English	Article							REAL-TIME FMRI; MULTISOURCE INTERFERENCE TASK; RESONANCE-IMAGING FMRI; DEFICIT/HYPERACTIVITY DISORDER; SUSTAINED ATTENTION; CONTROLLED-TRIAL; CLINICAL-TRIALS; WORKING-MEMORY; ADHD; METAANALYSIS	Attention Deficit Hyperactivity Disorder (ADHD) is characterized by poor cognitive control/ attention and hypofunctioning of the dorsal anterior cingulate cortex (dACC). In the current study, we investigated for the first time whether real-time fMRI neurofeedback (rt-fMRI) training targeted at increasing activation levels within dACC in adults with ADHD leads to a reduction of clinical symptoms and improved cognitive functioning. An exploratory randomized controlled treatment study with blinding of the participants was conducted. Participants with ADHD (n = 7 in the neurofeedback group, and n = 6 in the control group) attended four weekly MRI training sessions (60-min training time/session), during which they performed a mental calculation task at varying levels of difficulty, in order to learn how to up-regulate dACC activation. Only neurofeedback participants received continuous feedback information on actual brain activation levels within dACC. Before and after the training, ADHD symptoms and relevant cognitive functioning was assessed. Results showed that both groups achieved a significant increase in dACC activation levels over sessions. While there was no significant difference between the neurofeedback and control group in clinical outcome, neurofeedback participants showed stronger improvement on cognitive functioning. The current study demonstrates the general feasibility of the suggested rt-fMRI neurofeedback training approach as a potential novel treatment option for ADHD patients. Due to the study's small sample size, potential clinical benefits need to be further investigated in future studies.	[Zilverstand, Anna; Sorger, Bettina; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Zilverstand, Anna] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Slaats-Willemse, Dorine; Buitelaar, Jan K.] Karakter Univ, Ctr Child & Adolescent Psychiat, Nijmegen, Netherlands; [Slaats-Willemse, Dorine; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Kan, Cornelis C.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands; [Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands	Maastricht University; Icahn School of Medicine at Mount Sinai; Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Radboud University Nijmegen	Zilverstand, A (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	anna.zilverstand@gmail.com	Zilverstand, Anna/AFR-0554-2022; Buitelaar, J.K./AAY-7522-2020	Zilverstand, Anna/0000-0002-4889-9700; Sorger, Bettina/0000-0003-1393-3144; Goebel, Rainer/0000-0003-1780-2467	Netherlands Organisation for Scientific Research (Rubicon fellowship) [446-14-015]; BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	Netherlands Organisation for Scientific Research (Rubicon fellowship); BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of Netherlands Organisation for Scientific Research (Rubicon fellowship 446-14-015 to A.Z.; http://www.nwo.nl/en) and the BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs and The Netherlands Ministry of Education, Culture and Science (grant number: SSM06011 to A.Z., R.G., J.K.B.; http://www.rvo.nl/subsidies-regelingen/smart-mix SSM06011).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, CAUT STAT FOR US DSM, V5th Edn; Borm GF, 2005, CONTEMP CLIN TRIALS, V26, P637, DOI 10.1016/j.cct.2005.09.002; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Bron TI, 2014, EUR NEUROPSYCHOPHARM, V24, P519, DOI 10.1016/j.euroneuro.2014.01.007; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cotan, 2012, WECHSLER ADULT INTEL; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; DAUM I, 1993, J NEUROL NEUROSUR PS, V56, P94, DOI 10.1136/jnnp.56.1.94; De Sonneville L., 2005, TIJDSCHRIFT NEUROPSY, P27; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; DuPaul G. J., 1998, ADHD RATING SCALE 4; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Fehr T, 2007, BRAIN RES, V1172, P93, DOI 10.1016/j.brainres.2007.07.043; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goebel R., 2010, IMAGING MED, V2, P407; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Green CT, 2012, NEUROTHERAPEUTICS, V9, P639, DOI 10.1007/s13311-012-0124-y; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Holzapfel S., 1998, PRADIKTOREN DER SELB; Hoogman M, 2012, DONDERS SERIES, P97; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johnson KA, 2012, J NEUROIMAGING, V22, P58, DOI 10.1111/j.1552-6569.2010.00529.x; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kooij JJS, 2003, INTRO DIAGNOSTIC ASS; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Marchetta NDJ, 2008, J ATTEN DISORD, V11, P664, DOI 10.1177/1087054707305108; Murphy K, 1996, J ATTEN DISORD, P147; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; Rheinberg F, 2001, DIAGNOSTICA, V47, P57, DOI 10.1026//0012-1924.47.2.57; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rota G, 2009, HUMAN BRAIN MAPPING, V1605; Sattler, 2001, ASSESSMENT CHILDREN; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schneider MF, 2010, PSYCHIAT RES-NEUROIM, V183, P75, DOI 10.1016/j.pscychresns.2010.04.005; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Slaats-Willemse D, 2005, J AM ACAD CHILD PSY, V44, P385, DOI 10.1097/01.chi.0000153227.34473.c7; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Sorger B, NEUROSCIENCE IN PRES; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Stevens M.C., 2015, BRAIN IMAGING BEHAV; Stoeckel LE, 2014, NEUROIMAGE-CLIN, V5, P245, DOI 10.1016/j.nicl.2014.07.002; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Talairach J., 1988, NEUROPSYCHOLOGIA; Van de Loo-Neus GHH, 2011, EUROPEAN NEUROPSYCHO, P584; van Dongen-Boomsma M, 2013, J CLIN PSYCHIAT, V74, P821, DOI 10.4088/JCP.12m08321; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Vollebregt MA, 2013, J CHILD PSYCHOL PSYC; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Young KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088785; Zilverstand A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00148	70	47	47	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170795	10.1371/journal.pone.0170795	http://dx.doi.org/10.1371/journal.pone.0170795			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125735	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100050
J	Bondarenko, SM; Artemov, GN; Sharakhov, IV; Stegniy, VN				Bondarenko, Semen M.; Artemov, Gleb N.; Sharakhov, Igor V.; Stegniy, Vladimir N.			Tissue-specific features of the X chromosome and nucleolus spatial dynamics in a malaria mosquito, Anopheles atroparvus	PLOS ONE			English	Article							MELANOGASTER INTERPHASE NUCLEI; DROSOPHILA-MELANOGASTER; 3-DIMENSIONAL ORGANIZATION; SYSTEMIC REORGANIZATION; PHYLOGENETIC LEVELS; ARCHITECTURE; ENVELOPE; CELLS	Spatial organization of chromosome territories is important for maintenance of genomic stability and regulation of gene expression. Recent studies have shown tissue-specific features of chromosome attachments to the nuclear envelope in various organisms including malaria mosquitoes. However, other spatial characteristics of nucleus organization, like volume and shape of chromosome territories, have not been studied in Anopheles. We conducted a thorough analysis of tissue-specific features of the X chromosome and nucleolus volume and shape in follicular epithelium and nurse cells of the Anopheles atroparvus ovaries using a modern open-source software. DNA of the polytene X chromosome from ovarian nurse cells was obtained by microdissection and was used as a template for amplification with degenerate oligo primers. A fluorescently labeled X chromosome painting probe was hybridized with formaldehyde-fixed ovaries of mosquitoes using a 3D-FISH method. The nucleolus was stained by immunostaining with an anti-fibrillarin antibody. The analysis was conducted with TANGO a software for a chromosome spatial organization analysis. We show that the volume and position of the X chromosome have tissue-specific characteristics. Unlike nurse cell nuclei, the growth of follicular epithelium nuclei is not accompanied with the proportional growth of the X chromosome. However, the shape of the X chromosome does not differ between the tissues. The dynamics of the X chromosome attachment regions location is tissue -specific and it is correlated with the process of nucleus growth in follicular epithelium and nurse cells.	[Bondarenko, Semen M.; Artemov, Gleb N.; Sharakhov, Igor V.; Stegniy, Vladimir N.] Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia; [Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA	Tomsk State University; Virginia Polytechnic Institute & State University	Sharakhov, IV; Stegniy, VN (corresponding author), Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia.; Sharakhov, IV (corresponding author), Virginia Polytech Inst & State Univ, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	igor@vt.edu; stegniy@res.tsu.ru	Bondarenko, Semen/ABD-5283-2020; Stegniy, Vladimir/N-7656-2014; Artemov, Gleb/E-7935-2019; Stegniy, Vladimir/ABC-6763-2020; Artemov, Gleb N./N-7651-2014; Sharakhov, Igor/B-1972-2008	Bondarenko, Semen/0000-0003-0753-581X; Stegniy, Vladimir/0000-0001-8947-041X; Sharakhov, Igor/0000-0003-0752-3747	Russian Science Foundation [15-14-20011]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was performed using the grant from the Russian Science Foundation 15-14-20011 (to IVS). The funding agencies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Artemov GN, 2011, RUSS J GENET+, V47, P1161, DOI 10.1134/S1022795411100024; Artemov G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115281; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2010, COLD SPRING HARBOR P, V2; Fritz AJ, 2016, J CELL BIOCHEM, V117, P9, DOI 10.1002/jcb.25280; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Kinney NA, 2015, NUCLEUS-PHILA, V6, P212, DOI 10.1080/19491034.2015.1056441; Kinney NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091943; Kokhanenko AA, 2013, PROTOPLASMA, V250, P141, DOI 10.1007/s00709-012-0385-7; MARCHI A, 1994, HEREDITY, V72, P599, DOI 10.1038/hdy.1994.83; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Paz N, 2015, CHROMOSOME RES, V23, P285, DOI 10.1007/s10577-015-9467-7; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003; STEGNIY VN, 1987, GENETIKA+, V23, P821; STEGNY VN, 1991, GENETIKA+, V27, P828; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867	24	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171290	10.1371/journal.pone.0171290	http://dx.doi.org/10.1371/journal.pone.0171290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158219	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161700053
J	Dahl, KA; Fitzpatrick, MF; Spanger-Siegfried, E				Dahl, Kristina A.; Fitzpatrick, Melanie F.; Spanger-Siegfried, Erika			Sea level rise drives increased tidal flooding frequency at tide gauges along the US East and Gulf Coasts: Projections for 2030 and 2045	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; EXTREME	Tidal flooding is among the most tangible present-day effects of global sea level rise. Here, we utilize a set of NOAA tide gauges along the U.S. East and Gulf Coasts to evaluate the potential impact of future sea level rise on the frequency and severity of tidal flooding. Using the 2001-2015 time period as a baseline, we first determine how often tidal flooding currently occurs. Using localized sea level rise projections based on the Intermediate-Low, Intermediate-High, and Highest projections from the U.S. National Climate Assessment, we then determine the frequency and extent of such flooding at these locations for two near-term time horizons: 2030 and 2045. We show that increases in tidal flooding will be substantial and nearly universal at the 52 locations included in our analysis. Long before areas are permanently inundated, the steady creep of sea level rise will force many communities to grapple with chronic high tide flooding in the next 15 to 30 years.	[Dahl, Kristina A.] Dahl Sci, San Francisco, CA USA; [Spanger-Siegfried, Erika] Union Concerned Scientists, Climate & Energy Program, Cambridge, MA USA		Dahl, KA (corresponding author), Dahl Sci, San Francisco, CA USA.	kdahl@alum.mit.edu	Dahl, Kristina/AAC-4813-2021	Dahl, Kristina/0000-0001-6471-8845	Grantham Foundation; Barr Foundation; Energy Foundation	Grantham Foundation; Barr Foundation; Energy Foundation	The Union of Concerned Scientists received funding for this study from The Grantham Foundation, The Barr Foundation, The Energy Foundation, Mr. and Mrs. Jerry Babicka, Dr. Randall D. and Sally Knight. From these funds, the Union of Concerned Scientists provided Dahl Scientific support in the form of salaries for the first author (KAD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain M, 2009, OCEAN SCI, V5, P193, DOI 10.5194/os-5-193-2009; [Anonymous], 2014, SEA LEVEL RISE NUISA; Applegate A., 2014, PILOTONLINE; Atkinson L.P., 2013, SEA GRANT LAW POLICY, DOI DOI 10.1038/S41598-017-15309-5.AVAILABLE; Baart F, 2012, J COASTAL RES, V28, P511, DOI 10.2112/JCOASTRES-D-11-00169.1; Boon JD., 2011, J COASTAL RES, V2012; Cherniawsky JY, 2010, CONT SHELF RES, V30, P575, DOI 10.1016/j.csr.2009.10.002; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Climate Central, 2014, SURG SEAS SEA LEV RI; Davenport C, 2014, NY TIMES; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Eggington, 2013, RECURRENT FLOODING S; Eliot M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006306; Ezer T, 2014, EARTHS FUTURE, V2, P362, DOI 10.1002/2014EF000252; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; Flick RE, 2003, J WATERW PORT C-ASCE, V129, P155, DOI 10.1061/(ASCE)0733-950X(2003)129:4(155); Galloway J., 2015, AJC; Goddard PB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7346; Gregory K., 2013, NY TIMES; Haigh ID, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006645; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Horton R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032486; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Iowa Environmental Mesonet, 2015, IOW ENV MES VAL TIM; Jevrejeva S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042947; Kirkman R., MERLEAU PONTY ENV PH, P19; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Lake County Department of Economic Growth, 2016, COMPR PLAN PLANN HOR; Leuliette EW, 2011, OCEANOGRAPHY, V24, P122, DOI 10.5670/oceanog.2011.32; Milliken KT, 2008, GEOL SOC AM SPEC PAP, V443, P1, DOI 10.1130/2008.2443(01); Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; Moftakhari HR, 2015, GEOPHYS RES LETT, V42, P9846, DOI 10.1002/2015GL066072; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Muller M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006387; National Oceanic and Atmospheric Administration, 2013, IN AN NOAA TID CURR; National Oceanic and Atmospheric Administration, 2013, SEA LEV TRENDS NOAA; National Weather Service, 2015, ADV HYDR PRED SERV; Parris A., GLOBAL SEA LEVEL RIS, P1; Passeri DL, 2016, EARTHS FUTURE, V4, P159, DOI 10.1002/2015EF000332; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Prothero A., 2013, WLRN TV; Ray RD, 2006, CONT SHELF RES, V26, P422, DOI 10.1016/j.csr.2005.12.005; Ray RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040217; Ryan McNeill, 2014, REUTERS; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Spanger-Siegfried E, 2014, UNION SCI, V76; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sweet WV, 2014, EARTHS FUTURE, V2, P579, DOI 10.1002/2014EF000272; Tebaldi C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014032; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wadey MP, 2014, OCEAN SCI, V10, P1031, DOI 10.5194/os-10-1031-2014; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [10.7930/J0KW5CXT, DOI 10.7930/J0KW5CXT]; Whitney Bailey C, 2011, FLOOD MITIGATION STR; Witze A, 2008, NATURE, V452, P798, DOI 10.1038/452798a; Woodworth PL, 2010, CONT SHELF RES, V30, P1680, DOI 10.1016/j.csr.2010.07.002	60	47	47	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170949	10.1371/journal.pone.0170949	http://dx.doi.org/10.1371/journal.pone.0170949			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158209	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700021
J	Dasgupta, A; Sarkar, J; Ghosh, M; Bhattacharya, A; Mukherjee, A; Chattopadhyay, D; Acharya, K				Dasgupta, Adhiraj; Sarkar, Joy; Ghosh, Manosij; Bhattacharya, Amartya; Mukherjee, Anita; Chattopadhyay, Dipankar; Acharya, Krishnendu			Green conversion of graphene oxide to graphene nanosheets and its biosafety study	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; ECTOMYCORRHIZAL EDIBLE MUSHROOM; DIOXIDE TIO2 NANOPARTICLES; EXFOLIATED GRAPHITE OXIDE; MS/MS PROTEOME ANALYSIS; HEPATOMA HEPG2 CELLS; ALBONIGRA KROMBH. FR; IN-VITRO; SILVER NANOPARTICLES; DNA-DAMAGE	Chemical reduction of graphene oxide (GO) to graphene employs the use of toxic and environmentally harmful reducing agents, hindering mass production of graphene which is of tremendous technological importance. In this study we report a green approach to the synthesis of graphene, bio-reduced by crude polysaccharide. The polysaccharide reduces exfoliated GO to graphene at room temperature in an aqueous medium. Transmission electron microscopy image provides clear evidence for the formation of few layer graphene. Characterization of the resulting polysaccharide reduced GO by Raman spectroscopy, Fourier transform infrared spectroscopy and Energy dispersive X-ray analysis confirms reduction of GO to graphene. We also investigated the degree of biosafety of the reduced GO and found it to be safe under 100 mu g/ml.	[Dasgupta, Adhiraj; Sarkar, Joy; Acharya, Krishnendu] Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India; [Sarkar, Joy] Dinabandhu Andrews Coll, Dept Bot, Kolkata, W Bengal, India; [Ghosh, Manosij; Mukherjee, Anita] Univ Calcutta, Cell Biol & Genet Toxicol Lab, Ctr Adv Study Cell & Chromosome Res, Dept Bot, Kolkata, W Bengal, India; [Bhattacharya, Amartya; Chattopadhyay, Dipankar] Univ Calcutta, Dept Polymer Sci & Technol, Univ Coll Sci & Technol, Kolkata, W Bengal, India; [Acharya, Krishnendu] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Technol Campus, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; University of Calcutta; University of Calcutta	Acharya, K (corresponding author), Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India.; Acharya, K (corresponding author), Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Technol Campus, Kolkata, W Bengal, India.	krish_paper@yahoo.com	SARKAR, JOY/AAR-2992-2021; Acharya, Krishnendu/G-2317-2012; Ghosh, Manosij/G-3374-2013; Ghosh, Manosij/AAU-2853-2021	SARKAR, JOY/0000-0002-6404-7428; Acharya, Krishnendu/0000-0003-1193-1823; Ghosh, Manosij/0000-0001-5034-001X; Ghosh, Manosij/0000-0001-5034-001X; Chattopadhyay, Dipankar/0000-0002-0863-5882; Dasgupta, Adhiraj/0000-0002-3544-8257				AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akhavan O, 2013, CARBON, V54, P419, DOI 10.1016/j.carbon.2012.11.058; Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Cai SW, 2004, BIOCHEMISTRY-US, V43, P2541, DOI 10.1021/bi030149y; Cao AN, 2010, ADV MATER, V22, P103, DOI 10.1002/adma.200901920; Chen DZ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/32/325601; Das SK, 2009, LANGMUIR, V25, P8192, DOI 10.1021/la900585p; Devi T.R., 2010, INT J PHARM SCI REV, V2, P106, DOI DOI 10.HTTPS://D0I.0RG/10.1155/2012/741561; Dhawan A, 2010, ANAL BIOANAL CHEM, V398, P589, DOI 10.1007/s00216-010-3996-x; Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI [10.2217/nnm.10.158, 10.2217/NNM.10.158]; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Ghosh M, 2013, J APPL TOXICOL, V33, P1097, DOI 10.1002/jat.2863; Ghosh M, 2012, MUTAT RES-GEN TOX EN, V749, P60, DOI 10.1016/j.mrgentox.2012.08.007; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Ghosh M, 2010, CHEMOSPHERE, V81, P1253, DOI 10.1016/j.chemosphere.2010.09.022; GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R; Guo HL, 2009, ACS NANO, V3, P2653, DOI 10.1021/nn900227d; Khanra P, 2012, CHEM ENG J, V183, P526, DOI 10.1016/j.cej.2011.12.075; Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053; Kuila T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305710; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v; Lim JM, 2005, CARBOHYD POLYM, V61, P296, DOI 10.1016/j.carbpol.2005.04.004; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Matesanz MC, 2013, BIOMATERIALS, V34, P1562, DOI 10.1016/j.biomaterials.2012.11.001; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nandi AK, 2014, CARBOHYD POLYM, V99, P774, DOI 10.1016/j.carbpol.2013.09.016; Nandi AK, 2013, CARBOHYD POLYM, V94, P918, DOI 10.1016/j.carbpol.2013.02.019; Nandi AK, 2012, CARBOHYD RES, V363, P43, DOI 10.1016/j.carres.2012.10.002; Nitschke J, 2011, FOOD CHEM, V127, P791, DOI 10.1016/j.foodchem.2010.12.149; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Parlak O, 2014, ADV MAT; Parlak O, 2013, BIOSENS BIOELECTRON, V49, P53, DOI 10.1016/j.bios.2013.04.004; Patra P, 2012, CARBOHYD RES, V362, P1, DOI 10.1016/j.carres.2012.09.009; Qiao Y, 2013, ANAL CHEM, V85, P4107, DOI 10.1021/ac400242w; Qiu T, 2013, CARBOHYD POLYM, V98, P922, DOI 10.1016/j.carbpol.2013.07.014; Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175; Samanta S, 2013, CARBOHYD RES, V367, P33, DOI 10.1016/j.carres.2012.12.002; Sarkar J, 2014, BIOPROC BIOSYST ENG, V37, P165, DOI 10.1007/s00449-013-0982-7; Sarkar J, 2011, DIG J NANOMATER BIOS, V6, P563; Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393; Sathyavathi R, ADV SCI LETT, P138; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x; Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c; Singh AK, 2010, J NANOPART RES, V12, P1667, DOI 10.1007/s11051-009-9835-3; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Subarna Saha, 2013, International Journal of Green Pharmacy, V7, P182; Subbaiah YPV, 2016, ADV FUNCT MATER, V26, P2046, DOI 10.1002/adfm.201504202; Sui Y, 2009, NANO LETT, V9, P2973, DOI 10.1021/nl901396g; Sun ZP, 2010, ACS NANO, V4, P803, DOI 10.1021/nn901703e; Synytsya A, 2009, CARBOHYD POLYM, V76, P548, DOI 10.1016/j.carbpol.2008.11.021; Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vallabani NVS, 2011, J BIOMED NANOTECHNOL, V7, P106, DOI 10.1166/jbn.2011.1224; Wang GM, 2011, NANO RES, V4, P563, DOI 10.1007/s12274-011-0112-2; Wang HL, 2009, J AM CHEM SOC, V131, P9910, DOI 10.1021/ja904251p; William S., 1958, J AM CHEM SOC, V80, P1339, DOI DOI 10.1021/JA01539A017; Wu T, 2011, CHEM ENG J, V173, P144, DOI 10.1016/j.cej.2011.07.050; Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k; Yang C, 2010, JPC-J PLANAR CHROMAT, V23, P46, DOI 10.1556/JPC.23.2010.1.8; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Yuan JF, 2011, TOXICOL LETT, V207, P213, DOI 10.1016/j.toxlet.2011.09.014; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031; Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176; Zhou M, 2009, ANAL CHEM, V81, P5603, DOI 10.1021/ac900136z; Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387	78	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171607	10.1371/journal.pone.0171607	http://dx.doi.org/10.1371/journal.pone.0171607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158272	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700109
J	Kassouf, N; Syed, S; Larner, J; Amlot, R; Chilcott, RP				Kassouf, Nick; Syed, Sara; Larner, Joanne; Amlot, Richard; Chilcott, Robert P.			Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR)	PLOS ONE			English	Article							IN-VITRO SKIN; INVITRO PERCUTANEOUS-ABSORPTION; ORGANOPHOSPHORUS PESTICIDE; SULFUR MUSTARD; GUINEA-PIG; MULTICENTER; GLYPHOSATE; SIMULANT; EXPOSURE; BINDING	The UK's Initial Operational Response (IOR) is a revised process for the medical management of mass casualties potentially contaminated with hazardous materials. A critical element of the IOR is the introduction of immediate, on-scene disrobing and decontamination of casualties to limit the adverse health effects of exposure. Ad hoc cleansing of the skin with dry absorbent materials has previously been identified as a potential means of facilitating emergency decontamination. The purpose of this study was to evaluate the in vitro oil and water absorbency of a range of materials commonly found in the domestic and clinical environments and to determine the effectiveness of a small, but representative selection of such materials in skin decontamination, using an established ex vivo model. Five contaminants were used in the study: methyl salicylate, parathion, diethyl malonate, phorate and potassium cyanide. In vitro measurements of water and oil absorbency did not correlate with ex vivo measurements of skin decontamination. When measured ex vivo, dry decontamination was consistently more effective than a standard wet decontamination method ("rinsewipe-rinse") for removing liquid contaminants. However, dry decontamination was ineffective against particulate contamination. Collectively, these data confirm that absorbent materials such as wound dressings and tissue paper provide an effective, generic capability for emergency removal of liquid contaminants from the skin surface, but that wet decontamination should be used for non-liquid contaminants.	[Kassouf, Nick; Syed, Sara; Larner, Joanne; Chilcott, Robert P.] Univ Hertfordshire, Sch Pharm, Res Ctr Top Drug Delivery & Toxicol, Hatfield, Herts, England; [Amlot, Richard] Publ Hlth England, Microbial Risk Assessment & Behav Sci, Emergency Response Dept, Hlth Protect Directorate, Salisbury, Wilts, England	University of Hertfordshire; Public Health England	Chilcott, RP (corresponding author), Univ Hertfordshire, Sch Pharm, Res Ctr Top Drug Delivery & Toxicol, Hatfield, Herts, England.	tox.publications@herts.ac.uk	Kassouf, Nick/AAB-9994-2019; Kassouf, Nick/GVR-7186-2022	Kassouf, Nick/0000-0003-0519-1929; Chilcott, Robert/0000-0002-8845-9400	Department of Health Policy Research Programme (EDICTAS) [047/0200]	Department of Health Policy Research Programme (EDICTAS)	This report is independent research commissioned and funded by the Department of Health Policy Research Programme (EDICTAS 047/0200). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. All technical aspects of this work and the preparation of the manuscript were performed without sponsor input. The sponsor reviewed the final manuscript as part of a formal security approval process at the instigation of the authors.	[Anonymous], 2013, INITIAL OPERATIONAL; Ballantyne B, 1988, FUND APPL TOXICOL, V26, P325; BUCKS DAW, 1989, TOXICOL APPL PHARM, V100, P417, DOI 10.1016/0041-008X(89)90290-1; Butler D, 2014, NATURE, V506, P139, DOI 10.1038/506139a; Chilcott R. P., 2007, CHEM WARFARE AGENTS, V2, P409; Chilcott RP, 2014, ENVIRON INT, V72, P37, DOI 10.1016/j.envint.2014.02.006; Chilcott RP, 2005, J PHARM SCI-US, V94, P632, DOI 10.1002/jps.20229; Chilcott RP, 2001, J APPL TOXICOL, V21, P279, DOI 10.1002/jat.755; Edwards Falicia L, 2005, Int J Environ Res Public Health, V2, P430, DOI 10.3390/ijerph2005030007; Filon FL, 2006, J OCCUP ENVIRON MED, V48, P692, DOI 10.1097/01.jom.0000214474.61563.1c; HEWITT PG, 1995, FUND APPL TOXICOL, V26, P91, DOI 10.1006/faat.1995.1078; Hui XY, 2012, FOOD CHEM TOXICOL, V50, P2496, DOI 10.1016/j.fct.2012.03.069; Jones D. S., 2012, THESIS; Loke WK, 1999, J APPL TOXICOL, V19, P285, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<285::AID-JAT580>3.0.CO;2-X; Matar H, 2014, TOXICOL IN VITRO, V28, P492, DOI 10.1016/j.tiv.2014.01.001; Matar H, 2012, THESIS; Matar H, 2016, CUTAN OCUL TOXICOL, V35, P137, DOI 10.3109/15569527.2015.1072544; Mircioiu C, 2013, TOXICOL LETT, V219, P99, DOI 10.1016/j.toxlet.2013.03.005; Misik J, 2012, TOXICOL MECH METHOD, V22, P520, DOI 10.3109/15376516.2012.686535; Moody RP, 2006, FOOD CHEM TOXICOL, V44, P1783, DOI 10.1016/j.fct.2006.05.020; Moody RP, 1997, TOXICOL IN VITRO, V11, P251, DOI 10.1016/S0887-2333(97)00013-1; REIFENRATH WG, 1984, J PHARM SCI, V73, P1388, DOI 10.1002/jps.2600731016; Riviere JE, 2001, J APPL TOXICOL, V21, P91, DOI 10.1002/jat.718; Rolland P, 2013, TOXICOL IN VITRO, V27, P358, DOI 10.1016/j.tiv.2012.08.014; Snider TH, 2016, J TOXICOL SCI, V41, P511, DOI 10.2131/jts.41.511; Vale JA, 2014, OXFORD DESK REFERENC, P31; van de Sandt JJM, 2004, REGUL TOXICOL PHARM, V39, P271, DOI 10.1016/j.yrtph.2004.02.004; WEBER LWD, 1992, ARCH ENVIRON HEALTH, V47, P302, DOI 10.1080/00039896.1992.9938366; WESTER RC, 1991, FUND APPL TOXICOL, V16, P725, DOI 10.1016/0272-0590(91)90158-Z; WESTER RC, 1990, J TOXICOL ENV HEALTH, V31, P235, DOI 10.1080/15287399009531453; WESTER RC, 1993, FUND APPL TOXICOL, V20, P336, DOI 10.1006/faat.1993.1043; Zhai H, 2008, FOOD CHEM TOXICOL, V46, P2258, DOI 10.1016/j.fct.2008.03.001	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170966	10.1371/journal.pone.0170966	http://dx.doi.org/10.1371/journal.pone.0170966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152053	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000396161200062
J	Lindberg, P; Netter, P; Koller, M; Steinger, B; Klinkhammer-Schalke, M				Lindberg, Patricia; Netter, Petra; Koller, Michael; Steinger, Brunhilde; Klinkhammer-Schalke, Monika			Breast cancer survivors' recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial	PLOS ONE			English	Article							EUROPEAN-ORGANIZATION; NEGATIVE AFFECT; RESPONSE SHIFT; MEMORY BIAS; HEALTH; PERSONALITY; DIAGNOSIS; ACCURACY; SYMPTOMS; IMPLICIT	Background The recollections of survivors of breast cancer are an important source of information about the disease for their family, friends, and newly diagnosed patients. So far, little is known about these memories. This study investigated how accurately survivors of breast cancer remember their past quality of life (QoL) during the disease and if this memory is modified by women's present QoL and negative affect. Material and methods The longitudinal population-based study included 133 survivors of breast cancer (response rate 80%). Participants were asked for their present QoL and to recall their baseline QoL (EORTC QLQ-C30, QLQ-BR23) that had been assessed about seven years ago before discharge from hospital. The dependent variable was recall bias in ten QoL dimensions. Present QoL and negative affect (PANAS) were investigated as predictor variables. Results Overall, baseline QoL was retrospectively underrated on seven out of ten scales whereas no significant overestimation was found. In multiple linear regression analyses, controlling for confounders, a stronger underrating of QoL was significantly predicted by a lower present QoL on nine out of ten scales and by higher negative affect on six scales. Conclusions Survivors of breast cancer tend to underestimate their past QoL during the disease when asked about seven years later. Lower present QoL and higher negative affect contribute to this recall bias. This needs to be considered when interpreting retrospectively reported QoL data. Results are discussed in relation to theory of change or stability and mood congruency theory.	[Lindberg, Patricia; Steinger, Brunhilde; Klinkhammer-Schalke, Monika] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr Regensburg, Regensburg, Germany; [Netter, Petra] Univ Giessen, Dept Psychol, Giessen, Germany; [Koller, Michael] Univ Hosp Regensburg, Ctr Clin Trials, Regensburg, Germany	University of Regensburg; Justus Liebig University Giessen; University of Regensburg	Lindberg, P (corresponding author), Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr Regensburg, Regensburg, Germany.	patricia.lindberg@ur.de			German Cancer Aid [109216]	German Cancer Aid(Deutsche Krebshilfe)	This work was funded by the German Cancer Aid, 109216. The funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adang EMM, 1998, TRANSPL INT, V11, P11, DOI 10.1007/s001470050095; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Baddeley A, 2010, MEMORY, P137; Bitzer EM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-23; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024; CONWAY M, 1984, J PERS SOC PSYCHOL, V47, P738, DOI 10.1037/0022-3514.47.4.738; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Dabakuyo TS, 2013, QUAL LIFE RES, V22, P1, DOI 10.1007/s11136-012-0135-5; Edwards PJ, 2009, COCHRANE DATABASE SY, P3; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fransson P, 2005, ACTA ONCOL, V44, P355, DOI 10.1080/02841860510029806; Gilbert DT, 2009, SCIENCE, V323, P1617, DOI 10.1126/science.1166632; Hartl K, 2010, PSYCHO-ONCOLOGY, V19, P160, DOI 10.1002/pon.1536; Hinz A, 2014, ACTA ONCOL, V53, P958, DOI 10.3109/0284186X.2013.879998; Hirsch JK, 2012, QUAL LIFE RES, V21, P187, DOI 10.1007/s11136-011-9933-4; HJERMSTAD MJ, 1995, J CLIN ONCOL, V13, P1249, DOI 10.1200/JCO.1995.13.5.1249; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Howlader N, 2014, SEER CANC STAT REV; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Klinkhammer-Schalke M, 2012, BRIT J CANCER, V106, P826, DOI 10.1038/bjc.2012.4; Koller M, 1996, CANCER, V77, P983, DOI 10.1002/(SICI)1097-0142(19960301)77:5<983::AID-CNCR27>3.0.CO;2-Z; Koller M, 1999, CANCER-AM CANCER SOC, V86, P1609, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1609::AID-CNCR32>3.0.CO;2-3; KOPEC JA, 1990, J EPIDEMIOL COMMUN H, V44, P179, DOI 10.1136/jech.44.3.179; Krohne HW, 1996, DIAGNOSTICA, V42, P139; LARSEN RJ, 1992, J PERS SOC PSYCHOL, V62, P480, DOI 10.1037/0022-3514.62.3.480; Lindberg P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1573-6; Litwin MS, 1999, J CLIN ONCOL, V17, P2882, DOI 10.1200/JCO.1999.17.9.2882; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-65; Nieuwkerk PT, 2007, MED CARE, V45, P199, DOI 10.1097/01.mlr.0000246613.49214.46; Rees J, 2003, BJU INT, V92, P703, DOI 10.1046/j.1464-410X.2003.04462.x; Robert Koch Institut und Gesellschaft der epide-miologischen Krebsregister in Deutschland e.V, 2013, KREBS DEUTSCHL 2009; ROSS M, 1981, J PERS SOC PSYCHOL, V40, P627, DOI 10.1037/0022-3514.40.4.627; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; RUIZCABALLERO JA, 1994, COGNITION EMOTION, V8, P555, DOI 10.1080/02699939408408959; Safer MA, 2002, EMOTION, V2, P162, DOI 10.1037//1528-3542.2.2.162; Snyder CF, 2015, QUAL LIFE RES, V24, P1207, DOI 10.1007/s11136-014-0853-y; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Walentynowicz M, 2015, HEALTH PSYCHOL, V34, P1166, DOI 10.1037/hea0000222; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171519	10.1371/journal.pone.0171519	http://dx.doi.org/10.1371/journal.pone.0171519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152108	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200153
J	Melchior, J; Wang, N; Wiskott, L				Melchior, Jan; Wang, Nan; Wiskott, Laurenz			Gaussian-binary restricted Boltzmann machines for modeling natural image statistics	PLOS ONE			English	Article								We present a theoretical analysis of Gaussian-binary restricted Boltzmann machines (GRBMs) from the perspective of density models. The key aspect of this analysis is to show that GRBMs can be formulated as a constrained mixture of Gaussians, which gives a much better insight into the model's capabilities and limitations. We further show that GRBMs are capable of learning meaningful features without using a regularization term and that the results are comparable to those of independent component analysis. This is illustrated for both a two-dimensional blind source separation task and for modeling natural image patches. Our findings exemplify that reported difficulties in training GRBMs are due to the failure of the training algorithm rather than the model itself. Based on our analysis we derive a better training setup and show empirically that it leads to faster and more robust training of GRBMs. Finally, we compare different sampling algorithms for training GRBMs and show that Contrastive Divergence performs better than training methods that use a persistent Markov chain.	[Melchior, Jan; Wang, Nan; Wiskott, Laurenz] Ruhr Univ Bochum, Inst Neuroinformat, D-44801 Bochum, Germany	Ruhr University Bochum	Melchior, J (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, D-44801 Bochum, Germany.	jan.melchior@ini.rub.de	Wiskott, Laurenz/P-7715-2017	Wiskott, Laurenz/0000-0001-6237-740X	International Graduate School of Neuroscience at the Ruhr-Universitat Bochum	International Graduate School of Neuroscience at the Ruhr-Universitat Bochum	Author Nan Wang was employed by Institut fur Neuroinformatik, Ruhr-Universitat at Bochum at the time of the study and is now employed by Zalando SE. Zalando SE provided no financial support for the study. Nan Wang was supported by a scholarship of the International Graduate School of Neuroscience at the Ruhr-Universitat Bochum. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bengio Y., 2011, P 14 INT C ART INT S, P233; Bengio Y, 2006, P 19 INT C NEUR INF, P153; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bishop C. M., 2006, PATTERN RECOGN, P359; Cho K.H., 2013, P INT JOINT C NEUR N, P1; Cho K, 2011, LECT NOTES COMPUT SC, V6791, P10, DOI 10.1007/978-3-642-21735-7_2; Desjardins G., 2010, P INT C ART INT STAT; Erhan D, 2010, J MACH LEARN RES, V11, P625; Fischer Asja, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P14, DOI 10.1007/978-3-642-33275-3_2; Fischer A, 2011, NEURAL COMPUT, V23, P664, DOI 10.1162/NECO_a_00085; Fischer A, 2010, LECT NOTES COMPUT SC, V6354, P208, DOI 10.1007/978-3-642-15825-4_26; Freund Y, 1992, ADV NEURAL INFORM PR, V4, P912; Glorot X., 2010, P 13 INT C ART INT S, VVolume 9, P249; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Koster U, 2010, NEURAL COMPUT, V22, P2308, DOI 10.1162/NECO_a_00010; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Laparra V, 2011, IEEE T NEURAL NETWOR, V22, P537, DOI 10.1109/TNN.2011.2106511; Le Roux N, 2011, NEURAL COMPUT, V23, P593, DOI 10.1162/NECO_a_00086; Lee H., 2009, P ANN INT C MACH LEA, P609; Lee H., 2007, P C NEUR INF PROC SY; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Melchior J., 2012, THESIS; Melchior J., 2016, J MACHINE L IN PRESS, V17; Nair Vinod, 2010, P 27 INT C INT C MAC, P807; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Ranzato M., 2010, P 13 INT C ART INT S, P621; Ranzato M, 2010, PROC CVPR IEEE, P2551, DOI 10.1109/CVPR.2010.5539962; Salakhutdinov R., 2009, ARTIF INTELL, P1; Schulz H., 2010, NIPS 2010 WORKSHOP D, V1, P6; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194; Theis L, 2011, J MACH LEARN RES, V12, P3071; Tieleman T., 2008, P 25 INT C MACHINE L, P1064, DOI DOI 10.1145/1390156.1390290; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wang N, 2012, EUR S ART NEUR NETW, P287; Wang N, 2016, THESIS; Wang N., 2014, CORR; Welling M., 2004, ADV NEURAL INFORM PR, V17, P1481; Zetzsche C, 2001, NETWORK-COMP NEURAL, V12, P331, DOI 10.1088/0954-898X/12/3/306	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171015	10.1371/journal.pone.0171015	http://dx.doi.org/10.1371/journal.pone.0171015			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152552	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200072
J	Nagel, S; Pommerenke, C; Scherr, M; Meyer, C; Kaufmann, M; Battmer, K; MacLeod, RAF; Drexler, HG				Nagel, Stefan; Pommerenke, Claudia; Scherr, Michaela; Meyer, Corinna; Kaufmann, Maren; Battmer, Karin; MacLeod, Roderick A. F.; Drexler, Hans G.			NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HOX CODE; PROGENITOR CELLS; B-CELL; EXPRESSION; ACTIVATION; BINDING; NKX2-3; MOUSE; HEX	T-cell acute lymphoblastic leukemia (T-ALL) cells represent developmentally arrested T-cell progenitors, subsets of which aberrantly express homeobox genes of the NKL subclass, including TLX1, TLX3, NKX2-1, NKX2-5, NKX3-1 and MSX1. Here, we analyzed the transcriptional landscape of all 48 members of the NKL homeobox gene subclass in CD34+ hematopoietic stem and progenitor cells (HSPCs) and during lymphopoiesis, identifying activities of nine particular genes. Four of these were expressed in HSPCs (HHEX, HLX1, NKX2-3 and NKX3-1) and three in common lymphoid progenitors (HHEX, HLX1 and MSX1). Interestingly, our data indicated downregulation of NKL homeobox gene transcripts in late progenitors and mature T-cells, a phenomenon which might explain the oncogenic impact of this group of genes in T-ALL. Using MSX1-expressing T-ALL cell lines as models, we showed that HHEX activates while HLX1, NKX2-3 and NKX3-1 repress MSX1 transcription, demonstrating the mutual regulation and differential activities of these homeobox genes. Analysis of a public T-ALL expression profiling data set comprising 117 patient samples identified 20 aberrantly activated members of the NKL subclass, extending the number of known NKL homeobox oncogene candidates. While 7/20 genes were also active during hematopoiesis, the remaining 13 showed ectopic expression. Finally, comparative analyses of T-ALL patient and cell line profiling data of NKL-positive and NKL-negative samples indicated absence of shared target genes but instead highlighted deregulation of apoptosis as common oncogenic effect. Taken together, we present a comprehensive survey of NKL homeobox genes in early hematopoiesis, T-cell development and T-ALL, showing that these genes generate an NKL-code for the diverse stages of lymphoid development which might be fundamental for regular differentiation.	[Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; Kaufmann, Maren; MacLeod, Roderick A. F.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Scherr, Michaela; Battmer, Karin] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Hannover Medical School	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; BEDFORD FK, 1993, NUCLEIC ACIDS RES, V21, P1245, DOI 10.1093/nar/21.5.1245; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Drexler HG, 2010, GUIDE TO LEUKEMIA LY; Du XL, 2006, GENOMICS, V87, P693, DOI 10.1016/j.ygeno.2006.02.003; Eklund EA, 2006, CURR OPIN HEMATOL, V13, P67, DOI 10.1097/01.moh.0000208467.63861.d6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; George A, 2003, ONCOGENE, V22, P6764, DOI 10.1038/sj.onc.1206822; Hager-Theodorides AL, 2002, J IMMUNOL, P169; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; He H, 2011, ONCOGENE, V30, P379, DOI 10.1038/onc.2010.484; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hsu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138782; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; John G, 2011, MOL GENET METAB, V104, P174, DOI 10.1016/j.ymgme.2011.06.023; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Mack DL, 2002, IMMUNOLOGY, V107, P444, DOI 10.1046/j.1365-2567.2002.01523.x; MacLeod RAF, 2003, GENE CHROMOSOME CANC, V37, P84, DOI 10.1002/gcc.10194; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2016, ONCOTARGET, V7, P45398, DOI 10.18632/oncotarget.9982; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Nagel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040747; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Pabst O, 1999, DEVELOPMENT, V126, P2215; Reecy JM, 1997, DEV BIOL, V188, P295, DOI 10.1006/dbio.1997.8641; Rice KL, 2008, LEUKEMIA RES, V32, P873, DOI 10.1016/j.leukres.2007.11.001; Riz I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-181; Riz I, 2009, BIOCHEM BIOPH RES CO, V380, P361, DOI 10.1016/j.bbrc.2009.01.099; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Rothenberg EV, 2016, IMMUNOL REV, V271, P72, DOI 10.1111/imr.12417; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Steadman DJ, 2000, NUCLEIC ACIDS RES, V28, P2389, DOI 10.1093/nar/28.12.2389; Taghon T, 2003, LEUKEMIA, V17, P1157, DOI 10.1038/sj.leu.2402947; Wang RQ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/632837; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020454; Yu W, 2010, DIGEST DIS SCI, V55, P3171, DOI 10.1007/s10620-010-1138-0; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	63	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171164	10.1371/journal.pone.0171164	http://dx.doi.org/10.1371/journal.pone.0171164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151996	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200097
J	Rehm, J; Germann, T; Akbar, M; Pepke, W; Kauczor, HU; Weber, MA; Spira, D				Rehm, Johannes; Germann, Thomas; Akbar, Michael; Pepke, Wojciech; Kauczor, Hans-Ulrich; Weber, Marc-Andre; Spira, Daniel			3D-modeling of the spine using EOS imaging system: Inter-reader reproducibility and reliability	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; RADIATION	Objectives To retrospectively assess the interreader reproducibility and reliability of EOS 3D full spine reconstructions in patients with adolescent idiopathic scoliosis (AIS). Methods 73 patients with mean age of 17 years and a moderate AIS (median Cobb Angle 18.2) obtained low-dose standing biplanar radiographs with EOS. Two independent readers performed "full spine" 3D reconstructions of the spine with the "full-spine" method adjusting the bone contour of every thoracic and lumbar vertebra (Th1-L5). Interreader reproducibility was assessed regarding rotation of every single vertebra in the coronal (i.e. frontal), sagittal (i.e. lateral), and axial plane, T1/T12 kyphosis, T4/T12 kyphosis, L1/L5 lordosis, L1/S1 lordosis and pelvic parameters. Radiation exposure, scan-time and 3D reconstruction time were recorded. Results Interclass correlation (ICC) ranged between 0.83 and 0.98 for frontal vertebral rotation, between 0.94 and 0.99 for lateral vertebral rotation and between 0.51 and 0.88 for axial vertebral rotation. ICC was 0.92 for T1/T12 kyphosis, 0.95 for T4/T12 kyphosis, 0.90 for L1/L5 lordosis, 0.85 for L1/S1 lordosis, 0.97 for pelvic incidence, 0.96 for sacral slope, 0.98 for sagittal pelvic tilt and 0.94 for lateral pelvic tilt. The mean time for reconstruction was 14.9 minutes (reader 1: 14.6 minutes, reader 2: 15.2 minutes, p<0.0001). The mean total absorbed dose was 593.4pGy +/- 212.3 per patient. Conclusion EOS "full spine" 3D angle measurement of vertebral rotation proved to be reliable and was performed in an acceptable reconstruction time. Interreader reproducibility of axial rotation was limited to some degree in the upper and middle thoracic spine due the obtuse angulation of the pedicles and the processi spinosi in the frontal view somewhat complicating their delineation.	[Rehm, Johannes; Germann, Thomas; Kauczor, Hans-Ulrich; Weber, Marc-Andre; Spira, Daniel] Univ Hosp, Diagnost & Intervent Radiol, Heidelberg, Germany; [Akbar, Michael; Pepke, Wojciech] Univ Hosp, Clin Orthoped & Trauma Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rehm, J (corresponding author), Univ Hosp, Diagnost & Intervent Radiol, Heidelberg, Germany.	johannes.rehm@med.uni-heidelberg.de	Weber, Marc/GXA-0612-2022; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021		company EOS Imaging France	company EOS Imaging France	The department of Diagnostic and Interventional Radiology of University Hospital Heidelberg has received research funds from the company EOS Imaging France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Kasim K, 2009, EUR RADIOL, V19, P610, DOI 10.1007/s00330-008-1178-4; Al-Aubaidi Z, 2013, J PEDIATR ORTHOP B, V22, P409, DOI 10.1097/BPB.0b013e328361ae5b; Bone CM, 2000, J PEDIATR ORTHOPED, V20, P251, DOI 10.1097/00004694-200003000-00023; Charpark G., 1981, RECHERCHE, V128, P1384; Deschenes S, 2010, SPINE, V35, P989, DOI 10.1097/BRS.0b013e3181bdcaa4; Dubousset J, 2005, B ACAD NAT MED PARIS, V189, P287, DOI 10.1016/S0001-4079(19)33584-8; Dubousset J., 1992, INT S 3D SCOL DEF JO, P302; Dumas R, 2004, MED ENG PHYS, V26, P415, DOI 10.1016/j.medengphy.2004.02.004; Gangnet N, 2006, SPINE, V31, pE507, DOI 10.1097/01.brs.0000224533.19359.89; Gille O, 2007, SPINE, V32, P568, DOI 10.1097/01.brs.0000256866.25747.b3; Harrison DE, 2001, SPINE, V26, P235, DOI DOI 10.1097/00007632-200106010-00003; Humbert L, 2009, MED ENG PHYS, V31, P681, DOI 10.1016/j.medengphy.2009.01.003; Ilharreborde B, 2014, EUR SPINE J S4, pS397; Ilharreborde B, 2016, EUR SPINE J, V25, P526, DOI 10.1007/s00586-015-3960-8; Ilharreborde B, 2011, SPINE, V36, pE1306, DOI 10.1097/BRS.0b013e3182293548; Kloth JK, 2012, ROFO FORTSCHR RONTG, V185-1, P48; PERDRIOLLE R, 1987, ORTHOPEDICS, V10, P909; Presciutti SM, 2014, SPINE J, V14, P1984, DOI 10.1016/j.spinee.2013.11.055; Richards PJ, 2010, SPINE, V35, P430, DOI 10.1097/BRS.0b013e3181cdde47; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4	21	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171258	10.1371/journal.pone.0171258	http://dx.doi.org/10.1371/journal.pone.0171258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152019	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200117
J	Takase, Y; Usui, K; Shimizu, K; Kimura, Y; Ichihara, T; Ohkawa, T; Atsumi, J; Enokida, Y; Nakazawa, S; Obayashi, K; Ohtaki, Y; Nagashima, T; Mitani, Y; Takeyoshi, I				Takase, Yoshiaki; Usui, Kengo; Shimizu, Kimihiro; Kimura, Yasumasa; Ichihara, Tatsuo; Ohkawa, Takahiro; Atsumi, Jun; Enokida, Yasuaki; Nakazawa, Seshiru; Obayashi, Kai; Ohtaki, Yoichi; Nagashima, Toshiteru; Mitani, Yasumasa; Takeyoshi, Izumi			Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; GENE-MUTATIONS; ADENOCARCINOMAS; AMPLIFICATION	Somatic mutation in human epidermal growth factor receptor-related 2 gene (HER2) is one of the driver mutations in lung cancer. HER2 mutations are found in about 2% of lung adenocarcinomas (ADCs). Previous reports have been based mainly on diagnostic screening by Sanger sequencing or next-generation sequencing (NGS); however, these methods are time-consuming and complicated. We developed a rapid, simple, sensitive mutation detection assay for detecting HER2 12 base pair-duplicated insertion mutation based on the Eprobe-mediated PCR method (Eprobe-PCR) and validated the sensitivity of this assay system for clinical diagnostics. We examined 635 tumor samples and analyzed HER2 mutations using the EprobePCR method, NGS, and Sanger sequencing. In a serial dilution study, the Eprobe-PCR was able to detect mutant plasmid DNA when its concentration was reduced to 0.1% by mixing with wild-type DNA. We also confirmed amplification of the mutated plasmid DNA with only 10 copies per reaction. In ADCs, Eprobe-PCR detected the HER2 mutation in 2.02% (9/446), while Sanger sequencing detected it in 1.57% (7/446). Eprobe-PCR was able to detect the mutation in two samples that were undetectable by Sanger sequencing. All non-ADC samples were wild-type. There were no discrepancies between frozen and formalin-fixed paraffin-embedded tissues in the nine samples. HER2 mutations detected by NGS data validated the high sensitivity of the method. Therefore, this new technique can lead to precise molecular-targeted therapies.	[Takase, Yoshiaki; Shimizu, Kimihiro; Atsumi, Jun; Enokida, Yasuaki; Nakazawa, Seshiru; Obayashi, Kai; Ohtaki, Yoichi; Nagashima, Toshiteru; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gunma, Japan; [Usui, Kengo; Kimura, Yasumasa; Ohkawa, Takahiro] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Kimura, Yasumasa; Ichihara, Tatsuo; Mitani, Yasumasa] KK DNAFORM, Yokohama, Kanagawa, Japan; [Kimura, Yasumasa] Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, Tokyo, Japan	Gunma University; RIKEN; University of Tokyo	Usui, K (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	kengo.usui@riken.jp	Nakazawa, Seshiru/GLT-1855-2022; Takase, Yoshiaki/M-9908-2014	Takase, Yoshiaki/0000-0002-5159-4174	METI (Ministry of Economy, Trade and Industry, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); DNAFORM	METI (Ministry of Economy, Trade and Industry, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); DNAFORM	This work was supported by the subsidy of expenses by METI (Ministry of Economy, Trade and Industry, Japan) for measures for small business support to YM, and by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies to PC. K.K. DNAFORM provided support in the form of salaries for authors (Tatsuo Ichihara [TI], Yasumasa Mitani [YM]], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; De Greve J, 2015, LUNG CANCER, V88, P63, DOI 10.1016/j.lungcan.2015.01.013; Gandhi L, 2014, J CLIN ONCOL, V32, P68, DOI 10.1200/JCO.2012.47.2787; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Mazieres J, 2015, ANN ONCOL; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ricciardi GRR, 2014, J THORAC ONCOL, V9, P1750, DOI 10.1097/JTO.0000000000000379; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Yoshizawa A, 2014, LUNG CANCER, V85, P373, DOI 10.1016/j.lungcan.2014.06.007	20	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171225	10.1371/journal.pone.0171225	http://dx.doi.org/10.1371/journal.pone.0171225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152008	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200108
J	Xu, FF; Wang, KY; Wang, N; Li, GQ; Liu, DH				Xu, Fangfang; Wang, Kevin Yueju; Wang, Nan; Li, Gangqiang; Liu, Dehu			Bioactivity of a modified human Glucagon-like peptide-1	PLOS ONE			English	Article							IN-VIVO; EXPRESSION; GLUCOSE; DEGRADATION; PROTEIN	Diabetes has become the third largest cause of death in humans worldwide. Therefore, effective treatment for this disease remains a critical issue. Glucagon-like peptide-1 (GLP-1) plays an important role in glucose homeostasis, and therefore represents a promising candidate to use for the treatment of diabetes. Native GLP-1, however, is quickly degraded in in the circulatory system; which limits its clinical application. In the present study, a chemically-synthesized, modified analogue of human GLP-1 (mGLP-1) was designed. Our analyses indicated that, relative to native GLP-1, mGLP-1 is more resistant to trypsin and pancreatin degradation. mGLP-1 promotes mouse pancreatic beta-cell proliferation by up-regulating the expression level of cyclin E, CDK2, Bcl-2 and down-regulating Bax, p21, and stimulates insulin secretion. An oral glucose tolerance test indicated that mGLP-1 significantly improved glucose tolerance in mice. Intraperitoneal injections of mGLP-1 into streptozotocin (STZ)-induced type 2 diabetic mice significantly reduced blood sugar levels and stimulated insulin secretion. Oral gavages of mGLP-1 in diabetic mice did not result in significant hypoglycemic activity.	[Xu, Fangfang; Wang, Nan; Li, Gangqiang; Liu, Dehu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Kevin Yueju] Northeastern State Univ, Dept Nat Sci, Broken Arrow, OK USA	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Liu, DH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	liudehu2006@126.com			National Biotechnology Development Plan [2016ZX08005-004]; Researcher Foundation of the Chinese Academy of Agricultural Sciences	National Biotechnology Development Plan; Researcher Foundation of the Chinese Academy of Agricultural Sciences	This work was supported by the National Biotechnology Development Plan (2016ZX08005-004), and the Researcher Foundation of the Chinese Academy of Agricultural Sciences.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Brandsma M., 2009, Open Biotechnology Journal, V3, P57, DOI 10.2174/1874070700903010057; Bulotta A, 2004, CELL BIOCHEM BIOPHYS, P65, DOI 10.1385/CBB:40:3S:065; Cho YM, 2014, ANNU REV PHYSIOL, V76, P535, DOI 10.1146/annurev-physiol-021113-170315; DALY MM, 1951, J GEN PHYSIOL, V34, P439, DOI 10.1085/jgp.34.4.439; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; GIBALDI M, 1971, J PHARM SCI, V60, P1338, DOI 10.1002/jps.2600600909; Green BD, 2005, DIABETES OBES METAB, V7, P563, DOI 10.1111/j.1463-1326.2004.00430.x; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jomori T, 2008, JOMORI T; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knudsen LB, 1996, EUR J PHARMACOL, V318, P429, DOI 10.1016/S0014-2999(96)00795-9; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kong YL, 2016, ENZYME MICROB TECH, V82, P105, DOI 10.1016/j.enzmictec.2015.09.001; KREYMANN B, 1987, LANCET, V2, P1300; LeRoith D, 2002, AM J MED, V113, p3S; Ma BC, 2013, CURR PHARM BIOTECHNO, V14, P985; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perfetti R, 2000, EUR J ENDOCRINOL, V143, P717, DOI 10.1530/eje.0.1430717; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scheen AJ, 2003, ACTA CLIN BELG, V58, P335, DOI 10.1179/acb.2003.58.6.001; Tozaki H, 1998, J PHARM PHARMACOL, V50, P913, DOI 10.1111/j.2042-7158.1998.tb04008.x; Tu PP, 2015, CURR PHARM BIOTECHNO, V16, P564, DOI 10.2174/138920101606150407114815; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171601	10.1371/journal.pone.0171601	http://dx.doi.org/10.1371/journal.pone.0171601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152036	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200157
J	Mahajan, N; Wu, HJ; Bennett, RL; Troche, C; Licht, JD; Weber, JD; Maggi, LB; Tomasson, MH				Mahajan, Nitin; Wu, Hua-Jun; Bennett, Richard L.; Troche, Catalina; Licht, Jonathan D.; Weber, Jason D.; Maggi, Leonard B., Jr.; Tomasson, Michael H.			Sabotaging of the oxidative stress response by an oncogenic noncoding RNA	FASEB JOURNAL			English	Article						ACA11; multiple myeloma; NRF2; ROS; snoRNA	MULTIPLE-MYELOMA; GENE-EXPRESSION; TRANSLOCATION; MMSET; FGFR3	Overexpression of the multiple myeloma set domain (MMSET) Wolf-Hirschhorn syndrome candidate 1 gene, which contains an orphan box H/ACA class small nucleolar RNA, ACA11, in an intron, is associated with several cancer types, including multiple myeloma (MM). ACA11 and MMSET are overexpressed cotranscriptionally as a result of the t(4; 14) chromosomal translocation in a subset of patients with MM. RNA sequencing of CD138(+) tumor cells from t(4; 14)-positive and -negativeMMpatient bone marrow samples revealed an enhanced oxidative phosphorylation mRNA signature. Supporting these data, ACA11 overexpression in a t(4; 14)-negative MM cell line, MM1. S, demonstrated enhanced reactive oxygen species (ROS) levels. In addition, an enhancement of cell proliferation, increased soft agar colony size, and elevated ERK1/2 phosphorylation were observed. This ACA11-driven hyperproliferative phenotype depended on increased ROS levels as exogenously added antioxidants attenuate the increased proliferation. A major transcriptional regulator of the cellular antioxidant response, nuclear factor (erythroid-derived 2)-like 2 (NRF2), shuttled to the nucleus, as expected, in response to ACA11-driven increases in ROS; however, transcriptional up-regulation of some of NRF2's antioxidant target genes was abrogated in the presence of ACA11 overexpression. These data show for the first time that ACA11 promotes proliferation through inhibition of NRF2 function resulting in sustained ROS levels driving cancer cell proliferation.-Mahajan, N., Wu, H.-J., Bennett, R. L., Troche, C., Licht, J. D., Weber, J. D., Maggi, L. B., Jr., Tomasson, M. H. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA.	[Mahajan, Nitin; Weber, Jason D.; Maggi, Leonard B., Jr.; Tomasson, Michael H.] Washington Univ, Siteman Canc Ctr, Sch Med, Dept Med,Div Oncol, Box 8069,660 South Euclid Ave, St Louis, MO 63110 USA; [Wu, Hua-Jun] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Bennett, Richard L.; Troche, Catalina; Licht, Jonathan D.] Univ Florida, Coll Med, Univ Florida Hlth Canc Ctr, Dept Med,Div Hematol & Oncol, Gainesville, FL USA	Siteman Cancer Center; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of Florida	Maggi, LB; Tomasson, MH (corresponding author), Washington Univ, Siteman Canc Ctr, Sch Med, Dept Med,Div Oncol, Box 8069,660 South Euclid Ave, St Louis, MO 63110 USA.	lmaggi@dom.wustl.edu; tomasson@dom.wustl.edu	Maggi, Leonard/L-5217-2019; Bennett, Richard/ABF-9211-2021; Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Maggi, Leonard/0000-0003-0138-0984; Licht, Jonathan/0000-0002-3942-1369; Weber, Jason/0000-0002-1069-6983; Tomasson, Michael/0000-0003-4518-7123; Bennett, Richard/0000-0002-0243-2443	U.S. National Institutes of Health, National Cancer Institute [R01-CA174743, R01-CA-175349]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA175349, P30CA086862, R01CA174743] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the U.S. National Institutes of Health, National Cancer Institute (Grants R01-CA174743 to M.H.T. and L.B.M., and R01-CA-175349 to M.H.T.). The authors thank M. Bates (University of Iowa, Iowa City, IA, USA) for her critical review. The authors also thank all the members of the M.H.T. laboratory for discussion and suggestions, and the Genome Technology Access Center (Department of Genetics, Washington University School of Medicine) for help with genomic analysis.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Bratkovic T, 2014, BBA-GENE REGUL MECH, V1839, P438, DOI 10.1016/j.bbagrm.2014.04.009; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Desbarats L, 1996, EXPERIENTIA, V52, P1123, DOI 10.1007/BF01952111; Forys JT, 2014, CELL REP, V7, P514, DOI 10.1016/j.celrep.2014.03.026; HALPRIN KM, 1967, J INVEST DERMATOL, V48, P149, DOI 10.1038/jid.1967.24; He ZW, 2016, EXP HEMATOL, V44, P161, DOI 10.1016/j.exphem.2015.11.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan N, 2013, J BIOL CHEM, V288, P11611, DOI 10.1074/jbc.M112.410852; Makarova JA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P638, DOI 10.1134/S0006297913060096; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Nerini-Molteni S, 2008, BRIT J HAEMATOL, V141, P494, DOI 10.1111/j.1365-2141.2008.07066.x; Santra M, 2003, BLOOD, V101, P2374, DOI 10.1182/blood-2002-09-2801; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sharma A, 2009, LEUKEMIA LYMPHOMA, V50, P809, DOI 10.1080/10428190902802323; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Su H, 2014, ONCOGENE, V33, P1348, DOI 10.1038/onc.2013.89; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195	31	5	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					482	490		10.1096/fj.201600654R	http://dx.doi.org/10.1096/fj.201600654R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148777	Green Published			2022-12-26	WOS:000394235400005
J	Traykova, D; Schneider, B; Chojkier, M; Buck, M				Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina			Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients	PLOS ONE			English	Article							NITRIC-OXIDE; BACTERIAL-DNA; PORTAL-HYPERTENSION; SEPTIC SHOCK; LIVER-INJURY; MICE; IMMUNE; DYSFUNCTION; ASCITES	Background Recently, a complex microbiome was comprehensibly characterized in the serum and ascitic fluid of cirrhotic patients. In the current study, we investigated for the first time the induction of inflammatory pathways and Nitric Oxide, as well as the systemic hemodynamics in conjunction with the blood microbiome in a Child-Pugh class B cirrhotic cohort. Methods and Findings We used the Intestinal Infections Microbial DNA qPCR Array to screen for 53 bacterial DNA from the gut in the blood. Assays were designed using the 16S rRNA gene as a target, and PCR amplification primers (based on the Human Microbiome Project) and hydrolysis-probe detection. Eighteen systemic hemodynamic parameters were measured non-invasively by impedance cardiography using the BioZ ICG monitor. The inflammatory response was assessed by measuring blood cytokines, Nitric Oxide RNA arrays, and Nitric Oxide. In the blood of this cirrhotic cohort, we detected 19 of 53 bacterial species tested. The number of bacterial species was markedly increased in the blood of cirrhotic patients compared to control individuals (0.2+/-0.4 vs 3.1+/-2.3; 95% CI: 1.3 to 4.9; P = 0.0030). The total bacterial DNA was also increased in the blood of cirrhotic subjects compared to control subjects (0.2+/-1.1 vs 41.8+/-132.1; 95% CI: 6.0 to 77.2; P = 0.0022). In the cirrhotic cohort, the Cardiac Output increased by 37% and the Systemic Vascular Resistance decreased by 40% (P< 0.00001 for both compared to control subjects). Systemic Vascular Resistance was inversely correlated to blood bacterial DNA quantity (- 0.621; 95% CI - 0.843 to - 0.218; P = 0.0060), blood bacterial species number (- 0.593; 95% CI - 0.83 to - 0.175; P = 0.0095; logistic regression: Chi Square = 5.8877; P = 0.0152), and serum Nitric Oxide (- 0.705; 95% CI - 0.881 to - 0.355; P = 0.0011). Many members of the Nitric Oxide signaling pathway gene family were increased in cirrhotic subjects. Conclusions Our study identified blood bacterial DNA in similar to 90% of the cirrhotic patients without clinical evidences of infection, and suggests that the quantity of bacterial DNA in blood may stimulate signaling pathways, including Nitric Oxide, that could decrease systemic vascular resistance and increase cardiac output.	[Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Chojkier, Mario; Buck, Martina] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Chojkier, Mario] Univ Calif San Diego, Clin Translat Res Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Buck, M (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Buck, M (corresponding author), Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA.	buckmartina@gmail.com			University of California, San Diego, Department of Medicine; United States Department of Veterans Affairs Merit Review Award; United States National Institutes of Health (NIH) [1R41HL122022, 1R41HL127919, DK-87031, DK-46071, DK-84139]	University of California, San Diego, Department of Medicine; United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the University of California, San Diego, Department of Medicine; the United States Department of Veterans Affairs Merit Review Award (MC); and grants from United States National Institutes of Health (NIH): 1R41HL122022, 1R41HL127919, DK-87031 (MB/MC), DK-46071 (MC), DK-84139 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Bellot P, 2010, HEPATOLOGY, V52, P2044, DOI 10.1002/hep.23918; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; BOMZON A, 1994, HEPATOLOGY, V20, P1343, DOI 10.1002/hep.1840200535; Bosch J, 2008, SEMIN LIVER DIS, V28, P3, DOI 10.1055/s-2008-1040318; Buck M, 2016, SCI REPORTS; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Bunnell E, 2000, CRIT CARE MED, V28, P2713, DOI 10.1097/00003246-200008000-00005; CHOJKIER M, 1985, GASTROENTEROLOGY, V88, P115, DOI 10.1016/S0016-5085(85)80142-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Frances R, 2005, EUR J GASTROEN HEPAT, V17, P45, DOI 10.1097/00042737-200501000-00010; Frances R, 2008, HEPATOLOGY, V47, P978, DOI 10.1002/hep.22083; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; NATHAN C, 1994, J BIOL CHEM, V269, P13725; NAVA E, 1991, LANCET, V338, P1555, DOI 10.1016/0140-6736(91)92375-C; Ouyang X, 2013, NATURE COMMUNICATION; Paisse S., 2016, TRANSFUSION; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; PETROS A, 1991, LANCET, V338, P1557, DOI 10.1016/0140-6736(91)92376-D; Santiago A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25001; Szabo G, 2015, NATURE REV GASTROENT, P387; Tang WHW, 2009, AM HEART J, V157, P402, DOI 10.1016/j.ahj.2008.10.016; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Villanueva C, 2016, HEPATOLOGY, V63, P197, DOI 10.1002/hep.28264; WHITTLE BJR, 1992, HEPATOLOGY, V16, P1089, DOI 10.1002/hep.1840160437; Wiest R, 2012, J HEPATOL, V60, P197	32	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169310	10.1371/journal.pone.0169310	http://dx.doi.org/10.1371/journal.pone.0169310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146577	gold, Green Submitted, Green Published			2022-12-26	WOS:000396131700005
J	Lee, EJ; Kim, TW; Lee, KM; Lee, SH; Kim, H				Lee, Eun Ji; Kim, Tae-Woo; Lee, Kyoung Min; Lee, Seung Hyen; Kim, Hyunjoong			Factors Associated with the Retinal Nerve Fiber Layer Loss after Acute Primary Angle Closure: A Prospective EDI-OCT Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE ELEVATION; LAMINA-CRIBROSA DISPLACEMENT; CLEAR LENS EXTRACTION; VISUAL-FIELD; LONGITUDINAL CHANGES; AXONAL-TRANSPORT; ASIAN POPULATION; ANTERIOR-CHAMBER; GLAUCOMA	Purpose To determine the factors associated with retinal nerve fiber layer (RNFL) loss in eyes with acute primary angle-closure (APAC), particularly focusing on the influence of the change in the anterior lamina cribrosa surface depth (LCD). Methods After the initial presentation, 30 eyes with unilateral APAC were followed up at the following specific time points over a 12-month period: 1 week, 1-2 months, 2-3 months, 5-6 months, and 11-12 months. These follow-ups involved intraocular pressure measurements, enhanced depth-imaging spectral-domain optical coherence tomography (SD-OCT) scanning of the optic disc, and measurements of the circumpapillary RNFL thickness. The prelaminar tissue thickness (PLT) and LCD were determined in the SD-OCT images obtained at each follow-up visit. Results Repeated measures analysis of variance revealed a significant pattern of decrease in the global RNFL thickness, PLT, and LCD (all p<0.001). The global RNFL thickness decreased continuously throughout the follow-up period, while the PLT decreased until 5-6 months and did not change thereafter. The LCD reduced until 2-3 months and then also remained steady. Multivariable regression analysis revealed that symptoms with a longer duration before receiving laser peripheral iridotomy (LI) (p = 0.049) and a larger LCD reduction (p = 0.034) were significant factors associated with the conversion to an abnormal RNFL thickness defined using OCT normative data. Conclusion Early short-term decreases in the PLT and LCD and overall long-term decrease in the peripapillary RNFL were observed during a 12-month follow-up after an APAC episode. A longer duration of symptoms before receiving LI treatment and larger LCD reduction during follow-up were associated with the progressive RNFL loss. The LCD reduction may indicate a prior presence of significant pressure-induced stress that had been imposed on the optic nerve head at the time of APAC episode. Glaucomatous progression should be suspected in eyes showing LCD reduction after the APAC remission.	[Lee, Eun Ji; Kim, Tae-Woo; Lee, Kyoung Min; Lee, Seung Hyen] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Seoul, South Korea; [Kim, Hyunjoong] Yonsei Univ, Dept Appl Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Yonsei University	Lee, EJ (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Seoul, South Korea.	opticdisc@gmail.com		Lee, Seung Hyen/0000-0003-2189-2821; Kim, Tae-Woo/0000-0002-5180-0978	Cheil-Nammyung Foundation Research Fund	Cheil-Nammyung Foundation Research Fund	This study was supported by the 2014 Cheil-Nammyung Foundation Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; Aung T, 2004, OPHTHALMOLOGY, V111, P1464, DOI 10.1016/j.ophtha.2003.12.061; Aung T, 2004, OPHTHALMOLOGY, V111, P1475, DOI 10.1016/j.ophtha.2003.12.055; Aung T, 2001, ACTA OPHTHALMOL SCAN, V79, P298, DOI 10.1034/j.1600-0420.2001.790318.x; Bellezza AJ, 2003, BRIT J OPHTHALMOL, V87, P1284, DOI 10.1136/bjo.87.10.1284; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chen YJ, 2012, J OCUL PHARMACOL TH, V28, P529, DOI 10.1089/jop.2012.0006; Chew SSL, 2011, OPHTHALMOLOGY, V118, P254, DOI 10.1016/j.ophtha.2010.06.026; Dada T, 2015, J CATARACT REFR SURG, V41, P1470, DOI 10.1016/j.jcrs.2014.10.029; Fang AW, 2007, J GLAUCOMA, V16, P178, DOI 10.1097/IJG.0b013e31802d6dd8; Faridi OS, 2014, OPHTHALMOLOGY, V121, P1524, DOI 10.1016/j.ophtha.2014.02.017; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jiang R, 2015, OPHTHALMOLOGY, V122, P730, DOI 10.1016/j.ophtha.2014.11.008; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037499; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Lee EJ, 2015, OPHTHALMOLOGY; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2013, INVEST OPHTH VIS SCI, V54, P5392, DOI 10.1167/iovs.13-12205; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Lee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114935; Lee SH, 2015, JAMA OPHTHALMOL; Liu X, 2010, INT J OPHTHALMOL-CHI, V3, P152, DOI 10.3980/j.issn.2222-3959.2010.02.14; Man XF, 2015, GRAEF ARCH CLIN EXP, V253, P773, DOI 10.1007/s00417-015-2936-z; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P233, DOI 10.1167/iovs.12-10329; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2015, INVEST OPHTH VIS SCI, V56, P2059, DOI 10.1167/iovs.14-15540; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; QUIGLEY HA, 1979, ARCH OPHTHALMOL-CHIC, V97, P525, DOI 10.1001/archopht.1979.01020010269018; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Shen SY, 2006, OPHTHALMOLOGY, V113, P924, DOI 10.1016/j.ophtha.2006.01.070; Sng CCA, 2011, EYE, V25, P619, DOI 10.1038/eye.2011.31; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sullivan-Mee M, 2015, AM J OPHTHALMOL, V160, P637, DOI 10.1016/j.ajo.2015.06.024; Tan AM, 2009, CLIN EXP OPHTHALMOL, V37, P467, DOI 10.1111/j.1442-9071.2009.02060.x; Thomas R, 2003, ACTA OPHTHALMOL SCAN, V81, P480, DOI 10.1034/j.1600-0420.2003.00135.x; Tojo N, 2014, GRAEF ARCH CLIN EXP, V252, P1463, DOI 10.1007/s00417-014-2666-7; Tsai JC, 2006, AM J OPHTHALMOL, V141, P970, DOI 10.1016/j.ajo.2005.12.020; Tsai JC, 2007, INVEST OPHTH VIS SCI, V48, P1659, DOI 10.1167/iovs.06-0950; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0168678	10.1371/journal.pone.0168678	http://dx.doi.org/10.1371/journal.pone.0168678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141872	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129500003
J	Haegler, P; Grunig, D; Berger, B; Terracciano, L; Krahenbuhl, S; Bouitbir, J				Haegler, Patrizia; Grunig, David; Berger, Benjamin; Terracciano, Luigi; Krahenbuhl, Stephan; Bouitbir, Jamal			Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in Mice	PLOS ONE			English	Article							METHYLMALONYL-COA MUTASE; LIVER-MITOCHONDRIA; RATS; METABOLISM; TOXICITY; VITAMIN-B-12; INHIBITION; MECHANISMS; CIRRHOSIS; SKELETAL	The vitamin B-12 analog hydroxy-cobalamin[c-lactam] (HCCL) impairs hepatic mitochondrial protein synthesis and function of the electron transport chain in rats. We aimed to establish an in vivo model for mitochondrial dysfunction in mice, which could be used to investigate hepatotoxicity of mitochondrial toxicants. In a first step, we performed a dose-finding study in mice treated with HCCL 0.4 mg/kg and 4 mg/kg i.p. for two to four weeks. The plasma methylmalonate concentration was strongly increased at 4 mg/kg starting at three weeks of treatment. We subsequently treated mice daily with 4 mg/kg HCCL i.p. for three weeks and characterized liver function and histology as well as liver mitochondrial function. We found an increase in liver weight in HCCL-treated mice, which was paralleled by hepatocellular accumulation of triglycerides. In liver homogenate of HCCL-treated mice, the complex I activity of the electron transport chain was reduced, most likely explaining hepatocellular triglyceride accumulation. The activity of CPT1 was not affected by methylmalonyl-CoA in isolated liver mitochondria. Despite impaired complex I activity, mitochondrial superoxide anion production was not increased and the hepatocellular glutathione (GSH) pool was maintained. Finally, the mitochondrial DNA content was not altered with HCCL treatment. In conclusion, treatment of mice with HCCL is associated with increased liver weight explained by hepatocellular triglyceride accumulation. Hepatocellular fat accumulation is most likely a consequence of impaired activity of the mitochondrial electron transport chain. The impairment of complex I activity is not strong enough to result in ROS accumulation and reduction of the GSH stores.	[Haegler, Patrizia; Grunig, David; Berger, Benjamin; Krahenbuhl, Stephan; Bouitbir, Jamal] Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland; [Haegler, Patrizia; Grunig, David; Berger, Benjamin; Krahenbuhl, Stephan; Bouitbir, Jamal] Univ Basel, Dept Biomed, Basel, Switzerland; [Terracciano, Luigi; Krahenbuhl, Stephan; Bouitbir, Jamal] SCAHT, Basel, Switzerland; [Terracciano, Luigi] Univ Hosp, Inst Pathol, Dept Mol Pathol, Basel, Switzerland	University of Basel	Krahenbuhl, S (corresponding author), Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland.; Krahenbuhl, S (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.; Krahenbuhl, S (corresponding author), SCAHT, Basel, Switzerland.	kraehenbuehl@ubs.ch	Terracciano, Luigi M./AAB-5335-2022; Krähenbühl, Stephan/Z-4744-2019; BOUITBIR, Jamal/AAJ-6722-2020	Terracciano, Luigi M./0000-0002-9393-9660; Bouitbir, Jamal/0000-0003-4453-9457	Swiss National Science Foundation [31003A 156270]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant to Stephan Krahenbuhl from the Swiss National Science Foundation (31003A 156270).	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballhausen D, 2009, NEUROSCIENCE, V164, P578, DOI 10.1016/j.neuroscience.2009.08.028; Banerjee R, 2002, BIOCHEM SOC T, V30, P621, DOI 10.1042/bst0300621; BRASS EP, 1990, BIOCHEM J, V266, P809; Deodato F, 2006, AM J MED GENET C, V142C, P104, DOI 10.1002/ajmg.c.30090; Felser A, 2014, TOXICOLOGY, V323, P1, DOI 10.1016/j.tox.2014.05.011; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; FRENKEL EP, 1975, BRIT J HAEMATOL, V31, P501, DOI 10.1111/j.1365-2141.1975.tb00885.x; Gerlach C, 1997, HEPATOLOGY, V26, P573, DOI 10.1053/jhep.1997.v26.pm0009303485; Haegler P, 2015, TOXICOLOGY; Haegler P, 2015, TOXICOLOGY, V336, P48, DOI 10.1016/j.tox.2015.07.015; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kennedy JA, 1996, BIOCHEM PHARMACOL, V52, P273, DOI 10.1016/0006-2952(96)00204-3; Knapp AC, 2008, J PHARMACOL EXP THER, V324, P568, DOI 10.1124/jpet.107.131185; KRAHENBUHL S, 1990, J CLIN INVEST, V86, P2054, DOI 10.1172/JCI114942; Krahenbuhl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P1272, DOI 10.1016/0270-9139(94)90877-X; KRAHENBUHL S, 1992, HEPATOLOGY, V15, P1167, DOI 10.1002/hep.1840150631; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Krahenbuhl S, 2001, J HEPATOL, V34, P334, DOI 10.1016/S0168-8278(00)00106-9; KRAHLENBUHL S, 1990, HEPATOLOGY, V12, P526, DOI 10.1002/hep.1840120313; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Ledley FD, 1997, HUM MUTAT, V9, P1; LEEDS FS, 1994, J BIOL CHEM, V269, P3947; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Mutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075312; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Pieters N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063208; SAIDO H, 1993, BIOSCI BIOTECH BIOCH, V57, P607, DOI 10.1271/bbb.57.607; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; STABLER SP, 1991, J CLIN INVEST, V87, P1422, DOI 10.1172/JCI115148; Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891; Takahashi-Iniguez T, 2012, J ZHEJIANG UNIV-SC B, V13, P423, DOI 10.1631/jzus.B1100329; TANDLER B, 1991, ANAT RECORD, V231, P1, DOI 10.1002/ar.1092310102; WILKEMEYER MF, 1993, BIOCHEM J, V296, P663, DOI 10.1042/bj2960663	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171026	10.1371/journal.pone.0171026	http://dx.doi.org/10.1371/journal.pone.0171026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135329	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700040
J	Ujvari, D; Jakson, I; Babayeva, S; Salamon, D; Rethi, B; Gidlof, S; Hirschberg, AL				Ujvari, Dorina; Jakson, Ivika; Babayeva, Shabnam; Salamon, Daniel; Rethi, Bence; Gidlof, Sebastian; Hirschberg, Angelica Linden			Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FACTOR-BINDING PROTEIN-1; NONPREGNANT HUMAN ENDOMETRIUM; KINASE-B; PROGESTERONE-RECEPTOR; MENSTRUAL-CYCLE; EARLY-PREGNANCY; MESSENGER-RNA; FACTOR AFX; SIGNALING PATHWAYS	Insulin resistance and compensatory hyperinsulinemia are characteristic features of obesity and polycystic ovary syndrome, and both are associated with reduced fertility and implantation. There is little knowledge about the effect of insulin on the decidualization process and previous findings are contradictory. We investigated the effect of insulin on the regulation of forkhead box protein O1 (FOXO1), one of the most important transcription factors during decidualization. Endometrial stromal cells were isolated from six healthy, regularly menstruating women and decidualized in vitro. Gene expression levels of six putative FOXO1 target genes (including insulin-like growth factor binding protein-1 (IGFBP1) and prolactin (PRL)) were measured with Real-Time PCR following FOXO1 inhibition or insulin treatment. PI3K inhibition was used to identify the possible mechanism behind regulation. Subcellular localization of FOXO1 was analyzed with immunofluorescence. All the genes (IGFBP1, CTGF, INSR, DCN, LEFTY2), except prolactin, were evaluated as FOXO1 target genes in decidualizing stromal cells. Insulin caused a significant dose-dependent inhibition of the verified FOXO1 target genes. It was also demonstrated that insulin regulated FOXO1 target genes by transcriptional inactivation and nuclear export of FOXO1 via PI3K pathway. However, insulin did not inhibit the morphological transformation of endometrial stromal cells via transcriptional inactivation of FOXO1. This study provides new insights on the action of insulin on the endometrium via regulation of FOXO1. It is suggested that hyperinsulinemia results in dysregulation of a high number of FOXO1 controlled genes that may contribute to endometrial dysfunction and reproductive failure. Our findings may illuminate possible reasons for unexplained infertility.	[Ujvari, Dorina; Jakson, Ivika; Salamon, Daniel; Gidlof, Sebastian; Hirschberg, Angelica Linden] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Jakson, Ivika; Hirschberg, Angelica Linden] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Babayeva, Shabnam] Azerbaijan Med Univ, Dept Obstet & Gynecol 2, Baku, Azerbaijan; [Salamon, Daniel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Rethi, Bence] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Gidlof, Sebastian] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Ministry of Education of Azerbaijan Republic; Azerbaijan Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Ujvari, D (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	dorina.ujvari@ki.se	Hirschberg, Angelica/AAK-6693-2020; Ujvari, Dorina/AAS-8724-2021; Salamon, Daniel/AAZ-4807-2021; Rethi, Bence/C-5770-2013	Jakson, Ivika/0000-0003-4969-9871; Rethi, Bence/0000-0001-8220-5015	Swedish Research Council (Vetenskapsradet) [20324]; Stockholm County Council (Stockholms lans landsting)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Stockholm County Council (Stockholms lans landsting)	Support was provided by the Swedish Research Council (Vetenskapsradet) 20324 to ALH [www.vr.se]; and the Stockholm County Council (Stockholms lans landsting) to ALH, SG [www.sll.se]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Christian M, 2002, J BIOL CHEM, P277; Bouzas ICD, 2014, J PEDIATR ADOL GYNEC, V27, P335, DOI 10.1016/j.jpag.2014.01.002; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Falsetti L, 1996, GYNECOL ENDOCRINOL, V10, P319, DOI 10.3109/09513599609012818; Fan W, 2012, GYNECOL OBSTET INVES, V74, P56, DOI 10.1159/000336633; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; GIUDICE LC, 1992, J CLIN ENDOCR METAB, V75, P1235, DOI 10.1210/jc.75.5.1235; Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Horseman ND, 1997, EMBO J, V16, P6926; Irwin JC, 1998, GROWTH HORM IGF RES, V8, P21, DOI 10.1016/S1096-6374(98)80318-3; Jabbour HN, 1999, J CLIN ENDOCR METAB, V84, P4260, DOI 10.1210/jc.84.11.4260; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Jung SJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0665-2; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Katulski K, 2015, GYNECOL ENDOCRINOL, V31, P87, DOI 10.3109/09513590.2014.974535; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; KRASNOW JS, 1990, MOL ENDOCRINOL, V4, P13, DOI 10.1210/mend-4-1-13; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; LAHAT N, 1993, J NEUROIMMUNOL, V47, P35, DOI 10.1016/0165-5728(93)90282-4; Lathi RB, 2005, J CLIN ENDOCR METAB, V90, P1599, DOI 10.1210/jc.2004-1676; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Matsui N, 2004, ACTA OBSTET GYN SCAN, V83, P138, DOI 10.1111/j.0001-6349.2004.00256.x; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McAveney KM, 1996, ENDOCRINOLOGY, V137, P5723, DOI 10.1210/en.137.12.5723; MURPHY WJ, 1993, J EXP MED, V178, P231, DOI 10.1084/jem.178.1.231; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nevalainen MT, 1997, FASEB J, V11, P1297, DOI 10.1096/fasebj.11.14.9409549; Nybacka A, 2011, FERTIL STERIL, V96, P1508, DOI 10.1016/j.fertnstert.2011.09.006; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SATYASWAROOP PG, 1979, J CLIN ENDOCR METAB, V48, P639, DOI 10.1210/jcem-48-4-639; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Siddiqui MF, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.020; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; TABANELLI S, 1992, J STEROID BIOCHEM, V42, P337, DOI 10.1016/0960-0760(92)90137-8; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; THRAILKILL KM, 1989, ENDOCRINOLOGY, V124, P3010, DOI 10.1210/endo-124-6-3010; Ujvari D, 2014, HUM REPROD, V29, P1526, DOI 10.1093/humrep/deu114; Waddell JM, 2011, HUM REPROD, V26, P67, DOI 10.1093/humrep/deq294; WEISS DJ, 1994, METABOLISM, V43, P803, DOI 10.1016/0026-0495(94)90257-7; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; WU WX, 1995, J MOL ENDOCRINOL, V14, P255, DOI 10.1677/jme.0.0140255; Yuhki M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-104; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	66	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171004	10.1371/journal.pone.0171004	http://dx.doi.org/10.1371/journal.pone.0171004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135285	Green Submitted, Green Published, gold			2022-12-26	WOS:000396124700037
J	Bai, Y; Urushadze, L; Osikowicz, L; McKee, C; Kuzmin, I; Kandaurov, A; Babuadze, G; Natradze, I; Imnadze, P; Kosoy, M				Bai, Ying; Urushadze, Lela; Osikowicz, Lynn; McKee, Clifton; Kuzmin, Ivan; Kandaurov, Andrei; Babuadze, Giorgi; Natradze, Ioseb; Imnadze, Paata; Kosoy, Michael			Molecular Survey of Bacterial Zoonotic Agents in Bats from the Country of Georgia (Caucasus)	PLOS ONE			English	Article							RESERVOIR HOSTS; BARTONELLA SPP.; BRUCELLA; LEPTOSPIRA; DIVERSITY; PREVALENCE; PATTERNS; RODENTS; FOXES	are important reservoirs for many zoonotic pathogens. However, no surveys of bacterial pathogens in bats have been performed in the Caucasus region. To understand the occurrence and distribution of bacterial infections in these mammals, 218 bats belonging to eight species collected from four regions of Georgia were examined for Bartonella, Brucella, Leptospira, and Yersinia using molecular approaches. Bartonella DNA was detected in 77 (35%) bats from all eight species and was distributed in all four regions. The prevalence ranged 6-50% per bat species. The Bartonella DNA represented 25 unique genetic variants that clustered into 21 lineages. Brucella DNA was detected in two Miniopterus schreibersii bats and in two Myotis blythii bats, all of which were from Imereti (west-central region). Leptospira DNA was detected in 25 (13%) bats that included four M. schreibersii bats and 21 M. blythii bats collected from two regions. The Leptospira sequences represented five genetic variants with one of them being closely related to the zoonotic pathogen L. interrogans (98.6% genetic identity). No Yersinia DNA was detected in the bats. Mixed infections were observed in several cases. One M. blythii bat and one M. schreibersii bat were co-infected with Bartonella, Brucella, and Leptospira; one M. blythii bat and one M. schreibersii bat were co-infected with Bartonella and Brucella; 15 M. blythii bats and three M. schreibersii bats were co-infected with Bartonella and Leptospira. Our results suggest that bats in Georgia are exposed to multiple bacterial infections. Further studies are needed to evaluate pathogenicity of these agents to bats and their zoonotic potential.	[Bai, Ying; Osikowicz, Lynn; McKee, Clifton; Kosoy, Michael] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Urushadze, Lela; Babuadze, Giorgi; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Urushadze, Lela; Babuadze, Giorgi] Ilia State Univ, Inst Chem Biol, Tbilisi, Georgia; [McKee, Clifton] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Kuzmin, Ivan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kandaurov, Andrei; Natradze, Ioseb] Ilia State Univ, Inst Zool, Tbilisi, Georgia	Centers for Disease Control & Prevention - USA; National Center for Disease Control & Public Health - Georgia; Ilia State University; Colorado State University; University of Texas System; University of Texas Medical Branch Galveston; Ilia State University	Bai, Y (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	bby5@cdc.gov	Natradze, Ioseb/T-2066-2019; McKee, Clifton/I-4603-2019; Kandaurov, Andrei S./D-7965-2011	McKee, Clifton/0000-0002-6149-0598; 				Acha PN, 2001, ZOONOSES COMMUNICABL, V1, P3; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080894; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10; BAILY GG, 1992, J TROP MED HYG, V95, P271; BONDYREV I.V., 2015, GEOGRAPHY GEORGIA PR; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carrasco SE, 2014, VET MICROBIOL, V170, P325, DOI 10.1016/j.vetmic.2014.02.021; Childs-Sanford SE, 2009, J ZOO WILDLIFE MED, V40, P8, DOI 10.1638/2007-0033.1; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Dietrich M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005176; Dollinger P, 1998, P EAZWV BVSII SCI M, P1; EVERARD COR, 1983, J WILDLIFE DIS, V19, P192, DOI 10.7589/0090-3558-19.3.192; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; FENNESTAD K L, 1972, Journal of Wildlife Diseases, V8, P343; Bessa TAF, 2010, AM J TROP MED HYG, V82, P315, DOI 10.4269/ajtmh.2010.09-0227; HALLING SM, 1993, GENE, V133, P123, DOI 10.1016/0378-1119(93)90236-V; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Haque N, 2011, Mymensingh Med J, V20, P742; Hubalek Z, 2007, VECTOR-BORNE ZOONOT, V7, P679, DOI 10.1089/vbz.2007.0143; Kandelaki G, 2016, EMERG INFECT DIS, V22, P544, DOI 10.3201/eid2203.151823; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Mair N.S., 1973, Journal Wildl Dis, V9, P64; Mair N.S., 1968, S ZOOL SOC LOND, V24, P107; Malania L, 2016, AM J TROP MED HYG, V95, P466, DOI 10.4269/ajtmh.16-0041; Mamuchishvili N, 2014, Georgian Med News, P63; Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964; McKee CD, 2016, INFECT GENET EVOL, V44, P382, DOI 10.1016/j.meegid.2016.07.033; Messenger SL, 2003, EMERG INFECT DIS, V9, P151; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Olsen SC, 2014, VET PATHOL, V51, P1076, DOI 10.1177/0300985814540545; RICCIARDI I D, 1976, Journal of Wildlife Diseases, V12, P52; Sanodze L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1761-y; Scholz HC, 2009, VECTOR-BORNE ZOONOT, V9, P153, DOI 10.1089/vbz.2008.0036; Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17; STOENNER HG, 1957, AM J VET RES, V18, P947; Tiller RV, 2010, APPL ENVIRON MICROB, V76, P5837, DOI 10.1128/AEM.00620-10; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Diniz PPVD, 2007, VET RES, V38, P697, DOI 10.1051/vetres:2007023; Whitaker John O. Jr, 2009, P806; Wibbelt Gudrun, 2009, P775; Yavruyan E, 2008, BATS CONSERVATION AC	49	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171175	10.1371/journal.pone.0171175	http://dx.doi.org/10.1371/journal.pone.0171175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129398	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400005
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Spikman, Jacoba M.; van der Naalt, Joukje			Graph Analysis of Functional Brain Networks in Patients with Mild Traumatic Brain Injury	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; STRUCTURAL CONNECTIVITY; POSTTRAUMATIC-STRESS; EMOTION REGULATION; MRI; SYMPTOMS; ABNORMALITIES; DYSFUNCTION; CONCUSSION; COMPLAINTS	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders worldwide. Posttraumatic complaints are frequently reported, interfering with outcome. However, a consistent neural substrate has not yet been found. We used graph analysis to further unravel the complex interactions between functional brain networks, complaints, anxiety and depression in the sub-acute stage after mTBI. This study included 54 patients with uncomplicated mTBI and 20 matched healthy controls. Posttraumatic complaints, anxiety and depression were measured at two weeks post-injury. Patients were selected based on presence (n = 34) or absence (n = 20) of complaints. Resting-state fMRI scans were made approximately four weeks post-injury. High order independent component analysis resulted in 89 neural components that were included in subsequent graph analyses. No differences in graph measures were found between patients with mTBI and healthy controls. Regarding the two patient subgroups, degree, strength, local efficiency and eigenvector centrality of the bilateral posterior cingulate/precuneus and bilateral parahippocampal gyrus were higher, and eigenvector centrality of the frontal pole/bilateral middle & superior frontal gyrus was lower in patients with complaints compared to patients without complaints. In patients with mTBI, higher degree, strength and eigenvector centrality of default mode network components were related to higher depression scores, and higher degree and eigenvector centrality of executive network components were related to lower depression scores. In patients without complaints, one extra module was found compared to patients with complaints and healthy controls, consisting of the cingulate areas. In conclusion, this research extends the knowledge of functional network connectivity after mTBI. Specifically, our results suggest that an imbalance in the function of the default mode-and executive network plays a central role in the interaction between emotion regulation and the persistence of posttraumatic complaints.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps2012-06]	Dutch Brain Foundation	This work was supported by Dutch Brain Foundation, grant no. Ps2012-06. J.v.d.N. received the funding. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elseoud A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00037; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matuseviciene G, 2015, J REHABIL MED; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065470, 10.1371/annotation/fd9f9796-b42d-480d-b9f4-0adfbb919148]; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648; Rigon A, 2015, J NEUROTRAUM, V1, P1; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	80	29	29	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171031	10.1371/journal.pone.0171031	http://dx.doi.org/10.1371/journal.pone.0171031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129397	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400011
J	Yao, YG; Deng, HY; Ma, CZ; Yi, M; Ma, J				Yao, Yuangen; Deng, Haiyou; Ma, Chengzhang; Yi, Ming; Ma, Jun			Impact of Bounded Noise and Rewiring on the Formation and Instability of Spiral Waves in a Small-World Network of Hodgkin-Huxley Neurons	PLOS ONE			English	Article							SPREADING DEPRESSION; COHERENCE RESONANCE; EXCITABLE SYSTEM; BRAIN NETWORKS; CHICKEN RETINA; TRANSITION; DYNAMICS; MODEL; BREAKUP; MEDIA	Spiral waves are observed in the chemical, physical and biological systems, and the emergence of spiral waves in cardiac tissue is linked to some diseases such as heart ventricular fibrillation and epilepsy; thus it has importance in theoretical studies and potential medical applications. Noise is inevitable in neuronal systems and can change the electrical activities of neuron in different ways. Many previous theoretical studies about the impacts of noise on spiral waves focus an unbounded Gaussian noise and even colored noise. In this paper, the impacts of bounded noise and rewiring of network on the formation and instability of spiral waves are discussed in small-world (SW) network of Hodgkin-Huxley (HH) neurons through numerical simulations, and possible statistical analysis will be carried out. Firstly, we present SW network of HH neurons subjected to bounded noise. Then, it is numerically demonstrated that bounded noise with proper intensity sigma, amplitude A, or frequency f can facilitate the formation of spiral waves when rewiring probability p is below certain thresholds. In other words, bounded noise-induced resonant behavior can occur in the SW network of neurons. In addition, rewiring probability p always impairs spiral waves, while spiral waves are confirmed to be robust for small p, thus shortcut-induced phase transition of spiral wave with the increase of p is induced. Furthermore, statistical factors of synchronization are calculated to discern the phase transition of spatial pattern, and it is confirmed that larger factor of synchronization is approached with increasing of rewiring probability p, and the stability of spiral wave is destroyed.	[Yao, Yuangen; Deng, Haiyou; Ma, Chengzhang; Yi, Ming] Huazhong Agr Univ, Dept Phys, Coll Sci, Wuhan, Peoples R China; [Yao, Yuangen] Huazhong Agr Univ, Inst Appl Phys, Wuhan, Peoples R China; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China; [Ma, Jun] King Abdulaziz Univ, Dept Math, Fac Sci, NAAM Res Grp, Jeddah, Saudi Arabia	Huazhong Agricultural University; Huazhong Agricultural University; Lanzhou University of Technology; King Abdulaziz University	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.; Ma, J (corresponding author), King Abdulaziz Univ, Dept Math, Fac Sci, NAAM Res Grp, Jeddah, Saudi Arabia.	hyperchaos@163.com	Yi, Ming/B-5383-2011; Yao, Yuangen/D-9327-2018; Yi, Ming/AAB-7928-2022; Ma, Jun/G-2376-2010	Yi, Ming/0000-0001-7198-5511; Yao, Yuangen/0000-0001-6967-2487; Yi, Ming/0000-0001-7534-3049; Ma, Jun/0000-0002-6127-000X; Chengzhang, Ma/0000-0003-2742-1174	Fundamental Research Funds for the Central Universities [2662015QC041, 2662014BQ069]; National Natural Science Foundation of China [31601071, 11372122]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 2662015QC041 and 2662014BQ069) and the National Natural Science Foundation of China (Grant No. 31601071, 11372122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 2662015QC041 and 2662014BQ069) and the National Natural Science Foundation of China (Grant No. 31601071, 11372122).	[Anonymous], 1988, ACTA APPL MATH; BAR M, 1994, J CHEM PHYS, V100, P1202, DOI 10.1063/1.466650; BARKLEY D, 1991, PHYSICA D, V49, P61, DOI 10.1016/0167-2789(91)90194-E; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Bobryk RV, 2005, PHYSICA A, V358, P263, DOI 10.1016/j.physa.2005.03.055; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cai GQ, 2004, PROBABILIST ENG MECH, V19, P197, DOI 10.1016/j.probengmech.2004.02.002; Chai YZ, 2015, MOD PHYS LETT B, V29, DOI 10.1142/S0217984915501213; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gerstner W, 2002, SPIKING NEURON MODEL; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Guo W, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30116-1; Guo W, 2012, PHYSICA A, V391, P1270, DOI 10.1016/j.physa.2011.11.007; Holden AV, 2013, NONLINEAR WAVE PROCE; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jia YB, 2015, CHAOS, V25, DOI 10.1063/1.4938733; Jung P, 1998, CHAOS, V8, P567, DOI 10.1063/1.166338; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Liang XM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031916; Ma J, 2016, NONLINEAR DYNAM, V84, P497, DOI 10.1007/s11071-015-2502-6; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Ma J, 2012, COMMUN NONLINEAR SCI, V17, P4281, DOI 10.1016/j.cnsns.2012.03.009; Ma J, 2012, CHINESE SCI BULL, V57, P2094, DOI 10.1007/s11434-012-5114-2; Ma J, 2011, INT J MOD PHYS B, V25, P1653, DOI 10.1142/S0217979211100266; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; Ma J, 2010, SCI CHINA PHYS MECH, V53, P672, DOI 10.1007/s11433-010-0097-y; MIELKE A, 1995, ANN PHYS-LEIPZIG, V4, P476, DOI 10.1002/andp.19955070507; Ozer M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/40008; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Qin HX, 2015, COMMUN NONLINEAR SCI, V23, P164, DOI 10.1016/j.cnsns.2014.11.008; Sun XJ, 2011, EUR PHYS J B, V79, P61, DOI 10.1140/epjb/e2010-10031-3; Sun XJ, 2014, SCI CHINA TECHNOL SC, V57, P879, DOI 10.1007/s11431-014-5529-x; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wio HS, 2004, PHYSICA D, V193, P161, DOI 10.1016/j.physd.2004.01.017; Yang XL, 2014, PHYSICA A, V393, P617, DOI 10.1016/j.physa.2013.09.021; Yu Q, 2012, CHINESE PHYS B, V21; Zhou CS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.230602	47	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171273	10.1371/journal.pone.0171273	http://dx.doi.org/10.1371/journal.pone.0171273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129401	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400004
J	Li, TZ; Cai, WH; Zhan, JM				Li, Tianzeng; Cai, Wenhao; Zhan, Jiemin			Numerical Investigation of Swimmer's Gliding Stage with 6-DOF Movement	PLOS ONE			English	Article							DRAG	The purpose of this study is to analyze the motion status of swimmers during their gliding stage using a numerical simulation method. This simulation strategy is conducted by solving the 3D incompressible Navier-Stokes equations using the Realizable k-epsilon turbulence closure equations in combination with the Six Degrees of Freedom (6-DOF) method. The uneven mass distribution of a swimmer and the roughness of the surface of the body are taken into consideration. The hydrodynamic characteristics and movement characteristics of the swimmers at different launch speeds were analyzed. The calculated results suggest that an optimal instant for starting propulsive movement is when the velocity of the swimmer decreases by 1.75 m/s to 2.0 m/s from an initial horizontal velocity of 3.1 m/s to 3.5 m/s.	[Li, Tianzeng; Cai, Wenhao; Zhan, Jiemin] Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhan, JM (corresponding author), Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou, Guangdong, Peoples R China.	cejmzhan@gmail.com			Special Research Program of Public Welfare and Capacity Building in Guangdong Province [2015A020216008]; Science and Technology Project in Guangdong Province, China [2016A010104006]	Special Research Program of Public Welfare and Capacity Building in Guangdong Province; Science and Technology Project in Guangdong Province, China	This work is supported by Prof. Jiemin Zhan's project (Special Research Program of Public Welfare and Capacity Building in Guangdong Province, No. 2015A020216008). Also thanks to the suggestions from Dr. Ye-Jun Gong and the financial support from her project (Science and Technology Project in Guangdong Province, China, No. 2016A010104006).	ANSYS inc, 2016, ANSYS FLUENT THEOR G; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; Cebeci T, 1977, MOMENTUM TRANSFER BO, P1; Clarys JP, 1979, SWIMMING, P3; Cossor JM, 2001, INT S BIOM SPORTS IS, P70; Dempster WT., 1955, 55159 WADC WRIGHT PA; Elipot M, 2009, J BIOMECH, V42, P1367, DOI 10.1016/j.jbiomech.2009.03.032; Elipot M, 2010, J APPL BIOMECH, V26, P501, DOI 10.1123/jab.26.4.501; Hertel H., 1966, STRUCTURE FORM MOVEM; Kakimpa B, 2012, J WIND ENG IND AEROD, V111, P95, DOI 10.1016/j.jweia.2012.07.008; KOROBKIN AA, 1988, ANNU REV FLUID MECH, V20, P159; Li TZ, 2015, ACTA BIOENG BIOMECH, V17, P3, DOI 10.5277/ABB-00200-2014-03; Lyttle A, 1999, ISBS C P ARCH, V1; Lyttle A, 1999, J SCI MED SPORT, V2, P430; Lyttle A.D., 1998, J SWIMMING RES, V13, P15; Lyttle AD, 2000, J SPORT SCI, V18, P801, DOI 10.1080/026404100419856; Marinho D. A., 2009, LECT NOTES COMPUTATI, V72, P33, DOI DOI 10.1007/978-3-642-04466-3_; Marinho DA, 2011, J HUM KINET, V29, P49, DOI 10.2478/v10078-011-0039-4; Marinho DA, 2012, BRAZ ARCH BIOL TECHN, V55, P851, DOI 10.1590/S1516-89132012000600007; Naemi R, 2010, J SCI MED SPORT, V13, P444, DOI 10.1016/j.jsams.2009.04.009; Naemi R, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.3002764; Novais ML, 2012, J HUM KINET, V33, P55, DOI 10.2478/v10078-012-0044-2; Pendergast D, 2005, UNDERSEA HYPERBAR M, V32, P45; Popa CV, 2011, ACTA BIOENG BIOMECH, V13, P3; Popa CV, 2014, COMPUT METHOD BIOMEC, V17, P344, DOI 10.1080/10255842.2012.683429; Saha CK, 2011, BIOSYST ENG, V108, P227, DOI 10.1016/j.biosystemseng.2010.12.005; Shabana AA, 1996, J MECH DESIGN, V118, P171, DOI 10.1115/1.2826866; Tor E, 2015, J SCI MED SPORT, V18, P725, DOI 10.1016/j.jsams.2014.10.005; WELTNER K, 1987, AM J PHYS, V55, P50, DOI 10.1119/1.14960; Zaidi H, 2010, J BIOMECH, V43, P405, DOI 10.1016/j.jbiomech.2009.10.010; Zhan JM, 2015, CHINA OCEAN ENG, V29, P265, DOI 10.1007/s13344-014-0080-x	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170894	10.1371/journal.pone.0170894	http://dx.doi.org/10.1371/journal.pone.0170894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125724	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100030
J	Garfoot, AL; Dearing, KL; VanSchoiack, AD; Wysocki, VH; Rappleye, CA				Garfoot, Andrew L.; Dearing, Kacey L.; VanSchoiack, Andrew D.; Wysocki, Vicki H.; Rappleye, Chad A.			Eng1 and Exg8 Are the Major beta-Glucanases Secreted by the Fungal Pathogen Histoplasma capsulatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE RECOGNITION; CELL-SEPARATION; IDENTIFICATION; BINDING; HEAT-SHOCK-PROTEIN-60; MACROPHAGES; DECTIN-1; ALPHA-(1,3)-GLUCAN; BETA-1,3-GLUCANASE; REQUIREMENT	Fungal cell walls contain beta-glucan polysaccharides that stimulate immune responses when recognized by host immune cells. The fungal pathogen Histoplasma capsulatum minimizes detection of beta-glucan by host cells through at least two mechanisms: concealment of beta-glucans beneath beta-glucans and enzymatic removal of any exposed beta-glucan polysaccharides by the secreted glucanase Eng1. Histoplasma yeasts also secrete the putative glucanase Exg8, which may serve a similar role as Eng1 in removing exposed beta-glucans from the yeast cell surface. Here, we characterize the enzymatic specificity of the Eng1 and Exg8 proteins and show that Exg8 is an exo-beta 1,3-glucanase and Eng1 is an endo-beta 1,3-glucanase. Together, Eng1 and Exg8 account for nearly all of the total secreted glucanase activity of Histoplasma yeasts. Both Eng1 and Exg8 proteins are secreted through a conventional secretion signal and are modified posttranslationally by O-linked glycosylation. Both glucanases have near maximal activity at temperature and pH conditions experienced during infection of host cells, supporting roles in Histoplasma pathogenesis. Exg8 has a higher specific activity than Eng1 for beta 1,3-glucans; yet despite this, Exg8 does not reduce detection of yeasts by the host beta-glucan receptor Dectin-1. Exg8 is largely dispensable for virulence in vivo, in contrast to Eng1. These results show that Histoplasma yeasts secrete two beta 1,3glucanases and that Eng1 endoglucanase activity is the predominant factor responsible for removal of exposed cell wall beta-glucans to minimize host detection of Histoplasma yeasts.	[Garfoot, Andrew L.; Dearing, Kacey L.; Rappleye, Chad A.] Ohio State Univ, Dept Microbiol Microbial Infect & Immun, Columbus, OH 43210 USA; [VanSchoiack, Andrew D.; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rappleye, CA (corresponding author), 484 W 12th Ave,540 Biol Sci Bldg, Columbus, OH 43210 USA.	rappleye.1@osu.edu		Wysocki, Vicki/0000-0003-0495-2538; Rappleye, Chad/0000-0001-7880-5958	National Institutes of Health from NIAID [R21-AI117122]; National Institutes of Health Predoctoral Fellowship [T32AI112542]; National Institutes of Health NRSA; National Institutes of Health [R33AI085563]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117122, T32AI112542, R01AI083335] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Award R21-AI117122 from NIAID (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Predoctoral Fellowship T32AI112542 and National Institutes of Health NRSA training grant administered by the Center for Microbial Interface Biology (CMIB) at Ohio State University.; Both authors were supported by National Institutes of Health Grant R33AI085563 (to Marta Feldmesser).	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BULLOCK WE, 1987, J EXP MED, V165, P195, DOI 10.1084/jem.165.1.195; Edwards JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-695; Edwards JA, 2013, ANTIMICROB AGENTS CH, V57, P4349, DOI 10.1128/AAC.00459-13; Edwards JA, 2011, EUKARYOT CELL, V10, P87, DOI 10.1128/EC.00214-10; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Esteban PF, 2005, CURR MICROBIOL, V51, P385, DOI 10.1007/s00284-005-0066-2; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garfoot AL, 2016, MBIO, V7, DOI 10.1128/mBio.01388-15; Garfoot AL, 2016, FEBS J, V283, P619, DOI 10.1111/febs.13389; Goughenour KD, 2015, J CLIN MICROBIOL, V53, P3286, DOI 10.1128/JCM.00795-15; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Habich C, 2006, FEBS LETT, V580, P115, DOI 10.1016/j.febslet.2005.11.060; Holbrook ED, 2011, J PROTEOME RES, V10, P1929, DOI 10.1021/pr1011697; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Kemski MM, 2013, FUNGAL BIOL-UK, V117, P41, DOI 10.1016/j.funbio.2012.11.004; Lin J., 2010, SYNTHESIS LECT HUMAN, V3, P1, DOI [DOI 10.2200/S00274ED1V01Y201006HLT007, 10.2200/S00274ED1V01Y201006HLT007]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long KH, 2003, J IMMUNOL, V170, P487, DOI 10.4049/jimmunol.170.1.487; Martin-Cuadrado AB, 2008, FUNGAL GENET BIOL, V45, P542, DOI 10.1016/j.fgb.2007.09.001; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mouyna I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00081; NEWMAN SL, 1990, J CLIN INVEST, V85, P223, DOI 10.1172/JCI114416; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Ramada MHS, 2010, J MICROBIOL METH, V81, P6, DOI 10.1016/j.mimet.2010.01.010; Strasser JE, 1999, J IMMUNOL, V162, P6148; TAYLOR ML, 1989, CLIN EXP IMMUNOL, V75, P466; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; WORSHAM PL, 1988, J MED VET MYCOL, V26, P137; Youseff Brian H, 2012, Methods Mol Biol, V845, P151, DOI 10.1007/978-1-61779-539-8_10; Zemska Olga, 2012, Methods Mol Biol, V845, P51, DOI 10.1007/978-1-61779-539-8_4	39	24	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4801	4810		10.1074/jbc.M116.762104	http://dx.doi.org/10.1074/jbc.M116.762104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154008	Green Published, hybrid			2022-12-26	WOS:000397590400005
J	Kandemir, B; Dag, U; Gungor, BB; Durasi, IM; Erdogan, B; Sahin, E; Sezerman, U; Kurnaz, IA				Kandemir, Basak; Dag, Ugur; Gungor, Burcu Bakir; Durasi, Ilknur Melis; Erdogan, Burcu; Sahin, Eray; Sezerman, Ugur; Kurnaz, Isil Aksan			In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; KINASE ACTIVATION; PRECURSOR CELLS; MOTOR-NEURONS; EPH RECEPTORS; C-JUN; ETS; EXPRESSION; PROTEIN	Pea3 transcription factor belongs to the PEA3 subfamily within the ETS domain transcription factor superfamily, and has been largely studied in relation to its role in breast cancer metastasis. Nonetheless, Pea3 plays a role not only in breast tumor, but also in other tissues with branching morphogenesis, including kidneys, blood vasculature, bronchi and the developing nervous system. Identification of Pea3 target promoters in these systems are important for a thorough understanding of how Pea3 functions. Present study particularly focuses on the identification of novel neuronal targets of Pea3 in a combinatorial approach, through curation, computational analysis and microarray studies in a neuronal model system, SH-SY5Y neuroblastoma cells. We not only show that quite a number of genes in cancer, immune system and cell cycle pathways, among many others, are either up- or down-regulated by Pea3, but also identify novel targets including ephrins and ephrin receptors, semaphorins, cell adhesion molecules, as well as metalloproteases such as kallikreins, to be among potential target promoters in neuronal systems. Our overall results indicate that rather than early stages of neurite extension and axonal guidance, Pea3 is more involved in target identification and synaptic maturation.	[Kandemir, Basak; Durasi, Ilknur Melis; Sahin, Eray; Kurnaz, Isil Aksan] Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey; [Kandemir, Basak; Dag, Ugur; Erdogan, Burcu; Sahin, Eray] Yeditepe Univ, Biotechnol Grad Program, Istanbul, Turkey; [Gungor, Burcu Bakir; Durasi, Ilknur Melis; Sezerman, Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Kurnaz, Isil Aksan] Gebze Tech Univ, Inst Biotechnol, Kocaeli, Turkey; [Dag, Ugur] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Erdogan, Burcu] Boston Coll, Dept Biol, Chestnut Hill, MA USA; [Gungor, Burcu Bakir] Abdullah Gul Univ, Dept Comp Engn, Fac Engn, Kayseri, Turkey; [Sezerman, Ugur] Acibadem Univ, Fac Med, Istanbul, Turkey	Gebze Technical University; Yeditepe University; Sabanci University; Gebze Technical University; Howard Hughes Medical Institute; Boston College; Abdullah Gul University; Erciyes University; Acibadem University	Kurnaz, IA (corresponding author), Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey.; Kurnaz, IA (corresponding author), Gebze Tech Univ, Inst Biotechnol, Kocaeli, Turkey.	ikurnaz@gtu.edu.tr	Kandemir, Başak/ABC-7240-2020; DURASI, ILKNUR MELIS/AAE-8729-2021; Sahin, Eray/GZB-9354-2022; KURNAZ, ISIL/GXG-5616-2022; SEZERMAN, OSMAN U/X-6441-2018	Sahin, Eray/0000-0002-0873-2439; Bakir-Gungor, Burcu/0000-0002-2272-6270; Sezerman, Osman Ugur/0000-0003-0905-6783; kandemir, basak/0000-0003-1909-5778	TUBITAK BIDEB; TUBITAK [107S064, 214Z278]	TUBITAK BIDEB(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Support was provided by TUBITAK BIDEB project grants to UD and BE; TUBITAK grants no 107S064 and 214Z278 to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz NM, 2009, INT J DEV BIOL, V53, P559, DOI 10.1387/ijdb.082777na; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Caglayan B, 2010, J NEUROCHEM, V115, P16; Chaturvedi S, 2015, PEDIATR NEPHROL, V30, P561, DOI 10.1007/s00467-014-2825-4; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chen JH, 1996, ONCOGENE, V13, P1667; Chotteau-Lelievre A, 2001, MECH DEVELOP, V108, P191, DOI 10.1016/S0925-4773(01)00480-4; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Custer AW, 2003, J NEUROSCI, V23, P10032; Day BW, 2014, BRIT J CANCER, V111, P1255, DOI 10.1038/bjc.2014.73; de Launoit Y, 2000, ADV EXP MED BIOL, V480, P107; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; Demir O, 2008, NEUROSCI LETT, V437, P20, DOI 10.1016/j.neulet.2008.03.064; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Diaz-Balzac CA, 2015, CELL REP, V11, P1377, DOI 10.1016/j.celrep.2015.04.057; Diolaiti D, 2007, EXP CELL RES, V313, P2980, DOI 10.1016/j.yexcr.2007.06.002; Dong Y, 2014, BIOL CHEM, V395, P977, DOI 10.1515/hsz-2014-0147; Doty KR, 2015, BRAIN RES, V1617, P155, DOI 10.1016/j.brainres.2014.09.008; Duffy SL, 2006, GENE EXPR PATTERNS, V6, P719, DOI 10.1016/j.modgep.2005.12.007; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Endo R, 2009, J BIOL CHEM, V284, P26029, DOI 10.1074/jbc.M109.026443; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garcia-Garcia E, 2012, MOL BIOL CELL, V23, P1167, DOI 10.1091/mbc.E11-06-0524; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Giniger E, 2012, CURR OPIN GENET DEV, V22, P339, DOI 10.1016/j.gde.2012.04.003; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Gu CK, 2005, ONCOGENE, V24, P4243, DOI 10.1038/sj.onc.1208584; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hauser S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018989; Hayano Y, 2014, P NATL ACAD SCI USA, V111, P15226, DOI 10.1073/pnas.1402095111; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; HIGASHINO F, 1995, ONCOGENE, V10, P1461; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hua D, 2009, ACTA BIOCH BIOPH SIN, V41, P63, DOI 10.1093/abbs/gmn007; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Ishikawa Y, 2008, J NEUROSCI, V28, P843, DOI 10.1523/JNEUROSCI.4397-07.2008; Ishikawa Y, 2011, J PHYSIOL-LONDON, V589, P3559, DOI 10.1113/jphysiol.2011.206169; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; Jukam D, 2013, SCIENCE, V342, P211, DOI 10.1126/science.1238016; Kandemir B, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00059; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim M, 2014, BMB REP, V47, P540, DOI 10.5483/BMBRep.2014.47.10.177; Konar A, 2015, THER TARGETS NEUROL, V2, pe503; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Korja M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-57; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Leight ER, 2015, GENETICS, V199, P761, DOI 10.1534/genetics.114.172668; Li HX, 2008, PROTEIN SCI, V17, P664, DOI 10.1110/ps.073333208; Liao WX, 2010, HISTOL HISTOPATHOL, V25, P1181, DOI 10.14670/HH-25.1181; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lisle JE, 2015, EXP CELL RES, V333, P136, DOI 10.1016/j.yexcr.2015.02.014; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; McCabe KL, 2006, DEV DYNAM, V235, P327, DOI 10.1002/dvdy.20631; Meydan C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S13; Moleirinho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060028; MOSCOSO LM, 1995, J COMP NEUROL, V352, P321, DOI 10.1002/cne.903520302; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; North HA, 2013, CEREB CORTEX, V23, P1765, DOI 10.1093/cercor/bhs183; Oka T, 2002, NEUROSCI LETT, V321, P141, DOI 10.1016/S0304-3940(01)02470-3; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Park I, 2015, MOL CELLS, V38, P14, DOI 10.14348/molcells.2015.2116; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Qin J, 2000, ACTA NEUROPATHOL, V100, P168, DOI 10.1007/s004019900154; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Rugarli EI, 1996, HUM MOL GENET, V5, P1109, DOI 10.1093/hmg/5.8.1109; Ryu H, 2000, J IMMUNOL, V165, P2116, DOI 10.4049/jimmunol.165.4.2116; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Shannon P., 2014, MOTIFDB ANNOTATED CO; Shi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014570; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; TRIMBLE MS, 1993, ONCOGENE, V8, P3037; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Weisinger K, 2010, DEV BIOL, V344, P881, DOI 10.1016/j.ydbio.2010.06.001; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; YANG SH, 2006, BIOCHEM SOC SYMP, P121; Yukawa K, 2005, INT J MOL MED, V16, P115; Zhang XS, 2013, J BIOL CHEM, V288, P32742, DOI 10.1074/jbc.M113.478016; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015; Zou YM, 2004, NEURON, V43, P159, DOI 10.1016/j.neuron.2004.07.004	103	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170585	10.1371/journal.pone.0170585	http://dx.doi.org/10.1371/journal.pone.0170585			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158215	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161700015
J	Krezanoski, PJ; Campbell, JI; Santorino, D; Bangsberg, DR				Krezanoski, Paul J.; Campbell, Jeffrey I.; Santorino, Data; Bangsberg, David R.			Objective monitoring of Insecticide-treated bednet use to improve malaria prevention: SmartNet development and validation	PLOS ONE			English	Article							NETS; CAMPAIGN; COVERAGE	Malaria is a serious health concern for three billion people worldwide, killing nearly 600,000 people a year. Insecticide-treated bednets (ITNs) are an effective and valuable tool for preventing malaria and hundreds of millions of ITNs have been distributed throughout sub-Saharan Africa. Nevertheless, our current methods for measuring ITN use are inadequate to inform malaria prevention programs. The most common method, self-reported ITN use, is limited by 1) social desirability, 2) recall and 3) sampling bias. An acceptable objective and longitudinal method of assessing adherence to ITN use would improve our ability to better understand the determinants of ITN use and design more effective malaria prevention interventions. We describe the development and initial proof-of-concept validity testing of an ITN adherence monitoring tool called SmartNet. SmartNet uses conductive thread interwoven into an ITN and a microcontroller to detect the state of the ITN. We tested SmartNet among five volunteers using the device over their beds in Boston, USA for two weeks with the goal of evaluating device reliability, accuracy and acceptability to inform future device improvements. The device recorded data for 63.1% (35172/55711) of installed two-minute time intervals, with 97.3% (19990/20539) of the recording errors relating to battery failures. Overall, the device was 71.7% (25204/35172) accurate in determining the state of the ITN (whether it was folded up or unfurled) and performed significantly better at detecting an unfurled ITN than a folded ITN, 77.3% versus 68.4% (p<0.001). Participants noted no significant acceptability concerns and all participants felt SmartNet was easy or very easy to use. SmartNet is a novel approach to objectively measure ITN adherence over time. Our results suggest a variety of device improvements to both extend reliability and improve performance of SmartNet prior to deployment in a malaria-endemic setting.	[Krezanoski, Paul J.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; [Krezanoski, Paul J.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Campbell, Jeffrey I.] Harvard Med Sch, Boston, MA USA; [Santorino, Data] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Oregon Health & Science University; Portland State University	Krezanoski, PJ (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA.; Krezanoski, PJ (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Pediat, San Francisco, CA 94143 USA.	Paul.Krezanoski@ucsf.edu			American Academy of Pediatrics Resident Research Grant; Child Health Foundation Innovative Small Grants Program; Thrasher Research Foundation Early Career Award [11892]	American Academy of Pediatrics Resident Research Grant; Child Health Foundation Innovative Small Grants Program; Thrasher Research Foundation Early Career Award	Generous funding for this study was provided by an American Academy of Pediatrics Resident Research Grant (PJK), the Child Health Foundation Innovative Small Grants Program (PJK) and a Thrasher Research Foundation Early Career Award (PJK; #11892). The sponsors of this study had no role in the design, collection, analysis or interpretation of data, in the writing of the report, nor in the decision to submit the article for publication.	Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Becker-Dreps SI, 2009, AM J TROP MED HYG, V81, P496, DOI 10.4269/ajtmh.2009.81.496; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Cohee L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-76; Fernando SD, 2009, T ROY SOC TROP MED H, V103, P1204, DOI 10.1016/j.trstmh.2008.10.018; Frey C, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-70; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Haberer JE, 2012, AIDS BEHAV, V16, P375, DOI 10.1007/s10461-011-9933-y; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Koudou B, PARASITES VECTORS, V7; Krezanoski PJ, 2016, MALARIA RES TREATMEN; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Kuphaldt T.R., LESSONS ELECT CIRCUI, VI; Leake D W Jr, 1994, Asia Pac J Public Health, V7, P92; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; WHO, 2013, WORLD MALARIA REPORT 2013, P1	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0168116	10.1371/journal.pone.0168116	http://dx.doi.org/10.1371/journal.pone.0168116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158233	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700002
J	Arem, H; Pfeiffer, RM; Moore, SC; Irwin, ML; LaMonte, MJ; Sarto, GE; Nassir, R; Luo, JH; Chlebowski, RT; Brinton, LA; Matthews, CE				Arem, Hannah; Pfeiffer, Ruth M.; Moore, Steven C.; Irwin, Melinda L.; LaMonte, Michael J.; Sarto, Gloria E.; Nassir, Rami; Luo, Juhua; Chlebowski, Rowan T.; Brinton, Louise A.; Matthews, Charles E.			Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OVERWEIGHT; CARCINOMA; SURVIVAL; OBESITY	Higher body mass index (BMI) measured before endometrial cancer diagnosis has been associated with greater risk of developing endometrial cancer and higher mortality, but the association between BMI measured after diagnosis and mortality risk is unclear. We identified 467 women (91 deaths) in the Women's Health Initiative (WHI) with information on BMI measured after diagnosis and used Cox proportional hazards regression to generate hazard ratios (HR) and 95% confidence intervals (CI) for all-cause mortality. Comparing BMI 35+ with <25 kg/m(2), we observed no association with all-cause mortality (HR = 1.02, 95% CI 0.55-1.91). Our study does not support the hypothesis that higher BMI after endometrial cancer diagnosis is associated with poorer survival.	[Arem, Hannah] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA; [Pfeiffer, Ruth M.; Moore, Steven C.; Brinton, Louise A.; Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Irwin, Melinda L.] Yale Sch Publ Hlth, New Haven, CT USA; [Irwin, Melinda L.] Yale Canc Ctr, New Haven, CT USA; [LaMonte, Michael J.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Sarto, Gloria E.] UW Madison Dept Obstet & Gynecol, Madison, WI USA; [Nassir, Rami] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Luo, Juhua] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Arem, H (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.	hannaharem@gwu.edu	LaMonte, Mike/AAC-9953-2021; Moore, Steven/D-8760-2016; Nassir, Rami/ABC-2996-2021; matthews, Charles e/E-8073-2015	Moore, Steven/0000-0002-8169-1661; matthews, Charles e/0000-0001-8037-3103; luo, juhua/0000-0002-8901-4462	Intramural Research Division of the National Cancer Institute; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR001412] Funding Source: NIH RePORTER	Intramural Research Division of the National Cancer Institute; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by the Intramural Research Division of the National Cancer Institute; The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services (through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C).	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Arem H, 2016, CANCER CAUSE CONTROL, V27, P1403, DOI 10.1007/s10552-016-0813-7; Arem H, 2013, JNCI-J NATL CANCER I, V105, P342, DOI 10.1093/jnci/djs530; Arem H, 2013, GYNECOL ONCOL, V128, P181, DOI 10.1016/j.ygyno.2012.10.029; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Courneya KS, 2005, GYNECOL ONCOL, V97, P422, DOI 10.1016/j.ygyno.2005.01.007; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Food N, 2007, PHYS ACTIVITY PREVEN; Hewitt M., 2005, CANC PATIENT CANC SU; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Secord AA, 2016, GYNECOL ONCOL, V140, P184, DOI 10.1016/j.ygyno.2015.10.020; von Gruenigen VE, 2006, CANCER-AM CANCER SOC, V107, P2786, DOI 10.1002/cncr.22351; WOLFSON AH, 1992, GYNECOL ONCOL, V45, P142, DOI 10.1016/0090-8258(92)90276-O; World Cancer Research Fund International, 2014, DIET NUTR PHYS ACT B; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	15	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171250	10.1371/journal.pone.0171250	http://dx.doi.org/10.1371/journal.pone.0171250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152055	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200115
J	Chang, HC; Yang, HC; Chang, HY; Yeh, CJ; Chen, HH; Huang, KC; Pan, WH				Chang, Heng-Cheng; Yang, Hsin-Chou; Chang, Hsing-Yi; Yeh, Chih-Jung; Chen, Hsin-Hung; Huang, Kuo-Chin; Pan, Wen-Harn			Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY PATTERNS; PHYSICAL-ACTIVITY; NUTRITION TRANSITION; PUBLIC-HEALTH; RISK-FACTORS; EPIDEMIC; WEIGHT; ADULTS; OVERWEIGHT	Objective Obesity is one of the most important public health issues worldwide. Moreover, an extreme phenotype, morbid obesity (MO) has insidiously become a global problem. Therefore, we aimed to document the prevalence trend and to unveil the epidemiological characteristics of MO in Taiwan. Methods Nationally representative samples aged 19 years and above from three consecutive waves of Nutrition and Health survey in Taiwan: 1993-1996, 2005-2008, and 2013-2014 (n = 3,071; 1,673; and 1,440; respectively) were analyzed for prevalence trend. And 39 MO (BMI >= 35 kg/m(2)) cases from the two recent surveys compared with 156 age, gender, and survey-matched normal weight controls (BMI: 18.5-24 kg/m(2)) for epidemiological characteristics study. The reduced rank regression analysis was used to find dietary pattern associated with MO. Results The prevalence of overweight and obesity together (BMI >= 24 kg/m(2) was stabilized in the recent two surveys, but that of MO (0.4%, 0.6%, to 1.4%) and obesity (BMI >= 27 kg/m(2)) (11.8%, 17.9%, to 22.0%) increased sharply. MO cases tended to have lower levels of education, personal income, and physical activity. Furthermore, their dietary pattern featured with a higher consumption frequency of red meat, processed animal products, and sweets/sweetened beverage, but lower frequencies of fresh fruits, nuts, breakfast cereal, and dairy products. Conclusion This study documents a polarization phenomenon with smaller proportion of overweight people at the center and higher proportions of normal weight and obesity subjects at two extremes. MO was associated with low socioeconomic status and poor dietary pattern. The obesogenic dietary pattern became more prevalent in later time.	[Chang, Heng-Cheng; Pan, Wen-Harn] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Heng-Cheng; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Chang, Hsing-Yi; Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli County, Taiwan; [Yeh, Chih-Jung] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Chen, Hsin-Hung] Chang Jung Christian Univ, Dept Nutr & Hlth Sci, Tainan, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp & Coll Med, Dept Family Med, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chang Jung Christian University; National Taiwan University; National Taiwan University Hospital	Pan, WH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Pan, WH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli County, Taiwan.	pan@ibms.sinica.edu.tw	Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Yeh, Cj/AFC-0951-2022	Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; 	Department of Health [DOH FN8202, DOH-83-FS-41, DOH-84-FS-11, DOH-85-FS-11, DOH-86-FS-11, DOH-94-FS-6-4, DOH102-HP-1703]; Health Promotion Administration, Ministry of Health and Welfare in Taiwan [MOHW103-HPA-H-114-124710]	Department of Health; Health Promotion Administration, Ministry of Health and Welfare in Taiwan	This project was funded by Department of Health [DOH FN8202, DOH-83-FS-41, DOH-84-FS-11, DOH-85-FS-11, DOH-86-FS-11, DOH-94-FS-6-4, and DOH102-HP-1703] and Health Promotion Administration, Ministry of Health and Welfare in Taiwan [MOHW103-HPA-H-114-124710].	Appannah G, 2015, NUTR METAB CARDIOVAS, V25, P643, DOI 10.1016/j.numecd.2015.04.007; Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295; BOUCHARD C, 1991, AM J CLIN NUTR, V53, pS1561, DOI 10.1093/ajcn/53.6.1561S; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Lahti-Koski M, 2012, CLIN OBES, V2, P57, DOI 10.1111/j.1758-8111.2012.00035.x; Lao XQ, 2015, INT J OBESITY, V39, P288, DOI 10.1038/ijo.2014.95; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P45; Lien N, 2010, PUBLIC HEALTH NUTR, V13, P1680, DOI 10.1017/S1368980010002223; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manios Y, 2010, EUR J CLIN NUTR, V64, P1407, DOI 10.1038/ejcn.2010.168; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; Martin-Rodriguez E, 2015, OBES RES CLIN PRACT, V9, P435, DOI 10.1016/j.orcp.2015.04.003; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Pan WenHarn, 1999, Nutritional Sciences Journal, V24, P1; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; San-Cristobal R, 2015, NUTRIENTS, V7, P9523, DOI 10.3390/nu7115482; Shu L, 2015, NUTRIENTS, V7, P7995, DOI 10.3390/nu7095376; Ng SW, 2012, EMPIR ECON, V42, P413, DOI 10.1007/s00181-012-0547-7; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tu SH, 2011, ASIA PAC J CLIN NUTR, V20, P225; Tucker C., 2013, NATIONS HLTH, V43, P23; Twells Laurie K, 2014, CMAJ Open, V2, pE18, DOI 10.9778/cmajo.20130016; Visscher TLS, 2015, INT J OBESITY, V39, P189, DOI 10.1038/ijo.2014.98; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; (WHO) WHO, 2002, DIET NUTR PREV CHRON, DOI [10.2337/dc13-2085, DOI 10.2337/DC13-2085]; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization,, 2015, OB OV	53	100	101	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169577	10.1371/journal.pone.0169577	http://dx.doi.org/10.1371/journal.pone.0169577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152059	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200009
J	Diamantino-Miranda, J; Aguiar, SI; Carrico, JA; Melo-Cristino, J; Ramirez, M				Diamantino-Miranda, Jorge; Aguiar, Sandra Isabel; Carrico, Joao Andre; Melo-Cristino, Jose; Ramirez, Mario			Clonal and serotype dynamics of serogroup 6 isolates causing invasive pneumococcal disease in Portugal: 1999-2012	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; INFECTIONS; PREVALENCE; LOCUS	Although serogroup 6 was among the first to be recognized among Streptococcus pneumoniae, several new serotypes were identified since the introduction of pneumococcal conjugate vaccines (PCVs). A decrease of the 6B-2 variant among invasive pneumococcal disease (IPD), but not 6B-1, was noted post conjugate vaccine introduction, underpinned by a decrease of CC273 isolates. Serotype 6C was associated with adult IPD and increased in this age group representing two lineages (CC315 and CC395), while the same lineages expressed other serogroup 6 serotypes in children. Taken together, these findings suggest a potential cross-protection of PCVs against serotype 6C IPD among vaccinated children but not among adults. Serotype 6A became the most important serogroup 6 serotype in children but it decreased in adult IPD. No other serogroup 6 serotypes were detected, so available phenotypic or simple genotypic assays remain adequate for distinguishing serotypes within serogroup 6 isolates.	[Diamantino-Miranda, Jorge; Aguiar, Sandra Isabel; Carrico, Joao Andre; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal; [Aguiar, Sandra Isabel] Univ Lisbon, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal.	ramirez@medicina.ulisboa.pt	Melo-Cristino, Jose A G/H-3726-2013; Aguiar, Sandra Isabel Rodrigues/A-3500-2009; Carriço, Joao André/A-7367-2008; Ramirez, Mario/B-4993-2008	Melo-Cristino, Jose A G/0000-0001-8643-1722; Aguiar, Sandra Isabel Rodrigues/0000-0002-3041-383X; Carriço, Joao André/0000-0002-5274-2722; Ramirez, Mario/0000-0002-4084-6233; Miranda, Jorge/0000-0001-9128-2047	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81766/2011, SFRH/BPD/78376/2011, PTDC/DTP-EPI/1759/2012, PTDC/DTP-EPI/1555/2014]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	J. Diamantino-Miranda and S.I. Aguiar were supported by grants SFRH/BD/81766/2011 and SFRH/BPD/78376/2011, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. The work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/DTP-EPI/1759/2012 and PTDC/DTP-EPI/1555/2014) and an unrestricted Investigator initiated project from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Burton RL, 2016, J CLIN MICROBIOL, V54, P967, DOI 10.1128/JCM.03194-15; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUS S; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Horacio AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153602; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Kawaguchiya M, 2015, MICROB DRUG RESIST, V21, P209, DOI 10.1089/mdr.2014.0181; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; Marimon JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149047; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Nascimento M, 2016, BIOINFORMAT IN PRESS; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Serrano I, 2004, CLIN MICROBIOL INFEC, V10, P652, DOI 10.1111/j.1469-0691.2004.00869.x; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848	24	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170354	10.1371/journal.pone.0170354	http://dx.doi.org/10.1371/journal.pone.0170354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152029	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200021
J	Kim, KH; Yeo, SG; Yoo, BC; Myung, JK				Kim, Kyung-Hee; Yeo, Seung-Gu; Yoo, Byong Chul; Myung, Jae Kyung			Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells	PLOS ONE			English	Article							RAPAMYCIN-BINDING-PROTEIN; QUANTITATIVE PROTEOMICS; PLASMA-MEMBRANE; NA+/K+-ATPASE; GENE; S100A8/A9; APOPTOSIS; DIFFERENTIATION; DEGRADATION; MRP-14	Calgranulin B is known to be involved in tumor development, but the underlying molecular mechanism is not clear. To gain insight into possible roles of calgranulin B, we screened for calgranulin B-interacting molecules in the SNU-484 gastric cancer and the SNU-81 colon cancer cells. Calgranulin B-interacting partners were identified by yeast two-hybrid and functional information was obtained by computational analysis. Most of the calgranulin B interacting partners were involved in metabolic and cellular processes, and found to have molecular function of binding and catalytic activities. Interestingly, 46 molecules in the network of the calgranulin B-interacting proteins are known to be associated with cancer and FKBP2 was found to interact with calgranulin B in both SNU-484 and SNU-81 cells. Polyubiquitin-C encoded by UBC, which exhibited an interaction with calgranulin B, has been associated with various molecules of the extracellular space and plasma membrane identified in our screening, including Na-K-CI cotransporter 1 and dystonin in SNU-484 cells, and ATPase subunit beta-1 in SNU-81 cells. Our data provide novel insight into the roles of calgranulin B of gastrointestinal cancer cells, and offer new clues suggesting calgranulin B acts as an effector molecule through which the cell can communicate with the tumor microenvironment via polyubiquitin-C.	[Kim, Kyung-Hee] Natl Canc Ctr, Omics Core Lab, Res Inst, Goyang Si, Gyeonggi Do, South Korea; [Kim, Kyung-Hee; Yoo, Byong Chul] Natl Canc Ctr, Colorectal Canc Branch, Res Inst, Goyang Si, Gyeonggi Do, South Korea; [Yeo, Seung-Gu] Soonchunhyang Univ, Coll Med, Dept Radiat Oncol, Cheonan, Chungnam, South Korea; [Myung, Jae Kyung] Natl Canc Ctr, Dept Syst Canc Sci, Grad Sch Canc Sci & Policy, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Soonchunhyang University; National Cancer Center - Korea (NCC)	Myung, JK (corresponding author), Natl Canc Ctr, Dept Syst Canc Sci, Grad Sch Canc Sci & Policy, Goyang Si, Gyeonggi Do, South Korea.	jkmyung@ncc.re.kr	Kim, Hyung-Kwan/R-8375-2019; Yeo, Seung-Gu/ABC-1124-2021	Yeo, Seung-Gu/0000-0003-1371-1381; Kim, Kyung-Hee/0000-0003-0214-0296	National Cancer Center, Korea [NCC-1410870-3]; Soonchunhyang University	National Cancer Center, Korea; Soonchunhyang University	This work was supported by grants from the National Cancer Center, Korea (NCC-1410870-3) and the Soonchunhyang University Research Fund.	AguiarPasseti T, 1997, J LEUKOCYTE BIOL, V62, P852, DOI 10.1002/jlb.62.6.852; Algharabli J, 2012, CELL PHYSIOL BIOCHEM, V30, P33, DOI 10.1159/000339047; Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Borsy A, 2009, MOL GENET GENOMICS, V281, P301, DOI 10.1007/s00438-008-0413-7; Bulut GB, 2011, J BIOL CHEM, V286, P6449, DOI 10.1074/jbc.M110.186890; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; GRIMMOND S, 1995, HUM GENET, V95, P455; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Ivanchuk SM, 2008, CELL CYCLE, V7, P1836, DOI 10.4161/cc.7.12.6025; JIN YJ, 1991, P NATL ACAD SCI USA, V88, P6677, DOI 10.1073/pnas.88.15.6677; Kapoor S, 2009, INFLAMMATION, V32, P70, DOI 10.1007/s10753-009-9104-8; Kim BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106182; Kim K, 2016, ONCOTARGET, V7, P20368, DOI 10.18632/oncotarget.7783; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Newton RA, 1998, J IMMUNOL, V160, P1427; Piper RC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016808; Qin FJ, 2010, PATHOL ONCOL RES, V16, P353, DOI 10.1007/s12253-009-9225-2; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; ROTH J, 1992, IMMUNOBIOLOGY, V186, P304, DOI 10.1016/S0171-2985(11)80259-7; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Shibata F, 2004, EUR J BIOCHEM, V271, P2137, DOI 10.1111/j.1432-1033.2004.04129.x; Shiozaki A, 2014, WORLD J GASTROENTERO, V20, P6844, DOI 10.3748/wjg.v20.i22.6844; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stes E, 2014, J PROTEOME RES, V13, P3107, DOI 10.1021/pr4012443; Sun PL, 2015, QJM; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Tummala R, 2009, CANCER CHEMOTH PHARM, V64, P1187, DOI 10.1007/s00280-009-0985-x; Wagemans J, 2015, METHODS MOL BIOL, V1278, P409, DOI 10.1007/978-1-4939-2425-7_27; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yoo BC, 2008, DIS COLON RECTUM, V51, P1703, DOI 10.1007/s10350-008-9381-6; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200	51	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171232	10.1371/journal.pone.0171232	http://dx.doi.org/10.1371/journal.pone.0171232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152021	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200112
J	Pan, X; Bowman, M; Scott, RJ; Fitter, J; Smith, R; Zakar, T				Pan, Xin; Bowman, Maria; Scott, Rodney J.; Fitter, John; Smith, Roger; Zakar, Tamas			Promoter Methylation Pattern Controls Corticotropin Releasing Hormone Gene Activity in Human Trophoblasts	PLOS ONE			English	Article							DNA METHYLATION; HISTONE ACETYLATION; CPG METHYLATION; HUMAN PLACENTA; EXPRESSION; TRANSCRIPTION; CHROMATIN; BINDING	Placental CRH production increases with advancing pregnancy in women and its course predicts gestational length. We hypothesized that CRH gene expression in the placenta is epigenetically controlled setting gestational trajectories characteristic of normal and pathological pregnancies. Here we determined histone modification and DNA methylation levels and DNA methylation patterns at the CRH promoter in primary trophoblast cultures by chromatin immunoprecipitation combined with clonal bisulfite sequencing and identified the transcriptionally active epialleles that associate with particular histone modifications and transcription factors during syncytialisation and cAMP-stimulation. CRH gene expression increased during syncytial differentiation and cAMP stimulation, which was associated with increased activating and decreased repressive histone modification levels at the promoter. DNA methylation levels remained unchanged. The nine CpGs of the CRH proximal promoter were partially and allele-independently methylated displaying many (>100) epialleles. RNA-polymerase-II (Pol-II) bound only to three particular epialleles in cAMP-stimulated cells, while phospho-cAMP response element-binding protein (pCREB) bound to only one epiallele, which was different from those selected by Pol-II. Binding of TATA-binding protein increased during syncytial differentiation preferentially at epialleles compatible with Pol-II and pCREB binding. Histone-3 acetylation was detected only at epialleles targeted by Pol-II and pCREB, while gene activating histone-4 acetylation and histone-3-lysine-4 trimethylation occurred at CRH epialleles not associated with Pol-II or pCREB. The suppressive histone-3-lysine-27 trimethyl and-lysine-9 trimethyl modifications showed little or no epiallele preference. The epiallele selectivity of activating histone modifications and transcription factor binding demonstrates the epigenetic and functional diversity of the CRH gene in trophoblasts, which is controlled predominantly by the patterns, not the overall extent, of promoter methylation. We propose that conditions impacting on epiallele distribution influence the number of transcriptionally active CRH gene copies in the trophoblast cell population determining the gestational trajectory of placental CRH production in normal and pathological pregnancies.	[Pan, Xin; Bowman, Maria; Fitter, John; Smith, Roger; Zakar, Tamas] Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW, Australia; [Pan, Xin; Scott, Rodney J.; Fitter, John; Smith, Roger; Zakar, Tamas] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Scott, Rodney J.] Hunter Area Pathol Serv, Mol Med, New Lambton Hts, NSW, Australia; [Smith, Roger; Zakar, Tamas] John Hunter Hosp, New Lambton Hts, NSW, Australia; [Pan, Xin] Chongqing Med Univ, Dept Obstet & Gynaecol, Affiliated Hosp 2, Chongqing, Peoples R China	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital; Chongqing Medical University	Zakar, T (corresponding author), Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW, Australia.; Zakar, T (corresponding author), Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.; Zakar, T (corresponding author), John Hunter Hosp, New Lambton Hts, NSW, Australia.	Tamas.Zakar@newcastle.edu.au	Zakar, Tamas/G-7507-2013; Scott, Rodney/B-2827-2013	Smith, Roger/0000-0003-4720-0280; Scott, Rodney/0000-0001-7724-3404; Zakar, Tamas/0000-0002-1690-1159; Bowman, Maria/0000-0002-2333-7883	China Scholarship Council (CRC); School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia	China Scholarship Council (CRC)(China Scholarship Council); School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia	X.P. received support from the China Scholarship Council (CRC) and the School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER GK, 1990, MOL CELL ENDOCRINOL, V70, P165, DOI 10.1016/0303-7207(90)90156-3; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Berger RL, 1996, AM STAT, V50, P314, DOI 10.2307/2684927; Cheng YH, 2000, J CLIN ENDOCR METAB, V85, P1239, DOI 10.1210/jc.85.3.1239; COUTIFARIS C, 1991, ANN NY ACAD SCI, V622, P191; Di Stefano V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9806; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Elliott G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7363; Fogarty NME, 2011, J ANAT, V219, P601, DOI 10.1111/j.1469-7580.2011.01417.x; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; King BR, 2001, PEPTIDES, V22, P795, DOI 10.1016/S0196-9781(01)00393-X; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li YY, 2011, METHODS MOL BIOL, V791, P239, DOI 10.1007/978-1-61779-316-5_18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majzoub JA, 1995, ANN NY ACAD SCI, V771, P293, DOI 10.1111/j.1749-6632.1995.tb44689.x; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; Mitchell C, 2011, ENDOCRINOLOGY, V152, P2113, DOI 10.1210/en.2010-1327; Nicholson RC, 2004, FRONT BIOSCI, V9, P32, DOI 10.2741/1204; Nicholson RC, 2001, FRONT HORM RES, V27, P246; Pan X, 2015, INT J ENDOCRINOL, V2015, P1; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Scatena CD, 1998, MOL ENDOCRINOL, V12, P1228, DOI 10.1210/me.12.8.1228; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Sehringer B, 2005, ANAL BIOANAL CHEM, V383, P768, DOI 10.1007/s00216-005-0067-9; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith R, 2012, TRENDS ENDOCRIN MET, V23, P516, DOI 10.1016/j.tem.2012.05.002; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; SPENGLER D, 1992, MOL ENDOCRINOL, V6, P1931, DOI 10.1210/me.6.11.1931; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Wang AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094394; Wang B, 2012, MOL ENDOCRINOLOGY; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Williamson DS, 1996, ACCIDENT ANAL PREV, V28, P571, DOI 10.1016/0001-4575(96)00023-1; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170671	10.1371/journal.pone.0170671	http://dx.doi.org/10.1371/journal.pone.0170671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151936	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200032
J	Perez, T; Fernandez, M; Hammer, SE; Dominguez, A				Perez, Trinidad; Fernandez, Margarita; Hammer, Sabine E.; Dominguez, Ana			Multilocus Intron Trees Reveal Extensive Male- Biased Homogenization of Ancient Populations of Chamois (Rupicapra spp.) across Europe during Late Pleistocene	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; BAYESIAN-INFERENCE; PHYLOGENY; SEQUENCE; ORIGIN; PHYLOGEOGRAPHY; CONSERVATION; DIVERGENCE; DISPERSAL; SOFTWARE	The inferred phylogenetic relationships between organisms often depend on the molecular marker studied due to the diverse evolutionary mode and unlike evolutionary histories of different parts of the genome. Previous studies have shown conflicting patterns of differentiation of mtDNA and several nuclear markers in chamois (genus Rupicapra) that indicate a complex evolutionary picture. Chamois are mountain caprine that inhabit most of the medium to high altitude mountain ranges of southern Eurasia. The most accepted taxonomical classification considers two species, R.pyrenaica (with the subspecies parva, pyrenaica and ornata) from southwestern Europe and R. rupicapra (with the subspecies cartusiana, rupicapra, tatrica, carpatica, balcanica, asiatica and caucasica) from northeastern Europe. Phylogenies of mtDNA revealed three very old clades (from the early Pleistocene, 1.9 Mya) with a clear geographical signal. Here we analyze a set of 23 autosomal introns, comprising 15,411 nucleotides, in 14 individuals covering the 10 chamois subspecies. Introns offered an evolutionary scenario that contrasts with mtDNA. The nucleotidic diversity was 0.0013 +/- 0.0002, at the low range of what is found in other mammals even if a single species is considered. A coalescent multilocus analysis with * BEAST indicated that introns diversified 88 Kya, in the late Pleistocene, and the effective population size at the root was lower than 10,000 individuals. The dispersal of some few migrant males should have rapidly spread trough the populations of chamois, given the homogeneity of intron sequences. The striking differences between mitochondrial and nuclear markers can be attributed to strong female philopatry and extensive male dispersal. Our results highlight the need of analyzing multiple and varied genome components to capture the complex evolutionary history of organisms.	[Perez, Trinidad; Fernandez, Margarita; Dominguez, Ana] Univ Oviedo, Dept Biol Func, Julian Claveria 6, Oviedo, Spain; [Hammer, Sabine E.] Univ Vet Med Vienna, Dept Pathobiol, Inst Immunol, Vet Pl 1, Vienna, Austria	University of Oviedo; University of Veterinary Medicine Vienna	Dominguez, A (corresponding author), Univ Oviedo, Dept Biol Func, Julian Claveria 6, Oviedo, Spain.	sanjurjo@uniovi.es	Dominguez, Ana/E-4412-2010; Pérez, Trinidad/AAC-6729-2019	Dominguez, Ana/0000-0002-8610-5553; Pérez, Trinidad/0000-0003-1216-5593; Hammer, Sabine/0000-0003-1475-3938	Ministerio de Economia y Competitividad. Spain [CGL2011-25117]	Ministerio de Economia y Competitividad. Spain(Spanish Government)	Funded by Ministerio de Economia y Competitividad. Spain. (grant number CGL2011-25117).	Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Arnold M. L., 2004, WILSON Q, V2004, P60; Arnold ML, 2009, RETICULATE EVOLUTION, Vxii; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Cabrera A., 1914, FAUNA IBERICA MAMIFE, Vxviii; Camerano A., 1914, MEM R ACCAD SCI SFMN, V64, P1; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Corlatti L, 2011, MAMMAL REV, V41, P163, DOI 10.1111/j.1365-2907.2011.00187.x; Couturier MAJ, 1938, LE CHAMOIS; Cregut-Bonnoure E, 2007, QUATERNAIRE, V18, P73; Crestanello B, 2009, J HERED, V100, P691, DOI 10.1093/jhered/esp053; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez Philippe, 2007, Revue de Paleobiologie, V26, P425; GAILLARD JM, 1992, ONGULES / UNGULATES 91, P493; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Groves C, 2011, UNGULATE TAXONOMY; Grubb P., 1993, MAMMAL SPECIES WORLD, P374; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hammer S, 1995, ACTA THERIOL, P145; Hassanin A, 2013, MOL PHYLOGENET EVOL, V66, P766, DOI 10.1016/j.ympev.2012.11.003; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Heled J, 2013, BEAST BEAST 2 0 ESTI; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Igea J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-369; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Lalueza-Fox C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-70; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Loison A, 1999, J MAMMAL, V80, P620, DOI 10.2307/1383306; Lovari S., 1987, P51; Lovari S, 1980, B ZOOL, V47, P12; Lovari S, 1985, SAUGETIERKUNDLICHE M, V32, P113; MASINI F, 1988, QUATERNARY RES, V30, P339, DOI 10.1016/0033-5894(88)90009-9; Miller C, 1986, Z JAGDWISS, V33, P220; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nascetti G., 1985, P56; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEMBERTON JM, 1989, Z SAUGETIERKD, V54, P243; Perez T, 1996, BIOCHEM GENET, V34, P313, DOI 10.1007/BF02399950; Perez T, 2002, MOL PHYLOGENET EVOL, V25, P524, DOI 10.1016/S1055-7903(02)00296-8; Perez T, 2014, MOL PHYLOGENET EVOL, V79, P375, DOI 10.1016/j.ympev.2014.07.004; Perez T, 2013, MOL PHYLOGENET EVOL, V67, P621, DOI 10.1016/j.ympev.2013.02.027; Perez T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-272; PerezBarberia FJ, 1996, Z SAUGETIERKD, V61, P276; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2009, FIGTREE TREE FIGURE; Rambaut A., 2007, TRACER V1 4; Rodriguez F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-222; Rodriguez F, 2009, J HERED, V100, P47, DOI 10.1093/jhered/esn074; Rook L, 2010, QUATERN INT, V219, P134, DOI 10.1016/j.quaint.2010.01.007; Ropiquet A, 2005, MOL PHYLOGENET EVOL, V36, P154, DOI 10.1016/j.ympev.2005.01.002; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Schaschl H, 2005, IMMUNOGENETICS, V57, P108, DOI 10.1007/s00251-005-0784-4; Schaschl H, 2003, HEREDITY, V91, P125, DOI 10.1038/sj.hdy.6800290; SLATKIN M, 1981, GENETICS, V99, P323; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAJIMA F, 1983, GENETICS, V105, P437; Tonini J, 2015, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.34260cc27551a527b124ec5f6334b6be; Valdez R., 2011, HDB MAMMALS WORLD HO, V2, P741; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	76	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170392	10.1371/journal.pone.0170392	http://dx.doi.org/10.1371/journal.pone.0170392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146581	Green Published, gold, Green Submitted			2022-12-26	WOS:000396131700022
J	Sieuwerts, AM; Schrijver, WAME; Dalm, SU; de Weerd, V; Moelans, CB; ter Hoeve, N; van Diest, PJ; Martens, JWM; van Deurzen, CHM				Sieuwerts, Anieta M.; Schrijver, Willemijne A. M. E.; Dalm, Simone U.; de Weerd, Vanja; Moelans, Cathy B.; ter Hoeve, Natalie; van Diest, Paul J.; Martens, John W. M.; van Deurzen, Carolien H. M.			Progressive APOBEC3B mRNA expression in distant breast cancer metastases	PLOS ONE			English	Article							DELETION POLYMORPHISM; RECEPTOR CONVERSION; ENZYMATIC SOURCE; UP-REGULATION; MUTAGENESIS; DEAMINATION; MUTATIONS; CARCINOMA; PATTERNS; ALPHA	Background APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of cases and its expression is associated with poor prognosis. However, its expression in breast cancer metastases, which are the main causes of breast cancer-related death, remained to be elucidated. Patients and methods RNA was isolated from 55 primary breast cancers and paired metastases, including regional lymph node (N = 20) and distant metastases (N = 35). APOBEC3B mRNA levels were measured by RT-qPCR. Expression levels of the primary tumors and corresponding metastases were compared, including subgroup analysis by estrogen receptor (ER/ESR1) status. Results Overall, APOBEC3B mRNA levels of distant metastases were significantly higher as compared to the corresponding primary breast tumor (P = 0.0015), an effect that was not seen for loco-regional lymph node metastases (P = 0.23). Subgroup analysis by ER-status showed that increased APOBEC3B levels in distant metastases were restricted to metastases arising from ER-positive primary breast cancers (P = 0.002). However, regarding ERnegative primary tumors, only loco-regional lymph node metastases showed increased APOBEC3B expression when compared to the corresponding primary tumor (P = 0.028). Conclusion APOBEC3B mRNA levels are significantly higher in breast cancer metastases as compared to the corresponding ER-positive primary tumors. This suggests a potential role for APOBEC3B in luminal breast cancer progression, and consequently, a promising role for antiAPOBEC3B therapies in advanced stages of this frequent form of breast cancer.	[Sieuwerts, Anieta M.; de Weerd, Vanja; Martens, John W. M.] Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Sieuwerts, Anieta M.; Martens, John W. M.] Erasmus MC, Erasmus MC Canc Inst, Canc Genom Ctr, Rotterdam, Netherlands; [Schrijver, Willemijne A. M. E.; Moelans, Cathy B.; ter Hoeve, Natalie; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Dalm, Simone U.] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [van Deurzen, Carolien H. M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sieuwerts, AM (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.; Sieuwerts, AM (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Canc Genom Ctr, Rotterdam, Netherlands.	a.sieuwerts@erasmusmc.nl		Dalm, Simone/0000-0002-6393-6901	Cancer Genomics Netherlands; Netherlands Organization of Scientific Research (NWO)	Cancer Genomics Netherlands; Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by Cancer Genomics Netherlands (AMS and JWMM) and Netherlands Organization of Scientific Research (NWO) (JWMM). The supporters had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	[Anonymous], 2012, BREAST CANCER GUIDEL; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gwak M, 2014, TUMORI J, V100, pE112, DOI [10.1177/1636.17922, 10.1700/1636.17922]; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoefnagel LDC, 2013, ANN ONCOL, V24, P3017, DOI 10.1093/annonc/mdt390; Hoefnagel LDC, 2012, CANCER-AM CANCER SOC, V118, P4929, DOI 10.1002/cncr.27518; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Jin Z, 2014, ONCOL REP, V32, P1867, DOI 10.3892/or.2014.3437; Jiwa LS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-864; Kosumi K, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0739-7; Kroigard AB, 2016, BREAST J, V22, P420, DOI 10.1111/tbj.12596; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Land AM, 2015, ONCOTARGET, V6, P39969, DOI 10.18632/oncotarget.5483; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Nowarski R, 2013, CANCER RES, V73, P3494, DOI 10.1158/0008-5472.CAN-13-0728; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schrijver WAME, 2015, BREAST CANCER RES TR, V151, P41, DOI 10.1007/s10549-015-3362-y; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Tsuboi M, 2016, BREAST CANCER-TOKYO, V23, P780, DOI 10.1007/s12282-015-0641-8; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Zhang J, 2015, INT J CLIN EXP PATHO, V8, P5089; Zhang YF, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0056-9	35	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171343	10.1371/journal.pone.0171343	http://dx.doi.org/10.1371/journal.pone.0171343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141868	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500056
J	Karhula, SS; Finnila, MA; Lammi, MJ; Ylarinne, JH; Kauppinen, S; Rieppo, L; Pritzker, KPH; Nieminen, HJ; Saarakkala, S				Karhula, Sakari S.; Finnila, Mikko A.; Lammi, Mikko J.; Ylarinne, Janne H.; Kauppinen, Sami; Rieppo, Lassi; Pritzker, Kenneth P. H.; Nieminen, Heikki J.; Saarakkala, Simo			Effects of Articular Cartilage Constituents on Phosphotungstic Acid Enhanced Micro-Computed Tomography	PLOS ONE			English	Article							CT ARTHROGRAPHY; MATRIX METALLOPROTEINASES; GLYCOSAMINOGLYCAN CONTENT; COLLAGEN; QUANTITATION; CLEAVE; SITES	Contrast-enhanced micro-computed tomography (CE mu CT) with phosphotungstic acid (PTA) has shown potential for detecting collagen distribution of articular cartilage. However, the selectivity of the PTA staining to articular cartilage constituents remains to be elucidated. The aim of this study was to investigate the dependence of PTA for the collagen content in bovine articular cartilage. Adjacent bovine articular cartilage samples were treated with chondroitinase ABC and collagenase to degrade the proteoglycan and the collagen constituents in articular cartilage, respectively. Enzymatically degraded samples were compared to the untreated samples using CE mu CT and reference methods, such as Fourier-transform infrared imaging. Decrease in the X-ray attenuation of PTA in articular cartilage and collagen content was observed in cartilage depth of 0-13% and deeper in tissue after collagen degradation. Increase in the X-ray attenuation of PTA was observed in the cartilage depth of 13- 39% after proteoglycan degradation. The X-ray attenuation of PTA-labelled articular cartilage in CE mu CT is associated mainly with collagen content but the proteoglycans have a minor effect on the X-ray attenuation of the PTA-labelled articular cartilage. In conclusion, the PTA labeling provides a feasible CE mu CT method for 3D characterization of articular cartilage.	[Karhula, Sakari S.; Finnila, Mikko A.; Kauppinen, Sami; Rieppo, Lassi; Nieminen, Heikki J.; Saarakkala, Simo] Univ Oulu, Res Unit Med Imaging Phys & Technol, Fac Med, Oulu, Finland; [Karhula, Sakari S.] Univ Oulu, Infotech Doctoral Program, Oulu, Finland; [Finnila, Mikko A.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Finnila, Mikko A.; Rieppo, Lassi; Saarakkala, Simo] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Finnila, Mikko A.; Rieppo, Lassi; Saarakkala, Simo] Univ Oulu, Oulu, Finland; [Lammi, Mikko J.; Ylarinne, Janne H.] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Lammi, Mikko J.] Xi An Jiao Tong Univ, Key Lab Trace Elements & Endem Dis, Natl Hlth & Family Planning Commiss, Sch Publ Hlth,Hlth Sci Ctr, Xian, Peoples R China; [Pritzker, Kenneth P. H.; Nieminen, Heikki J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pritzker, Kenneth P. H.] Mt Sinai Hosp, Toronto, ON, Canada; [Nieminen, Heikki J.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Saarakkala, Simo] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland	University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; University of Oulu; Umea University; Xi'an Jiaotong University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Helsinki; University of Oulu	Karhula, SS (corresponding author), Univ Oulu, Res Unit Med Imaging Phys & Technol, Fac Med, Oulu, Finland.; Karhula, SS (corresponding author), Univ Oulu, Infotech Doctoral Program, Oulu, Finland.	sakari.karhula@oulu.fi	Lammi, Mikko/B-9291-2008; Nieminen, Heikki J./AGX-8430-2022; Karhula, Sakari/AAL-8862-2021; Finnila, Mikko/X-6492-2019; Rieppo, Lassi/AAP-2538-2020; Saarakkala, Simo/F-5839-2013	Lammi, Mikko/0000-0002-6181-9904; Nieminen, Heikki J./0000-0001-6084-1272; Saarakkala, Simo/0000-0003-2850-5484; Finnila, Mikko/0000-0002-3348-5759	European Research Council [336267]; Suomen Akatemia (Academy of Finland) [273571, 253579, 268378]; Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation)	European Research Council(European Research Council (ERC)European Commission); Suomen Akatemia (Academy of Finland); Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation)	This work was supported by: European Research Council (https://erc.europa.eu/), grant no: 336267, SS; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 273571, SS; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 253579, HJN; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 268378, SS; Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation, http://www.sigridjuselius.fi/foundation), grant no: N/A, SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from the Academy of Finland (grants no. 268378, 273571, 253579); Sigrid Juselius Foundation; European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 336267; and the strategic funding of the University of Oulu are acknowledged. We thank Veljekset Ronka Oy (Kemi, Finland) for providing the bovine joints.	Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E; Bansal PN, 2011, J ORTHOP RES, V29, P704, DOI 10.1002/jor.21312; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FOSANG AJ, 1993, BIOCHEM J, V295, P273, DOI 10.1042/bj2950273; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Freedman JD, 2014, ANGEW CHEM INT EDIT, V53, P8406, DOI 10.1002/anie.201404519; Hirvasniemi J, 2013, OSTEOARTHR CARTILAGE, V21, P434, DOI 10.1016/j.joca.2012.12.009; Joshi NS, 2009, J AM CHEM SOC, V131, P13234, DOI 10.1021/ja9053306; Kallioniemi AS, 2007, PHYS MED BIOL, V52, P1209, DOI 10.1088/0031-9155/52/4/024; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Lammi MJ, 2004, J RHEUMATOL, V31, P2449; Loret B, 2010, INT J SOLIDS STRUCT, V47, P2201, DOI 10.1016/j.ijsolstr.2010.04.010; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; Nieminen HJ, 2015, OSTEOARTHR CARTILAGE, V23, P1613, DOI 10.1016/j.joca.2015.05.004; Omoumi P, 2015, OSTEOARTHR CARTILAGE, V23, P224, DOI 10.1016/j.joca.2014.08.017; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pritzker K, 2003, OSTEOARTHRITIS; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Siebelt M, 2011, OSTEOARTHR CARTILAGE, V19, P1183, DOI 10.1016/j.joca.2011.07.006; Silvast TS, 2009, ACTA RADIOL, V50, P78, DOI 10.1080/02841850802572526; Summers GC, 2008, BIORHEOLOGY, V45, P365, DOI 10.3233/BIR-2008-0495; Toyoshima T, 2001, CONNECT TISSUE RES, V42, P281, DOI 10.3109/03008200109016842; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yoo HJ, 2011, RADIOLOGY, V261, P805, DOI 10.1148/radiol.11102495	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171075	10.1371/journal.pone.0171075	http://dx.doi.org/10.1371/journal.pone.0171075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135331	gold, Green Published			2022-12-26	WOS:000396124700046
J	Puccetti, A; Dolcino, M; Tinazzi, E; Moretta, F; D'Angelo, S; Olivieri, I; Lunardi, C				Puccetti, Antonio; Dolcino, Marzia; Tinazzi, Elisa; Moretta, Francesca; D'Angelo, Salvatore; Olivieri, Ignazio; Lunardi, Claudio			Antibodies Directed against a Peptide Epitope of a Klebsiella pneumoniae-Derived Protein Are Present in Ankylosing Spondylitis	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; AXIAL SPONDYLOARTHRITIS; PSORIATIC-ARTHRITIS; AUTOANTIBODIES; COLLAGEN; CELLS; EXPRESSION; CARTILAGE; FEATURES; PROPOSAL	Ankylosing spondylitis (AS) is a chronic inflammatory arthritis of unknown origin. Its autoimmune origin has been suggested but never proven. Several reports have implicated Klebsiella pneumoniae as a triggering or perpetuating factor in AS; however, its role in the disease pathogenesis remains debated. Moreover, despite extensive investigations, a biomarker for AS has not yet been identified. To clarify these issues, we screened a random peptide library with pooled IgGs obtained from 40 patients with AS. A peptide (AS peptide) selected from the library was recognized by serum IgGs from 170 of 200 (85%) patients with AS but not by serum specimens from 100 healthy controls. Interestingly, the AS peptide shows a sequence similarity with several molecules expressed at the fibrocartilaginous sites that are primarily involved in the AS inflammatory process. Moreover, the peptide is highly homologous to a Klebsiella pneumoniae dipeptidase (DPP) protein. The antibody affinity purified against the AS peptide recognizes the autoantigens and the DPP protein. Furthermore, serum IgG antibodies against the Klebsiella DPP121-145 peptide epitope were detected in 190 of 200 patients with AS (95%), 3 of 200 patients with rheumatoid arthritis (1.5%) and only 1 of 100 (1%) patients with psoriatic arthritis. Such reactivity was not detected in healthy control donors. Our results show that antibodies directed against an epitope of a Klebsiella pneumoniae-derived protein are present in nearly all patients with AS. In the absence of serological biomarkers for AS, such antibodies may represent a useful tool in the diagnosis of the disease.	[Puccetti, Antonio; Dolcino, Marzia] Pediat Hosp Bambino Gesu, Immunol Area, Rome, Italy; [Tinazzi, Elisa; Moretta, Francesca; Lunardi, Claudio] Univ Verona, Dept Med, Verona, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] Madonna delle Grazie Hosp Matera, Rheumatol Dept Lucania, Matera, Italy	IRCCS Bambino Gesu; University of Verona	Puccetti, A (corresponding author), Pediat Hosp Bambino Gesu, Immunol Area, Rome, Italy.	antonio.puccetti@opbg.net	Moretta, Francesca/Z-3169-2019; Tinazzi, Elisa/AAB-9450-2020; D'Angelo, Salvatore/H-9010-2012	Moretta, Francesca/0000-0002-1150-8622; D'Angelo, Salvatore/0000-0002-7442-1110				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Breban M, 2004, CURR MOL MED, V4, P31, DOI 10.2174/1566524043479347; Chou MY, 2002, GENOMICS, V79, P395, DOI 10.1006/geno.2002.6712; Coffre M, 2013, ARTHRITIS RHEUM-US, V65, P1510, DOI 10.1002/art.37936; Fert I, 2014, ARTHRITIS RHEUMATOL, V66, P841, DOI 10.1002/art.38318; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Locht H, 1999, CLIN EXP IMMUNOL, V117, P568; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; MakiIkola O, 1996, BRIT J RHEUMATOL, V35, P125; Rashid T, 2007, CLIN RHEUMATOL, V26, P858, DOI 10.1007/s10067-006-0488-7; Rashid T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/872632; Rashid T, 2011, DISCOV MED, V12, P187; ROSENBERG JN, 1979, ANN RHEUM DIS, V38, P526, DOI 10.1136/ard.38.6.526; Rysnik O, 2016, J AUTOIMMUN, V70, P12, DOI 10.1016/j.jaut.2016.03.009; Sieper J, 2006, BEST PRACT RES CL RH, V20, P401, DOI 10.1016/j.berh.2006.02.001; Talpin A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0417-0; Tani Y, 1997, CLIN EXP RHEUMATOL, V15, P295; Taurog JD, 2016, NEW ENGL J MED, V374, P2563, DOI 10.1056/NEJMra1406182; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tran TM, 2015, CURR OPIN RHEUMATOL, V27, P357, DOI 10.1097/BOR.0000000000000188; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Wright C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M9.00384; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	31	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171073	10.1371/journal.pone.0171073	http://dx.doi.org/10.1371/journal.pone.0171073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135336	gold, Green Published, Green Submitted			2022-12-26	WOS:000396124700045
J	Zhang, AG; Lai, HZ; Xu, JH; Huang, WK; Liu, YF; Zhao, DW; Chen, RA				Zhang, Aiguo; Lai, Hanzhang; Xu, Jiahua; Huang, Wenke; Liu, Yufu; Zhao, Dawei; Chen, Ruiai			Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; VIRUS INFECTION; INTRANASAL IMMUNIZATION; HUMAN HEALTH; A H9N2; H5N1; CHICKENS; CHINA; CELLS; MICE	Current commercial H9 avian influenza vaccines cannot provide satisfactory protective immunity against antigenic variant influenza viruses in ducks. Poly I:C, when used as an adjuvant, improves humoral and cellular immunity in many animals but has not been tested in ducks. In this study, we investigated the protective efficacy of Poly I:C as an adjuvant for an inactivated H9N2 Avian influenza vaccine in ducks. We found that an H9N2 vaccine administered with poly I:C (H9-PIC vaccine) induced a significantly more rapid response with higher anti-influenza antibody titers than those of the vaccine alone (H9 vaccine). Moreover, virus shedding was reduced in ducks immunized with the H9-PIC vaccine after challenge with an H9 subtype antigenic variant viruses. IFN-alpha, IFN-gamma, IL-6 and MHC-II mRNA levels were all elevated in ducks receiving the H9-PIC vaccine. In addition, lower expression level of MHC-I may be a reason for inefficient protective ability against heterologous influenza viruses in H9-PIC vaccination of ducks. In conclusion, poly I:C adjuvant enhanced both humoral and cellular immune responses in ducks induced by immunization of inactivated H9N2 vaccine.	[Zhang, Aiguo; Liu, Yufu; Zhao, Dawei; Chen, Ruiai] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Lai, Hanzhang; Xu, Jiahua; Huang, Wenke] Guangdong Enterprise Key Lab Biotechnol R&D Vet B, Zhaoqing, Guangdong, Peoples R China	South China Agricultural University	Chen, RA (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	chensa727@126.com			Technology Planning Project of Guangdong Province [20156020230011]	Technology Planning Project of Guangdong Province	This study was supported by the Technology Planning Project of Guangdong Province (Grant No. 20156020230011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capua I, 2002, ACTA TROP, V83, P1, DOI 10.1016/S0001-706X(02)00050-5; Chen H, 2003, VACCINE, V21, P4430, DOI 10.1016/S0264-410X(03)00430-4; Deng GH, 2013, J VIROL, V87, P9452, DOI 10.1128/JVI.00776-13; Shen EX, 2007, CELL MOL IMMUNOL, V4, P113; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; He HQ, 2012, DEV COMP IMMUNOL, V36, P756, DOI 10.1016/j.dci.2011.11.006; Huang ZY, 2012, VET IMMUNOL IMMUNOP, V150, P169, DOI 10.1016/j.vetimm.2012.09.010; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; Jin Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1110; Kang H, 2012, POULTRY SCI, V91, P1074, DOI 10.3382/ps.2011-01817; Kang YF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01283; Kim ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137608; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Liang JF, 2013, POULTRY SCI, V92, P2651, DOI 10.3382/ps.2013-03193; Liu YF, 2016, AVIAN DIS, V60, P817, DOI 10.1637/11452-061616-Reg; Maas R, 2011, AVIAN PATHOL, V40, P87, DOI 10.1080/03079457.2010.541226; McNally B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051351; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Neeland MR, 2014, VACCINE, V32, P6183, DOI 10.1016/j.vaccine.2014.09.036; Overton ET, 2014, VACCINE, V32, P5490, DOI 10.1016/j.vaccine.2014.07.078; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Paul MS, 2012, VACCINE, V30, P4524, DOI 10.1016/j.vaccine.2012.04.033; Sachan S, 2015, VACCINE, V33, P4526, DOI 10.1016/j.vaccine.2015.07.016; Salem ML, 2006, VACCINE, V24, P5119, DOI 10.1016/j.vaccine.2006.04.010; Singh SM, 2015, VACCINE, V33, P3947, DOI 10.1016/j.vaccine.2015.06.043; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; Tang YH, 2014, VET MICROBIOL, V172, P120, DOI 10.1016/j.vetmic.2014.05.007; Teng QY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0372-7; Thomas M, 2015, VACCINE, V33, P542, DOI 10.1016/j.vaccine.2014.11.034; Uchida Y, 2014, J VET MED SCI, V76, P1111, DOI 10.1292/jvms.13-0620; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100792; Yu SH, 2010, MOL BIOL REP, V37, P1295, DOI 10.1007/s11033-009-9504-8; Zapala L, 2011, ONCOL REP, V25, P831, DOI 10.3892/or.2010.1128; Zhao JC, 2012, J VIROL, V86, P11416, DOI 10.1128/JVI.01410-12; Zhu YB, 2015, ARCH VIROL, V160, P917, DOI 10.1007/s00705-015-2337-y	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170681	10.1371/journal.pone.0170681	http://dx.doi.org/10.1371/journal.pone.0170681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135294	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700017
J	Tsuji, A; Kuwamura, S; Shirai, A; Yuasa, K				Tsuji, Akihiko; Kuwamura, Shuji; Shirai, Akihiro; Yuasa, Keizo			Identification and Characterization of a 25 kDa Protein That Is Indispensable for the Efficient Saccharification of Eisenia bicyclis in the Digestive Fluid of Aplysia kurodai	PLOS ONE			English	Article							ECKLONIA-STOLONIFERA; ETHANOL-PRODUCTION; SALIVARY PROTEINS; PHLOROTANNINS; POLYPHENOLS; BINDING; MARINE; ENZYME; CLEAVAGE; CHITIN	The digestive fluid of the sea hare Aplysia kurodai can liberate approximately 2.5 mg of glucose from 10 mg of dried Eisenia bicyclis powder. Although laminaran, a major storage polysaccharide in E. bicyclis, is easily digested to glucose by the synergistic action of the 110 and 210 kDa A. kurodai beta-glucosidases (BGLs), glucose is not liberated from E. bicyclis by direct incubation with these BGLs. To clarify this discrepancy, we searched for an Eisenia hydrolysis enhancing protein (EHEP) in the digestive fluid of A. kurodai. A novel 25 kDa protein that enhances E. bicyclis saccharification by beta-glucosidases was purified to a homogeneous state from the digestive fluid of A. kurodai, and its cDNA was cloned from total cDNAs reverse-transcribed from hepatopancreas total RNA. The E. bicyclis extract strongly inhibited BGLs, suggesting some compound within this brown alga functioned as a feeding deterrent. However, when E. bicyclis was incubated with BGLs in the presence of EHEP, glucose production was markedly increased. As E. bicyclis is rich in phlorotannin, which are only found in brown algae, our study suggested that these compounds are the main BGL inhibitors in E. bicyclis extract. EHEP protects BGLs from phlorotannin inhibition by binding to phlorotannins and forming an insoluble complex with phloroglucinol and phlorotannins. These findings indicated that EHEP plays a key role in the saccharification of brown seaweeds containing phlorotannins in the digestive fluid of A. kurodai. This is the first report of EHEP as a phlorotannin-binding protein that protects BGLs from inhibition.	[Tsuji, Akihiko; Kuwamura, Shuji; Yuasa, Keizo] Univ Tokushima, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, 2-1 Minamijosanjima, Tokushima, Japan; [Shirai, Akihiro] Univ Tokushima, Grad Sch Biosci & Bioind, Dept Bioresource Chem & Technol, 2-1 Minamijosanjima, Tokushima, Japan	Tokushima University; Tokushima University	Tsuji, A (corresponding author), Univ Tokushima, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, 2-1 Minamijosanjima, Tokushima, Japan.	tsuji.akihiko@tokushima-u.ac.jp			Japan Society for the Promotion of Science [26450284]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (jsps.go.jp) to AT (No: 26450284).	Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Bhadury P, 2004, PLANTA, V219, P561, DOI 10.1007/s00425-004-1307-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brethauer S, 2010, BIORESOURCE TECHNOL, V101, P4862, DOI 10.1016/j.biortech.2009.11.009; CANNELL RJP, 1990, APPL BIOCHEM BIOTECH, V26, P85, DOI 10.1007/BF02798395; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Casu R, 1997, P NATL ACAD SCI USA, V94, P8939, DOI 10.1073/pnas.94.17.8939; Chowdhury MTH, 2014, J ENVIRON BIOL, V35, P713; Dutot M, 2012, APPL BIOCHEM BIOTECH, V167, P2234, DOI 10.1007/s12010-012-9761-1; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Eom SH, 2012, J SCI FOOD AGR, V92, P2084, DOI 10.1002/jsfa.5585; FUKUYAMA Y, 1989, CHEM PHARM BULL, V37, P349; GAO K, 1994, J APPL PHYCOL, V6, P45, DOI 10.1007/BF02185904; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harun R, 2014, BIOTECHNOL J, V9, P73, DOI 10.1002/biot.201200353; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Jung HA, 2014, J PHARM PHARMACOL, V66, P1180, DOI 10.1111/jphp.12241; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kellogg J, 2014, MAR DRUGS, V12, P5277, DOI 10.3390/md12105277; Kikuchi Y, 2008, J BIOCHEM, V144, P789, DOI 10.1093/jb/mvn132; Kim SM, 2011, APPL BIOCHEM BIOTECH, V165, P1296, DOI 10.1007/s12010-011-9347-3; Kumagai Y, 2010, COMP BIOCHEM PHYS B, V155, P138, DOI 10.1016/j.cbpb.2009.10.013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liw Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI [10.1007/s00253-005-0229-x, DOI 10.1007/S00253-005-0229-X]; Menshova RV, 2014, CARBOHYD POLYM, V99, P101, DOI 10.1016/j.carbpol.2013.08.037; Nelson N, 1944, J BIOL CHEM, V153, P375; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Pereira RC, 1999, BOT MAR, V42, P441, DOI 10.1515/BOT.1999.051; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Shibata T, 2004, J APPL PHYCOL, V16, P291, DOI 10.1023/B:JAPH.0000047781.24993.0a; Shibata T., 2014, American Journal of Plant Sciences, V5, P387, DOI 10.4236/ajps.2014.53051; Shibata T, 2002, EUR J PHYCOL, V37, P493, DOI 10.1017/S0967026202003918; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; Siegel B Z, 1973, CRC Crit Rev Microbiol, V3, P1, DOI 10.3109/10408417309108743; Skrt M, 2012, FOOD CHEM, V135, P2418, DOI 10.1016/j.foodchem.2012.06.114; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; Sotka EE, 2009, INTEGR COMP BIOL, V49, P291, DOI 10.1093/icb/icp049; STEINBERG PD, 1988, J EXP MAR BIOL ECOL, V120, P221, DOI 10.1016/0022-0981(88)90003-2; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Tsuji A, 2014, FEBS OPEN BIO, V4, P560, DOI 10.1016/j.fob.2014.06.002; Tsuji A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065418; Tsuji A, 2012, COMP BIOCHEM PHYS B, V163, P324, DOI 10.1016/j.cbpb.2012.08.005; Wei N, 2013, TRENDS BIOTECHNOL, V31, P70, DOI 10.1016/j.tibtech.2012.10.009; Yamashita Y, 2010, J BIOSCI BIOENG, V110, P79, DOI 10.1016/j.jbiosc.2009.12.009; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170669	10.1371/journal.pone.0170669	http://dx.doi.org/10.1371/journal.pone.0170669			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129373	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400047
J	Franzetti, GA; Laud-Duval, K; van der Ent, W; Brisac, A; Irondelle, M; Aubert, S; Dirksen, U; Bouvier, C; de Pinieux, G; Snaar-Jagalska, E; Chavrier, P; Delattre, O				Franzetti, G-A; Laud-Duval, K.; van der Ent, W.; Brisac, A.; Irondelle, M.; Aubert, S.; Dirksen, U.; Bouvier, C.; de Pinieux, G.; Snaar-Jagalska, E.; Chavrier, P.; Delattre, O.			Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells	ONCOGENE			English	Article							CHROMOSOME-TRANSLOCATION; MOLECULAR PATHOGENESIS; TRANSCRIPTION FACTOR; NEUROBLASTOMA-CELLS; GENOMIC LANDSCAPE; MELANOMA-CELLS; HUMAN TUMORS; IN-VITRO; GROWTH; EXPRESSION	Ewing sarcoma is characterized by the expression of the chimeric EWSR1-FLI1 transcription factor. Proteomic analyses indicate that the decrease of EWSR1-FLI1 expression leads to major changes in effectors of the dynamics of the actin cytoskeleton and the adhesion processes with a shift from cell-to-cell to cell-matrix adhesion. These changes are associated with a dramatic increase of in vivo cell migration and invasion potential. Importantly, EWSR1-FLI1 expression, evaluated by single-cell RT-ddPCR/immunofluorescence analyses, and activity, assessed by expression of EWSR1-FLI1 downstream targets, are heterogeneous in cell lines and in tumours and can fluctuate along time in a fully reversible process between EWSR1-FLI1(high) states, characterized by highly active cell proliferation, and EWSR1-FLI1(low) states where cells have a strong propensity to migrate, invade and metastasize. This new model of phenotypic plasticity proposes that the dynamic fluctuation of the expression level of a dominant oncogene is an intrinsic characteristic of its oncogenic potential.	[Franzetti, G-A; Laud-Duval, K.; van der Ent, W.; Brisac, A.; Irondelle, M.; Chavrier, P.; Delattre, O.] PSL Res Univ, Inst Curie, Paris 05, France; [Franzetti, G-A; Laud-Duval, K.; van der Ent, W.; Brisac, A.; Delattre, O.] Inst Curie, Res Ctr, INSERM U830, Genet & Biol Pediat Tumors Grp, 26 Rue Ulm, F-75005 Paris, Ile De France, France; [van der Ent, W.; Snaar-Jagalska, E.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Irondelle, M.; Chavrier, P.] Inst Curie, Res Ctr, UMR144, Membrane & Cytoskeleton Dynam Grp, Paris, France; [Irondelle, M.] Inst Curie, Res Ctr, UMR144, Cell & Tissue Imaging Facil PICT IBiSA, Paris, France; [Aubert, S.] Univ Hosp, Dept Pathol, Lille, France; [Dirksen, U.] Univ Hosp Muenster, Dept Pediat Hematol & Oncol, Albert Schweitzer Campus 1,A1, Munster, Germany; [Dirksen, U.] Westfalian Wilhelms Univ, Munster, Germany; [Bouvier, C.] La Timone Univ Hosp, Dept Pathol, Marseille, France; [de Pinieux, G.] Univ Hosp Tours, Dept Pathol, Chambray Les Tours, France; [de Pinieux, G.] Univ Tours, Chambray Les Tours, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; University of Munster; University of Munster; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Tours; Universite de Tours	Delattre, O (corresponding author), Inst Curie, Res Ctr, INSERM U830, Genet & Biol Pediat Tumors Grp, 26 Rue Ulm, F-75005 Paris, Ile De France, France.	Olivier.delattre@curie.fr	CHAVRIER, Philippe/B-4707-2010; Dirksen, Uta/AGX-8472-2022; CHAVRIER, Philippe/AAG-2645-2020	CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X; delattre, olivier/0000-0002-8730-2276; van der Ent, Wietske/0000-0003-2165-9624	INSERM; Ligue Nationale Contre le Cancer (Equipe labellisse); Institut National du Cancer [PLBIO14-237]; European PROVABES [ERA-649, 01KT1310]; ASSET [FP7- HEALTH- 2010-259348]; EEC [HEALTH-F2-2013-602856]; German Cancer Aid [DKH 108128]; Ministere de l'Enseignement Superieur et de la Recherche (France); FRM [FDT20130928190]; Stichting Kinderen Kankervrij [30677]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer (Equipe labellisse); Institut National du Cancer(Institut National du Cancer (INCA) France); European PROVABES; ASSET; EEC; German Cancer Aid(Deutsche Krebshilfe); Ministere de l'Enseignement Superieur et de la Recherche (France); FRM(Fondation pour la Recherche Medicale); Stichting Kinderen Kankervrij	This work was supported by grants from the Institut Curie, the INSERM, the Ligue Nationale Contre le Cancer (Equipe labellisse), the Institut National du Cancer (PLBIO14-237), the European PROVABES (ERA-649 NET TRANSCAN JTC- 2011; 01KT1310), ASSET (FP7- HEALTH- 2010-259348), and EEC (HEALTH-F2-2013-602856) projects, the German Cancer Aid (DKH 108128) and the following associations: the Societe Francaise de lutte contre les Cancers et des leucemies de l'enfant et de l'adolescent, the Etoile de Martin, Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon, Enfants et Sante, les Amis de Claire and M la vieavec Lisa. Georges-Alain Franzetti was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (France) and from the FRM (FDT20130928190). Wietske van der Ent was supported by Stichting Kinderen Kankervrij (Grant No. 30677). The authors are grateful to Laura Brulle-Soumare (INSERM U1143, CNRS UMR3666, Institut Curie, Paris, France) for her help with mice experiments. The authors would like to acknowledge the Nikon Imaging Center @ Institut Curie-CNRS and the Cell and Tissue Imaging Platform (member of FranceBioimaging) of the Genetics and Developmental Biology Department (UMR3215/U934) of Institut Curie, and also the Cytometry Plateform of Tumor Biology Department of Institut Curie.	Agra N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066281; Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Ban J, 2014, CANCER RES, V74, P6578, DOI 10.1158/0008-5472.CAN-14-1736; Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; BIEDLER JL, 1973, CANCER RES, V33, P2643; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Chakrabarti Lina, 2012, Front Oncol, V2, P82, DOI 10.3389/fonc.2012.00082; Chaturvedi A, 2014, MOL BIOL CELL, V25, P2695, DOI 10.1091/mbc.E14-01-0007; Chaturvedi Aashi, 2012, Genes Cancer, V3, P102, DOI 10.1177/1947601912457024; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DAHLIN DC, 1961, J BONE JOINT SURG AM, V43, P185, DOI 10.2106/00004623-196143020-00004; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deley M-CL, 2014, J CLIN ONCOL, V32, P2440; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Franzetti GA, 2013, ONCOGENE, V32, P3915, DOI 10.1038/onc.2012.403; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Girnita L, 2000, ONCOGENE, V19, P4298, DOI 10.1038/sj.onc.1203755; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; HaDuong JH, 2015, PEDIATR CLIN N AM, V62, P179, DOI 10.1016/j.pcl.2014.09.012; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kovar H, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00054; Krook MA, 2014, MOL CANCER RES, V12, P953, DOI 10.1158/1541-7786.MCR-13-0668; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Montagnac G, 2013, NATURE, V502, P567, DOI 10.1038/nature12571; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Poomthavorn P, 2009, ENDOCR-RELAT CANCER, V16, P991, DOI 10.1677/ERC-08-0340; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sengupta A, 2013, INT J ONCOL, V43, P803, DOI 10.3892/ijo.2013.2016; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Stoll G, 2013, NUCLEIC ACIDS RES, V41, P8853, DOI 10.1093/nar/gkt678; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; van der Ent W, 2014, J PATHOL, V233, P415, DOI 10.1002/path.4378; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; Wiles Elizabeth T, 2013, Genes Cancer, V4, P486, DOI 10.1177/1947601913506115	49	93	96	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3505	3514		10.1038/onc.2016.498	http://dx.doi.org/10.1038/onc.2016.498			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28135250	hybrid, Green Published			2022-12-26	WOS:000403878600001
J	Bender, KW; Blackburn, RK; Monaghan, J; Derbyshire, P; Menke, FLH; Zipfel, C; Goshe, MB; Zielinski, RE; Huber, SC				Bender, Kyle W.; Blackburn, R. Kevin; Monaghan, Jacqueline; Derbyshire, Paul; Menke, Frank L. H.; Zipfel, Cyril; Goshe, Michael B.; Zielinski, Raymond E.; Huber, Steven C.			Autophosphorylation-based Calcium (Ca2(+)) Sensitivity Priming and Ca2(+)/Calmodulin Inhibition of Arabidopsis thaliana Ca2(+)-dependent Protein Kinase 28 (CPK28)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; RECEPTOR-LIKE KINASE; SIGNALING NETWORK; BINDING; CDPK; ACTIVATION; CA2+; SPECIFICITY; PROVIDES; BIK1	Plant calcium (Ca2(+))-dependent protein kinases (CPKs) represent the primary Ca2(+) -dependent protein kinase activities in plant systems. CPKs are composed of a dual specificity (Ser/Thr and Tyr) kinase domain tethered to a calmodulin-like domain (CLD) via an autoinhibitory junction (J). Although regulation of CPKs by Ca2(+)has been extensively studied, the contribution of autophosphorylation in controlling CPK activity is less well understood. Furthermore, whether calmodulin (CaM) contributes to CPK regulation, as is the case for Ca2(+) /CaM-dependent protein kinases outside the plant lineage, remains an open question. We therefore screened a subset of plant CPKs for CaM binding and found that CPK28 is a high affinity Ca2(+)/CaM-binding protein. Using synthetic peptides and native gel electrophoresis, we coarsely mapped the CaM-binding domain to a site within the CPK28 J domain that overlaps with the known site of intramolecular interaction between the J domain and the CLD. Peptide kinase activity of fully dephosphorylated CPK28 was Ca2(+)-responsive and was inhibited by Ca2(+)/CaM. Using in situ autophosphorylated protein, we expand on the known set of CPK28 autophosphorylation sites, and we demonstrate that, unexpectedly, autophosphorylated CPK28 had enhanced kinase activity at physiological concentrations of Ca2(+)compared with the dephosphorylated protein, suggesting that autophosphorylation functions to prime CPK28 for Ca2(+) activation and might also allow CPK28 to remain active when Ca2(+) levels are low. Furthermore, CPK28 autophosphorylation substantially reduced sensitivity of the kinase to Ca2(+) /CaM inhibition. Overall, our analyses uncover new complexities in the control of CPK28 and provide mechanistic support for Ca2(+) signaling specificity through Ca2(+) sensor priming.	[Bender, Kyle W.; Zielinski, Raymond E.; Huber, Steven C.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Blackburn, R. Kevin; Goshe, Michael B.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Monaghan, Jacqueline; Derbyshire, Paul; Menke, Frank L. H.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Huber, Steven C.] Agr Res Serv, United States Dept Agr Agr, Urbana, IL 61801 USA; [Monaghan, Jacqueline] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA); Queens University - Canada	Bender, KW; Zielinski, RE (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	kwbender@illinois.edu; rez@illinois.edu	Bender, Kyle W/V-4678-2017; ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021; Bender, Kyle/AAJ-5993-2020; Menke, Frank/F-2739-2014	Bender, Kyle W/0000-0002-1805-8097; ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Bender, Kyle/0000-0002-1805-8097; Menke, Frank/0000-0003-2490-4824; Zielinski, Ray/0000-0003-0324-7407	National Science Foundation-IOS Grant [1354094]; National Science Foundation Grant [DBI-1126244]; North Carolina Agricultural Research Service; European Molecular Biology Organization and Anniversary Future Leader Fellowship from the United Kingdom Biotechnology and Biological Sciences Research Council [BB/M013499]; Gatsby Charitable Foundation; European Research Council Grant "PHOSPHinnATE"; United States Department of Agriculture-Agricultural Research Service; Direct For Biological Sciences [1354094] Funding Source: National Science Foundation; BBSRC [BBS/E/J/000PR9796, BB/M013499/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9796, BB/M013499/1] Funding Source: researchfish	National Science Foundation-IOS Grant; National Science Foundation Grant(National Science Foundation (NSF)); North Carolina Agricultural Research Service; European Molecular Biology Organization and Anniversary Future Leader Fellowship from the United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; European Research Council Grant "PHOSPHinnATE"; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Science Foundation-IOS Grant 1354094 (to S.C.H. and R.E.Z.), National Science Foundation Grant DBI-1126244, the North Carolina Agricultural Research Service (to M.B.G. and R.K.B.), European Molecular Biology Organization and Anniversary Future Leader Fellowship BB/M013499 from the United Kingdom Biotechnology and Biological Sciences Research Council (to J.M.), the Gatsby Charitable Foundation (to C.Z. and F.L.H.M.), European Research Council Grant "PHOSPHinnATE") (to C.Z.), and the United States Department of Agriculture-Agricultural Research Service (to S.C.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Bender KW, 2015, BIOCHEM J, V467, P399, DOI 10.1042/BJ20141403; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Boudsocq M, 2012, BIOCHEM J, V447, P291, DOI 10.1042/BJ20112072; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Charpenteau M, 2004, BIOCHEM J, V379, P841, DOI 10.1042/BJ20031045; Chaudhuri S, 1999, PLANT PHYSIOL, V120, P859, DOI 10.1104/pp.120.3.859; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Chen ZH, 2010, PLANT J, V61, P816, DOI 10.1111/j.1365-313X.2009.04108.x; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, FEBS LETT, V584, P4717, DOI 10.1016/j.febslet.2010.10.059; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Ingram JR, 2015, P NATL ACAD SCI USA, V112, pE4975, DOI 10.1073/pnas.1505914112; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kim HS, 2009, FEBS LETT, V583, P36, DOI 10.1016/j.febslet.2008.11.046; Laanemets K, 2013, PLANT PHYSIOL, V163, P504, DOI 10.1104/pp.113.220343; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Matschi S, 2013, PLANT J, V73, P883, DOI 10.1111/tpj.12090; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Monaghan J, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1018497; Monaghan J, 2014, CELL HOST MICROBE, V16, P605, DOI 10.1016/j.chom.2014.10.007; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2012, BIOCHEM J, V443, P515, DOI 10.1042/BJ20111871; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; SAHA P, 1995, BIOCHEM J, V305, P205, DOI 10.1042/bj3050205; Swatek KN, 2014, BIOCHEM J, V459, P15, DOI 10.1042/BJ20130035; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Wang Y, 2004, BIOCHEM J, V383, P73, DOI 10.1042/BJ20031907; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Zhang XRS, 2001, J MOL EVOL, V53, P214, DOI 10.1007/s002390010211; Zielinski Raymond E, 2002, Methods Mol Biol, V172, P143; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	46	28	28	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3988	4002		10.1074/jbc.M116.763243	http://dx.doi.org/10.1074/jbc.M116.763243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154194	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000395837100004
J	Salehi-Najafabadi, Z; Li, B; Valentino, V; Ng, C; Martin, H; Yu, Y; Wang, ZF; Kashyap, P; Yu, Y				Salehi-Najafabadi, Zahra; Li, Bin; Valentino, Victoria; Ng, Courtney; Martin, Hannah; Yu, Yang; Wang, Zhifei; Kashyap, Parul; Yu, Yong			Extracellular Loops Are Essential for the Assembly and Function of Polycystin Receptor-Ion Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; TRANSIENT RECEPTOR; DOMAIN; IDENTIFICATION; PKD2L1; PKD1L3; GENE; PROTEIN; OLIGOMERIZATION; LOCALIZATION	Polycystin complexes, or TRPP-PKD complexes, made of transient receptor potential channel polycystin (TRPP) and polycystic kidney disease (PKD) proteins, play key roles in coupling extracellular stimuli with intracellular Ca2+ signals. For example, the TRPP2-PKD1 complex has a crucial function in renal physiology, with mutations in either protein causing autosomal dominant polycystic kidney disease. In contrast, the TRPP3-PKD1L3 complex responds to lowpHand was proposed to be a sour taste receptor candidate. It has been shown previously that the protein partners interact via association of the C-terminal or transmembrane segments, with consequences for the assembly, surface expression, and function of the polycystin complexes. However, the roles of extracellular components, especially the loops that connect the transmembrane segments, in the assembly and function of the polycystin complex are largely unknown. Here, with an immunoprecipitation method, we found that extracellular loops between the first and second transmembrane segments of TRPP2 and TRPP3 associate with the extracellular loops between the sixth and seventh transmembrane segments ofPKD1and PKD1L3, respectively. Immunofluorescence and electrophysiology data further confirm that the associations between these loops are essential for the trafficking and function of the complexes. Interestingly, most of the extracellular loops are also found to be involved in homomeric assembly. Furthermore, autosomal dominant polycystic kidney disease-associated TRPP2 mutant T448K significantly weakened TRPP2 homomeric assembly but had no obvious effect on TRPP2-PKD1 heteromeric assembly. Our results demonstrate a crucial role of these functionally underexplored extracellular loops in the assembly and function of the polycystin complexes.	[Salehi-Najafabadi, Zahra; Li, Bin; Valentino, Victoria; Ng, Courtney; Martin, Hannah; Yu, Yang; Wang, Zhifei; Kashyap, Parul; Yu, Yong] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA	Saint John's University	Yu, Y (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	yuy2@stjohns.edu	Wang, Zhifei/AAN-2553-2021; Salehi Najafabadi, Zahra/C-6795-2017	Yu, Yong/0000-0002-1849-0779; Salehi Najafabadi, Zahra/0000-0002-0658-9966; Martin, Hannah/0000-0003-2028-5798	National Institutes of Health Grant [DK102092]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK102092] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK102092 (to Yong Yu). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cai YQ, 2014, J CLIN INVEST, V124, P5129, DOI 10.1172/JCI67273; Chapin HC, 2010, MOL BIOL CELL, V21, P4338, DOI 10.1091/mbc.E10-05-0407; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lam C, 2014, METHODS MOL BIOL, V1172, P193, DOI 10.1007/978-1-4939-0928-5_17; Li AR, 2003, GENOMICS, V81, P596, DOI 10.1016/S0888-7543(03)00048-X; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Molland KL, 2012, BBA-PROTEINS PROTEOM, V1824, P413, DOI 10.1016/j.bbapap.2011.12.002; Molland KL, 2010, BIOCHEM J, V429, P171, DOI 10.1042/BJ20091843; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Oatley P, 2012, BIOCHEMISTRY-US, V51, P2879, DOI 10.1021/bi300134b; Pavel MA, 2016, P NATL ACAD SCI USA, V113, pE2363, DOI 10.1073/pnas.1517066113; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Semmo M, 2014, HANDB EXP PHARMACOL, V222, P675, DOI 10.1007/978-3-642-54215-2_27; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Veldhuisen B, 1999, EUR J HUM GENET, V7, P860, DOI 10.1038/sj.ejhg.5200383; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Yang YF, 2015, J BIOL CHEM, V290, P10544, DOI 10.1074/jbc.M115.641803; Yu Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2257; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Zhu J, 2011, P NATL ACAD SCI USA, V108, P10133, DOI 10.1073/pnas.1017669108	49	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4210	4221		10.1074/jbc.M116.767897	http://dx.doi.org/10.1074/jbc.M116.767897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154010	Green Published, hybrid			2022-12-26	WOS:000395837100019
J	Eickmeier, O; Fussbroich, D; Mueller, K; Serve, F; Smaczny, C; Zielen, S; Schubert, R				Eickmeier, Olaf; Fussbroich, Daniela; Mueller, Klaus; Serve, Friederike; Smaczny, Christina; Zielen, Stefan; Schubert, Ralf			Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY INFLAMMATION; CFTR EXPRESSION; RESOLUTION; ASSOCIATION; NEUTROPHILS; MECHANISMS; STRATEGIES; PROFILES; CHILDREN	Background Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) locus lead to defective proteins and reduced Cl-secretion and Na+ hyperabsorption in the affected organs. In addition, patients suffering from CF display chronic inflammation that contributes to the pathogenesis of CF. Recent work suggests that CF patients have a reduced capacity to biosynthesize specialized pro-resolving lipid mediators (SPMs), which contributes to the development and duration of the unwanted inflammation. Alterations in the metabolism of arachidonic acid (AA) and docosahexaenoic acid (DHA) to specialized pro-resolving mediators (SPMs), like lipoxins (LXs), maresins (MaRs), protectins (PDs) and resolvins (Rvs), may play a major role on clinical impact of airway inflammation in CF. Methods In this study, our aims were to detect and quantitate Resolvin D1 (RvD1) in sputum and plasma from patients with CF and compare levels of RvD1 with biomarkers of inflammation and lung function. We studied 27 CF patients aged 6 to 55 years (median 16 years) in a prospective approach. Results DHA can be found in the plasma of our CF patients in the milligram range and is decreased in comparison to a healthy control group. The DHA-derived pro-resolving mediator Resolvin D1 (RvD1) was also present in the plasma (286.4 +/- 50 pg/ mL, mean +/- SEM) and sputum (30.0 +/- 2.6 pg/ mL, mean +/- SEM) samples from our patients with CF and showed a positive correlation with sputum inflammatory markers. The plasma concentrations of RvD1 were ten times higher than sputum concentrations. Interestingly, sputum RvD1/IL-8 levels showed a positive correlation with FEV1 (r(s) = 0.3962, p< 0.05). Conclusions SPMs, like RvD1, are well known to down-regulate inflammatory pathways. Our study shows that the bioactive lipid mediator RvD1, derived from DHA, was present in sputum and plasma of CF patients and may serve as a representative peripheral biomarker of the lung resolution program for CF patients.	[Eickmeier, Olaf; Fussbroich, Daniela; Mueller, Klaus; Serve, Friederike; Zielen, Stefan; Schubert, Ralf] Goethe Univ, Div Allergol Pulmonol & Cyst Fibrosis, Dept Children & Adolescents, Frankfurt, Germany; [Fussbroich, Daniela] Univ Appl Sci, Dept Food Technol, Fulda, Germany; [Smaczny, Christina] Goethe Univ, Dept Internal Med 3, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Eickmeier, O (corresponding author), Goethe Univ, Div Allergol Pulmonol & Cyst Fibrosis, Dept Children & Adolescents, Frankfurt, Germany.	olaf.eickmeier@kgu.de	Zielen, Stefan/AAD-7243-2020	Eickmeier, Olaf/0000-0003-2835-9886				Al-Turkmani MR, 2007, PROSTAG LEUKOTR ESS, V77, P309, DOI 10.1016/j.plefa.2007.10.009; BLANCHARD J, 1992, THER DRUG MONIT, V14, P48, DOI 10.1097/00007691-199202000-00008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruscia EM, 2016, CLIN CHEST MED, V37, P17, DOI 10.1016/j.ccm.2015.11.010; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Carevic M, 2015, EUR RESPIR J, V46, P395, DOI 10.1183/09031936.00173514; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Doring G, 2000, Paediatr Respir Rev, V1, P101, DOI 10.1053/prrv.2000.0030; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Eckrich J, 2016, J CYSTIC FIBROSIS OF; Efthimiadis A, 2002, EUR RESPIR J, V20, p19S, DOI 10.1183/09031936.02.00001902; Eickmeier O., 2013, Mediators of Inflammation, V2013, P913135, DOI 10.1155/2013/913135; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Elborn JS., 2016, LANCET LONDON ENGLAN; Ettorre M, 2014, BBA-GEN SUBJECTS, V1840, P3088, DOI 10.1016/j.bbagen.2014.07.010; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fantino E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-28; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Haworth O, 2007, EUR RESPIR J, V30, P980, DOI 10.1183/09031936.00005807; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024399; Karp CL, 2005, PROSTAG LEUKOTR ESS, V73, P263, DOI 10.1016/j.plefa.2005.05.015; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Kohn G, 1996, Z ERNAHRUNGSWISS, V35, P226, DOI 10.1007/BF01625685; Kormann MSD, 2012, EUR RESPIR J, V39, P1385, DOI 10.1183/09031936.00130011; Laval J, 2016, BIOL CHEM, V397, P485, DOI 10.1515/hsz-2015-0271; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Muller U, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/626530; Oliver C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002201.pub5; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Plant BJ, 2013, LANCET RESP MED, V1, P164, DOI 10.1016/S2213-2600(13)70025-0; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; Rosewich M, 2015, CYTOKINE, V73, P156, DOI 10.1016/j.cyto.2014.10.026; Rothman S, 1996, GASTROENTEROLOGY, V111, P833, DOI 10.1053/gast.1996.v111.agast961110833; Sagel SD, 2003, CURR OPIN PULM MED, V9, P516, DOI 10.1097/00063198-200311000-00012; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Shanshiashvili LV, 2012, MOL IMMUNOL, V51, P310, DOI 10.1016/j.molimm.2012.03.029; Starosta V, 2006, EUR RESPIR J, V28, P581, DOI 10.1183/09031936.06.00071405; Takashi M, 1990, JAPANESE J UROLOGY, V81, P116; Tu ML, 2013, SCI WORLD J, DOI 10.1155/2013/402140; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Wojewodka G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088567	56	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171249	10.1371/journal.pone.0171249	http://dx.doi.org/10.1371/journal.pone.0171249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158236	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700046
J	Jiang, YF; Dong, H; Eckmann, L; Hanson, EM; Ihn, KC; Mittal, RK				Jiang, Yanfen; Dong, Hui; Eckmann, Lars; Hanson, Elaine M.; Ihn, Katherine C.; Mittal, Ravinder K.			Visualizing the enteric nervous system using genetically engineered double reporter mice: Comparison with immunofluorescence	PLOS ONE			English	Article							MYENTERIC NEURONS; CHOLINE-ACETYLTRANSFERASE; IMMUNOREACTIVITY; INNERVATION; PROJECTIONS; EXPRESSION; PLEXUS	Background and aims The enteric nervous system (ENS) plays a crucial role in the control of gastrointestinal motility, secretion and absorption functions. Immunohistochemistry has been widely used to visualize neurons of the ENS for more than two decades. Genetically engineered mice that report specific proteins can also be used to visualize neurons of the ENS. The goal of our study was to develop a mouse that expresses fluorescent neuronal nitric oxide synthase (nNOS) and choline acetyltransferase (ChAT), the two proteins expressed in 95% of the ENS neurons. We compared ENS neurons visualized in the reporter mouse with the wild type mouse stained using classical immunostaining techniques. Methods Mice hemizygous for ChAT-ChR2-YFP BAC transgene with expression of the mhChR2: YFP fusion protein directed by ChAT promoter/enhancer regions on the BAC transgene were purchased commercially. The Cre/LoxP technique of somatic recombination was used to construct mice with nNOS positive neurons. The two mice were crossbred and tissues were harvested and examined using fluorescent microscopy. Immunostaining was performed in the wild type mice, using antibodies to nNOS, ChAT, Hu and PGP 9.5. Results Greater than 95% of the ENS neurons were positive for either nNOS or ChAT or both. The nNOS and ChAT neurons and their processes in the ENS were well visualized in all the regions of the GI tract, i.e., esophagus, small intestine and colon. The number of nNOS and ChAT neurons was approximately same in the reporter mouse and immunostaining method in the wild type mouse. The nNOS fluorescence in the reporter mouse was seen in both cytoplasm as well as nucleus but in the immunostained specimens it was seen only in the cytoplasm. Conclusion We propose that the genetically engineered double reporter mouse for ChAT and nNOS proteins is a powerful tool to study of the effects of various diseases on the ENS without the need for immunostaining.	[Jiang, Yanfen; Dong, Hui; Eckmann, Lars; Hanson, Elaine M.; Ihn, Katherine C.; Mittal, Ravinder K.] Univ Calif San Diego, Dept Med, Sch Med, Div Gastroenterol, San Diego, CA 92103 USA; [Mittal, Ravinder K.] San Diego VA Hlth Care Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego	Mittal, RK (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, Div Gastroenterol, San Diego, CA 92103 USA.; Mittal, RK (corresponding author), San Diego VA Hlth Care Syst, San Diego, CA 92161 USA.	rmittal@ucsd.edu	Mittal, Ravinder/ABH-2171-2021		VA MERIT Grant;  [P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	VA MERIT Grant; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by VA MERIT Grant to RKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by VA MERIT Grant to RKM. All images were taken at the UCSD School of Medicine Microscopy Core Laboratory, which is supported by the Grant P30 NS047101. We thank Jennifer Santini of the UCSD microscopy core for help with the image acquisition.	Brookes SJH, 1996, GASTROENTEROLOGY, V111, P108, DOI 10.1053/gast.1996.v111.pm8698189; Carbone SE, 2014, NEUROGASTROENT MOTIL, V26, P1812, DOI 10.1111/nmo.12453; Costa M., 2000, Gut, V47, piv15, DOI 10.1136/gut.47.suppl_4.iv15; COSTA M, 1992, NEUROSCI LETT, V148, P121, DOI 10.1016/0304-3940(92)90819-S; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hao MM, 2013, J COMP NEUROL, V521, P3358, DOI 10.1002/cne.23354; Mawe GM, 1997, MICROSC RES TECHNIQ, V39, P1, DOI 10.1002/(SICI)1097-0029(19971001)39:1<1::AID-JEMT1>3.0.CO;2-R; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Murphy EMA, 2007, NEUROGASTROENT MOTIL, V19, P126, DOI 10.1111/j.1365-2982.2006.00843.x; NEUHUBER WL, 1994, CELL TISSUE RES, V276, P23, DOI 10.1007/BF00354780; Porter AJ, 1996, GASTROENTEROLOGY, V111, P401, DOI 10.1053/gast.1996.v111.pm8690205; Porter AJ, 2002, GUT, V51, P70, DOI 10.1136/gut.51.1.70; Sang Q, 1997, J ANAT, V190, P209, DOI 10.1046/j.1469-7580.1997.19020209.x; Udit S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00134; Wattchow D, 2008, NEUROGASTROENT MOTIL, V20, P1298, DOI 10.1111/j.1365-2982.2008.01165.x	17	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171239	10.1371/journal.pone.0171239	http://dx.doi.org/10.1371/journal.pone.0171239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158225	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700045
J	Barrenschee, M; Wedel, T; Lange, C; Hohmeier, I; Cossais, F; Ebsen, M; Vogel, I; Bottner, M				Barrenschee, Martina; Wedel, Thilo; Lange, Christina; Hohmeier, Ines; Cossais, Francois; Ebsen, Michael; Vogel, Ilka; Boettner, Martina			No neuronal loss, but alterations of the GDNF system in asymptomatic diverticulosis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; COLONIC MOTILITY; DISEASE; EXPRESSION; GUIDELINES; INTESTINE; BEHALF; PLEXUS	Background Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor known to promote the survival and maintenance of neurons not only in the developing but also in the adult enteric nervous system. As diverticular disease (DD) is associated with reduced myenteric neurons, alterations of the GDNF system were studied in asymptomatic diverticulosis (diverticulosis) and DD. Methods Morphometric analysis for quantifying myenteric ganglia and neurons were assessed in colonic full-thickness sections of patients with diverticulosis and controls. Samples of tunica muscularis (TM) and laser-microdissected myenteric ganglia from patients with diverticulosis, DD and controls were analyzed for mRNA expression levels of GDNF, GFRA1, and RET by RT-qPCR. Myenteric protein expression of both receptors was quantified by fluorescence-immunohistochemistry of patients with diverticulosis, DD, and controls. Results Although no myenteric morphometric alterations were found in patients with diverticulosis, GDNF, GFRA1 and RET mRNA expression was down-regulated in the TM of patients with diverticulosis as well as DD. Furthermore GFRA1 and RET myenteric plexus mRNA expression of patients with diverticulosis and DD was down-regulated, whereas GDNF remained unaltered. Myenteric immunoreactivity of the receptors GFR alpha 1 and RET was decreased in both asymptomatic diverticulosis and DD patients. Conclusion Our data provide evidence for an impaired GDNF system at gene and protein level not only in DD but also during early stages of diverticula formation. Thus, the results strengthen the idea of a disturbed GDNF-responsiveness as contributive factor for a primary enteric neuropathy involved in the pathogenesis and disturbed intestinal motility observed in DD.	[Barrenschee, Martina; Wedel, Thilo; Lange, Christina; Hohmeier, Ines; Cossais, Francois; Boettner, Martina] Univ Kiel, Inst Anat, Kiel, Germany; [Ebsen, Michael] Stadt Krankenhaus Kiel, Dept Pathol, Kiel, Germany; [Vogel, Ilka] Stadt Krankenhaus Kiel, Dept Surg, Kiel, Germany	University of Kiel	Barrenschee, M (corresponding author), Univ Kiel, Inst Anat, Kiel, Germany.	m.barrenschee@anat.uni-kiel.de	Cossais, François/AFP-6523-2022; Barrenschee, Martina/AAS-9945-2020	Cossais, François/0000-0001-8043-296X; Barrenschee, Martina/0000-0002-0244-9333; Wedel, Thilo/0000-0002-8146-2711	German Research Society (Deutsche Forschungsgemeinschaft, DFG) [WE 2366/4-2]; Faculty of Medicine, University of Kiel [F347022]	German Research Society (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Faculty of Medicine, University of Kiel	This work was supported by research grants from the German Research Society (Deutsche Forschungsgemeinschaft, DFG WE 2366/4-2) and the Faculty of Medicine, University of Kiel (F347022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrenschee M, 2013, CELL TISSUE RES, V354, P371, DOI 10.1007/s00441-013-1690-y; Barrenschee M, 2015, HISTOCHEM CELL BIOL; Bassotti G, 2005, CLIN GASTROENTEROL H, V3, P248, DOI 10.1016/S1542-3565(04)00614-7; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bottner M, 2013, GUT, V62, P1753, DOI 10.1136/gutjnl-2012-302660; Bottner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066290; Bottner M, 2012, DIGEST DIS, V30, P19, DOI 10.1159/000335699; Bottner M, 2010, NEUROGASTROENT MOTIL, V22, P168, DOI [DOI 10.1111/J.1365-2982.2009.01424.X, 10. 1111/j. 1365-2982. 2009. 01424. x]; Burzynski G, 2009, NEUROGASTROENT MOTIL, V21, P113, DOI 10.1111/j.1365-2982.2008.01256.x; CORTESINI C, 1991, DIS COLON RECTUM, V34, P339, DOI 10.1007/BF02050595; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Deduchovas O, 2008, ANN ANAT, V190, P525, DOI 10.1016/j.aanat.2008.09.002; Espin F, 2014, NEUROGASTROENT MOTIL, V26, P1458, DOI 10.1111/nmo.12407; Feuerstein JD, 2016, MAYO CLIN P; Gallego D, 2013, INT J COLORECTAL DIS, V28, P1413, DOI 10.1007/s00384-013-1716-7; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; Iwase H, 2005, J CLIN GASTROENTEROL, V39, P674, DOI 10.1097/01.mcg.0000173856.84814.37; Knowles CH, 2010, GUT, V59, P882, DOI 10.1136/gut.2009.200444; Knowles CH, 2009, ACTA NEUROPATHOL, V118, P271, DOI 10.1007/s00401-009-0527-y; R Core Team, 2012, R LANG ENV STAT COMP; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schafer KH, 1999, EXP BRAIN RES, V125, P447, DOI 10.1007/s002210050702; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; Stollman N, 2004, LANCET, V363, P631, DOI 10.1016/S0140-6736(04)15597-9; Tursi A, 2016, THER ADV GASTROENTER, V9, P213, DOI 10.1177/1756283X15621228; Unsicker K, 1996, CELL TISSUE RES, V286, P175, DOI 10.1007/s004410050686; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; VORONINA TA, 1990, B EXP BIOL MED+, V109, P195, DOI 10.1007/BF00841669; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x; Wedel T, 2015, VISZERALMEDIZIN, V31, P76, DOI 10.1159/000381431	33	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171416	10.1371/journal.pone.0171416	http://dx.doi.org/10.1371/journal.pone.0171416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152033	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200142
J	Glinge, C; Clauss, S; Boddum, K; Jabbari, R; Jabbari, J; Risgaard, B; Tomsits, P; Hildebrand, B; Kaab, S; Wakili, R; Jespersen, T; Tfelt-Hansen, J				Glinge, Charlotte; Clauss, Sebastian; Boddum, Kim; Jabbari, Reza; Jabbari, Javad; Risgaard, Bjarke; Tomsits, Philipp; Hildebrand, Bianca; Kaeaeb, Stefan; Wakili, Reza; Jespersen, Thomas; Tfelt-Hansen, Jacob			Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BIOMARKERS; CANCER; SERUM; DIAGNOSIS	Background and aim The potential of microRNAs (miRNA) as non-invasive diagnostic, prognostic, and predictive biomarkers, as well as therapeutic targets, has recently been recognized. Previous studies have highlighted the importance of consistency in the methodology used, but to our knowledge, no study has described the methodology of sample preparation and storage systematically with respect to miRNAs as blood biomarkers. The aim of this study was to investigate the stability of miRNAs in blood under various relevant clinical and research conditions: different collection tubes, storage at different temperatures, physical disturbance, as well as serial freeze-thaw cycles. Methods Blood samples were collected from 12 healthy donors into different collection tubes containing anticoagulants, including EDTA, citrate and lithium-heparin, as well as into serum collection tubes. MiRNA stability was evaluated by measuring expression changes of miR-1, miR21 and miR-29b at different conditions: varying processing time of whole blood (up to 72 hours (h)), long-term storage (9 months at -80 degrees C), physical disturbance (1 and 8 h), as well as in a series of freeze/thaw cycles (1 and 4 times). Results Different collection tubes revealed comparable concentrations of miR-1, miR-21 and miR-29b. Tubes with lithium-heparin were found unsuitable for miRNA quantification. MiRNA levels were stable for at least 24 h at room temperature in whole blood, while separated fractions did show alterations within 24 h. There were significant changes in the miR-21 and miR-29b levels after 72 h incubation of whole blood at room temperature (p< 0.01 for both). Both miR-1 and miR-21 showed decreased levels after physical disturbance for 8 h in separated plasma and miR-1 in serum whole blood, while after 1 h of disturbance no changes were observed. Storage of samples at -80 degrees C extended the miRNA stability remarkably, however, miRNA levels in long-term stored (9 months) whole blood samples were significantly changed, which is in contrast to the plasma samples, where miR-21 or miR-29b levels were found to be stable. Repetitive (n = 4) freeze-thaw cycles resulted in a significant reduction of miRNA concentration both in plasma and serum samples. Conclusion This study highlights the importance of proper and systematic sample collection and preparation when measuring circulating miRNAs, e.g., in context of clinical trials. We demonstrated that the type of collection tubes, preparation, handling and storage of samples should be standardized to avoid confounding variables influencing the results.	[Glinge, Charlotte; Jabbari, Reza; Jabbari, Javad; Risgaard, Bjarke; Tfelt-Hansen, Jacob] Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen Univ Hosp, Copenhagen, Denmark; [Clauss, Sebastian; Tomsits, Philipp; Hildebrand, Bianca; Kaeaeb, Stefan; Wakili, Reza] Ludwig Maximilians Univ Munich LMU, Dept Med 1, Univ Hosp Munich, Campus Grosshadern, Munich, Germany; [Clauss, Sebastian] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Clauss, Sebastian; Tomsits, Philipp; Kaeaeb, Stefan; Wakili, Reza] MHA, DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany; [Boddum, Kim; Jespersen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Munich; Harvard University; Massachusetts General Hospital; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Copenhagen	Glinge, C (corresponding author), Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen Univ Hosp, Copenhagen, Denmark.	cglinge@gmail.com	Jabbari, Reza/AAM-6649-2021; Clauss, Sebastian/HDL-7189-2022; Tfelt-Hansen, Jacob/AAU-8691-2020	Jabbari, Reza/0000-0002-9432-0632; Clauss, Sebastian/0000-0002-5675-6128; Tfelt-Hansen, Jacob/0000-0003-3895-9316; Jespersen, Thomas/0000-0001-6575-360X	Novo Nordic Foundation; Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under REA grant [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK); German Centre for Cardiovascular Research (DZHK) [81X2600210, 81X2600204]; European Union [633193]; Danish Council for Independent Research Medical Sciences [DFF-1331-00313B]; Novo Nordisk Fonden [NNF13OC0007521, NNF14OC0011573] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under REA grant; German Centre for Cardiovascular Research (DZHK); German Centre for Cardiovascular Research (DZHK); European Union(European Commission); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Support from the Novo Nordic Foundation to JTH made this study possible. CG has received funding from The Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark. SC has received funding from The People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement No PIOF-GA-2012-328352. SC, PT, SK, and RW were supported by The German Centre for Cardiovascular Research (DZHK). Dres. Clauss, Kaab, Wakili were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). RW and SK received funding from The European Union's Horizon 2020 research and innovation programme under grant agreement No 633193 (CATCH ME). Danish Council for Independent Research Medical Sciences (DFF-1331-00313B) to TJ.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Farina NH, 2014, J CELL BIOCHEM, V115, P805, DOI 10.1002/jcb.24745; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Perron Marjorie P, 2007, Methods Mol Biol, V361, P311; Rice J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121948; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weckbach LT, 2016, CURR OPIN PHARMACOL, V27, P24, DOI 10.1016/j.coph.2016.01.001; Zhao H, 2014, CANCER EPIDEM BIOMAR, V23, P2643, DOI 10.1158/1055-9965.EPI-14-0550	31	166	170	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0167969	10.1371/journal.pone.0167969	http://dx.doi.org/10.1371/journal.pone.0167969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151938	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200003
J	Krieber, M; Bartl-Pokorny, KD; Pokorny, FB; Zhang, D; Landerl, K; Korner, C; Pernkopf, F; Pock, T; Einspieler, C; Marschik, PB				Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Zhang, Dajie; Landerl, Karin; Koerner, Christof; Pernkopf, Franz; Pock, Thomas; Einspieler, Christa; Marschik, Peter B.			Eye Movements during Silent and Oral Reading in a Regular Orthography: Basic Characteristics and Correlations with Childhood Cognitive Abilities and Adolescent Reading Skills	PLOS ONE			English	Article							PERCEPTUAL SPAN; CONSISTENT ORTHOGRAPHY; DYSLEXIC-CHILDREN; WORD-LENGTH; READERS; GERMAN; ACQUISITION; COMPREHENSION; FREQUENCY; PATTERNS	The present study aimed to define differences between silent and oral reading with respect to spatial and temporal eye movement parameters. Eye movements of 22 German-speaking adolescents (14 females; mean age = 13; 6 years; months) were recorded while reading an age-appropriate text silently and orally. Preschool cognitive abilities were assessed at the participants' age of 5; 7 (years; months) using the Kaufman Assessment Battery for Children. The participants' reading speed and reading comprehension at the age of 13; 6 (years; months) were determined using a standardized inventory to evaluate silent reading skills in German readers (Lesegeschwindigkeits-und -verstaendnistest fur Klassen 6-12). The results show that (i) reading mode significantly influenced both spatial and temporal characteristics of eye movement patterns; (ii) articulation decreased the consistency of intraindividual reading performances with regard to a significant number of eye movement parameters; (iii) reading skills predicted the majority of eye movement parameters during silent reading, but influenced only a restricted number of eye movement parameters when reading orally; (iv) differences with respect to a subset of eye movement parameters increased with reading skills; (v) an overall preschool cognitive performance score predicted reading skills at the age of 13; 6 (years; months), but not eye movement patterns during either silent or oral reading. However, we found a few significant correlations between preschool performances on subscales of sequential and simultaneous processing and eye movement parameters for both reading modes. Overall, the findings suggest that eye movement patterns depend on the reading mode. Preschool cognitive abilities were more closely related to eye movement patterns of oral than silent reading, while reading skills predicted eye movement patterns during silent reading, but less so during oral reading.	[Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Zhang, Dajie; Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Res Unit iDN Interdisciplinary Dev Neurosci, Inst Physiol, Ctr Physiol Med, Graz, Austria; [Pokorny, Florian B.; Pernkopf, Franz; Marschik, Peter B.] BioTechMed Graz, BEE PRI, Graz, Austria; [Pokorny, Florian B.] Tech Univ Munich, Machine Intelligence & Signal Proc Grp, Munich, Germany; [Landerl, Karin] Graz Univ, Inst Psychol, Dev Psychol, Graz, Austria; [Koerner, Christof] Graz Univ, Inst Psychol, Cognit Psychol & Neurosci, Graz, Austria; [Pernkopf, Franz] Graz Univ Technol, Signal Proc & Speech Commun Lab, Graz, Austria; [Pock, Thomas] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria; [Marschik, Peter B.] Karolinska Inst, Ctr Neurodev Disorders KIND, Dept Womens & Childrens Hlth, Stockholm, Sweden	Medical University of Graz; Technical University of Munich; University of Graz; University of Graz; Graz University of Technology; Graz University of Technology; Karolinska Institutet	Marschik, PB (corresponding author), Med Univ Graz, Res Unit iDN Interdisciplinary Dev Neurosci, Inst Physiol, Ctr Physiol Med, Graz, Austria.; Marschik, PB (corresponding author), BioTechMed Graz, BEE PRI, Graz, Austria.; Marschik, PB (corresponding author), Karolinska Inst, Ctr Neurodev Disorders KIND, Dept Womens & Childrens Hlth, Stockholm, Sweden.	peter.marschik@medunigraz.at	Bartl-Pokorny, Katrin/C-5396-2014; Einspieler, Christa/HHS-6481-2022; Marschik, Peter B/F-8195-2011	Landerl, Karin/0000-0003-4074-0233; Korner, Christof/0000-0002-3846-2337; Pokorny, Florian/0000-0001-9203-2904; Zhang, Dajie/0000-0001-6050-7426; Bartl-Pokorny, Katrin D./0000-0002-2658-1056; Marschik, Peter B/0000-0001-8932-0980	Country of Styria; City of Graz; Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI); Lanyar Foundation [P337]	Country of Styria; City of Graz; Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI); Lanyar Foundation	The study was supported by the Country of Styria, the City of Graz, the Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI; BioTechMed-Graz), and the Lanyar Foundation (P337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to the participants of our longitudinal study and their parents for their continuous support. We are grateful to Nina Bartl and Gunter Vogrinec for assistance in data analysis and technical assistance, and Miha Tavcar (scriptophil) for copy-editing the manuscript. We would also like to thank the Editor and the Reviewers for their guidance and their valuable comments on our manuscript. The study was supported by the Country of Styria, the City of Graz, the Brain, Ears & Eyes Pattern Recognition Initiative (BEE-PRI; BioTechMed-Graz), and the Lanyar Foundation (P337).	Anderson I. H., 1937, PSYCHOL MONOGR, V48, P61, DOI [10.1037/h0093393, DOI 10.1037/H0093393]; Ashby J, 2005, Q J EXP PSYCHOL-A, V58, P1065, DOI 10.1080/02724980443000476; Ashby J, 2012, ATTEN PERCEPT PSYCHO, V74, P634, DOI 10.3758/s13414-012-0277-0; Bartl-Pokorny KD, 2013, DEV NEUROREHABIL, V16, P188, DOI 10.3109/17518423.2013.773101; Brunswick N, 2012, J EXP CHILD PSYCHOL, V111, P268, DOI 10.1016/j.jecp.2011.08.001; Buswell GT, 1922, S ED MONOGRAPH, V21; Buswell GT, 1920, S ED MONOGRAPHS, V17; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; De Luca M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00696; Durrwachter U, 2010, ANN DYSLEXIA, V60, P86, DOI 10.1007/s11881-010-0034-9; Ferrer E, 2007, DEV PSYCHOL, V43, P1460, DOI 10.1037/0012-1649.43.6.1460; Hale AD, 2007, BEHAV ANAL TODAY, V8, P9, DOI [DOI 10.1037/H0100101, 10.1037/h0100101]; Hawelka S, 2005, VISION RES, V45, P855, DOI 10.1016/j.visres.2004.10.007; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Huestegge L, 2014, COGNITIVE PSYCHOL, V73, P72, DOI 10.1016/j.cogpsych.2014.06.001; Huestegge L, 2010, J EYE MOVEMENT RES, V3; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Inhoff AW, 2014, VIS COGN, V22, P354, DOI 10.1080/13506285.2013.879630; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; JUEL C, 1981, READ RES QUART, V16, P545, DOI 10.2307/747315; Kragler S., 1995, READING PSYCHOL INT, V6, P395, DOI DOI 10.1080/0270271950160402; Krieber M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145934; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Laubrock J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01432; Marschik PB, 2007, EARLY HUM DEV, V83, P107, DOI 10.1016/j.earlhumdev.2006.05.009; McCallum RS, 2004, PSYCHOL SCHOOLS, V41, P241, DOI 10.1002/pits.10152; McConkie G.W., 1991, VISION VISUAL DYSLEX; Melchers P., 2003, K ABC KAUFMAN ASSESS, V6; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; MILLER SD, 1985, J EDUC PSYCHOL, V77, P341, DOI 10.1037/0022-0663.77.3.341; Paeglis R, 2008, PROC SPIE, V7142, DOI 10.1117/12.815343; Prior S. M., 2001, READING PSYCHOL, V22, P1, DOI [10.1080/02702710151130172, DOI 10.1080/02702710151130172]; Rau AK, 2016, SCI STUD READ, V20, P203, DOI 10.1080/10888438.2015.1136913; Rau AK, 2015, J EXP CHILD PSYCHOL, V130, P92, DOI 10.1016/j.jecp.2014.09.012; Rau AK, 2014, SCI STUD READ, V18, P224, DOI 10.1080/10888438.2013.857673; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schneider W., 2007, LESEGESCHWINDIGKEITS; Schotter E.R., 2015, OXFORD HDB READING, P44; Schullerer P, 1999, B U BIOL UMWELTKUNDE, V8, P7; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; van den Boer M, 2014, J EXP CHILD PSYCHOL, V128, P138, DOI 10.1016/j.jecp.2014.07.008; Vorstius C, 2014, VIS COGN, V22, P458, DOI 10.1080/13506285.2014.881445; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170986	10.1371/journal.pone.0170986	http://dx.doi.org/10.1371/journal.pone.0170986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151950	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200066
J	Dey, S; Gupta, S; Sibanda, P; Chakraborty, A				Dey, Sharadia; Gupta, Srimanta; Sibanda, Precious; Chakraborty, Arun			Spatio-Temporal Variation and Futuristic Emission Scenario of Ambient Nitrogen Dioxide over an Urban Area of Eastern India Using GIS and Coupled AERMOD-WRF Model	PLOS ONE			English	Article							INDUSTRIAL SOURCE APPLICATIONS; DRIVERS BOUNDED RATIONALITY; AIR-QUALITY; SOURCE APPORTIONMENT; PARTICULATE MATTER; DISPERSION MODEL; POLLUTION; PREDICTION; POLLUTANTS; CITY	The present study focuses on the spatio-temporal variation of nitrogen dioxide (NO2) during June 2013 to May 2015 and its futuristic emission scenario over an urban area (Durgapur) of eastern India. The concentration of ambient NO2 shows seasonal as well as site specific characteristics. The site with high vehicular density (Muchipara) shows highest NO2 concentration followed by industrial site (DVC-DTPS Colony) and the residential site (B Zone), respectively. The seasonal variation of ambient NO2 over the study area is portrayed by means of Geographical Information System based Digital Elevation Model. Out of the total urban area under consideration (114.982 km(2)), the concentration of NO2 exceeded the National Ambient Air Quality Standard (NAAQS) permissible limit over an area of 5.000 km 2, 0.786 km(2) and 0.653 km(2) in post monsoon, winter and pre monsoon, respectively. Wind rose diagrams, correlation and regression analyses show that meteorology plays a crucial role in dilution and dispersion of NO2 near the earth's surface. Principal component analysis identifies vehicular source as the major source of NO2 in all the seasons over the urban region. Coupled AMS/EPA Regulatory Model (AERMOD)-Weather Research and Forecasting (WRF) model is used for predicting the concentration of NO2. Comparison of the observed and simulated data shows that the model overestimates the concentration of NO2 in all the seasons (except winter). The results show that coupled AERMOD-WRF model can overcome the unavailability of hourly surface as well as upper air meteorological data required for predicting the pollutant concentration, but improvement of emission inventory along with better understanding of the sinks and sources of ambient NO2 is essential for capturing the more realistic scenario.	[Dey, Sharadia; Sibanda, Precious] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01 Scottsville, Pietermaritzburg, South Africa; [Gupta, Srimanta] Univ Burdwan, Dept Environm Sci, Burdwan, W Bengal, India; [Chakraborty, Arun] Indian Inst Technol, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India	University of Kwazulu Natal; University of Burdwan; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Dey, S; Sibanda, P (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01 Scottsville, Pietermaritzburg, South Africa.	sharadiadey1985@gmail.com; sibandap@ukzn.ac.za	Sibanda, Precious/F-9616-2010; Gupta, Srimanta/J-5632-2017; Gupta, Srimanta/AAD-6756-2021; Chakraborty, Arun/AAD-9814-2021	Sibanda, Precious/0000-0003-2115-4642; Gupta, Srimanta/0000-0001-8426-5388; 	University of KwaZulu-Natal	University of KwaZulu-Natal	This work is funded by the University of KwaZulu-Natal.	Ali M, 2008, ENVIRON MONIT ASSESS, V136, P219, DOI 10.1007/s10661-007-9677-3; ARAI, 2007, AFL200607IOCL ARAI, P1; Boadh R, 2016, ATMOSFERA, V29, P61, DOI 10.20937/ATM.2016.29.01.05; Borge Garcia R., 2014, J GEOSCI ENV PROTECT, V2, P6, DOI DOI 10.4236/GEP.2014.21002; Bruno P, 2001, FRESEN J ANAL CHEM, V371, P1119, DOI 10.1007/s002160101084; Ceron-Breton J. G., 2013, WSEAS Transactions on Systems, V12, P55; Chattopadhyay S, 2012, THESIS; Cimorelli A. J., 2004, 454R03002D US EPA; Cimorelli AJ, 2005, J APPL METEOROL, V44, P682, DOI 10.1175/JAM2227.1; Dey S, 2014, ENVIRON FORENSICS, V2014, P112; Guo H, 2004, ENVIRON POLLUT, V129, P489, DOI 10.1016/j.envpol.2003.11.006; Gupta AK, 2008, ATMOS RES, V87, P103, DOI 10.1016/j.atmosres.2007.07.008; Gurjar B., 2004, ATMOS ENVIRON, V38, P5663, DOI DOI 10.1016/J.ATM0SENV.2004.05.057; Gvozdic V, 2011, ENVIRON MODEL ASSESS, V16, P491, DOI 10.1007/s10666-011-9256-4; He HD, 2015, STOCH ENV RES RISK A, V29, P2107, DOI 10.1007/s00477-014-0989-x; He HD, 2014, BUILD ENVIRON, V78, P111, DOI 10.1016/j.buildenv.2014.04.011; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; JACOBS MB, 1958, ANAL CHEM, V30, P426, DOI 10.1021/ac60135a032; Kandlikar M, 2000, ANNU REV ENERG ENV, V25, P629, DOI 10.1146/annurev.energy.25.1.629; Kaushik CP, 2006, ENVIRON MONIT ASSESS, V122, P27, DOI 10.1007/s10661-005-9161-x; Kesarkar AP, 2007, ATMOS ENVIRON, V41, P1976, DOI 10.1016/j.atmosenv.2006.10.042; Mohan M, 2011, ASIA-PAC J CHEM ENG, V6, P85, DOI 10.1002/apj.468; Otte TL, 2005, WEATHER FORECAST, V20, P367, DOI 10.1175/WAF855.1; Perry SG, 2005, J APPL METEOROL, V44, P694, DOI 10.1175/JAM2228.1; Raghavan S.C., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.1109/INFC0M.2010.5462024; RAO ST, 1986, ATMOS ENVIRON, V20, P1095, DOI 10.1016/0004-6981(86)90141-1; Salem AA, 2009, AIR QUAL ATMOS HLTH, V2, P133, DOI 10.1007/s11869-009-0040-4; Sharma N, 2004, TRANSPORT REV, V24, P409, DOI 10.1080/0144164042000196071; Sistla G, 2001, B AM METEOROL SOC, V82, P945, DOI 10.1175/1520-0477(2001)082<0945:AOEOTR>2.3.CO;2; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Tang TQ, 2017, PHYSICA A, V468, P322, DOI 10.1016/j.physa.2016.10.092; Tang TQ, 2015, TRANSPORT RES D-TR E, V41, P423, DOI 10.1016/j.trd.2015.10.016; Verma A, 2003, B ENVIRON CONTAM TOX, V70, P166, DOI 10.1007/s00128-002-0171-x; Xu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161992; Zhao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131878	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							E0170928	10.1371/journal.pone.0170928	http://dx.doi.org/10.1371/journal.pone.0170928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141866	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500027
J	Echeverri, A; Callahan, MM; Chan, KMA; Satterfield, T; Zhao, JY				Echeverri, Alejandra; Callahan, Megan M.; Chan, Kai M. A.; Satterfield, Terre; Zhao, Jiaying			Explicit Not Implicit Preferences Predict Conservation Intentions for Endangered Species and Biomes	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; SOUTH-AFRICA; COGNITION; BIODIVERSITY; ASSOCIATIONS; ATTITUDES; TABOOS	Conservation of biodiversity is determined in part by human preferences. Preferences relevant to conservation have been examined largely via explicit measures (e.g., a self-reported degree of liking), with implicit measures (e.g., preconscious, automatic evaluations) receiving relatively less attention. This is the case despite psychological evidence from other contexts that implicit preferences are more informative of behavior. Thus, the type of measure that predicts conservation intentions for biodiversity is unknown. We conducted three studies to examine conservation intentions in light of people's explicit and implicit preferences toward four endangered species (sea otter, American badger, caribou, yellow-breasted chat) and four biomes (forest, ocean, grassland, tundra). In Study 1 (n = 55), we found that people implicitly preferred caribou most, but explicitly preferred sea otter most, with a significant multiple regression where participants' explicit preferences dictated their stated intended donations for conservation of each species. In Study 2 (n = 57) we found that people implicitly and explicitly preferred forest and ocean over grassland and tundra. Explicit rather than implicit preferences predicted the intended donation for conservation of the ocean biome. Study 3 involved a broader online sample of participants (n = 463) and also found that explicit preferences dictated the intended donations for conservation of biomes and species. Our findings reveal discrepancies between implicit and explicit preferences toward species, but not toward biomes. Importantly, the results demonstrate that explicit rather than implicit preferences predict conservation intentions for biodiversity. The current findings have several implications for conservation and the communication of biodiversity initiatives.	[Echeverri, Alejandra; Callahan, Megan M.; Chan, Kai M. A.; Satterfield, Terre; Zhao, Jiaying] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Zhao, Jiaying] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Echeverri, A (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.	alejandra.echeverri@alumni.ubc.ca	Echeverri, Alejandra/GNP-5694-2022; Chan, Kai M A/C-1682-2009	Echeverri, Alejandra/0000-0002-8821-0509; Chan, Kai M A/0000-0002-7804-3276	Canada Research Chairs program; Leaders Opportunity Fund from the Canadian Foundation for Innovation [F07-0010, F14-05370]; NSERC Discovery Grant [RGPIN-2014-05617]; National Science Foundation [SES-0938099]; NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast); Colfuturo (Programa credto beca)	Canada Research Chairs program(Canada Research Chairs); Leaders Opportunity Fund from the Canadian Foundation for Innovation; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast); Colfuturo (Programa credto beca)	This work was supported by Canada Research Chairs program and the Leaders Opportunity Fund from the Canadian Foundation for Innovation [grant numbers F07-0010 for KC, and F14-05370 for JZ] (https://www.innovation.ca/en/OurFunds/CFlFunds/LeadersOpportunityFund/LeadersOpportunityFund1M2M); NSERC Discovery Grant [grant number RGPIN-2014-05617 for JZ] (http://www.nserc-crsrg.gc.ca/Protessors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp); National Science Foundation [grant number SES-0938099 for TS and MC] (http://www.nst.gov/funding/aboutfunding.jsp); NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast) for MC (http://terreweb.ubc.ca/about); and Colfuturo (Programa credto beca for AE) (http://www.colfuturo.org/financiacion-para-posgrados-en-el-exterior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot CE, 2015, PSYCHOL BULL, V141, P6, DOI 10.1037/a0038147; [Anonymous], 2012, GLOBE MAIL; Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Arnett JJ., 2012, ADOLESCENCE EMERGING; Axt JR, 2014, PSYCHOL SCI, V25, P1804, DOI 10.1177/0956797614543801; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Bargh J. A., 1984, HDB SOCIAL COGNITION, V1, P1; Batt S., 2009, BIOSCIENCE HORIZONS, V2, P180, DOI [https://doi.org/10.1093/biohorizons/hzp021, DOI 10.1093/BIOHORIZONS/HZP021]; Berger LR, 1996, J HUM EVOL, V30, P343, DOI 10.1006/jhev.1996.0027; Campbell TH, 2014, J PERS SOC PSYCHOL, V107, P809, DOI 10.1037/a0037963; Che D, 2006, GEOFORUM, V37, P212, DOI 10.1016/j.geoforum.2005.02.010; Czech B, 1998, CONSERV BIOL, V12, P1103, DOI 10.1046/j.1523-1739.1998.97253.x; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hall CM, 2011, J HERIT TOUR, V6, P309, DOI 10.1080/1743873X.2011.620116; Han KT, 2007, ENVIRON BEHAV, V39, P529, DOI 10.1177/0013916506292016; Heerwagen JH, 1995, BIOPHILIA HYPOTHESIS, V138, P138; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Kaltenborn BP, 2002, LANDSCAPE URBAN PLAN, V59, P1, DOI 10.1016/S0169-2046(01)00243-2; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; KAPLAN S, 1987, ENVIRON BEHAV, V19, P3, DOI 10.1177/0013916587191001; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Manfredo MJ, 2009, WHO CARES WILDLIFE; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Morse-Jones S, 2012, ECOL ECON, V78, P9, DOI 10.1016/j.ecolecon.2011.11.002; NAESS A, 1973, INQUIRY, V16, P95, DOI 10.1080/00201747308601682; Nosek BA, 2014, PLOS ONE, V9; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; RAYNER RJ, 1993, J HUM EVOL, V24, P219, DOI 10.1006/jhev.1993.1016; Schmidtz D., 1998, J APPL PHILOS, V15, P57, DOI [DOI 10.1111/1468-5930.00073, 10.1111/1468-5930.00073]; Schultz PW, 2004, J ENVIRON PSYCHOL, V24, P31, DOI 10.1016/S0272-4944(03)00022-7; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Simons Elwyn L., 2001, Lemur News, V6, P11; Singer P, 1995, PEOPLE PENGUINS PLAS, P79; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Smith L, 2012, CURATOR, V55, P453, DOI 10.1111/j.2151-6952.2012.00168.x; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Szalay L.B., 1978, SUBJECTIVE MEANING C; Teachman BA, 2001, J ABNORM PSYCHOL, V110, P226, DOI 10.1037/0021-843X.110.2.226; Tengo M, 2007, AMBIO, V36, P683, DOI 10.1579/0044-7447(2007)36[683:TAFGIP]2.0.CO;2; Turpie JK, 2003, ECOL ECON, V46, P199, DOI 10.1016/S0921-8009(03)00122-8; Ulrich R. S., 1995, BIOPHILIA HYPOTHESIS, P73; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Waters AM, 2011, MOTIV EMOTION, V35, P23, DOI 10.1007/s11031-010-9191-8; White PCL, 1999, J ENVIRON MANAGE, V55, P1, DOI 10.1006/jema.1998.0250; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; Woods B., 2000, J TOURISM STUDIES, V11, P25	52	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170973	10.1371/journal.pone.0170973	http://dx.doi.org/10.1371/journal.pone.0170973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135298	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700036
J	Hazzah, L; Bath, A; Dolrenry, S; Dickman, A; Frank, L				Hazzah, Leela; Bath, Alistair; Dolrenry, Stephanie; Dickman, Amy; Frank, Laurence			From Attitudes to Actions: Predictors of Lion Killing by Maasai Warriors	PLOS ONE			English	Article							LARGE CARNIVORES; PROTECTED AREAS; NATIONAL-PARK; PANTHERA-LEO; CONSERVATION; CONFLICT; LIVESTOCK; PREDATORS; COMMUNITY; DETERMINANTS	Despite legal protection, deliberate killing by local people is one of the major threats to the conservation of lions and other large carnivores in Africa. Addressing this problem poses particular challenges, mainly because it is difficult to uncover illicit behavior. This article examined two groups of Maasai warriors: individuals who have killed African lions (Panthera leo) and those who have not. We conducted interviews to explore the relationship between attitudes, intentions and known lion killing behavior. Factor analysis and logistic regression revealed that lion killing was mainly determined by: (a) general attitudes toward lions, (b) engagement in traditional customs, (c) lion killing intentions to defend property, and (d) socio- cultural killing intentions. Our results indicated that general attitudes toward lions were the strongest predictor of lion killing behavior. Influencing attitudes to encourage pro-conservation behavior may help reduce killing.	[Hazzah, Leela; Dolrenry, Stephanie] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Hazzah, Leela; Dolrenry, Stephanie; Frank, Laurence] Living Lions, Nanyuki, Kenya; [Bath, Alistair] Mem Univ, Dept Geog, Human Dimens Wildlife Management, St John, NF, Canada; [Dickman, Amy] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Oxford, England; [Frank, Laurence] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hazzah, Leela; Dolrenry, Stephanie] Lion Guardians, Nairobi, Kenya	University of Wisconsin System; University of Wisconsin Madison; Memorial University Newfoundland; University of Oxford; University of California System; University of California Berkeley	Hazzah, L (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.; Hazzah, L (corresponding author), Living Lions, Nanyuki, Kenya.; Hazzah, L (corresponding author), Lion Guardians, Nairobi, Kenya.	Lhazzah@gmail.com			Panthera Kaplan Graduate Award; Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship; Panthera	Panthera Kaplan Graduate Award; Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship; Panthera	This research was funded by Panthera Kaplan Graduate Award (https://www.panthera.org/grants-and-fellowships) to LH and by the Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship (http://www2.ed.gov/programs/iegpsddrap/index.html) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Eselenkei, Olgulului, and Mbirikani communities for their participation and collaboration. This study was conducted with the permission of the Government of Kenya (Permit No. MOEST 13/C689). A special thanks to L. Maamai for his critical field assistance and to D. Kaplan for his statistical help. This research was funded by Panthera and the Fulbright-Hays Doctoral Dissertation Research Fellowship. This manuscript was substantially improved by comments from four anonymous reviewers.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Aiyadurai A, 2010, ORYX, V44, P564, DOI 10.1017/S0030605309990937; Albarracin D, 2005, HANDBOOK OF ATTITUDES, P3; Ale S, 1998, INT SNOW LEOPARD TRU, V16, P417; Allendorf T, 2006, ENVIRON CONSERV, V33, P344, DOI 10.1017/S0376892906003389; [Anonymous], 2016, CAMBRIDGE DICT; Anthony B, 2007, ENVIRON CONSERV, V34, P236, DOI 10.1017/S0376892907004018; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; Bauer H, 2015, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092.en; Bernard H. R., 1998, HDB METHODS CULTURAL; Blackburn S, 2016, J APPL ECOL; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Browne-Nunez C., 2008, Human Dimensions of Wildlife, V13, P47, DOI 10.1080/10871200701812936; Browne-Nunez C.M, 2010, TOLERANCE WILDLIFE O; Conteh A, 2015, BIOL CONSERV, V189, P16, DOI 10.1016/j.biocon.2015.02.002; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dickman AJ, 2016, PROBLEMATIC WILDLIFE, P339, DOI [10.1007/978-3-319-22246-2_16, DOI 10.1007/978-3-319-22246-2_16]; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Dolrenry S., 2013, THESIS; Dolrenry S, 2016, CONSERV BIOL, V30, P467, DOI 10.1111/cobi.12703; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Eliason Stephen L., 2004, Human Dimensions of Wildlife, V9, P119, DOI 10.1080/10871200490441775; Fishbein M., 1992, INFLUENCING HUMAN BE, P29; Fox Jr J., 2015, APPL REGRESSION ANAL; Frank Laurence, 2011, Smithsonian Contributions to Zoology, P73; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Galaty J., 1993, BEING MAASAI; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Gorden R. L., 1977, UNIDIMENSIONAL SCALI; Groom R, 2008, ENVIRON CONSERV, V35, P242, DOI 10.1017/S037689290800489X; Hazzah L, 2011, EXPLORING ATTITUDES; Hazzah L., 2011, THESIS; Hazzah L, 2014, CONSERV BIOL, V28, P851, DOI 10.1111/cobi.12244; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Heberlein TA, 2012, CONSERV BIOL, V26, P583, DOI 10.1111/j.1523-1739.2012.01892.x; INFIELD M, 1988, BIOL CONSERV, V45, P21, DOI 10.1016/0006-3207(88)90050-X; Infield M, 2001, ORYX, V35, P48, DOI 10.1017/S0030605300031537; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Iucn Cat Specialist Group, 2006, REG CONS STRAT LION; Jackson P., 1996, BIOL CONSERVATION; Jhamvar-Shingote Ramaa, 2013, Human Dimensions of Wildlife, V18, P32, DOI 10.1080/10871209.2012.694578; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Kahler JS, 2012, INT J COMP APPL CRIM, V36, P103, DOI 10.1080/01924036.2012.669913; Law K. S., 2000, TRANSLATING QUESTION, DOI 10.4135/9781412986373; Lee TM, 2009, ENVIRON CONSERV, V36, P157, DOI 10.1017/S0376892909990178; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Liu F, 2011, BIOL CONSERV, V144, P538, DOI 10.1016/j.biocon.2010.10.009; Loveridge Andrew J., 2010, P161; Lyon K, 2009, NE RECR RES S BOLT L, P29; Maclennan S., 2009, BIOL CONSERV, V11, P2419; Maddox T., 2003, THESIS; Manfredo M.J., 2004, HUM DIMENS WILDL, V9, P1, DOI [10.1080/10871200490505765, DOI 10.1080/10871200490505765]; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; McCleery RA, 2006, WILDLIFE SOC B, V34, P537, DOI 10.2193/0091-7648(2006)34[537:UAIARI]2.0.CO;2; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Muth RM, 1998, SOC NATUR RESOUR, V11, P9, DOI 10.1080/08941929809381058; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; Okello MM, 2009, NAT RESOUR FORUM, V33, P123, DOI 10.1111/j.1477-8947.2009.01216.x; Ray J, 2013, LARGE CARNIVORES CON; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Riley EP, 2010, ORYX, V44, P235, DOI 10.1017/S0030605309990925; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Rust NA, 2016, SOC NATUR RESOUR, P1; Saitoti Tepilit Ole, 1986, WORLDS MAASAI WARRIO; SCHENSUL STEPHEN L., 1999, ESSENTIAL ETHNOGRAPH, V2; Sillero-Zubiri C, 2001, CONSERV BIOL SER, V5, P282; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Spear T., 1993, BEING MAASAI; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; St John FAV, 2010, WILDLIFE RES, V37, P658, DOI 10.1071/WR10032; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; TAMBIAH SJ, 1969, ETHNOLOGY, V8, P423, DOI 10.2307/3772910; Tarayia G N, 2004, J INT COMP LAW, V21, P183; Teel TL, 2010, INT J SOCIOL, V40, P104, DOI 10.2753/IJS0020-7659400306; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; WESTERN D, 1994, NATURAL CONNECTIONS, P15; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R., 2005, CONSERV BIOL; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992	90	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170796	10.1371/journal.pone.0170796	http://dx.doi.org/10.1371/journal.pone.0170796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135338	gold, Green Published, Green Submitted			2022-12-26	WOS:000396124700021
J	Machova, I; Hubalek, M; Lepsik, M; Bednarova, L; Pazderkova, M; Kopecky, V; Snasel, J; Dostal, J; Pichova, I				Machova, Iva; Hubalek, Martin; Lepsik, Martin; Bednarova, Lucie; Pazderkova, Marketa; Kopecky, Vladimir, Jr.; Snasel, Jan; Dostal, Jiri; Pichova, Ival			The Role of Cysteine Residues in Catalysis of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis	PLOS ONE			English	Article							STRUCTURAL INSIGHTS; METABOLISM; MECHANISM; PROTEINS; PEPCK; SITE	Mycobacterium tuberculosis (MTb), the causative agent of tuberculosis, can persist in macrophages for decades, maintaining its basic metabolic activities. Phosphoenolpyruvate carboxykinase (Pck; EC 4.1.1.32) is a key player in central carbon metabolism regulation. In replicating MTb, Pck is associated with gluconeogenesis, but in non-replicating MTb, it also catalyzes the reverse anaplerotic reaction. Here, we explored the role of selected cysteine residues in function of MTb Pck under different redox conditions. Using mass spectrometry analysis we confirmed formation of S-S bridge between cysteines C391 and C397 localized in the C-terminal subdomain. Molecular dynamics simulations of C391-C397 bridged model indicated local conformation changes needed for formation of the disulfide. Further, we used circular dichroism and Raman spectroscopy to analyze the influence of C391 and C397 mutations on Pck secondary and tertiary structures, and on enzyme activity and specificity. We demonstrate the regulatory role of C391 and C397 that form the S S bridge and in the reduced form stabilize Pck tertiary structure and conformation for gluconeogenic and anaplerotic reactions.	[Machova, Iva; Hubalek, Martin; Lepsik, Martin; Bednarova, Lucie; Pazderkova, Marketa; Snasel, Jan; Dostal, Jiri; Pichova, Ival] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Pazderkova, Marketa; Kopecky, Vladimir, Jr.] Charles Univ Prague, Inst Phys, Fac Math & Phys, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague	Pichova, I (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Lepšík, Martin/X-8603-2019; Kopecký, Vladimír/A-6965-2008; Pazderková, Markéta/AAH-7815-2020; Hubalek, Martin/H-1400-2014; Bednarova, Lucie/E-7622-2012; Machova, Iva/AAH-7522-2020; Machova, Iva/G-5578-2014; Dostal, Jiri/E-9584-2012; Lepsik, Martin/C-6614-2012	Lepšík, Martin/0000-0003-2607-8132; Kopecký, Vladimír/0000-0002-7331-9018; Pazderková, Markéta/0000-0003-1086-4497; Hubalek, Martin/0000-0003-0247-7956; Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Lepsik, Martin/0000-0003-2607-8132	Ministry of Education of the Czech Republic [LO1302]; Czech Science Foundation [P208/12/G016]; Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center" [LM2015070];  [RVO61388963]	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center"; 	This work was supported by NPU project LO1302 from the Ministry of Education of the Czech Republic and by project RVO61388963. ML was supported by the Czech Science Foundation (grant number P208/12/G016). This work was supported by NPU project LO1302 from the Ministry of Education of the Czech Republic and by project RVO61388963. ML was supported by the Czech Science Foundation (grant number P208/12/G016). This work was supported from the Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center LM2015070".	Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; CARLSON GM, 1978, BIOCHEMISTRY-US, V17, P5329, DOI 10.1021/bi00618a002; Case DA, 2014, AMBER 14; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kopecky V, 2006, VIB SPECTROSC, V42, P184, DOI 10.1016/j.vibspec.2006.04.019; KRAUTWURST H, 1995, BIOCHEMISTRY-US, V34, P6382, DOI 10.1021/bi00019a017; LEWIS CT, 1993, J BIOL CHEM, V268, P1628; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057; Machova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120682; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Pytelkova J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-3; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Srinivasan V, 2006, BIOL BULL-US, V210, P1, DOI 10.2307/4134531; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; Thomas GJ, 2002, BIOPOLYMERS, V67, P214, DOI 10.1002/bip.10105; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050	27	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170373	10.1371/journal.pone.0170373	http://dx.doi.org/10.1371/journal.pone.0170373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135343	Green Submitted, Green Published, gold			2022-12-26	WOS:000396124700012
J	Mirciov, CSG; Wilkins, SJ; Dunn, LA; Anderson, GJ; Frazer, DM				Mirciov, Cornel S. G.; Wilkins, Sarah J.; Dunn, Linda A.; Anderson, Gregory J.; Frazer, David M.			Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; SOLUBLE TRANSFERRIN RECEPTOR; BETA-THALASSEMIA; HEMOGLOBIN-DEFICIT; IRON-ABSORPTION; ERYTHROFERRONE CONTRIBUTES; ERYTHROPOIESIS; MICE; EXPRESSION; FERROPORTIN	Iron is crucial for many biological functions, but quantitatively the most important use of iron is in the production of hemoglobin in red blood cell precursors. The amount of iron in the plasma, and hence its availability for hemoglobin synthesis, is determined by the liver-derived iron regulatory hormone hepcidin. When the iron supply to erythroid precursors is limited, as often occurs during stimulated erythropoiesis, these cells produce signals to inhibit hepatic hepcidin production, thereby increasing the amount of iron that enters the plasma. How stimulated erythropoiesis suppresses hepcidin production is incompletely understood, but erythroferrone, Gdf15 and Twsg1 have emerged as candidate regulatory molecules. To further examine the relationship between erythropoiesis and the candidate erythroid regulators, we have studied five mouse models of anemia, including two models of beta-thalassemia (Hbb(th3/+) and RBC14), the hemoglobin deficit mouse (hbd), dietary iron deficient mice and mice treated with phenylhydrazine to induce acute hemolysis. Hematological parameters, iron status and the expression of Erfe (the gene encoding erythroferrone), Gdf15 and Twsg1 in the bone marrow and spleen were examined. Erfe expression was the most consistently upregulated of the candidate erythroid regulators in all of the mouse models examined. Gene expression was particularly high in the bone marrow and spleen of iron deficient animals, making erythroferrone an ideal candidate erythroid regulator, as its influence is strongest when iron supply to developing erythroid cells is limited. Gdf15 expression was also upregulated in most of the anemia models studied although the magnitude of the increase was generally less than that of Erfe. In contrast, very little regulation of Twsg1 was observed. These results support the prevailing hypothesis that erythroferrone is a promising erythroid regulator and demonstrate that Erfe expression is stimulated most strongly when the iron supply to developing erythroid cells is compromised.	[Mirciov, Cornel S. G.; Wilkins, Sarah J.; Dunn, Linda A.; Anderson, Gregory J.; Frazer, David M.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Herston, Qld, Australia; [Mirciov, Cornel S. G.; Anderson, Gregory J.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Frazer, DM (corresponding author), QIMR Berghofer Med Res Inst, Iron Metab Lab, Herston, Qld, Australia.	david.frazer@qimrberghofer.edu.au	Frazer, David M/L-3570-2014; Anderson, Gregory/G-4148-2013	Frazer, David M/0000-0003-4098-1379; Mirciov, Cornel/0000-0002-9083-2614; Anderson, Gregory/0000-0002-8814-5866	National Health and Medical Research Council of Australia [APP1051764]; Australian Government Research Training Program Scholarship (CSGM); Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship (CSGM)(Australian Government); Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM)	This work was supported by a project grant (APP1051764) from the National Health and Medical Research Council of Australia (GJA and DMF), an Australian Government Research Training Program Scholarship (CSGM), and a Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Aslam MF, 2014, FASEB J, V28, P3671, DOI 10.1096/fj.14-251520; Brown FC, 2013, BLOOD CELL MOL DIS, V50, P86, DOI 10.1016/j.bcmd.2012.09.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casanovas G, 2013, HAEMATOLOGICA, V98, P444, DOI 10.3324/haematol.2012.069807; CAZZOLA M, 1987, J LAB CLIN MED, V110, P734; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Fertrin KY, 2014, AM J HEMATOL, V89, P385, DOI 10.1002/ajh.23649; FINCH C, 1994, BLOOD, V84, P1697; Finkenstedt A, 2012, BLOOD CELL MOL DIS, V48, P233, DOI 10.1016/j.bcmd.2012.02.001; Flanagan JM, 2006, ACTA HAEMATOL-BASEL, V116, P249, DOI 10.1159/000095875; Frazer DM, 2016, BRIT J HAEMATOL, V175, P308, DOI 10.1111/bjh.14206; Frazer DM, 2014, BIOFACTORS, V40, P206, DOI 10.1002/biof.1148; Frazer DM, 2012, BRIT J HAEMATOL, V157, P615, DOI 10.1111/j.1365-2141.2012.09104.x; Frazer DM, 2003, BLOOD CELL MOL DIS, V30, P288, DOI 10.1016/S1079-9796(03)00039-1; Frazer DM, 2004, GUT, V53, P1509, DOI 10.1136/gut.2003.037416; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; GARRICK LM, 1987, EXP HEMATOL, V15, P671; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Lukaszyk E, 2016, INT UROL NEPHROL, V48, P839, DOI 10.1007/s11255-016-1278-z; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pasricha SR, 2013, BLOOD, V122, P124, DOI 10.1182/blood-2012-12-471441; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POOTRAKUL P, 1984, AM J CLIN PATHOL, V82, P289, DOI 10.1093/ajcp/82.3.289; Racz Z, 2011, NUCLEIC ACID THER, V21, P215, DOI 10.1089/nat.2010.0248; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Salojin KV, 2011, BLOOD, V117, P4895, DOI 10.1182/blood-2010-04-279653; Seldin MM, 2012, ADIPOCYTE, V1, P200, DOI 10.4161/adip.20877; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Speeckaert MM, 2010, CRIT REV CL LAB SCI, V47, P213, DOI 10.3109/10408363.2010.550461; Tamary H, 2008, BLOOD, V112, P5241, DOI 10.1182/blood-2008-06-165738; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Zhang AS, 2006, EXP HEMATOL, V34, P593, DOI 10.1016/j.exphem.2006.02.004	45	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171054	10.1371/journal.pone.0171054	http://dx.doi.org/10.1371/journal.pone.0171054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135344	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700044
J	Nowakiewicz, A; Ziolkowska, G; Zieba, P; Gnat, S; Troscianczyk, A; Adaszek, L				Nowakiewicz, Aneta; Ziolkowska, Grazyna; Zieba, Przemyslaw; Gnat, Sebastian; Troscianczyk, Aleksandra; Adaszek, Lukasz			Characterization of Multidrug Resistant E. faecalis Strains from Pigs of Local Origin by ADSRRS-Fingerprinting and MALDI-TOF MS; Evaluation of the Compatibility of Methods Employed for Multidrug Resistance Analysis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; FIELD GEL-ELECTROPHORESIS; ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECIUM; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; PLASMID COLOCALIZATION; ESCHERICHIA-COLI	The aim of this study was to characterize multidrug resistant E. faecalis strains from pigs of local origin and to analyse the relationship between resistance and genotypic and proteomic profiles by amplification of DNA fragments surrounding rare restriction sites (ADSRRS-fingerprinting) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). From the total pool of Enterococcus spp. isolated from 90 pigs, we selected 36 multidrug resistant E. faecalis strains, which represented three different phenotypic resistance profiles. Phenotypic resistance to tetracycline, macrolides, phenicols, and lincomycin and high-level resistance to aminoglycosides were confirmed by the occurrence of at least one corresponding resistance gene in each strain. Based on the analysis of the genotypic and phenotypic resistance of the strains tested, five distinct resistance profiles were generated. As a complement of this analysis, profiles of virulence genes were determined and these profiles corresponded to the phenotypic resistance profiles. The demonstration of resistance to a wide panel of antimicrobials by the strains tested in this study indicates the need of typing to determine the spread of resistance also at the local level. It seems that in the case of E. faecalis, type and scope of resistance strongly determines the genotypic pattern obtained with the ADSRRS-fingerprinting method. The ADSRRS-fingerprinting analysis showed consistency of the genetic profiles with the resistance profiles, while analysis of data with the use of the MALDI-TOF MS method did not demonstrate direct reproduction of the clustering pattern obtained with this method. Our observations were confirmed by statistical analysis (Simpson's index of diversity, Rand and Wallace coefficients). Even though the MALDI-TOF MS method showed slightly higher discrimination power than ADSRRS-fingerprinting, only the latter method allowed reproduction of the clustering pattern of isolates based on phenotypic resistance and analysis of resistance and virulence genes (Wallace coefficient 1.0). This feature seems to be the most useful for epidemiological purposes and short-term analysis.	[Nowakiewicz, Aneta; Ziolkowska, Grazyna; Gnat, Sebastian; Troscianczyk, Aleksandra] Univ Life Sci, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, Fac Vet Med, Lublin, Poland; [Zieba, Przemyslaw] State Vet Lab, Lublin, Poland; [Adaszek, Lukasz] Univ Life Sci, Dept Epizootiol, Fac Vet Med, Lublin, Poland; [Adaszek, Lukasz] Univ Life Sci, Clin Infect Dis, Fac Vet Med, Lublin, Poland		Nowakiewicz, A (corresponding author), Univ Life Sci, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, Fac Vet Med, Lublin, Poland.	anowakiewicz@gmail.com	Trościańczyk, Aleksandra/T-6583-2018; Gnat, Sebastian/J-4340-2019; Nowakiewicz, Aneta/J-6308-2019	Trościańczyk, Aleksandra/0000-0002-6400-2131; Gnat, Sebastian/0000-0001-9872-0046; Nowakiewicz, Aneta/0000-0003-3961-5291; Zieba, Przemyslaw/0000-0003-1881-0311; Adaszek, Lukasz/0000-0003-0261-2695				Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Adaszek L, 2014, PARASITOL RES, V113, P4293, DOI 10.1007/s00436-014-4124-1; Becker PT, 2014, MED MYCOL, V52, P826, DOI 10.1093/mmy/myu064; Bozdogan B, 1999, ANTIMICROB AGENTS CH, V43, P925, DOI 10.1128/AAC.43.4.925; Chandler JR, 2004, PEPTIDES, V25, P1377, DOI 10.1016/j.peptides.2003.10.020; Choi JM, 2015, CURR MICROBIOL, V70, P476, DOI 10.1007/s00284-014-0742-1; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Clinical and laboratory standards institute, 2014, M100S24 CLIN LAB STA, V34; Corso AC, 2007, INT J INFECT DIS, V11, P69, DOI 10.1016/j.ijid.2006.02.003; De Leener E, 2004, MICROB DRUG RESIST, V10, P341, DOI 10.1089/mdr.2004.10.341; Dicuonzo G, 2001, FEMS MICROBIOL LETT, V201, P205, DOI 10.1111/j.1574-6968.2001.tb10758.x; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Fard RMN, 2011, VET MICROBIOL, V148, P276, DOI 10.1016/j.vetmic.2010.09.002; Garrido AM., 2014, J INFECT DIS THERAPY, V2, P150, DOI DOI 10.4172/2332-0877.1000150; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Gnat S, 2016, J MED MICROBIOL; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Heuer OE, 2006, CLIN INFECT DIS, V43, P911, DOI 10.1086/507534; Hidano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121189; Hoang TTT, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1754-3; Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12; Hummel A, 2007, SYST APPL MICROBIOL, V30, P1, DOI 10.1016/j.syapm.2006.02.004; Huys G, 2004, APPL ENVIRON MICROB, V70, P1555, DOI 10.1128/AEM.70.3.1555-1562.2004; Jackson CR, 2010, J APPL MICROBIOL, V108, P2171, DOI 10.1111/j.1365-2672.2009.04619.x; Jackson CR, 2005, EPIDEMIOL INFECT, V133, P367, DOI 10.1017/S0950268804003395; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Katsunuma Y, 2008, J GEN APPL MICROBIOL, V54, P39, DOI 10.2323/jgam.54.39; Khan SA, 2005, MOL CELL PROBE, V19, P27, DOI 10.1016/j.mcp.2004.09.001; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Krawczyk B, 2003, FEMS IMMUNOL MED MIC, V38, P241, DOI 10.1016/S0928-8244(03)00149-4; Krawczyk B, 2003, J MICROBIOL METH, V52, P341, DOI 10.1016/S0167-7012(02)00187-2; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krutkiewicz A, 2010, FOLIA MICROBIOL, V55, P167, DOI 10.1007/s12223-010-0025-6; Lasch P, 2014, J MICROBIOL METH, V100, P58, DOI 10.1016/j.mimet.2014.02.015; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Mutters NT, 2015, J MED DIAGN METH, V4; Nagy E, 2013, ANAEROBE, V20, P20, DOI 10.1016/j.anaerobe.2013.01.007; Nakano S, 2014, INT J ANTIMICROB AG, V44, P256, DOI 10.1016/j.ijantimicag.2014.05.006; Novais A, 2014, EUR J CLIN MICROBIOL, V33, P1391, DOI 10.1007/s10096-014-2071-5; Novais C, 2013, J ANTIMICROB CHEMOTH, V68, P2746, DOI 10.1093/jac/dkt289; Nowakiewicz A, 2016, POULTRY SCI, P1; Nowakiewicz A, 2016, COMP IMMUNOL MICROB, V44, P21, DOI 10.1016/j.cimid.2015.11.003; Nowakiewicz A, 2015, J MED MICROBIOL, V64, P217, DOI 10.1099/jmm.0.000008; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Prieto AMG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00788; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Quintela-Baluja M, 2013, ELECTROPHORESIS, V34, P2240, DOI 10.1002/elps.201200699; Ramos S, 2012, ANN MICROBIOL, V62, P1485, DOI 10.1007/s13213-011-0402-7; Reiter KC, 2013, BRAZIL J INFECT CONT, V2, P112; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Rim JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/535027; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Sandrin TR, 2012, MASS SPECTROM REV; Santos T, 2015, J PROTEOMICS, V127, P321, DOI 10.1016/j.jprot.2015.02.017; Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schwaiger K, 2009, VET MICROBIOL, V139, P386, DOI 10.1016/j.vetmic.2009.06.005; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Seputiene V, 2012, POL J VET SCI, V15, P431, DOI 10.2478/v10181-012-0067-6; Shin HB, 2015, YONSEI MED J, V56, P550, DOI 10.3349/ymj.2015.56.2.550; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Spinali S, 2015, J CLIN MICROBIOL, V53, P760, DOI 10.1128/JCM.01635-14; Stepien-Pysniak D, 2016, ACTA VET HUNG, V64, P148, DOI 10.1556/004.2016.016; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Tremblay CL, 2012, J FOOD PROTECT, V75, P1595, DOI 10.4315/0362-028X.JFP-12-047; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Werner G., 2013, J BACTERIOL PARASITO, V5; Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]	75	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171160	10.1371/journal.pone.0171160	http://dx.doi.org/10.1371/journal.pone.0171160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135327	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700054
J	Wuest, SL; Stern, P; Casartelli, E; Egli, M				Wuest, Simon L.; Stern, Philip; Casartelli, Ernesto; Egli, Marcel			Fluid Dynamics Appearing during Simulated Microgravity Using Random Positioning Machines	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; SHEAR-STRESS; NITRIC-OXIDE; STEM-CELLS; BED REST; EXPRESSION; FORCE; PROLIFERATION; CHONDROCYTES	Random Positioning Machines (RPMs) are widely used as tools to simulate microgravity on ground. They consist of two gimbal mounted frames, which constantly rotate biological samples around two perpendicular axes and thus distribute the Earth's gravity vector in all directions over time. In recent years, the RPM is increasingly becoming appreciated as a laboratory instrument also in non-space-related research. For instance, it can be applied for the formation of scaffold-free spheroid cell clusters. The kinematic rotation of the RPM, however, does not only distribute the gravity vector in such a way that it averages to zero, but it also introduces local forces to the cell culture. These forces can be described by rigid body analysis. Although RPMs are commonly used in laboratories, the fluid motion in the cell culture flasks on the RPM and the possible effects of such on cells have not been examined until today; thus, such aspects have been widely neglected. In this study, we used a numerical approach to describe the fluid dynamic characteristic occurring inside a cell culture flask turning on an operating RPM. The simulations showed that the fluid motion within the cell culture flask never reached a steady state or neared a steady state condition. The fluid velocity depends on the rotational velocity of the RPM and is in the order of a few centimeters per second. The highest shear stresses are found along the flask walls; depending of the rotational velocity, they can reach up to a few 100 mPa. The shear stresses in the "bulk volume", however, are always smaller, and their magnitude is in the order of 10 mPa. In conclusion, RPMs are highly appreciated as reliable tools in microgravity research. They have even started to become useful instruments in new research fields of mechanobiology. Depending on the experiment, the fluid dynamic on the RPM cannot be neglected and needs to be taken into consideration. The results presented in this study elucidate the fluid motion and provide insight into the convection and shear stresses that occur inside a cell culture flask during RPM experiments.	[Wuest, Simon L.; Egli, Marcel] Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Aerosp Biomed Sci & Technol, Space Biol Grp, Hergiswil, Switzerland; [Stern, Philip; Casartelli, Ernesto] Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Fluid Mech & Hydraul Machines, Horw, Switzerland		Egli, M (corresponding author), Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Aerosp Biomed Sci & Technol, Space Biol Grp, Hergiswil, Switzerland.	marcel.egli@hslu.ch	Wuest, Simon/AAI-8620-2020	Wuest, Simon/0000-0002-5495-6951; Egli, Marcel/0000-0002-4064-2871				Aleshcheva G, 2015, MICROGRAVITY SCI TEC, P1; Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Bailey JF, 2014, J BIOMECH, V47, P2983, DOI 10.1016/j.jbiomech.2014.07.005; BARBEE KA, 1995, AM J PHYSIOL-HEART C, V268, pH1765, DOI 10.1152/ajpheart.1995.268.4.H1765; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Brungs S., 2016, MICROGRAVITY SCI TEC, P1; Buravkova LB, 2008, ACTA ASTRONAUT, V63, P603, DOI 10.1016/j.actaastro.2008.04.012; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gershovich P M, 2009, Tsitologiia, V51, P896; Gershovich Yu. G., 2011, Human Physiology, V37, P860, DOI 10.1134/S0362119711070139; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Kamal KY, 2015, LIFE SCI SPACE RES, V5, P47, DOI 10.1016/j.lssr.2015.04.004; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; Klaus DM, 1998, ADV SPACE RES, V21, P1315, DOI 10.1016/S0273-1177(97)00404-3; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Langtry RB, 2005, 43 AIAA AER SCI M EX; Lee MS, 2003, J CELL BIOCHEM, V90, P80, DOI 10.1002/jcb.10611; Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8; Leguy C. A., 2011, GRAVITATIONAL SPACE, V25; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Loon J.J.W.A.V, 2007, GRAVITATIONAL SPACE, V20; Majumder S, 2011, J CELL BIOCHEM, V112, P1898, DOI 10.1002/jcb.23110; Malaviya P, 2002, TISSUE ENG, V8, P581, DOI 10.1089/107632702760240508; Malek AM, 1996, J CELL SCI, V109, P713; Maynard J A, 1994, Iowa Orthop J, V14, P125; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Mesland, 1996, ESA MICROGRAVITY NEW, V9, P5; Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Papadaki M, 1996, BIOTECHNOL BIOENG, V50, P555, DOI 10.1002/(SICI)1097-0290(19960605)50:5<555::AID-BIT10>3.0.CO;2-I; Patel MJ, 2009, J CELL BIOCHEM, V106, P306, DOI 10.1002/jcb.22007; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Rudimov EG, 2015, B EXP BIOL MED+, V158, P573, DOI 10.1007/s10517-015-2809-9; Ryu HW, 2014, DNA CELL BIOL, V33, P128, DOI 10.1089/dna.2013.2089; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Siamwala JH, 2010, FEBS LETT, V584, P3415, DOI 10.1016/j.febslet.2010.06.039; Siamwala JH, 2010, PROTOPLASMA, V242, P3, DOI 10.1007/s00709-010-0114-z; Sinha Raj K, 2002, Spine J, V2, P239, DOI 10.1016/S1529-9430(02)00197-3; Slentz DH, 2001, IN VITRO CELL DEV-AN, V37, P148; Smith RL, 1995, J ORTHOPAED RES, V13, P824, DOI 10.1002/jor.1100130604; Sokolovskaya AA, 2014, ACTA ASTRONAUT, V99, P16, DOI 10.1016/j.actaastro.2014.01.032; Trappe SW, 2001, J APPL PHYSIOL, V91, P57, DOI 10.1152/jappl.2001.91.1.57; TSENG H, 1995, CIRC RES, V77, P869, DOI 10.1161/01.RES.77.5.869; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; van Loon JJWA, 2003, J BIOMECH ENG-T ASME, V125, P342, DOI 10.1115/1.1574521; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; WECHEZAK AR, 1985, LAB INVEST, V53, P639; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Wuest SL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/971474; Wuest SL, 2014, MICROGRAVITY SCI TEC, V26, P77, DOI 10.1007/s12217-014-9364-2; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Zwart SR, 2010, J BONE MINER RES, V25, P1049, DOI 10.1359/jbmr.091041	78	45	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170826	10.1371/journal.pone.0170826	http://dx.doi.org/10.1371/journal.pone.0170826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135286	Green Published, gold			2022-12-26	WOS:000396124700023
J	Enders, C; Braig, EM; Scherer, K; Werner, JU; Lang, GK; Lang, GE; Pfeiffer, F; Noel, P; Rummeny, E; Herzen, J				Enders, Christian; Braig, Eva-Maria; Scherer, Kai; Werner, Jens U.; Lang, Gerhard K.; Lang, Gabriele E.; Pfeiffer, Franz; Noel, Peter; Rummeny, Ernst; Herzen, Julia			Advanced Non-Destructive Ocular Visualization Methods by Improved X-Ray Imaging Techniques	PLOS ONE			English	Article							MICRO-CT; COMPUTED-TOMOGRAPHY; 7.1 T	Due to limited X-ray contrast, the use of micro-CT in histology is so far not as widespread as predicted. While specific staining procedures-mostly using iodine D address this shortcoming, long diffusion times restrict its use in the often time-constrained daily routine. Recently, a novel staining protocol has been proposed using a biochemical preconditioning step, which increases the permeability of the cells for the staining agent. This could enable the imaging of entire organs of small mammals at a yet unmatched image quality with reasonable preparation and scan times. We here propose an adaptation of this technique for virtual ophthalmology and histology by volumetrically assessing both human and porcine eyes. Hereby, we demonstrate that (contrast-enhanced) micro-CT can outperform conventional histology in the assessment of tumor entities, as well as functioning as a supplementary tool for surgeons in the positioning of intraocular implants in-vitro and as a general assessment tool for ophthalmologic specimens.	[Enders, Christian; Werner, Jens U.; Lang, Gerhard K.; Lang, Gabriele E.] Univ Ulm, Dept Ophthalmol, Prittwitzstr 43, D-89075 Ulm, Germany; [Braig, Eva-Maria; Scherer, Kai; Pfeiffer, Franz; Noel, Peter; Herzen, Julia] Tech Univ Munich, Dept Phys, Chair Biomed Phys, James Franck Str 1, D-85748 Garching, Germany; [Braig, Eva-Maria; Scherer, Kai; Pfeiffer, Franz; Noel, Peter; Herzen, Julia] Tech Univ Munich, Inst Med Engn IMETUM, James Franck Str 1, D-85748 Garching, Germany; [Braig, Eva-Maria; Pfeiffer, Franz; Noel, Peter; Rummeny, Ernst] Tech Univ Munich, Dept Diagnost & nterventionial Radiol, Ismaninger Str 22, D-81664 Munich, Germany	Ulm University; Technical University of Munich; Technical University of Munich; Technical University of Munich	Braig, EM (corresponding author), Tech Univ Munich, Dept Phys, Chair Biomed Phys, James Franck Str 1, D-85748 Garching, Germany.; Braig, EM (corresponding author), Tech Univ Munich, Inst Med Engn IMETUM, James Franck Str 1, D-85748 Garching, Germany.; Braig, EM (corresponding author), Tech Univ Munich, Dept Diagnost & nterventionial Radiol, Ismaninger Str 22, D-81664 Munich, Germany.	eva.braig@mytum.de		Noel, Peter/0000-0002-9671-6171	German Society of Ophthalmic Pathology [1/2016]	German Society of Ophthalmic Pathology	CE received a research grant (1/2016) from the German Society of Ophthalmic Pathology, http://www.dog.org/?cat=123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Juliana Martins de S. e Silva for providing the staining protocols and for the help with the accomplishment of the tissue staining. The Authors thank Grazyna Prystasz for histological sample preparation. The authors thank Dr. Tarun Mehra for providing remunerated editorial assistance. This study was supported, in part, by a research grant from the German Society of Ophthalmic Pathology.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Cox PG, 2014, PEERJ, V2, DOI 10.7717/peerj.448; CROW W, 1982, J COMPUT ASSIST TOMO, V6, P708, DOI 10.1097/00004728-198208000-00008; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Gekeler F, 2010, BRIT J OPHTHALMOL, V94, P843, DOI 10.1136/bjo.2009.170654; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Hong-qin Yang, 2007, Proceedings of the SPIE - The International Society for Optical Engineering, V6826, p68260T, DOI 10.1117/12.756303; Krueger PC, 2012, ORBIT, V31, P390, DOI 10.3109/01676830.2012.723783; Langheinrich AC, 2004, RADIOLOGY, V231, P675, DOI 10.1148/radiol.2313021718; Langner S, 2010, INVEST OPHTH VIS SCI, V51, P6575, DOI 10.1167/iovs.09-4865; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Rau TS, 2013, INT J COMPUT ASS RAD, V8, P481, DOI 10.1007/s11548-013-0825-7; Rueckel J, 2014, APPL RADIAT ISOTOPES, V94, P230, DOI 10.1016/j.apradiso.2014.08.014; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Silva JMDE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14088; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Winston Janet S, 2004, Breast J, V10, P200, DOI 10.1111/j.1075-122X.2004.21300.x	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170633	10.1371/journal.pone.0170633	http://dx.doi.org/10.1371/journal.pone.0170633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129364	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400051
J	Hayward, AC				Hayward, Andrew C.			Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients	PLOS ONE			English	Editorial Material							LONG-TERM-CARE; HOME STAFF; MORTALITY; INFECTIONS; RESIDENTS; OUTBREAKS; DISEASE		[Hayward, Andrew C.] UCL, Inst Epidemiol & Hlth Care, London, England	University of London; University College London	Hayward, AC (corresponding author), UCL, Inst Epidemiol & Hlth Care, London, England.	a.hayward@ucl.ac.uk	Hayward, Andrew/C-3268-2013	Hayward, Andrew/0000-0002-3549-6232	Department of Health Policy Research Programme	Department of Health Policy Research Programme	The study discussed was funded by the Department of Health Policy Research Programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Demicheli V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub5; Green HK, 2015, J PUBLIC HLTH OXF, V37, P295; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Langley JM, 2011, VACCINE, V29, P1921, DOI 10.1016/j.vaccine.2010.12.100; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Leung NHL, 2015, EPIDEMIOLOGY, V26, P862, DOI 10.1097/EDE.0000000000000340; Loeb M, 2000, CAN MED ASSOC J, V162, P1133; Matias G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3128-4; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Strausbaugh LJ, 2003, CLIN INFECT DIS, V36, P870, DOI 10.1086/368197; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Ward BJ, PLOS ONE	15	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169023	10.1371/journal.pone.0169023	http://dx.doi.org/10.1371/journal.pone.0169023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129326	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400071
J	Wang, XX; Huang, RF; Quan, RD				Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang			Mutation in Mg-Protoporphyrin IX Monomethyl Ester Cyclase Decreases Photosynthesis Capacity in Rice	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; OXIDATIVE CYCLASE; TETRAPYRROLE BIOSYNTHESIS; CHLOROPLAST DEVELOPMENT; ARABIDOPSIS CHL27; GENE-EXPRESSION; ISOCYCLIC RING; PHOTOSYSTEM-I; HIGHER-PLANTS; PROTEIN	In photosynthesis, the pigments chlorophyll a/b absorb light energy to convert to chemical energy in chloroplasts. Though most enzymes of chlorophyll biosynthesis from glutamyltRNA to chlorophyll a/b have been identified, the exact composition and regulation of the multimeric enzyme Mg-protoporphyrin IX monomethyl ester cyclase (MPEC) is largely unknown. In this study, we isolated a rice pale-green leaf mutant m167 with yellow-green leaf phenotype across the whole lifespan. Chlorophyll content decreases 43-51% and the granal stacks of chloroplasts becomes thinner in m167. Chlorophyll fluorescence parameters, including Fv/Fm (the maximum quantum efficiency of PSII) and quantum yield of PSII (Y(II)), were lower in m167 than those in wild type plants (WT), and photosynthesis rate decreases 40% in leaves of m167 mutant compared with WT plants, which lead to yield reduction in m167. Genetic analysis revealed that yellow-green leaf phenotype of m167 is controlled by a single recessive genetic locus. By positional cloning, a single mutated locus, G286A (Alanine 96 to Threonine in protein), was found in the coding sequence of LOC_ Os01g17170 (Rice Copper Response Defect 1, OsCRD1), encoding a putative subunit of MPEC. Expression profile analysis demonstrated that OsCRD1 is mainly expressed in green tissues of rice. Sequence alignment analysis of CRD1 indicated that Alanine 96 is very conserved in all green plants and photosynthetic bacteria. OsCRD1 protein mainly locates in chloroplast and the point mutation A96T in OsCRD1 does not change its location. Therefore, Alanine96 of OsCRD1 might be fundamental for MPEC activity, mutation of which leads to deficiency in chlorophyll biosynthesis and chloroplast development and decreases photosynthetic capacity in rice.	[Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Quan, RD (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.; Quan, RD (corresponding author), Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	quanruidang@caas.cn			Ministry of Agriculture of China [2014ZX08009-005, 2016ZX08009-003-005]; National Natural Science Foundation of China [31172025]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the Ministry of Agriculture of China (2014ZX08009-005, 2016ZX08009-003-005 to RQ) [http://english.agri.gov.cn/] and the National Natural Science Foundation of China (31172025 to RQ) [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Agriculture of China (2014ZX08009-005, 2016ZX08009-003-005) and National Natural Science Foundation of China (31172025).	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Albus CA, 2012, PLANT PHYSIOL, V160, P1923, DOI 10.1104/pp.112.206045; Bang WY, 2008, PLANT CELL PHYSIOL, V49, P1350, DOI 10.1093/pcp/pcn111; Biswal UC, 2003, CHLOROPLAST BIOGENES, P19; Bollivar D, 2014, FEBS J, V281, P2377, DOI 10.1111/febs.12790; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Caffarri S, 2014, CURR PROTEIN PEPT SC, V15, P296, DOI 10.2174/1389203715666140327102218; DUGGAN J, 1974, PLANT PHYSIOL, V53, P206, DOI 10.1104/pp.53.2.206; GOUGH S, 1972, BIOCHIM BIOPHYS ACTA, V286, P36, DOI 10.1016/0304-4165(72)90086-4; HODGINS RR, 1986, J PLANT PHYSIOL, V125, P311, DOI 10.1016/S0176-1617(86)80153-5; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Hung CY, 2010, J EXP BOT, V61, P1483, DOI 10.1093/jxb/erq020; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kahn VM, 1976, GENETICS BIOGENESIS, V184, P800; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Li RQ, 2014, THEOR APPL GENET, V127, P2491, DOI 10.1007/s00122-014-2393-9; MASCIA P, 1978, MOL GEN GENET, V161, P237, DOI 10.1007/BF00330996; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P492, DOI 10.1111/j.1751-1097.1997.tb08596.x; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Schlicke H, 2015, PROCEDIA CHEM, V14, P171, DOI 10.1016/j.proche.2015.03.025; Schreiber U., 1995, ECOPHYSIOLOGY PHOTOS, V100, P49, DOI [10.1007/978-3-642-79354-7_3, DOI 10.1007/978-3-642-79354-7_3]; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka Ryouichi, 2011, Arabidopsis Book, V9, pe0145, DOI 10.1199/tab.0145; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; WALKER CJ, 1991, BIOCHEM J, V276, P691, DOI 10.1042/bj2760691; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; WONG YS, 1984, PLANT PHYSIOL, V75, P658, DOI 10.1104/pp.75.3.658; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zheng CC, 1998, PLANT PHYSIOL, V116, P27, DOI 10.1104/pp.116.1.27; Zhou K., 2013, COMPLEX ADAPTIVE SYS, V1, P1, DOI DOI 10.1007/S00425-012-1756-1; Zhu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0821-5	43	7	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171118	10.1371/journal.pone.0171118	http://dx.doi.org/10.1371/journal.pone.0171118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129387	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400006
J	Stiebel-Kalish, H; Lotan, I; Brody, J; Chodick, G; Bialer, O; Marignier, R; Bach, M; Hellmann, MA				Stiebel-Kalish, Hadas; Lotan, Itay; Brody, Judith; Chodick, Gabriel; Bialer, Omer; Marignier, Romain; Bach, Michael; Hellmann, Mark Andrew			Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study	PLOS ONE			English	Article							MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; VISUAL-ACUITY TEST; NEUROMYELITIS-OPTICA; COHERENCE TOMOGRAPHY; SPECTRUM DISORDERS; MULTIPLE-SCLEROSIS; COUNTING FINGERS; HAND MOTION; ANTIBODIES; NMO	Background Optic neuritis (ON) in patients with anti-myelin oligodendrocyte glycoprotein (MOG)-IgG antibodies has been associated with a better clinical outcome than anti-aquaporin 4 (AQP4)-IgG ON. Average retinal nerve fiber layer thickness (RNFL) correlates with visual outcome after ON. Objectives The aim of this study was to examine whether anti-MOG-IgG ON is associated with better average RNFL compared to anti-AQP4-IgG ON, and whether this corresponds with a better visual outcome. Methods A retrospective study was done in a consecutive cohort of patients following anti-AQP4-IgG and anti-MOG-IgG ON. A generalized estimating equation (GEE) models analysis was used to compare average RNFL outcomes in ON eyes of patients with MOG-IgG to AQP4-IgGpositive patients, after adjusting for the number of ON events. The final mean visual field defect and visual acuity were compared between ON eyes of MOG-IgG and AQP4-IgG-positive patients. A correlation between average RNFL and visual function was performed in all study eyes. Results Sixteen patients were analyzed; ten AQP4-IgG-positive and six MOG-IgG-positive. The six patients with MOG-IgG had ten ON events with disc edema, five of which were bilateral. In the AQP4-IgG-positive ON events, 1/10 patients had disc edema. Final average RNFL was significantly better in eyes following MOG-IgG-ON (75.33 mu m), compared to 63.63 mu m in AQP4-IgG-ON, after adjusting for the number of ON attacks (GEE, p = 0.023). Mean visual field defects were significantly smaller (GEE, p = 0.046) among MOG-IgG positive ON eyes compared to AQP-IgG positive ON eyes, but last visual acuity did not differ between the groups (GEE, p = 0.153). Among all eyes, average RNFL positively correlated with mean visual field defect (GEE, p = 0.00015) and negatively correlated with final visual acuity (GEE, p = 0.00005). Conclusions Following ON, RNFL is better preserved in eyes of patients with MOG-IgG antibodies compared to those with AQP4-IgG antibodies, correlating with better visual outcomes.	[Stiebel-Kalish, Hadas; Lotan, Itay; Brody, Judith; Chodick, Gabriel; Bialer, Omer; Hellmann, Mark Andrew] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Stiebel-Kalish, Hadas; Brody, Judith; Bialer, Omer] Rabin Med Ctr, Dept Ophthalmol, Neuroophthalmol Unit, Petah Tiqwa, Israel; [Lotan, Itay; Hellmann, Mark Andrew] Rabin Med Ctr, Neuroimmunol Serv, Petah Tiqwa, Israel; [Lotan, Itay; Hellmann, Mark Andrew] Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; [Chodick, Gabriel] Tel Aviv Univ, Sackler Sch Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Marignier, Romain] Hosp Civils Lyon, Serv Neurol A, Hop Neurol Pierre Wertheimer, Lyon, France; [Bach, Michael] Univ Freiburg, Ctr Eye, Med Ctr, Freiburg, Germany; [Bach, Michael] Univ Freiburg, Fac Med, Freiburg, Germany	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; CHU Lyon; University of Freiburg; University of Freiburg	Stiebel-Kalish, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Stiebel-Kalish, H (corresponding author), Rabin Med Ctr, Dept Ophthalmol, Neuroophthalmol Unit, Petah Tiqwa, Israel.	kalishhadas@gmail.com	lotan, Itay/Q-8028-2019; Bach, Michael/A-6637-2010; Stiebel-Kalish, Hadas/ABA-8583-2020	lotan, Itay/0000-0002-4015-9783; Bach, Michael/0000-0003-2028-535X; Stiebel-Kalish, Hadas/0000-0001-7715-6706; /0000-0002-5189-8995				Akaishi T, 2016, J NEUROL NEUROSUR PS, V87, P446, DOI 10.1136/jnnp-2014-310206; Boudreault K, 2016, SEMIN OPHTHALMOL, V31, P117, DOI 10.3109/08820538.2015.1114835; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Hoftberger R, 2015, MULT SCLER J, V21, P866, DOI 10.1177/1352458514555785; Hokari M, 2016, ANN NEUROL, V79, P605, DOI 10.1002/ana.24608; Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0; Kaneko K, 2016, J NEUROL NEUROSURG P; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Kleiter I, 2016, ANN NEUROL, V79, P206, DOI 10.1002/ana.24554; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Marignier R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0577-8; Pache F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0720-6; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ramanathan S, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000040; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Wang JJ, 2016, NEUROLOGY; Willison HJ, 2012, NEUROLOGY, V79, P1198, DOI 10.1212/WNL.0b013e31826aadaf; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wingerchuk DM, 2015, NEUROLOGY	23	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170847	10.1371/journal.pone.0170847	http://dx.doi.org/10.1371/journal.pone.0170847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125740	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100036
J	Wang, JJ; Wu, CC; Lee, CL; Hsieh, SL; Chen, JB; Lee, CI				Wang, Jyh-Jye; Wu, Chih-Chung; Lee, Chun-Lin; Hsieh, Shu-Ling; Chen, Jin-Bor; Lee, Chu-I			Antimelanogenic, Antioxidant and Antiproliferative Effects of Antrodia camphorata Fruiting Bodies on B16-F0 Melanoma Cells	PLOS ONE			English	Article							EXTRACT; BODY	Antrodia camphorata is a fungus that is endemic to Taiwan, and its fruiting body has been used as a folk medicine for the prevention or treatment of diverse diseases. The present study is aimed at investigating the antimelanogenesis and antioxidation effect of the ethanolic extract of Antrodia camphorata fruiting body (EE-AC), as well as its antiproliferation effects in B16-F0 melanoma cells. Regarding antimelanogenic effects, EE-AC had effective cupric ions reducing capacity and expressed more potent inhibitory effect than kojic acid on mushroom tyrosinase activity. Moreover, EE-AC significantly inhibited cellular tyrosinase activity and the melanin content in B16-F0 cells at 12.5 mu g/mL concentration without cell toxicities. Regarding antioxidant effects, EE-AC exhibited potent DPPH radical-and SOD-like-scavenging activities. Regarding antiproliferative effects, EE-AC exhibited a selective cytotoxic effect and markedly inhibited the migration ability of B16-F0 cells. EE-AC increased the population of B16-F0 cells at sub-G1 phase of the cell cycle. EE-AC also caused the increase of early apoptotic cells and chromatin condensation, which indicated the apoptotic effects in B16-F0 cells. We demonstrated that EE-AC possessed antimelanogenic, antioxidant and anti-skin cancer actions. The results would contribute to the development and application of cosmetics, healthy food and pharmaceuticals.	[Wang, Jyh-Jye] Fooyin Univ, Dept Nutr & Hlth Sci, Kaohsiung, Taiwan; [Wu, Chih-Chung] Chang Jung Christian Univ, Dept Nutr & Hlth Sci, Tainan, Taiwan; [Lee, Chun-Lin] Natl Taitung Univ, Dept Life Sci, Taitung, Taiwan; [Hsieh, Shu-Ling] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Chen, Jin-Bor] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chen, Jin-Bor] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chu-I] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	Fooyin University; Chang Jung Christian University; National Kaohsiung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Fooyin University	Lee, CI (corresponding author), Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.	mt046@fy.edu.tw	Wu, Chih-Chung/AFB-8873-2022	Wu, Chih-Chung/0000-0002-6518-5312	Ministry of Education, Taiwan [99B-78-014]	Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This research was supported by the grant 99B-78-014 from the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanbi MHJ, 2013, APPL MICROBIOL BIOT, V97, P4385, DOI 10.1007/s00253-012-4311-x; Baurin N, 2002, J ETHNOPHARMACOL, V82, P155, DOI 10.1016/S0378-8741(02)00174-5; CHEN JS, 1991, J AGR FOOD CHEM, V39, P1897, DOI 10.1021/jf00011a001; Ding HY, 2011, PLANT FOOD HUM NUTR, V66, P275, DOI 10.1007/s11130-011-0235-3; Forni C, 2014, MOL BIOSYST, V10, P1255, DOI 10.1039/c3mb70316a; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Hseu YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/197309; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; JAY D, 1991, ARCH BIOCHEM BIOPHYS, V290, P463, DOI 10.1016/0003-9861(91)90567-3; Kim YJ, 2005, BIOL PHARM BULL, V28, P323, DOI 10.1248/bpb.28.323; Lee CI, 2014, FOOD FUNCT, V5, P3224, DOI [10.1039/c4fo00720d, 10.1039/C4FO00720D]; Lee CI, 2013, APPL MICROBIOL BIOT, V97, P1269, DOI 10.1007/s00253-012-4279-6; Li YQ, 2011, J MED PLANTS RES, V5, P1066; Maity P, 2014, INT J BIOL MACROMOL, V63, P140, DOI 10.1016/j.ijbiomac.2013.10.040; Sapkota K, 2010, BIOSCI BIOTECH BIOCH, V74, P1527, DOI 10.1271/bbb.100058; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Song TY, 2002, J AGR FOOD CHEM, V50, P3322, DOI 10.1021/jf011671z; Tsai Z-T., 1985, USE EFFECT GANODERMA, P116; Tu SH, 2012, J AGR FOOD CHEM, V60, P3612, DOI 10.1021/jf300221g; Wang LC, 2013, APPL MICROBIOL BIOT, V97, P9955, DOI 10.1007/s00253-013-5214-1; Wang LC, 2012, APPL MICROBIOL BIOT, V94, P1505, DOI 10.1007/s00253-012-3941-3; Wu MT, 2011, J AGR FOOD CHEM, V59, P4248, DOI 10.1021/jf104561h; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; Yeh CT, 2009, CANCER LETT, V285, P73, DOI 10.1016/j.canlet.2009.05.002	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170924	10.1371/journal.pone.0170924	http://dx.doi.org/10.1371/journal.pone.0170924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125738	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100023
J	Mine, S; Watanabe, M; Kamachi, S; Abe, Y; Ueda, T				Mine, Shouhei; Watanabe, Masahiro; Kamachi, Saori; Abe, Yoshito; Ueda, Tadashi			The Structure of an Archaeal beta-Glucosaminidase Provides Insight into Glycoside Hydrolase Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BASED CLASSIFICATION; CHITIN-BINDING DOMAIN; HYPERTHERMOPHILIC CHITINASE; ENZYME PROMISCUITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GALACTOSIDASE; RECOGNITION; MECHANISMS; EXPRESSION	The archaeal exo-beta-D-glucosaminidase (GlmA) is a dimeric enzyme that hydrolyzes chitosan oligosaccharides into monomer glucosamines. GlmA is a member of the glycosidase hydrolase (GH)-A superfamily-subfamily 35 and is a novel enzyme in terms of its primary structure. Here, we present the crystal structure of GlmA in complex with glucosamine at 1.27 angstrom resolution. The structure reveals that a monomeric form of GlmA shares structural homology with GH42 beta-galactosidases, whereas most of the spatial positions of the active site residues are identical to those of GH35 beta-galactosidases. We found that upon dimerization, the active site of GlmA changes shape, enhancing its ability to hydrolyze the smaller substrate in a manner similar to that of homotrimeric GH42 beta-galactosidase. However, GlmA can differentiate glucosamine from galactose based on one charged residue while using the "evolutionary heritage residue" it shares with GH35 beta-galactosidase. Our study suggests that GH35 and GH42 beta-galactosidases evolved by exploiting the structural features of GlmA.	[Mine, Shouhei] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst BMD, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan; [Watanabe, Masahiro; Kamachi, Saori] AIST, Res Inst Sustainable Chem ISC, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan; [Abe, Yoshito; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Kyushu University	Mine, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst BMD, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.; Watanabe, M (corresponding author), AIST, Res Inst Sustainable Chem ISC, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	s-mine@aist.go.jp; masa-watanabe@aist.go.jp	Mine, Shouhei/M-1640-2018; Abe, Yoshito/AAH-6141-2021; Abe, Yoshito/D-8370-2012	Mine, Shouhei/0000-0003-2031-4552; Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Watanabe, Masahiro/0000-0001-5211-1333	Japan Society for the Promotion of Science [25450143]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research 25450143 from the Japan Society for the Promotion of Science (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beecher CN, 2015, ANAL CHEM, V87, P6842, DOI 10.1021/acs.analchem.5b01181; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Juers DH, 1999, PROTEIN SCI, V8, P122; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu B, 2006, BIOTECHNOL LETT, V28, P1655, DOI 10.1007/s10529-006-9137-0; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2014, FEBS J, V281, P2584, DOI 10.1111/febs.12805; Mine S, 2014, J BIOCHEM, V155, P115, DOI 10.1093/jb/mvt104; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Richard JP, 1996, BIOCHEMISTRY-US, V35, P12387, DOI 10.1021/bi961029b; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Schwarz A, 2007, BIOCHEM J, V403, P441, DOI 10.1042/BJ20070042; Solomon HV, 2015, ACTA CRYSTALLOGR D, V71, P2433, DOI 10.1107/S1399004715018672; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Tanaka T, 2004, J BIOL CHEM, V279, P30021, DOI 10.1074/jbc.M314187200; Tanaka T, 2003, J BACTERIOL, V185, P5175, DOI 10.1128/JB.185.17.5175-5181.2003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Bueren AL, 2009, J MOL BIOL, V385, P131, DOI 10.1016/j.jmb.2008.10.031; Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zheng B, 2012, J INEQUAL APPL, DOI 10.1186/1029-242X-2012-201	42	6	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4996	5006		10.1074/jbc.M116.766535	http://dx.doi.org/10.1074/jbc.M116.766535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130448	hybrid, Green Published			2022-12-26	WOS:000397590400021
J	Casciano, JC; Duchemin, NJ; Lamontagne, RJ; Steel, LF; Bouchard, MJ				Casciano, Jessica C.; Duchemin, Nicholas J.; Lamontagne, R. Jason; Steel, Laura F.; Bouchard, Michael J.			Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; PRIMARY RAT HEPATOCYTES; X-PROTEIN; HBX PROTEIN; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; ACTIVATION; EXPRESSION; MITOCHONDRIA	Many viruses modulate calcium (Ca2+) signaling to create a cellular environment that is more permissive to viral replication, but for most viruses that regulate Ca2+ signaling, the mechanism underlying this regulation is not well understood. The hepatitis B virus (HBV) HBx protein modulates cytosolic Ca2+ levels to stimulate HBV replication in some liver cell lines. A chronic HBV infection is associated with life-threatening liver diseases, including hepatocellular carcinoma (HCC), and HBx modulation of cytosolic Ca2+ levels could have an important role in HBV pathogenesis. Whether HBx affects cytosolic Ca2+ in a normal hepatocyte, the natural site of an HBV infection, has not been addressed. Here, we report that HBx alters cytosolic Ca2+ signaling in cultured primary hepatocytes. We used single cell Ca2+ imaging of cultured primary rat hepatocytes to demonstrate that HBx elevates the cytosolic Ca2+ level in hepatocytes following an IP3-linked Ca2+ response; HBx effects were similar when expressed alone or in the context of replicating HBV. HBx elevation of the cytosolic Ca2+ level required extracellular Ca2+ influx and store-operated Ca2+ (SOC) entry and stimulated HBV replication in hepatocytes. We used both targeted RT-qPCR and transcriptome- wide RNAseq analyses to compare levels of SOC channel components and other Ca2+ signaling regulators in HBV-expressing and control hepatocytes and show that the transcript levels of these various proteins are not affected by HBV. We also show that HBx regulation of SOC-regulated Ca2+ accumulation is likely the consequence of HBV modulation of a SOC channel regulatory mechanism. In support of this, we link HBx enhancement of SOC-regulated Ca2+ accumulation to Ca2+ uptake by mitochondria and demonstrate that HBx stimulates mitochondrial Ca2+ uptake in primary hepatocytes. The results of our study may provide insights into viral mechanisms that affect Ca2+ signaling to regulate viral replication and virus-associated diseases.	[Casciano, Jessica C.; Duchemin, Nicholas J.] Drexel Univ, Program Mol & Cellular Biol & Genet, Grad Sch Biomed Sci & Profess Studies, Coll Med, Philadelphia, PA 19104 USA; [Lamontagne, R. Jason] Drexel Univ, Program Microbiol & Immunol, Grad Sch Biomed Sci & Profess Studies, Coll Med, Philadelphia, PA 19104 USA; [Steel, Laura F.] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Bouchard, Michael J.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Bouchard, MJ (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA.	michael.bouchard@drexelmed.edu	Lamontagne, Jason/AAP-5542-2020	Lamontagne, Jason/0000-0002-9068-3348	National Cancer Institute [F31CA171850]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant F31CA171850 to JCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, ISOLATION OF HEPATOC, V1; Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Bouchard MJ, 2003, J VIROL, V77, P7713, DOI 10.1128/JVI.77.14.7713-7719.2003; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casciano J, 2012, MODULATION CELL PROL; Chami M, 2003, J BIOL CHEM, V278, P31745, DOI 10.1074/jbc.M304202200; Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chen JL, 2003, BIOCHEM J, V373, P327, DOI 10.1042/BJ20021904; Choi YW, 2005, VIROLOGY, V332, P454, DOI 10.1016/j.virol.2004.11.019; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clippinger AJ, 2008, J VIROL, V82, P6798, DOI 10.1128/JVI.00154-08; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Condit R., 2007, FIELDS VIROLOGY, V1; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Delgado-Coello B, 2010, MOL CELL BIOCHEM, V344, P117, DOI 10.1007/s11010-010-0535-1; Dellis O, 2011, J BIOL CHEM, V286, P18583, DOI 10.1074/jbc.M111.222257; Dixon CJ, 2005, J PHARMACOL EXP THER, V313, P1305, DOI 10.1124/jpet.104.082743; Dufour JF, 1999, HEPATOLOGY, V30, P1018, DOI 10.1002/hep.510300421; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Enfissi A, 2004, CELL CALCIUM, V36, P459, DOI 10.1016/j.ceca.2004.04.004; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Gearhart TL, 2010, VIROLOGY, V407, P14, DOI 10.1016/j.virol.2010.07.042; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; GRIFFIN D S, 1987, Journal of Biochemical Toxicology, V2, P155, DOI 10.1002/jbt.2570020302; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Huh KW, 2002, MITOCHONDRION, V1, P349, DOI 10.1016/S1567-7249(01)00040-X; Hyser JM, 2013, J VIROL, V87, P13579, DOI 10.1128/JVI.02629-13; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Koike K, 2009, CANCER LETT, V286, P60, DOI 10.1016/j.canlet.2009.04.010; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; McClain SL, 2007, J VIROL, V81, P12061, DOI 10.1128/JVI.00740-07; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; MINE T, 1988, BIOCHIM BIOPHYS ACTA, V970, P166, DOI 10.1016/0167-4889(88)90175-9; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Oh JC, 2003, EXP MOL MED, V35, P301, DOI 10.1038/emm.2003.41; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Paszty K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005672; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Philippe R, 2015, BBA-MOL CELL RES, V1853, P892, DOI 10.1016/j.bbamcr.2015.01.010; Piechocki MP, 1999, CARCINOGENESIS, V20, P401, DOI 10.1093/carcin/20.3.401; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Rawat S, 2015, J VIROL, V89, P999, DOI 10.1128/JVI.02440-14; Rodrigues MA, 2008, HEPATOLOGY, V48, P1621, DOI 10.1002/hep.22424; Runge D, 2000, BIOCHEM BIOPH RES CO, V269, P46, DOI 10.1006/bbrc.2000.2215; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Scaglioni PP, 1997, VIROLOGY, V233, P374, DOI 10.1006/viro.1997.8594; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Seeger C, 2007, FIELDS VIROLOGY; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tan C, 2009, VIRUS RES, V145, P307, DOI 10.1016/j.virusres.2009.08.001; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Yang B, 2011, J VIROL; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	101	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168328	10.1371/journal.pone.0168328	http://dx.doi.org/10.1371/journal.pone.0168328			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151934	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200004
J	Goulet, TL; Shirur, KP; Ramsby, BD; Iglesias-Prieto, R				Goulet, Tamar L.; Shirur, Kartick P.; Ramsby, Blake D.; Iglesias-Prieto, Roberto			The effects of elevated seawater temperatures on Caribbean gorgonian corals and their algal symbionts, Symbiodinium spp.	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SEA FAN CORAL; REEF CORALS; BLEACHING SUSCEPTIBILITY; BIOCHEMICAL-COMPOSITION; ENVIRONMENTAL-STRESS; THERMAL-STRESS; CLIMATE-CHANGE; NITRIC-OXIDE; HOST	Global climate change not only leads to elevated seawater temperatures but also to episodic anomalously high or low temperatures lasting for several hours to days. Scleractinian corals are detrimentally affected by thermal fluctuations, which often lead to an uncoupling of their mutualism with Symbiodinium spp. (coral bleaching) and potentially coral death. Consequently, on many Caribbean reefs scleractinian coral cover has plummeted. Conversely, gorgonian corals persist, with their abundance even increasing. How gorgonians react to thermal anomalies has been investigated utilizing limited parameters of either the gorgonian, Symbiodinium or the combined symbiosis (holobiont). We employed a holistic approach to examine the effect of an experimental five-day elevated temperature episode on parameters of the host, symbiont, and the holobiont in Eunicea tourneforti, E. flexuosa and Pseudoplexaura porosa. These gorgonian corals reacted and coped with 32 degrees C seawater temperatures. Neither Symbiodinium genotypes nor densities differed between the ambient 29.5 degrees C and 32 degrees C. Chlorophyll a and c(2) per Symbiodinium cell, however, were lower at 32 degrees C leading to a reduction in chlorophyll content in the branches and an associated reduction in estimated absorbance and increase in the chlorophyll a specific absorption coefficient. The adjustments in the photochemical parameters led to changes in photochemical efficiencies, although these too showed that the gorgonians were coping. For example, the maximum excitation pressure, Q(m), was significantly lower at 32 degrees C than at 29.5 degrees C. In addition, although per dry weight the amount of protein and lipids were lower at 32 degrees C, the overall energy content in the tissues did not differ between the temperatures. Antioxidant activity either remained the same or increased following exposure to 32 degrees C further reiterating a response that dealt with the stressor. Taken together, the capability of Caribbean gorgonian corals to modify symbiont, host and consequently holobiont parameters may partially explain their persistence on reefs faced with climate change.	[Goulet, Tamar L.; Shirur, Kartick P.; Ramsby, Blake D.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Iglesias-Prieto, Roberto] Univ Nacl Autonoma Mexico, Unidad Acad Sistemas Arrecifales, Inst Ciencias Mar & Limnol, Puerto Morelos, Quintana Roo, Mexico; [Ramsby, Blake D.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Iglesias-Prieto, Roberto] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Mississippi; Universidad Nacional Autonoma de Mexico; James Cook University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Goulet, TL (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	tlgoulet@olemiss.edu		Ramsby, Blake/0000-0001-9961-945X	Graduate Student Council at the University of Mississippi; Society for Integrative & Comparative Biology; Sigma Xi [G20101015155231]; Richard Gilder School at the American Museum of Natural History; National Science Foundation [IOS 0747205]; REU supplement; National Science Foundation under MRI [DBI 1126379]	Graduate Student Council at the University of Mississippi; Society for Integrative & Comparative Biology; Sigma Xi; Richard Gilder School at the American Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); REU supplement; National Science Foundation under MRI	Funding for this work was provided by the Graduate Student Council at the University of Mississippi (http://gsc.olemiss.edu/research-grants/), the Society for Integrative & Comparative Biology (Fellowship for Graduate Student Travel, http://www.sicb.org/index.php3), Sigma Xi (Grants-in-Aid of Research, G20101015155231, https://www.sigmaxi.org/programs/grants-in-aid), and Richard Gilder School at the American Museum of Natural History (Lerner Gray Fund for Marine Research, http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships/#grants) to KPS, and the National Science Foundation under Grant No. IOS 0747205 and REU supplement to TLG. The FIowCAM particle analyzer was funded by the National Science Foundation under MRI Grant No. DBI 1126379. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (https://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baker DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055057; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bates D, LME4 LINEAR MIXED EF; BIRKELAND C, 1981, COPEIA, P169; Brown L, 2011, BIOPHARM INT, V24, pS4; Cary LR, 1915, P NATL ACAD SCI USA, V1, P285, DOI 10.1073/pnas.1.5.285; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Couch CS, 2008, MAR BIOL, V155, P281, DOI 10.1007/s00227-008-1024-x; DAHLGREN EJ, 1989, B MAR SCI, V45, P678; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Downs CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077173; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Drohan AF, 2005, B MAR SCI, V77, P257; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gates RD, 1999, AM ZOOL, V39, P30; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2005, LIMNOL OCEANOGR, V50, P1490, DOI 10.4319/lo.2005.50.5.1490; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Hannes AR, 2009, MAR ECOL PROG SER, V391, P65, DOI 10.3354/meps07990; Hawkins TD, 2014, CORAL REEFS, V33, P141, DOI 10.1007/s00338-013-1103-4; Hawkins TD, 2015, CORAL REEFS, V34, P1229, DOI 10.1007/s00338-015-1345-4; Hoadley KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18371; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Imbs AB, 2012, CORAL REEFS, V31, P41, DOI 10.1007/s00338-011-0817-4; Imbs AB, 2014, PHYTOCHEMISTRY, V101, P76, DOI 10.1016/j.phytochem.2014.02.012; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kemp DW, 2015, CORAL REEFS, V34, P535, DOI 10.1007/s00338-015-1277-z; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; Kopp C, 2015, MBIO, V6, DOI 10.1128/mBio.02299-14; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; Lasker HR, 2003, CORAL REEFS, V22, P23, DOI 10.1007/s00338-003-0276-7; LASKER HR, 1988, BIOL BULL, V174, P254, DOI 10.2307/1541952; LASKER HR, 1984, CORAL REEFS, V3, P183, DOI 10.1007/BF00288253; Lenz EA, 2015, CORAL REEFS, V34, P1099, DOI 10.1007/s00338-015-1315-x; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Levas S, 2016, CORAL REEFS, V35, P495, DOI 10.1007/s00338-015-1390-z; Li AG, 2014, CORAL REEFS, V33, P847, DOI 10.1007/s00338-014-1162-1; Lutz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139290; Magris RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140828; Mann WT, 2014, MAR BIOL, V161, P2213, DOI 10.1007/s00227-014-2499-2; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Michalek-Wagner K, 2001, CORAL REEFS, V19, P240, DOI 10.1007/PL00006959; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2006, MAR FRESHW BEHAV PHY, V39, P143, DOI 10.1080/10236240600708512; Mydlarz LD, 2011, COMP BIOCHEM PHYS A, V159, P372, DOI 10.1016/j.cbpa.2011.03.029; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Palmer CV, 2011, DEV COMP IMMUNOL, V35, P1096, DOI 10.1016/j.dci.2011.04.001; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Parkinson JE, 2015, J PHYCOL, V51, P850, DOI 10.1111/jpy.12340; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pinzon JHC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104787; Pinzon CJH, 2014, PEERJ, V2, DOI 10.7717/peerj.628; Pontasch S, 2014, MAR ECOL PROG SER, V516, P195, DOI 10.3354/meps11038; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; Prada C, 2014, MOL ECOL, V23, P3330, DOI 10.1111/mec.12808; R Core Team, 2013, R LANG ENV STAT COMP; Ramsby BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106419; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Rodriguez-Roman A, 2006, LIMNOL OCEANOGR, V51, P2702, DOI 10.4319/lo.2006.51.6.2702; Ross C, 2014, CORAL REEFS, V33, P513, DOI 10.1007/s00338-014-1142-5; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Ruzicka R, 2013, MAR ECOL PROG SER; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Schoepf V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1887; Schoepf V, 2014, GEOCHIM COSMOCHIM AC, V146, P164, DOI 10.1016/j.gca.2014.09.033; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shirur KP, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3008-6; Shirur KP, 2014, J EXP MAR BIOL ECOL, V461, P275, DOI 10.1016/j.jembe.2014.08.016; Slattery M, 2008, MAR ECOL PROG SER, V354, P169, DOI 10.3354/meps07200; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Strong AE, 2008, P 11 INT COR REEF S, P1324; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tanaka Y, 2015, ECOL MODEL, V309, P163, DOI 10.1016/j.ecolmodel.2015.04.017; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Villamizar E, 2014, MAR ECOL-EVOL PERSP, V35, P425, DOI 10.1111/maec.12099; Voss G. L., 1956, Bulletin of Marine Science of the Gulf and Caribbean, V6, P359; VREELAND HV, 1989, J EXP MAR BIOL ECOL, V129, P265, DOI 10.1016/0022-0981(89)90108-1; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Warner ME, 2010, DEVEL APPL PHYCOL, V4, P209, DOI 10.1007/978-90-481-9268-7_10; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597	121	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171032	10.1371/journal.pone.0171032	http://dx.doi.org/10.1371/journal.pone.0171032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152002	Green Published, Green Accepted, gold			2022-12-26	WOS:000396161200076
J	Morioka, Y; Nam, JM; Ohashi, T				Morioka, Yuka; Nam, Jin-Min; Ohashi, Takashi			Nik-related kinase regulates trophoblast proliferation and placental development by modulating AKT phosphorylation	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; EMBRYONIC STEM-CELLS; PROTEIN-KINASE; MICE LACKING; SKELETAL-MUSCLE; HOMEOBOX GENE; FETAL-GROWTH; MOUSE MODEL; B-ALPHA; DIFFERENTIATION	Nik-related kinase (Nrk) is a Ser/Thr kinase and was initially discovered as a molecule that was predominantly detected in skeletal muscles during development. A recent study using Nrk-null mice suggested the importance of Nrk in proper placental development; however, the molecular mechanism remains unknown. In this study, we demonstrated that differentiated trophoblasts from murine embryonic stem cells (ESCs) endogenously expressed Nrk and that Nrk disruption led to the enhanced proliferation of differentiated trophoblasts. This phenomenon may reflect the overproliferation of trophoblasts that has been reported in enlarged placentas of Nrk-null mice. Furthermore, we demonstrated that AKT phosphorylation at Ser473 was upregulated in Nrk-null trophoblasts and that inhibition of AKT phosphorylation cancelled the enhanced proliferation observed in differentiated Nrk-null trophoblasts. These results indicated that the upregulation of AKT phosphorylation was the possible cause of enhanced proliferation observed in Nrk-null trophoblasts. The upregulation of AKT phosphorylation was also confirmed in enlarged Nrk-null placentas in vivo, suggesting that proper regulation of AKT by Nrk was important for normal placental development. In addition, our detailed analysis on phosphorylation status of AKT isoforms in newly established trophoblast stem cells (TSCs) revealed that different levels of upregulation of AKT phosphorylation were occurred in Nrk-null TSCs depending on AKT isoforms. These results further support the importance of Nrk in proper development of trophoblast lineage cells and indicate the possible application of TSCs for the analysis of differently regulated activation mechanisms of AKT isoforms.	[Morioka, Yuka; Ohashi, Takashi] Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan; [Nam, Jin-Min] Hokkaido Univ, Global Stn Quantum Med Sci & Engn, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Morioka, Y (corresponding author), Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan.	yukamorioka@igm.hokudai.ac.jp	Nam, Jin-Min/D-6468-2012; morioka, yuka/A-9926-2009		Japan Society for Promotion of Science [24592454, 15K15591]; Kanzawa medical research foundation; Takeda Science Foundation; Ichiro Kanehara Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [15K15591] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa medical research foundation(Kanzawa Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for Promotion of Science (https://www.jsps.go.jp) KAKENHI Grant Number 24592454 (Y.M.); Japan Society for Promotion of Science (https://www.jsps.go.jp) KAKENHI Grant Number 15K15591 (Y.M.); Kanzawa medical research foundation (http://www.takeda-sci.or.jp) (Y.M.); Takeda Science Foundation (http://www.takeda-sci.or.jp) (Y.M.); Ichiro Kanehara Foundation (http://www.kanehara-zaidan.or.jp) (Y.M.); and Inamori Foundation (http://www.inamori-f.or.jp) (Y.M.). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Cerrato F, 2005, HUM MOL GENET, V14, P503, DOI 10.1093/hmg/ddi047; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chiao E, 2002, DEV BIOL, V243, P185, DOI 10.1006/dbio.2001.0554; Chun JY, 1999, DEV DYNAM, V216, P257, DOI 10.1002/(SICI)1097-0177(199911)216:3<257::AID-DVDY4>3.0.CO;2-0; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Denda K, 2011, J BIOL CHEM, V286, P28802, DOI 10.1074/jbc.M111.258160; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Fremin C, 2015, CELL REP, V12, P913, DOI 10.1016/j.celrep.2015.07.011; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Haslinger P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104778; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jackman SM, 2012, MOL REPROD DEV, V79, P564, DOI 10.1002/mrd.22062; Kakinuma H, 2005, CELL SIGNAL, V17, P1439, DOI 10.1016/j.cellsig.2005.03.004; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Kettle JG, 2012, J MED CHEM, V55, P1261, DOI 10.1021/jm201394e; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; Liao Y, 2010, AM J TRANSL RES, V2, P19; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morioka Y, 2014, GENESIS, V52, P68, DOI 10.1002/dvg.22727; Nagy A., 2003, MANIPULATING THE MOU; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada Y, 2009, GENESIS, V47, P217, DOI 10.1002/dvg.20469; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rohrschneider LR, 2000, GENE DEV, V14, P505; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Singh AT, 2012, MOL CELL ENDOCRINOL, V362, P48, DOI 10.1016/j.mce.2012.05.009; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171503	10.1371/journal.pone.0171503	http://dx.doi.org/10.1371/journal.pone.0171503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152035	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200150
J	Tsujimoto, H; Hanley, KA; Sundararajan, A; Devitt, NP; Schilkey, FD; Hansen, IA				Tsujimoto, Hitoshi; Hanley, Kathryn A.; Sundararajan, Anitha; Devitt, Nicholas P.; Schilkey, Faye D.; Hansen, Immo A.			Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; IMMUNE-RESPONSE; AEGYPTI; WOLBACHIA; TRANSMISSION; STRAINS; ACTIVATION; PROTEIN; SUSCEPTIBILITY; DISSEMINATION	Background The Asian tiger mosquito, Aedes albopictus is currently an important vector for dengue, chikungunya and Zika virus, and its role in transmission of arthropod-borne viruses (arboviruses) may increase in the future due to its ability to colonize temperate regions. In contrast to Aedes aegypti, the dominant vector of dengue, chikungunya and Zika virus, genetic responses of Ae. albopictus upon infection with an arbovirus are not well characterized. Here we present a study of the changes in transcript expression in Ae. albopictus exposed to dengue virus serotype 2 via feeding on an artificial bloodmeal. Methodology/Principal findings We isolated midguts and midgut-free carcasses of Ae. albopictus fed on bloodmeals containing dengue virus as well as controls fed on virus-free control meals at day 1 and day 5 post-feeding. We confirmed infection of midguts from mosquitoes sampled on day 5 post-feeding via RT-PCR. RNAseq analysis revealed dynamic modulation of the expression of several putative immunity and dengue virus-responsive genes, some of whose expression was verified by qRT-PCR. For example, a serine protease gene was up-regulated in the midgut at 1 day post infection, which may potentially enhance mosquito susceptibility to dengue infection, while 14 leucine-rich repeat genes, previously shown to be involved in mosquito antiviral defenses, were down-regulated in the carcass at 5 days post infection. The number of significantly modulated genes decreased over time in midguts and increased in carcasses. Conclusion/Significance Dengue virus exposure results in the modulation of genes in a time-and site-specific manner. Previous literature on the interaction between mosquitoes and mosquito-borne pathogens suggests that most of the changes that occurred in Ae. albopictus exposed to DENV would favor virus infection. Many genes identified in this study warrant further characterization to understand their role in viral manipulation of and antiviral response of Ae. albopictus.	[Tsujimoto, Hitoshi; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Sundararajan, Anitha; Devitt, Nicholas P.; Schilkey, Faye D.] Natl Ctr Genome Resources, NM INBRE Sequencing & Bioinformat Core, Santa Fe, NM USA; [Tsujimoto, Hitoshi] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	New Mexico State University; National Center for Genome Resources (NCGR); Texas A&M University System; Texas A&M University College Station	Tsujimoto, H (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Tsujimoto, H (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	HitTsujimoto@gmail.com			National Center for Genome Resources (NCGR); NM-INBRE pilot grant; National Institutes of Health (NIH) [4SC1AI109055-04]; NIH [1R15AI113628-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI109055, R15AI113628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	National Center for Genome Resources (NCGR); NM-INBRE pilot grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding by National Center for Genome Resources (NCGR), NM-INBRE pilot grant to HT, National Institutes of Health (NIH) 4SC1AI109055-04 to IAH, and NIH 1R15AI113628-01 to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112; Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252; Chisenhall DM, 2014, AM J TROP MED HYG, V90, P431, DOI 10.4269/ajtmh.13-0412; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318; Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008; Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200; Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339; Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macours N, 2004, INSECT BIOCHEM MOLEC, V34, P501, DOI 10.1016/j.ibmb.2004.03.007; McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019; METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937; Miller N. A., 2008, ALPHEUS J COMPUT SCI, V1, P132, DOI DOI 10.4172/JCSB.1000013; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Salas-Benito JS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/873404; Shin SW, 2011, EMBO REP, V12, P938, DOI 10.1038/embor.2011.130; Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007; Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025; Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565; Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; WHITEHEAD RH, 1971, T ROY SOC TROP MED H, V65, P661, DOI 10.1016/0035-9203(71)90051-4; WHO, 2009, WHO TECH REP SER, V958, P1; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4	69	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171345	10.1371/journal.pone.0171345	http://dx.doi.org/10.1371/journal.pone.0171345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152011	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200130
J	Zhang, BB; Yan, C; Fang, F; Du, Y; Ma, R; Li, XY; Yu, Q; Meng, D; Tang, RX; Zheng, KY				Zhang, Bei-Bei; Yan, Chao; Fang, Fan; Du, Ying; Ma, Rui; Li, Xiang-Yang; Yu, Qian; Meng, Di; Tang, Ren-Xian; Zheng, Kui-Yang			Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis	PLOS ONE			English	Article							REGULATORY T-CELLS; MOUSE STRAINS; INFECTION; LIVER; PATHOLOGY; SUSCEPTIBILITY; EXPRESSION; RESISTANCE; PHENOTYPE; RESPONSES	Previous studies showed that CD4(+)T cells responses might be involved in the process of biliary fibrosis. However, the underlying mechanism resulting in biliary fibrosis caused by Clonorchis sinensis remains not yet fully elucidated. The objectives of the present study were to investigate the different profiles of hepatic CD4(+)T cell subsets (Th1, Th2, Th17 and Treg cells) and their possible roles in the biliary fibrosis of different strains of mice (C57BL/6, BALB/c and FVB mice) induced by C. sinensis infection. C57BL/6, BALB/c and FVB mice were orally gavaged with 45 metacercariae. All mice were sacrificed on 28 days post infection in deep anesthesia conditions. The leukocytes in the liver were separated to examine CD4(+)T cell subsets by flow cytometry and the left lobe of liver was used to observe pathological changes, collagen depositions and the concentrations of hydroxyproline. The most serious cystic and fibrotic changes appeared in FVB infected mice indicated by gross observation, Masson's trichrome staining and hydroxyproline content detection. In contrast to C57BL/6 infected mice, diffuse nodules and more intensive fibrosis were observed in the BALB/c infected mice. No differences of the hepatic Th1 subset and Th17 subset were found among the three strains, but the hepatic Th2 and Treg cells and their relative cytokines were dramatically increased in the BALB/c and FVB infected groups compared with the C57BL/6 infected group (P<0.01). Importantly, increased Th2 subset and Treg subset all positively correlated with hydroxyproline contents (P<0.01). This result for the first time implied that the increased hepatic Th2 and Treg cell subsets were likely to play potential roles in the formation of biliary fibrosis in C. sinensis-infected mice.	[Zhang, Bei-Bei; Yan, Chao; Fang, Fan; Du, Ying; Ma, Rui; Li, Xiang-Yang; Yu, Qian; Tang, Ren-Xian; Zheng, Kui-Yang] Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou, Jiangsu, Peoples R China; [Meng, Di] Xuzhou Med Univ, Dept Pathol, Affiliated Hosp, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Tang, RX; Zheng, KY (corresponding author), Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou, Jiangsu, Peoples R China.	Tangrenxian-t@163.com; ZKY02@163.com	Yan, Chao/AAA-9403-2021		National Natural Science Foundation of China [81572019, 31302077]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College [53591317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College	Project support was provided in part by the National Natural Science Foundation of China (Grant Nos. 81572019 and 31302077), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in the year of 2014, the Starting Foundation for Talents of Xuzhou Medical College (Grant No. 53591317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha R, 2015, J IMMUNOL, V195, P2241, DOI 10.4049/jimmunol.1500745; Birjandi SZ, 2016, AM J PATHOL, V186, P2008, DOI 10.1016/j.ajpath.2016.03.020; Bouchery T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00487; Breloer M, 2017, PARASITOLOGY, V144, P295, DOI 10.1017/S0031182016000111; Bryan MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000733; Cao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074955; Choi YK, 2003, PARASITOL RES, V91, P87, DOI 10.1007/s00436-003-0934-2; Clough D, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0189; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Freitas JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005113; Guo QianQian, 2009, China Tropical Medicine, V9, P1187; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Hannestad K, 2009, J IMMUNOL, V183, P3542, DOI 10.4049/jimmunol.0900579; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Kim EM, 2012, PARASITOL INT, V61, P124, DOI 10.1016/j.parint.2011.07.001; Knott ML, 2009, PARASITOLOGY, V136, P93, DOI 10.1017/S0031182008005192; Kumar R, 2015, AM J RESP CRIT CARE, V192, P998, DOI 10.1164/rccm.201410-1820OC; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Liappas G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416480; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Maeng S, 2016, INT J PARASITOL, V46, P195, DOI 10.1016/j.ijpara.2015.11.003; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Moosbrugger-Martinz V, 2016, J CELL MOL MED, V20, P930, DOI 10.1111/jcmm.12806; Mourglia-Ettlin G, 2016, IMMUNOBIOLOGY, V221, P418, DOI 10.1016/j.imbio.2015.11.012; Okada F, 2014, YONAGO ACTA MED, V57, P65; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29844; Qian MB, 2016, LANCET, V387, P800, DOI 10.1016/S0140-6736(15)60313-0; Qian MB, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-4; Qiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042471; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Shi WB, 2010, CIRC-CARDIOVASC GENE, V3, P409, DOI 10.1161/CIRCGENETICS.110.957449; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Specht S, 2012, EXP PARASITOL, V132, P90, DOI 10.1016/j.exppara.2011.09.003; Uddin MH, 2012, PARASITOL INT, V61, P118, DOI 10.1016/j.parint.2011.07.002; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xu YQ, 2016, PARASITOL RES, V115, P2653, DOI 10.1007/s00436-016-5012-7; Yan C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143217; Yan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0675-y; Yang QL, 2015, KOREAN J PARASITOL, V53, P777, DOI 10.3347/kjp.2015.53.6.777; Zhang GW, 2014, ANN SURG ONCOL, V21, P3628, DOI 10.1245/s10434-014-3710-x; Zhang WW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0650-7	45	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171005	10.1371/journal.pone.0171005	http://dx.doi.org/10.1371/journal.pone.0171005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151995	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200069
J	Gimenez-Garzo, C; Garces, JJ; Urios, A; Mangas-Losada, A; Garcia-Garcia, R; Gonzalez-Lopez, O; Giner-Duran, R; Escudero-Garcia, D; Serra, MA; Soria, E; Felipo, V; Montoliu, C				Gimenez-Garzo, Carla; Garces, Juan Jose; Urios, Amparo; Mangas-Losada, Alba; Garcia-Garcia, Raquel; Gonzalez-Lopez, Olga; Giner-Duran, Remedios; Escudero-Garcia, Desamparados; Serra, Miguel Angel; Soria, Emilio; Felipo, Vicente; Montoliu, Carmina			The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; CRITICAL FLICKER FREQUENCY; BIMANUAL COORDINATION; VISUAL-ATTENTION; MOTOR IMPAIRMENT; LIVER-CIRRHOSIS; DIAGNOSIS; COVERT; CHALLENGE; VALIDITY	Background and aims The psychometric hepatic encephalopathy score (PHES) is the "gold standard" for minimal hepatic encephalopathy (MHE) diagnosis. Some reports suggest that some cirrhotic patients "without" MHE according to PHES show neurological deficits and other reports that neurological alterations are not homogeneous in all cirrhotic patients. This work aimed to assess whether: 1) a relevant proportion of cirrhotic patients show neurological deficits not detected by PHES; 2) cirrhotic patients with mild neurological deficits are a homogeneous population or may be classified in sub-groups according to specific deficits. Methods Cirrhotic patients "without" (n = 56) or "with" MHE (n = 41) according to PHES and controls (n = 52) performed psychometric tests assessing attention, concentration, mental processing speed, working memory and bimanual and visuomotor coordination. Heterogeneity of neurological alterations was analysed using Hierarchical Clustering Analysis. Results PHES classified as "with" MHE 42% of patients. Around 40% of patients "without" MHE according to PHES fail two psychometric tests. Oral SDMT, d2, bimanual and visuo-motor coordination tests are failed by 54, 51, 51 and 43% of patients, respectively. The earliest neurological alterations are different for different patients. Hierarchical clustering analysis shows that patients "without" MHE according to PHES may be classified in clusters according to the tests failed. In some patients coordination impairment appear before cognitive impairment while in others concentration and attention deficits appear before. Conclusions PHES is not sensitive enough to detect early neurological alterations in a relevant proportion of cirrhotic patients. Oral SDMT, d2 and bimanual and visuo-motor coordination tests are more sensitive. The earliest neurological alterations are different in different cirrhotic patients. These data also have relevant clinical implications. Patients classified as "without MHE" by PHES belonging to clusters 3 and 4 in our study have a high risk of suffering clinical complications, including overt HE and must be diagnosed and clinically followed.	[Gimenez-Garzo, Carla; Urios, Amparo; Garcia-Garcia, Raquel; Felipo, Vicente] Ctr Invest Principe Felipe Valencia, Lab Neurobiol, Valencia, Spain; [Garces, Juan Jose; Soria, Emilio] Escuela Tecn Super Ingn, IDAL, Valencia, Spain; [Urios, Amparo; Mangas-Losada, Alba; Montoliu, Carmina] Fdn Invest Hosp Clin Valencia, Inst Invest Sanitaria INCLIVA, Valencia, Spain; [Gonzalez-Lopez, Olga; Giner-Duran, Remedios] Hosp Arnau Vilanova, Serv Digest, Valencia, Spain; [Escudero-Garcia, Desamparados; Serra, Miguel Angel] Univ Valencia, Unidad Digest, Hosp Clin Valencia, Dept Med, Valencia, Spain; [Montoliu, Carmina] Univ Valencia, Dept Patol, Fac Med, Valencia, Spain	Prince Felipe Research Center; University of Valencia; University of Valencia	Felipo, V (corresponding author), Ctr Invest Principe Felipe Valencia, Lab Neurobiol, Valencia, Spain.	vfelipo@cipf.es	Montoliu, Carmina/ABB-1904-2021; Urios, Amparo/ABB-1879-2021; Escudero-Garcia, Desamparados/ABB-1929-2021; Felipo, Vicente/A-9265-2014	Felipo, Vicente/0000-0003-3145-9538; Garcia, Raquel/0000-0002-0911-1220; Urios, Amparo/0000-0003-2699-7040; Gimenez-Garzo, Carla/0000-0002-9748-443X; Soria Olivas, Emilio/0000-0002-9148-8405	Ministerio de Ciencia e Innovacion [SAF2011-23051, CSD2008-00005, SAF2014-51851-R, FIS PI12/00884, FIS PI15/00035]; Conselleria Educacion Generalitat Valenciana [PROMETEO-2009-027, PROMETEOII/2014/033, ACOMP/2014/026]; European Regional Development Funds (ERDF)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Educacion Generalitat Valenciana; European Regional Development Funds (ERDF)(European Commission)	This work was supported by Ministerio de Ciencia e Innovacion (SAF2011-23051, CSD2008-00005, SAF2014-51851-R) to VF and FIS PI12/00884 and FIS PI15/00035 to CM, Conselleria Educacion Generalitat Valenciana (PROMETEO-2009-027; PROMETEOII/2014/033 to VF and ACOMP/2014/026 to CM) and co-funded with European Regional Development Funds (ERDF).	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Amodio P, 1995, METAB BRAIN DIS, V10, P335, DOI 10.1007/BF02109363; Amodio P, 1998, HEPATOLOGY, V27, P1517, DOI 10.1002/hep.510270608; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2012, HEPATOLOGY, V55, P1164, DOI 10.1002/hep.25507; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Baltimore Williams and Wilkins. World Medical Organization, 1996, BMJ-BRIT MED J, V313, P1448; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Brickenkamp, 1998, THE D2 TEST OF ATTEN; Butz M, 2010, ACTA NEUROL SCAND, V122, P27, DOI 10.1111/j.1600-0404.2009.01246.x; Curran S, 2004, INT J GERIATR PSYCH, V19, P575, DOI 10.1002/gps.1134; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; ELSASS P, 1978, SCAND J GASTROENTERO, V13, P241, DOI 10.3109/00365527809181755; Felipo V, 2014, WORLD J GASTROENTERO, V20, P11815, DOI 10.3748/wjg.v20.i33.11815; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Groribaek L, 2014, J HEPATOL, V60, P612, DOI 10.1016/j.jhep.2013.10.020; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mardini H, 2008, GASTROENTEROLOGY, V135, P1582, DOI 10.1053/j.gastro.2008.06.043; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Montagnese S, 2014, WORLD J GASTROENTERO, V20, P15756, DOI 10.3748/wjg.v20.i42.15756; Montoliu C, 2007, J MOL MED, V85, P233, DOI 10.1007/s00109-006-0149-y; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Patidar KR, 2015, CLIN GASTROENTEROL H, V13, P2048, DOI 10.1016/j.cgh.2015.06.039; Pollok B, 2007, J COGNITIVE NEUROSCI, V19, P704, DOI 10.1162/jocn.2007.19.4.704; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Romero-Gomez M, 2004, HEPATOLOGY, V39, P939, DOI 10.1002/hep.20152; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586; Sharma P, 2010, HEPATOB PANCREAT DIS, V9, P27; Smith A., 1968, LEARNING DISORDERS, P83, DOI DOI 10.1080/13803390591004428; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P184, DOI 10.1099/00221287-17-1-184; Tukey JW, 1977, EXPLORATORY DATA ANA, VXVI, P688; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5	46	29	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171211	10.1371/journal.pone.0171211	http://dx.doi.org/10.1371/journal.pone.0171211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146589	gold, Green Published, Green Submitted			2022-12-26	WOS:000396131700028
J	Choi, HW; Hong, YJ; Kim, JS; Song, H; Cho, SG; Bae, H; Kim, C; Byun, SJ; Do, JT				Choi, Hyun Woo; Hong, Yean Ju; Kim, Jong Soo; Song, Hyuk; Cho, Ssang Gu; Bae, Hojae; Kim, Changsung; Byun, Sung June; Do, Jeong Tae			In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation	PLOS ONE			English	Article							TETRAPLOID MOUSE EMBRYOS; CENTRAL-NERVOUS-SYSTEM; TERATOMA FORMATION; SELF-RENEWAL; GENERATION; AGGREGATION; INDUCTION; NEURONS; CULTURE; NICHE	Like embryonic stem cells, induced pluripotent stem cells (iPSCs) can differentiate into all three germ layers in an in vitro system. Here, we developed a new technology for obtaining neural stem cells (NSCs) from iPSCs through chimera formation, in an in vivo environment. iPSCs contributed to the neural lineage in the chimera, which could be efficiently purified and directly cultured as NSCs in vitro. The iPSC-derived, in vivo-differentiated NSCs expressed NSC markers, and their gene-expression pattern more closely resembled that of fetal brain-derived NSCs than in vitro-differentiated NSCs. This system could be applied for differentiating pluripotent stem cells into specialized cell types whose differentiation protocols are not well established.	[Choi, Hyun Woo; Hong, Yean Ju; Kim, Jong Soo; Song, Hyuk; Cho, Ssang Gu; Do, Jeong Tae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Choi, Hyun Woo] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Bae, Hojae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul, South Korea; [Kim, Changsung] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Byun, Sung June] RDA, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun, Jeollabuk Do, South Korea	Konkuk University; Max Planck Society; Konkuk University; Sejong University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Do, JT (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea.	dojt@konkuk.ac.kr		bae, hojae/0000-0003-3057-4999; Cho, Ssang-Goo/0000-0002-0968-7932; Do, Jeong Tae/0000-0001-6721-1441	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A2A2A01003604, 2015R1A5A1009701]; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea [PJ01133802]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2015R1A2A2A01003604 and 2015R1A5A1009701) and the Next-Generation BioGreen 21 Program (grant no. PJ01133802) funded by the Rural Development Administration, Republic of Korea.	Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Choi DH, 2002, CELL TRANSPLANT, V11, P359; Choi HW, 2014, STEM CELLS, V32, P2596, DOI 10.1002/stem.1757; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; De Waele J, 2015, BIOMATERIALS, V41, P122, DOI 10.1016/j.biomaterials.2014.11.025; Do JT, 2011, STEM CELLS DEV, V20, P1063, DOI 10.1089/scd.2010.0385; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Hong YJ, 2016, STEM CELLS DEV, V25, P1311, DOI 10.1089/scd.2016.0124; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Reekmans K, 2012, REGEN MED, V7, P245, DOI [10.2217/rme.12.5, 10.2217/RME.12.5]; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170735	10.1371/journal.pone.0170735	http://dx.doi.org/10.1371/journal.pone.0170735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141814	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500016
J	Sharma, J; Leslie, HH; Kundu, F; Kruk, ME				Sharma, Jigyasa; Leslie, Hannah H.; Kundu, Francis; Kruk, Margaret E.			Poor Quality for Poor Women? Inequities in the Quality of Antenatal and Delivery Care in Kenya	PLOS ONE			English	Article							UNIVERSAL HEALTH COVERAGE; OF-CARE; NEWBORN HEALTH; MEDICAL-CARE; INTERVENTIONS; AFRICA; INDIA	Background Quality of healthcare is an important determinant of future progress in global health. However, the distributional aspects of quality of care have received inadequate attention. We assessed whether high quality maternal care is equitably distributed by (1) mapping the quality of maternal care in facilities located in poorer versus wealthier areas of Kenya; and (2) comparing the quality of maternal care available to Kenyans in and not in poverty. Methods We assessed three measures of maternal care quality: facility infrastructure and clinical quality of antenatal care and delivery care, using indicators from the 2010 Kenya Service Provision Assessment (SPA), a standardized facility survey with direct observation of maternal care provision. We calculated poverty of the area served by antenatal or delivery care facilities using the Multidimensional Poverty Index. We used regression analyses and nonparametric tests to assess differences in maternal care quality in facilities located in more and less impoverished areas. We estimated effective coverage with a minimum standard of care for the full population and those in poverty. Results A total of 564 facilities offering at least one maternal care service were included in this analysis. Quality of maternal care was low, particularly clinical quality of antenatal and delivery care, which averaged 0.52 and 0.58 out of 1 respectively, compared to 0.68 for structural inputs to care. Maternal healthcare quality varied by poverty level: at the facility level, all quality metrics were lowest for the most impoverished areas and increased significantly with greater wealth. Population access to a minimum standard (>= 0.75 of 1.00) of quality maternal care was both low and inequitable: only 17% of all women and 8% of impoverished women had access to minimally adequate delivery care. Conclusion The quality of maternal care is low in Kenya, and care available to the impoverished is significantly worse than that for the better off. To achieve the national targets of maternal and neonatal mortality reduction, policy initiatives need to tackle low quality of care, starting with high-poverty areas.	[Sharma, Jigyasa; Leslie, Hannah H.; Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Kundu, Francis] Natl Council Populat & Dev, Nairobi, Kenya	Harvard University; Harvard T.H. Chan School of Public Health	Sharma, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	jigyasa.sharma@mail.harvard.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432; Leslie, Hannah Hogan/0000-0002-7464-3645; Sharma, Jigyasa/0000-0001-8860-0710				[Anonymous], 2014, COUNTIES HIGHEST BUR; Barber SL, 2007, HEALTH AFFAIR, V26, pW352, DOI 10.1377/hlthaff.26.3.w352; Barber SL, 2007, HEALTH AFFAIR, V26, pW310, DOI 10.1377/hlthaff.26.3.w310; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Board on Global Health Institute of Medicine The National Academies of Sciences Engineering and Medicine., 2015, REV EV DIFF QUAL IMP; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Hansen PM, 2008, INT J QUAL HEALTH C, V20, P375, DOI 10.1093/intqhc/mzn039; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; HerediaPi IB, 2016, B WHO, V94; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE594, DOI 10.1016/S2214-109X(16)30131-0; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2016, LANCET GLOBAL HLTH; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Lee E, 2016, HLTH POLICY PLANNING; Leslie HH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002151; Leslie HH, 2016, HEALTH AFFAIR, V35, P1716, DOI 10.1377/hlthaff.2016.0261; Maru DSR, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-41; Ministry of Health, 2014, KEN HLTH POL 2014 20; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Reidpath DD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000062; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Sobel HL, 2016, HEALTH POLICY PLANN, V31, P547, DOI 10.1093/heapol/czv095; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; Tatem A, 2014, FINAL REPORT DEV HIG; The Partnership for Maternal Newborn and Child Health, 2006, OPP AFR NEWB; Tripathi V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129491; United Nations, 2015, 2030 AG SUST DEV; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Wirth Meg, 2008, East Afr J Public Health, V5, P133; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2015, GLOB OBS DAT REP; World Health Organization, 2016, MAT CHILD HLTH; World Health Organization, 2016, NEON CHILD HLTH PROF	42	58	58	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171236	10.1371/journal.pone.0171236	http://dx.doi.org/10.1371/journal.pone.0171236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141840	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500051
J	Han, Y; Yue, LZ; Wei, M; Ren, XB; Shao, ZH; Zhang, L; Levine, RL; Epling-Burnette, PK				Han, Ying; Yue, Lanzhu; Wei, Max; Ren, Xiubao; Shao, Zonghong; Zhang, Ling; Levine, Ross L.; Epling-Burnette, Pearlie K.			Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BONE-MARROW FIBROSIS; STEM-CELLS; STROMAL CELLS; MYELOPROLIFERATIVE NEOPLASMS; ACTIVATING MUTATION; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; FACTOR-BETA; TGF-BETA	Myelofibrosis is an indicator of poor prognosis in myeloproliferative neoplasms (MPNs), but the precise mechanism(s) contributing to extracellular matrix remodeling and collagen deposition in the bone marrow (BM) niche remains unanswered. In this study, we isolated mesenchymal stromal cells (MSCs) from mice transplanted with wild-type thrombopoietin receptor (MPL (WT)) and MPL (W515L) retroviral-transduced bone marrow. Using MSCs derived from MPL (W515) -transplant recipients, excessive collagen deposition was maintained in the absence of the virus and neoplastic hematopoietic cells suggested that the MSCs were reprogrammed in vivo. TGF beta production by malignant megakaryocytes plays a definitive role promoting myelofibrosis in MPNs. However, TGF beta was equally expressed by MSCs derived from MPL (WT) and MPL (W515L) expressing mice and the addition of neutralizing anti-TGF beta antibody only partially reduced collagen secretion in vitro. Interestingly, profibrotic MSCs displayed increased levels of pSmad3 and pSTAT3 suggesting that inflammatory mediators cooperating with the TGF beta-receptor signaling may maintain the aberrant pheno-type ex vivo. FGFb is a known suppressor of TGF beta signaling. Reduced collagen deposition by FGFb-treated MSCs derived from MPL (W515L) mice suggests that the activating pathway is vulnerable to this suppressive mediator. Therefore, our findings have implications for the future investigation of therapies to reverse fibrosis in MPNs.	[Han, Ying; Yue, Lanzhu; Wei, Max; Epling-Burnette, Pearlie K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Han, Ying; Ren, Xiubao] Tianjin Med Univ, Dept Biotherapy, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Key Lab Canc Immun, Tianjin, Peoples R China; [Yue, Lanzhu; Shao, Zonghong] Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China; [Zhang, Ling] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematopathol, Tampa, FL USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Ctr, New York, NY 10021 USA	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University; Tianjin Medical University; H Lee Moffitt Cancer Center & Research Institute; Memorial Sloan Kettering Cancer Center	Epling-Burnette, PK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Pearlie.Burnette@moffitt.org	levine, ross/AAE-7658-2019	yue, lanzhu/0000-0002-8578-7564	Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services - Moffitt Cancer Center Support grant [P30CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services - Moffitt Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services, sponsored by the Moffitt Cancer Center Support grant (P30CA076292).	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Berardis S, 2015, WORLD J GASTROENTERO, V21, P742, DOI 10.3748/wjg.v21.i3.742; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Bock O, 2005, J PATHOL, V205, P548, DOI 10.1002/path.1744; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; Ciaffoni F, 2015, BLOOD CELL MOL DIS, V54, P234, DOI 10.1016/j.bcmd.2014.12.005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gastinne T, 2007, EXP HEMATOL, V35, P64, DOI 10.1016/j.exphem.2006.08.016; Gentile TC, 1996, LEUKEMIA LYMPHOMA, V23, P365, DOI 10.3109/10428199609054840; Grande JP, 1997, J LAB CLIN MED, V130, P476, DOI 10.1016/S0022-2143(97)90124-4; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; KHALIL N, 1991, CIBA F SYMP, V157, P194; KINGREEN D, 1995, AM J HEMATOL, V50, P234, DOI 10.1002/ajh.2830500403; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kremyanskaya M, 2013, ONCOLOGY-NY, V27, P706; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Le Bousse-Kerdiles MC, 1999, ANN HEMATOL, V78, P437, DOI 10.1007/s002770050595; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu JH, 2000, BLOOD, V95, P3219; Liu JH, 2002, BLOOD, V100, P1449, DOI 10.1182/blood.V100.4.1449.h81602001449_1449_1453; Mailloux AW, 2013, J IMMUNOL, V191, P3578, DOI 10.4049/jimmunol.1203424; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Manshouri T, 2011, CANCER RES, V71, P3831, DOI 10.1158/0008-5472.CAN-10-4002; Matsuzaki K, 2014, J GASTROENTEROL, V49, P971, DOI 10.1007/s00535-013-0910-2; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Michiels JJ, 2015, ACTA HAEMATOL-BASEL, V133, P36, DOI 10.1159/000358580; Mudrabettu C, 2015, NEPHROLOGY, V20, P25, DOI 10.1111/nep.12338; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Papetti M, 2003, INVEST OPHTH VIS SCI, V44, P4994, DOI 10.1167/iovs.03-0291; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Popp Felix C, 2006, Curr Stem Cell Res Ther, V1, P411; Rolandsson S, 2014, PULM PHARMACOL THER, V29, P93, DOI 10.1016/j.pupt.2014.08.001; Roth S, 1998, HEPATOLOGY, V27, P1003, DOI 10.1002/hep.510270416; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schmitt A, 2000, BLOOD, V96, P1342, DOI 10.1182/blood.V96.4.1342; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Wlodarski MW, 2005, BLOOD, V106, P2769, DOI 10.1182/blood-2004-10-4045; Yoon SY, 2001, HAEMATOLOGICA, V86, P52; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0166014	10.1371/journal.pone.0166014	http://dx.doi.org/10.1371/journal.pone.0166014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135282	Green Submitted, gold, Green Published			2022-12-26	WOS:000396124700001
J	Hawelka, B; Sitko, I; Kazakopoulos, P; Beinat, E				Hawelka, Bartosz; Sitko, Izabela; Kazakopoulos, Pavlos; Beinat, Euro			Collective Prediction of Individual Mobility Traces for Users with Short Data History	PLOS ONE			English	Article								We present and test a sequential learning algorithm for the prediction of human mobility that leverages large datasets of sequences to improve prediction accuracy, in particular for users with a short and non-repetitive data history such as tourists in a foreign country. The algorithm compensates for the difficulty of predicting the next location when there is limited evidence of past behavior by leveraging the availability of sequences of other users in the same system that provide redundant records of typical behavioral patterns. We test the method on a dataset of 10 million roaming mobile phone users in a European country. The average prediction accuracy is significantly higher than that of individual sequence prediction algorithms, primarily constant order Markov models derived from the user's own data, that have been shown to achieve high accuracy in previous studies of human mobility. The proposed algorithm is generally applicable to improve any sequential prediction when there is a sufficiently rich and diverse dataset of sequences.	[Hawelka, Bartosz; Sitko, Izabela; Beinat, Euro] Salzburg Univ, Dept Geoinformat Z GIS, Salzburg, Austria; [Hawelka, Bartosz; Sitko, Izabela; Kazakopoulos, Pavlos; Beinat, Euro] CS Res Fdn, Amsterdam, Netherlands	Salzburg University	Hawelka, B (corresponding author), Salzburg Univ, Dept Geoinformat Z GIS, Salzburg, Austria.; Hawelka, B (corresponding author), CS Res Fdn, Amsterdam, Netherlands.	bartosz.hawelka@sbg.ac.at		Hawelka, Bartosz/0000-0003-0566-2655	CS Research Foundation; Austrian Science Fund (FWF) through the Doctoral College GIScience, Department of Geoinformatics - Z GIS, University of Salzburg, Austria [DK W 1237-N23]	CS Research Foundation; Austrian Science Fund (FWF) through the Doctoral College GIScience, Department of Geoinformatics - Z GIS, University of Salzburg, Austria	This research was funded by the CS Research Foundation (www.coliectivesensing.org) and by the Austrian Science Fund (FWF) through the Doctoral College GIScience (DK W 1237-N23), Department of Geoinformatics - Z GIS, University of Salzburg, Austria.	Blum A, 2005, LECT NOTES COMPUT SC, V3559, P621, DOI 10.1007/11503415_42; Blum A, 1997, MACH LEARN, V26, P5, DOI 10.1023/A:1007335615132; Borodin A, 2000, LECT NOTES COMPUT SC, V1776, P173, DOI 10.1007/10719839_19; Cesa-Bianchi N., 2006, PREDICTION LEARNING, DOI DOI 10.1017/CBO9780511546921; Cohen WW, 1999, ACM T INFORM SYST, V17, P141, DOI 10.1145/306686.306688; Cutland N., 1991, MATH FINANC, V1, P1; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; Devaine M, 2009, AGGREGATION SLEEPING; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FEDER M, 1992, IEEE T INFORM THEORY, V38, P1258, DOI 10.1109/18.144706; Freund Y., 1997, P 20 9 ANN ACM S THE, P334, DOI [10.1145/258533.258616, DOI 10.1145/258533.258616]; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jacobs A., 2011, THESIS; Kleinberg R, 2010, MACH LEARN, V80, P245, DOI 10.1007/s10994-010-5178-7; Li B, 2014, ACM COMPUT SURV, V46, DOI 10.1145/2512962; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mallet V, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014259; Mallet V, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD009978; Monteleoni Claire, 2011, Statistical Analysis and Data Mining, V4, P18, DOI 10.1002/sam.10126; Monteleoni C, 2003, ADV NEURAL INFORM PR; Noulas A, 2012, IEEE DATA MINING, P1038, DOI 10.1109/ICDM.2012.113; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Song LB, 2006, IEEE T MOBILE COMPUT, V5, P1633, DOI 10.1109/TMC.2006.185; Stoltz G, 2005, MACH LEARN, V59, P125, DOI 10.1007/s10994-005-0465-4; Tatem AJ, 2009, MALARIA J, V8, P10; Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716; Vovk V, 2009, J MACH LEARN RES, V10, P2445; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170907	10.1371/journal.pone.0170907	http://dx.doi.org/10.1371/journal.pone.0170907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135289	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700030
J	Li, BI; Ababon, MR; Matteson, PG; Lin, Y; Nanda, V; Millonig, JH				Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Lin, Yong; Nanda, Vikas; Millonig, James H.			Congenital Cataract in Mice Is Modified by Proximal Chromosome 15	PLOS ONE			English	Article							PROGRESSIVE-ANKYLOSIS GENE; PROTEIN-COUPLED RECEPTOR; QUANTITATIVE TRAIT LOCI; MOLECULAR-GENETICS; MOUSE MODELS; HETEROGENEITY; MUTATIONS; PATHWAY; GPR161; MICROCORNEA	The morphology and severity of human congenital cataract varies even among individuals with the same mutation, suggesting that genetic background modifies phenotypic penetrance. The spontaneous mouse mutant, vacuolated lens (vi), arose on the C3H/HeSnJ background. The mutation disrupts secondary lens fiber development by El 6.5, leading to full penetrance of congenital cataract. The v/locus was mapped to a frameshift deletion in the orphan G protein-coupled receptor, Gpr161, which is expressed in differentiating lens fiber cells. When Gpr161(vl/vl) C3H mice are crossed to MOLF/EiJ mice an unexpected rescue of cataract is observed, suggesting that MOLF modifiers affect cataract penetrance. Subsequent QTL analysis mapped three modifiers (Modvl3-5: Modifier of vl) and in this study we characterized Modvl4 (Chrl 5; LOD = 4.4). A Modv/4(MOLF) congenic was generated and is sufficient to rescue congenital cataract and the lens fiber defect at El 6.5. Additional phenotypic analysis on three subcongenic lines narrowed down the interval from 55 to 15Mb. In total only 18 protein-coding genes and 2 micro-RNAs are in this region. Fifteen of the 20 genes show detectable expression in the El 6.5 eye. Subsequent expression studies in Gpr161(vl/vl) and subcongenic El 6.5 eyes, bioinformatics analysis of C3H/MOLF polymorphisms, and the biological relevancy of the genes in the interval identified three genes (Cdh6, Ank and Trio) that likely contribute to the rescue of the lens phenotype. These studies demonstrate that modification of the Gpr161(vl/vl) cataract phenotype is likely due to genetic variants in at least one of three closely linked candidate genes on proximal Chr15.	[Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Nanda, Vikas; Millonig, James H.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Li, Bo I.; Millonig, James H.] Rutgers State Univ, Dept Neurosci & Cell Biol, Piscataway, NJ USA; [Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Nanda, Vikas; Millonig, James H.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ USA; [Lin, Yong] Rutgers State Univ, Rutgers Canc Inst New Jersey, Div Biometr, New Brunswick, NJ USA; [Nanda, Vikas] Rutgers State Univ, Dept Biochem, Piscataway, NJ USA; [Millonig, James H.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Li, Bo I.] Columbia Univ, Med Ctr, Irving Canc Res Ctr, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University	Millonig, JH (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Dept Neurosci & Cell Biol, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ USA.	millonig@cabm.rutgers.edu			New Jersey Commission on Spinal Cord Research [10-3092-SCR-E-0]	New Jersey Commission on Spinal Cord Research	This work was funded by the New Jersey Commission on Spinal Cord Research (http://www. state.nj.us/health/spinalcord/) (Grant number: 10-3092-SCR-E-0; Funding recipient: JHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Cailotto F, 2010, J BIOL CHEM, V285, P10572, DOI 10.1074/jbc.M109.050534; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Graw J, 1999, EYE, V13, P438, DOI 10.1038/eye.1999.118; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Haddrill M, 2009, CONGENITAL CATARACTS; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Jarquin VG, 2011, J DEV BEHAV PEDIATR, V32, P179, DOI 10.1097/DBP.0b013e31820b4260; Khan K, 2011, INVEST OPHTH VIS SCI, V52, P4294, DOI 10.1167/iovs.10-6776; Korstanje R, 2008, PHYSIOL GENOMICS, V35, P296, DOI 10.1152/physiolgenomics.90260.2008; Las Heras F, 2012, J RHEUMATOL, V39, P583, DOI DOI 10.3899/JRHEUM.110971; Li BI, 2015, DEV BIOL, V402, P17, DOI 10.1016/j.ydbio.2015.02.007; Liu Q, 2008, DEV NEUROBIOL, V68, P1107, DOI 10.1002/dneu.20646; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028085; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shafie SM, 2006, AM J OPHTHALMOL, V141, P750, DOI 10.1016/j.ajo.2005.10.050; Stewart DB, 2000, J BIOL CHEM, V275, P20707, DOI 10.1074/jbc.M000467200; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Williams LJ, 2005, PEDIATRICS, V116, P580, DOI 10.1542/peds.2005-0592; Xu W, 2014, MOL CARCINOGENESIS, DOI 10.1002/mc.22221; Zaka R, 2006, CURR OPIN RHEUMATOL, V18, P181, DOI 10.1097/01.bor.0000209432.36355.6e; Zhang SQ, 2015, STRUCTURE, V23, P527, DOI 10.1016/j.str.2015.01.009	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170724	10.1371/journal.pone.0170724	http://dx.doi.org/10.1371/journal.pone.0170724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135291	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700020
J	Marley, JV; Kotz, J; Engelke, C; Williams, M; Stephen, D; Coutinho, S; Trust, SK				Marley, Julia V.; Kotz, Jayne; Engelke, Catherine; Williams, Melissa; Stephen, Donna; Coutinho, Sudha; Trust, Stephanie K.			Validity and Acceptability of Kimberley Mum's Mood Scale to Screen for Perinatal Anxiety and Depression in Remote Aboriginal Health Care Settings	PLOS ONE			English	Article							INDIGENOUS COGNITIVE ASSESSMENT; POSTNATAL-DEPRESSION; POSTPARTUM DEPRESSION; ANTENATAL DEPRESSION; MATERNAL DEPRESSION; INTERVENTIONS; AUSTRALIANS; ANTEPARTUM; IMPAIRMENT; SYMPTOMS	Background The Edinburgh Postnatal Depression Scale (EPDS) is widely recommended for perinatal anxiety and depression screening. However, many Aboriginal women find EPDS language complex and confusing, and providers find using it with Aboriginal women challenging. The two part Kimberley Mum's Mood Scale (KMMS) was developed to improve screening: Part 1 is a Kimberley version of EPDS; Part 2 is a psychosocial tool that enables contextualisa-tion of Part 1 scores. We aimed to determine if KMMS is a valid and acceptable method of identifying Kimberley Aboriginal perinatal women at risk of anxiety or depressive disorders compared to a semi- structured clinical interview. Methods Across 15 sites in the Kimberley, Western Australia, 97 Aboriginal women aged 16 years and older who intended to continue with their pregnancy or had a baby within the previous 12 months were administered the KMMS by trained healthcare providers who provided an overall assessment of no, low, moderate or high risk; 91 participants were then indepen-dently assessed by a blinded clinical expert using Diagnostic and Statistical Manual of Men-tal Disorders, 4th Edition criteria. A qualitative approach was used to determine KMMS' acceptability. Results Part 1 had high internal consistency (Cronbach's alpha, 0.89), and overall KMMS risk equiv-alence for screening for anxiety or depressive disorders was moderate (sensitivity, 83%; specificity, 87%; positive predictive value, 68%). Participants found the process easy and useful, and healthcare providers found KMMS more useful than EPDS. Part 2 allowed healthcare providers to ask questions that gave participants an opportunity to express them-selves, resulting in a deeper understanding between them. Conclusion KMMS is an effective tool for identifying Kimberley Aboriginal perinatal women at risk of anx-iety and depressive disorders. Adoption of KMMS with culturally safe training and support is likely to improve screening processes, and with further validation may have broader applica-bility across remote Australia.	[Marley, Julia V.] Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia; [Marley, Julia V.; Engelke, Catherine; Stephen, Donna; Trust, Stephanie K.] Kimberley Aboriginal Med Serv Ltd, Broome, WA, Australia; [Kotz, Jayne] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Engelke, Catherine] Univ Western Australia, Rural Clin Sch Western Australia, Kununurra, WA, Australia; [Williams, Melissa] Western Australian Cty Hlth Serv, Broome, WA, Australia; [Trust, Stephanie K.] Kununurra Med, Kununurra, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia	Marley, JV (corresponding author), Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia.	Julia.Marley@rcswa.edu.au	Marley, Julia V/A-9515-2009	Marley, Julia V/0000-0003-1014-4860	Kimberley Aboriginal Medical Services Ltd; Rural Clinical School of Western Australia; Kimberley Pilbara Medicare Local	Kimberley Aboriginal Medical Services Ltd; Rural Clinical School of Western Australia; Kimberley Pilbara Medicare Local	Western Australia, and a grant for training by the Kimberley Pilbara Medicare Local. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This project was funded in part through the Kimberley Aboriginal Medical Services Ltd, a Small Project Grant by the Rural Clinical School of Western Australia, and a grant for training by the Kimberley Pilbara Medicare Local. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Y, 2014, WORKING TOGETHER ABO, P271; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094983; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Austin MPV, 2011, MED J AUSTRALIA, V195, P112, DOI 10.5694/j.1326-5377.2011.tb03236.x; Austin MP, 2003, ACTA PSYCHIAT SCAND, V107, P10, DOI 10.1034/j.1600-0447.2003.02024.x; Australian Bureau of Statistics, 2013, HLTH WELF AUSTR AB T; [Australian Health Ministers Advisory Council Ageing AGDoHa], 2012, CLIN PRACT GUID ANT; Australian Institute of Health and Welfare, 2012, EXP PER DEPR DAT 201; Bowen A, 2014, TRANSCULT PSYCHIATRY, V51, P93, DOI 10.1177/1363461513501712; Boyd RC, 2005, ARCH WOMEN MENT HLTH, V8, P141, DOI 10.1007/s00737-005-0096-6; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Campbell A, 2008, AUST J RURAL HEALTH, V16, P124, DOI 10.1111/j.1440-1584.2007.00930.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Dudgeon P., 2000, WORKING INDIGENOUS A; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Hendrick V, 2003, BRIT MED J, V327, P1003, DOI 10.1136/bmj.327.7422.1003; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Kettunen P, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0402-2; Kotz J, 2016, CONTEMP NURSE, V52, P42, DOI 10.1080/10376178.2016.1198710; Larson A, 2007, AUST NZ J PUBL HEAL, V31, P322, DOI 10.1111/j.1753-6405.2007.00079.x; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LoGiudice D, 2011, AUSTRALAS J AGEING, V30, P215, DOI 10.1111/j.1741-6612.2010.00486.x; Mc Loughlin F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0517-1; Morrell CJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20370; Nolvi S, 2016, INFANT BEHAV DEV, V43, P13, DOI 10.1016/j.infbeh.2016.03.003; Nonnenmacher N, 2016, ARCH WOMEN MENT HLTH, V19, P927, DOI 10.1007/s00737-016-0648-y; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Parker R., 2014, WORKING TOGETHER ABO, P113; Patton GC, 2015, LANCET, V386, P875, DOI 10.1016/S0140-6736(14)62248-0; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; Smith K, 2009, AUST PSYCHOL, V44, P54, DOI 10.1080/00050060802563463; Social Health Reference Group, 2004, NATL STRATEGIC FRAME; Straub H, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.033; The General Practice Mental Health Standards Collaboration, GP MENT HLTH TREATM; The KMMS Research team, 2016, KMMS 2015; WA Country Health Service the WA Perinatal Mental Health Unit., 2010, WA COUNTR HLTH SERV; Werner E, 2015, ARCH WOMEN MENT HLTH, V18, P41, DOI 10.1007/s00737-014-0475-y; Westeman T., 2004, AUST E J ADV MENT HL, V3, P88, DOI [DOI 10.5172/JAMH.3.3.88, https://doi.org/10.5172/jamh.3.3.88]; Zubrick S, 2005, W AUSTR ABORIGINAL C	43	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0168969	10.1371/journal.pone.0168969	http://dx.doi.org/10.1371/journal.pone.0168969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135275	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700003
J	Casadella, M; Cozzi-Lepri, A; Phillips, A; Noguera-Julian, M; Bickel, M; Sedlacek, D; Zilmer, K; Clotet, B; Lundgren, JD; Paredes, R				Casadella, Maria; Cozzi-Lepri, Alessandro; Phillips, Andrew; Noguera-Julian, Marc; Bickel, Markus; Sedlacek, Dalibor; Zilmer, Kai; Clotet, Bonaventura; Lundgren, Jens D.; Paredes, Roger		EuroSIDA EuroCOORD	Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; CORECEPTOR TROPISM; INFECTED PATIENTS; IMPACT; COHORT; PHENOTYPE; DEPLETION; USAGE	Objective To investigate if plasma HIV-1 tropism testing could identify subjects at higher risk for clinical progression and death in routine clinical management. Design Nested case-control study within the EuroSIDA cohort. Methods Cases were subjects with AIDS or who died from any cause, with a plasma sample with HIV-1 RNA >1000 copies/mL available for tropism testing 3 to 12 months prior to the event. At least 1 control matched for age, HIV-1 RNA and HCV status at the time of sampling were selected per each case. Conditional logistic regression was used to investigate exposures associated with clinical progression to AIDS or death. A linear mixed model with random intercept was used to compare CD4(+)T-cell slopes by HIV tropism over the 12 months following the date of sampling. Results The study included 266 subjects, 100 cases and 166 controls; one quarter had X4 HIV; 26% were ART-naive. Baseline factors independently associated with clinical progression or death were female gender (OR=2.13 vs. male, 95CI = 1.04, 4.36), p = 0.038), CD4(+)T-cell count (OR = 0.90 (95CI = 0.80, 1.00) per 100 cells/mm 3 higher, p = 0.058), being on ART (OR = 2.72 vs. being off-ART (95CI = 1.15, 6.41), p = 0.022) and calendar year of sample [OR = 0.84 (95CI = 0.77, 0.91) per more recent year, p<0.001). Baseline tropism was not associated with the risk of clinical progression or death. CD4(+)T-cell slopes did not differ within or between tropism groups. Conclusions The predictive role of plasma tropism determined using 454 sequencing in the context of people receiving cART with detectable VL is not helpful to identify subjects at higher risk for clinical progression to AIDS or death.	[Casadella, Maria; Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] IrsiCaixa AIDS Res Inst, Badalona, Catalonia, Spain; [Casadella, Maria; Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] Univ Autonoma Barcelona, Catalonia, Spain; [Cozzi-Lepri, Alessandro; Phillips, Andrew] Royal Free Hosp, London, England; [Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] Univ Vic Univ Cent Catalunya, Vic, Catalonia, Spain; [Bickel, Markus] Goethe Univ, Frankfurt, Germany; [Sedlacek, Dalibor] Charles Univ Hosp, Plzen, Czech Republic; [Zilmer, Kai] West Tallinn Cent Hosp, Tallinn, Estonia; [Clotet, Bonaventura; Paredes, Roger] Hosp Badalona Germans Trias & Pujol, HIV Unit, Badalona, Catalonia, Spain; [Lundgren, Jens D.] Univ Copenhagen, Dept Infect Dis, CHIP, Rigshosp, Copenhagen, Denmark	Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Goethe University Frankfurt; Charles University Prague; Hospital Germans Trias i Pujol; Rigshospitalet; University of Copenhagen	Casadella, M (corresponding author), IrsiCaixa AIDS Res Inst, Badalona, Catalonia, Spain.; Casadella, M (corresponding author), Univ Autonoma Barcelona, Catalonia, Spain.	mcasadella@irsicaixa.es	Noguera-Julian, Marc/F-8651-2016; Sedlacek, Dalibor/K-3035-2017; Sedlacek, Dalibor/P-6942-2019; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008; Casadella, Maria/L-8295-2016	Noguera-Julian, Marc/0000-0002-6194-1395; Sedlacek, Dalibor/0000-0003-4711-6679; Sedlacek, Dalibor/0000-0003-4711-6679; Phillips, Andrew N/0000-0003-2384-4807; Casadella, Maria/0000-0002-4115-2305	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Janssen RD; Merck and Co. Inc.; Pfizer Inc.; GlaxoSmithKline LLC; Swiss National Science Foundation [108787]; Redes Tematicas de Investigacion en SIDA [ISCIII RETIC RD12/0017/0002]; Accion Estrategica en Salud	European Commission(European CommissionEuropean Commission Joint Research Centre); Janssen RD; Merck and Co. Inc.(Merck & Company); Pfizer Inc.(Pfizer); GlaxoSmithKline LLC; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Redes Tematicas de Investigacion en SIDA; Accion Estrategica en Salud	Primary support for EuroSIDA was provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no 260694) programmes. Current support also includes unrestricted grants by Janssen R&D (www.janssen.com), Merck and Co. Inc. (www.merck.com), Pfizer Inc. (www.pfizer.com), GlaxoSmithKline LLC (www.gsk.com). The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). It was also partially supported by Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0002); Accion Estrategica en Salud. Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011; Institute de Salud Carlos III, Fondos FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HIV UK 2013 REPORT D; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Buisker TR, AIDS BEHAV; Carrington M, INFLUENCE HLA GENOTY; Casadella M, 2015, AIDS, V29, P1493, DOI 10.1097/QAD.0000000000000748; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Dalmau J, 2014, AIDS, V28, P1261, DOI 10.1097/QAD.0000000000000293; Detels R, 2012, PUBLIC HEALTH, V126, P196, DOI 10.1016/j.puhe.2011.11.013; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kuniholm MH, 2011, J VIROL, V85, P10826, DOI 10.1128/JVI.00804-11; Kuritzkes DR, 2011, J INFECT DIS, V203, P146, DOI 10.1093/infdis/jiq034; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Perez-Molina JA, 2012, HIV CLIN TRIALS, V13, P131, DOI 10.1310/hct1303-131; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Pou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067085; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Saunders P, HIV MED; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Thorsteinsson K, 2012, SCAND J INFECT DIS, V44, P766, DOI 10.3109/00365548.2012.684220; Tremblay C, 2013, CAN J INFECT DIS MED, V24, P202, DOI 10.1155/2013/982759; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0166613	10.1371/journal.pone.0166613	http://dx.doi.org/10.1371/journal.pone.0166613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129343	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400074
J	Gogoi-Tiwari, J; Williams, V; Waryah, CB; Costantino, P; Al-Salami, H; Mathavan, S; Wells, K; Tiwari, HK; Hegde, N; Isloor, S; Al-Sallami, H; Mukkur, T				Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Costantino, Paul; Al-Salami, Hani; Mathavan, Sangeetha; Wells, Kelsi; Tiwari, Harish Kumar; Hegde, Nagendra; Isloor, Shrikrishna; Al-Sallami, Hesham; Mukkur, Trilochan			Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; INFLAMMATORY RESPONSES; TNF-ALPHA; PATHOGENESIS; NEUTROPHIL; EXPRESSION; VIRULENCE; PROTEIN	Background Biofilm formation by Staphylococcus aureus is an important virulence attribute because of its potential to induce persistent antibiotic resistance, retard phagocytosis and either attenuate or promote inflammation, depending upon the disease syndrome, in vivo. This study was undertaken to evaluate the potential significance of strength of biofilm formation by clinical bovine mastitis-associated S. aureus in mammary tissue damage by using a mouse mastitis model. Methods Two S. aureus strains of the same capsular phenotype with different biofilm forming strengths were used to non-invasively infect mammary glands of lactating mice. Biofilm forming potential of these strains were determined by tissue culture plate method, ica typing and virulence gene profile per detection by PCR. Delivery of the infectious dose of S. aureus was directly through the teat lactiferous duct without invasive scraping of the teat surface. Both bacteriological and histological methods were used for analysis of mammary gland pathology of mice post-infection. Results Histopathological analysis of the infected mammary glands revealed that mice inoculated with the strong biofilm forming S. aureus strain produced marked acute mastitic lesions,showing profuse infiltration predominantly with neutrophils, with evidence of necrosis in the affected mammary glands. In contrast, the damage was significantly less severe in mammary glands of mice infected with the weak biofilm-forming S. aureus strain. Although both IL-1 beta and TNF-alpha inflammatory biomarkers were produced in infected mice, level of TNF-alpha produced was significantly higher (p<0.05) in mice inoculated with strong biofilm-forming S. aureus than the weak biofilm forming strain. Conclusion This finding suggests an important role of TNF-a in mammary gland pathology post-infection with strong biofilm-forming S. aureus in the acute mouse mastitis model, and offers an opportunity for the development of novel strategies for reduction of mammary tissue damage, with or without use of antimicrobials and/or anti-inflammatory compounds for the treatment of bovine mastitis.	[Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Costantino, Paul; Wells, Kelsi; Mukkur, Trilochan] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA, Australia; [Gogoi-Tiwari, Jully] Cent Agr Univ, Coll Vet Sci & Anim Husb, Aizawl, Mizoram, India; [Waryah, Charlene Babra] Albert Einstein Coll Med, Dept Med & Cell Biol, Bronx, NY 10467 USA; [Al-Salami, Hani; Mathavan, Sangeetha] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA, Australia; [Tiwari, Harish Kumar] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Hegde, Nagendra] Ella Fdn, Hyderabad, Andhra Pradesh, India; [Isloor, Shrikrishna] Karnataka Vet, Anim & Fisheries Sci Univ, Vet Coll, Bangalore, Karnataka, India; [Al-Sallami, Hesham] Univ Otago, Sch Pharm, Dunedin, New Zealand	Curtin University; Yeshiva University; Albert Einstein College of Medicine; Curtin University; Murdoch University; West Bengal University of Animal & Fishery Sciences; University of Otago	Mukkur, T (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA, Australia.	tk_mukkur@hotmail.com	Al-Sallami, Hesham S/AAB-1671-2019; Hegde, Nagendra R/H-3132-2019; Al-Salami, Hani/C-3766-2019; Tiwari, Harish/AAU-9372-2021	Al-Sallami, Hesham S/0000-0002-0685-327X; Hegde, Nagendra R/0000-0001-5260-2159; Al-Salami, Hani/0000-0003-0049-6969; Tiwari, Harish/0000-0002-6950-8422; Tiwari, Harish/0000-0002-2911-9895; Waryah, Charlene/0000-0002-1295-320X	Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia [BF040038]; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/Indo-Aus./04/06/2009]; Curtin University; Australian Postgraduate Award	Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Curtin University; Australian Postgraduate Award(Australian Government)	This work was supported by grants through the Australia India Strategic Research Fund [BF040038] from the Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia (to TM), and the India-Australia Biotechnology Fund [BT/Indo-Aus./04/06/2009] from the Department of Biotechnology, Ministry of Science and Technology, Government of India (to NH). Thanks are also due to Curtin University for providing the International Postgraduate Research Scholarship and the Australian Postgraduate Award to JG-T in support of her doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript"	ANDERSON JC, 1975, J COMP PATHOL, V85, P499, DOI 10.1016/0021-9975(75)90117-6; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Babra C, 2014, J BASIC MICROB, V54, P721, DOI 10.1002/jobm.201200557; Babra C, 2013, FOLIA MICROBIOL, V58, P469, DOI 10.1007/s12223-013-0232-z; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; BASELGA R, 1993, INFECT IMMUN, V61, P4857, DOI 10.1128/IAI.61.11.4857-4862.1993; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Blum JW, 2000, DOMEST ANIM ENDOCRIN, V19, P223, DOI 10.1016/S0739-7240(00)00079-5; Boonyayatra S., 2014, International Journal of Dairy Science, V9, P89, DOI 10.3923/ijds.2014.89.95; Boulanger V, 2002, J DAIRY SCI, V85, P562, DOI 10.3168/jds.S0022-0302(02)74109-X; Breyne K, 2015, J DAIRY SCI, V98, P1090, DOI 10.3168/jds.2014-8699; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Burow ME, 1999, CARCINOGENESIS, V20, P2057, DOI 10.1093/carcin/20.11.2057; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cantero D, 2013, INT FORUM ALLERGY RH, V3, P556, DOI 10.1002/alr.21146; CHANDLER RL, 1973, J COMP PATHOL, V83, P233, DOI 10.1016/0021-9975(73)90047-9; CHANDLER RL, 1970, J MED MICROBIOL, V3, P273, DOI 10.1099/00222615-3-2-273; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Cucarella C, 2002, INFECT IMMUN, V70, P3180, DOI 10.1128/IAI.70.6.3180-3186.2002; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; FOURNIER JM, 1984, INFECT IMMUN, V45, P87, DOI 10.1128/IAI.45.1.87-93.1984; FROST AJ, 1980, PROC R SOC SER B-BIO, V209, P431, DOI 10.1098/rspb.1980.0104; Gamble M., 2008, THEORY PRACTICE HIST, V6th, P121, DOI DOI 10.1016/B978-0-443-10279-0.50016-6; Gogoi-Tiwari J, 2015, Aust Vet J, V93, P278, DOI 10.1111/avj.12349; Gogoi-Tiwari J, 2015, BIOFOULING, V31, P543, DOI 10.1080/08927014.2015.1074681; Gogoi-Tiwari J, 2015, VIRULENCE, V6, P419, DOI 10.1080/21505594.2015.1043508; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062; HEALD CW, 1979, AM J VET RES, V40, P1294; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Kauf ACW, 2007, RES VET SCI, V82, P39, DOI 10.1016/j.rvsc.2006.05.006; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kornalijnslijper JE, 2004, VET MICROBIOL, V101, P177, DOI 10.1016/j.vetmic.2004.04.005; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Kuroishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P1011, DOI 10.1128/CDLI.10.6.1011-1018.2003; Lee SHI, 2014, J DAIRY SCI, V97, P1812, DOI 10.3168/jds.2013-7387; Leitner G, 2000, J VET MED B, V47, P581, DOI 10.1046/j.1439-0450.2000.00388.x; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Liu HL, 2015, BRAZ J INFECT DIS, V19, P498, DOI 10.1016/j.bjid.2015.07.003; Lone AG, 2015, INFECT IMMUN, V83, P2531, DOI 10.1128/IAI.03075-14; Mathur T, 2006, Indian J Med Microbiol, V24, P25; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Middleton JR, 2013, NMC 52 REG M P SAN D, P1; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nakajima Y, 1997, RES VET SCI, V62, P297, DOI 10.1016/S0034-5288(97)90209-5; Nazemi S, 2014, J DAIRY RES, V81, P445, DOI 10.1017/S0022029914000454; NICKERSON SC, 1981, AM J VET RES, V42, P1351; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; OLLETT WS, 1947, J PATHOL BACTERIOL, V59, P357; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Pereira UP, 2011, VET MICROBIOL, V148, P117, DOI 10.1016/j.vetmic.2010.10.003; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; PERSSON K, 1993, VET IMMUNOL IMMUNOP, V37, P99, DOI 10.1016/0165-2427(93)90058-C; Petersson-Wolfe C MI, 2010, VCES, V404, P229; Peton V, 2014, VET RES, V45, DOI 10.1186/s13567-014-0106-7; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; PRASAD LBM, 1968, CANADIAN VET J, V9, P170; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Ramakrishnan Y, 2015, J LARYNGOL OTOL, P1; SANCHEZ MS, 1994, J DAIRY SCI, V77, P1259, DOI 10.3168/jds.S0022-0302(94)77065-X; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Skipper R, 1989, J HISTOTECHNOL, V4, P303; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Tankersley A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-17; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Waryah CB, 2014, J MED MICROBIOL, V63, P1427, DOI [10.1099/jmm.0.77024-0, 10.1099/jmm.0.077024-0]; Waryah CB, 2016, FOLIA MICROBIOL, V61, P473, DOI 10.1007/s12223-016-0459-6; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004; Zhao G, 2013, ADV WOUND CARE, V2, P389, DOI 10.1089/wound.2012.0381; Zhao X, 2008, J ANIM SCI, V86, P57, DOI 10.2527/jas.2007-0302	91	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170668	10.1371/journal.pone.0170668	http://dx.doi.org/10.1371/journal.pone.0170668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129375	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400048
J	Pan, X; Ping, YM; Cui, LJ; Li, W; Zhang, XD; Zhou, J; Yu, FH; Prinzing, A				Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian; Yu, Fei-Hai; Prinzing, Andreas			Plant Litter Submergence Affects the Water Quality of a Constructed Wetland	PLOS ONE			English	Article							DOMESTIC WASTE-WATER; LEAF-LITTER; DECOMPOSITION; PERFORMANCE; MACROPHYTES; NUTRIENTS; REMOVAL; BIOMASS	Plant litter is an indispensable component of constructed wetlands, but how the submergence of plant litter affects their ecosystem functions and services, such as water purification, is still unclear. Moreover, it is also unclear whether the effects of plant litter submergence depend on other factors such as the duration of litter submergence, water source or litter species identity. Here we conducted a greenhouse experiment by submerging the litter of 7 wetland plant species into three types of water substrates and monitoring changes in water nutrient concentrations. Litter submergence affected water quality positively via decreasing the concentration of nitrate nitrogen and negatively via increasing the concentrations of total nitrogen, ammonium nitrogen and total phosphorus. The effects of litter submergence depended on the duration of litter submergence, the water source, the litter species identity, and the plant life form. Different plant species had different effects on the water nutrient concentrations during litter submergence, and the effects of floating plants might be more negative than that of emergent plants. These results are novel evidence of how the submergence of different plant (life form) litter may affect the purification function of constructed wetlands. For water at low eutrophication levels, submerging a relative small amount of plant litter might improve water quality, via benefiting the denitrification process in water. These findings emphasized the management of floating plant litter (a potential removal) during the maintenance of human-controlled wetland ecosystems and provided a potential tool to improve the water quality of constructed wetlands via submerging plant litter of different types.	[Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China; [Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Prinzing, Andreas] Univ Rennes 1, CNRS, Campus Beaulieu,Batiment 14 A, Rennes, France	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Forestry; Institute of Wetland Research, CAF; Beijing Forestry University; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Cui, LJ (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China.	lkyclj@126.com	Yu, Fei-Hai/O-9395-2016; Pan, Xu/W-1607-2017	Yu, Fei-Hai/0000-0001-5007-1745; Pan, Xu/0000-0003-3733-1981	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" [201404305]; Fundamental Research Funds for the Central Non-profit Research Institute of CAF [CAFYBB2014QB025]; China Postdoctoral Science Foundation [2015M571161]; National Natural Science Foundation of China [31300400]	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China"; Fundamental Research Funds for the Central Non-profit Research Institute of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" (No.201404305), Fundamental Research Funds for the Central Non-profit Research Institute of CAF (CAFYBB2014QB025), China Postdoctoral Science Foundation (2015M571161) and National Natural Science Foundation of China (31300400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Bachand PAM, 2000, ECOL ENG, V14, P17; Bojcevska H, 2007, ECOL ENG, V29, P66, DOI 10.1016/j.ecoleng.2006.07.015; Brix H, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00047-4; Calheiros CSC, 2009, ECOL ENG, V35, P744, DOI 10.1016/j.ecoleng.2008.11.010; Chen Y, 2015, ECOL ENG, V84, P38, DOI 10.1016/j.ecoleng.2015.07.013; Chen Y, 2014, BIORESOURCE TECHNOL, V157, P341, DOI 10.1016/j.biortech.2014.01.137; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Gaudet CL, 1988, COMP APPROACH PREDIC; Gottschall N, 2007, ECOL ENG, V29, P154, DOI 10.1016/j.ecoleng.2006.06.004; Gulis V, 2004, FRESHWATER BIOL, V49, P1437, DOI 10.1111/j.1365-2427.2004.01281.x; Guntenspergen GR, 1985, 7912516 NSF DEB, V791, P2516; Hobbie SE, 2014, URBAN ECOSYST, V17, P369, DOI 10.1007/s11252-013-0329-9; Huang Q, 2016, ENVIRON SCI POLLUT R, P1; IWA, 2001, CONSTR WETL POLL CON; JOHNSTON CA, 1991, CRIT REV ENV CONTR, V21, P491, DOI 10.1080/10643389109388425; Keddy P, 1998, J VEG SCI, V9, P777, DOI 10.2307/3237043; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Nurk K, 2005, J ENVIRON SCI HEAL A, V40, P1201, DOI 10.1081/ESE-200055659; Pan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123291; Park JBK, 2008, BIORESOURCE TECHNOL, V99, P2711, DOI 10.1016/j.biortech.2007.07.009; Srivastava Jatin, 2008, Reviews in Environmental Science and Bio/Technology, V7, P255, DOI 10.1007/s11157-008-9135-x; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; Tanner CC, 2002, ECOL ENG, V18, P499, DOI 10.1016/S0925-8574(02)00011-3; TIAN G, 1992, SOIL BIOL BIOCHEM, V24, P1051, DOI 10.1016/0038-0717(92)90035-V; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Vymazal J, 2013, ECOL ENG, V61, P582, DOI 10.1016/j.ecoleng.2013.06.023; Vymazal J, 2011, HYDROBIOLOGIA, V674, P133, DOI 10.1007/s10750-011-0738-9; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Yang Q, 2007, J INTEGR PLANT BIOL, V49, P437, DOI 10.1111/j.1744-7909.2007.00389.x; Zhang Y, 2014, WETL ECOL MANAG, V22, P493, DOI 10.1007/s11273-014-9347-5	33	9	11	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171019	10.1371/journal.pone.0171019	http://dx.doi.org/10.1371/journal.pone.0171019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129405	gold, Green Submitted, Green Published			2022-12-26	WOS:000396211400012
J	Frouws, MA; Reimers, MS; Swets, M; Bastiaannet, E; Prinse, B; van Eijk, R; Lemmens, VEPP; van Herk-Sukel, MPP; van Wezel, T; Kuppen, PJK; Morreau, H; van de Velde, CJH; Liefers, GJ				Frouws, Martine A.; Reimers, Marlies S.; Swets, Marloes; Bastiaannet, Esther; Prinse, Bianca; van Eijk, Ronald; Lemmens, Valery E. P. P.; van Herk-Sukel, Myrthe P. P.; van Wezel, Tom; Kuppen, Peter J. K.; Morreau, Hans; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan			The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis	PLOS ONE			English	Article							COLORECTAL-CANCER; RANDOMIZED-TRIALS; LYNCH SYNDROME; THERAPY; RISK; METAANALYSIS; METASTASIS; SUBTYPES; MAPK	Background Use of aspirin after diagnosis of colon cancer has been associated with improved survival. Identification of cancer subtypes that respond to aspirin treatment may help develop personalized treatment regimens. The aim of this study was to investigate the influence of BRAF and KRAS mutation status on the association between aspirin use and overall survival after colon cancer diagnosis. Methods A random selection of 599 patients with colon cancer were analyzed, selected from the Eindhoven Cancer Registry, and BRAF and KRAS mutation status was determined. Data on aspirin use (80 mg) were obtained from the PHARMO Database Network. Parametric survival models with exponential (Poisson) distribution were used. Results Aspirin use after colon cancer diagnosis was associated with improved overall survival in wild-type BRAF tumors, adjusted rate ratio (RR) of 0.60 (95% CI 0.44-0.83). In contrast, aspirin use in BRAF mutated tumors was not associated with an improved survival (RR 1.11, 95% CI 0.57-2.16). P-value for interaction was non-significant. KRAS mutational status did not differentiate in the association between aspirin use and survival. Conclusion Low-dose aspirin use after colon cancer diagnosis was associated with improved survival in BRAF wild-type tumors only. However, the large confidence interval of the rate ratio for the use of aspirin in patients with BRAF mutation does not rule out a possible benefit. These results preclude BRAF and KRAS mutation status to be used as a marker for individualized treatment with aspirin, if aspirin becomes regular adjuvant treatment for colon cancer patients in the future.	[Frouws, Martine A.; Reimers, Marlies S.; Swets, Marloes; Bastiaannet, Esther; Prinse, Bianca; Kuppen, Peter J. K.; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [van Eijk, Ronald; van Wezel, Tom; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Lemmens, Valery E. P. P.] Comprehens Canc Org Netherlands, Eindhoven, Netherlands; [Lemmens, Valery E. P. P.] Erasmus MC Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van Herk-Sukel, Myrthe P. P.] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Liefers, GJ (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	v.lemmens@iknl.nl; myrthe.van.herk@pharmo.nl; g.j.liefers@lumc.nl	Kuppen, Peter/J-2342-2016; van Wezel, Tom/Z-3092-2019; van de Velde, Cornelis/AAY-8360-2020; van Wezel, Tom/AAL-5626-2021	Kuppen, Peter/0000-0002-0294-3251; van Wezel, Tom/0000-0001-5773-7730; van Eijk, Ronald/0000-0001-7955-6295				Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bastiaannet E, 2012, BRIT J CANCER, V106, P1564, DOI 10.1038/bjc.2012.101; Burn J, 2012, DIGEST DIS, V30, P39, DOI 10.1159/000341892; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coyle C, 2016, CURRENT COLORECTAL C; Coyle C, 2016, CONTEMP CLIN TRIALS, V51, P56, DOI 10.1016/j.cct.2016.10.004; Elwood PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152402; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Guillem-Llobat P, 2016, ONCOTARGET; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Linnekamp JF, 2015, CANCER RES, V75, P245, DOI 10.1158/0008-5472.CAN-14-2240; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Paleari L, 2016, CLIN ONCOL-UK, V28, P317, DOI 10.1016/j.clon.2015.11.008; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Reimers MS, 2014, JAMA INT MED; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Rothwell PM, 2012, LANCET; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Sinicrope FA, 2016, CLIN GASTROENTEROL H, V14, P651, DOI 10.1016/j.cgh.2016.02.008; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; van Eijk R, 2013, EXP MOL PATHOL, V94, P121, DOI 10.1016/j.yexmp.2012.06.004; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; van Lier MGF, 2012, J PATHOL, V226, P764, DOI 10.1002/path.3963; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170775	10.1371/journal.pone.0170775	http://dx.doi.org/10.1371/journal.pone.0170775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125730	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100055
J	Rajashekar, Y; Shivanandappa, T				Rajashekar, Yallappa; Shivanandappa, Thimmappa			Mode of Action of the Natural Insecticide, Decaleside Involves Sodium Pump Inhibition	PLOS ONE			English	Article							PALYTOXIN; NA+,K+-ATPASE; MECHANISM; ATPASE; BIOCHEMISTRY; PRODUCTS; TARGETS; DIPTERA	Decalesides are a new class of natural insecticides which are toxic to insects by contact via the tarsal gustatory chemosensilla. The symptoms of their toxicity to insects and the rapid knockdown effect suggest neurotoxic action, but the precise mode of action and the molecular targets for decaleside action are not known. We have presented experimental evidence for the involvement of sodium pump inhibition in the insecticidal action of decaleside in the cockroach and housefly. The knockdown effect of decaleside is concomitant with the in vivo inhibition of Na+, K+ -ATPase in the head and thorax. The lack of insecticidal action by experimental ablation of tarsi or blocking the tarsal sites with paraffin correlated with lack of inhibition of Na+- K+ ATPase in vivo. Maltotriose, a trisaccharide, partially rescued the toxic action of decaleside as well as inhibition of the enzyme, suggesting the possible involvement of gustatory sugar receptors. In vitro studies with crude insect enzyme preparation and purified porcine Na+, K+ -ATPase showed that decaleside competitively inhibited the enzyme involving the ATP binding site. Our study shows that the insecticidal action of decaleside via the tarsal gustatory sites is causally linked to the inhibition of sodium pump which represents a unique mode of action. The precise target(s) for decaleside in the tarsal chemosensilla and the pathway linked to inhibition of sodium pump and the insecticidal action remain to be understood.	[Rajashekar, Yallappa; Shivanandappa, Thimmappa] CSIR, Cent Food Technol Res Inst, Dept Food Protectants & Infestat Control, Mysore, Karnataka, India; [Rajashekar, Yallappa] Govt India, Anim Bioresources Programme, Inst Bioresources & Sustainable Dev, Dept Biotechnol, Imphal, Manipur, India; [Shivanandappa, Thimmappa] Univ Mysore, Dept Studies Zool, Mysore, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD); University of Mysore	Shivanandappa, T (corresponding author), CSIR, Cent Food Technol Res Inst, Dept Food Protectants & Infestat Control, Mysore, Karnataka, India.	tshivanandappa@yahoo.com						ALBRECHT CP, 1987, J ECON ENTOMOL, V80, P344, DOI 10.1093/jee/80.2.344; BLOJ B, 1973, BIOCHIM BIOPHYS ACTA, V311, P67, DOI 10.1016/0005-2736(73)90255-1; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Bonting SL, 1970, MEMBRANES ION TRANSP, V1, P257; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Dobler S, 2012, P NATL ACAD SCI USA, V109, P13040, DOI 10.1073/pnas.1202111109; Elbert A, 2008, MODERN CROP PROTECTI, V3, P753; Faulde MK, 2006, J STORED PROD RES, V42, P253, DOI 10.1016/j.jspr.2005.03.001; Finney D.J., 1971, PROBIT ANAL; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; HARVEY WR, 1983, J EXP BIOL, V106, P91; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ishaaya I, 2001, BIOCHEMICAL SITES OF INSECTICIDE ACTION AND RESISTANCE, P1; Ishaaya Isaac, 2007, Entomological Research, V37, P148, DOI 10.1111/j.1748-5967.2007.00104.x; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumura F, 1985, TOXICOLOGY INSECTICI, V2; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Morgan ED, 2009, BIOORGAN MED CHEM, V17, P4096, DOI 10.1016/j.bmc.2008.11.081; Mori S, 2016, TETRAHEDRON LETT, V57, P3612, DOI 10.1016/j.tetlet.2016.06.108; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; NORRIS DM, 1981, INSECT BIOCHEM, V11, P743, DOI 10.1016/0020-1790(81)90067-6; Pavela R, 2008, PHYTOTHER RES, V22, P274, DOI 10.1002/ptr.2300; Petschenka G, 2012, J INSECT PHYSIOL, V58, P607, DOI 10.1016/j.jinsphys.2011.12.012; Rajashekar Y, 2010, J FOOD SCI TECH MYS, V47, P310, DOI 10.1007/s13197-010-0049-6; Rajashekar Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20546; Rajashekar Y, 2012, NATURWISSENSCHAFTEN, V99, P843, DOI 10.1007/s00114-012-0966-5; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Schmutterer H., 1995, P326; Shivanandappa T., 2014, ADV PLANT BIOPESTICI, V1st ed., P323; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Tang HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29155; Thompson GD, 2000, PEST MANAG SCI, V56, P696, DOI 10.1002/1526-4998(200008)56:8<696::AID-PS182>3.0.CO;2-5; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tosteson M. T., 2000, SEAFOOD FRESHWATER T, p[549, 549]; Vale-Gonzalez C, 2007, TOXICON, V50, P541, DOI 10.1016/j.toxicon.2007.04.024; VIJVERBERG HPM, 1982, NATURE, V295, P601, DOI 10.1038/295601a0; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	49	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170836	10.1371/journal.pone.0170836	http://dx.doi.org/10.1371/journal.pone.0170836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125742	Green Published, gold, Green Accepted			2022-12-26	WOS:000396176100039
J	Didiasova, M; Singh, R; Wilhelm, J; Kwapiszewska, G; Wujak, L; Zakrzewicz, D; Schaefer, L; Markart, P; Seeger, W; Lauth, M; Wygrecka, M				Didiasova, Miroslava; Singh, Rajeev; Wilhelm, Jochen; Kwapiszewska, Grazyna; Wujak, Lukasz; Zakrzewicz, Dariusz; Schaefer, Liliana; Markart, Philipp; Seeger, Werner; Lauth, Matthias; Wygrecka, Malgorzata			Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; hedgehog signaling; TGF-beta signaling	IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG FIBROSIS; GROWTH-FACTOR-BETA; SONIC HEDGEHOG; TGF-BETA; EXPRESSION; INVOLVEMENT; ACTIVATION; SUPPRESSOR; CROSSTALK	Pirfenidone is an antifibrotic drug, recently approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Although pirfenidone exhibits anti-inflammatory, antioxidant, and antifibrotic properties, the molecular mechanis munderlying its protective effects remains unknown. Here, we link pirfenidone action with the regulation of the profibrotic hedgehog (Hh) signaling pathway. We demonstrate that pirfenidone selectively destabilizes the glioma-associated oncogene homolog (GLI) 2 protein, the primary activator of Hh-mediated gene transcription. Consequently, pirfenidone decreases overall Hh pathway activity in patients with IPF and in patient-derived primary lung fibroblasts and leads to diminished levels of Hh target genes, such as GLI1, Hh receptor Patched-1, alpha-smooth muscle actin, and fibronectin, and to reduced cell migration and proliferation. Interestingly, Hh-triggered TGF-beta 1 expression potentiated Hh responsiveness of primary lung fibroblasts by elevating the available pool of glioma-associated oncogene homolog (GLI) 1/GLI2, thus creating a vicious cycle of amplifying fibrotic processes. Because GLI transcription factors are not only crucial for Hh-mediated changes but are also required as mediators of TGF-beta signaling, our findings suggest that pirfenidone exerts its clinically beneficial effects through dual Hh/TGF-beta inhibitionby targeting the GLI2 protein.-Didiasova, M., Singh, R., Wilhelm, J., K wapiszewska, G., Wujak, L., Zakrzewicz, D., Schaefer, L., Markart, P., Seeger, W., Lauth, M., Wygrecka, M. Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.	[Didiasova, Miroslava; Wujak, Lukasz; Zakrzewicz, Dariusz; Wygrecka, Malgorzata] Univ Giessen & Marburg Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany; [Wilhelm, Jochen; Markart, Philipp; Seeger, Werner] Univ Giessen & Marburg Lung Ctr, Dept Internal Med, Giessen, Germany; [Singh, Rajeev; Lauth, Matthias] Philipps Univ, Inst Mol Biol & Tumor Res IMT, Ctr Tumor Biol & Immunol, Marburg, Germany; [Wilhelm, Jochen; Markart, Philipp; Seeger, Werner; Wygrecka, Malgorzata] Justus Liebig Univ, German Ctr Lung Res, Giessen, Germany; [Kwapiszewska, Grazyna] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Schaefer, Liliana] Goethe Univ, Inst Pharmacol & Toxicol, Sch Med, Frankfurt, Germany	Philipps University Marburg; Justus Liebig University Giessen; Ludwig Boltzmann Institute; Goethe University Frankfurt	Wygrecka, M (corresponding author), Univ Giessen & Marburg Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wilhelm, Jochen/AAX-4302-2021; Wygrecka, Malgorzata/AAZ-3679-2020	Wilhelm, Jochen/0000-0001-5544-9647; Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Seeger, Werner/0000-0003-1946-0894; Lauth, Matthias/0000-0001-5922-5384; Kwapiszewska, grazyna/0000-0003-0518-9079; Schaefer, Liliana/0000-0002-3318-3005	Von-Behring-Rontgen Foundation; German Research Foundation [WY119/1-3]; Oskar Helene Heim Foundation; German Center for Lung Research	Von-Behring-Rontgen Foundation; German Research Foundation(German Research Foundation (DFG)); Oskar Helene Heim Foundation; German Center for Lung Research	This study was funded by the Von-Behring-Rontgen Foundation (to M.L. and M.W.), the German Research Foundation (Grant WY119/1-3; to M.W.), the Oskar Helene Heim Foundation (to P.M.), and the German Center for Lung Research (to P.M. and M.W.).The authors thank Y. Horn, M. Schwinn, and H. Thiele (all from the Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany) for excellent technical assistance. J.W., P.M., W.S., and M. W. are members of the German Center for Lung Research. The authors declare no conflicts of interest.	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Cho ME, 2010, EXPERT OPIN INV DRUG, V19, P275, DOI 10.1517/13543780903501539; Choi K, 2012, MOL VIS, V18, P1010; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Coon DR, 2006, EXP MOL PATHOL, V80, P119, DOI 10.1016/j.yexmp.2005.12.003; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Giri Shri N., 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P169; Hanna A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0509-3; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Hu BA, 2015, AM J RESP CELL MOL, V52, P418, DOI 10.1165/rcmb.2014-0108OC; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; IYER SN, 1995, J LAB CLIN MED, V125, P779; Iyer SN, 2000, INFLAMMATION, V24, P477, DOI 10.1023/A:1007068313370; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Louro ID, 2002, CANCER RES, V62, P5867; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Miura Y, 2014, EUR RESPIR J, V44; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Okamoto Tatsuya, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P359; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wygrecka M, 2011, AM J RESP CRIT CARE, V183, P1703, DOI 10.1164/rccm.201009-1479OC; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	39	55	55	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1916	1928		10.1096/fj.201600892RR	http://dx.doi.org/10.1096/fj.201600892RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148565				2022-12-26	WOS:000399195500014
J	Airi, V; Prantoni, S; Calegari, M; Baldi, VL; Gizzi, F; Marchini, C; Levy, O; Falini, G; Dubinsky, Z; Goffredo, S				Airi, Valentina; Prantoni, Selena; Calegari, Marco; Baldi, Veronica Lisini; Gizzi, Francesca; Marchini, Chiara; Levy, Oren; Falini, Giuseppe; Dubinsky, Zvy; Goffredo, Stefano			Reproductive output of a non-zooxanthellate temperate coral is unaffected by temperature along an extended latitudinal gradient	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BALANOPHYLLIA-EUROPAEA SCLERACTINIA; LEPTOPSAMMIA-PRUVOTI SCLERACTINIA; CLIMATE-CHANGE IMPACTS; SEXUAL REPRODUCTION; GROWTH; DENDROPHYLLIIDAE; MORTALITY; PATTERNS; WINNERS	Global environmental change, in marine ecosystems, is associated with concurrent shifts in water temperature, circulation, stratification, and nutrient input, with potentially wide-ranging biological effects. Variations in seawater temperature might alter physiological functioning, reproductive efficiency, and demographic traits of marine organisms, leading to shifts in population size and abundance. Differences in temperature tolerances between organisms can identify individual and ecological characteristics, which make corals able to persist and adapt in a climate change context. Here we investigated the possible effect of temperature on the reproductive output of the solitary non-zooxanthellate temperate coral Leptopsammia pruvoti, along an 8 degrees latitudinal gradient. Samples have been collected in six populations along the gradient and each polyp was examined using histological and cyto-histometric analyses. We coupled our results with previous studies on the growth, demography, and calcification of L. pruvoti along the same temperature gradient, and compared them with those of another sympatric zooxanthellate coral Balanophyllia europaea to understand which trophic strategy makes the coral more tolerant to increasing temperature. The nonzooxanthellate species seemed to be quite tolerant to temperature increases, probably due to the lack of the symbiosis with zooxanthellae. To our knowledge, this is the first field investigation of the relationship between reproductive output and temperature increase of a temperate asymbiotic coral, providing novel insights into the poorly studied non-zooxanthellate scleractinians.	[Airi, Valentina; Prantoni, Selena; Calegari, Marco; Baldi, Veronica Lisini; Gizzi, Francesca; Marchini, Chiara; Goffredo, Stefano] Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Falini, Giuseppe] Univ Bologna, Dept Chem Giacomo Ciamician, Bologna, Italy	University of Bologna; Bar Ilan University; University of Bologna	Goffredo, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy.; Dubinsky, Z (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	zvykalmog@gmail.com; s.goffredo@unibo.it	Gizzi, Francesca/Q-4866-2019	Gizzi, Francesca/0000-0001-9447-8694; Airi, Valentina/0000-0002-6118-7441; goffredo, stefano/0000-0002-5022-9503	European Research Council under the European Union [249930]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no 249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091792; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Ateweberhan M, 2013, MAR POLLUT BULL, V74, P526, DOI 10.1016/j.marpolbul.2013.06.011; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Caroselli E, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-32; Caroselli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037848; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2010, MAR BIOL, V157, P2603, DOI 10.1007/s00227-010-1522-5; Goffredo S, 2009, ISR J ECOL EVOL, V55, P99, DOI 10.1560/IJEE.55.2.99; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Howells EJ, 2013, ECOLOGY, V94, P1078, DOI 10.1890/12-1257.1; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kleypas JA, 1999, AM ZOOL, V39, P146; Korta M, 2010, FISH RES, V104, P56, DOI 10.1016/j.fishres.2010.01.010; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Linares C, 2013, MAR ENVIRON RES, V89, P45, DOI 10.1016/j.marenvres.2013.04.009; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; Roth L, 2010, MAR ECOL PROG SER, V411, P73, DOI 10.3354/meps08640; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203	39	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171051	10.1371/journal.pone.0171051	http://dx.doi.org/10.1371/journal.pone.0171051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158213	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700025
J	Nora, A; Karvonen, L; Renvall, H; Parviainen, T; Kim, JY; Service, E; Salmelin, R				Nora, Anni; Karvonen, Leena; Renvall, Hanna; Parviainen, Tiina; Kim, Jeong-Young; Service, Elisabet; Salmelin, Riitta			Children show right-lateralized effects of spoken word-form learning	PLOS ONE			English	Article							EARLY LANGUAGE-ACQUISITION; SURFACE-BASED ANALYSIS; CEREBRAL LATERALIZATION; HEMISPHERIC-ASYMMETRY; DEVELOPMENTAL-CHANGES; PHONOLOGICAL STM; VOCABULARY SIZE; FUNCTIONAL MRI; YOUNG-CHILDREN; HUMAN BRAIN	It is commonly thought that phonological learning is different in young children compared to adults, possibly due to the speech processing system not yet having reached full native-language specialization. However, the neurocognitive mechanisms of phonological learning in children are poorly understood. We employed magnetoencephalography (MEG) to track cortical correlates of incidental learning of meaningless word forms over two days as 6-8year- olds overtly repeated them. Native (Finnish) pseudowords were compared with words of foreign sound structure (Korean) to investigate whether the cortical learning effects would be more dependent on previous proficiency in the language rather than maturational factors. Half of the items were encountered four times on the first day and once more on the following day. Incidental learning of these recurring word forms manifested as improved repetition accuracy and a correlated reduction of activation in the right superior temporal cortex, similarly for both languages and on both experimental days, and in contrast to a salient left-hemisphere emphasis previously reported in adults. We propose that children, when learning new word forms in either native or foreign language, are not yet constrained by left-hemispheric segmental processing and established sublexical native-language representations. Instead, they may rely more on supra-segmental contours and prosody.	[Nora, Anni; Karvonen, Leena; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Nora, Anni; Karvonen, Leena; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Aalto Neurolmaging, Espoo, Finland; [Parviainen, Tiina] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Kim, Jeong-Young] Univ Helsinki, Dept World Cultures, Helsinki, Finland; [Service, Elisabet] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada	Aalto University; Aalto University; University of Jyvaskyla; University of Helsinki; McMaster University	Nora, A (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland.; Nora, A (corresponding author), Aalto Univ, Aalto Neurolmaging, Espoo, Finland.	anni.nora@aalto.fi	Service, Elisabet/M-7686-2015; Parviainen, Tiina/I-4803-2016; Salmelin, Riitta H/I-7044-2012	Service, Elisabet/0000-0002-7698-1189; Parviainen, Tiina/0000-0001-6992-5157; Salmelin, Riitta H/0000-0003-2499-193X; Jeong-Young, jeong-young.kim@helsinki.fi/0000-0002-0169-3596	Academy of Finland [255349, 256459, 283071, 292552, 127401]; Doctoral Program Brain and Mind; Foundation for Aalto University Science and Technology; Sigrid Juselius Foundation; National Sciences and Engineering Research Council of Canada (NSERC) [245327]	Academy of Finland(Academy of Finland); Doctoral Program Brain and Mind; Foundation for Aalto University Science and Technology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Academy of Finland (grant numbers #255349, #256459, #283071, and #292552 to RS, #127401 to HR), the Doctoral Program Brain and Mind (to AN), the Foundation for Aalto University Science and Technology (to AN), the Sigrid Juselius Foundation (to RS), and the National Sciences and Engineering Research Council of Canada (NSERC; grant number #245327 to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Aoyama K., 2008, IRAL-INT REV APPL LI, V46, P61, DOI DOI 10.1515/IRAL.2008.003; Berl MM, 2014, HUM BRAIN MAPP, V35, P270, DOI 10.1002/hbm.22179; Bishop D. V. M., 2012, PLOS ONE, V7; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Bonte M, 2004, CLIN NEUROPHYSIOL, V115, P409, DOI 10.1016/S1388-2457(03)00361-4; Conboy BT, 2006, DEVELOPMENTAL SCI, V9, pF1, DOI 10.1111/j.1467-7687.2005.00453.x; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2015, NAT REV NEUROSCI, V16, P234, DOI 10.1038/nrn3924; Dehaene-Lambertz G, 2006, TRENDS NEUROSCI, V29, P367, DOI 10.1016/j.tins.2006.05.011; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FLEGE JE, 1987, APPLIED LINGUISTICS, V8, P162, DOI DOI 10.1093/APPLIN/8.2.162; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1990, ELECTROEN CLIN NEURO, P3; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kooijman V, 2005, COGNITIVE BRAIN RES, V24, P109, DOI 10.1016/j.cogbrainres.2004.12.009; Kovacs G, 2008, LANG LEARN, V58, P597, DOI 10.1111/j.1467-9922.2008.00451.x; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lonnrot E., 1874, FINSKT SVENSKT LEXIC; Majerus S, 2005, BRAIN LANG, V92, P320, DOI 10.1016/j.bandl.2004.07.003; Majerus S, 2004, J MEM LANG, V51, P297, DOI 10.1016/j.jml.2004.05.002; Makela J P, 1990, Adv Neurol, V54, P177; McNealy K, 2011, DEVELOPMENTAL SCI, V14, P1261, DOI 10.1111/j.1467-7687.2011.01075.x; Mills DL, 2005, COGNITIVE DEV, V20, P19, DOI 10.1016/j.cogdev.2004.07.001; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Nora A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126652; Nora A, 2012, NEUROIMAGE, V63, P789, DOI 10.1016/j.neuroimage.2012.07.026; Oh GE, 2011, J PHONETICS, V39, P156, DOI 10.1016/j.wocn.2011.01.002; Ojima S, 2011, J COGNITIVE NEUROSCI, V23, P183, DOI 10.1162/jocn.2010.21425; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parviainen T, 2011, HUM BRAIN MAPP, V32, P2193, DOI 10.1002/hbm.21181; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Pierce LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10073; Plante E, 2015, LATERALITY, V20, P306, DOI 10.1080/1357650X.2014.963597; Plaut DC, 1999, CARN S COGN, P381; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Rauschecker AM, 2008, HUM BRAIN MAPP, V29, P1231, DOI 10.1002/hbm.20460; Rigler H, 2015, DEV PSYCHOL, V51, P1690, DOI 10.1037/dev0000044; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; Service E, 2014, LANG LEARN, V64, P215, DOI 10.1111/lang.12051; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Thompson EC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19737; Torkildsen JV, 2009, BRAIN LANG, V108, P73, DOI 10.1016/j.bandl.2008.09.005; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Uutela K, 2001, NEUROIMAGE, V14, P1424, DOI 10.1006/nimg.2001.0915; Vanvooren S, 2014, J NEUROSCI, V34, P1523, DOI 10.1523/JNEUROSCI.3209-13.2014; Walley A. C., 2003, READ WRIT, V16, P5, DOI [DOI 10.1023/A:1021789804977, 10.1023/a:1021789804977]; Weighall A., 2016, BRAIN LANG; Weiss-Croft LJ, 2015, NEUROIMAGE, V123, P269, DOI 10.1016/j.neuroimage.2015.07.046; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Yoncheva Y, 2014, NEUROIMAGE, V97, P262, DOI 10.1016/j.neuroimage.2014.04.006; Yoshimura Y, 2014, NEUROIMAGE, V101, P440, DOI 10.1016/j.neuroimage.2014.07.034; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	69	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171034	10.1371/journal.pone.0171034	http://dx.doi.org/10.1371/journal.pone.0171034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158201	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700024
J	Polimene, L; Clark, D; Kimmance, S; McCormack, P				Polimene, Luca; Clark, Darren; Kimmance, Susan; McCormack, Paul			A substantial fraction of phytoplankton-derived DON is resistant to degradation by a metabolically versatile, widely distributed marine bacterium	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; AMMONIUM REGENERATION; ATLANTIC-OCEAN; CARBON; MICROBES; PICOPLANKTON; POPULATIONS; DYNAMICS; MODEL	The capacity of bacteria for degrading dissolved organic nitrogen (DON) and remineralising ammonium is of importance for marine ecosystems, as nitrogen availability frequently limits productivity. Here, we assess the capacity of a widely distributed and metabolically versatile marine bacterium to degrade phytoplankton-derived dissolved organic carbon (DOC) and nitrogen. To achieve this, we lysed exponentially growing diatoms and used the derived dissolved organic matter (DOM) to support an axenic culture of Alteromonas sp.. Bacterial biomass (as particulate carbon and nitrogen) was monitored for 70 days while growth dynamics (cell count), DOM (DOC, DON) and dissolved nutrient concentrations were monitored for up to 208 days. Bacterial biomass increased rapidly within the first 7 days prior to a period of growth/death cycles potentially linked to rapid nutrient recycling. We found that approximate to 75% of the initial DOC and approximate to 35% of the initial DON were consumed by bacteria within 40 and 4 days respectively, leaving a significant fraction of DOM resilient to degradation by this bacterial species. The different rates and extents to which DOC and DON were accessed resulted in changes in DOM stoichiometry and the iterative relationship between DOM quality and bacterial growth over time influenced bacterial cell C: N molar ratio. C: N values increased to 10 during the growth phase before decreasing to values of approximate to 5, indicating a change from relative N-limitation/C-sufficiency to relative C-limitation/ N-sufficiency. Consequently, despite its reported metabolic versatility, we demonstrate that Alteromonas sp. was unable to access all phytoplankton derived DOM and that a bacterial community is likely to be required. By making the relatively simple assumption that an experimentally derived fraction of DOM remains resilient to bacterial degradation, these experimental results were corroborated by numerical simulations using a previously published model describing the interaction between DOM and bacteria in marine systems, thus supporting our hypothesis.	[Polimene, Luca; Clark, Darren; Kimmance, Susan] Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England; [McCormack, Paul] Univ Plymouth, Petr & Environm Geochem Grp, Biogeochem Res Ctr, Plymouth, Devon, England	Plymouth Marine Laboratory; University of Plymouth	Polimene, L (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	luca@pml.ac.uk	McCormack, Paul/AAJ-2420-2021	McCormack, Paul/0000-0001-9775-7904	UK NERC; NERC/Defra Shelf Seas Biogeochemistry program (NERC project) [NE/K001876/1]; NERC [CC059]; Natural Environment Research Council [pml010010, NE/K001876/1, pml010002] Funding Source: researchfish; NERC [pml010010, NE/K001876/1, pml010002] Funding Source: UKRI	UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC/Defra Shelf Seas Biogeochemistry program (NERC project); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	LP, DC and SK were part funded through the UK NERC (www.nerc.ac.uk/) national capability in sustained observation and marine modelling. LP was part funded through the NERC/Defra Shelf Seas Biogeochemistry program (NERC project number NE/K001876/1). We gratefully acknowledge support from the NERC (2014 Capital Investment award number CC059) for an Ultra High Performance Liquid Chromatograph-Time of Flight-Mass Spectrometer (uHPLC-TOF-MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI DOI 10.1016/B978-012088426-1/50027-5; Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berg GM, 2006, AQUAT MICROB ECOL, V42, P215, DOI 10.3354/ame042215; Blackford JC, 2004, J MARINE SYST, V52, P191, DOI 10.1016/j.jmarsys.2004.02.004; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Butenschoen M, 2016, GEOSCI MODEL DEV, V9, P1293, DOI 10.5194/gmd-9-1293-2016; Carlson CA, 2007, OCEANOGRAPHY, V20, P89, DOI 10.5670/oceanog.2007.52; Clark DR, 2008, LIMNOL OCEANOGR, V53, P52, DOI 10.4319/lo.2008.53.1.0052; GOLDMAN JC, 1987, LIMNOL OCEANOGR, V32, P1239, DOI 10.4319/lo.1987.32.6.1239; GUO LD, 1994, MAR CHEM, V45, P105, DOI 10.1016/0304-4203(94)90095-7; Hansell D.A., 2005, EOS T AM GEOPHYS UN, V86, P318, DOI DOI 10.1029/2005EO350003; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Hopkinson CS, 2005, NATURE, V433, P142, DOI 10.1038/nature03191; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; KEPKAY PE, 1993, MAR ECOL PROG SER, V100, P233, DOI 10.3354/meps100233; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Meon B, 2001, MAR CHEM, V75, P185, DOI 10.1016/S0304-4203(01)00036-6; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Nagata T, 1996, MAR ECOL PROG SER, V132, P241, DOI 10.3354/meps132241; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Pedler BE, 2014, PNAS; Polimene L, 2006, AQUAT MICROB ECOL, V43, P127, DOI 10.3354/ame043127; Polimene L, 2012, BIOGEOCHEMISTRY, V110, P243, DOI 10.1007/s10533-011-9674-z; Schuster S, 1998, MAR ECOL PROG SER, V166, P99, DOI 10.3354/meps166099; Sipler RE, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P127, DOI 10.1016/B978-0-12-405940-5.00004-2; Stoderegger K, 1998, LIMNOL OCEANOGR, V43, P877, DOI 10.4319/lo.1998.43.5.0877; Tarran GA, 2015, PROG OCEANOGR, V137, P446, DOI 10.1016/j.pocean.2015.04.024; Therkildsen MS, 1997, AQUAT MICROB ECOL, V13, P213, DOI 10.3354/ame013213; TRANVIK LJ, 1993, FEMS MICROBIOL ECOL, V12, P177; VernonClark R. N., 1995, CHEM ECOL, V11, P69; Woodward EMS, 2001, DEEP-SEA RES PT II, V48, P775, DOI 10.1016/S0967-0645(00)00097-7	39	1	1	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171391	10.1371/journal.pone.0171391	http://dx.doi.org/10.1371/journal.pone.0171391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158278	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000396161700072
J	Chaabane, A; Neifar, L; Justine, JL				Chaabane, Amira; Neifar, Lassad; Justine, Jean-Lou			Diplectanids from Mycteroperca spp. (Epinephelidae) in the Mediterranean Sea: Redescriptions of six species from material collected off Tunisia and Libya, proposal for the 'Pseudorhabdosynochus riouxi group', and a taxonomic key	PLOS ONE			English	Article							CORAL-REEF FISH; N. SP MONOGENEA; NEW-CALEDONIA; DICENTRARCHUS-LABRAX; NEMATODA PHILOMETRIDAE; PARASITE BIODIVERSITY; MACULATUS PERCIFORMES; POPULATION-DYNAMICS; CULTURED GROUPERS; VAL. PERCIFORMES	Diplectanid monogeneans are gill parasites that can infect fish in huge numbers and thus become harmful, especially in maricultured fish. It is therefore useful to have taxonomic tools, such as keys, to identify species. The following diplectanid species from groupers of the Mediterranean Sea were studied: five species of PseudorhabdosynochusYamaguti, 1958, including P. riouxi (Oliver, 1986) Kritsky & Beverley-Burton, 1986 from the dusky grouper Mycteroperca marginata, P. enitsujiNeifar & Euzet, 2007, P. bouaini Neifar & Euzet, 2007, P. dolicocolpos Neifar & Euzet, 2007 and P. sinediscus Neifar & Euzet, 2007 from the goldblotch grouper M. costae, and Echinoplectanum echinophallus (Euzet & Oliver, 1965) Justine & Euzet, 2006 from the dusky grouper. New material was obtained from fish collected from off Tunisia and Libya and compared to the type-material and voucher specimens in museum collections. Identifications of fish were confirmed by barcoding of cytochrome c oxidase subunit I (C01) sequences. The sclerotized vagina was considered the most important structure for systematics. The three species P. riouxi, P. bouaini, and P. enitsuji share a common general structure of the sclerotized vagina with a conspicuous spherical secondary chamber. We thus propose the Pseudorhabdosynochus riouxi group' to accommodate them. Pseudorhabdosynochus dolicocolpos has an elongate vaginal structure that is completely different from all its congeneric species reported from the Mediterranean Sea, and Pseudorhabdosynochus sinediscus has a sclerotized vagina in which the secondary chamber is not visible, and a haptor without squamodiscs. A taxonomic key to diplectanid species on Mycteroperca spp. in the Mediterranean Sea is proposed; it includes ten species of Pseudorhabdosynochus and one species of Echinoplectanum.	[Chaabane, Amira; Neifar, Lassad] Univ Sfax, Lab Biodiversite & Ecosyst Aquat, Fac Sci Sfax, Sfax, Tunisia; [Justine, Jean-Lou] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, ISYEB,Evolut,Biodiversite,UMR7205,CNRS,EPHE,UPMC, Paris, France	Universite de Sfax; Faculty of Sciences Sfax; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Chaabane, A (corresponding author), Univ Sfax, Lab Biodiversite & Ecosyst Aquat, Fac Sci Sfax, Sfax, Tunisia.	amirachaabene@hotmail.fr	Chaabane, Amira/AAQ-3021-2021; Justine, Jean-Lou/B-1298-2010	Chaabane, Amira/0000-0002-2931-4113; Justine, Jean-Lou/0000-0002-7155-4540	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	This work was supported by Ministere des Affaires Etrangeres, France: grant BIOPARMED-ENVIMED, http://www.mistrals-home.org/spip.php?rubrique82; and Museum National d'Histoire Naturelle, France: Grant PARSUDMED, [https://www.mnhn.fr/fr]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli L, 2010, AQUACULTURE, V307, P179, DOI 10.1016/j.aquaculture.2010.07.028; BALASURIYA LKS, 1995, J BIOSCIENCE, V6, P30; Bu SSH, 1999, J HELMINTHOL, V73, P301; Chaabane A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159886; Chaabane A, 2016, PEERJ, V4, DOI 10.7717/peerj.2233; Chaabane A, 2015, PARASITE, V22, DOI 10.1051/parasite/2015005; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; De Liberato C., 2000, PARASSITOLOGIA S1, V42, P166; Dezfuli BS, 2007, PARASITOL RES, V100, P707, DOI 10.1007/s00436-006-0343-4; Dyer William G., 1995, Journal of Aquatic Animal Health, V7, P337, DOI 10.1577/1548-8667(1995)007&lt;0337:KNSDOG&gt;2.3.CO;2; Euzet L., 1984, Archives de l'Institut Pasteur de Tunis, V61, P463; EUZET LOUIS, 1965, ANN PARASITOL HUM COMP, V40, P517; Gijon-Botella H, 1998, PARASITOLOGY INT S, V47, P289; GONZALEZLANZA C, 1991, PARASITOL RES, V77, P307, DOI 10.1007/BF00930906; Heemstra P.C., 1993, FAO FISH SYNOP, V125, P382, DOI [10.1016/j.rsma.2020.101388, DOI 10.1016/J.RSMA.2020.101388]; *INT COMM ZOOL NOM, 1999, INT COD ZOOL NOM INT; Isshiki T, 2007, FISH PATHOL, V42, P71, DOI 10.3147/jsfp.42.71; Journo C, 2006, SYST PARASITOL, V64, P173, DOI 10.1007/s11230-006-9029-7; Justine JL, 2008, SYST PARASITOL, V71, P145, DOI 10.1007/s11230-008-9156-4; Justine JL, 2008, ACTA PARASITOL, V53, P127, DOI 10.2478/s11686-008-0021-z; Justine JL, 2007, SYST PARASITOL, V68, P195, DOI 10.1007/s11230-007-9096-4; Justine JL, 2007, SYST PARASITOL, V66, P81, DOI 10.1007/s11230-006-9057-3; Justine JL, 2010, FOLIA PARASIT, V57, P237, DOI 10.14411/fp.2010.032; Justine JL, 2010, BELG J ZOOL, V140, P155; Justine JL, 2010, SYST PARASITOL, V77, P81, DOI 10.1007/s11230-010-9263-x; Justine Jean-Lou, 2007, Zootaxa, V1543, P1; Justine JL, 2006, SYST PARASITOL, V64, P147, DOI 10.1007/s11230-006-9028-8; Justine JL, 2005, SYST PARASITOL, V62, P1, DOI 10.1007/s11230-005-5480-0; KRITSKY DC, 1986, P BIOL SOC WASH, V99, P17; Kritsky DC, 2015, PARASITE, V22, DOI 10.1051/parasite/2015024; Luo YF, 2010, HELMINTHOLOGIA, V47, P241, DOI 10.2478/s11687-010-0038-3; Luo YF, 2010, J PARASITOL, V96, P541, DOI 10.1645/GE-2286.1; MALMBERG G, 1957, FOREKOMSTEN GYRODACT, P19; Moravec F, 2016, PARASITE, V23, DOI 10.1051/parasite/2016008; Moravec F, 2016, SYST PARASITOL, V93, P115, DOI 10.1007/s11230-015-9610-z; Neifar L, 2007, FOLIA PARASIT, V54, P117, DOI 10.14411/fp.2007.017; OLIVER G, 1986, SYST PARASITOL, V8, P317, DOI 10.1007/BF00009739; OLIVER G, 1992, TRAVAUX SCI PARC NAT, V37, P101; Oliver G, 1987, THESIS; Palm HW, 2011, PARASITOLOGY, V138, P1793, DOI 10.1017/S0031182011000011; PAPERNA I, 1979, AQUACULTURE, V16, P173, DOI 10.1016/0044-8486(79)90148-0; RADUJKOVIC B M, 1989, Acta Adriatica, V30, P51; Roumbedakis K, 2014, BRAZ J BIOL, V73, P871, DOI 10.1590/S1519-698420130004000025; Ruckert S, 2009, PARASITOL RES, V104, P523, DOI 10.1007/s00436-008-1226-7; Sanchez-Garcia N, 2015, J HELMINTHOL, V89, P217, DOI 10.1017/S0022149X13000813; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Sigura A, 2008, ZOOTAXA, P1; Swan D. C., 1936, Bulletin of Entomological Research London, V27, P389, DOI 10.1017/S0007485300058259; Vidal-Martinez VM, 1998, FOLIA PARASIT, V45, P221; Yang TB, 2005, SYST PARASITOL, V62, P221, DOI 10.1007/s11230-005-5497-4; Yang TB, 2006, SYST PARASITOL, V63, P127, DOI 10.1007/s11230-005-9006-6	52	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171392	10.1371/journal.pone.0171392	http://dx.doi.org/10.1371/journal.pone.0171392			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152034	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200138
J	Tournu, H; Carroll, J; Latimer, B; Dragoi, AM; Dykes, S; Cardelli, J; Peters, TL; Eberle, KE; Palmer, GE				Tournu, Helene; Carroll, Jennifer; Latimer, Brian; Dragoi, Ana-Maria; Dykes, Samantha; Cardelli, James; Peters, Tracy L.; Eberle, Karen E.; Palmer, Glen E.			Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans	PLOS ONE			English	Article							IN-VITRO; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; CRYPTOCOCCUS-NEOFORMANS; REDUCED SUSCEPTIBILITY; FUNGAL-INFECTIONS; AMPHOTERICIN-B; MURINE MODEL; CELL-CYCLE	The fungal vacuole is a large acidified organelle that performs a variety of cellular functions. At least a sub-set of these functions are crucial for pathogenic species of fungi, such as Candida albicans, to survive within and invade mammalian tissue as mutants with severe defects in vacuolar biogenesis are avirulent. We therefore sought to identify chemical probes that disrupt the normal function and/or integrity of the fungal vacuole to provide tools for the functional analysis of this organelle as well as potential experimental therapeutics. A convenient indicator of vacuolar integrity based upon the intracellular accumulation of an endogenously produced pigment was adapted to identify Vacuole Disrupting chemical Agents (VDAs). Several chemical libraries were screened and a set of 29 compounds demonstrated to reproducibly cause loss of pigmentation, including 9 azole antifungals, a statin and 3 NSAIDs. Quantitative analysis of vacuolar morphology revealed that (excluding the azoles) a sub-set of 14 VDAs significantly alter vacuolar number, size and/or shape. Many C. albicans mutants with impaired vacuolar function are deficient in the formation of hyphal elements, a process essential for its pathogenicity. Accordingly, all 14 VDAs negatively impact C. albicans hyphal morphogenesis. Fungal selectivity was observed for approximately half of the VDA compounds identified, since they did not alter the morphology of the equivalent mammalian organelle, the lysosome. Collectively, these compounds comprise of a new collection of chemical probes that directly or indirectly perturb normal vacuolar function in C. albicans.	[Tournu, Helene; Peters, Tracy L.; Palmer, Glen E.] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm,Div Clin & Expt Therapeut, Memphis, TN 38163 USA; [Carroll, Jennifer; Latimer, Brian; Dragoi, Ana-Maria; Dykes, Samantha; Cardelli, James] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Med, Shreveport, LA 71105 USA; [Eberle, Karen E.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Palmer, GE (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm,Div Clin & Expt Therapeut, Memphis, TN 38163 USA.	gpalmer5@uthsc.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21A1097664, R01A1099080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099080] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers R21A1097664 and R01A1099080 received by Dr. Glen E. Palmer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chavez-Dozal AA, 2014, INT J ANTIMICROB AG, V43, P86, DOI 10.1016/j.ijantimicag.2013.08.018; Cohen BE, 2016, ANTIMICROB AGENTS CH, V60, P5122, DOI 10.1128/AAC.00878-16; Cornet M, 2006, ANTIMICROB AGENTS CH, V50, P3492, DOI 10.1128/AAC.00391-06; Costa-de-Oliveira S, 2015, ANTIMICROB AGENTS CH, V59, P4289, DOI 10.1128/AAC.05056-14; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; FISHER CR, 1969, BIOCHEM BIOPH RES CO, V34, P306, DOI 10.1016/0006-291X(69)90832-8; FONZI WA, 1993, GENETICS, V134, P717; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GOODWIN SD, 1995, CLIN INFECT DIS, V20, P755, DOI 10.1093/clinids/20.4.755; GOW NAR, 1982, J GEN MICROBIOL, V128, P2195; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Hakki M, 2006, ANTIMICROB AGENTS CH, V50, P2522, DOI 10.1128/AAC.00148-06; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Johnston DA, 2009, INFECT IMMUN; Johnston DA, 2013, EUKARYOT CELL, V12, P1039, DOI 10.1128/EC.00359-12; Johnston DA, 2009, INFECT IMMUN, V77, P2343, DOI 10.1128/IAI.01458-08; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Liu YP, 2014, EUKARYOT CELL, V13, P279, DOI 10.1128/EC.00295-13; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Luna-Tapia A, 2015, EUKARYOT CELL, V14, P1006, DOI 10.1128/EC.00116-15; Luna-Tapia A, 2015, ANTIMICROB AGENTS CH, V59, P2410, DOI 10.1128/AAC.04239-14; Maertens J, 2001, EUR J CANCER CARE, V10, P56, DOI 10.1046/j.1365-2354.2001.00241.x; McCormack PL, 2005, DRUGS, V65, P2049, DOI 10.2165/00003495-200565140-00009; Miller CD, 2006, PHARMACOTHERAPY, V26, P877, DOI 10.1592/phco.26.6.877; Palanisamy SKA, 2010, EUKARYOT CELL, V9, P266, DOI 10.1128/EC.00295-09; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Palmer GE, 2010, EUKARYOT CELL, V9, P1755, DOI 10.1128/EC.00029-10; Pereira-Leite C, 2013, PROG LIPID RES, V52, P571, DOI 10.1016/j.plipres.2013.08.003; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; POULTER RTM, 1983, J BACTERIOL, V156, P1066, DOI 10.1128/JB.156.3.1066-1077.1983; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Saville SP, 2009, CLIN VACCINE IMMUNOL, V16, P430, DOI 10.1128/CVI.00480-08; SCOTT EM, 1995, ANTIMICROB AGENTS CH, V39, P2610, DOI 10.1128/AAC.39.12.2610; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Vermitsky JP, 2004, ANTIMICROB AGENTS CH, V48, P3773, DOI 10.1128/AAC.48.10.3773-3781.2004; WADA Y, 1992, J BIOL CHEM, V267, P18665; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zouhar J, 2004, P NATL ACAD SCI USA, V101, P9497, DOI 10.1073/pnas.0402121101	66	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171145	10.1371/journal.pone.0171145	http://dx.doi.org/10.1371/journal.pone.0171145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151949	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200093
J	Uranga, J; Arrizabalaga, H; Boyra, G; Hernandez, MC; Goni, N; Arregui, I; Fernandes, JA; Yurramendi, Y; Santiago, J				Uranga, Jon; Arrizabalaga, Haritz; Boyra, Guillermo; Hernandez, Maria Carmen; Goni, Nicolas; Arregui, Igor; Fernandes, Jose A.; Yurramendi, Yosu; Santiago, Josu			Detecting the presence-absence of bluefin tuna by automated analysis of medium-range sonars on fishing vessels	PLOS ONE			English	Article							THUNNUS-THYNNUS; UNIT EFFORT; FISHERIES; SCHOOLS; BISCAY; BAY; MANAGEMENT; ECOLOGY; STOCKS; CATCH	This study presents a methodology for the automated analysis of commercial medium range sonar signals for detecting presence/absence of bluefin tuna (Tunnus thynnus) in the Bay of Biscay. The approach uses image processing techniques to analyze sonar screen shots. For each sonar image we extracted measurable regions and analyzed their characteristics. Scientific data was used to classify each region into a class ("tuna" or "no-tuna") and build a dataset to train and evaluate classification models by using supervised learning. The methodology performed well when validated with commercial sonar screenshots, and has the potential to automatically analyze high volumes of data at a low cost. This represents a first milestone towards the development of acoustic, fishery-independent indices of abundance for bluefin tuna in the Bay of Biscay. Future research lines and additional alternatives to inform stock assessments are also discussed.	[Uranga, Jon; Arrizabalaga, Haritz; Boyra, Guillermo; Goni, Nicolas; Arregui, Igor; Santiago, Josu] AZTI Tecnalia, Div Marine Res, Pasaia, Spain; [Hernandez, Maria Carmen; Yurramendi, Yosu] Univ Basque Country, Comp Sci & Artificial Intelligence Dept, Donostia San Sebastian, Spain; [Hernandez, Maria Carmen] Univ Tras Os Montes & Alto Douro, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Fernandes, Jose A.] Plymouth Marine Lab, Plymouth, Devon, England	AZTI; University of Basque Country; University of Tras-os-Montes & Alto Douro; Plymouth Marine Laboratory	Uranga, J (corresponding author), AZTI Tecnalia, Div Marine Res, Pasaia, Spain.	juranga.research@gmail.com	Hernandez, María/GYU-3543-2022; Arrizabalaga, Haritz/B-8238-2009; Fernandes, Jose A./B-8985-2009; Salvador, Jose Antonio Fernandes/AAH-7939-2019; Romay, Manuel M. Graña/L-1341-2014; Hernández Gómez, Carmen/S-1239-2018; Boyra, GUILLERMO/AAB-2137-2019	Arrizabalaga, Haritz/0000-0002-3861-6316; Fernandes, Jose A./0000-0003-4677-6077; Salvador, Jose Antonio Fernandes/0000-0003-4677-6077; Romay, Manuel M. Graña/0000-0001-7373-4097; Hernandez Gomez, Carmen/0000-0002-6645-9880	Basque Government [0033-2011, GV 351NPVA00062]; Natural Environment Research Council [pml010005, pml010010] Funding Source: researchfish; NERC [pml010010, pml010005] Funding Source: UKRI	Basque Government(Basque Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the Basque Government through PhD grant 0033-2011 to JU and grant GV 351NPVA00062 to HA (AZTI-Tecnalia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Arreguin-Sanchez F, 1997, OCEANOGRAPHIC LIT RE, V1, P58; Arrizabalaga H, 2015, DEEP-SEA RES PT II, V113, P102, DOI 10.1016/j.dsr2.2014.07.001; Bachiller E, 2012, LIMNOL OCEANOGR-METH, V10, P1, DOI 10.4319/lom.2012.10.1; Bauer RK, 2015, MAR ECOL PROG SER, V534, P221, DOI 10.3354/meps11392; Bishop C.M., 1995, NEURAL NETWORKS PATT; Brehmer P, 2007, AQUAT LIVING RESOUR, V20, P377, DOI 10.1051/alr:2008016; Brehmer P, 2006, FISH FISH, V7, P165, DOI 10.1111/j.1467-2979.2006.00218.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chapelle O., 2006, SEMISUPERVISED LEARN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dalen J, 2007, COLLECTION ACOUSTIC, V287; Di Natale Antonio, 2014, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V70, P459; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Dragesund O, 1965, PATTERN RECOGNITION; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandes JA, 2009, J PLANKTON RES, V31, P19, DOI 10.1093/plankt/fbn098; Freeman EA, 2008, J STAT SOFTW, V23, P1; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; GERLOTTO F, 1992, FISH RES, V14, P251, DOI 10.1016/0165-7836(92)90035-R; Goni N, 2010, PROG OCEANOGR, V86, P115, DOI 10.1016/j.pocean.2010.04.016; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haykin S., 2004, NEURAL NETWORKS, DOI DOI 10.5555/541500; HEWITT RP, 1976, FISH B-NOAA, V74, P281; ICCAT, 2013, INT COMM CONS ATL CO, V69, P1; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Itoh T, 2012, REPORT PISTON LINE T; Itoh T, 2004, REV ACOUSTIC MONITOR, P03; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lutcavage M, 1997, FISH B-NOAA, V95, P300; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Mayer L, 2002, ICES J MAR SCI, V59, P216, DOI 10.1006/jmsc.2001.1125; Melvin G, 2002, ICES J MAR SCI, V59, P179, DOI 10.1006/jmsc.2001.1124; Melvin G, 2001, AKSG0104 U AL SEA; Melvin GD, 2016, ICEJ MARINE SCI J; Miquel J, 2006, ACOUSTIC SELECTIVITY; Misund OA, 1997, REV FISH BIOL FISHER, V7, P1, DOI 10.1023/A:1018476523423; O'Driscoll RL, 1998, DEEP-SEA RES PT II, V45, P1295, DOI 10.1016/S0967-0645(98)00035-6; Petitgas P, 2009, AQUAT LIVING RESOUR, V22, P119, DOI 10.1051/alr/2009014; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Marin E, 2003, ICES J MAR SCI, V60, P1216, DOI 10.1016/S1054-3139(03)00139-5; Santiago J., 2016, COLLECTIVE VOLUME SC, V72, P1694; Simmonds J., 2008, FISHERIES ACOUSTICS; Smith P. E., 1970, P INT S BIOL SOUND S, V31; Standing Committee of theNationalAssembly, 2016, RES URB CLASS VIETN; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; Trygonis V, 2016, FISH RES, V177, P39, DOI 10.1016/j.fishres.2016.01.013; Venables W., 2013, MODERN APPL STAT S, V53, P86; Weber TC, 2013, J ACOUST SOC AM, V133, P3802, DOI 10.1121/1.4802646; Witten I.H., 2005, DATA MINING PRACTICA; Wood J. M., 2007, WEB J; Zarauz L, 2008, J PLANKTON RES, V30, P857, DOI 10.1093/plankt/fbn049	58	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171382	10.1371/journal.pone.0171382	http://dx.doi.org/10.1371/journal.pone.0171382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152032	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000396161200136
J	von Ossowski, L; Li, LL; Moykkynen, T; Coleman, SK; Courtney, MJ; Keinanen, K				von Ossowski, Lotta; Li, Li-Li; Moykkynen, Tommi; Coleman, Sarah K.; Courtney, Michael J.; Keinanen, Kari			Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; NITRIC-OXIDE PRODUCTION; S-NITROSYLATION; PDZ DOMAINS; GLUTAMATE RECEPTORS; SUBUNIT COMPOSITION; SURFACE EXPRESSION; ACID RECEPTOR; GLUR1 SUBUNIT; SAP97	Recent studies indicate that glutamatergic signaling involves, and is regulated by, thiol modifying and redox-active compounds. In this study, we examined the role of a reactive cysteine residue, Cys-893, in the cytosolic C-terminal tail of GluA1 AMPA receptor as a potential regulatory target. Elimination of the thiol function by substitution of serine for Cys-893 led to increased steady-state expression level and strongly reduced interaction with SAP97, a major cytosolic interaction partner of GluA1 C-terminus. Moreover, we found that of the three cysteine residues in GluA1 C-terminal tail, Cys-893 is the predominant target for Snitrosylation induced by exogenous nitric oxide donors in cultured cells and lysates. Co-precipitation experiments provided evidence for native association of SAP97 with neuronal nitric oxide synthase (nNOS) and for the potential coupling of Ca2+- permeable GluA1 receptors with nNOS via SAP97. Our results show that Cys-893 can serve as a molecular target for regulatory thiol modifications of GluA1 receptors, including the effects of nitric oxide.	[von Ossowski, Lotta; Moykkynen, Tommi; Coleman, Sarah K.; Keinanen, Kari] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, Helsinki, Finland; [Li, Li-Li; Courtney, Michael J.] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Li, Li-Li; Courtney, Michael J.] Univ Turku, Turku, Finland; [Li, Li-Li] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Coleman, Sarah K.] Univ Westminster, Dept Life Sci, London, England	University of Helsinki; Abo Akademi University; University of Turku; University of Turku; University of Eastern Finland; University of Westminster	Keinanen, K (corresponding author), Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, Helsinki, Finland.	kari.keinanen@helsinki.fi	Courtney, Michael J/D-6648-2016	Courtney, Michael J/0000-0001-8693-3933; Li, Li-Li/0000-0002-8888-153X; Coleman, Sarah/0000-0002-1066-8296	Magnus Ehrnrooth Foundation; Alfred Kordelin Foundation; Orion Research Foundation	Magnus Ehrnrooth Foundation; Alfred Kordelin Foundation; Orion Research Foundation	This work was supported by The Magnus Ehrnrooth Foundation (LvO), The Alfred Kordelin Foundation (LL), and Orion Research Foundation (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Grossi L, 2002, J ORG CHEM, V67, P8625, DOI 10.1021/jo026154+; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Komiyama T, 1997, BIOORG MED CHEM LETT, V7, P175, DOI 10.1016/S0960-894X(96)00608-7; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Lin LH, 2001, NEUROSCIENCE, V106, P801, DOI 10.1016/S0306-4522(01)00331-1; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nakamura T, 2011, ANTIOXID REDOX SIGN, V14, P1479, DOI 10.1089/ars.2010.3570; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Radenovic L, 2005, BRAIN RES BULL, V67, P133, DOI 10.1016/j.brainresbull.2005.06.019; Reimers JM, 2011, BRAIN RES, V1367, P223, DOI 10.1016/j.brainres.2010.10.016; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shen L, 2000, J NEUROSCI, V20, P7932; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchino S, 2006, J NEUROCHEM, V97, P1203, DOI 10.1111/j.1471-4159.2006.03831.x; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Yamada K, 1997, NEUROSCI RES, V28, P93, DOI 10.1016/S0168-0102(97)00032-1; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171489	10.1371/journal.pone.0171489	http://dx.doi.org/10.1371/journal.pone.0171489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152104	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200147
J	Guyot, C; Arlettaz, R; Korner, P; Jacot, A				Guyot, Claire; Arlettaz, Raphael; Korner, Pius; Jacot, Alain			Temporal and Spatial Scales Matter: Circannual Habitat Selection by Bird Communities in Vineyards	PLOS ONE			English	Article							INVERTEBRATE-FEEDING BIRDS; SHRIKES LANIUS-COLLURIO; GRANIVOROUS BIRDS; AGRICULTURAL INTENSIFICATION; FARMLAND BIODIVERSITY; BIOLOGICAL-CONTROL; FORAGING HABITAT; FIELD MARGINS; MANAGEMENT; LANDSCAPE	Vineyards are likely to be regionally important for wildlife, but we lack biodiversity studies in this agroecosystem which is undergoing a rapid management revolution. As vine cultivation is restricted to arid and warm climatic regions, biodiversity-friendly management would promote species typical of southern biomes. Vineyards are often intensively cultivated, mostly surrounded by few natural features and offering a fairly mineral appearance with little ground vegetation cover. Ground vegetation cover and composition may further strongly vary with respect to season, influencing patterns of habitat selection by ecological communities. We investigated season-specific bird-habitat associations to highlight the importance of semi-natural habitat features and vineyard ground vegetation cover throughout the year. Given that avian habitat selection varies according to taxa, guilds and spatial scale, we modelled bird-habitat associations in all months at two spatial scales using mixed effects regression models. At the landscape scale, birds were recorded along 10 1-km long transects in Southwestern Switzerland (February 2014-January 2015). At the field scale, we compared the characteristics of visited and unvisited vineyard fields (hereafter called parcels). Bird abundance in vineyards tripled in winter compared to summer. Vineyards surrounded by a greater amount of hedges and small woods harboured higher bird abundance, species richness and diversity, especially during the winter season. Regarding ground vegetation, birds showed a season-specific habitat selection pattern, notably a marked preference for ground-vegetated parcels in winter and for intermediate vegetation cover in spring and summer. These season-specific preferences might be related to species-specific life histories: more insectivorous, ground-foraging species occur during the breeding season whereas granivores predominate in winter. These results highlight the importance of investigating habitat selection at different spatial scales and all along the annual cycle in order to draw practical, season-specific management recommendations for promoting avian biodiversity in farmland.	[Guyot, Claire; Arlettaz, Raphael; Jacot, Alain] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Dept Biol, Bern, Switzerland; [Arlettaz, Raphael; Jacot, Alain] Swiss Ornithol Inst, Field Stn Valais, Sion, Switzerland; [Korner, Pius] Swiss Ornithol Inst, Sempach, Switzerland	University of Bern; Swiss Ornithological Institute; Swiss Ornithological Institute	Guyot, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Dept Biol, Bern, Switzerland.	claire.guyot@iee.unibe.ch	Arlettaz, Raphael/O-2182-2016	Arlettaz, Raphael/0000-0001-6360-5339	University of Bern; Swiss Ornithological Institute; Swiss National Science Foundation [31003A_149780]	University of Bern; Swiss Ornithological Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided by the University of Bern and the Swiss Ornithological Institute to RA and AJ. This project was supported by a Swiss National Science Foundation Grant to A.J. (No. 31003A_149780). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arlettaz R, 2012, J ORNITHOL, V153, P229, DOI 10.1007/s10336-011-0737-7; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Assandri G, 2016, AGR ECOSYST ENVIRON, V223, P250, DOI 10.1016/j.agee.2016.03.014; Atkinson PW, 2004, IBIS, V146, P99, DOI 10.1111/j.1474-919X.2004.00346.x; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Batary P, 2010, BIOL CONSERV, V143, P2020, DOI 10.1016/j.biocon.2010.05.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; Brambilla M, 2009, ANIM CONSERV, V12, P71, DOI 10.1111/j.1469-1795.2008.00226.x; Brambilla M, 2008, IBIS, V150, P628, DOI 10.1111/j.1474-919X.2008.00822.x; Brambilla M, 2007, BIRD STUDY, V54, P160, DOI 10.1080/00063650709461471; Brambilla M, 2015, ECOL RES, V30, P597, DOI 10.1007/s11284-015-1260-8; Brambilla M, 2013, ARDEOLA, V60, P73, DOI 10.13157/arla.60.1.2012.73; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Brambilla M, 2009, ORNIS FENNICA, V86, P41; Buckingham DL, 2011, AGR ECOSYST ENVIRON, V142, P256, DOI 10.1016/j.agee.2011.05.017; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caprio E, 2015, AGR SYST, V136, P61, DOI 10.1016/j.agsy.2015.02.009; Ceresa F, 2012, BIRD STUDY, V59, P327, DOI 10.1080/00063657.2012.676623; Cohen M, 2015, AGR ECOSYST ENVIRON, V212, P175, DOI 10.1016/j.agee.2015.06.023; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; Duarte J, 2014, BIRD STUDY, V61, P193, DOI 10.1080/00063657.2014.901294; Eggers S, 2011, BIOL CONSERV, V144, P1137, DOI 10.1016/j.biocon.2010.12.033; ESRI (Environmental Systems Resource Institute, 2015, ARCMAP 10 2 2 ESRI R; Evans KL, 2003, BIRD STUDY, V50, P8, DOI 10.1080/00063650309461284; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2009, BIRD STUDY, V56, P34, DOI 10.1080/00063650802648127; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; Fuller RJ, 2001, AGR ECOSYST ENVIRON, V84, P79, DOI 10.1016/S0167-8809(00)00194-8; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gaigher R, 2015, BIOL CONSERV, V186, P69, DOI 10.1016/j.biocon.2015.03.003; Gelman A., 2021, ARM DATA ANAL USING; George TL, 2001, RESTOR ECOL, V9, P272, DOI 10.1046/j.1526-100x.2001.009003272.x; Gillespie M, 2012, J INSECT CONSERV, V16, P13, DOI 10.1007/s10841-011-9390-y; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Gilroy JJ, 2010, IBIS, V152, P90, DOI 10.1111/j.1474-919X.2009.00988.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Herzon I, 2014, AGR ECOSYST ENVIRON, V183, P78, DOI 10.1016/j.agee.2013.10.015; Hinsley SA, 2000, J ENVIRON MANAGE, V60, P33, DOI 10.1006/jema.2000.0360; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kehinde T, 2014, AGR FOREST ENTOMOL, V16, P95, DOI 10.1111/afe.12038; Korner-Nievergelt F, 2015, BAYESIAN DATA ANAL E; Kosinski Z, 2000, EKOL BRATISLAVA, V19, P307; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Laiolo P, 2005, CONSERV BIOL, V19, P1547, DOI 10.1111/j.1523-1739.2005.004376.x; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; MacLeod CJ, 2012, J APPL ECOL, V49, P652, DOI 10.1111/j.1365-2664.2012.02135.x; McCracken DI, 2004, IBIS, V146, P108, DOI 10.1111/j.1474-919X.2004.00360.x; Menz MHM, 2009, ARDEA, V97, P323, DOI 10.5253/078.097.0308; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Morris AJ, 2004, IBIS, V146, P155, DOI 10.1111/j.1474-919X.2004.00361.x; Myczko L, 2013, ECOL RES, V28, P503, DOI 10.1007/s11284-013-1039-8; Nascimbene J, 2012, ENVIRON MANAGE, V49, P1054, DOI 10.1007/s00267-012-9834-5; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; Perkins AJ, 2002, AGR ECOSYST ENVIRON, V93, P413, DOI 10.1016/S0167-8809(01)00306-1; Pewsey A., 2013, CIRCULAR STAT R, DOI [10.1080/09332480.2015.1016851, DOI 10.1080/09332480.2015.1016851]; Pickett SRA, 2011, ECOGRAPHY, V34, P955, DOI 10.1111/j.1600-0587.2011.06608.x; Pithon JA, 2016, BASIC APPL ECOL, V17, P240, DOI 10.1016/j.baae.2015.12.004; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2015, R LANG EVN STAT COMP; Rosin ZM, 2016, PEERJ, V4, DOI 10.7717/peerj.2105; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schmid H, 2004, BERWACHUNG BESTANDES; Sierro Antoine, 2003, Nos Oiseaux, V50, P89; Siriwardena GM, 2008, IBIS, V150, P585, DOI 10.1111/j.1474-919X.2008.00828.x; Tagmann-Ioset A, 2012, ACTA OECOL, V39, P25, DOI 10.1016/j.actao.2011.11.003; Trivellone V, 2012, INSECT CONSERV DIVER, V5, P75, DOI 10.1111/j.1752-4598.2011.00151.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; TUCKER GM, 1992, J APPL ECOL, V29, P779, DOI 10.2307/2404488; Verhulst J, 2004, AGR ECOSYST ENVIRON, V104, P465, DOI 10.1016/j.agee.2004.01.043; Vickery J., 2012, BIRDS HABITAT RELATI, P177, DOI DOI 10.1017/CBO9781139021654.009; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Weisshaupt N, 2011, BIRD STUDY, V58, P111, DOI 10.1080/00063657.2011.556183; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson JD, 2005, IBIS, V147, P453, DOI 10.1111/j.1474-919x.2005.00440.x; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x	87	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170176	10.1371/journal.pone.0170176	http://dx.doi.org/10.1371/journal.pone.0170176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146570	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700016
J	Costa, S; Nicosia, A; Cuttitta, A; Gianguzza, F; Ragusa, MA				Costa, Salvatore; Nicosia, Aldo; Cuttitta, Angela; Gianguzza, Fabrizio; Ragusa, Maria Antonietta			An Intronic cis-Regulatory Element Is Crucial for the Alpha Tubulin PI-Tub alpha 1 alpha Gene Activation in the Ciliary Band and Animal Pole Neurogenic Domains during Sea Urchin Development	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NEURAL DEVELOPMENT; NERVOUS-SYSTEM; ANTERIOR NEUROECTODERM; SPECIFICATION; EXPRESSION; PATTERNS; INSIGHTS; EMBRYOS; COMPETENCE	In sea urchin development, structures derived from neurogenic territory control the swimming and feeding responses of the pluteus as well as the process of metamorphosis. We have previously isolated an alpha tubulin family member of Paracentrotus lividus (PI-Tubal a, formerly known as PI-Talpha2 that is specifically expressed in the ciliary band and animal pole neurogenic domains of the sea urchin embryo. In order to identify cis-regulatory elements controlling its spatio-temporal expression, we conducted gene transfer experiments, transgene deletions and site specific mutagenesis. Thus, a genomic region of about 2.6 Kb of PI-Tubal a, containing four Interspecifically Conserved Regions (ICRs), was identified as responsible for proper gene expression. An enhancer role was ascribed to ICR1 and ICR2, while ICR3 exerted a pivotal role in basal expression, restricting Tuba1a expression to the proper territories of the embryo. Additionally, the mutation of the forkhead box consensus sequence binding site in ICR3 prevented PI-Tubal a expression.	[Costa, Salvatore; Gianguzza, Fabrizio; Ragusa, Maria Antonietta] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [Nicosia, Aldo; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, Detached Unit Capo Granitola, Lab Mol Ecol & Biotechnol, Torretta Granitola, Trapani, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Ragusa, MA (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy.	maria.ragusa@unipa.it	Cuttitta, Angela/AAK-2097-2020; Nicosia, Aldo/R-4462-2017	Cuttitta, Angela/0000-0002-4896-5114; Nicosia, Aldo/0000-0002-1013-2862; Ragusa, Maria Antonietta/0000-0002-8760-1022; Costa, Salvatore/0000-0003-2798-4401	Universita degli Studi di Palermo FFR - EX [4201/2007, 3098/2012]	Universita degli Studi di Palermo FFR - EX	This work was supported by the Universita degli Studi di Palermo FFR - EX60% [grant numbers 4201/2007 to FG and 3098/2012 to MAR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Barsi JC, 2015, DEVELOPMENT, V142, P953, DOI 10.1242/dev.117986; Bishop CD, 2013, DEV BIOL, V377, P236, DOI 10.1016/j.ydbio.2013.03.006; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Burke RD, 2014, GENESIS, V52, P208, DOI 10.1002/dvg.22750; Byrne M, 2007, EVOL DEV, V9, P432, DOI 10.1111/j.1525-142X.2007.00189.x; Casano C, 1996, INT J DEV BIOL, V40, P1033; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; Costa S, 2004, BIOCHEM BIOPH RES CO, V316, P446, DOI 10.1016/j.bbrc.2004.02.070; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; Domanskyi A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00275; Dunn EF, 2007, EVOL DEV, V9, P10, DOI 10.1111/j.1525-142X.2006.00134.x; Emanuele M, 2011, INT J DEV BIOL, V55, P591, DOI 10.1387/ijdb.103264me; Garner S, 2016, DEVELOPMENT, V143, P286, DOI 10.1242/dev.124503; GIANGUZZA F, 1995, INT J DEV BIOL, V39, P477; Hirokawa T, 2008, DEV GENES EVOL, V218, P15, DOI 10.1007/s00427-007-0196-6; Israel JW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002391; Kos R, 2001, DEVELOPMENT, V128, P1467; Lapraz F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9434; Li EH, 2013, DEV BIOL, V382, P268, DOI 10.1016/j.ydbio.2013.07.027; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; Murabe N, 2008, J COMP NEUROL, V509, P271, DOI 10.1002/cne.21742; Nakajima Y, 2004, EVOL DEV, V6, P95, DOI 10.1111/j.1525-142X.2004.04011.x; Nakano H, 2006, DEV BIOL, V292, P205, DOI 10.1016/j.ydbio.2005.12.038; Nakano H, 2009, DEV GENES EVOL, V219, P565, DOI 10.1007/s00427-010-0317-5; Nelms B. L., 2010, DEV BIOL, V1, P1; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Poustka AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r85; Ragusa MA, 2012, MOL BIOL REP, V39, P2633, DOI 10.1007/s11033-011-1016-7; Range R, 2014, GENESIS, V52, P222, DOI 10.1002/dvg.22759; Range RC, 2016, DEVELOPMENT, V143, P1523, DOI 10.1242/dev.128165; Range RC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001467; Saudemont A, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001259, DOI 10.1371/J0URNAL.PGEN.1001259]; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Stott SRW, 2013, J NEUROSCI, V33, P8022, DOI 10.1523/JNEUROSCI.4774-12.2013; Tan Y, 2010, GLOB TELECOMM CONF; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Wei Z, 2016, DEVELOPMENT, V143, P298, DOI 10.1242/dev.125989; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yaguchi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006001; Yaguchi S, 2008, DEV CELL, V14, P97, DOI 10.1016/j.devcel.2007.10.012; Yaguchi S, 2006, DEVELOPMENT, V133, P2337, DOI 10.1242/dev.02396; Yaguchi S, 2010, DEV BIOL, V347, P71, DOI 10.1016/j.ydbio.2010.08.009; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yankura KA, 2013, P NATL ACAD SCI USA, V110, P8591, DOI 10.1073/pnas.1220903110; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170969	10.1371/journal.pone.0170969	http://dx.doi.org/10.1371/journal.pone.0170969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141828	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500031
J	dos Santos, MD; Kretschmer, R; Frankl-Vilches, C; Bakker, A; Gahr, M; O'Brien, PCM; Ferguson-Smith, MA; de Oliveira, EHC				dos Santos, Michelly da Silva; Kretschmer, Rafael; Frankl-Vilches, Carolina; Bakker, Antje; Gahr, Manfred; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.; de Oliveira, Edivaldo H. C.			Comparative Cytogenetics between Two Important Songbird, Models: The Zebra Finch and the Canary	PLOS ONE			English	Article							CHICKEN GALLUS-GALLUS; AVIAN GENOME EVOLUTION; 5S RDNA; TAENIOPYGIA-GUTTATA; CHROMOSOME; BIRDS; SEQUENCES; ORGANIZATION; MACROCHROMOSOMES; CONSERVATION	Songbird species (order Passeriformes, suborder Oscines) are important models in various experimental fields spanning behavioural genomics to neurobiology. Although the genomes of some songbird species were sequenced recently, the chromosomal organization of these species is mostly unknown. Here we focused on the two most studied songbird species in neuroscience, the zebra finch (Taeniopygia guttata) and the canary (Serinus canaria). In order to clarify these issues and also to integrate chromosome data with their assembled genomes, we used classical and molecular cytogenetics in both zebra finch and canary to define their chromosomal homology, localization of heterochromatic blocks and distribution of rDNA clusters. We confirmed the same diploid number (2n = 80) in both species, as previously reported. FISH experiments confirmed the occurrence of multiple paracentric and pericentric inversions previously found in other species of Passeriformes, providing a cytogenetic signature for this order, and corroborating data from in silico analyses. Additionally, compared to other Passeriformes, we detected differences in the zebra finch karyotype concerning the morphology of some chromosomes, in the distribution of 5S rDNA clusters, and an inversion in chromosome 1.	[dos Santos, Michelly da Silva] UFPA, ICB, Programa Posgrad Genet & Biol Mol, Belem, Para, Brazil; [Kretschmer, Rafael] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Frankl-Vilches, Carolina; Bakker, Antje; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [de Oliveira, Edivaldo H. C.] Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil; [de Oliveira, Edivaldo H. C.] Fed Univ Para, ICEN, Fac Ciencias Nat, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Rio Grande do Sul; Max Planck Society; University of Cambridge; Instituto Evandro Chagas; Universidade Federal do Para	de Oliveira, EHC (corresponding author), Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil.; de Oliveira, EHC (corresponding author), Fed Univ Para, ICEN, Fac Ciencias Nat, Belem, Para, Brazil.	ehco@ufpa.br	de Oliveira, Edivaldo H. C./C-3368-2013; Kretschmer, Rafael/M-7293-2019; Kretschmer, Rafael/B-7206-2017	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Kretschmer, Rafael/0000-0002-6856-2152; Kretschmer, Rafael/0000-0002-6856-2152	PROPESP/UFPA; Max Planck Institute for Ornithology; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309699/2015-0]; Instituto Evandro Chagas	PROPESP/UFPA; Max Planck Institute for Ornithology(Max Planck Society); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Evandro Chagas	The authors would like to thank PROPESP/UFPA, Max Planck Institute for Ornithology, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, for financial support (309699/2015-0), as well as Institute Evandro Chagas, for logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank PROPESP/UFPA, Max Planck Institute for Ornithology, and Instituto Evandro Chagas, for support. We would like to thank Dr. Marcelo Cioffi (UFSC, Sao Carlos, SP-Brazil), for kindly providing the 5S and 18/28S rDNA probes.	Barbosa MD, 2013, GENET MOL BIOL, V36, P70, DOI 10.1590/S1415-47572013000100010; Barker FK, 2014, MOL PHYLOGENET EVOL, V79, P313, DOI 10.1016/j.ympev.2014.06.011; CARRASCAL LM, 1992, J BIOGEOGR, V19, P383, DOI 10.2307/2845566; Cioffi MB, 2011, CYTOGENET GENOME RES, V134, P295, DOI 10.1159/000329481; Oliveira EHC, 2010, CHROMOSOME RES, V18, P349, DOI 10.1007/s10577-010-9117-z; Daniels LM, 2003, CHROMOSOME RES, V11, P305, DOI 10.1023/A:1024008522122; de Oliveira EHC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070071; de Oliveira EHC, 2005, CHROMOSOMA, V114, P338, DOI 10.1007/s00412-005-0009-5; Delany ME, 2000, CYTOGENET CELL GENET, V90, P139, DOI 10.1159/000015649; Demin A, 2015, PREPRINT; Derjusheva S, 2004, CHROMOSOME RES, V12, P715, DOI 10.1023/B:CHRO.0000045779.50641.00; dos Santos MD, 2015, GENETICA, V143, P535, DOI 10.1007/s10709-015-9851-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dyomin AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157464; Farre M, 2016, GENOME BIOL EVOL, V8, P2442, DOI 10.1093/gbe/evw166; Ferreira IA, 2007, CYTOGENET GENOME RES, V118, P78, DOI 10.1159/000106445; Frankl-Vilches C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0578-9; Gill LF, 2015, ELIFE, V4, DOI 10.7554/eLife.07770; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Islam FB, 2014, J POULT SCI, V51, P1, DOI 10.2141/jpsa.0130090; Itoh Y, 2005, CHROMOSOME RES, V13, P47, DOI 10.1007/s10577-005-6602-x; Itoh Y, 2011, CHROMOSOMA, V120, P255, DOI 10.1007/s00412-010-0308-3; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kretschmer R, 2014, J BIOTECHNOLOGY BIOD, V5, P140; Kretschmer R, 2015, BIOL J LINN SOC, V115, P391, DOI 10.1111/bij.12504; Kretschmer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103338; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; Ledesma Mario A., 2006, Revista Brasileira de Ornitologia, V14, P59; Martins Cesar, 2004, P335; McPherson MC, 2014, CHROMOSOME RES, V22, P71, DOI 10.1007/s10577-014-9411-2; Merlo MA, 2013, J MOL EVOL, V76, P83, DOI 10.1007/s00239-013-9541-8; Nanda I, 2011, CYTOGENET GENOME RES, V132, P165, DOI 10.1159/000322358; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nanda I., 1994, GENOME RES, V65, P190, DOI DOI 10.1159/000133630; OHNO S, 1964, CHROMOSOMA, V15, P280, DOI 10.1007/BF00321513; Pigozzi MI, 1998, CHROMOSOME RES, V6, P105, DOI 10.1023/A:1009234912307; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Raudsepp T, 2002, CYTOGENET GENOME RES, V98, P54, DOI 10.1159/000068532; Romanov MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1060; SEABRIGH.M, 1971, LANCET, V2, P971; Shaw P, 2012, PLANT PHYSIOL, V158, P44, DOI 10.1104/pp.111.188052; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P111, DOI 10.1159/000078570; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Stapley J, 2008, GENETICS, V179, P651, DOI 10.1534/genetics.107.086264; SUMNER AT, 1974, EXP CELL RES, V83, P438, DOI 10.1016/0014-4827(74)90366-8; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Zeigler H., 2002, BEHAV NEUROBIOLOGY B; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	50	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170997	10.1371/journal.pone.0170997	http://dx.doi.org/10.1371/journal.pone.0170997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129381	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400013
J	Eibler, D; Abdurahman, H; Ruoff, T; Kaffarnik, S; Steingass, H; Vetter, W				Eibler, Dorothee; Abdurahman, Halima; Ruoff, Tanja; Kaffarnik, Stefanie; Steingass, Herbert; Vetter, Walter			Unexpected Formation of Low Amounts of (R)-Configurated anteiso-Fatty Acids in Rumen Fluid Experiments	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; BACILLUS-SUBTILIS; METHYL-ESTERS; L-ISOLEUCINE; ISO-FATTY; RAT SKIN; MILK-FAT; BIOSYNTHESIS; METABOLISM; BACTERIA	Anteiso-fatty acids (aFA) with odd carbon number are a class of branchedchain fatty acids (BCFA) mainly produced by bacteria. Bacterial sources are also made responsible for their occurrence in the low percentrange in lipids of ruminants (meat and milk) and fish. aFAs are chiral molecules and typically occur predominantly in form of (S)-enantiomers, and their primary precursor has been noted to be isoleucine. Yet, low proportions of (R)-aFAs were also detected in fish and cheese samples. Here we investigated the potential formation of (R)-aFAs by means of incubation experiments with rumen fluid from fistulated cows. Supplementation of rumen fluid with both L- and DL-isoleucine, resulted in a significant (a <0.05) increase of the aFA concentrations but in both cases enantiopure (S)-aFAs were observed. By contrast, incubations without addition of any isoleucine lead to a significant (a <0.05) formation of small proportions of (R)-aFAs similarly to those previously observed in fish and cheese. These results were consistently reproduced in three different years with rumen fluid from different cows fed different diets. All findings point to the existence of a further biosynthesis pathway of aFAs with different stereospecificity than the classic one using isoleucine as primer.	[Eibler, Dorothee; Abdurahman, Halima; Ruoff, Tanja; Kaffarnik, Stefanie; Vetter, Walter] Univ Hohenheim, Inst Food Chem 170B, Stuttgart, Germany; [Steingass, Herbert] Univ Hohenheim, Inst Anim Sci 460A, Stuttgart, Germany	University Hohenheim; University Hohenheim	Vetter, W (corresponding author), Univ Hohenheim, Inst Food Chem 170B, Stuttgart, Germany.	walter.vetter@uni-hohenheim.de		Eibler, Dorothee/0000-0001-6838-8206	Ministry of Science, Research and Art of Baden-Wurttemberg (Germany) [N271]	Ministry of Science, Research and Art of Baden-Wurttemberg (Germany)	This work was supported by the Ministry of Science, Research and Art of Baden-Wurttemberg (Germany); DE; grant N271 (https://www.uni-hohenheim.de/landesgraduiertenfoerderung). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1970, COMP BIOCHEM PHYSIOL, V32, P117, DOI 10.1016/0010-406X(70)90160-X; ADAMS E, 1972, ENZYMES, V6, P479; BADA JL, 1972, EARTH PLANET SC LETT, V15, P1, DOI 10.1016/0012-821X(72)90022-2; BADA JL, 1986, NATURE, V319, P314, DOI 10.1038/319314a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Deutsche Gesellschaft fur Fettwissenschaft, 2012, FETTS DTSCH EINH UNT; Eibler D, 2015, J AGR FOOD CHEM, V63, P8921, DOI 10.1021/acs.jafc.5b03877; FULCO AJ, 1983, PROG LIPID RES, V22, P133, DOI 10.1016/0163-7827(83)90005-X; GERSON T, 1959, BIOCHEM J, V73, P594, DOI 10.1042/bj0730594; HANSEN RP, 1952, BIOCHEM J, V52, P203, DOI 10.1042/bj0520203; HARFOOT C G, 1978, Progress in Lipid Research, V17, P21, DOI 10.1016/0079-6832(78)90004-6; Hauff S, 2010, LIPIDS, V45, P357, DOI 10.1007/s11745-010-3400-9; Hauff S, 2010, J CHROMATOGR A, V1217, P1683, DOI 10.1016/j.chroma.2010.01.036; Hauff S, 2010, J AGR FOOD CHEM, V58, P707, DOI 10.1021/jf9034805; Hauff S, 2009, ANAL CHIM ACTA, V636, P229, DOI 10.1016/j.aca.2009.01.056; Kaffarnik S, 2015, J AGR FOOD CHEM, V63, P469, DOI 10.1021/jf505452u; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KANEDA T, 1977, BACTERIOL REV, V41, P391, DOI 10.1128/MMBR.41.2.391-418.1977; KANEDA T, 1966, BIOCHIM BIOPHYS ACTA, V125, P43, DOI 10.1016/0005-2760(66)90142-1; KANEDA T, 1988, BIOCHIM BIOPHYS ACTA, V960, P10, DOI 10.1016/0005-2760(88)90003-3; KANEDA T, 1971, BIOCHEMISTRY-US, V10, P340, DOI 10.1021/bi00778a022; KANEDA T, 1963, J BIOL CHEM, V238, P1229; KEENEY M, 1962, J AM OIL CHEM SOC, V39, P198, DOI 10.1007/BF02635818; LIVINGSTON M, 1957, BIOCHEM J, V65, P438, DOI 10.1042/bj0650438; MAMER OA, 1992, J BIOL CHEM, V267, P22141; Mamer OA, 2001, J CHROMATOGR B, V758, P49, DOI 10.1016/S0378-4347(01)00111-6; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; MORICE IM, 1956, BIOCHEM J, V64, P461, DOI 10.1042/bj0640461; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; OKU H, 1988, J BIOL CHEM, V263, P18386; OKU H, 1994, BBA-LIPID LIPID MET, V1214, P279; OKU H, 1995, BIOSCI BIOTECH BIOCH, V59, P891, DOI 10.1271/bbb.59.891; Or-Rashid MM, 2007, J ANIM SCI, V85, P1228, DOI 10.2527/jas.2006-385; Ran-Ressler RR, 2014, BRIT J NUTR, V112, P565, DOI 10.1017/S0007114514001081; Sachs L., 2006, ANGEW STAT METHODENS, V12th ed., DOI [10.1007/978-3-540-32161-3, DOI 10.1007/978-3-540-32161-3]; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; SMITH GG, 1978, J ORG CHEM, V43, P1, DOI 10.1021/jo00395a001; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; Thurnhofer S, 2005, J AGR FOOD CHEM, V53, P8896, DOI 10.1021/jf051468u; Thurnhofer S, 2008, EUR FOOD RES TECHNOL, V226, P975, DOI 10.1007/s00217-007-0619-7; Thurnhofer S, 2007, ANAL CHEM, V79, P4696, DOI 10.1021/ac0702894; Thurnhofer S, 2007, TETRAHEDRON, V63, P1140, DOI 10.1016/j.tet.2006.11.059; TWEEDIE JW, 1966, J SCI FOOD AGR, V17, P241, DOI 10.1002/jsfa.2740170603; Vetter W, 2001, FOOD REV INT, V17, P113, DOI 10.1081/FRI-100000513	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170788	10.1371/journal.pone.0170788	http://dx.doi.org/10.1371/journal.pone.0170788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129363	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400035
J	Kogo, H; Murata, J; Murata, S; Higashi, T				Kogo, Haruki; Murata, Jun; Murata, Shin; Higashi, Toshio			Validity of a New Quantitative Evaluation Method that Uses the Depth of the Surface Imprint as an Indicator for Pitting Edema	PLOS ONE			English	Article							LYMPHEDEMA; MRI	This study examined the validity of a practical evaluation method for pitting edema by comparing it to other methods, including circumference measurements and ultrasound image measurements. Fifty-one patients (102 legs) from a convalescent ward in Maruyama Hospital were recruited for study 1, and 47 patients (94 legs) from a convalescent ward in Morinaga Hospital were recruited for study 2. The relationship between the depth of the surface imprint and circumferential measurements, as well as the relationship between the depth of the surface imprint and the thickness of the subcutaneous soft tissue on an ultrasonogram, were analyzed using a Spearman correlation coefficient by rank. There was no significant relationship between the surface imprint depth and circumferential measurements. However, there was a significant relationship between the depth of the surface imprint and the thickness of the subcutaneous soft tissue as measured on an ultrasonogram (correlation coefficient 0.736). Our findings suggest that our novel evaluation method for pitting edema, based on a measurement of the surface imprint depth, is both valid and useful.	[Kogo, Haruki] Nishikyushu Univ, Fac Rehabil Sci, Kanzaki, Saga, Japan; [Kogo, Haruki; Murata, Jun; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Murata, Shin] Kyoto Tachibana Univ, Fac Hlth Sci, Yamashina Ku, Kyoto, Japan	Nagasaki University; Kyoto Tachibana University	Kogo, H (corresponding author), Nishikyushu Univ, Fac Rehabil Sci, Kanzaki, Saga, Japan.; Kogo, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.	kogoha@nisikyu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [JP 16K01807]; Nagasaki University; Grants-in-Aid for Scientific Research [16K01807] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nagasaki University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number: JP 16K01807) and Nagasaki University, which paid for English proofreading for the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisawa M, 1996, ACTA OBSTET GYN JPN, V48, P25; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; Dimakakos PB, 1997, INT SURG, V82, P411; Gerber LH, 1998, CANCER, V83, P2803, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2803::AID-CNCR29>3.3.CO;2-N; Hirota A, 2008, J JPN COLL ANGIOL, V48, P159; Imanaka S, 1997, Nihon Ronen Igakkai Zasshi, V34, P668; Kogo H, 2015, J PHYS THER SCI, V27, P1735, DOI 10.1589/jpts.27.1735; Lu Q, 2014, CLIN RADIOL, V69, P1287, DOI 10.1016/j.crad.2014.08.011; Maihafer George C, 2003, J Hand Ther, V16, P305, DOI 10.1197/S0894-1130(03)00155-8; Mawdsley RH, 2000, J ORTHOP SPORT PHYS, V30, P149, DOI 10.2519/jospt.2000.30.3.149; Niimi Kiyoaki, 2014, Ann Vasc Dis, V7, P369, DOI 10.3400/avd.oa.14-00104; Ohashi Toshio, 2007, Nihon Seirigaku Zasshi, V69, P102; Pellecchia Geraldine L, 2003, J Hand Ther, V16, P300, DOI 10.1197/S0894-1130(03)00154-6; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Tamaki K, 2006, SOGO RINSHO, V55, P2594; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; Terada S, 2010, J PHYS THER SCI, V22, P129, DOI 10.1589/jpts.22.129; Yoshida S, 2001, BRIT J RADIOL, V74, P1013, DOI 10.1259/bjr.74.887.741013	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170810	10.1371/journal.pone.0170810	http://dx.doi.org/10.1371/journal.pone.0170810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129366	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400031
J	Msalya, G; Kim, ES; Laisser, ELK; Kipanyula, MJ; Karimuribo, ED; Kusiluka, LJM; Chenyambuga, SW; Rothschild, MF				Msalya, George; Kim, Eui-Soo; Laisser, Emmanuel L. K.; Kipanyula, Maulilio J.; Karimuribo, Esron D.; Kusiluka, Lughano J. M.; Chenyambuga, Sebastian W.; Rothschild, Max F.			Determination of Genetic Structure and Signatures of Selection in Three Strains of Tanzania Shorthorn Zebu, Boran and Friesian Cattle by Genome- Wide SNP Analyses	PLOS ONE			English	Article							DAIRY-CATTLE; BOS-TAURUS; R-PACKAGE; POPULATIONS; BREEDS; DIVERSITY; MARKERS; TOOL; ASSOCIATION; ANCESTRY	Background More than 90 percent of cattle in Tanzania belong to the indigenous Tanzania Short Horn Zebu (TSZ) population which has been classified into 12 strains based on historical evidence, morphological characteristics, and geographic distribution. However, specific genetic information of each TSZ population has been lacking and has caused difficulties in designing programs such as selection, crossbreeding, breed improvement or conservation. This study was designed to evaluate the genetic structure, assess genetic relationships, and to identify signatures of selection among cattle of Tanzania with the main goal of understanding genetic relationship, variation and uniqueness among them. Methodology/Principal findings The Illumina Bos indicus SNP 80K BeadChip was used to genotype genome wide SNPs in 168 DNA samples obtained from three strains of TSZ cattle namely Maasai, Tarime and Sukuma as well as two comparative breeds; Boran and Friesian. Population structure and signatures of selection were examined using principal component analysis (PCA), admixture analysis, pairwise distances (FST), integrated haplotype score (iHS), identical by state (IBS) and runs of homozygosity (ROH). There was a low level of inbreeding (F similar to 0.01) in the TSZ population compared to the Boran and Friesian breeds. The analyses of FST, IBS and admixture identified no considerable differentiation between TSZ trains. Importantly, common ancestry in Boran and TSZ were revealed based on admixture and IBD, implying gene flow between two populations. In addition, Friesian ancestry was found in Boran. A few common significant iHS were detected, which may reflect influence of recent selection in each breed or strain. Conclusions Population admixture and selection signatures could be applied to develop conservation plan of TSZ cattle as well as future breeding programs in East African cattle.	[Msalya, George; Laisser, Emmanuel L. K.; Chenyambuga, Sebastian W.] Sokoine Univ Agr, Dept Anim Aquaculture & Range Sci, Morogoro, Tanzania; [Kim, Eui-Soo; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Laisser, Emmanuel L. K.] Minist Educ & Vocat Training, Inspectorate Dept Eastern Zone, Morogoro, Tanzania; [Kipanyula, Maulilio J.] SUA, Dept Vet Anat, Morogoro, Tanzania; [Karimuribo, Esron D.; Kusiluka, Lughano J. M.] SUA, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Kusiluka, Lughano J. M.] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania	Sokoine University of Agriculture; Iowa State University; Sokoine University of Agriculture; Sokoine University of Agriculture; Nelson Mandela African Institution of Science & Technology	Msalya, G (corresponding author), Sokoine Univ Agr, Dept Anim Aquaculture & Range Sci, Morogoro, Tanzania.	msalya@suanet.ac.tz		Laisser, Emmanuel/0000-0001-7023-4759; Msalya, George/0000-0001-7005-247X	Norwegian Agency for International Development (NORAD); Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University; Hatch Funding	Norwegian Agency for International Development (NORAD); Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University; Hatch Funding	We acknowledge the generous funding of The Norwegian Agency for International Development (NORAD) to the Tarime Zebu cattle project through the programme for Enhancing Pro poor Innovation in Natural Resources and Agricultural Value Chains (EPINAV) at Sokoine University of Agriculture. Additional funding for genotyping at GENESEEK was received from the Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University and Hatch Funding.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Xing, 2015, Open Journal of Animal Sciences, V5, P358, DOI 10.4236/ojas.2015.54040; Dadi H, 2008, ANIM GENET, V39, P425, DOI 10.1111/j.1365-2052.2008.01748.x; Edea Zewdu, 2012, Genomics & Informatics, V10, P200, DOI 10.5808/GI.2012.10.3.200; Epstein H., 1971, THE ORIGIN OF THE DO, V1, P573; EXCOFFIER L, 1992, GENETICS, V131, P479; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gorbach DM, 2010, J ANIM BREED GENET, V127, P348, DOI 10.1111/j.1439-0388.2010.00864.x; Gu L, 2009, IMMUNOL LETT, V123, P179, DOI 10.1016/j.imlet.2009.03.010; GWAKISA PS, 1994, ANIM GENET, V25, P89, DOI 10.1111/j.1365-2052.1994.tb00085.x; Haegeman A, 2003, ANIM GENET, V34, P290, DOI 10.1046/j.1365-2052.2003.00994.x; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kim ES, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00443; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kurwijila RL, 2001, P SUA MU ENRECA PROJ, P2; Laisser ELK, 2015, LIVESTOCK RES RURAL, V27, P64; Laisser ELK, 2014, TROP ANIM HEALTH PRO, V46, P1391, DOI 10.1007/s11250-014-0651-0; Lin BZ, 2010, ANIM SCI J, V81, P281, DOI 10.1111/j.1740-0929.2010.00744.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Lutz TA, 2001, AM J PHYSIOL-REG I, V280, pR1697, DOI 10.1152/ajpregu.2001.280.6.R1697; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; Mchau KW, 2006, TANZANIA J AGR SCI, V7, P67; McTavish EJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1469-5; MLDF, 2014, LIV SECT DEV PROGR M, P13; Msanga Y.N., 2001, P SUA MU ENRECA PROJ, P36; Mwambene P. L., 2012, Animal Genetic Resources, P31; Mwatawala HW, 2001, FARM ANIMAL GENETIC, P102; Nishimura R, 2010, J REPROD DEVELOP, V56, P110, DOI 10.1262/jrd.09-162E; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rege J. E. O., 1999, Animal Genetic Resources Information, P1; REYNOLDS J, 1983, GENETICS, V105, P767; Sambrook J., 2001, MOL CLONING LAB MANU; Sorensen AC, 2005, J DAIRY SCI, V88, P1865, DOI 10.3168/jds.S0022-0302(05)72861-7; Syrstad O, 1998, TROP ANIM HEALTH PRO, V30, P257, DOI 10.1023/A:1005083430140; Syrstad O, 1996, TROP ANIM HEALTH PRO, V28, P223, DOI 10.1007/BF02240940; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watanabe A, 2001, COMP BIOCHEM PHYS B, V130, P547, DOI 10.1016/S1096-4959(01)00464-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]; Zhang QQ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0227-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	52	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171088	10.1371/journal.pone.0171088	http://dx.doi.org/10.1371/journal.pone.0171088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129396	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400008
J	Okoduwa, SIR; Umar, IA; James, DB; Inuwa, HM				Okoduwa, Stanley Irobekhian Reuben; Umar, Ismaila A.; James, Dorcas B.; Inuwa, Hajiya M.			Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies	PLOS ONE			English	Article							HIGH-FAT DIET; BETA-CELL MASS; ANIMAL-MODELS; RESISTANCE; FRUCTOSE; GLUCOSE	Background Pathophysiological investigation of disease in a suitable animal model is a classical approach towards development of a credible therapeutic strategy. This study examined appropriate insulin level in selecting animal model for type 2 diabetes (T2D) studies. Method Albino Wistar rats (150-200g) were divided into two groups fed with commercially available normal-diet-feed (NDF) and water or fortified diet feed (FDF) (10g NDF per gram of margarine) with 20% fructose solution as drinking water. After 6 weeks of dietary regimen both groups were divided into 5 sub-groups and injected intraperitoneally with a graded dose of streptozotocin (STZ) (0, 25, 35, 45 & 55mg/kg bw.). Result The result showed that the FDF-fed rats increased significantly in body weight, basal serum insulin, total cholesterol, triglycerides and blood glucose levels as compared to NDF-fed rats. Ten days post STZ induction, the groups treated with STZ (45 & 55 mg/kg) developed frank hyperglycaemia with < 46.8% serum insulin, a severe deficiency typical of diabetes type 1. The NDF25 and NDF35 groups with 75.7% and 64.4% serum insulin respectively presented relative normoglycemia, whereas the FDF35 (85.8% serum insulin) were notably hyperglycaemia (>300 mg/dL) throughout the 6weeks post diabetes confirmation. These FDF35 rats were sensitive to glibenclamide, metformin and pioglitazone in lowering hyperglycaemia, hypertriglyceridemia and hypercholesterolemia Conclusion The hyperglycaemia stability of the FDF35 rats (85.5% insulin) together with their sensitivity to 3 different hypoglycaemic drugs strongly suggests their suitability as a non-genetic model of T2D. Hence the study shows that circulating serum insulin >= 85.8% with overt hyperglycaemia may be utilized as the benchmark in selecting rat models for T2D studies.	[Okoduwa, Stanley Irobekhian Reuben; Umar, Ismaila A.; James, Dorcas B.; Inuwa, Hajiya M.] Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria; [Okoduwa, Stanley Irobekhian Reuben] Nigerian Inst Leather & Sci Technol, Directorate Res & Dev, Zaria, Nigeria	Ahmadu Bello University	Okoduwa, SIR (corresponding author), Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria.; Okoduwa, SIR (corresponding author), Nigerian Inst Leather & Sci Technol, Directorate Res & Dev, Zaria, Nigeria.	siroplc@gmail.com	Okoduwa, S.I.R./H-6826-2019	Okoduwa, S.I.R./0000-0002-3542-495X; OKODUWA, Stanley Irobekhian Reuben/0000-0002-5471-6544				Aida Zarfeshani, 2012, Pakistan Journal of Nutrition, V11, P21; Akpaso M. I., 2011, British Journal of Medicine and Medical Research, V1, P24; Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2012, AJMMS, V2, P45, DOI [10.5923/j.ajmms.20120203.04, DOI 10.5923/J.AJMMS.20120203.04]; Atawodi SE, 2005, AFR J BIOTECHNOL, V4, P128; Bantle JP, 2006, NES NUTR WS, V11, P83, DOI 10.1159/000094427; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cantley J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0140-6; de Moura RF, 2009, BRIT J NUTR, V101, P1178, DOI 10.1017/S0007114508066774; Dupas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146821; Eddouks M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/142087; Fasola T, 2010, ETHNOBOTANICAL LEAFL, V14, P759; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Gajda A. M., 2007, ANIMAL LAB NEWS; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Han DH, 1997, DIABETES, V46, P1761, DOI 10.2337/diabetes.46.11.1761; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Holman RR, 2013, NAT REV ENDOCRINOL, V9, P67, DOI 10.1038/nrendo.2012.243; HOOGWERF BJ, 1983, J CLIN ENDOCR METAB, V56, P60, DOI 10.1210/jcem-56-1-60; Hu SH, 2013, EXP CLIN ENDOCR DIAB, V121, P220, DOI 10.1055/s-0032-1333277; IDF, 2013, DIABETES ATLAS; IDF, 2015, ATLAS; Kargar C, 2008, DIABETES OBES METAB, V10, P43, DOI 10.1111/j.1463-1326.2008.00940.x; Khan HBH, 2013, INFLAMMOPHARMACOLOGY, V21, P37, DOI 10.1007/s10787-011-0109-1; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Krishna B. D., 2012, Journal of Indian Veterinary Association, Kerala (JIVA), V10, P22; Kuate D, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0051-0; Leiter EH, 2009, METHODS MOL BIOL, V560, P1, DOI 10.1007/978-1-59745-448-3_1; Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Modu S, 2013, IJMPAM S1, V1; Nepton S, 2013, ENDOCRINOL METAB, P115; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Sasidharan SR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/752870; Schaalan M, 2009, J DIABETES COMPLICAT, V23, P199, DOI 10.1016/j.jdiacomp.2008.02.003; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stark AH, 2000, EUR J NUTR, V39, P229, DOI 10.1007/s003940070016; Suman RK, 2016, ADV PHARM SCI, V2016, P11; Wang GY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0892; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Wilson RD, 2012, PHARMACOL REP, V64, P129, DOI 10.1016/S1734-1140(12)70739-9; Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045	50	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170971	10.1371/journal.pone.0170971	http://dx.doi.org/10.1371/journal.pone.0170971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129400	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400016
J	Huish, S; Thelwell, C; Longstaff, C				Huish, Sian; Thelwell, Craig; Longstaff, Colin			Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CLUSTER 2B STREPTOKINASE; GROUP-A STREPTOCOCCI; M-PROTEIN; KINETIC MECHANISM; BINDING; VARIANTS; COMPLEX; DOMAIN; STAPHYLOKINASE	Streptokinase is a virulence factor of streptococci and acts as a plasminogen activator to generate the serine protease plasmin which promotes bacterial metastasis. Streptokinase isolated from group C streptococci has been used therapeutically as a thrombolytic agent for many years and its mechanism of action has been extensively studied. However, group A streptococci are associated with invasive and potentially fatal infections, but less detail is available on the mechanism of action of streptokinase from these bacteria. We have expressed recombinant streptokinase from a group C strain to investigate the therapeutic molecule (here termed rSK-H46A) and a molecule isolated from a cluster 2a strain from group A (rSK-M1GAS) which is known to produce the fibrinogen binding, M1 protein, and is associated with life-threatening disease. Detailed enzyme kinetic models have been prepared which show how fibrinogen-streptokinase-plasminogen complexes regulate plasmin generation, and also the effect of fibrin interactions. As is the case with rSK-H46A our data with rSK-M1GAS support a "trigger and bullet" mechanism requiring the initial formation of SK center dot plasminogen complexes which are replaced by more active SK center dot plasmin as plasmin becomes available. This model includes the important fibrinogen interactions that stimulate plasmin generation. In a fibrin matrix rSK-M1GAS has a 24 fold higher specific activity than the fibrin-specific thrombolytic agent, tissue plasminogen activator, and 15 fold higher specific activity than rSK-H46A. However, in vivo fibrin specificity would be undermined by fibrinogen stimulation. Given the observed importance of M1 surface receptors or released M1 protein to virulence of cluster 2a strain streptococci, studies on streptokinase activity regulation by fibrin and fibrinogen may provide additional routes to addressing bacterial invasion and infectious diseases.	[Huish, Sian] Cambridge Donor Ctr, NHS Blood & Transplant, Component Dev Lab, Cambridge, England; [Thelwell, Craig; Longstaff, Colin] Natl Inst Biol Stand & Controls, Biotherapeut Sect, South Mimms, Herts, England	National Institute for Biological Standards & Control	Longstaff, C (corresponding author), Natl Inst Biol Stand & Controls, Biotherapeut Sect, South Mimms, Herts, England.	colin.longstaff@nibsc.org	Longstaff, Colin/D-2413-2013; Thelwell, Craig/E-2572-2013	Longstaff, Colin/0000-0001-7608-208X; Thelwell, Craig/0000-0003-4802-2332	NIBSC	NIBSC	The authors received funding from NIBSC as part of their routine work of for PhD research to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, **DATA OBJECT**; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BERGE A, 1993, J BIOL CHEM, V268, P25417; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bhattacharya S., 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/482096; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; Commission E., 2013, ALT INJ MON EUR PHAR, P2007; Cook SM, 2014, BIOCHEM J, V458, P23, DOI 10.1042/BJ20131305; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; Lizano S, 2005, INFECT IMMUN, V73, P4451, DOI 10.1128/IAI.73.7.4451-4453.2005; Longstaff C, 2004, J THROMB HAEMOST, V2, P1416, DOI 10.1111/j.1538-7836.2004.00816.x; Longstaff C., 2016, CLOTLYSISCL PROGRAM; Longstaff C., 2016, ZYMOGENACTNCL PROGRA; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Nolan M, 2013, J BIOL CHEM, V288, P29482, DOI 10.1074/jbc.M113.477935; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Sanderson-Smith ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003469; Sarkar D, 2008, USE R, P1; Sazonova IY, 2004, J BIOL CHEM, V279, P24994, DOI 10.1074/jbc.M400253200; Silva MMCG, 2012, J THROMB HAEMOST, V10, P2354, DOI 10.1111/j.1538-7836.2012.04925.x; Sinniger V, 1999, J BIOL CHEM, V274, P12414, DOI 10.1074/jbc.274.18.12414; Smeesters PR, 2009, EXPERT REV VACCINES, V8, P1705, DOI 10.1586/ERV.09.133; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; STIEF TW, 1989, THROMB RES, V56, P221, DOI 10.1016/0049-3848(89)90164-3; Sun H, 2011, J THROMB HAEMOST, V9, P189, DOI 10.1111/j.1538-7836.2011.04316.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; TAKADA A, 1980, THROMB RES, V19, P767, DOI 10.1016/0049-3848(80)90003-1; Team RC, 2015, LANG ENV STAT COMP; Thelwell C, 2014, J THROMB HAEMOST, V12, P1229, DOI 10.1111/jth.12629; Thelwell C, 2014, SEMIN THROMB HEMOST, V40, P205, DOI 10.1055/s-0033-1364188; Verstraete M, 2000, AM J MED, V109, P52, DOI 10.1016/S0002-9343(00)00380-6; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhang Y, 2012, J BIOL CHEM, V287, P19171, DOI 10.1074/jbc.M112.359315; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V444, P595, DOI 10.1016/j.bbrc.2014.01.109; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	59	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170936	10.1371/journal.pone.0170936	http://dx.doi.org/10.1371/journal.pone.0170936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125743	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100018
J	Verschuuren, M; De Vylder, J; Catrysse, H; Robijns, J; Philips, W; De Vos, WH				Verschuuren, Marlies; De Vylder, Jonas; Catrysse, Hannes; Robijns, Joke; Philips, Wilfried; De Vos, Winnok H.			Accurate Detection of Dysmorphic Nuclei Using Dynamic Programming and Supervised Classification	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; IMAGE; ENVELOPE; SHAPE; DISRUPTIONS; ALGORITHM; ENTROPY; SNAKES; SYSTEM	A vast array of pathologies is typified by the presence of nuclei with an abnormal morphology. Dysmorphic nuclear phenotypes feature dramatic size changes or foldings, but also entail much subtler deviations such as nuclear protrusions called blebs. Due to their unpredictable size, shape and intensity, dysmorphic nuclei are often not accurately detected in standard image analysis routines. To enable accurate detection of dysmorphic nuclei in confocal and widefield fluorescence microscopy images, we have developed an automated segmentation algorithm, called Blebbed Nuclei Detector (BleND), which relies on two-pass thresholding for initial nuclear contour detection, and an optimal path finding algorithm, based on dynamic programming, for refining these contours. Using a robust error metric, we show that our method matches manual segmentation in terms of precision and outperforms state-of-the-art nuclear segmentation methods. Its high performance allowed for building and integrating a robust classifier that recognizes dysmorphic nuclei with an accuracy above 95%. The combined segmentation-classification routine is bound to facilitate nucleus-based diagnostics and enable real-time recognition of dysmorphic nuclei in intelligent microscopy workflows.	[Verschuuren, Marlies; Robijns, Joke; De Vos, Winnok H.] Univ Antwerp, Dept Vet Sci, Antwerp, Belgium; [De Vylder, Jonas; Philips, Wilfried] Univ Ghent, Dept Telecommun & Informat Proc, IPI, IMinds, Ghent, Belgium; [Catrysse, Hannes] Inst Agr & Fisheries Res ILVO, Melle, Belgium; [De Vos, Winnok H.] Univ Ghent, Dept Mol Biotechnol, Ghent, Belgium	University of Antwerp; Ghent University; IMEC; Institute For Agricultural & Fisheries Research; Ghent University	De Vos, WH (corresponding author), Univ Antwerp, Dept Vet Sci, Antwerp, Belgium.; De Vos, WH (corresponding author), Univ Ghent, Dept Mol Biotechnol, Ghent, Belgium.	Winnok.DeVos@UAntwerpen.be	de vos, winnok/A-6445-2012	de vos, winnok/0000-0003-0960-6781	Flemish Institute for Scientific Research (FWO) [11ZF116N]; University of Antwerp [BOF/29267, BOF/30112]	Flemish Institute for Scientific Research (FWO)(FWO); University of Antwerp	This work was supported by the Flemish Institute for Scientific Research (FWO PhD Fellowship awarded to MV, Grant No: 11ZF116N; www.fwo.be) and the University of Antwerp (awarded to WDV, Grant BOF/29267 and BOF/30112; www.uantwerpen.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan S, 2013, IEEE T MED IMAGING, V32, P1121, DOI 10.1109/TMI.2013.2255309; Baggett D, 2005, CYTOM PART A, V67A, P137, DOI 10.1002/cyto.a.20162; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Choi S, 2014, NUCLEUS, V2, P570; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Cornelissen F, 2013, J BIOMOL SCREEN, V18, P807, DOI 10.1177/1087057113486518; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002; De Vylder J, 2011, CYTOM PART A, V79A, P580, DOI 10.1002/cyto.a.21055; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DOYLE W, 1962, J ACM, V9, P259, DOI 10.1145/321119.321123; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Dubuisson M-P, 1994, C PATT REC C A COMP, V1; FURUTA N, 1995, BREEDING SCI, V45, P315; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Gudla PR, 2008, CYTOM PART A, V73A, P451, DOI 10.1002/cyto.a.20550; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Houben F, 2013, HISTOCHEM CELL BIOL, V139, P119, DOI 10.1007/s00418-012-1005-5; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Jackson C, 2011, BIOINFORMATICS, V27, P1854, DOI 10.1093/bioinformatics/btr286; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Kubben N, 2016, METHODS, V96, P46, DOI 10.1016/j.ymeth.2015.08.024; Lesko Milan, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1485, DOI 10.1109/ICPR.2010.367; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Nandy K, 2007, P 2 WORKSH MICR IM A, P6718; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; R Core Team, 2018, R LANG ENV STAT COMP; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Robijns J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30325; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wenus J, 2009, BIOTECHNIQUES, V47, P1033, DOI 10.2144/000113247; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	57	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170688	10.1371/journal.pone.0170688	http://dx.doi.org/10.1371/journal.pone.0170688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125723	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100073
J	Gunn, LH; Valegard, K; Andersson, I				Gunn, Laura H.; Valegard, Karin; Andersson, Inger			A unique structural domain in Methanococcoides burtonii ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) acts as a small subunit mimic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; CRYSTAL-STRUCTURE; ARCHAEAL RUBISCO; 1,5-BISPHOSPHATE CARBOXYLASE; PSI-BLAST; PROTEIN; EVOLUTION; OXYGENASE; COMPLEX; PHOTOSYNTHESIS	The catalytic inefficiencies of the CO2-fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) often limit plant productivity. Strategies to engineer more efficient plant Rubiscos have been hampered by evolutionary constraints, prompting interest in Rubisco isoforms from non-photosynthetic organisms. The methanogenic archaeon Methanococcoides burtonii contains a Rubisco isoform that functions to scavenge the ribulose-1,5-bisphosphate (RuBP) by-product of purine/pyrimidine metabolism. The crystal structure of M. burtonii Rubisco (MbR) presented here at 2.6A degrees resolution is composed of catalytic large subunits (LSu) assembled into pentamers of dimers, (L-2)(5), and differs from Rubiscos from higher plants where LSus are glued together by small subunits (SSu) into hexadecameric L8S8 enzymes. MbRcontains a unique 29-amino acid insertion near the C terminus, which folds as a separate domain in the structure. This domain, which is visualized for the first time in this study, is located in a similar position to SSus in L8S8 enzymes between LSus of adjacent L-2 dimers, where negatively charged residues coordinate around a Mg2+ ion in a fashion that suggests this domain may be important for the assembly process. The Rubisco assembly domain is thus an inbuilt SSu mimic that concentrates L-2 dimers. MbRassembly is ligand-stimulated, and we show that only 6-carbon molecules with a particular stereochemistry at the C-3 carbon can induce oligomerization. Based on MbR structure, subunit arrangement, sequence, phylogenetic distribution, and function, MbRand a subset of Rubiscos from the Methanosarcinales order are proposed to belong to a new Rubisco subgroup, named form IIIB.	[Gunn, Laura H.; Valegard, Karin; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, Husargatan 3,Box 596, S-75124 Uppsala, Sweden	Uppsala University	Gunn, LH (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Husargatan 3,Box 596, S-75124 Uppsala, Sweden.	laura.gunn@icm.uu.se		Andersson, Inger/0000-0002-2729-0787	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bricogne G., 2011, BUSTER VERSION 2 10; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Danson MJ, 1996, PROTEIN ENG, V9, P629, DOI 10.1093/protein/9.8.629; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Hanson MR, 2016, PLANT J, V87, P38, DOI 10.1111/tpj.13139; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; LEE EH, 1993, J BIOL CHEM, V268, P26583; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller-Cajar O, 2007, BIOESSAYS, V29, P722, DOI 10.1002/bies.20616; Nei M., 2000, MOL EVOLUTION PHYLOG, p[33, 99]; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Saito Y, 2009, J BIOL CHEM, V284, P13256, DOI 10.1074/jbc.M807095200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Smrcka A. V., 1990, THESIS; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor TC, 1996, J BIOL CHEM, V271, P32894, DOI 10.1074/jbc.271.51.32894; Taylor TC, 1997, BIOCHEMISTRY-US, V36, P4041, DOI 10.1021/bi962818w; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wilson RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22284; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte B. H., 2012, THESIS; Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172; ZHU GH, 1990, PLANT PHYSIOL, V93, P244, DOI 10.1104/pp.93.1.244; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354	69	12	12	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6838	6850		10.1074/jbc.M116.767145	http://dx.doi.org/10.1074/jbc.M116.767145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28154188	Green Published, hybrid			2022-12-26	WOS:000399813400033
J	Gu, CF; Nguyen, HN; Hofer, A; Jessen, HJ; Dai, XM; Wang, HC; Shears, SB				Gu, Chunfang; Nguyen, Hoai-Nghia; Hofer, Alexandre; Jessen, Henning J.; Dai, Xuming; Wang, Huanchen; Shears, Stephen B.			The Significance of the Bifunctional Kinase/Phosphatase Activities of Diphosphoinositol Pentakisphosphate Kinases (PPIP5Ks) for Coupling Inositol Pyrophosphate Cell Signaling to Cellular Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED FAMILY; HEXAKISPHOSPHATE; ROBUSTNESS; IDENTIFICATION; CYCLES; DOMAIN; ROLES; SERUM	Proteins responsible for Pi homeostasis are critical for all life. In Saccharomyces cerevisiae, extracellular [P-1] is "sensed" by the inositol-hexakisphosphate kinase (IP6K) that synthesizes the intracellular inositol pyrophosphate 5-diphosphoinositol 1,2,3,4,6-pentakisphosphate (5-InsP(7)) as follows: during a period of Pi starvation, there is a decline in cellular [ATP]; the unusually low affinity of IP6Ks for ATP compels 5-InsP(7) levels to fall in parallel (Azevedo, C.,and Saiardi, A. (2017) Trends. Biochem. Sci. 42, 219-231. Hitherto, such P-1 sensing has not been documented in metazoans. Here, using a human intestinal epithelial cell line (HCT116), we show that levels of both 5-InsP(7) and ATP decrease upon [P-1] starvation and subsequently recover during Pi replenishment. However, a separate inositol pyrophosphate, 1,5-bisdiphosphoinositol 2,3,4,6-tetrakisphosphate (InsP(8)), reacts more dramatically (i.e. with a wider dynamic range and greater sensitivity). To understand this novel InsP(8) response, we characterized kinetic properties of the bifunctional 5-InsP(7) kinase/InsP(8) phosphatase activities of full-length diphosphoinositol pentakisphosphate kinases (PPIP5Ks). These data fulfil previously published criteria for any bifunctional kinase/phosphatase to exhibit concentration robustness, permitting levels of the kinase product (InsP(8) in this case) to fluctuate independently of varying precursor (i.e. 5-InsP(7)) pool size. Moreover, we report that InsP(8) phosphatase activities of PPIP5Ks are strongly inhibited by P-1 (40-90% within the 0-1 mM range). For PPIP5K2, P-1 sensing by InsP(8) is amplified by a 2-fold activation of 5-InsP(7) kinase activity by P-1 within the 0-5 mM range. Overall, our data reveal mechanisms that can contribute to specificity in inositol pyrophosphate sig-naling, regulating InsP(8) turnover independently of 5-InsP(7), in response to fluctuations in extracellular supply of a key nutrient.	[Gu, Chunfang; Nguyen, Hoai-Nghia; Wang, Huanchen; Shears, Stephen B.] NIEHS, Natl Inst Hlth, Lab Signal Transduct, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Hofer, Alexandre] Univ Zurich, Dept Chem, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland; [Jessen, Henning J.] Albert Ludwigs Univ, Inst Organ Chem, Albertstrasse 21, D-79104 Freiburg, Germany; [Dai, Xuming] Univ N Carolina, McAllister Heart Inst, Div Cardiol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Zurich; University of Freiburg; University of North Carolina; University of North Carolina Chapel Hill	Shears, SB (corresponding author), NIEHS, Natl Inst Hlth, Lab Signal Transduct, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	shears@niehs.nih.gov	Hofer, Alexandre/L-9975-2017; Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014; Shears, Stephen B/C-6335-2019; Hofer, Alexandre/Y-9852-2019	Hofer, Alexandre/0000-0001-6396-3689; Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484; Shears, Stephen B/0000-0001-7309-8916; Hofer, Alexandre/0000-0001-6396-3689; Wang, Huanchen/0000-0003-2701-7155	Intramural Research Program of the NIEHS, National Institutes of Health; National Science Foundation [PP00P2_157607]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Swiss National Science Foundation Grant PP00P2_157607.; Partially supported by National Center for Advancing Translational Sciences, National Institutes of Health Grant UL1TR001111.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dasgupta T, 2014, J BIOL CHEM, V289, P13010, DOI 10.1074/jbc.M113.546515; Dexter JP, 2015, INTEGR BIOL-UK, V7, P883, DOI 10.1039/c5ib00009b; DICK CF, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/103980; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gu CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165286; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Ingram SW, 2003, BIOCHEM J, V369, P519, DOI 10.1042/BJ20020733; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Komaba H, 2016, KIDNEY INT, V90, P753, DOI 10.1016/j.kint.2016.03.039; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; MacDonald JA, 2005, FEBS J, V272, P120, DOI 10.1111/j.1432-1033.2004.04388.x; Machkalyan G, 2016, CELL SIGNAL, V28, P401, DOI 10.1016/j.cellsig.2016.02.002; Marks J, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12281; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; NEWSHOLME EA, 1983, BIOCHEM SOC T, V11, P52, DOI 10.1042/bst0110052; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Pavlovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10622; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; SOBOLL S, 1978, EUR J BIOCHEM, V87, P377, DOI 10.1111/j.1432-1033.1978.tb12387.x; Straube R, 2013, BIOPHYS J, V105, P1925, DOI 10.1016/j.bpj.2013.09.010; Thota SG, 2015, J BIOSCIENCES, V40, P593, DOI 10.1007/s12038-015-9549-x; Tobey SL, 2003, ORG LETT, V5, P2029, DOI 10.1021/ol034427x; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Weaver JD, 2013, BIOSCIENCE REP, V33, P229, DOI 10.1042/BSR20120115; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Wu MX, 2016, P NATL ACAD SCI USA, V113, pE6757, DOI 10.1073/pnas.1606853113; Wundenberg T, 2012, BIOL CHEM, V393, P979, DOI 10.1515/hsz-2012-0133	49	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4544	4555		10.1074/jbc.M116.765743	http://dx.doi.org/10.1074/jbc.M116.765743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28126903	Green Published, hybrid			2022-12-26	WOS:000397585100013
J	Neofytou, MC; Tsangaras, K; Kypri, E; Loizides, C; Ioannides, M; Achilleos, A; Mina, P; Keravnou, A; Sismani, C; Koumbaris, G; Patsalis, PC				Neofytou, Maria C.; Tsangaras, Kyriakos; Kypri, Elena; Loizides, Charalambos; Ioannides, Marios; Achilleos, Achilleas; Mina, Petros; Keravnou, Anna; Sismani, Carolina; Koumbaris, George; Patsalis, Philippos C.			Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA; FETAL FRACTION; DIGITAL PCR; DIAGNOSIS; MICRODELETION; ABNORMALITIES; TRISOMY-21; ANEUPLOIDY; 22Q11.2	Noninvasive prenatal testing (NIPT) using whole genome and targeted sequencing has become increasingly accepted for clinical detection of Trisomy 21 and sex chromosome aneuploidies. Few studies have shown that sub-chromosomal deletions or duplications associated with genetic syndromes can also be detected in the fetus noninvasively. There are still limitations on these methodologies such as the detection of variants of unknown clinical significance, high number of false positives, and difficulties to detect small aberrations. We utilized a recently developed targeted sequencing approach for the development of a NIPT assay, for large and small size deletions/duplications, which overcomes these existing limitations. Artificial pregnancies with microdeletion/microduplication syndromes were created by spiking DNA from affected samples into cell free DNA (cfDNA) from non-pregnant samples. Unaffected spiked samples and normal pregnancies were used as controls. Target Capture Sequences (TACS) for seven syndromes were designed and utilized for targeted capture enrichment followed by sequencing. Data was analyzed using a statistical pipeline to identify deletions or duplications on targeted regions. Following the assay development a proof of concept study using 33 normal pregnancies, 21 artificial affected and 17 artificial unaffected pregnancies was carried out to test the sensitivity and specificity of the assay. All 21 abnormal spiked-in samples were correctly classified as subchromosomal aneuploidies while the 33 normal pregnancies or 17 normal spiked-in samples resulted in a false positive result. We have developed an NIPT assay for the detection of sub-chromosomal deletions and duplications using the targeted capture enrichment technology. This assay demonstrates high accuracy, high read depth of the genomic region of interest, and can identify deletions/duplications as small as 0.5 Mb. NIPT of fetal microdeletion/microduplication syndromes can be of enormous benefit in the management of pregnancies at risk both for prospective parents and health care providers.	[Neofytou, Maria C.; Kypri, Elena; Keravnou, Anna; Koumbaris, George; Patsalis, Philippos C.] Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus; [Tsangaras, Kyriakos; Kypri, Elena; Loizides, Charalambos; Ioannides, Marios; Achilleos, Achilleas; Mina, Petros; Koumbaris, George; Patsalis, Philippos C.] NIPD Genet Ltd, Nicosia, Cyprus; [Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus		Patsalis, PC (corresponding author), Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus.; Patsalis, PC (corresponding author), NIPD Genet Ltd, Nicosia, Cyprus.	p.patsalis@nipd.com						Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Canick JA, 2013, PRENATAL DIAG, V33, P667, DOI 10.1002/pd.4126; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Comm Genetics, 2015, OBSTET GYNECOL, V126, P691, DOI 10.1097/01.AOG.0000471171.86798.ac; Dondorp W, 2015, EUR J HUM GENET, V23, P1438, DOI 10.1038/ejhg.2015.57; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Grati FR, 2015, PRENATAL DIAG, V35, P801, DOI 10.1002/pd.4613; Gropman AL, 2010, J DEV BEHAV PEDIATR, V31, P582, DOI 10.1097/DBP.0b013e3181ee384e; Gross SJ, 2016, ULTRASOUND OBST GYN, V47, P177, DOI 10.1002/uog.15754; Holland BJ, 2015, ULTRASOUND OBST GYN, V45, P631, DOI 10.1002/uog.14882; Hui L, 2016, ULTRASOUND OBST GYN, V47, P137, DOI 10.1002/uog.15845; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koumbaris G, 2016, CLIN CHEM, V62, P848, DOI 10.1373/clinchem.2015.252502; Kyriakou S, 2013, PRENATAL DIAG, V33, P650, DOI 10.1002/pd.4140; Lee Mi-Young, 2014, Obstet Gynecol Sci, V57, P11, DOI 10.5468/ogs.2014.57.1.11; Lefkowitz RB, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2016, ULTRASOUND OBST GYN, V47, P53, DOI 10.1002/uog.14911; Lo KK, 2016, AM J HUM GENET, V98, P34, DOI 10.1016/j.ajhg.2015.11.016; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maya I, 2010, PRENATAL DIAG, V30, P1131, DOI 10.1002/pd.2626; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Papageorgiou EA, 2014, GENES-BASEL, V5, P310, DOI 10.3390/genes5020310; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Sahoo T, 2006, GENET MED, V8, P719, DOI 10.1097/01.gim.0000245576.47154.63; Souka AP, 2001, ULTRASOUND OBST GYN, V18, P9, DOI 10.1046/j.1469-0705.2001.00454.x; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095633; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Watson CT, 2014, ANNU REV GENOM HUM G, V15, P215, DOI 10.1146/annurev-genom-091212-153408; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yaron Y, 2015, OBSTET GYNECOL, V126, P1095, DOI 10.1097/AOG.0000000000001091; Yin AH, 2015, P NATL ACAD SCI USA, V112, P14670, DOI 10.1073/pnas.1518151112; Zhao C, 2015, CLIN CHEM, V61, P608, DOI 10.1373/clinchem.2014.233312; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	54	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171319	10.1371/journal.pone.0171319	http://dx.doi.org/10.1371/journal.pone.0171319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158220	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700060
J	Ning, SY; Wei, JF; Feng, JN				Ning, Shuoying; Wei, Jiufeng; Feng, Jinian			Predicting the current potential and future world wide distribution of the onion maggot, Delia antiqua using maximum entropy ecological niche modeling	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; DIPTERA ANTHOMYIIDAE; TEMPERATURE; PERFORMANCE; COLEOPTERA; PHENOLOGY; VOLTINISM; RANGES; MAXENT	Climate change will markedly impact biology, population ecology, and spatial distribution patterns of insect pests because of the influence of future greenhouse effects on insect development and population dynamics. Onion maggot, Delia antiqua, larvae are subterranean pests with limited mobility, that directly feed on bulbs of Allium sp. and render them completely unmarketable. Modeling the spatial distribution of such a widespread and damaging pest is crucial not only to identify current potentially suitable climactic areas but also to predict where the pest is likely to spread in the future so that appropriate monitoring and management programs can be developed. In this study, Maximum Entropy Niche Modeling was used to estimate the current potential distribution of D. antiqua and to predict the future distribution of this species in 2030, 2050, 2070 and 2080 by using emission scenario (A2) with 7 climate variables. The results of this study show that currently highly suitable habitats for D. antiqua occur throughout most of East Asia, some regions of North America, Western Europe, and Western Asian countries near the Caspian sea and Black Sea. In the future, we predict an even broader distribution of this pest spread more extensively throughout Asia, North America and Europe, particularly in most of European countries, Central regions of United States and much of East Asia. Our present day and future predictions can enhance strategic planning of agricultural organizations by identifying regions that will need to develop Integrated Pest Management programs to manage the onion maggot. The distribution forecasts will also help governments to optimize economic investments in management programs for this pest by identifying regions that are or will become less suitable for current and future infestations.	[Ning, Shuoying; Feng, Jinian] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China; [Wei, Jiufeng] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Ning, Shuoying; Feng, Jinian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Shanxi Agricultural University; Northwest A&F University - China	Feng, JN (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China.; Feng, JN (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	jinianf@nwsuaf.edu.cn	JIufeng, Wei/ABD-4026-2020		Special Fund for Agro-scientific Research in Public Interest [201303027]	Special Fund for Agro-scientific Research in Public Interest	This research was financially supported by the Special Fund for Agro-scientific Research in Public Interest (Grant No. 201303027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Duan JJ, 2014, BIOCONTROL, V59, P659, DOI 10.1007/s10526-014-9604-9; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Eckenrode C. J., 1995, NEW YORKS FOOD LIFE; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellis P.R., 1979, Bulletin of the Entomological Society of America, V25, P151; Faccoli M, 2009, ENVIRON ENTOMOL, V38, P307, DOI 10.1603/022.038.0202; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FINCH S, 1989, ANNU REV ENTOMOL, V34, P117, DOI 10.1146/annurev.en.34.010189.001001; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Frodsham A. C., 1996, NEW YORK STATE IPM P, V119; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hill D. S., 1987, AGRI INSECT PESTS TE; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Hof AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052574; IPCC, 2007, CONTRIBUTION WORKING; Ishikawa Y, 2000, J INSECT PHYSIOL, V46, P161, DOI 10.1016/S0022-1910(99)00112-2; Jerzy S., 2009, VEGETABLE CROPS RES, V71, P5; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kausrud K, 2012, BIOL REV, V87, P34, DOI 10.1111/j.1469-185X.2011.00183.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Latinne A., 2015, J MODERN OPTICS, P1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; LIU HJ, 1982, ENVIRON ENTOMOL, V11, P751, DOI 10.1093/ee/11.3.751; McDonald RS, 1997, ENVIRON ENTOMOL, V26, P624, DOI 10.1093/ee/26.3.624; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nault BA, 2006, CROP PROT, V25, P58, DOI 10.1016/j.cropro.2005.03.020; Nault BA, 2006, J ECON ENTOMOL, V99, P1375, DOI 10.1603/0022-0493-99.4.1375; Nault BA, 2011, J ECON ENTOMOL, V104, P1622, DOI 10.1603/EC11175; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; PERRON J. P., 1961, CANADIAN ENT, V93, P101; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poprawski T. V., 1985, APPL ENTOMOL ZOOL, V20, P801; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Severin HHP, 1915, J ECON ENTOMOL, V8, P342, DOI 10.1093/jee/8.3.342; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; Stevnbak K., 2009, EARTH ENV SCI, V4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; Ungerer MJ, 1999, J BIOGEOGR, V26, P1133, DOI 10.1046/j.1365-2699.1999.00363.x; Wang DB, 2005, ACTA HORTIC, P327; Watari Y, 2014, ENTOMOL SCI, V17, P191, DOI 10.1111/ens.12034; Watari Y, 2010, J INSECT PHYSIOL, V56, P1192, DOI 10.1016/j.jinsphys.2010.03.022; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Williams DW, 2002, AGR FOREST ENTOMOL, V4, P87, DOI 10.1046/j.1461-9563.2002.00124.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yousuf F, 2014, BIOL CONTROL, V79, P67, DOI 10.1016/j.biocontrol.2014.08.007; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	62	15	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171190	10.1371/journal.pone.0171190	http://dx.doi.org/10.1371/journal.pone.0171190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158259	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700040
J	Boudon, SM; Vuorinen, A; Geotti-Bianchini, P; Wandeler, E; Kratschmar, DV; Heldl, M; Campiche, R; Jackson, E; Odermatt, A				Boudon, Stephanie M.; Vuorinen, Anna; Geotti-Bianchini, Piero; Wandeler, Eliane; Kratschmar, Denise V.; Heldl, Marc; Campiche, Remo; Jackson, Eileen; Odermatt, Alex			Novel 11 beta-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR; ULTRAVIOLET-RADIATION; MOLECULAR-MECHANISMS; CYTOKINE PRODUCTION; AGED SKIN; IN-VIVO; TYPE-1; CORTICOSTEROIDS; STIMULATION	Activity and selectivity assessment of new bi-aryl amide 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) inhibitors, prepared in a modular manner via Suzuki cross-coupling, are described. Several compounds inhibiting 11 beta-HSD1 at nanomolar concentrations were identified. Compounds 2b, 3e, 7b and 12e were shown to selectively inhibit 11 beta-HSD1 over 11 beta-HSD2, 17 beta-HSD1 and 17 beta-HSD2. These inhibitors also potently inhibited 11 beta-HSD1 activity in intact HEK293 cells expressing the recombinant enzyme and in intact primary human keratinocytes expressing endogenous 11 beta-HSD1. Moreover, compounds 2b, 3e and 12e were tested for their activity in human skin biopsies. They were able to prevent, at least in part, both the cortisone- and the UV-mediated decreases in collagen content. Thus, inhibition of 11 beta-HSD1 by these compounds can be further investigated to delay or prevent UV-mediated skin damage and skin aging.	[Boudon, Stephanie M.; Geotti-Bianchini, Piero; Wandeler, Eliane; Heldl, Marc; Campiche, Remo; Jackson, Eileen] DSM Nutr Prod Ltd, Kaiseraugst, Switzerland; [Vuorinen, Anna; Kratschmar, Denise V.; Odermatt, Alex] Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, Basel, Switzerland	DSM NV; University of Basel	Jackson, E (corresponding author), DSM Nutr Prod Ltd, Kaiseraugst, Switzerland.; Odermatt, A (corresponding author), Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, Basel, Switzerland.	eileen.jackson@dsm.com; alex.odermatt@unibas.ch	Campiche, Remo/AAW-2700-2020	Campiche, Remo/0000-0002-2216-7851; Winter, denise V./0000-0002-3764-1747	Swiss National Science Foundation [31003A-159454]; DSM Nutritional Products Ltd; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DSM Nutritional Products Ltd; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (www.snf.ch) grant number 31003A-159454 to AO (AO, AV, DVK), and by DSM Nutritional Products Ltd (SB, PGB, EW, MH, RC, EJ). The Swiss National Science Foundation provided support in the form of finances for consumables for AO, AV, DVK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DSM Nutritional Products Ltd provided support in the form of salaries for authors [SB, PGB, EW, MH, RC, EJ], and was involved in the decision of the study design and the selection of compounds to be synthesized, but did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Averbeck M, 2010, EXP DERMATOL, V19, P757, DOI 10.1111/j.1600-0625.2010.01099.x; Baker ME, 2004, FEBS LETT, V574, P167, DOI 10.1016/j.febslet.2004.08.023; Barf T, 2002, J MED CHEM, V45, P3813, DOI 10.1021/jm025530f; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURK MJ, 1994, J AM CHEM SOC, V116, P10847, DOI 10.1021/ja00102a085; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chebotaev DV, 2007, J INVEST DERMATOL, V127, P2749, DOI 10.1038/sj.jid.5700992; Cirillo N, 2011, J CELL BIOCHEM, V112, P1499, DOI 10.1002/jcb.23081; Del Bino S, 2006, PIGM CELL RES, V19, P606, DOI 10.1111/j.1600-0749.2006.00338.x; Gumy C, 2009, FITOTERAPIA; Haapasaari KM, 1997, SKIN PHARMACOL, V10, P261; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Korolev DN, 2005, TETRAHEDRON LETT, V46, P5751, DOI 10.1016/j.tetlet.2005.06.085; Korting HC, 2002, SKIN PHARMACOL APPL, V15, P85, DOI 10.1159/000049394; Labrie F, 2000, HORM RES, V54, P218, DOI 10.1159/000053264; LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; OIKARINEN A, 1992, J INVEST DERMATOL, V98, P220, DOI 10.1111/1523-1747.ep12555884; Oishi Y, 2002, BRIT J DERMATOL, V147, P859, DOI 10.1046/j.1365-2133.2002.04949.x; SCHWARZ T, 1989, J PHOTOCH PHOTOBIO B, V4, P1, DOI 10.1016/1011-1344(89)80097-1; Schweizer RAS, 2003, MOL CELL ENDOCRINOL, V212, P41, DOI 10.1016/j.mce.2003.09.027; Scott JS, 2014, J MED CHEM, V57, P4466, DOI 10.1021/jm4014746; Skarydova L, 2012, DRUG METAB REV, V44, P173, DOI 10.3109/03602532.2011.638304; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Sun DQ, 2011, CURR TOP MED CHEM, V11, P1464, DOI 10.2174/156802611795860988; Terao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093051; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Venkatraj M, 2012, BIOORGAN MED CHEM, V20, P1557, DOI 10.1016/j.bmc.2011.12.040; Vuorinen A, 2014, J MED CHEM, V57, P5995, DOI 10.1021/jm5004914; Werth VP, 1998, ARCH DERMATOL RES, V290, P388, DOI 10.1007/s004030050322; Wikstrom AC, 2003, J ENDOCRINOL, V178, P331, DOI 10.1677/joe.0.1780331	49	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171079	10.1371/journal.pone.0171079	http://dx.doi.org/10.1371/journal.pone.0171079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152550	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000396161200086
J	Li, TT; Xie, Y; Bowe, B; Xian, H; Al-Aly, Z				Li, Tingting; Xie, Yan; Bowe, Benjamin; Xian, Hong; Al-Aly, Ziyad			Serum phosphorus levels and risk of incident dementia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SMALL VESSEL DISEASE; ALL-CAUSE MORTALITY; DIETARY PHOSPHORUS; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; NHANES-III; PHOSPHATE; ADULTS; ATHEROSCLEROSIS	Higher serum phosphorous is associated with cerebral small vessel disease, an important driver of cognitive decline and dementia. Whether serum phosphorous, a potentially modifiable parameter, associates with risk of incident dementia is not known. We aimed to examine the association between serum phosphorous and risk of incident dementia and to determine if the association is modified by age. We used the United States Department of Veterans Affairs national databases to build a longitudinal observational cohort of US veterans without prior history of dementia and with at least one outpatient serum phosphorus between October 2008 and September 2010 and followed them until September 2014. Serum phosphorus was categorized into quintiles: <= 2.9, >2.9 to <= 3.2, >3.2 to <= 3.5, >3.5 to <= 3.9, >3.9 mg/dL. There were 744,235 participants in the overall cohort. Over a median follow-up of 5.07 years (Interquartile range [IQR]: 4.28, 5.63), adjusted Cox models show that compared to quintile 2, the risk of incident dementia was increased in quintile 4 (Hazard Ratio [HR] = 1.05; CI = 1.01-1.10) and quintile 5 (HR = 1.14; CI = 1.09-1.20). In cohort participants <= 60 years old, the risk of incident dementia was increased in quintile 4 (HR = 1.29; CI = 1.12-1.49) and 5 (HR = 1.45; CI = 1.26-1.68). In participants > 60 years old, the risk was not significant in quintile 4, and was attenuated in quintile 5 (HR = 1.10; CI = 1.051.16). Formal interaction analyses showed that the association between phosphorous and dementia was more pronounced in those younger than 60, and attenuated in those older than 60 (P for interaction was 0.004 and <= 0.0001 in quintiles 4 and 5; respectively). We conclude that higher serum phosphorous is associated with increased risk of incident dementia. This association is stronger in younger cohort participants. The identification of serum phosphorous as a risk factor for incident dementia has public health relevance and might inform the design and implementation of risk reduction strategies.	[Li, Tingting; Xie, Yan; Bowe, Benjamin; Xian, Hong; Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, Res & Educ Serv, St Louis, MO 63106 USA; [Li, Tingting; Al-Aly, Ziyad] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Xian, Hong] St Louis Univ, Dept Biostat, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO 63106 USA	Washington University (WUSTL); Saint Louis University	Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, Res & Educ Serv, St Louis, MO 63106 USA.; Al-Aly, Z (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO 63106 USA.	zalaly@gmail.com	Al-Aly, Ziyad/S-4439-2016	Al-Aly, Ziyad/0000-0002-2600-0434; Xie, Yan/0000-0002-2457-9382; Li, Tingting/0000-0001-7331-9619	US Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center [Al-Aly-01]	US Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center(US Department of Veterans Affairs)	Support was provided by a grant from the US Department of Veterans Affairs (for ZAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for VA/Centers for Medicare and Medicaid Services (CMS) data is provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (Project ID Al-Aly-01).	Abbasian N, 2015, J AM SOC NEPHROL, V26, P2152, DOI 10.1681/ASN.2014070642; Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; [Anonymous], 2010, J AM DIET ASSOC, V110, P1549, DOI 10.1016/j.jada.2010.08.022; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Bharmal MF, 2007, ALZ DIS ASSOC DIS, V21, P92, DOI 10.1097/WAD.0b013e31805c0835; Bowe B, 2016, CLIN J AM SOC NEPHRO; Bowe B XY, 2016, KIDNEY INT REPORTS; Bowe B, 2016, KIDNEY INT, V89, P886, DOI 10.1016/j.kint.2015.12.034; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Calvo MS, 1996, J NUTR, V126, pS1168, DOI 10.1093/jn/126.suppl_4.1168S; Chang AR, 2014, AM J KIDNEY DIS, V64, P567, DOI 10.1053/j.ajkd.2014.04.028; Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dursun I, 2009, NEPHROL DIAL TRANSPL, V24, P2511, DOI 10.1093/ndt/gfp066; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Gutierrez OM, 2013, ADV NUTR, V4, P723, DOI 10.3945/an.113.004812; Khatri M, 2009, J AM SOC NEPHROL, V20, P2427, DOI 10.1681/ASN.2008101090; Kim BJ, 2015, J STROKE, V17, P101, DOI 10.5853/jos.2015.17.2.101; Leon JB, 2013, J RENAL NUTR, V23, P265, DOI 10.1053/j.jrn.2012.12.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; Murphy Patricia A, 2002, Eff Clin Pract, V5, pE4; Murray AM BE, 2015, J AM SOC NEPHROLOGY, V26; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Oddone Eugene Z, 2008, N C Med J, V69, P35; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Reis JP, 2013, ATHEROSCLEROSIS, V231, P72, DOI 10.1016/j.atherosclerosis.2013.08.038; Relph Wendy-Ling, 2016, Nurs Older People, V28, P16, DOI 10.7748/nop.28.3.16.s22; Sanders C, 2016, J ALZHEIMERS DIS JAD; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Spaccavento S, 2009, ARCH GERONTOL GERIAT, V48, P356, DOI 10.1016/j.archger.2008.03.002; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Toyoda K, 2015, J STROKE, V17, P31, DOI 10.5853/jos.2015.17.1.31; Uribarri J, 2003, SEMIN DIALYSIS, V16, P186, DOI 10.1046/j.1525-139X.2003.16037.x; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Watari E, 2015, J CLIN BIOCHEM NUTR, V56, P35, DOI 10.3164/jcbn.14-96; Wright CB, 2016, STROKE J CEREBRAL CI; Wright CB, 2014, NEUROLOGY, V82, P1700, DOI 10.1212/WNL.0000000000000410; Xie Y, 2016, J AM SOC NEPHROLOGY; Xie Y, 2016, AM J KIDNEY DIS OFFI; Xie Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149283; Xie Y, 2015, CLIN J AM SOC NEPHRO, V10, P1946, DOI 10.2215/CJN.04480415; Yoo KD, 2016, AM J KIDNEY DIS, V67, P79, DOI 10.1053/j.ajkd.2015.06.027	54	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171377	10.1371/journal.pone.0171377	http://dx.doi.org/10.1371/journal.pone.0171377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152028	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200135
J	Zilm, PS; Butnejski, V; Rossi-Fedele, G; Kidd, SP; Edwards, S; Vasilev, K				Zilm, Peter S.; Butnejski, Victor; Rossi-Fedele, Giampiero; Kidd, Stephen P.; Edwards, Suzanne; Vasilev, Krasimir			D-amino acids reduce Enterococcus faecalis biofilms in vitro and in the presence of antimicrobials used for root canal treatment	PLOS ONE			English	Article							APICAL PERIODONTITIS; FILLED TEETH; MICROTITER PLATES; SRB BIOFILM; QUANTIFICATION; IDENTIFICATION; STAPHYLOCOCCI; MEDICAMENTS; INFECTIONS; MITIGATION	Enterococcus faecalis is the most frequent species present in post-treatment disease and plays a significant role in persistent periapical infections following root canal treatment. Its ability to persist in stressful environments is inter alia, due to its ability to form biofilms. The presence of certain D-amino acids (DAAs) has previously been shown to reduce formation of Bacillus subtilis biofilms. The aims of this investigation were to determine if DAAs disrupt biofilms in early and late growth stages for clinical E. faecalis strains and to test their efficacy in disrupting E. faecalis biofilms grown in sub-minimum inhibitory concentrations of commonly used endodontic biocides. From thirty-seven E. faecalis strains, the ten "best" biofilm producers were used to test the ability of a mixture containing D-leucine, D-methionine, D-tyrosine and D-tryptophan to reduce biofilm growth over a period of 24, 72 and 144 hours and when compared to their cognate L-Amino Acids (LAAs). We have previously shown that sub-MIC levels of tetracycline and sodium hypochlorite promotes biofilm growth in clinical strains of E. faecalis. DAAs were therefore tested for their effectiveness to reduce biofilm growth in the presence of sub-minimal concentrations of sodium hypochlorite (NaOCl-0.031%) and Odontocide (TM) (0.25% w/v), and in the presence of Odontopaste (TM) (0.25% w/v). DAAs significantly reduced biofilm formation for all strains tested in vitro, while DAAs significantly reduced biofilm formation compared to LAAs. The inhibitory effect of DAAs on biofilm formation was concentration dependent. DAAs were also shown to be effective in reducing E. faecalis biofilms in the presence of Odontopaste (TM) and sub-MIC levels of NaOCl and Odontocide (TM). The results suggest that the inclusion of DAAs into current endodontic procedures may reduce E. faecalis biofilms.	[Zilm, Peter S.; Butnejski, Victor; Rossi-Fedele, Giampiero] Univ Adelaide, Microbiol Lab, Sch Dent, Adelaide, SA, Australia; [Kidd, Stephen P.] Univ Adelaide, Sch Biol Sci, Australian Ctr Antimicrobial Resistance Ecol, Res Ctr Infect Dis, Adelaide, SA, Australia; [Edwards, Suzanne] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Vasilev, Krasimir] Univ South Australia, Sch Engn, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of South Australia	Zilm, PS (corresponding author), Univ Adelaide, Microbiol Lab, Sch Dent, Adelaide, SA, Australia.	peter.zilm@adelaide.edu.au	Vasilev, Krasimir/C-5248-2008; kidd, stephen/H-8799-2012	kidd, stephen/0000-0002-2118-1651; Zilm, Peter/0000-0001-7554-9717; Vasilev, Krasimir/0000-0003-3534-4754	Australian Dental Research Foundation	Australian Dental Research Foundation	The authors are very grateful to the Australian Dental Research Foundation for their support in this research through the Colin Cormie Scholarship for V. Butnejski. The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.	Athanassiadis B, 2007, AUST DENT J, V52, pS64, DOI 10.1111/j.1834-7819.2007.tb00527.x; Bui LMG, 2015, INFECT IMMUN, V83, P470, DOI 10.1128/IAI.02702-14; Cathro P, 2016, FEBS OPEN BIO, V6, P586, DOI 10.1002/2211-5463.12075; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; Dahlen G, 2000, ORAL MICROBIOL IMMUN, V15, P309, DOI 10.1034/j.1399-302x.2000.150507.x; Extremina CI, 2011, J MICROBIOL METH, V84, P167, DOI 10.1016/j.mimet.2010.11.007; Fonseca AP, 2007, INT J ANTIMICROB AG, V30, P236, DOI 10.1016/j.ijantimicag.2007.04.011; HAAPASALO M, 1987, J DENT RES, V66, P1375, DOI 10.1177/00220345870660081801; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jenkinson HF, 2001, TRENDS MICROBIOL, V9, P9, DOI 10.1016/S0966-842X(00)01891-6; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Li YC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00896; McLean RJC, 2004, J MICROBIOL METH, V58, P351, DOI 10.1016/j.mimet.2004.04.016; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; Nair PNR, 2014, INT ENDOD J, V47, P1003, DOI 10.1111/iej.12287; Nair PNR, 2006, INT ENDOD J, V39, P249, DOI 10.1111/j.1365-2591.2006.01099.x; Peciuliene V, 2001, INT ENDOD J, V34, P429, DOI 10.1046/j.1365-2591.2001.00411.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x; Ramon-Perez ML, 2014, J MED MICROBIOL, V63, P1369, DOI 10.1099/jmm.0.075796-0; Sarkar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117613; Singh KV, 2002, ANTIMICROB AGENTS CH, V46, P1845, DOI 10.1128/AAC.46.6.1845-1850.2002; Sjogren U, 1997, INT ENDOD J, V30, P297, DOI 10.1111/j.1365-2591.1997.tb00714.x; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2001, EUR J CLIN MICROBIOL, V20, P502; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Wilson CE, 2015, INT ENDOD J, V48, P210, DOI 10.1111/iej.12301; Xu D, 2012, WORLD J MICROB BIOT, V28, P3067, DOI 10.1007/s11274-012-1116-0; Xu D, 2012, WORLD J MICROB BIOT, V28, P1641, DOI 10.1007/s11274-011-0970-5	33	41	42	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170670	10.1371/journal.pone.0170670	http://dx.doi.org/10.1371/journal.pone.0170670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151960	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000396161200031
J	Chen, ZY; Jing, YL; Wen, Q; Ding, XP; Wang, T; Mu, XM; Chenzhang, YW; Cao, M				Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man			E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China	PLOS ONE			English	Article							CERVICAL-CANCER; RISK; LESIONS; WOMEN; PREVALENCE; PREDICTION; PROVINCE; ASSOCIATION; VARIABILITY; INFECTION	Cancer of the cervix is associated with infection by certain types of human papillomavirus (HPV). The gene variants differ in immune responses and oncogenic potential. The E6 and E7 proteins encoded by high-risk HPV play a key role in cellular transformation. HPV-33 and HPV-58 types are highly prevalent among Chinese women. To study the gene intratypic variations, polymorphisms and positive selections of HPV-33 and HPV-58 E6/E7 in southwest China, HPV-33 (E6, E7: n = 216) and HPV-58 (E6, E7: n = 405) E6 and E7 genes were sequenced and compared to others submitted to GenBank. Phylogenetic trees were constructed by Maximum-likelihood and the Kimura 2-parameters methods by MEGA 6 (Molecular Evolutionary Genetics Analysis version 6.0). The diversity of secondary structure was analyzed by PSIPred software. The selection pressures acting on the E6/E7 genes were estimated by PAML 4.8 (Phylogenetic Analyses by Maximun Likelihood version4.8) software. The positive sites of HPV-33 and HPV-58 E6/E7 were contrasted by ClustalX 2.1. Among 216 HPV-33 E6 sequences, 8 single nucleotide mutations were observed with 6/8 non-synonymous and 2/8 synonymous mutations. The 216 HPV-33 E7 sequences showed 3 single nucleotide mutations that were non-synonymous. The 405 HPV-58 E6 sequences revealed 8 single nucleotide mutations with 4/8 non-synonymous and 4/8 synonymous mutations. Among 405 HPV-58 E7 sequences, 13 single nucleotide mutations were observed with 10/13 non-synonymous mutations and 3/13 synonymous mutations. The selective pressure analysis showed that all HPV-33 and 4/6 HPV-58 E6/E7 major non-synonymous mutations were sites of positive selection. All variations were observed in sites belonging to major histocompatibility complex and/or B-cell predicted epitopes. K93N and R145 (I/N) were observed in both HPV-33 and HPV-58 E6.	[Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China; [Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Bioresource Res & Utilizat Joint Key Lab Sichuan, Chongqing, Sichuan, Peoples R China; [Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu, Peoples R China	Sichuan University; Sichuan University	Ding, XP (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China.; Ding, XP (corresponding author), Bioresource Res & Utilizat Joint Key Lab Sichuan, Chongqing, Sichuan, Peoples R China.; Ding, XP (corresponding author), Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu, Peoples R China.	brainding@scu.edu.cn						Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bae JH, 2009, J MICROBIOL BIOTECHN, V19, P1051, DOI 10.4014/jmb.0812.679; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005; Cento V, 2011, J MED VIROL, V83, P1752, DOI 10.1002/jmv.22201; Chan PKS, 2013, INT J CANCER, V132, P2528, DOI 10.1002/ijc.27932; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chemes LB, 2014, BIOCHEMISTRY-US, V53, P1680, DOI 10.1021/bi401562e; Chen AA, 2014, VIROLOGY, V448, P356, DOI 10.1016/j.virol.2013.10.033; Chen CA, 2006, INT J GYNECOL CANCER, V16, P1801, DOI 10.1111/j.1525-1438.2006.00655.x; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen ZY, 2015, INT J GYNECOL OBSTET, V131, P277, DOI 10.1016/j.ijgo.2015.06.027; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garbuglia AR, 2007, NEW MICROBIOL, V30, P377; Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011; Hamza AA, 2012, SYST APPL MICROBIOL, V35, P183, DOI 10.1016/j.syapm.2011.12.005; Hwang T, 1999, J KOREAN MED SCI, V14, P593, DOI 10.3346/jkms.1999.14.6.593; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khouadri S, 2006, J INFECT DIS, V194, P886, DOI 10.1086/507431; Li JK, 2012, J CLIN MICROBIOL, V50, P1079, DOI 10.1128/JCM.06214-11; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liu JH, 2012, INFECT GENET EVOL, V12, P1466, DOI 10.1016/j.meegid.2012.05.004; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Rampias T, 2014, ORAL ONCOL, V50, P356, DOI 10.1016/j.oraloncology.2013.07.011; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Shen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056614; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Sun ZR, 2010, INT J GYNECOL OBSTET, V109, P105, DOI 10.1016/j.ijgo.2009.11.026; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wu EQ, 2009, J GEN VIROL, V90, P1229, DOI 10.1099/vir.0.008227-0; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435; Yang LJ, 2014, INFECT GENET EVOL, V21, P395, DOI 10.1016/j.meegid.2013.12.009; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055204; Zhao R, 2009, BRIT J CANCER, V101, P1635, DOI 10.1038/sj.bjc.6605351	53	12	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171140	10.1371/journal.pone.0171140	http://dx.doi.org/10.1371/journal.pone.0171140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141822	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500042
J	Li, L; Miao, WG; Liu, WB; Zhang, SJ				Li, Le; Miao, Weiguo; Liu, Wenbo; Zhang, Shujian			The signal peptide-like segment of hpaXm is required for its association to the cell wall in transgenic tobacco plants	PLOS ONE			English	Article							ORYZAE PV. ORYZICOLA; HRP PATHOGENICITY ISLAND; HARPIN-ENCODING GENE; DISEASE RESISTANCE; HYPERSENSITIVE RESPONSE; ERWINIA-AMYLOVORA; YERSINIA-ENTEROCOLITICA; ACQUIRED-RESISTANCE; TRANSLOCATORS YOPB; III SECRETION	Harpins, encoded by hrp (hypersensitive response and pathogenicity) genes of Gram-negative plant pathogens, are elicitors of hypersensitive response (HR). HpaXm is a novel harpin-like protein described from cotton leaf blight bacteria, Xanthomonas citri subsp. malvacearum-a synonym of X. campestris pv. malvacearum (Smith 1901-1978). A putative signal peptide (1-MNSLNTQIGANSSFL-15) of hpaXm was predicted in the nitroxyl-terminal (N-terminal) by SignalP (SignalP 3.0 server). Here, we explored the function of the N-terminal leader peptide like segment of hpaXm using transgenic tobacco (Nicotiana tabacum cv. Xanthi nc.). Transgenic tobacco lines expressing the full-length hpaXm and the signal peptide-like segment-deleted mutant hpaXm Delta LP were developed using transformation mediated by Agrobacterium tumefaciens. The target genes were confirmed integrated into the tobacco genomes and expressed normally. Using immune colloidal-gold detection technique, hpaXm protein was found to be transferred to the cytoplasm, the cell membrane, and organelles such as chloroplasts, mitochondria, and nucleus, as well as the cell wall. However, the deletion mutant hpaXm Delta LP expressed in transgenic tobacco was found unable to cross the membrane to reach the cell wall. Additionally, soluble proteins extracted from plants transformed with hpaXm and hpaXm Delta LP were bio-active. Defensive micro-HR induced by the transgene expression of hpaXm and hpaXm Delta LP were observed on transgenic tobacco leaves. Disease resistance bioassays to tobacco mosaic virus (TMV) showed that tobacco plants transformed with hpaXm and with hpaXm Delta LP exhibited enhanced resistance to TMV. In summary, the N-terminal signal peptide-like segment (1-45 bp) in hpaXm sequence is not necessary for transgene expression, bioactivity of hpaXm and resistance to TMV in transgenic tobacco, but is required for the protein to be translocated to the cell wall.	[Li, Le; Miao, Weiguo; Liu, Wenbo] Hainan Univ, Coll Environm & Plant Protect, Haikou, Hainan Province, Peoples R China; [Li, Le; Miao, Weiguo; Liu, Wenbo] Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan Province, Peoples R China; [Zhang, Shujian] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA	Hainan University; United States Department of Agriculture (USDA)	Miao, WG (corresponding author), Hainan Univ, Coll Environm & Plant Protect, Haikou, Hainan Province, Peoples R China.; Miao, WG (corresponding author), Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan Province, Peoples R China.	miao@hainu.edu.cn			National agricultural industrial technology system [CARS-34-GW8]; National Natural Science Foundation ofChina [31360029, 31160359]; Doctoral Fund of Ministry of Education [20124601110004, 20104601110004]; National Key Basic Research Plan of China [2011CB111612]; Hainan University [kqd1006]; Doctoral Program of Higher Education of China [20124601110004]; National Natural Science Foundation of China [31360029)]	National agricultural industrial technology system; National Natural Science Foundation ofChina(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education; National Key Basic Research Plan of China(National Basic Research Program of China); Hainan University; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National agricultural industrial technology system (CARS-34-GW8) to WM; National Natural Science Foundation ofChina under Grant (31360029,31160359) to WM; Doctoral Fund of Ministry of Education (20124601110004, 20104601110004) to WM; National Key Basic Research Plan of China (2011CB111612) to WM and the Research and start-up capital of Hainan University (kqd1006) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31360029) and The Research Fund for the Doctoral Program of Higher Education of China (20124601110004). The studies were conceived and planned by WG Miao; L Li carried out the molecular genetic studies and the transgenic related works, participated in the sequence alignment, the protein analysis and the TMV inoculation, and simultaneously drafted the manuscript. WG Miao participated in the design of the study. L Li performed the statistical analysis and took part in the protein analysis and the virus inoculation. The manuscript was edited and prepared by L Li, and was reviewed by SJ Zhang along with WG Miao. WB Liu managed the laboratory and custodies all the experimental materials. All authors read and approved the final manuscript. Special thanks to Yunqin Li, ZheJiang University, for helping with the immuno-colloidal gold test.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Berberich T, 1995, PLANT MOL BIOL, V29, P611, DOI 10.1007/BF00020988; Bollag D.M., 1996, PROTEIN METHODS; Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Chen L, 2008, PHYTOPATHOLOGY, V98, P781, DOI 10.1094/PHYTO-98-7-0781; Choi MS, 2012, PLANT PATHOLOGY J, V28, P364, DOI 10.5423/PPJ.OA.09.2012.0136; Choi MS, 2013, MPMI, V1, P54; Clark MS, 1997, PLANT MOL BIOL LAB M; Dong H, 2000, PHYTOPATHOLOGY, V90, P801, DOI 10.1094/PHYTO.2000.90.8.801; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; DOUGLAS CM, 1987, J BACTERIOL, V169, P4962, DOI 10.1128/jb.169.11.4962-4966.1987; Economou A, 2000, FEBS LETT, V476, P18, DOI 10.1016/S0014-5793(00)01662-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fu MQ, 2014, J EXP BOT, V65, P1439, DOI 10.1093/jxb/ert488; Gallie DR, 1998, BIOCHEM BIOPH RES CO, V245, P295, DOI 10.1006/bbrc.1998.8427; Gerhardt P, 1981, MANUAL METHODS GEN B; Hoyos ME, 1996, MOL PLANT MICROBE IN, V9, P608, DOI 10.1094/MPMI-9-0608; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Klement Z, 1990, METHODS PHYTOBACTERI, V568; Lambert AM, 1982, PNAS, V79; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Li L., 2015, THESIS; Li RG, 1999, SCI CHINA SER C, V42, P96, DOI 10.1007/BF02881754; Li X, 2014, BIORESOUR BIOPROCESS, V1, P1, DOI [10.1186/s40643-014-0013-9, DOI 10.1186/S40643-014-0013-9, DOI 10.1007/S10404-014-1340-Z]; Meng Fanbo, 2007, THESIS; Miao W. G., 2009, THESIS; Miao WG, 2010, J EXP BOT, V61, P4263, DOI 10.1093/jxb/erq227; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Miao WG, 2009, AMINO ACIDS, V37, P120; Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Racape J, 2005, MOL MICROBIOL, V58, P1406, DOI 10.1111/j.1365-2958.2004.04910.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Sohn S, 2007, MOL CELLS, V24, P232; Strobel NE, 1996, PLANT J, V9, P431, DOI 10.1046/j.1365-313X.1996.09040431.x; Tsunemi K, 2011, MOL PLANT PATHOL, V12, P709, DOI [10.1111/j.1364-3703.2011.00705.x, 10.1111/J.1364-3703.2011.00705.X]; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Wang XY, 2008, APPL MICROBIOL BIOT, V81, P359, DOI 10.1007/s00253-008-1651-7; Wang XY, 2007, MOL BIOL REP, V34, P189, DOI 10.1007/s11033-006-9034-6; WEI ZM, 1993, J BACTERIOL, V175, P7958, DOI 10.1128/JB.175.24.7958-7967.1993; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wu XJ, 2007, J BIOSCIENCES, V32, P1119, DOI 10.1007/s12038-007-0113-1; [余云舟 Yu Yunzhou], 2003, [吉林农业大学学报, Journal of Jilin Agricultural University], V25, P257	59	4	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170931	10.1371/journal.pone.0170931	http://dx.doi.org/10.1371/journal.pone.0170931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141855	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500028
J	Fan, Y; Mok, CKP; Chan, MCW; Zhang, Y; Nal, B; Kien, F; Bruzzone, R; Sanyal, S				Fan, Ying; Mok, Chris Ka-Pun; Chan, Michael Chi Wai; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana			Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G1 PHASE PROGRESSION; A VIRUS; M2 PROTEIN; RETINOBLASTOMA PROTEIN; POLYMERASE COMPLEX; CYTOPLASMIC TAIL; ION-CHANNEL; HIV-1 INFECTION; M1 PROTEIN; KINASE	To identify new host factors that modulate the replication of influenza A virus, we performed a yeast two-hybrid screen using the cytoplasmic tail of matrix protein 2 from the highly pathogenic H5N1 strain. The screen revealed a high-score interaction with cyclin D3, a key regulator of cell cycle early G(1) phase. M2-cyclin D3 interaction was validated through GST pull-down and recapitulated in influenza A/WSN/33-infected cells. Knockdown of Ccnd3 by small interfering RNA significantly enhanced virus progeny titers in cell culture supernatants. Interestingly, the increase in virus production was due to cyclin D3 deficiency per se and not merely a consequence of cell cycle deregulation. A combined knockdown of Ccnd3 and Rb1, which rescued cell cycle progression into S phase, failed to normalize virus production. Infection by influenza A virus triggered redistribution of cyclin D3 from the nucleus to the cytoplasm, followed by its proteasomal degradation. When overexpressed in HEK 293T cells, cyclin D3 impaired binding of M2 with M1, which is essential for proper assembly of progeny virions, lending further support to its role as a putative restriction factor. Our study describes the identification and characterization of cyclin D3 as a novel interactor of influenza A virus M2 protein. We hypothesize that competitive inhibition of M1-M2 interaction by cyclin D3 impairs infectious virion formation and results in attenuated virus production. In addition, we provide mechanistic insights into the dynamic interplay of influenza virus with the host cell cycle machinery during infection.	[Fan, Ying; Mok, Chris Ka-Pun; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana] Univ Hong Kong, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China; [Fan, Ying; Mok, Chris Ka-Pun; Chan, Michael Chi Wai; Zhang, Yang; Nal, Beatrice; Kien, Francois; Bruzzone, Roberto; Sanyal, Sumana] Univ Hong Kong, Influenza Res Ctr, Sch Publ Hlth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Fan, Ying] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 4HN, Scotland; [Zhang, Yang] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Nal, Beatrice] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, London UB8 3PH, England; [Kien, Francois] French German Adv Translat Ctr, Ksilink, F-67000 Strasbourg, France; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, F-75015 Paris, France	University of Hong Kong; University of Hong Kong; University of Dundee; Harbin Institute of Technology; University Town of Shenzhen; Brunel University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bruzzone, R; Sanyal, S (corresponding author), Univ Hong Kong, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.; Bruzzone, R; Sanyal, S (corresponding author), Univ Hong Kong, Influenza Res Ctr, Sch Publ Hlth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	bruzzone@hku.hk; sanyal@hku.hk	Mok, Chris Ka Pun/ABD-2667-2021; NAL, Beatrice/GYU-8888-2022; Sanyal, Sumana/AAF-5155-2020; Bruzzone, Roberto/G-9355-2017; Zhang, Yang/AAK-8021-2021; Chan, Michael Chi Wai/C-4212-2009; Sanyal, Sumana/I-7975-2013	Bruzzone, Roberto/0000-0003-4373-1447; Zhang, Yang/0000-0002-3503-5161; Chan, Michael Chi Wai/0000-0001-8174-8405; Sanyal, Sumana/0000-0002-6230-5366; Nal, Beatrice/0000-0003-3452-7524	Research Fund for the Control of Infectious Diseases [RFCID 11101332]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Hong Kong Special Administrative Region, China [T11-705/14N, 17113915]	Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grants Committee; Hong Kong Special Administrative Region, China	This work was supported by Research Fund for the Control of Infectious Diseases Grant RFCID 11101332 and Area of Excellence Scheme of the University Grants Committee Grant AoE/M-12/06 and also supported in part by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Projects T11-705/14N and 17113915). The authors declare that they have no conflicts of interest with the contents of this article.	AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Balasubramaniam VRMT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-196; BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Dove BK, 2012, PROTEOMICS, V12, P1431, DOI 10.1002/pmic.201100470; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; Eward KL, 2004, CELL CYCLE, V3, P1057; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Faussillon M, 2005, CANCER LETT, V221, P67, DOI 10.1016/j.canlet.2004.08.010; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan ZH, 2010, PROTEIN CELL, V1, P944, DOI 10.1007/s13238-010-0115-x; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Henkel JR, 1998, J BIOL CHEM, V273, P6518, DOI 10.1074/jbc.273.11.6518; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; INABA T, 1992, GENOMICS, V13, P565, DOI 10.1016/0888-7543(92)90126-D; Iwatsuki-Horimoto K, 2006, J VIROL, V80, P5233, DOI 10.1128/JVI.00049-06; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; KEYOMARSI K, 1994, CANCER RES, V54, P380; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KOBAYASHI H, 1992, MOL BIOL CELL, V3, P1279, DOI 10.1091/mbc.3.11.1279; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; LUKAS J, 1995, ONCOGENE, V10, P2125; Le L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022970; Ma H., 2012, ADV PHYS CHEM, V2012, DOI DOI 10.1100/2012/541786; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mi SF, 2010, SCI CHINA LIFE SCI, V53, P1098, DOI 10.1007/s11427-010-4048-7; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; NUGENT JHA, 1991, J CELL SCI, V99, P669; PALMERO I, 1993, ONCOGENE, V8, P1049; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Planz O, 2003, J VIROL, V77, P11186, DOI 10.1128/JVI.77.20.11186-11192.2003; Pokrovskaja K, 1996, CELL GROWTH DIFFER, V7, P1723; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shoemaker JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-117; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Sorrell DA, 1999, PLANT PHYSIOL, V119, P343, DOI 10.1104/pp.119.1.343; STOOF JC, 1992, EUR J PHARMACOL, V213, P439, DOI 10.1016/0014-2999(92)90634-G; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thomas JM, 1998, VIROLOGY, V252, P54, DOI 10.1006/viro.1998.9384; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wallensten A, 2009, EUROSURVEILLANCE, V14, P6; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; World Health Organization, 2016, FACT SHEET SOL STAR; Xie ZJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P153, DOI 10.1006/abbi.1996.0237; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	86	26	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5070	5088		10.1074/jbc.M117.776112	http://dx.doi.org/10.1074/jbc.M117.776112			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28130444	hybrid, Green Published			2022-12-26	WOS:000397590400027
J	Furukawa, M; Ohkawara, H; Ogawa, K; Ikeda, K; Ueda, K; Shichishima-Nakamura, A; Ito, E; Imai, JI; Yanagisawa, Y; Honma, R; Watanabe, S; Waguri, S; Ikezoe, T; Takeishi, Y				Furukawa, Miki; Ohkawara, Hiroshi; Ogawa, Kazuei; Ikeda, Kazuhiko; Ueda, Koki; Shichishima-Nakamura, Akiko; Ito, Emi; Imai, Jun-Ichi; Yanagisawa, Yuka; Honma, Reiko; Watanabe, Shinya; Waguri, Satoshi; Ikezoe, Takayuki; Takeishi, Yasuchika			Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECEPTOR TYROSINE KINASE; PROTEIN-S; EXPRESSION; GAS6; AXL; PROLIFERATION; INHIBITION; AXIS; MICROENVIRONMENT	The pathogenesis of multiple myeloma (MM) has not yet been fully elucidated. Our microarray analysis and immunohistochemistry revealed significant up-regulation of growth arrest-specific gene 6 (Gas6), a vitamin K-dependent protein with a structural homology with protein S, in bone marrow (BM) cells of MM patients. ELISA showed that the serum levels of soluble Gas6 were significantly increased in the MM patients when compared with healthy controls. Gas6 was overexpressed in the human CD138-positive MM cell line RPMI-8226. Exogenous Gas6 suppressed apoptosis induced by serum deprivation and enhanced cell proliferation of the MM cells. The conditional medium from the human BM stromal cell line HS-5 induced cell proliferation and anti-apoptosis of the MM cells with extracellular signal-regulated kinase, Akt, and nuclear factor-kappa B phosphorylation, which were reversed by the neutralizing antibody to Gas6 or IL-6. The TAM family receptor Mer, which has been identified as a Gas6 receptor, was overexpressed in BM cells of MM patients. The knockdown of Mer by siRNA inhibited cell proliferation, anti-apoptosis, and up-regulation of intercellular cell adhesion molecule-1 (ICAM-1) in MM cells stimulated by an HS-5 cell-conditioned medium. Furthermore, the Gas6-neutralizing antibody reduced the up-regulation of IL-6 and ICAM-1 induced by a HS-5 cell-conditioned medium in MM cells. The present study provides new evidence that autocrine and paracrine stimulation of Gas6 in concert with IL-6 contributes to the pathogenesis of MM, suggesting that Gas6-Mer-related signaling pathways may be a promising novel target for treating MM.	[Furukawa, Miki; Ohkawara, Hiroshi; Ogawa, Kazuei; Ikeda, Kazuhiko; Ueda, Koki; Shichishima-Nakamura, Akiko; Ikezoe, Takayuki] Fukushima Med Univ, Dept Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan; [Ikeda, Kazuhiko] Fukushima Med Univ, Blood Transfus & Transplantat Immunol, Fukushima 9601295, Japan; [Takeishi, Yasuchika] Fukushima Med Univ, Cardiovasc Med, Fukushima 9601295, Japan; [Ito, Emi; Imai, Jun-Ichi; Yanagisawa, Yuka; Watanabe, Shinya; Waguri, Satoshi] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan; [Honma, Reiko] NIPPON GENE Co Ltd, Tokyo 1010054, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Ohkawara, H (corresponding author), Fukushima Med Univ, Dept Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	ohkawara@fmu.ac.jp		Ohkawara, Hiroshi/0000-0002-3129-1977	Fukushima Medical University Research Project; Japan Society for the Promotion of Science [16K19583, 2479080]	Fukushima Medical University Research Project; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Fukushima Medical University Research Project and Grants-in-Aid for Scientific Research 2479080 and 16K19583 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Ben-Batalla I, 2013, BLOOD, V122, P2443, DOI 10.1182/blood-2013-03-491431; CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Dirks W, 1999, LEUKEMIA RES, V23, P643, DOI 10.1016/S0145-2126(99)00075-2; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Faid L, 1996, EUR J HAEMATOL, V57, P349; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hansson M, 2015, CLIN CANCER RES, V21, P2730, DOI 10.1158/1078-0432.CCR-14-3090; Harada-Shirado K, 2015, BRIT J HAEMATOL, V168, P338, DOI 10.1111/bjh.13129; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2001, SEMIN ONCOL, V28, P607, DOI 10.1053/sonc.2001.28608; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jiang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133940; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KLEIN B, 1989, BLOOD, V73, P517; Klein B, 1992, Curr Top Microbiol Immunol, V182, P237; Lee-Sherick AB, 2013, ONCOGENE, V32, P5359, DOI 10.1038/onc.2013.40; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu Q, 2016, J BIOL CHEM, V291, P4779, DOI 10.1074/jbc.M115.683052; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; Mc Cormack O, 2008, BRIT J CANCER, V98, P1141, DOI 10.1038/sj.bjc.6604260; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Miura A, 2006, FEBS LETT, V580, P6871, DOI 10.1016/j.febslet.2006.11.041; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Munoz X, 2004, HUM MUTAT, V23, P506, DOI 10.1002/humu.20025; Murray MY, 2015, CELL CYCLE, V14, P2367, DOI 10.1080/15384101.2014.998067; NEUBAUER A, 1994, BLOOD, V84, P1931; Noll JE, 2014, HAEMATOLOGICA, V99, P163, DOI 10.3324/haematol.2013.090977; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Ohkawara H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105697; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Ramakrishnan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050005; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Shiozawa Y, 2010, EXP HEMATOL, V38, P132, DOI 10.1016/j.exphem.2009.11.002; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waizenegger JS, 2015, LEUKEMIA, V29, P696, DOI 10.1038/leu.2014.236; Wallace SR, 2001, CANCER-AM CANCER SOC, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Whitman SP, 2014, LEUKEMIA, V28, P1252, DOI 10.1038/leu.2013.371; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141	56	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4280	4292		10.1074/jbc.M116.733030	http://dx.doi.org/10.1074/jbc.M116.733030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154173	hybrid, Green Published			2022-12-26	WOS:000395837100025
J	Tang, LY; Heller, M; Meng, Z; Yu, LR; Tang, Y; Zhou, M; Zhang, YE				Tang, Liu-Ya; Heller, Mary; Meng, Zhaojing; Yu, Li-Rong; Tang, Yi; Zhou, Ming; Zhang, Ying E.			Transforming Growth Factor-beta (TGF-beta) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STELLATE CELLS; JUNB PROMOTER; STAT3; EXPRESSION; IL-6; PHOSPHORYLATION; HEPATOCYTES; TRANSDUCERS; APOPTOSIS; ELEMENT	Transforming growth factor-beta (TGF-beta) signals through both SMAD and non-SMAD pathways to elicit a wide array of biological effects. Existing data have shown the association and coordination between STATs and SMAD sin mediating TGF-beta functions in hepatic cells, but it is not clear how STATs are activated under these circumstances. Here, we report that JAK1 is a constitutive TGF beta RI binding protein and is absolutely required for phosphorylation of STATs in a SMAD-independent manner within minutes of TGF-beta stimulation. Following the activation of SMADs, TGF-beta also induces a second phase of STAT phosphorylation that requires SMADs, de novo protein synthesis, and contribution from JAK1. Our global gene expression profiling indicates that the non-SMAD JAK1/STAT pathway is essential for the expression of a subset of TGF-beta target genes in hepatic stellate cells, and the cooperation between the JAK1STAT3 and SMAD pathways is critical to the roles of TGF-beta in liver fibrosis.	[Tang, Liu-Ya; Heller, Mary; Tang, Yi; Zhang, Ying E.] Natl Inst Hlth, Lab Cellular & Mol Biol, Ctr Canc Res, NCI, Bethesda, MD 20892 USA; [Meng, Zhaojing; Yu, Li-Rong; Zhou, Ming] Frederick Natl Lab Canc Res, Prot Characterizat Lab, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Yu, Li-Rong] Div System Biol, Biomarkers & Alternat Models Branch, Food & Drug Adm, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Zhang, YE (corresponding author), Natl Inst Hlth, Lab Cellular & Mol Biol, Ctr Canc Res, NCI, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Yu, Li-Rong/0000-0001-6084-991X	National Institutes of Health; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the National Institutes of Health, NCI, Center for Cancer Research (to Y.E.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; COFFER P, 1995, ONCOGENE, V10, P985; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kojima H, 1996, ONCOGENE, V12, P547; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Kusaba M, 2007, J HEPATOL, V47, P546, DOI 10.1016/j.jhep.2007.04.017; Liu Y, 2004, GENESIS, V40, P118, DOI 10.1002/gene.20072; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Wang G, 2016, ONCOGENE, V35, P4388, DOI 10.1038/onc.2015.446; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang Y. E., 2016, COLD SPRING HARB PER, V9	36	142	148	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4302	4312		10.1074/jbc.M116.773085	http://dx.doi.org/10.1074/jbc.M116.773085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154170	hybrid, Green Published			2022-12-26	WOS:000395837100027
J	Lovelace, ES; Maurice, NJ; Miller, HW; Slichter, CK; Harrington, R; Magaret, A; Prlic, M; De Rosa, S; Polyak, SJ				Lovelace, Erica S.; Maurice, Nicholas J.; Miller, Hannah W.; Slichter, Chloe K.; Harrington, Robert; Magaret, Amalia; Prlic, Martin; De Rosa, Stephen; Polyak, Stephen J.			Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; T-CELLS; MICROBIAL TRANSLOCATION; DISEASE PROGRESSION; INFECTED PATIENTS; IN-VITRO; HIV; SILIBININ; RESPONSES; CD4(+)	Silymarin (SM), and its flavonolignan components, alter cellular metabolism and inhibit inflammatory status in human liver and T cell lines. In this study, we hypothesized that SM suppresses both acute and chronic immune activation (CIA), including in the context of HIV infection. SM treatment suppressed the expression of T cell activation and exhaustion markers on CD4+ and CD8+ T cells from chronically-infected, HIV-positive subjects. SM also showed a trend towards modifying CD4+ T cell memory subsets from HIV+ subjects. In the HIV-negative setting, SM treatment showed trends towards suppressing pro-inflammatory cytokines from non-activated and pathogen-associated molecular pattern (PAMP)-activated primary human monocytes, and non-activated and cytokine-and T cell receptor (TCR)-activated mucosal-associated invariant T (MAIT) cells. The data suggest that SM elicits broad anti-inflammatory and immunoregulatory activity in primary human immune cells. By using novel compounds to alter cellular inflammatory status, it may be possible to regulate inflammation in both non-disease and disease states.	[Lovelace, Erica S.; Magaret, Amalia; Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Maurice, Nicholas J.; Miller, Hannah W.; Slichter, Chloe K.; Magaret, Amalia; Prlic, Martin; De Rosa, Stephen] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Slichter, Chloe K.; Prlic, Martin; Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Harrington, Robert] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Magaret, Amalia] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Polyak, SJ (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Polyak, SJ (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Polyak, SJ (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	polyak@uw.edu		Maurice, Nicholas/0000-0002-2667-472X	National Center for Complementary and Integrative Health (NCCIH) [5R01AT006842]; National Institute of Allergy and Infectious Diseases (NIAID) [T32 AI007509]; University of Washington Center for AIDS Research under National Institutes of Health (NIH) [P30AI027757]	National Center for Complementary and Integrative Health (NCCIH); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research under National Institutes of Health (NIH)	This work was supported by grant 5R01AT006842 to SJP from National Center for Complementary and Integrative Health (NCCIH) https://nccih.nih.gov/; Grant T32 AI007509 to CKS from the National Institute of Allergy and Infectious Diseases (NIAID) https://www.niaid.nih.gov/; Pilot funding to SJP from the University of Washington Center for AIDS Research under National Institutes of Health (NIH) award number P30AI027757 (from NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK) https://www.niaid.nih.gov/ research/centers aids research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beinhardt S, 2012, J HEPATOL, V56, pS77, DOI 10.1016/S0168-8278(12)60191-3; Beinhardt S, 2011, J HEPATOL, V54, P591, DOI 10.1016/j.jhep.2010.09.009; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; De Wit S, 2011, AIDS, V25, P1332, DOI 10.1097/QAD.0b013e328347c083; Ferenci P, 2008, GASTROENTEROLOGY, V135, P1561, DOI 10.1053/j.gastro.2008.07.072; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Graf TN, 2007, PLANTA MED, V73, P1495, DOI 10.1055/s-2007-990239; Graf TN, 2016, J PHARMACEUT BIOMED, V126, P26, DOI 10.1016/j.jpba.2016.04.028; Hearps AC, 2014, CURR HIV-AIDS REP, V11, P20, DOI 10.1007/s11904-013-0190-8; HO HN, 1993, J IMMUNOL, V150, P3070; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ipp H, 2014, CRIT REV CL LAB SCI, V51, P98, DOI 10.3109/10408363.2013.865702; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; KANELLOPOULOS JM, 1983, EMBO J, V2, P1807, DOI 10.1002/j.1460-2075.1983.tb01662.x; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Larbi A, 2014, STEM CELLS DEV, V23, P2983, DOI 10.1089/scd.2014.0171; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; LEVACHER M, 1992, CLIN EXP IMMUNOL, V90, P376; Lovelace ES, 2015, J NAT PROD; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; McClure J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041832; McComsey GA, 2001, AIDS, V15, P321, DOI 10.1097/00002030-200102160-00004; McKinney EF, 2016, IMMUNOL CELL BIOL, V94, P935, DOI 10.1038/icb.2016.81; Moncunill G, 2015, CYTOM PART A, V87A, P289, DOI 10.1002/cyto.a.22590; Morishima C, 2010, GASTROENTEROLOGY, V138, P671, DOI 10.1053/j.gastro.2009.09.021; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Napier RJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00344; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuman UP, 2010, J HEPATOL, V52, P951, DOI 10.1016/j.jhep.2010.02.002; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; O'Brien M, 2013, JOURNAL OF ACQUIRED; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Polyak SJ, 2013, ANTIVIR THER, V18, P141, DOI 10.3851/IMP2402; Polyak SJ, 2013, HEPATOLOGY, V57, P1262, DOI 10.1002/hep.26179; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seeff LB, 2008, HEPATOLOGY, V47, P605, DOI 10.1002/hep.22044; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Slichter CK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86292; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Taiwo B, 2013, CURR HIV-AIDS REP, V10, P21, DOI 10.1007/s11904-012-0147-3; THOMAS Y, 1984, J MOL CELL IMMUNOL, V1, P103; Utay NS, 2016, CURR OPIN HIV AIDS, V11, P131, DOI 10.1097/COH.0000000000000242; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wagoner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016464; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171139	10.1371/journal.pone.0171139	http://dx.doi.org/10.1371/journal.pone.0171139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158203	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700033
J	Someya, S; Kujoth, GC; Kim, MJ; Hacker, TA; Vermulst, M; Weindruch, R; Prolla, TA				Someya, Shinichi; Kujoth, Gregory C.; Kim, Mi-Jung; Hacker, Timothy A.; Vermulst, Marc; Weindruch, Richard; Prolla, Tomas A.			Effects of calorie restriction on the lifespan and healthspan of POLG mitochondrial mutator mice	PLOS ONE			English	Article							OXIDATIVE DAMAGE; DNA POLYMERASE; AGED RAT; MUTATIONS; OVEREXPRESSION; MUSCLE; REPLICATION; PHENOTYPES; STRESS; BRAIN	Mitochondrial DNA (mtDNA) mutations are thought to have a causative role in age-related pathologies. We have shown previously that mitochondrial mutator mice (Polg(D257A/D257A)), harboring a proofreading-deficient version of the mtDNA polymerase gamma (POLG), accumulate mtDNA mutations in multiple tissues and display several features of accelerated aging. Calorie restriction (CR) is known to delay the onset of age-related diseases and to extend the lifespan of a variety of species, including rodents. In the current study we investigated the effects of CR on the lifespan and healthspan of mitochondrial mutator mice. Longterm CR did not increase the median or maximum lifespan of Polg(D257A/D257A) mice. Furthermore, CR did not reduce mtDNA deletions in the heart and muscle, accelerated sarcopenia, testicular atrophy, nor improve the alterations in cardiac parameters that are present in aged mitochondrial mutator mice. Therefore, our findings suggest that accumulation of mtDNA mutations may interfere with the beneficial action of CR in aging retardation.	[Someya, Shinichi; Kim, Mi-Jung] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA; [Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Vermulst, Marc] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Weindruch, Richard] Univ Wisconsin, Geriatr Res Educ & Clin Ctr, Vet Adm Hosp, Madison, WI USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.; Prolla, TA (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.	taprolla@wisc.edu		Someya, Shinichi/0000-0001-9895-6227	NIH [RO1 AG021905, RO1 DC012552, R01 DC014437, R03 DC011840]; American Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award; NATIONAL INSTITUTE ON AGING [R01AG021905, P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011840, R01DC012552, R01DC014437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grants RO1 AG021905 (T.A.P.), RO1 DC012552 (S.S.), R01 DC014437 (S.S.) and R03 DC011840 (S.S.), American Federation for Aging Research Grant (S.S.), and NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award (S.S.).	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720; Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025; FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011; Hamilton R, 2016, J NEUROL SCI, V370, P47, DOI 10.1016/j.jns.2016.09.021; Han C, 2013, EXP GERONTOL, V48, P1091, DOI 10.1016/j.exger.2013.02.014; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Lezza AMS, 2008, NEUROCHEM RES, V33, P2609, DOI 10.1007/s11064-008-9866-7; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011; Muller FL, 2007, AM J PHYSL REGUL INT, V293; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407	36	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171159	10.1371/journal.pone.0171159	http://dx.doi.org/10.1371/journal.pone.0171159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158260	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700034
J	Nguyen, TPL; Schuiling-Veninga, CCM; Nguyen, TBY; Vu, TH; Wright, EP; Postma, MJ				Nguyen, Thi-Phuong-Lan; Schuiling-Veninga, Catharina C. M.; Nguyen, Thi Bach Yen; Vu, Thu-Hang; Wright, E. Pamela; Postma, Maarten J.			Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ANTIHYPERTENSIVE MEDICATION; CARDIOVASCULAR-DISEASE; CLINICAL-OUTCOMES; RISK; HOSPITALIZATION; HEALTH; DRUGS; DISCONTINUATION; PERSISTENCE	Objectives The purposes of this study were to assess the adherence to medication of hypertensive patients visiting community health stations in a rural area in Vietnam, to examine the relationship between levels of adherence and cardiovascular risk among hypertensive patients and to further understand factors influencing adherence. Methods This study is part of a prospective one-year study conducted on hypertension management in a population aged 35 to 64 years. Data on age, sex, blood pressure and blood test results were collected at baseline. Cardiovascular risk was based on the Cardiovascular Risk Prediction Model for populations in Asia. To calculate medication adherence, the number of days the drug was taken was divided by the number of days since the first day of the prescription. A threshold of 80% was applied to differentiate between adherence and nonadherence. In-depth interviews were conducted among 18 subjects, including subjects classified as adherent and as non-adherent. Results Among 315 patients analyzed, 49.8% of the patients were adherent. Qualitative investigation revealed discrepancies in classification of adherence and non-adherence based on quantitative analysis and interviews. No significant difference in medication compliance between two cardiovascular disease risk groups (< 10% vs. > 10% risk) was found, also not after controlling for age, sex, and ethnicity ( adjusted odds ratio at 1.068; 95% CI: 0.614 to 1.857). The odds of medication adherence in females was 1.531 times higher than in males but the difference was not statistically significant ( 95% CI: 0.957 to 2.448). Each one-year increase in age resulted in patients being 1.036 times more likely to be compliant (95% CI: 1.002 to 1.072). Awareness of complications related to hypertension was given as the main reason for adherence to therapy. Conclusions Medication adherence rate was relatively low among hypertensive subjects. The data suggest that rather than risk profile, the factor of age should be considered for guiding the choice on who to target for improving medication adherence.	[Nguyen, Thi-Phuong-Lan; Schuiling-Veninga, Catharina C. M.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands; [Nguyen, Thi Bach Yen] Ha Noi Univ Med, Dept Hlth Econ, Hanoi, Vietnam; [Vu, Thu-Hang] Thai Nguyen Univ Med & Pharm, Thai Nguyen, Vietnam; [Wright, E. Pamela] Med Comm Netherlands Vietnam, Amsterdam, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & Hlth CaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Thai Nguyen University; University of Groningen; University of Groningen	Nguyen, TPL (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands.	ntplan75@gmail.com		Postma, Maarten/0000-0002-6306-3653	NUFFIC (Netherlands)	NUFFIC (Netherlands)(Netherlands Government)	The research was funded by a NUFFIC (Netherlands) project for PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research was funded by a NUFFIC (Netherlands) project for PhD research. Thanks go to the staff of the community health stations in Trung Thanh, Cu Van, La Hien and Tuc Tranh for their co-operation in the study.	Alsabbagh MHDW, 2014, VALUE HEALTH, V17, P288, DOI 10.1016/j.jval.2013.11.011; Bailey JE, 1996, CLIN THER, V18, P1252, DOI 10.1016/S0149-2918(96)80080-4; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bramley TJ, 2006, J MANAGE CARE PHARM, V12, P239, DOI 10.18553/jmcp.2006.12.3.239; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P121, DOI 10.1185/030079908X253843; Burnier M, 2011, INT J CLIN PRACT, V65, P127, DOI 10.1111/j.1742-1241.2010.02616.x; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Chen SL, 2014, J ADV NURS, V70, P2031, DOI 10.1111/jan.12361; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Corrao G, 2011, J HYPERTENS, V29, P610, DOI 10.1097/HJH.0b013e328342ca97; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd; Esposti LD, 2011, CLINICOECONOMIC OUTC, V3, P47, DOI 10.2147/CEOR.S15619; Fitz-Simon Nicola, 2005, Ther Clin Risk Manag, V1, P93, DOI 10.2147/tcrm.1.2.93.62915; Fongwa MN, 2008, VASC HEALTH RISK MAN, V4, P157, DOI 10.2147/vhrm.2008.04.01.157; Gascon JJ, 2004, FAM PRACT, V21, P125, DOI 10.1093/fampra/cmh202; Grassi G, 2011, BLOOD PRESSURE, V20, P196, DOI 10.3109/08037051.2011.557902; Grosso G, 2011, Ann Ig, V23, P173; Hashmi SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000280; Hughes D, 2007, VALUE HEALTH, V10, P498, DOI 10.1111/j.1524-4733.2007.00205.x; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Khanam MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25028; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Lagi A, 2006, INTERN EMERG MED, V1, P204, DOI 10.1007/BF02934738; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Lewis LM, 2012, J CARDIOVASC NURS, V27, P208, DOI 10.1097/JCN.0b013e318215bb8f; Lewis LM, 2012, J CLIN HYPERTENS, V14, P250, DOI 10.1111/j.1751-7176.2012.00591.x; Lowy A, 2011, INT J CLIN PRACT, V65, P41, DOI 10.1111/j.1742-1241.2010.02569.x; MARSHALL IJ, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E3953; Matsumura K, 2013, QJM-INT J MED, V106, P909, DOI 10.1093/qjmed/hct121; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Nguyen Thi Phuong Lan, 2014, Value Health Reg Issues, V3, P87, DOI 10.1016/j.vhri.2014.03.003; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Park JH, 2008, INT J CARDIOL, V128, P392, DOI 10.1016/j.ijcard.2007.04.114; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Nguyen N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-325; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Rimando M, 2013, ETHNIC DIS, V23, P469; Rosenbaum L, 2015, NEW ENGL J MED, V372, P7, DOI 10.1056/NEJMp1413816; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Schoenthaler A, 2009, PATIENT EDUC COUNS, V75, P185, DOI 10.1016/j.pec.2008.09.018; Shin S, 2013, HYPERTENS RES, V36, P1000, DOI 10.1038/hr.2013.85; Simonyi G, 2013, ORVOSI HETILAP, V154, P1587, DOI 10.1556/OH.2013.29692; Tajeu GS, 2016, HYPERTENSION, V68, P565, DOI 10.1161/HYPERTENSIONAHA.116.07720; Tsiantou V, 2010, PATIENT PREFER ADHER, V4, P335, DOI 10.2147/PPA.S12326; Wilinski Jerzy, 2013, Przegl Lek, V70, P377; Wong MCS, 2011, J CLIN PHARM THER, V36, P179, DOI 10.1111/j.1365-2710.2010.01174.x; Wong MCS, 2013, INT J CARDIOL, V167, P1438, DOI 10.1016/j.ijcard.2012.04.060; World Health Organization, PREV CARD DIS; Wu PH, 2010, AM J HYPERTENS, V23, P155, DOI 10.1038/ajh.2009.210	51	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171203	10.1371/journal.pone.0171203	http://dx.doi.org/10.1371/journal.pone.0171203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146584	Green Published, gold, Green Submitted			2022-12-26	WOS:000396131700026
J	Schnell, NK; Johnson, GD				Schnell, Nalani K.; Johnson, G. David			Evolution of a Functional Head Joint in Deep-Sea Fishes (Stomiidae)	PLOS ONE			English	Article							GULF-OF-MEXICO; DRAGON FISH; TELEOSTEI; BIOMECHANICS; ASSEMBLAGE; BEHAVIOR; PISCES	The head and anterior trunk region of most actinopterygian fishes is stiffened as, uniquely within vertebrates, the pectoral girdles have a direct and often strong connection through the posttemporal to the posterior region of the skull. Members of the mesopelagic fish family Stomiidae have their pectoral girdle separated from the skull. This connection is lost in several teleost groups, but the stomiids have an additional evolutionary novelty-a flexible connection between the occiput and the first vertebra, where only the notochord persists. Several studies suggested that stomiids engulf significantly large prey items and conjectured about the functional role of the anterior part of the vertebral column; however, there has been no precise anatomical description of this complex. Here we describe a unique configuration comprising the occiput and the notochordal sheath in Aristostomias, Eustomias, Malacosteus, Pachystomias, and Photostomias that represents a true functional head joint in teleosts and discuss its potential phylogenetic implications. In these genera, the chordal sheath is folded inward ventrally beneath its connection to the basioccipital and embraces the occipital condyle when in a resting position. In the resting position (wherein the head is not manipulatively elevated), this condyle is completely embraced by the ventral fold of the notochord. A manual manipulative elevation of the head in cleared and stained specimens unfolds the ventral sheath of the notochord. As a consequence, the cranium can be pulled up and back significantly farther than in all other teleost taxa that lack such a functional head joint and thereby can reach mouth gapes up to 120 degrees.	[Schnell, Nalani K.] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite,ISYEB,UMR 7205,CNRS,UPMC,EPHE, Paris, France; [Johnson, G. David] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Smithsonian Institution; Smithsonian National Museum of Natural History	Schnell, NK (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite,ISYEB,UMR 7205,CNRS,UPMC,EPHE, Paris, France.	nschnell@mnhn.fr		Schnell, Nalani/0000-0003-2060-4656; Johnson, G D/0000-0003-4339-6589	NKS in the Division of Fishes at the National Museum of Natural History; Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes	NKS in the Division of Fishes at the National Museum of Natural History; Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes	This study was initiated during a Smithsonian Predoctoral Fellowship of NKS in the Division of Fishes at the National Museum of Natural History and further supported by the Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes (2008/2009).	BERRA TM, 1989, FISHERIES, V14, P2, DOI 10.1577/1548-8446(1989)014<0002:BEBAFM>2.0.CO;2; Brauer A, 1908, ANATOMISCHER TEIL, V15, P1; CLARKE TA, 1982, FISH B-NOAA, V80, P287; CLARKE WD, 1963, NATURE, V198, P1244, DOI 10.1038/1981244a0; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Domagk G., 1933, MEDIZIN CHEMIE, V1, P126; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Eschmeyer WN, CATALOG FISHES GENER; Fink W.L, 1985, MISC PUBL MUS ZOOL, V171, P1; Gunther K., 1959, Dana Reports, VNo. 49, P1; Kenaley CP, 2014, EVOLUTION, V68, P996, DOI 10.1111/evo.12322; Kenaley CP, 2012, BIOL J LINN SOC, V106, P224, DOI 10.1111/j.1095-8312.2012.01854.x; Morrow JE, 1964, FISHES W N ATLANTIC, P351; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PARTRIDGE JC, 1995, NATURE, V375, P21, DOI 10.1038/375021a0; Regan C.T., 1930, DANA REP, V6, P1; Schnell NK, 2008, J MORPHOL, V269, P513, DOI 10.1002/jmor.10584; Schnell NK, 2012, COPEIA, P394, DOI 10.1643/CG-11-051; Schnell NK, 2010, J MORPHOL, V271, P1006, DOI 10.1002/jmor.10858; SONG JK, 1995, COPEIA, P114; Sutton TT, 1996, MAR BIOL, V127, P179, DOI 10.1007/BF00942102; Sutton TT, 1996, B MAR SCI, V59, P530; TAYLOR W R, 1985, Cybium, V9, P107; Tchernavin V. V., 1953, FEEDING MECH DEEP SE; Westneat MW, 2006, FISH PHYSIOL, V23, P29, DOI 10.1016/S1546-5098(05)23002-9	25	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170224	10.1371/journal.pone.0170224	http://dx.doi.org/10.1371/journal.pone.0170224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146571	Green Submitted, Green Published, gold			2022-12-26	WOS:000396131700017
J	Villenave, R; Wales, SQ; Hamkins-Indik, T; Papafragkou, E; Weaver, JC; Ferrante, TC; Bahinski, A; Elkins, CA; Kulka, M; Ingber, DE				Villenave, Remi; Wales, Samantha Q.; Hamkins-Indik, Tiama; Papafragkou, Efstathia; Weaver, James C.; Ferrante, Thomas C.; Bahinski, Anthony; Elkins, Christopher A.; Kulka, Michael; Ingber, Donald E.			Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro	PLOS ONE			English	Article							EPITHELIAL-CELLS; CILIATED CELLS; RELEASE; DISEASE; REPLICATION; ACTIVATION; INTESTINE; STRAINS; SIGNALS; VACCINE	Analysis of enterovirus infection is difficult in animals because they express different virus receptors than humans, and static cell culture systems do not reproduce the physical complexity of the human intestinal epithelium. Here, using coxsackievirus B1 (CVB1) as a prototype enterovirus strain, we demonstrate that human enterovirus infection, replication and infectious virus production can be analyzed in vitro in a human Gut-on-a-Chip microfluidic device that supports culture of highly differentiated human villus intestinal epithelium under conditions of fluid flow and peristalsis-like motions. When CVB1 was introduced into the epithelium-lined intestinal lumen of the device, virions entered the epithelium, replicated inside the cells producing detectable cytopathic effects (CPEs), and both infectious virions and inflammatory cytokines were released in a polarized manner from the cell apex, as they could be detected in the effluent from the epithelial microchannel. When the virus was introduced via a basal route of infection (by inoculating virus into fluid flowing through a parallel lower 'vascular' channel separated from the epithelial channel by a porous membrane), significantly lower viral titers, decreased CPEs, and delayed caspase-3 activation were observed; however, cytokines continued to be secreted apically. The presence of continuous fluid flow through the epithelial lumen also resulted in production of a gradient of CPEs consistent with the flow direction. Thus, the human Gut-on-a-Chip may provide a suitable in vitro model for enteric virus infection and for investigating mechanisms of enterovirus pathogenesis.	[Villenave, Remi; Hamkins-Indik, Tiama; Weaver, James C.; Ferrante, Thomas C.; Bahinski, Anthony; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Wales, Samantha Q.; Papafragkou, Efstathia; Elkins, Christopher A.; Kulka, Michael] US FDA, Mol Virol Team, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Ingber, Donald E.] Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Med Sch, Boston, MA 02115 USA; [Villenave, Remi] Emulate Inc, Boston, MA USA; [Bahinski, Anthony] GlaxoSmithKline, King Of Prussia, PA USA	Harvard University; US Food & Drug Administration (FDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; GlaxoSmithKline	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Weaver, James C./AAE-7870-2019	Elkins, Christopher/0000-0002-6029-9812	FDA [HHSF223201310079C]; DARPA [HR0011-15-C-0094]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Food and Drug Administration [HHSF223201310079C]; Defense Advanced Research Projects Agency [HR0011-15-C-0094]	FDA(United States Department of Health & Human Services); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering at Harvard University; Food and Drug Administration(United States Department of Health & Human Services); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants from the Food and Drug Administration (HHSF223201310079C) and The Defense Advanced Research Projects Agency (HR0011-15-C-0094), and by the Wyss Institute for Biologically Inspired Engineering at Harvard University.	[Anonymous], 2009, FIELDS VIROLOGY, P490; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Blank CA, 2000, J VIROL, V74, P6476, DOI 10.1128/JVI.74.14.6476-6484.2000; Bozym RA, 2011, MOL BIOL CELL, V22, P3010, DOI 10.1091/mbc.E11-02-0094; Cai ZJ, 2015, CIRC-HEART FAIL, V8, P809, DOI 10.1161/CIRCHEARTFAILURE.114.001244; Cifuente JO, 2011, J MED VIROL, V83, P1571, DOI 10.1002/jmv.22133; Conaldi PG, 1997, J INFECT DIS, V175, P693, DOI 10.1093/infdis/175.3.693; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Drummond CG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00030-15; Fairweather D, 2007, METHODS, V41, P118, DOI 10.1016/j.ymeth.2006.07.009; Gibbons DL, 2011, MUCOSAL IMMUNOL, V4, P148, DOI 10.1038/mi.2010.85; Harris KG, 2015, CELL HOST MICROBE, V18, P221, DOI 10.1016/j.chom.2015.07.007; Ishikawa T, 2011, J THEOR BIOL, V279, P63, DOI 10.1016/j.jtbi.2011.03.026; Katoh H, 2015, J VIROL, V89, P12026, DOI 10.1128/JVI.02048-15; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, P153; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kulka M, 2009, VIROLOGY, V388, P169, DOI 10.1016/j.virol.2009.03.014; Larsson PG, 2015, DIABETOLOGIA, V58, P346, DOI 10.1007/s00125-014-3436-0; Lentle RG, 2008, J COMP PHYSIOL B, V178, P257, DOI 10.1007/s00360-007-0217-9; Naim HY, 2000, EMBO J, V19, P3576, DOI 10.1093/emboj/19.14.3576; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Pallansch M. A., 2009, Clinical virology manual, P249; Pan JY, 2015, J VIROL, V89, P1324, DOI 10.1128/JVI.02798-14; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Sin J, 2015, VIROLOGY, V484, P288, DOI 10.1016/j.virol.2015.06.006; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Vassileva-Pencheva R, 2010, ANTIVIR RES, V85, P366, DOI 10.1016/j.antiviral.2009.11.003; Villenave R, 2010, J VIROL, V84, P11718, DOI 10.1128/JVI.00798-10; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P858; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P890; Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	38	100	102	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169412	10.1371/journal.pone.0169412	http://dx.doi.org/10.1371/journal.pone.0169412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146569	gold, Green Published, Green Submitted			2022-12-26	WOS:000396131700006
J	den Harder, AM; Sucha, D; van Hamersvelt, RW; Budde, RPJ; de Jong, PA; Schilham, AMR; Bos, C; Breur, JMPJ; Leiner, T				den Harder, A. M.; Sucha, D.; van Hamersvelt, R. W.; Budde, R. P. J.; de Jong, P. A.; Schilham, A. M. R.; Bos, C.; Breur, J. M. P. J.; Leiner, T.			Imaging of pediatric great vessel stents: Computed tomography or magnetic resonance imaging?	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; IN-VITRO; CT; SAFETY; MRI; ANGIOGRAPHY; CHILDREN	Background Complications might occur after great vessel stent implantation in children. Therefore follow-up using imaging is warranted. Purpose To determine the optimal imaging modality for the assessment of stents used to treat great vessel obstructions in children. Material and methods Five different large vessel stents were evaluated in an in-vitro setting. All stents were expanded to the maximal vendor recommended diameter (20mm; n = 4 or 10mm; n = 1), placed in an anthropomorphic chest phantom and imaged with a 256-slice CT-scanner. MRI images were acquired at 1.5T using a multi-slice T(2)(-)weighted turbo spin echo, an RF-spoiled three-dimensional T-1-weighted Fast Field Echo and a balanced turbo field echo 3D sequence. Two blinded observers assessed stent lumen visibility (measured diameter/true diameter *100%) in the center and at the outlets of the stent. Reproducibility of diameter measurements was evaluated using the intraclass correlation coefficient for reliability and 95% limits of agreement for agreement analysis. Results Median stent lumen visibility was 88 (IQR 86-90)% with CT for all stents at both the center and outlets. With MRI, the T-2-weighted turbo spin echo sequence was preferred which resulted in 82 (78-84%) stent lumen visibility. Interobserver reliability and agreement was good for both CT (ICC 0.997, mean difference -0.51 [-1.07-0.05] mm) and MRI measurements ( ICC 0.951, mean difference -0.05 [-2.52--2.41] mm). Conclusion Good in-stent lumen visibility was achievable in this in-vitro study with both CT and MRI in different great vessel stents. Overall reliability was good with clinical acceptable limits of agreement for both CT and MRI. However, common conditions such as in-stent stenosis and associated aneurysms were not tested in this in-vitro study, limiting the value of the in-vitro study.	[den Harder, A. M.; Sucha, D.; van Hamersvelt, R. W.; de Jong, P. A.; Schilham, A. M. R.; Bos, C.; Leiner, T.] Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands; [Budde, R. P. J.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Breur, J. M. P. J.] Univ Utrecht, Med Ctr, Dept Pediat Cardiol, Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University	den Harder, AM (corresponding author), Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands.	a.m.denharder@umcutrecht.nl	van Hamersvelt, Robbert/J-4325-2019; breur, hans/AAY-2340-2020; Harder, Annemarie M. den/J-3266-2019; Budde, Ricardo/E-4252-2015	van Hamersvelt, Robbert/0000-0002-6084-0656; Harder, Annemarie M. den/0000-0002-9679-396X; 				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chakrabarti S, 2010, HEART, V96, P1212, DOI 10.1136/hrt.2009.170928; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; den Harder AM, 2015, AM J ROENTGENOL, V204, P645, DOI 10.2214/AJR.14.12590; Eichhorn JG, 2006, CATHETER CARDIO INTE, V68, P11, DOI 10.1002/ccd.20760; Eichhorn JG, 2008, CATHETER CARDIO INTE, V72, P544, DOI 10.1002/ccd.21680; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Holton A, 2002, J CARDIOV MAGN RESON, V4, P423, DOI 10.1081/JCMR-120016381; Hug J, 2000, RADIOLOGY, V216, P781, DOI 10.1148/radiology.216.3.r00se03781; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Maintz D, 2006, EUR RADIOL, V16, P818, DOI 10.1007/s00330-005-0062-8; Nordmeyer J, 2010, AM J ROENTGENOL, V195, P865, DOI 10.2214/AJR.09.4166; OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923; Parker MW, 2015, PEDIATRICS; Quality Assurance in Radiology and Medicine (QRM) GmbH, 2008, ANTHR CARD PHANT; Rutledge JM, 2001, CATHETER CARDIO INTE, V53, P519, DOI 10.1002/ccd.1214; Shih Ming-Chen Paul, 2006, AJR Am J Roentgenol, V187, pW302, DOI 10.2214/AJR.05.0424; Strohm O, 1999, J CARDIOV MAGN RESON, V1, P239, DOI 10.3109/10976649909088336; Strouse PJ, 1996, AM J CARDIOL, V78, P490, DOI 10.1016/0002-9149(97)00004-0; Sun Z, 2010, SINGAP MED J, V51, P457; Taylor AM, 2008, PEDIATR RADIOL, V38, pS433, DOI 10.1007/s00247-008-0843-8; Turner D R, 2007, Semin Intervent Radiol, V24, P153, DOI 10.1055/s-2007-980052; van der Laan MJ, 2004, J ENDOVASC THER, V11, P366, DOI 10.1583/04-1246.1; Yang WJ, 2012, KOREAN J RADIOL, V13, P20, DOI 10.3348/kjr.2012.13.1.20	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171138	10.1371/journal.pone.0171138	http://dx.doi.org/10.1371/journal.pone.0171138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141852	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500041
J	Anderson, BM; Thiele, KR; Krauss, SL; Barrett, MD				Anderson, Benjamin M.; Thiele, Kevin R.; Krauss, Siegfried L.; Barrett, Matthew D.			Genotyping-by-Sequencing in a Species Complex of Australian Hummock Grasses (Triodia): Methodological Insights and Phylogenetic Resolution	PLOS ONE			English	Article							COALESCENT MODEL; EVOLUTIONARY HISTORY; WESTERN-AUSTRALIA; DE-NOVO; TREES; POACEAE; PHYLOGENOMICS; DIVERSITY; LIZARDS; INTROGRESSION	Next-generation sequencing is becoming increasingly accessible to researchers asking bio-systematic questions, but current best practice in both choosing a specific approach and effectively analysing the resulting data set is still being explored. We present a case study for the use of genotyping-by-sequencing (GBS) to resolve relationships in a species complex of Australian arid and semi-arid grasses (Triodia R.Br.), highlighting our solutions to methodological challenges in the use of GBS data. We merged overlapping paired-end reads then optimised locus assembly in the program PyRAD to generate GBS data sets for phylogenetic and distance-based analyses. In addition to traditional concatenation analyses in RAxML, we also demonstrate the novel use of summary species tree analyses (taking gene trees as input) with GBS loci. We found that while species tree analyses were relatively robust to variation in PyRAD assembly parameters, our RAxML analyses resulted in well-supported but conflicting topologies under different assembly settings. Despite this conflict, multiple clades in the complex were consistently supported as distinct across analyses. Our GBS data assembly and analyses improve the resolution of taxa and phylogenetic relationships in the Triodia basedowii complex compared to our previous study based on Sanger sequencing of nuclear (ITS/ETS) and chloroplast (rps16-trnK spacer) markers. The genomic results also partly support previous evidence for hybridization between species in the complex. Our methodological insights for analysing GBS data will assist researchers using similar data to resolve phylogenetic relationships within species complexes.	[Anderson, Benjamin M.; Thiele, Kevin R.; Krauss, Siegfried L.; Barrett, Matthew D.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Anderson, Benjamin M.; Krauss, Siegfried L.; Barrett, Matthew D.] Bot Gardens & Parks Author, Kings Pk & Bot Garden, Kings Pk, WA, Australia; [Thiele, Kevin R.] Western Australia Herbarium, Dept Pk & Wildlife, Kensington, NSW, Australia	University of Western Australia	Anderson, BM (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.; Anderson, BM (corresponding author), Bot Gardens & Parks Author, Kings Pk & Bot Garden, Kings Pk, WA, Australia.	banderson2914@gmail.com	Barrett, Matthew D/H-8435-2012; Thiele, Kevin/W-1876-2019	Barrett, Matthew D/0000-0002-2926-4291; Thiele, Kevin/0000-0002-6658-6636; Anderson, Benjamin/0000-0001-9755-4365; Krauss, Siegfried/0000-0002-7280-6324	Australian Research Council [120100350]; ANZ Trustees Holsworth Wildlife Research Endowment; governments of Australia and Western Australia; International Postgraduate Research Scholarship at the University of Western Australia; Australian Postgraduate Award at the University of Western Australia; UWA Top-up scholarship at the University of Western Australia	Australian Research Council(Australian Research Council); ANZ Trustees Holsworth Wildlife Research Endowment; governments of Australia and Western Australia; International Postgraduate Research Scholarship at the University of Western Australia; Australian Postgraduate Award at the University of Western Australia; UWA Top-up scholarship at the University of Western Australia	This research was partly supported by the Australian Research Council Linkage Project 120100350 (Cls Grierson, Krauss et al. in collaboration with Rio Tinto Iron Ore, Chevron, Botanic Gardens and Parks Authority and the Department of Parks and Wildlife). Fieldwork was partly supported by an ANZ Trustees Holsworth Wildlife Research Endowment to BMA. Sequencing costs were partly covered by the Australasian Systematic Botany Society through a Hansjorg Eichler Scientific Research Grant to BMA. Initial testing of assembly programs was conducted with resources provided by the Pawsey Supercomputing Centre with funding from the governments of Australia and Western Australia. BMA was supported by an International Postgraduate Research Scholarship, Australian Postgraduate Award and UWA Top-up scholarship at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2014, NATURE, V511, P83, DOI 10.1038/nature13285; Anderson BM, 2016, MOL PHYLOGENET EVOL, V101, P142, DOI 10.1016/j.ympev.2016.05.014; Armstrong G., 2008, Journal of the Royal Society of Western Australia, V91, P313; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baldassarre DT, 2014, EVOLUTION, V68, P2644, DOI 10.1111/evo.12457; Barker WR., 2005, AUST SYST BOT SOC NE, V122, P11; Barrett R.L., 2005, FLORA AUSTR, P458; Barrett Russell L., 2015, Nuytsia, V26, P21; Barrett RL, 2011, TELOPEA, V13, P57; Beadle N., 1981, VEGETATION AUSTR; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crisp MD, 2015, PHYTOTAXA, V230, P293; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2016, MOL PHYLOGENET EVOL, V94, P447, DOI 10.1016/j.ympev.2015.10.027; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Giarla TC, 2015, SYST BIOL, V64, P727, DOI 10.1093/sysbio/syv029; Gohli J, 2015, MOL ECOL, V24, P180, DOI 10.1111/mec.13008; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grabowski PP, 2014, MOL ECOL, V23, P4059, DOI 10.1111/mec.12845; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; GRIFFIN GF, 1990, J VEG SCI, V1, P435, DOI 10.2307/3235776; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamlin JAP, 2014, ECOL EVOL, V4, P743, DOI 10.1002/ece3.964; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Hurry CR, 2012, AUST SYST BOT, V25, P304, DOI 10.1071/SB10044; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jarvis A, 2008, HOLE FILLED SEAMLESS; KITCHENER DJ, 1983, AUST J ZOOL, V31, P361, DOI 10.1071/ZO9830361; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lazarides M, 1997, AUST SYST BOT, V10, P381, DOI 10.1071/SB96012; Leache AD, 2015, SYST BIOL, V64, P1032, DOI 10.1093/sysbio/syv053; Leache AD, 2015, GENOME BIOL EVOL, V7, P706, DOI 10.1093/gbe/evv026; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; MORTON SR, 1988, AM NAT, V132, P237, DOI 10.1086/284847; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyron RA, 2014, MOL PHYLOGENET EVOL, V81, P221, DOI 10.1016/j.ympev.2014.08.023; Python Software Foundation, 2016, PYTH LANG REF VERS 2; Rambaut A., 2014, FIGTREE WWW DOCUMENT; Rambaut A., 2014, TRACER; Rivers D.M., 2016, CLADISTICS; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Sedeek KEM, 2014, MOL ECOL, V23, P6192, DOI 10.1111/mec.12992; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Simmons MP, 2014, MOL PHYLOGENET EVOL, V74, P1, DOI 10.1016/j.ympev.2014.01.030; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Springer MS, 2016, MOL PHYLOGENET EVOL, V94, P1, DOI 10.1016/j.ympev.2015.07.018; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicher JW, 2016, SYST BIOL, V65, P128, DOI 10.1093/sysbio/syv058; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vachaspati P, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S3; Waters C, 2010, AUST J BOT, V58, P23, DOI 10.1071/BT09138; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	74	21	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171053	10.1371/journal.pone.0171053	http://dx.doi.org/10.1371/journal.pone.0171053			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135342	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700043
J	Han, Y; Liu, Y; Wang, HY; Liu, XJ				Han, Ying; Liu, Yuan; Wang, Haoyou; Liu, Xiangjun			The Evolution of Vicia ramuliflora (Fabaceae) at Tetraploid and Diploid Levels Revealed with FISH and RAPD	PLOS ONE			English	Article							GENOME EVOLUTION; POLYPLOIDY; DIVERSITY; GENES	Vicia ramuliflora L. is a widely distributed species in Eurasia with high economic value. For past 200 years, it has evolved a tetraploid cytotype and new subspecies at the diploid level. Based on taxonomy, cytogeography and other lines of evidence, previous studies have provided valuable information about the evolution of V. ramuliflora ploidy level, but due to the limited resolution of traditional methods, important questions remain. In this study, fluorescence in situ hybridization (FISH) and random amplified polymorphic DNA (RAPD) were used to analyze the evolution of V. ramuliflora at the diploid and tetraploid levels. Our aim was to reveal the genomic constitution and parents of the tetraploid V. ramuliflora and the relationships among diploid V. ramuliflora populations. Our study showed that the tetraploid cytotype of V. ramuliflora at Changbai Mountains (M) has identical 18S and 5S rDNA distribution patterns with the diploid Hengdaohezi population (B) and the diploid Dailing population (H). However, UPGMA clustering, Neighbor-Joining clustering and principal coordinates analysis based on RAPD showed that the tetraploid cytotype (M) has more close relationships with Qianshan diploid population T. Based on our results and the fact that inter specific hybridization among Vicia species is very difficult, we think that the tetraploid V. ramuliflora is an autotetraploid and its genomic origin still needs further study. In addition, our study also found that Qianshan diploid population (T) had evolved distinct new traits compared with other diploid populations, which hints that V. ramuliflora evolved further at diploid level. We suggest that diploid population T be re-classified as a new subspecies.	[Han, Ying] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Liu, Yuan; Liu, Xiangjun] Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China; [Wang, Haoyou] Harbin Normal Univ, Sch Life Sci & Technol, Harbin, Peoples R China	Southwest University of Science & Technology - China; Tianjin Normal University; Harbin Normal University	Han, Y (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China.	hanxx908@umn.edu			National Natural Science Foundation of China [30070060, 31300511]; Science Foundation for The Excellent Youth Scholars of Ministry of Education of China [1692]; China Scholarship Council [201408510074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for The Excellent Youth Scholars of Ministry of Education of China; China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (30070060): this funder had a role in study design, data collection and analysis, decision to publish; Science Foundation for The Excellent Youth Scholars of Ministry of Education of China (1692): this funder had a role in study design, data collection and analysis, decision to publish; National Natural Science Foundation of China (31300511): this funder had a role in preparation of the manuscript and decision to publish; and China Scholarship Council (201408510074): this funder had a role in preparation of the manuscript and decision to publish.	Abdullah AY, 2010, TROP ANIM HEALTH PRO, V42, P293, DOI 10.1007/s11250-009-9420-x; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alzueta C, 2001, J ANIM SCI, V79, P2449; Belling J, 1925, J GENET, V15, P245, DOI 10.1007/BF02983121; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Caballero R., 2008, J SUSTAIN AGR, V3, P133; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu PY, 1976, FLORA NE CHINA HERBS; GRANT V, 1952, CHROMOSOMA, V5, P372; Haddad SG, 2006, LIVEST SCI, V99, P221, DOI 10.1016/j.livprodsci.2005.06.014; Han Y, 2010, BIOCHEM GENET, V48, P385, DOI 10.1007/s10528-009-9320-9; Kay Q. O. N, 1969, WATSONIA, V7, P130; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Li RJ, 1996, STUDY BIOSYSTEMATICS; Li RJ, 1993, B BOT RES CHINA, V13, P243; [李骁 Li Xiao], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P1814; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu SY, 2011, SCI HORTIC-AMSTERDAM, V127, P411, DOI 10.1016/j.scienta.2010.10.012; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MCHALE NA, 1983, CAN J GENET CYTOL, V25, P609, DOI 10.1139/g83-091; Plitmann U., 1989, Monographs in Systematic Botany from the Missouri Botanical Garden, V29, P487; Rohlf PJ, 1997, NTSYS PC NUMERICAL T; Traldi JB, 2013, GENET MOL RES, V12, P463, DOI 10.4238/2013.February.8.11; Wei JZ, 1995, GENOME, V38, P1230, DOI 10.1139/g95-161; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xia ZD, 1996, ZHIWU FENLEI XUEBAO, V34, P421; Xu BS, 1984, ACTA BOT YUNNANICA, V7, P425; Yeh F.C, 1999, POPGENE VERSION 3 2; Zhang DM, 1999, AM J BOT, V86, P735, DOI 10.2307/2656583; 刘祥君, 1997, 植物研究, V17, P421	36	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170695	10.1371/journal.pone.0170695	http://dx.doi.org/10.1371/journal.pone.0170695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135314	Green Submitted, Green Published, gold			2022-12-26	WOS:000396124700019
J	Acerbi, L; Vijayakumar, S; Wolpert, DM				Acerbi, Luigi; Vijayakumar, Sethu; Wolpert, Daniel M.			Target Uncertainty Mediates Sensorimotor Error Correction	PLOS ONE			English	Article							BAYESIAN DECISION-THEORY; FEEDBACK-CONTROL; VISUAL FEEDBACK; PERCEPTION; HAND; NOISE	Human movements are prone to errors that arise from inaccuracies in both our perceptual processing and execution of motor commands. We can reduce such errors by both improving our estimates of the state of the world and through online error correction of the ongoing action. Two prominent frameworks that explain how humans solve these problems are Bayesian estimation and stochastic optimal feedback control. Here we examine the interaction between estimation and control by asking if uncertainty in estimates affects how subjects correct for errors that may arise during the movement. Unbeknownst to participants, we randomly shifted the visual feedback of their finger position as they reached to indicate the center of mass of an object. Even though participants were given ample time to compensate for this perturbation, they only fully corrected for the induced error on trials with low uncertainty about center of mass, with correction only partial in trials involving more uncertainty. The analysis of subjects' scores revealed that participants corrected for errors just enough to avoid significant decrease in their overall scores, in agreement with the minimal intervention principle of optimal feedback control. We explain this behavior with a term in the loss function that accounts for the additional effort of adjusting one's response. By suggesting that subjects' decision uncertainty, as reflected in their posterior distribution, is a major factor in determining how their sensorimotor system responds to error, our findings support theoretical models in which the decision making and control processes are fully integrated.	[Acerbi, Luigi; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland; [Acerbi, Luigi] Univ Edinburgh, Sch Informat, Doctoral Training Ctr Neuroinformat & Computat Ne, Edinburgh, Midlothian, Scotland; [Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge, England; [Acerbi, Luigi] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Edinburgh; University of Edinburgh; University of Cambridge; New York University	Acerbi, L (corresponding author), Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland.; Acerbi, L (corresponding author), Univ Edinburgh, Sch Informat, Doctoral Training Ctr Neuroinformat & Computat Ne, Edinburgh, Midlothian, Scotland.; Acerbi, L (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	luigi.acerbi@nyu.edu	Acerbi, Luigi/H-3131-2019	Acerbi, Luigi/0000-0001-7471-7336; Wolpert, Daniel/0000-0003-2011-2790	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F500385/1, BB/F529254/1]; UK Biotechnology and Biological Sciences Research Council (BBSRC); UK Medical Research Council (MRC); Wellcome Trust; Human Frontiers Science Program; Royal Society Noreen Murray Professorship in Neurobiology; Microsoft Research; Royal Academy of Engineering; EU; eDIKT initiative	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Human Frontiers Science Program(Human Frontier Science Program); Royal Society Noreen Murray Professorship in Neurobiology; Microsoft Research(Microsoft); Royal Academy of Engineering(Royal Academy of Engineering - UK); EU(European Commission); eDIKT initiative	This work was supported in part by grants EP/F500385/1 and BB/F529254/1 for the University of Edinburgh School of Informatics Doctoral Training Centre in Neuroinformatics and Computational Neuroscience from the UK Engineering and Physical Sciences Research Council (EPSRC), UK Biotechnology and Biological Sciences Research Council (BBSRC), and the UK Medical Research Council (MRC) to L. Acerbi. This work was also supported by the Wellcome Trust, the Human Frontiers Science Program, and the Royal Society Noreen Murray Professorship in Neurobiology (D. M. Wolpert). S. Vijayakumar is supported through grants from Microsoft Research, Royal Academy of Engineering and EU FP7 programs. The work has made use of resources provided by the Edinburgh Compute and Data Facility, which has support from the eDIKT initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003661; Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Crevecoeur F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003177; Dimitriou M, 2013, J NEUROSCI, V33, P10898, DOI 10.1523/JNEUROSCI.5669-12.2013; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friedenberg J, 2002, PERCEPT PSYCHOPHYS, V64, P531, DOI 10.3758/BF03194724; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Grau-Moya J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002698; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; Izawa J, 2008, J NEUROSCI, V28, P11360, DOI 10.1523/JNEUROSCI.3063-08.2008; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Ma WJ, 2012, TRENDS COGN SCI, V16, P511, DOI 10.1016/j.tics.2012.08.010; Maloney LT, 2009, VISUAL NEUROSCI, V26, P147, DOI 10.1017/S0952523808080905; Mitrovic D, 2010, STUD COMPUT INTELL, V264, P65; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Rawlik Konrad, 2013, P 23 INT JOINT C ART; Sarlegna FR, 2014, VISION RES; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seydell A, 2008, J NEUROSCI, V28, P4356, DOI 10.1523/JNEUROSCI.0647-08.2008; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; van Dam LCJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078757; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2	50	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170466	10.1371/journal.pone.0170466	http://dx.doi.org/10.1371/journal.pone.0170466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129323	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400057
J	Henley, AB; Yang, L; Chuang, KL; Sahuri-Arisoylu, M; Wu, LH; Bligh, SWA; Bell, JD				Henley, Aine Brigette; Yang, Ling; Chuang, Kun-Lin; Sahuri-Arisoylu, Meliz; Wu, Li-Hong; Bligh, S. W. Annie; Bell, Jimmy David			Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'	PLOS ONE			English	Article							CELL LUNG-CARCINOMA; MITOCHONDRIAL DYSFUNCTION; COLON-CANCER; IN-VITRO; WITHAFERIN; ATP; INHIBITION; METABOLISM; GENERATION; QUERCETIN	Withania somnifera extracts are known for their anti-cancerous, anti-inflammatory and antioxidative properties. One of their mechanisms of actions is to modulate mitochondrial function through increasing oxidative stress. Recently `priming' has been suggested as a potential mechanism for enhancing cancer cell death. In this study we demonstrate that `priming', in HT-29 colon cells, with W. somnifera root extract increased the potency of the chemotherapeutic agent cisplatin. We have also showed the W. somnifera root extract enhanced mitochondrial dysfunction and that the underlying mechanism of `priming' was selectively through increased ROS. Moreover, we showed that this effect was not seen in non-cancerous cells.	[Henley, Aine Brigette; Sahuri-Arisoylu, Meliz; Bligh, S. W. Annie; Bell, Jimmy David] Univ Westminster, Fac Sci & Technol, Dept Life Sci, London, England; [Yang, Ling; Chuang, Kun-Lin] China Med Univ, Coll Pharm, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Wu, Li-Hong] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Henley, Aine Brigette] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden	University of Westminster; China Medical University Taiwan; Shanghai University of Traditional Chinese Medicine; Karolinska Institutet	Bligh, SWA (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Life Sci, London, England.	a.bligh@westminster.ac.uk	Bligh, Annie/AAI-9786-2020	Bligh, Annie/0000-0002-4757-2159; Bell, Jimmy/0000-0003-3804-1281	MRC [MC_U120061305] Funding Source: UKRI; Medical Research Council [MC_U120061305] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Biswal BM, 2013, INTEGR CANCER THER, V12, P312, DOI 10.1177/1534735412464551; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Caley ACR., 2012, SURGERY, V30, P186, DOI DOI 10.1016/J.MPSUR.2012.01.004; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hahm ER, 2011, MOL CARCINOGEN, V50, P614, DOI 10.1002/mc.20760; Halder B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137498; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Jiang K, 2015, ONCOL REP, V33, P2711, DOI 10.3892/or.2015.3915; Kuhar M, 2006, ANTICANCER RES, V26, P1297; Kuhar M., 2007, J CANC MOL, V3, P121, DOI DOI 10.29685/JCM.200708.0004; Kumar A, 2012, MOL CELL BIOCHEM, V371, P43, DOI 10.1007/s11010-012-1421-9; Kumar P, 2009, J MED FOOD, V12, P591, DOI 10.1089/jmf.2008.0028; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li X, 2015, CANCER LETT, V357, P219, DOI 10.1016/j.canlet.2014.11.026; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Mei Y., 2014, BIOCH BIOPHYS ACTA; Muller MF, 2016, VIRCHOWS ARCH, V469, P125, DOI 10.1007/s00428-016-1956-3; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Rajeswaran A, 2008, LUNG CANCER, V59, P1, DOI 10.1016/j.lungcan.2007.07.012; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sarosiek KA, 2013, TRENDS CELL BIOL, V23, P612, DOI 10.1016/j.tcb.2013.08.003; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sharma H, 2005, CANCER BIOL THER, V4, P949, DOI 10.4161/cbt.4.9.1908; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yadav B, 2010, INDIAN J PHARM SCI, V72, P659, DOI 10.4103/0250-474X.78543; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhang X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3983	47	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170917	10.1371/journal.pone.0170917	http://dx.doi.org/10.1371/journal.pone.0170917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129345	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400027
J	He, Y; Northey, JJ; Pelletier, A; Kos, Z; Meunier, L; Haibe-Kains, B; Mes-Masson, AM; Cote, JF; Siegel, PM; Lamarche-Vane, N				He, Y.; Northey, J. J.; Pelletier, A.; Kos, Z.; Meunier, L.; Haibe-Kains, B.; Mes-Masson, A-M; Cote, J-F; Siegel, P. M.; Lamarche-Vane, N.			The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer	ONCOGENE			English	Article							SMAD-INTERACTING PROTEIN-1; GTPASE-ACTIVATING PROTEIN; ADAMS-OLIVER SYNDROME; OF-FUNCTION MUTATIONS; PHOSPHORYLATES CDGAP; CELL MOTILITY; EXPRESSION; GENE; ARHGAP31; RECEPTOR	The loss of E-cadherin causes dysfunction of the cell-cell junction machinery, which is an initial step in epithelial-to-mesenchymal transition (EMT), facilitating cancer cell invasion and the formation of metastases. A set of transcriptional repressors of E-cadherin (CDH1) gene expression, including Snail1, Snail2 and Zeb2 mediate E-cadherin downregulation in breast cancer. However, the molecular mechanisms underlying the control of E-cadherin expression in breast cancer progression remain largely unknown. Here, by using global gene expression approaches, we uncover a novel function for Cdc42 GTPase-activating protein (CdGAP) in the regulation of expression of genes involved in EMT. We found that CdGAP used its proline-rich domain to form a functional complex with Zeb2 to mediate the repression of E-cadherin expression in ErbB2-transformed breast cancer cells. Conversely, knockdown of CdGAP expression led to a decrease of the transcriptional repressors Snail1 and Zeb2, and this correlated with an increase in E-cadherin levels, restoration of cell-cell junctions, and epithelial-like morphological changes. In vivo, loss of CdGAP in ErbB2-transformed breast cancer cells impaired tumor growth and suppressed metastasis to lungs. Finally, CdGAP was highly expressed in basal-type breast cancer cells, and its strong expression correlated with poor prognosis in breast cancer patients. Together, these data support a previously unknown nuclear function for CdGAP where it cooperates in a GAP-independent manner with transcriptional repressors to function as a critical modulator of breast cancer through repression of E-cadherin transcription. Targeting Zeb2-CdGAP interactions may represent novel therapeutic opportunities for breast cancer treatment.	[He, Y.; Lamarche-Vane, N.] McGill Univ, Dept Anat & Cell Biol, McGill Univ Hlth Ctr, Canc Res Program,Res Inst, Montreal, PQ, Canada; [Northey, J. J.; Siegel, P. M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Pelletier, A.; Cote, J-F] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Kos, Z.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Meunier, L.; Mes-Masson, A-M] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Haibe-Kains, B.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Haibe-Kains, B.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Haibe-Kains, B.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Northey, J. J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of California System; University of California San Francisco	Lamarche-Vane, N (corresponding author), McGill Univ, Anat & Cell Biol, RI MUHC, 1001 Boul Decarie,Room E02-6230, Montreal, PQ H4A 3J1, Canada.	Nathalie.lamarche@mcgill.ca	Northey, Jason/AAX-6365-2021; Haibe-Kains, Benjamin/D-3702-2011	Northey, Jason/0000-0003-3115-2560; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Haibe-Kains, Benjamin/0000-0002-7684-0079	FRSQ chercheur-national; William Dawson scholar; Canadian Institute for Health Research (CIHR) [MOP-119544, MOP-144425]; FRQS senior scholarship	FRSQ chercheur-national(Fonds de la Recherche en Sante du Quebec); William Dawson scholar; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRQS senior scholarship	We thank Dr Patricia Tonin for helpful discussions and Dr John J Bergeron for critically reading this manuscript. We are grateful to Dr Morag Park (McGill University) for providing the Zeb2 and E-cadherin-luc constructs. We thank Dr Torsten Nielsen for providing the human breast cancer TMA and the CdGAP IHC staining through the Genetic Pathology Evaluation Center (GPEC), ZF Dong for IHC staining of primary tumors, Dr Min Fu for assistance with confocal microscopy at the imaging platform of the RI-MUHC, Martin Primeau and Vilayphone Luangrath for affinity purification of the CdGAP antibodies. NL-V was a recipient of a FRSQ chercheur-national and a William Dawson scholar. Canadian Institute for Health Research (CIHR) MOP-119544 to NL-V and MOP-144425 to JFC. JFC is a recipient of a FRQS senior scholarship.	Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Barras D, 2014, CANCER METAST REV, V33, P87, DOI 10.1007/s10555-013-9458-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caron C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27485; Danek EI, 2007, J BIOL CHEM, V282, P3624, DOI 10.1074/jbc.M610073200; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hajra KM, 2002, CANCER RES, V62, P1613; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hu QP, 2016, INT J CANCER, V138, P2804, DOI 10.1002/ijc.29982; Isrie M, 2014, AM J MED GENET A, V164, P1576, DOI 10.1002/ajmg.a.36486; Karimzadeh F, 2012, J BIOL CHEM, V287, P19610, DOI 10.1074/jbc.M112.344606; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Liu CL, 2002, AM J PATHOL, V161, P1557, DOI 10.1016/S0002-9440(10)64434-3; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Makretsov N, 2003, HUM PATHOL, V34, P1001, DOI 10.1053/S0046-8177(03)00411-8; Meester JAN, 2015, AM J HUM GENET, V97, P475, DOI 10.1016/j.ajhg.2015.07.015; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Naji L, 2011, BIOCHEM BIOPH RES CO, V409, P96, DOI 10.1016/j.bbrc.2011.04.116; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Parker RL, 2002, AM J CLIN PATHOL, V117, P723; Sanchez-Tillo E, 2011, AM J CANCER RES, V1, P897; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Southgate L, 2015, CIRC-CARDIOVASC GENE, V8, P572, DOI 10.1161/CIRCGENETICS.115.001086; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tabaries S, 2015, ONCOTARGET, V6, P9476, DOI 10.18632/oncotarget.3269; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang CA, 2014, CANCER RES, V74, P7357, DOI 10.1158/0008-5472.CAN-14-0666; Wang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5735; Wong TS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/921564; Wu ZQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4998	46	26	28	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3490	3503		10.1038/onc.2016.492	http://dx.doi.org/10.1038/onc.2016.492			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28135249	Green Accepted			2022-12-26	WOS:000403340700012
J	Gillissen, B; Richter, A; Richter, A; Preissner, R; Schulze-Osthoff, K; Essmann, F; Daniel, PT				Gillissen, Bernhard; Richter, Anja; Richter, Antje; Preissner, Robert; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.			Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-MEDIATED APOPTOSIS; HEPATOCELLULAR-CARCINOMA; BCL-2 FAMILY; CANCER-CELLS; CASPASE ACTIVATION; IN-VITRO; DEATH; PROTEIN; INHIBITION; RECEPTOR	Renal cell carcinoma (RCC) is polyresistant to chemo-and radiotherapy and biologicals, including TNF-related apoptosisinducing ligand (TRAIL). Sorafenib, a multikinase inhibitor approved for the treatment of RCC, has been shown to sensitize cancer cells to TRAIL-induced apoptosis, in particular by downregulation of the Bak-inhibitory Bcl-2 family protein Mcl-1. Here we demonstrate that sorafenib overcomes TRAIL resistance in RCC by a mechanism that does not rely on Mcl-1 downregulation. Instead, sorafenib induces rapid dissipation of the mitochondrial membrane potential (Delta psi m) that is accompanied by the accumulation of reactive oxygen species (ROS). Loss of Delta psi m and ROS production induced by sorafenib are independent of caspase activities and do not depend on the presence of the proapoptotic Bcl-2 family proteins Bax or Bak, indicating that both events are functionally upstream of the mitochondrial apoptosis signaling cascade. More intriguingly, we find that it is sorafenib-induced ROS accumulation that enables TRAIL to activate caspase-8 in RCC. This leads to apoptosis that involves activation of an amplification loop via the mitochondrial apoptosis pathway. Thus, our mechanistic data indicate that sorafenib bypasses central resistance mechanisms through a direct induction of Delta psi m breakdown and ROS production. Activation of this pathway might represent a useful strategy to overcome the cell-inherent resistance to cancer therapeutics, including TRAIL, in multiresistant cancers such as RCC.	[Gillissen, Bernhard; Richter, Anja; Richter, Antje; Daniel, Peter T.] Humboldt Univ, Univ Med Ctr Charite, Dept Hematol Oncol & Tumor Immunol, Campus Berlin Buch, Berlin, Germany; [Gillissen, Bernhard; Richter, Anja; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.] German Canc Consortium, D-69120 Heidelberg, Germany; [Gillissen, Bernhard; Richter, Anja; Schulze-Osthoff, Klaus; Essmann, Frank; Daniel, Peter T.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Daniel, Peter T.] Max Delbruck Ctr Mol Med, Clin & Mol Oncol, D-13125 Berlin, Germany; [Schulze-Osthoff, Klaus; Essmann, Frank] Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany; [Preissner, Robert] Univ Med Ctr Charite, Inst Physiol, D-13125 Berlin, Germany; [Preissner, Robert] Univ Med Ctr Charite, Expt Clin Res Ctr, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daniel, PT (corresponding author), Univ Med Ctr Charite, Clin & Mol Oncol, Lindenberger Weg 80, D-13125 Berlin, Germany.; Daniel, PT (corresponding author), Max Delbruck Ctr Mol Med, Lindenberger Weg 80, D-13125 Berlin, Germany.	pdaniel@mdc-berlin.de	Essmann, Frank/ABG-7409-2020; Schulze-Osthoff, Klaus/N-9025-2013	Essmann, Frank/0000-0003-4369-8456; Schulze-Osthoff, Klaus/0000-0003-1443-2720; preissner, robert/0000-0002-2407-1087; Gillissen, Bernhard/0000-0002-1815-2091	Stiftung Urologische Forschung Berlin; Deutsche Krebshilfe; Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum	Stiftung Urologische Forschung Berlin; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum	This work was supported by the Stiftung Urologische Forschung Berlin, Deutsche Krebshilfe, and Deutsches Konsortium fur Translationale Krebsforschung (DKTK) - Deutsches Krebsforschungszentrum. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulghani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075414; Bender T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011106; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Bracarda S, 2007, ANN ONCOL, V18, P22, DOI 10.1093/annonc/mdm219; Brooks AD, 2010, MOL CANCER RES, V8, P729, DOI 10.1158/1541-7786.MCR-10-0022; Bull VH, 2012, J PROTEOME RES, V11, P1609, DOI 10.1021/pr200790e; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen KF, 2013, BRIT J PHARMACOL, V168, P658, DOI 10.1111/j.1476-5381.2012.02212.x; Chen KF, 2010, CLIN CANCER RES, V16, P5189, DOI 10.1158/1078-0432.CCR-09-3389; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Coriat R, 2012, MOL CANCER THER, V11, P2284, DOI 10.1158/1535-7163.MCT-12-0093; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Gillissen B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.67; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hemmati PG, 2010, J MOL MED, V88, P609, DOI 10.1007/s00109-010-0606-5; Hoffmann JC, 2009, MOL CELL BIOL, V29, P4431, DOI 10.1128/MCB.02261-07; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuo YC, 2012, BIOMED PHARMACOTHER, V66, P12, DOI 10.1016/j.biopha.2011.09.011; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; Nojiri K, 2013, INT J ONCOL, V42, P101, DOI 10.3892/ijo.2012.1676; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Perez-Cruz I, 2007, APOPTOSIS, V12, P225, DOI 10.1007/s10495-006-0475-0; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; Schmelz K, 2004, ONCOGENE, V23, P6743, DOI 10.1038/sj.onc.1207848; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wang C, 2012, COMMUN ASSOC INF SYS, V31, P105; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	57	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6478	6492		10.1074/jbc.M116.754184	http://dx.doi.org/10.1074/jbc.M116.754184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28154184	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000399813400006
J	Irure, J; Asensio, E; Rodrigo, E; Romon, I; Gomez, J; Arias, M; Lopez-Hoyos, M; Segundo, DS				Irure, Juan; Asensio, Esther; Rodrigo, Emilio; Romon, Inigo; Gomez, Javier; Arias, Manuel; Lopez-Hoyos, Marcos; Segundo, David San			Improvement in the definition of anti-HLA antibody profile in highly sensitized patients	PLOS ONE			English	Article							COMPLEMENT INTERFERENCE; KIDNEY-TRANSPLANT; STRENGTH	The definition of anti-HLA antibody profile in highly sensitized patients on a waiting list is crucial when virtual crossmatch is used in organ allocation systems, but also when used to identify the true deleterious anti-HLA antibodies. Here we propose different levels of risk based on the results of anti-HLA antibody testing in neat serum (N) and after sera dilution (DIL) and C1q test in 18 highly sensitized patients. This group was heterogeneous in terms of anti-HLA antibody titers and their ability to fix complement. After dilution, 15 out of 18 patients (83.3%) showed a reduction of positive bead counts whereas 4 patients showed a prozone effect and complement fixation was demonstrated. The high dilution of sera and ascertaining the complement fixation allow the accurate definition of risk anti-HLA antibody profiles in highly sensitized patients, as demonstrated in 5 of the sensitized patients who were transplanted.	[Irure, Juan; Asensio, Esther; Lopez-Hoyos, Marcos; Segundo, David San] Univ Hosp Marques de Valdecilla, Serv Immunol, IDIVAL, Santander, Spain; [Irure, Juan; Asensio, Esther; Romon, Inigo; Lopez-Hoyos, Marcos; Segundo, David San] Univ Hosp Marques de Valdecilla, Tissue Typing Lab, Santander, Spain; [Rodrigo, Emilio; Arias, Manuel] Univ Hosp Marques de Valdecilla, Serv Nephrol, IDIVAL, Santander, Spain; [Gomez, Javier] Univ Hosp Marques de Valdecilla, Pathol Serv, IDIVAL, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Segundo, DS (corresponding author), Univ Hosp Marques de Valdecilla, Serv Immunol, IDIVAL, Santander, Spain.; Segundo, DS (corresponding author), Univ Hosp Marques de Valdecilla, Tissue Typing Lab, Santander, Spain.	dsansegundo@humv.es	José Javier, Gómez-Román/AAC-8156-2021; López-Hoyos, Marcos/ABC-1024-2020; Romón, Iñigo/M-3497-2019; San Segundo, David/O-9499-2016	José Javier, Gómez-Román/0000-0002-2849-9435; López-Hoyos, Marcos/0000-0003-0562-427X; Romón, Iñigo/0000-0003-2428-4469; San Segundo, David/0000-0001-5745-9072				Berth M, 2015, AM J TRANSPLANTATION; Bray RA, 2009, CURR OPIN ORGAN TRAN, V14, P392, DOI 10.1097/MOT.0b013e32832d31c7; Endres RO, 2010, TRANSFUSION, V50, P1749, DOI 10.1111/j.1537-2995.2010.02589.x; Guidicelli G, 2013, TRANSPL IMMUNOL, V29, P17, DOI 10.1016/j.trim.2013.09.005; Jackson Annette M, 2014, Clin Transpl, P131; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Minucci PB, 2011, EXP CLIN TRANSPLANT, V9, P381; Morris GP, 2010, HUM IMMUNOL, V71, P268, DOI 10.1016/j.humimm.2010.01.003; Tait BD, 2010, TISSUE ANTIGENS, V76, P87, DOI 10.1111/j.1399-0039.2010.01486.x; Tait BD, 2013, TRANSPLANTATION, V95, P19, DOI 10.1097/TP.0b013e31827a19cc; Tambur AR, 2015, AM J TRANSPLANT, V15, P2421, DOI 10.1111/ajt.13295; Tambur AR, 2009, AM J TRANSPLANT, V9, P1886, DOI 10.1111/j.1600-6143.2009.02724.x; Visentin J, 2015, AM J TRANSPLANT, V15, P3271, DOI 10.1111/ajt.13452; Visentin J, 2014, TRANSPLANTATION, V98, P625, DOI 10.1097/TP.0000000000000315	14	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171463	10.1371/journal.pone.0171463	http://dx.doi.org/10.1371/journal.pone.0171463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158255	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700082
J	Li, YH; Wang, HP; Yao, H; O'Bryant, P; Rapp, D; Guo, L; Waly, EA				Li, Yan-He; Wang, Han-Ping; Yao, Hong; O'Bryant, Paul; Rapp, Dean; Guo, Liang; Waly, Eman A.			De novo transcriptome sequencing and analysis of male, pseudo-male and female yellow perch, Perca flavescens	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; KINASE TYPE M2; PYRUVATE-KINASE; CELL-PROLIFERATION; GENE-EXPRESSION; TUMOR-GROWTH; ANNOTATION; MARKERS; GENOME; DIFFERENTIATION	Transcriptome sequencing could facilitate discovery of sex-biased genes, biological pathways and molecular markers, which could help clarify the molecular mechanism of sex determination and sexual dimorphism, and assist with selective breeding in aquaculture. Yellow perch has unique gonad system and sexual dimorphism and is an alternative model to study mechanism of sex determination, sexual dimorphism and sexual selection. In this study, we performed the de novo assembly of yellow perch gonads and muscle transcriptomes by high throughput Illumina sequencing. A total of 212,180 contigs were obtained, ranging from 127 to 64,876 bp, and N50 of 1,066 bp. The assembly RNA-Seq contigs (>= 200bp) were then used for subsequent analyses, including annotation, pathway analysis, and microsatellites discovery. No female-and pseudo-male-biased genes were involved in any pathways while male-biased genes were involved in 29 pathways, and neuroactive ligand receptor interaction and enzyme of trypsin (enzyme code, EC: 3.4.21.4) was highly involved. Pyruvate kinase (enzyme code, EC: 2.7.1.40), which plays important roles in cell proliferation, was highly expressed in muscles. In addition, a total of 183,939 SNPs, 11,286 InDels and 41,479 microsatellites were identified. This study is the first report on transcriptome information in Percids, and provides rich resources for conducting further studies on understanding the molecular basis of sex determinations, sexual dimorphism, and sexual selection in fish, and for population studies and marker-assisted selection in Percids.	[Li, Yan-He; Wang, Han-Ping; Yao, Hong; O'Bryant, Paul; Rapp, Dean; Guo, Liang; Waly, Eman A.] Ohio State Univ South Ctr, Fish Genet & Breeding Lab, Piketon, OH 45661 USA; [Li, Yan-He] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Wang, HP (corresponding author), Ohio State Univ South Ctr, Fish Genet & Breeding Lab, Piketon, OH 45661 USA.	wang.900@osu.edu		Abd El-Gawad, Eman/0000-0001-7516-2969; Li, Yanhe/0000-0001-6451-4527	National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture [2010-38879-20946]	National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	This study was supported by the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture, under Agreement 2010-38879-20946. Salaries and research support were provided by state and federal funds appropriated to The Ohio State University, Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Blazer VS, 2013, SCI TOTAL ENVIRON, V447, P198, DOI 10.1016/j.scitotenv.2012.12.088; Buermans H. P., 2014, BIOCH BIOPHYSICA ACT; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Carmichael SN, 2013, BIOMED RES INT, V14, P408, DOI DOI 10.1155/2014/291067; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; de Cerio OD, 2012, ENVIRON SCI TECHNOL, V46, P7763, DOI 10.1021/es301132b; Doll JC, 2013, T AM FISH SOC, V142, P1012, DOI 10.1080/00028487.2013.793615; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Grzybowski M, 2010, T AM FISH SOC, V139, P270, DOI 10.1577/T07-276.1; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Henderson BA, 2003, CAN J FISH AQUAT SCI, V60, P1345, DOI 10.1139/F03-115; Hood L, 2014, GENETICS GENES GENOM; Krist'an J, 2012, TURK J FISH AQUAT SC, V12, P191, DOI 10.4194/1303-2712-v12_2_01; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Lynn SG, 2006, THESIS; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; MALISON JA, 1986, CAN J FISH AQUAT SCI, V43, P26, DOI 10.1139/f86-004; Manousaki T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-655; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Munro Cathy L., 2012, Proceedings of the Nova Scotian Institute of Science, V47, P131; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoenebeck C, 2012, T AM FISH SOC, V141, P199, DOI 10.1080/00028487.2012.655119; Sharma E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-400; Sun LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050676; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Uphoff CS, 2012, J FRESHWATER ECOL, V27, P507, DOI 10.1080/02705060.2012.684893; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Wei J, 2013, PHYSIOL GENOMICS, V45, P171, DOI 10.1152/physiolgenomics.00139.2011; Wu CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6227; Xue P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144458; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	49	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171187	10.1371/journal.pone.0171187	http://dx.doi.org/10.1371/journal.pone.0171187			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158238	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700038
J	Pornsuwan, S; Maenpuen, S; Kamutira, P; Watthaisong, P; Thotsaporn, K; Tongsook, C; Juttulapa, M; Nijvipakul, S; Chaiyen, P				Pornsuwan, Soraya; Maenpuen, Somchart; Kamutira, Philaiwarong; Watthaisong, Pratchaya; Thotsaporn, Kittisak; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai			3,4-Dihydroxyphenylacetate 2,3-dioxygenase from Pseudomonas aeruginosa: An Fe(II)containing enzyme with fast turnover	PLOS ONE			English	Article							2-HIS-1-CARBOXYLATE FACIAL TRIAD; CLEAVING CATECHOL DIOXYGENASE; NONHEME IRON(II) ENZYMES; HOMOPROTOCATECHUATE 2,3-DIOXYGENASE; ESCHERICHIA-COLI; 2,3-DIHYDROXYPHENYLPROPIONATE 1,2-DIOXYGENASE; ACINETOBACTER-BAUMANNII; DEPENDENT DIOXYGENASES; EXTRADIOL DIOXYGENASE; BREVIBACTERIUM FUSCUM	3,4-dihydroxyphenylacetate (DHPA) dioxygenase (DHPAO) from Pseudomonas aeruginosa (PaDHPAO) was overexpressed in Escherichia coli and purified to homogeneity. As the enzyme lost activity over time, a protocol to reactivate and conserve PaDHPAO activity has been developed. Addition of Fe(II), DTT and ascorbic acid or ROS scavenging enzymes (catalase or superoxide dismutase) was required to preserve enzyme stability. Metal content and activity analyses indicated that PaDHPAO uses Fe(II) as a metal cofactor. NMR analysis of the reaction product indicated that PaDHPAO catalyzes the 2,3-extradiol ring-cleavage of DHPA to form 5-carboxymethyl-2-hydroxymuconate semialdehyde (CHMS) which has a molar absorptivity of 32.23 mM(-1) cm(-1) at 380 nm and pH 7.5. Steady-state kinetics under air-saturated conditions at 25 degrees C and pH 7.5 showed a Km for DHPA of 58 +/- 8 mu M and a k(cat) of 64 s(-1), indicating that the turnover of PaDHPAO is relatively fast compared to other DHPAOs. The pH-rate profile of the PaDHPAO reaction shows a bell-shaped plot that exhibits a maximum activity at pH 7.5 with two pK(a) values of 6.5 +/- 0.1 and 8.9 +/- 0.1. Study of the effect of temperature on PaDHPAO activity indicated that the enzyme activity increases as temperature increases up to 55 degrees C. The Arrhenius plot of ln(k'(cat)) versus the reciprocal of the absolute temperature shows two correlations with a transition temperature at 35 degrees C. Two activation energy values (Ea) above and below the transition temperature were calculated as 42 and 14 kJ/mol, respectively. The data imply that the rate determining steps of the PaDHPAO reaction at temperatures above and below 35 degrees C may be different. Sequence similarity network analysis indicated that PaDHPAO belongs to the enzyme clusters that are largely unexplored. As PaDHPAO has a high turnover number compared to most of the enzymes previously reported, understanding its biochemical and biophysical properties should be useful for future applications in biotechnology.	[Pornsuwan, Soraya] Mahidol Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [Maenpuen, Somchart; Kamutira, Philaiwarong] Burapha Univ, Dept Biochem, Fac Sci, Chon Buri, Thailand; [Watthaisong, Pratchaya; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Watthaisong, Pratchaya; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand; [Thotsaporn, Kittisak] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok, Thailand	Mahidol University; Burapha University; Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand.	pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Maenpuen, Somchart/0000-0001-7770-4178; Watthaisong, Pratchaya/0000-0001-7340-7715	Thailand Research Fund [MRG5280150, RTA5980001, MRG5980001]; Mahidol University; Burapha University	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Burapha University	Financial support by the Thailand Research Fund (Grants MRG5280150 (to S.P.), RTA5980001 (to P.C.), MRG5980001 (to S.M.)), Mahidol University (to P.C.), and Burapha University (to S.M.) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1964, BIOCHIM BIOPHYS ACTA, V93, P483, DOI 10.1016/0304-4165(64)90332-0; Alcalde M, 2015, TRENDS BIOTECHNOL, V33, P155, DOI 10.1016/j.tibtech.2014.12.007; BOLDT YR, 1995, J BACTERIOL, V177, P1225, DOI 10.1128/jb.177.5.1225-1232.1995; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; BUGG TDH, 1993, BIOCHIM BIOPHYS ACTA, V1202, P258, DOI 10.1016/0167-4838(93)90013-H; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Colaco HG, 2016, METALLOMICS, V8, P327, DOI 10.1039/c5mt00291e; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emerson JP, 2007, ANGEW CHEM INT EDIT, V46, P8553, DOI 10.1002/anie.200703057; Fersht A, 1999, STRUCTURE AND MECHAN; Fielding AJ, 2014, J BIOL INORG CHEM, V19, P491, DOI 10.1007/s00775-014-1122-9; Fielding AJ, 2012, J AM CHEM SOC, V134, P796, DOI 10.1021/ja2095365; Fielding AJ, 2011, J BIOL INORG CHEM, V16, P341, DOI 10.1007/s00775-010-0732-0; GIBELLO A, 1994, BIOCHEM J, V301, P145, DOI 10.1042/bj3010145; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; JAMALUDDIN MP, 1977, J BACTERIOL, V129, P690, DOI 10.1128/JB.129.2.690-697.1977; Johnson CW, 2015, METAB ENG, V28, P240, DOI 10.1016/j.ymben.2015.01.005; KIM K, 1985, J BIOL CHEM, V260, P5394; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; KITA H, 1965, J BIOCHEM-TOKYO, V58, P116, DOI 10.1093/oxfordjournals.jbchem.a128172; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, BIOCHEMISTRY-US, V47, P11168, DOI 10.1021/bi801459q; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Li DF, 2013, ACTA CRYSTALLOGR D, V69, P32, DOI 10.1107/S0907444912042072; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Maenpuen S, 2016, ADV BIOTECHNOLGY EM; Mbughuni MM, 2010, P NATL ACAD SCI USA, V107, P16788, DOI 10.1073/pnas.1010015107; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; OLSON PE, 1992, APPL ENVIRON MICROB, V58, P2820, DOI 10.1128/AEM.58.9.2820-2826.1992; ONOKAMIMOTO M, 1973, J BIOCHEM, V74, P1049; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Pollegioni L, 2015, FEBS J, V282, P1190, DOI 10.1111/febs.13224; QUE L, 1981, J BIOL CHEM, V256, P941; Reynolds MF, 2003, J BIOL INORG CHEM, V8, P263, DOI 10.1007/s00775-002-0411-x; ROPER DI, 1990, FEBS LETT, V275, P53, DOI 10.1016/0014-5793(90)81437-S; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thotsaporn K, 2016, J MOL CATAL B-ENZYM, V134, P353, DOI 10.1016/j.molcatb.2016.09.003; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wang YZ, 1997, PROTEIN EXPRES PURIF, V10, P1, DOI 10.1006/prep.1996.0703; Whiting AK, 1996, BIOCHEMISTRY-US, V35, P160, DOI 10.1021/bi951979h; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	49	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171135	10.1371/journal.pone.0171135	http://dx.doi.org/10.1371/journal.pone.0171135			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158217	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700031
J	Toft-Petersen, AP; Torp-Pedersen, C; Weinreich, UM; Rasmussen, BS				Toft-Petersen, Anne Pernille; Torp-Pedersen, Christian; Weinreich, Ulla Moller; Rasmussen, Bodil Steen			Trends in assisted ventilation and outcome for obstructive pulmonary disease exacerbations. A nationwide study	PLOS ONE			English	Article							ACUTE RESPIRATORY-FAILURE; INTENSIVE-CARE-UNIT; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; COPD EXACERBATIONS; MORTALITY; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PREVALENCE	Background Non-invasive ventilation (NIV) has been used for decades in treatment of exacerbations of chronic obstructive pulmonary disease (COPD). The impact of the changing use of assisted ventilation in acute exacerbations on outcomes has not been fully elucidated and we aimed to describe these changes in the Danish population and describe their consequences for mortality. Methods A register-based study was conducted of a cohort of 12,847 patients admitted for acute exacerbation of COPD (AECOPD) from 2004 through 2011, treated with invasive mechanical ventilation (IMV) or NIV for the first time. Age, sex, in-hospital mortality rates, time to death or readmission for AECOPD were established and changes over time tracked. Results The number of admissions for AECOPD where assisted ventilation was used was 1,130 in 2004 and had increased by 145% in 2011. First time ventilations increased by 88%. This was mainly due to an increase in use of NIV accounting for 36% of the total number of assisted ventilations in 2004 and 67% in 2011. The number of IMV with or without NIV treatments remained constant. The mean age of NIV patients increased from 71.5 to 73.6 years, but remained constant at 70.0 years in IMV patients. Mortality rates both in hospital and after discharge for patients receiving NIV remained constant throughout the period. In-hospital mortality following IMV increased from 30% to 38%, but mortality after discharge remained stable. Conclusion Assisted ventilation has been increasingly used in a broader spectrum of AECOPD patients since the introduction of NIV. The changes in treatment strategies have been followed by shifts in in-hospital mortality rates following IMV.	[Toft-Petersen, Anne Pernille; Torp-Pedersen, Christian; Weinreich, Ulla Moller; Rasmussen, Bodil Steen] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Weinreich, Ulla Moller] Aalborg Univ Hosp, Dept Resp Dis, Aalborg, Denmark; [Rasmussen, Bodil Steen] Aalborg Univ Hosp, Dept Anaesthesia & Intens Care, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Toft-Petersen, AP (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	aptp@rn.dk; ctp@heart.dk	Weinreich, Ulla M/L-9069-2013	Weinreich, Ulla M/0000-0003-1975-3654; Rasmussen, Bodil Steen/0000-0003-2190-145X; Toft-Petersen, Anne Pernille/0000-0001-6029-255X				Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; Carpe-Carpe B, 2013, ARCH BRONCONEUMOL, V49, P330, DOI 10.1016/j.arbres.2013.04.006; Chandra D, 2012, AM J RESP CRIT CARE, V185, P152, DOI 10.1164/rccm.201106-1094OC; Conti G, 2002, INTENS CARE MED, V28, P1701, DOI 10.1007/s00134-002-1478-0; de Miguel-Diez J, 2013, RESP MED, V107, P717, DOI 10.1016/j.rmed.2013.01.007; Dres M, 2013, CRIT CARE MED, V41, P1884, DOI 10.1097/CCM.0b013e31828a2bd8; Fiorino S, 2015, INTERN MED J; Funk GC, 2013, EUR RESPIR J, V41, P792, DOI 10.1183/09031936.00226411; Gacouin A, 2015, RESP CARE, V60, P210, DOI 10.4187/respcare.03467; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG; Husted MG, 2014, BMJ SUPPORT PALLIAT, V4, P146, DOI 10.1136/bmjspcare-2013-000601; Johannesdottir Sigrun A, 2013, J Med Econ, V16, P897, DOI 10.3111/13696998.2013.800525; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Jurjevic M, 2009, COLLEGIUM ANTROPOL, V33, P791; Kaul S, 2009, COPD, V6, P171, DOI 10.1080/15412550902902646; Larsen OB, 2005, SUNDHEDSSTYRELSEN KL; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Lindenauer PK, 2014, JAMA INT MED, V1-12; Lykkegaard J, 2012, RESP MED, V106, P1396, DOI 10.1016/j.rmed.2012.06.004; Lykkegaard J, 2012, RESP MED, V106, P549, DOI 10.1016/j.rmed.2011.11.001; Mery E, 2013, CRIT CARE, V17, DOI 10.1186/cc12688; Ongel EA, 2014, INT J CHRONIC OBSTR, V9, P1187, DOI 10.2147/COPD.S70257; Pierson DJ, 2009, RESP CARE, V54, P40; Quintana JM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-66; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Stefan MS, 2014, CHEST J; Stefan MS, 2015, CRIT CARE MED, V1; Stelfox HT, 2012, ARCH INTERN MED, V172, P467, DOI 10.1001/archinternmed.2011.2315; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Titlestad IL, 2013, INT J CHRONIC OBSTR, V8, P215, DOI 10.2147/COPD.S42632; Titlestad Ingrid Louise, 2008, Ugeskr Laeger, V170, P240; Tottenborg SS, 2013, DAN MED J, V60; Walkey Allan J, 2013, Ann Am Thorac Soc, V10, P10, DOI 10.1513/AnnalsATS.201206-034OC	37	9	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171713	10.1371/journal.pone.0171713	http://dx.doi.org/10.1371/journal.pone.0171713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158267	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700119
J	Park, HJ; Park, CH; Lee, SE; Lee, GD; Byun, MK; Lee, S; Lee, KA; Kim, TH; Kim, SH; Yang, SY; Kim, HJ; Ahn, CM				Park, Hye Jung; Park, Chul Hwan; Lee, Sang Eun; Lee, Geun Dong; Byun, Min Kwang; Lee, Sungsoo; Lee, Kyung-A; Kim, Tae Hoon; Kim, Seong Han; Yang, Seo Yeon; Kim, Hyung Jung; Ahn, Chul Min			Birt-Hogg-Dube syndrome prospectively detected by review of chest computed tomography scans	PLOS ONE			English	Article							PRIMARY SPONTANEOUS PNEUMOTHORAX; PULMONARY CYSTS; CT FINDINGS; LUNG CYSTS; FLCN-GENE; HEREDITARY; MANAGEMENT; FAMILIES; MUTATION; FEATURES	Purpose Birt-Hogg-Dube syndrome (BHD) is a rare disorder caused by mutations in the gene that encodes folliculin (FLCN) and is inherited in an autosomal dominant manner. BHD is commonly accompanied by fibrofolliculomas, renal tumors, multiple pulmonary cysts, and spontaneous pneumothorax. The aim of this study was to detect BHD prospectively in patients undergoing chest computed tomography (CT) scans and to evaluate further the characteristics of BHD in Korea. Methods We prospectively checked and reviewed the chest CT scans obtained for 10,883 patients at Gangnam Severance Hospital, Seoul, Korea, from June 1, 2015 to May 31, 2016. Seventeen patients met the study inclusion criteria and underwent screening for FLCN mutation to confirm BHD. We analyzed the characteristics of the patients confirmed to have BHD and those for a further 6 patients who had previously been described in Korea. Results Six (0.06%) of the 10,883 patients reviewed were diagnosed with BHD. There was no difference in demographic or clinical features between the patients with BHD (n = 6) and those without BHD (n = 11). Pneumothorax was present in 50% of the patients with BHD but typical skin and renal lesions were absent. The maximum size of the cysts in the BHD group (median 39.4 mm; interquartile range [IQR] 11.4 mm) was significantly larger than that in the non-BHD group (median 15.8 mm; IQR 7.8 mm; P = 0.001). Variable morphology was seen in 100.0% of the cysts in the BHD group but in only 18.2% of the cysts in the non-BHD group (P = 0.002). Nine (95%) of the total of 12 Korean patients with BHD had experienced pneumothorax. Typical skin and renal lesions were present in 20.0% of patients with BHD. Conclusions Our findings suggest that BHD can be detected if chest CT scans are read in detail.	[Park, Hye Jung; Byun, Min Kwang; Kim, Seong Han; Yang, Seo Yeon; Kim, Hyung Jung; Ahn, Chul Min] Yonsei Univ, Dept Internal Med, Gangnam Severance Hosp, Pulm Div,Coll Med, Seoul, South Korea; [Park, Chul Hwan; Kim, Tae Hoon] Yonsei Univ, Dept Radiol, Gangnam Severance Hosp, Coll Med, Seoul, South Korea; [Lee, Sang Eun] Yonsei Univ, Coll Med, Dept Dermatol, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Geun Dong; Lee, Sungsoo] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ahn, CM (corresponding author), Yonsei Univ, Dept Internal Med, Gangnam Severance Hosp, Pulm Div,Coll Med, Seoul, South Korea.	ahn5302@yuhs.ac		/0000-0003-3598-2529; Lee, Sang Eun/0000-0003-4720-9955; Lee, Kyung-A/0000-0001-5320-6705; Byun, Min Kwang/0000-0003-1525-1745; Park, Hye Jung/0000-0002-1862-1003; Lee, Sungsoo/0000-0001-8998-9510; Park, Chul Hwan/0000-0002-0004-9475	Yonsei University College of Medicine [6-2015-0032]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2015 (Grant Number: 6-2015-0032). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PP, 2011, AM J ROENTGENOL, V196, P349, DOI 10.2214/AJR.10.4757; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Coleman JA, 2009, CURR OPIN UROL, V19, P478, DOI 10.1097/MOU.0b013e32832f0d40; Ding YB, 2015, AM J MED GENET A, V167, P1125, DOI 10.1002/ajmg.a.36979; Furuya M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151476; Furuya M, 2013, J CLIN PATHOL, V66, P178, DOI 10.1136/jclinpath-2012-201200; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; James W., 2015, ANDREWS DIS SKIN CLI; Johannesma PC, 2015, EUR RESPIR J, V45, P1191, DOI 10.1183/09031936.00196914; Kahnoski K, 2003, J MED GENET, V40, P511, DOI 10.1136/jmg.40.7.511; Kim EH, 2008, J KOREAN MED SCI, V23, P332, DOI 10.3346/jkms.2008.23.2.332; Kim J, 2012, GENE, V499, P339, DOI 10.1016/j.gene.2012.03.037; Kunogi M, 2010, J MED GENET, V47, P281, DOI 10.1136/jmg.2009.070565; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Murakami Y, 2014, CASE REP DERMATOL, V6, P20, DOI 10.1159/000358216; Park G, 2011, ANN DERMATOL, V23, pS188, DOI 10.5021/ad.2011.23.S2.S188; Pavlovich CP, 2005, J UROLOGY, V173, P1482, DOI 10.1097/01.ju.0000154629.45832.30; Ponti G, 2013, CRIT REV ONCOL HEMAT, V85, P239, DOI 10.1016/j.critrevonc.2012.07.001; Ren HZ, 2008, CLIN GENET, V74, P178, DOI 10.1111/j.1399-0004.2008.01030.x; Shin WW, 2011, ANN DERMATOL, V23, pS193, DOI 10.5021/ad.2011.23.S2.S193; Skolnik K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0339-2; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Tobino K, 2012, EUR J RADIOL, V81, P1340, DOI 10.1016/j.ejrad.2011.03.039; Tobino K, 2011, EUR J RADIOL, V77, P403, DOI 10.1016/j.ejrad.2009.09.004; Tomassetti S, 2011, RESP MED, V105, P768, DOI 10.1016/j.rmed.2011.01.002; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Yang CY, 2013, J POSTGRAD MED, V59, P321, DOI 10.4103/0022-3859.123169	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170713	10.1371/journal.pone.0170713	http://dx.doi.org/10.1371/journal.pone.0170713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151982	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200037
J	Giezendanner, S; Jung, C; Banderet, HR; Otte, IC; Gudat, H; Haller, DM; Elger, BS; Zemp, E; Bally, K				Giezendanner, Stephanie; Jung, Corinna; Banderet, Hans-Ruedi; Otte, Ina Carola; Gudat, Heike; Haller, Dagmar M.; Elger, Bernice S.; Zemp, Elisabeth; Bally, Klaus			General Practitioners' Attitudes towards Essential Competencies in End-of-Life Care: A Cross-Sectional Survey	PLOS ONE			English	Article							PALLIATIVE CARE; QUALITY INDICATORS; BARRIERS; SPIRITUALITY; EUTHANASIA; COMMUNICATION; PROFESSIONALS; FACILITATORS; CONFIDENCE; FRAMEWORK	Background Identifying essential competencies in end-of-life care, as well as general practitioners' (GPs) confidence in these competencies, is essential to guide training and quality improvement efforts in this domain. Aim To determine which competencies in end-of-life care are considered important by GPs, to assess GPs' confidence in these competencies in a European context and their reasons to refer terminally ill patients to a specialist. Design and Setting Cross-sectional postal survey involving a stratified random sample of 2000 GPs in Switzerland in 2014. Method Survey development was informed by a previous qualitative exploration of relevant end-of-life GP competencies. Main outcome measures were GPs' assessment of the importance of and confidence in 18 attributes of end-of-life care competencies, and reasons for transferring care of terminally-ill patients to a specialist. GP characteristics associated with main outcome measures were tested using multivariate regression models. Results The response rate was 31%. Ninety-nine percent of GPs considered the recognition and treatment of pain as important, 86% felt confident about it. Few GPs felt confident in cultural (16%), spiritual (38%) and legal end-of-life competencies such as responding to patients seeking assisted suicide (35%) although more than half of the respondents regarded these competencies as important. Most frequent reasons to refer terminally ill patients to a specialist were lack of time (30%), better training of specialists (23%) and end-of-life care being incompatible with other duties (19%). In multiple regression analyses, confidence in end-of-life care was positively associated with GPs' age, practice size, home visits and palliative training. Conclusions GPs considered non-somatic competencies (such as spiritual, cultural, ethical and legal aspects) nearly as important as pain and symptom control. Yet, few GPs felt confident in these non-somatic competencies. These findings should inform training and quality improvement efforts in this domain, in particular for younger, less experienced GPs.	[Giezendanner, Stephanie; Jung, Corinna; Banderet, Hans-Ruedi; Bally, Klaus] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland; [Otte, Ina Carola; Elger, Bernice S.] Univ Basel, Inst Biomed Eth, Basel, Switzerland; [Gudat, Heike] Hosp Palliat Care, Hospiz Pk, Arlesheim, Basel District, Switzerland; [Haller, Dagmar M.] Univ Geneva, Primary Care Unit, Geneva, Switzerland; [Haller, Dagmar M.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Elger, Bernice S.] Univ Geneva, Ctr Legal Med, Geneva, Switzerland; [Zemp, Elisabeth] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Zemp, Elisabeth] Univ Basel, Basel, Switzerland	University of Basel; University of Basel; University of Geneva; University of Melbourne; University of Geneva; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Giezendanner, S (corresponding author), Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland.	stephanie.giezendanner@unibas.ch	Elger, Bernice Simone/V-7265-2017; Haller, Dagmar M./AAA-5078-2021	Elger, Bernice Simone/0000-0002-4249-7399; Otte, Ina/0000-0003-0280-0899; Haller, Dagmar/0000-0003-1781-3318; Giezendanner, Stephanie/0000-0001-5660-9446	Swiss National Science Foundation [SNSF: 406740_139341]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Swiss National Science Foundation (http://www.snf.ch/D/Seiten/default.aspx) (SNSF: 406740_139341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SCHWEIZ ARZTEZTG, V90; Becker G, 2007, WIEN KLIN WOCHENSCHR, V119, P112, DOI 10.1007/s00508-006-0724-9; Blank RH, 2011, J LAW MED ETHICS, V39, P201, DOI 10.1111/j.1748-720X.2011.00589.x; Boerma W., 2003, PROFILES GEN PRACTIC; Borgsteede SD, 2006, BRIT J GEN PRACT, V56, P20; Brauer S, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14142; Claessen SJJ, 2011, J PAIN SYMPTOM MANAG, V42, P169, DOI 10.1016/j.jpainsymman.2010.10.267; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; De Vleminck A, 2013, SCAND J PRIM HEALTH, V31, P215, DOI 10.3109/02813432.2013.854590; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; EAPC Task Force on Medical Education, 2007, CURRICULUM IN PALLIA; Economist Intelligence Unit, 2010, RANK END OF LIF CAR, DOI [10.1111/1.1748-720X.2011.00589.x, DOI 10.1111/J.1748-720X.2011.00589.X]; Eychmuller S, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0485-0; Fletcher T. D., 2010, PSYCHOMETRIC APPL PS; Gamondi C., 2013, EUROPEAN J PALLIATIV, V20, P86; Garcia C, 2007, ARCH DERMATOL, V143, P120, DOI 10.1001/archderm.143.1.120-b; Georges JJ, 2008, J MED ETHICS, V34, P150, DOI 10.1136/jme.2007.020909; Gorlen T, 2012, DAN MED J, V59; Groot MM, 2005, PALLIATIVE MED, V19, P111, DOI 10.1191/0269216305pm937oa; Gysels M, 2012, J PAIN SYMPTOM MANAG, V44, P285, DOI 10.1016/j.jpainsymman.2011.09.013; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; Hansford P, 2007, END LIFE CARE, V1, P56; Helena K, 2015, BMC MED ED, V15; Hirooka K, 2014, JPN J CLIN ONCOL, V44, P249, DOI 10.1093/jjco/hyt204; Hostettler S., 2015, SCHWEIZERISCHE ARZTE, V96, P462; Iversen T, 2011, INT J HEALTH CARE FI, V11, P245, DOI 10.1007/s10754-011-9101-y; Kelley K, 2012, METHODOLOGY; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Liddy C, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-22; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; Marr L, 2007, J PALLIAT MED, V10, P169, DOI 10.1089/jpm.2006.0076.R1; McDonald RP, 1999, TEST THEORY UNIFIED; McGlade KJ, 2000, BRIT J GEN PRACT, V50, P794; Mitchell GK, 2011, AUST FAM PHYSICIAN, V40, P517; Mitchell GK, 2004, MED J AUSTRALIA, V180, P207, DOI 10.5694/j.1326-5377.2004.tb05885.x; O'Brien AP, 2012, ASIA-PAC J CLIN ONCO, V8, P3, DOI 10.1111/j.1743-7563.2011.01510.x; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Pereira J, 2008, PALLIATIVE MED, V22, P730, DOI 10.1177/0269216308094560; Puchalski CM, 2004, CLIN GERIATR MED, V20, P689, DOI 10.1016/j.cger.2004.07.004; R Core Team, 2018, R LANG ENV STAT COMP; Revelle W., 2014, PSYCH PROCEDURES PER, V1; Rhee JJO, 2008, J PALLIAT MED, V11, P980, DOI 10.1089/jpm.2007.0251; Ruijs CDM, 2011, FAM PRACT, V28, P689, DOI 10.1093/fampra/cmr035; Schnakenberg R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1257-1; Schweizer Arzteschaft (FMH), 2014, FMH ARZT; Selman L, 2016, BMJ SUPPORT PALLIAT, V6, P231, DOI 10.1136/bmjspcare-2015-000879; Shipman C, 2001, PALLIATIVE MED, V15, P191, DOI 10.1191/026921601678576176; Slort W, 2011, PALLIATIVE MED, V25, P613, DOI 10.1177/0269216310395987; Steinhauser K. E., 2000, JAMA, V284; Theile G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-24; Todorov V, 2009, J STAT SOFTW, V32, P1; Trizano-Hermosilla I, 2016, BEST ALTERNATIVES CR; van den Berg Michael J, 2006, BMC Fam Pract, V7, P58, DOI 10.1186/1471-2296-7-58; van den Brink-Muinen A, 2003, FAM PRACT, V20, P478, DOI 10.1093/fampra/cmg426; Vermandere M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606663; Wasner M, 2005, PALLIATIVE MED, V19, P99, DOI 10.1191/0269216305pm995oa; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	59	23	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170168	10.1371/journal.pone.0170168	http://dx.doi.org/10.1371/journal.pone.0170168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146566	Green Published, gold, Green Submitted			2022-12-26	WOS:000396131700015
J	Fujita, S; Tanaka, S; Maeda, D; Morita, H; Fujisaka, T; Takeda, Y; Ito, T; Ishizaka, N				Fujita, Shu-ichi; Tanaka, Suguru; Maeda, Daichi; Morita, Hideaki; Fujisaka, Tomohiro; Takeda, Yoshihiro; Ito, Takahide; Ishizaka, Nobukazu			Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level	PLOS ONE			English	Article							HEART-FAILURE; INFLAMMATION; DISEASE; SUPAR; HYPERTROPHY; CANCER; PROGRESSION; POPULATION; ARTHRITIS	Background Recent studies have suggested that soluble urokinase plasminogen activator receptor (suPAR), a biomarker of subclinical levels of inflammation, is significantly correlated with cardiovascular events. Purpose We investigated the association between suPAR and left ventricular ejection fraction (LVEF), left ventricular mass index (LVMI), and plasma B-type natriuretic peptide (BNP) among cardiac inpatients. Methods and Results In total, 242 patients (mean age 71.3 +/- 9.8 years; 70 women) admitted to the cardiology department were enrolled in the study. suPAR was significantly correlated with LVEF (R = -0.24, P<0.001), LVMI (R = 0.16, P = 0.014) and BNP (R = 0.46, P<0.001). In logistic regression analysis, the highest suPAR tertile (> 3236 pg/mL) was associated with low LVEF (< 50%) and elevated BNP (> 300 pg/mL) with an odds ratio of 3.84 (95% confidence interval [CI], 1.22-12.1) and 5.36 (95% CI, 1.32-21.8), respectively, after adjusting for age, sex, log-transformed estimated glomerular filtration rate (log(eGFR)), C-reactive protein, and diuretic use. The association between suPAR and LVMI was not statistically significant. In multivariate receiver operating characteristic analysis, addition of log(suPAR) to the combination of age, sex, log(eGFR) and CRP incrementally improved the prediction of low LVEF (area under the curve [AUC], 0.827 to 0.852, P = 0.046) and BNP >= 300 pg/mL (AUC, 0.869 to 0.906; P = 0.029). Conclusions suPAR was associated with low LVEF and elevated BNP, but not with left ventricular hypertrophy, independent of CRP, renal function, and diuretic use among cardiac inpatients who were not undergoing chronic hemodialysis.	[Fujita, Shu-ichi; Tanaka, Suguru; Maeda, Daichi; Morita, Hideaki; Fujisaka, Tomohiro; Takeda, Yoshihiro; Ito, Takahide; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@osaka-med.ac.jp			Ministry of Education, Science, and Culture of Japan [15K09106]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106).	Borne Y, 2014, EUR J HEART FAIL, V16, P377, DOI 10.1002/ejhf.49; Briasoulis A, 2016, HEART FAIL REV, V21, P169, DOI 10.1007/s10741-016-9533-z; Cook AD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2946; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Eapen DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001118; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; Gyetko MR, 2002, J IMMUNOL, V168, P801, DOI 10.4049/jimmunol.168.2.801; Hahm E, 2016, NAT MED; Han B, 2005, ONCOL REP, V14, P105; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Hodges GW, 2015, CAN J CARDIOL, V31, P1293, DOI 10.1016/j.cjca.2015.03.023; Hsu PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049100; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kruger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058506; Li L, 2010, MOL CELL BIOCHEM, V342, P183, DOI 10.1007/s11010-010-0482-x; Lyngbaek S, 2013, INT J CARDIOL, V167, P2904, DOI 10.1016/j.ijcard.2012.07.018; Marechaux S, 2016, J CARD FAIL, V22, P3, DOI 10.1016/j.cardfail.2015.09.003; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mehta SK, 2007, HYPERTENSION, V49, P1385, DOI 10.1161/HYPERTENSIONAHA.107.087890; Mekonnen G, 2015, ATHEROSCLEROSIS, V239, P55, DOI 10.1016/j.atherosclerosis.2014.12.025; Nakagomi A, 2012, CIRC J, V76, P2130, DOI 10.1253/circj.CJ-11-1123; Persson M, 2012, ATHEROSCLEROSIS, V220, P502, DOI 10.1016/j.atherosclerosis.2011.10.039; Pliyev BK, 2010, INFLAMMATION, V33, P1, DOI 10.1007/s10753-009-9152-0; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Schulz CA, 2016, SOLUBLE UROKINASE TY; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Sorensen MH, 2014, ATHEROSCLEROSIS, V237, P60, DOI 10.1016/j.atherosclerosis.2014.08.035; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Theilade S, 2016, EUR J ENDOCRINOL, V174, P745, DOI 10.1530/EJE-15-0986; van der Walt C, 2013, HEART LUNG CIRC, V22, P924, DOI 10.1016/j.hlc.2013.03.075; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170546	10.1371/journal.pone.0170546	http://dx.doi.org/10.1371/journal.pone.0170546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135310	gold, Green Published, Green Submitted			2022-12-26	WOS:000396124700015
J	Waiho, K; Fazhan, H; Shahreza, MS; Moh, JHZ; Noorbaiduri, S; Wong, LL; Sinnasamy, S; Ikhwanuddin, M				Waiho, Khor; Fazhan, Hanafiah; Shahreza, Md Sheriff; Zhong Moh, Julia Hwei; Noorbaiduri, Shaibani; Wong, Li Lian; Sinnasamy, Saranya; Ikhwanuddin, Mhd			Transcriptome Analysis and Differential Gene Expression on the Testis of Orange Mud Crab, Scylla olivacea, during Sexual Maturation	PLOS ONE			English	Article							CHINESE MITTEN CRAB; SINGLE NUCLEOTIDE POLYMORPHISMS; SHRIMP LITOPENAEUS-VANNAMEI; FRESH-WATER PRAWN; VASA-LIKE GENE; HYPERGLYCEMIC HORMONE; OVARIAN MATURATION; ERIOCHEIR-SINENSIS; WHITE SHRIMP; KURUMA PRAWN	Adequate genetic information is essential for sustainable crustacean fisheries and aqua-culture management. The commercially important orange mud crab, Scylla olivacea, is prevalent in Southeast Asia region and is highly sought after. Although it is a suitable aqua-culture candidate, full domestication of this species is hampered by the lack of knowledge about the sexual maturation process and the molecular mechanisms behind it, especially in males. To date, data on its whole genome is yet to be reported for S. olivacea. The available transcriptome data published previously on this species focus primarily on females and the role of central nervous system in reproductive development. De novo transcriptome sequencing for the testes of S. olivacea from immature, maturing and mature stages were performed. A total of approximately 144 million high-quality reads were generated and de novo assembled into 160,569 transcripts with a total length of 142.2 Mb. Approximately 15-23% of the total assembled transcripts were annotated when compared to public protein sequence databases (i. e. UniProt database, Interpro database, Pfam database and Drosophila melanogaster protein database), and GO-categorised with GO Ontology terms. A total of 156,181 high-quality Single-Nucleotide Polymorphisms (SNPs) were mined from the transcriptome data of present study. Transcriptome comparison among the testes of different maturation stages revealed one gene (beta crystallin like gene) with the most significant differential expression-up-regulated in immature stage and down-regulated in maturing and mature stages. This was further validated by qRT-PCR. In conclusion, a comprehensive transcriptome of the testis of orange mud crabs from different maturation stages were obtained. This report provides an invaluable resource for enhancing our understanding of this species' genome structure and biology, as expressed and controlled by their gonads.	[Waiho, Khor; Fazhan, Hanafiah; Shahreza, Md Sheriff; Zhong Moh, Julia Hwei; Noorbaiduri, Shaibani; Wong, Li Lian; Ikhwanuddin, Mhd] Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Terengganu, Malaysia; [Shahreza, Md Sheriff] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu, Terengganu, Malaysia; [Sinnasamy, Saranya] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu; Universiti Malaysia Terengganu; Universiti Malaysia Terengganu	Waiho, K; Ikhwanuddin, M (corresponding author), Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Terengganu, Malaysia.	waihokhor@gmail.com; ikhwanuddin@umt.edu.my	Wong, Li Lian/AAG-5568-2020; Waiho, Khor/W-6655-2019; WONG, LI LIAN/ABE-1887-2022; Ikhwanuddin, Mhd/L-9136-2019; Fazhan, Hanafiah/I-7329-2018; Fazhan, Hanafiah/J-3553-2019	Wong, Li Lian/0000-0001-9045-4556; Waiho, Khor/0000-0002-2632-3612; Ikhwanuddin, Mhd/0000-0002-6430-0876; Fazhan, Hanafiah/0000-0002-5497-9723; Fazhan, Hanafiah/0000-0002-5497-9723	Ministry of Education Malaysia [53131]	Ministry of Education Malaysia(Ministry of Education, Malaysia)	Support for this project was provided by the Ministry of Education Malaysia (http://www.moe.gov.my/en/home)) under the Niche Research Grant Scheme (NRGS) (grant number: 53131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo ED, 2007, MOL REPROD DEV, V74, P172, DOI 10.1002/mrd.20622; Alberts-Hubatsch H, 2015, HYDROBIOLOGIA; Albrechtsen A, 2016, MAR GENOMICS IN PRES; Anbarasu M, 2013, TURK J BIOL, V37, P507, DOI 10.3906/biy-1203-59; Aquiloni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050047; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Bao CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17055; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray W.A., 1992, Developments in Aquaculture and Fisheries Science, V23, P93; Chang ES, 2001, AM ZOOL, V41, P380, DOI 10.1668/0003-1569(2001)041[0380:CHHFOP]2.0.CO;2; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Christie AE, 2016, GEN COMP ENDOCR, V230, P1, DOI 10.1016/j.ygcen.2016.03.008; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; Cunningham TJ, 2015, REJUV RES, V18, P136, DOI 10.1089/rej.2014.1620; DEJONG WW, 1989, TRENDS BIOCHEM SCI, V14, P365, DOI 10.1016/0968-0004(89)90009-1; DJAKIEW D, 1994, BIOL REPROD, V51, P214, DOI 10.1095/biolreprod51.2.214; Duffy DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-131; DuPrey KM, 2007, MOL VIS, V13, P366; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Gao Q, 2014, BIOCHEM BIOPH RES CO, V453, P37, DOI 10.1016/j.bbrc.2014.09.049; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hara Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2007-1; Harms L, 2013, COMP BIOCHEM PHYS D, V8, P344, DOI 10.1016/j.cbd.2013.09.004; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hopkins P.M., 2009, ECDYSONE STRUCTURES, P73, DOI DOI 10.1007/978-1-4020-9112-4_3; Hsu YWA, 2006, J EXP BIOL, V209, P3241, DOI 10.1242/jeb.02372; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang XS, 2014, ANIM REPROD SCI, V150, P139, DOI 10.1016/j.anireprosci.2014.09.004; Ikhwanuddin M, 2011, FISH RES, V108, P299, DOI 10.1016/j.fishres.2011.01.001; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Konczal M, 2014, MOL ECOL RESOUR, V14, P381, DOI 10.1111/1755-0998.12186; Kornthong N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115867; Kornthong N, 2014, MICROSC RES TECHNIQ, V77, P189, DOI 10.1002/jemt.22327; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CJ, 2013, REPRODUCTION, V145, pR89, DOI 10.1530/REP-12-0466; Li E, 2014, POULT FISH WILDL SCI, V2, P2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YJ, 2014, DEV BIOL, V394, P129, DOI 10.1016/j.ydbio.2014.07.016; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Luo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152572; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102668; Magabo KS, 2000, INVEST OPHTH VIS SCI, V41, P3056; Mantione KJ, 2014, MED SCI MONIT BASIC, V20, P138, DOI 10.12659/MSMBR.892101; Meng XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128659; MOREAU R, 1988, ARCH INSECT BIOCHEM, V8, P135, DOI 10.1002/arch.940080207; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; Muller D, 2006, HISTOCHEM CELL BIOL, V126, P199, DOI 10.1007/s00418-006-0155-8; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Nakkrasae LI, 2007, MOL REPROD DEV, V74, P835, DOI 10.1002/mrd.20680; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Ozhan-Kizil G, 2009, DEV BIOL, V327, P230, DOI 10.1016/j.ydbio.2008.10.028; Pervaiz PA, 2014, J ENVIRON BIOL, V35, P821; Pervaiz Pervaiz Ahmed, 2011, World Journal of Zoology, V6, P159; Prasertlux S, 2010, AQUACULTURE, V308, pS83, DOI 10.1016/j.aquaculture.2010.06.038; Qiao H, 2015, GENET MOL RES, V14, P2041, DOI 10.4238/2015.March.20.14; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosly HAAM, 2013, MOL BIOL REP, V40, P6407, DOI 10.1007/s11033-013-2755-4; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen HS, 2015, J WORLD AQUACULT SOC, V46, P421, DOI 10.1111/jwas.12207; Simeo CG, 2011, INVERTEBR REPROD DEV, V55, P91, DOI 10.1080/07924259.2011.553406; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Sweeney AM, 2007, THESIS DUKE U DURHAM; Tagmount A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009327; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Tahara D, 2003, AQUACULTURE, V220, P791, DOI 10.1016/S0044-8486(02)00402-7; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Veenstra JA, 2010, INSECT BIOCHEM MOLEC, V40, P354, DOI 10.1016/j.ibmb.2010.03.001; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Waiho K, CRUSTACEANA IN PRESS; Waiho K, 2015, AQUACULT REP, V2, P50, DOI 10.1016/j.aqrep.2015.08.004; Waiho K, 2016, MAR BIOL RES, V12, P726, DOI 10.1080/17451000.2016.1200726; Walton ME, 2006, ESTUAR COAST SHELF S, V66, P493, DOI 10.1016/j.ecss.2005.09.015; Wang Q, 2012, J INSECT PHYSIOL, V58, P960, DOI 10.1016/j.jinsphys.2012.04.012; Wang RJ, 2012, FRESHW SCI, V31, P695, DOI 10.1899/11-149.1; Wang YL, 2012, MOL BIOL REP, V39, P4327, DOI 10.1007/s11033-011-1220-5; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yang SP, 2014, FEBS OPEN BIO, V4, P976, DOI 10.1016/j.fob.2014.09.005; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang SD, 2005, BIOINFORMATICS, V21, P4378, DOI 10.1093/bioinformatics/bti717; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhou QR, 2010, CHIN J OCEANOL LIMN, V28, P37, DOI 10.1007/s00343-010-9231-y	104	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171095	10.1371/journal.pone.0171095	http://dx.doi.org/10.1371/journal.pone.0171095			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135340	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700048
J	Lieberman-Cribbin, W; Liu, B; Schneider, S; Schwartz, R; Taioli, E				Lieberman-Cribbin, Wil; Liu, Bian; Schneider, Samantha; Schwartz, Rebecca; Taioli, Emanuela			Self-Reported and FEMA Flood Exposure Assessment after Hurricane Sandy: Association with Mental Health Outcomes	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOLOGICAL DISTRESS; PSYCHOMETRIC PROPERTIES; NATURAL DISASTER; PTSD CHECKLIST; GULF-COAST; KATRINA; IMPACT; SURVIVORS; SYMPTOMATOLOGY	Hurricane Sandy caused extensive physical and economic damage; the long-term mental health consequences are unknown. Flooding is a central component of hurricane exposure, influencing mental health through multiple pathways that unfold over months after flooding recedes. Here we assess the concordance in self-reported and Federal Emergency Management (FEMA) flood exposure after Hurricane Sandy and determine the associations between flooding and anxiety, depression, and post-traumatic stress disorder (PTSD). Self-reported flood data and mental health symptoms were obtained through validated questionnaires from New York City and Long Island residents (N = 1231) following Sandy. Self-reported flood data was compared to FEMA data obtained from the FEMA Modeling Task Force Hurricane Sandy Impact Analysis. Multivariable logistic regressions were performed to determine the relationship between flooding exposure and mental health outcomes. There were significant discrepancies between self-reported and FEMA flood exposure data. Self-reported dichotomous flooding was positively associated with anxiety (ORadj: 1.5 [95% CI: 1.1-1.9]), depression (ORadj: 1.7 [1.3-2.2]), and PTSD (ORadj: 2.5 [1.8-3.4]), while self-reported continuous flooding was associated with depression (ORadj: 1.1 [1.01-1.12]) and PTSD (ORadj: 1.2 [1.1-1.2]). Models with FEMA dichotomous flooding (ORadj: 2.1 [1.5-2.8]) or FEMA continuous flooding (ORadj: 1.1 [1.1-1.2]) were only significantly associated with PTSD. Associations between mental health and flooding vary according to type of flood exposure measure utilized. Future hurricane preparedness and recovery efforts must integrate micro and macro-level flood exposures in order to accurately determine flood exposure risk during storms and realize the long-term importance of flooding on these three mental health symptoms.	[Lieberman-Cribbin, Wil; Liu, Bian; Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Lieberman-Cribbin, Wil; Liu, Bian; Taioli, Emanuela] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Schneider, Samantha; Schwartz, Rebecca] Hofstra Northwell Sch Med, Dept Occupat Med Epidemiol & Prevent, Manhasset, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Northwell Health	Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.; Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA.	emanuela.taioli@mountsinai.org		Liu, Bian/0000-0001-9166-693X	Centers for Disease Control and Prevention [U01-TP000573-01]; Office of the Assistant Secretary for Preparedness and Response [HITEP150029-01-00]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of the Assistant Secretary for Preparedness and Response	This work was supported by the The Centers for Disease Control and Prevention under award number U01-TP000573-01 (Emanuela Taioli, http://www.cdc.gov/grants/), and the Office of the Assistant Secretary for Preparedness and Response under HITEP150029-01-00 (Emanuela Taioli, http://www.phe.gov/about/aspr/pages/default.aspx), as well as a private donation given to Northwell Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this presentation was supported by The Centers for Disease Control and Prevention under award number U01-TP000573-01, and the Office of the Assistant Secretary for Preparedness and Response under HITEP150029-01-00, as well as a private donation given to Northwell Health.	Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Bei B, 2013, AGING MENT HEALTH, V17, P992, DOI 10.1080/13607863.2013.799119; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blake ES., 2013, NATL HURRICANE CTR, V12, P1; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bourque LB, 2006, ANN AM ACAD POLIT SS, V604, P129, DOI 10.1177/0002716205284920; Carroll B, 2009, HEALTH PLACE, V15, P540, DOI 10.1016/j.healthplace.2008.08.009; Cieslak R, 2009, ANXIETY STRESS COPIN, V22, P449, DOI 10.1080/10615800802403815; FEMA (Federal Emergency Management Agency), 2015, FEMA MOD TASK FORC M; Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119929; First M. B., 1994, DIAGNOSTIC STAT MANU; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Gonzalez R., 2013, WELL DID NYCS FLOOD; Heir T, 2008, PSYCHIATRY, V71, P266, DOI 10.1521/psyc.2008.71.3.266; Heir T, 2009, BRIT J PSYCHIAT, V194, P510, DOI 10.1192/bjp.bp.108.056580; Hirschel MJ, 2009, PSYCHOL SERV, V6, P293, DOI 10.1037/a0017467; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Leon KA, 2007, SOC PSYCH PSYCH EPID, V42, P1005, DOI 10.1007/s00127-007-0260-6; Litz B.T, 1993, PTSD CHECKL PCL REL; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lowe SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125761; Lowe SR, 2013, J TRAUMA STRESS, V26, P753, DOI 10.1002/jts.21872; Mason V, 2010, PSYCHOL HEALTH MED, V15, P61, DOI 10.1080/13548500903483478; Massengill D, 2010, SAS GLOBAL FORUM 201; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Neria Y, 2012, JAMA-J AM MED ASSOC, V308, P2571, DOI 10.1001/jama.2012.110700; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145; Paxson C, 2012, SOC SCI MED, V74, P150, DOI 10.1016/j.socscimed.2011.10.004; Pietrzak RH, 2013, J PSYCHIATR RES, V47, P520, DOI 10.1016/j.jpsychires.2012.12.005; Pietrzak RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038964; Redlener, 2006, EDGE CHILDREN FAMILI; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; Schwartz R, 2015, DISASTER MED PUBLIC, P1; Shaw A., 2013, PRO PUBLICA 2013; Smith BW, 2000, J TRAUMA STRESS, V13, P349, DOI 10.1023/A:1007745920466; Stanke C, 2012, PLOS CURRENTS DISAST; Sullivan G, 2013, J NERV MENT DIS, V201, P161, DOI 10.1097/NMD.0b013e31827f636d; Taioli E., 2014, AM J DISASTER MED, V10, P339; Tunstall Sylvia, 2006, Journal of Water and Health, V4, P365, DOI 10.2166/wh.2006.031; Weisler RH, 2006, JAMA-J AM MED ASSOC, V296, P585, DOI 10.1001/jama.296.5.585	49	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170965	10.1371/journal.pone.0170965	http://dx.doi.org/10.1371/journal.pone.0170965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129410	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400018
J	Oong, XY; Ng, KT; Tan, JL; Chan, KG; Kamarulzaman, A; Chan, YF; Sam, IC; Tee, KK				Oong, Xiang Yong; Ng, Kim Tien; Tan, Joon Ling; Chan, Kok Gan; Kamarulzaman, Adeeba; Chan, Yoke Fun; Sam, I-Ching; Tee, Kok Keng			Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014	PLOS ONE			English	Article							B VIRUSES; LINEAGES; EVOLUTION; CHINA; GENE; DYNAMICS	Reassortment of genetic segments between and within influenza B lineages (Victoria and Yamagata) has been shown to generate novel reassortants with unique genetic characteristics. Based on hemagglutinin (HA) and neuraminidase (NA) genes, recent surveillance study has identified reassortment properties in B/Phuket/3073/2013-like virus, which is currently used in the WHO-recommended influenza vaccine. To understand the potential reassortment patterns for all gene segments, four B/Phuket/3073/2013-like viruses and two unique reassortants (one each from Yamagata and Victoria) detected in Malaysia from 2012-2014 were subjected to whole-genome sequencing. Each gene was phylogenetically classified into lineages, clades and sub-clades. Three B/Phuket/3073/2013-like viruses from Yamagata lineage were found to be intra-clade reassortants, possessing PA and NA genes derived from Stockholm/12-like sub-clade, while the remaining genes from Wisconsin/ 01-like sub-clade (both sub-clades were within Yamagata Clade 3/Yam-3). However, the other B/Phuket/3073/2013-like virus had NS gene that derived from Stockholm/12-like sub-clade instead of Wisconsin/01-like sub-clade. One inter-clade reassortant had Yamagata Clade 2/Yam-2-derived HA and NP, and its remaining genes were Yam-3-derived. Within Victoria Clade 1/Vic-1 in Victoria lineage, one virus had intra-clade reassortment properties: HA and PB2 from Vic-1B sub-clade, MP and NS from a unique sub-clade "Vic-1C", and the remaining genes from Vic-1A sub-clade. Although random reassortment event may generate unique reassortants, detailed phylogenetic classification of gene segments showed possible genetic linkage between PA and NA genes in B/Phuket/3073/2013-like viruses, which requires further investigation. Understanding on reassortment patterns in influenza B evolution may contribute to future vaccine design.	[Oong, Xiang Yong; Ng, Kim Tien; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Tan, Joon Ling; Chan, Yoke Fun; Sam, I-Ching; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010; Ng, Kim Tien/K-7667-2013; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010; Chan, Kok Gan/B-8347-2010; Tee, Kok Keng/A-8148-2008	Ng, Kim Tien/0000-0002-4097-9984; Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; Chan, Kok Gan/0000-0002-1883-1115; Tee, Kok Keng/0000-0002-7923-5448; Oong, Xiang Yong/0000-0002-1426-1987	Ministry of Education, Malaysia (High Impact Research) [UM.C/625/1/HIR/MOE/CHAN/02/02, UM.C/625/1/HIR/MOHE/MED/42]; sanofi-aventis, Malaysia [FLU29-EXT]; diagnostic virology laboratory in UMMC;  [PG084-2015A]	Ministry of Education, Malaysia (High Impact Research); sanofi-aventis, Malaysia; diagnostic virology laboratory in UMMC; 	This work was supported by grants from the Ministry of Education, Malaysia (High Impact Research UM.C/625/1/HIR/MOE/CHAN/02/02 and UM.C/625/1/HIR/MOHE/MED/42), the Postgraduate Research Fund (PG084-2015A), and sanofi-aventis, Malaysia (FLU29-EXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We would like to thank Nyoke Pin Wong, See Wie Teoh, Yong Kek Pang, Nik Sherina Hanafi, Tommy Tsan-Yuk Lam, and the diagnostic virology laboratory in UMMC for assistance and support.	[Anonymous], 2015, FEBR 2015 INT REP; Arvia R, 2014, VIRUSES-BASEL, V6, P4437, DOI 10.3390/v6114437; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Dudas G, 2015, MOL BIOL EVOL, V32, P162, DOI 10.1093/molbev/msu287; Fang QX, 2015, ARCH VIROL, V160, P1083, DOI 10.1007/s00705-015-2362-x; GISAID, 2016, EPIFLU DAT; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Pabbaraju K, 2011, J CLIN MICROBIOL, V49, P1738, DOI 10.1128/JCM.02090-10; Patil KN, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00951-13; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Sam IC, 2015, J VIROL, V89, P9689, DOI 10.1128/JVI.00708-15; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; WHO. Influenza Centre London, 2015, SEPT 2014 INT REP; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Zhu N, 2013, VIRUS GENES, V46, P28, DOI 10.1007/s11262-012-0826-6	30	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170610	10.1371/journal.pone.0170610	http://dx.doi.org/10.1371/journal.pone.0170610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129386	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000396211400052
J	De Santi, C; Vencken, S; Blake, J; Haase, B; Benes, V; Gemignani, F; Landi, S; Greene, CM				De Santi, Chiara; Vencken, Sebastian; Blake, Jonathon; Haase, Bettina; Benes, Vladimir; Gemignani, Federica; Landi, Stefano; Greene, Catherine M.			Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing	PLOS ONE			English	Article							MALIGNANT MESOTHELIOMA; GENE-EXPRESSION; CELL; TARGET; SIGNATURE; PROMOTER; MIR-145; SITE	MicroRNAs (miRNAs) are small non-coding RNAs that regulate mRNA expression mainly by silencing target transcripts via binding to miRNA recognition elements (MREs) in the 3'untranslated region (3'UTR). The identification of bona fide targets is challenging for researchers working on the functional aspect of miRNAs. Recently, we developed a method (miR-CATCH) based on biotinylated DNA antisense oligonucleotides that capture the mRNA of interest and facilitates the characterisation of miRNAs:: mRNA interactions in a physiological cellular context. Here, the miR-CATCH technique was applied to the mesothelin (MSLN) gene and coupled with next generation sequencing (NGS), to identify miRNAs that regulate MSLN mRNA and that may be responsible for its increased protein levels found in malignant pleural mesothelioma (MPM). Biotinylated MSLN oligos were employed to isolate miRNA:: MSLN mRNA complexes from a normal cell line (Met-5A) which expresses low levels of MSLN. MiRNAs targeting the MSLN mRNA were identified by NGS and miR-21-5p and miR-100-5p were selected for further validation analyses. MiR-21-5p was shown to be able to modulate MSLN expression in miRNA mimic experiments in a panel of malignant and non-malignant cell lines. Further miRNA inhibitor experiments and luciferase assays in Mero-14 cells validated miR-215p as a true regulator of MSLN. Moreover, in vitro experiments showed that treatment with miR-21-5p mimic reduced proliferation of MPM cell lines. Altogether, this work shows that the miR-CATCH technique, coupled with NGS and in vitro validation, represents a reliable method to identify native miRNA:: mRNA interactions. MiR-21-5p is suggested as novel regulator of MSLN with a possible functional role in cellular growth.	[De Santi, Chiara; Vencken, Sebastian; Greene, Catherine M.] Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Dublin, Ireland; [Blake, Jonathon; Haase, Bettina; Benes, Vladimir] EMBL European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Gemignani, Federica; Landi, Stefano] Univ Pisa, Dept Biol, Pisa, Italy	Royal College of Surgeons - Ireland; European Molecular Biology Laboratory (EMBL); University of Pisa	Landi, S (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	stefano.landi@unipi.it	Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; GEMIGNANI, Federica/0000-0003-1297-0701; De Santi, Chiara/0000-0003-3856-0858	Science Foundation Ireland [12/TIDA/B2265]; European Respiratory Society/GlaxoSmithKline Rare Disease Award; Ministero della Salute-Bando Ricerca Finalizzata [RF-2009-1529895]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Respiratory Society/GlaxoSmithKline Rare Disease Award; Ministero della Salute-Bando Ricerca Finalizzata	This work was supported by several grants: Science Foundation Ireland 12/TIDA/B2265, The European Respiratory Society/GlaxoSmithKline Rare Disease Award 2013 and Ministero della Salute-Bando Ricerca Finalizzata 2009 (RF-2009-1529895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen M, 2014, J MOL DIAGN, V16, P418, DOI 10.1016/j.jmoldx.2014.03.002; Argani P, 2001, CLIN CANCER RES, V7, P3862; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Cappellesso R, 2016, CANCER CYTOPATHOL, V124, P28, DOI 10.1002/cncy.21646; Cioce M, 2014, ONCOGENE, V33, P5319, DOI 10.1038/onc.2013.476; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Garritano S, 2014, J THORAC ONCOL, V9, P1662, DOI 10.1097/JTO.0000000000000322; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; KE Y, 1989, AM J PATHOL, V134, P979; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kirschner MB, 2015, MOL ONCOL, V9, P715, DOI 10.1016/j.molonc.2014.11.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin-Muller C, 2013, CLIN CANCER RES, V19, P5901, DOI 10.1158/1078-0432.CCR-12-3776; Melaiu O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085935; Melnik BC, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0377-9; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; O'Shannessy DJ, 2013, INT J MOL SCI, V14, P13687, DOI 10.3390/ijms140713687; Obulhasim G, 2010, EUR J GYNAECOL ONCOL, V31, P63; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Piscopo P, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00031; Sato N, 2003, CANCER RES, V63, P4158; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shi J, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040042; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tan K, 2010, HUM PATHOL, V41, P1330, DOI 10.1016/j.humpath.2010.03.002; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Vencken S, 2015, METHODS MOL BIOL, V1218, P365, DOI 10.1007/978-1-4939-1538-5_23; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170999	10.1371/journal.pone.0170999	http://dx.doi.org/10.1371/journal.pone.0170999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125734	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100010
J	Britain, CM; Dorsett, KA; Bellis, SL				Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.			The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIALYLATION; GLYCOSYLATION; RECEPTOR; AKT; EXPRESSION; APOPTOSIS; ADHESION; ACTIVATION; RESISTANCE	A hallmark of cancer cells is the ability to survive and proliferate when challenged with stressors such as growth factor insufficiency. In this study, we report a novel glycosylation-dependent mechanism that protects tumor cells from serum growth factor withdrawal. Our results suggest that the beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal-I) sialyltransferase, which is up-regulated in numerous cancers, promotes the survival of serum-starved cells. Using ovarian and pancreatic cancer cell models with ST6Gal-I overexpression or knockdown, we find that serum-starved cells with high ST6Gal-I levels exhibit increased activation of prosurvival signaling molecules, including pAkt, p-p70S6K, and pNF kappa B. Correspondingly, ST6Gal-I activity augments the expression of tumor-promoting pNF kappa B transcriptional targets such as IL-6, IL-8, and the apoptosis inhibitor cIAP2. ST6Gal-I also potentiates expression of the cell cycle regulator cyclin D2, leading to increased phosphorylation and inactivation of the cell cycle inhibitor pRb. Consistent with these results, serum-starved cells with high ST6Gal-I expression maintain a greater number of S phase cells compared with low ST6Gal-I expressors, reflecting enhanced proliferation. Finally, selective enrichment in clonal variants with high ST6Gal-I expression is observed upon prolonged serum deprivation, supporting the concept that ST6Gal-I confers a survival advantage. Collectively, these results implicate a functional role for ST6Gal-I in fostering tumor cell survival within the serum-depleted tumor microenvironment.	[Britain, Colleen M.; Dorsett, Kaitlyn A.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982A McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982A McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health [P30AR048311, P30AI027767]; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093, T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UAB Flow Cytometry Core Facility for assistance (supported by National Institutes of Health Grants P30AR048311 and P30AI027767).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Clark AS, 2002, MOL CANCER THER, V1, P707; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Fukumori T, 2003, CANCER RES, V63, P8302; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945; Ip CKM, 2014, ONCOTARGET, V5, P9133; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takahashi M, 2016, MOL ASPECTS MED, V51, P56, DOI 10.1016/j.mam.2016.04.008; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	49	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4663	4673		10.1074/jbc.M116.763862	http://dx.doi.org/10.1074/jbc.M116.763862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154177	hybrid, Green Published			2022-12-26	WOS:000397585100023
J	Beydoun, R; Hamood, MA; Zubieta, DMG; Kondapalli, KC				Beydoun, Rami; Hamood, Mohamed A.; Zubieta, Daniela M. Gomez; Kondapalli, Kalyan C.			Na+/H+ Exchanger 9 Regulates Iron Mobilization at the Blood-Brain Barrier in Response to Iron Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; RESTLESS LEGS SYNDROME; NEURODEGENERATIVE DISORDERS; GENE-EXPRESSION; RAT-BRAIN; MODEL; COCULTURE; TRANSPORT; ACCUMULATION; PERMEABILITY	Iron is essential for brain function, with loss of iron homeo-stasis in the brain linked to neurological diseases ranging from rare syndromes to more common disorders, such as Parkinson's and Alzheimer's diseases. Iron entry into the brain is regulated by the blood-brain barrier (BBB). Molecular mechanisms regulating this transport are poorly understood. Using an in vitro model of the BBB, we identify NHE9, an endosomal cation/proton exchanger, as a novel regulator of this system. Human brain microvascular endothelial cells (hBMVECs) that constitute the BBB receive brain iron status information via paracrine signals from ensheathing astrocytes. In hBMVECs, we show that NHE9 expression is up-regulated very early in a physiological response invoked by paracrine signals from iron-starved astrocytes. Ectopic expression of NHE9 in hBMVECs without external cues induced up-regulation of the transferrin receptor (TfR) and down-regulation of ferritin, leading to an increase in iron uptake. Mechanistically, we demonstrate that NHE9 localizes to recycling endosomes in hBMVECs where it raises the endosomal pH. The ensuing alkalization of the endosomal lumen increased translocation of TfRs to the hBMVEC membrane. TfRs on the membrane were previously shown to facilitate both recycling-dependent and -independent iron uptake. We propose that NHE9 regulates TfR-dependent, recycling-independent iron uptake in hBMVECs by fine-tuning the endosomal pH in response to paracrine signals and is therefore an important regulator in iron mobilization pathway at the BBB.	[Zubieta, Daniela M. Gomez; Kondapalli, Kalyan C.] Univ Michigan Dearborn, Dept Nat Sci, 4901 Evergreen Rd,ASC 207, Dearborn, MI 48128 USA	University of Michigan System; University of Michigan Dearborn	Kondapalli, KC (corresponding author), Univ Michigan Dearborn, Dept Nat Sci, 4901 Evergreen Rd,ASC 207, Dearborn, MI 48128 USA.	kondap@umich.edu	Kondapalli, Kalyan C/N-8097-2019		Office of Research and Sponsored Programs, University of Michigan-Dearborn; Department of Natural Sciences	Office of Research and Sponsored Programs, University of Michigan-Dearborn; Department of Natural Sciences	This work was supported by funds provided to Kalyan C. Kondapalli by the Department of Natural Sciences and Office of Research and Sponsored Programs, University of Michigan-Dearborn. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Allen Institute for Brain Science, 2010, ALL HUM BRAIN ATL; Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Boveri M, 2005, GLIA, V51, P187, DOI 10.1002/glia.20189; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cabantchik ZI, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00045; Cardon M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000062; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Coelho L., 2010, INT J SOFTWARE SCI C, DOI [10.1109/COGINF, DOI 10.1109/COGINF.2009.5250695]; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Demeuse P, 2002, J NEUROSCI METH, V121, P21, DOI 10.1016/S0165-0270(02)00225-X; Diaz-Coranguez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060655; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; DSa C, 1996, MOL BRAIN RES, V41, P105, DOI 10.1016/0169-328X(96)00073-3; Du F, 2015, MOL NEUROBIOL, V52, P101, DOI 10.1007/s12035-014-8847-x; Duck KA, 2016, BIOMETALS, V29, P573, DOI 10.1007/s10534-016-9952-2; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hurst RD, 1996, J CELL PHYSIOL, V167, P81, DOI 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.3.CO;2-F; Kondapalli KC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7289; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; Levy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092165; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; McCarthy RC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00031; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Patak J, 2017, AUTISM RES, V10, P414, DOI 10.1002/aur.1670; Perez-Palma E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095413; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simpson IA, 2015, J CEREBR BLOOD F MET, V35, P48, DOI 10.1038/jcbfm.2014.168; THEIL EC, 1990, J BIOL CHEM, V265, P4771; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Yang LN, 2016, AM J MED GENET B, V171, P363, DOI 10.1002/ajmg.b.32415; Youdim M. B., 1988, BRAIN IRON NEUROCHEM, P25; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang-James Y, 2012, DEV NEUROSCI-BASEL, V34, P218, DOI 10.1159/000338813; Zhang-James Y, 2011, AM J MED GENET B, V156B, P835, DOI 10.1002/ajmg.b.31229; Zhao HS, 2016, PROG NEUROBIOL, V138, P19, DOI 10.1016/j.pneurobio.2016.02.002	57	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4293	4301		10.1074/jbc.M116.769240	http://dx.doi.org/10.1074/jbc.M116.769240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130443	Green Published, hybrid			2022-12-26	WOS:000395837100026
J	Hung, MS; Chen, IC; Lee, CP; Huang, RJ; Chen, PC; Tsai, YH; Yang, YH				Hung, Ming-Szu; Chen, I-Chuan; Lee, Chuan-Pin; Huang, Ru-Jiun; Chen, Pau-Chung; Tsai, Ying-Huang; Yang, Yao-Hsu			Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study	PLOS ONE			English	Article							OVERCOMES GEFITINIB RESISTANCE; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; 1ST-LINE TREATMENT; RISK-FACTORS; CHEMOTHERAPY; METAANALYSIS; THERAPY; COHORT; IMPACT	Long-term use of statins has been reported to reduce the risk of death in patients with lung cancer. This study investigated the effect of statin use among patients with lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) therapy. A nationwide, population-based case-control study was conducted using the Taiwan National Health Insurance Research Database. From January 1, 1997 to December 31, 2012, a total of 1,707 statin and 6,828 non-statin matched lung cancer cohorts with EGFR-TKIs treatment were studied. Statin use was associated with a reduced risk of death (HR: 0.58, 95% CI: 0.54-0.62, p < 0.001). In addition, statin use was associated with a significantly longer median progression-free survival (8.3 months, 95% CI: 7.6-8.9 vs. 6.1 months, 95% CI: 6.0-6.4, p < 0.001) and median overall survival (35.5 months, 95% CI: 33.8-38.1 vs. 23.9 months, 95% CI: 23.4-24.7, p < 0.001). In conclusion, statins might potentially enhance the therapeutic effect and increase survival in patients with lung cancer receiving EGFR-TKI therapy.	[Hung, Ming-Szu; Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Thorac Oncol, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi Branch, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan; [Lee, Chuan-Pin; Huang, Ru-Jiun] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Chen, Pau-Chung; Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Tsai, Ying-Huang] Chang Gung Univ, Dept Resp Care, Coll Med, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Thorac Oncol, Chiayi Branch, Chiayi, Taiwan.; Yang, YH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.; Tsai, YH (corresponding author), Chang Gung Univ, Dept Resp Care, Coll Med, Taoyuan, Taiwan.; Yang, YH (corresponding author), Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Chiayi, Taiwan.; Yang, YH (corresponding author), Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan.	chestmed@cgmh.org.tw; r95841012@ntu.edu.tw	楊, 曜旭/A-3450-2019; Chen, Pau-Chung/H-5686-2011	楊, 曜旭/0000-0002-8080-0504; Chen, Pau-Chung/0000-0002-6242-5974	Chang Gung Memorial Hospital, Chiayi Branch, Taiwan [CORPG6D0161]	Chang Gung Memorial Hospital, Chiayi Branch, Taiwan	This study was supported by a grant from Chang Gung Memorial Hospital, Chiayi Branch (CORPG6D0161) (to YHY), Taiwan (R.O.C.).	Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Chang CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000444; Chen J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.312; Chen J, 2012, MOL ONCOL, V6, P62, DOI 10.1016/j.molonc.2011.11.003; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; D'Antonio C, 2014, THER ADV MED ONCOL, V6, P101, DOI 10.1177/1758834014521110; Fiala O, 2015, TUMOR BIOL, V36, P5801, DOI 10.1007/s13277-015-3249-x; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Han JY, 2011, CLIN CANCER RES, V17, P1553, DOI 10.1158/1078-0432.CCR-10-2525; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Hsu CL, 2015, J GERIATR ONCOL, V6, P38, DOI 10.1016/j.jgo.2014.09.178; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Huang W, 2016, ONCOTARGET; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Hwang KE, 2011, INVEST NEW DRUG, V29, P945, DOI 10.1007/s10637-010-9450-2; Khullar OV, 2015, J AM COLL SURGEONS, V220, P156, DOI 10.1016/j.jamcollsurg.2014.10.009; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McDavid K, 2003, ARCH INTERN MED, V163, P2135, DOI 10.1001/archinte.163.18.2135; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park IH, 2010, INVEST NEW DRUG, V28, P791, DOI 10.1007/s10637-009-9319-4; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vallianou NG, 2014, ANTI-CANCER AGENT ME, V14, P706, DOI 10.2174/1871520613666131129105035; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Zhou C, 2015, ANN ONCOL, V26, P1877, DOI 10.1093/annonc/mdv276; Zhu LH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003528	41	45	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171137	10.1371/journal.pone.0171137	http://dx.doi.org/10.1371/journal.pone.0171137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158206	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700032
J	Tang, LQ; Fang, XF; Winesett, SP; Cheng, CY; Binder, HJ; Rivkees, SA; Cheng, SX				Tang, Lieqi; Fang, Xiefan; Winesett, Steven P.; Cheng, Catherine Y.; Binder, Henry J.; Rivkees, Scott A.; Cheng, Sam X.			Bumetanide increases Cl--dependent short-circuit current in late distal colon: Evidence for the presence of active electrogenic Cl- absorption	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; APICAL MEMBRANE-VESICLES; FLUID SECRETION; CHLORIDE COTRANSPORTER; FUNCTIONAL EXPRESSION; ELECTROLYTE SECRETION; POTASSIUM ABSORPTION; MOLECULAR-CLONING; SODIUM-TRANSPORT; PROXIMAL COLON	Mammalian colonic epithelia consist of cells that are capable of both absorbing and secreting Cl-. The present studies employing Ussing chamber technique identified two opposing short-circuit current (I-sc) responses to basolateral bumetanide in rat distal colon. Apart from the transepithelial Cl--secretory I-sc in early distal colon that was inhibited by bumetanide, bumetanide also stimulated I-sc in late distal colon that had not previously been identified. Since bumetanide inhibits basolateral Na+-K+-2Cl(-) cotransporter (NKCC) in crypt cells and basolateral K+-Cl- cotransporter (KCC) in surface epithelium, we proposed this stimulatory I-sc could represent a KCC-mediated Cl- absorptive current. In support of this hypothesis, ion substitution experiments established Cl- dependency of this absorptive I-sc and transport inhibitor studies demonstrated the involvement of an apical Cl- conductance. Current distribution and RNA sequencing analyses revealed that this Cl- absorptive Isc is closely associated with epithelial Na+ channel (ENaC) but is not dependent on ENaC activity. Thus, inhibition of ENaC by 10 mu M amiloride or benzamil neither altered the direction nor its activity. Physiological studies suggested that this Cl- absorptive Isc senses dietary Cl- content; thus when dietary Cl- was low, Cl- absorptive I-sc was up-regulated. In contrast, when dietary Cl- was increased, Cl- absorptive I-sc was down-regulated. We conclude that an active Cl- extrusion mechanism exists in ENaC-expressing late distal colon and likely operates in parallel with ENaC to facilitate NaCl absorption.	[Tang, Lieqi; Fang, Xiefan; Winesett, Steven P.; Cheng, Catherine Y.; Rivkees, Scott A.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Binder, Henry J.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Cheng, Sam X.] Univ Florida, Dept Pediat Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Yale University; State University System of Florida; University of Florida	Cheng, SX (corresponding author), Univ Florida, Dept Pediat Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA.	sam.cheng@ufl.edu		Cheng, Sam/0000-0003-0252-9357	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [HD079674]; Children's Digestive Health and Nutrition Foundation [00102979]; Children's Miracle Network (SXC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD079674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Children's Digestive Health and Nutrition Foundation; Children's Miracle Network (SXC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (https://www.nichd.nih.gov/Pages/index.aspx) award number HD079674 (SXC), Children's Digestive Health and Nutrition Foundation (http://www.naspghan.org/content/9/en/NASPGHAN-Foundation) award number 00102979 (SXC), and Children's Miracle Network (SXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Binder HJ, 2010, ANNU REV PHYSIOL, V72, P297, DOI 10.1146/annurev-physiol-021909-135817; Catalan M, 2004, GASTROENTEROLOGY, V126, P1104, DOI 10.1053/j.gastro.2004.01.010; Cheng SX, 2012, AM J PHYSIOL-GASTR L, V303, pG60, DOI 10.1152/ajpgi.00425.2011; Cheng SX, 2016, WORLD J GASTROENTERO, V22, P2711, DOI 10.3748/wjg.v22.i9.2711; Cheng SX, 2004, GASTROENTEROLOGY, V126, P148, DOI 10.1053/j.gastro.2003.10.064; Cheng SX, 2002, AM J PHYSIOL-GASTR L, V283, pG240, DOI 10.1152/ajpgi.00500.2001; Cho JH, 1998, AM J PHYSIOL-CELL PH, V274, pC586, DOI 10.1152/ajpcell.1998.274.3.C586; Dorge A, 1998, PFLUG ARCH EUR J PHY, V436, P280, DOI 10.1007/s004240050633; Ecke D, 1996, PFLUG ARCH EUR J PHY, V431, P984, DOI 10.1007/s004240050095; Fang X, 2016, FASEB J OFFICIAL PUB; FOSTER ES, 1986, AM J PHYSIOL, V251, pG619, DOI 10.1152/ajpgi.1986.251.5.G619; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; HAAS M, 1983, AM J PHYSIOL, V245, pC235, DOI 10.1152/ajpcell.1983.245.3.C235; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; Hebert SC, 2004, CELL CALCIUM, V35, P239, DOI 10.1016/j.ceca.2003.10.015; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LARSEN EH, 1991, PHYSIOL REV, V71, P235, DOI 10.1152/physrev.1991.71.1.235; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; RAJENDRAN VM, 1989, J BIOL CHEM, V264, P18638; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; REDDY MM, 1994, AM J PHYSIOL-CELL PH, V267, pC1136, DOI 10.1152/ajpcell.1994.267.4.C1136; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Sangan P, 2000, J BIOL CHEM, V275, P30813, DOI 10.1074/jbc.M003931200; Schultheiss G, 1998, ACTA PHYSIOL SCAND, V164, P219; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Talbot C, 2010, AM J PHYSIOL-GASTR L, V299, pG358, DOI 10.1152/ajpgi.00151.2010; Tang LQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00245; Tang LQ, 2015, AM J PHYSIOL-GASTR L, V308, pG874, DOI 10.1152/ajpgi.00341.2014; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; VOUTE CL, 1978, J MEMBRANE BIOL, V40, P151, DOI 10.1007/BF02026003; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; WILLS NK, 1985, J PHYSIOL-LONDON, V358, P433, DOI 10.1113/jphysiol.1985.sp015560; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zhu JX, 2011, TRANSL RES, V158, P146, DOI 10.1016/j.trsl.2011.04.003; Zhu JX, 2005, EUR J PHARMACOL, V510, P187, DOI 10.1016/j.ejphar.2005.01.026	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171045	10.1371/journal.pone.0171045	http://dx.doi.org/10.1371/journal.pone.0171045			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152000	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200079
J	Gladilin, E				Gladilin, Evgeny			Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; FUNCTIONAL MODULES; IDENTIFICATION; PATTERNS; ORGANIZATION; MODULARITY; CENTRALITY; COMPLEXES; TOPOLOGY; BIOLOGY	Malignant transformation is known to involve substantial rearrangement of the molecular genetic landscape of the cell. A common approach to analysis of these alterations is a reductionist one and consists of finding a compact set of differentially expressed genes or associated signaling pathways. However, due to intrinsic tumor heterogeneity and tissue specificity, biomarkers defined by a small number of genes/pathways exhibit substantial variability. As an alternative to compact differential signatures, global features of genetic cell machinery are conceivable. Global network descriptors suggested in previous works are, however, known to potentially be biased by overrepresentation of interactions between frequently studied genes-proteins. Here, we construct a cellular network of 74538 directional and differential gene expression weighted protein-protein and gene regulatory interactions, and perform graph-theoretical analysis of global human interactome using a novel, degree independent feature-the normalized total communicability (NTC). We apply this framework to assess differences in total information flow between different cancer (BRCA/COAD/GBM) and non-cancer interactomes. Our experimental results reveal that different cancer interactomes are characterized by significant enhancement of long-range NTC, which arises from circulation of information flow within robustly organized gene subnetworks. Although enhancement of NTC emerges in different cancer types from different genomic profiles, we identified a subset of 90 common genes that are related to elevated NTC in all studied tumors. Our ontological analysis shows that these genes are associated with enhanced cell division, DNA replication, stress response, and other cellular functions and processes typically upregulated in cancer. We conclude that enhancement of long-range NTC manifested in the correlated activity of genes whose tight coordination is required for survival and proliferation of all tumor cells, and, thus, can be seen as a graph-theoretical equivalent to some hallmarks of cancer. The computational framework for differential network analysis presented herein is of potential interest for a wide range of network perturbation problems given by single or multiple gene-protein activation-inhibition.	[Gladilin, Evgeny] German Canc Res Ctr, Div Theoret Bioinformat, Berliner Str 41, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Heidelberg Univ, BioQuant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Heidelberg Univ, IPMB, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Gatersleben, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Gladilin, E (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Berliner Str 41, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Heidelberg Univ, BioQuant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Heidelberg Univ, IPMB, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Gatersleben, Germany.	evgeny.gladilin@gmail.com						Albert R, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032811; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Benzi M, 2013, J COMPLEX NETW, V1, P124, DOI 10.1093/comnet/cnt007; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Christensen C, 2007, INT J BIFURCAT CHAOS, V17, P2201, DOI 10.1142/S021812740701835X; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Davis TA, 2006, FUND ALGORITHMS, V2, P1, DOI 10.1137/1.9780898718881; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Feng JX, 2011, IEEE ACM T COMPUT BI, V8, P621, DOI 10.1109/TCBB.2010.78; Guney E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094686; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanisch Daniel, 2002, Bioinformatics, V18 Suppl 1, pS145; Heng HHQ, 2011, GENOMICS, V98, P242, DOI 10.1016/j.ygeno.2011.05.008; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Islam Md Fahmid, 2013, J Clin Bioinforma, V3, P19, DOI 10.1186/2043-9113-3-19; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Komurov K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-154; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-158; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Pandey G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109130; Platzer A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-224; Rai A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06368; Schaefer MH, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00260; Schramm G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-162; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Tuck DP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-236; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Weiss JN, 2012, CIRC RES, V111, P493, DOI 10.1161/CIRCRESAHA.112.269084; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170953	10.1371/journal.pone.0170953	http://dx.doi.org/10.1371/journal.pone.0170953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141819	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129500030
J	Aguilar, VS; van de Gronde, JJ; Lamoth, CJC; van Diest, M; Maurits, NM; Roerdink, JBTM				Aguilar, Venustiano Soancatl; van de Gronde, Jasper J.; Lamoth, Claudine J. C.; van Diest, Mike; Maurits, Natasha M.; Roerdink, Jos B. T. M.			Visual Data Exploration for Balance Quantification in Real-Time During Exergaming	PLOS ONE			English	Article							POSTURAL CONTROL; OLDER-PEOPLE; BODY SWAY; STABILITY; PATTERNS; FALLS; MANAGEMENT; MOVEMENT; KINECT	Unintentional injuries are among the ten leading causes of death in older adults; falls cause 60% of these deaths. Despite their effectiveness to improve balance and reduce the risk of falls, balance training programs have several drawbacks in practice, such as lack of engaging elements, boring exercises, and the effort and cost of travelling, ultimately resulting in low adherence. Exergames, that is, digital games controlled by body movements, have been proposed as an alternative to improve balance. One of the main challenges for exergames is to automatically quantify balance during game-play in order to adapt the game difficulty according to the skills of the player. Here we perform a multidimensional exploratory data analysis, using visualization techniques, to find useful measures for quantifying balance in real-time. First, we visualize exergaming data, derived from 400 force plate recordings of 40 participants from 20 to 79 years and 10 trials per participant, as heat maps and violin plots to get quick insight into the nature of the data. Second, we extract known and new features from the data, such as instantaneous speed, measures of dispersion, turbulence measures derived from speed, and curvature values. Finally, we analyze and visualize these features using several visualizations such as a heat map, overlapping violin plots, a parallel coordinate plot, a projection of the two first principal components, and a scatter plot matrix. Our visualizations and findings suggest that heat maps and violin plots can provide quick insight and directions for further data exploration. The most promising measures to quantify balance in real-time are speed, curvature and a turbulence measure, because these measures show age-related changes in balance performance. The next step is to apply the present techniques to data of whole body movements as recorded by devices such as Kinect.	[Aguilar, Venustiano Soancatl; van de Gronde, Jasper J.; Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Lamoth, Claudine J. C.; van Diest, Mike] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van Diest, Mike] INCAS3, Assen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Aguilar, VS (corresponding author), Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands.	v.soancatl.aguilar@rug.nl	Roerdink, Jos B.T.M/B-3631-2008; Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823; Maurits, Natasha/0000-0001-6231-7044; Soancatl Aguilar, Venustiano/0000-0001-6833-403X	INCAS3; 8D-Games; Northern Netherlands Provinces Alliance, Course for the North; Mexican National Council of Science and Technology (CONACYT) [313791]	INCAS3; 8D-Games; Northern Netherlands Provinces Alliance, Course for the North; Mexican National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The exergaming project has been performed on behalf of research center SPRINT of the UMCG and was supported by INCAS3 and 8D-Games. The project was financially supported by the Northern Netherlands Provinces Alliance, Course for the North. Data reported in the presented paper were collected in the realm of this project. Venustiano Soancatl Aguilar was supported by the Mexican National Council of Science and Technology (CONACYT) under scholarship number 313791.r The exergaming project has been performed on behalf of research center SPRINT of the UMCG and was supported by INCAS<SUP>3</SUP> and 8D-Games. The project was financially supported by the Northern Netherlands Provinces Alliance, Course for the North. Data reported in the presented paper were collected in the realm of this project. Venustiano Soancatl Aguilar was supported by the Mexican National Council of Science and Technology (CONACYT) under scholarship number 313791.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; Aigner W, 2011, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-0-85729-079-3; ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; [Anonymous], 2007, WHO GLOB REP FALLP; [Anonymous], 2021, LANG ENV STAT COMP; Bradshaw P, 1971, INTRO TURBULENCE ITS; Burgers C, 2015, COMPUT HUM BEHAV, V48, P94, DOI 10.1016/j.chb.2015.01.038; Carpman N., 2011, TURBULENCE INTENSITY; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; Clemons TE, 2000, COMPUT STAT DATA AN, V34, P51, DOI 10.1016/S0167-9473(99)00074-2; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Dowle M, 2015, DATA TABLE EXTENSION; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fox J., 2019, R COMPANION APPL REG, V.; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Gintautas D, 2013, MULTIDIMENSIONAL DAT; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Hall KS, 2017, J GERONTOL A-BIOL, V72, P572, DOI 10.1093/gerona/glw120; Heinrich J, 2013, STAR P EUR, V2013, P95, DOI [10.2312/conf/EG2013/stars/095-116, DOI 10.2312/CONF/EG2013/STARS/095-116]; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Inselberg A., 2009, PARALLEL COORDINATES, V1; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Kosse NM., 2011, J CYBER THERAPY REHA, V4, P399; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Larsen LH, 2013, GAMES HEALTH J, V2, P205, DOI 10.1089/g4h.2013.0036; Legendre P, 1988, NUMERICAL ECOLOGY; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lu LF, 2016, J VISUAL LANG COMPUT, V33, P3, DOI 10.1016/j.jvlc.2015.12.001; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARTIN JD, 1971, AM SOCIOL REV, V36, P496, DOI 10.2307/2093089; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Pratt V., 2011, COLL MATH J, V40, P1; Pressley Andrew, 2001, ELEMENTARY DIFFERENT; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Robinson L, 2014, DISABIL REHABIL, V36, P379, DOI 10.3109/09638288.2013.797507; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Soancatl V, 2016, EUROVIS 2016 POSTERS, P25; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Sun TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069471; Tsinober A, 2009, FLUID MECH APPL, V92, P1, DOI 10.1007/978-90-481-3174-7; Tukey JW, 1977, EXPLORATORY DATA ANA; van Diest M, 2016, GAIT POSTURE, V44, P161, DOI 10.1016/j.gaitpost.2015.11.019; van Diest M., 2016, THESIS; van Diest M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134350; van Diest M, 2014, J BIOMECH, V47, P2925, DOI 10.1016/j.jbiomech.2014.07.017; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Wiemeyer J, 2015, GAMES HEALTH J, V4, P58, DOI 10.1089/g4h.2014.0078; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Woollacott MH, 1996, J AGING PHYS ACTIV, V4, P214, DOI 10.1123/japa.4.3.214; Wu S, 2009, PATTERN RECOGN, V42, P194, DOI 10.1016/j.patcog.2008.06.023; Zhou H, 2008, COMPUT GRAPH FORUM, V27, P1047, DOI 10.1111/j.1467-8659.2008.01241.x	70	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170906	10.1371/journal.pone.0170906	http://dx.doi.org/10.1371/journal.pone.0170906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135284	Green Published, gold			2022-12-26	WOS:000396124700029
J	Verma, K; Datta, S				Verma, Kuldeep; Datta, Sunando			The Monomeric GTPase Rab35 Regulates Phagocytic Cup Formation and Phagosomal Maturation in Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-R; ENDOPLASMIC-RETICULUM; MYOSIN IB; PARASITE; MEMBRANE; COMPLEX; PROTEINS; CYTOSKELETON; RECRUITMENT; BIOGENESIS	One of the hallmarks of amoebic colitis is the detection of Entamoeba histolytica (Eh) trophozoites with ingested erythrocytes. Therefore, erythrophagocytosis is traditionally considered as one of the most important criteria to identify the pathogenic behavior of the amoebic trophozoites. Phagocytosis is an essential process for the proliferation and virulence of this parasite. Phagocytic cargo, upon internalization, follows a defined trafficking route to amoebic lysosomal degradation machinery. Here, we demonstrated the role of EhRab35 in the early and late phases of erythrophagocytosis by the amoeba. EhRab35 showed large vacuolar as well as punctate vesicular localization. The spatiotemporal dynamics of vacuolar EhRab35 and its exchange with soluble cytosolic pool were monitored by fluorescence recovery after photobleaching experiments. Using extensive microscopy and biochemical methods, we demonstrated that upon incubation with RBCs EhRab35 is recruited to the site of phagocytic cups as well as to the nascent phagosomes that har-bor Gal/GalNAc lectin and actin. Overexpression of a dominant negative mutant of EhRab35 reduced phagocytic cup formation and thereby reducedRBCinternalization, suggesting a potential role of the Rab GTPase in the cup formation. Furthermore, we also performed a phagosomal maturation assay and observed that the activated form of EhRab35 significantly increased the rate of RBC degradation. Interestingly, this mutant also significantly enhanced the number of acidic compartments in the trophozoites. Taken together, our results suggest that EhRab35 is involved in the initial stage of phagocytosis as well as in the phagolysosomal biogenesis in E. histolytica and thus contributes to the pathogenicity of the parasite.	[Verma, Kuldeep; Datta, Sunando] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal Bypass Rd, Bhauri 462030, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Datta, S (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Bhopal Bypass Rd, Bhauri 462030, Madhya Pradesh, India.	sunando@iiserb.ac.in		Verma, Kuldeep/0000-0002-8912-3781	Max Planck Gesellschaft, Germany; Department of Biotechnology, New Delhi, India; Department of Science and Technology, India [IGSTC/MPG/PG(SD)/2011]	Max Planck Gesellschaft, Germany(Max Planck Society); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported in part by Max Planck Gesellschaft, Germany and Department of Science and Technology, India partner group funding (Grant IGSTC/MPG/PG(SD)/2011, December 19, 2011). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Department of Biotechnology, New Delhi, India DBT-IISc postdoctoral fellowship.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; [Anonymous], 1997, Epidemiol Bull, V18, P13; Aslam S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003055; Babuta M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005310; BAILEY GB, 1985, J EXP MED, V162, P546, DOI 10.1084/jem.162.2.546; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bracha Rivka, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020048; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CARDELLI JA, 1989, J BIOL CHEM, V264, P3454; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chen CS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-21; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Coppolino MG, 2001, J CELL SCI, V114, P4307; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dikshit N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005083; Duclos S, 2000, J CELL SCI, V113, P3531; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Emmanuel M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004666; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foret L, 2012, CURR BIOL, V22, P1381, DOI 10.1016/j.cub.2012.06.021; GONZALEZRUIZ A, 1994, J CLIN PATHOL, V47, P236, DOI 10.1136/jcp.47.3.236; Gunther J, 2011, AM J TROP MED HYG, V85, P1038, DOI 10.4269/ajtmh.2011.11-0288; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hanadate Y, 2016, CELL MICROBIOL, V18, P1358, DOI 10.1111/cmi.12570; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hernandes-Alejandro M, 2013, PARASITOL RES, V112, P1631, DOI 10.1007/s00436-013-3318-2; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Labruyere E, 2003, J CELL SCI, V116, P61, DOI 10.1242/jcs.00190; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Mansuri MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004411; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Olivos-Garcia A, 2004, EXP MOL PATHOL, V77, P66, DOI 10.1016/j.yexmp.2003.09.003; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramalho JS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-26; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RODRIGUEZ MA, 1986, J INFECT DIS, V154, P27, DOI 10.1093/infdis/154.1.27; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Talamas-Lara D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/626259; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TRISSL D, 1978, J EXP MED, V148, P1137, DOI 10.1084/jem.148.5.1137; Verma K, 2016, MOL MICROBIOL, V102, P1043, DOI 10.1111/mmi.13533; Verma K, 2015, CELL MICROBIOL, V17, P1779, DOI 10.1111/cmi.12470; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Voigt H, 1999, J CELL SCI, V112, P1191; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Wheeler DB, 2015, SCIENCE, V350, P211, DOI 10.1126/science.aaa4903; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	82	16	16	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4960	4975		10.1074/jbc.M117.775007	http://dx.doi.org/10.1074/jbc.M117.775007			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28126902	Green Published, hybrid			2022-12-26	WOS:000397590400018
J	Dahmene, M; Berard, M; Oueslati, A				Dahmene, Manel; Berard, Morgan; Oueslati, Abid			Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated -Synuclein-selective Autophagic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein (a-synuclein); protein degradation; protein kinase; protein phosphorylation; ubiquitin	UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; IN-VIVO; NEURODEGENERATIVE DISEASES; MAMMALIAN-CELLS; NERVOUS-SYSTEM; CULTURED-CELLS; BODY FORMATION; LEWY BODIES	Increasing lines of evidence support the causal link between -synuclein (-syn) accumulation in the brain and Parkinson's disease (PD) pathogenesis. Therefore, lowering -syn protein levels may represent a viable therapeutic strategy for the treatment of PD and related disorders. We recently described a novel selective -syn degradation pathway, catalyzed by the activity of the Polo-like kinase 2 (PLK2), capable of reducing -syn protein expression and suppressing its toxicity in vivo. However, the exact molecular mechanisms underlying this degradation route remain elusive. In the present study we report that among PLK family members, PLK3 is also able to catalyze -syn phosphorylation and degradation in living cells. Using pharmacological and genetic approaches, we confirmed the implication of the macroautophagy on PLK2-mediated -syn turnover, and our observations suggest a concomitant co-degradation of these two proteins. Moreover, we showed that the N-terminal region of -syn is important for PLK2-mediated -syn phosphorylation and degradation and is implicated in the physical interaction between the two proteins. We also demonstrated that PLK2 polyubiquitination is important for PLK2-syn protein complex degradation, and we hypothesize that this post-translational modification may act as a signal for the selective recognition by the macroautophagy machinery. Finally, we observed that the PD-linked mutation E46K enhances PLK2-mediated -syn degradation, suggesting that this mutated form is a bona fide substrate of this degradation pathway. In conclusion, our study provides a detailed description of the new degradation route of -syn and offers new opportunities for the development of therapeutic strategies aiming to reduce -syn protein accumulation and toxicity.	[Oueslati, Abid] Univ Laval, CHU Quebec Res Ctr, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Oueslati, A (corresponding author), Univ Laval, CHU Quebec Res Ctr, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada.	Abid.Oueslati@crchudequebec.ulaval.ca	Oueslati, Abid/ABG-8116-2020	Oueslati, Abid/0000-0003-1122-7086	Natural Sciences and Engineering Research Council of Canada (NSERC); CHU de Quebec Foundation; CHU de Quebec Research Center-Universite Laval	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CHU de Quebec Foundation; CHU de Quebec Research Center-Universite Laval	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the CHU de Quebec Foundation, and CHU de Quebec Research Center-Universite Laval. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Burre J, 2015, J PARKINSON DIS, V5, P699, DOI 10.3233/JPD-150642; Carroll B, 2013, ESSAYS BIOCHEM, V55, P119, DOI [10.1042/bse0550119, 10.1042/BSE0550119]; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guan HC, 2012, J VIROL, V86, P5594, DOI 10.1128/JVI.06811-11; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Kim E, 2014, BIOCHEM BIOPH RES CO, V449, P399, DOI 10.1016/j.bbrc.2014.05.063; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lindner JM, 2013, MOL CELL BIOL, V33, P4628, DOI 10.1128/MCB.01590-12; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Mbefo MK, 2015, J BIOL CHEM, V290, P9412, DOI 10.1074/jbc.M114.610774; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oueslati Abid, 2014, Exp Neurobiol, V23, P324, DOI 10.5607/en.2014.23.4.324; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Rozeboom AM, 2012, NEUROSCIENCE, V202, P147, DOI 10.1016/j.neuroscience.2011.11.003; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Wang H, 2015, INT J BIOCHEM CELL B, V62, P24, DOI 10.1016/j.biocel.2015.02.011; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yogosawa S, 2005, J BIOL CHEM, V280, P41619, DOI 10.1074/jbc.M508397200	52	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3919	3928		10.1074/jbc.M116.759373	http://dx.doi.org/10.1074/jbc.M116.759373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28154193	Green Published, hybrid			2022-12-26	WOS:000395542500032
J	Mahlaba, TAM; Monadjem, A; McCleery, R; Belmain, SR				Mahlaba, Themb'alilahlwa A. M.; Monadjem, Ara; McCleery, Robert; Belmain, Steven R.			Domestic cats and dogs create a landscape of fear for pest rodents around rural homesteads	PLOS ONE			English	Article							PREDATOR ODORS; FELIS-CATUS; RATS; MANAGEMENT; RISK; KNOWLEDGE; ATTITUDES; WILDLIFE; BEHAVIOR; SCENT	Using domestic predators such as cats to control rodent pest problems around farms and homesteads is common across the world. However, practical scientific evidence on the impact of such biological control in agricultural settings is often lacking. We tested whether the presence of domestic cats and/or dogs in rural homesteads would affect the foraging behaviour of pest rodents. We estimated giving up densities (GUDs) from established feeding patches and estimated relative rodent activity using tracking tiles at 40 homesteads across four agricultural communities. We found that the presence of cats and dogs at the same homestead significantly reduced activity and increased GUDs (i.e. increased perception of foraging cost) of pest rodent species. However, if only cats or dogs alone were present at the homestead there was no observed difference in rodent foraging activity in comparison to homesteads with no cats or dogs. Our results suggest that pest rodent activity can be discouraged through the presence of domestic predators. When different types of predator are present together they likely create a heightened landscape of fear for foraging rodents.	[Mahlaba, Themb'alilahlwa A. M.; Monadjem, Ara] Univ Swaziland, Dept Biol Sci, Private Bag 4, Kwaluseni, Swaziland; [Monadjem, Ara] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Private Bag 20, Pretoria, South Africa; [McCleery, Robert] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	University of Pretoria; State University System of Florida; University of Florida; University of Greenwich	Mahlaba, TAM (corresponding author), Univ Swaziland, Dept Biol Sci, Private Bag 4, Kwaluseni, Swaziland.	tmahlaba@uniswa.sz	Belmain, Steven R/F-7758-2012; Monadjem, Ara/K-7279-2014	Belmain, Steven R/0000-0002-5590-7545; McCleery, Robert/0000-0001-7018-005X; Monadjem, Ara/0000-0003-1906-4023	ACP-EU Co-operation Programme in Science and Technology (ST II); Intra-ACP envelope of the 10th European Development Budget Line [2011 21.06.02]; StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science [EuropeAid/133437/D/ACT/ACPTPS, FED2013330-223]	ACP-EU Co-operation Programme in Science and Technology (ST II); Intra-ACP envelope of the 10th European Development Budget Line; StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science	This work was supported by the ACP-EU Co-operation Programme in Science and Technology (S&T II); Intra-ACP envelope of the 10th European Development & Budget Line 2011 21.06.02; Reference: EuropeAid/133437/D/ACT/ACPTPS StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science, Contract number: FED2013330-223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; ARMSTRONG AK, 1987, STUD FAMILY PLANN, V18, P371, DOI 10.2307/1966603; Baker PJ, 2003, MAMMAL REV, V33, P95, DOI 10.1046/j.1365-2907.2003.00003.x; Banks Peter B., 2003, Australian Zoologist, V32, P406; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Bedoya-Perez MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1541, DOI 10.1007/s00265-013-1609-3; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brown JS, 1999, EVOL ECOL RES, V1, P49; Brown PR, 2008, INT J PEST MANAGE, V54, P69, DOI 10.1080/09670870701474047; Burwash MD, 1998, J CHEM ECOL, V24, P49, DOI 10.1023/A:1022384728170; Butler JRA, 2002, ANIM CONSERV, V5, P29, DOI 10.1017/S136794300200104X; Bytheway JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P715, DOI 10.1007/s00265-013-1494-9; Campos CB, 2007, J ZOOL, V273, P14, DOI 10.1111/j.1469-7998.2007.00291.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CHILDS JE, 1986, J MAMMAL, V67, P196, DOI 10.2307/1381025; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Emerson SE, 2011, ANIM BEHAV, V81, P455, DOI 10.1016/j.anbehav.2010.11.018; Engeman R, 2006, INT BIODETER BIODEGR, V58, P2, DOI 10.1016/j.ibiod.2006.03.004; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kays R. W., 2004, ANIMAL CONSERVATION, V7, P1; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindgren P. M. F., 1995, NAT WILDL RES CTR RE; MacDonald D. W., 1995, P199; Macdonald D.W., 2006, ENCY MAMMALS; Makundi RH, 2005, BELG J ZOOL, V135, P153; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; Mazerolle M.J, 2016, AICCMODAVG MODEL SEL; Monadjem A, 2011, WILDLIFE RES, V38, P603, DOI 10.1071/WR10130; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; PAQUET PC, 1991, CAN J ZOOL, V69, P1721, DOI 10.1139/z91-240; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schmidt K, 2015, MAMMAL RES, V60, P275, DOI 10.1007/s13364-015-0229-x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silmi M., 2013, J INDONES NAT HIST, V1, P31; Skaug H, 2012, GLMMADMB GEN LINEAR; Strauss A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1551, DOI 10.1007/s00265-008-0584-6; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Taylor PJ, 2012, WILDLIFE RES, V39, P51, DOI 10.1071/WR11111; van der Merwe M, 2008, J MAMMAL, V89, P1162, DOI 10.1644/08-MAMM-A-035.1; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; Wheeler HC, 2014, ANIM BEHAV, V95, P1, DOI 10.1016/j.anbehav.2014.06.005; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; WODZICKI K, 1973, B WORLD HEALTH ORGAN, V48, P461; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Yonas M, 2010, CROP PROT, V29, P532, DOI 10.1016/j.cropro.2009.12.006	49	47	50	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171593	10.1371/journal.pone.0171593	http://dx.doi.org/10.1371/journal.pone.0171593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158266	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000396161700105
J	Tokubuchi, I; Tajiri, Y; Iwata, S; Hara, K; Wada, N; Hashinaga, T; Nakayama, H; Mifune, H; Yamada, K				Tokubuchi, Ichiro; Tajiri, Yuji; Iwata, Shimpei; Hara, Kento; Wada, Nobuhiko; Hashinaga, Toshihiko; Nakayama, Hitomi; Mifune, Hiroharu; Yamada, Kentaro			Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT DIABETES-MELLITUS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; AMP; PHOSPHORYLATION; GLUCOSE; OBESITY; WEIGHT; MICE	Objective Metformin is known to have a beneficial effect on body weight and body composition, although the precise mechanism has not been elucidated yet. The aim of this study is to investigate the effects of metformin on energy metabolism and anthropometric factors in both human subjects and rats. Methods In human studies, metformin (1500mg/day) was administered to 23 healthy subjects and 18 patients with type 2 diabetes for 2 weeks. Metabolic parameters and energy metabolism were measured during a meal tolerance test in the morning before and after the treatment of metformin. In animal studies, 13 weeks old SD rats were fed 25-26 g of standard chow only during 12-hours dark phase with either treated by metformin (2.5mg/ml in drinking water) or not for 2 weeks, and metabolic parameters, anthropometric factors and energy metabolism together with expressions related to fat oxidation and adaptive thermogenesis were measured either in fasting or post-prandial state at 15 weeks old. Results Post-prandial plasma lactate concentration was significantly increased after the metformin treatment in both healthy subjects and diabetic patients. Although energy expenditure (EE) did not change, baseline respiratory quotient (RQ) was significantly decreased and postprandial RQ was significantly increased vice versa following the metformin treatment in both groups. By the administration of metformin to SD rats for 2 weeks, plasma levels of lactate and pyruvate were significantly increased in both fasting and post-prandial states. RQ during a fasting state was significantly decreased in metformin-treated rats compared to controls with no effect on EE. Metformin treatment brought about a significant reduction of visceral fat mass compared to controls accompanied by an up-regulation of fat oxidation related enzyme in the liver, UCP-1 in the brown adipose tissue and UCP-3 in the skeletal muscle. Conclusion From the results obtained, beneficial effects of metformin on visceral fat reduction has been demonstrated probably through a mechanism for a potential shift of fuel resource into fat oxidation and an upregulation of adaptive thermogenesis independent of an anorexigenic effect of this drug.	[Tokubuchi, Ichiro; Tajiri, Yuji; Iwata, Shimpei; Hara, Kento; Wada, Nobuhiko; Hashinaga, Toshihiko; Nakayama, Hitomi; Yamada, Kentaro] Kurume Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kurume, Fukuoka, Japan; [Mifune, Hiroharu] Kurume Univ, Sch Med, Inst Anim Experimentat, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Tajiri, Y (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kurume, Fukuoka, Japan.	tajiriy@med.kurume-u.ac.jp						Aghili R, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0088-z; Avignon A, 2000, DIABETES OBES METAB, V2, P229, DOI 10.1046/j.1463-1326.2000.00082.x; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Fery F, 1997, METABOLISM, V46, P227, DOI 10.1016/S0026-0495(97)90307-3; Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hauton D, 2011, METABOLISM, V60, P32, DOI 10.1016/j.metabol.2009.12.015; Helvaci MR, 2008, INTERNAL MED, V47, P697, DOI 10.2169/internalmedicine.47.0787; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Ke JY, 2015, NUTR METAB, V12, DOI 10.1186/1743-7075-12-1; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim HJ, 2013, AM J PHYSIOL-REG I, V305, pR499, DOI 10.1152/ajpregu.00099.2013; Lee AJ, 1996, PHARMACOTHERAPY, V16, P327; Lee CK, 2012, DIABETES METAB J, V36, P293, DOI 10.4093/dmj.2012.36.4.293; Lusk G, 1924, J BIOL CHEM, V59, P41; Mandavilli A, 2004, NAT MED, V10, P325, DOI 10.1038/nm0404-325; MATTHAEI S, 1993, ENDOCRINOLOGY, V133, P304, DOI 10.1210/en.133.1.304; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Rouquet T, 2014, OBESITY, V22, P2552, DOI 10.1002/oby.20902; Schimmack G, 2006, DIABETES OBES METAB, V8, P591, DOI 10.1111/j.1463-1326.2005.00561.x; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; TAYLOR KG, 1979, DIABETOLOGIA, V16, P313, DOI 10.1007/BF01223620; Tessari P, 2008, ACTA DIABETOL, V45, P143, DOI 10.1007/s00592-008-0032-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Wada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067712; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	64	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171293	10.1371/journal.pone.0171293	http://dx.doi.org/10.1371/journal.pone.0171293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158227	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161700054
J	Abizari, AR; Azupogo, F; Brouwer, ID				Abizari, Abdul-Razak; Azupogo, Fusta; Brouwer, Inge D.			Subclinical inflammation influences the association between vitamin A- and iron status among schoolchildren in Ghana	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; SCHOOL-AGED CHILDREN; DEFICIENCY ANEMIA; A SUPPLEMENTATION; SERUM RETINOL; NUTRITIONAL-STATUS; FERRITIN; INFECTION; IODINE; ASSAY	Background and objective In resource-poor settings, micronutrient deficiencies such as vitamin A deficiency may coexist with iron-deficiency. In this study we assessed the iron and vitamin A status of schoolchildren and the association between vitamin A and iron status. Methods A cross-sectional design using the baseline data of a dietary intervention trial conducted among randomly selected 5-12 years old schoolchildren (n = 224) from 2 rural schools in northern Ghana. Hemoglobin (Hb), serum ferritin (SF) and serum transferrin receptor (sTfR) concentrations were used as measures of iron status. Retinol binding protein (RBP) was used as a measure of vitamin A status. Subclinical inflammation (SCI) was measured using C-reactive protein (CRP) and alpha(1)-acid glycoprotein (AGP) concentrations. We examined the cross-sectional association between vitamin A and iron status biomarkers with multiple linear regressions. Results The proportions of schoolchildren with anemia (WHO criteria), iron-deficiency (ID, SF<15 mu g/l and/orsTfR>8.5mg/l) and iron-deficiency anemia (IDA, concurrent anemia and ID) were 63.8%, 68.3% and 46.4% respectively. Low or marginal vitamin A status (0.70 mu mol/l <= RBP < 1.05 mu mol/l) was present in 48.2% while 37.5% of the schoolchildren had vitamin A deficiency (VAD, RBP < 0.70 mu mol/l). The prevalence of SCI as well as concurrent VAD and ID were 48.7% and 25% respectively. RBP was associated with Hb (beta = 7.2, P = 0.05) but not SF (beta = 20.7, P = 0.33) and sTfR concentration (beta = 12.0, P = 0.63). In the presence of SCI, RBP was not associated with hemoglobin status but a significant positive association was observed among children without SCI. Conclusions The study shows that RBP is significantly associated with Hb concentration but not with SF and sTfR. The observed relationship between RBP and Hb is only significant in the absence of SCI.	[Abizari, Abdul-Razak] Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana; [Azupogo, Fusta] Univ Dev Studies, Dept Family & Consumer Sci, Fac Agr, Tamale, Ghana; [Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University for Development Studies; University for Development Studies; Wageningen University & Research	Abizari, AR (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana.	abizaria@yahoo.com	Brouwer, Inge D/K-8455-2013	Brouwer, Inge/0000-0002-2554-7227; Azupogo, Fusta/0000-0003-0467-0856	Nestle Foundation for Nutrition Research [FN4042]	Nestle Foundation for Nutrition Research(Nestle SA)	Funding for this research was received from Nestle Foundation for Nutrition Research with grant number FN4042. The grant was received by Abdul-Razak Abizari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; Abizari AR, 2012, J NUTR, V142, P1836, DOI 10.3945/jn.112.165753; Ahmed F, 2006, PUBLIC HEALTH NUTR, V9, P345, DOI 10.1079/PHN2006858; Al-Mekhlafi HM, 2014, NUTRIENTS, V6, P190, DOI 10.3390/nu6010190; [Anonymous], NUTR ANEMIA; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Atimati a O, 2013, NIGER J PAEDIAT, V40, P379; Avornyo VK, 2015, ANN M AM SOC AGR, P1; Baeten JM, 2004, AM J CLIN NUTR, V79, P218; Batra J, 2005, INDIAN J CLIN BIOCHE, V20, P119, DOI 10.1007/BF02867410; BLOEM MW, 1995, P NUTR SOC, V54, P501, DOI 10.1079/PNS19950018; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Cogill B, 2003, ANTHROPOMETRIC INDIC; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Silva Lara Lívia Santos da, 2015, Rev. bras. epidemiol., V18, P490, DOI 10.1590/1980-5497201500020016; Edwin AK, 2011, PAN AFR MED J, V10; Egbi G., 2012, African Journal of Food, Agriculture, Nutrition and Development, V12, P5946; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Gebremedhin S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-79; ghanadistrict.com, 2006, GHAN DISTR REP ALL D; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Gibson RS, 2015, FOOD NUTR BULL, V31, P134; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hashizume M, 2005, PUBLIC HEALTH NUTR, V8, P564, DOI 10.1079/PHN2004717; Herrador Z, 2014, PLOS ONE, V9, P1; Hettiarachchi M, 2012, MATERN CHILD NUTR, V8, P259, DOI 10.1111/j.1740-8709.2010.00290.x; Htet MK, 2013, PUBLIC HEALTH NUTR, V17, P1; Jauregui-Lobera I, 2014, NEUROPSYCH DIS TREAT, V10, P2087, DOI 10.2147/NDT.S72491; Kennedy G., 2013, GUID MEAS HOUS IND D; Lulla RR, 2010, PEDIATR BLOOD CANCER, V55, P141, DOI 10.1002/pbc.22471; Marasinghe E, 2015, ASIA PAC J CLIN NUTR, V24, P144, DOI 10.6133/apjcn.2015.24.1.17; Mariath AB, 2010, CIENC SAUDE COLETIVA, V15, P509, DOI 10.1590/S1413-81232010000200027; Mwanri L, 2000, J NUTR, V130, P2691, DOI 10.1093/jn/130.11.2691; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Otupiri E, 2012, J SCI TECHNOL, V32, P1; Palafox NA, 2003, NUTRITION, V19, P405, DOI 10.1016/S0899-9007(02)01104-8; Persson V, 2000, PUBLIC HEALTH NUTR, V3, P83, DOI 10.1017/S1368980000000100; Pfeiffer CM, 2007, CLIN CHIM ACTA, V382, P112, DOI 10.1016/j.cca.2007.04.008; Righetti AA, 2013, AM J CLIN NUTR, V97, P1364, DOI 10.3945/ajcn.112.050302; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sales MC, 2013, NUTR HOSP, V28, P734, DOI 10.3305/nh.2013.28.3.6396; Sanghvi T, 2007, FOOD NUTR BULL, V28, pS160; Sanjoaquin MA, 2009, MALARIA J, V8, P1; Semba RD, 2008, NUTR HEALTH SER, P1, DOI 10.1007/978-1-59745-464-3; Semba RD, 2010, NUTRITION, V26, P958, DOI 10.1016/j.nut.2009.08.010; Singh V, 2004, EUR J CLIN NUTR, V58, P1342, DOI 10.1038/sj.ejcn.1601973; Sommer A., 1998, AM J EPIDEMIOL, V147, P1175, DOI [10.1093/oxfordjournals. aje.a009416, DOI 10.1093/OXFORDJOURNALS.AJE.A009416]; Swati K, 2012, NATL J MED RES, V2, P188; Talsma EF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0256-5; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; UNICEF and Micronutrient Initiative, 2004, VIT MIN DEF GLOB PRO; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; Wessells KR, 2014, J NUTR, V144, P2050, DOI 10.3945/jn.114.200345; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; WHO, 2010, PRIOR ASS VIT A IR S; *WHO, 1996, IND ASS VIT A DEF TH; Wieringa FT, 2003, AM J CLIN NUTR, V77, P651, DOI 10.1093/ajcn/77.3.651; Willows ND, 2003, NUTR RES, V23, P891, DOI 10.1016/S0271-5317(03)00076-9; Zimmermann M, 2000, AM J CLIN NUTR, V71, P88; Zimmermann MB, 2004, AM J CLIN NUTR, V80, P1283, DOI 10.1093/ajcn/80.5.1283; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580, DOI 10.1093/ajcn/84.3.580	67	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170747	10.1371/journal.pone.0170747	http://dx.doi.org/10.1371/journal.pone.0170747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152069	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200041
J	Ebers, A; Stroup, S; Mpagama, S; Kisonga, R; Lekule, I; Liu, J; Heysell, S				Ebers, Andrew; Stroup, Suzanne; Mpagama, Stellah; Kisonga, Riziki; Lekule, Isaack; Liu, Jie; Heysell, Scott			Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; MOXIFLOXACIN	Therapeutic drug monitoring may improve multidrug-resistant tuberculosis (MDR-TB) treatment outcomes. Levofloxacin demonstrates significant individual pharmacokinetic variability. Thus, we sought to develop and validate a high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection for levofloxacin in patients on MDR-TB treatment. The HPLC-UV method is based on a solid phase extraction (SPE) and a direct injection into the HPLC system. The limit of quantification was 0.25 mu g/mL, and the assay was linear over the concentration range of 0.25(_)15 mu g/mL (y = 0.5668x(_)0.0603, R-2 = 0.9992) for the determination of levofloxacin in plasma. The HPLC-UV methodology achieved excellent accuracy and reproducibility along a clinically meaningful range. The intra-assay RSD% of low, medium, and high quality control samples (QC) were 1.93, 2.44, and 1.90, respectively, while the inter-assay RSD% were 3.74, 5.65, and 3.30, respectively. The mean recovery was 96.84%. This method was then utilized to measure levofloxacin concentrations from patients' plasma samples from a retrospective cohort of consecutive enrolled subjects treated for MDR-TB at the national TB hospital in Tanzania during 5/3/2013-8/31/2015. Plasma was collected at 2 hours after levofloxacin administration, the time of estimated peak concentration (eC(max)) treatment. Forty-one MDR-TB patients had plasma available and 39 had traceable programmatic outcomes. Only 13 (32%) patients had any plasma concentration that reached the lower range of the expected literature derived C-max with the median eC(max) being 5.86 (3.33-9.08 mu g/ml). Using Classification and Regression Tree analysis, an eC(max) >= 7.55 mu g/mL was identified as the threshold which best predicted cure. Analyzing this CART derived threshold on treatment outcome, the time to sputum culture conversion was 38.3 +/- 22.7 days vs. 47.8 +/- 26.5 days (p = 0.27) and a greater proportion were cured, in 10 out of 15 (66.7%) vs. 6 out of 18 (33.3%) (p = 0.06) respectively. Furthermore, one patient with an eC(max)/minimum inhibitory concentration (MIC) of only 1.13 acquired extensively drug resistant (XDR)-TB while undergoing treatment. The individual variability of levofloxacin concentrations in MDR-TB patients from Tanzania supports further study of the application of onsite therapeutic drug monitoring and MIC testing.	[Ebers, Andrew; Stroup, Suzanne; Liu, Jie; Heysell, Scott] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Mpagama, Stellah; Kisonga, Riziki; Lekule, Isaack] Kibongoto Infect Dis Hosp, Kilimanjaro, Tanzania	University of Virginia	Ebers, A (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	ae7d@hscmail.mcc.virginia.edu			National Institutes of Health [U01 A1115594, K23 A1099019, 5T32A1007046-39]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, T32AI007046, U01AI115594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants U01 A1115594 (to SH), K23 A1099019 (to SH), and 5T32A1007046-39 (to AE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alffenaar JWC, 2010, THER DRUG MONIT, V32, P97, DOI 10.1097/FTD.0b013e3181cc6d6f; Alsultan A, 2015, ANTIMICROB AGENTS CH, V59, P3800, DOI 10.1128/AAC.00341-15; Alsultan A, 2014, DRUGS, V74, P839, DOI 10.1007/s40265-014-0222-8; Babalik A, 2011, CAN RESPIR J, V18, P225, DOI 10.1155/2011/307150; Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Han M, 2013, J ANTIMICROB CHEMOTH, V68, P2066, DOI 10.1093/jac/dkt154; Heysell SK, 2015, ANTIMICROB AGENTS CH, V59, P7104, DOI 10.1128/AAC.01117-15; Heysell Scott K, 2013, Tuberc Res Treat, V2013, P129723, DOI 10.1155/2013/129723; Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374; Holland DP, 2009, PHARMACOTHERAPY, V29, P503, DOI 10.1592/phco.29.5.503; Kumar M.T., 2011, INT J CURRENT RES, V3, P247; Lee SH, 2015, YONSEI MED J, V56, P961, DOI 10.3349/ymj.2015.56.4.961; Li JH, 2004, CHEST, V126, P1770, DOI 10.1378/chest.126.6.1770; Magis-Escurra C, 2012, PULM PHARMACOL THER, V25, P83, DOI 10.1016/j.pupt.2011.12.001; Manika K, 2012, EUR RESPIR J, V40, P1051, DOI 10.1183/09031936.00202411; Mpagama SG, 2014, ANTIMICROB AGENTS CH, V58, P782, DOI 10.1128/AAC.01549-13; Mpagama SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062034; Ndusilo ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122769; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Prahl JB, 2014, J ANTIMICROB CHEMOTH, V69, P2841, DOI 10.1093/jac/dku210; Ray J, 2003, INTERN MED J, V33, P229, DOI 10.1046/j.1445-5994.2003.00390.x; Sturkenboom MGG, 2015, ANTIMICROB AGENTS CH, V59, P2474, DOI 10.1128/AAC.05173-14; Van Tongeren L, 2013, INT J TUBERC LUNG D, V17, P221, DOI 10.5588/ijtld.12.0279; Vu DH, 2012, ANTIMICROB AGENTS CH, V56, P5758, DOI 10.1128/AAC.01054-12; Yu X, 2016, J CELL MOL MED, V20, P3, DOI 10.1111/jcmm.12649	30	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170663	10.1371/journal.pone.0170663	http://dx.doi.org/10.1371/journal.pone.0170663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141813	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500014
J	Xie, LL; Zhang, K; Rasmussen, D; Wang, JP; Wu, DY; Roemmich, JN; Bundy, A; Johnson, WT; Claycombe, K				Xie, Linglin; Zhang, Ke; Rasmussen, Dane; Wang, Junpeng; Wu, Dayong; Roemmich, James N.; Bundy, Amy; Johnson, W. Thomas; Claycombe, Kate			Effects of prenatal low protein and postnatal high fat diets on visceral adipose tissue macrophage phenotypes and IL-6 expression in Sprague Dawley rat offspring	PLOS ONE			English	Article							PREGNANCY INDUCES HYPERTENSION; LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; MATERNAL NUTRITION; ISLET FUNCTION; IN-UTERO; OBESITY	Adipose tissue macrophages (ATM) are implicated in adipose tissue inflammation and obesity-related insulin resistance. Maternal low protein models result in fetal programming of obesity. The study aims to answer whether maternal undernutrition by protein restriction affects the ATM M1 or M2 phenotype under postnatal high fat diet in F1 offspring. Using a rat model of prenatal low protein (LP, 8% protein) diet followed by a postnatal high fat energy diet (HE, 45% fat) or low fat normal energy diet (NE, 10% fat) for 12 weeks, we investigated the effects of these diets on adiposity, programming of the offspring ATM phenotype, and the associated inflammatory response in adipose tissue. Fat mass in newborn and 12-week old LP fed offspring was lower than that of normal protein (20%; NP) fed offspring; however, the adipose tissue growth rate was higher compared to the NP fed offspring. While LP did not affect the number of CD68(+) or CD206(+) cells in adipose tissue of NE offspring, it attenuated the number of these cells in offspring fed HE. In offspring fed HE, LP offspring had a lower percentage of CD11c(+) CD206(+) ATMs, whose abundancy was correlated with the size of the adipocytes. Noteworthy, similar to HE treatment, LP increased gene expression of IL-6 within ATMs. Two-way ANOVA showed an interaction of prenatal LP and postnatal HE on IL-6 and IL-1 beta transcription. Overall, both LP and HE diets impact ATM phenotype by affecting the ratio of CD11c(+) CD206(+) ATMs and the expression of IL-6.	[Xie, Linglin] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Xie, Linglin; Rasmussen, Dane] Univ North Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND USA; [Zhang, Ke] Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND USA; [Zhang, Ke] Univ North Dakota, ND INBRE Bioinformat Core, Grand Forks, ND USA; [Wang, Junpeng; Wu, Dayong] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Boston, MA 02111 USA; [Roemmich, James N.; Bundy, Amy; Johnson, W. Thomas; Claycombe, Kate] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA	Texas A&M University System; Texas A&M University College Station; University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks; Tufts University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Xie, LL (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.; Xie, LL (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND USA.; Claycombe, K (corresponding author), USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA.	linglin.xie@tamu.edu; kate.claycombe@ars.usda.gov	Wang, Junpeng/K-9909-2018	Wang, Junpeng/0000-0002-5464-7884; Roemmich, James/0000-0002-6270-9678	National Institutes of Health [NIH-1R15HL117238]; National Center for Research Resources [5P20RR016471-12/8 P20 GM103442-12]; American Heart Association [13SDG14650009]; USDA Agricultural Research Service Project [3062-51000-052-00D]; USDA National Institute of Food and Agriculture, [Hatch] project [1010406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); USDA Agricultural Research Service Project; USDA National Institute of Food and Agriculture, [Hatch] project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Institutes of Health (NIH-1R15HL117238 to author LX, National Center for Research Resources, 5P20RR016471-12/8 P20 GM103442-12 to authors LX and KZ) and the American Heart Association (13SDG14650009 to author LX). This work was also supported by USDA Agricultural Research Service Project #3062-51000-052-00D to author KJC and by the USDA National Institute of Food and Agriculture, [Hatch] project [1010406] to author LX.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Anderson SE, 2012, PEDIATRICS, V129, P132, DOI 10.1542/peds.2011-0972; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Claycombe KJ, 2013, J NUTR; Cox AR, 2010, PEDIATR RES, V68, P16, DOI [10.1203/PDR.0b013e3181e17c90, 10.1203/00006450-201011001-00026]; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Gaillard R, 2016, OBESITY, V24, P1320, DOI 10.1002/oby.21484; Gangula PRR, 2005, AM J OBSTET GYNECOL, V192, P952, DOI 10.1016/j.ajog.2004.09.008; Gosby AK, 2010, OBESITY, V18, P1593, DOI 10.1038/oby.2009.449; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KUSIN JA, 1992, LANCET, V340, P623, DOI 10.1016/0140-6736(92)92168-F; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Meier JJ, 2009, DIABETES, V58, P1255, DOI 10.2337/db09-0225; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ong KK, 2002, BEST PRACT RES CL EN, V16, P191, DOI 10.1053/beem.2002.0195; Ortega MT, 2011, CELL IMMUNOL, V271, P124, DOI 10.1016/j.cellimm.2011.06.012; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Poore KR, 2004, DIABETOLOGIA, V47, P340, DOI 10.1007/s00125-003-1305-3; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Ramachandran P, 2002, NUTR REV, V60, pS26, DOI 10.1301/00296640260130704; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Remacle C, 2004, INT J OBESITY, V28, pS46, DOI 10.1038/sj.ijo.0802800; Reynolds CM, 2013, ENDOCRINOLOGY, V154, P2676, DOI 10.1210/en.2013-1146; Sathishkumar K, 2012, BRIT J NUTR, V107, P665, DOI 10.1017/S0007114511003448; Sathishkumar K, 2009, J VASC RES, V46, P229, DOI 10.1159/000166390; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STRAUS DS, 1990, ENDOCRINOLOGY, V127, P1849, DOI 10.1210/endo-127-4-1849; Tarry-Adkins JL, 2010, FASEB J, V24, P2762, DOI 10.1096/fj.10-156075; Tuchscherer M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-232; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilson MR, 1997, J ENDOCRINOL, V154, P177, DOI 10.1677/joe.0.1540177; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	47	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0169581	10.1371/journal.pone.0169581	http://dx.doi.org/10.1371/journal.pone.0169581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141871	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129500004
J	Lysaght, T; Capps, B; Bailey, M; Bickford, D; Coker, R; Lederman, Z; Watson, S; Tambyah, PA				Lysaght, Tamra; Capps, Benjamin; Bailey, Michele; Bickford, David; Coker, Richard; Lederman, Zohar; Watson, Sangeetha; Tambyah, Paul Anantharajah			Justice Is the Missing Link in One Health: Results of a Mixed Methods Study in an Urban City State	PLOS ONE			English	Article							DISEASE EMERGENCE	Background One Health (OH) is an interdisciplinary collaborative approach to human and animal health that aims to break down conventional research and policy 'silos'. OH has been used to develop strategies for zoonotic Emerging Infectious Diseases (EID). However, the ethical case for OH as an alternative to more traditional public health approaches is largely absent from the discourse. To study the ethics of OH, we examined perceptions of the human health and ecological priorities for the management of zoonotic EID in the Southeast Asia country of Singapore. Methods We conducted a mixed methods study using a modified Delphi technique with a panel of 32 opinion leaders and 11 semi-structured interviews with a sub-set of those experts in Singapore. Panellists rated concepts of OH and priorities for zoonotic EID preparedness planning using a series of scenarios developed through the study. Interview data were examined qualitatively using thematic analysis. Findings We found that panellists agreed that OH is a cross-disciplinary collaboration among the veterinary, medical, and ecological sciences, as well as relevant government agencies encompassing animal, human, and environmental health. Although human health was often framed as the most important priority in zoonotic EID planning, our qualitative analysis suggested that consideration of non-human animal health and welfare was also important for an effective and ethical response. The panellists also suggested that effective pandemic planning demands regional leadership and investment from wealthier countries to better enable international cooperation. Conclusion We argue that EID planning under an OH approach would benefit greatly from an ethical ecological framework that accounts for justice in human, animal, and environmental health.	[Lysaght, Tamra; Lederman, Zohar; Watson, Sangeetha] Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore; [Capps, Benjamin] Dalhousie Univ, Dept Bioeth, Halifax, NS, Canada; [Bailey, Michele] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Bickford, David] Rimba, 4 Jalan 1-9D, Bandar Baru Bangi, Selangor, Malaysia; [Coker, Richard] London Sch Hyg & Trop Med, London, England; [Tambyah, Paul Anantharajah] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	National University of Singapore; Dalhousie University; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Lysaght, T (corresponding author), Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore.	tlysaght@nus.edu.sg	Lysaght, Tamra/AAU-9525-2020; Lederman, Zohar/GWZ-3014-2022	Lederman, Zohar/0000-0003-0547-1066; Lysaght, Tamra/0000-0002-7125-4206; Capps, Benjamin/0000-0002-9104-6025	Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore [MOH/CDPHRG/0011/2014]	Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore	This research was funded with a Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore (MOH/CDPHRG/0011/2014) for the project: One Health, Zoonotic Diseases and Pandemic Planning: Creating a Bioethics Framework in Singapore, URL: https://www.moh.gov.sg/content/moh_web/home/Fundings and Medical Research/communicable diseasespublichealthresearchgrant.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agri-Food & Veterinary Authority of Singapore, 2013, AVA MAINT EM PREP DE; Agriculture and Veterinary Authority, 2015, WORK TOG ON ANN REP; American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP; Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223; Bioethics Advisory Committee, 2015, ETH GUID HUM BIOM RE; Bolzoni L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000747; Capps B, 2015, J AGR ENVIRON ETHIC, P1; Capps B, 2015, BIOETHICS, V29, P588, DOI 10.1111/bioe.12145; Centers for Disease Control and Prevention, 2013, ONE HLTH; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Davis L, 2011, CONSIDERING ANIMALS: CONTEMPORARY STUDIES IN HUMAN-ANIMAL RELATIONS, P183; Degeling C, 2016, PUBLIC HLTH ETHICS; Degeling C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2617-1; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Faculty of Public Health of the Royal Colleges of Physicians, 2016, WHAT IS PUBL HLTH; Garrett L, 2016, WHOS FAIRY DUST FINA; Goldberg TL, LANCET, V386, pe37; Hazelton B, 2013, FUTURE MICROBIOL, V8, P461, DOI [10.2217/FMB.13.19, 10.2217/fmb.13.19]; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Lai A, 2013, IMPACT DISASTERS DIS; Leach M, 2013, SOC SCI MED, V88, P10, DOI 10.1016/j.socscimed.2013.03.017; Lederman Z, 2016, PUBLIC HEALTH ETH-UK, V9, P5, DOI 10.1093/phe/phw002; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Ministry of Health, 2014, PAND READ RESP PLAN; Morse SS, 2004, REV SCI TECH OIE, V23, P443, DOI 10.20506/rst.23.2.1494; Ong CWM, 2009, LANCET INFECT DIS, V9, P397, DOI 10.1016/S1473-3099(09)70159-8; Pang T, 2015, LANCET GLOB HEALTH, V3, pE496, DOI 10.1016/S2214-109X(15)00102-3; Rawls J., 1971, THEORY JUSTICE; Rayens MK., 2000, POLICY POLIT NURS PR, V1, P308, DOI DOI 10.1177/152715440000100409; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Singapore Cooperation Program, 2016, OVERVIEW; Siong LG, 2016, ONE 3 MONKEYS BEING; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; World Bank, 2012, ZOON DIS PREV CONTR; World Health Organisation, 1931, LEAG NAT HLTH ORG IN; World Health Organization, 2008, REG OFF W PAC ZOON D; World Health Organization, 2016, W AFR EB OUTBR FUND; World Organisation for Animal Health, 2014, WHO OIE OP FRAM GOOD; Zengkun F, 2013, CULL NOT CULL PESKY	40	18	18	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170967	10.1371/journal.pone.0170967	http://dx.doi.org/10.1371/journal.pone.0170967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129409	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400017
J	DeBalsi, KL; Longley, MJ; Hoff, KE; Copeland, WC				DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.			Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase gamma Disease Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; PATHOGENIC MUTATIONS; EXONUCLEASE ACTIVITY; BIOCHEMICAL-ANALYSIS; AUTOSOMAL-DOMINANT; ACCESSORY SUBUNIT; REPLICATION; DISORDERS; TOXICITY	Human mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) is the only polymerase known to replicate the mitochondrial genome. The Pol gamma holoenzyme consists of the p140 catalytic subunit (POLG) and the p55 homodimeric accessory subunit (POLG2), which enhances binding of Pol gamma to DNA and promotes processivity of the holoenzyme. Mutations within POLG impede maintenance of mtDNA and cause mitochondrial diseases. Two common POLG mutations usually found in cis in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions. To determine whether T251I or P587L is the primary pathogenic allele or whether both substitutions are required to cause disease, we overproduced and purified WT, T251I, P587L, and T251I + P587L double variant forms of recombinant Pol gamma. Biochemical characterization of these variants revealed impaired DNA binding affinity, reduced thermostability, diminished exonuclease activity, defective catalytic activity, and compromisedDNAprocessivity, even in the presence of the p55 accessory subunit. However, physical association with p55 was unperturbed, suggesting intersubunit affinities similar to WT. Notably, although the single mutants were similarly impaired, a dramatic synergistic effect was found for the double mutant across all parameters. In conclusion, our analyses suggest that individually both T251I and P587L substitutions functionally impair Pol gamma, with greater pathogenicity predicted for the single P587L variant. Combining T251I and P587L induces extreme thermal lability and leads to synergistic nucleotide and DNA binding defects, which severely impair catalytic activity and correlate with presentation of disease in patients.	[DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.] NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	Intramural Research Program of the NIEHS, National Institutes of Health [ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078, ZIAES065078] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIEHS, National Institutes of Health, Grant ES 065078. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C; Al-Zubeidi D, 2014, PEDIATR NEUROL, V51, P448, DOI 10.1016/j.pediatrneurol.2014.04.006; Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150; Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686; Caito SW, 2015, ANTIOXID REDOX SIGN, V23, P578, DOI 10.1089/ars.2015.6289; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409; Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006; Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Gonzalez-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; Lucas P, 1997, CR ACAD SCI III-VIE, V320, P299, DOI 10.1016/S0764-4469(97)82771-0; Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303; McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171; Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105; Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004; Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180; Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891; Stumpf JD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004748; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x; Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002; Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240; Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209	67	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4198	4209		10.1074/jbc.M116.773341	http://dx.doi.org/10.1074/jbc.M116.773341			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154168	Green Published, hybrid			2022-12-26	WOS:000395837100018
J	Mukherjee, A; Wang, ZJ; Kinlough, CL; Poland, PA; Marciszyn, AL; Montalbetti, N; Carattino, MD; Butterworth, MB; Kleyman, TR; Hughey, RP				Mukherjee, Anindit; Wang, Zhijian; Kinlough, Carol L.; Poland, Paul A.; Marciszyn, Allison L.; Montalbetti, Nicolas; Carattino, Marcelo D.; Butterworth, Michael B.; Kleyman, Thomas R.; Hughey, Rebecca P.			Specific Palmitoyltransferases Associate with and Activate the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; PROTEIN PALMITOYLATION; BETA-SUBUNIT; MEDIATED PALMITOYLATION; ALPHA-SUBUNIT; VACUOLAR H+; ENAC; 2-BROMOPALMITATE; LOCALIZATION; RESIDUES	The epithelial sodium channel (ENaC) has an important role in regulating extracellular fluid volume and blood pressure, as well as airway surface liquid volume and mucociliary clearance. ENaC is a trimer of three homologous subunits (alpha, beta, and gamma). We previously reported that cytoplasmic residues on the beta (beta Cys-43 and beta Cys-557) and gamma (gamma Cys-33 and gamma Cys-41) subunits are palmitoylated. Mutation of Cys that blocked ENaC palmitoylation also reduced channel open probability. Furthermore, gamma subunit palmitoylation had a dominant role over beta subunit palmitoylation in regulating ENaC. To determine which palmitoyltransferases (termed DHHCs) regulate the channel, mouse ENaCs were co-expressed in Xenopus oocytes with each of the 23 mouse DHHCs. ENaC activity was significantly increased by DHHCs 1, 2, 3, 7, and 14. ENaC activation by DHHCs was lost when gamma subunit palmitoylation sites were mutated, whereas DHHCs 1, 2, and 14 still activated ENaC lacking beta subunit palmitoylation sites. beta subunit palmitoylation was increased by ENaC co-expression withDHHC7. Both wild type ENaC and channels lacking beta and gamma palmitoylation sites co-immunoprecipitated with the five activating DHHCs, suggesting that ENaC forms a complex with multiple DHHCs. RT-PCR revealed that transcripts for the five activatingDHHCswere present in culturedmCCD(cl1) cells, and DHHC 3 was expressed in aquaporin 2-positive principal cells of mouse aldosterone-sensitive distal nephron where ENaC is localized. Treatment of polarized mCCD(cl1) cells with a general inhibitor of palmitoylation reduced ENaC-mediated Na+ currents within minutes. Our results indicate that specific DHHCs have a role in regulating ENaC.	[Mukherjee, Anindit; Wang, Zhijian; Kinlough, Carol L.; Poland, Paul A.; Marciszyn, Allison L.; Montalbetti, Nicolas; Carattino, Marcelo D.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Butterworth, Michael B.; Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Elect Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Yang, Wei/HIA-0360-2022; Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540	National Institutes of Health [R01 DK065161, R37 DK051391, R01 DK102843, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102843, R37DK051391, P30DK079307, R01DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK065161 (to T. R. K. and R. P. H.), R37 DK051391 (to T. R. K.), R01 DK102843 (to M. B. B.), and P30 DK079307 (to T. R. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-bataineh MM, 2014, AM J PHYSIOL-RENAL, V306, pF981, DOI 10.1152/ajprenal.00362.2013; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Heiler S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0105-y; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Mueller GM, 2012, AM J PHYSIOL-RENAL, V303, pF220, DOI 10.1152/ajprenal.00493.2011; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pedro MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075232; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Ronzaud C, 2014, PHYSIOLOGY, V29, P16, DOI 10.1152/physiol.00021.2013; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SCHMIDT MFG, 1979, P NATL ACAD SCI USA, V76, P1687, DOI 10.1073/pnas.76.4.1687; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Szkudelski T, 2011, LIFE SCI, V89, P450, DOI 10.1016/j.lfs.2011.07.010; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004	68	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4152	4163		10.1074/jbc.M117.776146	http://dx.doi.org/10.1074/jbc.M117.776146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154191	Green Published, hybrid			2022-12-26	WOS:000395837100015
J	Adomako-Ankomah, Y; Chenoweth, MS; Durfee, K; Doumbia, S; Konate, D; Doumbouya, M; Keita, AS; Nikolaeva, D; Tullo, GS; Anderson, JM; Fairhurst, RM; Daniels, R; Volkman, SK; Diakite, M; Miura, K; Long, CA				Adomako-Ankomah, Yaw; Chenoweth, Matthew S.; Durfee, Katelyn; Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Keita, Abdoul S.; Nikolaeva, Daria; Tullo, Gregory S.; Anderson, Jennifer M.; Fairhurst, Rick M.; Daniels, Rachel; Volkman, Sarah K.; Diakite, Mahamadou; Miura, Kazutoyo; Long, Carole A.			High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SENEGALESE CHILDREN; ENDEMIC AREA; INFECTION; COHORT; EPIDEMIOLOGY; POPULATION; PARASITES; COMPLEXITY; TRACKING	The effects of persistent Plasmodium falciparum (Pf) infection and multiclonality on subsequent risk of clinical malaria have been reported, but the relationship between these 2 parameters and their relative impacts on the clinical outcome of infection are not understood. A longitudinal cohort study was conducted in a seasonal and high-transmission area of Mali, in which 500 subjects aged 1-65 years were followed for 1 year. Blood samples were collected every 2 weeks, and incident malaria cases were diagnosed and treated. Pf infection in each individual at each time point was assessed by species-specific nestedPCR, and Pf longitudinal prevalence per person (PfLP, proportion of Pf-positive samples over 1 year) was calculated. Multiclonality of Pf infection was measured using a 24-SNP DNA barcoding assay at 4 time-points (two in wet season, and two in dry season) over one year. PfLP was positively correlated with multiclonality at each time point (all r >= 0.36; all P <= 0.011). When host factors (e. g., age, gender), PfLP, and multiclonality (at the beginning of the transmission season) were analyzed together, only increasing age and high PfLP were associated with reduced clinical malaria occurrence or reduced number of malaria episodes (for both outcomes, P<0.001 for age, and P = 0.005 for PfLP). When age, PfLP and baseline Pf positivity were analyzed together, the effect of high PfLP remained significant even after adjusting for the other two factors (P = 0.001 for malaria occurrence and P<0.001 for number of episodes). In addition to host age and baseline Pf positivity, both of which have been reported as important modifiers of clinical malaria risk, our results demonstrate that persistent parasite carriage, but not baseline multiclonality, is associated with reduced risk of clinical disease in this population. Our study emphasizes the importance of considering repeated parasite exposure in future studies that evaluate clinical malaria risk.	[Adomako-Ankomah, Yaw; Chenoweth, Matthew S.; Nikolaeva, Daria; Tullo, Gregory S.; Anderson, Jennifer M.; Fairhurst, Rick M.; Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Durfee, Katelyn; Daniels, Rachel; Volkman, Sarah K.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Keita, Abdoul S.; Diakite, Mahamadou] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Daniels, Rachel] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Daniels, Rachel; Volkman, Sarah K.] Broad Inst MIT & Harvard, Program Infect Dis, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; University of Science & Technology of Bamako; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Simmons University	Miura, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	kmiura@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	National Institute of Allergy and Infectious Diseases National Institutes of Health; Bill and Melinda Gates Foundation, Seattle, WA [OPP1053604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062, ZIAAI001020, ZIAAI001000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases National Institutes of Health and the Bill and Melinda Gates Foundation, Seattle, WA [award no. OPP1053604]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Babiker HA, 2013, DRUG RESIST UPDATE, V16, P1, DOI 10.1016/j.drup.2013.02.001; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Bei AK, 2015, INFECT IMMUN, V83, P276, DOI 10.1128/IAI.01979-14; Betuela I, 2012, TROP MED INT HEALTH, V17, P1181, DOI 10.1111/j.1365-3156.2012.03062.x; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112; Donnelly B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1299-1; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Galinsky K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-4; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Jenkins R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0781-5; Kaisar MMM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-169; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Le Port A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-193; Liljander A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016940; Liljander A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013649; Lopera-Mesa TM, 2015, LANCET HAEMATOL, V2, pE140, DOI 10.1016/S2352-3026(15)00043-5; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mharakurwa S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-89; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060182; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Pemberton-Ross P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0805-1; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Pinkevych M, 2014, J INFECT DIS, V209, P1136, DOI 10.1093/infdis/jit613; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sonden K, 2015, J INFECT DIS, V212, P608, DOI 10.1093/infdis/jiv088; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Wampfler R, 2014, J INFECT DIS, V210, P1188, DOI 10.1093/infdis/jiu236; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; World Health Organization, 2015, WORLD MAL REP 2015	41	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170948	10.1371/journal.pone.0170948	http://dx.doi.org/10.1371/journal.pone.0170948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158202	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700020
J	Nordholm, AC; Soborg, B; Andersson, M; Hoffmann, S; Skinhoj, P; Koch, A				Nordholm, Anne Christine; Soborg, Bolette; Andersson, Mikael; Hoffmann, Steen; Skinhoj, Peter; Koch, Anders			CNS infections in Greenland: A nationwide register-based cohort study	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; ACUTE BACTERIAL-MENINGITIS; EPIDEMIOLOGY; POPULATION; DIAGNOSIS; INFANTS; SYSTEM	Background Indigenous Arctic people suffer from high rates of infectious diseases. However, the burden of central nervous system (CNS) infections is poorly documented. This study aimed to estimate incidence rates and mortality of CNS infections among Inuits and non-Inuits in Greenland and in Denmark. Methods We conducted a nationwide cohort study using the populations of Greenland and Denmark 1990-2012. Information on CNS infection hospitalizations and pathogens was retrieved from national registries and laboratories. Incidence rates were estimated as cases per 100,000 person-years. Incidence rate ratios were calculated using log-linear Poisson-regression. Mortality was estimated using Kaplan-Meier curves and Log Rank test. Results The incidence rate of CNS infections was twice as high in Greenland (35.6 per 100,000 person years) as in Denmark (17.7 per 100,000 person years), but equally high among Inuits in Greenland and Denmark (38.2 and 35.4, respectively). Mortality from CNS infections was 2 fold higher among Inuits (10.5%) than among non-Inuits (4.8%) with a fivefold higher case fatality rate in Inuit toddlers. Conclusion Overall, Inuits living in Greenland and Denmark suffer from twice the rate of CNS infections compared with non-Inuits, and Inuit toddlers carried the highest risk of mortality. Further studies regarding risk factors such as genetic susceptibility, life style and socioeconomic factors are warranted.	[Nordholm, Anne Christine; Soborg, Bolette; Andersson, Mikael; Koch, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Hoffmann, Steen] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Skinhoj, Peter] Rigshosp, Dept Infect Dis, Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut; Rigshospitalet; University of Copenhagen	Nordholm, AC (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.	anch@ssi.dk	Nordholm, Anne Christine/AAX-8990-2021	Nordholm, Anne Christine/0000-0001-7702-6020; Koch, Anders/0000-0001-9205-1048	Lundbeck Foundation [9688-9325]; Aase and Ejnar Danielsens Foundation [9688-9341]	Lundbeck Foundation(Lundbeckfonden); Aase and Ejnar Danielsens Foundation	This work was supported by the Lundbeck Foundation (Grant number 9688-9325) and the Aase and Ejnar Danielsens Foundation (Grant number 9688-9341). None of these sponsors had any role in the preparation or submission of this study.	Agrawal S, 2011, PEDIATR DRUGS, V13, P385, DOI 10.2165/11593340-000000000-00000; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2013, BELYSNING GRONQENDED; Bjerregaard PMD, 2008, HLTH TRANSITIONS ARC; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Bruce MG, 2008, EMERG INFECT DIS, V14, P25, DOI 10.3201/eid1401.071315; Christiansen J, 2004, SCAND J INFECT DIS, V36, P325, DOI 10.1080/00365540410020460; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; GILSDORF JR, 1977, AM J EPIDEMIOL, V106, P388, DOI 10.1093/oxfordjournals.aje.a112480; Goldacre MJ, 2014, EPIDEMIOL INFECT, V142, P371, DOI 10.1017/S095026881300099X; Gounder PP, 2015, J INFECTION, V71, P179, DOI 10.1016/j.jinf.2015.04.001; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; JUEL K, 2004, MORTALITY DENMARK 10; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Koch A, 2003, AM J EPIDEMIOL, V158, P374, DOI 10.1093/aje/kwg143; Koch A, 2011, VALIDERING GRONLANDS; Koch A, 2011, INFECT DIS GEOGRAPHI; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Meyer A, 2008, EMERG INFECT DIS, V14, P76, DOI 10.3201/eid1401.071240; Michelsen SW, 2014, THORAX, V69, P851, DOI 10.1136/thoraxjnl-2014-205688; NICOLLE LE, 1982, J INFECT DIS, V145, P103, DOI 10.1093/infdis/145.1.103; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749; Singleton R, 2013, PEDIATR INFECT DIS J, V32, P257, DOI 10.1097/INF.0b013e3182748ada; The Danish Health Authority, 2000, CHILDH VACC PROGR DE; Thomson RB, 2001, INFECT DIS CLIN N AM, V15, P1047, DOI 10.1016/S0891-5520(05)70186-0; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; WOTTON KA, 1981, CAN MED ASSOC J, V124, P887	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171094	10.1371/journal.pone.0171094	http://dx.doi.org/10.1371/journal.pone.0171094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158207	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700029
J	Chandler, TL; White, HM				Chandler, Tawny L.; White, Heather M.			Choline and methionine differentially alter methyl carbon metabolism in bovine neonatal hepatocytes	PLOS ONE			English	Article							RUMEN-PROTECTED METHIONINE; LACTATING DAIRY-COWS; BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; CULTURED RAT HEPATOCYTES; SUPPLEMENTARY FOLIC-ACID; OXIDATIVE STRESS; GENE-EXPRESSION; SMARTAMINE M; FATTY-ACIDS; IN-VITRO	Intersections in hepatic methyl group metabolism pathways highlights potential competition or compensation of methyl donors. The objective of this experiment was to examine the expression of genes related to methyl group transfer and lipid metabolism in response to increasing concentrations of choline chloride (CC) and DL-methionine (DLM) in primary neonatal hepatocytes that were or were not exposed to fatty acids (FA). Primary hepatocytes isolated from 4 neonatal Holstein calves were maintained as monolayer cultures for 24 h before treatment with CC (61, 128, 2028, and 4528 mu mol/L) and DLM (16, 30, 100, 300 mu mol/L), with or without a 1 mmol/L FA cocktail in a factorial arrangement. After 24 h of treatment, media was collected for quantification of reactive oxygen species (ROS) and very low-density lipoprotein (VLDL), and cell lysates were collected for quantification of gene expression. No interactions were detected between CC, DLM, or FA. Both CC and DLM decreased the expression of methionine adenosyltransferase 1A (MAT1A). Increasing CC did not alter betaine-homocysteine S-methyltranferase (BHMT) but did increase 5-methyltetrahydrofolate- homocysteine methyltransferase (MTR) and methylenetetrahydrofolate reductase (MTHFR) expression. Increasing DLM decreased expression of BHMT and MTR, but did not affect MTHFR. Expression of both phosphatidylethanolamine N-methyltransferase (PEMT) and microsomal triglyceride transfer protein (MTTP) were decreased by increasing CC and DLM, while carnitine palmitoyltransferase 1A (CPT1A) was unaffected by either. Treatment with FA decreased the expression of MAT1A, MTR, MTHFR and tended to decrease PEMT but did not affect BHMT and MTTP. Treatment with FA increased CPT1A expression. Increasing CC increased secretion of VLDL and decreased the accumulation of ROS in media. Within neonatal bovine hepatocytes, choline and methionine differentially regulate methyl carbon pathways and suggest that choline may play a critical role in donating methyl groups to support methionine regeneration. Stimulating VLDL export and decreasing ROS accumulation suggests that increasing CC is hepato-protective.	[Chandler, Tawny L.; White, Heather M.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	White, HM (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu		Chandler, Tawny/0000-0001-6299-9436	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	This research was supported by funding provided through the Real Science Initiative Grant by Balchem Corporation, New Hampton, NY (http://www.balchem com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artegoitia VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103412; Berry M. N. A. M., 1991, LAB TECHNIQUES BIOCH, V21, P121; Berthiaume R, 2006, J DAIRY SCI, V89, P1621, DOI 10.3168/jds.S0022-0302(06)72229-9; Blum JW, 1999, J DAIRY SCI, V82, P1991, DOI 10.3168/jds.S0022-0302(99)75435-4; Bremmer DR, 2000, J DAIRY SCI, V83, P2239, DOI 10.3168/jds.S0022-0302(00)75108-3; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; CadornigaValino C, 1997, J DAIRY SCI, V80, P646, DOI 10.3168/jds.S0022-0302(97)75983-6; Carmel R, 2002, HOMOCYSTEINE HLTH DI; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cooke RF, 2007, J DAIRY SCI, V90, P2413, DOI 10.3168/jds.2006-028; Davidson S, 2008, J DAIRY SCI, V91, P1552, DOI 10.3168/jds.2007-0721; de Veth MJ, 2016, J DAIRY SCI, V12, P1; DONKIN SS, 1994, AM J PHYSIOL, V266, pR1229, DOI 10.1152/ajpregu.1994.266.4.R1229; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; Donkin SS, 1997, J ANIM SCI, V75, P3082; EMMANUEL B, 1984, J DAIRY SCI, V67, P1912, DOI 10.3168/jds.S0022-0302(84)81524-6; FINKELSTEIN JD, 1984, BIOCHEM BIOPH RES CO, V118, P14, DOI 10.1016/0006-291X(84)91060-X; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Herrick KJ, 2014, J DAIRY SCI S1, V97, P1896; KLEPPE BB, 1988, J DAIRY SCI, V71, P1813, DOI 10.3168/jds.S0022-0302(88)79750-7; Lambert BD, 2002, J NUTR, V132, P2004, DOI 10.1093/jn/132.7.2004; Lapierre H, 2012, J DAIRY SCI, V95, P353, DOI 10.3168/jds.2011-4553; Lapierre H, 2011, J DAIRY SCI, V94, P1526, DOI 10.3168/jds.2010-3914; Li P, 2013, J DAIRY SCI, V96, P3840, DOI 10.3168/jds.2012-6160; Li X, 2016, J DAIRY SCI, V99, P4574, DOI 10.3168/jds.2015-10609; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lobley GE, 1996, BRIT J NUTR, V75, P47, DOI 10.1079/BJN19960109; Loest CA, 2002, J ANIM SCI, V80, P2197; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mashek DG, 2003, J DAIRY SCI, V86, P2390, DOI 10.3168/jds.S0022-0302(03)73833-8; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Powell CL, 2010, TOXICOL SCI, V115, P131, DOI 10.1093/toxsci/kfq031; Preynat A, 2009, J DAIRY SCI, V92, P677, DOI 10.3168/jds.2008-1525; Preynat A, 2010, J DAIRY SCI, V93, P2130, DOI 10.3168/jds.2009-2796; Preynat A, 2009, J DAIRY SCI, V92, P1685, DOI 10.3168/jds.2008-1572; PRITCHARD PH, 1981, BIOCHEM J, V196, P261, DOI 10.1042/bj1960261; PULLEN DL, 1990, J ANIM SCI, V68, P1395; ROGERS JA, 1987, J DAIRY SCI, V70, P789, DOI 10.3168/jds.S0022-0302(87)80075-9; Sales J, 2010, J DAIRY SCI, V93, P3746, DOI 10.3168/jds.2010-3106; SCHWAB CG, 1992, J DAIRY SCI, V75, P3486, DOI 10.3168/jds.S0022-0302(92)78125-9; SHARMA BK, 1989, J DAIRY SCI, V72, P2772, DOI 10.3168/jds.S0022-0302(89)79421-2; SNOSWELL AM, 1987, COMP BIOCHEM PHYS B, V88, P383, DOI 10.1016/0305-0491(87)90317-8; Sordillo LM, 2016, J DAIRY SCI, V99, P4967, DOI 10.3168/jds.2015-10354; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Spears JW, 2008, VET J, V176, P70, DOI 10.1016/j.tvjl.2007.12.015; Strang BD, 1998, J DAIRY SCI, V81, P740, DOI 10.3168/jds.S0022-0302(98)75630-9; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; TISDALE MJ, 1984, BRIT J CANCER, V49, P315, DOI 10.1038/bjc.1984.49; Torres L, 2000, FASEB J, V14, P95, DOI 10.1096/fasebj.14.1.95; VANCE JE, 1986, J BIOL CHEM, V261, P4486; White HM, 2012, J DAIRY SCI, V95, P1249, DOI 10.3168/jds.2011-4644; XUE GP, 1985, BIOCHEM INT, V11, P381; XUE GP, 1985, COMP BIOCHEM PHYS B, V80, P489, DOI 10.1016/0305-0491(85)90278-0; XUE GP, 1986, COMP BIOCHEM PHYS B, V85, P601, DOI 10.1016/0305-0491(86)90055-6; Zanton GI, 2014, J DAIRY SCI, V97, P7085, DOI 10.3168/jds.2014-8220; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523; Zhang Q, 2016, J DAIRY SCI S1, V99, P1096; Zhang Q, 2016, J DAIRY SCI, V99, P8451, DOI 10.3168/jds.2016-11312; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	68	45	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171080	10.1371/journal.pone.0171080	http://dx.doi.org/10.1371/journal.pone.0171080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152052	Green Published, gold			2022-12-26	WOS:000396161200087
J	Chou, CH; Chou, YE; Chuang, CY; Yang, SF; Lin, CW				Chou, Chia-Hsuan; Chou, Ying-Erh; Chuang, Chun-Yi; Yang, Shun-Fa; Lin, Chiao-Wen			Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; AURORA-KINASE; BETEL QUID; PHE31ILE POLYMORPHISM; SUSCEPTIBILITY GENE; COLORECTAL CANCERS; BREAST-CARCINOMA; RISK; ASSOCIATION; METAANALYSIS	Background Oral squamous cell carcinoma (OSCC) is the sixth and fourth most common cause of cancer death in men worldwide and in Taiwan, respectively. AURKA, which encodes a centrosome-related serine/threonine kinase, is frequently amplified and overexpressed in many human cancers, particularly advanced OSCC. We conducted a hospital-based case-control study to estimate AURKA single-nucleotide polymorphisms (SNPs) and environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics. Methodology/Principal findings We enrolled a total of 876 OSCC patients and 1200 controls. Four SNPs of AURKA, namely rs1047972, rs2273535, rs2064863, and rs6024836, were analyzed using realtime polymerase chain reaction (PCR). Among the 1420 smokers, the AURKA polymorphism carriers with the betel nut chewing habit had a higher risk of oral cancer than AURKA wild-type (WT) carriers without the betel nut chewing habit. Patients with the AURKA rs2064863 gene had a 1.365-fold higher risk of stage III or IV OSCC (95% confidence interval [CI] 1.029-1.811) than those with the rs2064863 WT gene. Furthermore, carriers of the AURKA rs1047972/rs2273535/rs2064863 C-A-T haplotype had a 1.736-fold (95% CI 1.110-2.715) higher risk of OSCC than controls (C-T-T, the most common haplotype). Among patients with the betel quid chewing habit, carriers of other haplotypes (C-T-T, C-A-G, T-A-T, T-A-G, T-T-T, and C-T-G) had a 12.857-fold (95% CI 10.731-15.404) increased risk, and carriers of the C-A-T haplotype had the highest risk (AOR: 31.120; 95% CI 13.864-69.850) of OSCC, compared with those without the betel quid chewing who harbored other haplotypes. Conclusions In conclusion, betel nut chewing combined with the AURKA C-A-T haplotypes lead to a high risk of OSCC. These findings reveal a novel genetic-environmental predisposition for oral tumorigenesis.	[Chou, Chia-Hsuan; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chou, Chia-Hsuan; Chou, Ying-Erh; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chou, Ying-Erh; Chuang, Chun-Yi] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chuang, Chun-Yi] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital Taiwan [CSH-2016-E-002-Y2]	Chung Shan Medical University Hospital Taiwan	This study was supported by CSH-2016-E-002-Y2 from Chung Shan Medical University Hospital Taiwan, respectively. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Cheng HL, 2016, ONCOTARGET, V7, P69384, DOI 10.18632/oncotarget.12082; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Chiu CC, 2010, BIOCHEM BIOPH RES CO, V399, P60, DOI 10.1016/j.bbrc.2010.07.042; Chou YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093692; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; Chuang TP, 2016, ONCOTARGET; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Cox DG, 2006, CANCER CAUSE CONTROL, V17, P81, DOI 10.1007/s10552-005-0429-9; Dai ZJ, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0091-y; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Goos JACM, 2013, BRIT J CANCER, V109, P2445, DOI 10.1038/bjc.2013.608; Guo XG, 2014, ASIAN PAC J CANCER P, V15, P6709, DOI 10.7314/APJCP.2014.15.16.6709; Hamad HMA, 2006, ANN ONCOL, V17, P32, DOI 10.1093/annonc.mdl985; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; Jia L, 2014, MOL CANCER RES, V12, P1779, DOI 10.1158/1541-7786.MCR-14-0191; Jin YT, 1996, ORAL ONCOL, V32B, P343, DOI 10.1016/0964-1955(96)00018-8; Ju H, 2006, CANCER LETT, V242, P273, DOI 10.1016/j.canlet.2005.11.015; Kao SY, 2015, CHIN J DENT RES, V18, P7, DOI 10.3290/j.cjdr.a33965,PubMed:25815378; Kao SY, 2010, J PATHOL, V222, P99, DOI 10.1002/path.2737; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; KUO MYP, 1994, J ORAL PATHOL MED, V23, P70, DOI 10.1111/j.1600-0714.1994.tb00259.x; Lee CP, 2015, CLIN ORAL INVEST, V19, P1825, DOI 10.1007/s00784-015-1432-5; LeeChen SF, 1996, MUTAGENESIS, V11, P519, DOI 10.1093/mutage/11.5.519; Li YD, 2015, TUMOR BIOL, V36, P3557, DOI 10.1007/s13277-014-2992-8; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lin CW, 2015, HEAD NECK-J SCI SPEC, V37, P1425, DOI 10.1002/hed.23771; Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X; Matarasso N, 2007, NEOPLASIA, V9, P707, DOI 10.1593/neo.07322; Miao XP, 2004, CANCER RES, V64, P2680, DOI 10.1158/0008-5472.CAN-04-0651; Pickhard A, 2014, ONCOTARGET, V5, P5428, DOI 10.18632/oncotarget.2117; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Su CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002092; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Sun T, 2004, CARCINOGENESIS, V25, P2225, DOI 10.1093/carcin/bgh244; Taylor NJ, 2015, MOL CARCINOGEN, V54, P1668, DOI 10.1002/mc.22238; Treekitkarnmongkol W, 2016, CARCINOGENESIS; Wang C, 2016, TARGETED ONCOLOGY; Wang CK, 1996, MUTAT RES-ENVIR MUTA, V360, P165, DOI 10.1016/S0165-1161(96)90013-8; Xu LZ, 2014, ONCOTARGET, V5, P7498, DOI 10.18632/oncotarget.2241; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171583	10.1371/journal.pone.0171583	http://dx.doi.org/10.1371/journal.pone.0171583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152093	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200156
J	Contreras-Soto, RI; Mora, F; de Oliveira, MAR; Higashi, W; Scapim, CA; Schuster, I				Contreras-Soto, Rodrigo Ivan; Mora, Freddy; Rott de Oliveira, Marco Antonio; Higashi, Wilson; Scapim, Carlos Alberto; Schuster, Ivan			A Genome-Wide Association Study for Agronomic Traits in Soybean Using SNP Markers and SNP-Based Haplotype Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; GLYCINE-MAX; QUANTITATIVE TRAITS; YIELD QTL; MODEL; LOCI; POPULATIONS; ENVIRONMENT; GERMPLASM	Mapping quantitative trait loci through the use of linkage disequilibrium (LD) in populations of unrelated individuals provides a valuable approach for dissecting the genetic basis of complex traits in soybean (Glycine max). The haplotype-based genome-wide association study (GWAS) has now been proposed as a complementary approach to intensify benefits from LD, which enable to assess the genetic determinants of agronomic traits. In this study a GWAS was undertaken to identify genomic regions that control 100-seed weight (SW), plant height (PH) and seed yield (SY) in a soybean association mapping panel using single nucleotide polymorphism (SNP) markers and haplotype information. The soybean cultivars (N = 169) were field-evaluated across four locations of southern Brazil. The genome-wide haplotype association analysis (941 haplotypes) identified eleven, seventeen and fifty-nine SNP-based haplotypes significantly associated with SY, SW and PH, respectively. Although most marker-trait associations were environment and trait specific, stable haplotype associations were identified for SY and SW across environments (i. e., haplotypes Gm12_ Hap12). The haplotype block 42 on Chr19 (Gm19_ Hap42) was confirmed to be associated with PH in two environments. These findings enable us to refine the breeding strategy for tropical soybean, which confirm that haplotype-based GWAS can provide new insights on the genetic determinants that are not captured by the single-marker approach.	[Contreras-Soto, Rodrigo Ivan; Scapim, Carlos Alberto] Univ Estadual Maringa, Dept Agron, Ave Colombo, Maringa, PR, Brazil; [Mora, Freddy] Univ Talca, Inst Biol Sci, Casilla, Talca, Chile; [Rott de Oliveira, Marco Antonio; Higashi, Wilson] COODETEC, BR, Cascavel, PR, Brazil; [Schuster, Ivan] Dow Agrosci, Rod Anhanguera, Cravinhos, SP, Brazil	Universidade Estadual de Maringa; Universidad de Talca	Contreras-Soto, RI (corresponding author), Univ Estadual Maringa, Dept Agron, Ave Colombo, Maringa, PR, Brazil.	contrerasudec@gmail.com	scapim, Carlos/ABE-6461-2020; Mora-Poblete, Freddy/AAZ-1585-2020; Contreras-Soto, Rodrigo/N-5664-2019; Schuster, Ivan/C-7941-2015	Contreras-Soto, Rodrigo/0000-0001-6468-9394; Schuster, Ivan/0000-0002-5781-2339	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico); COODETEC; Dow Agrosciences	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); COODETEC; Dow Agrosciences	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico) provided the funding to support all genotyping made for this study. Marco Antonio Rott de Oliveira and Wilson Higashi receive a salary from COODETEC. Ivan Schuster receives a salary from Dow Agrosciences. COODETEC made the field assays and data collection. Dow Agrosciences did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Shafy H, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-35; Alliprandini LF, 2009, CROP SCI, V49, P801, DOI 10.2135/cropsci2008.07.0390; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cober ER, 2000, CAN J PLANT SCI, V80, P527, DOI 10.4141/P99-146; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; Embrapa, 2011, SIST PROD EMBR SOJ; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Fischer-Kilbienski I, 2010, PLANT MOL BIOL, V73, P379, DOI 10.1007/s11103-010-9618-3; Fox CM, 2015, CROP SCI, V55, P992, DOI 10.2135/cropsci2014.10.0688; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Garner C, 2003, GENET EPIDEMIOL, V24, P57, DOI 10.1002/gepi.10217; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; Hamblin MT, 2011, PLANT GENOME-US, V4, P145, DOI 10.3835/plantgenome2011.03.0008; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Holland JB, 2006, CROP SCI, V46, P642, DOI 10.2135/cropsci2005.0191; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Kim YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-477; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee SH, 1996, CROP SCI, V36, P728, DOI 10.2135/cropsci1996.0011183X003600030035x; Liang HZ, 2010, AGR SCI CHINA, V9, P1108, DOI 10.1016/S1671-2927(09)60197-8; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; MANSUR LM, 1993, THEOR APPL GENET, V86, P907, DOI 10.1007/BF00211040; Mora F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00909; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Recker JR, 2014, CROP SCI, V54, P939, DOI 10.2135/cropsci2013.07.0447; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuster I, 2011, CROP BREED APPL BIOT, V11, P50, DOI 10.1590/S1984-70332011000500008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; SoyBase, 2016, USDA ARS SOYB GEN GE; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Sun YN, 2012, MOL BIOL REP, V39, P9435, DOI 10.1007/s11033-012-1808-4; Swain SM, 2002, PLANT PHYSIOL, V129, P605, DOI 10.1104/pp.020002; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang K, 2011, GENES GENOM, V33, P685, DOI 10.1007/s13258-011-0043-z; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang JP, 2016, THEOR APPL GENET, V129, P117, DOI 10.1007/s00122-015-2614-x; Zhao FP, 2012, G3-GENES GENOM GENET, V2, P779, DOI 10.1534/g3.112.002980	56	80	89	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171105	10.1371/journal.pone.0171105	http://dx.doi.org/10.1371/journal.pone.0171105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152092	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200089
J	Dickson, BJ; Gatie, MI; Spice, DM; Kelly, GM				Dickson, Benjamin J.; Gatie, Mohamed I.; Spice, Danielle M.; Kelly, Gregory M.			NOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; NADPH OXIDASES; OXIDATIVE STRESS; REDOX REGULATION; CARCINOMA-CELLS; REACTIVE OXYGEN; ACTIVATION; NUCLEOREDOXIN; PROTEIN; TRANSCRIPTION	Mouse F9 cells differentiate to primitive endoderm (PrE) when treated with retinoic acid (RA). Differentiation is accompanied by increased reactive oxygen species (ROS) levels, and while treating F9 cells with antioxidants attenuates differentiation, H2O2 treatment alone is sufficient to induce PrE. We identified the NADPH oxidase (NOX) complexes as candidates for the source of this endogenous ROS, and within this gene family, and over the course of differentiation, Nox1 and Nox4 show the greatest upregulation induced by RA. Gata6, encoding a master regulator of extraembryonic endoderm is also up-regulated by RA and we provide evidence that NOX1 and NOX4 protein levels increase in F9 cells overexpressing Gata6. Pan-NOX and NOX1-specific inhibitors significantly reduced the ability of RA to induce PrE, and this was recapitulated using a genetic approach to knockdown Nox1 and/or Nox4 transcripts. Interestingly, overexpressing either gene in untreated F9 cells did not induce differentiation, even though each elevated ROS levels. Thus, the data suggests that ROS produced during PrE differentiation is dependent in part on increased NOX1 and NOX4 levels, which is under the control of GATA6. Furthermore, these results suggest that the combined activity of multiple NOX proteins is necessary for the differentiation of F9 cells to primitive endoderm.	[Dickson, Benjamin J.; Gatie, Mohamed I.; Spice, Danielle M.; Kelly, Gregory M.] Western Univ, Dept Biol, Mol Genet Unit, London, ON, Canada; [Kelly, Gregory M.] Child Hlth Res Inst, London, ON, Canada; [Kelly, Gregory M.] Ontario Inst Regenerat Med, Toronto, ON, Canada; [Dickson, Benjamin J.] Proteocyte Diagnost, Toronto, ON, Canada	Western University (University of Western Ontario)	Kelly, GM (corresponding author), Western Univ, Dept Biol, Mol Genet Unit, London, ON, Canada.; Kelly, GM (corresponding author), Child Hlth Res Inst, London, ON, Canada.; Kelly, GM (corresponding author), Ontario Inst Regenerat Med, Toronto, ON, Canada.	gkelly@uwo.ca	Kelly, Gregory/AAF-3400-2020	Kelly, Gregory/0000-0001-8612-364X; Spice, Danielle/0000-0002-7038-0067; Gatie, Mohamed I./0000-0001-8500-5609; Dickson, Barry/0000-0003-0715-892X	Natural Sciences and Engineering Research Council of Canada [R2615A02004]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Support was provided by the Natural Sciences and Engineering Research Council of Canada, Discovery Grant R2615A02004 [http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp].	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bahn YJ, 2015, J LIPID RES, V56, P294, DOI 10.1194/jlr.M054056; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; Golenia G G M. I., 2016, BIOCH CELL IN PRESS; Hagiwara N, 2013, CELL TISSUE RES, V354, P581, DOI 10.1007/s00441-013-1680-0; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hwang JTK, 2012, STEM CELLS DEV, V21, P3220, DOI 10.1089/scd.2011.0492; Inoue A, 2009, BIOCHEM BIOPH RES CO, V390, P564, DOI 10.1016/j.bbrc.2009.10.005; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Krawetz R, 2008, CELL SIGNAL, V20, P506, DOI 10.1016/j.cellsig.2007.11.001; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Landry WD, 2014, BIOCHEM SOC T, V42, P934, DOI 10.1042/BST20140060; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Pekarcikova L, 2016, CELL SIGNAL, V28, P924, DOI [10.1016/j.cellsig2016.04.007, 10.1016/j.cellsig.2016.04.007]; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rezende F, 2016, ANTIOXID REDOX SIGN, V24, P392, DOI 10.1089/ars.2015.6314; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Sandieson L, 2014, STEM CELLS DEV, V23, P1037, DOI 10.1089/scd.2014.0010; Sattayakhom A, 2011, J CANCER RES CLIN, V137, P1669, DOI 10.1007/s00432-011-1041-x; Schlupf J, 2014, DIFFERENTIATION, V87, P209, DOI 10.1016/j.diff.2014.07.003; Sirokmany G, 2016, TRENDS PHARMACOL SCI, V37, P318, DOI 10.1016/j.tips.2016.01.006; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Wen JWH, 2012, CELL SIGNAL, V24, P2337, DOI 10.1016/j.cellsig.2012.07.024; Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008	39	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170812	10.1371/journal.pone.0170812	http://dx.doi.org/10.1371/journal.pone.0170812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152080	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200045
J	Kusuma, GD; Brennecke, SP; O'Connor, AJ; Kalionis, B; Heath, DE				Kusuma, Gina D.; Brennecke, Shaun P.; O'Connor, Andrea J.; Kalionis, Bill; Heath, Daniel E.			Decellularized extracellular matrices produced from immortal cell lines derived from different parts of the placenta support primary mesenchymal stem cell expansion	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; CHORIONIC VILLI; OXIDATIVE STRESS; PROGENITOR CELLS; EX-VIVO; FETAL; CULTURE; PROLIFERATION; DECIDUA	Mesenchymal stem/stromal cells (MSCs) exhibit undesired phenotypic changes during ex vivo expansion, limiting production of the large quantities of high quality primary MSCs needed for both basic research and cell therapies. Primary MSCs retain many desired MSC properties including proliferative capacity and differentiation potential when expanded on decellularized extracellular matrix (dECM) prepared from primary MSCs. However, the need to use low passage number primary MSCs (passage 3 or lower) to produce the dECM drastically limits the utility and impact of this technology. Here, we report that primary MSCs expanded on dECM prepared from high passage number (passage 25) human telomerase reverse transcriptase (hTERT) transduced immortal MSC cell lines also exhibit increased proliferation and osteogenic differentiation. Two hTERT-transduced placenta-derived MSC cell lines, CMSC29 and DMSC23 [derived from placental chorionic villi (CMSCs) and decidua basalis (DMSCs), respectively], were used to prepare dECM-coated substrates. These dECM substrates showed structural and biochemical differences. Primary DMSCs cultured on dECM-DMSC23 showed a three-fold increase in cell number after 14 days expansion in culture and increased osteogenic differentiation compared with controls. Primary CMSCs cultured on the dECM-DMSC23 exhibited a two-fold increase in cell number and increased osteogenic differentiation. We conclude that immortal MSC cell lines derived from different parts of the placenta produce dECM with varying abilities for supporting increased primary MSC expansion while maintaining important primary MSC properties. Additionally, this is the first demonstration of using high passage number cells to produce dECM that can promote primary MSC expansion, and this advancement greatly increases the feasibility and applicability of dECM-based technologies.	[Kusuma, Gina D.; Brennecke, Shaun P.; Kalionis, Bill] Royal Womens Hosp, Dept Maternal Fetal Med, Pregnancy Res Ctr, Parkville, Vic, Australia; [Kusuma, Gina D.; O'Connor, Andrea J.; Heath, Daniel E.] Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia; [Brennecke, Shaun P.; Kalionis, Bill] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Kalionis, B (corresponding author), Royal Womens Hosp, Dept Maternal Fetal Med, Pregnancy Res Ctr, Parkville, Vic, Australia.; Heath, DE (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia.; Kalionis, B (corresponding author), Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia.	bill.kalionis@thewomensu.org.au; daniel.heath@unimelb.edu.au	KALIONIS, BILL/B-4766-2011; Brennecke, Shaun/AFV-3919-2022; O'Connor, Andrea J/B-1225-2011; Kusuma, Gina/AAF-3381-2019	Brennecke, Shaun/0000-0003-3070-6971; O'Connor, Andrea J/0000-0001-6925-885X; Kusuma, Gina/0000-0001-7042-3795; Heath, Daniel/0000-0003-3171-886X	University of Melbourne	University of Melbourne(University of Melbourne)	Funding was provided through the University of Melbourne Early Career Researcher scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Abumaree MH, 2013, STEM CELL REV REP, V9, P16, DOI 10.1007/s12015-012-9385-4; Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Braekke K, 2006, PEDIATR RES, V60, P560, DOI 10.1203/01.pdr.0000242299.01219.6a; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; Castrechini NM, 2012, REPROD SCI; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fierabracci A, 2015, EXPERT OPIN BIOL TH, P1; Fitzpatrick LE, 2015, BIOMATER SCI-UK, V3, P12, DOI [10.1039/C4BM00246F, 10.1039/c4bm00246f]; Haddad R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/216806; Heath DE, 2015, LAB CHIP, V15, P2073, DOI 10.1039/c4lc01416b; Heath DE, 2012, ACTA BIOMATER, V8, P2899, DOI 10.1016/j.actbio.2012.03.052; Heath DE, 2010, J BIOMED MATER RES A, V94A, P1195, DOI 10.1002/jbm.a.32802; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jung S., 2012, STEM CELLS INT, V2012, DOI [DOI 10.1155/2012/123030, 10.1155/2012/123030]; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; Kusuma GD, 2015, PLACENTA, V36, P312, DOI 10.1016/j.placenta.2014.12.014; Kusuma GD, 2016, STEM CELL REV REP, V12, P285, DOI 10.1007/s12015-016-9649-5; Kusuma GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141246; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Londono R, 2015, ANN BIOMED ENG, V43, P577, DOI 10.1007/s10439-014-1103-8; Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Ng CP, 2014, BIOMATERIALS, V35, P4046, DOI 10.1016/j.biomaterials.2014.01.081; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pattabhi SR, 2014, DIFFERENTIATION, V88, P131, DOI 10.1016/j.diff.2014.12.005; Qin SQ, 2016, PLACENTA, V39, P134, DOI 10.1016/j.placenta.2016.01.018; Rakian R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0235-6; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026; Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436	46	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171488	10.1371/journal.pone.0171488	http://dx.doi.org/10.1371/journal.pone.0171488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152107	gold, Green Published			2022-12-26	WOS:000396161200146
J	Muller, F; Hagedoorn, M; Tuinman, MA				Mueller, Fabiola; Hagedoorn, Mariet; Tuinman, Marrit A.			Chronic multimorbidity impairs role functioning in middle-aged and older individuals mostly when non-partnered or living alone	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; CHRONIC DISEASES; COMORBIDITY; DISTRESS; PEOPLE; ARRANGEMENTS; DECLINE; ADULTS	Background Due to the aging of the population, society includes a growing proportion of older individuals prone to chronic morbidity. This study aimed to investigate the adverse effects of single and multiple chronic morbidity on psychosocial health and whether these effects are more pronounced in individuals who are non-partnered or living alone. Materials and methods Baseline data from the 'Lifelines Cohort Study' collected between 2006 and 2013 in the Netherlands were used. Individuals aged 50+ (n = 25,214) were categorized according to their health status (healthy, single chronic morbidity, multiple chronic morbidity), relationship status (partnered, non-partnered), and living arrangement (living with someone, living alone). Analyses of covariance (ANCOVA) were performed to study the main- and the interaction-effects on mental health and role functioning as assessed with the RAND-36. Results Irrespective of having chronic morbidity, having a partner was associated with better mental health when partners shared a home. Individuals with single and especially multiple chronic morbidity had impaired role functioning. Having a partner mitigated the adverse effects of multimorbidity on role functioning, but only in individuals who shared a home with their partner. Non-partnered individuals with multimorbidity and those not sharing a home with their partner demonstrated impaired role functioning. Conclusions The results demonstrate that multimorbidity negatively affects role functioning, but not the mental health, of middle-aged and older individuals. Sharing a home with a partner can mitigate these adverse effects, while other combinations of relationship status and living arrangement do not. Offering intervention to those individuals most vulnerable to impaired functioning may relieve some of the increasing pressure on the health care system. An individual's relationship status along with one's living arrangement could foster the identification of a target group for such interventions attempting to sustain physical functioning or to adapt daily goals.	[Mueller, Fabiola; Hagedoorn, Mariet; Tuinman, Marrit A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Antonius Deusinglaan 1, Groningen, Netherlands	University of Groningen	Muller, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Antonius Deusinglaan 1, Groningen, Netherlands.	f.muller@umcg.nl	Müller, Fabiola/AFM-7755-2022; Hagedoorn, Mariet/B-5056-2010	Müller, Fabiola/0000-0002-0412-7469; Hagedoorn, Mariet/0000-0003-3444-3662	Dutch Cancer Society [RUG 2009-4442]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (URL: https://www.kwf.nl/english/). The grant number is RUG 2009-4442 (Fellowship Marrit Tuinman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2012, METEN ALGEMENE GEZON; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; BRETTSCHNEIDER C, 2013, PLOS ONE, V0008; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Diener E, 2000, J CROSS CULT PSYCHOL, V31, P419, DOI 10.1177/0022022100031004001; Hagedoorn M, 2006, PSYCHOL AGING, V21, P611, DOI 10.1037/0882-7974.21.3.611; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Henning-Smith C, 2016, J APPL GERONTOL, V35, P39, DOI 10.1177/0733464814530805; Holden L, 2015, QUAL LIFE RES, V24, P2075, DOI 10.1007/s11136-015-0946-2; Hopman P, 2016, QUAL LIFE RES, V25, P651, DOI 10.1007/s11136-015-1102-8; Hughes ME, 2002, J HEALTH SOC BEHAV, V43, P1, DOI 10.2307/3090242; Ip EH, 2013, J GERONTOL A-BIOL, V68, P426, DOI 10.1093/gerona/gls186; Jayasinghe UW, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-50; Jones SMW, 2016, AGING MENT HEALTH, V20, P309, DOI 10.1080/13607863.2015.1008988; Joutsenniemi K, 2006, J EPIDEMIOL COMMUN H, V60, P468, DOI 10.1136/jech.2005.040741; Kamiya Y, 2013, AGING MENT HEALTH, V17, P349, DOI 10.1080/13607863.2012.747078; Klijs B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137203; Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0; Lewin AC., 2016, J FAM ISSUES, P1; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Matcham F, 2014, SEMIN ARTHRITIS RHEU, V44, P123, DOI 10.1016/j.semarthrit.2014.05.001; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P358, DOI 10.1016/j.jclinepi.2010.04.016; Rijken M, 2005, QUAL LIFE RES, V14, P45, DOI 10.1007/s11136-004-0616-2; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Soulsby L. K., 2015, PSYCHOLOGY, V6, P1349, DOI DOI 10.4236/PSYCH.2015.611132; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Strohm CQ, 2009, DEMOGR RES, V21, P177, DOI 10.4054/DemRes.2009.21.7; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; Tuinman MA, 2015, PSYCHO-ONCOLOGY, V24, P699, DOI 10.1002/pon.3712; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952	38	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170525	10.1371/journal.pone.0170525	http://dx.doi.org/10.1371/journal.pone.0170525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151967	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200024
J	Zhang, RS; Qi, H; Sun, YZ; Xiao, S; Lim, BL				Zhang, Renshan; Qi, Hua; Sun, Yuzhe; Xiao, Shi; Lim, Boon Leong			Transgenic Arabidopsis thaliana containing increased levels of ATP and sucrose is more susceptible to Pseudomonas syringae	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; NUCLEOTIDE-BINDING SITE; GATED ION-CHANNEL; INNATE IMMUNITY; MICROBIAL PATHOGENS; SIGNALING PATHWAYS; DEFENSE RESPONSES; SALICYLIC-ACID; FITNESS COSTS; CROSS-TALK	Disease resistance exerts a fitness cost on plants, presumably due to the extra consumption of energy and carbon. In this study, we examined whether transgenic Arabidopsis thaliana with increased levels of ATP and sucrose is more resistant or susceptible to pathogen infection. Lines of A. thaliana over-expressing purple acid phosphatase 2 (AtPAP2) (OE lines) contain increased levels of ATP and sucrose, with improved growth rate and seed production. Compared to wild type (WT) and pap2 lines, the OE lines were more susceptible to several Pseudomonas syringae pv. tomato (Pst) strains carrying AvrRpm1, AvrRpt2 AvrRps4, AvrPtoB, HrcC and WT strain DC3000. The increased susceptibility of the OE lines to Pst strains cannot solely be attributed to the suppressed expression of R-genes but must also be attributed to the suppression of downstream signaling components, such as MOS2, EDS1 and EDS5. Before infection, the levels of salicylic acid (SA) and jasmonic acid (JA) precursor OPDA were similar in the leaves of OE, pap2 and WT plants, whereas the levels of JA and its derivative JA-Ile were significantly lower in the leaves of OE lines and higher in the pap2 line. The expression of JA marker defense gene PDF1.2 was up-regulated in the OE lines compared to the WT prior to Pst DC3000 infection, but its expression was lower in the OE lines after infection. In summary, high fitness Arabidopsis thaliana exhibited altered JA metabolism and broad suppression of R-genes and downstream genes as well as a higher susceptibility to Pst infections.	[Zhang, Renshan; Sun, Yuzhe; Lim, Boon Leong] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Qi, Hua; Xiao, Shi] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Qi, Hua; Xiao, Shi] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Lim, Boon Leong] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Zhang, Renshan] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China	University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lim, BL (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.; Lim, BL (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	bllim@hku.hk	; Lim, Boon Leong/D-3104-2009	Zhang, Renshan/0000-0002-5705-8030; Lim, Boon Leong/0000-0002-2720-2353	Woo Ting Sang Agricultural Development Research Fund; General Research Fund [HKU772012M]; Innovation and Technology Fund of the HKSAR	Woo Ting Sang Agricultural Development Research Fund; General Research Fund; Innovation and Technology Fund of the HKSAR	This work was supported by the Woo Ting Sang Agricultural Development Research Fund, the General Research Fund (HKU772012M) and the Innovation and Technology Fund (Funding Support to Partner State Key Laboratories in Hong Kong) of the HKSAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Brouwer M, 2003, FEMS MICROBIOL LETT, V228, P241, DOI 10.1016/S0378-1097(03)00759-6; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; CRUTE I, 1994, MONOGRAPH COLD SPRIN, V27, P705; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Law YS, 2015, PLANT PHYSIOL, V169, P1344, DOI 10.1104/pp.15.01115; Liang C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00922; Liang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-116; Lin NC, 2007, MOL PLANT MICROBE IN, V20, P806, DOI 10.1094/MPMI-20-7-0806; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Monaghan J, 2010, CAN J PLANT PATHOL, V32, P35, DOI 10.1080/07060661003621001; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Murillo I, 2003, PLANT J, V36, P330, DOI 10.1046/j.1365-313X.2003.01880.x; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Sun F, 2013, BMC GENOMICS, P14; Sun F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-752; Sun F, 2012, PLANT SIGNAL BEHAV, V7, P927, DOI 10.4161/psb.20769; Sun F, 2012, NEW PHYTOL, V194, P206, DOI 10.1111/j.1469-8137.2011.04026.x; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thibaud MC, 2004, PLANT PHYSIOL BIOCH, V42, P81, DOI 10.1016/j.plaphy.2003.10.012; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Zhang RS, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1239687; Zhang YL, 2005, CURR BIOL, V15, P1936, DOI 10.1016/j.cub.2005.09.038; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	55	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171040	10.1371/journal.pone.0171040	http://dx.doi.org/10.1371/journal.pone.0171040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152090	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200078
J	Goldenberg, SM; Krusi, A; Zhang, E; Chettiar, J; Shannon, K				Goldenberg, Shira M.; Krusi, Andrea; Zhang, Emma; Chettiar, Jill; Shannon, Kate			Structural Determinants of Health among Im/Migrants in the Indoor Sex Industry: Experiences of Workers and Managers/Owners in Metropolitan Vancouver	PLOS ONE			English	Article							MASSAGE PARLOR INDUSTRY; CONDOM USE; TRUCK DRIVERS; HIV/STI RISK; HIV RISK; VIOLENCE; MIGRANT; MOBILITY; CONTEXT; ACCULTURATION	Background Globally, im/migrant women are overrepresented in the sex industry and experience disproportionate health inequities. Despite evidence that the health impacts of migration may vary according to the timing and stage of migration (e.g., early arrival vs. long-term migration), limited evidence exists regarding social and structural determinants of health across different stages of migration, especially among im/migrants engaged in sex work. Our aim was to describe and analyze the evolving social and structural determinants of health and safety across the arrival and settlement process for im/migrants in the indoor sex industry. Methods We analyzed qualitative interviews conducted with 44 im/migrant sex workers and managers/owners working in indoor sex establishments (e.g., massage parlours, micro-brothels) in Metropolitan Vancouver, Canada in 2011; quantitative data from AESHA, a larger community-based cohort, were used to describe socio-demographic and social and structural characteristics of im/migrant sex workers. Results Based on quantitative data among 198 im/migrant workers in AESHA, 78.3% were Chinese-born, the median duration in Canada was 6 years, and most (86.4%) serviced clients in formal indoor establishments. Qualitative narratives revealed diverse pathways into sex work upon arrival to Canada, including language barriers to conventional labour markets and the higher pay and relative flexibility of sex work. Once engaged in sex work, fear associated with police raids (e.g., immigration concerns, sex work disclosure) and language barriers to sexual negotiation and health, social and legal supports posed pervasive challenges to health, safety and human rights during long-term settlement in Canada. Conclusions Findings highlight the critical influences of criminalization, language barriers, and stigma and discrimination related to sex work and im/migrant status in shaping occupational health and safety for im/migrants engaged in sex work. Interventions and policy reforms that emphasize human rights and occupational health are needed to promote health and wellbeing across the arrival and settlement process.	[Goldenberg, Shira M.; Krusi, Andrea; Zhang, Emma; Chettiar, Jill; Shannon, Kate] British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Goldenberg, Shira M.] Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC, Canada; [Krusi, Andrea; Shannon, Kate] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of British Columbia	Goldenberg, SM (corresponding author), British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.; Goldenberg, SM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC, Canada.	gshi-sg@cfenet.ubc.ca	Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749	US National Institutes of Health [R01DA033147]; Canadian Institutes of Health Research/Public Health Agency of Canada [HEB-330155]; Canadian Institutes for Health Research New Investigator Award; National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research; Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648, R01DA033147] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research/Public Health Agency of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the US National Institutes of Health (R01DA033147) and the Canadian Institutes of Health Research/Public Health Agency of Canada (HEB-330155). SG is supported by a Canadian Institutes for Health Research New Investigator Award and the National Institutes of Health (R01DA028648). AK is supported through the Canadian Institutes of Health Research. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all those who contributed their time and expertise to this project, particularly participants, community advisory board members and partner agencies. We wish to acknowledge Andrea Krusi, Jessica Jia, Chrissy Taylor, Solanna Anderson, Elena Argento, Krista Butler, Jane Li, Minshu Mo, Vivian Liu, Helen Wang, Peter Vann, Sarah Allan, and Jill Chettiar for their research and administrative support. This research was supported by the US National Institutes of Health (R01DA033147) and the Canadian Institutes of Health Research/Public Health Agency of Canada (HEB-330155). SG is supported by a Canadian Institutes for Health Research New Investigator Award and the National Institutes of Health (R01DA028648). AK is supported through the Canadian Institutes of Health Research. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award.	Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Acevedo-Garcia D, 2012, SOC SCI MED, V75, P2060, DOI 10.1016/j.socscimed.2012.04.040; Adanu RMK, 2009, INT J GYNECOL OBSTET, V106, P179, DOI 10.1016/j.ijgo.2009.03.036; Anderson S, LICENSING P IN PRESS; Apostolopoulos Yorghos, 2006, J Immigr Minor Health, V8, P291, DOI 10.1007/s10903-006-9334-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Benach J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001043; Benach J, 2010, AM J IND MED, V53, P338, DOI 10.1002/ajim.20717; Brouwer KC, 2009, J IMMIGR MINOR HEALT, V11, P1, DOI 10.1007/s10903-008-9119-5; Bungay V, 2012, HEALTH CARE WOMEN IN, V33, P262, DOI 10.1080/07399332.2011.603868; Canada S, 2011, NAT HOUS SURV FOC GE; Canada S. B. C, 2009, IMM TRENDS 2009 HIGH; Castaneda H, 2013, SOC SCI MED, V84, P94, DOI 10.1016/j.socscimed.2013.02.010; Choi SYP, 2011, SOCIOL HEALTH ILL, V33, P33, DOI 10.1111/j.1467-9566.2010.01265.x; Decker MR, 2014, LANCET; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Derose Kathryn Pitkin, 2009, MED CARE RES REV; Duff P, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-61; Farmer P, 2003, PATHOLOGIES OF POWER; Farmer P., 2010, RACE ETHNICITY MULTI, V3, P11; Fernandez C, 2008, SPAN ECON REV, V10, P83, DOI 10.1007/s10108-007-9032-4; Finch BK, 2004, INT MIGR REV, V38, P236, DOI 10.1111/j.1747-7379.2004.tb00195.x; GALTUNG J, 1971, J PEACE RES, V8, P73, DOI 10.1177/002234337100800108; Global Commission on HIV and the Law, 2012, RIGHTS RIGHTS HLTH; Goldenberg S, 2010, FIELD ACTIONS SCI RE, P1; Goldenberg S, 2013, INT MIGRATION; Goldenberg SM, 2015, J IMMIGR MINOR HEALT, V17, P21, DOI 10.1007/s10903-014-0011-1; Goldenberg SM, 2014, J URBAN HEALTH, V91, P736, DOI 10.1007/s11524-014-9888-1; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Goldenberg SM, 2011, SOC SCI MED, V72, P1185, DOI 10.1016/j.socscimed.2011.02.014; Handlovsky I, 2012, CULT HEALTH SEX, V14, P1007, DOI 10.1080/13691058.2012.712720; Holmes SM, 2006, PLOS MED, V3, P1776, DOI 10.1371/journal.pmed.0030448; Krusi A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005191; Lippman SA, 2007, SOC SCI MED, V65, P2464, DOI 10.1016/j.socscimed.2007.07.002; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Morris MD, 2009, J COMMUN HEALTH, V34, P529, DOI 10.1007/s10900-009-9175-3; Nemoto T, 2005, AIDS EDUC PREV, V17, P444, DOI 10.1521/aeap.2005.17.5.444; Nemoto T, 2004, AIDS BEHAV, V8, P475, DOI 10.1007/s10461-004-7331-4; Oza KK, 2014, INT J GYNECOLOGY OBS; Pivot Legal Society, 2006, DECR SEX WORK HUM RI; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; Platt L, 2013, SEX TRANSM INFECT, V89, P311, DOI 10.1136/sextrans-2012-050491; Ragsdale Kathleen, 2007, J Cult Divers, V14, P26; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Shannon K., 2014, LANCET; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Sou J, 2015, SEX TRANSM DIS, V42, P312, DOI 10.1097/OLQ.0000000000000276; Steen R, 2015, LANCET, V385, P94, DOI 10.1016/S0140-6736(14)60966-1; Sunmola AM, 2005, AIDS CARE, V17, P208, DOI 10.1080/09540120512331325699; UN Human Rights Council, 2021, REP MEANS ADDR HUM R; United Nations Population Division, 2009, INT MIGR STOCK 2008; Viruell-Fuentes EA, 2007, SOC SCI MED, V65, P1524, DOI 10.1016/j.socscimed.2007.05.010; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	63	73	73	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170642	10.1371/journal.pone.0170642	http://dx.doi.org/10.1371/journal.pone.0170642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141835	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129500013
J	Ortiz-Zapater, E; Lee, RW; Owen, W; Weitsman, G; Fruhwirth, G; Dunn, RG; Neat, MJ; McCaughan, F; Parker, P; Ng, T; Santis, G				Ortiz-Zapater, Elena; Lee, Richard W.; Owen, William; Weitsman, Gregory; Fruhwirth, Gilbert; Dunn, Robert G.; Neat, Michael J.; McCaughan, Frank; Parker, Peter; Ng, Tony; Santis, George			MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; HEPATOCYTE GROWTH; ACQUIRED-RESISTANCE; CANCER PATIENTS; MUTATIONS; ACTIVATION; GEFITINIB; ERLOTINIB; OVEREXPRESSION	Advanced lung cancer has poor survival with few therapies. EGFR tyrosine kinase inhibitors (TKIs) have high response rates in patients with activating EGFR mutations, but acquired resistance is inevitable. Acquisition of the EGFR T790M mutation causes over 50% of resistance; MET amplification is also common. Preclinical data suggest synergy between MET and EGFR inhibitors. We hypothesized that EGFR-MET dimerization determines response to MET inhibition, depending on EGFR mutation status, independently of MET copy number. We tested this hypothesis by generating isogenic cell lines from NCI-H1975 cells, which co-express L858R and T790M EGFR mutations, namely H1975(L858R/T790M) (EGFR TKI resistant); H1975(L858R) (sensitized) and H1975(WT) (wild-type). We assessed cell proliferation in vitro and tumor growth/stroma formation in derived xenograft models in response to a MET TKI (SGX523) and correlated with EGFR-MET dimerization assessed by Forster Resonance Energy Transfer (FRET). SGX523 significantly reduced H1975(L858R/T790M) cell proliferation, xenograft tumor growth and decreased ERK phosphorylation. The same was not seen in H1975(L858R) or H1975(WT) cells. SGX523 only reduced stroma formation in H1975(L858R). SGX523 reduced EGFR-MET dimerization in H1975(L858R/T790M) but induced dimer formation in H1975(L858R) with no effect in H1975(WT). Our data suggests that MET inhibition by SGX523 and EGFR-MET heterodimerisation are determined by EGFR genotype. As tumor behaviour is modulated by this interaction, this could determine treatment efficacy.	[Ortiz-Zapater, Elena; Lee, Richard W.; Owen, William; McCaughan, Frank; Santis, George] Kings Coll London, Guys Hosp, Div Asthma Allergy & Lung Biol, London, England; [Weitsman, Gregory; Ng, Tony] Kings Coll London, Randall Div Cell & Mol Biophys, Richard Dimbleby Dept Canc Res, London, England; [Fruhwirth, Gilbert] Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Imaging Chem & Biol, Rayne Inst,St Thomas Hosp, London, England; [Dunn, Robert G.; Neat, Michael J.] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Viapath, Dept Canc Genet, London, England; [Parker, Peter; Ng, Tony] Kings Coll London, Div Canc Studies, London, England; [Parker, Peter] Francis Crick Inst, Prot Phosphorylat Lab, London, England; [Ng, Tony] Kings Coll London, Guys Hosp, Breast Canc Res Unit, London, England; [Ng, Tony] UCL, UCL Canc Inst, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Francis Crick Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London	Santis, G (corresponding author), Kings Coll London, Guys Hosp, Div Asthma Allergy & Lung Biol, London, England.	elena.ortiz-zapater@kcl.ac.uk; george.santis@kcl.ac.uk	Fruhwirth, Gilbert/AAP-5559-2021; Ortiz-Zapater, Elena/HCI-3340-2022	Fruhwirth, Gilbert/0000-0002-1438-2674; Ortiz Zapater, Elena/0000-0002-7437-4772; Lee, Richard/0000-0001-8368-3406; parker, peter/0000-0002-6218-2933; Ng, Tony/0000-0003-3894-5619	BBSRC Program; MRC Clinical Training Research Fellowship; National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration; Guy's & St Thomas' National Health Service Foundation Trust; Crick Institute; BBSRC [BB/G007160/1] Funding Source: UKRI; MRC [MR/L001772/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish; Cancer Research UK [16463] Funding Source: researchfish; Medical Research Council [MR/L001772/1] Funding Source: researchfish; National Institute for Health Research [ACF-2007-17-016] Funding Source: researchfish	BBSRC Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Clinical Training Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration; Guy's & St Thomas' National Health Service Foundation Trust; Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a BBSRC Program grant to GS, PP and TN; an MRC Clinical Training Research Fellowship to RL; a grateful patient to GS; and the National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration with Guy's & St Thomas' National Health Service Foundation Trust and the Crick Institute (GS and WO).; We are grateful to Dorota Dudka and Hassan Farah for technical support and Maddy Parsons and Penny Morton for critical discussion of the work. This work was supported by a BBSRC Program grant to GS, PP and TN, an MRC Clinical Training Research Fellowship to RL, a grateful patient to GS and the National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration with Guy's & St Thomas' National Health Service Foundation Trust and the Crick Institute (GS and WO).	Alaoui-Jamali MA, 2003, CANCER RES, V63, P3764; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen HJ, 2009, PATHOL ONCOL RES, V15, P651, DOI 10.1007/s12253-009-9167-8; Claus J, 2014, BIOCHEM SOC T, V42, P831, DOI 10.1042/BST20140043; Drilon A, 2016, J THORACIC ONCOLOGY, V16, P31179; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Menis J, 2013, TRANSL LUNG CANCER R, V2, P23, DOI 10.3978/j.issn.2218-6751.2012.12.04; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Rizzino A., IN VITRO, V20, P815; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tanaka A, 2012, LUNG CANCER, V75, P89, DOI 10.1016/j.lungcan.2011.06.004; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wang XD, 2010, J CELL MOL MED, V14, P833, DOI 10.1111/j.1582-4934.2010.01040.x; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898	35	11	13	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170798	10.1371/journal.pone.0170798	http://dx.doi.org/10.1371/journal.pone.0170798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141869	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500021
J	Fisse, AL; Kemmling, A; Teuber, A; Wersching, H; Young, P; Dittrich, R; Ritter, M; Dziewas, R; Minnerup, J				Fisse, Anna Lena; Kemmling, Andre; Teuber, Anja; Wersching, Heike; Young, Peter; Dittrich, Ralf; Ritter, Martin; Dziewas, Rainer; Minnerup, Jens			The Association of Lesion Location and Sleep Related Breathing Disorder in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							APNEA; DEFINITIONS; INFARCTION	Background and aims Sleep related breathing disorders (SRBD) are common in patients with ischemic stroke and are associated with poor outcome. SRBD after stroke were assumed to be a direct consequence of injury of specific central nervous system structures. However, whether specific locations of ischemic infarcts cause SRBD is yet unknown. We therefore investigated the association of ischemic lesion location with SRBD. Methods Patients with acute ischemic stroke treated on our stroke unit were included in a prospective observational study. All patients underwent magnetic resonance imaging (MRI) and polygraphy in the acute phase after stroke. SRBD was defined by an apnea-hypopnea index (AHI) >= 10. MRI were evaluated using standardized maps to depict voxel-wise probability distribution of infarction for patients with and without SRBD. Groups were compared using logistic regression analysis. Results Of 142 patients included, 86 (59%) had a SRBD. Age, body mass index and prevalence of arterial hypertension were significantly higher in patients with SRBD. There was no statistically significant association between any lesion location and SRBD. Conclusion We found no association of lesion location and SRBD in stroke patients, whereas established risk factors for SRBD, known from general population, were significantly associated with SRBD. Given the high prevalence of SRBD in stroke patients, these findings suggest that cerebral ischemia facilitates the occurrence of SRBD in patients with pre-existing risk factors rather than causing it by damaging specific central nervous system structures. Our findings can be used to identify stroke patients who might benefit from polygraphy screening.	[Fisse, Anna Lena; Dittrich, Ralf; Ritter, Martin; Dziewas, Rainer; Minnerup, Jens] Univ Munster, Dept Neurol, Munster, Germany; [Kemmling, Andre] Univ Lubeck, Dept Neuroradiol, Lubeck, Germany; [Teuber, Anja; Wersching, Heike] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Young, Peter] Dept Sleep Med & Neuromuscular Disorders, Munster, Germany; [Fisse, Anna Lena] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany	University of Munster; University of Lubeck; University of Munster; Ruhr University Bochum	Fisse, AL (corresponding author), Univ Munster, Dept Neurol, Munster, Germany.; Fisse, AL (corresponding author), Ruhr Univ Bochum, Dept Neurol, Bochum, Germany.	a.fisse@uni-muenster.de	Fisse, Anna Lena/Q-7543-2019; Dziewas, Rainer/AAX-9505-2020	Fisse, Anna Lena/0000-0003-0493-8656; Dziewas, Rainer/0000-0003-1592-8461	Else Kroner-Fresenius-Stiftung [2014_EKES.16]; German Federal Ministry of Education and Research (BMBF) [01ER0816, 01GM1511E]; Lowensteinstiftung	Else Kroner-Fresenius-Stiftung; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Lowensteinstiftung	JM is supported by the Else Kroner-Fresenius-Stiftung (2014_EKES.16). HW is supported by a grant from the German Federal Ministry of Education and Research (BMBF, grant 01ER0816). PY is supported by the Lowensteinstiftung and the German Federal Ministry of Education and Research (BMBF, grant 01GM1511E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson JA, 2015, SLEEP, V38, P1431, DOI 10.5665/sleep.4984; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ahn SH, 2013, J CLIN NEUROL, V9, P9, DOI 10.3988/jcn.2013.9.1.9; Bonnin-Vilaplana M, 2009, J NEUROL, V256, P2036, DOI 10.1007/s00415-009-5236-x; Broadley SA, 2007, J CLIN NEUROSCI, V14, P328, DOI 10.1016/j.jocn.2006.01.017; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown DL, 2014, SLEEP MED, V15, P887, DOI 10.1016/j.sleep.2014.04.003; Chen R, 2010, NEUROIMAGE, V49, P597, DOI 10.1016/j.neuroimage.2009.07.061; Harbison JA, 2000, QJM-MON J ASSOC PHYS, V93, P647, DOI 10.1093/qjmed/93.10.647; Johnson KG, 2010, CHEST, V138, P239, DOI 10.1378/chest.10-0513; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Kemmling A, 2012, CLIN NEURORADIOL, V22, P79, DOI 10.1007/s00062-011-0123-0; Minnerup J, 2012, STROKE, V43, P1137, DOI 10.1161/STROKEAHA.111.637611; Stahl SM, 2015, SLEEP MED, V16, P1198, DOI 10.1016/j.sleep.2015.07.003; STRADLING JR, 1995, THORAX, V50, P683, DOI 10.1136/thx.50.6.683; Suntrup S, 2015, EUR J NEUROL, V22, P832, DOI 10.1111/ene.12670	16	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171243	10.1371/journal.pone.0171243	http://dx.doi.org/10.1371/journal.pone.0171243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135315	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700055
J	Chen, W; He, Y; Gao, Y; Zhang, CP; Chen, CS; Bi, SY; Yang, P; Wang, YW; Wang, WJ				Chen, Wen; He, Yong; Gao, Yang; Zhang, Cuiping; Chen, Chuansheng; Bi, Suyu; Yang, Pin; Wang, Yiwen; Wang, Wenjing			Long-Term Experience of Chinese Calligraphic Handwriting Is Associated with Better Executive Functions and Stronger Resting-State Functional Connectivity in Related Brain Regions	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; RANDOMIZED CONTROLLED-TRIAL; WORKING-MEMORY; SUSTAINED ATTENTION; TEMPORAL-LOBE; NEURAL BASIS; INHIBITION; CHILDREN; PERFORMANCE; CORTEX	Chinese calligraphic handwriting (CCH) is a traditional art form that requires high levels of concentration and motor control. Previous research has linked short-term training in CCH to improvements in attention and memory. Little is known about the potential impacts of longterm CCH practice on a broader array of executive functions and their potential neural substrates. In this cross-sectional study, we recruited 36 practitioners with at least 5 years of CCH experience and 50 control subjects with no more than one month of CCH practice and investigated their differences in the three components of executive functions (i.e., shifting, updating, and inhibition). Valid resting-state fMRI data were collected from 31 CCH and 40 control participants. Compared with the controls, CCH individuals showed better updating (as measured by the Corsi Block Test) and inhibition (as measured by the Stroop WordColor Test), but the two groups did not differ in shifting (as measured by a cue-target task). The CCH group showed stronger resting-state functional connectivity (RSFC) than the control group in brain areas involved in updating and inhibition. These results suggested that long-term CCH training may be associated with improvements in specific aspects of executive functions and strengthened neural networks in related brain regions.	[Chen, Wen; He, Yong; Gao, Yang; Zhang, Cuiping; Wang, Wenjing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Chen, Wen; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Yong; Wang, Wenjing] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Bi, Suyu] Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China; [Bi, Suyu; Wang, Yiwen] Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China; [Yang, Pin] Natl Palace Museum, Conservat Dept, Beijing, Peoples R China	Beijing Normal University; University of California System; University of California Irvine; Beijing Normal University; Beijing Foreign Studies University; Beijing Normal University	Wang, WJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Wang, WJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Wang, YW (corresponding author), Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China.	wyiw@sina.com; wangwenjing@bnu.edu.cn	Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022; He, Yong/C-2161-2009; He, Yong/Q-5756-2018	Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495; He, Yong/0000-0002-7039-2850	Ministry of Education of China [14YJAZH081]; National Natural Science Foundation of China [31221003]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 14YJAZH081 Project (received by W.J.W.) of the Ministry of Education of China (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe27921/) and the No. 31221003 Project (received by Y.H.) of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/). The funding of 14YJAZH081 Project was mainly for study design, data analysis and decision to publish, while the No. 31221003 Project was mainly for data collection.	[Anonymous], 1999, ORIENTAL ART, V45, P106; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chagn KI, 2011, LECT NOTES COMPUT SC, V6524, P432; Chen ZC, 2013, NEUROIMAGE, V66, P577, DOI 10.1016/j.neuroimage.2012.10.028; Chiang Y., 1973, INTRO ITS AESTHETIC, P13; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Compton RJ, 2000, COGNITION EMOTION, V14, P401, DOI 10.1080/026999300378897; Corsi P.M., 1972, DISS ABSTR INT, V34, p819B, DOI DOI 10.1016/B978-0-12-564350-4.50011-7; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Feldman G, 2010, BEHAV RES THER, V48, P1002, DOI 10.1016/j.brat.2010.06.006; Gao DG, 1994, INFORM PROCESSING CH, P191; Gasquoine PG, 2013, NEUROSCI BIOBEHAV R, V37, P340, DOI 10.1016/j.neubiorev.2013.01.002; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Heijden AHC, 1992, SELECTIVE ATTENTION; Hudetz JA, 2004, PSYCHOL REP, V95, P53, DOI 10.2466/pr0.95.1.53-70; Hudetz JA, 2000, PSYCHOL REP, V86, P15, DOI 10.2466/PR0.86.1.15-20; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Johnson KJ, 2010, COGNITION EMOTION, V24, P299, DOI 10.1080/02699930903384667; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Kao HSR, 2006, INT J PSYCHOL, V41, P282, DOI 10.1080/00207590544000059; KAO HSR, 1976, ERGONOMICS, V19, P667, DOI 10.1080/00140137608931582; Kao HSR, 2004, PERCEPT MOTOR SKILL, V99, P1269, DOI 10.2466/pms.99.3f.1269-1273; Kao HSR, 1986, MODES HANDWRITING CO; Kao HSR, 1986, EXPLORATORY STUDY EE; Kao HSR, 1989, PSYCHOPHYSIOLOGICAL; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kellogg RT., 1999, COGNITIVE DEMANDS WR, P25; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Kwok TCY, 2011, CLIN INTERV AGING, V6, P269, DOI 10.2147/CIA.S25395; Langley LK, 2005, PSYCHOL AGING, V20, P356, DOI 10.1037/0882-7974.20.2.356; Lao-Kaim NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124027; Leube DT, 2003, COGNITIVE BRAIN RES, V18, P97, DOI 10.1016/j.cogbrainres.2003.09.008; Lynn MT, 2014, BRAIN STRUCTURE FUNC; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olive T, 2002, INT J PSYCHOL, V37, P209, DOI 10.1080/00207590244000089; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; Rapport MD, 2000, J CLIN CHILD PSYCHOL, V29, P555, DOI 10.1207/S15374424JCCP2904_8; Raven JC, 1998, MANUAL RAVENS ADV PR; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberg JM, 2015, HUM BRAIN MAPP, V36, P3194, DOI 10.1002/hbm.22838; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Turkstra LS, 2002, J COMMUN DISORD, V35, P467, DOI 10.1016/S0021-9924(02)00118-1; Ungar L, 2010, PSYCHIAT RES-NEUROIM, V181, P24, DOI 10.1016/j.pscychresns.2009.07.005; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van Paasschen J, 2013, NEUROREHAB NEURAL RE, V27, P448, DOI 10.1177/1545968312471902; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Xu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/975190; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang XL, 2010, INT J NURS STUD, V47, P550, DOI 10.1016/j.ijnurstu.2009.10.014; Yang Z, 2015, DEV COGN NEUROS-NETH, V15, P67, DOI 10.1016/j.dcn.2015.07.007; Yin SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145826; Ziereis S, 2015, RES DEV DISABIL, V38, P181, DOI 10.1016/j.ridd.2014.12.005; Zoccatelli G, 2010, EXP BRAIN RES, V207, P139, DOI 10.1007/s00221-010-2433-x; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	83	8	8	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170660	10.1371/journal.pone.0170660	http://dx.doi.org/10.1371/journal.pone.0170660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129407	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400049
J	Chua, J; Lim, B; Fenwick, EK; Gan, ATL; Tan, AG; Lamoureux, E; Mitchell, P; Wang, JJ; Wong, TY; Cheng, CY				Chua, Jacqueline; Lim, Blanche; Fenwick, Eva K.; Gan, Alfred Tau Liang; Tan, Ava Grace; Lamoureux, Ecosse; Mitchell, Paul; Wang, Jie Jin; Wong, Tien Yin; Cheng, Ching-Yu			Prevalence, Risk Factors, and Impact of Undiagnosed Visually Significant Cataract: The Singapore Epidemiology of Eye Diseases Study	PLOS ONE			English	Article							LENS OPACITIES; ANDHRA-PRADESH; RURAL CHINESE; SURGERY; POPULATION; IMPAIRMENT; ADULTS; METHODOLOGY; SURVIVAL; PEOPLE	Objective To determine the prevalence, risk factors, and impact of undiagnosed visually significant cataract in an Asian population. Methods The Singapore Epidemiology of Eye Diseases is a population-based study where 8,697 adults of Malay, Indian, and Chinese ethnicities aged > 40 years were invited for an eye examination, including lens photograph, to establish cataract diagnosis. Visually significant cataract was defined by Wisconsin Cataract Grading System and a best-corrected visual acuity <20/40 with cataract as the primary cause of vision impairment. Participants were deemed 'undiagnosed' if they had visually significant cataract and reported no prior physician diagnosis of cataract. Visual functioning (VF) was assessed with the VF-11 questionnaire validated using Rasch analysis. Results Among the 925 participants with visually significant cataract, 636 (68.8%) were unaware of their cataract status. Age-standardized prevalence varied according to ethnicity, with Malays having higher rates than Chinese and Indians. Factors independently associated with having undiagnosed visually significant cataract were: Malay ethnicity, lower educational attainment, in employment, and without a history of diabetes (all P<0.05). In those with undiagnosed visually significant cataract, half had bilateral visual impairment, which was significantly associated with 24.8% poorer visual functioning compared to those with unilateral visual impairment (P<0.001). Conclusions Two-thirds of Singaporean adults with visually significant cataract were previously undiagnosed. Half of these cases had bilateral visual impairment and substantially reduced quality of life. Public health strategies targeting elderly patients, such as regular screening for visual impairment and timely referral to ophthalmologists in order to prevent progression to bilateral visual impairment when visual function is compromised are warranted.	[Chua, Jacqueline; Lim, Blanche; Fenwick, Eva K.; Gan, Alfred Tau Liang; Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Chua, Jacqueline; Fenwick, Eva K.; Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Duke NUS Med Sch, Singapore, Singapore; [Fenwick, Eva K.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Tan, Ava Grace; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Tan, Ava Grace; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; University of Sydney; Westmead Institute for Medical Research; National University of Singapore	Cheng, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Cheng, CY (corresponding author), Duke NUS Med Sch, Singapore, Singapore.; Cheng, CY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	chingyu.cheng@duke-nus.edu.sg	Lamoureux, Ecosse/Z-5482-2019; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; Cheng, Ching-Yu/Y-2229-2019; Wong, Tien Yin/AAC-9724-2020	Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; Chua, Jacqueline/0000-0002-6474-5293; Tan, Ava Grace/0000-0003-3344-0339	National Medical Research Council, Singapore [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council, Singapore [08/1/35/19/550, 09/1/35/19/616]; Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship [1072987]	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by the National Medical Research Council (grants: 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008; CG/SERI/2010) and Biomedical Research Council (grants: 08/1/35/19/550, 09/1/35/19/616), Singapore. C-YC is supported by National Medical Research Council (CSA/033/2012). EF is funded by the Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (#1072987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Busbee BG, 2002, OPHTHALMOLOGY, V109, P606, DOI 10.1016/S0161-6420(01)00971-X; Chou R, 2016, JAMA-J AM MED ASSOC, V315, P915, DOI 10.1001/jama.2016.0783; Chua J, 2015, OPHTHALMOLOGY; Chua J, 2015, JAMA OPHTHALMOLOGY; Chua J, 2015, OPHTHALMOLOGY, V122, P2169, DOI 10.1016/j.ophtha.2015.06.052; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; [Department of Statistics MoTaI Republic of Singapore Statistics Do], 2001, CENS POP 2000 STAT R; Duan XR, 2013, GRAEF ARCH CLIN EXP, V251, P203, DOI 10.1007/s00417-012-2012-x; Fong CSU, 2014, AM J OPHTHALMOL, V157, P163, DOI 10.1016/j.ajo.2013.08.018; Fong CSU, 2013, OPHTHALMOLOGY, V120, P1720, DOI 10.1016/j.ophtha.2013.02.009; Fong Timothy W, 2007, Psychiatry (Edgmont), V4, P51; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Gomersall T, 2011, QUAL HEALTH RES, V21, P853, DOI 10.1177/1049732311402096; Gray CS, 2006, J CATARACT REFR SURG, V32, P60, DOI 10.1016/j.jcrs.2005.07.040; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584; Huang OS, 2013, OPHTHAL EPIDEMIOL, V20, P52, DOI 10.3109/09286586.2012.751429; Huang OS, 2015, BRIT J OPHTHALMOLOGY; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Kovai V, 2014, OPHTHAL EPIDEMIOL, V21, P144, DOI 10.3109/09286586.2014.903980; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lamoureux EL, 2009, INVEST OPHTH VIS SCI, V50, P2607, DOI 10.1167/iovs.08-2359; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; McGwin G, 2003, J CATARACT REFR SURG, V29, P941, DOI 10.1016/S0886-3350(02)01846-1; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Nirmalan PK, 2003, INVEST OPHTH VIS SCI, V44, P4639, DOI 10.1167/iovs.03-0011; Panday M, 2015, CLIN EXPT OPHTHALMOL; Sabanayagam C, 2016, OPHTHALMOLOGY; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P908, DOI 10.1001/jama.2016.0763; Tan AG, 2012, OPHTHAL EPIDEMIOL, V19, P380, DOI 10.3109/09286586.2012.733479; Tan Ava Grace, 2006, BMC Ophthalmol, V6, P17, DOI 10.1186/1471-2415-6-17; Tsai SY, 2003, OPHTHALMOLOGY, V110, P1089, DOI 10.1016/S0161-6420(03)00243-4; Varma R, 2008, MED CARE, V46, P497, DOI 10.1097/MLR.0b013e31816080fe; Vashist P, 2011, OPHTHALMOLOGY, V118, pe1; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Zhang X, 2012, AM J OPHTHALMOL S, V154, pe1, DOI DOI 10.1016/J.AJ0.2011.08.045	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170804	10.1371/journal.pone.0170804	http://dx.doi.org/10.1371/journal.pone.0170804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129358	Green Published, gold			2022-12-26	WOS:000396211400032
J	Hollo, G				Hollo, Gabor			Relationship between optical coherence tomography sector peripapillary angioflow-density and Octopus visual field cluster mean defect values	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; FIBER LAYER THICKNESS; OPEN-ANGLE GLAUCOMA; VESSEL DENSITY; BLOOD-FLOW; OCT ANGIOGRAPHY; NERVE HEAD; EYES; DISK; SEVERITY	Purpose To compare the relationship of Octopus perimeter cluster mean-defect (cluster MD) values with the spatially corresponding optical coherence tomography (OCT) sector peripapillary angioflow vessel-density (PAFD) and sector retinal nerve fiber layer thickness (RNFLT) values. Methods High quality PAFD and RNFLT images acquired on the same day with the Angiovue/RTVueXR Avanti OCT (Optovue Inc., Fremont, USA) on 1 eye of 27 stable early-to-moderate glaucoma, 22 medically controlled ocular hypertensive and 13 healthy participants were analyzed. Octopus G2 normal visual field test was made within 3 months from the imaging. Results Total peripapillary PAFD and RNFLT showed similar strong positive correlation with global mean sensitivity (r-values: 0.6710 and 0.6088, P< 0.0001), and similar (P = 0.9614) strong negative correlation (r-values: -0.4462 and -0.4412, P <= 0.004) with global MD. Both inferotemporal and superotemporal sector PAFD were significantly (<= 0.039) lower in glaucoma than in the other groups. No significant difference between the corresponding inferotemporal and superotemporal parameters was seen. The coefficient of determination (R-2) calculated for the relationship between inferotemporal sector PAFD and superotemporal cluster MD (0.5141, P< 0.0001) was significantly greater than that between inferotemporal sector RNFLT and superotemporal cluster MD (0.2546, P = 0.0001). The R-2 values calculated for the relationships between superotemporal sector PAFD and RNFLT, and inferotemporal cluster MD were similar (0.3747 and 0.4037, respectively, P< 0.0001). Conclusion In the current population the relationship between inferotemporal sector PAFD and superotemporal cluster MD was strong. It was stronger than that between inferotemporal sector RNFLT and superotemporal cluster MD. Further investigations are necessary to clarify if our results are valid for other populations and can be usefully applied for glaucoma research.	[Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary	Semmelweis University	Hollo, G (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	hollo.gabor@med.semmelweis-univ.hu						AIRAKSINEN PJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P206, DOI 10.1001/archopht.1992.01080140062028; Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Costa VP, 2014, ACTA OPHTHALMOL, V92, pe252, DOI 10.1111/aos.12298; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Hollo G, 1997, INT OPHTHALMOL, V20, P71, DOI 10.1007/BF00212949; Hollo G, 1997, INT OPHTHALMOL, V20, P63; Hollo G, 2017, BRIT J OPHTHALMOL, V101, P150, DOI 10.1136/bjophthalmol-2015-307759; Hollo G, 2016, INT OPHTHALMOL, V36, P915, DOI 10.1007/s10792-016-0207-6; Hollo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161631; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P522, DOI 10.1007/BF02169199; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Naghizadeh F, 2014, J GLAUCOMA, V23, P11, DOI 10.1097/IJG.0b013e318264cda2; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Pinto LA, 2016, ACTA OPHTHALMOL, V94, P592, DOI 10.1111/aos.12962; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; QUIGLEY HA, 1984, INVEST OPHTH VIS SCI, V25, P918; Tektas OY, 2010, INVEST OPHTH VIS SCI, V51, P5083, DOI 10.1167/iovs.09-5101; TUULONEN A, 1991, AM J OPHTHALMOL, V111, P485, DOI 10.1016/S0002-9394(14)72385-2; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Werne A, 2008, SURV OPHTHALMOL, V53, P559, DOI 10.1016/j.survophthal.2008.08.021; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944	32	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171541	10.1371/journal.pone.0171541	http://dx.doi.org/10.1371/journal.pone.0171541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152106	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200154
J	Kim, DJ; Lee, MW; Choi, JS; Lee, SG; Park, JY; Kim, SW				Kim, Dae Jin; Lee, Min Woo; Choi, Jeong Su; Lee, Seung Gwan; Park, Jee Yoon; Kim, Suhng Wook			Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species	PLOS ONE			English	Article							ALBICANS BIOFILMS; ESSENTIAL OIL; PLANT-ORIGIN; INFECTIONS; TERPENOIDS; COMPONENTS; LINALOOL; GROWTH	The aim of this study was to investigate the ability of hinokitiol to inhibit the formation of Candida biofilms. Biofilm inhibition was evaluated by quantification of the biofilm metabolic activity with XTT assay. Hinokitiol efficiently prevented biofilm formation in both fluconazole-susceptible and fluconazole-resistant strains of Candida species. We determined the expression levels of specific genes previously implicated in biofilm development of C. albicans cells by realtime RT-PCR. The expression levels of genes associated with adhesion process, HWP1 and ALS3, were downregulated by hinokitiol. Transcript levels of UME6 and HGC1, responsible for long-term hyphal maintenance, were also decreased by hinokitiol. The expression level of CYR1, which encodes the component of signaling pathway of hyphal formation-cAMP-PKA was suppressed by hinokitiol. Its upstream general regulator RAS1 was also suppressed by hinokitiol. These results indicate that hinokitiol may have therapeutic potential in the treatment and prevention of biofilm-associated Candida infections.	[Kim, Dae Jin; Lee, Min Woo; Choi, Jeong Su; Lee, Seung Gwan; Kim, Suhng Wook] Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul, South Korea; [Park, Jee Yoon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SW (corresponding author), Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul, South Korea.	swkimkorea@korea.ac.kr	Park, Jee Yoon/ABC-3368-2021		Korea University [K1508301]	Korea University	This research was supported by a grant from Korea University (K1508301).	Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Clinical and Laboratory Standards Institute, 2008, APPROVED STANDARD M2; Doke SK, 2014, J GEN APPL MICROBIOL, V60, P163, DOI 10.2323/jgam.60.163; Gilbard JP, 2010, CORNEA, V29, P559, DOI 10.1097/ICO.0b013e3181bd9f79; Holcombe LJ, 2010, MICROBIOL-SGM, V156, P1476, DOI 10.1099/mic.0.037549-0; Hsu CC, 2013, MED MYCOL, V51, P473, DOI 10.3109/13693786.2012.743051; Inamori Y, 2000, BIOL PHARM BULL, V23, P995, DOI 10.1248/bpb.23.995; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Komaki N, 2008, BIOL PHARM BULL, V31, P735, DOI 10.1248/bpb.31.735; Krenn BM, 2009, J VIROL, V83, P58, DOI 10.1128/JVI.01543-08; Kucharikova S, 2013, ANTIMICROB AGENTS CH, V57, P2365, DOI 10.1128/AAC.02288-12; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Liu SC, 2006, BIOCHEM BIOPH RES CO, V351, P26, DOI 10.1016/j.bbrc.2006.09.166; McCarty TP, 2016, INFECT DIS CLIN N AM, V30, P103, DOI 10.1016/j.idc.2015.10.013; Morita Y, 2004, BIOL PHARM BULL, V27, P899, DOI 10.1248/bpb.27.899; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004; O'Connor L, 2010, EUKARYOT CELL, V9, P1383, DOI 10.1128/EC.00042-10; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Raut JS, 2013, BIOFOULING, V29, P87, DOI 10.1080/08927014.2012.749398; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Tampieri MP, 2005, MYCOPATHOLOGIA, V159, P339, DOI 10.1007/s11046-003-4790-5; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099103; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Uppuluri P, 2009, J CLIN MICROBIOL, V47, P4078, DOI 10.1128/JCM.01377-09; Yapar N, 2011, MED MYCOL, V49, P26, DOI 10.3109/13693786.2010.501344; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	32	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171244	10.1371/journal.pone.0171244	http://dx.doi.org/10.1371/journal.pone.0171244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152096	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200113
J	Lima, DF; de Lima, LI; Rocha, JA; de Andrade, IM; Grazina, LG; Villa, C; Meira, L; Veras, LMC; Azevedo, IFS; Biase, AG; Costa, J; Oliveira, MBPP; Mafra, I; Leite, JRDD				Lima, David Fernandes; de Lima, Luiza Ianny; Rocha, Jefferson Almeida; de Andrade, Ivanilza Moreira; Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa Veras, Leiz Maria; Sousa Azevedo, Iabita Fabiana; Biase, Adriele Giaretta; Costa, Joana; Oliveira, Maria Beatriz P. P.; Mafra, Isabel; de Souza de Almeida Leite, Jose Roberto			Seasonal change in main alkaloids of jaborandi (Pilocarpus microphyllus Stapf ex Wardleworth), an economically important species from the Brazilian flora	PLOS ONE			English	Article							EPIISOPILOTURINE; SYSTEM; PLANT	Pilocarpus microphyllus Stapf ex Wardleworth (jaborandi, Rutaceae) is one of the most important Brazilian medicinal species owing to its content of pilocarpine (PIL), an alkaloid used for treating glaucoma and xerostomia. This species contains another alkaloid, epiisopiloturine (EPI), which has demonstrated effectiveness against schistosomiasis. The aim of this work was to assess seasonal changes of PIL and EPI in three populations of cultivated P. microphyllus from northeastern Brazil over one year, including the dry and rainy seasons. Alkaloid profiles were correlated to phenotypic and genetic patterns in the morphological and molecular characterizations. PIL was the primary alkaloid and its levels differed among populations in all months except September. The S01 population (green line) showed an especially high PIL content compared to populations S02 and S03 (traditional line), which had similar alkaloid contents. PIL content gradually decreased in the three populations in the rainy season. EPI content was significantly different between the green line (S01) and the traditional line (S02 and S03). S01 had a significantly lower EPI content in all months, demonstrating that it was not the best source for EPI extraction. Inter simple sequence repeat (ISSR) markers and morphological analyses clearly separated S01 from S02 and S03, in agreement with the alkaloid results. This study shows the first correlation between the chemical, morphological, and molecular markers of P. microphyllus and highlights the potential benefits of a multidisciplinary research approach aimed at supporting both industry and conservation of natural resources.	[Lima, David Fernandes; de Lima, Luiza Ianny; de Andrade, Ivanilza Moreira; Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa Veras, Leiz Maria] Univ Fed Piaui, Nucleo Pesquisa Biodiversidade & Biotecnol, Campus Ministro Reis Velloso, Parnaiba, Piaui, Brazil; [Lima, David Fernandes] Univ Fed Vale Sao Francisco, Fac Med, Paulo Afonso, BA, Brazil; [Lima, David Fernandes] Univ Fed Piaui, Programa Posgrad Biotecnol, Rede Nordeste Biotecnol, Teresina, Piaui, Brazil; [Rocha, Jefferson Almeida] Univ Fed Maranhao, Grp Pesquisa Ciencias Nat & Biotecnol, Grajau, Maranhao, Brazil; [Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa, Joana; Oliveira, Maria Beatriz P. P.; Mafra, Isabel] Univ Porto, Requimte Laqv, Fac Farm, Oporto, Portugal; [Sousa Azevedo, Iabita Fabiana; Biase, Adriele Giaretta] Univ Sao Paulo, Dept Estat & Expt Agron, Escola Super Agr Luiz de Queiroz, Sao Paulo, SP, Brazil; [de Souza de Almeida Leite, Jose Roberto] Univ Brasilia, Fac Med, Brasilia, DF, Brazil	Universidade Federal do Piaui; Universidade Federal do Vale do Sao Francisco; Universidade Federal do Piaui; Universidade Federal do Maranhao; Universidade do Porto; Universidade de Sao Paulo; Universidade de Brasilia	Leite, JRDD (corresponding author), Univ Brasilia, Fac Med, Brasilia, DF, Brazil.	jrsaleite@gmail.com	Mafra, Isabel/D-8207-2013; Villa, Caterina/AAC-9297-2019; Costa, Joana/K-1255-2013; Rocha, Jefferson/AAS-9043-2020; Veras, Leiz M C/H-8873-2013; Oliveira, M. Beatriz PP/D-9025-2013; Grazina, Liliana/AAD-2258-2019	Mafra, Isabel/0000-0001-5311-8895; Villa, Caterina/0000-0002-9471-3612; Costa, Joana/0000-0002-8229-2902; Rocha, Jefferson/0000-0001-6619-2293; Oliveira, M. Beatriz PP/0000-0002-6767-6596; Grazina, Liliana/0000-0001-9033-9486; Lima, Luiza/0000-0002-7912-8175	Marie Curie Actions [612545]	Marie Curie Actions(European Commission)	Funded by Marie Curie Actions. Author: IM. Grant number: FP7-PEOPLE-2013-IRSES through the project no. 612545 entitled "GMOsensor". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2007, RAPID COMMUN MASS SP, V21, P1205, DOI 10.1002/rcm.2942; Abreu IN, 2011, PLANTA MED, V77, P293, DOI 10.1055/s-0030-1250314; Agban Y, 2016, INT J PHARMACEUT, V501, P96, DOI 10.1016/j.ijpharm.2016.01.069; AndradeNeto M, 1996, PHYTOCHEMISTRY, V42, P885, DOI 10.1016/0031-9422(95)00852-7; [Anonymous], 1969, DIC PLANT UT BRAS; [Anonymous], 2010, ORIGINPRO 8 5 SOFTW; Archer E., 2016, RFPERMUTE ESTIMATE P; Avancini G, 2003, PHYTOCHEMISTRY, V63, P171, DOI 10.1016/S0031-9422(03)00102-X; Blackith RE., 1971, MULTIVARIATE MORPHOM; Brandao MGL, 2008, J ETHNOPHARMACOL, V120, P141, DOI 10.1016/j.jep.2008.08.004; Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; Cruz CD, 1990, THESIS; Doyle J. J., 1987, PHYTOCHEM B, P11; EXCOFFIER L, 1992, GENETICS, V131, P479; Flanagan N.S., 2012, COMPREHENSIVE GUIDE; Gil-Montoya JA, 2016, MED ORAL PATOL ORAL; Guimaraes MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003656; Guimaraes MA, 2014, J NANOSCI NANOTECHNO, V14, P4519, DOI 10.1166/jnn.2014.8248; HARPER DAT, 2001, PALAEONTOLOGIA ELECT, V4; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Liu B, 2001, MOL ECOL NOTES, V1, P205, DOI 10.1046/j.1471-8278.2001.00073.x; Marcus LF, 1990, SPECIAL PUBLICATION, V2, P77; Melo CM, 2014, J THERM ANAL CALORIM, V120, P689, DOI DOI 10.1007/s10973-014-4163-y; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Monteiro Júlio M., 2006, Rev. bras. farmacogn., V16, P338, DOI 10.1590/S0102-695X2006000300010; Moura E. F., 2005, Revista Brasileira de Plantas Medicinais, V7, P1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinheiro CUB, 1997, ECON BOT, V51, P49, DOI 10.1007/BF02910403; Reyment R. A., 1991, MULTIDIMENSIONAL PAL; Rocha JA, 2014, FOREST RES, V3; Samarakoon T, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200236; Sandhu SS, 2006, SCI AGR, V63, P478, DOI 10.1590/S0103-90162006000500010; Santos Ana Paula, 2004, Rev. Bras. Cienc. Farm., V40, P116, DOI 10.1590/S1516-93322004000200002; SAS Institute, 2016, SAS STAT SOFTW REL 9; Silva VG, 2013, J NAT PROD, V76, P1071, DOI 10.1021/np400099m; Skorupa Ladislau A., 2003, Braz. J. Bot., V26, P263, DOI 10.1590/S0100-84042003000200015; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stevens P.F., 2016, ANGIOSPERM PHYLOGENY; Veras LMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066702; VOIGTLANDER HW, 1978, ARCH PHARM, V311, P927, DOI 10.1002/ardp.19783111106; Wolfe AD, 1998, MOL ECOL, V7, P1107, DOI 10.1046/j.1365-294x.1998.00425.x; Wolfe AD, 2005, METHOD ENZYMOL, V395, P134, DOI 10.1016/S0076-6879(05)95009-X	42	6	6	13	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170281	10.1371/journal.pone.0170281	http://dx.doi.org/10.1371/journal.pone.0170281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151972	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200019
J	Stok, FM; Hoffmann, S; Volkert, D; Boeing, H; Ensenauer, R; Stelmach-Mardas, M; Kiesswetter, E; Weber, A; Rohm, H; Lien, N; Brug, J; Holdsworth, M; Renner, B				Stok, F. Marijn; Hoffmann, Stefan; Volkert, Dorothee; Boeing, Heiner; Ensenauer, Regina; Stelmach-Mardas, Marta; Kiesswetter, Eva; Weber, Alisa; Rohm, Harald; Lien, Nanna; Brug, Johannes; Holdsworth, Michelle; Renner, Britta			The DONE framework: Creation, evaluation, and updating of an interdisciplinary, dynamic framework 2.0 of determinants of nutrition and eating	PLOS ONE			English	Article							FOOD CHOICE; BEHAVIOR; HEALTH	The question of which factors drive human eating and nutrition is a key issue in many branches of science. We describe the creation, evaluation, and updating of an interdisciplinary, interactive, and evolving "framework 2.0" of Determinants Of Nutrition and Eating (DONE). The DONE framework was created by an interdisciplinary workgroup in a multiphase, multimethod process. Modifiability, relationship strength, and population-level effect of the determinants were rated to identify areas of priority for research and interventions. External experts positively evaluated the usefulness, comprehensiveness, and quality of the DONE framework. An approach to continue updating the framework with the help of experts was piloted. The DONE framework can be freely accessed (http://uni-konstanz.de/DONE) and used in a highly flexible manner: determinants can be sorted, filtered and visualized for both very specific research questions as well as more general queries. The dynamic nature of the framework allows it to evolve as experts can continually add new determinants and ratings. We anticipate this framework will be useful for research prioritization and intervention development.	[Stok, F. Marijn; Renner, Britta] Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany; [Hoffmann, Stefan] Univ Kiel, Inst Business Adm, Esp Mkt, Kiel, Germany; [Volkert, Dorothee; Kiesswetter, Eva] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biomed Aging, Erlangen, Germany; [Boeing, Heiner; Stelmach-Mardas, Marta] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Ensenauer, Regina] Heinrich Heine Univ Dusseldorf, Expt Pediat & Metab, Univ Childrens Hosp, Dusseldorf, Germany; [Stelmach-Mardas, Marta] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland; [Weber, Alisa] Ludwig Maximilians Univ Munchen, Inst Social Pediat & Youth Med, Munich, Germany; [Rohm, Harald] Tech Univ Dresden, Chair Food Engn, Dresden, Germany; [Lien, Nanna] Univ Oslo, Fac Med, Oslo, Norway; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Holdsworth, Michelle] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Konstanz; University of Kiel; University of Erlangen Nuremberg; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Poznan University of Medical Sciences; University of Munich; Technische Universitat Dresden; University of Oslo; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Sheffield	Stok, FM; Renner, B (corresponding author), Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany.	marijn.stok@uni-konstanz.de; britta.renner@uni-konstanz.de	holdsworth, michelle/AAH-5400-2020; Renner, Britta/AAW-1895-2020; Brug, Johannes/A-8242-2018; Hoffmann, Stefan/O-6170-2015	holdsworth, michelle/0000-0001-6028-885X; Renner, Britta/0000-0001-8385-2839; Brug, Johannes/0000-0002-1904-7349; Hoffmann, Stefan/0000-0001-5307-4060; Briody, Jonathan/0000-0002-0641-1551	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Research Foundation Flanders; Finnish Funding Agency for Technology and Innovation (Tekes); Institut National de la Recherche Agronomique (INRA); Federal Ministry of Education and Research (BMBF); Health Research Board (HRB); Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; Netherlands Organisation for Health Research and Development (ZonMw); Research Council of Norway, Division for Society and Health; National Centre for Research and Development; Carlos III Institute of Health (ISCIII); Medical Research Council (MRC)	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Research Foundation Flanders(FWO); Finnish Funding Agency for Technology and Innovation (Tekes)(Finnish Funding Agency for Technology & Innovation (TEKES)); Institut National de la Recherche Agronomique (INRA); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Health Research Board (HRB); Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Council of Norway, Division for Society and Health(Research Council of Norway); National Centre for Research and Development; Carlos III Institute of Health (ISCIII)(Instituto de Salud Carlos III); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agencies supporting this work are (in alphabetical order of participating Member State): Belgium: Research Foundation Flanders; Finland: Finnish Funding Agency for Technology and Innovation (Tekes); France: Institut National de la Recherche Agronomique (INRA); Germany: Federal Ministry of Education and Research (BMBF); Ireland: The Health Research Board (HRB); Italy: Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway, Division for Society and Health; Poland: The National Centre for Research and Development; Spain: Carlos III Institute of Health (ISCIII); The United Kingdom: The Medical Research Council (MRC).	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bandura A., 1986, SOCIAL FDN THOUGHT A; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Bock A. -K., 2014, JRC FORESIGHT STUDY; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Buzan T, 2006, MIND MAPPING; Contento IR, 2008, ASIA PAC J CLIN NUTR, V17, P176; Economos CD, 2001, NUTR REV, V59, pS40; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Hofmann W, 2012, PSYCHOL SCI, V23, P582, DOI 10.1177/0956797612437426; Hummel E, 2016, ECOL FOOD N IN PRESS; Koster EP, 2009, FOOD QUAL PREFER, V20, P70, DOI 10.1016/j.foodqual.2007.11.002; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lakerveld J, 2014, INT J BEHAV NUTR PHY, V11, P1, DOI DOI 10.1186/s12966-014-0143-7; Prochaska J. O., 1984, TRANSTHEORETICAL APP; Renner B, 2003, BLACKW SER HLTH PSYC, P169; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Schwarzer R, 1999, J Health Psychol, V4, P115, DOI 10.1177/135910539900400208; Sleddens EFC, 2015, NUTR REV, V73, P477, DOI 10.1093/nutrit/nuv007; Symmank C, APPETITE IN PRESS; Vlaev I, 2015, REV GEN PSYCHOL, V19, P69, DOI 10.1037/gpr0000029; Wansink B, 2007, ENVIRON BEHAV, V39, P106, DOI 10.1177/0013916506295573; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Wexler M. N., 2001, J KNOWLEDGE MANAGEME, V5, P249, DOI DOI 10.1108/EUM0000000005868	25	85	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171077	10.1371/journal.pone.0171077	http://dx.doi.org/10.1371/journal.pone.0171077			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152005	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396161200085
J	Sagulenko, E; Nouwens, A; Webb, RI; Green, K; Yee, B; Morgan, G; Leis, A; Lee, KC; Butler, MK; Chia, N; Pham, UTP; Lindgreen, S; Catchpole, R; Poole, AM; Fuerst, JA				Sagulenko, Evgeny; Nouwens, Amanda; Webb, Richard I.; Green, Kathryn; Yee, Benjamin; Morgan, Garry; Leis, Andrew; Lee, Kuo-Chang; Butler, Margaret K.; Chia, Nicholas; Uyen Thi Phuong Pham; Lindgreen, Stinus; Catchpole, Ryan; Poole, Anthony M.; Fuerst, John A.			Nuclear Pore-Like Structures in a Compartmentalized Bacterium	PLOS ONE			English	Article							PEPTIDOGLYCAN CELL-WALL; GEMMATA-OBSCURIGLOBUS; MOLECULAR ARCHITECTURE; CRYOELECTRON TOMOGRAPHY; BUDDING BACTERIA; OUTER-MEMBRANE; COMPLEX; PLANCTOMYCES; PROTEOME; PLAN	Planctomycetes are distinguished from other Bacteria by compartmentalization of cells via internal membranes, interpretation of which has been subject to recent debate regarding potential relations to Gram-negative cell structure. In our interpretation of the available data, the planctomycete Gemmata obscuriglobus contains a nuclear body compartment, and thus possesses a type of cell organization with parallels to the eukaryote nucleus. Here we show that pore-like structures occur in internal membranes of G. obscuriglobus and that they have elements structurally similar to eukaryote nuclear pores, including a basket, ring-spoke structure, and eight-fold rotational symmetry. Bioinformatic analysis of proteomic data reveals that some of the G. obscuriglobus proteins associated with pore-containing membranes possess structural domains found in eukaryote nuclear pore complexes. Moreover, immunogold labelling demonstrates localization of one such protein, containing a beta-propeller domain, specifically to the G. obscuriglobus pore-like structures. Finding bacterial pores within internal cell membranes and with structural similarities to eukaryote nuclear pore complexes raises the dual possibilities of either hitherto undetected homology or stunning evolutionary convergence.	[Sagulenko, Evgeny; Nouwens, Amanda; Yee, Benjamin; Lee, Kuo-Chang; Butler, Margaret K.; Uyen Thi Phuong Pham; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Webb, Richard I.; Green, Kathryn; Morgan, Garry] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Leis, Andrew] CSIRO Livestock Ind, Australian Anim Hlth Lab, Biosecur Microscopy Facil ABMF, Geelong, Vic, Australia; [Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Lindgreen, Stinus; Catchpole, Ryan; Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Catchpole, Ryan; Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch, New Zealand; [Poole, Anthony M.] Univ Canterbury, Wilson Ctr, Christchurch, New Zealand; [Poole, Anthony M.] Univ Auckland, Bioinformat Inst, Sch Biol Sci, Auckland, New Zealand	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Illinois System; University of Illinois Urbana-Champaign; University of Canterbury; University of Canterbury; University of Canterbury; University of Auckland	Fuerst, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	j.fuerst@uq.edu.au	Fuerst, John/I-8649-2012; Leis, Andrew/AAH-4344-2020	Fuerst, John/0000-0002-6451-8533; Leis, Andrew/0000-0003-4905-9401; Nouwens, Amanda/0000-0003-4069-8266; Poole, Anthony/0000-0001-9940-2824	Australian Research Council Discovery Project [DP0881485]; Royal Society of New Zealand [RDF-U0C1101]	Australian Research Council Discovery Project(Australian Research Council); Royal Society of New Zealand(Royal Society of New Zealand)	JAF was supported by Australian Research Council Discovery Project DP0881485. AMP was supported by Royal Society of New Zealand RDF-U0C1101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2014, J CELL SCI, V127, P277, DOI 10.1242/jcs.137596; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brohawn Stephen G, 2009, Commun Integr Biol, V2, P205; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Devos DP, 2014, ANTON LEEUW INT J G, V105, P271, DOI 10.1007/s10482-013-0087-y; Devos DP, 2014, TRENDS MICROBIOL, V22, P14, DOI 10.1016/j.tim.2013.10.008; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Field MC, 2014, TRAFFIC, V15, P141, DOI 10.1111/tra.12141; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; FRANKE WW, 1966, J CELL BIOL, V31, P619, DOI 10.1083/jcb.31.3.619; FRANKE WW, 1970, J CELL BIOL, V46, P379, DOI 10.1083/jcb.46.2.379; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; FRIEDMAN MH, 1970, J ULTRA MOL STRUCT R, V32, P226, DOI 10.1016/S0022-5320(70)80003-X; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; GALL JG, 1967, J CELL BIOL, V32, P391, DOI 10.1083/jcb.32.2.391; Gottshall EY, 2014, P NATL ACAD SCI USA, V111, P11067, DOI 10.1073/pnas.1409187111; Hieu CX, 2008, PROTEOMICS, V8, P1608, DOI 10.1002/pmic.200701017; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hirst J, 2014, ELIFE, V3, DOI 10.7554/eLife.02866; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Jeske O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8116; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Mahat R, 2015, J BACTERIOL; MARKHAM R, 1963, VIROLOGY, V20, P88, DOI 10.1016/0042-6822(63)90143-0; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McInerney JO, 2011, BIOESSAYS, V33, P810, DOI 10.1002/bies.201100045; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Sagulenko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091344; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; SCHMIDT JM, 1978, CURR MICROBIOL, V1, P65, DOI 10.1007/BF02605417; Speth DR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00304; STACKEBRANDT E, 1986, FEMS MICROBIOL LETT, V37, P289, DOI 10.1016/0378-1097(86)90421-0; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; STRAMBIODECASTILLIA C, 1995, J CELL BIOL, V131, P19, DOI 10.1083/jcb.131.1.19; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; van Teeseling MCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7878; Voigt B, 2012, PROTEOMICS, V12, P1781, DOI 10.1002/pmic.201100512; Wang J, 2002, APPL ENVIRON MICROB, V68, P417, DOI 10.1128/AEM.68.1.417-422.2002; WARD N, 2004, PROKARYOTES EVOLVING; Williams TA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0336; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169432	10.1371/journal.pone.0169432	http://dx.doi.org/10.1371/journal.pone.0169432			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146565	gold, Green Published, Green Submitted			2022-12-26	WOS:000396131700008
J	Xue, B; Shao, YY; Saunders, RMK; Tan, YH				Xue, Bine; Shao, Yun-Yun; Saunders, Richard M. K.; Tan, Yun-Hong			Alphonsea glandulosa (Annonaceae), a New Species from Yunnan, China	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC SUPPORT; POLLINATION; FITZALANIA; EVOLUTION; INFERENCE; REVISION; MEIOGYNE; MRBAYES; FAMILY; GENERA	Alphonsea glandulosa sp. nov. is described from Yunnan Province in south-west China. It is easily distinguished from all previously described Alphonsea species by the possession of glandular tissue at the base of the adaxial surface of the inner petals. Nectar was observed throughout the flowering period, including the pistillate phase and subsequent staminate phase. Small curculionid beetles were observed as floral visitors and are inferred to be effective pollinators since they carry pollen grains. A phylogenetic analysis was conducted to confirm the placement of this new species within Alphonsea and the evolution of the inner petal glands and specialized pollinator reward tissues throughout the family.	[Xue, Bine; Shao, Yun-Yun] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Xue, Bine; Shao, Yun-Yun] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Shao, Yun-Yun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Tan, Yun-Hong] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Tan, Yun-Hong] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Nay Pyi Taw, Myanmar	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Hong Kong; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Tan, YH (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	xuebine@scib.ac.cn; tyh@xtbg.org.cn	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761; Xue, Bine/0000-0002-4515-4316	National Natural Science Foundation of China [31400199]; special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research [201207002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research	Financial support was provided by a grant from National Natural Science Foundation of China (www.nstc.gov.cn; grant no. 31400199) awarded to Bine Xue, and a special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research (http://www.zyzypc.com.cn/; grant no. 201207002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abedini M, 2013, PLANT SPEC BIOL, V28, P185, DOI 10.1111/j.1442-1984.2012.00371.x; Ban NT, 2000, FLORA VIETNAM, V1, P5; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Chaowasku T, 2013, EUR J TAXON, V64, DOI 10.5852/ejt.2013.64; Chaowasku T, 2013, NORD J BOT, V31, P680, DOI 10.1111/j.1756-1051.2012.01785.x; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2010, GENEIOUS V5 1; Durkee L. T., 1983, The biology of nectaries, P1; Erkens RHJ, 2014, TAXON, V63, P1244, DOI 10.12705/636.34; Finet A, 1906, BULLETIN DE LA SOCIE, V4, P164; Finet A, 1907, FLORE GENERALE DE LI, P123; Fu L.G., 1992, CHINA PLANT RED DATA, V1; Guo X, 2014, J SYST EVOL, V52, P1, DOI 10.1111/jse.12064; Hooker JD, 1872, THE FLORA OF BRITISH, V1, P90; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST CATEGO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KESSLER PJA, 1990, BLUMEA, V34, P505; KESSLER PJA, 1988, BLUMEA, V33, P1; Kessler PJA., 1995, BOT JB SYST, V118, P81; Li, 1979, FLORA REIPUBLICAE PO, V30, P10; Li PT, 2011, FLORA CHINA, V19, P672; Maas PJM, 2003, FLORA NEOTROPICA MON, V88, P1, DOI DOI 10.2307/4393920; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; McNeill J, 2012, REGNUM VEG, V154, P1; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller MA, 2011, P 2011 TERAGRID C EX, P41, DOI DOI 10.1145/2016741.2016785; Mols JB, 2004, AM J BOT, V91, P590, DOI 10.3732/ajb.91.4.590; Mols JB, 2003, BLUMEA, V48, P421; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Murray N.A., 1993, SYSTEMATIC BOT MONOG, V40, P89, DOI [10.2307/25027830, DOI 10.2307/25027830]; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; NORMAN EM, 1986, B TORREY BOT CLUB, V113, P16, DOI 10.2307/2996229; Nylander JAA., 2004, MRMODELTEST 2 2; Okada Hiroshi, 1996, Acta Phytotaxonomica et Geobotanica, V47, P1; OLESEN JM, 1992, FLORA, V187, P9; Pang CC, 2014, BOT J LINN SOC, V174, P93, DOI 10.1111/boj.12118; Pang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059951; Pierre, 1881, FLORE FORESTIERE DE, V16; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Su Y.C.F., 2006, SYSTEMATIC BOT MONOG, V79, P1; Thiers B., 2015, NEW YORK BOTANICAL G; Thomas DC, 2012, TAXON, V61, P559, DOI 10.1002/tax.613006; Turner IM, 2015, BLUMEA, V59, P206, DOI 10.3767/000651915X688443; Turner I. M., 2009, Gardens' Bulletin (Singapore), V61, P185; van Heusden ECH, 1992, BLUMEA, P1, DOI DOI 10.1111/J.1756-1051.1993.TB00089.X; van Zuilen CM, 1996, THESIS; Westra LYT, 2012, PHYTOKEYS, V12, P1, DOI 10.3897/phytokeys.12.2771; WESTRA LYT, 1985, P K NED AKAD C BIOL, V88, P449; Xu J, 2012, ECOL INDIC, V36, P749; Xue B, 2014, SYST BOT, V39, P396, DOI 10.1600/036364414X680825; Xue B, 2012, TAXON, V61, P1021, DOI 10.1002/tax.615009; Zhou LL, 2009, SYST BIODIVERS, V7, P249, DOI 10.1017/S1477200009003028	57	9	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170107	10.1371/journal.pone.0170107	http://dx.doi.org/10.1371/journal.pone.0170107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146564	gold, Green Published, Green Submitted			2022-12-26	WOS:000396131700013
J	Da, CJ; Li, F; Shen, BL; Yan, PC; Song, J; Ma, DS				Da, ChaoJiu; Li, Fang; Shen, BingLu; Yan, PengCheng; Song, Jian; Ma, DeShan			Detection of a sudden change of the field time series based on the Lorenz system	PLOS ONE			English	Article							DYNAMIC-MODEL; PRECIPITATION; ALGORITHM; PACIFIC; CHINA; DELAY; FLOW	We conducted an exploratory study of the detection of a sudden change of the field time series based on the numerical solution of the Lorenz system. First, the time when the Lorenz path jumped between the regions on the left and right of the equilibrium point of the Lorenz system was quantitatively marked and the sudden change time of the Lorenz system was obtained. Second, the numerical solution of the Lorenz system was regarded as a vector; thus, this solution could be considered as a vector time series. We transformed the vector time series into a time series using the vector inner product, considering the geometric and topological features of the Lorenz system path. Third, the sudden change of the resulting time series was detected using the sliding t-test method. Comparing the test results with the quantitatively marked time indicated that the method could detect every sudden change of the Lorenz path, thus the method is effective. Finally, we used the method to detect the sudden change of the pressure field time series and temperature field time series, and obtained good results for both series, which indicates that the method can apply to high-dimension vector time series. Mathematically, there is no essential difference between the field time series and vector time series; thus, we provide a new method for the detection of the sudden change of the field time series.	[Da, ChaoJiu; Li, Fang; Ma, DeShan] Northwest Univ Nationalities, Sch Math, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu; Li, Fang; Ma, DeShan] Northwest Univ Nationalities, Inst Comp Sci, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu] Lanzhou Univ, Coll Atmospher Sci, Lanzhou, Gansu, Peoples R China; [Shen, BingLu] Chengdu Univ Informat Technol, Coll Atmospher Sci, Chengdu, Sichuan, Peoples R China; [Yan, PengCheng] CMA, Inst Arid Meteorol, Lanzhou, Gansu, Peoples R China; [Song, Jian] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Northwest Minzu University; Northwest Minzu University; Lanzhou University; Chengdu University of Information Technology; China Meteorological Administration; Inner Mongolia University of Technology	Da, CJ (corresponding author), Northwest Univ Nationalities, Sch Math, Lanzhou, Gansu, Peoples R China.; Da, CJ (corresponding author), Northwest Univ Nationalities, Inst Comp Sci, Lanzhou, Gansu, Peoples R China.; Da, CJ (corresponding author), Lanzhou Univ, Coll Atmospher Sci, Lanzhou, Gansu, Peoples R China.	jtdcj@163.com		Da, ChaoJiu/0000-0003-3171-704X	National Natural Science Foundation of China [41465002, 41530531]; National Basic Research Program of China [2013CB430204]; Science Research Project of the Inner Mongolian Autonomous Region high school [NJZY16006]; Fundamental Research Funds for the Central Universities China [Yxm2015179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Research Project of the Inner Mongolian Autonomous Region high school; Fundamental Research Funds for the Central Universities China(Fundamental Research Funds for the Central Universities)	This project was supported by the National Natural Science Foundation of China (Grant Nos. 41465002, 41530531), the National Basic Research Program of China (Grant No. 2013CB430204), the Science Research Project of the Inner Mongolian Autonomous Region high school (Grant No. NJZY16006) and the Fundamental Research Funds for the Central Universities China (Grant No. Yxm2015179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Project Supported by the National Natural Science Foundation of China (Grant Nos. 41465002, 41530531), the National Basic Research Program of China (Grant No. 2013CB430204), the Science Research Project of the Inner Mongolian Autonomous Region high school (Grant No.NJZY16006) and the Fundamental Research Funds for the Central Universities China (Grant No. Yxm2015179).	Arnol'd V. I., 1992, GEOMETRICAL METHODS; CHARNEY JG, 1979, J ATMOS SCI, V36, P1205, DOI 10.1175/1520-0469(1979)036<1205:MFEITA>2.0.CO;2; Da CJ, 2014, ACTA PHYS SIN-CH ED, V63, DOI 10.7498/aps.63.029201; Daniell P.J, 1953, LECT CAUCHYS PROBLEM; Feng G L, 1999, Q J APPL METEOROL, V10, P470; Feng GL, 2001, ACTA PHYS SIN-CH ED, V50, P606, DOI 10.7498/aps.50.606; Feng GL, 2013, SCI CHINA EARTH SCI, V56, P1576, DOI 10.1007/s11430-012-4527-8; Fu Z B, 1992, CHINESE J ATMOSPHERI, V16, P482; Gong ZQ, 2006, ACTA PHYS SIN-CH ED, V55, P3180, DOI 10.7498/aps.55.3180; Gong ZQ, 2016, WEATHER FORECAST, V31, P1381, DOI 10.1175/WAF-D-16-0007.1; Gong ZQ, 2006, ACTA PHYS SIN-CH ED, V55, P477, DOI 10.7498/aps.55.477; Hou W, 2006, ACTA PHYS SIN-CH ED, V55, P2663, DOI 10.7498/aps.55.2663; Huang JP, 1996, J ATMOS SCI, V53, P370, DOI 10.1175/1520-0469(1996)053<0370:CSAOFI>2.0.CO;2; HUANG JP, 1992, SCI CHINA SER B, V35, P207; HUANG JP, 1993, Q J ROY METEOR SOC, V119, P547, DOI 10.1002/qj.49711951111; HUANG JP, 1991, SCI CHINA SER B, V34, P1246; Jianping Huang, 1991, SCI CHINA SER B, V34, P331; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; [沈柏竹 Shen Baizhu], 2015, [地理科学, Scientia Geographica Sinica], V35, P1299; Shen Baizhu, 2011, Acta Meteorologica Sinica, V69, P320; Sun GQ, 2016, PHYS LIFE REV, V08; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Thom R., 1974, POETICS, V3, P7, DOI [10.1016/0304-422X(74)90010-2., DOI 10.1016/0304-422X(74)90010-2]; Trenberth K E, 1990, B AM METEOROLOGICAL, V71, P377; Wei F, 2008, MODERN CLIMATIC STAT; Wu YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26470; Wu YP, 2015, APPL MATH COMPUT, V268, P478, DOI 10.1016/j.amc.2015.06.059; [颜鹏程 Yan Pengcheng], 2014, [大气科学, Chinese Journal of Atmospheric Sciences], V38, P861; Ye D Z, 1958, ACTA METEOROLOGICA S, V29, P249; Yi Lian, 2010, CHINESE J ATMOSPHERI, V34, P429; Zeeman E C., 1975, CATASTROPHE THEORY R; Zheng ZH, 2009, ACTA PHYS SIN-CH ED, V58, P7359, DOI 10.7498/aps.58.7359; Zhi R, 2006, ACTA PHYS SIN-CH ED, V55, P6185, DOI 10.7498/aps.55.6185	39	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170720	10.1371/journal.pone.0170720	http://dx.doi.org/10.1371/journal.pone.0170720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141832	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500015
J	Shevchouk, OT; Ball, GF; Cornil, CA; Balthazart, J				Shevchouk, Olesya T.; Ball, Gregory F.; Cornil, Charlotte A.; Balthazart, Jacques			Studies of HVC Plasticity in Adult Canaries Reveal Social Effects and Sex Differences as Well as Limitations of Multiple Markers Available to Assess Adult Neurogenesis	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; SONG-CONTROL-SYSTEM; HIGH VOCAL CENTER; SINGING BEHAVIOR; CELL-PROLIFERATION; CONTROL NUCLEI; AROMATASE-ACTIVITY; BRAIN AROMATASE; ACUTE STRESS; NEURONS	In songbirds, neurogenesis in the song control nucleus HVC is sensitive to the hormonal and social environment but the dynamics of this process is difficult to assess with a single exogenous marker of new neurons. We simultaneously used three independent markers to investigate HVC neurogenesis in male and female canaries. Males were castrated, implanted with testosterone and housed either alone (M), with a female (M-F) or with another male (M-M) while females were implanted with 17 beta-estradiol and housed with a male (F-M). All subjects received injections of the two thymidine analogues, BrdU and of EdU, respectively 21 and 10 days before brain collection. Cells containing BrdU or EdU or expressing doublecortin (DCX), which labels newborn neurons, were quantified. Social context and sex differentially affected total BrdU(+), EdU(+), BrdU(+) EdU(-) and DCX+ populations. M-M males had a higher density of BrdU(+) cells in the ventricular zone adjacent to HVC and of EdU(+) in HVC than M-F males. M birds had a higher ratio of BrdU(+) EdU(-) to EdU(+) cells than M-F subjects suggesting higher survival of newer neurons in the former group. Total number of HVC DCX+ cells was lower in M-F than in M-M males. Sex differences were also dependent of the type of marker used. Several technical limitations associated with the use of these multiple markers were also identified. These results indicate that proliferation, recruitment and survival of new neurons can be independently affected by environmental conditions and effects can only be fully discerned through the use of multiple neurogenesis markers.	[Shevchouk, Olesya T.; Cornil, Charlotte A.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	University of Liege; University System of Maryland; University of Maryland College Park	Balthazart, J (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	jbalthazart@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019; Shevchouk, Olesya/AAB-9955-2022; Balthazart, Jacques/H-6865-2019	Cornil, Charlotte Anne/0000-0002-5536-7753; Shevchouk, Olesya/0000-0003-1870-5749; Balthazart, Jacques/0000-0001-9492-2126; Ball, Gregory/0000-0002-4784-0520	National Institutes of Health/National, Institute of Neurological Disorders and Stroke [R01 35467]; Belgian Science Policy [SSTC IAP P7/17]	National Institutes of Health/National, Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Belgian Science Policy(Belgian Federal Science Policy Office)	Support was provided by: 1) National Institutes of Health/National, Institute of Neurological Disorders and Stroke - Grant R01 35467- to GFB and JB [http://www.ninds.nih.gov/]; 2) Belgian Science Policy - Grant SSTC IAP P7/17 to JB and CAC [http://belspo.be/belspo/index fr.stm]; 3) F.R.S.-FNRS Research Associate to CAC [http://www.fnrs.be/].; This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (Grant R01 35467) to G.F.B. and J.B. and Grant SSTC IAP P7/17 from the Belgian Science Policy (to J.B. and C.A.C.). C.A.C. is F.R.S.-FNRS Research Associate.	Adar E, 2008, BEHAV BRAIN RES, V187, P178, DOI 10.1016/j.bbr.2007.09.011; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Alvarez-Borda B, 2002, J NEUROSCI, V22, P8684; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Alward BA, 2014, EUR J NEUROSCI, V40, P2941, DOI 10.1111/ejn.12658; Alward BA, 2013, P NATL ACAD SCI USA, V110, P19573, DOI 10.1073/pnas.1311371110; Amy M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140196; Appeltants D, 2003, NEUROSCIENCE, V121, P801, DOI 10.1016/S0306-4522(03)00496-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Ball Gregory F., 2002, P649; Balthazart J, 2008, EUR J NEUROSCI, V27, P801, DOI 10.1111/j.1460-9568.2008.06059.x; Balthazart J, 2016, FRONT NEUROENDOCRIN, V41, P3, DOI 10.1016/j.yfrne.2016.03.003; Balthazart J, 2014, J COMP NEUROL, V522, P4100, DOI 10.1002/cne.23661; Balthazart J, 2014, BRAIN BEHAV EVOLUT, V84, P1, DOI 10.1159/000362917; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Barker JM, 2014, J CHEM NEUROANAT, V55, P1, DOI 10.1016/j.jchemneu.2013.10.005; Barker JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058826; Barker JM, 2012, FENS M BARC SP; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Boseret G, 2007, J CHEM NEUROANAT, V33, P140, DOI 10.1016/j.jchemneu.2007.02.002; Boseret G, 2006, J NEUROBIOL, V66, P1044, DOI 10.1002/neu.20268; Brenowitz EA, 2015, COLD SPRING HARB PER, V7, P1; BRENOWITZ EA, 2008, NEUROSCIENCE BIRDSON, P332; BROWN SD, 1993, J NEUROSCI, V13, P2024; CATCHPOLE CK, 1973, BEHAVIOUR, V46, P300, DOI 10.1163/156853973X00067; Cattan A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126078; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418064; Chen Z, 2013, NEUROSCIENCE, V239, P139, DOI 10.1016/j.neuroscience.2012.12.043; CUTHILL I, 1985, ANIM BEHAV, V33, P326, DOI 10.1016/S0003-3472(85)80146-9; de Bournonville C, 2016, HORM BEHAV, V83, P45, DOI 10.1016/j.yhbeh.2016.05.011; de Bournonville C, 2013, PSYCHONEUROENDOCRINO, V38, P789, DOI 10.1016/j.psyneuen.2012.09.001; DELVILLE Y, 1984, GEN COMP ENDOCR, V55, P295, DOI 10.1016/0016-6480(84)90115-1; Dickens MJ, 2014, HORM BEHAV, V65, P154, DOI 10.1016/j.yhbeh.2013.12.011; Dickens MJ, 2013, J NEUROENDOCRINOL, V25, P329, DOI 10.1111/jne.12012; Dickens MJ, 2012, J NEUROENDOCRINOL, V24, P1322, DOI 10.1111/j.1365-2826.2012.02340.x; Dickens MJ, 2011, ENDOCRINOLOGY, V152, P4242, DOI 10.1210/en.2011-1341; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GORDONWEEKS PR, 1991, J CELL SCI, P45; GOULD E, 1992, J NEUROSCI, V12, P3642; Guigueno MF, 2016, DEV NEUROBIOL, V76, P1226, DOI 10.1002/dneu.22385; Hall ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040060; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; HINDE RA, 1976, HORM BEHAV, V7, P293, DOI 10.1016/0018-506X(76)90035-0; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Katz A, 2008, EUR J NEUROSCI, V28, P99, DOI 10.1111/j.1460-9568.2008.06303.x; Kirn JR, 1999, J COMP NEUROL, V411, P487; KREBS JR, 1981, ANIM BEHAV, V29, P635, DOI 10.1016/S0003-3472(81)80134-0; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; Larson TA, 2013, P NATL ACAD SCI USA, V110, P16640, DOI 10.1073/pnas.1310237110; LEBOUCHER G, 1994, ETHOLOGY, V97, P190; Leitner S, 2007, DEV NEUROBIOL, V67, P1478, DOI 10.1002/dneu.20521; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Liboska R, 2012, PLOS ONE, V7, P1; Lipkind D, 2002, BEHAV BRAIN RES, V133, P31, DOI 10.1016/S0166-4328(01)00416-8; Llorens-Martin M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00076; Madison FN, 2015, GEN COMP ENDOCR, V215, P61, DOI 10.1016/j.ygcen.2014.09.008; MOORE MC, 1983, J ZOOL, V199, P137, DOI 10.1111/j.1469-7998.1983.tb02085.x; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; MORTON ML, 1985, COMP BIOCHEM PHYS A, V80, P93, DOI 10.1016/0300-9629(85)90684-X; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Perfito N, 2015, ENDOCRINOLOGY, V156, P694, DOI 10.1210/en.2014-1450; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sartor JJ, 2005, HORM BEHAV, V47, P467, DOI 10.1016/j.yhbeh.2004.12.004; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; Stevenson TJ, 2008, GEN COMP ENDOCR, V156, P385, DOI 10.1016/j.ygcen.2008.01.015; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Vellema M, 2014, BRAIN BEHAV EVOLUT, V84, P5, DOI 10.1159/000363125; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Vermeulen A, 2016, BEHAV ECOL SOCIOBIOL, V70, P585, DOI 10.1007/s00265-016-2077-3; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yamamura T, 2011, J NEUROSCI, V31, P9649, DOI 10.1523/JNEUROSCI.0088-11.2011; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	91	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170938	10.1371/journal.pone.0170938	http://dx.doi.org/10.1371/journal.pone.0170938			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141859	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500029
J	Hair, PS; Sass, LA; Krishna, NK; Cunnion, KM				Hair, Pamela S.; Sass, Laura A.; Krishna, Neel K.; Cunnion, Kenji M.			Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)	PLOS ONE			English	Article							ASTROVIRUS COAT PROTEIN; CLASSICAL PATHWAY; ACTIVATION; OXIDANTS; MARKERS	Myeloperoxidase is the major peroxidase enzyme in neutrophil granules and implicated in contributing to inflammatory lung damage in cystic fibrosis. Free myeloperoxidase is present in cystic fibrosis lung fluid and generates hypochlorous acid. Here we report a new inhibitor of myeloperoxidase activity, Peptide Inhibitor of Complement C1 (PIC1). Using TMB as the oxidizing substrate, PIC1 inhibited myeloperoxidase activity in cystic fibrosis sputum soluble fractions by an average of a 3.4-fold decrease (P = 0.02). PIC1 also dose-dependently inhibited myeloperoxidase activity in a neutrophil lysate or purified myeloperoxidase by up to 28 fold (P < 0.001). PIC1 inhibited myeloperoxidase activity similarly, on a molar basis, as the specific myeloperoxidase inhibitor 4-Aminobenzoic acid hydrazide (ABAH) for various oxidizing substrates. PIC1 was able to protect the heme ring of myeloperoxidase from destruction by NaOCI, assayed by spectral analysis. PIC1 incubated with oxidized TMB reversed the oxidation state of TMB, as measured by absorbance at 450 nm, with a 20-fold reduction in oxidized TMB (P = 0.02). This result was consistent with an antioxidant mechanism for PIC1. In summary, PIC1 inhibits the peroxidase activity of myeloperoxidase in CF sputum likely via an antioxidant mechanism.	[Hair, Pamela S.; Sass, Laura A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sass, Laura A.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Sass, Laura A.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	cunniokm@evms.edu		Cunnion, Kenji/0000-0001-8604-348X				Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Carlin JB, 2001, J PAEDIATR CHILD H, V37, P72, DOI 10.1046/j.1440-1754.2001.00634.x; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Fong Siew Wai, 2015, BMC Res Notes, V8, P679, DOI 10.1186/s13104-015-1677-8; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hasmann A, 2013, ANN CLIN BIOCHEM, V50, P245, DOI 10.1258/acb.2011.010249; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kato Y, 2016, J CLIN BIOCHEM NUTR, V58, P99, DOI 10.3164/jcbn.15-104; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Kim JS, 2006, CHEST, V129, P1148, DOI 10.1378/chest.129.5.1148; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Kumar PS, 2016, TRANSFUSION, V56, P2133, DOI 10.1111/trf.13674; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; MOHAMMED JR, 1988, J LAB CLIN MED, V112, P711; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Ruiz-Delgado GJ, 2009, ACTA HAEMATOL-BASEL, V122, P1, DOI 10.1159/000227267; Sass LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144723; SCHIOTZ PO, 1979, ACTA PATH MICRO IM C, V87, P1; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; Vasu VT, 2011, FREE RADICAL RES, V45, P165, DOI 10.3109/10715762.2010.521154; WITKOSARSAT V, 1995, AM J RESP CRIT CARE, V152, P1910, DOI 10.1164/ajrccm.152.6.8520754	31	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170203	10.1371/journal.pone.0170203	http://dx.doi.org/10.1371/journal.pone.0170203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135312	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700011
J	Liu, PC; Lu, G; Deng, Y; Wang, CD; Su, XW; Zhou, JY; Chan, TM; Hu, X; Poon, WS				Liu, Pi Chu; Lu, Gang; Deng, Yi; Wang, Cheng Dong; Su, Xian Wei; Zhou, Jing Ye; Chan, Tat Ming; Hu, Xiang; Poon, Wai Sang			Inhibition of NF-kappa B Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; HUMAN HEPATOMA-CELLS; BREAST-CANCER; DEATH RECEPTORS; MEDIATED APOPTOSIS; UP-REGULATION; EXPRESSION; RESISTANCE; PROTEIN; PROLIFERATION	Glioblastoma is a common malignant brain tumor and it is refractory to therapy because it usually contains a mixture of cell types. The tumor necrosis factor-related apoptosis inducing ligand (TRAIL) has been shown to induce apoptosis in a range of tumor cell types. Previously, we found that two human glioblastoma cell lines are resistant to TRAIL, while lovastatin sensitizes these glioblastoma cells to TRAIL-induced cell death. In this study, we investigated the mechanisms underlying the TRAIL-induced apoptosis in human glioblastoma cell lines by lovastatin. Furthermore, we have confirmed the anti-tumor effect of combination therapy with lovastatin and TRAIL in the subcutaneous brain tumor model. We showed that lovastatin significantly up-regulated the expression of death receptor 5 (DR5) in glioblastoma cell lines as well as in tumor-bearing mice with peri-tumoral administration of lovastatin. Further study in glioblastoma cell lines suggested that lovastatin treatment could inhibit NF-kappa B and Erk/MAPK pathways but activates JNK pathway. These results suggest that lovastatin sensitizes TRAIL-induced apoptosis by up-regulation of DR5 level via NF-kappa B inactivation, but also directly induces apoptosis by dysregulation of MAPK pathway. Our in vivo study showed that local peri-tumoral co-injection of lovastatin and TRAIL substantially reduced tumor growth compared with single injection of lovastatin or TRAIL in subcutaneous nude mice model. This study suggests that combined treatment of lovastatin and TRAIL is a promising therapeutic strategy to TRAIL-resistant glioblastoma.	[Liu, Pi Chu; Lu, Gang; Wang, Cheng Dong; Su, Xian Wei; Zhou, Jing Ye; Chan, Tat Ming; Poon, Wai Sang] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Hu, Xiang] Shenzhen Beike Cell Engn Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Southern University of Science & Technology	Poon, WS (corresponding author), Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Poon, Wai S/HGD-3084-2022	Wang, Chengdong/0000-0001-9891-8765	Hong Kong Government Innovation and Technology Fund [GHX/005/11SZ]	Hong Kong Government Innovation and Technology Fund	This work was partly supported by the Hong Kong Government Innovation and Technology Fund (http://www.itc.gov.hk/en/welcome.htm) with the grant number GHX/005/11SZ to WSP, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Bjarnadottir O, 2013, BREAST CANCER RES TR, V138, P499, DOI 10.1007/s10549-013-2473-6; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chan DYL, 2008, J NEURO-ONCOL, V86, P273, DOI 10.1007/s11060-007-9475-3; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Cimini Annamaria, 2011, ISRN Oncol, V2011, P787490, DOI 10.5402/2011/787490; Di Matola T, 2001, EUR J ENDOCRINOL, V145, P645, DOI 10.1530/eje.0.1450645; Dorsey JF, 2009, MOL CANCER THER, V8, P3285, DOI 10.1158/1535-7163.MCT-09-0415; Eggert A, 2001, CANCER RES, V61, P1314; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; French LE, 2003, CELL DEATH DIFFER, V10, P117, DOI 10.1038/sj.cdd.4401185; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Higgins MJ, 2012, BREAST CANCER RES TR, V131, P915, DOI 10.1007/s10549-011-1858-7; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hus M, 2011, ANN HEMATOL, V90, P1161, DOI 10.1007/s00277-011-1276-2; Jane EP, 2011, MOL CANCER THER, V10, P198, DOI 10.1158/1535-7163.MCT-10-0725; Johnson MD, 2002, J NEURO-ONCOL, V56, P133, DOI 10.1023/A:1014588214966; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Klawitter J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2485; Larner J, 1998, AM J CLIN ONCOL-CANC, V21, P579, DOI 10.1097/00000421-199812000-00010; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lee J, 2014, INVEST NEW DRUG, V32, P535, DOI 10.1007/s10637-014-0065-x; Liang SL, 2006, J IMMUNOL, V177, P651, DOI 10.4049/jimmunol.177.1.651; Liu HL, 2009, CANCER CHEMOTH PHARM, V63, P997, DOI 10.1007/s00280-008-0830-7; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Weller M, 2010, NEURO-ONCOLOGY, V12, P319, DOI 10.1093/neuonc/noq027; Yao J, 2015, ONCOL REP, V34, P2011, DOI 10.3892/or.2015.4153; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	37	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171157	10.1371/journal.pone.0171157	http://dx.doi.org/10.1371/journal.pone.0171157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135339	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700053
J	Ji, C; Guo, HD; Jin, SQ; Yang, J				Ji, Chen; Guo, Hongdong; Jin, Songqing; Yang, Jin			Outsourcing Agricultural Production: Evidence from Rice Farmers in Zhejiang Province	PLOS ONE			English	Article								China has recorded positive growth rates of grain production for the past eleven consecutive years. This is a remarkable accomplishment given that China's rapid industrialization and urbanization has led to a vast reduction of arable land and agricultural labor to non-agricultural sectors. While there are many factors contributing to this happy outcome, one potential contributing factor that has received increasing attention is the emergence of agricultural production outsourcing, a new rural institution that has emerged in recent years. This study aims to contribute to the limited but growing literature on agricultural production outsourcing in China. Specifically, this study analyzes factors affecting farmers' decisions to outsource any or some production tasks using data from rice farmers in Zhejiang province. Results from a logistic model show that farm size and government subsidy encourages farmers to outsource while ownership of agricultural machines and land fragmentation have negative effects on farmers' decisions to outsource production tasks. Results also showed that determinants of outsourcing decisions vary with the production tasks that farmers outsourced.	[Ji, Chen; Guo, Hongdong; Jin, Songqing] Zhejiang Univ, China Acad Rural Dev, Hangzhou, Zhejiang, Peoples R China; [Jin, Songqing] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA; [Yang, Jin] Huazhong Univ Technol & Sci, Dept Econ, Sch Econ, Wuhan, Hubei, Peoples R China	Zhejiang University; Michigan State University; Huazhong University of Science & Technology	Yang, J (corresponding author), Huazhong Univ Technol & Sci, Dept Econ, Sch Econ, Wuhan, Hubei, Peoples R China.	yangjin8849@163.com	Jin, Songqing/W-4340-2019	Jin, Songqing/0000-0001-8514-7930	National Science Foundation of China (NSFC) [71473218, 71333011]; Michigan State University's AgBioResearch; Fundamental Research Funds for the Central Universities, HUST [2016AB006]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Michigan State University's AgBioResearch; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Guo acknowledges funding support from the National Science Foundation of China (NSFC) (No. 71473218 and & No. 71333011). Jin gratefully acknowledges support from Michigan State University's AgBioResearch. Yang acknowledges funding support from the Fundamental Research Funds for the Central Universities, HUST: 2016AB006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CHINAS GRAIN IND RES; Azadi H, 2013, GLOBAL PLANET CHANGE, V100, P20, DOI 10.1016/j.gloplacha.2012.10.002; Carter CA, 2012, APPL ECON PERSPECT P, V34, P1, DOI 10.1093/aepp/ppr047; FOSTER A. D., 2011, ARE INDIAN FAR UNPUB; Huang JK, 2010, AGR ECON-BLACKWELL, V41, P47, DOI 10.1111/j.1574-0862.2010.00487.x; Jin SQ, 2010, J PROD ANAL, V33, P191, DOI 10.1007/s11123-009-0145-7; Jin SQ, 2009, J COMP ECON, V37, P629, DOI 10.1016/j.jce.2009.04.005; Li YQ, 2015, J AGR MANAGEMENT I M, V18, P17; Liao X, 2011, ISSUES AGR EC, V12, P12; Liu Y, 2016, 01525 IFPRI; NBSC, 2011, REL 6 NAT CENS DAT C; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Teklemariam D, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030213; Vandergeten E, 2016, LANDSCAPE ECOL, V31, P1395, DOI 10.1007/s10980-016-0365-y; Wang ZG, 2011, CHINA AGR EC, V9, P4; Yang J, 2013, AM J AGR ECON, V95, P1245, DOI 10.1093/ajae/aat027; Yu WuSheng, 2010, Journal of Agricultural Economics, V61, P343, DOI 10.1111/j.1477-9552.2010.00242.x; Yu XH, 2009, FRONT ECON CHINA, V4, P633, DOI 10.1007/s11459-009-0034-y; Zhan J., 2016, J NANJING AGR U, V16, P117; Zhang X. B., 2015, IFPRI - Discussion Papers; Zhang XD, 2011, J SYST ENG ELECTRON, V22, P22, DOI 10.3969/j.issn.1004-4132.2011.01.003; Zhang YJ, 2011, AGR ECON-BLACKWELL, V42, P495, DOI 10.1111/j.1574-0862.2010.00532.x	22	25	26	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170861	10.1371/journal.pone.0170861	http://dx.doi.org/10.1371/journal.pone.0170861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129362	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400030
J	Moiroux, N; Chandre, F; Hougard, JM; Corbel, V; Pennetier, C				Moiroux, Nicolas; Chandre, Fabrice; Hougard, Jean-Marc; Corbel, Vincent; Pennetier, Cedric			Remote Effect of Insecticide-Treated Nets and the Personal Protection against Malaria Mosquito Bites	PLOS ONE			English	Article							HUMAN SKIN EMANATIONS; ANOPHELES-GAMBIAE; BED NETS; AEDES-ALBOPICTUS; KDR MUTATION; VECTORS; FIELD; BEDNETS; TRANSMISSION; PREVENTION	Experimental huts are part of the WHO process for testing and evaluation of Insecticide Treated Nets (ITN) in semi-field conditions. Experimental Hut Trials (EHTs) mostly focus on two main indicators (i.e., mortality and blood feeding reduction) that serve as efficacy criteria to obtain WHO interim recommendation. However, several other outputs that rely on counts of vectors collected in the huts are neglected although they can give useful information about vectors' behavior and personal protection provided by ITNs. In particular, EHTs allow to measure the deterrent effect and personal protection of ITNs. To provide a better assessment of ITNs efficacy, we performed a retrospective analysis of the deterrence and the personal protection against malaria transmission for 12 unwashed and 13 washed ITNs evaluated through EHTs conducted in West Africa. A significant deterrent effect was shown for six of the 12 unwashed ITNs tested. When washed 20 times, only three ITNs had significant deterrent effect (Rate Ratios (RR)<1; p<0.05) and three showed an apparent "attractiveness" (RR> 1; p<0.01). When compared to the untreated net, all unwashed ITNs showed lower number of blood-fed Anopheles indicating a significant personal protection (RR<1, p<0.05). However, when washed 20 times, three ITNs that were found to be attractive did not significantly reduce human-vector contact (p>0.05). Current WHO efficacy criteria do not sufficiently take into account the deterrence effect of ITNs. Moreover, the deterrence variability is rarely discussed in EHT's reports. Our findings highlighted the long-range effect (deterrent or attractive) of ITNs that may have significant consequences for personal/ community protection against malaria transmission. Indicators measuring the deterrence should be further considered for the evaluation of ITNs.	[Moiroux, Nicolas; Chandre, Fabrice; Hougard, Jean-Marc; Corbel, Vincent; Pennetier, Cedric] Univ Montpellier, IRD, MIVEGEC, IRD 224,CNRS 5290, Montpellier, France; [Moiroux, Nicolas] IRSS, Bobo Dioulasso, Burkina Faso; [Pennetier, Cedric] IPR, Bouake, Cote Ivoire	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Moiroux, N (corresponding author), Univ Montpellier, IRD, MIVEGEC, IRD 224,CNRS 5290, Montpellier, France.; Moiroux, N (corresponding author), IRSS, Bobo Dioulasso, Burkina Faso.	nicolas.moiroux@ird.fr	Moiroux, Nicolas/AFT-2925-2022; Chandre, Fabrice/Q-3429-2019	Moiroux, Nicolas/0000-0001-6755-6167; Chandre, Fabrice/0000-0002-1994-9705; Pennetier, Cedric/0000-0002-3362-6371; corbel, vincent/0000-0003-0995-3257	WHO	WHO(World Health Organization)	Trials listed in Table 1 and used in the analysis received financial support from WHO. All authors are employed by Institut de Recherche pour le Developpement (IRD). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angioy AM, 2003, CHEM SENSES, V28, P279, DOI 10.1093/chemse/28.4.279; [Anonymous], 2010, R LANG ENV STAT COMP; BAKER TC, 1981, ENVIRON ENTOMOL, V10, P211, DOI 10.1093/ee/10.2.211; Barlow SM, 2001, FOOD CHEM TOXICOL, V39, P407, DOI 10.1016/S0278-6915(00)00152-6; Bhatt S, 2015, NATURE; Bomann W, 1995, BAYER PUBLIC HEALTH, V30, P5; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Clements AN., 1999, SENSORY RECEPTION BE; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Fanello C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P323; Guha L, 2014, PARASITOL RES, V113, P3781, DOI 10.1007/s00436-014-4044-0; Guyatt HL, 2002, TRENDS PARASITOL, V18, P12, DOI 10.1016/S1471-4922(01)02143-2; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Mutuku FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-46; Ngufor C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3270; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; Porciani A, 2016, BIORXIV; Seenivasagan T, 2014, PARASITOL RES, V113, P1927, DOI 10.1007/s00436-014-3840-x; Skaug H, 2012, GLMMADMB GEN LINEAR; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; WHO, 2005, WHOCDSWHOPESGCDPP200; WHO, 2011, GUID MON DUR LONG LA; WHO, 2008, 11 WHOPES WORK GROUP; WHO, 2013, WHOHTMNTDWHOPES20133, P89; WHO, 2014, WHOHTMGMPMPAC20145; WHO Pesticide Evaluation Scheme, 2009, 13 13 WHOPES WORK GR; WHO Pesticide Evaluation Scheme, 2012, 15 WHOPES WORK GROUP; WHO Pesticide Evaluation Scheme, 2011, 14 14 WHOPES WORK GR; WHO Pesticide Evaluation Scheme, 2007, 10 WHOPES WORK GROUP; WHO Pesticide Evaluation Scheme, 2009, 12 WHOPES WORK GROUP; World Health Organization, 2015, WORLD MAL REP 2015, P243; World Health Organization, 2012, GEN RISK ASS MOD INS; World Health Organization, 2016, WHO REC LONG LAST IN	48	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170732	10.1371/journal.pone.0170732	http://dx.doi.org/10.1371/journal.pone.0170732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129371	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400043
J	Murphy, CD; Roodvoets, MS; Austen, EJ; Dolan, A; Barnett, A; Campbell, DA				Murphy, Cole D.; Roodvoets, Mitchell S.; Austen, Emily J.; Dolan, Allison; Barnett, Audrey; Campbell, Douglas A.			Photoinactivation of Photosystem II in Prochlorococcus and Synechococcus	PLOS ONE			English	Article							ORANGE CAROTENOID PROTEIN; CHLOROPHYLL-A FLUORESCENCE; SINGLET OXYGEN PRODUCTION; PSBA GENE-EXPRESSION; ELECTRON-TRANSPORT; FLAVODIIRON PROTEINS; EXCITATION PRESSURE; ENERGY-DISSIPATION; ACTION SPECTRUM; UV-RADIATION	The marine picocyanobacteria Synechococcus and Prochlorococcus numerically dominate open ocean phytoplankton. Although evolutionarily related they are ecologically distinct, with different strategies to harvest, manage and exploit light. We grew representative strains of Synechococcus and Prochlorococcus and tracked their susceptibility to photoinactivation of Photosystem II under a range of light levels. As expected blue light provoked more rapid photoinactivation than did an equivalent level of red light. The previous growth light level altered the susceptibility of Synechococcus, but not Prochlorococcus, to this photoinactivation. We resolved a simple linear pattern when we expressed the yield of photoinactivation on the basis of photons delivered to Photosystem II photochemistry, plotted versus excitation pressure upon Photosystem II, the balance between excitation and downstream metabolism. A high excitation pressure increases the generation of reactive oxygen species, and thus increases the yield of photoinactivation of Photosystem II. Blue photons, however, retained a higher baseline photoinactivation across a wide range of excitation pressures. Our experiments thus uncovered the relative influences of the direct photoinactivation of Photosystem II by blue photons which dominates under low to moderate blue light, and photoinactivation as a side effect of reactive oxygen species which dominates under higher excitation pressure. Synechococcus enjoyed a positive metabolic return upon the repair or the synthesis of a Photosystem II, across the range of light levels we tested. In contrast Prochlorococcus only enjoyed a positive return upon synthesis of a Photosystem II up to 400 mu mol photons m(-2) s(-1). These differential cost-benefits probably underlie the distinct photoacclimation strategies of the species.	[Murphy, Cole D.; Roodvoets, Mitchell S.] Mt Allison Univ, Biochem & Chem, Sackville, NB, Canada; [Austen, Emily J.; Dolan, Allison; Campbell, Douglas A.] Mt Allison Univ, Biol, Sackville, NB, Canada; [Barnett, Audrey] Michigan Technol Univ, Houghton, MI 49931 USA	Mount Allison University; Mount Allison University; Michigan Technological University	Campbell, DA (corresponding author), Mt Allison Univ, Biol, Sackville, NB, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463; Austen, Emily/0000-0002-0087-1338	Canada Research Chair program; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; New Brunswick Foundation for Innovation; Mount Allison University; NSERC Canada	Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); New Brunswick Foundation for Innovation; Mount Allison University; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Canada Research Chair program (DC) and the Natural Sciences and Engineering Research Council of Canada (DC), using equipment funded by the Canada Foundation for Innovation and the New Brunswick Foundation for Innovation (DC). CM and MR were supported by summer fellowships from Mount Allison University. EA & AB were supported by NSERC Canada Engage funding to write PSIWORX-R scripts for extracting and analyzing chlorophyll fluorescence induction and relaxation parameters from data generated by PSI Fluorometers, with sponsorship from QuBit Systems, Kingston, Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyeva Y, 2013, P NATL ACAD SCI USA, V110, P4111, DOI 10.1073/pnas.1221194110; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; ANDERSSON B, 1992, J PHOTOCH PHOTOBIO B, V15, P15, DOI 10.1016/1011-1344(92)87003-R; Bachmann KM, 2004, FUNCT PLANT BIOL, V31, P803, DOI 10.1071/FP04022; Bagby SC, 2015, ISME J, V9, P2232, DOI 10.1038/ismej.2015.36; Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailey S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1410, DOI 10.1111/j.1751-1097.2008.00453.x; Behrenfeld MJ, 2002, MAR ECOL PROG SER, V228, P103, DOI 10.3354/meps228103; Bennett DIG, 2013, J AM CHEM SOC, V135, P9164, DOI 10.1021/ja403685a; Bersanini L, 2014, PLANT PHYSIOL, V164, P805, DOI 10.1104/pp.113.231969; Blot N, 2011, PLANT PHYSIOL, V156, P1934, DOI 10.1104/pp.111.174714; BORNMAN JF, 1989, J PHOTOCH PHOTOBIO B, V4, P145, DOI 10.1016/1011-1344(89)80001-6; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; Bruckner RC, 2003, BIOCHEMISTRY-US, V42, P10843, DOI 10.1021/bi034516h; Campbell D, 1999, PHYSIOL PLANTARUM, V105, P746, DOI 10.1034/j.1399-3054.1999.105420.x; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Campbell D, 1996, PHOTOSYNTH RES, V47, P131, DOI 10.1007/BF00016176; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Chow WS, 2012, PHOTOSYNTH RES, V113, P63, DOI 10.1007/s11120-012-9740-y; CRESPI JM, 1986, J STRUCT GEOL, V8, P799, DOI 10.1016/0191-8141(86)90026-X; Croce R, 2011, J PHOTOCH PHOTOBIO B, V104, P142, DOI 10.1016/j.jphotobiol.2011.02.015; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Elzhov TV, 2013, LM R INTERFACE LEVEN; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Finkel Z., 2007, LIGHT ABSORPTION SIZ, P1; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gomez-Baena G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003416; Gorbunov MY, 2011, BBA-BIOENERGETICS, V1807, P1591, DOI 10.1016/j.bbabio.2011.08.009; Grossman AR, 2010, J PHYCOL, V46, P629, DOI 10.1111/j.1529-8817.2010.00852.x; Hachiya T, 2007, PLANT CELL ENVIRON, V30, P1269, DOI 10.1111/j.1365-3040.2007.01701.x; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Herranen M, 2001, PHYSIOL PLANTARUM, V112, P531, DOI 10.1034/j.1399-3054.2001.1120410.x; HOFF AJ, 1981, Q REV BIOPHYS, V14, P599, DOI 10.1017/S0033583500002481; Huner GP, 1996, TRENDS PLANT SCI, V3, P224; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; JUNG J, 1990, PHOTOCHEM PHOTOBIOL, V52, P1003, DOI 10.1111/j.1751-1097.1990.tb01817.x; KATZ JJ, 1978, ANNU REV BIOPHYS BIO, V7, P393, DOI 10.1146/annurev.bb.07.060178.002141; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Kirilovsky D, 2015, PHOTOSYNTH RES, V126, P3, DOI 10.1007/s11120-014-0031-7; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LEY AC, 1982, BIOCHIM BIOPHYS ACTA, V680, P95, DOI 10.1016/0005-2728(82)90320-6; Li G, 2015, NEW PHYTOL, V205, P533, DOI 10.1111/nph.13037; Llabres M, 2006, LIMNOL OCEANOGR, V51, P21, DOI 10.4319/lo.2006.51.1.0021; Llabres M, 2010, AQUAT MICROB ECOL, V59, P151, DOI 10.3354/ame01392; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Mackey KRM, 2013, PLANT PHYSIOL, V163, P815, DOI 10.1104/pp.113.221937; MAUZERALL D, 1989, BIOCHIM BIOPHYS ACTA, V974, P119, DOI 10.1016/S0005-2728(89)80365-2; MAXWELL DP, 1995, PLANT PHYSIOL, V107, P687, DOI 10.1104/pp.107.3.687; MAYES SR, 1991, BIOCHIM BIOPHYS ACTA, V1060, P1, DOI 10.1016/S0005-2728(05)80112-4; Mella-Flores D, 2012, FRONT MICROBIOL, V3; Miyata K, 2012, PHOTOSYNTH RES, V113, P165, DOI 10.1007/s11120-012-9767-0; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murphy CD, 2017, LIMNOL OCEANOGR-METH, V15, P54, DOI 10.1002/lom3.10142; Mustila H, 2016, PLANT CELL PHYSIOL, V57, P1468, DOI 10.1093/pcp/pcw047; Neale PJ, 2014, BIOGEOSCIENCES, V11, P2883, DOI 10.5194/bg-11-2883-2014; Neale PJ, 2016, GLOBAL CHANGE BIOLOG; Ni G, 2016, PHOTOSYNTHESIS RES; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2014, APPL MICROBIOL BIOT, P1; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Noguchi K, 2001, PLANT CELL ENVIRON, V24, P831, DOI 10.1046/j.1365-3040.2001.00728.x; Not F, 2005, LATE SUMMER COMMUNIT; Oguchi R, 2011, PHYSIOL PLANTARUM, V142, P47, DOI 10.1111/j.1399-3054.2011.01452.x; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Oliver RL, 2003, J PLANKTON RES, V25, P1107, DOI 10.1093/plankt/25.9.1107; Oxborough K, 1997, PHOTOSYNTH RES, V54, P1997, DOI DOI 10.1023/A:1005936823310; Park YI, 1997, PLANT PHYSIOL, V115, P151, DOI 10.1104/pp.115.1.151; Park YI, 1996, PHOTOSYNTH RES, V50, P23, DOI 10.1007/BF00018218; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Paulsen ML, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00191; PENNINGDEVRIES FWT, 1975, ANN BOT-LONDON, V39, P77; Pessarakli M., 2005, HDB PHOTOSYNTHESIS; R Core Team, 2013, R LANG ENV STAT COMP; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; RAVEN JA, 1984, NEW PHYTOL, V98, P593, DOI 10.1111/j.1469-8137.1984.tb04152.x; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; REDLINGER T, 1982, P NATL ACAD SCI-BIOL, V79, P5542, DOI 10.1073/pnas.79.18.5542; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; Rinalducci S, 2004, BBA-BIOENERGETICS, V1608, P63, DOI 10.1016/j.bbabio.2003.10.009; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rova EM, 1996, J BIOL CHEM, V271, P28918, DOI 10.1074/jbc.271.46.28918; Santabarbara S, 2002, PHOTOCHEM PHOTOBIOL, V75, P613, DOI 10.1562/0031-8655(2002)075<0613:PIVAIV>2.0.CO;2; Scanlan DJ, 2003, ADV MICROBIAL PHYSL, P1; SCHATZ GH, 1988, BIOPHYS J, V54, P397, DOI 10.1016/S0006-3495(88)82973-4; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Schweitzer C, 2003, CHEM REV, V103, P1685, DOI 10.1021/cr010371d; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sinclair J, 1996, PHOTOSYNTH RES, V50, P33, DOI 10.1007/BF00018219; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Tyystjarvi T, 1998, FEBS LETT, V436, P483, DOI 10.1016/S0014-5793(98)01181-8; Tyystjarvi T, 1996, PHOTOSYNTH RES, V47, P111, DOI 10.1007/BF00016174; Tyystjarvi T, 2002, FEBS LETT, V516, P167, DOI 10.1016/S0014-5793(02)02537-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VANMIEGHEM F, 1995, BIOCHEMISTRY-US, V34, P4798, DOI 10.1021/bi00014a038; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; VASSILIEV IR, 1994, PHOTOSYNTH RES, V42, P51, DOI 10.1007/BF00019058; Wang WL, 2005, J PHYCOL, V41, P685, DOI 10.1111/j.1529-8817.2005.00089.x; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; Wiethaus J, 2010, EUR J CELL BIOL, V89, P1005, DOI 10.1016/j.ejcb.2010.06.017; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Zavafer A, 2015, J PHOTOCH PHOTOBIO B, V152, P247, DOI 10.1016/j.jphotobiol.2015.08.007; Zerihun A, 1998, NEW PHYTOL, V138, P1, DOI 10.1046/j.1469-8137.1998.00893.x; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331; Zorz Jackie K., 2015, Life-Basel, V5, P403, DOI 10.3390/life5010403; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	132	21	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0168991	10.1371/journal.pone.0168991	http://dx.doi.org/10.1371/journal.pone.0168991			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129341	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400072
J	Cataldo, LR; Mizgier, ML; Sagua, RB; Jana, F; Cardenas, C; Llanos, P; Busso, D; Olmos, P; Galgani, JAE; Santos, JAL; Cortes, VA				Rodrigo Cataldo, Luis; Mizgier, Maria L.; Bravo Sagua, Roberto; Jana, Fabian; Cardenas, Cesar; Llanos, Paola; Busso, Dolores; Olmos, Pablo; Galgani, Jose A. E.; Santos, Jose A. L.; Cortes, Victor A.			Prolonged Activation of the Htr2b Serotonin Receptor Impairs Glucose Stimulated Insulin Secretion and Mitochondrial Function in MIN6 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELL; 5-HYDROXYTRYPTAMINE; PGC-1-ALPHA; RELEASE; MOUSE; METABOLISM; ISLETS; LINE; RAT; OVEREXPRESSION	Aims Pancreatic beta-cells synthesize and release serotonin (5 hydroxytryptamine, 5HT); however, the role of 5HT receptors on glucose stimulated insulin secretion (GSIS) and the mechanisms mediating this function is not fully understood. The aims of this study were to determine the expression profile of 5HT receptors in murine MIN6 beta-cells and to examine the effects of pharmacological activation of 5HT receptor Htr2b on GSIS and mitochondrial function. Materials and Methods mRNA levels of 5HT receptors in MIN6 cells were quantified by RT qPCR. GSIS was assessed in MIN6 cells in response to global serotonergic activation with 5HT and pharmacological Htr2b activation or inhibition with BW723C86 or SB204741, respectively. In response to Htr2b activation also was evaluated the mRNA and protein levels of PGC1 alpha and PPARy by RT-qPCR and western blotting and mitochondrial function by oxygen consumption rate (OCR) and ATP cellular content. Results We found that mRNA levels of most 5HT receptors were either very low or undetectable in MIN6 cells. By contrast, Htr2b mRNA was present at moderate levels in these cells. Preincubation (6 h) of MIN6 cells with 5HT or BW723C86 reduced GSIS and the effect of 5HT was prevented by SB204741. Preincubation with BW723C86 increased PGC1a and PPARy mRNA and protein levels and decreased mitochondrial respiration and ATP content in MIN6 cells. Conclusions Our results indicate that prolonged Htr2b activation in murine beta-cells decreases glucose-stimulated insulin secretion and mitochondrial activity by mechanisms likely dependent on enhanced PGC1 alpha/PPARy expression.	[Rodrigo Cataldo, Luis; Mizgier, Maria L.; Busso, Dolores; Olmos, Pablo; Galgani, Jose A. E.; Santos, Jose A. L.; Cortes, Victor A.] Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile; [Bravo Sagua, Roberto] Univ Chile, Inst Nutr & Food Technol INTA, Santiago, Chile; [Jana, Fabian; Cardenas, Cesar] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Santiago, Chile; [Cardenas, Cesar] Gerosci Ctr Brain Hlth & Metab, Santiago, Chile; [Cardenas, Cesar] Buck Inst Res Aging, Novato, CA USA; [Olmos, Pablo] Univ Chile, Inst Res Dent Sci, Sch Odontol, Santiago, Chile; [Galgani, Jose A. E.] Pontificia Univ Catolica Chile, Sch Med, Nutr & Dietet Program, UDA Hlth Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Buck Institute for Research on Aging; Universidad de Chile; Pontificia Universidad Catolica de Chile	Cortes, VA (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile.	vcortes@med.puc.cl	Busso, Dolores/K-7375-2012; Mizgier, Maria/AAU-7804-2021; Bravo-Sagua, Roberto/K-1103-2018; Bravo-Sagua, Roberto/AAG-1245-2019; Jaña, Fabián/D-9364-2017; Busso, Dolores/AAF-2568-2020; Santos, Jose Luis/D-1818-2017	Busso, Dolores/0000-0003-2113-1926; Bravo-Sagua, Roberto/0000-0001-8873-8699; Bravo-Sagua, Roberto/0000-0001-8873-8699; Jaña, Fabián/0000-0001-7786-4569; Cortes, Victor/0000-0002-1658-0965; Santos, Jose Luis/0000-0003-2895-0369; Mizgier, Maria Luisa/0000-0002-6396-8823; CATALDO, LUIS RODRIGO/0000-0003-1225-414X; Llanos, Paola/0000-0003-1383-7961	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1141134, 1120586, 1120443, 1160332, 1130217]; Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias [15150012]; Comision Nacional de Investigacion en Ciencia y Tecnologia [21140087, 3160226, 3140458]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias; Comision Nacional de Investigacion en Ciencia y Tecnologia	This research was funded by "Fondo Nacional de Desarrollo Cientifico y Tecnologico" grants; 1141134 (VC), 1120586 (JLS), 1120443 (CC), 1160332 (CC), 1130217 (JEG). "Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias" grant 15150012 (CC). "Comision Nacional de Investigacion en Ciencia y Tecnologia"; doctoral scholarship 21140087 (LRC), postdoctoral fellowship 3160226 (RBS), postdoctoral fellowship 3140458 (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; BARRADAS MA, 1988, EUR J CLIN INVEST, V18, P399, DOI 10.1111/j.1365-2362.1988.tb01030.x; Bennet H, 2016, DIABETOLOGIA; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Besseiche A, 2015, DIABETES METABOLISM; Cataldo LR, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3793781; Cataldo LR, 2015, EXP CLIN ENDOCR DIAB, V123, P473, DOI 10.1055/s-0035-1549964; Dalboge LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082813; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; FELDMAN JM, 1972, J CLIN ENDOCR METAB, V35, P307, DOI 10.1210/jcem-35-2-307; FELDMAN JM, 1970, ENDOCRINOLOGY, V86, P66; Fukui M, 2012, DIABETES CARE, V35, P163, DOI 10.2337/dc11-1619; Ho JE, 2013, DIABETES, V62, P2689, DOI 10.2337/db12-0754; HOYER D, 1994, PHARMACOL REV, V46, P157; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim K, 2014, ENDOCRINOLOGY; Kohler M, 1998, FEBS LETT, V441, P97, DOI 10.1016/S0014-5793(98)01539-7; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; KURSAR JD, 1992, MOL PHARMACOL, V42, P549; LERNMARK A, 1971, HORM METAB RES, V3, P305, DOI 10.1055/s-0028-1094131; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; LUNDQUIST I, 1971, DIABETOLOGIA, V7, P414, DOI 10.1007/BF01212056; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakamichi Y, 2003, BIOCHEM BIOPH RES CO, V306, P832, DOI 10.1016/S0006-291X(03)01045-3; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Nile DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115433; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Oropeza D, 2015, MOL METAB, V4, P811, DOI 10.1016/j.molmet.2015.08.001; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SIREK A, 1970, CAN MED ASSOC J, V102, P846; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621; Valtat B, 2012, DIABETES; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Zawalich WS, 2004, ENDOCRINE, V23, P11, DOI 10.1385/ENDO:23:1:11; Zawalich WS, 1996, PFLUG ARCH EUR J PHY, V432, P589, DOI 10.1007/s004240050174; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	46	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170213	10.1371/journal.pone.0170213	http://dx.doi.org/10.1371/journal.pone.0170213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129327	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400061
J	Wang, B; Jin, HY; Li, Q; Chen, DD; Zhao, L; Tang, YH; Kato, T; Gu, S				Wang, Bin; Jin, Haiyan; Li, Qi; Chen, Dongdong; Zhao, Liang; Tang, Yanhong; Kato, Tomomichi; Gu, Song			Diurnal and Seasonal Variations in the Net Ecosystem CO2 Exchange of a Pasture in the Three-River Source Region of the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							CARBON-DIOXIDE EXCHANGE; PERENNIAL GRASS MIXTURES; LEYMUS-CHINENSIS STEPPE; WATER-VAPOR EXCHANGE; ALPINE MEADOW; INNER-MONGOLIA; SOIL-TYPE; FLUXES; TEMPERATURE; ATMOSPHERE	Carbon dioxide (CO2) exchange between the atmosphere and grassland ecosystems is very important for the global carbon balance. To assess the CO2 flux and its relationship to environmental factors, the eddy covariance method was used to evaluate the diurnal cycle and seasonal pattern of the net ecosystem CO2 exchange (NEE) of a cultivated pasture in the Three-River Source Region (TRSR) on the Qinghai-Tibetan Plateau from January 1 to December 31, 2008. The diurnal variations in the NEE and ecosystem respiration (R-e) during the growing season exhibited single-peak patterns, the maximum and minimum CO2 uptake observed during the noon hours and night; and the maximum and minimum R-e took place in the afternoon and early morning, respectively. The minimum hourly NEE rate and the maximum hourly R-e rate were -7.89 and 5.03 mu mol CO2 m(-2) s(-1), respectively. The NEE and R-e showed clear seasonal variations, with lower values in winter and higher values in the peak growth period. The highest daily values for C uptake and R-e were observed on August 12 (-2.91 g C m(-2) d(-1)) and July 28 (5.04 g C m(-2) day(-1)), respectively. The annual total NEE and R-e were -140.01 and 403.57 g C m(-2) year(-1), respectively. The apparent quantum yield (alpha) was -0.0275 mu mol mu mol(-1) for the entire growing period, and the alpha values for the pasture's light response curve varied with the leaf area index (LAI), air temperature (T-a), soil water content (SWC) and vapor pressure deficit (VPD). Piecewise regression results indicated that the optimum T-a and VPD for the daytime NEE were 14.1 degrees C and 0.65 kPa, respectively. The daytime NEE decreased with increasing SWC, and the temperature sensitivity of respiration (Q(10)) was 3.0 during the growing season, which was controlled by the SWC conditions. Path analysis suggested that the soil temperature at a depth of 5 cm (T-soil) was the most important environmental factor affecting daily variations in NEE during the growing season, and the photosynthetic photon flux density (PPFD) was the major limiting factor for this cultivated pasture.	[Wang, Bin; Jin, Haiyan] State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China; [Wang, Bin] Qiqihar Univ, Coll Life Sci & Agr & Forestry, Qiqihar, Peoples R China; [Li, Qi; Chen, Dongdong; Zhao, Liang] Chinese Acad Sci, Northwest Plateau Inst Biol, Xining, Peoples R China; [Tang, Yanhong] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Kato, Tomomichi] Univ Tsukuba, Doctoral Program Biol Sci, Tsukuba, Ibaraki, Japan; [Gu, Song] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	State Oceanic Administration; Qiqihar University; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS; National Institute for Environmental Studies - Japan; University of Tsukuba; Nankai University	Wang, B (corresponding author), State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China.; Wang, B (corresponding author), Qiqihar Univ, Coll Life Sci & Agr & Forestry, Qiqihar, Peoples R China.; Gu, S (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	wbin03@sina.com; songgu@nankai.edu.cn	Zhao, Liang/T-9147-2019; Li, Qi/H-4374-2011; Kato, Tomomichi/X-7390-2019	Kato, Tomomichi/0000-0003-3757-3243; Li, Qi/0000-0001-5168-2492; Tang, Yanhong/0000-0001-7207-1965	National Natural Science Foundation of China [31570478]; State's Key Project of Research and Development Plan [2016YFC0501905]; Scientific Research Fund of the Second Institute of Oceanography, SOA [JG1506]; State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund [SKLGAE201506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State's Key Project of Research and Development Plan; Scientific Research Fund of the Second Institute of Oceanography, SOA; State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund	This study was supported by the National Natural Science Foundation of China (31570478), the State's Key Project of Research and Development Plan (2016YFC0501905), the Scientific Research Fund of the Second Institute of Oceanography, SOA under contract No. JG1506 and the State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund (SKLGAE201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31570478), the State's Key Project of Research and Development Plan (2016YFC0501905), the Scientific Research Fund of the Second Institute of Oceanography, SOA under contract No. JG1506 and the State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund (SKLGAE201506).	ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; BALDOCCHI DD, 1995, PLANT CELL ENVIRON, V18, P1157, DOI 10.1111/j.1365-3040.1995.tb00626.x; Chen GM, 2005, SICHUAN CAOYUAN, V10, P37; Dong SK, 2012, SOIL SCI SOC AM J, V76, P2256, DOI 10.2136/sssaj2012.0092; Dong SK, 2010, AFR J AGR RES, V5, P3542; Dong SK, 2005, WEED RES, V45, P114, DOI 10.1111/j.1365-3180.2004.00440.x; Dong SK, 2004, GRASS FORAGE SCI, V59, P298, DOI 10.1111/j.1365-2494.2004.00429.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Feiziene D, 2012, ACTA AGR SCAND B-S P, V62, P311, DOI 10.1080/09064710.2011.614272; Feng S., 1998, CHINESE SCI BULL, V43, P633, DOI 10.1360/csb1998-43-6-633; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Gao X.S., 2006, JOURNAL OF QINGHAI U, V5, P37; Gu S, 2005, PHYTON-ANN REI BOT A, V45, P361; Gu S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003584; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hao YB, 2006, SCI CHINA SER D, V49, P186, DOI 10.1007/s11430-006-8186-5; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; Kang XC, 1996, J GLACIOL GEOCRYOL S, V18, P281; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kato T, 2008, GLOBAL CHANGE BIOL, V14, P2333, DOI 10.1111/j.1365-2486.2008.01646.x; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; KURAHOTTA M, 1987, PLANT CELL PHYSIOL, V28, P1321; Li SG, 2005, GLOBAL CHANGE BIOL, V11, P1941, DOI 10.1111/j.1365-2486.2005.01047.x; Li YY, 2015, SOIL BIOL BIOCHEM, V80, P306, DOI 10.1016/j.soilbio.2014.10.026; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; McFadden JP, 2003, ECOLOGY, V84, P2762, DOI 10.1890/01-0444; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Novick KA, 2004, OECOLOGIA, V138, P259, DOI 10.1007/s00442-003-1388-z; OGREN E, 1993, PLANT PHYSIOL, V101, P1013, DOI 10.1104/pp.101.3.1013; Polley HW, 2006, GLOBAL CHANGE BIOL, V12, P1390, DOI 10.1111/j.1365-2486.2006.01187.x; POTVIN C, 1986, OECOLOGIA, V69, P499, DOI 10.1007/BF00410354; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; SCHULZE ED, 1995, ECOPHYSIOLOGY PHOTOS; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Su XK, 2015, J MT SCI-ENGL, V12, P582, DOI 10.1007/s11629-014-3043-z; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang Q. J., 2005, J LANZHOU U, V41, P1; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wohlfahrt G, 2008, ECOSYSTEMS, V11, P1338, DOI 10.1007/s10021-008-9196-2; Wu GL, 2010, PLANT SOIL, V333, P469, DOI 10.1007/s11104-010-0363-9; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Zhao Liang, 2008, Zhiwu Shengtai Xuebao, V32, P544, DOI 10.3773/j.issn.1005-264x.2008.03.003; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	55	11	11	11	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170963	10.1371/journal.pone.0170963	http://dx.doi.org/10.1371/journal.pone.0170963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129406	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400020
J	Martinez-Rincon, RO; Rivera-Perez, C; Diambra, L; Noriega, FG				Martinez-Rincon, Raul O.; Rivera-Perez, Crisalejandra; Diambra, Luis; Noriega, Fernando G.			Modeling the flux of metabolites in the juvenile hormone biosynthesis pathway using generalized additive models and ordinary differential equations	PLOS ONE			English	Article							CORPORA-ALLATA; FARNESOIC ACID; MEVALONATE PATHWAY; METHYL FARNESOATE; JH BIOSYNTHESIS; ENZYME; DEHYDROGENASE; ALLATOSTATIN; STIMULATION; EXPRESSION	Juvenile hormone (JH) regulates development and reproductive maturation in insects. The corpora allata (CA) from female adult mosquitoes synthesize fluctuating levels of JH, which have been linked to the ovarian development and are influenced by nutritional signals. The rate of JH biosynthesis is controlled by the rate of flux of isoprenoids in the pathway, which is the outcome of a complex interplay of changes in precursor pools and enzyme levels. A comprehensive study of the changes in enzymatic activities and precursor pool sizes have been previously reported for the mosquito Aedes aegypti JH biosynthesis pathway. In the present studies, we used two different quantitative approaches to describe and predict how changes in the individual metabolic reactions in the pathway affect JH synthesis. First, we constructed generalized additive models (GAMs) that described the association between changes in specific metabolite concentrations with changes in enzymatic activities and substrate concentrations. Changes in substrate concentrations explained 50% or more of the model deviances in 7 of the 13 metabolic steps analyzed. Addition of information on enzymatic activities almost always improved the fitness of GAMs built solely based on substrate concentrations. GAMs were validated using experimental data that were not included when the model was built. In addition, a system of ordinary differential equations (ODE) was developed to describe the instantaneous changes in metabolites as a function of the levels of enzymatic catalytic activities. The results demonstrated the ability of the models to predict changes in the flux of metabolites in the JH pathway, and can be used in the future to design and validate experimental manipulations of JH synthesis.	[Martinez-Rincon, Raul O.; Rivera-Perez, Crisalejandra] CONACYT, Ctr Invest Biol Noroeste CIBNOR, La Paz, Baja Calif Sur, Mexico; [Diambra, Luis] UNLP, CREG, La Plata, Buenos Aires, Argentina; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Noriega, Fernando G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; National University of La Plata; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.; Noriega, FG (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	fnoriega@fiu.edu	Martínez-Rincón, Raúl Octavio/AAJ-2658-2021; Rivera-Perez, Crisalejandra/AAM-1269-2021; L, Diambra/F-6319-2015; Martínez-Rincón, Raúl/E-6641-2019	Martínez-Rincón, Raúl Octavio/0000-0002-1204-716X; L, Diambra/0000-0001-8052-4880; Martínez-Rincón, Raúl/0000-0002-1204-716X	NIH-NIAID [2R01AI045545-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID Grant No. 2R01AI045545-15 to FGN.	Agresti A., 2015, FDN LINEAR GEN LINEA; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; COUILLAUD F, 1991, INSECT BIOCHEM, V21, P131, DOI 10.1016/0020-1790(91)90042-D; Crawley MJ, 2013, R BOOK, P557; Evans G., 1993, PRACTICAL NUMERICAL; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; FEYEREISEN R, 1987, MOL CELL ENDOCRINOL, V53, P227, DOI 10.1016/0303-7207(87)90178-X; FEYEREISEN R, 1987, J BIOL CHEM, V262, P2676; FEYEREISEN R, 1981, INSECT BIOCHEM, V11, P401, DOI 10.1016/0020-1790(81)90073-1; FEYEREISEN R, 1981, EUR J BIOCHEM, V118, P231; Feyereisen R., 1985, P391; Goldbeter A, 2013, FEBS LETT, V587, P2778, DOI 10.1016/j.febslet.2013.07.031; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Nijhout HF, 2008, J INSECT PHYSIOL, V54, P255, DOI 10.1016/j.jinsphys.2007.09.008; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Nouzova M, 2015, INSECT BIOCHEM MOLEC, V57, P20, DOI 10.1016/j.ibmb.2014.12.003; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Nyati P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143107; Rivera-Perez C, 2015, INSECT BIOCHEM MOLEC, V64, P44, DOI 10.1016/j.ibmb.2015.07.010; Rivera-Perez C, 2014, INSECT BIOCHEM MOLEC, V51, P1, DOI 10.1016/j.ibmb.2014.05.001; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Sutherland TD, 1996, MOL CELL ENDOCRINOL, V120, P115, DOI 10.1016/0303-7207(96)03825-7; Tobe SS, 2012, ADV I PHYS, V18, P305; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171516	10.1371/journal.pone.0171516	http://dx.doi.org/10.1371/journal.pone.0171516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158248	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700091
J	Theriault, BC; Woo, SK; Karimy, JK; Keledjian, K; Stokum, JA; Sarkar, A; Coksaygan, T; Ivanova, S; Gerzanich, V; Simard, JM				Theriault, Brianna Carusillo; Woo, Seung Kyoon; Karimy, Jason K.; Keledjian, Kaspar; Stokum, Jesse A.; Sarkar, Amrita; Coksaygan, Turhan; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc			Cerebral microbleeds in a neonatal rat model	PLOS ONE			English	Article							PERIVENTRICULAR WHITE-MATTER; AMEBOID MICROGLIAL CELLS; HYPOXIA-ISCHEMIA; BRAIN; HEMORRHAGE; PRETERM; MATRIX-METALLOPROTEINASE-9; ENCEPHALOPATHY; VULNERABILITY; INHIBITION	Background In adult humans, cerebral microbleeds play important roles in neurodegenerative diseases but in neonates, the consequences of cerebral microbleeds are unknown. In rats, a single pro-angiogenic stimulus in utero predisposes to cerebral microbleeds after birth at term, a time when late oligodendrocyte progenitors (pre-oligodendrocytes) dominate in the rat brain. We hypothesized that two independent pro-angiogenic stimuli in utero would be associated with a high likelihood of perinatal microbleeds that would be severely damaging to white matter. Methods Pregnant Wistar rats were subjected to intrauterine ischemia (IUI) and low-dose maternal lipopolysaccharide (mLPS) at embryonic day (E) 19. Pups were born vaginally or abdominally at E21-22. Brains were evaluated for angiogenic markers, microhemorrhages, myelination and axonal development. Neurological function was assessed out to 6 weeks. Results mRNA (Vegf, Cd31, Mmp2, Mmp9, Timp1, Timp2) and protein (CD31, MMP2, MMP9) for angiogenic markers, in situ proteolytic activity, and collagen IV immunoreactivity were altered, consistent with an angiogenic response. Vaginally delivered pups exposed to prenatal IUI+mLPS had spontaneous cerebral microbleeds, abnormal neurological function, and dysmorphic, hypomyelinated white matter and axonopathy. Pups exposed to the same pro-angiogenic stimuli in utero but delivered abdominally had minimal cerebral microbleeds, preserved myelination and axonal development, and neurological function similar to naive controls. Conclusions In rats, pro-angiogenic stimuli in utero can predispose to vascular fragility and lead to cerebral microbleeds. The study of microbleeds in the neonatal rat brain at full gestation may give insights into the consequences of microbleeds in human preterm infants during critical periods of white matter development.	[Theriault, Brianna Carusillo; Woo, Seung Kyoon; Karimy, Jason K.; Keledjian, Kaspar; Stokum, Jesse A.; Sarkar, Amrita; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Coksaygan, Turhan; Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu		Sarkar, Amrita/0000-0001-5925-4281; sarkar, amrita/0000-0002-5828-9682				Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 1998, J NEUROSCI, V18, P6241; Back SA, 2014, CLIN PERINATOL, V41, P1, DOI 10.1016/j.clp.2013.11.001; Bailey KR, 2009, METHODS BEHAV ANAL N; Ballabh P, 2007, NAT MED, V13, P477, DOI 10.1038/nm1558; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; Berger R, 2002, J SOC GYNECOL INVEST, V9, P319, DOI 10.1016/S1071-5576(02)00164-8; Bhatta SRC, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/186560; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Cai J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002379; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; DarleyUsmar V, 1996, PHARM RES-DORDR, V13, P649, DOI 10.1023/A:1016079012214; de Bruine FT, 2014, PEDIATR RADIOL, V44, P305, DOI 10.1007/s00247-013-2803-1; de Vries LS, 2015, NEUROPEDIATRICS, V46, P234, DOI 10.1055/s-0035-1554102; Dubrovskaya N M, 2010, Neurosci Behav Physiol, V40, P231, DOI 10.1007/s11055-009-9235-2; Ebersole JL, 2010, J PERIODONTAL RES, V45, P1, DOI 10.1111/j.1600-0765.2008.01169.x; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; James AH, 2010, HAEMOPHILIA, V16, P420, DOI 10.1111/j.1365-2516.2009.02142.x; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Kessel I, 2015, AM J PERINATOL; Kessel I, 2016, AM J PERINAT, V33, P130, DOI 10.1055/s-0035-1560042; Kinney HC, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/295389; Koltz MT, 2011, J NEUROSURG-PEDIATR, V8, P628, DOI 10.3171/2011.9.PEDS11174; Lee EJ, 2016, J STROKE, V18, P38, DOI 10.5853/jos.2015.01410; LEVITON A, 1991, J CHILD NEUROL, V6, P35, DOI 10.1177/088307389100600107; Loitfelder M, 2012, PANMINERVA MED, V54, P149; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Ma B, 2015, J TISSUE ENG REGEN M; Mackay LB, 2009, J PERINAT MED, V37, P313, DOI 10.1515/JPM.2009.075; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; McIntyre S, 2013, DEV MED CHILD NEUROL, V55, P499, DOI 10.1111/dmcn.12017; Okamoto T, 2010, EARLY HUM DEV, V86, P251, DOI 10.1016/j.earlhumdev.2010.03.007; Ozkan A, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-16; Rathnasamy G, 2016, MOL NEUROBIOL, V53, P4713, DOI 10.1007/s12035-015-9389-6; Rathnasamy G, 2014, NEUROPHARMACOLOGY, V77, P428, DOI 10.1016/j.neuropharm.2013.10.024; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Salomon L J, 2003, J Matern Fetal Neonatal Med, V13, P224; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P342, DOI 10.1196/annals.1306.027; Schulz CG, 2004, PEDIATR RES, V55, P794, DOI 10.1203/01.PDR.0000120683.68630.FB; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sepehry AA, 2016, AM J NEURORADIOL, V37, P215, DOI 10.3174/ajnr.A4525; Shams S, 2016, BIOMARK MED, V10, P9, DOI 10.2217/bmm.15.101; Sie LTL, 2000, AM J NEURORADIOL, V21, P852; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Soul JS, 2009, J THORAC CARDIOV SUR, V138, P374, DOI 10.1016/j.jtcvs.2009.02.027; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tosun C, 2015, PEDIATR RES, V77, P663, DOI 10.1038/pr.2015.34; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Xue MZ, 2006, J NEUROSCI, V26, P10281, DOI 10.1523/JNEUROSCI.2806-06.2006; Xue MZ, 2005, BRAIN PATHOL, V15, P273; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	55	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171163	10.1371/journal.pone.0171163	http://dx.doi.org/10.1371/journal.pone.0171163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158198	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161700035
J	Umarov, RK; Solovyev, VV				Umarov, Ramzan Kh.; Solovyev, Victor V.			Recognition of prokaryotic and eukaryotic promoters using convolutional deep learning neural networks	PLOS ONE			English	Article							SEQUENCE; PREDICTION; ANNOTATION	Accurate computational identification of promoters remains a challenge as these key DNA regulatory regions have variable structures composed of functional motifs that provide gene-specific initiation of transcription. In this paper we utilize Convolutional Neural Networks (CNN) to analyze sequence characteristics of prokaryotic and eukaryotic promoters and build their predictive models. We trained a similar CNN architecture on promoters of five distant organisms: human, mouse, plant (Arabidopsis), and two bacteria (Escherichia coli and Bacillus subtilis). We found that CNN trained on sigma70 subclass of Escherichia coli promoter gives an excellent classification of promoters and non-promoter sequences (Sn = 0.90, Sp = 0.96, CC = 0.84). The Bacillus subtilis promoters identification CNN model achieves Sn = 0.91, Sp = 0.95, and CC = 0.86. For human, mouse and Arabidopsis promoters we employed CNNs for identification of two well-known promoter classes (TATA and non-TATA promoters). CNN models nicely recognize these complex functional regions. For human promoters Sn/Sp/CC accuracy of prediction reached 0.95/0.98/0,90 on TATA and 0.90/0.98/0.89 for non-TATA promoter sequences, respectively. For Arabidopsis we observed Sn/Sp/CC 0.95/0.97/0.91 (TATA) and 0.94/0.94/0.86 (non-TATA) promoters. Thus, the developed CNN models, implemented in CNNProm program, demonstrated the ability of deep learning approach to grasp complex promoter sequence characteristics and achieve significantly higher accuracy compared to the previously developed promoter prediction programs. We also propose random substitution procedure to discover positionally conserved promoter functional elements. As the suggested approach does not require knowledge of any specific promoter features, it can be easily extended to identify promoters and other complex functional regions in sequences of many other and especially newly sequenced genomes.	[Umarov, Ramzan Kh.] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Solovyev, Victor V.] Softberry Inc, Mt Kisco, NY 10549 USA	King Abdullah University of Science & Technology	Solovyev, VV (corresponding author), Softberry Inc, Mt Kisco, NY 10549 USA.	victor@softberry.com	Solovyev, Victor/C-4614-2013	Solovyev, Victor/0000-0001-8885-493X; Umarov, Ramzan/0000-0003-3477-7101	King Abdullah University of Science and Technology; Softberry Inc.	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Softberry Inc.	This study was supported by the King Abdullah University of Science and Technology and Softberry Inc. The King Abdullah University of Science and Technology provided support in the form of salaries for authors RU and VS. VS is employed by Softberry Inc. and provided support for VS in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; [Anonymous], 2008, 2008 IEEE Hot Chips 20 Symposium (HCS), DOI 10.1109/HOTCHIPS.2008.7476516; [Anonymous], 2012, ARXIV12115590; Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Azad AKM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-19; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Chollet F., 2015, KERAS DEEP LEARNING; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gordon L, 2003, BIOINFORMATICS, V19, P1964, DOI 10.1093/bioinformatics/btg265; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; Jacques PE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-423; Kingma DP., 2014, ADAM METHOD STOCHAST; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meysman P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088717; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shahmuradov IA, 2005, NUCLEIC ACIDS RES, V33, P1069, DOI 10.1093/nar/gki247; Solovjev V, 2011, METAGENOMICITAPP, P61; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tatarinova Tatiana, 2013, Quant Biol, V1, P261; Theano Development Team, 2016, ARXIV160502688; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	43	118	120	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171410	10.1371/journal.pone.0171410	http://dx.doi.org/10.1371/journal.pone.0171410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158264	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700076
J	Nieuwenhuis, JG; Noorthoorn, EO; Nijman, HLI; Naarding, P; Mulder, CL				Nieuwenhuis, Jeanet Grietje; Noorthoorn, Eric Onno; Nijman, Henk Llewellyn Inge; Naarding, Paul; Mulder, Cornelis Lambert			A Blind Spot? Screening for Mild Intellectual Disability and Borderline Intellectual Functioning in Admitted Psychiatric Patients: Prevalence and Associations with Coercive Measures	PLOS ONE			English	Article							DISORDERS; PEOPLE; RATES	Background Failure to detect psychiatric patients' intellectual disabilities may lead to inappropriate treatment and greater use of coercive measures. Aims In this prospective dynamic cohort study we screened for intellectual disabilities in patients admitted to psychiatric wards, and investigated the use of coercive measures with these patients. Methods We used the Screener for Intelligence and Learning disabilities (SCIL) to screen patients admitted to two acute psychiatric wards, and assessed patient characteristics and coercive measures during their stay and over the last 5 years. Results Results on the SCIL suggested that 43.8% of the sample had Mild Intellectual Disability or Borderline Intellectual Functioning (MID/BIF). During their current stay and earlier stays in the previous 5 years, these patients had an increased risk of involuntary admission (OR 2.71; SD 1.28-5.70) and coercive measures (OR 3.95, SD 1.47-10.54). Conclusions This study suggests that functioning on the level of MID/BIF is very prevalent in admitted psychiatric patients and requires specific attention from mental health care staff.	[Nieuwenhuis, Jeanet Grietje] GGNet Mental Hlth Ctr, VGGNet, Warnsveld, Netherlands; [Noorthoorn, Eric Onno] Dutch Informat Ctr Coerc Measures, Bilthoven, Netherlands; [Noorthoorn, Eric Onno; Naarding, Paul] GGNet Mental Hlth Ctr, Apeldoorn, Netherlands; [Nijman, Henk Llewellyn Inge] Altrecht Aventurijn, Den Dolder, Netherlands; [Mulder, Cornelis Lambert] Erasmus MC, Epidemiol & Social Psychiat Res Inst, Prins Constantijnweg 48-54, Rotterdam, Netherlands; [Mulder, Cornelis Lambert] Parnassia Psychiat Inst, Prins Constantijnweg 48-54, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Parnassia Psychiatric Institute	Nieuwenhuis, JG (corresponding author), GGNet Mental Hlth Ctr, VGGNet, Warnsveld, Netherlands.	j.nieuwenhuis@ggnet.nl	Mulder, Cornelis Lambert/HGU-3446-2022	Nieuwenhuis, Jeanet/0000-0002-3781-8709	Oude and Nieuwe Gasthuis foundation, Zutphen	Oude and Nieuwe Gasthuis foundation, Zutphen	The study was funded by the Oude and Nieuwe Gasthuis foundation, Zutphen, whose assets in the Zutphen region provide annual funding for mental-health innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers L, 2015, INT J NURS STUD, V52, P1412, DOI 10.1016/j.ijnurstu.2015.05.001; Burge P, 2006, J DEV DISABILITIES, V15, P96; Cooper SA, 2006, PSYCHIATRY, V5, p[9, 306], DOI DOI 10.1053/J.MPPSY.2006.06.009; Fernell E, 2010, ACTA PAEDIATR, V99, P748, DOI 10.1111/j.1651-2227.2010.01707.x; Fletcher R, 2007, DIAGNOSTIC MANUAL IN; Gigi K, 2014, EUR NEUROPSYCHOPHARM, V24, P1793, DOI 10.1016/j.euroneuro.2014.07.016; Hurley AD, 2006, CURR OPIN PSYCHIATR, V19, P465, DOI 10.1097/01.yco.0000238471.84206.0a; Janssen WA, 2011, INT J LAW PSYCHIAT, V34, P429, DOI 10.1016/j.ijlp.2011.10.008; Kaal HL, 2015, J INTELLECT DISABIL, V6, P94, DOI 10.1108/JIDOB-04-2015-0008; Kaal HL, SCIL SCREENER INTELL, p[128, 1017]; Moonen X, 2010, ONDERZOEK PRAKTIJK, V8, P8; Morgan VA, 2008, BRIT J PSYCHIAT, V193, P364, DOI 10.1192/bjp.bp.107.044461; Muskett C, 2014, INT J MENT HEALTH NU, V23, P51, DOI 10.1111/inm.12012; Neijmeijer L, 2010, LICHT VERSTANDELIJK; Nijman H., J APPL RES IN PRESS; Pogge DL, 2014, RES DEV DISABIL, V35, P1705, DOI 10.1016/j.ridd.2014.03.012; Prasher VP, 2006, PSYCHIATRY, V5, P3002; Snell ME, 2009, INTELLECT DEV DISAB, V47, P220, DOI 10.1352/1934-9556-47.3.220; Stuurman S, 2008, INTELLIGENETIEONDERZ; Tyrer P, 1999, LANCET, V354, P999; van Duijvenbode N, 2015, RES DEV DISABIL, V38, P319, DOI 10.1016/j.ridd.2014.12.029; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wullink M, 2007, J INTELL DISABIL RES, V51, P511, DOI 10.1111/j.1365-2788.2006.00917.x	24	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168847	10.1371/journal.pone.0168847	http://dx.doi.org/10.1371/journal.pone.0168847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151977	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200006
J	Perescis, MFJ; de Bruin, N; Heijink, L; Kruse, C; Vinogradova, L; Luttjohann, A; van Luijtelaar, G; van Rijn, CM				Perescis, Martin F. J.; de Bruin, Natasja; Heijink, Liesbeth; Kruse, Chris; Vinogradova, Lyudmila; Luttjohann, Annika; van Luijtelaar, Gilles; van Rijn, Clementina M.			Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; RECEPTOR ANTAGONISTS; BEHAVIORAL-RESPONSES; AUDIOGENIC EPILEPSY; MAZE TASK; CB1; MODEL; RECORDINGS; SPIKES; BRAIN	Cannabinoid CB1 antagonists have been investigated for possible treatment of e.g. obesity-related disorders. However, clinical application was halted due to their symptoms of anxiety and depression. In addition to these adverse effects, we have shown earlier that chronic treatment with the CB1 antagonist rimonabant may induce EEG-confirmed convulsive seizures. In a regulatory repeat-dose toxicity study violent episodes of ''muscle spasms'' were observed in Wistar rats, daily dosed with the CB1 receptor antagonist SLV326 during 5 months. The aim of the present follow-up study was to investigate whether these violent movements were of an epileptic origin. In selected SLV326-treated and control animals, EEG and behavior were monitored for 24 hours. 25% of SLV326 treated animals showed 1 to 21 EEG-confirmed generalized convulsive seizures, whereas controls were seizure-free. The behavioral seizures were typical for a limbic origin. Moreover, interictal spikes were found in 38% of treated animals. The frequency spectrum of the interictal EEG of the treated rats showed a lower theta peak frequency, as well as lower gamma power compared to the controls. These frequency changes were state-dependent: they were only found during high locomotor activity. It is concluded that long term blockade of the endogenous cannabinoid system can provoke limbic seizures in otherwise healthy rats. Additionally, SLV326 alters the frequency spectrum of the EEG when rats are highly active, suggesting effects on complex behavior and cognition.	[Perescis, Martin F. J.; van Luijtelaar, Gilles; van Rijn, Clementina M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Perescis, Martin F. J.] HAS Univ Appl Sci, Shertogenbosch, Netherlands; [de Bruin, Natasja; Heijink, Liesbeth; Kruse, Chris] Abbott Healthcare Prod BV, Weesp, Netherlands; [Vinogradova, Lyudmila] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Luttjohann, Annika] Westfal Wilhelms Univ Munster, Inst Physiol 1, Munster, Germany; [de Bruin, Natasja] Goethe Univ Frankfurt, Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany; [Heijink, Liesbeth] Astellas Pharma Europe R&D, Dept Drug Discovery Sci & Management Europe, Leiden, Netherlands; [Kruse, Chris] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Radboud University Nijmegen; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; University of Munster; Fraunhofer Gesellschaft; Goethe University Frankfurt; Astellas Pharmaceuticals; University of Amsterdam	Perescis, MFJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Perescis, MFJ (corresponding author), HAS Univ Appl Sci, Shertogenbosch, Netherlands.	m.perescis@has.nl	van Rijn, Clementina/D-5828-2012; Vinogradova, Ljudmila/F-9578-2017; de Bruin, Natasja/D-8063-2014	de Bruin, Natasja/0000-0002-2456-2783; van Rijn, Clementina/0000-0002-1103-6338; Vinogradova, Lyudmila/0000-0003-0336-606X; Luttjohann, Annika/0000-0002-9248-1264	Abbott Healthcare Products BV, Weesp, The Netherlands	Abbott Healthcare Products BV, Weesp, The Netherlands	This study was funded by Abbott Healthcare Products BV (formerly Solvay Pharmaceuticals), Weesp, The Netherlands. The funder provided support in the form of salaries for authors [NB, LH, CK], but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The funders gave permission to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghaei I, 2015, EPILEPSY RES, V117, P23, DOI 10.1016/j.eplepsyres.2015.08.010; Alger BE, 2006, NEURON, V51, P393, DOI 10.1016/j.neuron.2006.08.003; Black MD, 2011, PSYCHOPHARMACOLOGY, V215, P149, DOI 10.1007/s00213-010-2124-0; Bourien J, 2005, CLIN NEUROPHYSIOL, V116, P443, DOI 10.1016/j.clinph.2004.08.010; Braakman HMH, 2009, EPILEPSIA, V50, P2171, DOI 10.1111/j.1528-1167.2009.02203.x; Carletti F, 2015, NEUROSCIENCE, V303, P149, DOI 10.1016/j.neuroscience.2015.06.047; COENEN AML, 1975, PHYSIOL BEHAV, V14, P391, DOI 10.1016/0031-9384(75)90053-0; CORCORAN ME, 1978, EPILEPSIA, V19, P47; Cortes-Briones J, 2015, NEUROPSYCHOPHARMACOL; D'Souza DC, 2012, NEUROPSYCHOPHARMACOL, V37, P1632, DOI 10.1038/npp.2012.8; de Bruin NMWJ, 2010, NEUROBIOL LEARN MEM, V93, P522, DOI 10.1016/j.nlm.2010.01.010; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; *EMEA, 2009, EUR PUBL ASS REP EPA; Hajos M, 2008, BIOL PSYCHIAT, V63, P1075, DOI 10.1016/j.biopsych.2007.12.005; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hsu DA, 2015, CLIN NEUROPHYSIOLOGY; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Karanian DA, 2007, J PHARMACOL EXP THER, V322, P1059, DOI 10.1124/jpet.107.120147; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Koessler L, 2015, BRAIN TOPOGR, V28, P5, DOI 10.1007/s10548-014-0417-z; Kow RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095922; Krishnan B, 2015, CLIN NEUROPHYSIOL, V126, P667, DOI 10.1016/j.clinph.2014.07.014; Krsek P, 2013, EPILEPSIA, V54, P1913, DOI 10.1111/epi.12371; Lange JHM, 2008, CHEM REC, V8, P156, DOI 10.1002/tcr.20147; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lee TTY, 2015, NEUROPHARMACOLOGY, V99, P89, DOI 10.1016/j.neuropharm.2015.07.021; Li SF, 2013, IEEE T NEUR SYS REH, V21, P880, DOI 10.1109/TNSRE.2013.2282153; Lichtman AH, 2000, EUR J PHARMACOL, V404, P175, DOI 10.1016/S0014-2999(00)00615-4; Maheshwari A, 2016, EPILEPSIA, V57, P79, DOI 10.1111/epi.13265; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mazzola C, 2003, EUR J PHARMACOL, V477, P219, DOI 10.1016/j.ejphar.2003.08.026; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Niso G, 2015, NEUROIMAGE-CLIN, V8, P503, DOI 10.1016/j.nicl.2015.05.008; Nottage JF, 2015, PSYCHOPHARMACOLOGY, V232, P519, DOI 10.1007/s00213-014-3684-1; Patrylo PR, 2007, EPILEPSIA, V48, P1964, DOI 10.1111/j.1528-1167.2007.01139.x; Pedreira C, 2014, NEUROIMAGE, V99, P461, DOI 10.1016/j.neuroimage.2014.05.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raver SM, 2013, NEUROPSYCHOPHARMACOL, V38, P2338, DOI 10.1038/npp.2013.164; Rodriguez-Manzo G, 2015, BEHAV PHARMACOL, V26, P607, DOI 10.1097/FBP.0000000000000154; Shafaroodi H, 2013, EUR J PHARMACOL, V714, P1, DOI 10.1016/j.ejphar.2013.05.040; Shan GG, 2013, J BIOPHARM STAT, V23, P1081, DOI 10.1080/10543406.2013.813525; Solbrig MV, 2005, EXP NEUROL, V194, P355, DOI 10.1016/j.expneurol.2005.02.017; Staba RJ, 2014, NEUROTHERAPEUTICS, V11, P334, DOI 10.1007/s13311-014-0259-0; Suleymanova EM, 2016, NEUROSCIENCE, V9, P30367; van Lier H, 2003, J NEUROSCI, V23, P2459; van Rijn CM, 2011, PHARMACOL REP, V63, P165; Vilela LR, 2015, TOXICOL APPL PHARM, V286, P178, DOI 10.1016/j.taap.2015.04.013; Vinogradova LV, 2015, PHARMACOL REP, V67, P501, DOI 10.1016/j.pharep.2014.12.002; Vinogradova LV, 2011, EPILEPSY RES, V96, P250, DOI 10.1016/j.eplepsyres.2011.06.007; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; WILLINSKY MD, 1975, PSYCHOPHARMACOLOGIA, V41, P123, DOI 10.1007/BF00421068; Wolff MC, 2003, EUR J PHARMACOL, V477, P213, DOI 10.1016/j.ejphar.2003.08.025	55	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0165363	10.1371/journal.pone.0165363	http://dx.doi.org/10.1371/journal.pone.0165363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151935	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200002
J	Montenegro, MF; Cabezas-Herrera, J; Campoy, FJ; Munoz-Delgado, E; Vidal, CJ				Fernanda Montenegro, Maria; Cabezas-Herrera, Juan; Javier Campoy, F.; Munoz-Delgado, Encarnacion; Vidal, Cecilio J.			Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptor	FASEB JOURNAL			English	Article						AChE transcripts; N-AChE variants; acetylcholine; cholinergic signaling; GPI anchorage	MEMBRANE-ANCHOR PRIMA; MUSCULAR-DYSTROPHY; READTHROUGH ACETYLCHOLINESTERASE; CHOLINESTERASE ACTIVITY; PROTEIN INTERACTIONS; MEROSIN DEFICIENCY; ALZHEIMERS-DISEASE; MYASTHENIA-GRAVIS; INDUCED APOPTOSIS; RAT-LIVER	The observation of acetylcholinesterase (AChE) type H (AChE(H)), which is the predominant AChE variant in visceral organs and immune cells, in lipid rafts of muscle supports functional reasons for the raft targeting of glypiated AChE(H). The search for these reasons revealed that liver AChE activity is mostly confined to rafts and that the liver is able to make N-extended AChE variants and target them to rafts. These results prompted us to test whether AChE and muscarinic receptors existed in the same raft. Isolation of flotillin-2-rich raft fractions by their buoyancy in sucrose gradients, followed by immunoadsorption and matrix-assisted laser desorption ionization-time of flight-mass spectrometry application, gave the following results: 1) most hepatic AChE activity emanates from AChE-HmRNA, and its product, glypiated AChE(H), accumulates in rafts; 2) N-extended N-AChE readthrough variant, nonglypiated N-AChE(H), and N-AChE tailed variant were all identified in liver rafts; and 3) M3 AChRs were observed in rafts, and coprecipitation of raft-confined N-AChE and M3 receptors by using anti-M3 antibodies showed that enzyme and receptor reside in the same raft unit. A raft domain that harbors tightly packed muscarinic receptor and AChE may represent a molecular device that, by means of which, the intensity and duration of cholinergic inputs are regulated.- Montenegro, M. F., Cabezas-Herrera, J., Campoy, F. J., Munoz-Delgado, E., Vidal, C. J. Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors.	[Fernanda Montenegro, Maria; Javier Campoy, F.; Munoz-Delgado, Encarnacion; Vidal, Cecilio J.] Univ Murcia, IMIB, Dept Bioquim & Biol Mol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Cabezas-Herrera, Juan] Univ Hosp Virgen Arrixaca, IMIB Arrixaca, Clin Anal Serv, Mol Therapy & Biomarkers Res Grp, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Vidal, CJ (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Edificio Vet,Apdo 4021, E-30071 Murcia, Spain.	cevidal@um.es	Muñoz-Delgado, Encarnación/P-3490-2014; CABEZAS-HERRERA, JUAN/J-9434-2015; Montenegro, Maria Fernanda/AAF-2695-2021	Muñoz-Delgado, Encarnación/0000-0002-5874-6708; CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Vidal, Cecilio J./0000-0002-0769-5955; Campoy, Francisco Javier/0000-0002-4901-5524; Montenegro, Maria Fernanda/0000-0002-0064-0484	Fundacion Seneca de la Region de Murcia [PI83/00840/FS01]; University of Murcia	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); University of Murcia	The authors thank Dr. Alejandro Torrecillas (University of Murcia) for help with MALDI-TOF-MS experiments, Dr. Nigel M. Hooper (University of Leeds, Leeds, United Kingdom) for providing us with a sample of PIPLC of Bacillus thuringiensis, and Dr. Hermona Soreq (The Hebrew University, Jerusalem, Israel) for critical reading of and useful comments on the manuscript. This research was supported by the Fundacion Seneca de la Region de Murcia (PI83/00840/FS01) and institutional funds of the University of Murcia.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Berson A, 2010, RAMBAM MAIMONIDES ME, V1, DOI 10.5041/RMMJ.10014; Brenner T, 2003, FASEB J, V17, P214, DOI 10.1096/fj.02-0609com; Cartaud A, 2011, BIOL CELL, V103, P287, DOI 10.1042/BC20110018; Cassiman D, 2002, AM J PATHOL, V161, P521, DOI 10.1016/S0002-9440(10)64208-3; Cserzo M, 2004, BIOINFORMATICS, V20, P136, DOI 10.1093/bioinformatics/btg394; Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490; Dewar BJ, 2002, J PHARMACOL EXP THER, V301, P930, DOI 10.1124/jpet.301.3.930; Diaz-Rohrer B, 2014, BBA-BIOMEMBRANES, V1838, P3003, DOI 10.1016/j.bbamem.2014.07.029; Ekman M, 2012, EUR J PHARMACOL, V683, P238, DOI 10.1016/j.ejphar.2012.02.039; Montenegro MF, 2014, CHEM-BIOL INTERACT, V216, P1, DOI 10.1016/j.cbi.2014.03.008; Feron O, 1999, LIFE SCI, V64, P471, DOI 10.1016/S0024-3205(98)00590-6; Garcia-Ayllon MS, 2014, NEUROBIOL AGING, V35, P1526, DOI 10.1016/j.neurobiolaging.2014.01.147; Garcia-Ayllon MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044598; Garcia-Ayllon MS, 1999, NEUROSCI LETT, V265, P211, DOI 10.1016/S0304-3940(99)00252-9; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; Gomez JL, 2000, J NEUROSCI RES, V62, P134, DOI 10.1002/1097-4547(20001001)62:1<134::AID-JNR14>3.0.CO;2-T; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Hicks D, 2011, J NEUROCHEM, V116, P742, DOI 10.1111/j.1471-4159.2010.07032.x; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005; Fernandez-Gomez FJ, 2010, J NEUROSCI RES, V88, P155, DOI 10.1002/jnr.22177; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khurana S, 2010, J PHARMACOL EXP THER, V333, P639, DOI 10.1124/jpet.109.165118; Lee J, 2007, J VIROL, V81, P9121, DOI 10.1128/JVI.00136-07; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Levitan I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00065; Li JH, 2009, DIABETES, V58, P2776, DOI 10.2337/db09-0522; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Marzioni M, 2009, CLIN REV ALLERG IMMU, V36, P13, DOI 10.1007/s12016-008-8090-1; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Mor I, 2008, CHEM-BIOL INTERACT, V175, P11, DOI 10.1016/j.cbi.2008.05.019; Munoz-Delgado E, 2010, FEBS J, V277, P4519, DOI 10.1111/j.1742-4658.2010.07861.x; Nieto-Ceron S, 2005, J NEUROCHEM, V95, P1035, DOI 10.1111/j.1471-4159.2005.03433.x; Ohno K, 2014, J MOL NEUROSCI, V53, P359, DOI 10.1007/s12031-013-0170-x; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Perez-Aguilar B, 2015, BBA-MOL BASIS DIS, V1852, P1380, DOI 10.1016/j.bbadis.2015.04.003; Perry C, 2007, LEUKEMIA, V21, P1472, DOI 10.1038/sj.leu.2404722; Ponce J, 2010, PROTEOMICS, V10, P1954, DOI 10.1002/pmic.200900055; Ruiz-Espejo F, 2002, BREAST CANCER RES TR, V72, P11, DOI 10.1023/A:1014904701723; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shakirova Y, 2010, EUR J PHARMACOL, V634, P142, DOI 10.1016/j.ejphar.2010.02.017; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiota M, 2000, AM J PHYSIOL-ENDOC M, V278, pE544, DOI 10.1152/ajpendo.2000.278.3.E544; Soeda J, 2012, BIOCHEM BIOPH RES CO, V417, P17, DOI 10.1016/j.bbrc.2011.10.151; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Moral-Naranjo MT, 2010, BBA-MOL BASIS DIS, V1802, P754, DOI 10.1016/j.bbadis.2010.05.011; Toiber D, 2009, J NEURAL TRANSM, V116, P1435, DOI 10.1007/s00702-009-0249-2; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Torrent J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0188-0; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Vidal CJ, 2013, CHEM-BIOL INTERACT, V203, P330, DOI 10.1016/j.cbi.2012.08.001; Borroni MV, 2016, BBA-BIOMEMBRANES, V1858, P2662, DOI 10.1016/j.bbamem.2016.07.005; Watt NT, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00041; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	66	3	3	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					544	555		10.1096/fj.201600609R	http://dx.doi.org/10.1096/fj.201600609R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148778				2022-12-26	WOS:000394235400010
J	Khayati, K; Antikainen, H; Bonder, EM; Weber, GF; Kruger, WD; Jakubowski, H; Dobrowolski, R				Khayati, Khoosheh; Antikainen, Henri; Bonder, Edward M.; Weber, Gregory F.; Kruger, Warren D.; Jakubowski, Hieronim; Dobrowolski, Radek			The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice	FASEB JOURNAL			English	Article						metabolism; lysosomal clearance; signaling; Alzheimer's disease	CYSTATHIONINE BETA-SYNTHASE; TRANSFER-RNA-SYNTHETASE; ALZHEIMERS-DISEASE; RAG GTPASES; PATHOLOGICAL CONSEQUENCES; PRESENILIN DEFICIENCY; POSSIBLE MECHANISM; ESCHERICHIA-COLI; LYSOSOME; LEUCINE	The molecular mechanisms leading to and responsible for age-related, sporadic Alzheimer's disease (AD) remain largely unknown. It is well documented that aging patients with elevated levels of the amino acid metabolite homocysteine (Hcy) are at high risk of developing AD. We investigated the impact of Hcy on molecular clearance pathways in mammalian cells, including in vitro cultured induced pluripotent stem cell-derived forebrain neurons and in vivo neurons in mouse brains. Exposure to Hcy resulted in up-regulation of the mechanistic target of rapamycin complex 1 (mTORC1) activity, one of the major kinases in cells that is tightly linked to anabolic and catabolic pathways. Hcy is sensed by a constitutive protein complex composed of leucyl-tRNA-synthetase and folliculin, which regulates mTOR tethering to lysosomal membranes. In hyperhomocysteinemic human cells and cystathionine -synthase-deficient mouse brains, we find an acute and chronic inhibition of the molecular clearance of protein products resulting in a buildup of abnormal proteins, including -amyloid and phospho-Tau. Formation of these protein aggregates leads to AD-like neurodegeneration. This pathology can be prevented by inhibition of mTORC1 or by induction of autophagy. We conclude that an increase of intracellular Hcy levels predisposes neurons to develop abnormal protein aggregates, which are hallmarks of AD and its associated onset and pathophysiology with age.	[Khayati, Khoosheh; Antikainen, Henri; Bonder, Edward M.; Weber, Gregory F.; Dobrowolski, Radek] Rutgers State Univ, New Jersey Inst Technol, Federated Dept Biol Sci, Life Sci Ctr, 225 Univ Ave, Newark, NJ 07102 USA; [Kruger, Warren D.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Jakubowski, Hieronim] Int Ctr Publ Hlth, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Jakubowski, Hieronim] Inst Bioorgan Chem, Poznan, Poland; [Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland	New Jersey Institute of Technology; Rutgers State University Newark; Rutgers State University New Brunswick; Fox Chase Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Life Sciences	Dobrowolski, R (corresponding author), Rutgers State Univ, New Jersey Inst Technol, Federated Dept Biol Sci, Life Sci Ctr, 225 Univ Ave, Newark, NJ 07102 USA.	r.dobrowolski@rutgers.edu	Jakubowski, Hieronim/AAA-6834-2019; Kruger, Warren/Y-2541-2018; Jakubowski, Hieronim/A-2510-2017	Jakubowski, Hieronim/0000-0001-5845-4409; kruger, warren/0000-0002-4990-3695; Dobrowolski, Radek/0000-0002-1805-5806	Polish National Science Center [2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091]; Rutgers University-Newark Research Office; New Jersey Brain Health Institute	Polish National Science Center; Rutgers University-Newark Research Office; New Jersey Brain Health Institute	This work was supported by grants from the Polish National Science Center (2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, and 2013/11/B/NZ1/00091) and the Rutgers University-Newark Research Office and the New Jersey Brain Health Institute (to H.J. and R.D.). The authors thank Drs. Andrea Ballabio (TIGEM, Pozzuoli, Italy) for the CLEAR-Luciferase, David Sabatini (Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, USA) for pRK5-HA GST RagC and Flag-Leucyl tRNA synthetase pRK5, Tamotsu Yoshimori (Osaka University, Osaka, Japan) for ptfLC3, and Shawn Ferguson (Yale School of Medicine, New Haven, CT, USA) for ptdTomato-N1-FLCN constructs, and the members of our laboratory for their helpful comments.	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243; Borowczyk K, 2012, J ALZHEIMERS DIS, V30, P225, DOI 10.3233/JAD-2012-111940; Chung YC, 2016, J THROMB HAEMOST, V14, P1442, DOI 10.1111/jth.13340; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Dobrowolski R, 2012, CELL REP, V2, P1316, DOI 10.1016/j.celrep.2012.09.026; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hamilton N, 2009, TRAFFIC, V10, P951, DOI 10.1111/j.1600-0854.2009.00938.x; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; MUDD SH, 1985, AM J HUM GENET, V37, P1; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Nnah I.C., 2015, CELL DEATH THER, V1, P11; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Reddy K, 2016, CELL REP, V14, P2166, DOI 10.1016/j.celrep.2016.02.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Strauss KA, 2007, MOL GENET METAB, V91, P165, DOI 10.1016/j.ymgme.2007.02.012; Suszynska J, 2010, J ALZHEIMERS DIS, V19, P1177, DOI 10.3233/JAD-2010-1311; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yates Sharon C, 2013, Acta Neuropathol Commun, V1, P3, DOI 10.1186/2051-5960-1-3; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	34	35	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					598	609		10.1096/fj.201600915R	http://dx.doi.org/10.1096/fj.201600915R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148781				2022-12-26	WOS:000394235400014
J	Ruark, CL; Koenning, SR; Davis, EL; Opperman, CH; Lommel, SA; Mitchum, MG; Sit, TL				Ruark, Casey L.; Koenning, Stephen R.; Davis, Eric L.; Opperman, Charles H.; Lommel, Steven A.; Mitchum, Melissa G.; Sit, Tim L.			Soybean cyst nematode culture collections and field populations from North Carolina and Missouri reveal high incidences of infection by viruses	PLOS ONE			English	Article							HETERODERA-GLYCINES; TRANSMISSION; EXPRESSION; PARTICLES; DISEASE; PLANT	Five viruses were previously discovered infecting soybean cyst nematodes (SCN; Heterodera glycines) from greenhouse cultures maintained in Illinois. In this study, the five viruses [ScNV, ScPV, ScRV, ScTV, and SbCNV-5] were detected within SCN greenhouse and field populations from North Carolina (NC) and Missouri (MO). The prevalence and titers of viruses in SCN from 43 greenhouse cultures and 25 field populations were analyzed using qRT-PCR. Viral titers within SCN greenhouse cultures were similar throughout juvenile development, and the presence of viral anti-genomic RNAs within egg, second-stage juvenile (J2), and pooled J3 and J4 stages suggests active viral replication within the nematode. Viruses were found at similar or lower levels within field populations of SCN compared with greenhouse cultures of North Carolina populations. Five greenhouse cultures harbored all five known viruses whereas in most populations a mixture of fewer viruses was detected. In contrast, three greenhouse cultures of similar descent to one another did not possess any detectable viruses and primarily differed in location of the cultures (NC versus MO). Several of these SCN viruses were also detected in Heterodera trifolii (clover cyst) and Heterodera schachtii (beet cyst), but not the other cyst, root-knot, or reniform nematode species tested. Viruses were not detected within soybean host plant tissue. If nematode infection with viruses is truly more common than first considered, the potential influence on nematode biology, pathogenicity, ecology, and control warrants continued investigation.	[Ruark, Casey L.; Koenning, Stephen R.; Davis, Eric L.; Opperman, Charles H.; Lommel, Steven A.; Sit, Tim L.] North Carolina State Univ, Dept Entomol & Plant Pathol, 2510 Thomas Hall, Raleigh, NC 27695 USA; [Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, Bond Life Sci Ctr 371H, Columbia, MO USA; [Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, Bond Life Sci Ctr 371H, Columbia, MO USA	University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sit, TL (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, 2510 Thomas Hall, Raleigh, NC 27695 USA.	tim@ncsu.edu		Sit, Tim/0000-0001-7302-823X	NC Soybean Producers Association [12-13]; National Science Foundation Graduate Research Fellowship Grant [DGE-1252376]	NC Soybean Producers Association; National Science Foundation Graduate Research Fellowship Grant	NC Soybean Producers Association, Grant 12-13, http://ncsoy.org/. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1252376 to CLR, https://www.nsfgrfp.org/.	Bekal S, 2014, J GEN VIROL, V95, P1272, DOI 10.1099/vir.0.060889-0; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Bernard EC, 2010, J NEMATOL, V42, P139; BROWN DJF, 1995, ANNU REV PHYTOPATHOL, V33, P223, DOI 10.1146/annurev.py.33.090195.001255; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colgrove AL, 2008, J NEMATOL, V40, P39; Dong K, 1997, GENETICS, V146, P1311; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; FOOR WE, 1972, J PARASITOL, V58, P1065, DOI 10.2307/3278136; Franz CJ, 2014, VIROLOGY, V448, P255, DOI 10.1016/j.virol.2013.09.024; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Gardner M, 2017, G3; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hooper DJ, 1974, NEMATODE VECTORS PLA, P1; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Koenning S. R., 1998, Journal of Nematology, V30, P569; LOEWENBERG JR, 1959, NATURE, V184, P1896, DOI 10.1038/1841896a0; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Mitchum MG, 2007, PLANT DIS, V91, P1473, DOI 10.1094/PDIS-91-11-1473; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POINAR GO, 1977, NATURE, V266, P256, DOI 10.1038/266256a0; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Skantar AM, 2012, J NEMATOL, V44, P58; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Wrather JA, 2006, J NEMATOL, V38, P173; ZUCKERMA.BM, 1973, NEMATOLOGICA, V19, P117, DOI 10.1163/187529273X00187	28	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171514	10.1371/journal.pone.0171514	http://dx.doi.org/10.1371/journal.pone.0171514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141854	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129500057
J	Casselli, T; Qureshi, H; Peterson, E; Perley, D; Blake, E; Jokinen, B; Abbas, A; Nechaev, S; Watt, JA; Dhasarathy, A; Brissette, CA				Casselli, Timothy; Qureshi, Humaira; Peterson, Elizabeth; Perley, Danielle; Blake, Emily; Jokinen, Bradley; Abbas, Ata; Nechaev, Sergei; Watt, John A.; Dhasarathy, Archana; Brissette, Catherine A.			MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; EXPRESSION ANALYSIS; BACTERIAL ADHESION; GENE-EXPRESSION; NEUROBORRELIOSIS; CELLS; INFLAMMATION; ACTIVATION; MICROGLIA; CHITIN	Lyme disease is caused by infection with the bacterium Borrelia burgdorferi (Bb), which is transmitted to humans by deer ticks. The infection manifests usually as a rash and minor systemic symptoms; however, the bacteria can spread to other tissues, causing joint pain, carditis, and neurological symptoms. Lyme neuroborreliosis presents itself in several ways, such as Bell's palsy, meningitis, and encephalitis. The molecular basis for neuroborreliosis is poorly understood. Analysis of the changes in the expression levels of messenger RNAs and non-coding RNAs, including microRNAs, following Bb infection could therefore provide vital information on the pathogenesis and clinical symptoms of neuroborreliosis. To this end, we used cultured primary human astrocytes, key responders to CNS infection and important components of the blood-brain barrier, as a model system to study RNA and microRNA changes in the CNS caused by Bb. Using whole transcriptome RNA-seq, we found significant changes in 38 microRNAs and 275 mRNAs at 24 and 48 hours following Bb infection. Several of the RNA changes affect pathways involved in immune response, development, chromatin assembly (including histones) and cell adhesion. Further, several of the microRNA predicted target mRNAs were also differentially regulated. Overall, our results indicate that exposure to Bb causes significant changes to the transcriptome and microRNA profile of astrocytes, which has implications in the pathogenesis, and hence potential treatment strategies to combat this disease.	[Casselli, Timothy; Qureshi, Humaira; Peterson, Elizabeth; Perley, Danielle; Blake, Emily; Jokinen, Bradley; Abbas, Ata; Nechaev, Sergei; Watt, John A.; Dhasarathy, Archana; Brissette, Catherine A.] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Qureshi, Humaira] Habib Univ, Karachi, Pakistan; [Blake, Emily] Nova Southeastern Univ, Ft Lauderdale, FL USA	University of North Dakota Grand Forks; Nova Southeastern University	Dhasarathy, A; Brissette, CA (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	archana.dhasarathy@med.und.edu; catherine.brissette@med.und.edu	Nechaev, Sergei/AAQ-3450-2021	Casselli, Timothy/0000-0003-1954-2443; Blake, Emily/0000-0001-5556-7061; Abbas, Ata/0000-0001-8272-1853; Brissette, Catherine/0000-0003-0792-1403	NIH [P20GM104360-01, R21A1125775-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI125775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH P20GM104360-01 to SN, AD and CAB, https:// projectreporter.nih.gov./project_info _description. cfm?aid=9100426& NIH R21A1125775-01 to AD and CAB, hittps://projectreporter.nih.gov/project_info_description. cfm?aid=9164595& and a UND Faculty Seed Grant to CAB and JAW.; The authors thank Adam Scheidegger, Director of the UND Epigenomics core, and members of the Dhasarathy and Brissette laboratories for helpful discussion, critical evaluation and reading of the manuscript. This work was supported by NIH P20GM104360-01 to SN, AD and CAB; NIH R21AI125775-01 to AD and CAB, and a UND Faculty Seed Grant to CAB and JAW.	Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Aucott JN, 2015, INFECT DIS CLIN N AM, V29, P309, DOI 10.1016/j.idc.2015.02.012; Back T, 2013, J NEUROL, V260, P1569, DOI 10.1007/s00415-013-6831-4; Bacon R.M., 2006, MMWR SURVEILL SUMM, V57, P1; Bai Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35642; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223; Bohr S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140440; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Brenu EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102783; Brissette CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00041; Brissette CA, 2013, ASN NEURO, V5, DOI 10.1042/AN20130010; Brissette CA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-249; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cardoso AL, 2016, CURR OPIN PHARMACOL, V26, P1, DOI 10.1016/j.coph.2015.09.001; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cuzzocrea S, 2005, FASEB J, V19, P1253, DOI 10.1096/fj.04-3556com; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Fallon BA, 2010, NEUROBIOL DIS, V37, P534, DOI 10.1016/j.nbd.2009.11.016; Ferracin M, 2011, SEMIN ONCOL, V38, P764, DOI 10.1053/j.seminoncol.2011.08.005; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gu L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/265868; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Hooper M, 2007, J CLIN PATHOL, V60, P466, DOI 10.1136/jcp.2006.042408; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Jacek E, 2013, J NEUROIMMUNOL, V255, P85, DOI 10.1016/j.jneuroim.2012.10.011; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Khan S, 2015, CASE REP NEUROL, V7, P162, DOI 10.1159/000438696; Koedel U, 2015, NAT REV NEUROL, V11, P446, DOI 10.1038/nrneurol.2015.121; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Komaroff AL, 2015, ANN INTERN MED, V162, P871, DOI 10.7326/M15-0647; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; LaFrance ME, 2011, INFECT IMMUN, V79, P3249, DOI 10.1128/IAI.05122-11; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Li F, 2016, CANC RES; Lochhead RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135142; Lochhead RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004212; Magnusson JP, 2016, DEVELOPMENT, V143, P1075, DOI 10.1242/dev.133975; Marion CR, 2016, INFECT IMMUN, V84, P2094, DOI 10.1128/IAI.00055-16; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Myers TA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000659; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Parthasarathy G, 2013, APOPTOSIS; Parthasarathy G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0274-z; Parthasarathy G, 2013, NEUROSCI LETT, V556, P200, DOI 10.1016/j.neulet.2013.10.032; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramesh G, 2015, AM J PATHOL IN PRESS; Ramesh G, 2008, AM J PATHOL, V173, P1415, DOI 10.2353/ajpath.2008.080483; Ramesh G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-72; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rhodes RG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-21; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupprecht TA, 2008, MOL MED, V14, P205, DOI 10.2119/2007-00091.Rupprecht; Schmidt H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0386-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; Stevanato L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt437; Su W, 2015, BRAIN BEHAV IMMUN; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; You S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007848; Zajkowska J, 2015, INFECT DIS-NOR, V47, P1, DOI 10.3109/00365548.2014.961544; Zuckert WR, 2007, CURR PROTOC MICROBIO	87	18	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170961	10.1371/journal.pone.0170961	http://dx.doi.org/10.1371/journal.pone.0170961			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135303	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700035
J	Jans, J; Wicht, O; Widjaja, I; Ahout, IML; de Groot, R; Guichelaar, T; Luytjes, W; de Jonge, MI; de Haan, CAM; Ferwerda, G				Jans, Jop; Wicht, Oliver; Widjaja, Ivy; Ahout, Inge M. L.; de Groot, Ronald; Guichelaar, Teun; Luytjes, Willem; de Jonge, Marien I.; de Haan, Cornelis A. M.; Ferwerda, Gerben			Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; NEUTRALIZING ANTIBODIES; FUSION GLYCOPROTEIN; BIRTH-COHORT; INFANTS; RESPONSES; PROTECTION; CHILDREN; IMMUNIZATION; GENERATION	Respiratory syncytial virus (RSV) is the leading cause for respiratory illness that requires hospitalization in infancy. High levels of maternal antibodies can protect against RSV infection. However, RSV-infected infants can suffer from severe disease symptoms even in the presence of high levels of RSV-specific antibodies. This study analyzes several serological characteristics to explore potential deficiencies or surpluses of antibodies that could relate to severe disease symptoms. We compare serum antibodies from hospitalized patients who suffered severe symptoms as well as uninfected infants. Disease severity markers were oxygen therapy, tachypnea, oxygen saturation, admission to the intensive care unit and duration of hospitalization. Antibodies against RSV G protein and a prefusion F epitope correlated with in vitro neutralization. Avidity of RSV-specific IgG antibodies was lower in RSVinfected infants compared to uninfected controls. Severe disease symptoms were unrelated to RSV-specific IgG antibody titers, avidity of RSV-IgG, virus neutralization capacity or titers against pre-and postfusion F or G protein ectodomains and the prefusion F antigenic site O. In conclusion, the detailed serological characterization did not indicate dysfunctional or epitope- skewed composition of serum antibodies in hospitalized RSV-infected infants suffering from severe disease symptoms. It remains unclear, whether specific antibody fractions could diminish disease symptoms.	[Jans, Jop; Wicht, Oliver; Ahout, Inge M. L.; de Groot, Ronald; de Jonge, Marien I.; Ferwerda, Gerben] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Wicht, Oliver; Guichelaar, Teun; Luytjes, Willem] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Widjaja, Ivy; de Haan, Cornelis A. M.] Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands	Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment; Utrecht University	Ferwerda, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Gerben.Ferwerda@radboudumc.nl	Guichelaar, Teun/AEQ-7065-2022; de Groot, R./H-8039-2014; Ferwerda, J.G./L-4305-2015; de Jonge, Marien I./P-5869-2015; Ahout, Inge ML/P-8666-2015; Wicht, Oliver/L-8714-2013	Guichelaar, Teun/0000-0002-5112-8923; de Jonge, Marien I./0000-0003-2812-5895; Wicht, Oliver/0000-0003-3266-8075; de Haan, Cornelis/0000-0002-4459-9874	Virgo consortium - Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]; Dutch Ministry of Health, Welfare and Sport [S112008]	Virgo consortium - Dutch government; Netherlands Genomics Initiative (NGI); Dutch Ministry of Health, Welfare and Sport	GF is supported by the Virgo consortium, funded by the Dutch government project number FES0908, and by the Netherlands Genomics Initiative (NGI) project number 050-060-452. OW and WL are supported by the Strategic Program RIVM (SPR) S112008, Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Atwell JE, 2016, J INFECT DIS, V213, P423, DOI 10.1093/infdis/jiv401; Bont L, 2016, INFECT DIS THER, V5, P271, DOI 10.1007/s40121-016-0123-0; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Cullen LM, 2015, J VIROL, V89, P6835, DOI 10.1128/JVI.00384-15; Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Freitas GRO, 2011, J MED VIROL, V83, P1826, DOI 10.1002/jmv.22134; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Gomez RS, 2016, IMMUNOLOGY, V147, P55, DOI 10.1111/imm.12541; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; van der Zalm MM, 2009, PEDIATR INFECT DIS J, V28, P472, DOI 10.1097/INF.0b013e318195e26e; van Remmerden Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-253; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Widjaja I, 2016, J VIROL, V90, P5965, DOI 10.1128/JVI.00235-16; Widjaja I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130829; Widjojoatmodjo MN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-114; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	33	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170877	10.1371/journal.pone.0170877	http://dx.doi.org/10.1371/journal.pone.0170877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135305	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700026
J	Li, M; Carey, J; Cristiano, S; Susztak, K; Coresh, J; Boerwinkle, E; Kao, WHL; Beaty, TH; Kottgen, A; Scharpf, RB				Li, Man; Carey, Jacob; Cristiano, Stephen; Susztak, Katalin; Coresh, Josef; Boerwinkle, Eric; Kao, Wen Hong L.; Beaty, Terri H.; Koettgen, Anna; Scharpf, Robert B.			Genome-Wide Association of Copy Number Polymorphisms and Kidney Function	PLOS ONE			English	Article							SERUM CYSTATIN-C; RENAL-FUNCTION; CNV ANALYSIS; DISEASE; CREATININE; DELETIONS; LINKAGE; GENE; GFR; SNP	Genome-wide association studies (GWAS) using single nucleotide polymorphisms (SNPs) have identified more than 50 loci associated with estimated glomerular filtration rate (eGFR), a measure of kidney function. However, significant SNPs account for a small proportion of eGFR variability. Other forms of genetic variation have not been comprehensively evaluated for association with eGFR. In this study, we assess whether changes in germline DNA copy number are associated with GFR estimated from serum creatinine, eGFRcrea. We used hidden Markov models (HMMs) to identify copy number polymorphic regions (CNPs) from highthroughput SNP arrays for 2,514 African (AA) and 8,645 European ancestry (EA) participants in the Atherosclerosis Risk in Communities (ARIC) study. Separately for the EA and AA cohorts, we used Bayesian Gaussian mixture models to estimate copy number at regions identified by the HMM or previously reported in the HapMap Project. We identified 312 and 464 autosomal CNPs among individuals of EA and AA, respectively. Multivariate models adjusted for SNP-derived covariates of population structure identified one CNP in the EA cohort near genome-wide statistical significance (Bonferroni-adjusted p = 0.067) located on chromosome 5 (876-880kb). Overall, our findings suggest a limited role of CNPs in explaining eGFR variability.	[Li, Man; Carey, Jacob; Coresh, Josef; Kao, Wen Hong L.; Beaty, Terri H.; Koettgen, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Li, Man] Univ Utah, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA; [Cristiano, Stephen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Susztak, Katalin] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Coresh, Josef; Kao, Wen Hong L.] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Koettgen, Anna] Univ Freiburg, Fac Med, Med Ctr, Div Genet Epidemiol, Freiburg, Germany; [Scharpf, Robert B.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Freiburg; Johns Hopkins University; Johns Hopkins Medicine	Scharpf, RB (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	rscharpf@jhu.edu	Li, Man/AAX-3400-2020; Susztak, Katalin/ABE-7474-2021	Li, Man/0000-0002-3839-0281; Susztak, Katalin/0000-0002-1005-3726	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, T32-HL0072024]; NIH [5RC2HL102419]; German Research Foundation [KO 3598/2-1];  [UL1RR025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635, DP3DK108220] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). ML was supported by a National Heart, Lung, and Blood Institute T32-HL0072024 Cardiovascular Epidemiology Training Grant. AK was supported by the Emmy Noether Program (KO 3598/2-1) of the German Research Foundation.	Aerts E, 2016, OBESITY, V24, P970, DOI 10.1002/oby.21435; Bochud M, 2005, KIDNEY INT, V67, P61, DOI 10.1111/j.1523-1755.2005.00055.x; Cao Y, 2016, GENET MED, V18, P1052, DOI 10.1038/gim.2015.216; Cardin N, 2011, GENET EPIDEMIOL, V35, P536, DOI 10.1002/gepi.20604; Caruana G, 2015, PEDIATR NEPHROL, V30, P487, DOI 10.1007/s00467-014-2962-9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cox A, 2007, ELAND EFFICIENT LARG; Derks EM, 2013, AM J MED GENET B, V162, P847, DOI 10.1002/ajmg.b.32189; Fernandez-Rozadilla C, 2014, HUM GENET, V133, P525, DOI 10.1007/s00439-013-1390-4; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Grayson BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015393; Hasstedt SJ, 2015, J OBES, V2015, DOI 10.1155/2015/623431; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, EVIDENCE BASED APPRO; Klamt J, 2016, BIRTH DEFECTS RES A, V106, P767, DOI 10.1002/bdra.23539; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Nahas ME, 2005, KIDNEY INT, V68, P2918, DOI 10.1111/j.1523-1755.2005.00774.x; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Placha G, 2006, DIABETES, V55, P3358, DOI 10.2337/db06-0781; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sapkota Y, 2016, CYTOGENETIC GENOME R; Scharpf RB, 2008, ANN APPL STAT, V2, P687, DOI 10.1214/07-AOAS155; Scharpf RB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-81; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; Shi J, 2016, J INVESTIGATIVE DERM; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Sutrala SR, 2007, SCHIZOPHR RES, V96, P93, DOI 10.1016/j.schres.2007.07.029; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tin A, GENOME WIDE ASS STUD; Venter JC, 2015, CLIN CHEM, V61, P1207, DOI 10.1373/clinchem.2014.237016; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Younkin SG, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-24; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170815	10.1371/journal.pone.0170815	http://dx.doi.org/10.1371/journal.pone.0170815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135296	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700022
J	Barthel, R; Seidl, R				Barthel, Roland; Seidl, Roman			Interdisciplinary Collaboration between Natural and Social Sciences - Status and Trends Exemplified in Groundwater Research	PLOS ONE			English	Article							MULTIDISCIPLINARY RESEARCH; COCITATION ANALYSIS; CITATION ANALYSIS; WATER; HYDROLOGY; BIBLIOMETRICS; INDICATORS; MANAGEMENT	Interdisciplinary collaboration, particularly between natural and social sciences, is perceived as crucial to solving the significant challenges facing humanity. However, despite the need for such collaboration being expressed more frequently and intensely, it remains unclear to what degree such collaboration actually takes place, what trends and developments there are and which actors are involved. Previous studies, often based on bibliometric analysis of large bodies of literature, partly observed an increase in interdisciplinary collaboration in general, but in particular, the collaboration among distant fields was less explored. Other more qualitative studies found that interdisciplinary collaboration, particularly between natural and social scientists was not well developed, and obstacles abounded. To shed some light on the actual status and developments of this collaboration, we performed an analysis based on a sample of articles on groundwater research. We first identified journals and articles therein that potentially combined natural and social science aspects of groundwater research. Next, we analysed the disciplinary composition of their authors' teams, cited references, titles and keywords, making use of our detailed personal expertise in groundwater research and its interdisciplinary aspects. We combined several indicators developed from this analysis into a final classification of the degree of multidisciplinarity of each article. Covering the period between 1990 and 2014, we found that the overall percentage of multidisciplinary articles was in the low single-digit range, with only slight increases over the past decades. The interdisciplinarity of individuals plays a major role compared to interdisciplinarity involving two or more researchers. If collaboration with natural sciences takes place, social science is represented most often by economists. As a side result, we found that journals publishing multidisciplinary research had lower impact factors on average, and multidisciplinary papers were cited much less than mono-disciplinary ones.	[Barthel, Roland] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Seidl, Roman] Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland	University of Gothenburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barthel, R (corresponding author), Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden.	roland.barthel@gvc.gu.se	Barthel, Roland/F-8723-2011	Barthel, Roland/0000-0003-2004-6199; Seidl, Roman/0000-0002-6658-8789				[Anonymous], 2015, Nature, V525, P305, DOI 10.1038/525305a; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Bensman SJ, 2009, J AM SOC INF SCI TEC, V60, P1097, DOI 10.1002/asi.21020; Burell A., 2008, AGRARWIRTSCHAFT, V57, P57; Calatrava Moreno MDC, 2016, SCIENTOMETRICS, V107, P213, DOI 10.1007/s11192-016-1842-4; Campbell LM, 2005, CONSERV BIOL, V19, P574, DOI 10.1111/j.1523-1739.2005.00058.x; Carayol N, 2005, RES EVALUAT, V14, P70, DOI 10.3152/147154405781776355; Cobourn KM, 2015, AM J AGR ECON, V97, P786, DOI 10.1093/ajae/aav001; Fischer ARH, 2011, INTERDISCIPL SCI REV, V36, P341, DOI 10.1179/030801811X13160755918688; Froedeman R, 2010, OXFORD HDB INTERDISC; Galloway DL, 2010, HYDROGEOL J, V18, P807, DOI 10.1007/s10040-010-0585-1; Greaves J, 2010, POLIT STUD-LONDON, V58, P320, DOI 10.1111/j.1467-9248.2009.00828.x; Hadorn G., 2008, HDB TRANSDISCIPLINAR; Hassan SU, 2014, SCIENTOMETRICS, V99, P549, DOI 10.1007/s11192-013-1193-3; HEBERLEIN TA, 1988, SOC NATUR RESOUR, V1, P5, DOI 10.1080/08941928809380634; Hood WW, 2001, SCIENTOMETRICS, V52, P291, DOI 10.1023/A:1017919924342; Huberli R., 2001, TRANSDISCIPLINARITY, P6; Huutoniemi K, 2010, RES POLICY, V39, P79, DOI 10.1016/j.respol.2009.09.011; Jahn T, 2012, ECOL ECON, V79, P1, DOI 10.1016/j.ecolecon.2012.04.017; KANAZAWA MT, 1992, WATER RESOUR RES, V28, P1507, DOI 10.1029/92WR00198; King C, 2012, AMBIO, V41, P490, DOI 10.1007/s13280-012-0255-8; Langevin CD, 2012, GROUND WATER, V50, P333, DOI 10.1111/j.1745-6584.2012.00937.x; Ledford H., 2015, NATURE, V76, P2445; Lerner DN, 2011, WATER ENVIRON J, V25, P345, DOI 10.1111/j.1747-6593.2010.00229.x; Levitt JM, 2008, J AM SOC INF SCI TEC, V59, P1973, DOI 10.1002/asi.20914; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Lund JR, 2015, WATER RESOUR RES, V51, P5905, DOI 10.1002/2015WR017125; Madani K, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010849; Merkx F, 2008, RES EVALUAT, V17, P4, DOI 10.3152/095820208X280880; Miller CT, 2002, GROUND WATER, V40, P224, DOI 10.1111/j.1745-6584.2002.tb02650.x; Montanari A, 2013, HYDROLOG SCI J, V58, P1256, DOI 10.1080/02626667.2013.809088; Montanari A, 2015, WATER RESOUR RES, V51, P6797, DOI 10.1002/2015WR017998; Mugabushaka AM, 2016, SCIENTOMETRICS, V107, P593, DOI 10.1007/s11192-016-1865-x; Osareh F, 1996, LIBRI, V46, P149, DOI 10.1515/libr.1996.46.3.149; Osareh F, 1996, LIBRI, V46, P217, DOI 10.1515/libr.1996.46.4.217; Phillipson J, 2006, J AGR ECON, V57, P163, DOI 10.1111/j.1477-9552.2006.00044.x; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Pudovkin AI, 2004, P ASIST ANNU, V41, P507, DOI 10.1002/meet.1450410159; Reddy VR, 2014, J HYDROL, V518, P1, DOI 10.1016/j.jhydrol.2014.06.022; Repko A.F., 2011, CASE STUDIES INTERDI; Ross A, 2012, WATER POLICY, V14, P709, DOI 10.2166/wp.2012.129; Roy ED, 2013, BIOSCIENCE, V63, P745, DOI 10.1093/bioscience/63.9.745; Rylance R, 2015, NATURE, V525, P313, DOI 10.1038/525313a; Savenije HHG, 2008, PHYS CHEM EARTH, V33, P290, DOI 10.1016/j.pce.2008.02.003; Schwartz FW, 2013, GROUND WATER, V51, P1, DOI 10.1111/gwat.12008; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Sivapalan M, 2012, HYDROL PROCESS, V26, P1270, DOI 10.1002/hyp.8426; Strang V., 2015, EVALUATING INTERDISC; Strang V., 2007, ENV DEV SUSTAIN, V11, P1, DOI DOI 10.1007/S10668-007-9095-2; Szostak R, 2015, NATURE, V526, P506, DOI 10.1038/526506d; Taher TM, 2016, HYDROGEOL J, V24, P1593, DOI 10.1007/s10040-016-1435-6; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Uiterkamp AJMS, 2007, J SOC ISSUES, V63, P175, DOI 10.1111/j.1540-4560.2007.00502.x; Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a; van Rijnsoever FJ, 2011, RES POLICY, V40, P463, DOI 10.1016/j.respol.2010.11.001; Vasbinder JW, 2010, NATURE, V463, P876, DOI 10.1038/463876a; Viseu A, 2015, NATURE, V525, P291, DOI 10.1038/525291a; Vogel RM, 2015, WATER RESOUR RES, V51, P4409, DOI 10.1002/2015WR017049; Wagener T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008906; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Wang Q, 2016, J INFORMETR, V10, P347, DOI 10.1016/j.joi.2016.02.003; Wood WW, 2012, GROUND WATER, V50, P167, DOI 10.1111/j.1745-6584.2011.00900.x; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095	66	36	37	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170754	10.1371/journal.pone.0170754	http://dx.doi.org/10.1371/journal.pone.0170754			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129352	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400039
J	Yasgar, A; Titus, SA; Wang, YH; Danchik, C; Yang, SM; Vasiliou, V; Jadhav, A; Maloney, DJ; Simeonov, A; Martinez, NJ				Yasgar, Adam; Titus, Steven A.; Wang, Yuhong; Danchik, Carina; Yang, Shyh-Ming; Vasiliou, Vasilis; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton; Martinez, Natalia J.			A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity	PLOS ONE			English	Article							HUMAN ALDEHYDE DEHYDROGENASES; HUMAN MITOCHONDRIAL; ALDH1A1; CANCER; INHIBITOR; ALCOHOL; CONTRIBUTES; METASTASIS; VALIDATION; EXPRESSION	Aldehyde dehydrogenase enzymes (ALDHs) have a broad spectrum of biological activities through the oxidation of both endogenous and exogenous aldehydes. Increased expression of ALDH1A1 has been identified in a wide-range of human cancer stem cells and is associated with cancer relapse and poor prognosis, raising the potential of ALDH1A1 as a therapeutic target. To facilitate quantitative high-throughput screening (qHTS) campaigns for the discovery, characterization and structure-activity-relationship (SAR) studies of small molecule ALDH1A1 inhibitors with cellular activity, we show herein the miniaturization to 1536-well format and automation of a high-content cell-based ALDEFLUOR assay. We demonstrate the utility of this assay by generating dose-response curves on a comprehensive set of prior art inhibitors as well as hundreds of ALDH1A1 inhibitors synthesized in house. Finally, we established a screening paradigm using a pair of cell lines with low and high ALDH1A1 expression, respectively, to uncover novel cell-active ALDH1A1-specific inhibitors from a collection of over 1,000 small molecules.	[Yasgar, Adam; Titus, Steven A.; Wang, Yuhong; Danchik, Carina; Yang, Shyh-Ming; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton; Martinez, Natalia J.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA; [Vasiliou, Vasilis] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Yale University	Simeonov, A; Martinez, NJ (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA.	asimeono@mail.nih.gov; natalia.martinez@nih.gov		Jadhav, Ajit/0000-0001-7955-1451; vasiliou, vasilis/0000-0003-2552-3118; Danchik, Carina/0000-0003-2032-3467; Yasgar, Adam/0000-0001-7350-1402	National Center for Advancing Translational Sciences; NIH grants [M022057, EY11490]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000192, UL1TR001863] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the intramural research program (IRP) of the National Center for Advancing Translational Sciences and in part by NIH grants M022057 and EY11490.; This work was supported by the intramural research program of the National Center for Advancing Translational Sciences. We thank Carleen Klumpp-Thomas for assistance with assay automation and the compound management group (Paul Shinn, Danielle Bougie, Crystal McKnight, Misha Itkin, and Zina Itkin) for sourcing, quality control, formatting, and plating all compounds.	Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Banh A, 2011, CLIN CANCER RES, V17, P7265, DOI 10.1158/1078-0432.CCR-11-0179; Buckanovich RL, 2013, US Patent, Patent No. [US 20150297577, 20150297577]; Chen C.H., 2014, PCT Patent WO, Patent No. [2014160034., 2014160034]; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Davis MI, 2016, ASSAY DRUG DEV TECHN, V14, P207, DOI 10.1089/adt.2016.706; Haas J, 2004, ASSAY GUIDANCE MANUA; Hong IS, 2015, RECENT PAT ANTI-CANC, V10, P2; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jackson Brian, 2011, Human Genomics, V5, P283; Kahlert C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-275; KEUNG WM, 1993, P NATL ACAD SCI USA, V90, P1247, DOI 10.1073/pnas.90.4.1247; Khanna M, 2011, J BIOL CHEM, V286, P43486, DOI 10.1074/jbc.M111.293597; Kiefer FW, 2012, ENDOCRINOLOGY, V153, P3089, DOI 10.1210/en.2011-2104; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim J, 2015, INT J QUAL STUD HEAL, V10, DOI 10.3402/qhw.v10.27501; Kimble-Hill AC, 2014, J MED CHEM, V57, P714, DOI 10.1021/jm401377v; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Lam JP, 1997, BIOCHEMISTRY-US, V36, P13748, DOI 10.1021/bi970948e; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Ming WY, 2013, ASSAY DRUG DEV TECHN, V11, P388, DOI 10.1089/adt.2013.513; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan CA, 2015, CHEM-BIOL INTERACT, V234, P18, DOI 10.1016/j.cbi.2014.12.008; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Parajuli B, 2014, J MED CHEM, V57, P449, DOI 10.1021/jm401508p; Pors K, 2014, DRUG DISCOV TODAY, V19, P1953, DOI 10.1016/j.drudis.2014.09.009; Rodriguez-Torres M, 2016, CLIN EXP METASTAS, V33, P97, DOI 10.1007/s10585-015-9755-9; Sanders TJ, 2014, GASTROENTEROLOGY, V146, P1278, DOI 10.1053/j.gastro.2014.01.057; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Seethala R, 2009, HDB DRUG SCREENING, pxiii; Smith C, 2015, ADV EXP MED BIOL, V815, P349, DOI 10.1007/978-3-319-09614-8_20; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Thomas ML, 2016, MOL ONCOLOGY; Tomita H, 2016, ONCOTARGET, DOI 10.18632/oncotarget.6920; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P2, DOI 10.1016/j.cbi.2012.10.026; Xiao TL, 2009, J TOXICOL ENV HEAL A, V72, P577, DOI 10.1080/15287390802706371; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Xu SL, 2014, INT J CLIN EXP PATHO, V7, P2976; YANG SP, 2015, DYN VEH COUPL SYST, P1, DOI DOI 10.1021/ACS.JMEDCHEM.5B00577; Yao LN, 2010, NAT MED, V16, P1024, DOI 10.1038/nm.2200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	48	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170937	10.1371/journal.pone.0170937	http://dx.doi.org/10.1371/journal.pone.0170937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129349	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400025
J	Rahe, MC; Murtaugh, MP				Rahe, Michael C.; Murtaugh, Michael P.			Interleukin-21 Drives Proliferation and Differentiation of Porcine Memory B Cells into Antibody Secreting Cells	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; PLASMA-CELLS; BONE-MARROW; LYMPHOCYTE RESPONSES; ANIMAL-MODELS; UP-REGULATION; CDNA CLONING; HUMAN NAIVE; HUMAN CD154; IL-21	Immunological prevention of infectious disease, especially viral, is based on antigen-specific long-lived memory B cells. To test for cellular proliferation and differentiation factors in swine, an outbred model for humans, CD21(+) B cells were activated in vitro with CD40L and stimulated with purported stimulatory cytokines to characterize functional responses. IL-21 induced a 3-fold expansion in total cell numbers with roughly 15% of all B cells differentiating to IgM or IgG antibody secreting cells (ASCs.) However, even with robust proliferation, cellular viability rapidly deteriorated. Therefore, a proliferation inducing ligand (APRIL) and B cell activating factor (BAFF) were evaluated as survival and maintenance factors. BAFF was effective at enhancing the viability of mature B cells as well as ASCs, while APRIL was only effective for ASCs. Both cytokines increased approximately two-fold the amount of IgM and IgG which was secreted by IL-21 differentiated ASCs. Mature B cells from porcine reproductive and respiratory virus (PRRSV) immune and naive age-matched pigs were activated and treated with IL-21 and then tested for memory cell differentiation using a PRRSV non-structural protein 7 ELISPOT and ELISA. PRRSV immune pigs were positive on both ELISPOT and ELISA while naive animals were negative on both assays. These results highlight the IL-21-driven expansion and differentiation of memory B cells in vitro without stimulation of the surface immunoglobulin receptor complex, as well as the establishment of a defined memory B cell culture system for characterization of vaccine responses in outbred animals.	[Rahe, Michael C.; Murtaugh, Michael P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Rahe, MC (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	rahex008@umn.edu		Rahe, Michael/0000-0001-8863-5868	United States Department of Agriculture National Institute of Food and Agriculture [2015-06966]; National Institutes of Health fellowship [T32 OD010993]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010993] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by United States Department of Agriculture National Institute of Food and Agriculture grant 2015-06966 (https://nifa.usda.gov/grants) and a National Institutes of Health fellowship to MCR from the training grant T32 OD010993 (http://grants.nih.govt/grants/funding/ac_search_results.htm?text_curr=t32).; We thank Diem Ngo for technical assistance. The research was supported by USDA NIFA grant 2015-06966 and an NIH fellowship to MCR from the training grant T32 OD010993.	Ahmadi T, 2008, IMMUNOLOGY, V124, P129, DOI 10.1111/j.1365-2567.2007.02749.x; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bergamin F, 2007, EUR J IMMUNOL, V37, P3122, DOI 10.1002/eji.200636791; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brown E, 2009, CLIN VACCINE IMMUNOL, V16, P628, DOI 10.1128/CVI.00483-08; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chaperot L, 1999, EXP HEMATOL, V27, P479, DOI 10.1016/S0301-472X(98)00059-9; Crawley A, 2003, VET IMMUNOL IMMUNOP, V91, P141, DOI 10.1016/S0165-2427(02)00293-3; de Masson A, 2015, BLOOD, V125, P1830, DOI 10.1182/blood-2014-09-599159; Ding BB, 2013, J IMMUNOL, V190, P1827, DOI 10.4049/jimmunol.1201678; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Hasbold J, 1999, J IMMUNOL, V163, P4175; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; Leeth CM, 2016, DIABETES; Li Y., 2015, CHINA MODERN ED EQUI, V2015, P61, DOI DOI 10.1002/HEP.27725; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Mizrahi M, 2013, IMMUNOLOGY, V140, P362, DOI 10.1111/imm.12149; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Ramadani F, 2016, ALLERGY; Renner S, 2016, THERIOGENOLOGY, V86, P406, DOI 10.1016/j.theriogenology.2016.04.055; Reutner K, 2012, DEV COMP IMMUNOL, V38, P321, DOI 10.1016/j.dci.2012.06.011; Rushworth SA, 2001, TRANSPLANTATION, V72, P127, DOI 10.1097/00007890-200107150-00025; Rushworth SA, 2000, TRANSPLANTATION, V69, P936; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; Seidl T, 2012, IMMUNOLOGY, V135, P207, DOI 10.1111/j.1365-2567.2011.03524.x; Shui Y, 2008, VET IMMUNOL IMMUNOP, V125, P190, DOI 10.1016/j.vetimm.2008.05.003; Sinkora M, 2013, DEV COMP IMMUNOL, V39, P409, DOI 10.1016/j.dci.2012.10.010; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Takamatsu H, 1999, IMMUNOLOGY, V97, P211, DOI 10.1046/j.1365-2567.1999.00770.x; TROTTER PJ, 1995, BIOCHEM J, V308, P591, DOI 10.1042/bj3080591; Tsuji S, 2011, BLOOD, V118, P5832, DOI 10.1182/blood-2011-05-353961; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171171	10.1371/journal.pone.0171171	http://dx.doi.org/10.1371/journal.pone.0171171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125737	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100005
J	Delorimier, E; Hinman, MN; Copperman, J; Datta, K; Guenza, M; Berglund, JA				delorimier, Elaine; Hinman, Melissa N.; Copperman, Jeremy; Datta, Kausiki; Guenza, Marina; Berglund, J. Andrew			Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY; MOLECULAR SIMULATION; BASE-PAIRS; RECOGNITION; PROTEINS; STABILIZATION; STABILITIES; MECHANISMS; PARAMETERS; MISMATCHES	Myotonic dystrophy type 2 is a genetic neuromuscular disease caused by the expression of expanded CCUG repeat RNAs from the non-coding region of the (C) under bar CHC-type zinc finger (n) under bar ucleic acid- (b) under bar inding (p) under bar rotein (CNBP) gene. These CCUG repeats bind and sequester a family of RNA-binding proteins known as Muscleblind-like 1, 2, and 3 (MBNL1, MBNL2, and MBNL3), and sequestration plays a significant role in pathogenicity. MBNL proteins are alternative splicing regulators that bind to the consensus RNA sequence YGCY (Y = pyrimidine). This consensus sequence is found in the toxic RNAs (CCUG repeats) and in cellular RNA substrates that MBNL proteins have been shown to bind. Replacing the uridine in CCUG repeats with pseudouridine (Psi) resulted in a modest reduction of MBNL1 binding. Interestingly, Psi modification of a minimally structured RNA containing YGCY motifs resulted in more robust inhibition of MBNL1 binding. The different levels of inhibition between CCUG repeat and minimally structured RNA binding appear to be due to the ability to modify both pyrimidines in the YGCY motif, which is not possible in the CCUG repeats. Molecular dynamic studies of unmodified and pseudouridylated minimally structured RNAs suggest that reducing the flexibility of the minimally structured RNA leads to reduced binding by MBNL1.	[delorimier, Elaine; Hinman, Melissa N.; Copperman, Jeremy; Guenza, Marina; Berglund, J. Andrew] Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA; [Datta, Kausiki; Berglund, J. Andrew] Univ Florida, Coll Med, Ctr NeuroGenet, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Berglund, J. Andrew] Univ Florida, Ctr NeuroGenet, Dept Biochem & Mol Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA	University of Oregon; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Berglund, JA (corresponding author), Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA.; Berglund, JA (corresponding author), Univ Florida, Coll Med, Ctr NeuroGenet, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.; Berglund, JA (corresponding author), Univ Florida, Ctr NeuroGenet, Dept Biochem & Mol Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA.	aberglund@ufl.edu	Guenza, Marina/H-6526-2017; Berglund, Andrew/AAS-1065-2021	Guenza, Marina/0000-0002-1151-4766; Hinman, Melissa/0000-0002-0743-646X	Muscular Dystrophy Association [294447]; National Institutes of Health [AR059833]; Myotonic Dystrophy/Wyck Foundation [Wyck-FF-2014-0013]; American Heart Association Pre-doctoral Fellowship [13PRE17350007]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059833] Funding Source: NIH RePORTER; Division Of Chemistry [1362500] Funding Source: National Science Foundation	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myotonic Dystrophy/Wyck Foundation; American Heart Association Pre-doctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Muscular Dystrophy Association Grant 294447 (to J.A.B.), National Institutes of Health Grant AR059833 (to J.A.B.), Myotonic Dystrophy/Wyck Foundation Grant Wyck-FF-2014-0013 (to M.N.H.), and American Heart Association Pre-doctoral Fellowship 13PRE17350007 (to E.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aduri R, 2007, J CHEM THEORY COMPUT, V3, P1464, DOI 10.1021/ct600329w; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cass D, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-20; Charette M, 2000, IUBMB LIFE, V49, P341; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; deLorimier E, 2014, NUCLEIC ACIDS RES, V42, P12768, DOI 10.1093/nar/gku941; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Fu Y, 2012, CHEMBIOCHEM, V13, P112, DOI 10.1002/cbic.201100487; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hudson GA, 2013, RNA, V19, P1474, DOI 10.1261/rna.039610.113; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lietzke SE, 1996, STRUCTURE, V4, P917, DOI 10.1016/S0969-2126(96)00099-8; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; SANTALUCIA J, 1991, BIOCHEMISTRY-US, V30, P8242, DOI 10.1021/bi00247a021; Sheng J, 2013, NUCLEIC ACIDS RES, V41, P10476, DOI 10.1093/nar/gkt799; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; WU M, 1995, BIOCHEMISTRY-US, V34, P3204, DOI 10.1021/bi00010a009; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x	34	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4350	4357		10.1074/jbc.M116.770768	http://dx.doi.org/10.1074/jbc.M116.770768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130447	Green Published, hybrid			2022-12-26	WOS:000395837100031
J	Francis, JW; Newman, LE; Cunningham, LA; Kahn, RA				Francis, Joshua W.; Newman, Laura E.; Cunningham, Leslie A.; Kahn, Richard A.			A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and beta-Tubulin Is Required for Maintaining the Microtubule Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLDING COFACTOR-D; FISSION YEAST; ALPHA-TUBULIN; PROTEIN; COMPLEX; MUTATIONS; DYNAMICS; ENCEPHALOPATHY; MORPHOGENESIS; CYTOKINESIS	Microtubule dynamics involves the polymerization and de-polymerization of tubulin dimers and is an essential and highly regulated process required for cell viability, architecture, and division. The regulation of the microtubule network also depends on the maintenance of a pool of alpha beta-tubulin heterodimers. These dimers are the end result of complex folding and assembly events, requiring the TCP1 Ring Complex (TriC or CCT) chaperonin and five tubulin-specific chaperones, tubulin binding cofactors A-E (TBCA-TBCE). However, models of the actions of these chaperones are incomplete or inconsistent. We previously purified TBCD from bovine tissues and showed that it tightly binds the small GTPase ARL2 but appears to be inactive. Here, in an effort to identify the functional form of TBCD and using non-denaturing gels and immunoblotting, we analyzed lysates from a number of mouse tissues and cell lines to identify the quaternary state(s) of TBCD and ARL2. We found that both proteins co-migrated in native gels in a complex of similar to 200 kDa that also contained beta-tubulin. Using human embryonic kidney cells enabled the purification of the TBCD center dot ARL2 center dot beta-tubulin trimer found in cell and tissue lysates as well as two other novel TBCD complexes. Characterization of ARL2 point mutants that disrupt binding to TBCD suggested that the ARL2-TBCD interaction is critical for proper maintenance of microtubule densities in cells. We conclude that the TBCD center dot ARL2 center dot beta-tubulin trimer represents a functional complex whose activity is fundamental to microtubule dynamics.	[Francis, Joshua W.; Newman, Laura E.; Cunningham, Leslie A.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X	National Institutes of Health [5R01GM090158, 1F31CA189672, 1F31GM111047]; American Heart Association Predoctoral Fellowship [14PRE18840040]; Emory University Integrated Cellular Imaging Microscopy Core; Proteomics Core of the Emory Neuroscience NINDS; National Institutes of Health Core Facilities Grant [P30NS055077]; Emory Integrated Genomics Core - Emory University School of Medicine; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CANCER INSTITUTE [F31CA189672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122568, R01GM090158, F31GM111047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Emory University Integrated Cellular Imaging Microscopy Core; Proteomics Core of the Emory Neuroscience NINDS; National Institutes of Health Core Facilities Grant; Emory Integrated Genomics Core - Emory University School of Medicine; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants 5R01GM090158 (to R.A.K.), 1F31CA189672 (to J.W.F.), and 1F31GM111047 (to L.E.N.) and American Heart Association Predoctoral Fellowship 14PRE18840040 (to L.E.N.). This research was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core and Proteomics Core of the Emory Neuroscience NINDS, National Institutes of Health Core Facilities Grant P30NS055077. This study was also supported in part by the Emory Integrated Genomics Core, which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award UL1TR000454. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Chen K, 2016, J CELL BIOL, V212, P661, DOI 10.1083/jcb.201503047; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Edvardson S, 2016, HUM MOL GENET, V25, P4635, DOI 10.1093/hmg/ddw292; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Flex E, 2016, AM J HUM GENET, V99, P962, DOI 10.1016/j.ajhg.2016.08.003; Francis Joshua W, 2016, Small GTPases, V7, P188; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Ikeda T, 2017, J HUM GENET, V62, P473, DOI 10.1038/jhg.2016.149; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; Fanarraga ML, 2010, METHOD CELL BIOL, V95, P59, DOI 10.1016/S0091-679X(10)95005-X; Fanarraga ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008846; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Miyake N, 2016, AM J HUM GENET, V99, P950, DOI 10.1016/j.ajhg.2016.08.005; Montecinos-Franjola F, 2016, J BIOL CHEM, V291, P9281, DOI 10.1074/jbc.M115.699728; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Okumura M, 2015, J NEUROSCI, V35, P1979, DOI 10.1523/JNEUROSCI.0973-14.2015; Pode-Shakked B, 2017, CLIN GENET, V91, P725, DOI 10.1111/cge.12914; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; Serna M, 2015, J CELL SCI, V128, P1824, DOI 10.1242/jcs.167387; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STEARNS T, 1990, GENETICS, V124, P251; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	39	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4336	4349		10.1074/jbc.M116.770909	http://dx.doi.org/10.1074/jbc.M116.770909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28126905	Green Published, hybrid			2022-12-26	WOS:000395837100030
J	Moss, B				Moss, Bernard			Investigating Viruses during the Transformation of Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; MESSENGER-RNA GUANYLYLTRANSFERASE; GENETICALLY-ENGINEERED POXVIRUSES; DOUBLE-STRANDED-RNA; VACCINIA VIRUS; METHYLATED NUCLEOTIDES; HEMOGLOBIN-SYNTHESIS; AMPHIBIAN METAMORPHOSIS; POLYMERASE ACTIVITY; LIVE VACCINES	This Reflections article describes my early work on viral enzymes and the discovery of mRNA capping, how my training in medicine and biochemistry merged as I evolved into a virologist, the development of viruses as vaccine vectors, and how scientific and technological developments during the 1970s and beyond set the stage for the interrogation of nearly every step in the reproductive cycle of vaccinia virus (VACV), a large DNA virus with about 200 genes. The reader may view this article as a work in progress, because I remain actively engaged in research at the National Institutes of Health (NIH) notwithstanding 50 memorable years there.	[Moss, Bernard] NIH, NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moss, B (corresponding author), NIH, NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	bmoss@niaid.nih.gov		Moss, Bernard/0000-0002-2154-8564	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001074, ZIAAI000307] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Two individuals stand out in my scientific development: Vernon Ingram and Norman Salzman. Both encouraged and supported me to become an independent investigator. Norman nominated me for tenure at NIH and promoted me to a Section Head. The NIH now honors Norman's memory by holding an annual virology symposium in his name. I thank Stuart Isaacs for comments on an early draft of the manuscript. Most importantly, I am grateful to my wife Toby and children Rob, Jennifer, and David for their patience and love when I neglected them for work. Preparation of this article was supported by the Division of Intramural Research, NIAID, National Institutes of Health.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; BARBOSA E, 1978, J BIOL CHEM, V253, P7692; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BAROUDY BM, 1980, J BIOL CHEM, V255, P4372; BECKER Y, 1964, P NATL ACAD SCI USA, V51, P577, DOI 10.1073/pnas.51.4.577; Bisht H, 2009, J VIROL, V83, P9140, DOI 10.1128/JVI.00875-09; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BOTH GW, 1975, P NATL ACAD SCI USA, V72, P1189, DOI 10.1073/pnas.72.3.1189; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Darnell JE, 2013, J BIOL CHEM, V288, P12957, DOI 10.1074/jbc.X113.471722; ENSINGER MJ, 1976, J BIOL CHEM, V251, P5283; FUERST TR, 1989, P NATL ACAD SCI USA, V86, P2549, DOI 10.1073/pnas.86.8.2549; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; Joklik WK, 2005, J BIOL CHEM, V280, P40385, DOI 10.1074/JBC.X500005200; KATES JR, 1967, P NATL ACAD SCI USA, V58, P134, DOI 10.1073/pnas.58.1.134; KEITH JM, 1982, BIOCHEMISTRY-US, V21, P327, DOI 10.1021/bi00531a020; KEITH JM, 1978, J BIOL CHEM, V253, P5033; KESSLER D, 1960, BIOCHIM BIOPHYS ACTA, V38, P549, DOI 10.1016/0006-3002(60)91290-7; KLEIMAN JH, 1975, J BIOL CHEM, V250, P2420; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; MARTIN SA, 1975, J BIOL CHEM, V250, P9322; Maruri-Avidal L, 2013, J VIROL, V87, P12313, DOI 10.1128/JVI.02137-13; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MIURA KI, 1974, J MOL BIOL, V86, P31, DOI 10.1016/S0022-2836(74)80005-7; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; MOSS B, 1976, J VIROL, V17, P385, DOI 10.1128/JVI.17.2.385-392.1976; MOSS B, 1969, NATURE, V224, P1280, DOI 10.1038/2241280a0; MOSS B, 1968, J VIROL, V2, P1016, DOI 10.1128/JVI.2.10.1016-1027.1968; MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977; MOSS B, 1973, NATURE-NEW BIOL, V245, P59, DOI 10.1038/newbio245059a0; MOSS B, 1968, J MOL BIOL, V32, P493, DOI 10.1016/0022-2836(68)90337-9; MOSS B, 1968, J MOL BIOL, V32, P481, DOI 10.1016/0022-2836(68)90336-7; MOSS B, 1977, CELL, V10, P113, DOI 10.1016/0092-8674(77)90145-3; MOSS B, 1965, P NATL ACAD SCI USA, V54, P967, DOI 10.1073/pnas.54.3.967; Moss B, 2013, FIELDS VIROLOGY, P2129; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199; Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; MUNYON W, 1967, P NATL ACAD SCI USA, V58, P2280, DOI 10.1073/pnas.58.6.2280; MUTHUKRISHNAN S, 1976, BIOCHEMISTRY-US, V15, P5761, DOI 10.1021/bi00671a012; ODA KI, 1967, J MOL BIOL, V27, P395, DOI 10.1016/0022-2836(67)90047-2; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PANICALI D, 1982, P NATL ACAD SCI-BIOL, V79, P4927, DOI 10.1073/pnas.79.16.4927; PAOLETTI E, 1974, J BIOL CHEM, V249, P3273; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Parrish S, 2007, J VIROL, V81, P12973, DOI 10.1128/JVI.01668-07; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; SALZMAN NP, 1964, J MOL BIOL, V8, P405, DOI 10.1016/S0022-2836(64)80204-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ LB, 1975, J BIOL CHEM, V250, P3221; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; SHATKIN AJ, 1974, P NATL ACAD SCI USA, V71, P3204, DOI 10.1073/pnas.71.8.3204; SHATKIN AJ, 1968, P NATL ACAD SCI USA, V61, P1462, DOI 10.1073/pnas.61.4.1462; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; SUBAKSHA.JH, 1969, NATURE, V222, P341, DOI 10.1038/222341a0; SUTTER G, 1994, J VIROL, V68, P4109, DOI 10.1128/JVI.68.7.4109-4116.1994; Thomas L, 1974, LIVES CELL NOTES BIO; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VENKATESAN S, 1980, J BIOL CHEM, V255, P2829; VENKATESAN S, 1982, P NATL ACAD SCI-BIOL, V79, P340, DOI 10.1073/pnas.79.2.340; VENKATESAN S, 1981, CELL, V25, P805, DOI 10.1016/0092-8674(81)90188-4; Warren RD, 2012, J VIROL, V86, P9514, DOI 10.1128/JVI.06902-11; WEI CM, 1974, P NATL ACAD SCI USA, V71, P3014, DOI 10.1073/pnas.71.8.3014; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; WITTEK R, 1980, NATURE, V285, P21, DOI 10.1038/285021a0; WITTEK R, 1977, J VIROL, V23, P669, DOI 10.1128/JVI.23.3.669-678.1977; WITTEK R, 1980, CELL, V21, P487, DOI 10.1016/0092-8674(80)90485-7; Yang ZL, 2015, J VIROL, V89, P6874, DOI 10.1128/JVI.00528-15; ZHANG YF, 1991, P NATL ACAD SCI USA, V88, P1511, DOI 10.1073/pnas.88.4.1511	97	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3958	3969		10.1074/jbc.X117.778712	http://dx.doi.org/10.1074/jbc.X117.778712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154190	hybrid, Green Published			2022-12-26	WOS:000395837100001
J	Guo, F; Dai, JH; Zhang, JX; Ma, YC; Zhu, GH; Shen, JJ; Niu, GQ				Guo, Fei; Dai, Jianhao; Zhang, Junxiang; Ma, Yichuan; Zhu, Guanghui; Shen, Junjie; Niu, Guoqi			Individualized 3D printing navigation template for pedicle screw fixation in upper cervical spine	PLOS ONE			English	Article							BIOMECHANICAL ANALYSIS; COMPARATIVE ACCURACY; GUIDE TEMPLATE; PLACEMENT; LUMBAR	Purpose Pedicle screw fixation in the upper cervical spine is a difficult and high-risk procedure. The screw is difficult to place rapidly and accurately, and can lead to serious injury of spinal cord or vertebral artery. The aim of this study was to design an individualized 3D printing navigation template for pedicle screw fixation in the upper cervical spine. Methods Using CT thin slices data, we employed computer software to design the navigation template for pedicle screw fixation in the upper cervical spine (atlas and axis). The upper cervical spine models and navigation templates were produced by 3D printer with equal proportion, two sets for each case. In one set (Test group), pedicle screws fixation were guided by the navigation template; in the second set (Control group), the screws were fixed under fluoroscopy. According to the degree of pedicle cortex perforation and whether the screw needed to be refitted, the fixation effects were divided into 3 types: Type I, screw is fully located within the vertebral pedicle; Type II, degree of pedicle cortex perforation is < 1 mm, but with good internal fixation stability and no need to renovate; Type III, degree of pedicle cortex perforation is > 1 mm or with the poor internal fixation stability and in need of renovation. Type I and Type II were acceptable placements; Type III placements were unacceptable. Results A total of 19 upper cervical spine and 19 navigation templates were printed, and 37 pedicle screws were fixed in each group. Type I screw-placements in the test group totaled 32; Type II totaled 3; and Type III totaled 2; with an acceptable rate of 94.60%. Type I screw placements in the control group totaled 23; Type II totaled 3; and Type III totaled 11, with an acceptable rate of 70.27%. The acceptability rate in test group was higher than the rate in control group. The operation time and fluoroscopic frequency for each screw were decreased, compared with control group. Conclusion The individualized 3D printing navigation template for pedicle screw fixation is easy and safe, with a high success rate in the upper cervical spine surgery.	[Guo, Fei; Zhang, Junxiang; Ma, Yichuan; Zhu, Guanghui; Shen, Junjie] Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China; [Dai, Jianhao] First Peoples Hosp Huainan, Dept Orthoped, Huainan, Anhui, Peoples R China; [Niu, Guoqi] Bengbu Med Coll, Affiliated Hosp 1, Dept Orthoped, Bengbu, Anhui, Peoples R China	Bengbu Medical College; Bengbu Medical College	Ma, YC (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China.; Niu, GQ (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Orthoped, Bengbu, Anhui, Peoples R China.	horse818@sina.com; ngqdjh7535@163.com			Natural Science Research Project of Anhui Colleges and Universities [KJ2015B100by]	Natural Science Research Project of Anhui Colleges and Universities	The project was funded by the Natural Science Research Project of Anhui Colleges and Universities (Reference No: KJ2015B100by, FG, URL: http://www.ahedu.gov.cn/).	Amiot LP, 2000, SPINE, V25, P606, DOI 10.1097/00007632-200003010-00012; Bergeson RK, 2008, SPINE, V33, pE501, DOI 10.1097/BRS.0b013e31817b61af; CHEN CY, 2013, EVID-BASED COMPL ALT, V2013, P12, DOI DOI 10.1371/J0URNAL.P0NE.0081159; Chen HF, 2016, INT ORTHOP, V40, P827, DOI 10.1007/s00264-015-2813-8; Hecht N, 2016, EUR SPINE J, V25, P716, DOI 10.1007/s00586-015-3814-4; Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009; Kaneyama S, 2014, J NEUROSURG-SPINE, V21, P231, DOI 10.3171/2014.3.SPINE13730; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007; Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b; Kovanda TJ, 2015, J NEUROSURG-PEDIATR, P1; Lang Z, 2016, SPINE, V41, P39, DOI 10.1097/BRS.0000000000001111; Lu S, 2009, INT J MED ROBOT COMP, V5, P184, DOI 10.1002/rcs.249; Ludwig SC, 2000, SPINE, V25, P2675, DOI 10.1097/00007632-200010150-00022; Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009; Park JH, 2015, J NEUROSURG-SPINE, V23, P35, DOI 10.3171/2014.11.SPINE14805; Upendra BN, 2008, SPINE, V33, P384, DOI 10.1097/BRS.0b013e3181646ba1; Yeom JS, 2013, SPINE J, V13, P775, DOI 10.1016/j.spinee.2013.04.005; Yoshihara H, 2013, J NEUROSURG-SPINE, V19, P614, DOI 10.3171/2013.8.SPINE13136; Zhang YZ, 2009, CHIN J TRAUMATOL, V12, P214, DOI 10.3760/cma.j.issn.1008-1275.2009.04.005; Zhou YJ, 2016, WSPOLCZESNA ONKOL, V20, P73, DOI 10.5114/wo.2016.58503; Zhou Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005557	22	51	58	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171509	10.1371/journal.pone.0171509	http://dx.doi.org/10.1371/journal.pone.0171509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152039	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200151
J	Himori, K; Abe, M; Tatebayashi, D; Lee, J; Westerblad, H; Lanner, JT; Yamada, T				Himori, Koichi; Abe, Masami; Tatebayashi, Daisuke; Lee, Jaesik; Westerblad, Hakan; Lanner, Johanna T.; Yamada, Takashi			Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension	PLOS ONE			English	Article							SKELETAL-MUSCLE; ARTERIAL-HYPERTENSION; NITRIC-OXIDE; HEART-FAILURE; DYSFUNCTION; MICE; MECHANISMS; MODEL; RAT; PEROXYNITRITE	Patients with pulmonary hypertension (PH) suffer from inspiratory insufficiency, which has been associated with intrinsic contractile dysfunction in diaphragm muscle. Here, we examined the role of redox stress in PH-induced diaphragm weakness by using the novel antioxidant, EUK-134. Male Wistar rats were randomly divided into control (CNT), CNT + EUK-134 (CNT + EUK), monocrotaline-induced PH (PH), and PH + EUK groups. PH was induced by a single intraperitoneal injection of monocrotaline (60 mg/kg body weight). EUK-134 (3 mg/kg body weight/day), a cell permeable mimetic of superoxide dismutase (SOD) and catalase, was daily intraperitoneally administered starting one day after induction of PH. After four weeks, diaphragm muscles were excised for mechanical and biochemical analyses. There was a decrease in specific tetanic force in diaphragm bundles from the PH group, which was accompanied by increases in: protein expression of NADPH oxidase 2/gp91phox, SOD2, and catalase; 3-nitrotyrosine content and aggregation of actin; glutathione oxidation. Treatment with EUK-134 prevented the force decrease and the actin modifications in PH diaphragm bundles. These data show that redox stress plays a pivotal role in PH-induced diaphragm weakness. Thus, antioxidant treatment can be a promising strategy for PH patients with inspiratory failure.	[Himori, Koichi; Abe, Masami; Tatebayashi, Daisuke; Lee, Jaesik; Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Sapporo Medical University; Karolinska Institutet	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Yamada, Takashi/AAZ-6212-2021; Yamada, Takashi/U-8443-2019	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029	Japan Society for the Promotion of Science [26702021]; Ake Wiberg foundation [M14-0210]; KI Rheumatology fund [2014reum42670, R-481591]; Swedish Research Council [521-2012-1645]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ake Wiberg foundation; KI Rheumatology fund; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by: Japan Society for the Promotion of Science: 26702021: https://www.jsps.go.jp/english/; Ake Wiberg foundation: M14-0210. http://ake-wiberg.set, KI Rheumatology fund: 2014reum42670. https://fonder.ki.se/;Reumatikerforbundet: R-481591. https://www.reumatikerforbundet.org/; Swedish Research Council: 521-2012-1645. https://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Ahn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062702; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; de Man FS, 2011, AM J RESP CRIT CARE, V183, P1411, DOI 10.1164/rccm.201003-0354OC; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; GONZALEZ PK, 1995, J PHARMACOL EXP THER, V275, P798; Hirschfield W, 2000, AM J PHYSIOL-REG I, V278, pR95, DOI 10.1152/ajpregu.2000.278.1.R95; Kabitz HJ, 2008, CLIN SCI, V114, P165, DOI 10.1042/CS20070238; Kim JH, 2012, FREE RADICAL BIO MED, V52, P1597, DOI 10.1016/j.freeradbiomed.2012.01.015; Lawler JM, 2014, AM J PHYSIOL-REG I, V306, pR470, DOI 10.1152/ajpregu.00371.2013; Manders E, 2012, AM J PHYSIOL-LUNG C, V303, pL1070, DOI 10.1152/ajplung.00135.2012; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Pal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063989; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Pong K, 2000, BRAIN RES, V881, P182, DOI 10.1016/S0006-8993(00)02841-9; Redout EM, 2010, AM J PHYSIOL-HEART C, V298, pH1038, DOI 10.1152/ajpheart.00097.2009; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Sharpe MA, 2002, BIOCHEM J, V366, P97, DOI 10.1042/bj20020154; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stasko SA, 2013, J APPL PHYSIOL, V114, P1629, DOI 10.1152/japplphysiol.00871.2012; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Supinski GS, 2007, J APPL PHYSIOL, V102, P2056, DOI 10.1152/japplphysiol.01138.2006; Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7; Tiago T, 2006, BIOCHEM BIOPH RES CO, V342, P44, DOI 10.1016/j.bbrc.2006.01.112; Vassilakopoulos T, 2003, AM J PHYSIOL-LUNG C, V284, pL452, DOI 10.1152/ajplung.00270.2002; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; WADA M, 1996, AM J PHYSIOL-CELL PH, V271, pC1250; Westerblad H, 2000, EUR J APPL PHYSIOL, V83, P166, DOI 10.1007/s004210000275; Wust RCI, 2012, AM J PHYSIOL-HEART C, V302, pH402, DOI 10.1152/ajpheart.00653.2011; Yamada T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0045-7; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169146	10.1371/journal.pone.0169146	http://dx.doi.org/10.1371/journal.pone.0169146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152009	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200008
J	Martin-Hernandez, R; Higes, M; Sagastume, S; Juarranz, A; Dias-Almeida, J; Budge, GE; Meana, A; Boonham, N				Martin-Hernandez, Raquel; Higes, Mariano; Sagastume, Soledad; Juarranz, Angeles; Dias-Almeida, Joyce; Budge, Giles E.; Meana, Aranzazu; Boonham, Neil			Microsporidia infection impacts the host cell's cycle and reduces host cell apoptosis	PLOS ONE			English	Article							REAL-TIME PCR; NOSEMA-CERANAE; APIS-MELLIFERA; S-PHASE; TRANSCRIPTION FACTOR; PROTOZOAN PARASITES; PROTEASE RECEPTOR-1; MASS-SPECTROMETRY; JUVENILE-HORMONE; PROGRESSION	Intracellular parasites can alter the cellular machinery of host cells to create a safe haven for their survival. In this regard, microsporidia are obligate intracellular fungal parasites with extremely reduced genomes and hence, they are strongly dependent on their host for energy and resources. To date, there are few studies into host cell manipulation by microsporidia, most of which have focused on morphological aspects. The microsporidia Nosema apis and Nosema ceranae are worldwide parasites of honey bees, infecting their ventricular epithelial cells. In this work, quantitative gene expression and histology were studied to investigate how these two parasites manipulate their host's cells at the molecular level. Both these microsporidia provoke infection-induced regulation of genes involved in apoptosis and the cell cycle. The up-regulation of buffy (which encodes a pro-survival protein) and BIRC5 (belonging to the Inhibitor Apoptosis protein family) was observed after infection, shedding light on the pathways that these pathogens use to inhibit host cell apoptosis. Curiously, different routes related to cell cycle were modified after infection by each microsporidia. In the case of N. apis, cyclin B1, dacapo and E2F2 were up-regulated, whereas only cyclin E was up-regulated by N. ceranae, in both cases promoting the G1/S phase transition. This is the first report describing molecular pathways related to parasite-host interactions that are probably intended to ensure the parasite's survival within the cell.	[Martin-Hernandez, Raquel; Higes, Mariano; Sagastume, Soledad] Consejeria Agr Junta Comunidades Castilla La Manc, Lab Patol Apicola, Ctr Invest Apicola & Agroambiental, IRIAF, Marchamalo, Spain; [Martin-Hernandez, Raquel] Fdn Parque Cient & Tecnol Albacete, Inst Recursos Humanos Ciencia & Tecnol INCRECYT, FEDER, Albacete, Spain; [Juarranz, Angeles; Dias-Almeida, Joyce] Univ Autonoma Madrid, Dept Biol, Fac Ciencias, Madrid, Spain; [Budge, Giles E.; Boonham, Neil] Fera, York, N Yorkshire, England; [Budge, Giles E.; Boonham, Neil] Newcastle Univ, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Meana, Aranzazu] Univ Complutense Madrid, Dept Sanidad Anim, Fac Vet, Madrid, Spain	Autonomous University of Madrid; Food & Environment Research Agency; Newcastle University - UK; Complutense University of Madrid	Martin-Hernandez, R (corresponding author), Consejeria Agr Junta Comunidades Castilla La Manc, Lab Patol Apicola, Ctr Invest Apicola & Agroambiental, IRIAF, Marchamalo, Spain.	rmhernandez@jccm.es	Martin-Hernandez, Raquel/J-7507-2013; Sagastume, Soledad/AAR-5616-2021; Higes, Mariano/N-9380-2017; Mañes, Aránzazu Meana/C-6360-2017	Martin-Hernandez, Raquel/0000-0002-1730-9368; Sagastume, Soledad/0000-0003-1350-2600; Higes, Mariano/0000-0001-7338-5851; Mañes, Aránzazu Meana/0000-0002-7599-7226; Dias de Almeida, Joyce/0000-0001-7144-5435; Boonham, Neil/0000-0002-8886-5708	INIA (FEDER) PROJECT [RTA2012-00072-C02-01]	INIA (FEDER) PROJECT	This work was supported by INIA (FEDER) PROJECT RTA2012-00072-C02-01. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials. In fact, this organization only provided funds for acquisition of research materials and they provided no salaries for any author.	Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; ALTIERI DC, 1994, BIOCHEMISTRY-US, V33, P13848, DOI 10.1021/bi00250a039; ALTIERI DC, 1994, J BIOL CHEM, V269, P3139; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ares AM, 2012, J CHROMATOGR B, V899, P146, DOI 10.1016/j.jchromb.2012.05.016; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Bakowski MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004200; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Botias C, 2012, ENVIRON MICROBIOL, V14, P845, DOI 10.1111/j.1462-2920.2011.02647.x; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; James ER, 2004, TRENDS PARASITOL, V20, P280, DOI 10.1016/j.pt.2004.04.004; Joyce NC, 2004, INVEST OPHTH VIS SCI, V45, P1340, DOI 10.1167/iovs.03-0335; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kurze C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140174; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Ma ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084137; Manque PA, 2011, INFECT IMMUN, V79, P1855, DOI 10.1128/IAI.00643-10; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; PAN C, 1995, NUCLEIC ACIDS RES, V23, P3673, DOI 10.1093/nar/23.18.3673; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Rodrigues V, 2012, CELL MICROBIOL, V14, P325, DOI 10.1111/j.1462-5822.2011.01737.x; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Szumowski SC, 2015, CURR OPIN MICROBIOL, V26, P10, DOI 10.1016/j.mib.2015.03.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vavra Jiri, 1999, P7; Vidau C, 2014, J INVERTEBR PATHOL, V121, P89, DOI 10.1016/j.jip.2014.07.002; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Williams BAP, 2009, CELL MICROBIOL, V11, P1551, DOI 10.1111/j.1462-5822.2009.01362.x; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zander E., 1909, LEIPZ BIENENZTG, V24, P164; Zander E., 1909, LEIPZIGER BIENENZEIT, V24, P147	57	50	50	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170183	10.1371/journal.pone.0170183	http://dx.doi.org/10.1371/journal.pone.0170183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152065	gold, Green Published			2022-12-26	WOS:000396161200016
J	Morishita, F; Garfin, AMCG; Lew, W; Oh, KH; Yadav, RP; Reston, JC; Infante, LL; Acala, MRC; Palanca, DL; Kim, HJ; Nishikiori, N				Morishita, Fukushi; Garfin, Anna Marie Celina Gonzales; Lew, Woojin; Oh, Kyung Hyun; Yadav, Rajendra-Prasad; Reston, Janeth Cuencaho; Infante, Lenie Lucio; Acala, Maria Rebethia Crueldad; Palanca, Dean Lim; Kim, Hee Jin; Nishikiori, Nobuyuki			Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines	PLOS ONE			English	Article							PREVALENCE SURVEY; URBAN SLUMS; RISK GROUPS; ADOLESCENTS; KAMPALA; BURDEN	Background Globally, case detection of tuberculosis (TB) has stabilized in recent years. Active case finding (ACF) has regained an increased attention as a complementary strategy to fill the case detection gap. In the Philippines, the DetecTB project implemented an innovative ACF strategy that offered a one-stop diagnostic service with a mobile unit equipped with enhanced diagnostic tools including chest X-ray (CXR) and Xpert (R) MTB/RIF (Xpert). The project targeted the rural poor, the urban poor, prison inmates, indigenous population and high school students. Methods This is a retrospective review of TB screening data from 25,103 individuals. A descriptive analysis was carried out to compare screening and treatment outcomes across target populations. Univariate and multivariate analyses were performed to identify predictors of TB for each population. The composition of bacteriologically-confirmed cases by smear and symptom status was further investigated. Results The highest yield with lowest number needed to screen NNS) was found in prison (6.2%, NNS: 16), followed by indigenous population (2.9%, NNS: 34), the rural poor (2.2%, NNS: 45), the urban poor (2.1%, NNS: 48), and high school (0.2%, NNS: 495). The treatment success rate for all populations was high with 89.5% in rifampicin-susceptible patients and 83.3% in rifampicin-resistant patients. A relatively higher loss to follow-up rate was observed in indigenous population (7.5%) and the rural poor (6.4%). Only cough more than two weeks showed a significant association with TB diagnosis in all target populations (Adjusted Odds Ratio ranging from 1.71 to 6.73) while other symptoms and demographic factors varied in their strength of association. The urban poor had the highest proportion of smear-positive patients with cough more than two weeks (72.0%). The proportion of smear-negative (Xpert-positive) patients without cough more than two weeks was the highest in indigenous population (39.3%), followed by prison inmates (27.7%), and the rural poor (22.8%). Conclusions The innovative ACF strategy using mobile unit yielded a substantial number of TB patients and achieved successful treatment outcomes. TB screening in prison, indigenous population, and urban and rural poor communities was found to be effective. The combined use of CXR and Xpert largely contributed to increased case detection.	[Morishita, Fukushi; Nishikiori, Nobuyuki] World Hlth Org Reg Off Western Pacific, Manila, Philippines; [Garfin, Anna Marie Celina Gonzales] Dept Hlth, Natl TB Control Programme, Manila, Philippines; [Lew, Woojin] World Hlth Org Representat Off Mongolia, Ulaanbaatar, Mongolia; [Oh, Kyung Hyun; Kim, Hee Jin] Korean Inst TB, Cheongju, South Korea; [Yadav, Rajendra-Prasad; Reston, Janeth Cuencaho; Infante, Lenie Lucio] World Hlth Org Representat Off Philippines, Manila, Philippines; [Acala, Maria Rebethia Crueldad] Prov Hlth Off Palawan, Puerto Princesa, Philippines; [Palanca, Dean Lim] City Hlth Off Puerto Princesa City, Puerto Princesa, Philippines	World Health Organization; Philippine Department Health; World Health Organization; World Health Organization	Morishita, F (corresponding author), World Hlth Org Reg Off Western Pacific, Manila, Philippines.	morishita.fukushi@gmail.com	Kim, Heejin/HII-8568-2022	Nishikiori, Nobuyuki/0000-0003-0962-8868; Yadav, Rajendra Prasad/0000-0002-0398-1313	Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Government of Japan through Ministry of Health, Labour and Welfare	Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Government of Japan through Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	The DetecTB project was funded by the Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH). This study was financially supported by the Government of the Republic of Korea through Korean Centers for Disease Control & Prevention, and the Government of Japan through Ministry of Health, Labour and Welfare. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the views of the authors' organization or affiliations.	Adetifa IMO, 2016, B WORLD HEALTH ORGAN, V94, P433, DOI 10.2471/BLT.14.151670; Banu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077721; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; CASSELS A, 1982, TUBERCLE, V63, P175, DOI 10.1016/S0041-3879(82)80028-7; Cavanaugh JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047855; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Department of Health Philippines, 2014, MAN PROC NAT TUB CON, V5th; Eang MT, 2012, BMC PUBLIC HEALTH, V12, P1; Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; International Committee of the Red Cross, 2010, PHIL PROT DIGN PLAC; International Committee of the Red Cross, 2016, PHIL LARG MASS SCREE; International Union Against Tuberculosis and Lung Disease, 2009, PHIL TB SOC PUBL STU; John S, 2015, INT J TUBERC LUNG D, V19, P463, DOI 10.5588/ijtld.14.0679; Kapata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146392; Khanal S, 2016, PUBLIC HEALTH ACTION, V6, P136, DOI 10.5588/pha.16.0015; KNCV Tuberculosis Foundation, 2008, WORK DOC CHEST XRAY; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Law I, 2015, TROP MED INT HEALTH, V20, P1146, DOI 10.1111/tmi.12536; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754; Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652; Mahomed H, 2013, TUBERCULOSIS, V93, P357, DOI 10.1016/j.tube.2013.02.007; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Morishita F, 2016, PLOS ONE, V11; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Nduba V, 2015, INT J INFECT DIS, V35, P11, DOI 10.1016/j.ijid.2015.03.008; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Ogbudebe CL, 2015, INT J MYCOBACT, V4, P18, DOI 10.1016/j.ijmyco.2014.12.007; Prasad BM, 2016, PUBLIC HEALTH ACTION, V6, P15, DOI 10.5588/pha.15.0035; Romualdez AG, 2011, PHILIPPINES HLTH SYS; Santha T, 2003, INT J TUBERC LUNG D, V7, P258; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro AE, SYST REV NUMBER NEED; Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385; Tropical Disease Foundation Inc. Department of Health the Philippines, 2008, NAT TUB PREV SURV 20; United Nations, 2015, 2030 AG SUST DEV; Van't Hoog A, 2013, SYST REV SENSITIVITY; Vianzon R, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2012.3.4.022, 10.5365/wpsar.2012.3.4.022]; Waako J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-349; WHO, 2016, GLOB TUB REP; WHO, 2013, WHOHTMTB201304; World Health Organisation, 2015, WHOHTMTB201516; World Health Organization, 2013, DEFINITIONS REPORTIN; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	52	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171310	10.1371/journal.pone.0171310	http://dx.doi.org/10.1371/journal.pone.0171310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152082	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200124
J	Patino-Galindo, JA; Torres-Puente, M; Bracho, MA; Alastrue, I; Juan, A; Navarro, D; Galindo, MJ; Gimeno, C; Ortega, E; Gonzalez-Candelas, F				Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Alastrue, Ignacio; Juan, Amparo; Navarro, David; Galindo, Maria Jose; Gimeno, Concepcion; Ortega, Enrique; Gonzalez-Candelas, Fernando			Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PERFORMANCE; REVEALS; TRENDS; SEX; MEN; ERA	We describe and characterize an exceptionally large HIV-1 subtype B transmission cluster occurring in the Comunidad Valenciana (CV, Spain). A total of 1806 HIV-1 protease-reverse transcriptase (PR/RT) sequences from different patients were obtained in the CV between 2004 and 2014. After subtyping and generating a phylogenetic tree with additional HIV-1 subtype B sequences, a very large transmission cluster which included almost exclusively sequences from the CV was detected (n = 143 patients). This cluster was then validated and characterized with further maximum-likelihood phylogenetic analyses and Bayesian coalescent reconstructions. With these analyses, the CV cluster was delimited to 113 patients, predominately men who have sex with men (MSM). Although it was significantly located in the city of Valencia (n = 105), phylogenetic analyses suggested this cluster derives from a larger HIV lineage affecting other Spanish localities (n = 194). Coalescent analyses estimated its expansion in Valencia to have started between 1998 and 2004. From 2004 to 2009, members of this cluster represented only 1.46% of the HIV-1 subtype B samples studied in Valencia (n = 5/143), whereas from 2010 onwards its prevalence raised to 12.64% (n = 100/791). In conclusion, we have detected a very large transmission cluster in the CV where it has experienced a very fast growth in the recent years in the city of Valencia, thus contributing significantly to the HIV epidemic in this locality. Its transmission efficiency evidences shortcomings in HIV control measures in Spain and particularly in Valencia.	[Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Gonzalez-Candelas, Fernando] Univ Valencia, Unidad Mixta Infecc & Salud Publ FISABIO, CSISP, Valencia, Spain; [Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Gonzalez-Candelas, Fernando] CIBER Epidemiol & Salud Publ, Valencia, Spain; [Alastrue, Ignacio; Juan, Amparo] Unidad Prevenc SIDA & Otras ITS, Valencia, Spain; [Navarro, David; Galindo, Maria Jose] Univ Valencia, Hosp Clin Univ, Valencia, Spain; [Gimeno, Concepcion; Ortega, Enrique] Hosp Gen Univ, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinic Universitari de Valencia; University of Valencia; Hospital Clinic Universitari de Valencia	Gonzalez-Candelas, F (corresponding author), Univ Valencia, Unidad Mixta Infecc & Salud Publ FISABIO, CSISP, Valencia, Spain.; Gonzalez-Candelas, F (corresponding author), CIBER Epidemiol & Salud Publ, Valencia, Spain.	fernando.gonzalez@uv.es	Candelas, Fernando Gonzalez/G-5681-2010; Bracho, Maria/K-6018-2014; Torres-Puente, Manuela/P-1791-2016	Candelas, Fernando Gonzalez/0000-0002-0879-5798; Bracho, Maria/0000-0002-9204-5526; Torres-Puente, Manuela/0000-0002-8352-180X; Patino-Galindo, Juan Angel/0000-0002-6832-7179	Ministerio de Economia y Competitividad (Spanish Government) [BFU2014-58565-R]; Ministerio de Sanidad y Consumo (Spanish Government) [CP07/00078]; Gilead Science SL	Ministerio de Economia y Competitividad (Spanish Government); Ministerio de Sanidad y Consumo (Spanish Government); Gilead Science SL(Gilead Sciences)	This work was partly supported by project BFU2014-58565-R from Ministerio de Economia y Competitividad (Spanish Government) to FGC, project CP07/00078 from Ministerio de Sanidad y Consumo (Spanish Government) to MAB, and Gilead Science SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Bracho MA, 2014, JAIDS-J ACQ IMM DEF, V65, pE130, DOI 10.1097/01.qai.0000435602.73469.56; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001898; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; DGSP, 2014, VIG EP VIH SIDA ENES; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holguin A, 2005, J MED VIROL, V75, P374, DOI 10.1002/jmv.20280; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Galindo JAP, 2015, J CLIN VIROL, V69, P146, DOI 10.1016/j.jcv.2015.06.094; Patino-Galindo JA, 2016, INFECT GENET EVOL, V40, P91, DOI 10.1016/j.meegid.2016.02.028; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2016, R FDN STAT COMP; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; UNAIDS/WHO, 2002, REP GLOB HIV AIDS EP; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171062	10.1371/journal.pone.0171062	http://dx.doi.org/10.1371/journal.pone.0171062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152089	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200081
J	van den Berg, EH; Amini, M; Schreuder, TCMA; Dullaart, RPF; Faber, KN; Alizadeh, BZ; Blokzijl, H				van den Berg, Eline H.; Amini, Marzyeh; Schreuder, Tim C. M. A.; Dullaart, Robin P. F.; Faber, Klaas Nico; Alizadeh, Behrooz Z.; Blokzijl, Hans			Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE VALUES; METABOLIC SYNDROME; HEPATIC STEATOSIS; RISK-FACTORS; INSULIN-RESISTANCE; RENAL-DISEASE; UNITED-STATES; STEATOHEPATITIS; ATHEROSCLEROSIS	Background & aims Non-alcoholic fatty liver disease is an increasing health issue that develops rather unnoticed with obesity, type 2 diabetes mellitus and metabolic syndrome. We investigated prevalence, determinants and associated metabolic abnormalities of non-alcoholic fatty liver disease in the largest population-based cohort to date. Methods Biochemical characteristics, type 2 diabetes mellitus and metabolic syndrome were determined in the Lifelines Cohort Study (N = 167,729), a population-based cohort in the North of the Netherlands. Non-alcoholic fatty liver disease was defined as Fatty Liver Index (FLI)>= 60. Exclusion criteria were age <18 years, immigrants, missing data to assess FLI and metabolic syndrome, excessive alcohol use, previous-diagnosed hepatitis or cirrhosis and nonfasting blood sampling. Results Out of 37,496 included participants (median age 44 years, 62.1% female), 8,259 (22.0%) had a FLI >= 60. Individuals with a FLI >= 60 were more often male, older, obese, had higher levels of hemoglobinA1c, fasting glucose, liver enzymes, total cholesterol, low-density lipoprotein cholesterol, triglycerides, c-reactive protein and leucocytes and lower high-density lipoprotein cholesterol (all P<0.0001). Participants with a FLI >= 60 showed higher prevalence of type 2 diabetes mellitus (9.3% vs. 1.4%), metabolic syndrome (54.2% vs. 6.2%), impaired renal function (20.1% vs. 8.7%) and cardiovascular disease (4.6% vs. 1.6%) (all P<0.0001). Multivariable logistic analysis showed that smoking, hemoglobin, leucocytes, c-reactive protein, platelets, alanine aminotransferase, alkaline phosphatase, albumin, impaired renal function (OR 1.27, 95% CI 1.15-1.41), metabolic syndrome (OR 11.89, 95% CI 11.03-12.82) and its individual components hyperglycemia (OR 2.53, 95% CI 2.34-2.72), hypertension (OR 1.89, 95% CI 1.77-2.01) and reduced high-density lipoprotein cholesterol (OR 3.44, 95% CI 3.22-3.68) were independently associated with suspected non-alcoholic fatty liver disease (all P<0.0001). Conclusion Twenty-two percent (22.0%) of the population in the North of the Netherlands is suspected to suffer from non-alcoholic fatty liver disease, coinciding with a significant increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease and impaired renal function.	[van den Berg, Eline H.; Schreuder, Tim C. M. A.; Faber, Klaas Nico; Alizadeh, Behrooz Z.; Blokzijl, Hans] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Amini, Marzyeh; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	e.h.van.den.berg@umcg.nl		van den Berg, Eline H./0000-0003-2703-2320	Netherlands Organization for Scientific Research [175.010.2007.006]; Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium (KP7) [261433]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium (KP7)	The Lifelines Cohort Study was supported by the Netherlands Organization for Scientific Research [grant 175.010.2007.006]; the Economic Structure Enhancing Fund of the Dutch government; the Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; the Dutch Diabetes Research Foundation and the National Consortium for Healthy Ageing and the BioSHaRE-EU consortium (KP7, project reference 261433). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caballeria L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Day CP, 2006, CLIN MED, V6, P19, DOI 10.7861/clinmedicine.6-1-19; Dullaart RPF, 2015, CLIN BIOCHEM, V48, P1045, DOI 10.1016/j.clinbiochem.2015.06.016; EASL, 2016, J HEPATOL; Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963; Foroughi Mehdi, 2016, Adv Biomed Res, V5, P28, DOI 10.4103/2277-9175.176368; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kanerva N, 2014, AM J CLIN NUTR, V100, P1133, DOI 10.3945/ajcn.114.086074; Klijs B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137203; Kotronen A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-237; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Loguercio C, 2001, J HEPATOL, V35, P568, DOI 10.1016/S0168-8278(01)00192-1; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Ludwig U, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0030-5; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Papatheodoridis GV, 2007, EUR J GASTROEN HEPAT, V19, P281, DOI 10.1097/MEG.0b013e328011438b; Pendino GM, 2005, HEPATOLOGY, V41, P1151, DOI 10.1002/hep.20689; Radu C, 2008, J GASTROINTEST LIVER, V17, P255; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Rockey DC, 2009, HEPATOLOGY BALTIMORE, P1017; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Suomela E, 2015, ANN MED, V47, P40, DOI 10.3109/07853890.2014.966752; Tarnoki AD, 2012, LIVER INT, V32, P1287, DOI 10.1111/j.1478-3231.2012.02823.x; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Volzke H, 2005, WORLD J GASTROENTERO, V11, P1848; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yilmaz Y, 2012, EUR J CLIN INVEST, V42, P411, DOI 10.1111/j.1365-2362.2011.02597.x; Younossi ZM, 2015, HEPATOLOGY; Yu CH, 2012, J HEPATOL, V56, P241, DOI 10.1016/j.jhep.2011.05.027; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026; Zois CD, 2010, WORLD J GASTROENTERO, V16, P3944, DOI 10.3748/wjg.v16.i31.3944	45	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171502	10.1371/journal.pone.0171502	http://dx.doi.org/10.1371/journal.pone.0171502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152105	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200149
J	Yang, XL; Liu, LP; Hao, QF; Zou, DY; Zhang, XL; Zhang, LP; Li, HM; Qiao, Y; Zhao, HS; Zhou, L				Yang, Xiaoli; Liu, Liping; Hao, Qingfang; Zou, Deyong; Zhang, Xiaoli; Zhang, Liping; Li, Hongmei; Qiao, Yong; Zhao, Huansheng; Zhou, Lei			Development and Evaluation of Up Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; MYOCARDIAL-ISCHEMIA; REPORTERS; IMMUNOASSAY; DYSFUNCTION; INFECTION; ANTIGEN; POINT; SERUM	A newly assay, up-converting phosphor technology-based lateral flow (UPT-LF) assay, was developed for rapid and quantitative detection of N-terminal fragment of B-type natriuretic peptide precursor (NT-proBNP), one of the most important serum molecular maker of heat failure, in plasma samples as a point of care testing (POCT) method for diagnosis of acute heart failure. Human plasma from 197 patients with acute heart failure and 200 healthy controls was assessed using the UPT-LF assay, in a comparison with a Roche Elecsys assay. The limit of detection of the UPT-LF assay, with a coefficient of variation (CV) of less than 15%, was 116 ng/L, which is lower than the clinical diagnosis cutoff (150 ng/mL). The linear range was 50-35,000 ng/L. The CVs were less than 10% for both UPT-LF and Roche Elecsys assays for plasma samples under different storages, demonstrating the good stability and reproducibility. There are certain linear correlations between the results of UPT-LF and Roche Elecsys assay for EDTA-K2 and heparin-anticoagulated plasma, as well as for serum samples. For UPT-LF assay, there is a significant correlation between the values derived from analysis of EDTA-K2 and heparin-anticoagulated plasma samples (R = 0.995). No statistically significant difference was found between serum and plasma samples for UPT-LF assay. Our results demonstrate that NT-proBNP levels in healthy adults are elevated with age and had a relationship with sex, and with the age increase the NT-proBNP levels of females are significantly higher than those of males (p<0.01). The UPT-LF assay has a high reproducibility, stability, sensitivity, specificity, and is consistent with Roche Elecsys assay, and therefore it could be used as a POCT method for the quantitative detection of NT-proBNP in blood for clinical diagnosis and research of acute heart failure.	[Yang, Xiaoli; Liu, Liping; Hao, Qingfang; Zou, Deyong; Zhang, Xiaoli; Zhang, Liping; Li, Hongmei] Chinese Peoples Armed Police Forces, Clin Lab, Gen Hosp, Beijing, Peoples R China; [Qiao, Yong; Zhao, Huansheng] Beijing Hotgen Biotech Co Ltd, Beijing, Peoples R China; [Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhou, Lei] POCT Bioemergency & Clin BZ0329, Beijing Key Lab, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, XL (corresponding author), Chinese Peoples Armed Police Forces, Clin Lab, Gen Hosp, Beijing, Peoples R China.; Zhou, L (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Zhou, L (corresponding author), POCT Bioemergency & Clin BZ0329, Beijing Key Lab, Beijing, Peoples R China.	yangxiaolitwins@163.com; ammszhoulei@163.com	liu, li/HGC-0900-2022		National Development and Reform Commission of China [[2013] 2140]; Beijing Municipal Government of China; National High Technology Research and Development Program of China [2013AA032205]; Beijing Nova Programme [Z151100000315086]; National Key Research and Development Program [2016YFC1202502]; Science and Technology Program of Guangzhou, China [2014Y200090]	National Development and Reform Commission of China; Beijing Municipal Government of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Nova Programme(Beijing Municipal Science & Technology Commission); National Key Research and Development Program; Science and Technology Program of Guangzhou, China	This study was supported by Health Program of National Development and Reform Commission of China (grant no. [2013] 2140), Science Innovation Program of Beijing Municipal Government of China (program title "magnetic beads and alkaline phosphatase chemiluminescence-based full-automatic POCT system"), the National High Technology Research and Development Program of China (no. 2013AA032205), Beijing Nova Programme (grant no. Z151100000315086), National Key Research and Development Program (no. 2016YFC1202502), and Science and Technology Program of Guangzhou, China (no. 2014Y200090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt M, 2011, CARDIOVASC J AFR, V22, P85, DOI CVJ-21.027; Caselli C, 2016, ARTERIOSCL THROM VAS, V36, P757, DOI 10.1161/ATVBAHA.115.306818; Corstjens P, 2001, CLIN CHEM, V47, P1885; Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2003, ANAL BIOCHEM, V312, P191, DOI 10.1016/S0003-2697(02)00505-5; Di Serio F, 2005, CLIN CHEM LAB MED, V43, P1263, DOI 10.1515/CCLM.2005.217; Dietl A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164060; Galvani M, 2004, CIRCULATION, V110, P128, DOI 10.1161/01.CIR.0000134480.06723.D8; Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902; Hildebrandt P, 2010, EUR HEART J, V31, P1881, DOI 10.1093/eurheartj/ehq163; Hua F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17178; Iqbal N, 2013, EXPERT REV CARDIOVAS, V11, P1155, DOI 10.1586/14779072.2013.832476; Jungbauer CG, 2012, BIOMARK MED, V6, P789, DOI [10.2217/BMM.12.67, 10.2217/bmm.12.67]; Jungbauer CG, 2010, EUR J HEART FAIL, V12, P331, DOI 10.1093/eurjhf/hfq016; Juntunen E, 2016, ANAL BIOCHEM, V492, P13, DOI 10.1016/j.ab.2015.09.009; Karl J, 1999, SCAND J CLIN LAB INV, V59, P177; Leosdottir M, 2011, SCAND CARDIOVASC J, V45, P294, DOI 10.3109/14017431.2011.581763; Liang WB, 2012, BIOSENS BIOELECTRON, V31, P480, DOI 10.1016/j.bios.2011.11.021; Lin CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147930; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep34926; McDonagh TA, 2004, EUR J HEART FAIL, V6, P269, DOI 10.1016/j.ejheart.2004.01.010; Mladosievicova B, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-86; Mokkapati VK, 2007, ANN NY ACAD SCI, V1098, P476, DOI 10.1196/annals.1384.021; Panagopoulou V, 2013, CURR TOP MED CHEM, V13, P82, DOI 10.2174/1568026611313020002; Riezebos RK, 2005, AM HEART J, V150, P1255, DOI 10.1016/j.ahj.2005.02.003; Riezebos Robert K, 2006, Acute Card Care, V8, P51, DOI 10.1080/14628840600627972; Sarzani R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153759; Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009; Taub Pam R, 2010, Congest Heart Fail, V16 Suppl 1, pS19, DOI 10.1111/j.1751-7133.2010.00168.x; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105305; Zhao Y, 2016, TALANTA, V161, P297, DOI 10.1016/j.talanta.2016.08.058; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21342; Zuiderwijk M, 2003, CLIN BIOCHEM, V36, P401, DOI 10.1016/S0009-9120(03)00057-2	35	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171376	10.1371/journal.pone.0171376	http://dx.doi.org/10.1371/journal.pone.0171376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151978	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200134
J	Jarve, A; Muhlstedt, S; Qadri, F; Nickl, B; Schulz, H; Hubner, N; Ozcelik, C; Bader, M				Jaerve, Anne; Muehlstedt, Silke; Qadri, Fatimunnisa; Nickl, Bernadette; Schulz, Herbert; Huebner, Norbert; Oezcelik, Cemil; Bader, Michael			Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction	FASEB JOURNAL			English	Article						heart; DBA; 2J; inflammation; osteoactivin; macrophages	TRANSCRIPTION FACTOR MITF; EXTRACELLULAR-MATRIX; DC-HIL; DILATED CARDIOMYOPATHY; NEUROPROTECTIVE FACTOR; TRANSMEMBRANE PROTEIN; MMP-3 EXPRESSION; SKELETAL-MUSCLE; UP-REGULATION; CELL-LINES	Cardiac diseases are the leading cause of death. Available treatment approaches are not sufficient to reverse persistent cardiac damage after injury; thus, the search for new therapeutic targets is essential. Our microarray-based screening in rat hearts 24 h after myocardial infarction (MI) yielded glycoprotein nonmetastatic melanoma protein B (GPNMB), which is known to be involved in inflammation and fibrosis after tissue injury. However, its role in the heart was elusive. We found increased cardiac expression levels of GPNMB in rats and mice after MI. Analysis of DBA/2J mice, which lack functional GPNMB due to a spontaneous point mutation, showed that systemic GPNMB deficiency was associated with preserved cardiac function and less left ventricular dilation after MI compared with DBA/2J mice with reconstituted GPNMB expression. These improvements were associated with decreased expression of matrix metalloproteinase 9, the cardiac stress genes for natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide), and -myosin heavy chain after MI. Moreover, GPNMB deficiency attenuated the dilated cardiomyopathy in muscle lim protein knockout mice but could not prevent cardiac hypertrophy induced by isoprenaline infusion. This is the first experimental study to show that GPNMB adversely influences myocardial remodeling.	[Jaerve, Anne; Muehlstedt, Silke; Qadri, Fatimunnisa; Nickl, Bernadette; Schulz, Herbert; Huebner, Norbert; Bader, Michael] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Jaerve, Anne] Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Muehlstedt, Silke; Bader, Michael] Humboldt Univ, Fac Math & Nat Sci 1, Berlin, Germany; [Muehlstedt, Silke; Nickl, Bernadette; Bader, Michael] Berlin Inst Hlth, Berlin, Germany; [Oezcelik, Cemil; Bader, Michael] Charit Univ Med, Berlin, Germany; [Bader, Michael] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany; [Schulz, Herbert] Univ Cologne, Cologne Ctr Genom, Cologne, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Berlin Institute of Health; German Centre for Cardiovascular Research; University of Lubeck; University of Cologne	Bader, M (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	mbader@mdc-berlin.de	Bader, Michael/K-2124-2013	Jarve, Anne/0000-0003-2096-0706; Bader, Michael/0000-0003-4780-4164; Nickl, Bernadette/0000-0002-1998-8157	Berlin-Brandenburg School of Regenerative Therapies	Berlin-Brandenburg School of Regenerative Therapies	This work was supported by a fellowship from the Berlin-Brandenburg School of Regenerative Therapies (to A.J.). The authors thank the following collaborators at the Max Delbruck Center for Molecular Medicine: Martin Taube and Stefanie Schelenz for assistance with echocardiography, Tanja Filipowski for technical assistance, Astrid Schiche for technical assistance in experimental MI induction, and Gabriele Born and Lisa Mallis for technical assistance in microarray hybridization and histological procedures, respectively. The authors declare no conflicts of interest.	Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-30; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Boerrigter Guido, 2009, Heart Fail Clin, V5, P501, DOI 10.1016/j.hfc.2009.04.002; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Carvalho JS, 1996, EUR HEART J, V17, P1233; Ceriani L, 2007, CLIN CHEM LAB MED, V45, P226, DOI 10.1515/CCLM.2007.040; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, J IMMUNOL, V183, P5190, DOI 10.4049/jimmunol.0901319; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dalal S, 2014, AM J PHYSIOL-HEART C, V306, pH1182, DOI 10.1152/ajpheart.00954.2013; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fiorentini C, 2014, EXP CELL RES, V323, P100, DOI 10.1016/j.yexcr.2014.02.025; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; Garcia LF, 2015, EINSTEIN-SAO PAULO, V13, P89, DOI 10.1590/S1679-45082015AO2970; Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Hutchinson KR, 2011, J APPL PHYSIOL, V111, P1778, DOI 10.1152/japplphysiol.00691.2011; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iyer RP, 2016, AM J PHYSIOL-HEART C, V311, pH190, DOI 10.1152/ajpheart.00243.2016; Kojima T, 2001, THROMB HAEMOSTASIS, V85, P793; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kumagai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143413; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Mill JG, 2011, BRAZ J MED BIOL RES, V44, P890, DOI 10.1590/S0100-879X2011000900010; Nagahara Y, 2015, J NEUROSCI RES, V93, P1552, DOI 10.1002/jnr.23619; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Omura S, 2014, CIRC-CARDIOVASC GENE, V7, DOI 10.1161/CIRCGENETICS.114.000505; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Phatharajaree W, 2007, CAN J CARDIOL, V23, P727, DOI 10.1016/S0828-282X(07)70818-8; Podesser BK, 2001, AM J PHYSIOL-HEART C, V280, pH984, DOI 10.1152/ajpheart.2001.280.3.H984; Psarras S, 2012, EUR HEART J, V33, P1954, DOI 10.1093/eurheartj/ehr119; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Scholer J, 2015, J BIOL CHEM, V290, P8154, DOI 10.1074/jbc.M114.615922; Selim AA, 2009, MED SCI MONITOR, V15, pMT19; Shi FY, 2014, J MOL NEUROSCI, V54, P234, DOI 10.1007/s12031-014-0280-0; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Takahashi R, 2011, J CARDIOL, V57, P325, DOI 10.1016/j.jjcc.2011.01.012; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yu B, 2016, J CELL BIOCHEM, V117, P1511, DOI 10.1002/jcb.25394; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	65	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					556	568		10.1096/fj.201600613R	http://dx.doi.org/10.1096/fj.201600613R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148779				2022-12-26	WOS:000394235400011
J	Qian, XL; Zhang, J; Li, PZ; Lang, RG; Li, WD; Sun, H; Liu, FF; Guo, XJ; Gu, F; Fu, L				Qian, Xiao-Long; Zhang, Jun; Li, Pei-Ze; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li			Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)	PLOS ONE			English	Article							GENE-EXPRESSION; KINASE-ACTIVITY; GROWTH; ACTIVATION; MDA-9/SYNTENIN; METASTASIS; SYNTENIN; PATTERNS; ADHESION; RESISTANT	Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The aim of this study was to investigate if SDCBP is a potential marker to indicate whether a TNBC is suitable for dasatinib therapy. This study applied co-immunoprecipitation to identify the interaction between SDCBP and c-src in TNBC cell lines. In addition, immunohistochemistry was used to investigate SDCBP and tyrosine-419 phosphorylated c-src (p-c-src-Y419) expression in TNBC tissues. SDCBP-overexpressing MDA-MB-231 cells were then constructed to evaluate the effects of dasatinib on SDCBP-induced TNBC progression in vitro and tumor formation in nude mice. We found wild-type SDCBP interacted with c-src and promoted the phosphorylation of c-src; this phosphorylation was completely blocked by dasatinib. SDCBP lacking the PDZ domain had no such effect. Among the 52 consecutive random TNBC cases examined, the expression of SDCBP was consistent with that of p-c-src-Y419, and positively correlated with histological grading or Ki-67 levels. SDCBP overexpression significantly accelerated the proliferation and cell cycle progression of the TNBC cell line MDA-MB-231; these effects were prevented by dasatinib treatment. However, the subsequent inhibition of p27 expression partially restored the proliferation and viability of the TNBC cells. The results of this study suggest that SDCBP interacts with c-src, regulates G1/S in TNBC cells, and enhances tumor cell proliferation by promoting the tyrosine phosphorylation of c-src at residue 419. Dasatinib inhibits such phosphorylation and blocks SDCBP-induced cell cycle progression. Therefore, SDCBP might be an important marker for identifying TNBC cases that are suitable for dasatinib therapy.	[Qian, Xiao-Long; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Pathol & Lab, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Zhang, Jun] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Surg, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Pei-Ze] Tianjin Polytech Univ, Dept Math, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tiangong University	Qian, XL (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Pathol & Lab, Tianjin, Peoples R China.; Qian, XL (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.; Qian, XL (corresponding author), Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.; Qian, XL (corresponding author), Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China.	xiaolong_qian36@aliyun.com			National Natural Science Foundation of China [81302292, 81272358, 81672637]; National Natural Science Foundation of Tianjin City, China [15JCQNJC45300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin City, China	This work was supported by National Natural Science Foundation of China (Grant No. 81302292 to XQ, Grant No. 81272358 to FG, Grant No. 81672637 to LF); National Natural Science Foundation of Tianjin City, China (Grant No. 15JCQNJC45300 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Agrawal M, 2010, CURR HEMATOL MALIG R, V5, P70, DOI 10.1007/s11899-010-0045-y; Aissaoui H, 2015, J BIOL CHEM, V290, P3333, DOI 10.1074/jbc.M114.606913; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Alvarez RH, 2010, CANCER, V107, P1918; Amant F, 2004, GYNECOL ONCOL, V93, P680, DOI 10.1016/j.ygyno.2004.03.021; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Brave M, 2008, CLIN CANCER RES, V14, P352, DOI 10.1158/1078-0432.CCR-07-4175; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; He T, 2015, MOL MED REP, V12, P4063, DOI 10.3892/mmr.2015.4003; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kanomata N, 2011, J CLIN PATHOL, V64, P578, DOI 10.1136/jclinpath-2011-200042; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Liedtke C, 2015, CURR OPIN OBSTET GYN, V27, P77, DOI 10.1097/GCO.0000000000000137; Liu X, 2013, J NANOMATER, V2013, DOI 10.1155/2013/938370; Morgan L, 2009, CANCER BIOL THER, V8, P1550, DOI 10.4161/cbt.8.16.8954; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Palma G, 2015, ONCOTARGET, V6, P26560, DOI 10.18632/oncotarget.5306; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Qian XL, 2016, BREAST CANCER RES TR, V159, P31, DOI 10.1007/s10549-016-3917-6; Qian XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060046; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yang Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3442; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012	49	26	26	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171169	10.1371/journal.pone.0171169	http://dx.doi.org/10.1371/journal.pone.0171169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141839	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129500047
J	Demilew, YM; Nigussie, AA				Demilew, Yeshalem Mulugeta; Nigussie, Azezu Asres			Knowledge of Health Professionals on Folic Acid Use and Their Prescribing Practice in Bahir Dar City Administration, Northwest Ethiopia: Cross-Sectional Study	PLOS ONE			English	Article								Background Taking folic acid supplement during periconception period is effective to prevent neural tube defects. Unfortunately, a minority of Ethiopian women took folic acid supplement during this period. Low consumption of folic acid might be correlated with knowledge and prescribing practice of health professionals. Therefore, this study was conducted to assess knowledge and prescribing practice of health professionals. Methods Institution based cross- sectional quantitative study supplemented by qualitative approach using thematic content analysis of in-depth interview was conducted. A total of 424 health professionals were selected by simple random sampling technique. A convenience sam-pling technique was used to generate the qualitative data. Bivariable and multivariable logis-tic regression analysis were used to identify factors associated with knowledge of health professionals. Result About 47.7% of health professionals had sufficient knowledge and 9.7% of them had prescribed folic acid to women during periconception period. Age, having work experience in ANC clinic, and being a general practitioner were independent predictors for knowledge of health professionals. Lack of guideline to use as a reference, refreshment training and clear direction from health bureau, time constraint, differing patient priorities, and competing top-ics were some of the reasons for insufficient knowledge and poor practice. Conclusion The majority of the health professionals had insufficient knowledge and poor prescribing practice on folic acid during periconception period. Lack of guideline to be used as a refer-ence, refreshment training and clear direction from health bureau, time constraint, differing patient priorities, and competing topics were some of the reasons for low level of knowledge and poor prescribing practice. Thus, guideline to use as a reference, refreshment training, incorporate the topic in the curriculum of health professionals and supportive supervision should be given to increase the knowledge and prescribing practice of health professionals. Regional Health Bureau should give priority on prevention of birth defects.	[Demilew, Yeshalem Mulugeta] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Nigussie, Azezu Asres] Bahir Dar Univ, Midwifery Dept, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Demilew, YM (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	yeshalem_mulugeta@yahoo.com						Abedi G., 2011, World Applied Sciences Journal, V12, P944; Abelman S, 2007, HLTH CARE PROVIDERS; Amhara National Regional State finance and economic development Bureau, 2015, REG POP PROJ REP; Bitzer J, 2013, INT J WOMENS HEALTH, V5, P201, DOI 10.2147/IJWH.S40149; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buttriss J., 2004, Nutrition Bulletin, V29, P234, DOI 10.1111/j.1467-3010.2004.00429.x; Eithan A, 2011, KNOWLEDGE ATTITUDES; Gaym A., 2000, Ethiopian Journal of Health Development, V14, P335; Green J., 2018, QUALITATIVE METHODS, VFourth; Hall J G, 1998, Adv Pediatr, V45, P1; Hodgetts V, 2014, BJOG; Kadir RA, 2002, CAN MED ASSOC J, V167, P255; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S2; McDonald Sarah D, 2003, J Obstet Gynaecol Can, V25, P115; Mohammed A, 2013, THERAPEUTIC INNOVATI, V47, P417; Muchowski K, 2004, J FAM PRACTICE, V53, P126; Nilsen RM, 2006, AM J CLIN NUTR, V84, P1134, DOI 10.1093/ajcn/84.5.1134; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; da Silva CAP, 2010, SAO PAULO MED J, V128, P324, DOI 10.1590/S1516-31802010000600003; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Power ML, 2000, OBSTET GYNECOL, V95, P895, DOI 10.1016/S0029-7844(00)00793-6; Rodrigues Claire R., 2012, Pharmacy Practice (Internet), V10, P168, DOI 10.4321/s1886-36552012000300007; Sean ML, 2001, J NUTR, P439; Sorri Gemechu, 2015, Ethiop Med J, V53, P119; Spencer J, 1994, QUALITATIVE DATA ANA; Strauss A., 1990, BASICS QUALITATIVE R; Talaulikar VS, 2011, OBSTET GYNECOL SURV, V66, P240, DOI 10.1097/OGX.0b013e318223614c; Williams JL, 2006, MATERN CHILD HLTH J, V10, pS67, DOI 10.1007/s10995-006-0088-9	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170116	10.1371/journal.pone.0170116	http://dx.doi.org/10.1371/journal.pone.0170116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135302	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700009
J	Sollanek, KJ; Burniston, JG; Kavazis, AN; Morton, AB; Wiggs, MP; Ahn, B; Smuder, AJ; Powers, SK				Sollanek, Kurt J.; Burniston, Jatin G.; Kavazis, Andreas N.; Morton, Aaron B.; Wiggs, Michael P.; Ahn, Bumsoo; Smuder, Ashley J.; Powers, Scott K.			Global Proteome Changes in the Rat Diaphragm Induced by Endurance Exercise Training	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HIGH-INTENSITY EXERCISE; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; INTERMYOFIBRILLAR MITOCHONDRIA; HYDROGEN-SULFIDE; DYSFUNCTION; PROTECTS; REVEALS; IDENTIFICATION	Mechanical ventilation (MV) is a life-saving intervention for many critically ill patients. Unfortunately, prolonged MV results in the rapid development of diaphragmatic atrophy and weakness. Importantly, endurance exercise training results in a diaphragmatic phenotype that is protected against ventilator-induced diaphragmatic atrophy and weakness. The mechanisms responsible for this exercise-induced protection against ventilator-induced diaphragmatic atrophy remain unknown. Therefore, to investigate exercise-induced changes in diaphragm muscle proteins, we compared the diaphragmatic proteome from sedentary and exercise-trained rats. Specifically, using label-free liquid chromatography-mass spectrometry, we performed a proteomics analysis of both soluble proteins and mitochondrial proteins isolated from diaphragm muscle. The total number of diaphragm proteins profiled in the soluble protein fraction and mitochondrial protein fraction were 813 and 732, respectively. Endurance exercise training significantly (P< 0.05, FDR < 10%) altered the abundance of 70 proteins in the soluble diaphragm proteome and 25 proteins of the mitochondrial proteome. In particular, key cytoprotective proteins that increased in relative abundance following exercise training included mitochondrial fission process 1 (Mtfp1; MTP18), 3-mercaptopyruvate sulfurtransferase (3MPST), microsomal glutathione S-transferase 3 (Mgst3; GST-III), and heat shock protein 70 kDa protein 1A/1B (HSP70). While these proteins are known to be cytoprotective in several cell types, the cyto-protective roles of these proteins have yet to be fully elucidated in diaphragm muscle fibers. Based upon these important findings, future experiments can now determine which of these diaphragmatic proteins are sufficient and/or required to promote exercise-induced protection against inactivity-induced muscle atrophy.	[Sollanek, Kurt J.; Morton, Aaron B.; Wiggs, Michael P.; Ahn, Bumsoo; Smuder, Ashley J.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Burniston, Jatin G.] Liverpool John Moores Univ, Res Inst Sport & Exercise, Liverpool, Merseyside, England; [Kavazis, Andreas N.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Sollanek, Kurt J.] Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA; [Wiggs, Michael P.] Univ Texas Tyler, Dept Hlth & Kinesiol, Tyler, TX 75799 USA; [Ahn, Bumsoo] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK USA	State University System of Florida; University of Florida; Liverpool John Moores University; Auburn University System; Auburn University; California State University System; Sonoma State University; University of Texas System; University of Texas at Tyler; Oklahoma Medical Research Foundation	Sollanek, KJ (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA.; Sollanek, KJ (corresponding author), Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA.	sollanek@sonoma.edu	Burniston, Jatin/AAB-8831-2020; Ahn, Bumsoo/AAK-3818-2021; Burniston, Jatin G/B-7833-2008; Ahn, Bumsoo/GNP-7749-2022	Burniston, Jatin/0000-0001-7303-9318; Burniston, Jatin G/0000-0001-7303-9318; Ahn, Bumsoo/0000-0002-2743-7099; Morton, Aaron/0000-0002-9790-705X	National Institutes of Health award [R01 AR064189]; AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064189] Funding Source: NIH RePORTER	National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health awarded to SKP (R01 AR064189). Moreover, this research was supported by an AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation awarded to KJS.	Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005; Alves RMP, 2010, J GERONTOL A-BIOL, V65, P832, DOI 10.1093/gerona/glq081; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Burniston JG, 2014, PROTEOMICS, V14, P2339, DOI 10.1002/pmic.201400118; Burniston JG, 2011, EXPERT REV PROTEOMIC, V8, P361, DOI [10.1586/EPR.11.17, 10.1586/epr.11.17]; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; de Oliveira BM, 2014, MOL CELL PROTEOMICS, V13, P3001, DOI 10.1074/mcp.M113.032276; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173; Gandra PG, 2012, SCAND J MED SCI SPOR, V22, P207, DOI 10.1111/j.1600-0838.2010.01235.x; Gandra PG, 2012, PROTEOMICS, V12, P2663, DOI 10.1002/pmic.201200137; Guelfi KJ, 2006, CLIN EXP PHARMACOL P, V33, P952, DOI 10.1111/j.1440-1681.2006.04470.x; Hody S, 2013, MED SCI SPORT EXER, V45, P1460, DOI 10.1249/MSS.0b013e3182894a33; Hody S, 2011, MED SCI SPORT EXER, V43, P2281, DOI 10.1249/MSS.0b013e318222edf3; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichinoseki-Sekine N, 2014, J APPL PHYSIOL, V117, P518, DOI 10.1152/japplphysiol.00170.2014; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, pH928, DOI 10.1152/ajpheart.01231.2007; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kimura H, 2011, EXP PHYSIOL, V96, P833, DOI 10.1113/expphysiol.2011.057455; LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Lewis P, 2016, AM J RESP CELL MOL, V55, P12, DOI 10.1165/rcmb.2015-0272OC; Liping-zhao, 2012, BIOL RES, V45, P75, DOI 10.4067/S0716-97602012000100010; LOCKE M, 1995, AM J PHYSIOL-HEART C, V269, pH320, DOI 10.1152/ajpheart.1995.269.1.H320; Magherini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071839; Magherini F, 2012, J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Malm C, 2012, HISTOCHEM CELL BIOL, V138, P89, DOI 10.1007/s00418-012-0946-z; Matsumura CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065831; Morton JP, 2006, J APPL PHYSIOL, V101, P176, DOI 10.1152/japplphysiol.00046.2006; Morton JP, 2009, SPORTS MED, V39, P643, DOI 10.2165/00007256-200939080-00003; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Naylor DJ, 1998, J BIOL CHEM, V273, P21169, DOI 10.1074/jbc.273.33.21169; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Paulsen G, 2007, AM J PHYSIOL-REG I, V293, pR844, DOI 10.1152/ajpregu.00677.2006; Picard M, 2012, AM J RESP CRIT CARE; Picard M, 2015, J APPL PHYSIOL, V118, P1161, DOI 10.1152/japplphysiol.00873.2014; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, ANTIOXID REDOX SIGN, V15, P2519, DOI 10.1089/ars.2011.3973; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009; Predmore Benjamin L, 2011, Expert Rev Clin Pharmacol, V4, P83, DOI 10.1586/ecp.10.56; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Salah H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7099; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Shen Y, 2010, BIOCHIMIE, V92, P530, DOI 10.1016/j.biochi.2010.02.001; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Sollanek KJ, 2015, J APPL PHYSIOL, V118, P849, DOI 10.1152/japplphysiol.00797.2014; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Tondera D, 2004, J BIOL CHEM, V279, P31544, DOI 10.1074/jbc.M404704200; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Vassilakopoulos T, 2008, INTENS CARE MED, V34, P7, DOI 10.1007/s00134-007-0866-x; Wang C, 2009, INT J FOOD SCI NUTR, V1, P1, DOI DOI 10.1109/IWQ0S.2009.5201385; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Xiao RJ, 2011, APOPTOSIS, V16, P221, DOI 10.1007/s10495-010-0566-9; Yamaguchi W, 2010, J BIOCHEM, V148, P327, DOI 10.1093/jb/mvq073; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	71	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171007	10.1371/journal.pone.0171007	http://dx.doi.org/10.1371/journal.pone.0171007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135290	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000396124700038
J	Zhang, X; Mu, YN; Mu, PF; Ao, JQ; Chen, XH				Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua			Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; AEROMONAS-SALMONICIDA; EXPRESSION ANALYSIS; EXOGENOUS ANTIGENS; READ ALIGNMENT; FISH; RECEPTOR; INTERLEUKIN-1-BETA; PATHWAYS; HOMOLOG	Vaccination is an effective and safe strategy for combating bacterial diseases in fish, but the mechanisms underlying the early immune response after vaccination remain to be elucidated. In the present study, we used RNA-seq technology to perform transcriptome analysis of spleens from large yellow croaker (Larimichthys crocea) induced by inactivated trivalent bacterial vaccine (Vibrio parahaemolyticus, Vibrio alginolyticus and Aeromonas hydrophila). A total of 2,789 or 1,511 differentially expressed genes (DEGs) were obtained at 24 or 72 h after vaccination, including 1,132 or 842 remarkably up-regulated genes and 1,657 or 669 remarkably down-regulated genes, respectively. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichments revealed that numerous DEGs belong to immune-relevant genes, involved in many immune-relevant pathways. Most of the strongly up-regulated DEGs are innate defense molecules, such as antimicrobial peptides, complement components, lectins, and transferrins. Trivalent bacterial vaccine affected the expressions of many components associated with bacterial ligand-depending Toll-like receptor signaling pathways and inflammasome formation, indicating that multiple innate immune processes were activated at the early period of vaccination in large yellow croaker. Moreover, the expression levels of genes involved in antigen processing were also up-regulated by bacterial vaccine. However, the expression levels of several T cell receptors and related CD molecules and signal transducers were down-regulated, suggesting that the T cell receptor signaling pathway was rapidly suppressed after vaccination. These results provide the comprehensive insights into the early immune response of large yellow croaker to vaccination and valuable information for developing a highly immunogenic vaccine against bacterial infection in teleosts.	[Zhang, Xin; Mu, Yinnan] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China; [Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua] Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China; [Chen, Xinhua] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ningbo University; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Chen, XH (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China.; Chen, XH (corresponding author), Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.; Chen, XH (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	chenxinhua@tio.org.cn			National Natural Science Foundation of China [31530080, 31372556]; National Basic Research Program of China [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31530080 and 31372556) and National Basic Research Program of China (2015CB755903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Ali CER, 2014, FRONT GENET, V5, P1027; Ao JQ, 2015, INT J MOL SCI, V16, P29631, DOI 10.3390/ijms161226175; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Basu M, 2012, FISH SHELLFISH IMMUN, V32, P121, DOI 10.1016/j.fsi.2011.10.031; Caipang CMA, 2009, COMP BIOCHEM PHYS B, V153, P261, DOI 10.1016/j.cbpb.2009.03.005; Campbell DJ, 2000, J IMMUNOL, V164, P168, DOI 10.4049/jimmunol.164.1.168; [曹军 CAO Jun], 2007, [湖北农业科学, Hubei Agricultural Sciences], V46, P808; Chen Q, 2008, DIS AQUAT ORGAN, V80, P181, DOI 10.3354/dao01933; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; DEC C, 1990, J FISH DIS, V13, P369, DOI 10.1111/j.1365-2761.1990.tb00795.x; Dijkstra JM, 2001, FISH SHELLFISH IMMUN, V11, P437, DOI 10.1006/fsim.2001.0351; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Ewart KV, 2001, ICES J MAR SCI, V58, P380, DOI 10.1006/jmsc.2000.1020; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Guo BY, 2016, FISH SHELLFISH IMMUN, V51, P211, DOI 10.1016/j.fsi.2016.01.015; Hong WS, 2003, AQUACULTURE, V227, P305, DOI 10.1016/S0044-8486(03)00511-8; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SY, 2009, DEV COMP IMMUNOL, V33, P1268, DOI 10.1016/j.dci.2009.07.008; Martin SAM, 2006, MOL IMMUNOL, V43, P1900, DOI 10.1016/j.molimm.2005.10.007; Mellman I, 2010, CURR OPIN IMMUNOL, V22, P78, DOI 10.1016/j.coi.2010.01.013; Mu YN, 2015, FISH SHELLFISH IMMUN, V44, P462, DOI 10.1016/j.fsi.2015.03.026; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Mu YN, 2010, DEV COMP IMMUNOL, V34, P300, DOI 10.1016/j.dci.2009.10.009; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Qi ZT, 2016, FISH SHELLFISH IMMUN, V49, P194, DOI 10.1016/j.fsi.2015.12.029; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; Reimann J, 1997, CURR OPIN IMMUNOL, V9, P462, DOI 10.1016/S0952-7915(97)80096-9; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Tian C, 2010, FISH SHELLFISH IMMUN, V28, P445, DOI 10.1016/j.fsi.2009.11.024; Villumsen KR, 2015, FISH SHELLFISH IMMUN, V42, P193, DOI 10.1016/j.fsi.2014.09.024; Villumsen KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093845; Vojtech LN, 2012, INFECT IMMUN, V80, P2878, DOI 10.1128/IAI.00543-12; Wang HL, 2015, FISH SHELLFISH IMMUN, V42, P272, DOI 10.1016/j.fsi.2014.11.006; [汪玉华 Wang Yuhua], 2013, [应用海洋学学报, Journal of Applied Oceanography], V32, P383; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wei YC, 2011, VET IMMUNOL IMMUNOP, V141, P173, DOI 10.1016/j.vetimm.2011.02.016; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wu Z.P., 2004, J XIAMEN UNIV-NAT SC, V43, P112; Yan Q., 2001, J JIMEI U NAT SCI, V3, P191, DOI [10.19715/j.jmuzr.2001.03.001, DOI 10.19715/J.JMUZR.2001.03.001]; Yang DH, 2013, DEV COMP IMMUNOL, V40, P132, DOI 10.1016/j.dci.2013.01.014; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yang Y, 2016, FISH SHELLFISH IMMUN, V51, P329, DOI 10.1016/j.fsi.2016.02.035; Zhang X, 2015, FISH SHELLFISH IMMUN, V43, P209, DOI 10.1016/j.fsi.2014.11.018; Zheng WB, 2007, IMMUNOL LETT, V113, P107, DOI 10.1016/j.imlet.2007.08.001; Zhu JJ, 2015, FISH SHELLFISH IMMUN, V46, P346, DOI 10.1016/j.fsi.2015.06.027	56	13	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170958	10.1371/journal.pone.0170958	http://dx.doi.org/10.1371/journal.pone.0170958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135311	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700034
J	Gosselin, A; Lelievre, E; Ravalihasy, A; Lydie, N; Lert, F; du Lou, AD				Gosselin, Anne; Lelievre, Eva; Ravalihasy, Andrainolo; Lydie, Nathalie; Lert, France; du Lou, Annabel Desgrees		Parcours Study Grp	"Times Are Changing": The Impact of HIV Diagnosis on Sub-Saharan Migrants' Lives in France	PLOS ONE			English	Article							OCCUPATIONAL TRAJECTORIES; EMPLOYMENT; FAMILY; LIFE; NORMALIZATION; IMMIGRANTS; DISEASE; HEALTH; AIDS	Background Migrants account for 35% of HIV diagnoses in the European Union (ECDC/WHO 2014). Little is known about the impact of such a lifelong infection diagnosis on lives that are already disrupted by migration. In this paper, we assess the impact of HIV diagnosis on activity, union, well-being among African migrants living in France, the second group most affected by HIV after MSM. We compare it with the impact of the diagnosis of Hepatitis B, another lifelong infection affecting African migrants. Methods We use the ANRS PARCOURS survey, a retrospective life-event survey led in 2012-2013 in 74 health structures in Paris greater area which collected 926 life histories of Sub-Saharan migrants living with HIV and 779 with Hepatitis B. We modelled the probability year by year since 18 years of age until data collection to lose one's activity, to experience a conjugal break up and degradation of well-being and we estimated the impact of migration and of HIV and Hepatitis B diagnoses on these probabilities, after adjustment on other factors, thanks to discrete-time logistic regressions. Results Migration entailed loss of activity and conjugal break up, though HIV diagnosis after migration did not statistically impact on these outcomes. Yet HIV diagnosis had a massive negative impact on well-being (aOR = 11.31 [4.64-27.56] for men and 5.75 [2.79 -11.86] for women). This negative impact on well-being tended to diminish for persons diagnosed after 2004. The negative impact of HIV diagnosis on African migrants' well-being seems to be attenuated in the last decade, which hints at a normalization of the subjective experience of HIV diagnosis.	[Gosselin, Anne; Ravalihasy, Andrainolo; du Lou, Annabel Desgrees] Univ Paris 05, IRD, UMR 196, CEPED, 45 Rue St Peres, Paris, France; [Gosselin, Anne; Lelievre, Eva] INED French Inst Demog Studies, 133 Bd Devout, Paris, France; [Lydie, Nathalie] Sante Publ France, Site Carrefour Pleyel,42 Bd Liberat, St Denis, France; [Lert, France] Hop Paul Brousse, CESP, INSERM, Villejuif, France; [du Lou, Annabel Desgrees] IRD, 44 Bd Dunkerque, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut de Recherche pour le Developpement (IRD)	Gosselin, A (corresponding author), Univ Paris 05, IRD, UMR 196, CEPED, 45 Rue St Peres, Paris, France.; Gosselin, A (corresponding author), INED French Inst Demog Studies, 133 Bd Devout, Paris, France.	anne.gosselin@ceped.org	Gosselin, Anne/ABA-1571-2020; Le Strat, Yann/C-9848-2013	Gosselin, Anne/0000-0002-6876-8249; Desgrees du Lou, annabel/0000-0002-2223-5316; Ravalihasy, Andrainolo/0000-0003-0880-6319; Le Strat, Yann/0000-0002-6180-4200; Pourette, Dolores/0000-0002-3599-8806; Dray-Spira, Rosemary/0000-0001-7646-3667	French National Agency for research on AIDS and Viral hepatitis (ANRS); General Direction of Health (DGS, French Ministry of Health); National Institute for Prevention and Education for Health (INPES)	French National Agency for research on AIDS and Viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); General Direction of Health (DGS, French Ministry of Health); National Institute for Prevention and Education for Health (INPES)	This study was supported by the French National Agency for research on AIDS and Viral hepatitis (ANRS), the General Direction of Health (DGS, French Ministry of Health) and the National Institute for Prevention and Education for Health (INPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AG had full access to all the data and final responsibility for the decision to submit for publication.; This study was supported by the French National Agency for research on AIDS and Viral hepatitis (ANRS), the General Direction of Health (DGS, French Ministry of Health) and the National Institute for Prevention and Education for Health (INPES). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation or writing of the paper.	Akresh IR, 2008, POPUL DEV REV, V34, P435, DOI 10.1111/j.1728-4457.2008.00231.x; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Annequin M, 2015, AIDS, V29, P1537, DOI 10.1097/QAD.0000000000000722; Atkinson P., 1997, QUAL INQ, V3, P304, DOI DOI 10.1177/107780049700300304; Baizan P, 2014, EUR J POPUL, V30, P65, DOI 10.1007/s10680-013-9305-6; Block L, 2013, EUR J MIGR LAW, V15, P203, DOI 10.1163/15718166-12342031; BOURDIEU P, 1986, ACTES RECHERCHE SCI, V62-63, P69, DOI DOI 10.3406/ARSS.1986.2317; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CARRICABURU D, 1995, SOCIOL HLTH ILLN, V17; Cazein F, 2015, B EPIDEMIOLOGIQUE HE, P9; Desclaux A, 2014, Bull Soc Pathol Exot, V107, P244, DOI 10.1007/s13149-014-0347-8; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; Desgrees-du-Lou A, 2009, SOC SCI MED, V69, P892, DOI 10.1016/j.socscimed.2009.05.045; Dray-Spira R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000255079.39352.9b; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Gerbier-Aublanc M, 2016, THESIS; Heggebo K, 2015, SOC SCI MED, V130, P115, DOI 10.1016/j.socscimed.2015.02.010; Institut national de veille sanitaire, 2009, NUM THEM SURV PREV H; Le Coeur S, 2005, POPULATION, V60, P551, DOI 10.3917/popu.504.0551; Lelievre E, 2016, 33 CEPED; Lellevre E, 2015, B SOCIOL METHODOL, V125, P125; Lert F., 2014, VIVRE AVEC VIH DOM E; Lert F, 2013, 2627 I NAT VEILL SAN; Marsicano E, 2014, AIDS CARE, V26, pS97, DOI 10.1080/09540121.2014.907385; Mazanderani F, 2015, SOC SCI MED, V131, P66, DOI 10.1016/j.socscimed.2015.02.041; Minton JW, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2316; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Obucina O, 2013, DEMOGR RES, V28, P547, DOI 10.4054/DemRes.2013.28.19; Pailhe A, 2013, LONGITUD LIFE COURSE, V4, P196; Pierret J, 2007, SOC SCI MED, V65, P1595, DOI 10.1016/j.socscimed.2007.06.017; Pourette D, 2013, SANTE PUBLIQUE, V25, P561, DOI 10.3917/spub.135.0561; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Rosen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012731; Rosenbrock R, 2000, SOC SCI MED, V50, P1607, DOI 10.1016/S0277-9536(99)00469-4; Smith JH, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-47; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tsai AC, 2013, AIDS BEHAV, V17, P2725, DOI 10.1007/s10461-013-0503-3; UNAIDS, 2014, GLOB STAT FACT SHEET	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170226	10.1371/journal.pone.0170226	http://dx.doi.org/10.1371/journal.pone.0170226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129342	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400060
J	Lund, KT; Riaz, S; Walker, MA				Lund, Karl T.; Riaz, Summaira; Walker, M. Andrew			Population Structure, Diversity and Reproductive Mode of the Grape Phylloxera (Daktulosphaira vitifoliae) across Its Native Range	PLOS ONE			English	Article							LIFE-CYCLE VARIATION; GENETIC-STRUCTURE; HOST-PLANT; HOMOPTERA; APHID; PEST; DNA; SPECIALIZATION; HEMIPTERA; EXPANSION	Grape Phylloxera, Daktulosphaira vitifoliae, is a gall-forming insect that feeds on the leaves and roots of many Vitis species. The roots of the cultivated V. vinifera cultivars and hybrids are highly susceptible to grape phylloxera feeding damage. The native range of this insect covers most of North America, and it is particularly abundant in the eastern and central United States. Phylloxera was introduced from North America to almost all grape-growing regions across five of the temperate zone continents. It devastated vineyards in each of these regions causing large-scale disruptions to grape growers, wine makers and national economies. In order to understand the population diversity of grape phylloxera in its native range, more than 500 samples from 19 States and 34 samples from the introduced range (northern California, Europe and South America) were genotyped with 32 simple sequence repeat markers. STRUCTURE, a model based clustering method identified five populations within these samples. The five populations were confirmed by a neighbor-joining tree and principal coordinate analysis (PCoA). These populations were distinguished by their Vitis species hosts and their geographic locations. Samples collected from California, Europe and South America traced back to phylloxera sampled in the northeastern United States on V. riparia, with some influence from phylloxera collected along the Atlantic Coast and Central Plains on V. vulpina. Reproductive statistics conclusively confirmed that sexual reproduction is common in the native range and is combined with cyclical parthenogenesis. Native grape phylloxera populations were identified to be under Hardy-Weinberg equilibrium. The identification of admixed samples between many of these populations indicates that shared environments facilitate sexual reproduction between different host associated populations to create new genotypes of phylloxera. This study also found that assortative mating might occur across the sympatric range of the V. vulpina west and V. cinerea populations.	[Lund, Karl T.; Riaz, Summaira; Walker, M. Andrew] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Walker, MA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	awalker@ucdavis.edu		Riaz, Summaira/0000-0001-7739-144X	California Grape Rootstock Improvement Commission [08-004533]	California Grape Rootstock Improvement Commission	This work was supported by the California Grape Rootstock Improvement Commission, 08-004533.	Cao J, 2011, J ECON ENTOMOL, V105, P583; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Clarke LJ, 2013, J BIOGEOGR, V40, P1071, DOI 10.1111/jbi.12066; Corrie AM, 2004, HEREDITY, V92, P118, DOI 10.1038/sj.hdy.6800393; Corrie AM, 2002, HEREDITY, V88, P203, DOI 10.1038/sj.hdy.6800028; Corrie AM, 2003, B ENTOMOL RES, V93, P193, DOI 10.1079/BER2003232; DEBENEDICTIS JA, 1992, J ECON ENTOMOL, V85, P1527, DOI 10.1093/jee/85.4.1527; Delmotte F, 2014, PROPOSAL SEQUENCE GE; Dickey AM, 2012, ENTOMOL EXP APPL, V143, P127, DOI 10.1111/j.1570-7458.2012.01250.x; Downie D, 1998, SOUTHWEST ENTOMOL, V23, P11; Downie DA, 2000, ENVIRON ENTOMOL, V29, P979, DOI 10.1603/0046-225X-29.5.979; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Forneck A, 2000, GENOME, V43, P669, DOI 10.1139/gen-43-4-669; Forneck A, 2009, ENTOMOL EXP APPL, V131, P1, DOI 10.1111/j.1570-7458.2008.00811.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; GRANETT J, 1987, J ECON ENTOMOL, V80, P327, DOI 10.1093/jee/80.2.327; Guillemaud T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021263; Herbert KS, 2010, B ENTOMOL RES, V100, P671, DOI 10.1017/S0007485310000027; Jaquiery J, 2012, MOL ECOL, V21, P5251, DOI 10.1111/mec.12048; LIDER LLOYD A., 1958, HILGARDIA, V27, P287; Lin H, 2006, AM J ENOL VITICULT, V57, P33; Lin H, 1996, VITIS, V35, P87; Lin H, 1999, ANN ENTOMOL SOC AM, V92, P376, DOI 10.1093/aesa/92.3.376; Lund KT, 2013, THESIS; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; Mitchell SG, 2013, QUATERNARY RES, V79, P274, DOI 10.1016/j.yqres.2012.11.001; Munson T.V., 1909, FDN AM GRAPE CULTURE; NEI M, 1978, GENETICS, V89, P583; Park SDE, 2001, THESIS; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Powell KS, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P96, DOI 10.1079/9781845934613.0096; Pritchard JK, 2000, GENETICS, V155, P945; Riaz S, 2014, VITIS, V53, P95; Riaz S, 2016, AM J ENOLOGY VITICUL; Sandrock C, 2011, MOL ECOL, V20, P4165, DOI 10.1111/j.1365-294X.2011.05242.x; Sha QY, 2011, GENET EPIDEMIOL, V35, P671, DOI 10.1002/gepi.20617; Smadja CM, 2012, EVOLUTION, V66, P2723, DOI 10.1111/j.1558-5646.2012.01612.x; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; Tennessen JA, 2008, COPEIA, P558, DOI 10.1643/CG-06-038; Vorwerk S, 2006, GENOME, V49, P678, DOI 10.1139/G06-028; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woolaver LG, 2013, CONSERV GENET, V14, P559, DOI 10.1007/s10592-013-0444-4; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang B, 2012, MOL ECOL, V21, P2130, DOI 10.1111/j.1365-294X.2012.05517.x	52	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170678	10.1371/journal.pone.0170678	http://dx.doi.org/10.1371/journal.pone.0170678			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125736	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100075
J	Winn, NC; Grunewald, ZI; Liu, Y; Heden, TD; Nyhoff, LM; Kanaley, JA				Winn, Nathan C.; Grunewald, Zachary I.; Liu, Ying; Heden, Timothy D.; Nyhoff, Lauren M.; Kanaley, Jill A.			Plasma Irisin Modestly Increases during Moderate and High-Intensity Afternoon Exercise in Obese Females	PLOS ONE			English	Article							FNDC5 GENE-EXPRESSION; SKELETAL-MUSCLE; CIRCULATING IRISIN; PHYSICAL-ACTIVITY; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; AEROBIC EXERCISE; ADIPOSE-TISSUE; HEALTHY; HUMANS	Background and Purpose Irisin is an exercise-responsive myokine that has been proposed to exert anti-obesity benefits; yet its response during exercise in obese women is not described. This study characterized plasma irisin levels during a single bout of afternoon isocaloric-exercise of different intensities (moderate-vs high-intensity) in obese females. Methods Eleven obese females participated in 3 randomized study days beginning at 1600h: 1) no exercise (NoEx), 2) moderate exercise (ModEx; 55% VO(2)max) and 3) high intensity interval exercise (IntEx; 4 min (80%VO(2)max)/3 min (50% VO(2)max). Frequent blood samples were analyzed for glucose and lactate (whole-blood), and insulin, c-peptide, glucagon, and irisin (plasma) throughout 190 min of testing. Results Plasma irisin increased above baseline during ModEx and IntEx (P<0.05), but not NoEx (P>0.05). Peak irisin levels during ModEx and IntEx exercise were 11.9 +/- 3.4% and 12.3 +/- 4.1% relative to baseline (P<0.05), respectively, with no differences between exercise intensities (P>0.05). Irisin levels remained elevated above resting for 125 minutes post-exercise during ModEx, whereas levels returned to baseline within 15 minutes post-exercise during IntEx. Similarly, no associations were found between plasma irisin levels and circulating lactate, glucose, insulin, c-peptide, or glucagon among study days (P>0.05). However, there was an inverse association between basal irisin and lean mass (r = -0.70, P = 0.01). Conclusion A single bout of moderate and high intensity afternoon exercise induces modest increases in circulating irisin concentrations during exercise; however the regulation post-exercise appears to be dimorphic between exercise intensity in obese females. Future studies are needed to compare morning and afternoon exercise on irisin secretion.	[Winn, Nathan C.; Grunewald, Zachary I.; Liu, Ying; Nyhoff, Lauren M.; Kanaley, Jill A.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Heden, Timothy D.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC USA; [Heden, Timothy D.] East Carolina Univ, Dept Kinesiol, Greenville, NC USA	University of Missouri System; University of Missouri Columbia; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Kanaley, JA (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.	kanaleyj@missouri.edu	Winn, Nathan/X-6390-2019	Winn, Nathan/0000-0002-5276-0592	National Institute of Health [R21DK084467-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084467] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Health R21DK084467-01 (NIDDK.nih.gov) role of sponsor in design etc: no role	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouchard C, 1991, SPORTS EI EXERCISE E, V23, P643; Cartee GD, 2015, AM J PHYSIOL-ENDOC M, V309, pE949, DOI 10.1152/ajpendo.00416.2015; Chen JQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/1476-511X-14-2; Chtourou H, 2012, J STRENGTH COND RES, V26, P1984, DOI 10.1519/JSC.0b013e31825770a7; Daskalopoulou SS, 2014, EUR J ENDOCRINOL, V171, P343, DOI 10.1530/EJE-14-0204; Ellefsen S, 2014, EUR J APPL PHYSIOL, V114, P1875, DOI 10.1007/s00421-014-2922-x; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hew-Butler T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12262; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Huh J Young, 2014, J CLIN ENDOCRINOLOGY; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Kanaley JA, 2014, INT J OBESITY, V38, P266, DOI 10.1038/ijo.2013.84; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Nygaard H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121367; Nyhoff LM, 2015, PEPTIDES, V71, P94, DOI 10.1016/j.peptides.2015.07.004; Ost M, 2016, FREE RADICAL BIO MED, V98, P78, DOI 10.1016/j.freeradbiomed.2016.02.018; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Polyzos SA, 2015, METABOLISM, V64, P1611, DOI 10.1016/j.metabol.2015.09.001; Polyzos SA, 2015, METABOLISM, V64, P937, DOI 10.1016/j.metabol.2015.06.005; Qiu SH, 2015, SPORTS MED, V45, P1577, DOI 10.1007/s40279-014-0293-4; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rohling M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2868652; Sanchis-Gomar F, 2014, HORM METAB RES, V46, P591, DOI 10.1055/s-0033-1363283; Sanchis-Gomar F, 2014, HORMONE METABOLIC RE; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Thyfault JP, 2008, AM J PHYSIOL-REG I, V294, pR1103, DOI [10.1152/ajpregu.00542.2007, 10.1152/ajpregu.00924.2007]; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tsuchiya Y, 2015, METABOLISM, V64, P1042, DOI 10.1016/j.metabol.2015.05.010; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031; Xin C, 2016, INT J OBESITY, V40, P443, DOI 10.1038/ijo.2015.199; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	53	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170690	10.1371/journal.pone.0170690	http://dx.doi.org/10.1371/journal.pone.0170690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125733	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100072
J	Ertan, NZ; Bozfakioglu, S; Ugurel, E; Sinan, M; Yalcin, O				Ertan, Nesrin Zeynep; Bozfakioglu, Semra; Ugurel, Elif; Sinan, Mukaddes; Yalcin, Ozlem			Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysis	PLOS ONE			English	Article							OSMOTIC GRADIENT EKTACYTOMETRY; OXIDATIVE STRESS; ELONGATION INDEX; ANALYZER LORCA; HEMODIALYSIS; DEFORMABILITY; FAILURE; EFFICIENCY; SURVIVAL; CHANNELS	In this study, we investigated the effects of peritoneal dialysis on hemorheological and hematological parameters and their relations with oxidant and antioxidant status of uremic patients. Hemorheological parameters (erythrocyte deformability, erythrocyte aggregation, osmotic deformability, blood and plasma viscosity) were measured in patients with renal insufficiency undergoing peritoneal dialysis (PD) and volunteers. Erythrocyte deformability, osmotic deformability and aggregation in both autologous plasma and 3% dextran 70 were measured by laser diffraction ektacytometry. Enzyme activities of glutathione peroxidase, superoxide dismutase and catalase were studied in erythrocytes; lipid peroxidation was studied by measuring the amount of malondialdehyde in both erythrocytes and plasma samples. Blood viscosity at native hematocrit was significantly lower in PD patients at all measured shear rates compared to controls, but it was high in PD patients at corrected (45%) hematocrit. Erythrocyte deformability did not show any difference between the two groups. Osmotic deformability was significantly lower in PD patients compared to controls. Aggregation index values were significantly high in PD patients in plasma Catalase and glutathione peroxidase activities in erythrocytes were decreased in PD patients whereas superoxide dismutase activity was increased compared to controls. Malondialdehyde was significantly increased in erythrocytes and plasma samples of PD patients which also shows correlations with aggregation parameters. It has been concluded that erythrocytes in PD patients are more prone to aggregation and this tendency could be influenced by lipid peroxidation activity in patient's plasma. These results imply that uremic conditions, loss of plasma proteins and an increased risk of oxidative stress because of decreasing levels of antioxidant enzymes affect erythrocyte rheology during peritoneal dialysis. This level of distortion may have crucial effects, impairing the blood flow dynamics and causing inadequate microcirculatory perfusion.	[Ertan, Nesrin Zeynep; Sinan, Mukaddes] Istanbul Univ, Dept Physiol, Istanbul, Turkey; [Bozfakioglu, Semra] Istanbul Univ, Dept Nephrol, Istanbul, Turkey; [Ugurel, Elif; Yalcin, Ozlem] Koc Univ, Dept Physiol, Istanbul, Turkey	Istanbul University; Istanbul University; Koc University	Yalcin, O (corresponding author), Koc Univ, Dept Physiol, Istanbul, Turkey.	ozlemyalcin@ku.edu.tr	Yalcin, Ozlem/AAF-4036-2019	Yalcin, Ozlem/0000-0001-5547-6653	Seed Fund of Koc University [00006]; Research Foundation of Istanbul University [55613]	Seed Fund of Koc University; Research Foundation of Istanbul University(Istanbul University)	This study was supported by the Seed Fund of Koc University (No: 00006) and the Research Foundation of Istanbul University (No: 55613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi AF, 2004, SAUDI MED J, V25, P1186; Baskurt OK, 2009, SCAND J CLIN LAB INV, V69, P777, DOI 10.3109/00365510903266069; Borzych-Duzalka D, 2013, J AM SOC NEPHROL, V24, P665, DOI 10.1681/ASN.2012050433; CASATI S, 1989, NEPHROL DIAL TRANSPL, V4, P718, DOI 10.1093/ndt/4.8.718; CASATI S, 1987, BMJ-BRIT MED J, V295, P1017, DOI 10.1136/bmj.295.6605.1017; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; Clermont G, 2000, CARDIOVASC RES, V47, P618, DOI 10.1016/S0008-6363(00)00117-6; DORMANDY J, 1985, CLIN HEMORHEOL, V5, P975; FERIANI M, 1992, AM J KIDNEY DIS, V19, P131, DOI 10.1016/S0272-6386(12)70121-X; Fontana F, 2016, CLIN HEMORH IN PRESS; Guo CH, 2011, PERITON DIALYSIS INT, V31, P583, DOI 10.3747/pdi.2009.00225; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; HARDEMAN MR, 1994, CLIN HEMORHEOL, V14, P619; Heimburger O, 2015, HDB DIALYSIS, P408; Ibrahim FF, 2002, RENAL FAILURE, V24, P779, DOI 10.1081/JDI-120015680; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang KS, 2004, AM J PHYSIOL-RENAL, V286, pF1046, DOI 10.1152/ajprenal.00263.2003; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Martin-Mateo MC, 1998, RENAL FAILURE, V20, P117, DOI 10.3109/08860229809045094; MCGRATH LT, 1995, CLIN CHIM ACTA, V235, P179, DOI 10.1016/0009-8981(95)06027-X; McGregor D, 2000, NEPHRON, V85, P215, DOI 10.1159/000045664; MOHANDAS N, 1980, J CLIN INVEST, V66, P563, DOI 10.1172/JCI109888; Nemeth N, 2015, SCAND J CLIN LAB INV, V75, P213, DOI 10.3109/00365513.2014.993695; Nowak-Piszczek E, 2003, CLIN HEMORHEOL MICRO, V28, P251; Piagnerelli M, 2003, INTENS CARE MED, V29, P1052, DOI 10.1007/s00134-003-1783-2; Pietrzycka A, 2010, NEPHROL DIAL POL, V14, P22; Puchades MJ, 2013, CLIN NEPHROL, V80, P177, DOI 10.5414/CN107639; Sotirakopoulos N, 2004, RENAL FAILURE, V26, P179, DOI 10.1081/JDI-120038517; Stepniewska J, 2014, BLOOD PURIFICAT, V37, P4, DOI 10.1159/000356806; Szikszai Z, 2003, CLIN HEMORHEOL MICRO, V28, P201; TAYLOR JE, 1992, PERITON DIALYSIS INT, V12, P221; Vos FE, 2011, AM J KIDNEY DIS, V58, P591, DOI 10.1053/j.ajkd.2011.03.031	34	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171371	10.1371/journal.pone.0171371	http://dx.doi.org/10.1371/journal.pone.0171371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158274	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700070
J	Hsieh, KLC; Tsai, RJ; Teng, YC; Lo, CM				Hsieh, Kevin Li-Chun; Tsai, Ruei-Je; Teng, Yu-Chuan; Lo, Chung-Ming			Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIOBLASTOMA-MULTIFORME; GENE-EXPRESSION; BREAST MASSES; CLASSIFICATION; ASTROCYTOMA; POPULATION; TUMORS	The effects of a computer-aided diagnosis (CAD) system based on quantitative intensity features with magnetic resonance (MR) imaging (MRI) were evaluated by examining radiologists' performance in grading gliomas. The acquired MRI database included 71 lower-grade gliomas and 34 glioblastomas. Quantitative image features were extracted from the tumor area and combined in a CAD system to generate a prediction model. The effect of the CAD system was evaluated in a two-stage procedure. First, a radiologist performed a conventional reading. A sequential second reading was determined with a malignancy estimation by the CAD system. Each MR image was regularly read by one radiologist out of a group of three radiologists. The CAD system achieved an accuracy of 87% (91/105), a sensitivity of 79% (27/34), a specificity of 90% (64/71), and an area under the receiver operating characteristic curve (Az) of 0.89. In the evaluation, the radiologists' Az values significantly improved from 0.81, 0.87, and 0.84 to 0.90, 0.90, and 0.88 with p = 0.0011, 0.0076, and 0.0167, respectively. Based on the MR image features, the proposed CAD system not only performed well in distinguishing glioblastomas from lower-grade gliomas but also provided suggestions about glioma grading to reinforce radiologists' confidence rating.	[Hsieh, Kevin Li-Chun; Tsai, Ruei-Je; Teng, Yu-Chuan] Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Hsieh, Kevin Li-Chun] Taipei Med Univ, Coll Med, Res Ctr Translat Imaging, Taipei, Taiwan; [Lo, Chung-Ming] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Lo, CM (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan.	buddylo@tmu.edu.tw		Lo, Chung-Ming/0000-0001-5068-6002; Tsai, Ruei-Je/0000-0002-7403-9130	Ministry of Science and Technology in Taiwan [MOST 104-2218-E-038-004, MOST 105-2314-B-038-04]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by The Ministry of Science and Technology in Taiwan [https://www.most.gov.tw/?l-en] (MOST 104-2218-E-038-004 and MOST 105-2314-B-038-04) to KH and CML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Bai X, 2011, NEURORADIOLOGY, V53, P533, DOI 10.1007/s00234-011-0846-2; Blasberg RG, 2007, CLIN CANCER RES, V13, P3444, DOI 10.1158/1078-0432.CCR-07-0936; Boroczky L, 2013, AM J ROENTGENOL, V200, P277, DOI 10.2214/AJR.12.8718; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Perez-Larraya JG, 2014, ONCOLOGIST, V19, P1258, DOI 10.1634/theoncologist.2014-0170; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; Gur D, 2006, AM J ROENTGENOL, V187, P1474, DOI 10.2214/AJR.06.1384; Guzman-De-Villoria JA, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0035-8; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hsieh KLC, 2017, COMPUT METH PROG BIO, V139, P31, DOI 10.1016/j.cmpb.2016.10.021; Jackson A, 2007, CLIN CANCER RES, V13, P3449, DOI 10.1158/1078-0432.CCR-07-0238; Kim SH, 2011, CLIN NEUROPATHOL, V30, P328, DOI 10.5414/NP300404; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Litjens GJS, 2015, EUR RADIOL, V25, P3187, DOI 10.1007/s00330-015-3743-y; Lo CM, 2015, COMPUT METH PROG BIO, V122, P354, DOI 10.1016/j.cmpb.2015.09.004; Lo CM, 2015, ULTRASOUND MED BIOL, V41, P2039, DOI 10.1016/j.ultrasmedbio.2015.03.003; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; Moon WK, 2013, COMPUT METH PROG BIO, V111, P84, DOI 10.1016/j.cmpb.2013.03.017; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Osborn A.G., 2015, DIAGNOSTIC IMAGING B; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Scott JN, 2002, NEUROLOGY, V59, P947, DOI 10.1212/WNL.59.6.947; Upadhyay N, 2014, BRIT J RADIOLOGY	34	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171342	10.1371/journal.pone.0171342	http://dx.doi.org/10.1371/journal.pone.0171342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158235	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700063
J	Lama, A; Santoro, A; Corrado, B; Pirozzi, C; Paciello, O; Pagano, TB; Russo, S; Calignano, A; Raso, GM; Meli, R				Lama, Adriano; Santoro, Anna; Corrado, Bruno; Pirozzi, Claudio; Paciello, Orlando; Pagano, Teresa Bruna; Russo, Sergio; Calignano, Antonio; Raso, Giuseppina Mattace; Meli, Rosaria			Extracorporeal shock waves alone or combined with raloxifene promote bone formation and suppress resorption in ovariectomized rats	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; MINERAL DENSITY; CATHEPSIN-K; BODY-COMPOSITION; OSTEOPOROSIS; ESTROGEN; FRACTURES; THERAPY; DIFFERENTIATION; ADIPONECTIN	Osteoporosis is a metabolic skeletal disease characterized by an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. We examined the beneficial effect of shock waves (SW) alone or in combination with raloxifene (RAL) on bone loss in ovariectomized rats (OVX). Sixteen weeks after surgery, OVX were treated for five weeks with SW at the antero-lateral side of the right hind leg, one session weekly, at 3 Hz (EFD of 0.33 mJ/mm2), or with RAL (5 mg/kg/die, per os) or with SW+RAL. Sera, femurs, tibiae and vertebrae were sampled for following biochemical and histological analysis. SW, alone or combined with RAL, prevented femur weight reduction and the deterioration of trabecular microarchitecture both in femur and vertebrae. All treatments increased Speed of Sound (SoS) values, improving bone mineral density, altered by OVX. Serum parameters involved in bone remodeling (alkaline phosphatase, receptor activator of nuclear factor kappa -B ligand, osteoprotegerin) and osteoblast proliferation (PTH), altered by ovariectomy, were restored by SW and RAL alone or in combination. In tibiae, SW+RAL significantly reduced cathepsin k and TNF-a levels, indicating the inhibition of osteoclast activity, while all treatments significantly increased runt -related transcription factor 2 and bone morphogenetic-2 expression, suggesting an increase in osteoblastogenic activity. Finally, in bone marrow from tibiae, SW or RAL reduced PPARy and adiponectin transcription, indicating a shift of mesenchymal cells toward osteoblastogenesis, without showing a synergistic effect. Our data indicate SW therapy, alone and in combination with raloxifene, as an innovative strategy to limit the hypoestrogenic bone loss, restoring the balance between bone formation and resorption.	[Lama, Adriano; Santoro, Anna; Pirozzi, Claudio; Calignano, Antonio; Raso, Giuseppina Mattace; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Santoro, Anna] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT USA; [Corrado, Bruno; Russo, Sergio] Univ Naples Federico II, Sch Med & Surg, Dept Publ Hlth, Naples, Italy; [Paciello, Orlando; Pagano, Teresa Bruna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; Yale University; University of Naples Federico II; University of Naples Federico II	Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	meli@unina.it	Pirozzi, Claudio/S-2760-2016; Corrado, Bruno/U-9495-2017; Lama, Adriano/AAC-1964-2020; Calignano, Antonio/K-2542-2018	Corrado, Bruno/0000-0003-0990-3428; Lama, Adriano/0000-0002-5816-1400; Meli, Rosaria/0000-0002-6246-6813; Pirozzi, Claudio/0000-0002-3409-5744; Santoro, Anna/0000-0002-2276-5659; Mattace Raso, Giuseppina/0000-0002-5254-139X	Storz Medical AG, Tagerwilen, Switzerland	Storz Medical AG, Tagerwilen, Switzerland	This study was supported by Storz Medical AG, Tagerwilen, Switzerland. This external company provided an economical support for fulfillment of the study, contributing to purchase of laboratory equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript which did not contribute to experimental model design, experiment realization, data analysis, results interpretation and manuscript writing. There was no additional external funding received for this study.	AMEND SR, 2016, JOVE-J VIS EXP, V110, DOI [DOI 10.3791/53936, 10.3791/53936]; Amo C, 1996, INVEST RADIOL, V31, P114, DOI 10.1097/00004424-199602000-00009; Appelman-Dijkstra NM, 2014, BEST PRACT RES CL EN, V28, P843, DOI 10.1016/j.beem.2014.07.003; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; CHAUSSY C, 1982, J UROLOGY, V127, P417, DOI 10.1016/S0022-5347(17)53841-0; Cheng H, 2015, INT J SURG ONCOL, V2015, DOI 10.1155/2015/397260; D'Agostin MC, 2016, J BIOL REG HOMEOS AG, V30, P323; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dobnig H, 2004, EXPERT OPIN PHARMACO, V5, P1153, DOI 10.1517/eoph.5.5.1153.31088; Eastell R, 2014, J BONE MINER RES, V29, P458, DOI 10.1002/jbmr.2047; Engelke K, 2015, J BONE MINER RES, V30, P30, DOI 10.1002/jbmr.2292; Fu Y, 2014, CELL PROLIFERAT, V47, P604, DOI 10.1111/cpr.12131; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; ILAGAN J, 1993, J APPL PHYSIOL, V74, P2092, DOI 10.1152/jappl.1993.74.5.2092; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Luisetto G, 1999, J ULTRAS MED, V18, P225; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Mariotto S, 2009, CURR MED CHEM, V16, P2366, DOI 10.2174/092986709788682119; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Narasaki Kazuto, 2003, J Orthop Sci, V8, P474, DOI 10.1007/s00776-003-0664-4; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ng KW, 2014, CURR OPIN PHARMACOL, V16, P58, DOI 10.1016/j.coph.2014.03.004; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Pennypacker BL, 2011, J BONE MINER RES, V26, P252, DOI 10.1002/jbmr.223; Pietschmann P, 2015, WIEN MED WOCHENSCHR, V165, P47, DOI 10.1007/s10354-015-0347-8; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Lacativa PGS, 2010, ARQ BRAS ENDOCRINOL, V54, P123, DOI 10.1590/S0004-27302010000200007; Sathishkumar S, 2008, J DENT RES, V87, P687, DOI 10.1177/154405910808700703; Schilling T, 2014, J STEROID BIOCHEM, V139, P252, DOI 10.1016/j.jsbmb.2012.12.006; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Somjen D, 2011, J ENDOCRINOL INVEST, V34, P106, DOI [10.1007/BF03347039, 10.3275/7108]; Syed FA, 2008, OSTEOPOROSIS INT, V19, P1323, DOI 10.1007/s00198-008-0574-6; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Troen BR, 2004, DRUG NEWS PERSPECT, V17, P19, DOI 10.1358/dnp.2004.17.1.829022; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; van der Jagt OP, 2013, J ORTHOP RES, V31, P768, DOI 10.1002/jor.22258; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008; Wagner N, 2010, DEV BIOL, V339, P1, DOI 10.1016/j.ydbio.2009.11.036; Wang CJ, 2009, NITRIC OXIDE-BIOL CH, V20, P298, DOI 10.1016/j.niox.2009.02.006; Wang CJ, 2001, CLIN ORTHOP RELAT R, P95; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Yin Tsung-Cheng, 2011, Chang Gung Med J, V34, P367	53	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171276	10.1371/journal.pone.0171276	http://dx.doi.org/10.1371/journal.pone.0171276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158228	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700051
J	Takeda, T; Yamamoto, H; Kanzaki, H; Suzawa, K; Yoshioka, T; Tomida, S; Cui, XJ; Murali, R; Namba, K; Sato, H; Torigoe, H; Watanabe, M; Shien, K; Soh, J; Asano, H; Tsukuda, K; Kitamura, Y; Miyoshi, S; Sendo, T; Toyooka, S				Takeda, Tatsuaki; Yamamoto, Hiromasa; Kanzaki, Hirotaka; Suzawa, Ken; Yoshioka, Takahiro; Tomida, Shuta; Cui, Xiaojiang; Murali, Ramachandran; Namba, Kei; Sato, Hiroki; Torigoe, Hidejiro; Watanabe, Mototsugu; Shien, Kazuhiko; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Kitamura, Yoshihisa; Miyoshi, Shinichiro; Sendo, Toshiaki; Toyooka, Shinichi			Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; LUNG-CANCER; RECEPTOR; HER2; SRC; INHIBITION; ACTIVATION; EXPRESSION; THERAPIES; CELLS	Background Overexpression of human epidermal growth factor receptor 2 (HER2) is observed in approximately 15-23% of breast cancers and these cancers are classified as HER2-positive breast cancer. Trastuzumab is the first-line targeted therapeutic drug for HER2-positive breast cancer and has improved patient overall survival. However, acquired resistance to trastuzumab is still a critical issue in breast cancer treatment. We previously established a trastuzumabresistant breast cancer cell line (named as BT-474-R) from a trastuzumab-sensitive HER2-amplified cell line BT-474. Lapatinib is also a molecular-targeted drug for HER2-positive breast cancer, which acquired the resistance to trastuzumab. Acquired resistance to lapatinib is also an issue to be conquered. Methods We established trastuzumab/lapatinib-dual resistant cell line (named as BT-474-RL2) by additionally treating BT-474-R with lapatinib. We analyzed the mechanisms of resistance to trastuzumab and lapatinib. Besides, we analyzed the effect of the detected resistance mechanism in HER2-positive breast cancer patients. Results Proto-oncogene tyrosine-protein kinase Yes1, which is one of the Src family members, was amplified, overexpressed and activated in BT-474-R and BT-474-RL2. Silencing of Yes1 by siRNA induced both BT-474-R and BT-474-RL2 to restore the sensitivity to trastuzumab and lapatinib. Pharmaceutical inhibition of Yes1 by the Src inhibitor dasatinib was also effective to restore the sensitivity to trastuzumab and lapatinib in the two resistant cell lines. Combination treatment with dasatinib and trastuzumab induced down-regulation of signaling molecules such as HER2 and Akt. Moreover, the combination treatments induced G1-phase cell-cycle arrest and apoptosis. Consistent with cell line data, high expression of Yes1 mRNA was correlated with worse prognosis in patients with HER2-positive breast cancer. Conclusion Yes1 plays an important role in acquired resistance to trastuzumab and lapatinib in HER2-positive breast cancer. Our data suggest that pharmacological inhibition of Yes1 may be an effective strategy to overcome resistance to trastuzumab and lapatinib.	[Takeda, Tatsuaki; Kanzaki, Hirotaka; Kitamura, Yoshihisa; Sendo, Toshiaki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Pharm, Okayama, Okayama, Japan; [Yamamoto, Hiromasa; Suzawa, Ken; Namba, Kei; Sato, Hiroki; Torigoe, Hidejiro; Watanabe, Mototsugu; Shien, Kazuhiko; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Okayama, Japan; [Yoshioka, Takahiro; Torigoe, Hidejiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama, Japan; [Tomida, Shuta] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biobank, Okayama, Okayama, Japan; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Murali, Ramachandran] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Okayama University; Okayama University; Okayama University; Okayama University; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Toyooka, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Okayama, Japan.; Toyooka, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama, Japan.	toyooka@md.okayama-u.ac.jp	Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; KITAMURA, Yoshihisa/B-2036-2011; Kitamura, Yoshihisa/HCH-9498-2022; Murali, Ramachandran/D-1132-2009; Tsukuda, Kazunori/AAY-2985-2020; Yamamoto, Hiromasa/A-3719-2012; Shien, Kazuhiko/B-8560-2012	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; KITAMURA, Yoshihisa/0000-0002-3652-3722; Murali, Ramachandran/0000-0002-8384-2793; Tsukuda, Kazunori/0000-0001-6293-1693; Yamamoto, Hiromasa/0000-0002-5330-5460; Shien, Kazuhiko/0000-0002-4959-4220	Japan Society for the Promotion of Science (JSPS KAKENHI) [25293302]; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI grant number: 25293302 to ST), [https://www.jsps.go/english/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WD, 2014, INT J CANCER, V135, P1356, DOI 10.1002/ijc.28782; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Dziadziuszko R, 2016, J THORAC ONCOL, V11, P1273, DOI 10.1016/j.jtho.2016.04.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Formisano L, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3650; Gori S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156221; Han SQ, 2014, MABS-AUSTIN, V6, P403, DOI 10.4161/mabs.27443; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanzaki Hirotaka, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P1, DOI 10.1089/mab.2015.0056; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Kute TE, 2009, CANCER IMMUNOL IMMUN, V58, P1889, DOI 10.1007/s00262-009-0700-0; Malvezzi M, 2016, ANN ONCOL, V27, P725, DOI 10.1093/annonc/mdw022; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Muthuswamy SK, 2011, NAT MED, V17, P416, DOI 10.1038/nm0411-416; Nagaraja V, 2015, J GASTROINTEST ONCOL, V6, P143, DOI 10.3978/j.issn.2078-6891.2014.107; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagy P, 2005, CANCER RES, V65, P473; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Rexer BN, 2013, CLIN CANCER RES, V19, P5390, DOI 10.1158/1078-0432.CCR-13-1038; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Sharial MSNM, 2012, ANN ONCOL, V23, P3007, DOI 10.1093/annonc/mds200; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tang P, 2016, ARCH PATHOL LAB MED, V140, P806, DOI 10.5858/arpa.2015-0133-RA; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171356	10.1371/journal.pone.0171356	http://dx.doi.org/10.1371/journal.pone.0171356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158234	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700064
J	Elliott, LS; Henderson, JC; Neradilek, MB; Moyer, NA; Ashcraft, KC; Thirumaran, RK				Elliott, Lindsay S.; Henderson, John C.; Neradilek, Moni B.; Moyer, Nicolas A.; Ashcraft, Kristine C.; Thirumaran, Ranjit K.			Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; EMERGENCY-DEPARTMENT VISITS; HOSPITALIZED-PATIENTS; CYP2D6; CARE; GUIDELINES; GENOTYPES; CYP2C19; EVENTS; ADULTS	Background In polypharmacy patients under home health management, pharmacogenetic testing coupled with guidance from a clinical decision support tool (CDST) on reducing drug, gene, and cumulative interaction risk may provide valuable insights in prescription drug treatment, reducing re-hospitalization and emergency department (ED) visits. We assessed the clinical impact of pharmacogenetic profiling integrating binary and cumulative drug and gene interaction warnings on home health polypharmacy patients. Methods and findings This prospective, open-label, randomized controlled trial was conducted at one hospital-based home health agency between February 2015 and February 2016. Recruitment came from patient referrals to home health at hospital discharge. Eligible patients were aged 50 years and older and taking or initiating treatment with medications with potential or significant drug-gene-based interactions. Subjects (n = 110) were randomized to pharmacogenetic profiling (n = 57). The study pharmacist reviewed drug-drug, drug-gene, and cumulative drug and/or gene interactions using the YouScript (R) CDST to provide drug therapy recommendations to clinicians. The control group (n = 53) received treatment as usual including pharmacist guided medication management using a standard drug information resource. The primary outcome measure was the number of re-hospitalizations and ED visits at 30 and 60 days after discharge from the hospital. The mean number of re-hospitalizations per patient in the tested vs. untested group was 0.25 vs. 0.38 at 30 days (relative risk (RR), 0.65; 95% confidence interval (CI), 0.32-1.28; P = 0.21) and 0.33 vs. 0.70 at 60 days following enrollment (RR, 0.48; 95% CI, 0.27-0.82; P = 0.007). The mean number of ED visits per patient in the tested vs. untested group was 0.25 vs. 0.40 at 30 days (RR, 0.62; 95% CI, 0.31-1.21; P = 0.16) and 0.39 vs. 0.66 at 60 days (RR, 0.58; 95% CI, 0.34-0.99; P = 0.045). Differences in composite outcomes at 60 days (exploratory endpoints) were also found. Of the total 124 drug therapy recommendations passed on to clinicians, 96 (77%) were followed. These findings should be verified with additional prospective confirmatory studies involving real-world applications in larger populations to broaden acceptance in routine clinical practice. Conclusions Pharmacogenetic testing of polypharmacy patients aged 50 and older, supported by an appropriate CDST, considerably reduced re-hospitalizations and ED visits at 60 days following enrollment resulting in potential health resource utilization savings and improved healthcare.	[Elliott, Lindsay S.] Harding Univ, Coll Pharm, Dept Pharm Practice, Unity Hlth White Cty Med Ctr, Searcy, AR 72149 USA; [Henderson, John C.] Unity Hlth White Cty Med Ctr, Searcy, AR USA; [Neradilek, Moni B.] Mt Whisper Light Stat, Seattle, WA USA; [Moyer, Nicolas A.; Ashcraft, Kristine C.; Thirumaran, Ranjit K.] Genelex Corp, Clin Pharmacogen Div, Seattle, WA 98121 USA		Elliott, LS (corresponding author), Harding Univ, Coll Pharm, Dept Pharm Practice, Unity Hlth White Cty Med Ctr, Searcy, AR 72149 USA.; Thirumaran, RK (corresponding author), Genelex Corp, Clin Pharmacogen Div, Seattle, WA 98121 USA.	lselliott@harding.edu; ranjit@genelex.com			Genelex Corporation; Mountain-Whisper-Light Statistics	Genelex Corporation; Mountain-Whisper-Light Statistics	The study was supported by a small non conditional research grant from Genelex Corporation (http://genelex.com/) in the form of compensation for time to author LSE. Genelex Corporation provided in-kind services consisting of buccal swab collection materials, shipping, genotyping all patient DNA and providing the YouScript (R) report. The Genelex Corporation and Mountain-Whisper-Light Statistics provided support in the form of salaries for authors [NAM, KCA, RKT and MBN] and played a role in the design and conduct of the study; management and analysis of data; and the preparation and review of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alagoz O, 2016, PHARMACOGENOMICS J, V16, P129, DOI 10.1038/tpj.2015.39; [Anonymous], 2010, SEARC ARK POP CENS 2; [Anonymous], 2015, TABLE PHARMACOGENOMI; [Anonymous], 2015, HOM HLTH CAR SERV AS, P213; [Anonymous], 2010, FDA GUID IND PHARM P; Azhar Gohar WJ, 2016, J RES DEV, V4; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113; Brixner D, 2016, J MED ECON, V19, P213, DOI 10.3111/13696998.2015.1110160; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cardelli M, 2012, DRUG SAFETY, V35, P3, DOI 10.1007/BF03319099; Caudle KE, 2016, STANDARDIZING TERMS; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fagerness J, 2014, AM J MANAG CARE, V20, pE146; Gaedigk A, 2016, GENET MED; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hocum BT, 2016, AM J HEALTH-SYST PH, V73, P61, DOI 10.2146/ajhp150273; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kahan BC, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-99; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lisbeth P, 2016, EUR J CLIN PHARMACOL, V72, P175, DOI 10.1007/s00228-015-1965-1; MLaC K, 2014, TRENDS HLTH CAR EXP; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Rizzo E, 2013, BECKERS HOSP REV; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Sikdar KC, 2012, ANN PHARMACOTHER, V46, P960, DOI 10.1345/aph.1Q529; US Food and Drug Administration, DRUG DEV DRUG INT TA; Verbeurgt P, 2014, PHARMACOGENOMICS, V15, P655, DOI 10.2217/pgs.14.6; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	36	84	87	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170905	10.1371/journal.pone.0170905	http://dx.doi.org/10.1371/journal.pone.0170905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151991	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200058
J	Pogrebnyakov, I; Jendresen, CB; Nielsen, AT				Pogrebnyakov, Ivan; Jendresen, Christian Bille; Nielsen, Alex Toftgaard			Genetic toolbox for controlled expression of functional proteins in Geobacillus spp.	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS; SHUTTLE VECTOR; OPERON; SEQUENCE; ETHANOL; DNA; THERMOGLUCOSIDASIUS; TRANSFORMATION; KAUSTOPHILUS; CONVERSION	Species of genus Geobacillus are thermophilic bacteria and play an ever increasing role as hosts for biotechnological applications both in academia and industry. Here we screened a number of Geobacillus strains to determine which industrially relevant carbon sources they can utilize. One of the strains, G. thermoglucosidasius C56-YS93, was then chosen to develop a toolbox for controlled gene expression over a wide range of levels. It includes a library of semi-synthetic constitutive promoters (76-fold difference in expression levels) and an inducible promoter from the xylA gene. A library of synthetic in silico designed ribosome binding sites was also created for further tuning of translation. The P-xylA was further used to successfully express native and heterologous xylanases in G. thermoglucosidasius. This toolbox enables fine-tuning of gene expression in Geobacillus species for metabolic engineering approaches in production of biochemicals and heterologous proteins.	[Pogrebnyakov, Ivan; Jendresen, Christian Bille; Nielsen, Alex Toftgaard] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	Technical University of Denmark	Nielsen, AT (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.	atn@biosustain.dtu.dk		Nielsen, Alex Toftgaard/0000-0001-6616-0187	Novo Nordisk Foundation [NNF15OC0015246]; European Union [317058]; Novo Nordisk Fonden [NNF10CC1016517, NNF16OC0021814, NNF15OC0015246] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Cell Factory Optimization] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was supported by the Novo Nordisk Foundation (http://novonordiskfonden.dk/en) to CBJ (NNF15OC0015246) and to ATN, and a PhD grant from the People Programme (Marie Curie Actions) of the European Union Seventh Framework Programme FP7-People-2012-ITN, under grant agreement No. 317058, "BACTORY" (http://ec.europa.eu/research/mariecureactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard K, 2014, APPL MICROBIOL BIOT, V98, P6715, DOI 10.1007/s00253-014-5746-z; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Bosma E.F., 2013, CURR BIOTECHNOL, V2, P360, DOI [10.2174/22115501113026660028, DOI 10.2174/18722083113076660028, DOI 10.2174/22115501113026660028]; Braatsch S, 2008, BIOTECHNIQUES, V45, P335, DOI 10.2144/000112907; Brumm PJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0031-z; Brumm PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00430; Cavaleiro AM, 2015, ACS SYNTH BIOL, V4, P1042, DOI 10.1021/acssynbio.5b00113; Chen XG, 2004, EXTREMOPHILES, V8, P489, DOI 10.1007/s00792-004-0412-5; Leow TC, 2007, EXTREMOPHILES, V11, P527, DOI 10.1007/s00792-007-0069-y; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Clark ME, 2006, HYDROMETALLURGY, V83, P3, DOI 10.1016/j.hydromet.2006.03.046; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005; Fong JCN, 2006, EXTREMOPHILES, V10, P363, DOI 10.1007/s00792-006-0507-2; GARTNER D, 1992, MOL GEN GENET, V232, P415; Gu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-255; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Ingram LO, 2010, J BIOMED BIOTECHNOL, V2010; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Kananaviciute R, 2015, J MICROBIOL METH, V111, P31, DOI 10.1016/j.mimet.2015.02.002; KRAUS A, 1994, J BACTERIOL, V176, P1738, DOI 10.1128/jb.176.6.1738-1745.1994; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; LIAO H, 1986, P NATL ACAD SCI USA, V83, P576, DOI 10.1073/pnas.83.3.576; Lin PP, 2014, METAB ENG, V24, P1, DOI 10.1016/j.ymben.2014.03.006; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Martin C, 2011, CELL CHEM TECHNOL, V45, P487; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Mechaly A, 2000, J BIOTECHNOL, V78, P83, DOI 10.1016/S0168-1656(99)00226-6; Mok SC, 2013, ENZYME MICROB TECH, V53, P46, DOI 10.1016/j.enzmictec.2013.03.009; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Narumi I, 1992, BIOTECHNOL TECH, V6, P83, DOI 10.1007/BF02438695; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J, 1989, MOL CLONING LAB MANU, P626; Sarrouh B., 2012, J BIOPROCESS BIOTECH, V1, P1, DOI DOI 10.HTTP://CBC.D0L0RG/10.4172/2155-9821.S4-002; SCHON U, 1993, J BACTERIOL, V175, P2465; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Stammen S, 2010, APPL ENVIRON MICROB, V76, P4037, DOI 10.1128/AEM.00431-10; Suzuki H, 2013, APPL ENVIRON MICROB, V79, P5151, DOI 10.1128/AEM.01506-13; Taylor MP, 2008, PLASMID, V60, P45, DOI 10.1016/j.plasmid.2008.04.001; Taylor MP, 2009, TRENDS BIOTECHNOL, V27, P398, DOI 10.1016/j.tibtech.2009.03.006; Tyo KEJ, 2011, METHODS ENZYMOLOGY; Van Zyl LJ, 2014, APPL MICROBIOL BIOT, V98, P1247, DOI 10.1007/s00253-013-5380-1; Wittlich P, 2001, BIOTECHNOL LETT, V23, P463, DOI 10.1023/A:1010329321185; Zeigler DR, 2001, GENUS GEOBACILLUS BA; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	57	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171313	10.1371/journal.pone.0171313	http://dx.doi.org/10.1371/journal.pone.0171313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152017	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200125
J	Xia, XY; Larios-Valencia, J; Liu, Z; Xiang, F; Kan, BA; Wang, H; Zhu, J				Xia, Xiaoyun; Larios-Valencia, Jessie; Liu, Zhi; Xiang, Fu; Kan, Biao; Wang, Hui; Zhu, Jun			OxyR-activated expression of Dps is important for Vibrio cholerae oxidative stress resistance and pathogenesis	PLOS ONE			English	Article							DNA-BINDING PROTEIN; VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; MULTIPLE STRESSES; HYDROGEN-PEROXIDE; STATIONARY-PHASE; STARVED CELLS; COLONIZATION; DETOXIFICATION; PROMOTER	Vibrio cholerae is the causative agent of cholera, a dehydrating diarrheal disease. This Gram-negative pathogen is able to modulate its gene expression in order to combat stresses encountered in both aquatic and host environments, including stress posed by reactive oxygen species (ROS). In order to further the understanding of V. cholerae's transcriptional response to ROS, we performed an RNA sequencing analysis to determine the transcriptional profile of V. cholerae when exposed to hydrogen hydroperoxide. Of 135 differentially expressed genes, VC0139 was amongst the genes with the largest induction. VC0139 encodes a protein homologous to the DPS (DNA-binding protein from starved cells) protein family, which are widely conserved and are implicated in ROS resistance in other bacteria. Using a promoter reporter assay, we show that during exponential growth, dps is induced by H2O2 in a manner dependent on the ROS-sensing transcriptional regulator, OxyR. Upon entry into stationary phase, the major stationary phase regulator RpoS is required to transcribe dps. Deletion of dps impaired V. cholerae resistance to both inorganic and organic hydroperoxides. Furthermore, we show that Dps is involved in resistance to multiple environmental stresses. Finally, we found that Dps is important for V. cholerae adult mouse colonization, but becomes dispensable in the presence of antioxidants. Taken together, our results suggest that Dps plays vital roles in both V. cholerae stress resistance and pathogenesis.	[Xia, Xiaoyun; Wang, Hui; Zhu, Jun] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Xia, Xiaoyun; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Larios-Valencia, Jessie; Liu, Zhi; Zhu, Jun] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Liu, Zhi] Huazhong Univ Sci & Technol, Dept Biotechnol, Wuhan, Peoples R China; [Xiang, Fu] Huanggang Normal Univ, Coll Life Sci, Huanggang, Peoples R China; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Pennsylvania; Pennsylvania Medicine; Huazhong University of Science & Technology; Huanggang Normal University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wang, H; Zhu, J (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.; Zhu, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wanghui@njau.edu.cn; junzhu@mail.med.upenn.edu		Larios Valencia, Jessie/0000-0003-2144-8675; WANG, HUI/0000-0001-8865-3599	National Natural Science Foundation of China [81371763]; National Key Basic Research Program of China [2015CB554203, 2015CB554201]; Ministry of Health of China [2016YFC1200103]; NIH/NIAID [R01AI120489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120489] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Health of China; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by National Natural Science Foundation of China 81371763 (to H.W.), National Key Basic Research Program of China 2015CB554203 (to H.W.) and 2015CB554201 (to B.K.), Priority Project from the Ministry of Health of China 2016YFC1200103 (to B.K.), and NIH/NIAID R01AI120489 (to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Asakura H, 2007, ENVIRON MICROBIOL, V9, P869, DOI 10.1111/j.1462-2920.2006.01206.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bhattacharyya S, 2004, BBA-GEN SUBJECTS, V1670, P69, DOI 10.1016/j.bbagen.2003.10.016; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Karas VO, 2015, J BACTERIOL, V197, P3206, DOI 10.1128/JB.00475-15; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu Z, 2016, MOL MICROBI IN PRESS; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Liu Z, 2016, CELL REP, V14, P347, DOI 10.1016/j.celrep.2015.12.038; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; LOMOVSKAYA OL, 1994, J BACTERIOL, V176, P3928, DOI 10.1128/JB.176.13.3928-3935.1994; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Qadri F, 2002, CLIN DIAGN LAB IMMUN, V9, P221, DOI 10.1128/CDLI.9.2.221-229.2002; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Stern AM, 2012, MBIO, V3, DOI 10.1128/mBio.00013-12; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thieme D, 2010, MICROBIOL RES, V165, P108, DOI 10.1016/j.micres.2008.12.003; Thomas KU, 2006, MAR POLLUT BULL, V52, P1425, DOI 10.1016/j.marpolbul.2006.04.011; Thomson JJ, 2014, J BACTERIOL, V196, P3872, DOI 10.1128/JB.01824-14; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wu B, 2015, J MICROBIOL METH, V115, P147, DOI 10.1016/j.mimet.2015.05.016; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	49	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171201	10.1371/journal.pone.0171201	http://dx.doi.org/10.1371/journal.pone.0171201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151956	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200102
J	Bonny, JW; Lindberg, JC; Pacampara, MC				Bonny, Justin W.; Lindberg, Jenna C.; Pacampara, Marc C.			Hip Hop Dance Experience Linked to Sociocognitive Ability	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; DELIBERATE PRACTICE; VIDEO GAMES; MENTAL ROTATION; MOTOR EXPERTISE; OPERATION SPAN; ACHIEVEMENT; PERFORMANCE; TASKS; VERSION	Expertise within gaming (e.g., chess, video games) and kinesthetic (e.g., sports, classical dance) activities has been found to be linked with specific cognitive skills. Some of these skills, working memory, mental rotation, problem solving, are linked to higher performance in science, technology, math, and engineering (STEM) disciplines. In the present study, we examined whether experience in a different activity, hip hop dance, is also linked to cognitive abilities connected with STEM skills as well as social cognition ability. Dancers who varied in hip hop and other dance style experience were presented with a set of computerized tasks that assessed working memory capacity, mental rotation speed, problem solving efficiency, and theory of mind. We found that, when controlling for demographic factors and other dance style experience, those with greater hip hop dance experience were faster at mentally rotating images of hands at greater angle disparities and there was a trend for greater accuracy at identifying positive emotions displayed by cropped images of human faces. We suggest that hip hop dance, similar to other more technical activities such as video gameplay, tap some specific cognitive abilities that underlie STEM skills. Furthermore, we suggest that hip hop dance experience can be used to reach populations who may not otherwise be interested in other kinesthetic or gaming activities and potentially enhance select sociocognitive skills.	[Bonny, Justin W.; Lindberg, Jenna C.; Pacampara, Marc C.] Foundry10, Seattle, WA 98105 USA; [Bonny, Justin W.] Morgan State Univ, Dept Psychol, Baltimore, MD 21239 USA	Morgan State University	Bonny, JW (corresponding author), Foundry10, Seattle, WA 98105 USA.; Bonny, JW (corresponding author), Morgan State Univ, Dept Psychol, Baltimore, MD 21239 USA.	justin@foundry10.org	Bonny, Justin/GWZ-4864-2022	Bonny, Justin/0000-0002-1601-5114				Adachi PJC, 2013, J YOUTH ADOLESCENCE, V42, P1041, DOI 10.1007/s10964-013-9913-9; Appelbaum LG, 2013, ATTEN PERCEPT PSYCHO, V75, P1161, DOI 10.3758/s13414-013-0472-7; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2008, FITTING LINEAR MIXED; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Bonny JW, 2017, COMPUT HUM BEHAV, V66, P377, DOI 10.1016/j.chb.2016.10.005; Bonny JW, 2016, P SIGCHI C HUM FACT; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Campitelli G, 2011, CURR DIR PSYCHOL SCI, V20, P280, DOI 10.1177/0963721411421922; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Cherney ID, 2008, SEX ROLES, V59, P776, DOI 10.1007/s11199-008-9498-z; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Crook SR, 2014, CHILD DEV, V85, P405, DOI 10.1111/cdev.12129; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fitzgibbon ML, 2006, OBESITY, V14, P1616, DOI 10.1038/oby.2006.186; Foster JL, 2015, MEM COGNITION, V43, P226, DOI 10.3758/s13421-014-0461-7; Furley P, 2010, PERCEPT MOTOR SKILL, V110, P801, DOI 10.2466/PMS.110.3.801-808; Ganis G., 2015, J OPEN PSYCHOL DATA, V3, pe3, DOI [10.5334/jopd.ai, DOI 10.5334/JOPD.AI]; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Goldstein T. R., 2009, IMAGIN COGN PERS, V29, P115, DOI [10.2190/IC.29.2.c, DOI 10.2190/IC.29.2.C]; Goldstein TR, 2012, J COGN DEV, V13, P19, DOI 10.1080/15248372.2011.573514; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hambrick DZ, 2014, INTELLIGENCE, V45, P34, DOI 10.1016/j.intell.2013.04.001; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Hodges NJ, 2004, J EXP PSYCHOL-APPL, V10, P219, DOI 10.1037/1076-898X.10.4.219; Hohmann T, 2011, J COGN PSYCHOL, V23, P403, DOI 10.1080/20445911.2011.525504; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; Jansen P., 2013, CREAT ED, V4, P418, DOI [10.4236/ce.2013.46060, DOI 10.4236/CE.2013.46060]; Jola C., 2005, SPAT COGN COMPUT, V5, P217; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kaltner S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00505; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Meinz EJ, 2012, J APPL RES MEM COGN, V1, P34, DOI 10.1016/j.jarmac.2011.11.001; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Morgan M, 2011, DAEDALUS-US, V140, P176, DOI 10.1162/DAED_a_00086; OECD, 2013, LESS PISA 2012 US ST; Ojofeitimi S, 2012, SCAND J MED SCI SPOR, V22, P347, DOI 10.1111/j.1600-0838.2010.01173.x; Oswald FL, 2014, BEHAV RES METHODS; Ozel S, 2002, PERCEPT MOTOR SKILL, V95, P1141, DOI 10.2466/PMS.95.8.1141-1154; Parsad B., 2012, ARTS ED PUBLIC ELEME; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; Powers KL, 2013, PSYCHON B REV, V20, P1055, DOI 10.3758/s13423-013-0418-z; Quaiser-Pohl C, 2002, BRIT J EDUC PSYCHOL, V72, P245, DOI 10.1348/000709902158874; R Core Team, 2021, R LANGUAGE ENV STAT; Rajakumar M, 2012, HIP HOP DANCE; RANDEL JM, 1992, SIMULAT GAMING, V23, P261, DOI 10.1177/1046878192233001; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Respress T, 2006, RECLAIMING CHILD YOU, V15, P24; Revelle W., 2020, PSYCH PROCEDURES PER; Robinson TN, 2003, ETHN DIS, V13; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sikora DM, 2010, DEV NEUROPSYCHOL, V21, P243; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Steggemann Y, 2011, BRAIN COGNITION, V76, P97, DOI 10.1016/j.bandc.2011.02.013; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; ULRICH R, 1994, J EXP PSYCHOL GEN, V123, P34, DOI 10.1037/0096-3445.123.1.34; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2005, INTELLIGENCE, V33, P67, DOI 10.1016/j.intell.2004.08.003; Unsworth N, 2015, PSYCHOL SCI, V26, P759, DOI 10.1177/0956797615570367; Unterrainer JM, 2006, BRIT J PSYCHOL, V97, P299, DOI 10.1348/000712605X71407; Uttal DH, 2013, CURR DIR PSYCHOL SCI, V22, P367, DOI 10.1177/0963721413484756; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Williams AM, 2011, APPL COGNITIVE PSYCH, V25, P432, DOI 10.1002/acp.1710; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572	88	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169947	10.1371/journal.pone.0169947	http://dx.doi.org/10.1371/journal.pone.0169947			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146562	Green Published, gold, Green Submitted			2022-12-26	WOS:000396131700010
J	Fang, TL; Carver, BF; Hunger, RM; Yan, LL				Fang, Tilin; Carver, Brett F.; Hunger, Robert M.; Yan, Liuling			Mis-Spliced Lr34 Transcript Events in Winter Wheat	PLOS ONE			English	Article							LEAF RUST RESISTANCE; DURABLE RESISTANCE; GENE; DIVERSITY; LR34/YR18; MARKERS; LOCI; QTL	Lr34 in wheat is a non-race-specific gene that confers resistance against multiple fungal pathogens. The resistant allele Lr34 and the susceptible allele Lr34s can be distinguished by three polymorphisms that cause alternation of deduced amino acid sequences of Lr34 at the protein level. In seedlings of a cultivar carrying the resistant Lr34r allele, only a portion (35%) of its transcripts was correctly spliced and the majority (65%) of its transcripts were incorrectly spliced due to multiple mis-splicing events. Lr34 mis-splicing events were also observed at adult plant age when this gene exerts its function. All of the mis-spliced Lr34r cDNA transcripts observed in this study resulted in a premature stop codon due to a shift of the open reading frame; hence, the mis-spliced Lr34r cDNAs were deduced to encode incomplete proteins. Even if a cultivar has a functional Lr34 gene, its transcripts might not completely splice in a correct pattern. These findings suggested that the partial resistance conferred by a quantitative gene might be due to mis-splicing events in its transcripts; hence, the resistance of the gene could be increased by eliminating or mutating regulators that cause mis-splicing events in wheat.	[Fang, Tilin; Carver, Brett F.; Yan, Liuling] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Hunger, Robert M.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Yan, LL (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	liuling.yan@okstate.edu			USDA National Institute of Food and Agriculture [2011-68002-30029]; Oklahoma Center of Advanced Science and Technology [OCAST-131-033]; Oklahoma Agricultural Experiment Station; Oklahoma Wheat Research Foundation	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Oklahoma Center of Advanced Science and Technology; Oklahoma Agricultural Experiment Station; Oklahoma Wheat Research Foundation	This project was supported by the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture and from the Oklahoma Center of Advanced Science and Technology (OCAST-131-033). This research project was also partially funded by the Oklahoma Agricultural Experiment Station and the Oklahoma Wheat Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul SD, 1994, THESIS; BJARKO ME, 1988, PHYTOPATHOLOGY, V78, P457, DOI 10.1094/Phyto-78-457; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bossolini E, 2006, THEOR APPL GENET, V113, P1049, DOI 10.1007/s00122-006-0364-5; CALDWELL RM, 1970, PHYTOPATHOLOGY, V60, P1287, DOI 10.1094/Phyto-60-1696; Cao SH, 2010, THEOR APPL GENET, V121, P385, DOI 10.1007/s00122-010-1317-6; Dakouri A, 2010, THEOR APPL GENET, V121, P373, DOI 10.1007/s00122-010-1316-7; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Kolmer JA, 2011, CROP SCI, V51, P526, DOI 10.2135/cropsci2010.06.0381; Kolmer JA., 2009, WHEAT SCI TRADE, P89, DOI [10.1002/9780813818832.ch5, DOI 10.1002/9780813818832.CH5]; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kroner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023331; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McIntosh RA, 2008, MAC GENE; PARLEVLIET JE, 1977, EUPHYTICA, V26, P5, DOI 10.1007/BF00032062; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Schnurbusch T, 2004, THEOR APPL GENET, V108, P477, DOI 10.1007/s00122-003-1444-4; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh Ravi P., 2007, P109; SINGH RP, 1993, PLANT DIS, V77, P1103, DOI 10.1094/PD-77-1103; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Vergne E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-206	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171149	10.1371/journal.pone.0171149	http://dx.doi.org/10.1371/journal.pone.0171149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135317	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700052
J	Huang, XY; Zang, XN; Wu, F; Jin, YM; Wang, HT; Liu, C; Ding, YT; He, BX; Xiao, DF; Song, XW; Liu, Z				Huang, Xiaoyun; Zang, Xiaonan; Wu, Fei; Jin, Yuming; Wang, Haitao; Liu, Chang; Ding, Yating; He, Bangxiang; Xiao, Dongfang; Song, Xinwei; Liu, Zhu			Transcriptome Sequencing of Gracilariopsis lemaneiformis to Analyze the Genes Related to Optically Active Phycoerythrin Synthesis	PLOS ONE			English	Article							RED ALGA; RHODOPHYTA; ACCLIMATION; GROWTH; YIELD; GRACILARIACEAE; CULTURE; AGAR	Gracilariopsis lemaneiformis (aka Gracilaria lemaneiformis) is a red macroalga rich in phycoerythrin, which can capture light efficiently and transfer it to photosystemII. However, little is known about the synthesis of optically active phycoerythrinin in G. lemaneiformis at the molecular level. With the advent of high-throughput sequencing technology, analysis of genetic information for G. lemaneiformis by transcriptome sequencing is an effective means to get a deeper insight into the molecular mechanism of phycoerythrin synthesis. Illumina technology was employed to sequence the transcriptome of two strains of G. lemaneiformisthe wild type and a green-pigmented mutant. We obtained a total of 86915 assembled unigenes as a reference gene set, and 42884 unigenes were annotated in at least one public database. Taking the above transcriptome sequencing as a reference gene set, 4041 differentially expressed genes were screened to analyze and compare the gene expression profiles of the wild type and green mutant. By GO and KEGG pathway analysis, we concluded that three factors, including a reduction in the expression level of apo-phycoerythrin, an increase of chlorophyll light-harvesting complex synthesis, and reduction of phycoerythrobilin by competitive inhibition, caused the reduction of optically active phycoerythrin in the green- pigmented mutant.	[Huang, Xiaoyun; Zang, Xiaonan; Wu, Fei; Jin, Yuming; Wang, Haitao; Liu, Chang; Ding, Yating; He, Bangxiang; Xiao, Dongfang; Song, Xinwei; Liu, Zhu] Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Shandong, Peoples R China	Ocean University of China	Zang, XN (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Shandong, Peoples R China.	xnzang@ouc.edu.cn			National Natural Science Foundation of China [31472255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31472255).; This work was supported by the National Natural Science Foundation of China (Grant No. 31472255). We thank Dr. John P. van der Meer for his comments and editing of the manuscript. We thank Professor Weizhou Chen for providing the green mutant of Gracilariopsis lemaneiformis.	Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Everroad RC, 2012, MOL PHYLOGENET EVOL, V64, P381, DOI 10.1016/j.ympev.2012.04.013; Freile-Pelegrin Y, 2005, BIORESOURCE TECHNOL, V96, P295, DOI 10.1016/j.biortech.2004.04.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; LAPOINTE BE, 1978, AQUACULTURE, V15, P185, DOI 10.1016/0044-8486(78)90030-3; Llansola-Portoles MJ, 2016, BBA-BIOENERGETICS, V1857, P1759, DOI 10.1016/j.bbabio.2016.08.006; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; MacColl R, 1999, POLAR BIOL, V22, P384, DOI 10.1007/s003000050433; Marinho-Soriano E, 2003, BIORESOURCE TECHNOL, V90, P329, DOI 10.1016/S0960-8524(03)00112-3; Marinho-Soriano E, 2001, J BIOTECHNOL, V89, P81, DOI 10.1016/S0168-1656(01)00255-3; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wientjes E, 2013, J PHYS CHEM B, V117, P11200, DOI 10.1021/jp401663w; Wobbe L, 2016, TRENDS PLANT SCI, V21, P55, DOI 10.1016/j.tplants.2015.10.004; Wu HY, 2015, S AFR J BOT, V100, P27, DOI 10.1016/j.sajb.2015.05.017; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2015, GENE, V565, P252, DOI 10.1016/j.gene.2015.04.013; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046	21	23	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170855	10.1371/journal.pone.0170855	http://dx.doi.org/10.1371/journal.pone.0170855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135287	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700025
J	Jaschinski, W				Jaschinski, Wolfgang			Individual Objective and Subjective Fixation Disparity in Near Vision	PLOS ONE			English	Article							BINOCULAR COORDINATION; RETINAL CORRESPONDENCE; VIEWING DISTANCE; DARK VERGENCE; STIMULI; ACCOMMODATION; MISALIGNMENT; HETEROPHORIA; PARAMETERS; DIRECTION	Binocular vision refers to the integration of images in the two eyes for improved visual perfor-mance and depth perception. One aspect of binocular vision is the fixation disparity, which is a suboptimal condition in individuals with respect to binocular eye movement control and subsequent neural processing. The objective fixation disparity refers to the vergence angle between the visual axes, which is measured with eye trackers. Subjective fixation disparity is tested with two monocular nonius lines which indicate the physical nonius separation required for perceived alignment. Subjective and objective fixation disparity represent the different physiological mechanisms of motor and sensory fusion, but the precise relation between these two is still unclear. This study measures both types of fixation disparity at viewing distances of 40, 30, and 24 cm while observers fixated a central stationary fusion target. 20 young adult subjects with normal binocular vision were tested repeatedly to inves-tigate individual differences. For heterophoria and subjective fixation disparity, this study replicated that the binocular system does not properly adjust to near targets: outward (exo) deviations typically increase as the viewing distance is shortened. This exo proximity effect -however-was not found for objective fixation disparity, which-on the average- was zero. But individuals can have reliable outward (exo) or inward (eso) vergence errors. Cases with eso objective fixation disparity tend to have less exo states of subjective fixation disparity and heterophoria. In summary, the two types of fixation disparity seem to respond in a differ-ent way when the viewing distance is shortened. Motor and sensory fusion-as reflected by objective and subjective fixation disparity-exhibit complex interactions that may differ between individuals (eso versus exo) and vary with viewing distance (far versus near vision).	[Jaschinski, Wolfgang] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Jaschinski, W (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	Jaschinski@ifado.de		Jaschinski, Wolfgang/0000-0002-2986-0341	DFG [JA 747/5-2]	DFG(German Research Foundation (DFG))	This research was supported by the grant DFG JA 747/5-2 of the German Research Council.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; CARTER DB, 1980, AM J OPTOM PHYS OPT, V57, P610; Collewijn H, 1991, VISION VISUAL DYSF A, V404, P121; Erkelens CJ, 1997, VISION RES, V37, P1735, DOI 10.1016/S0042-6989(96)00323-9; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P441, DOI 10.1098/rspb.1989.0031; Evans BJW, 2007, PICKWELLS BINOCULAR; Fogt N, 1998, VISION RES, V38, P411, DOI 10.1016/S0042-6989(97)00142-9; Fogt N, 1998, VISION RES, V38, P2711, DOI 10.1016/S0042-6989(97)00448-3; FRANCIS EL, 1983, VISION RES, V23, P13, DOI 10.1016/0042-6989(83)90036-6; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Heller D, 1998, CURRENT OCULOMOTOR R; Howard IP, 2012, PERCEIVING IN DEPTH, V1; Howard IP, 2012, PERCEIVING IN DEPTH, V3; Howard IP, 2012, PERCEIVING DEPTH STE, V2; Jainta S, 2010, J EYE MOVEMENT RES, V3; Jainta S, 2012, INVEST OPHTH VIS SCI, V53, P5762, DOI 10.1167/iovs.12-9707; Jainta S, 2011, INVEST OPHTH VIS SCI, V52, P9416, DOI 10.1167/iovs.11-8237; JAMPOLSKY A, 1957, AM J OPHTHALMOL, V43, P97, DOI 10.1016/0002-9394(57)92094-9; Jaschinski W, 2005, OPTOMETRY VISION SCI, V82, P988, DOI 10.1097/01.opx.0000187843.46805.a4; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1997, OPHTHAL PHYSL OPT, V17, P324, DOI 10.1111/j.1475-1313.1997.tb00064.x; Jaschinski W, 2001, VISION RES, V41, P923, DOI 10.1016/S0042-6989(00)00322-9; Jaschinski W, 2007, OPHTHAL PHYSL OPT, V27, P85, DOI 10.1111/j.1475-1313.2006.00448.x; Jaschinski W, 2016, J EYE MOVEMENT RES, V9, DOI 10.16910/jemr.9.4.2; Jaschinski W, 2010, OPHTHAL PHYSL OPT, V30, P379, DOI 10.1111/j.1475-1313.2010.00753.x; JASCHINSKIKRUZA W, 1994, VISION RES, V34, P1197, DOI 10.1016/0042-6989(94)90301-8; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; KERTESZ AE, 1988, VISION RES, V28, P313, DOI 10.1016/0042-6989(88)90159-9; KERTESZ AE, 1987, AM J OPTOM PHYS OPT, V64, P734; Kirkby JA, 2013, BEHAV RES METHODS, V45, P664, DOI 10.3758/s13428-012-0301-2; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Kloke WB, 2006, BIOL PSYCHOL, V73, P220, DOI 10.1016/j.biopsycho.2006.04.004; Le Bigot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043150; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Mallett RJF, 1974, OPHTHALMIC OPT, V14, P1156; Nuthmann A, 2014, VIS COGN, V22, P259, DOI 10.1080/13506285.2013.876480; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; Ogle KN, 1967, OCULOMOTOR IMBALANCE; OWENS DA, 1975, VISION RES, V15, P1161, DOI 10.1016/0042-6989(75)90016-4; PICKWELL LD, 1991, OPHTHAL PHYSL OPT, V11, P291, DOI 10.1111/j.1475-1313.1991.tb00227.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; REMOLE A, 1985, AM J OPTOM PHYS OPT, V62, P25; REMOLE A, 1986, AM J OPTOM PHYS OPT, V63, P631; REMOLE A, 1984, AM J OPTOM PHYS OPT, V61, P118; ROBERTSON K, 1986, Investigative Ophthalmology and Visual Science, V27, P79; Scheiman M, 2008, CLIN MANAGEMENT BINO; Schor CM, 1991, VISION VISUAL DISFUN, V9, P179; Schroth V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138871; Sheedy JE, 1983, VERGENCE EYE MOVEMEN, P517; Shimono K, 1998, VISION RES, V38, P591, DOI 10.1016/S0042-6989(97)00168-5; Ukwade MT, 2000, OPTOMETRY VISION SCI, V77, P309, DOI 10.1097/00006324-200006000-00011; Vatterott DB, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00533; WICK B, 1991, OPTOMETRY VISION SCI, V68, P146, DOI 10.1097/00006324-199102000-00011; Winter B, 2013, ARXIV13085499	56	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170190	10.1371/journal.pone.0170190	http://dx.doi.org/10.1371/journal.pone.0170190			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135308	Green Submitted, Green Published, gold			2022-12-26	WOS:000396124700010
J	Kim, S; Tridane, A				Kim, Sehjeong; Tridane, Abdessamad			Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated	PLOS ONE			English	Article							BETA-THALASSEMIA; HEALTH; CONSANGUINITY; HEMOGLOBIN; PREVALENCE; DISORDERS; PROGRAMS	Thalassemia is a genetic blood disorder that causes abnormal hemoglobin. Hemoglobin is a protein in red blood cells that carries oxygen and is made of two proteins from four a-globin genes and two beta-globin genes. A defect in one or more of these genes causes thalassemia. The treatment of thalassemia mostly depends on life-long blood transfusions and removal of excessive iron from the blood stream. Such tremendous blood consumption puts pressure on the national blood stock in many countries. In particular, in the United Arab Emirates (UAE), various forms of thalassemia prevention have been used and hence, the substantial reduction of the thalassemia major population has been achieved. However, the thalassemia carrier population still remains high, which leads to the potential increase in the thalassemia major population through carrier-carrier marriages. In this work, we investigate the long-term impact and efficacy of thalassemia prevention measures via mathematical modeling at a population level. To our best knowledge, this type of assessment has not been done before and there is no mathematical model that has investigated such a problem for thalassemia or any blood disorders at a population level. By using UAE data, we perform numerical simulations of our model and conduct sensitivity analysis of parameter values to see which parameter values affect most the dynamics of our model. We discover that the prevention measures can contribute to reduce the prevalence of the disease only in the short term but not eradicate the disease in the long term.	[Kim, Sehjeong; Tridane, Abdessamad] United Arab Emirates Univ, Dept Math Sci, Abu Dhabi, U Arab Emirates	United Arab Emirates University	Kim, S (corresponding author), United Arab Emirates Univ, Dept Math Sci, Abu Dhabi, U Arab Emirates.	sehjung.kim@uaeu.ac.ae	Tridane, Abdessamad/I-3147-2019	Tridane, Abdessamad/0000-0001-8471-7807	United Arab Emirates University [315106, 315105]	United Arab Emirates University	SK is supported in part by the United Arab Emirates University Start-up grant with No. 315106 and AT by the United Arab Emirates University Start-up grant with No. 315105 with www.uaeu.ac.ae. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh B, 2014, HEMOGLOBIN, V38, P56, DOI 10.3109/03630269.2013.848811; Al-Gazali LI, 2005, COMMUNITY GENET, V8, P186, DOI 10.1159/000086764; Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232; Alswaidi FM, 2009, J MED SCREEN, V16, P22, DOI 10.1258/jms.2008.008029; Baysal E, 2005, COMMUNITY GENET, V8, P35, DOI 10.1159/000083336; Baysal E, 2011, HEMOGLOBIN, V35, P581, DOI 10.3109/03630269.2011.634706; Belhoul KM, 2013, HEMOGLOBIN, V37, P359, DOI 10.3109/03630269.2013.791627; Bittles AH, 2010, EARLY HUM DEV, V86, P737, DOI 10.1016/j.earlhumdev.2010.08.003; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Cao A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011775; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Danjou F, 2011, HAEMATOL-HEMATOL J, V96, P1573, DOI 10.3324/haematol.2011.055962; Denic S, 2013, HEMOGLOBIN, V37, P351, DOI 10.3109/03630269.2013.790827; Federal Competitiveness and Statistics Authority, 2015, STAT SUBJ; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Health Authority Abu Dhabi, 2013, HLTH STAT 2013; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; R Development Core Team, 2016, R LANG ENV STAT COMP; Saffi M, 2015, PUBLIC HEALTH GENOM, V18, P193, DOI 10.1159/000430837; Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research, 2015, PUBL HLTH UN AR EM R; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Thalassemia Foundation of Canada, 2009, GUID CLIN CAR PAT TH; Vichinsky EP, 2005, ANN NY ACAD SCI, V1054, P18, DOI 10.1196/annals.1345.003; Weatherall DJ, 2010, ANN NY ACAD SCI, V1202, P17, DOI 10.1111/j.1749-6632.2010.05546.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	27	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170485	10.1371/journal.pone.0170485	http://dx.doi.org/10.1371/journal.pone.0170485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135306	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700014
J	del Valle-Mendoza, J; Orellana-Peralta, F; Marcelo-Rodriguez, A; Verne, E; Esquivel-Vizcarra, M; Silva-Caso, W; Aguilar-Luis, MA; Weilg, P; Casabona-Ore, V; Ugarte, C; del Valle, LJ				del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Marcelo-Rodriguez, Alvaro; Verne, Eduardo; Esquivel-Vizcarra, Monica; Silva-Caso, Wilmer; Angel Aguilar-Luis, Miguel; Weilg, Pablo; Casabona-Ore, Veronica; Ugarte, Claudia; del Valle, Luis J.			High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHLAMYDOPHILA-PNEUMONIAE; HOSPITALIZED CHILDREN; EPIDEMIOLOGY; ETIOLOGY	Background Mycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible for pneumonia and a leading cause of morbidity and mortality in low income countries. The study objective is to determine the prevalence of this pathogens in Peruvian children with acute respiratory infections. Methods A consecutive cross-sectional study was conducted in Lima, Peru from May 2009 to September 2010. A total of 675 children admitted with clinical diagnoses of acute respiratory infections were tested for Mycoplasma pneumoniae and Chlamydia pneumoniae detection by polymerase chain reaction (PCR), and clinical symptoms were registered by the attending physician. Results Mycoplasma pneumonia was detected in 25.19% (170/675) of nasopharyngeal samples and Chlamydia pneumonia in 10.52% (71/675). The most common symptoms in patients with these atypical pathogens were rhinorrhea, cough and fever. A higher prevalence of Mycoplasma pneumoniae cases were registered in summer, between December 2009 and March 2010. Conclusions Mycoplasma pneumoniae and Chlamydia pneumonia are a significant cause of morbidity in Peruvian children with acute respiratory infections (ARI). Further studies should evaluate the use of reliable techniques such as PCR in Peru in order to avoid underdiagnoses of these atypical pathogens.	[del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Angel Aguilar-Luis, Miguel; Weilg, Pablo; Casabona-Ore, Veronica; Ugarte, Claudia] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res & Innovat Ctr, Sch Med, Lima, Peru; [del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Esquivel-Vizcarra, Monica; Angel Aguilar-Luis, Miguel; Casabona-Ore, Veronica] Inst Invest Nutr, Lima, Peru; [Marcelo-Rodriguez, Alvaro] Univ Nacl Federico Villarreal, Lima, Peru; [Verne, Eduardo; Ugarte, Claudia] Hosp Nacl Cayetano Heredia, Lima, Peru; [del Valle, Luis J.] Univ Politecn Cataluna, Barcelona Tech, ETSEIB, Ctr Biotecnol Mol CEBIM,Dept Engn Quim, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Nacional Federico Villarreal; Universitat Politecnica de Catalunya	del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res & Innovat Ctr, Sch Med, Lima, Peru.; del Valle-Mendoza, J (corresponding author), Inst Invest Nutr, Lima, Peru.; del Valle, LJ (corresponding author), Univ Politecn Cataluna, Barcelona Tech, ETSEIB, Ctr Biotecnol Mol CEBIM,Dept Engn Quim, Barcelona, Spain.	jdelvall@upc.edu.pe; luis.javier.del.valle@upc.edu	Del Valle, Luis J./I-1342-2015; Aguilar-Luis, Miguel Angel/C-8686-2018; del Valle Mendoza, Juana/C-9805-2018; Silva, Wilmer Gianfranco/D-2699-2018; CASABONA ORE, VERONICA DANIXA/F-1248-2018	Del Valle, Luis J./0000-0001-9916-1741; Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; del Valle Mendoza, Juana/0000-0002-6011-5040; Silva, Wilmer Gianfranco/0000-0003-1086-8084; CASABONA ORE, VERONICA DANIXA/0000-0002-9922-3786; Weilg Espejo, Pablo Renato/0000-0002-9711-2193	Programa de Ciencia y Tecnologia, Peru [071-FINCyT-PIN-2008]	Programa de Ciencia y Tecnologia, Peru	This work has been supported by Programa de Ciencia y Tecnologia, Contrato No 071-FINCyT-PIN-2008, Peru. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beersma MFC, 2005, J CLIN MICROBIOL, V43, P2277, DOI 10.1128/JCM.43.5.2277-2285.2005; Blystad H, 2012, EURO SURVEILL, V17; Chalker VJ, 2012, EURO SURVEILL, V17; Chen Ling-ling, 2012, Zhonghua Er Ke Za Zhi, V50, P211; Chen ZR, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-34; Chiang WC, 2007, RESPIROLOGY, V12, P254, DOI 10.1111/j.1440-1843.2006.01036.x; Mendoza JD, 2015, J MED VIROL, V87, P917, DOI 10.1002/jmv.24159; Dumke R, 2015, EMERG INFECT DIS, V21, P426, DOI 10.3201/eid2103.140927; Eibach D, 2012, EURO SURVEILL, V17; El Seify MY, 2016, EUR J MICROBIOL IMMU, V6, P206, DOI 10.1556/1886.2016.00022; Grassi T, 2014, J INFECT DEV COUNTR, V8, P379, DOI 10.3855/jidc.4458; He XY, 2013, DIAGN MICR INFEC DIS, V75, P22, DOI 10.1016/j.diagmicrobio.2012.08.027; Huong P, 2015, JPN J INFECT DIS; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kurz H, 2009, PEDIATR PULM, V44, P873, DOI 10.1002/ppul.21059; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119170; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Maass V, 2011, J CLIN MICROBIOL, V49, P3681, DOI 10.1128/JCM.01092-11; Mathew JL, 2015, J GLOB HEALTH, V5, P223, DOI 10.7189/jogh.05.020418; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Miranda J., ACTA MED; Nir-Paz R., 2012, EURO SURVEILL, V17; Pavic-Espinoza I, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1287-z; Huong PLT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1304; Samransamruajkit R, 2008, JPN J INFECT DIS, V61, P36; Schmidt SM, 2003, INFECTION, V31, P410, DOI 10.1007/s15010-003-3159-5; Song Q, 2015, INT J CLIN EXP MED, V8, P15666; Wertheim H, 2015, INFLUENZA OTHER RESP; Xu YC, 2011, WORLD J PEDIATR, V7, P240, DOI 10.1007/s12519-011-0318-0	29	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170787	10.1371/journal.pone.0170787	http://dx.doi.org/10.1371/journal.pone.0170787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129377	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400036
J	Eloi, JC; Epifanio, M; de Goncalves, MM; Pellicioli, A; Vieira, PFG; Dias, HB; Bruscato, N; Soder, RB; Santana, JCB; Mouzaki, M; Baldisserotto, M				Eloi, Juliana Cristina; Epifanio, Matias; de Goncalves, Marilia Maia; Pellicioli, Augusto; Giora Vieira, Patricia Froelich; Dias, Henrique Bregolin; Bruscato, Neide; Soder, Ricardo Bernardi; Batista Santana, Joao Carlos; Mouzaki, Marialena; Baldisserotto, Matteo			Quantification of Abdominal Fat in Obese and Healthy Adolescents Using 3 Tesla Magnetic Resonance Imaging and Free Software for Image Analysis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; PUBERTAL CHANGES; CHILDREN; ASSOCIATION	Background and Aims Computed tomography, which uses ionizing radiation and expensive software packages for analysis of scans, can be used to quantify abdominal fat. The objective of this study is to measure abdominal fat with 3T MRI using free software for image analysis and to correlate these findings with anthropometric and laboratory parameters in adolescents. Methods This prospective observational study included 24 overweight/obese and 33 healthy adolescents (mean age 16.55 years). All participants underwent abdominal MRI exams. Visceral and subcutaneous fat area and percentage were correlated with anthropometric parameters, lipid profile, glucose metabolism, and insulin resistance. Student's t test and Mann-Whitney's test was applied. Pearson's chi-square test was used to compare proportions. To determine associations Pearson's linear correlation or Spearman's correlation were used. Results In both groups, waist circumference (WC) was associated with visceral fat area (P = 0.001 and P = 0.01 respectively), and triglycerides were associated with fat percentage (P = 0.046 and P = 0.071 respectively). In obese individuals, total cholesterol/HDL ratio was associated with visceral fat area (P = 0.03) and percentage (P = 0.09), and insulin and HOMA- IR were associated with visceral fat area (P = 0.001) and percentage (P = 0.005). Conclusions 3T MRI can provide reliable and good quality images for quantification of visceral and subcutaneous fat by using a free software package. The results demonstrate that WC is a good predictor of visceral fat in obese adolescents and visceral fat area is associated with total cholesterol/HDL ratio, insulin and HOMA-IR.	[Eloi, Juliana Cristina; Epifanio, Matias] Univ Catolica Rio Grande Sul PUCRS, Hosp Sao Lucas Pontificia, Pediat Gastroenterol Serv, Porto Alegre, RS, Brazil; [de Goncalves, Marilia Maia; Pellicioli, Augusto; Giora Vieira, Patricia Froelich; Dias, Henrique Bregolin] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Soder, Ricardo Bernardi] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil; [Batista Santana, Joao Carlos] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Mouzaki, Marialena] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Toronto, ON, Canada; [Baldisserotto, Matteo] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Pontificia Universidade Catolica Do Rio Grande Do Sul	Baldisserotto, M (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil.	matteob@terra.com.br	Baldisserotto, Matteo/AAD-8447-2022; Epifanio, Matias/M-8561-2013	Epifanio, Matias/0000-0002-7676-8513	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Universal 14/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The current study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant, resulted of Notice Universal 14/2012 with grant equivalent to US D: 13,000.	ABATE N, 1994, J LIPID RES, V35, P1490; Agredo-Zuniga RA, 2015, BRIT J NUTR, V114, P700, DOI 10.1017/S0007114515002275; Benfield LL, 2008, INT J OBESITY, V32, P91, DOI 10.1038/sj.ijo.0803780; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Clemente G, 2015, INT J FOOD SCI NUTR, V66, P466, DOI 10.3109/09637486.2015.1042845; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Du Bois D, 1989, Nutrition, V5, P303; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S0007114500000982; Gonzalez-Casanova I, 2013, REV PANAM SALUD PUBL, V33, P349, DOI 10.1590/S1020-49892013000500006; Grober-Gratz D, 2013, HORM RES PAEDIAT, V80, P170, DOI 10.1159/000354224; Guntsche Z, 2010, J PEDIATR ENDOCR MET, V23, P245; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Karlsson AK, 2013, OBESITY, V21, P1018, DOI 10.1002/oby.20205; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Li XJ, 2008, MAGN RESON IMAGING, V26, P188, DOI 10.1016/j.mri.2007.06.006; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mehmet Sezgin Bu, J ELECT IMAGING, V13, P146; Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002; Nambiar S, 2013, J PAEDIATR CHILD H, V49, pE281, DOI 10.1111/jpc.12147; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Sottier D, 2013, Diagn Interv Imaging, V94, P879, DOI 10.1016/j.diii.2013.04.006; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tong YB, 2014, MED PHYS, V41, DOI 10.1118/1.4876275	37	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0167625	10.1371/journal.pone.0167625	http://dx.doi.org/10.1371/journal.pone.0167625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129354	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400073
J	Kreis, C; Lupatsch, JE; Niggli, F; Egger, M; Kuehni, CE; Spycher, BD				Kreis, Christian; Lupatsch, Judith E.; Niggli, Felix; Egger, Matthias; Kuehni, Claudia E.; Spycher, Ben D.		Swiss Paediatric Oncol Grp; Swiss Natl Cohort Study Grp	Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME TRANSLOCATIONS; GREAT-BRITAIN; ETIOLOGY; CANCER; PATTERNS; CLONES	Background Many studies have observed space-time clustering of childhood leukemia (CL) yet few have attempted to elicit etiological clues from such clustering. We recently reported space-time clustering of CL around birth, and now aim to generate etiological hypotheses by comparing clustered and nonclustered cases. We also investigated whether the clustering resulted from many small aggregations of cases or from a few larger clusters. Methods We identified cases of persons born and diagnosed between 1985 and 2014 at age 0-15 years from the Swiss Childhood Cancer Registry. We determined spatial and temporal lags that maximized evidence of clustering based on the Knox test and classified cases born within these lags from another case as clustered. Using logistic regression adjusted for child population density, we determined whether clustering status was associated with age at diagnosis, immunophenotype, cytogenetic subtype, perinatal and socioeconomic characteristics, and pollution sources. Results Analyses included 1,282 cases of which 242 were clustered (born within 1 km and 2 years from another case). Of all investigated characteristics only the t(12; 21)(p13; q22) translocation (resulting in ETV6-RUNX1 fusion) differed significantly in prevalence between clustered and nonclustered cases (40% and 25%, respectively; adjusted OR 2.54 [1.52-4.23]; p = 0.003). Spatio-temporal clustering was driven by an excess of aggregations of two or three children rather than by a few large clusters. Conclusion Our findings suggest ETV6-RUNX1 is associated with space-time clustering of CL and are consistent with an infection interacting with that oncogene in early life leading to clinical leukemia.	[Kreis, Christian; Lupatsch, Judith E.; Egger, Matthias; Kuehni, Claudia E.; Spycher, Ben D.] Univ Bern, ISPM, Bern, Switzerland; [Niggli, Felix] Univ Childrens Hosp Zurich, Zurich, Switzerland	University of Bern; University Children's Hospital Zurich	Spycher, BD (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	ben.spycher@ispm.unibe.ch	Spycher, Ben D/B-3308-2008; Niggli, Felix/L-6547-2017	Spycher, Ben D/0000-0002-1430-5695; Niggli, Felix/0000-0002-7553-3712; Bopp, Matthias/0000-0003-0766-3723; Kreis, Christian/0000-0001-5273-1954; Egger, Matthias/0000-0001-7462-5132	Swiss Cancer Research [3049-08-2012, 3515-08-2014]; Swiss Federal Office of Public Health [08.001616, 10.002946, 12.008357, PZ00P3_147987]; Swiss Cancer League [02224-03-2008]; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); National Institute of Cancer Epidemiology and Registration; Swiss National Science Foundation [3347CO-108806, 33CS30-134273, 33CS30-148415]	Swiss Cancer Research; Swiss Federal Office of Public Health; Swiss Cancer League; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); National Institute of Cancer Epidemiology and Registration; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss Cancer Research (https://gap.swisscancer.ch) grants 3049-08-2012 and 3515-08-2014 (BDS); Swiss Federal Office of Public Health (http://www.bag.admin.ch) grants 08.001616, 10.002946 and 12.008357 (CEK); Swiss Cancer League (http://www.krebsliga.ch) grant 02224-03-2008 (CEK) and Swiss National Science Foundation (http://www.snf.ch/) fellowship PZ00P3_147987 (BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), the Federal Office of Health (FOH) and the National Institute of Cancer Epidemiology and Registration (www.nicer.ch). The work of the Swiss National Cohort Study was supported by the Swiss National Science Foundation (3347CO-108806, 33CS30-134273, 33CS30-148415).	Alexander FE, 1998, BRIT J CANCER, V77, P812, DOI 10.1038/bjc.1998.132; Baker RD, 1996, J APPL STAT, V23, P543, DOI 10.1080/02664769624080; Bellec S, 2006, BRIT J CANCER, V94, P763, DOI 10.1038/sj.bjc.6602980; Birch JM, 2000, BRIT J CANCER, V82, P1571, DOI 10.1054/bjoc.1999.1072; Bondy JA, 2008, GRAPH THEORY, VXII; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Filippini T, 2015, J ENVIRON SCI HEAL C, V33, P36, DOI 10.1080/10590501.2015.1002999; GILMAN EA, 1995, J EPIDEMIOL COMMUN H, V49, P158, DOI 10.1136/jech.49.2.158; Gilman EA, 1999, EUR J CANCER, V35, P91, DOI 10.1016/S0959-8049(98)00345-1; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2011, BLOOD, V117, P369, DOI 10.1182/blood-2010-09-309351; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; GREAVES MF, 1988, LEUKEMIA, V2, P120; Gustafsson B, 1999, BRIT J CANCER, V79, P655, DOI 10.1038/sj.bjc.6690103; HOLM S, 1979, SCAND J STAT, V6, P65; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; KINLEN L, 1988, LANCET, V2, P1323; Kinlen LJ, 2012, BRIT J CANCER, V107, P1163, DOI 10.1038/bjc.2012.402; KNOX EG, 1992, J EPIDEMIOL COMMUN H, V46, P566, DOI 10.1136/jech.46.6.566; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kreis C, 2016, INT J CANCER, V138, P2127, DOI 10.1002/ijc.29955; Kulldorff M, 1999, BIOMETRICS, V55, P544, DOI 10.1111/j.0006-341X.1999.00544.x; Laurier D, 2014, J RADIOL PROT, V34, pR53, DOI 10.1088/0952-4746/34/3/R53; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; LITTLE J, 1999, IARC SCI PUBLICATION, V149; McNally RJQ, 2006, INT J CANCER, V118, P2840, DOI 10.1002/ijc.21726; McNally RJQ, 2004, BRIT J HAEMATOL, V127, P243, DOI 10.1111/j.1365-2141.2004.05166.x; McNally RJQ, 2002, BRIT J CANCER, V87, P513, DOI 10.1038/sj.bjc.6600498; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; MORRIS V, 1990, J EPIDEMIOL COMMUN H, V44, P55, DOI 10.1136/jech.44.1.55; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Onozuka D, 2008, EPIDEMIOLOGY, V19, P824, DOI 10.1097/EDE.0b013e3181880eda; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Petridou E, 1996, BRIT J CANCER, V73, P1278, DOI 10.1038/bjc.1996.245; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Pyatt D, 2010, CHEM-BIOL INTERACT, V184, P151, DOI 10.1016/j.cbi.2010.01.002; Schindler M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14225; Smith M, 1997, J IMMUNOTHER, V20, P89, DOI 10.1097/00002371-199703000-00001; Spycher BD, 2015, EUR J EPIDEMIOL, V30, P1263, DOI 10.1007/s10654-015-0091-9; Spycher BD, 2011, INT J EPIDEMIOL, V40, P1247, DOI 10.1093/ije/dyr115; Teuffel O, 2004, LEUKEMIA, V18, P1624, DOI 10.1038/sj.leu.2403462; Wakeford R, 2013, J RADIOL PROT, V33, P1, DOI 10.1088/0952-4746/33/1/1; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; Williams JR, 2001, J ROY STAT SOC A STA, V164, P49, DOI 10.1111/1467-985X.00185	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170020	10.1371/journal.pone.0170020	http://dx.doi.org/10.1371/journal.pone.0170020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129329	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000396211400066
J	Wu, QX; An, JQ; She, RP; Shi, RH; Hao, WZ; Soomro, M; Yuan, XR; Yang, JL; Wang, JY				Wu, Qiaoxing; An, Junqing; She, Ruiping; Shi, Ruihan; Hao, Wenzhuo; Soomro, MajidHussain; Yuan, Xuerui; Yang, Jinling; Wang, Jingyuan			Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits	PLOS ONE			English	Article								Increasing evidence demonstrates that hepatitis E virus (HEV) can be transmitted across species. According to previous reports, swine HEV has two genotypes, genotype 3 and 4, and both can infect humans by the fecal-oral route. Thus, it is crucial for the control of HEV zoonotic transmission to evaluate the dynamics of viral shedding and distribution in different tissues during cross-species infection by HEV. In this study, rabbits were infected with genotype 4 swine HEV by the intraperitoneal route. The results showed that HEV RNA not only shed in the feces but also in the saliva of some rabbits during infection with swine HEV. Viremia appeared late after infection, and anti-HEV IgG was not obvious until the appearance of high viremia levels. After the rabbits were euthanized, a histopathological examination showed that the livers developed overt hepatitis accompanied by an elevation of alanine aminotransferase (ALT) and aspartate transaminase (AST). Furthermore, HEV RNA was detected in various tissues, especially in the salivary glands and tonsils. Subsequently, negative- stranded HEV RNA was practiced in tissues with positive HEV RNA, which demonstrated that HEV replicated in the tissues. Next, we harvested additional tissues from the liver, salivary gland, tonsil, spleen, thymus gland, lymph node and intestine, which are known as replication sites of swine HEV. Additionally, we also observed the HEV antigen distributed in the organs above through immunohistochemical staining. These results demonstrate that rabbits could be used as an animal model for researching cross-species infection of genotype 4 HEV. It is also noteworthy that HEV can shed in the saliva and presents the risk of droplet transmission. These new data provide valuable information for understanding cross-species infection by HEV.	[Wu, Qiaoxing; An, Junqing; She, Ruiping; Shi, Ruihan; Hao, Wenzhuo; Soomro, MajidHussain; Yuan, Xuerui; Yang, Jinling; Wang, Jingyuan] China Agr Univ, Coll Vet Med, Lab Vet Pathol & Publ Hlth, Beijing, Peoples R China	China Agricultural University	She, RP (corresponding author), China Agr Univ, Coll Vet Med, Lab Vet Pathol & Publ Hlth, Beijing, Peoples R China.	sheruiping@126.com		Wu, Qiaoxing/0000-0001-7362-6424	National Natural Science Foundation of China [31072110, 31272515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No.31072110, 31272515).; We thank Wei Li, Heng Li, Yang Zhang, Yifei Yang and Yuanheng Wu for their help with the experiments and Feng Yu at the University of California Davis for language revision of the paper. This study was supported by the National Natural Science Foundation of China (Grant No.31472165, 31272515). The American Journal Experts thoroughly copyedit the manuscript for language.	[Anonymous], 2014, INT J CHEM ENG; [Anonymous], 2005, J CLIN MICROBIOL, V1, P49; Ansari IH, 2000, J MED VIROL, V60, P275, DOI 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.3.CO;2-0; Beyaz F, 2010, VET RES COMMUN, V34, P255, DOI 10.1007/s11259-010-9349-6; Bose PD, 2014, J GEN VIROL, V95, P1266, DOI 10.1099/vir.0.063602-0; Bouwknegt M, 2008, VET RES, V5, P498; Cossaboom CM, 2012, J GEN VIROL, V93, P1687, DOI 10.1099/vir.0.041509-0; Geng YS, 2016, J HEPATOL, V64, P37, DOI 10.1016/j.jhep.2015.08.034; Huang F, 2016, HEPATOLOGY; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Johne R, 2011, EMERG INFECT DIS, V17, P1982, DOI 10.3201/eid1710.110283; Kasorndorkbua C., 2004, DISSERTATION ABSTR B, V65-12, P6232; Li TC, 2016, VET MICROBIOL, V183, P30, DOI 10.1016/j.vetmic.2015.11.014; Li WG, 2009, J MED VIROL, V81, P1591, DOI 10.1002/jmv.21573; Liu L, 2016, J MED VIROL, V88, P681, DOI 10.1002/jmv.24374; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma H, 2010, PLOS ONE, V2, P1; Mao JD, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/157645; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Payne CJ, 1999, VET MICROBIOL, V68, P119, DOI 10.1016/S0378-1135(99)00067-X; Renou C, 2007, EMERG INFECT DIS, V13, P1094, DOI 10.3201/eid1307.070063; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Shi R, 2016, J VIRAL HEPATITIS; Soomro MH, 2015, VIRUS RES, V3, P588; Takagi T, 2010, J CLIN MICROBIOL, V48, P1112, DOI [10.1128/JCM.02002-09, DOI 10.1128/JCM.02002-09]; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tian DY, 2006, WORLD J GASTROENTERO, V12, P3919, DOI 10.3748/wjg.v12.i24.3919; van de Garde MDB, 2016, J VIROL, V90, P4394, DOI 10.1128/JVI.00114-16; Wang L., 2016, GUT; Wang L, 2016, J INFECTION, V73, P271, DOI 10.1016/j.jinf.2016.06.005; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140; Yang YF, 2015, VIRUS RES, V208, P171, DOI 10.1016/j.virusres.2015.06.007; Yang YF, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0375-z; ZHANG W, 2008, EPIDEMIOL INFECT, V08; Zhang YD, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931256; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	43	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171277	10.1371/journal.pone.0171277	http://dx.doi.org/10.1371/journal.pone.0171277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129390	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400003
J	Zhang, QH; Mahapatra, T; Huang, FF; Tang, WM; Guo, YF; Tang, SY; Lei, Y; Feng, L; Wang, AN; Zhang, LY; Zhang, JP				Zhang, Qinghua; Mahapatra, Tanmay; Huang, Feifei; Tang, Weiming; Guo, Yufang; Tang, Songyuan; Lei, Yang; Feng, Lei; Wang, Anni; Zhang, Liuyi; Zhang, Jingping			Association between Anthropometric Measures and Indicators for Hypertension Control among Kazakh-Chinese Hypertension Patients in Xinjiang, China: Results from a Cross-sectional Study	PLOS ONE			English	Article							PULSE PRESSURE INDEX; ANKLE-BRACHIAL INDEX; TO-HEIGHT RATIO; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; WAIST CIRCUMFERENCE; PRACTICE GUIDELINES; RISK-FACTORS; OBESITY; PREVALENCE	Background Among Kazakh-Chinese population in Xinjiang province of China, prevalence of obesity and hypertension were 40.1% and 50.3% respectively, the highest across all ethnic groups residing in this pastureland. Despite this, there remained a dearth of information regarding the association between the anthropometric measures [body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), Waist-to-height ratio (WHtR) etc.] and indicators for hypertension control [achieved levels of systolic and diastolic blood pressures (SBP and DBP), pulse pressure index (PPI), ankle-brachial index (ABI) etc.] among them. Method A cross-sectional study was conducted in Xinjiang to determine the distribution and interrelationships of the anthropometric measures and indicators for achieved BP control as well as their predictors among hypertension patients of Kazakh-Chinese ethnicity. Out of 550 randomly selected patients, 516 completed the interview, anthropometry and BP assessments. Results In the sample population, average SBP, DBP and PP were 156.26 +/- 24.40mmHg, 87.55 +/- 14.73mmHg and 68.71 +/- 19.39mmHg respectively. Bivariate analysis identified age, gender, education, duration of hypertension, WC and BMI being factors influencing the achieved levels of BP. Adjusted multiple linear regression models elicited positive associations of age (beta(a) = 0.152, p = 0.001) and duration of hypertension (beta(a) = 0.132, p = 0.003) with achieved level of SBP as well as BMI (beta(a) = 0.135, p = 0.002) with DBP. Age (beta(a) = 0.207, p < 0.001) and WHtR (beta(a) = 0.304, p = 0.005) were positively and WC (beta(a) = -0.406, p < 0.001) was negatively associated with PPI. Increasing age (beta(a) = -0.125, p = 0.005), female gender (beta(a) = -0.122, p = 0.005) and 5years' duration of hypertension (beta(a) = -0.091, p < 0.039) were negatively associated with ABI. After adjustment for socio- demographic variables, hypertensive patients with (reference = without) abdominal obesity had 93% (p = 0.013) higher odds of missing the target BP control. Conclusion Anthropometric measures and indicators for blood pressure control among Kazakh-Chinese patients were far beyond normal. Several anthropometric measures appeared useful for monitoring BP. Using them, regular screening and consequent targeted intervention were required urgently to control hypertension among Kazakh- Chinese.	[Zhang, Qinghua; Guo, Yufang; Wang, Anni; Zhang, Liuyi; Zhang, Jingping] Cent South Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China; [Zhang, Qinghua] Xinjiang Med Univ, Sch Nursing, Urumqi, Xinjiang, Peoples R China; [Mahapatra, Tanmay] Univ Calif Los Angeles, Los Angeles, CA USA; [Huang, Feifei] Fujian Med Univ, Sch Nursing, Fuzhou, Fu Jian, Peoples R China; [Tang, Weiming; Tang, Songyuan] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Lei, Yang] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Feng, Lei] Peoples Hosp Xinjiang Uyghur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China	Central South University; Xinjiang Medical University; University of California System; University of California Los Angeles; Fujian Medical University; Chinese University of Hong Kong	Zhang, JP (corresponding author), Cent South Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China.	jpzhang1965@163.com	Anni, Wang/AAH-5183-2019; Zhang, Jingping/ABA-4179-2020	Anni, Wang/0000-0003-3109-7514; Zhang, Jingping/0000-0002-7800-9617	Fundamental Research Funds for the Central South University [2013zzts079]; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China [15YJCZH223]	Fundamental Research Funds for the Central South University; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China	This study was supported by the Fundamental Research Funds for the Central South University (number 2013zzts079) and the Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China (number 15YJCZH223) to Qinghua Zhang. The funders had role in study design, data collection, analysis, preparation of the manuscript and decision regarding submission for publication of the article.	Aekplakorn W, 2006, INT J OBESITY, V30, P1782, DOI 10.1038/sj.ijo.0803346; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alsuwaida A, 2011, CLIN EXP HYPERTENS, V33, P354, DOI 10.3109/10641963.2010.531857; Armstrong C, 2014, AM FAM PHYSICIAN, V90, P503; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Cai AP, 2015, CLIN EXP HYPERTENS, V37, P267, DOI 10.3109/10641963.2014.954713; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Moraes Suzana Alves de, 2015, Rev. bras. epidemiol., V18, P157, DOI 10.1590/1980-5497201500010013; ESH/ESC, 2013, BLOOD PRESSURE, V22, P193, DOI DOI 10.3109/08037051.2013.812549; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jayawardana R, 2013, DIABETES RES CLIN PR, V99, P292, DOI 10.1016/j.diabres.2012.12.013; Lamina C, 2006, EUR HEART J, V27, P2580, DOI 10.1093/eurheartj/ehl228; Lee WH, 2014, AM J HYPERTENS, V27, P454, DOI 10.1093/ajh/hpt228; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li YC, 2014, J AM COLL CARDIOL, V64, pC96; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Cheng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1139; Liu F, 2014, J AM COLL CARDIOL, V64, pC96; Liu Fen, 2010, Zhonghua Yi Xue Za Zhi, V90, P3259; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Maximova K, 2011, J HYPERTENS, V29, P2075, DOI 10.1097/HJH.0b013e32834be614; Mello RB, 2011, CIRCULATION, V124; Mi YJ, 2015, AM J PREV MED, V49, P661, DOI 10.1016/j.amepre.2015.05.005; [倪平 NI Pin], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P378; Nyamdorj R, 2008, J HYPERTENS, V26, P866, DOI 10.1097/HJH.0b013e3282f624b7; Park SH, 2013, J AM SOC HYPERTENS, V7, P420, DOI 10.1016/j.jash.2013.06.002; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Peng-Lin Y, 2009, MED HYPOTHESES, V72, P729, DOI 10.1016/j.mehy.2008.12.041; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Rodea-Montero ER, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/195407; Redon J, 2008, J HYPERTENS, V26, P1757, DOI 10.1097/HJH.0b013e3283077f03; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Rivera-Soto WT, 2016, P R HEALTH SCI J, V35, P20; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Taylor BC, 2011, J GEN INTERN MED, V26, P685, DOI 10.1007/s11606-011-1660-6; Wang XD, 2015, J AM COLL CARDIOL, V66, pC205, DOI 10.1016/j.jacc.2015.06.783; Yalcin BM, 2005, FAM PRACT, V22, P541, DOI 10.1093/fampra/cmi043	40	6	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170959	10.1371/journal.pone.0170959	http://dx.doi.org/10.1371/journal.pone.0170959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129402	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400021
J	Deb, DK; Bao, RY; Li, YC				Deb, Dilip K.; Bao, Riyue; Li, Yan Chun			Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney	FASEB JOURNAL			English	Article						diabetic complication; renal fibrosis; histone acetylation; ChIP-Seq; protein kinase A	VITAMIN-D-RECEPTOR; EMBRYONIC STEM-CELLS; MODEL-BASED ANALYSIS; CHIP-SEQ MACS; DIABETIC-NEPHROPATHY; HISTONE ACETYLATION; GENE-EXPRESSION; MESANGIAL CELLS; HUMAN MONOCYTES; GROWTH-FACTOR	Hyperglycemia is a major pathogenic factor that promotes diabetic nephropathy, but the underlying mechanism remains incompletely understood. Here, we show that high glucose induced cAMP response element-binding protein (CREB)-binding protein (CBP)-mediated H3K9/14 hyperacetylation in approximately 5000 gene promoters in glomerular mesangial cells, including those of Tgfb1, Tgfb3, and Ctgf, the major profibrotic factors that are known to drive diabetic renal fibrogenesis. In these promoters, H3K9/14 hyperacetylation was closely associated with NF-kappa B or CREB motifs. Chromatin immunoprecipitation assays confirmed that hyperglycemia promoted phospho-p65 or phospho-CREB and CBP bindings and RNA polymerase II recruitment to these promoters in mesangial cells as well as in glomeruli that were purified from type I and type II diabetic mice. Under hyperglycemia, cAMP production and PKA activity were markedly increased as a result of glucose transporter 1-mediated glucose influx that drives glucose metabolism and ATP production, which led to increased phosphorylation of p65 and CREB. Inhibition of adenylyl cyclase or PKA activity blocked p65 and CREB phosphorylation, CBP recruitment, and histone acetylation in these promoters. Collectively, these data demonstrate that the cAMP-PKA pathway plays a key role in epigenetic regulation of key profibrotic factors in diabetes.-Deb, D. K., Bao, R., Li, Y. C. Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.	[Deb, Dilip K.; Li, Yan Chun] Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA; [Bao, Riyue] Univ Chicago, Ctr Res Informat, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Li, YC (corresponding author), Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu			Genzyme Corp.; U.S. National Institutes of Health (NIH) Clinical and Translational Science [CTSA-NIH UL1 TR000430]; Center for Research Informatics of The University of Chicago Biological Science Division; NIH Institute for Translational Medicine [CTSA-NIH UL1 RR024999]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	Genzyme Corp.(Sanofi-AventisGenzyme Corporation); U.S. National Institutes of Health (NIH) Clinical and Translational Science; Center for Research Informatics of The University of Chicago Biological Science Division; NIH Institute for Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a Genzyme Renal Innovations Program research grant from the Genzyme Corp., U.S. National Institutes of Health (NIH) Clinical and Translational Science Award Grant CTSA-NIH UL1 TR000430, the Center for Research Informatics of The University of Chicago Biological Science Division, and the NIH Institute for Translational Medicine Grant CTSA-NIH UL1 RR024999. The authors declare no conflicts of interest.	Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Birukova AA, 2004, AM J PHYSIOL-LUNG C, V287, pL86, DOI 10.1152/ajplung.00441.2003; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Centers for Disease Control and Prevention, 2014, 2014 NAT DIAB STAT R; Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; HEILIG C, 1995, LAB INVEST, V73, P674; Heilig CW, 1997, DIABETES, V46, P1030, DOI 10.2337/diabetes.46.6.1030; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KURTZ A, 1983, P NATL ACAD SCI-BIOL, V80, P4008, DOI 10.1073/pnas.80.13.4008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; MARCUS RG, 1994, AM J PHYSIOL-RENAL, V267, pF816, DOI 10.1152/ajprenal.1994.267.5.F816; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Miao F, 2008, J IMMUNOL, V180, P2264, DOI 10.4049/jimmunol.180.4.2264; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Murata H, 1997, J INVEST DERMATOL, V108, P258, DOI 10.1111/1523-1747.ep12286451; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Schaan BD, 2001, HORM METAB RES, V33, P664, DOI 10.1055/s-2001-18683; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	57	32	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2065	2075		10.1096/fj.201601116R	http://dx.doi.org/10.1096/fj.201601116R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148567	Green Published			2022-12-26	WOS:000399195500026
J	He, CY; Zhang, GY; Zhang, JG; Zeng, YF; Liu, JJ				He, Caiyun; Zhang, Guoyun; Zhang, Jianguo; Zeng, Yanfei; Liu, Juanjuan			Integrated analysis of multiomic data reveals the role of the antioxidant network in the quality of sea buckthorn berry	FASEB JOURNAL			English	Article						ascorbic acid; berry colorcarotenoids; flavonoids; UDP-glucuronosyltransferase	REGULATES PROANTHOCYANIDIN SYNTHESIS; MYB TRANSCRIPTION FACTOR; ASCORBIC-ACID; FRUIT-DEVELOPMENT; CAROTENOID BIOSYNTHESIS; VITAMIN-C; HIPPOPHAE-RHAMNOIDES; GENE-EXPRESSION; MESSENGER-RNA; BETA-CAROTENE	Berries of sea buckthorn, known as the "king of vitamin C," are abundant in antioxidants, have attractive colors, and are an excellent material with which to study the relationships between berry color, antioxidants, and berry quality. No study has yet determined the molecular basis of the relationship between sea buckhorn berries and their color and antioxidant levels. By using RNA-seq, LC-MS/MS, and LC/GC-MS technology and selecting red (darkest colored) and yellow (lightest colored) sea buckthorn berries at different development stages, this study showed that the red and yellow berry resulted from a higher ratio of lycopene to beta-carotene and of b-carotene to lycopene content, respectively. The uronic acid pathway-a known animal pathway-in ascorbic acid synthesis was found in sea buckthorn berries, and the higher expression of UDP-glucuronosyltransferase in red berries was consistent with the higher content of ascorbic acid. In summary, multiomic data showed that the color of sea buckthorn berries is mainly determined by b-carotene and lycopene; red sea buckthorn berries were richer than yellow berries in antioxidants, such as carotenoids, flavonoids, and ascorbic acid; and the animal pathway might be operating in sea buckthorn.-He, C., Zhang, G., Zhang, J., Zeng, Y., Liu, J. Integrated analysis of multiomic data reveals the role of the antioxidant network in the quality of sea buckthorn berry.	[He, Caiyun; Zhang, Guoyun; Zhang, Jianguo; Zeng, Yanfei; Liu, Juanjuan] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat, State Forestry Adm,Res Inst Forestry, Beijing, Peoples R China; [Zhang, Jianguo] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Zhang, JG (corresponding author), Chinese Acad Forestry, Xianshan Rd, Beijing 100091, Peoples R China.	zhangjg@caf.ac.cn			Basic Research Fund of Rapid Innovation Fund (RIF) [RIF-2014-04]; National Natural Science Foundation of China [31470616]; Special Fund for Forest Scientific Research in the Public Welfare [201504103]	Basic Research Fund of Rapid Innovation Fund (RIF); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Forest Scientific Research in the Public Welfare	The authors thank Hongmei Luo (Chinese Academy of Forestry) for helping with the sampling. This work was supported by the Basic Research Fund of Rapid Innovation Fund (RIF; Grant RIF-2014-04), National Natural Science Foundation of China (31470616), and the Special Fund for Forest Scientific Research in the Public Welfare (201504103). RNA-seq data have been deposited at the European Nucleotide Archive under accession PRJEB12839. MS proteomics data have been deposited to the ProteomeXchange Consortium via the Proteomics Identifications (PRIDE) partner repository with data set identifier PXD004251. The authors declare no conflicts of interest.	Abbott JA, 1999, POSTHARVEST BIOL TEC, V15, P207, DOI 10.1016/S0925-5214(98)00086-6; Abu-Reidah IM, 2014, ELECTROPHORESIS, V35, P1571, DOI 10.1002/elps.201300646; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alos E, 2014, PLANTA, V239, P1113, DOI 10.1007/s00425-014-2044-z; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borovsky Y, 2013, THEOR APPL GENET, V126, P557, DOI 10.1007/s00122-012-2001-9; Castro SM, 2008, FOOD CHEM, V107, P1436, DOI 10.1016/j.foodchem.2007.09.074; CHATTERJEE I, 1961, ANN NY ACAD SCI, V92, P36, DOI 10.1111/j.1749-6632.1961.tb46105.x; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Di Vaio C, 2015, J SCI FOOD AGR, V95, P2124, DOI 10.1002/jsfa.6929; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He CY, 2016, PROTEOMICS, V16, P2688, DOI 10.1002/pmic.201600160; Hosseinian FS, 2007, J AGR FOOD CHEM, V55, P10832, DOI 10.1021/jf072529m; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Jakobek L, 2007, DEUT LEBENSM-RUNDSCH, V103, P58; Jeong ST, 2006, PLANT SCI, V170, P61, DOI 10.1016/j.plantsci.2005.07.025; Kang BS, 2014, PLANTA, V240, P1011, DOI 10.1007/s00425-014-2052-z; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Kim Y, 2007, FOOD CHEM, V105, P1327, DOI 10.1016/j.foodchem.2007.03.050; King MC, 2002, J AMER POMOLOG SOC, V56, P223; Krejcarova J, 2015, ACTA VET BRNO, V84, P257, DOI 10.2754/avb201584030257; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Ling Y, 2013, J PHARMACEUT BIOMED, V85, P1, DOI 10.1016/j.jpba.2013.06.011; Liu BL, 2015, PLANT PHYSIOL BIOCH, V86, P181, DOI 10.1016/j.plaphy.2014.12.003; Liu YM, 2011, ANAL BIOANAL CHEM, V400, P1405, DOI 10.1007/s00216-011-4880-z; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Raj Kumar, 2011, Research Journal of Medicinal Plant, V5, P491, DOI 10.3923/rjmp.2011.491.499; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Simonne A. H., 1997, Journal of Food Composition and Analysis, V10, P299, DOI 10.1006/jfca.1997.0544; Smimoff N, 2003, NAT BIOTECHNOL, V21, P134, DOI 10.1038/nbt0203-134; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smita S, 2013, J GENET, V92, P363, DOI 10.1007/s12041-013-0275-6; Sun DQ, 2010, AFR J BIOTECHNOL, V9, P3272; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Vimolmangkang S, 2014, GENE, V534, P78, DOI 10.1016/j.gene.2013.10.007; Wang H. L., 1994, CHINAS FOREIGN TRADE, V5, P17; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zeb A, 2004, PAK J NUTR, V3, P99, DOI DOI 10.3923/PJN.2004.99.106; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	52	13	16	2	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1929	1938		10.1096/fj.201600974R	http://dx.doi.org/10.1096/fj.201600974R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126735				2022-12-26	WOS:000399195500015
J	Lee, H; Park, JR; Kim, WJ; Sundar, IK; Rahman, I; Park, SM; Yang, SR				Lee, Hanbyeol; Park, Jeong-Ran; Kim, Woo Jin; Sundar, Isaac K.; Rahman, Irfan; Park, Sung-Min; Yang, Se-Ran			Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling	FASEB JOURNAL			English	Article						FPS-ZM1; Nrf2; COPD; emphysema	GLYCATION END-PRODUCTS; OBSTRUCTIVE PULMONARY-DISEASE; SOLUBLE RECEPTOR; LUNG-FUNCTION; MICE; INFLAMMATION; COPD; EXPRESSION; LIGANDS; NRF2	The receptor for advanced glycan end products (RAGE) has been identified as a susceptibility gene for chronic obstructive pulmonary disease (COPD) in genome-wide association studies (GWASs). However, less is known about how RAGE is involved in the pathogenesis of COPD. To determine the molecular mechanism by which RAGE influences COPD in experimental COPD models, we investigated the efficacy of the RAGE-specific antagonist FPS-ZM1 administration in in vivo and in vitro COPD models. We injected elastase intratracheally and the RAGE antagonist FPS-ZM1 in mice, and the infiltrated inflammatory cells and cytokines were assessed by ELISA. Cellular expression of RAGE was determined in protein, serum, and bronchoalveolar lavage fluid of mice and lungs and serum of human donors and patients with COPD. Downstream damage-associated molecular pattern (DAMP) pathway activation in vivo and in vitro and in patients with COPD was assessed by immunofluorescence staining, Western blot analysis, and ELISA. The expression of membrane RAGE in initiating the inflammatory response and of soluble RAGE acting as a decoy were associated with up-regulation of the DAMP-related signaling pathway via Nrf2. FPS-ZM1 administration significantly reversed emphysema in the lung of mice. Moreover, FPS-ZM1 treatment significantly reduced lung inflammation in Nrf2(+/+) , but not in Nrf2(-/-) mice. Thus, our data indicate for the first time that RAGE inhibition has an essential protective role in COPD. Our observation of RAGE inhibition provided novel insight into its potential as a therapeutic target in emphysema/COPD.-Lee, H., Park, J.-R., Kim, W. J., Sundar, I. K., Rahman, I., Park, S.-M., Yang. S.-R. Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling.	[Lee, Hanbyeol; Park, Jeong-Ran; Park, Sung-Min; Yang, Se-Ran] Kangwon Natl Univ, Dept Thorac & Cardiovasc Surg, Chunchon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Chunchon, South Korea; [Sundar, Isaac K.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA	Kangwon National University; Kangwon National University; University of Rochester	Yang, SR (corresponding author), Kangwon Natl Univ, Sch Med, 1 Kangwondaehak Gil, Chunchon 200701, Gangwon, South Korea.; Yang, SR (corresponding author), Kangwon Natl Univ, Stem Cell Inst, 1 Kangwondaehak Gil, Chunchon 200701, Gangwon, South Korea.	seran.yang@gmail.com	Sundar, Isaac K/F-8764-2012; Kim, Woo Jin/A-8216-2019	Sundar, Isaac K/0000-0001-6742-3460; Kim, Woo Jin/0000-0003-2927-370X	National Research Foundation of Korea (NRF) - Korean government [NRF2014R1A2A2A01003737]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL085613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The biospecimens and data used for this study were provided by the Biobank of Soonchunhyang, Kyungpook and the Korea University Guro Hospital, a member of the National Biobank of Korea. This work was supported by the National Research Foundation of Korea (NRF; Grant NRF2014R1A2A2A01003737) funded by the Korean government (to S.-R.Y.) and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant 1R01HL085613 (to I.R.). The authors declare no conflicts of interest.	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Alzheimer's Disease Cooperative Study, 2014, NEUROLOGY, V82, P1536; Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Bodine BG, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0133-y; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Davis BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033304; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hunt WR, 2016, J CYST FIBROS, V15, P681, DOI 10.1016/j.jcf.2015.12.011; Iwamoto H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-68; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim WJ, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S80227; Kim WJ, 2014, LUNG, V192, P473, DOI 10.1007/s00408-014-9579-4; Lee H, 2016, TOXICOL LETT, V240, P140, DOI 10.1016/j.toxlet.2015.10.030; Lee H, 2014, IN VITRO CELL DEV-AN, V50, P731, DOI 10.1007/s11626-014-9763-0; Li M, 2015, RESPIROLOGY, V20, P998, DOI 10.1111/resp.12557; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pahwa R, 2016, J DIABETES COMPLICAT, V30, P1186, DOI 10.1016/j.jdiacomp.2016.03.005; Park JR, 2016, IN VITRO CELL DEV-AN, V52, P545, DOI 10.1007/s11626-016-0008-2; Pouwels SD, 2015, EUR RESPIR J, V45, P1482, DOI 10.1183/09031936.00158414; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; Robinson AB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00301; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Sukkar MB, 2013, AM J RESP CRIT CARE, V188, P893, DOI 10.1164/rccm.201308-1489ED; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Ueno M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7332; Wood TT, 2014, AM J PHYSIOL-LUNG C, V307, pL758, DOI 10.1152/ajplung.00185.2014; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Young RP, 2011, EUR RESPIR J, V38, P743, DOI 10.1183/09031936.00041711; Zabini D, 2015, J CELL MOL MED, V19, P1151, DOI 10.1111/jcmm.12519; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhang YH, 2014, J THORAC DIS, V6, P734, DOI 10.3978/j.issn.2072-1439.2014.04.31	54	37	37	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2076	2089		10.1096/fj.201601155R	http://dx.doi.org/10.1096/fj.201601155R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148566	Green Published			2022-12-26	WOS:000399195500027
J	Schmidt, EA; Fee, BE; Henry, SC; Nichols, AG; Shinohara, ML; Rathmell, JC; Maclver, NJ; Coers, J; Ilkayeva, OR; Koves, TR; Taylor, GA				Schmidt, Elyse A.; Fee, Brian E.; Henry, Stanley C.; Nichols, Amanda G.; Shinohara, Mari L.; Rathmell, Jeffrey C.; Maclver, Nancie J.; Coers, Jorn; Ilkayeva, Olga R.; Koves, Timothy R.; Taylor, Gregory A.			Metabolic Alterations Contribute to Enhanced Inflammatory Cytokine Production in Irgm1-deficient Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-AUTONOMOUS IMMUNITY; MITOCHONDRIAL DYNAMICS; ENDOPLASMIC-RETICULUM; RESISTANCE GTPASES; INDUCIBLE GTPASES; IRG PROTEINS; AUTOPHAGY; IMMUNOMETABOLISM; ACTIVATION; SUSCEPTIBILITY	The immunity-related GTPases (IRGs) are a family of proteins that are induced by interferon (IFN)-gamma and play pivotal roles in immune and inflammatory responses. IRGs ostensibly function as dynamin-like proteins that bind to intracellular membranes and promote remodeling and trafficking of those membranes. Prior studies have shown that loss of Irgm1 in mice leads to increased lethality to bacterial infections as well as enhanced inflammation to non-infectious stimuli; however, the mechanisms underlying these phenotypes are unclear. In the studies reported here, we found that uninfected Irgm1-deficient mice displayed high levels of serum cytokines typifying profound autoinflammation. Similar increases in cytokine production were also seen in cultured, IFN-gamma-primed macrophages that lacked Irgm1. A series of metabolic studies indicated that the enhanced cytokine production was associated with marked metabolic changes in the Irgm1-deficient macrophages, including increased glycolysis and an accumulation of long chain acylcarnitines. Cells were exposed to the glycolytic inhibitor, 2-deoxyglucose, or fatty acid synthase inhibitors to perturb the metabolic alterations, which resulted in dampening of the excessive cytokine production. These results suggest that Irgm1 deficiency drives metabolic dysfunction in macrophages in a manner that is cell-autonomous and independent of infectious triggers. This may be a significant contributor to excessive inflammation seen in Irgm1-deficient mice in different contexts.	[Schmidt, Elyse A.; Shinohara, Mari L.; Coers, Jorn; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Nichols, Amanda G.; Maclver, Nancie J.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Endocrinol & Diabet, Durham, NC 27710 USA; [Shinohara, Mari L.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ilkayeva, Olga R.; Koves, Timothy R.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Koves, Timothy R.; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Koves, Timothy R.; Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Fee, Brian E.; Henry, Stanley C.; Taylor, Gregory A.] Durham Vet Affairs Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA; [Rathmell, Jeffrey C.] Vanderbilt Univ, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; Vanderbilt University	Taylor, GA (corresponding author), 508 Fulton St,Rm N3008, Durham, NC 27705 USA.	gregory.taylor@duke.edu	Koves, Tim/I-4806-2012	Koves, Tim/0000-0001-8763-5866; MacIver, Nancie/0000-0003-3676-9391; Shinohara, Mari/0000-0002-6808-9844; Coers, Jorn/0000-0001-8707-4608	NIAID, National Institutes of Health [UC6-AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088100, R01AI057831, UC6AI058607, R01AI103197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106090] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002369] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs. Tso-Pang Yao, Patrick Seed, and David Pickup for many helpful conversations regarding this work. Cytokine profiling was performed under the management of Dr. Heather E. Lynch and the direction of Dr. Gregory D. Sempowski in the Immunology Unit of the Duke Regional Biocontainment Laboratory, which received partial support for construction from NIAID, National Institutes of Health, Grant UC6-AI058607.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; [Anonymous], 2014, THESIS; Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; DOUGAN G, 1988, J INFECT DIS, V158, P1329, DOI 10.1093/infdis/158.6.1329; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Freitag J, 2016, IMMUNOL CELL BIOL, V94, P925, DOI 10.1038/icb.2016.77; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Hahn WS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1033, DOI 10.1152/ajpendo.00422.2013; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963; Henry SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095021; Henry SC, 2010, J LEUKOCYTE BIOL, V87, P333, DOI 10.1189/jlb.0509299; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Infantino V, 2014, BBA-GENE REGUL MECH, V1839, P1217, DOI 10.1016/j.bbagrm.2014.07.013; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091522; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Lin YC, 2016, J HEPATOL, V65, P1209, DOI 10.1016/j.jhep.2016.06.029; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Maric-Biresev J, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0255-4; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Perkins DJ, 2016, J INTERF CYTOK RES, V36, P454, DOI 10.1089/jir.2016.0003; Petkova DS, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00426; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qi XF, 2011, J CELL PHYSIOL, V226, P58, DOI 10.1002/jcp.22303; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schertzer JD, 2014, IMMUNOL CELL BIOL, V92, P303, DOI 10.1038/icb.2014.12; Schwartz YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P246, DOI 10.1134/S0006297912030030; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Springer HM, 2013, J IMMUNOL, V191, P1765, DOI 10.4049/jimmunol.1300641; Steinberg GR, 2014, IMMUNOL CELL BIOL, V92, P340, DOI 10.1038/icb.2014.11; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang Y, 2014, J ATHEROSCLER THROMB, V21, P381, DOI 10.5551/jat.23929; Wei WC, 2015, J LEUKOCYTE BIOL, V97, P1071, DOI 10.1189/jlb.2A0414-206RR; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Xia FC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01867; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	94	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4651	4662		10.1074/jbc.M116.770735	http://dx.doi.org/10.1074/jbc.M116.770735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154172	Green Published, hybrid			2022-12-26	WOS:000397585100022
J	Meng, ZJ; Duan, AW; Chen, DL; Dassanayake, KB; Wang, X; Liu, ZG; Liu, H; Gao, SG				Meng, Zhaojiang; Duan, Aiwang; Chen, Deli; Dassanayake, Kithsiri Bandara; Wang, Xiaosen; Liu, Zugui; Liu, Hao; Gao, Shengguo			Suitable indicators using stem diameter variation-derived indices to monitor the water status of greenhouse tomato plants	PLOS ONE			English	Article							DAILY TRUNK SHRINKAGE; YOUNG LEMON TREES; DEFICIT IRRIGATION; SAP FLOW; SENSITIVE INDICATOR; THRESHOLD VALUES; OLIVE TREES; FRUIT SIZE; STRESS; GROWTH	It is very important to seek a simple nondestructive method to continuously measure plant water status for irrigation scheduling. Changes in stem diameter in response to plant water status and soil water content (SWC) were experimentally investigated during the growing seasons of 2011/2012 and 2012/2013 in pot-cultivated tomato (Lycopersicon esculentum L.) plants in a plastic greenhouse. This study was conducted to determine suitable SDV (stem diameter variation)-derived indices as indicators of tomato plant water status for irrigation scheduling. The experiment was designed as a two-factor randomized block using the SWC and growth stages as variables. The SWC was controlled at 70-80% (well-watered), 60-70% (slightly deficit watered), 50-60% (moderately deficit watered) of the field capacity (FC), and the prescribed growing stages were vegetative, flowering and fruit-forming, and harvesting stages. Regression analysis showed that the SD6 (the difference between the stem diameter value at 06: 00 am and the initial sensor reading) was closely related to the SWC (p<0.01) during rapid vegetative growth, whereas the MDS (the maximum daily shrinkage) was closely related to the SWC (p<0.01) during slow vegetative growth. Our results suggest that SDV-derived indicators can be used for determining plant water status and for scheduling irrigation at different growth/developmental stages.	[Meng, Zhaojiang; Duan, Aiwang; Wang, Xiaosen; Liu, Zugui; Liu, Hao; Gao, Shengguo] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China; [Chen, Deli; Dassanayake, Kithsiri Bandara] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; University of Melbourne	Meng, ZJ (corresponding author), Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China.	zhaojiang_meng@aliyun.com			earmarked fund for the National High Technology Research and Development Program of China (863 Program of China) [2011AA100509]; key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture; Chinese farmland ecosystem research station in open country in Shang Qiu	earmarked fund for the National High Technology Research and Development Program of China (863 Program of China)(National High Technology Research and Development Program of China); key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture; Chinese farmland ecosystem research station in open country in Shang Qiu	The study was financially supported by the earmarked fund for the National High Technology Research and Development Program of China (863 Program of China, grant numbers: 2011AA100509), key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture, and the funds of Chinese farmland ecosystem research station in open country in Shang Qiu.	Badal E, 2010, AGR WATER MANAGE, V98, P143, DOI 10.1016/j.agwat.2010.08.007; CHEN LH, 1971, CROP SCI, V11, P428, DOI 10.2135/cropsci1971.0011183X001100030036x; Conejero W, 2011, ENVIRON EXP BOT, V71, P409, DOI 10.1016/j.envexpbot.2011.02.014; Cuevas MV, 2010, AGR WATER MANAGE, V97, P1293, DOI 10.1016/j.agwat.2010.03.011; de la Rosa JM, 2013, AGR WATER MANAGE, V126, P133, DOI 10.1016/j.agwat.2013.05.009; De Swaef T, 2009, AGR WATER MANAGE, V96, P541, DOI 10.1016/j.agwat.2008.09.013; De Swaef T, 2010, FUNCT PLANT BIOL, V37, P429, DOI 10.1071/FP09233; Deslauriers A, 2003, TREES-STRUCT FUNCT, V17, P477, DOI 10.1007/s00468-003-0260-4; Domingo R, 1996, IRRIGATION SCI, V16, P115, DOI 10.1007/BF02215619; Downes G, 1999, TREES-STRUCT FUNCT, V14, P102, DOI 10.1007/PL00009752; Fernandez JE, 2011, AGR WATER MANAGE, V98, P1813, DOI 10.1016/j.agwat.2011.06.011; Ferreira MI, 1997, ACTA HORTIC, P379, DOI 10.17660/ActaHortic.1997.449.53; Gallardo M, 2006, J HORTIC SCI BIOTECH, V81, P483, DOI 10.1080/14620316.2006.11512092; Gallardo M, 2014, RESPONSE STEM DIAMET; Garcia-Orellana Y, 2007, AGR WATER MANAGE, V89, P167, DOI 10.1016/j.agwat.2006.12.008; Goldhamer D. A., 2003, California Agriculture, V57, P138, DOI 10.3733/ca.v057n04p138; Goldhamer DA, 2004, IRRIGATION SCI, V23, P11, DOI 10.1007/s00271-003-0088-0; Goldhamer DA, 2001, IRRIGATION SCI, V20, P115, DOI 10.1007/s002710000034; HUCK MG, 1977, AGRON J, V69, P593, DOI 10.2134/agronj1977.00021962006900040017x; Intrigliolo DS, 2004, IRRIGATION SCI, V23, P93, DOI 10.1007/s00271-004-0097-7; Johnson RS, 2000, HORTSCIENCE, V35, P1048, DOI 10.21273/HORTSCI.35.6.1048; KATERJI N, 1988, AGRONOMIE, V8, P425, DOI 10.1051/agro:19880508; Khairi NM, 2012, PROCEDIA ENGINEER, V41, P1421, DOI 10.1016/j.proeng.2012.07.330; Kramer P.J., 1983, WATER RELATIONS PLAN, P489; Lee B.W., 1998, AGR INFO TECH ASIA O, P87; Livellara N, 2011, AGR WATER MANAGE, V98, P684, DOI 10.1016/j.agwat.2010.11.005; MCBURNEY T, 1984, J EXP BOT, V35, P1787, DOI 10.1093/jxb/35.12.1787; MCCUTCHAN H, 1992, J AM SOC HORTIC SCI, V117, P607, DOI 10.21273/JASHS.117.4.607; Moreno F, 2006, AGR WATER MANAGE, V84, P290, DOI 10.1016/j.agwat.2006.03.005; Moriana A, 2013, SCI HORTIC-AMSTERDAM, V164, P102, DOI 10.1016/j.scienta.2013.09.029; Moriana A, 2010, AGR WATER MANAGE, V97, P1822, DOI 10.1016/j.agwat.2010.06.022; Moriana A, 2002, IRRIGATION SCI, V21, P83, DOI 10.1007/s00271-001-0053-8; Naor A, 2008, TREE PHYSIOL, V28, P1255, DOI 10.1093/treephys/28.8.1255; Naor A, 1999, J AM SOC HORTIC SCI, V124, P189, DOI 10.21273/JASHS.124.2.189; Naor A., 2006, Horticultural Reviews, V32, P111; Nortes PA, 2005, AGR WATER MANAGE, V77, P296, DOI 10.1016/j.agwat.2004.09.034; Ortuno MF, 2009, AGR WATER MANAGE, V96, P80, DOI 10.1016/j.agwat.2008.07.001; Ortuno MF, 2006, PLANT SOIL, V279, P229, DOI 10.1007/s11104-005-1302-z; Ortuno MF, 2006, TREES-STRUCT FUNCT, V20, P1, DOI 10.1007/s00468-005-0004-8; Ortuno MF, 2005, ENVIRON EXP BOT, V54, P155, DOI 10.1016/j.envexpbot.2004.06.009; Ortuno MF, 2004, PLANT SOIL, V267, P263, DOI 10.1007/s11104-005-0108-3; Ortuno MF, 2004, PLANT SCI, V167, P275, DOI 10.1016/j.plantsci.2004.03.023; Remorini D, 2003, IRRIGATION SCI, V22, P39, DOI 10.1007/s00271-003-0068-4; SO HB, 1979, AGRON J, V71, P675, DOI 10.2134/agronj1979.00021962007100040037x; Stao N, 1995, ACTA HORTIC, V226, P91; Steduto P, 2007, IRRIGATION SCI, V25, P189, DOI 10.1007/s00271-007-0064-1; Valancogne C, 1997, ACTA HORTIC, P423, DOI 10.17660/ActaHortic.1997.449.59; Velez JE, 2007, AGR WATER MANAGE, V90, P197, DOI 10.1016/j.agwat.2007.03.007; Yatapanage KG, 2001, AGRON J, V93, P1341, DOI 10.2134/agronj2001.1341; Yu KS, 1999, J FRUIT SCI, V2, P86; Yuan XK, 2015, PHOTOSYNTHETICA, V53, P1	51	15	16	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171423	10.1371/journal.pone.0171423	http://dx.doi.org/10.1371/journal.pone.0171423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158246	gold, Green Published			2022-12-26	WOS:000396161700077
J	Miermans, CA; Kusters, RPT; Hoogenraad, CC; Storm, C				Miermans, C. A.; Kusters, R. P. T.; Hoogenraad, C. C.; Storm, C.			Biophysical model of the role of actin remodeling on dendritic spine morphology	PLOS ONE			English	Article							SERIAL ELECTRON-MICROSCOPY; LONG-TERM POTENTIATION; RECYCLING ENDOSOMES; MEMBRANE TENSION; RAT HIPPOCAMPUS; DYNAMICS; PLASTICITY; CYTOSKELETON; PROTRUSION; FILOPODIA	Dendritic spines are small membranous structures that protrude from the neuronal dendrite. Each spine contains a synaptic contact site that may connect its parent dendrite to the axons of neighboring neurons. Dendritic spines are markedly distinct in shape and size, and certain types of stimulation prompt spines to evolve, in fairly predictable fashion, from thin nascent morphologies to the mushroom-like shapes associated with mature spines. It is well established that the remodeling of spines is strongly dependent upon the actin cytoskeleton inside the spine. A general framework that details the precise role of actin in directing the transitions between the various spine shapes is lacking. We address this issue, and present a quantitative, model-based scenario for spine plasticity validated using realistic and physiologically relevant parameters. Our model points to a crucial role for the actin cytoskeleton. In the early stages of spine formation, the interplay between the elastic properties of the spine membrane and the protrusive forces generated in the actin cytoskeleton propels the incipient spine. In the maturation stage, actin remodeling in the form of the combined dynamics of branched and bundled actin is required to form mature, mushroom-like spines. Importantly, our model shows that constricting the spine-neck aids in the stabilization of mature spines, thus pointing to a role in stabilization and maintenance for additional factors such as ring-like F-actin structures. Taken together, our model provides unique insights into the fundamental role of actin remodeling and polymerization forces during spine formation and maturation.	[Miermans, C. A.; Kusters, R. P. T.; Storm, C.] Eindhoven Univ Technol, Dept Appl Phys, Theory Polymers & Soft Matter, Eindhoven, Netherlands; [Hoogenraad, C. C.] Univ Utrecht, Cell Biol, Fac Sci, Utrecht, Netherlands; [Storm, C.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Miermans, C. A.] Ludwig Maximilians Univ Munchen, Arnold Sommerfeld Ctr Theoret Phys, Theoret Stat & Biol Phys, Munich, Germany	Eindhoven University of Technology; Utrecht University; Eindhoven University of Technology; University of Munich	Miermans, CA (corresponding author), Eindhoven Univ Technol, Dept Appl Phys, Theory Polymers & Soft Matter, Eindhoven, Netherlands.; Miermans, CA (corresponding author), Ludwig Maximilians Univ Munchen, Arnold Sommerfeld Ctr Theoret Phys, Theoret Stat & Biol Phys, Munich, Germany.	c.miermans@lmu.de	Storm, Cornelis/K-1486-2013	Storm, Cornelis/0000-0002-4391-8984; Miermans, Christiaan/0000-0002-3810-4660				Angelov B, 2000, P 1 INT C GEOM INT Q, P27; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bar J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37136; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Chazeau A, 2014, EMBO J, V33, P2745, DOI 10.15252/embj.201488837; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Ewers H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113916; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; JULICHER F, 1994, PHYS REV E, V49, P4728, DOI 10.1103/PhysRevE.49.4728; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Powers TR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041901; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; Semrau S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088101; Shao JY, 1999, BIOPHYS J, V77, P587, DOI 10.1016/S0006-3495(99)76915-8; Stone M, 2012, MATH PHYS, DOI [10.1017/CB09780511627040, DOI 10.1017/CB09780511627040]; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	40	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170113	10.1371/journal.pone.0170113	http://dx.doi.org/10.1371/journal.pone.0170113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158194	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700008
J	Park, YJ; Koh, J; Kwon, JT; Park, YS; Yang, LJ; Cha, S				Park, Yun-Jong; Koh, Jin; Kwon, Jin Teak; Park, Yong-Seok; Yang, Lijun; Cha, Seunghee			Uncovering stem cell differentiation factors for salivary gland regeneration by quantitative analysis of differential proteomes	PLOS ONE			English	Article							TCF3 REPRESSION; STROMAL CELLS; BONE-MARROW; NECK-CANCER; EXPRESSION; PTF1A; PLURIPOTENCY; RADIATION; THERAPY; MIST1	Severe xerostomia (dry mouth) compromises the quality of life in patients with Sjogren's syndrome or radiation therapy for head and neck cancer. A clinical management of xerostomia is often unsatisfactory as most interventions are palliative with limited efficacy. Following up our previous study demonstrating that mouse BM-MSCs are capable of differentiating into salivary epithelial cells in a co-culture system, we further explored the molecular basis that governs the MSC reprogramming by utilizing high-throughput iTRAQ-2D-LC-MS/MS-based proteomics. Our data revealed the novel induction of pancreas-specific transcription factor 1a (PTF1 alpha), muscle, intestine and stomach expression-1 (MIST-1), and achaete-scute complex homolog 3 (ASCL3) in 7 day co-cultured MSCs but not in control MSCs. More importantly, a common notion of pancreatic-specific expression of PTF1 alpha was challenged for the first time by our verification of PTF1 alpha expression in the mouse salivary glands. Furthermore, a molecular network simulation of our selected putative MSC reprogramming factors demonstrated evidence for their perspective roles in salivary gland development. In conclusion, quantitative proteomics with extensive data analyses narrowed down a set of MSC reprograming factors potentially contributing to salivary gland regeneration. Identification of their differential/synergistic impact on MSC conversion warrants further investigation.	[Park, Yun-Jong; Kwon, Jin Teak; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA; [Koh, Jin] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Park, Yong-Seok] Seoul Natl Univ, Dept Oral Anat, Sch Dent, Seoul, South Korea; [Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Seoul National University (SNU); State University System of Florida; University of Florida	Cha, S (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA.	scha@dental.ufl.edu			NIH/NIDCR [DE019644, DE025726]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A2074617]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025726] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grants DE019644 and DE025726 (SC) and The National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A2074617) (YSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2013, WIRES DEV BIOL, V2, P531, DOI 10.1002/wdev.99; Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Arany S, 2011, DEV BIOL, V353, P186, DOI 10.1016/j.ydbio.2011.02.025; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bell M, 1999, J RHEUMATOL, V26, P2051; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Fiegel HC, 2006, J CELL MOL MED, V10, P577, DOI 10.1111/j.1582-4934.2006.tb00422.x; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Fox RI, 2002, SCAND J RHEUMATOL, V31, P3; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geraerts M, 2007, STEM CELLS, V25, P263, DOI 10.1634/stemcells.2006-0364; GREENSPAN D, 1987, CANCER, V59, P1123, DOI 10.1002/1097-0142(19870315)59:6<1123::AID-CNCR2820590614>3.0.CO;2-X; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Huang L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0061-x; Humphreys-Beher MG, 1999, ARCH ORAL BIOL, V44, pS21, DOI 10.1016/S0003-9969(99)00045-X; Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Metzler MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125153; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Mimeault M, 2006, STEM CELLS, V24, P2319, DOI 10.1634/stemcells.2006-0066; Nair GG, 2014, STEM CELLS, V32, P1195, DOI 10.1002/stem.1616; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112158; Passier R, 2003, CARDIOVASC RES, V58, P324, DOI 10.1016/S0008-6363(02)00770-8; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pringle S, 2011, JOURNAL OF VISUALIZE; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Redman RS, 2008, BIOTECH HISTOCHEM, V83, P103, DOI 10.1080/10520290802374683; Saarilahti K, 2005, RADIOTHER ONCOL, V74, P251, DOI 10.1016/j.radonc.2004.11.004; Santana A, 2006, J CELL MOL MED, V10, P866, DOI 10.2755/jcmm010.004.06; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; van Vliet Patrick, 2007, Expert Rev Cardiovasc Ther, V5, P33, DOI 10.1586/14779072.5.1.33; Vissink A, 2015, ORAL DIS, V21, pE1, DOI 10.1111/odi.12222; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu YX, 2008, MED HYPOTHESES, V71, P390, DOI 10.1016/j.mehy.2008.03.046; Yang YH, 2012, STEM CELL TRANSL MED, V1, P843, DOI 10.5966/sctm.2012-0083; Yaniv A, 2010, TISSUE ENG PART C-ME, DOI [10.1016/j.ydbio.2011.02.025, DOI 10.1016/J.YDBIO.2011.02.025]; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Zuo Q, 2013, INT ORTHOP, V37, P747, DOI 10.1007/s00264-013-1782-z	77	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169677	10.1371/journal.pone.0169677	http://dx.doi.org/10.1371/journal.pone.0169677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158262	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700005
J	Stolarska, MA; Rammohan, AR				Stolarska, Magdalena A.; Rammohan, Aravind R.			Center or periphery? Modeling the effects of focal adhesion placement during cell spreading	PLOS ONE			English	Article							SUBSTRATE RIGIDITY; GROWTH; STIFFNESS; STRESS; CONTRACTION; FORCE; ARCHITECTURE; MECHANICS; MOTILITY; ASSAYS	Focal adhesions are often observed at the cell's periphery. We provide an explanation for this observation using a system-level mathematical model of a cell interacting with a two-dimensional substrate. The model describes the biological cell as a hypoelastic continuum material whose behavior is coupled to a deformable, linear elastic substrate via focal adhesions that are represented by collections of linear elastic attachments between the cell and the substrate. The evolution of the focal adhesions is coupled to local intracellular stresses which arise from mechanical cell-substrate interactions. Using this model we show that the cell has at least three mechanisms through which it can control its intracellular stresses: focal adhesion position, size, and attachment strength. We also propose that one reason why focal adhesions are typically located on the cell periphery instead of its center is because peripheral focal adhesions allow the cell to be more sensitive to changes in the microenvironment. This increased sensitivity is caused by the fact that peripherally located focal adhesions allow the cells to modulate its intracellular properties over a much larger portion of the cell area.	[Stolarska, Magdalena A.] Univ St Thomas, Dept Math, St Paul, MN 55105 USA; [Rammohan, Aravind R.] Corning Inc, Adv Modeling & Anal, Corning, NY 14831 USA	University of St Thomas Minnesota; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Rammohan, AR (corresponding author), Univ St Thomas, Dept Math, St Paul, MN 55105 USA.	mastolarska@stthomas.edu; RammohanA@corning.com			Corning, Inc.; Center for Applied Mathematics at the University of St. Thomas	Corning, Inc.; Center for Applied Mathematics at the University of St. Thomas	The authors received small amounts of funding from Corning, Inc. and the Center for Applied Mathematics at the University of St. Thomas for this work. Funding was not part of a grant received by the authors. Rather, it was used to provide travel funds so that the author could attend conferences and spend time collaborating on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranson IS, 2016, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-319-24448-8_1; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Buenemann M, 2010, BIOPHYS J, V99, P50, DOI 10.1016/j.bpj.2010.03.057; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; Greiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077328; Haupt BJ, 2007, LANGMUIR, V23, P9352, DOI 10.1021/la700693f; Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Leonov AI, 2000, INT J SOLIDS STRUCT, V37, P2565, DOI 10.1016/S0020-7683(99)00009-8; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Olberding JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012043; Pathak A, 2008, J R SOC INTERFACE, V5, P507, DOI 10.1098/rsif.2007.1182; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rajagopal KR, 2009, P ROY SOC A-MATH PHY, V465, P493, DOI 10.1098/rspa.2008.0319; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Skalak R, 1982, P IUTAM S FIN EL, P347; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stephanou A, 2008, J THEOR BIOL, V253, P701, DOI 10.1016/j.jtbi.2008.04.035; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Vernerey FJ, 2014, J MATH BIOL, V68, P989, DOI 10.1007/s00285-013-0656-8; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Walcott S, 2011, BIOPHYS J, V101, P2919, DOI 10.1016/j.bpj.2011.11.010; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yip AK, 2013, BIOPHYS J, V104, P19, DOI 10.1016/j.bpj.2012.11.3805; Ziebert F, 2014, EUR PHYS J-SPEC TOP, V223, P1265, DOI 10.1140/epjst/e2014-02190-2	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171430	10.1371/journal.pone.0171430	http://dx.doi.org/10.1371/journal.pone.0171430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158263	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700078
J	Costa, MS; Silva, RJ; Paulino-Neto, HF; Pereira, MJB				Costa, Marilza Silva; Silva, Ricardo Jose; Paulino-Neto, Hipolito Ferreira; Barbosa Pereira, Monica Josene			Beetle pollination and flowering rhythm of Annona coriacea Mart. (Annonaceae) in Brazilian cerrado: Behavioral features of its principal pollinators	PLOS ONE			English	Article							FLORAL SCENT; REPRODUCTIVE-BIOLOGY; BREEDING SYSTEMS; CONSEQUENCES; LANDSCAPE; COMMUNITY; DIVERSE	The conservation and sustainable management of Annona coriacea requires knowledge of its floral and reproductive biology, and of its main pollinators and their life cycles. In this work, we analyzed these aspects in detail. Floral biology was assessed by observing flowers from the beginning of anthesis to senescence. The visiting hours and behavior of floral visitors in the floral chamber were recorded, as were the sites of oviposition. Excavations were undertaken around specimens of A. coriacea to determine the location of immature pollinators. Anthesis was nocturnal, starting at sunset, and lasted for 52-56 h. The flowers were bisexual, protogynous and emitted a strong scent similar to the plant's own ripe fruit. There was pronounced synchrony among all floral events (the period and duration of stigmatic receptivity, release of odor, pollen release and drooping flowers) in different individuals, but no synchrony in the same individuals. All of the flowers monitored were visited by beetle species of the genera Cyclocephala and Arriguttia. Beetles arrived at the flowers with their bodies covered in pollen and these pollen grains were transferred to the stigmata while foraging on nutritious tissues at the base of the petals. With dehiscence of the stamens and retention within the floral chamber, the bodies of the floral visitors were again covered with pollen which they carried to newly opened flowers, thus promoting the cycle of pollination. After leaving the flowers, female beetles often excavated holes in the soil to lay eggs. Larvae were found between the leaf litter and the first layer of soil under specimens of A. coriacea. Cyclocephala beetles were the main pollinators of A. coriacea, but Arriguttia brevissima was also considered a pollinator and is the first species of this genus to be observed in Annonaceae flowers. Annona coriacea was found to be self-compatible with a low reproductive efficiency in the area studied. The results of this investigation provide ecological data that should contribute to the conservation and economic exploitation of A. coriacea.	[Costa, Marilza Silva] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Silva, Ricardo Jose] Univ Estado Mato Grosso UNEMAT, Lab Zool, CPEDA, Tangara Da Serra, MT, Brazil; [Paulino-Neto, Hipolito Ferreira] Univ Sao Paulo, Programa Posgrad Entomol, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Paulino-Neto, Hipolito Ferreira] UEMG, Curso Ciencias Biol, Unidade Passos, MG, Brazil; [Paulino-Neto, Hipolito Ferreira] UEMG, LEPEC, Unidade Passos, MG, Brazil; [Barbosa Pereira, Monica Josene] Univ Estado Mato Grosso UNEMAT, Dept Agron, Lab Entomol, CPEDA, Tangara Da Serra, MT, Brazil	Universidade Federal de Vicosa; Universidade do Estado de Mato Grosso; Universidade de Sao Paulo; Universidade do Estado de Mato Grosso	Costa, MS (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	marilza.costa@ufv.br	Pereira, Mônica J.B./F-4736-2014; Neto, Hipólito Ferreira Paulino/Q-1662-2019	Neto, Hipólito Ferreira Paulino/0000-0003-4993-1191; Silva, Ricardo/0000-0002-0792-5925	Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD) [02958/09-0]	Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), scholarships for graduation. Hipolito Ferreira Paulino-Neto was supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD, grant no. 02958/09-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar JR, 2000, REV CIENC AGRON, V31, P51; Almeida S.P., 1998, CERRADO AMBIENTE FLO, P169; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Barroso MG, 2002, SISTEMATICA ANGIOSPE; Batalha M. A., 2001, Acta Botanica Brasilica, V15, P289, DOI 10.1590/S0102-33062001000300001; BAWA KS, 1974, EVOLUTION, V28, P85, DOI [10.2307/2407241, 10.1111/j.1558-5646.1974.tb00729.x]; BULLOCK SH, 1985, BIOTROPICA, V17, P287, DOI 10.2307/2388591; Buzato S, 1994, RES 45 C NAC BOT, P64; Castro AAJF, 1999, ANN MO BOT GARD, V86, P192, DOI 10.2307/2666220; Maia ACD, 2012, J CHEM ECOL, V38, P1072, DOI 10.1007/s10886-012-0173-z; Nogueira GAD, 2013, BIOTA NEOTROP, V13, P86, DOI 10.1590/S1676-06032013000100009; Eugenio P., 1990, Plant Systematics and Evolution, V172, P35; Franco AM, 2011, REV BRAS ENTOMOL, V55, P381, DOI 10.1590/S0085-56262011000300011; Ghazoul J, 2004, BIOTROPICA, V36, P156, DOI 10.1111/j.1744-7429.2004.tb00308.x; Golin V, 2011, CIENC RURAL, V41, P101, DOI 10.1590/S0103-84782011000100016; Goodrich KR, 2012, BOT J LINN SOC, V169, P262, DOI 10.1111/j.1095-8339.2012.01220.x; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P189, DOI 10.1007/BF00936405; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P165, DOI 10.1007/BF00936404; Gottsberger G., 2006, LIFE CERRADO S AM TR, V1; Gottsberger Gerhard, 1999, Plant Species Biology, V14, P143, DOI 10.1046/j.1442-1984.1999.00018.x; Gottsberger Gerhard, 1996, Progress in Botany, V57, P368; Gottsberger Gerhard, 1994, Revista Brasileira de Biologia, V54, P391; Gottsberger G, 2013, PLANT SYST EVOL, V299, P793, DOI 10.1007/s00606-013-0763-4; Gottsberger G, 2012, BOT J LINN SOC, V169, P245, DOI 10.1111/j.1095-8339.2011.01209.x; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; HERRERA CM, 1989, OECOLOGIA, V80, P241, DOI 10.1007/BF00380158; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Jurgens A, 2000, PHYTOCHEMISTRY, V55, P551, DOI 10.1016/S0031-9422(00)00241-7; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Kiill L, BIOL FLORAL SISTEMA; Kuchmeister H, POLINIZAC ESPECIES A; Lopes LE, 2007, OECOLOGIA, V154, P305, DOI 10.1007/s00442-007-0830-z; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; Maues MM, 2012, POLINIZADORES BRASIL, P49; Cavalcante Tadeu Robson Melo, 2009, Bragantia, V68, P13, DOI 10.1590/S0006-87052009000100002; Mendes FN, 2011, BIOTA NEOTROP, V11, P103, DOI 10.1590/S1676-06032011000400011; Mendonca RC, 1998, CERRADO ECOLOGIA FLO, V289-556, DOI DOI 10.1590/S0100-84042008000300005; Montesinos D, 2015, WEB ECOL, V14, P79, DOI 10.5194/we-14-79-2014; Morellato L. P. C., 1992, HIST NATURAL SERRA J, P98; Munin Roberto Lobo, 2008, Braz. J. Bot., V31, P15, DOI 10.1590/S0100-84042008000100003; Oliveira P.E., 2008, CERRADO ECOLOGIA FLO, V2, P274; Oliveira PE, 2000, FLORA, V195, P311; Neto HFP, 2013, BRAZ J BOT, V36, P55, DOI 10.1007/s40415-013-0011-8; Paulino-Neto HF., 2006, CIENCIA HOJE, V38, P59; Paulino-Neto HF, 2014, 11 C LAT BOT SEPT 20, P462; Paulino-Neto HF, 2014, BIOL POLINIZACAO, P297; Paulino-Neto HF, 2014, REV BRAS FRUTIC, V36, P132, DOI 10.1590/S0100-29452014000500016; Paulino-Neto HP, UM SISTEMA EM PERIGO; Ponchel Y, 2006, DYNASTIDAE WORLD BIO; Puker Anderson, 2009, Biota Neotrop., V9, P105; RAMIREZ N, 1992, BOT J LINN SOC, V110, P277, DOI 10.1111/j.1095-8339.1992.tb00294.x; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Rodrigues SR, 2010, NEOTROP ENTOMOL, V39, P15, DOI 10.1590/S1519-566X2010000100003; Ruiz-Zapata T R, 1978, BIOTROPICA, V10, P221; Santos V, 2007, REV AGR, V82, P288; Saraiva A.M., 2012, POLINIZADORES BRASIL, P153; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Silberbauer-Gottsberger I, 1988, REV BRAS BIOL; Silberbauer-Gottsberger I., 2006, LIFE CERRADO S AM TR, V2; Silva CA, 2009, BIOTA CICLO ESTUDOS, V1, P1; Silva Celice Alexandre, 2010, Biotemas, V23, P69; Silva RR, 2013, BIOTA NEOTROP, V13, P297, DOI 10.1590/S1676-06032013000200029; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Tannus, 2006, BIOTA NEOTROP, V6, P1, DOI DOI 10.1590/S1676-06032006000300008; Webber A. C., 1981, Acta Amazonica, V11, P61; Webber A.C., 2000, REV BRAS BOT, V23, P421, DOI 10.1590/S0100-84042000000400008; Westra L.Y.T., 1993, ANNONACEAE NEWSLETTE, V9, P29	69	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171092	10.1371/journal.pone.0171092	http://dx.doi.org/10.1371/journal.pone.0171092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152094	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200088
J	Fatima, F; Fei, Y; Ali, A; Mohammad, M; Erlandsson, MC; Bokarewa, MI; Nawaz, M; Valadi, H; Na, ML; Jin, T				Fatima, Farah; Fei, Ying; Ali, Abukar; Mohammad, Majd; Erlandsson, Malin C.; Bokarewa, Maria I.; Nawaz, Muhammad; Valadi, Hadi; Na, Manli; Jin, Tao			Radiological features of experimental staphylococcal septic arthritis by micro computed tomography scan	PLOS ONE			English	Article							BONE TURNOVER MARKERS; AUREUS; MODEL; METASTASES; INFECTION; SEPSIS; CT	Background Permanent joint dysfunction due to bone destruction occurs in up to 50% of patients with septic arthritis. Recently, imaging technologies such as micro computed tomography (mu CT) scan have been widely used for preclinical models of autoimmune joint disorders. However, the radiological features of septic arthritis in mice are still largely unknown. Methods NMRI mice were intravenously or intra-articularly inoculated with S. aureus Newman or LS1 strain. The radiological and clinical signs of septic arthritis were followed for 10 days using mu CT. We assessed the correlations between joint radiological changes and clinical signs, histological changes, and serum levels of cytokines. Results On days 5-7 after intravenous infection, bone destruction verified by mu CT became evident in most of the infected joints. Radiological signs of bone destruction were dependent on the bacterial dose. The site most commonly affected by septic arthritis was the distal femur in knees. The bone destruction detected by mu CT was positively correlated with histological changes in both local and hematogenous septic arthritis. The serum levels of IL-6 were significantly correlated with the severity of joint destruction. Conclusion mu CT is a sensitive method for monitoring disease progression and determining the severity of bone destruction in a mouse model of septic arthritis. IL-6 may be used as a biomarker for bone destruction in septic arthritis.	[Fatima, Farah; Ali, Abukar; Mohammad, Majd; Erlandsson, Malin C.; Bokarewa, Maria I.; Nawaz, Muhammad; Valadi, Hadi; Na, Manli; Jin, Tao] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Fatima, Farah; Nawaz, Muhammad] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Pathol & Forens Med, Sao Paulo, Brazil; [Fei, Ying] GuiZhou Med Univ, Affiliated Hosp, Dept Microbiol & Immunol, Guiyang, Peoples R China; [Jin, Tao] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden	University of Gothenburg; Universidade de Sao Paulo; Guizhou Medical University; Sahlgrenska University Hospital	Jin, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.; Jin, T (corresponding author), Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden.	tao.jin@rheuma.gu.se	Na, Manli/AAM-9864-2020; Fatima, Farah/AAB-8297-2019; Nawaz, Muhammad/B-6596-2014; Bokarewa, Maria I/A-8114-2019; Jin, Tao/K-3323-2015; Valadi, Hadi/ABH-9766-2020	Fatima, Farah/0000-0002-0696-8675; Nawaz, Muhammad/0000-0002-0792-8296; Bokarewa, Maria I/0000-0001-9424-5145; Jin, Tao/0000-0001-9039-0628; Valadi, Hadi/0000-0003-3482-2451; Ali, Abukar/0000-0002-1963-3356; Mohammad, Majd/0000-0002-3672-2991; Na, Manli/0000-0002-7306-8941	Swedish Medical Research Council [523-2013-2750]; Swedish Medical Society [SLS-496741, SLS-402871]; Stiftelsen Clas Groschinskys Minnesfond [M1566, M14099, M1626]; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation [SLS-501701]; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning [2015-00056, 2016-075]; Professor Nanna Svartz Fond [2015-00074]; Adlerbertska Forskningsstiftelsen; Coordination for the improvement of higher education personnel, CAPES; National Natural Science Foundation of China [81460334]; State Scholarship Fund of China Scholarship Council [201508525101]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning; Professor Nanna Svartz Fond; Adlerbertska Forskningsstiftelsen; Coordination for the improvement of higher education personnel, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This work was supported by the Swedish Medical Research Council (grant 523-2013-2750 to T. Jin), the Swedish Medical Society (SLS-496741 and SLS-402871 to T. Jin), the Stiftelsen Clas Groschinskys Minnesfond (grant M1566, M14099, and M1626 to T. Jin), the Royal Society of Arts and Sciences in Gothenburg (grant to T. Jin and ML. Na), the Wilhelm and Martina Lundgren Foundation (grant to T. Jin, ML. Na, and A. Ali), the Scandinavian Society for Antimicrobial Chemotherapy Foundation (grant SLS-501701 to T. Jin), Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning (grant 2015-00056 and 2016-075 to T. Jin), Professor Nanna Svartz Fond (grant 2015-00074 to T. Jin), and Adlerbertska Forskningsstiftelsen (grant to T. Jin and ML. Na), Coordination for the improvement of higher education personnel, CAPES (grant to F. Fatima and M. Nawaz), National Natural Science Foundation of China (grant 81460334 to Y. Fei), and the State Scholarship Fund of China Scholarship Council (grant 201508525101 to Y. Fei). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131645; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Andrisano-Ruggieri R, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016629527; Aruga A, 1997, BRIT J CANCER, V76, P760, DOI 10.1038/bjc.1997.458; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Blomqvist C, 1996, BRIT J CANCER, V73, P1074, DOI 10.1038/bjc.1996.207; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Colavite PM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-19; EPSTEIN JH, 1986, J RHEUMATOL, V13, P1105; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; GOLD RH, 1991, AM J ROENTGENOL, V157, P365, DOI 10.2214/ajr.157.2.1853823; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Kaandorp CJE, 1997, ANN RHEUM DIS, V56, P470, DOI 10.1136/ard.56.8.470; Khoury BM, 2015, CONNECT TISSUE RES, V56, P106, DOI 10.3109/03008207.2015.1005211; Koopmans N, 2007, J UROLOGY, V178, P849, DOI 10.1016/j.juro.2007.05.029; Lane NE, 1998, J BONE MINER RES, V13, P229, DOI 10.1359/jbmr.1998.13.2.229; Marenzana M, 2015, BEST PRACT RES CL RH, V29, P715, DOI 10.1016/j.berh.2016.02.001; McQueen FM, 2013, BEST PRACT RES CL RH, V27, P499, DOI 10.1016/j.berh.2013.09.005; Mohan G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3543; Molne L, 2000, J INVEST DERMATOL, V114, P1120, DOI 10.1046/j.1523-1747.2000.00973.x; Na ML, 2016, INFECT IMMUN, V84, P930, DOI 10.1128/IAI.01520-15; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pecoraro V, 2015, CRIT REV ONCOL HEMAT, V96, P54, DOI 10.1016/j.critrevonc.2015.05.001; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Silva MD, 2004, MOL IMAGING, V3, P312, DOI 10.1162/1535350042973562; Tarkowski A, 2001, TRENDS MICROBIOL, V9, P321, DOI 10.1016/S0966-842X(01)02078-9; Vesga O, 1996, J INFECT DIS, V173, P739, DOI 10.1093/infdis/173.3.739	33	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171222	10.1371/journal.pone.0171222	http://dx.doi.org/10.1371/journal.pone.0171222			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152087	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200107
J	Purcell, RV; Pearson, J; Aitchison, A; Dixon, L; Frizelle, FA; Keenan, JI				Purcell, Rachel V.; Pearson, John; Aitchison, Alan; Dixon, Liane; Frizelle, Frank A.; Keenan, Jacqueline I.			Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER; MICROBIOTA; INTERLEUKIN-8; INFLAMMATION; PROTEIN; DRIVER	Background Enterotoxigenic Bacteroides fragilis (ETBF) is a toxin-producing bacteria thought to possibly promote colorectal carcinogenesis by modulating the mucosal immune response and inducing epithelial cell changes. Here, we aim to examine the association of colonic mucosal colonization with ETBF and the presence of a range of lesions on the colonic neoplastic spectrum. Methods Mucosal tissue from up to four different colonic sites was obtained from a consecutive series of 150 patients referred for colonoscopy. The presence and relative abundance of the B. fragilis toxin gene (bft) in each tissue sample was determined using quantitative PCR, and associations with clinicopathological characteristics were analysed. Findings We found a high concordance of ETBF between different colonic sites (86%). Univariate analysis showed statistically significant associations between ETBF positivity and the presence of low-grade dysplasia (LGD), tubular adenomas (TA), and serrated polyps (P-values of 0.007, 0.027, and 0.007, respectively). A higher relative abundance of ETBF was significantly associated with LGD and TA (P-values of < 0.0001 and 0.025, respectively). Increased ETBF positivity and abundance was also associated with left-sided biopsies, compared to those from the right side of the colon. Conclusion Our results showing association of ETBF positivity and increased abundance with early-stage carcinogenic lesions underlines its importance in the development of colorectal cancer, and we suggest that detection of ETBF may be a potential marker of early colorectal carcinogenesis.	[Purcell, Rachel V.; Aitchison, Alan; Dixon, Liane; Frizelle, Frank A.; Keenan, Jacqueline I.] Univ Otago, Dept Surg, Christchurch, New Zealand; [Pearson, John] Univ Otago, Biostat & Computat Biol Unit, Christchurch, New Zealand	University of Otago; University of Otago	Purcell, RV (corresponding author), Univ Otago, Dept Surg, Christchurch, New Zealand.	rachel.purcell@otago.ac.nz	Pearson, John F/D-7428-2012; Purcell, Rachel/M-2479-2019	Pearson, John F/0000-0001-5607-4517; Aitchison, Alan/0000-0002-0857-1815; Purcell, Rachel/0000-0002-2684-4530				Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Brucher BLDM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-331; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen LA, 2015, EUR J CLIN MICROBIOL, V34, P1871, DOI 10.1007/s10096-015-2425-7; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Flemer B, 2016, GUT; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Geng JW, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-26; Hajishengallis G, 2016, TRENDS MICROBIOL, V24, P477, DOI 10.1016/j.tim.2016.02.010; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hwang Soonjae, 2013, Immune Netw, V13, P213, DOI 10.4110/in.2013.13.5.213; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mo Health, 2015, SEL CANC 2012 2013 2; Moncrief JS, 1998, INFECT IMMUN, V66, P1735, DOI 10.1128/IAI.66.4.1735-1739.1998; Purcell RV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34554; Sanfilippo L, 2000, CLIN EXP IMMUNOL, V119, P456, DOI 10.1046/j.1365-2249.2000.01155.x; Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Snover DC, 2010, WHO CLASSIFICATION T, P160; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; Wu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xie L L, 2016, Zhonghua Yi Xue Za Zhi, V96, P954, DOI 10.3760/cma.j.issn.0376-2491.2016.12.010	30	117	124	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171602	10.1371/journal.pone.0171602	http://dx.doi.org/10.1371/journal.pone.0171602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151975	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200158
J	Pelletier, D; Lapointe, ME; Wulder, MA; White, JC; Cardille, JA				Pelletier, David; Lapointe, Marc-Elie; Wulder, Michael A.; White, Joanne C.; Cardille, Jeffrey A.			Forest Connectivity Regions of Canada Using Circuit Theory and Image Analysis	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; RESISTANCE SURFACES; SPATIAL-PATTERNS; FRAGMENTATION; DISPERSAL; CORRIDORS; MODEL; AREA	Ecological processes are increasingly well understood over smaller areas, yet information regarding interconnections and the hierarchical nature of ecosystems remains less studied and understood. Information on connectivity over large areas with high resolution source information provides for both local detail and regional context. The emerging capacity to apply circuit theory to create maps of omnidirectional connectivity provides an opportunity for improved and quantitative depictions of forest connectivity, supporting the formation and testing of hypotheses about the density of animal movement, ecosystem structure, and related links to natural and anthropogenic forces. In this research, our goal was to delineate regions where connectivity regimes are similar across the boreal region of Canada using new quantitative analyses for characterizing connectivity over large areas (e.g., millions of hectares). Utilizing the Earth Observation for Sustainable Development of forests (EOSD) circa 2000 Landsat-derived land-cover map, we created and analyzed a national-scale map of omnidirectional forest connectivity at 25m resolution over 10000 tiles of 625 km(2) each, spanning the forested regions of Canada. Using image recognition software to detect corridors, pinch points, and barriers to movements at multiple spatial scales in each tile, we developed a simple measure of the structural complexity of connectivity patterns in omnidirectional connectivity maps. We then mapped the Circuitscape resistance distance measure and used it in conjunction with the complexity data to study connectivity characteristics in each forested ecozone. Ecozone boundaries masked substantial systematic patterns in connectivity characteristics that are uncovered using a new classification of connectivity patterns that revealed six clear groups of forest connectivity patterns found in Canada. The resulting maps allow exploration of omnidirectional forest connectivity patterns at full resolution while permitting quantitative analyses of connectivity over broad areas, informing modeling, planning and monitoring efforts.	[Pelletier, David; Cardille, Jeffrey A.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Pelletier, David; Cardille, Jeffrey A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Lapointe, Marc-Elie] Coll Montmorency, Dept Math, Laval, PQ, Canada; [Wulder, Michael A.; White, Joanne C.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	McGill University; McGill University; Natural Resources Canada; Canadian Forest Service	Cardille, JA (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.; Cardille, JA (corresponding author), McGill Univ, McGill Sch Environm, Montreal, PQ, Canada.	jeffrey.cardille@mcgill.ca	White, Joanne C./Z-1981-2019; Wulder, Michael A/J-5597-2016	White, Joanne C./0000-0003-4674-0373; Wulder, Michael A/0000-0002-6942-1896; Cardille, Jeffrey/0000-0002-4667-9085	Government of Canada, via the Canadian Forest Service of Natural Resources Canada; Canadian Space Agency; Discovery grant from the Natural Sciences and Engineering Research Council	Government of Canada, via the Canadian Forest Service of Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Canadian Space Agency(Canadian Space Agency); Discovery grant from the Natural Sciences and Engineering Research Council	Aspects of this research were supported through the Government of Canada, via the Canadian Forest Service (http://cfs.nrcan.gc.ca/) of Natural Resources Canada (http://www.nrcan.gc.ca/) and the Canadian Space Agency (http://www.asc-csa.gc.ca/), and a Discovery grant from the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/).	Anderson M., 2012, RESILIENT SITES TERR; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Breckheimer I, 2014, CONSERV BIOL, V28, P1584, DOI 10.1111/cobi.12362; Canadian Forest Service, STAT CAN FOR ANN REP; Cardille J, 2005, BIOSCIENCE, V55, P983, DOI 10.1641/0006-3568(2005)055[0983:MCSPAS]2.0.CO;2; Cardille JA, 2012, ENVIRON MANAGE, V49, P163, DOI 10.1007/s00267-011-9785-2; Dramstad WE, 2009, NORSK GEOGR TIDSSKR, V63, P246, DOI 10.1080/00291950903368359; FAO, GLOB FOR RES ASS 201; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fraley C, 2012, 597 U WASH; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Giroux-Bougard X, 2015, GENE FLOW ARCTIC WET; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Guindon L, 2014, CAN J FOREST RES, V44, P1545, DOI 10.1139/cjfr-2014-0229; Hermosilla T, 2016, INT J DIGIT EARTH, V9, P1035, DOI 10.1080/17538947.2016.1187673; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Kupfer J.A., 2012, PROGR PHYS GEOGRAPHY, V2012; Lechner AM, 2015, LANDSCAPE URBAN PLAN, V141, P11, DOI 10.1016/j.landurbplan.2015.04.008; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Marrotte RR, 2014, MOL ECOL, V23, P3983, DOI 10.1111/mec.12847; McGarigal K., 2012, TECH REP; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Miura S, 2015, FOREST ECOL MANAG, V352, P35, DOI 10.1016/j.foreco.2015.03.039; Moilanen A, 2001, OIKOS, V95, P147, DOI 10.1034/j.1600-0706.2001.950116.x; Pelletier D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084135; Peterman WE, 2014, MOL ECOL, V23, P2402, DOI 10.1111/mec.12747; Pickell PD, 2016, INT J REMOTE SENS, V37, P138, DOI 10.1080/2150704X.2015.1126375; Pierik ME, 2016, ECOL INDIC, V67, P807, DOI 10.1016/j.ecolind.2016.03.032; R Core Team, 2013, R LANG ENV STAT COMP; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Shah VB, 2008, 7 PYTH SCI C 2008 PA; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vogt P, 2009, ECOL INDIC, V9, P64, DOI 10.1016/j.ecolind.2008.01.011; Vogt P, 2007, ECOL INDIC, V7, P481, DOI 10.1016/j.ecolind.2006.11.001; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; Wiken E., 1986, ECOLOGICAL LAND CLAS, V19; Wulder MA, 2011, CAN GEOGR-GEOGR CAN, V55, P288, DOI 10.1111/j.1541-0064.2010.00335.x; Wulder MA, 2008, CAN J REMOTE SENS, V34, P563, DOI 10.5589/m08-081; Wulder MA, 2008, CAN J REMOTE SENS, V34, P549, DOI 10.5589/m08-066; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	56	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169428	10.1371/journal.pone.0169428	http://dx.doi.org/10.1371/journal.pone.0169428			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146573	Green Submitted, Green Published, gold			2022-12-26	WOS:000396131700007
J	Coffey, LL; Pesavento, PA; Keesler, RI; Singapuri, A; Watanabe, J; Watanabe, R; Yee, J; Bliss-Moreau, E; Cruzen, C; Christe, KL; Reader, JR; von Morgenland, W; Gibbons, AM; Allen, AM; Linnen, J; Gao, K; Delwart, E; Simmons, G; Stone, M; Lanteri, M; Bakkour, S; Busch, M; Morrison, J; Van Rompay, KKA				Coffey, Lark L.; Pesavento, Patricia A.; Keesler, Rebekah I.; Singapuri, Anil; Watanabe, Jennifer; Watanabe, Rie; Yee, JoAnn; Bliss-Moreau, Eliza; Cruzen, Christina; Christe, Kari L.; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Allen, A. Mark; Linnen, Jeff; Gao, Kui; Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael; Morrison, John; Van Rompay, Koen K. A.			Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; TRANSMISSION; PATHOGENESIS; TRANSFUSION; VACCINE; BRAZIL; CELLS; MODEL	Animal models of Zika virus (ZIKV) are needed to better understand tropism and pathogenesis and to test candidate vaccines and therapies to curtail the pandemic. Humans and rhesus macaques possess similar fetal development and placental biology that is not shared between humans and rodents. We inoculated 2 non-pregnant rhesus macaques with a 2015 Brazilian ZIKV strain. Consistent with most human infections, the animals experienced no clinical disease but developed short-lived plasma viremias that cleared as neutralizing antibody developed. In 1 animal, viral RNA (vRNA) could be detected longer in whole blood than in plasma. Despite no major histopathologic changes, many adult tissues contained vRNA 14 days post-infection with highest levels in hemolymphatic tissues. These observations warrant further studies to investigate ZIKV persistence and its potential clinical implications for transmission via blood products or tissue and organ transplants.	[Coffey, Lark L.; Pesavento, Patricia A.; Singapuri, Anil; Watanabe, Rie] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Keesler, Rebekah I.; Watanabe, Jennifer; Yee, JoAnn; Bliss-Moreau, Eliza; Cruzen, Christina; Christe, Kari L.; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Allen, A. Mark; Morrison, John; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Linnen, Jeff; Gao, Kui] Hologic, San Diego, CA USA; [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA; [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Coffey, LL (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.; Van Rompay, KKA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	lcoffey@ucdavis.edu; kkvanrompay@ucdavis.edu	Christe, Kari/AAD-5929-2022; Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023; Coffey, Lark/0000-0002-0718-5146	CNPRC; Office of Research Infrastructure Programs/OD [P510D011107]; Pathology, Microbiology and Immunology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	CNPRC; Office of Research Infrastructure Programs/OD; Pathology, Microbiology and Immunology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a CNPRC pilot research grant to LC and KVR, the Office of Research Infrastructure Programs/OD (P510D011107), and start up funds from the Pathology, Microbiology and Immunology Department to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although JL and KG are employees of Hologic, their role in the study was to test samples from macaques. Hologic did not provide any funding or salary support for other manuscript co-authors.; We acknowledge the research and support staff at CNPRC for their assistance with all aspects of the study, as well as the UC Davis IACUC and Environmental Health and Safety Offices for expedited approval for work on this project. Sarah Mills, Abigail Spinner and the staff of the Pathogen Detection Laboratory and Clinical Laboratories at CNPRC were especially helpful with necropsies and biospecimen processing, and analysis. Kathy West provided illustrations. The Zika research team at the Wisconsin National Primate Research Center provided ongoing advice and data-sharing. The Unite des Virus Emergents, Marseille, France, provided the inactivated French Polynesia 2013 standard. This study was supported by a CNPRC pilot research grant to LC and KVR, the Office of Research Infrastructure Programs/OD (P510D011107), and start up funds from the Pathology, Microbiology and Immunology Department to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although JL and KG are employees of Hologic, their role in the study was to test samples from macaques. Hologic did not provide any funding or salary support for other manuscript co-authors.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004682, 10.1371/journal.pntd.0004750]; [Anonymous], 2016, WHO DIRECTOR GEN SUM; Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158; Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Centers for Disease Control and Prevention (CDC), 2016, ZIKA VIRUS; CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hologic, 2016, APT ZIK VIR ASS; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lessler J, 2016, BULLETIN OF THE WORL; Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017; Lustig Y, 2016, EURO SURVEILL, V21; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pan American Health Organization, 2016, COUNTR TERR AUT TRAN; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Scharko AM, 1996, P NATL ACAD SCI USA, V93, P6425, DOI 10.1073/pnas.93.13.6425; Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841; Stone M, 2017, TRANSFUSION IN PRESS; Van Rompay KKA, 2004, J VIROL, V78, P5324, DOI 10.1128/JVI.78.10.5324-5337.2004; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	44	70	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171148	10.1371/journal.pone.0171148	http://dx.doi.org/10.1371/journal.pone.0171148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141843	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129500044
J	Waldschmidt, L; Junkereit, V; Bahring, R				Waldschmidt, Lara; Junkereit, Vera; Baehring, Robert			KChIP2 genotype dependence of transient outward current (I-to) properties in cardiomyocytes isolated from male and female mice	PLOS ONE			English	Article							MOUSE VENTRICULAR MYOCYTES; CHANNEL-INTERACTING PROTEIN-2; KV4 ALPHA-SUBUNIT; K+ CHANNEL; POTASSIUM CHANNELS; 3-DIMENSIONAL STRUCTURE; CARDIAC REPOLARIZATION; GENE-EXPRESSION; HEART-FAILURE; MESSENGER-RNA	The transient outward current (I-to) in cardiomyocytes is largely mediated by Kv4 channels associated with Kv Channel Interacting Protein 2 (KChIP2). A knockout model has documented the critical role of KChIP2 in I-to expression. The present study was conducted to characterize in both sexes the dependence of I-to properties, including current magnitude, inactivation kinetics, recovery from inactivation and voltage dependence of inactivation, on the number of functional KChIP2 alleles. For this purpose we performed whole-cell patch-clamp experiments on isolated left ventricular cardiomyocytes from male and female mice which had different KChIP2 genotypes; i.e., wild-type (KChIP2(+/+)), heterozygous knockout (KChIP2(-/-)) or complete knockout of KChIP2 (KChIP2(-/-)). We found in both sexes a KChIP2 gene dosage effect (i.e., a proportionality between number of alleles and phenotype) on I-to magnitude, however, concerning other I-to properties, KChIP2(+/-) resembled KChIP2(+/+.) Only in the total absence of KChIP2 (KChIP2(-/-)) we observed a slowing of I-to kinetics, a slowing of recovery from inactivation and a negative shift of a portion of the voltage dependence of inactivation. In a minor fraction of KChIP2(-/-) myocytes I-to was completely lost. The distinct KChIP2 genotype dependences of I-to magnitude and inactivation kinetics, respectively, seen in cardiomyocytes were reproduced with two-electrode voltage-clamp experiments on Xenopus oocytes expressing Kv4.2 and different amounts of KChIP2. Our results corroborate the critical role of KChIP2 in controlling I-to properties. They demonstrate that the Kv4.2/KChIP2 interaction in cardiomyocytes is highly dynamic, with a clear KChIP2 gene dosage effect on Kv4 channel surface expression but not on inactivation gating.	[Waldschmidt, Lara; Junkereit, Vera; Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Bahring, R (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany.	r.baehring@uke.de		Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft (DFG) [BA2055/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grant BA2055/3 of the Deutsche Forschungsgemeinschaft (DFG) to RB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Clark RB, 2001, J PHYSIOL-LONDON, V537, P979; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Decher N, 2004, J PHYSIOL-LONDON, V557, P761, DOI 10.1113/jphysiol.2004.066720; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Fiset C, 1997, J PHYSIOL-LONDON, V500, P51, DOI 10.1113/jphysiol.1997.sp021998; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonczi M, 2012, GEN PHYSIOL BIOPHYS, V31, P153, DOI 10.4149/gpb_2012_017; Goltz D, 2007, CARDIOVASC RES, V74, P85, DOI 10.1016/j.cardiores.2007.01.001; Grubb S, 2014, J CARDIOVASC ELECTR, V25, P896, DOI 10.1111/jce.12422; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kim LA, 2004, J BIOL CHEM, V279, P5549, DOI 10.1074/jbc.M311332200; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Kobayashi T, 2003, J MOL CELL CARDIOL, V35, P1073, DOI 10.1016/S0022-2828(03)00199-8; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133274; Liu J, 2011, BASIC RES CARDIOL, V106, P189, DOI 10.1007/s00395-010-0134-z; London B, 1998, J PHYSIOL-LONDON, V509, P171, DOI 10.1111/j.1469-7793.1998.171bo.x; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Plotnikov AN, 2004, CIRCULATION, V110, P489, DOI 10.1161/01.CIR.0000137823.64947.52; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Thomsen MB, 2009, HEART RHYTHM, V6, P370, DOI 10.1016/j.hrthm.2008.11.023; Tozakidou M, 2010, J MOL CELL CARDIOL, V48, P140, DOI 10.1016/j.yjmcc.2009.08.027; Trepanier-Boulay W, 2001, CIRC RES, V89, P437, DOI 10.1161/hh1701.095644; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wang YG, 2003, J MOL CELL CARDIOL, V35, P1083, DOI 10.1016/S0022-2828(03)00200-1; Wickenden AD, 1999, CIRC RES, V85, P1067; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171213	10.1371/journal.pone.0171213	http://dx.doi.org/10.1371/journal.pone.0171213			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141821	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500048
J	Andreini, C; Rosato, A; Banci, L				Andreini, Claudia; Rosato, Antonio; Banci, Lucia			The Relationship between Environmental Dioxygen and Iron-Sulfur Proteins Explored at the Genome Level	PLOS ONE			English	Article							FE-S CLUSTER; OXIDATIVE STRESS; BIOGENESIS; EVOLUTION; CHEMISTRY; OXYGEN; MITOCHONDRIA; SUPEROXIDE; MATURATION; INSIGHTS	About 2 billion years ago, the atmosphere of the Earth experienced a great change due to the buildup of dioxygen produced by photosynthetic organisms. This transition caused a reduction of iron bioavailability and at the same time exposed living organisms to the threat of oxidative stress. Iron-sulfur (Fe-S) clusters require iron ions for their biosynthesis and are labile if exposed to reactive oxygen species. To assess how the above transition influenced the usage of Fe-S clusters by organisms, we compared the distribution of the Fe-S proteins encoded by the genomes of more than 400 prokaryotic organisms as a function of their dioxygen requirements. Aerobic organisms use less Fe-S proteins than the majority of anaerobic organisms with a similar genome size. Furthermore, aerobes have evolved specific Fe-S proteins that bind the less iron-demanding and more chemically stable Fe2S2 clusters while reducing the number of Fe4S4-binding proteins in their genomes. However, there is a shared core of Fe-S protein families composed mainly by Fe4S4-binding proteins. Members of these families are present also in humans. The distribution of human Fe-S proteins within cell compartments shows that mitochondrial proteins are inherited from prokaryotic proteins of aerobes, whereas nuclear and cytoplasmic Fe-S proteins are inherited from anaerobic organisms.	[Andreini, Claudia; Rosato, Antonio; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Andreini, Claudia; Rosato, Antonio; Banci, Lucia] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy.; Banci, L (corresponding author), Univ Florence, Dept Chem, Sesto Fiorentino, Italy.	banci@cerm.unifi.it	Andreini, Claudia/D-5614-2014; Rosato, Antonio/D-8548-2011; Rosato, Antonio/M-3250-2019; Andreini, Claudia/AAB-2364-2022	Andreini, Claudia/0000-0003-4329-8225; Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; Andreini, Claudia/0000-0003-4329-8225; BANCI, LUCIA/0000-0003-0562-5774	European Commission [284209]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (http://ec.europa.eu/index_en.htm) Grant n. 284209 to LB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Andreini C, 2007, PROTEINS, V67, P317, DOI 10.1002/prot.21324; Andreini C, 2016, J PROTEOME RES, V15, P1308, DOI 10.1021/acs.jproteome.6b00045; Andreini C, 2011, J CHEM INF MODEL, V51, P730, DOI 10.1021/ci100392q; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Bruska MK, 2015, CHEM-EUR J, V21, P19081, DOI 10.1002/chem.201503008; Capozzi F, 1998, STRUCT BOND, V90, P127; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Han GW, 2010, ACTA CRYSTALLOGR F, V66, P1326, DOI 10.1107/S1744309110037619; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Outten FW, 2015, BBA-MOL CELL RES, V1853, P1464, DOI 10.1016/j.bbamcr.2014.11.001; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Roche B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005134; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284	42	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171279	10.1371/journal.pone.0171279	http://dx.doi.org/10.1371/journal.pone.0171279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135316	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700057
J	Hansen, HB; Damgaard, PB; Margaryan, A; Stenderup, J; Lynnerup, N; Willerslev, E; Allentoft, ME				Hansen, Henrik B.; Damgaard, Peter B.; Margaryan, Ashot; Stenderup, Jesper; Lynnerup, Niels; Willerslev, Eske; Allentoft, Morten E.			Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum	PLOS ONE			English	Article							STRONTIUM ISOTOPE RATIOS; GENOME SEQUENCE; PATTERNS	Large-scale genomic analyses of ancient human populations have become feasible partly due to refined sampling methods. The inner part of petrous bones and the cementum layer in teeth roots are currently recognized as the best substrates for such research. We present a comparative analysis of DNA preservation in these two substrates obtained from the same human skulls, across a range of different ages and preservation environments. Both substrates display significantly higher endogenous DNA content (average of 16.4% and 40.0% for teeth and petrous bones, respectively) than parietal skull bone (average of 2.2%). Despite sample-to-sample variation, petrous bone overall performs better than tooth cementum (p = 0.001). This difference, however, is driven largely by a cluster of viking skeletons from one particular locality, showing relatively poor molecular tooth preservation (< 10% endogenous DNA). In the remaining skeletons there is no systematic difference between the two substrates. A crude preservation (good/bad) applied to each sample prior to DNA-extraction predicted the above/below 10% endogenous DNA threshold in 80% of the cases. Interestingly, we observe signficantly higher levels of cytosine to thymine deamination damage and lower proportions of mitochondrial/nuclear DNA in petrous bone compared to tooth cementum. Lastly, we show that petrous bones from ancient cremated individuals contain no measurable levels of authentic human DNA. Based on these findings we discuss the pros and cons of sampling the different elements.	[Hansen, Henrik B.; Damgaard, Peter B.; Margaryan, Ashot; Stenderup, Jesper; Willerslev, Eske; Allentoft, Morten E.] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Lynnerup, Niels] Univ Copenhagen, Dept Forens Med, Unit Forens Anthropol, Copenhagen, Denmark; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Cambridge, England	University of Copenhagen; University of Copenhagen; University of Cambridge; Wellcome Trust Sanger Institute	Allentoft, ME (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark.	morten.allentoft@gmail.com	Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011	Willerslev, Eske/0000-0002-7081-6748; Allentoft, Morten/0000-0003-4424-3568; Margaryan, Ashot/0000-0002-2576-2429	Centre for GeoGenetics; Danish National Resarch Foundation [DNRF94]; Lundbeck Foundation; University of Copehagen (KU2016 programme); Villum Foundation (Young Investigator Programme) [10120]; Villum Fonden [00010120] Funding Source: researchfish	Centre for GeoGenetics; Danish National Resarch Foundation; Lundbeck Foundation(Lundbeckfonden); University of Copehagen (KU2016 programme); Villum Foundation (Young Investigator Programme); Villum Fonden(Villum Fonden)	This work was supported by Centre for GeoGenetics is supported by The Danish National Resarch Foundation (DNRF94) and the Lundbeck Foundation. The work presented in this study was funded by University of Copehagen (KU2016 programme) and The Villum Foundation (Young Investigator Programme, grant no. 10120 to MEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Ceri Falys, Emma Usmanova, Alina Kolbyna, Irina Shevnina, Andrey Logvin, and Vladislav Zhitenev for having provided access to the skeletons included in this study as part of an ongoing collaboration. Centre for GeoGenetics is supported by The Danish National Resarch Foundation (DNRF94) and the Lundbeck Foundation. The work presented in this study was funded by University of Copehagen (KU2016 programme) and The Villum Foundation (Young Investigator Programme, grant no. 10120 to MEA).	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Damgaard PB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11184; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Frei KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10431; Frisch T, 1998, BONE, V22, P677, DOI 10.1016/S8756-3282(98)00050-7; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gamba C, 2016, MOL ECOL RESOUR, V16, P459, DOI 10.1111/1755-0998.12470; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haak W., 2015, NATURE; Harvig L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101603; Higgins D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126935; Homoe P, 1996, J LARYNGOL OTOL, V110, P1114; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jonsson H, 2013, BIOINFORMATICS; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Martin M, 2011, EMBNET J, V17; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Noren A, 2005, AM J PHYS ANTHROPOL, V128, P318, DOI 10.1002/ajpa.20245; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; Powell ML, 1985, ANAL DENT WEAR CARIE; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sarkissian CD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0387; Scott G. R., 2000, ANTHR MODERN HUMAN T; Skoglund P., 2016, NATURE; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	47	84	90	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170940	10.1371/journal.pone.0170940	http://dx.doi.org/10.1371/journal.pone.0170940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129388	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400023
J	Huang, L; Duan, CC; Zhao, YJ; Gao, L; Niu, CH; Xu, JB; Li, SY				Huang, Li; Duan, Cuicui; Zhao, Yujuan; Gao, Lei; Niu, Chunhua; Xu, Jingbo; Li, Shengyu			Reduction of Aflatoxin B-1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food "Tofu"	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL-ABSORPTION; OXIDATIVE STRESS; DAIRY STRAINS; BINDING; METABOLISM; ACTIVATION; EXCRETION; IMMUNITY; PROTECT	In this study, we investigated the potential of Lactobacillus plantarum isolated from Chinese traditional fermented foods to reduce the toxicity of aflatoxin B-1 (AFB(1)), and its subsequent detoxification mechanism. Among all the investigated L. plantarum strains, L. plantarum C88 showed the strongest AFB(1) binding capacity in vitro, and was orally administered to mice with liver oxidative damage induced by AFB(1). In the therapy groups, the mice that received L. plantarum C88, especially heat-killed L. plantarum C88, after a single dose of AFB(1) exposure, showed an increase in unabsorbed AFB(1) in the feces. Moreover, the effects of L. plantarum C88 on the enzymes and non-enzymes antioxidant abilities in serum and liver, histological alterations of liver were assayed. The results indicated that compared to the control group, L. plantarum C88 alone administration induced significant increase of antioxidant capacity, but did not induce any significant changes in the histological picture. Compared to the mice that received AFB(1) only, L. plantarum C88 treatment could weaken oxidative stress by enhancing the activity of antioxidant enzymes and elevating the expression of Glutathione S-transferase (GST) A3 through Nuclear factor erythroid (derived factor 2) related factor 2 (Nrf2) pathway. Furthermore, cytochrome P450 (CYP 450) 1A2 and CYP 3A4 expression was inhibited by L. plantarum C88, and urinary aflatoxin B-1-N-7-guanine (AFB-N-7-guanine), a AFB(1) metabolite formed by CYP 1A2 and CYP 3A4, was significantly reduced by the presence of viable L. plantarum C88. Meanwhile, the significant improvements were showed in histological pictures of the liver tissues in mice orally administered with viable L. plantarum C88. Collectively, L. plantarum C88 may alleviate AFB(1) toxicity by increasing fecal AFB(1) excretion, reversing deficits in antioxidant defense systems and regulating the metabolism of AFB(1).	[Huang, Li; Xu, Jingbo] Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China; [Duan, Cuicui; Zhao, Yujuan; Gao, Lei; Niu, Chunhua; Li, Shengyu] Jilin Acad Agr Sci, Inst Agro Food Technol, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Jilin Academy of Agricultural Sciences	Xu, JB (corresponding author), Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China.; Li, SY (corresponding author), Jilin Acad Agr Sci, Inst Agro Food Technol, Changchun, Jilin, Peoples R China.	xujb515@nenu.edu.cn; lisy720@126.com			Modern Agroindustrial Technology Research Systems in China [CARS-37]; National Public Benefit Research (Agriculture) Foundation [201303085]; Jilin Agricultural Innovation Project [52110302]	Modern Agroindustrial Technology Research Systems in China; National Public Benefit Research (Agriculture) Foundation; Jilin Agricultural Innovation Project	This work was financially supported by Modern Agroindustrial Technology Research Systems in China (CARS-37), National Public Benefit Research (Agriculture) Foundation (201303085), and Jilin Agricultural Innovation Project (52110302). SL received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ben Salah-Abbes J, 2015, J IMMUNOTOXICOL, V12, P40, DOI 10.3109/1547691X.2014.880534; Chang Injeong, 2007, Mycobiology, V35, P76, DOI 10.4489/MYCO.2007.35.2.076; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; Eaton DL, 2014, CANCER PREV RES, V7, P653, DOI 10.1158/1940-6207.CAPR-14-0119; El-Nezami H, 1998, FOOD CHEM TOXICOL, V36, P321, DOI 10.1016/S0278-6915(97)00160-9; Gerbaldo GA, 2012, FEMS MICROBIOL LETT, V332, P27, DOI 10.1111/j.1574-6968.2012.02570.x; Gratz S, 2007, APPL ENVIRON MICROB, V73, P3958, DOI 10.1128/AEM.02944-06; Gratz S, 2006, APPL ENVIRON MICROB, V72, P7398, DOI 10.1128/AEM.01348-06; Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Haskard CA, 2001, APPL ENVIRON MICROB, V67, P3086, DOI 10.1128/AEM.67.7.3086-3091.2001; Hatakka K, 2008, INT J FOOD MICROBIOL, V128, P406, DOI 10.1016/j.ijfoodmicro.2008.09.010; Hathout AS, 2011, TOXICON, V58, P179, DOI 10.1016/j.toxicon.2011.05.015; Hernandez-Mendoza A, 2009, J APPL MICROBIOL, V107, P395, DOI 10.1111/j.1365-2672.2009.04217.x; Hernandez-Mendoza A, 2011, J BASIC MICROB, V51, P263, DOI 10.1002/jobm.201000119; IARC, 2002, MON EV CARC RISKS HU, V82; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Jiang Y, 2005, INT IMMUNOL, V17, P807, DOI 10.1093/intimm/dxh262; Kamdem LK, 2006, CHEM RES TOXICOL, V19, P577, DOI 10.1021/tx050358e; Kumar M, 2012, BRIT J NUTR, V107, P1006, DOI 10.1017/S0007114511003953; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048; Meng XY, 2015, EXP THER MED, V10, P2277, DOI 10.3892/etm.2015.2787; Mykkanen H, 2005, INT J CANCER, V115, P879, DOI 10.1002/ijc.20951; Peltonen K, 2001, J DAIRY SCI, V84, P2152, DOI 10.3168/jds.S0022-0302(01)74660-7; Rawal S, 2010, RES VET SCI, V89, P325, DOI 10.1016/j.rvsc.2010.04.011; Samuel MS, 2014, INT BIODETER BIODEGR, V86, P202, DOI 10.1016/j.ibiod.2013.08.026; Wang S, 2012, J DAIRY SCI, V95, P4813, DOI 10.3168/jds.2012-5426; Yang F, 2007, ADV MATER, V19, P4166, DOI 10.1002/adma.200700837; Yunus AW, 2011, TOXINS, V3, P566, DOI 10.3390/toxins3060566	30	56	60	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170109	10.1371/journal.pone.0170109	http://dx.doi.org/10.1371/journal.pone.0170109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129335	Green Submitted, gold, Green Published			2022-12-26	WOS:000396211400063
J	Schlott, F; Steubl, D; Hoffmann, D; Matevossian, E; Lutz, J; Heemann, U; Hosel, V; Busch, DH; Renders, L; Neuenhahn, M				Schlott, Fabian; Steubl, Dominik; Hoffmann, Dieter; Matevossian, Edouard; Lutz, Jens; Heemann, Uwe; Hoesel, Volker; Busch, Dirk H.; Renders, Lutz; Neuenhahn, Michael			Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; MEMORY T; RECIPIENTS; DISEASE; CELLS; IMPACT; PROPHYLAXIS; PREVENTION; RISK; MANAGEMENT	Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or-seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to the CMV-IgG-serostatus, with donor+/recipient-(D+/R-) patients carrying the highest risk for CMV-replication. However, risk factors predisposing for primary infection in CMV-seronegative recipients are still not fully elucidated. Therefore, we monitored D+/R-high-risk patients undergoing kidney transplantation in combination with antiviral prophylaxis for the incidence of CMV-viremia for a median follow-up time of 784 days (156-1155 days). In this period, we analyzed the functional CMV-specific T cell response by intracellular cytokine staining and CMV-serology by ELISA. Only four of eight D +/R-patients developed clinically relevant CMV-viremia followed by seroconversion. Viremia triggered expansion of functional CMV-specific T cells correlating with protection against secondary CMV-reactivations. In contrast, all other patients remained permanently aviremic and showed no immunological correlate of infection after discontinuation of antiviral prophylaxis for up to three years. Comparing cold ischemic times (CIT) of viremic (median = 1020 min; 720-1080 min) and aviremic patients (median = 335 min; 120-660 min) revealed significantly (p = 0.0286) protracted CIT in patients with primary CMV-infection. Taken together, primary CMV-infection affects only a subgroup of D+/R-patients correlating with length of CIT. Therefore, patients with extended CIT should be thoroughly monitored for CMV-replication well beyond discontinuation of antiviral prophylaxis. In contrast, patients with short CIT remained permanently uninfected and might benefit from shorter prophylactic treatment.	[Schlott, Fabian; Busch, Dirk H.; Neuenhahn, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schlott, Fabian; Matevossian, Edouard; Heemann, Uwe; Busch, Dirk H.; Renders, Lutz; Neuenhahn, Michael] Partner Site Munich, German Ctr Infect Res DZIF, Munich, Germany; [Steubl, Dominik; Heemann, Uwe; Renders, Lutz] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Germany; [Hoffmann, Dieter] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Matevossian, Edouard] Tech Univ Munich, Dept Surg, Transplantat Zentrum Munchen, Klinikum Rechts Isar, Munich, Germany; [Lutz, Jens] Johannes Gutenberg Univ Mainz, Dept Med, Nephrol Sect 1, Mainz, Germany; [Hoesel, Volker] Tech Univ Munich, Chair Biomath, Garching, Germany	Technical University of Munich; German Center for Infection Research; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Technical University of Munich	Neuenhahn, M (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Neuenhahn, M (corresponding author), Partner Site Munich, German Ctr Infect Res DZIF, Munich, Germany.	michael.neuenhahn@tum.de			Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre) [TR36 (TP-A10)]; German Center for Infection Research (DZIF), partner site Munich, Munich, Germany	Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre); German Center for Infection Research (DZIF), partner site Munich, Munich, Germany	The work was supported by the following: Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre) TR36 (TP-A10); http://www.sfb-tr36.com/; MN; and German Center for Infection Research (DZIF), partner site Munich, Munich, Germany; http://www.dzif.de/; MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs SK, 2008, CLIN INFECT DIS, V46, P840, DOI 10.1086/528718; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Helantera I, 2014, TRANSPL INFECT DIS, V16, P568, DOI 10.1111/tid.12247; Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x; Kanter J, 2009, TRANSPL P, V41, P2156, DOI 10.1016/j.transproceed.2009.06.057; KIDGO, 2009, AM J TRANSPLANT S3, V9, pS1; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Kotton CN, 2010, NAT REV NEPHROL, V6, P711, DOI 10.1038/nrneph.2010.141; Lucia M, 2014, CLIN INFECT DIS, V59, P1537, DOI 10.1093/cid/ciu589; Mengelle C, 2015, J MED VIROL, V87, P836, DOI 10.1002/jmv.23964; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; Reischig T, 2012, J AM SOC NEPHROL, V23, P1588, DOI 10.1681/ASN.2012010100; Reusser P, 1999, J INFECT DIS, V180, P247, DOI 10.1086/314879; Roman A, 2014, TRANSPLANT REV-ORLAN, V28, P84, DOI 10.1016/j.trre.2014.01.001; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Sagedal S, 2002, AM J TRANSPLANT, V2, P850, DOI 10.1034/j.1600-6143.2002.20907.x; Salvadori Maurizio, 2015, World J Transplant, V5, P52, DOI 10.5500/wjt.v5.i2.52; Shabir S, 2013, J AM SOC NEPHROL, V24, P1698, DOI 10.1681/ASN.2013040340; STEIN J, 1993, J GEN VIROL, V74, P2333, DOI 10.1099/0022-1317-74-11-2333; Tennankore KK, 2016, KIDNEY INT, V89, P648, DOI 10.1016/j.kint.2015.09.002; Terrazzini Nadia, 2014, F1000Prime Rep, V6, P28, DOI 10.12703/P6-28; Zhuang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12623	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171035	10.1371/journal.pone.0171035	http://dx.doi.org/10.1371/journal.pone.0171035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129395	Green Submitted, gold, Green Published			2022-12-26	WOS:000396211400010
J	Korshavn, KJ; Satriano, C; Lin, YX; Zhang, RC; Dulchavsky, M; Bhunia, A; Ivanova, MI; Lee, YH; La Rosa, C; Lim, MH; Ramamoorthy, A				Korshavn, Kyle J.; Satriano, Cristina; Lin, Yuxi; Zhang, Rongchun; Dulchavsky, Mark; Bhunia, Anirban; Ivanova, Magdalena I.; Lee, Young-Ho; La Rosa, Carmelo; Lim, Mi Hee; Ramamoorthy, Ayyalusamy			Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid- beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; ALPHA-SYNUCLEIN; MEMBRANE FRAGMENTATION; PHOSPHOLIPID-BILAYERS; PROTEIN AGGREGATION; OXIDATIVE STRESS; FIBRILS; BINDING; STATE	The aggregation of amyloid-beta (A beta) on lipid bilayers has been implicated as Amechanism by which A beta exerts its toxicity in Alzheimer's disease (AD). Lipid bilayer thinning has been observed during both oxidative stress and protein aggregation in AD, but whether these pathological modifications of the bilayer correlate withA beta misfolding is unclear. Here, we studied peptide-lipid interactions in synthetic bilayers of the shortchain lipid dilauroyl phosphatidylcholine (DLPC) as Asimplified model for diseased bilayers to determine their impact on A beta aggregate, protofibril, and fibril formation. A beta aggregation and fibril formation in membranes composed of dioleoyl phosphatidylcholine (DOPC) or 1-palmitoyl-2-oleoyl phosphatidylcholine mimicking normal bilayers served as controls. Differences in aggregate formation and stability were monitored by a combination of thioflavin-T fluorescence, circular dichroism, atomic force microscopy, transmission electron microscopy, and NMR. Despite the ability of all three lipid bilayers to catalyze aggregation, DLPC accelerates aggregation at much lower concentrations and prevents the fibrillation of A beta at low micromolar concentrations. DLPC stabilized globular, membrane-associated oligomers, which could disrupt the bilayer integrity. DLPC bilayers also remodeled preformed amyloid fibrils into Apseudo-unfolded, molten globule state, which resembled on-pathway, protofibrillar aggregates. Whereas the stabilized, membrane-associated oligomers were found to be nontoxic, the remodeled species displayed toxicity similar to that of conventionally prepared aggregates. These results provide mechanistic insights into the roles that pathologically thin bilayers may play in A beta aggregation on neuronal bilayers, and pathological lipid oxidation may contribute to A beta misfolding.	[Korshavn, Kyle J.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Korshavn, Kyle J.; Zhang, Rongchun; Ivanova, Magdalena I.; Ramamoorthy, Ayyalusamy] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Dulchavsky, Mark; Ivanova, Magdalena I.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Satriano, Cristina; La Rosa, Carmelo] Univ Catania, Dept Chem Sci, I-95124 Catania, Italy; [Lin, Yuxi; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Bhunia, Anirban] Bose Inst, Dept Biophys, Kolkata 700009, W Bengal, India; [Lim, Mi Hee] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan 44919, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Catania; Osaka University; Department of Science & Technology (India); Bose Institute; Ulsan National Institute of Science & Technology (UNIST)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Ramamoorthy, A (corresponding author), Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Cristina, Satriano/A-3976-2012; Zhang, Rongchun/A-5656-2015; Lim, Mi Hee/D-1913-2018; La Rosa, Carmelo/A-2631-2012	Cristina, Satriano/0000-0001-5348-5863; Zhang, Rongchun/0000-0002-2480-2652; La Rosa, Carmelo/0000-0002-7123-5347; Korshavn, Kyle/0000-0003-2623-1838; Bhunia, Anirban/0000-0002-8752-2842; Dulchavsky, Mark/0000-0002-5253-8924	National Institutes of Health [AG048934]; Protein Folding Initiative at the University of Michigan; National Research Foundation of Korea (NRF) - Korean Government [NRF-2014S1A2A2028270]; University of Catania Grant FIR; NATIONAL INSTITUTE ON AGING [R01AG048934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Initiative at the University of Michigan; National Research Foundation of Korea (NRF) - Korean Government; University of Catania Grant FIR; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG048934 (to A. R.), the Protein Folding Initiative at the University of Michigan (to M. H. L., M. I. I., and A. R.), National Research Foundation of Korea (NRF) Grant NRF-2014S1A2A2028270 funded by the Korean Government (to M. H. L. and A. R.), and University of Catania Grant FIR 2014 (to C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahsan N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09862; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Arce FT, 2011, SOFT MATTER, V7, P5267, DOI 10.1039/c1sm05162h; Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Batzli KM, 2015, MAT SCI ENG C-MATER, V48, P359, DOI 10.1016/j.msec.2014.09.015; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Beranova L, 2010, LANGMUIR, V26, P6140, DOI 10.1021/la100657a; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bradley-Whitman MA, 2015, ARCH TOXICOL, V89, P1035, DOI 10.1007/s00204-015-1517-6; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Buboltz JT, 2005, LANGMUIR, V21, P6296, DOI 10.1021/la047086k; Canale C, 2013, BIOPHYS CHEM, V182, P23, DOI 10.1016/j.bpc.2013.07.010; Cao P, 2012, BIOCHEMISTRY-US, V51, P2670, DOI 10.1021/bi2015162; Chiurchiu V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7909380; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elkins MR, 2016, J AM CHEM SOC, V138, P9840, DOI 10.1021/jacs.6b03715; FATTAL DR, 1993, BIOPHYS J, V65, P1795, DOI 10.1016/S0006-3495(93)81249-9; Fleming PJ, 2012, BBA-BIOMEMBRANES, V1818, P126, DOI 10.1016/j.bbamem.2011.07.016; Galvagnion C, 2016, P NATL ACAD SCI USA, V113, P7065, DOI 10.1073/pnas.1601899113; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Korshavn KJ, 2016, CHEM COMMUN, V52, P882, DOI 10.1039/c5cc08634e; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; Kumar S, 2013, CHEM COMMUN, V49, P4749, DOI 10.1039/c3cc41452c; La Rosa C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948323; LAROSA C, 1995, J PHYS CHEM-US, V99, P14864, DOI 10.1021/j100040a041; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039; Lockhart C, 2014, BBA-BIOMEMBRANES, V1838, P2678, DOI 10.1016/j.bbamem.2014.07.010; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Manetto GD, 2005, J THERM ANAL CALORIM, V80, P263, DOI 10.1007/s10973-005-0646-1; Marsh D., 1990, CRC HDB LIPID BILAYE, P816; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Nakazawa Y, 2009, CHEM PHYS LIPIDS, V158, P54, DOI 10.1016/j.chemphyslip.2008.12.001; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nichols MR, 2015, BIOCHEMISTRY-US, V54, P2193, DOI 10.1021/bi500957g; Noda S, 2016, BIOCHEMISTRY-US, V55, P3937, DOI 10.1021/acs.biochem.6b00231; Nystrom S, 2012, J BIOL CHEM, V287, P25975, DOI 10.1074/jbc.M112.372136; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Pithadia AS, 2016, CHEM COMMUN, V52, P942, DOI 10.1039/c5cc07792c; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Rankenberg JM, 2012, BIOCHEMISTRY-US, V51, P3554, DOI 10.1021/bi300281k; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Satriano C, 2017, COLLOID SURFACE B, V149, P48, DOI 10.1016/j.colsurfb.2016.10.004; Satriano C, 2012, PHYS CHEM CHEM PHYS, V14, P16695, DOI 10.1039/c2cp43254d; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Scalisi S, 2010, CHEMBIOCHEM, V11, P1856, DOI 10.1002/cbic.201000090; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Sciacca MFM, 2016, BIOPHYS J, V111, P140, DOI 10.1016/j.bpj.2016.05.050; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; So M, 2015, LANGMUIR, V31, P9973, DOI 10.1021/acs.langmuir.5b02186; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefanovic AND, 2015, BIOCHEMISTRY-US, V54, P3142, DOI 10.1021/bi501369k; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Wong AG, 2016, BIOCHEMISTRY-US, V55, P510, DOI 10.1021/acs.biochem.5b01107; Yates EA, 2014, BIOCHEMISTRY-US, V53, P7038, DOI 10.1021/bi500792f; Yates EA, 2013, J MOL BIOL, V425, P1915, DOI 10.1016/j.jmb.2013.03.022; Yi XY, 2015, BIOCHEMISTRY-US, V54, P6323, DOI 10.1021/acs.biochem.5b00719; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	80	102	101	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4638	4650		10.1074/jbc.M116.764092	http://dx.doi.org/10.1074/jbc.M116.764092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154182	Green Published, hybrid			2022-12-26	WOS:000397585100021
J	Britton, GJ; Mitchell, RE; Burton, BR; Wraith, DC				Britton, Graham J.; Mitchell, Ruth E.; Burton, Bronwen R.; Wraith, David C.			Protein kinase C theta is required for efficient induction of IL-10-secreting T cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-SPECIFIC IMMUNOTHERAPY; PKC-THETA; TRANSPLANT RECIPIENTS; REGULATORY CELLS; IN-VIVO; IL-10; EXPRESSION; DIFFERENTIATION; SOTRASTAURIN	Secretion of interleukin-10 (IL-10) by CD4(+) T cells is an essential immunoregulatory mechanism. The work presented here assesses the role of the signaling molecule protein kinase C theta (PKC theta) in the induction of IL-10 expression in CD4(+) T cells. Using wildtype and PKC theta-deficient Tg4 T cell receptor transgenic mice, we implemented a well-described protocol of repeated doses of myelin basic protein (MBP) Ac1-9[4Y] antigen to induce Tr1-like IL-10(+) T cells. We find that PKC theta is required for the efficient induction of IL-10 following antigen administration. Both serum concentrations of IL-10 and the proportion of IL-10(+) T cells were reduced in PKC theta-deficient mice relative to wildtype mice following [4Y] treatment. We further characterized the T cells of [4Y] treated PKC theta-deficient Tg4 mice and found reduced expression of the transcription factors cMaf, Nfil3 and FoxP3 and the surface receptors PD-1 and Tim3, all of which have been associated with the differentiation or function of IL-10(+) T cells. Finally, we demonstrated that, unlike [4Y] treated wildtype Tg4 T cells, cells from PKC theta-deficient mice were unable to suppress the priming of naive T cells in vitro and in vivo. In summary, we present data demonstrating a role for PKC theta in the induction of suppressive, IL-10-secreting T cells induced in TCR-transgenic mice following chronic antigen administration. This should be considered when contemplating PKC theta as a suitable drug target for inducing immune suppression and graft tolerance.	[Britton, Graham J.; Mitchell, Ruth E.; Burton, Bronwen R.; Wraith, David C.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Britton, Graham J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Wraith, David C.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Bristol; Icahn School of Medicine at Mount Sinai; University of Birmingham	Wraith, DC (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.; Wraith, DC (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	D.Wraith@bham.ac.uk	Britton, Graham/CAI-2177-2022; Britton, Graham/V-1370-2019	Britton, Graham/0000-0003-4630-1223; Wraith, David/0000-0003-2147-5614	Wellcome Trust; Medical Research Council; GB; MRC [MR/K007645/1] Funding Source: UKRI; Medical Research Council [MR/K007645/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GB; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust, Medical Research Council, GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2014, DRUG DISCOV TODAY, V19, P1217, DOI 10.1016/j.drudis.2014.05.008; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Burkhart C, 1999, INT IMMUNOL, V11, P1625, DOI 10.1093/intimm/11.10.1625; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chand S, 2012, CURR PHARM DESIGN, V18, P4725, DOI 10.2174/138161212802651625; Friman S, 2011, AM J TRANSPLANT, V11, P1444, DOI 10.1111/j.1600-6143.2011.03538.x; Gabrysova L, 2010, EUR J IMMUNOL, V40, P1386, DOI 10.1002/eji.200940151; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Morley SC, 2008, J IMMUNOL, V181, P4696, DOI 10.4049/jimmunol.181.7.4696; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Nicolson KS, 2006, J IMMUNOL, V176, P5329, DOI 10.4049/jimmunol.176.9.5329; Pfeifhofer-Obermair C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0137-y; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Tedesco-Silva H, 2013, AM J TRANSPLANT, V13, P1757, DOI 10.1111/ajt.12255; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Yang MX, 2015, J EXP MED, V212, P253, DOI 10.1084/jem.20141703; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171547	10.1371/journal.pone.0171547	http://dx.doi.org/10.1371/journal.pone.0171547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158245	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700097
J	Chew, F; Wu, XW				Chew, Fiona; Wu, Xianwei			Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage	PLOS ONE			English	Article							HEALTH INITIATIVE TRIAL; CORONARY-HEART-DISEASE; OBSTETRICIAN-GYNECOLOGISTS; POSTMENOPAUSAL WOMEN; NEWSPAPER COVERAGE; PRIMARY PREVENTION; TIMING HYPOTHESIS; PRACTICE PATTERNS; PARADIGM SHIFT; ATTITUDES	Objective Medical reviews and research comprise a key information source for news media stories on medical therapies and innovations as well as for physicians in updating their practice. The present study examined medical review journal articles, physician surveys and news media coverage of hormone replacement therapy (HT) to assess the relationship between the three information sources and whether/if they contributed to a state-of-the-science gap (a condition when the evaluation of a medical condition or therapy ascertained by the highest standards of investigation is incongruent with the science-in-practice such as physician recommendations and patient actions). Methods We content-analyzed 177 randomly sampled HT medical reviews between 2002 and 2014, and HT news valence in three major TV networks, newspapers and magazines/internet sites in 2002-2003, 2008-2009 and 2012-14. The focus in both analyses was whether HT benefits outweighed risks, risks outweighed benefits or both risks and benefits were presented. We also qualitatively content-analyzed all 19 surveys of US physicians' HT recommendations from 2002 to 2009, and 2012 to 2014. Results Medical reviews yielded a mixed picture about HT (40.1% benefits, 26.0% risks, and 33.9% both benefits and risks). While a majority of physician surveys were pro-HT 10/19), eight showed varied attitudes and one was negative. Newspaper and television coverage reflected a pro and con balance while magazine stories were more positive in the later reporting period. Conclusion Medical journal review articles, physicians, and media reports all provide varying view points towards hormone therapy use thus leading to limited knowledge about the actual risks and benefits of HT among peri-and menopausal women and a state-of-the-science gap.	[Chew, Fiona] Syracuse Univ, SI Newhouse Sch Publ Commun, Syracuse, NY USA; [Wu, Xianwei] Univ Iowa, Sch Journalism & Mass Commun, Iowa City, IA USA	Syracuse University; University of Iowa	Chew, F (corresponding author), Syracuse Univ, SI Newhouse Sch Publ Commun, Syracuse, NY USA.	cmrfchew@syr.edu						[Anonymous], 2012, MONDAYMORNING   0625; [Anonymous], 2010, NAT AMB MED CAR SURV; Audit Bureau of Circulation, 2010, AV CIRC US NEWSP; Birkhauser MH, 2008, CLIMACTERIC, V11, P192, DOI 10.1080/13697130802060455; Breslau Erica S, 2003, J Am Med Womens Assoc (1972), V58, P33; Brett AS, 2005, J GEN INTERN MED, V20, P416, DOI 10.1111/j.1525-1497.2005.0089.x; Chew F, 2004, FAM MED, V36, P645; Chew F, 1995, PUBLIC UNDERST SCI, V4, P17; Chew F, 2006, SCI COMMUN, V27, P1; Christian AH, 2007, J WOMENS HEALTH, V16, P68, DOI 10.1089/jwh.2006.M072; Coomarasamy A, 2001, Health Info Libr J, V18, P183, DOI 10.1046/j.1365-2532.2001.00349.x; Devi Gayatri, 2013, Menopause Int, V19, P121, DOI 10.1177/1754045313478941; Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Food and Drug Administration, 2009, QUEST ANSW ESTR ESTR; Fugh-Berman A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000425; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Gallup, 2002, AM RAT CONF DOCT; Gurney EP, 2014, J STEROID BIOCHEM, V142, P4, DOI 10.1016/j.jsbmb.2013.10.009; Haas JS, 2007, J GEN INTERN MED, V22, P68, DOI 10.1007/s11606-007-0122-7; Haas JS, 2006, J GEN INTERN MED, V21, P304, DOI 10.1111/j.1525-1497.2006.00342.x; Henwood F, 2003, SOCIOL HEALTH ILL, V25, P589, DOI 10.1111/1467-9566.00360; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Hing E, 2006, OBSTET GYNECOL, V108, P33, DOI 10.1097/01.AOG.0000220502.77153.5a; Hodis HN, 2014, J STEROID BIOCHEM, V142, P68, DOI 10.1016/j.jsbmb.2013.06.011; Hodis HN, 2013, J AM GERIATR SOC, V61, P1011, DOI 10.1111/jgs.12281; Hodis HN, 2013, J AM GERIATR SOC, V61, P1005, DOI 10.1111/jgs.12140; Hou NQ, 2013, JNCI-J NATL CANCER I, V105, P1365, DOI 10.1093/jnci/djt207; Huston SA, 2009, WOMEN HEALTH ISS, V19, P144, DOI 10.1016/j.whi.2009.01.004; Jones Teresa H, 2007, BMC Pediatr, V7, P1, DOI 10.1186/1471-2431-7-1; Kahn C, 2001, Mark Health Serv, V21, P12; Kelly JP, 2005, PHARMACOEPIDEM DR S, V14, P837, DOI 10.1002/pds.1103; Kiatpongsan S, 2014, MENOPAUSE, V21, P33, DOI [10.1097/gme.0000000000000129, 10.1097/GME.0000000000000129]; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kosteniuk JG, 2013, J MED LIBR ASSOC, V101, P32, DOI 10.3163/1536-5050.101.1.006; Langer RD, 2012, CLIMACTERIC, V15, P206, DOI 10.3109/13697137.2012.666916; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; McIntosh J, 2005, AM J HEALTH-SYST PH, V62, P1031, DOI [10.1111/j.1525-1497.2005.0221.x, DOI 10.1111/J.1525-1497.2005.0221.X]; Morgan MA, 2010, OBSTET GYNECOL, V116, P715, DOI 10.1097/AOG.0b013e3181eeb630; MRI+, 2009, AUD SURV REP; Neuendorf K. A, 2002, CONTENT ANAL GUIDEBO; Newton KM, 2010, MENOPAUSE, V17, P734, DOI 10.1097/gme.0b013e3181d2ce57; North American Menopause Society, 2012, OV MEN; Power ML, 2008, MED DECIS MAKING, V28, P411, DOI 10.1177/0272989X07312722; Power ML, 2007, MENOPAUSE, V14, P20, DOI 10.1097/01.gme.0000229571.44505.cb; Power ML, 2006, J REPROD MED, V51, P525; Power ML, 2009, MENOPAUSE, V16, P500, DOI 10.1097/gme.0b013e31818fc36e; Power ML, 2006, MENOPAUSE, V13, P434, DOI 10.1097/01.gme.0000185753.77704.65; Rigby AJ, 2007, MENOPAUSE, V14, P853, DOI 10.1097/gme.0b013e3180333a33; Rolnick SJ, 2005, MENOPAUSE, V12, P399, DOI 10.1097/01.GME.0000148644.55486.36; Rossouw JE, 2013, OBSTET GYNECOL, V121, P172, DOI [10.1097/AOG.0b013e31827a08c8, http://10.1097/AOG.0b013e31827a08c8]; Rossouw JE, 2002, J HYPERTENS, V20, pS62; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Seagram B., 2003, GREATEST EXPT EVER P; Singer N., 2009, NY TIMES; Stevenson JC, 2013, MATURITAS, V76, P10, DOI 10.1016/j.maturitas.2013.05.018; Tsai SA, 2011, MENOPAUSE, V18, P385, DOI 10.1097/gme.0b013e3181f43404; TVbythenumbers.com, 2011, WORLD NEWS DIAN SAW; USPSTF, 2012, FIN REC STAT MEN HOR; Verschoor CC, 2012, STRATEGIC FINANC AUG, P11; Viera AJ, 2005, FAM MED, V37, P360; Wathen CN, 2006, J HEALTH COMMUN, V11, P477, DOI 10.1080/10810730600751979; Wilson RA, 1966, FEMININE FOREVER	65	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171189	10.1371/journal.pone.0171189	http://dx.doi.org/10.1371/journal.pone.0171189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158240	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700039
J	Sidova, V; Zoufaly, P; Pokorny, J; Dzubak, P; Hajduch, M; Popa, I; Urban, M				Sidova, Veronika; Zoufaly, Pavel; Pokorny, Jan; Dzubak, Petr; Hajduch, Marian; Popa, Igor; Urban, Milan			Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives	PLOS ONE			English	Article							POTENTIAL ANTICANCER AGENTS; BIOLOGICAL EVALUATION; PENTACYCLIC TRITERPENOIDS; LUPANE TRITERPENOIDS; ANTITUMOR-ACTIVITY; BETULONIC ACID; CANCER-CELLS; DERIVATIVES; SAPONINS; HEDERAGENIN	In this work, we describe synthesis of conjugates of betulinic acid with substituted triazoles prepared via Huisgen 1,3-cycloaddition. All compounds contain free 28-COOH group. Allylic bromination of protected betulinic acid by NBS gave corresponding 30-bromoderivatives, their substitution with sodium azides produced 30-azidoderivatives and these azides were subjected to Cu-I catalysed Huisgen 1,3-cycloaddition to give the final conjugates. Reactions had moderate to high yields. All new compounds were tested for their in vitro cytotoxic activities on eight cancer and two non-cancer cell lines. The most active compounds were conjugates of 3 beta-O-acetylbetulinic acid and among them, conjugate with triazole substituted by benzaldehyde 9b was the best with IC50 of 3.3 mu M and therapeutic index of 9.1. Five compounds in this study had IC50 below 10 mu M and inhibited DNA and RNA synthesis and caused block in G0/G1 cell cycle phase which is highly similar to actinomycin D. It is unusual that here prepared 3 beta-O-acetates were more active than compounds with the free 3-OH group and this suggests that this set may have common mechanism of action that is different from the mechanism of action of previously known 3 beta-O-acetoxybetulinic acid derivatives. Benzaldehyde type conjugate 9b is the best candidate for further drug development.	[Sidova, Veronika; Zoufaly, Pavel; Pokorny, Jan; Popa, Igor; Urban, Milan] Palacky Univ, Fac Sci, Dept Organ Chem, Olomouc, Czech Republic; [Dzubak, Petr; Hajduch, Marian; Popa, Igor; Urban, Milan] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Urban, M (corresponding author), Palacky Univ, Fac Sci, Dept Organ Chem, Olomouc, Czech Republic.; Urban, M (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	milan.urban@gmail.com	Hajduch, Marian/J-4015-2014; Urban, Milan/C-9611-2010; Urban, Milan/AAW-4540-2020; Dzubak, Petr/D-2175-2013	Hajduch, Marian/0000-0002-4834-908X; Urban, Milan/0000-0002-8249-028X; Urban, Milan/0000-0002-8249-028X; Pokorny, Jan/0000-0001-9265-8608; Dzubak, Petr/0000-0002-3098-5969	Czech Science Foundation [15-05620S]; Palacky University [IGA_PrF_2016_020, IGA_LF_2016_19]; Technology Agency of the Czech Republic [TE01020028]; National Sustainability Programme [LO1304]	Czech Science Foundation(Grant Agency of the Czech Republic); Palacky University; Technology Agency of the Czech Republic; National Sustainability Programme	All material, chemicals, and small equipment for both chemistry and biology was paid by Czech Science Foundation (15-05620S); stipendia to students were paid by internal grants of Palacky University IGA_PrF_2016_020, IGA_LF_2016_19. Starting terpenes were paid from the Technology Agency of the Czech Republic (TE01020028). The infrastructural part (Institute of Molecular and Translational Medicine) is supported by the National Sustainability Programme (LO1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antimonova AN, 2013, CHEM NAT COMPD+, V49, P657, DOI 10.1007/s10600-013-0702-1; Borkova L, 2016, EUR J MED CHEM, V121, P120, DOI 10.1016/j.ejmech.2016.05.029; Borkova L, 2015, EUR J MED CHEM, V96, P482, DOI 10.1016/j.ejmech.2015.03.068; Bourderioux A, 2011, J MED CHEM, V54, P5498, DOI 10.1021/jm2005173; Chakraborty B, 2015, EUR J MED CHEM, V102, P93, DOI 10.1016/j.ejmech.2015.07.035; Chianese G, 2010, J NAT PROD, V73, P1448, DOI 10.1021/np100325q; Csuk R, 2012, EUR J MED CHEM, V53, P337, DOI 10.1016/j.ejmech.2012.04.023; Csuk R, 2011, ARCH PHARM, V344, P37, DOI 10.1002/ardp.201000232; Csuk R, 2010, BIOORGAN MED CHEM, V18, P7252, DOI 10.1016/j.bmc.2010.08.023; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Dang Z, 2013, J MED CHEM, V56, P2029, DOI 10.1021/jm3016969; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Flekhter O. B., 2000, RUSS J BIOORG CHEM+, V26, P192, DOI DOI 10.1007/BF02786345; Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801; Gao J, 2012, BIOORG MED CHEM LETT, V22, P2396, DOI 10.1016/j.bmcl.2012.02.032; Gauthier C, 2009, J NAT PROD, V72, P72, DOI 10.1021/np800579x; Ghosh P, 2011, INDIAN J CHEM B, V50, P1519; Govdi AI, 2011, RUSS CHEM B+, V60, P2401, DOI 10.1007/s11172-011-0369-3; Govdi AI, 2015, MEDCHEMCOMM, V6, P230, DOI 10.1039/c4md00236a; Gruza M, 2014, ACTA POL PHARM, V71, P959; Hill RA, 2015, NAT PROD REP, V32, P273, DOI 10.1039/c4np00101j; Innocente A, 2014, CHEM BIOL DRUG DES, V83, P344, DOI 10.1111/cbdd.12251; Khan I, 2016, EUR J MED CHEM, V108, P104, DOI 10.1016/j.ejmech.2015.11.018; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kim HK, 2005, INT J BIOCHEM CELL B, V37, P1921, DOI 10.1016/j.biocel.2005.04.015; Kommera H, 2010, EUR J MED CHEM, V45, P3346, DOI 10.1016/j.ejmech.2010.04.018; Kvasnica M, 2015, NAT PROD REP, V32, P1303, DOI 10.1039/c5np00015g; Leunis JC, 2013, Betulonic and Betulinic Acid Derivatives, Patent No. 8586569; Majeed R, 2013, EUR J MED CHEM, V63, P782, DOI 10.1016/j.ejmech.2013.03.028; Morikawa T, 2014, PHYTOCHEMISTRY, V102, P169, DOI 10.1016/j.phytochem.2014.03.002; Noskova V, 2002, NEOPLASMA, V49, P418; Parida PK, 2014, BIOORG MED CHEM LETT, V24, P3865, DOI 10.1016/j.bmcl.2014.06.054; Patro JN, 2009, BIOCHEMISTRY-US, V48, P8271, DOI 10.1021/bi900777s; Qian KD, 2011, BIOORG MED CHEM LETT, V21, P5944, DOI 10.1016/j.bmcl.2011.07.072; Rashid S, 2013, EUR J MED CHEM, V66, P238, DOI 10.1016/j.ejmech.2013.05.029; Rodriguez-Hernandez D, 2016, EUR J MED CHEM, V124, P153, DOI 10.1016/j.ejmech.2016.08.030; Rodriguez-Hernandez D, 2016, EUR J MED CHEM, V115, P257, DOI 10.1016/j.ejmech.2016.03.018; Sanchez-Quesada C, 2013, J AGR FOOD CHEM, V61, P12173, DOI 10.1021/jf403154e; Sarek J, 2010, CANCER ETIOL DIAGN T, P159; Shi W, 2015, J ASIAN NAT PROD RES, V17, P159, DOI 10.1080/10286020.2014.979164; Soural M, 2015, BIOCONJUGATE CHEM, V26, P2563, DOI 10.1021/acs.bioconjchem.5b00567; Spivak AY, 2016, TETRAHEDRON, V72, P1249, DOI 10.1016/j.tet.2016.01.024; Srinivasan T, 2002, BIOORG MED CHEM LETT, V12, P2803, DOI 10.1016/S0960-894X(02)00623-6; Ngoc TD, 2014, BIOORGAN MED CHEM, V22, P3292, DOI 10.1016/j.bmc.2014.04.061; Thi TAD, 2014, BIOORG MED CHEM LETT, V24, P5190, DOI 10.1016/j.bmcl.2014.09.079; Urban M, 2005, BIOORGAN MED CHEM, V13, P5527, DOI 10.1016/j.bmc.2005.07.011; Urban M., 2015, TERPENOIDS SQUALENE, P25; Urban M, 2006, SYNTHESIS-STUTTGART, P3979, DOI 10.1055/s-2006-950327; Urban M, 2007, J NAT PROD, V70, P526, DOI 10.1021/np060436d; Urban M, 2012, BIOORGAN MED CHEM, V20, P3666, DOI 10.1016/j.bmc.2012.03.066; Uzenkova NV, 2005, CHEM NAT COMPD+, V41, P692, DOI 10.1007/s10600-006-0014-9; Vasilevsky SF, 2011, BIOORG MED CHEM LETT, V21, P62, DOI 10.1016/j.bmcl.2010.11.072; Vlk M, 2016, J RADIOANAL NUCL CH, V308, P733, DOI 10.1007/s10967-015-4479-5; Pertino MW, 2013, MOLECULES, V18, P7661, DOI 10.3390/molecules18077661; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Wei GF, 2015, ORG BIOMOL CHEM, V13, P1507, DOI 10.1039/c4ob01605j; Willmann M, 2009, EUR J CLIN INVEST, V39, P384, DOI 10.1111/j.1365-2362.2009.02105.x; Xu J, 2012, J MED CHEM, V55, P3122, DOI 10.1021/jm201540h; YANO S, 1989, CHEM PHARM BULL, V37, P2500, DOI 10.1248/cpb.37.2500; Zhang LY, 2014, CHEM BIOL DRUG DES, V83, P297, DOI 10.1111/cbdd.12241; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	61	26	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171621	10.1371/journal.pone.0171621	http://dx.doi.org/10.1371/journal.pone.0171621			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158265	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700114
J	Solis-Lopez, A; Kriebs, U; Marx, A; Mannebach, S; Liedtke, WB; Caterina, MJ; Freichel, M; Tsvilovskyy, VV				Solis-Lopez, A.; Kriebs, U.; Marx, A.; Mannebach, S.; Liedtke, W. B.; Caterina, M. J.; Freichel, M.; Tsvilovskyy, V. V.			Analysis of TRPV channel activation by stimulation of FC epsilon RI and MRGPR receptors in mouse peritoneal mast cells	PLOS ONE			English	Article							MICE LACKING; PHYSICAL STIMULI; GENE-EXPRESSION; CATION CHANNELS; HOMEOSTASIS; RESPONSES; RELEASE; CALCIUM; MODEL; PAIN	The activation of mast cells (MC) is part of the innate and adaptive immune responses and depends on Ca2+ entry across the plasma membrane, leading to the release of preformed inflammatory mediators by degranulation or by de novo synthesis. The calcium conducting channels of the TRPV family, known by their thermo and osmotic sensitivity, have been proposed to be involved in the MC activation in murine, rat, and human mast cell models. So far, immortalized mast cell lines and nonspecific TRPV blockers have been employed to characterize the role of TRPV channels in MC. The aim of this work was to elucidate the physiological role of TRPV channels by using primary peritoneal mast cells (PMCs), a model of connective tissue type mast cells. Our RT-PCR and NanoString analysis identified the expression of TRPV1, TRPV2, and TRPV4 channels in PMCs. For determination of the functional role of the expressed TRPV channels we performed measurements of intracellular free Ca2+ concentrations and beta-hexosaminidase release in PMCs obtained from wild type and mice deficient for corresponding TRPV1, TRPV2 and TRPV4 in response to various receptor-mediated and physical stimuli. Furthermore, substances known as activators of corresponding TRPV-channels were also tested using these assays. Our results demonstrate that TRPV1, TRPV2, and TRPV4 do not participate in activation pathways triggered by activation of the high-affinity receptors for IgE (Fc epsilon RI), Mrgprb2 receptor, or Endothelin-1 receptor nor by heat or osmotic stimulation in mouse PMCs.	[Solis-Lopez, A.; Kriebs, U.; Marx, A.; Freichel, M.; Tsvilovskyy, V. V.] Heidelberg Univ, Inst Pharmakol, Heidelberg, Baden Wurttembe, Germany; [Mannebach, S.] Univ Saarland, Expt & Klin Pharmakol & Toxikol, Homburg, Saarland, Germany; [Liedtke, W. B.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, Baltimore, MD USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Biol Chem, Baltimore, MD USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosci, Baltimore, MD USA	Ruprecht Karls University Heidelberg; Saarland University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tsvilovskyy, VV (corresponding author), Heidelberg Univ, Inst Pharmakol, Heidelberg, Baden Wurttembe, Germany.	volodymyr.tsvilovskyy@pharma.uni-heidelberg.de	Liedtke, Wolfgang/GNH-1878-2022		German Academic Exchange Service, DAAD; DFG Priority Programme [1394]; Transregional Collaborative Research Centre (TR-SFB) [152]	German Academic Exchange Service, DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); DFG Priority Programme(German Research Foundation (DFG)); Transregional Collaborative Research Centre (TR-SFB)	This work was supported by the German Academic Exchange Service, DAAD (PhD scholarship for AS), by the DFG Priority Programme 1394 (MF) and by the Transregional Collaborative Research Centre (TR-SFB) 152 (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bradding P, 2003, J LEUKOCYTE BIOL, V73, P614, DOI 10.1189/jlb.1202602; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen Y, 2016, J BIOL CHEM, V291, P10252, DOI 10.1074/jbc.M116.716464; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Freichel M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00150; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kim KS, 2010, KOREAN J PHYSIOL PHA, V14, P419, DOI 10.4196/kjpp.2010.14.6.419; Kojima I, 2014, HANDB EXP PHARMACOL, V222, P247, DOI 10.1007/978-3-642-54215-2_10; Lazzeri M, 2004, EUR UROL, V46, P792, DOI 10.1016/j.eururo.2004.08.007; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Mascarenhas NL, J INVEST DERMATOL, DOI 10.1016/j.yjmcc.2011.06.012; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nilius F, 2014, MAMMALIAN TRANSIENT; Nishihara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022246; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Stokes AJ, 2004, J EXP MED, V200, P137, DOI 10.1084/jem.20032082; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vukman KV, 2012, INFLAMM RES, V61, P79, DOI 10.1007/s00011-011-0394-6; Yang WZ, 2007, PHOTOCHEM PHOTOBIOL, V83, P979, DOI 10.1111/j.1751-1097.2007.00116.x; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053	40	20	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171366	10.1371/journal.pone.0171366	http://dx.doi.org/10.1371/journal.pone.0171366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158279	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700066
J	Kim, J; Shimizu, C; Kingsmore, SF; Veeraraghavan, N; Levy, E; dos Santos, AMR; Yang, H; Flatley, J; Hoang, LT; Hibberd, ML; Tremoulet, AH; Harismendy, O; Ohno-Machado, L; Burns, JC				Kim, Jihoon; Shimizu, Chisato; Kingsmore, Stephen F.; Veeraraghavan, Narayanan; Levy, Eric; dos Santos, Andre M. Ribeiro; Yang, Hai; Flatley, Jay; Hoang, Long Truong; Hibberd, Martin L.; Tremoulet, Adriana H.; Harismendy, Olivier; Ohno-Machado, Lucila; Burns, Jane C.			Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility	PLOS ONE			English	Article							WIDE ASSOCIATION; ANIMAL-MODEL; T-CELLS; LOCI; HOSPITALIZATIONS; EXPRESSION; SNPS; GENE; IDENTIFICATION; INTERLEUKIN-6	Kawasaki disease (KD) is the most common acquired pediatric heart disease. We analyzed Whole Genome Sequences (WGS) from a 6-member African American family in which KD affected two of four children. We sought rare, potentially causative genotypes by sequentially applying the following WGS filters: sequence quality scores, inheritance model (recessive homozygous and compound heterozygous), predicted deleteriousness, allele frequency, genes in KD-associated pathways or with significant associations in published KD genome-wide association studies (GWAS), and with differential expression in KD blood transcriptomes. Biologically plausible genotypes were identified in twelve variants in six genes in the two affected children. The affected siblings were compound heterozygous for the rare variants p. Leu194Pro and p. Arg247Lys in Toll-like receptor 6 (TLR6), which affect TLR6 signaling. The affected children were also homozygous for three common, linked (r(2) = 1) intronic single nucleotide variants (SNVs) in TLR6 (rs56245262, rs56083757 and rs7669329), that have previously shown association with KD in cohorts of European descent. Using transcriptome data from pre-treatment whole blood of KD subjects (n = 146), expression quantitative trait loci (eQTL) analyses were performed. Subjects homozygous for the intronic risk allele (A allele of TLR6 rs56245262) had differential expression of Interleukin-6 (IL-6) as a function of genotype (p = 0.0007) and a higher erythrocyte sedimentation rate at diagnosis. TLR6 plays an important role in pathogen-associated molecular pattern recognition, and sequence variations may affect binding affinities that in turn influence KD susceptibility. This integrative genomic approach illustrates how the analysis of WGS in multiplex families with a complex genetic disease allows examination of both the common disease-common variant and common disease-rare variant hypotheses.	[Kim, Jihoon; Levy, Eric; dos Santos, Andre M. Ribeiro; Yang, Hai; Harismendy, Olivier; Ohno-Machado, Lucila] Univ Calif San Diego, Dept Biomed Informat, La Jolla, CA 92093 USA; [Shimizu, Chisato; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kingsmore, Stephen F.; Veeraraghavan, Narayanan] Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA USA; [Levy, Eric] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Flatley, Jay] Illumina, San Diego, CA USA; [Hoang, Long Truong] Genome Inst Singapore, Singapore, Singapore; [Hibberd, Martin L.] London Sch Hyg & Trop Med, Depatment Pathogen Mol Biol, London, England; [Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA 92123 USA; [Harismendy, Olivier] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Illumina; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of London; London School of Hygiene & Tropical Medicine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kim, J (corresponding author), Univ Calif San Diego, Dept Biomed Informat, La Jolla, CA 92093 USA.; Burns, JC (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	j5kim@ucsd.edu; jcburns@ucsd.edu	Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888; Hibberd, Martin/0000-0001-8587-1849; Kingsmore, Stephen/0000-0001-7180-2527; Shimizu, Chisato/0000-0002-3149-2699	National Institute of Health [U54HL108460]; Gordon and Marilyn Macklin Foundation's private grant; Rady Children's Institute for Genomic Medicine, San Diego; NIH Roadmap for Medical Research [U54HL108460]; Gordon and Marilyn Macklin Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Marilyn Macklin Foundation's private grant; Rady Children's Institute for Genomic Medicine, San Diego; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Marilyn Macklin Foundation	National Institute of Health grant U54HL108460 to LOM; Gordon and Marilyn Macklin Foundation's private grant to JCB and AHT; Rady Children's Institute for Genomic Medicine, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although Dr. Flatley was CEO of Illumina at the time that this research was initiated, Illumina did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support for the whole genome sequencing. Dr. Flatley's role was as a contributor to the interpretation of data and review of the manuscript.; We thank the family who donated their whole genome sequences. We also thank Francesca Marrassi PhD. for helpful discussion of the TLR6 exonic variants and the International Kawasaki Disease Genetics consortium for the original GWAS dataset. This work was funded by the NIH Roadmap for Medical Research, Grant U54HL108460, a grant from the Gordon and Marilyn Macklin Foundation and by Rady Children's Institute for Genomic Medicine, San Diego.	Abuhammour WM, 2005, CLIN PEDIATR, V44, P721, DOI 10.1177/000992280504400812; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alphonse MP, 2016, J IMMUNOL; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Ben-Ali M, 2011, HUM MUTAT, V32, P643, DOI 10.1002/humu.21486; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2015, EXPERT REV CLIN IMMU, V11, P819, DOI 10.1586/1744666X.2015.1044980; Chang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072037; Cybulsky AV, 2016, BBA-MOL CELL RES, V1863, P2147, DOI 10.1016/j.bbamcr.2016.05.015; Daniels LB, 2012, CIRCULATION, V125, P2447, DOI 10.1161/CIRCULATIONAHA.111.082107; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dinwiddie DL, 2013, GENOMICS, V102, P442, DOI 10.1016/j.ygeno.2013.08.008; Franco A, 2014, AUTOIMMUNITY, V47, P95, DOI 10.3109/08916934.2013.860524; FURUKAWA S, 1992, EUR J PEDIATR, V151, P44, DOI 10.1007/BF02073890; Gibbons RV, 2002, ARCH PEDIAT ADOL MED, V156, P492, DOI 10.1001/archpedi.156.5.492; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gordon JB, 2016, JACC-CARDIOVASC INTE, V9, P687, DOI 10.1016/j.jcin.2015.12.011; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Huang SK, 2013, J PEDIATR-US, V163, P126, DOI 10.1016/j.jpeds.2012.12.011; Kamphans T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070151; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Labuda LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095241; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; LEHMAN TJA, 1988, CLIN IMMUNOL IMMUNOP, V48, P108, DOI 10.1016/0090-1229(88)90161-4; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Nakamura Y, 2015, CIRCULATION S2, V131, P12; Nakamura Y, 2013, J EPIDEMIOL, V23, P429, DOI 10.2188/jea.JE20130048; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145486; Onouchi Y, 2012, CIRC J, V76, P1581, DOI 10.1253/circj.CJ-12-0568; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Rodo X, 2014, P NATL ACAD SCI USA, V111, P7952, DOI 10.1073/pnas.1400380111; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; Shimizu C, CIRCULATION IN PRESS; Shrestha S, 2015, INT J IMMUNOGENET, V42, P140, DOI 10.1111/iji.12190; Shvartsur Anna, 2015, Genes Cancer, V6, P84; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stittrich Anna B, 2016, Hum Genome Var, V3, P15060, DOI 10.1038/hgv.2015.60; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Takahashi K, 2004, INFLAMM RES, V53, P72, DOI 10.1007/s00011-003-1225-1; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Yan YL, 2013, HUM GENET, V132, P669, DOI 10.1007/s00439-013-1279-2; Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006	57	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170977	10.1371/journal.pone.0170977	http://dx.doi.org/10.1371/journal.pone.0170977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151979	Green Published, Green Accepted, gold			2022-12-26	WOS:000396161200063
J	Song, Y; Jun, JH; Shin, EJ; Kwak, YL; Shin, JS; Shim, JK				Song, Young; Jun, Ji-Hae; Shin, Eun-Jung; Kwak, Young-Lan; Shin, Jeon-Soo; Shim, Jae-Kwang			Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: Mechanistic insights associated with high-mobility group box 1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIC-STROKE; OXIDATIVE STRESS; GLUCOSE; MANAGEMENT; RELEASE; INJURY; DEATH; TRIAL	hyperglycemia Hyperglycemia, which reduces the efficacy of treatments and worsens clinical outcomes, is common in stroke. Ability of pregabalin to reduce neuroexcitotoxicity may provide protection against stroke, even under hyperglycemia. We investigated its protective effect against hyperglycemic stroke and its possible molecular mechanisms. Male Wistar rats administered dextrose to cause hyperglycemia, underwent middle cerebral artery occlusion for 1 h and subsequent reperfusion. Rats were treated with an intraperitoneal injection of 30 mg/kg pregabalin or an equal amount of normal saline at the onset of reperfusion (n = 16 per group). At 24 h after reperfusion, neurological deficit, infarct volume, and apoptotic cell count were assessed. Western blot analysis was performed to determine protein expression of high-mobility group box 1 (HMGB1), toll-like receptor-4 (TLR-4), phosphorylated nuclear factor-kappa B (p-NF-kappa B), interleukin-1beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), phosphorylated inducible and endothelial nitric oxide synthase (p-iNOS, p-eNOS), Bcl-2, Bax, Cytochrome C, and caspase-3 in the brain. Pregabalin-treated rats showed significantly improved neurological function (31% decrease in score), reduced infarct size (by 33%), fewer apoptotic cells (by 63%), and lower expression levels of HMGB1, TLR4, p-NF-kappa B, IL-1 beta, and TNF-alpha, compared with control rats. Decreased p-iNOS and increased p-eNOS expressions were also observed. Expression of Bax, Cytochrome C, and cleaved caspase-3/caspase3 was significantly downregulated, while Bcl-2 expression was increased by pregabalin treatment. Pregabalin administration upon reperfusion decreased neuronal death and improved neurological function in hyperglycemic stroke rats. Cogent mechanisms would include attenuation of HMGB1/TLR-4-mediated inflammation and favorable modulation of the NOS.	[Song, Young; Kwak, Young-Lan; Shim, Jae-Kwang] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Song, Young; Jun, Ji-Hae; Shin, Eun-Jung; Kwak, Young-Lan; Shim, Jae-Kwang] Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Brain Korea PLUS Med Sci 21, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Song, Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shim, JK (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.; Shim, JK (corresponding author), Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	aneshim@yuhs.ac	Kwak, Young-Lan/AAF-5093-2021	Kwak, Young-Lan/0000-0002-2984-9927; Shin, Jeon-Soo/0000-0002-8294-3234; Shim, Jae-Kwang/0000-0001-9093-9692; Jun, Ji Hae/0000-0002-8080-0715; Song, Young/0000-0003-4597-387X	faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea) [6-2013-0069]	faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea)	This study was supported by a faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea) for 6-2013-0069. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Bemeur C, 2007, NEUROCHEM INT, V50, P890, DOI 10.1016/j.neuint.2007.03.002; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carrillo-Sepulveda MA, 2015, J MOL MED, V93, P1341, DOI 10.1007/s00109-015-1318-7; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fabian RH, 2012, TRANSL STROKE RES, V3, P482, DOI 10.1007/s12975-012-0210-9; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Huang JY, 2013, BRAIN RES, V1535, P148, DOI 10.1016/j.brainres.2013.08.057; Huang MH, 2012, EUR J PHARMACOL, V677, P71, DOI 10.1016/j.ejphar.2011.12.011; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Joshi I, 2006, EUR J PHARMACOL, V553, P82, DOI 10.1016/j.ejphar.2006.09.019; KASTE M, 1994, STROKE, V25, P1348, DOI 10.1161/01.STR.25.7.1348; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kawai N, 1997, ACT NEUR S, V70, P27; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; MacDougall NJJ, 2011, J CEREBR BLOOD F MET, V31, P807, DOI 10.1038/jcbfm.2010.210; Masrur S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002193; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Shim JK, 2014, J THORAC CARDIOV SUR, V148, P298, DOI 10.1016/j.jtcvs.2014.02.076; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Toth C, 2014, THER ADV DRUG SAF, V5, P38, DOI 10.1177/2042098613505614; Villalba N, 2016, J NEUROTRAUMA; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Yokoo N, 2004, ANESTH ANALG, V99, P896, DOI 10.1213/01.ANE.0000132973.32387.8B; Yoon JS, 2011, NEUROBIOL DIS, V41, P624, DOI 10.1016/j.nbd.2010.11.011	40	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171147	10.1371/journal.pone.0171147	http://dx.doi.org/10.1371/journal.pone.0171147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152042	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200094
J	Gaziv, G; Noy, L; Liron, Y; Alon, U				Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri			A reduced-dimensionality approach to uncovering dyadic modes of body motion in conversations	PLOS ONE			English	Article							JOINT ACTION; INTERACTIONAL SYNCHRONY; DYNAMICS; MOVEMENT; BEHAVIOR; RAPPORT; PSEUDOSYNCHRONY; ASSOCIATION; CONSTRAINTS; LISTENERS	Face-to-face conversations are central to human communication and a fascinating example of joint action. Beyond verbal content, one of the primary ways in which information is conveyed in conversations is body language. Body motion in natural conversations has been difficult to study precisely due to the large number of coordinates at play. There is need for fresh approaches to analyze and understand the data, in order to ask whether dyads show basic building blocks of coupled motion. Here we present a method for analyzing body motion during joint action using depth-sensing cameras, and use it to analyze a sample of scientific conversations. Our method consists of three steps: defining modes of body motion of individual participants, defining dyadic modes made of combinations of these individual modes, and lastly defining motion motifs as dyadic modes that occur significantly more often than expected given the single-person motion statistics. As a proof-of-concept, we analyze the motion of 12 dyads of scientists measured using two Microsoft Kinect cameras. In our sample, we find that out of many possible modes, only two were motion motifs: synchronized parallel torso motion in which the participants swayed from side to side in sync, and still segments where neither person moved. We find evidence of dyad individuality in the use of motion modes. For a randomly selected subset of 5 dyads, this individuality was maintained for at least 6 months. The present approach to simplify complex motion data and to define motion motifs may be used to understand other joint tasks and interactions. The analysis tools developed here and the motion dataset are publicly available.	[Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri] Weizmann Inst Sci, Theatre Lab, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Alon, U (corresponding author), Weizmann Inst Sci, Theatre Lab, Rehovot, Israel.	urialon@weizmann.ac.il	Noy, Lior/GQZ-3657-2022		EU-FP7-Health-NoE-Systems Microscopy; Rising Tide Foundation; Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science	EU-FP7-Health-NoE-Systems Microscopy; Rising Tide Foundation; Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science	This work was supported by EU-FP7-Health-NoE-Systems Microscopy and Rising Tide Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair. We thank members of our lab for discussions, Yuval Hart, Avi Mayo, Hagar Goldberg, Liron Rozenkrantz, Assi Dahan, and Hila Sheftel. We thank Scott Kelso for insightful comments on the manuscript, Partick Healey, Ido Lavi and Michael Schober for discussions, Tamar Danon and Roxanne Halper for assistance.	Abney DH, 2015, COGN PROCESS, V16, P325, DOI 10.1007/s10339-015-0648-2; Alon U., 2006, INTRO SYSTEMS BIOL D; Argyle M., 1994, PSYCHOL INTERPERSONA; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; BERNIERI FJ, 1994, PERS SOC PSYCHOL B, V20, P303, DOI 10.1177/0146167294203008; Black DR, 2007, MOTOR CONTROL, V11, P348, DOI 10.1123/mcj.11.4.348; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Borin, 2012, CONVERSATION, V19, P325; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Campbell N, 2007, LECT NOTES COMPUT SC, V4775, P117; Clark Herbert H., 1996, USING LANGUAGE, DOI [10.1017/ CBO9780511620539, DOI 10.1017/CB09780511620539, 10.1017/CBO9780511620539]; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; CONDON WS, 1967, J PSYCHIAT RES, V5, P221, DOI 10.1016/0022-3956(67)90004-0; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Dahan A, 2016, PLOS ONE, V11, P1, DOI [10.1371/journal.pone.0160747, DOI 10.1371/J0URNAL.P0NE.0160747]; Dale R, 2013, PSYCHOL LEARN MOTIV, V59, P43, DOI 10.1016/B978-0-12-407187-2.00002-2; Dale R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00355; DITTMANN AT, 1968, J PERS SOC PSYCHOL, V9, P79, DOI 10.1037/h0025722; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Eshghi A., 2012, P 34 ANN C COGN SCI, P479; Eshghi A., 2015, P 11 INT C COMP SEM, P261; Fusaroli R, 2016, COGNITIVE SCI, V40, P145, DOI 10.1111/cogs.12251; Fusaroli R, 2012, PSYCHOL SCI, V23, P931, DOI 10.1177/0956797612436816; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Garrod S, 2009, TOP COGN SCI, V1, P292, DOI 10.1111/j.1756-8765.2009.01020.x; GOODWIN C, 1980, SOCIOL INQ, V50, P272, DOI 10.1111/j.1475-682X.1980.tb00023.x; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; Gregoromichelaki Eleni, 2011, DIALOGUE DISCOURSE, V2, P199; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hart Y, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01130; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Howes C., 2011, DIALOGUE DISCOURSE, V2, P279, DOI DOI 10.5087/D&D.V2I1.362; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Jung C, 2011, EXP BRAIN RES, V211, P471, DOI 10.1007/s00221-011-2665-4; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso JAS, 2016, TRENDS COGN SCI, V20, P868, DOI 10.1016/j.tics.2016.08.011; Kelso JAS, 2014, IEEE SYS MAN CYBERN, P2240, DOI 10.1109/SMC.2014.6974258; Kelso JAS, 1998, NATURE, V392, P814, DOI 10.1038/33922; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kendon A, 2010, LECT NOTES COMPUT SC, V5967, P1; Kestenberg Amighi J., 1999, MEANING MOVEMENT DEV; Kimura M, 2006, J NONVERBAL BEHAV, V30, P115, DOI 10.1007/s10919-006-0011-5; Knapp M.L., 2014, CENGAGE LEARNING, VEight; Koiso H, 1998, LANG SPEECH, V41, P295, DOI 10.1177/002383099804100404; Korem Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004224; KRAUSS RM, 1977, J PERS SOC PSYCHOL, V35, P523, DOI 10.1037/0022-3514.35.7.523; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Lavelle M, 2013, SCHIZOPHRENIA BULL, V39, P1150, DOI 10.1093/schbul/sbs091; Magnusson MS, 2000, BEHAV RES METH INS C, V32, P93, DOI 10.3758/BF03200792; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monster D, 2016, PHYSIOL BEHAV, V156, P24, DOI 10.1016/j.physbeh.2016.01.004; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Nordham CA, 2016, INTERPERSONAL COORDINATION AND PERFORMANCE IN SOCIAL SYSTEMS, P32; Noy L, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00187, 10.3389/fnhum.2015.00187]; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Pasupathi M, 1998, DISCOURSE PROCESS, V26, P1, DOI 10.1080/01638539809545035; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Purver Matthew, 2009, P SIGDIAL 2009 C 10, P262, DOI 10.3115/1708376.1708413; Ramenzoni VC, 2012, HUM MOVEMENT SCI, V31, P1253, DOI 10.1016/j.humov.2011.12.004; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reed BS, 2010, CULT STUD SCI EDUCAT, V5, P859, DOI 10.1007/s11422-010-9289-z; Rennung M, 2016, Z PSYCHOL, V224, P168, DOI 10.1027/2151-2604/a000252; Reuzel E, 2013, J NONVERBAL BEHAV, V37, P281, DOI 10.1007/s10919-013-0158-9; Richardson D., 2008, EMBODIED COMMUNICATI, P75, DOI DOI 10.1093/ACPROF:OSO/9780199231751.003.0004; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Scheflen A., 1982, INTERACTION RHYTHMS, P13; Schmidt RC, 2012, J NONVERBAL BEHAV, V36, P263, DOI 10.1007/s10919-012-0138-5; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2007, J EXP PSYCHOL HUMAN, V33, P201, DOI 10.1037/0096-1523.33.1.201; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Won AS, 2014, J NONVERBAL BEHAV, V38, P389, DOI 10.1007/s10919-014-0186-0; Yngve V.H., 1970, 6 REG M CHIC LING SO, P567	95	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170786	10.1371/journal.pone.0170786	http://dx.doi.org/10.1371/journal.pone.0170786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141861	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500020
J	Sanjurjo-Rodriguez, C; Castro-Vinuelas, R; Hermida-Gomez, T; Fernandez-Vazquez, T; Fuentes-Boquete, IM; de Toro-Santos, FJ; Diaz-Prado, SM; Blanco-Garcia, FJ				Sanjurjo-Rodriguez, Clara; Castro-Vinuelas, Rocio; Hermida-Gomez, Tamara; Fernandez-Vazquez, Tania; Manuel Fuentes-Boquete, Isaac; Javier de Toro-Santos, Francisco; Maria Diaz-Prado, Silvia; Javier Blanco-Garcia, Francisco			Ovine Mesenchymal Stromal Cells: Morphologic, Phenotypic and Functional Characterization for Osteochondral Tissue Engineering	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; BONE; CARTILAGE; DIFFERENTIATION; SCAFFOLD; GROWTH; BIOMATERIALS; EFFICACY; REPAIR	Introduction Knowledge of ovine mesenchymal stromal cells (oMSCs) is currently expanding. Tissue engineering combining scaffolding with oMSCs provides promising therapies for the treatment of osteochondral diseases. Purpose The aim was to isolate and characterize oMSCs from bone marrow aspirates (oBMSCs) and to assess their usefulness for osteochondral repair using beta-tricalcium phosphate (bTCP) and type I collagen (Col I) scaffolds. Methods Cells isolated from ovine bone marrow were characterized morphologically, phenotypically, and functionally. oBMSCs were cultured with osteogenic medium on bTCP and Col I scaffolds. The resulting constructs were evaluated by histology, immunohistochemistry and electron microscopy studies. Furthermore, oBMSCs were cultured on Col I scaffolds to develop an in vitro cartilage repair model that was assessed using a modified International Cartilage Research Society (ICRS) II scale. Results oBMSCs presented morphology, surface marker pattern and multipotent capacities similar to those of human BMSCs. oBMSCs seeded on Col I gave rise to osteogenic neotissue. Assessment by the modified ICRS II scale revealed that fibrocartilage/hyaline cartilage was obtained in the in vitro repair model. Conclusions The isolated ovine cells were demonstrated to be oBMSCs. oBMSCs cultured on Col I sponges successfully synthesized osteochondral tissue. The data suggest that oBMSCs have potential for use in preclinical models prior to human clinical studies.	[Sanjurjo-Rodriguez, Clara; Castro-Vinuelas, Rocio; Manuel Fuentes-Boquete, Isaac; Javier de Toro-Santos, Francisco; Maria Diaz-Prado, Silvia] Univ A Coruna, Inst Biomed Res A Coruna INIBIC, Cell Therapy & Regenerat Med Unit,Rheumatol Grp, CHUAC,Galician Hlth Serv SERGAS,Dept Med,Fac Hl, La Coruna, Spain; [Castro-Vinuelas, Rocio; Hermida-Gomez, Tamara; Fernandez-Vazquez, Tania; Javier Blanco-Garcia, Francisco] CHUAC, Tissue Bioengn & Cell Therapy Unit GBTTC CHUAC, Inst Biomed Res A Coruna INIBIC, Rheumatol Grp,Galician Hlth Serv SERGAS, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Diaz-Prado, SM (corresponding author), Univ A Coruna, Inst Biomed Res A Coruna INIBIC, Cell Therapy & Regenerat Med Unit,Rheumatol Grp, CHUAC,Galician Hlth Serv SERGAS,Dept Med,Fac Hl, La Coruna, Spain.; Blanco-Garcia, FJ (corresponding author), CHUAC, Tissue Bioengn & Cell Therapy Unit GBTTC CHUAC, Inst Biomed Res A Coruna INIBIC, Rheumatol Grp,Galician Hlth Serv SERGAS, La Coruna, Spain.	s.diaz1@udc.es; fblagar@sergas.es	Blanco, Francisco J./C-3192-2014; Sanjurjo-Rodríguez, Clara/ABE-8108-2020; diaz-prado, silvia MA/B-4191-2015; DÍAZ-PRADO, SILVIA MARIA/ABH-6665-2020; Boquete, Isaac Manuel Fuentes/C-8865-2015; Sanjurjo-Rodríguez, Clara/T-2580-2017; de toro, javier/ABH-4217-2020	Blanco, Francisco J./0000-0001-9821-7635; Sanjurjo-Rodríguez, Clara/0000-0003-2702-7804; diaz-prado, silvia MA/0000-0001-9776-2180; DÍAZ-PRADO, SILVIA MARIA/0000-0001-9776-2180; Boquete, Isaac Manuel Fuentes/0000-0003-1056-4507; Sanjurjo-Rodríguez, Clara/0000-0003-2702-7804; Hermida Gomez, Tamara/0000-0001-7405-4595; Castro Vinuelas, Rocio/0000-0003-4881-273X; de-Toro, Javier/0000-0001-6131-1273	Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid [S2009/MAT-1472, 52009/MAT-1472]; Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia [R2014/050, GPC2014/048]; Fundacion Espanola de Reumatologia; Diputacion de A Coruna (Spain)	Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid; Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia; Fundacion Espanola de Reumatologia; Diputacion de A Coruna (Spain)	This study was supported by grants: Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid (S2009/MAT-1472); Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia (R2014/050 and GPC2014/048); Fundacion Espanola de Reumatologia (2014 grant); RCV was beneficiary of a grant from Diputacion de A Coruna (Spain).; We want to thank Bruna Parma from Opocrin, S.P.A. for supplying Col I scaffolds; V. SeoaneMato and J.M. Cruz-Valino from Instituto Corunes de Implantologia y Rehabilitacion Oral (ICIRO) for kindly providing bTCP scaffolds; UCEX (Unit of Experimental Surgery) from CHUAC for providing ovine cartilage samples; Ada Castro-Couceiro, Ph.D. for electron microscopy research support services at the Universidade da Coruna (SAI-UDC); and laboratory staff: Maria Jose Sanchez-Dopico, Purificacion Filgueira-Fernandez, Noa Goyanes-Rey and Ines Seijo-Calvino from INIBIC-CHUAC for their support and assistance. This study was supported by grants: ICIRO, Servizo Galego de Salude; Universidade da Coruna (UDC); Catedra Bioiberica from UDC; CAM (52009/MAT-1472); CIBER-BBN from Instituto de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular (REDICENT), Xunta de Galicia (R2014/050); GPC, Xunta de Galicia (GPC2014/048); Fundacion Espanola de Reumatologia (2014 grant); R. Castro-Vinuelas was beneficiary of a grant from Diputacion de A Coruna (Spain).	Adamzyk C, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/387324; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Boos AM, 2011, J CELLULAR MOL MED, V15; Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Cicione C, 2015, CELL TISSUE BANK, V16, P195, DOI 10.1007/s10561-014-9472-7; Colosimo A, 2013, CYTOTHERAPY, V15, P930, DOI 10.1016/j.jcyt.2013.03.014; Desantis S, 2015, ANN ANAT, V201, P43, DOI 10.1016/j.aanat.2015.06.002; Dhollander AAM, 2012, J KNEE SURG, V25, P179, DOI 10.1055/s-0032-1322596; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Jawhari JJ, 2015, J ORTHOP RES; Endres M, 2012, J ORTHOPAEDIC SURG R, V7; Fadel L, 2011, ACTA CIRURGICA BRASI, V26; Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891; Fuentes-Boquete IM, 2008, OPEN TRANSPLANTATION, V2, P21; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grogan SP, 2007, ARTHRITIS RHEUM-US, V56, P586, DOI 10.1002/art.22408; Gronthos S, 2006, CALCIFIED TISSUE INT, V79, P310, DOI 10.1007/s00223-006-0040-4; Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32; Hamdan BMYN, 2012, EXPT GERONTOLOGY, V47; Jager M, 2006, IN VIVO, V20, P205; Jahroomishirazi R, 2014, CELLS TISSUES ORGANS, V200, P141, DOI 10.1159/000381534; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1; Landa-Solis C, 2015, CELL TISSUE BANK; Liao JF, 2014, J BIOMED NANOTECHNOL, V10, P3085, DOI 10.1166/jbn.2014.1934; Lindroos B, 2010, TISSUE ENG PT A, V16, P2281, DOI [10.1089/ten.tea.2009.0621, 10.1089/ten.TEA.2009.0621]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutianov M, 2011, J THEOR BIOL, V289, P136, DOI 10.1016/j.jtbi.2011.08.007; Lyahyai J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-169; Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068; McCarty Rosa C, 2010, Open Orthop J, V4, P204, DOI 10.2174/1874325001004010204; McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; Mesallati T, 2014, J TISSUE ENG REGEN M, V8, P152; Mrugala D, 2008, ANN RHEUMATIC DIS, V67; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Ozen A, 2013, MICROSCOPY RES, V1, P17, DOI DOI 10.4236/MR.2013.13004; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Perdikouri C, 2015, CALCIFIED TISSUE INT, V96, P11, DOI 10.1007/s00223-014-9930-z; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Reichert JC, 2010, J TISSUE ENG REGENER, V4; Rentsch C, 2010, IN VITRO CELL DEV-AN, V46, P624, DOI 10.1007/s11626-010-9316-0; Rentsch C, 2010, IN VITRO CELLULAR DE, V46; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Royo-Canas M, 2009, J ORTHOPAEDIC RES, V27; Rozemuller H, 2010, STEM CELLS DEV, V19, P1911, DOI 10.1089/scd.2009.0510; Sanjurjo-Rodriguez C, 2014, J REGENERATIVE MED, V3; Schmitt SC, 2008, J MATER SCI-MATER M, V19, P1441, DOI 10.1007/s10856-007-3238-8; Schulz RM, 2008, BIOMEDICAL MAT ENG, V18; Sharma S, 2014, J CLIN DIAGN RES, V8, P309, DOI 10.7860/JCDR/2014/7609.3937; Somers P, 2012, GROWTH FACTORS, V30, P37, DOI 10.3109/08977194.2011.634411; Song FL, 2014, INT J CLIN EXP PATHO, V7, P1415; Suarez-Gonzalez D, 2014, TISSUE ENG PT A, V20, P2077, DOI 10.1089/ten.tea.2013.0358; Tian Y., 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/819232; Ude CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098770; van Haaften EE, 2016, J ORTHOP RES; Yang Y, 2015, INT J CLIN EXP MED, V8, P3202; Zannettino ACW, 2010, TISSUE ENG A, V16; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zhao Y., 2012, J NANOTECHNOL, V2012, P1, DOI DOI 10.1186/1741-7015-10-3]; Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212; Zscharnack M, 2010, AM J SPORTS MED, V38	66	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171231	10.1371/journal.pone.0171231	http://dx.doi.org/10.1371/journal.pone.0171231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141815	Green Published, gold			2022-12-26	WOS:000396129500050
J	Walsh, RP; Michaels, HJ				Walsh, Ryan P.; Michaels, Helen J.			When it pays to cheat: Examining how generalized food deception increases male and female fitness in a terrestrial orchid	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; FLORAL DISPLAY SIZE; INBREEDING DEPRESSION; REPRODUCTIVE SUCCESS; SPUR LENGTH; POLLEN LIMITATION; SUPPLEMENTATION EXPERIMENTS; GYMNADENIA-CONOPSEA; INFLORESCENCE SIZE; FRUIT-SET	Background Experimental manipulations of floral nectar in food deceptive species can reveal insights into the evolutionary consequences of the deceptive strategy. When coupled to pollen tracking, the effects of the deceptive pollination syndrome on both male and female reproductive success may be quantified. Attraction of pollinators in deceit-pollinated species often relies on producing a conspicuous floral display which may increase visibility to pollinators, but inturn may increase within plant selfing. Methodology To understand the role of deception in Orchidaceae reproduction we studied Cypripedium candidum. All species of the Cypripedium genus employ a generalized food deceptive pollination strategy and have been suggested as a model system for the study of pollinator deception. We conducted a nectar addition experiment that randomly assigned the four plants closest to a transect point to receive one of four histochemical dyes. Two individuals selected for nectar addition in each of altogether 25 blocks received 2 mu l of 25% sucrose solution in the labellum of each flower, while two others received no artificial nectar. Number of fruits produced, fruit mass and fruit abortion were scored at the end of the four-month experiment. Results Nectar addition increased (p<0.0001) self-pollination and pollen discounting by nearly 3x, while plants not receiving nectar had greater (p<0.0001) numbers of non-self pollinia deposited and lower rates of pollen discounting. There was a non-significant (p = 0.0645) trend for deceptive plants to set more fruit, while presence of nectar did not affect pollen export. Conclusions This study demonstrates the adaptive advantages of food deception by showing a concurrent reduction in particular male and female functions when a food reward is restored to a deceptive flower. We found generalized food deception to not only decrease inbreeding depression in the system, but concurrently have no effect on pollinator attraction and fruit set when compared with rewarding flowers.	[Walsh, Ryan P.] Toledo Zool Soc, Dept Conservat, Toledo, OH 43609 USA; [Michaels, Helen J.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	University System of Ohio; Bowling Green State University	Walsh, RP (corresponding author), Toledo Zool Soc, Dept Conservat, Toledo, OH 43609 USA.	Ryan.Walsh@ToledoZoo.org		Walsh, Ryan/0000-0001-8040-6032				Ackerman J.D., 1981, Madrono, V28, P101; [Anonymous], 1793, ENTDECKTE GEHEIMNIS, DOI [10.5962/bhl.title.50179, DOI 10.5962/BHL.TITLE.50179]; Aragon Susan, 2001, Lindleyana, V16, P3; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; Bernhardt P, 2010, BOT REV, V76, P204, DOI 10.1007/s12229-010-9042-z; Borba EL, 2001, ANN BOT-LONDON, V88, P89, DOI 10.1006/anbo.2001.1435; BOWLES M. L., 1983, NAT AREA J, V3, P14; BURD M, 1995, J ECOL, V83, P865, DOI 10.2307/2261423; CALVO RN, 1990, AM J BOT, V77, P1378, DOI 10.2307/2444598; CATLING PM, 1980, CAN FIELD NAT, V94, P435; Chapurlat E, 2015, NEW PHYTOL, V208, P1264, DOI 10.1111/nph.13555; Cheney KL, 2008, BEHAV ECOL, V19, P583, DOI 10.1093/beheco/arn001; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; CURTIS JT, 1946, J WILDLIFE MANAGE, V10, P303, DOI 10.2307/3796237; Curtis JT, 1943, AM J BOT, V30, P199, DOI 10.2307/2437240; Cusick AW, 1980, CYPRIPEDIUM CANDIDUM; Dafni A, 1990, EVOLUTIONARY BIOL, P193; Darwin C., 1877, VARIOUS CONTRIVANCES; de Jager ML, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2861; DEJONG TJ, 1993, TRENDS ECOL EVOL, V8, P321, DOI 10.1016/0169-5347(93)90239-L; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Ellis AG, 2010, INT J PLANT SCI, V171, P1010, DOI 10.1086/656351; Faegri K, 1971, PRINCIPLES POLLINATI; Ferdy JB, 1998, AM NAT, V152, P696, DOI 10.1086/286200; Ferdy JB, 2001, CAN J BOT, V79, P1181, DOI 10.1139/cjb-79-10-1181; FRITZ AL, 1990, NORD J BOT, V9, P577, DOI 10.1111/j.1756-1051.1990.tb00548.x; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Garcia CM, 2012, P R SOC B, V279, P2262; Gill DE, 1989, SPECIATION ITS CONSE, V458, P481; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Gumbert A, 2001, BIOL J LINN SOC, V72, P419, DOI [10.1111/j.1095-8312.2001.tb01328.x, 10.1006/bijl.2000.0510]; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HOLSINGER KE, 1994, AM NAT, V144, P799, DOI 10.1086/285707; Jersakova J, 2006, OECOLOGIA, V147, P60, DOI 10.1007/s00442-005-0254-6; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Jersakova J, 2009, SIGNAL COMMUN PLANTS, P223, DOI 10.1007/978-3-540-89230-4_12; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Johnson SD, 2004, P ROY SOC B-BIOL SCI, V271, P803, DOI 10.1098/rspb.2003.2659; Johnson SD, 2005, BIOL J LINN SOC, V86, P175, DOI 10.1111/j.1095-8312.2005.00541.x; Johnson SD, 2000, PLANT SYST EVOL, V222, P243, DOI 10.1007/BF00984105; Johnson SD, 1999, ECOLOGY, V80, P2607, DOI 10.1890/0012-9658(1999)080[2607:PCGATE]2.0.CO;2; JOHNSTON MO, 1994, EVOLUTION, V48, P1735, DOI 10.1111/j.1558-5646.1994.tb02209.x; Juillet N, 2007, PLANT SYST EVOL, V265, P123, DOI 10.1007/s00606-006-0507-9; Kindlmann P, 2006, FOLIA GEOBOT, V41, P47, DOI 10.1007/BF02805261; Knight TM, 2006, AM J BOT, V93, P271, DOI 10.3732/ajb.93.2.271; Kropf M, 2008, OECOLOGIA, V155, P497, DOI 10.1007/s00442-007-0919-4; LEE TD, 1982, ECOLOGY, V63, P1363, DOI 10.2307/1938864; Li P, 2010, PLANT SYST EVOL, V286, P167, DOI 10.1007/s00606-010-0296-z; Liao WJ, 2014, AM NAT, V184, P580, DOI 10.1086/678117; Lipow SR, 2002, INT J PLANT SCI, V163, P775, DOI 10.1086/342083; LOPEZPORTILLO J, 1993, FUNCT ECOL, V7, P452, DOI 10.2307/2390032; Melendez-Ackerman EJ, 2001, PLANT SYST EVOL, V227, P27, DOI 10.1007/s006060170054; Mitchell RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076312; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; Ne'eman G, 2006, J INSECT BEHAV, V19, P383, DOI 10.1007/s10905-006-9030-7; Neiland MRM, 1998, AM J BOT, V85, P1657, DOI 10.2307/2446499; NILSSON LA, 1980, BOT NOTISER, V133, P367; NILSSON LA, 1992, NATURE, V360, P666, DOI 10.1038/360666a0; NILSSON LA, 1983, NATURE, V305, P799, DOI 10.1038/305799a0; O'Connell LM, 1998, ECOLOGY, V79, P1246, DOI 10.2307/176740; PEAKALL R, 1989, PLANT SYST EVOL, V167, P137, DOI 10.1007/BF00936402; PRIMACK RB, 1990, AM NAT, V136, P638, DOI 10.1086/285120; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Scopece G, 2015, PLANT BIOLOGY, V17, P545, DOI 10.1111/plb.12224; Scopece G, 2010, AM NAT, V175, P98, DOI 10.1086/648555; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Sletvold N, 2017, FUNCT ECOL, V31, P135, DOI 10.1111/1365-2435.12757; Sletvold N, 2011, ECOLOGY, V92, P2167, DOI 10.1890/11-0791.1; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Smithson A, 2002, AM J BOT, V89, P1579, DOI 10.3732/ajb.89.10.1579; Smithson A, 2006, NEW PHYTOL, V169, P419, DOI 10.1111/j.1469-8137.2005.01592.x; Smithson A, 1996, J EVOLUTION BIOL, V9, P571, DOI 10.1046/j.1420-9101.1996.9050571.x; Smithson A, 2001, P ROY SOC B-BIOL SCI, V268, P1435, DOI 10.1098/rspb.2001.1705; Snow A. A., 1996, FLORAL BIOL STUDIES, P191; SNOW AA, 1993, ANNU REV ECOL SYST, V24, P331, DOI 10.1146/annurev.es.24.110193.001555; Stoutamire W.P., 1967, MICH BOT, V6, P159; Sun HQ, 2009, ANN BOT-LONDON, V103, P1227, DOI 10.1093/aob/mcp066; Svedarsky W, 1996, RESTORATION MANAGEME, V14, P179; Tremblay Raymond L., 1994, Lindleyana, V9, P161; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Verdu M, 2006, EVOLUTION, V60, P2056, DOI 10.1111/j.0014-3820.2006.tb01843.x; Wake CM, 2007, LANKESTERIANA, V7, P423; Walsh RP, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu031; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x	87	9	9	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171286	10.1371/journal.pone.0171286	http://dx.doi.org/10.1371/journal.pone.0171286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141838	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129500055
J	Zaheer, R; Dugat-Bony, E; Holman, D; Cousteix, E; Xu, Y; Munns, K; Selinger, LJ; Barbieri, R; Alexander, T; McAllister, TA; Selinger, LB				Zaheer, Rahat; Dugat-Bony, Eric; Holman, Devon; Cousteix, Elodie; Xu, Yong; Munns, Krysty; Selinger, Lorna J.; Barbieri, Rutn; Alexander, Trevor; McAllister, Tim A.; Selinger, L. Brent			Changes in bacterial community composition of Escherichia coli O157:H7 super-shedder cattle occur in the lower intestine	PLOS ONE			English	Article							FEEDLOT CATTLE; GASTROINTESTINAL-TRACT; MICROBIAL-POPULATIONS; RECTOANAL JUNCTION; DIVERSITY; O157-H7; COLONIZATION; GENE; FECES; SALMONELLA	Escherichia coli O157:H7 is a foodborne pathogen that colonizes ruminants. Cattle are considered the primary reservoir of E. coli O157:H7 with super-shedders, defined as individuals excreting > 10(4) E. coli O157:H7 CFU g(-1) feces. The mechanisms leading to the super-shedding condition are largely unknown. Here, we used 16S rRNA gene pyrosequencing to examine the composition of the fecal bacterial community in order to investigate changes in the bacterial microbiota at several locations along the digestive tract (from the duodenum to the rectal-anal junction) in 5 steers previously identified as super-shedders and 5 non-shedders. The overall bacterial community structure did not differ by E. coli O157:H7 shedding status; but several differences in the relative abundance of taxa and OTUs were noted between the two groups. The genus Prevotella was most enriched in the non-shedders while the genus Ruminococcus and the Bacteroidetes phylum were notably enriched in the super-shedders. There was greater bacterial diversity and richness in samples collected from the lower-as compared to the upper gastrointestinal tract (GI). The spiral colon was the only GI location that differed in terms of bacterial diversity between super-shedders and non-shedders. These findings reinforced linkages between E. coli O157:H7 colonization in cattle and the nature of the microbial community inhabiting the digestive tract of supershedders.	[Zaheer, Rahat; Holman, Devon; Munns, Krysty; Selinger, Lorna J.; Barbieri, Rutn; Alexander, Trevor; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Dugat-Bony, Eric] Univ Paris Saclay, UMR Genie & Microbiol Proc Alimentaires, AgroParisTech, INRA, Thiverval Grignon, France; [Cousteix, Elodie; Xu, Yong; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada	Agriculture & Agri Food Canada; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Lethbridge	Selinger, LB (corresponding author), Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca; selibl@uleth.ca	Dugat-Bony, Eric/K-2455-2014; Holman, Devin/H-8693-2019; McAllister, Tim A./R-9201-2017	Dugat-Bony, Eric/0000-0002-5182-0063; Holman, Devin/0000-0001-5306-3732; McAllister, Tim A./0000-0002-8266-6513; Zaheer, Rahat/0000-0003-3307-4666	Alberta Livestock and Meat Agency Ltd.; Genome Alberta; Abase program of Agriculture and Agri-Food Canada	Alberta Livestock and Meat Agency Ltd.; Genome Alberta; Abase program of Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research work was conducted with the funding from the 'Alberta Livestock and Meat Agency Ltd., Genome Alberta as well as the Abase program of Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callaway TR, 2006, FOODBORNE PATHOG DIS, V3, P234, DOI 10.1089/fpd.2006.3.234; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carlson BA, 2009, APPL ENVIRON MICROB, V75, P5927, DOI 10.1128/AEM.00972-09; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duffy G, 2003, J APPL MICROBIOL, V94, p94S; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Lone AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075325; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Messori S, 2013, VET MICROBIOL, V162, P173, DOI 10.1016/j.vetmic.2012.09.001; Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621; Myer PR, 2015, J ANIM SCI, V93, P5327, DOI 10.2527/jas.2015-9415; Myer PR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1201-6; Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Reinstein S, 2007, APPL ENVIRON MICROB, V73, P1002, DOI 10.1128/AEM.02037-06; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stanford K, 2005, J DAIRY SCI, V88, P4441, DOI 10.3168/jds.S0022-0302(05)73131-3; Stanford K, 2005, J FOOD PROTECT, V68, P26, DOI 10.4315/0362-028X-68.1.26; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stoffregen WC, 2004, J VET DIAGN INVEST, V16, P79, DOI 10.1177/104063870401600114; Sullivan LE, 2015, APPL ENVIRON MICROB, V81, P7460, DOI 10.1128/AEM.01956-15; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Walle KV, 2013, VET IMMUNOL IMMUNOP, V152, P109, DOI 10.1016/j.vetimm.2012.09.028; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151284; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098115; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	67	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170050	10.1371/journal.pone.0170050	http://dx.doi.org/10.1371/journal.pone.0170050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141846	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500006
J	Inoue, K; Arai, M; Fujisawa, M; Saito, K; Fukushi, M				Inoue, Kazumasa; Arai, Moeko; Fujisawa, Makoto; Saito, Kyouko; Fukushi, Masahiro			Detailed Distribution Map of Absorbed Dose Rate in Air in Tokatsu Area of Chiba Prefecture, Japan, Constructed by Car-Borne Survey 4 Years after the Fukushima Daiichi Nuclear Power Plant Accident	PLOS ONE			English	Article							METROPOLITAN TOKYO; TERRESTRIAL; RADIATION	A car-borne survey was carried out in the northwestern, or Tokatsu, area of Chiba Prefecture, Japan, to make a detailed distribution map of absorbed dose rate in air four years after the Fukushima Daiichi Nuclear Power Plant accident. This area was chosen because it was the most heavily radionuclide contaminated part of Chiba Prefecture and it neighbors metropolitan Tokyo. Measurements were performed using a 3-in x 3-in NaI(Tl) scintillation spectrometer in June 2015. The survey route covered the whole Tokatsu area which includes six cities. A heterogeneous distribution of absorbed dose rate in air was observed on the dose distribution map. Especially, higher absorbed dose rates in air exceeding 80 nGy h(-1) were observed along national roads constructed using high porosity asphalt, whereas lower absorbed dose rates in air were observed along local roads constructed using low porosity asphalt. The difference between these asphalt types resulted in a heterogeneous dose distribution in the Tokatsu area. The mean of the contribution ratio of artificial radionuclides to absorbed dose rate in air measured 4 years after the accident was 29% (9-50%) in the Tokatsu area. The maximum absorbed dose rate in air, 201 nGy h(-1) was observed at Kashiwa City. Radiocesium was deposited in the upper 1 cm surface layer of the high porosity asphalt which was collected in Kashiwa City and the environmental half-life of the absorbed dose rate in air was estimated to be 1.7 years.	[Inoue, Kazumasa; Arai, Moeko; Fujisawa, Makoto; Fukushi, Masahiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa ku, Tokyo, Japan; [Saito, Kyouko] Nihon Inst Med Sci, Dept Radiol Technol, Fac Hlth Sci, Saitama, Japan		Inoue, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa ku, Tokyo, Japan.	kzminoue@tmu.ac.jp			Tokyo Metropolitan University	Tokyo Metropolitan University	This work was funded by the strategic research fund of Tokyo Metropolitan University (2014 - 2015).	ABE S, 1981, J NUCL SCI TECHNOL, V18, P21, DOI 10.3327/jnst.18.21; Andoh M, 2015, J ENVIRON RADIOACTIV, V139, P266, DOI 10.1016/j.jenvrad.2014.05.014; Cenh JI, 2007, HEALTH PHYS, V93, P325, DOI [10.1097/01.HP.0000278417.08952.52, DOI 10.1097/01.HP.0000278417.08952.52]; Furukawa M., 2012, RAD EMERG MED, V1, P11; Hosoda M, 2016, JPN J HLTH PHYS, V51, P41, DOI DOI 10.5453/JHPS.51.41; Hosoda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124433; Hosoda M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00087; Iimoto T, 2015, RADIAT PROT DOSIM, V167, P358, DOI 10.1093/rpd/ncv279; Inoue K, 2015, RADIAT PROT DOSIM, V167, P231, DOI 10.1093/rpd/ncv251; Inoue K, 2016, J ENVIRON RADIOACTIV, V158, P1, DOI 10.1016/j.jenvrad.2016.03.022; Inoue K, 2016, J RADIOANAL NUCL CH, V307, P507, DOI 10.1007/s10967-015-4164-8; Inoue K, 2015, J RADIOANAL NUCL CH, V303, P2159, DOI 10.1007/s10967-014-3669-x; International Atomic Energy Agency, 1979, IAEATECDOC225; Joint committee for guides In measurements 2008 Joint committee for guides In measurements, 2008, JCGM, V100; Kashiwa City Office, 2012, AMB DOS RAT TOK 6 CI; Lai K. K., 1996, RADIOISOT, V45, P696; Machart P, 2007, J ENVIRON RADIOACTIV, V97, P70, DOI 10.1016/j.jenvrad.2007.05.003; Maedera F, 2016, RADIAT PROT DOSIM, V168, P561, DOI 10.1093/rpd/ncv370; Minato S., 2001, Radioisotopes, V50, P463, DOI 10.3769/radioisotopes.50.10_463; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Moriuchi S, 1990, JPN J HLTH PHYS, V25, P121; Nishizawa Kanae, 2004, Nippon Acta Radiologica, V64, P151; Nuclear Regulation Authority, 2011, EXT SIT DISTR MAP RA; Prohl G, 2006, J ENVIRON RADIOACTIV, V91, P41, DOI 10.1016/j.jenvrad.2006.08.004; Roed J., 1998, MECH DECONTAMINATION; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Statistics Bureau Ministry of Internal Affairs and Communications Japan, 2014, FUND ASP SOC LIF 201; Sugino Masato, 2007, Radioisotopes, V56, P315; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, UNSCEAR 2013 REP ANN; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	30	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171100	10.1371/journal.pone.0171100	http://dx.doi.org/10.1371/journal.pone.0171100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129382	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400007
J	Macianskiene, R; Almanaityte, M; Jekabsone, A; Mubagwa, K				Macianskiene, Regina; Almanaityte, Mante; Jekabsone, Aiste; Mubagwa, Kanigula			Modulation of Human Cardiac TRPM7 Current by Extracellular Acidic pH Depends upon Extracellular Concentrations of Divalent Cations	PLOS ONE			English	Article							HUMAN ATRIAL MYOCYTES; VENTRICULAR-FUNCTION; KINASE TRPM7; CHANNEL; MAGNESIUM; ISCHEMIA; MG2+; CALCIUM; SUPPRESSION; SENSITIVITY	TRPM7 channels participate in a variety of physiological/pathological processes. TRPM7 currents are modulated by protons but opposing effects of external pH (pH(o)) (potentiation vs inhibition) have been reported. TRPM7 has been less studied in human cardiomyocytes than in heart-derived non-cardiomyocyte cells. We used the whole-cell patch-clamp technique on isolated human atrial cardiomyocytes to investigate the impact of an acidic pHo on the TRPM7 current. With voltage-dependent and other ion channels inhibited, cardiomyocytes were challenged with external acidification in either the presence or the absence of extracellular divalent cations. TRPM7 outward and inward currents were increased by acidic pHo in extracellular medium containing Ca2+ and Mg2+, but suppressed by acidic pHo in the absence of extracellular Ca2+ and Mg2+. The potentiating effect in the presence of extracellular divalents occurred at pHo below 6 and was voltage-dependent. The inhibitory effect in the absence of extracellular divalents was already marked at pHo of 6 and was practically voltage-independent. TRPM7 current density was higher in cardiomyocytes from patients with history of coronary vascular disease and the difference compared to cardiomyocytes from patients without history of myocardial ischemia increased with acidic pHo. We demonstrate that proton-induced modification of TRPM7 currents depends on the presence of extracellular Ca2+ and Mg2+. Variability of the TRPM7 current density in human cardiomyocytes is related to the clinical history, being higher in atrial fibrillation and in ischemic cardiomyopathy.	[Macianskiene, Regina; Almanaityte, Mante] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Jekabsone, Aiste] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania; [Mubagwa, Kanigula] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; KU Leuven	Macianskiene, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	regina.macianskiene@lsmuni.lt	Jekabsone, Aiste/AAY-5182-2020; Jekabsone, Aiste/ABA-3462-2020	Jekabsone, Aiste/0000-0003-1527-6221	European Social Fund [MM NKP FK_VP1-3.1-WM-08-K-01-022]	European Social Fund(European Social Fund (ESF))	This research was supported by the European Social Fund to RM (project code number: MM NKP FK_VP1-3.1-WM-08-K-01-022).	Almanaityte M, 2015, ACTA PHYSIOL, V215, P74; Almanaityte M, 2014, BIOPHYS J, V106, p753A, DOI 10.1016/j.bpj.2013.11.4146; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1004, DOI 10.1152/ajpcell.00422.2011; Chu XP, 2003, J PHYSIOL-LONDON, V550, P385, DOI 10.1113/jphysiol.2003.043091; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Demir T, 2014, MOL BIOL REP, V41, P2845, DOI 10.1007/s11033-014-3139-0; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Fleig A, 2014, HANDB EXP PHARMACOL, V222, P521, DOI 10.1007/978-3-642-54215-2_21; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Gwanyanya A, 2004, J PHYSIOL-LONDON, V559, P761, DOI 10.1113/jphysiol.2004.067637; Hara K, 2010, AM J MED GENET B, V153B, P310, DOI 10.1002/ajmg.b.30966; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Istrate B, 2012, NONHOMOGENOUS DISTRI; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim BJ, 2008, CANCER SCI, V99, P2502, DOI 10.1111/j.1349-7006.2008.00982.x; Komukai K, 2002, AM J PHYSIOL-HEART C, V283, pH715, DOI 10.1152/ajpheart.01000.2001; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Macianskiene R, 2008, CELL PHYSIOL BIOCHEM, V22, P109, DOI 10.1159/000149788; Macianskiene R, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-75; Martisiene I, 2011, CHARACTERIZATION TRP; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Mubagwa K, 1997, J PHYSIOL-LONDON, V502, P235, DOI 10.1111/j.1469-7793.1997.235bk.x; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Numata T, 2008, J BIOL CHEM, V283, P15097, DOI 10.1074/jbc.M709261200; Ortega A, 2016, ESC HEART FAIL, V3, P220, DOI 10.1002/ehf2.12085; Penner R., 2007, V179, P313; Pujadas S, 2010, EUR J RADIOL, V75, pE88, DOI 10.1016/j.ejrad.2009.12.012; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Runnels L, 2002, NATURE CELL BIOL, V4; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07599; Sah R, 2014, P NATL ACAD SCI USA, V111, P6528, DOI 10.1073/pnas.1405727111; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Yu Y, 2014, CELL CALCIUM, V55, P252, DOI 10.1016/j.ceca.2014.02.019; Zakharov SI, 2003, BRIT J PHARMACOL, V138, P234, DOI 10.1038/sj.bjp.0705074; Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170923	10.1371/journal.pone.0170923	http://dx.doi.org/10.1371/journal.pone.0170923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129376	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400026
J	Aykul, S; Parenti, A; Chu, KY; Reske, J; Floer, M; Ralston, A; Martinez-Hackert, E				Aykul, Senem; Parenti, Anthony; Chu, Kit Yee; Reske, Jake; Floer, Monique; Ralston, Amy; Martinez-Hackert, Erik			Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; REPULSIVE GUIDANCE MOLECULE; LEFT-RIGHT AXIS; EGF-CFC FAMILY; TGF-BETA; VERTEBRATE DEVELOPMENT; SIGNALING PATHWAY; COLORECTAL-CANCER; VISCERAL ENDODERM; MOUSE EMBRYO	Transforming growth factor beta (TGF-beta) pathways are key determinants of cell fate in animals. Their basic mechanism of action is simple. However, to produce cell-specific responses, TGF-beta pathways are heavily regulated by secondary factors, such as membrane-associated EGF-CFC family proteins. Cellular activities of EGF-CFC proteins have been described, but their molecular functions, including how the mammalian homologs Cripto-1 and Cryptic recognize and regulate TGF-beta family ligands, are less clear. Here we use purified human Cripto-1 and mouse Cryptic produced in mammalian cells to show that these two EGF-CFC homologs have distinct, highly specific ligand binding activities. Cripto-1 interacts with BMP-4 in addition to its known partner Nodal, whereas Cryptic interacts only with Activin B. These interactions depend on the integrity of the protein, as truncated or deglycosylated Cripto-1 lacked BMP-4 binding activity. Significantly, Cripto-1 and Cryptic blocked binding of their cognate ligands to type I and type II TGF-beta receptors, indicating that Cripto-1 and Cryptic contact ligands at their receptor interaction surfaces and, thus, that they could inhibit their ligands. Indeed, soluble Cripto-1 and Cryptic inhibited ligand signaling in various cell-based assays, including SMAD-mediated luciferase reporter gene expression, and differentiation of a multipotent stem cell line. But in agreement with previous work, the membrane bound form of Cripto-1 potentiated signaling, revealing a critical role of membrane association for its established cellular activity. Thus, our studies provide new insights into the mechanism of ligand recognition by this enigmatic family of membrane-anchored TGF-beta family signaling regulators and link membrane association with their signal potentiating activities.	[Aykul, Senem; Parenti, Anthony; Chu, Kit Yee; Reske, Jake; Floer, Monique; Ralston, Amy; Martinez-Hackert, Erik] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Martinez-Hackert, E (corresponding author), Rm 509,603 Wilson Rd, E Lansing, MI 48824 USA.	emh@msu.edu		Martinez-Hackert, Erik/0000-0002-6182-7023; AYKUL, SENEM/0000-0001-7250-2913; Ralston, Amy/0000-0003-3755-8262	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health [R41 AR068804, R43 CA203180, R01 GM104009]; NATIONAL CANCER INSTITUTE [R43CA203180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104009] Funding Source: NIH RePORTER	Michigan State University; Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Michigan State University, the Clinical and Translational Sciences Institute, and National Institutes of Health Grants R41 AR068804, R43 CA203180, and R01 GM104009 (to A. R.). S. A., E. M. H., and Michigan State University have filed a patent application on the use of Cripto-1/Cryptic as inhibitors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Aykul S, 2016, ANAL BIOCHEM, V508, P97, DOI 10.1016/j.ab.2016.06.025; Aykul S, 2016, J BIOL CHEM, V291, P10792, DOI 10.1074/jbc.M115.713487; Aykul S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114954; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bianco C, 2003, CANCER RES, V63, P1192; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blanchet MH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1165027; Calvanese L, 2010, BIOPOLYMERS, V93, P1011, DOI 10.1002/bip.21517; Calvanese L, 2009, J PEPT SCI, V15, P175, DOI 10.1002/psc.1091; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Francescangeli F, 2015, CELL DEATH DIFFER, V22, P1700, DOI 10.1038/cdd.2015.19; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gjidoda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093971; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Liguori GL, 2008, DEV BIOL, V315, P280, DOI 10.1016/j.ydbio.2007.12.027; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Miyoshi N, 2010, INT J ONCOL, V36, P563, DOI 10.3892/ijo_00000530; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; Nagaoka T, 2013, CELL SIGNAL, V25, P178, DOI 10.1016/j.cellsig.2012.09.024; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; Parenti A, 2016, STEM CELL REP, V6, P447, DOI 10.1016/j.stemcr.2016.02.003; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 1997, DEVELOPMENT, V124, P429; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Watanabe K, 2007, J BIOL CHEM, V282, P35772, DOI 10.1074/jbc.M707351200; Watanabe K, 2007, J BIOL CHEM, V282, P31643, DOI 10.1074/jbc.M702713200; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Xu CH, 1999, DEVELOPMENT, V126, P483; Xu CH, 2014, TUMOR BIOL, V35, P8673, DOI 10.1007/s13277-014-2039-1; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	67	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4138	4151		10.1074/jbc.M116.747501	http://dx.doi.org/10.1074/jbc.M116.747501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28126904	hybrid, Green Published			2022-12-26	WOS:000404672500002
J	Bu, PL; Le, Y; Zhang, Y; Zhang, YC; Cheng, XG				Bu, Pengli; Le, Yuan; Zhang, Yue; Zhang, Youcai; Cheng, Xingguo			Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B; COTRANSPORTING POLYPEPTIDE; GENE-EXPRESSION; D VIRUSES; LIVER; PROLACTIN; ABSORPTION; ENTRY; RATS; NTCP	Sodium-taurocholate co-transporting polypeptide (Ntcp/NTCP) is the major uptake transporter of bile salts in mouse and human livers. In certain diseases, including endotoxemia, cholestasis, diabetes, and hepatocarcinoma, Ntcp/NTCP expression is markedly reduced, which interferes with enterohepatic circulation of bile salts, impairing the absorption of lipophilic compounds. Therefore, normal Ntcp/NTCP expression in the liver is physiologically important. Berberine is an herbal medicine used historically to improve liver function and has recently been shown to repress STAT signaling. However, berberine effects on Ntcp/NTCP expression are unknown, prompting use to investigate this possible connection. Our results showed that berberine dose-dependently increased Ntcp expression in male mouse liver and decreased taurocholic acid levels in serum but increased them in the liver. In mouse and human hepatoma cells, berberine induced Ntcp/NTCP mRNA and protein expression and increased cellular uptake of [3H] taurocholate. Mechanistically, berberine decreased nuclear protein levels of phospho-JAK2 and phospho-STAT5, thus disrupting the JAK2-STAT5 signaling. Moreover, berberine stimulated luciferase reporter expression from the mouse Ntcp promoter when one putative STAT5 response element (RE) (-1137 bp) was deleted and from the human NTCP promoter when three putative STAT5REs (-2898, -2164, and -691 bp) were deleted. Chromatin immunoprecipitation demonstrated that berberine decreased binding of phospho-STAT5 protein to the -2164 and -691 bp STAT5REs in the human NTCP promoter. In summary, berberine-disrupted STAT5 signaling promoted mouse and human Ntcp/NTCP expression, resulting in enhanced bile acid uptake. Therefore, berberine may be a therapeutic candidate compound for maintaining bile acid homeostasis.	[Bu, Pengli; Le, Yuan; Zhang, Yue; Cheng, Xingguo] St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA; [Bu, Pengli] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA; [Zhang, Yue] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Saint John's University; Saint John's University; Tianjin University	Cheng, XG (corresponding author), St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA.	chengx@stjohns.edu	Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; Zhang, Yue/0000-0002-1161-0141	St. John's University	St. John's University	This work is supported in part by internal research funds including the new faculty start fund and a seed grant (to X. C.) from St. John's University. The authors declare that they have no conflicts of interest with the contents of this article.	Abd El-Wahab Abeer E, 2013, BMC Complement Altern Med, V13, P218, DOI 10.1186/1472-6882-13-218; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; Bollard J, 2017, GUT, V66, P1286, DOI 10.1136/gutjnl-2016-312268; Cao JS, 2001, ENDOCRINOLOGY, V142, P4212, DOI 10.1210/en.142.10.4212; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; GANGULY T, 1993, J PHARMACOL EXP THER, V267, P82; Ganguly TC, 1997, J CLIN INVEST, V99, P2906, DOI 10.1172/JCI119485; GANGULY TC, 1994, BIOCHEM J, V303, P33, DOI 10.1042/bj3030033; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Gartung C, 1996, GASTROENTEROLOGY, V110, P199, DOI 10.1053/gast.1996.v110.pm8536857; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; HAGENBUCH B, 1990, J BIOL CHEM, V265, P5357; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Jaffe CA, 1998, J CLIN INVEST, V102, P153, DOI 10.1172/JCI2908; Kang J, 2016, ONCOTARGET; Kim BH, 2011, BRIT J PHARMACOL, V164, P106, DOI 10.1111/j.1476-5381.2011.01353.x; Kumar A, 2015, EUR J PHARMACOL, V761, P288, DOI 10.1016/j.ejphar.2015.05.068; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Li YH, 2016, PHARMACOL RES, V110, P227, DOI 10.1016/j.phrs.2016.02.010; Liu J, 2014, TOXICOL SCI, V141, P538, DOI 10.1093/toxsci/kfu151; Liu XF, 2016, BIOMED PHARMACOTHER, V79, P222, DOI 10.1016/j.biopha.2016.02.015; LIU Y, 1995, AM J PHYSIOL-GASTR L, V268, pG11, DOI 10.1152/ajpgi.1995.268.1.G11; Newall CA., 1996, HERBAL MED GUIDE HLT; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Simon FR, 2004, AM J PHYSIOL-GASTR L, V287, pG782, DOI 10.1152/ajpgi.00379.2003; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhu T, 2015, AM J CHINESE MED, V43, P1487, DOI 10.1142/S0192415X15500846; Zollner G, 2005, LIVER INT, V25, P367, DOI 10.1111/j.1478-3231.2005.01033.x	42	10	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4602	4613		10.1074/jbc.M116.757567	http://dx.doi.org/10.1074/jbc.M116.757567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154180	Green Published, hybrid			2022-12-26	WOS:000397585100018
J	Wall, AA; Luo, L; Hung, Y; Tong, SJ; Condon, ND; Blumenthal, A; Sweet, MJ; Stow, JL				Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Blumenthal, Antje; Sweet, Matthew J.; Stow, Jennifer L.			Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase gamma Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED MACROPHAGES; GROWTH-FACTOR; PI3K-GAMMA; MTOR; PI3K; INFLAMMATION; DISCOVERY; RUFFLES; PATHWAY; BINDING	LPS-mediated activation of Toll-like receptor 4 (TLR4) in macrophages results in the coordinated release of proinflammatory cytokines, followed by regulatory mediators, to ensure that this potentially destructive pathway is tightly regulated. We showed previously that Rab8a recruits PI3K gamma for Akt-dependent signaling during TLR4 activation to limit the production of the proinflammatory cytokines IL-6 and IL-12p40 while enhancing the release of the regulatory/ anti-inflammatory cytokine IL-10. Here we broaden the array of immune receptors controlled by Rab8a-PI3K gamma and further define the Rab-mediated membrane domains required for signaling. With CRISPR/Cas9mediated gene editing to stably knock out and recover Rab8a in macrophage cell lines, we match Akt signaling profiles with cytokine outputs, confirming that Rab8a is a novel regulator of the Akt/mammalian target of rapamycin (mTOR) pathway downstream of multiple TLRs. Upondeveloping a Rab8a activation assay, weshow that TLR3 and 9 agonists also activate Rab8a. Live-cell imaging reveals that Rab8a is first recruited to the plasma membrane and dorsal ruffles, but it is retained during collapse of ruffles to form macropinosomes enriched for phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5) P3) and phosphatidylinositol 3,4-bisphosphate (PI(3,4) P-2), suggesting that the macropinosome is the location where Rab8a is active. We pinpoint macropinosomes as the sites for Rab8-mediated biasing of inflammatory signaling responses via inducible production of anti-inflammatory cytokines. Thus, Rab8a and PI3K gamma are positioned in multiple TLR pathways, and this signalingaxismayserveasapharmacologicallytractabletargetduring infection and inflammation.	[Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB, Brisbane, Qld 4072, Australia; [Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia; [Blumenthal, Antje] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland; University of Queensland	Stow, JL (corresponding author), Univ Queensland, IMB, Brisbane, Qld 4072, Australia.; Stow, JL (corresponding author), Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia.	j.stow@imb.uq.edu.au	Tong, Samuel/GPX-6390-2022; Sweet, Matthew J/F-2229-2011; Blumenthal, Antje/A-3608-2011; Wall, Adam/C-5985-2017; Luo, Lin/B-7845-2016; Stow, Jennifer/I-4723-2013	Tong, Samuel/0000-0002-4950-3544; Sweet, Matthew J/0000-0002-0406-8139; Blumenthal, Antje/0000-0003-3673-7015; Wall, Adam/0000-0001-8301-2899; Luo, Lin/0000-0001-5556-7096; Stow, Jennifer/0000-0002-5409-9101; Hung, Yu/0000-0003-1461-5287	National Health and Medical Research Council of Australia [APP1003021, APP1098710, APP1107914]; Australian Infectious Diseases Research Centre	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre	This work was supported by the National Health and Medical Research Council of Australia (Fellowship APP1003021 to J. L. S., Grant APP1098710 to J. L. S. and A. B., and Senior Research Fellowship APP1107914 to M. J. S.) and was supported by the Australian Infectious Diseases Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ariffin JK, 2016, ANTIMICROB AGENTS CH, V60, P1521, DOI 10.1128/AAC.01876-15; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Evans CA, 2016, ACS MED CHEM LETT, V7, P862, DOI 10.1021/acsmedchemlett.6b00238; Hagemann Nina, 2012, Small GTPases, V3, P107, DOI 10.4161/sgtp.19380; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HUME DA, 1982, ADV EXP MED BIOL, V155, P261; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Luo L, 2016, J BIOL CHEM, V291, P9411, DOI 10.1074/jbc.M115.703108; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Welliver TP, 2012, BIOL OPEN, V1, P754, DOI 10.1242/bio.20121784; Yeo JC, 2015, MOL BIOL CELL, V26, P952, DOI 10.1091/mbc.E14-10-1457; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207	38	38	38	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4411	4422		10.1074/jbc.M116.766337	http://dx.doi.org/10.1074/jbc.M116.766337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130450	Green Published, hybrid			2022-12-26	WOS:000397585100003
J	Choi, JW; Moon, S; Jang, EJ; Lee, CH; Park, JS				Choi, Jong Wook; Moon, Shinje; Jang, Eun Jung; Lee, Chang Hwa; Park, Joon-Sung			Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; CHRONIC KIDNEY-DISEASE; GENERAL-POPULATION; MENDELIAN RANDOMIZATION; GLUCOKINASE MUTATIONS; DIABETES-MELLITUS; RENAL-FAILURE; RISK; PREVALENCE; COMPLICATIONS	Increased glycemic exposure, even below the diagnostic criteria for diabetes mellitus, is crucial in the pathogenesis of diabetic microvascular complications represented by microalbuminuria. Nonetheless, there is limited evidence regarding which single nucleotide polymorphisms (SNPs) are associated with prediabetes and whether genetic predisposition to prediabetes is related to microalbuminuria, especially in the general population. Our objective was to answer these questions. We conducted a genomewide association study (GWAS) separately on two population-based cohorts, Ansung and Ansan, in the Korean Genome and Epidemiology Study (KoGES). The initial GWAS was carried out on the Ansung cohort, followed by a replication study on the Ansan cohort. A total of 5682 native Korean participants without a significant medical illness were classified into either control group (n = 3153) or prediabetic group (n = 2529). In the GWAS, we identified two susceptibility loci associated with prediabetes, one at 17p15.3-p15.1 in the GCK gene and another at 7p15.1 in YKT6. When variations in GCK and YKT6 were used as a model of prediabetes, this genetically determined prediabetes increased microalbuminuria. Multiple logistic regression analyses revealed that fasting glucose concentration in plasma and SNP rs2908289 in GCK were associated with microalbuminuria, and adjustment for age, gender, smoking history, systolic blood pressure, waist circumference, and serum triglyceride levels did not attenuate this association. Our results suggest that prediabetes and the associated SNPs may predispose to microalbuminuria before the diagnosis of diabetes mellitus. Further studies are needed to explore the details of the physiological and molecular mechanisms underlying this genetic association.	[Choi, Jong Wook; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Moon, Shinje] Hallym Univ, Coll Med, Div Endocrinol & Metab, Seoul, South Korea; [Jang, Eun Jung] Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea	Hanyang University; Hallym University; Korea Centers for Disease Control & Prevention (KCDC)	Lee, CH; Park, JS (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr						[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Brouwers MCGJ, 2015, TRENDS MOL MED, V21, P583, DOI 10.1016/j.molmed.2015.08.004; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Gu Y, 2011, TRANSL RES, V157, P111, DOI 10.1016/j.trsl.2010.11.003; HAFFNER SM, 1993, DIABETOLOGIA, V36, P1002, DOI 10.1007/BF02374491; Hishida A, 2014, J NEPHROL, V27, P143, DOI 10.1007/s40620-013-0025-0; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kim CH, 2014, DIABETES RES CLIN PR, V106, pE18, DOI 10.1016/j.diabres.2014.09.004; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kim Y, 2016, INT J EPIDEMIOL; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Kivimaki M, 2008, EUR HEART J, V29, P2552, DOI 10.1093/eurheartj/ehn252; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Krolewski AS, 2012, SEMIN NEPHROL, V32, P407, DOI 10.1016/j.semnephrol.2012.07.002; Li H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-24; Maeda S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000842; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Meigs JB, 2002, DIABETES CARE, V25, P977, DOI 10.2337/diacare.25.6.977; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Pezzolesi MG, 2009, DIABETES, V58, P2698, DOI 10.2337/db09-0641; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Ruiz-Martinez M., 2016, ONCOTARGET; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szopa M, 2015, EUR J ENDOCRINOL, V172, P277, DOI 10.1530/EJE-14-0713; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Wasada T, 1997, DIABETES RES CLIN PR, V34, P157, DOI 10.1016/S0168-8227(96)01348-4; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Won JB, 2014, EVID BASED COMP ALTE, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083273; Xu W, 2013, INT J MOL SCI, V14, P6467, DOI 10.3390/ijms14036467	44	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171367	10.1371/journal.pone.0171367	http://dx.doi.org/10.1371/journal.pone.0171367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158221	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700067
J	Baslam, M; Baroja-Fernandez, E; Ricarte-Bermejo, A; Sanchez-Lopez, AM; Aranjuelo, I; Bahaji, A; Munoz, FJ; Almagro, G; Pujol, P; Galarza, R; Teixidor, P; Pozueta-Romero, J				Baslam, Marouane; Baroja-Fernandez, Edurne; Ricarte-Bermejo, Adriana; Maria Sanchez-Lopez, Angela; Aranjuelo, Iker; Bahaji, Abdellatif; Jose Munoz, Francisco; Almagro, Goizeder; Pujol, Pablo; Galarza, Regina; Teixidor, Pilar; Pozueta-Romero, Javier			Genetic and isotope ratio mass spectrometric evidence for the occurrence of starch degradation and cycling in illuminated Arabidopsis leaves	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; NUCLEAR-MAGNETIC-RESONANCE; SUGAR-BEET LEAVES; MAIZE ROOT-TIPS; TRANSITORY STARCH; BETA-AMYLASE; FUTILE CYCLES; CARBOHYDRATE-METABOLISM; CIRCADIAN REGULATION; SUSPENSION-CULTURES	Although there is a great wealth of data supporting the occurrence of simultaneous synthesis and breakdown of storage carbohydrate in many organisms, previous (CO2)-C-13 pulse-chase based studies indicated that starch degradation does not operate in illuminated Arabidopsis leaves. Here we show that leaves of gwd, sex4, bam4, barn1/bam3 and amy3/isa3/Ida starch breakdown mutants accumulate higher levels of starch than wild type (WT) leaves when cultured under continuous light (CL) conditions. We also show that leaves of CL grown dpel plants impaired in the plastidic disproportionating enzyme accumulate higher levels of maltotriose than WT leaves, the overall data providing evidence for the occurrence of extensive starch degradation in illuminated leaves. Moreover, we show that leaves of CL grown mexl/ pglct plants impaired in the chloroplastic maltose and glucose transporters display a severe dwarf phenotype and accumulate high levels of maltose, strongly indicating that the MEX1 and pGIcT transporters are involved in the export of starch breakdown products to the cytosol to support growth during illumination. To investigate whether starch breakdown products can be recycled back to starch during illumination through a mechanism involving ADP-glucose pyrophosphorylase (AGP) we conducted kinetic analyses of the stable isotope carbon composition (delta C-13) in starch of leaves of (CO2)-C-13 pulsed-chased WT and AGP lacking aps1 plants. Notably, the rate of increase of delta C-13 in starch of aps1 leaves during the pulse was exceedingly higher than that of WT leaves. Furthermore, delta C-13 decline in starch of aps1 leaves during the chase was much faster than that of WT leaves, which provides strong evidence for the occurrence of AGP-mediated cycling of starch breakdown products in illuminated Arabidopsis leaves.	[Baslam, Marouane; Baroja-Fernandez, Edurne; Ricarte-Bermejo, Adriana; Maria Sanchez-Lopez, Angela; Aranjuelo, Iker; Bahaji, Abdellatif; Jose Munoz, Francisco; Almagro, Goizeder; Pozueta-Romero, Javier] UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Irunako Etorbidea 123, Mutiloabeti, Nafarroa, Spain; [Pujol, Pablo; Galarza, Regina] Univ Publ Navarra, Serv Apoyo Invest, Campus Arrosadia, Iruna, Nafarroa, Spain; [Teixidor, Pilar] Univ Barcelona, Ctr Cient & Tecnol, C Lluis Sole & Sabaris 1-3, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Universidad Publica de Navarra; University of Barcelona	Pozueta-Romero, J (corresponding author), UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Irunako Etorbidea 123, Mutiloabeti, Nafarroa, Spain.	javier.pozueta@unavarra.es	Bahaji, Abdellatif/C-4105-2015; Pozueta-Romero, Javier/AAP-9341-2021; Sánchez-López, Ángela María/Y-9884-2019; Edurne, Baroja-Fernandez/I-4037-2012; Pozueta-Romero, Javier/G-3766-2011; Muñoz, Francisco/I-3547-2012; Almagro, Goizeder/Y-9900-2019; Aranjuelo, Iker/N-5635-2019; BASLAM, Marouane/K-9312-2014	Bahaji, Abdellatif/0000-0002-5270-497X; Pozueta-Romero, Javier/0000-0002-0335-9663; Sánchez-López, Ángela María/0000-0001-9620-0258; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Pozueta-Romero, Javier/0000-0002-0335-9663; Muñoz, Francisco/0000-0002-0426-2118; Almagro, Goizeder/0000-0001-7035-9965; Aranjuelo, Iker/0000-0002-8231-5043; Ricarte-Bermejo, Adriana/0000-0003-3051-876X; BASLAM, Marouane/0000-0003-3598-7565	Comision Interministerial de Ciencia y Tecnologia; Fondo Europeo de Desarrollo Regional (Spain) [BIO2010-18239, BIO2013-49125-C2-1-P]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission)	Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) Grant numbers: BIO2010-18239 and BIO2013-49125-C2-1-P, http://www.mineco.gob.es/portal/site/mineco/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; Alonso AP, 2007, PHYTOCHEMISTRY, V68, P2222, DOI 10.1016/j.phytochem.2007.04.022; Alonso AP, 2005, PLANT PHYSIOL, V138, P2220, DOI 10.1104/pp.105.062083; Bago B, 1999, PLANT PHYSIOL, V121, P263, DOI 10.1104/pp.121.1.263; Bahaji A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119641; Bahaji A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104997; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P1162, DOI 10.1093/pcp/pcr067; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Boschker HTS, 2008, RAPID COMMUN MASS SP, V22, P3902, DOI 10.1002/rcm.3804; Bruggeman Q, 2015, PLANT CELL, V27, P1801, DOI 10.1105/tpc.15.00068; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; DAVID M, 1990, J CLIN INVEST, V86, P612, DOI 10.1172/JCI114752; DIEUAIDENOUBHANI M, 1995, J BIOL CHEM, V270, P13147, DOI 10.1074/jbc.270.22.13147; FONDY BR, 1985, PLANT PHYSIOL, V78, P753, DOI 10.1104/pp.78.4.753; Gamez-Arjona FM, 2011, PLANT BIOTECHNOL J, V9, P1049, DOI 10.1111/j.1467-7652.2011.00626.x; GAUDET G, 1992, EUR J BIOCHEM, V207, P155, DOI 10.1111/j.1432-1033.1992.tb17032.x; GEIGENBERGER P, 1991, PLANTA, V185, P81, DOI 10.1007/BF00194518; Guedon E, 2000, J BACTERIOL, V182, P2010, DOI 10.1128/JB.182.7.2010-2017.2000; Hausler RE, 1998, PLANTA, V204, P366, DOI 10.1007/s004250050268; HILL SA, 1994, PLANTA, V192, P52, DOI 10.1007/BF00198692; Jones ME, 2002, J THEOR BIOL, V217, P509, DOI 10.1006/jtbi.2002.3042; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kleczkowski LA, 2000, BBA-PROTEIN STRUCT M, V1476, P103, DOI 10.1016/S0167-4838(99)00229-0; Kleczkowski LA, 1999, FEBS LETT, V448, P153, DOI 10.1016/S0014-5793(99)00346-4; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; LEHMANN M, 1976, ARCH MICROBIOL, V111, P93, DOI 10.1007/BF00446554; LI B, 1992, PLANT PHYSIOL, V99, P1393, DOI 10.1104/pp.99.4.1393; Li J, 2012, PLANT CELL PHYSIOL, V53, P433, DOI 10.1093/pcp/pcr193; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; Lozovaya VV, 1996, PLANT PHYSIOL, V111, P921, DOI 10.1104/pp.111.3.921; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Sanchez-Lopez AM, 2016, PLANT PHYSIOL, V172, P1989, DOI 10.1104/pp.16.00945; MASSILLON D, 1995, J BIOL CHEM, V270, P19351, DOI 10.1074/jbc.270.33.19351; Matheron C, 1998, APPL ENVIRON MICROB, V64, P74; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Moerdijk-Poortvliet TCW, 2015, RAPID COMMUN MASS SP, V29, P1205, DOI 10.1002/rcm.7217; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; NAVAS MA, 1993, P NATL ACAD SCI USA, V90, P1290, DOI 10.1073/pnas.90.4.1290; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Portais JC, 2002, MICROBIOLOGY REV, V26, P375; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; RAO IM, 1995, PLANT PHYSIOL, V107, P1313, DOI 10.1104/pp.107.4.1313; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Sanchez-Lopez A M, 2016, PLANT CELL ENV; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Schneider A, 2002, PLANT J, V32, P685, DOI 10.1046/j.1365-313X.2002.01460.x; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; STITT M, 1981, BIOCHIM BIOPHYS ACTA, V638, P1, DOI 10.1016/0005-2728(81)90179-1; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Sun JD, 1999, PLANT PHYSIOL, V119, P267, DOI 10.1104/pp.119.1.267; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; WENDLER R, 1991, PLANTA, V183, P31, DOI 10.1007/BF00197564; Zanella M, 2016, J EXP BOT, V67, P1819, DOI 10.1093/jxb/erv572; Zeeman SC, 2002, PLANT PHYSIOL, V129, P516, DOI 10.1104/pp.003756; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319	76	15	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171245	10.1371/journal.pone.0171245	http://dx.doi.org/10.1371/journal.pone.0171245			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152100	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200114
J	Yasui, K; Sakai, K; Kano, T; Owaki, D; Ishiguro, A				Yasui, Kotaro; Sakai, Kazuhiko; Kano, Takeshi; Owaki, Dai; Ishiguro, Akio			Decentralized control scheme for myriapod robot inspired by adaptive and resilient centipede locomotion	PLOS ONE			English	Article							UNEVEN TERRAIN	Recently, myriapods have attracted the attention of engineers because mobile robots that mimic them potentially have the capability of producing highly stable, adaptive, and resilient behaviors. The major challenge here is to develop a control scheme that can coordinate their numerous legs in real time, and an autonomous decentralized control could be the key to solve this problem. Therefore, we focus on real centipedes and aim to design a decentralized control scheme for myriapod robots by drawing inspiration from behavioral experiments on centipede locomotion under unusual conditions. In the behavioral experiments, we observed the response to the removal of a part of the terrain and to amputation of several legs. Further, we determined that the ground reaction force is significant for generating rhythmic leg movements; the motion of each leg is likely affected by a sensory input from its neighboring legs. Thus, we constructed a two-dimensional model wherein a simple local reflexive mechanism was implemented in each leg. We performed simulations by using this model and demonstrated that the myriapod robot could move adaptively to changes in the environment and body properties. Our findings will shed new light on designing adaptive and resilient myriapod robots that can function under various circumstances.	[Yasui, Kotaro; Sakai, Kazuhiko; Kano, Takeshi; Owaki, Dai; Ishiguro, Akio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Ishiguro, Akio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Yasui, K (corresponding author), Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan.	k.yasui@riec.tohoku.ac.jp	Yasui, Kotaro/AEV-3178-2022	Owaki, Dai/0000-0003-1217-3892	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Science and Technology Agency, CREST http://www.jst.go.jp/kisoken/crest/en/index.html) to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/11/110001; Braga RR, 2008, BIOSIGNALS 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, VOL II, P58; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Dubey S., 2015, INT J APPL ENG RES, V10, P7357; Hoffman KL, 2011, IEEE INT C INT ROBOT, P1479, DOI 10.1109/IROS.2011.6048268; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Inagaki S, 2010, IEEE INT C INT ROBOT, P5341, DOI 10.1109/IROS.2010.5651324; Koh D, 2010, P IEEE RAS-EMBS INT, P877, DOI 10.1109/BIOROB.2010.5627776; Kuroda S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0205; Manton, 1977, ARTHROPODA HABITS FU; Matthey L, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1860, DOI 10.1109/IROS.2008.4650999; Maus HM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1073; Onat A, 2001, P 1 INT C INF TECHN, P191; Owaki D, 2010, IEEE INT CONF ROBOT, P5237, DOI 10.1109/ROBOT.2010.5509166; Pfeifer R., 2006, BODY SHAPES WAY WE T; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Umedachi T, 2010, BIOL CYBERN, V102, P261, DOI 10.1007/s00422-010-0367-9	17	11	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171421	10.1371/journal.pone.0171421	http://dx.doi.org/10.1371/journal.pone.0171421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152103	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200144
J	Hahnloser, RHR; Narula, G				Hahnloser, Richard H. R.; Narula, Gagan			A Bayesian Account of Vocal Adaptation to Pitch-Shifted Auditory Feedback	PLOS ONE			English	Article							RESPONSES; ERROR; VOCALIZATION; FREQUENCY; DYNAMICS; LEVEL	Motor systems are highly adaptive. Both birds and humans compensate for synthetically induced shifts in the pitch (fundamental frequency) of auditory feedback stemming from their vocalizations. Pitch-shift compensation is partial in the sense that large shifts lead to smaller relative compensatory adjustments of vocal pitch than small shifts. Also, compensa-tion is larger in subjects with high motor variability. To formulate a mechanistic description of these findings, we adapt a Bayesian model of error relevance. We assume that vocal-auditory feedback loops in the brain cope optimally with known sensory and motor variability. Based on measurements of motor variability, optimal compensatory responses in our model provide accurate fits to published experimental data. Optimal compensation correctly pre-dicts sensory acuity, which has been estimated in psychophysical experiments as justnoticeable pitch differences. Our model extends the utility of Bayesian approaches to adap-tive vocal behaviors.	[Hahnloser, Richard H. R.; Narula, Gagan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; ETH, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hahnloser, RHR; Narula, G (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	rich@ini.ethz.ch; gnarula@ini.ethz.ch		Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation Project [31003A_156976/1]	Swiss National Science Foundation Project(Swiss National Science Foundation (SNSF))	Support was provided by the Swiss National Science Foundation Project, 31003A_156976/1 [http://www.snf.ch/en/funding/projects/projects-in -all-disciplines/Pages/default. aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Alex Pouget, Homare Yamahachi, and Ryosuke Tachibana for helpful discussions and feedback on the manuscript and the support by the Swiss National Science Foundation, Project 31003A_1569761/1.	Bauer JJ, 2006, J ACOUST SOC AM, V119, P2363, DOI 10.1121/1.2173513; Bauer JJ, 2003, J ACOUST SOC AM, V114, P1048, DOI 10.1121/1.1592161; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Castro LNG, 2014, CURR BIOL, V24, P1050, DOI 10.1016/j.cub.2014.03.049; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2008, EXP BRAIN RES, V190, P279, DOI 10.1007/s00221-008-1473-y; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kelly CW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00075; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Liu C, 2013, J ACOUST SOC AM, V134, P3011, DOI 10.1121/1.4820887; Liu HJ, 2007, J ACOUST SOC AM, V122, P3671, DOI 10.1121/1.2800254; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Natke U, 2003, J ACOUST SOC AM, V113, P1587, DOI 10.1121/1.1543928; Scheerer NE, 2012, NEUROSCI LETT, V529, P128, DOI 10.1016/j.neulet.2012.09.012; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sober SJ, 2012, P NATL ACAD SCI USA, P1; Tokarev K, 2014, COLD SPRING HARB APR; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117901; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0169795	10.1371/journal.pone.0169795	http://dx.doi.org/10.1371/journal.pone.0169795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135267	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000396124700005
J	Khayyat, SM; Khayyat, SMS; Alhazmi, RSH; Mohamed, MMA; Hadi, MA				Khayyat, Sarah M.; Saeed Khayyat, Salwa M.; Hyat Alhazmi, Raghda S.; Mohamed, Mahmoud M. A.; Hadi, Muhammad Abdul			Predictors of Medication Adherence and Blood Pressure Control among Saudi Hypertensive Patients Attending Primary Care Clinics: A Cross-Sectional Study	PLOS ONE			English	Article							SCALE	Purpose To assess the level of medication adherence and to investigate predictors of medication adherence and blood pressure control among hypertensive patients attending primary healthcare clinics in Makkah, Saudi Arabia. Patients and methods Hypertensive patients meeting the eligibility criteria were recruited from eight primary care clinics between January and May 2016 for this study. The patients completed Arabic version of Morisky Medication Adherence Scale (MMAS-8), an eight-item validated, self-reported measure to assess medication adherence. A structured data collection form was used to record patients' sociodemographic, medical and medication data. Results Two hundred and four patients, of which 71.6% were females, participated in the study. Patients' mean age was 59.1 (SD 12.2). The mean number of medication used by patients was 4.4 (SD 1.89). More than half (110; 54%) of the patients were non-adherent to their medications (MMAS score < 6). Binary regression analysis showed that highly adherent patients (MMAS score = 8) were about five times (OR 4.91 [95% CI: 1.85-12.93; P = 0.01]) more likely to have controlled blood pressure compared to low adherent patients. Female gender (OR 0.40 [95% CI: 0.20-0.80; P = 0.01]), Age > 65 years (OR 2.0 [95% CI: 1.0-4.2; P = 0.04]), and being diabetic (OR 0.25 [95% CI: 0.1-0.6; P = 0.04]) were found to be independent predictors of medication adherence. Conclusion Medication adherence is alarmingly low among hypertensive patients attending primary care clinics in Saudi Arabia which may partly explain observed poor blood pressure control. There is a clear need to educate patients about the importance of medication adherence and its impact on improving clinical outcomes. Future research should identify barriers to medication adherence among Saudi hypertensive patients.	[Khayyat, Sarah M.; Mohamed, Mahmoud M. A.] Umm Al Qura Univ, Dept Clin Pharm, Fac Pharm, Mecca, Saudi Arabia; [Saeed Khayyat, Salwa M.; Hyat Alhazmi, Raghda S.] Minist Hlth, Publ Hlth Ctr, Mecca, Saudi Arabia; [Mohamed, Mahmoud M. A.] Umm Al Qura Univ, Pharmaceut Res Ctr, Deanship Sci Res, Mecca, Saudi Arabia; [Hadi, Muhammad Abdul] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England	Umm Al Qura University; Ministry of Health - Saudi Arabia; Umm Al Qura University; University of Leeds	Khayyat, SM (corresponding author), Umm Al Qura Univ, Dept Clin Pharm, Fac Pharm, Mecca, Saudi Arabia.	smkhayat@uqu.edu.sa	mohamed, mostafa/AFE-7371-2022; Hadi, Muhammad Abdul/AAL-7439-2020	mohamed, mostafa/0000-0002-1421-2667; Hadi, Muhammad Abdul/0000-0003-0108-7833; M. Khayyat, Sarah/0000-0002-0316-1825				Al Solami F.J.A., 2012, CLIN MED DIAGNOSTICS, V2, P27, DOI DOI 10.5923/J.CMD.20120204.02; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Al-Ramahi R, 2015, J EPIDEMIOL GLOB HEA, V5, P125, DOI 10.1016/j.jegh.2014.05.005; Al-Sowielem LS, 1998, E MEDITERR HEALTH J, V4, P301; Alhewiti Abdullah, 2014, Int J Family Med, V2014, P479596, DOI 10.1155/2014/479596; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Fernandez-Arias M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112875; Frisoli TM, 2011, EUR HEART J, V32, P3081, DOI 10.1093/eurheartj/ehr379; Hyre Amanda D, 2007, J Clin Hypertens (Greenwich), V9, P179, DOI 10.1111/j.1524-6175.2007.06372.x; Institute for Health Metrics and Evaluation (IHME), 2013, GBD ARR DIAGR SAUD A; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kang CD, 2015, INT J CARDIOL, V182, P250, DOI 10.1016/j.ijcard.2014.12.064; Khalil SA, 1997, J HYPERTENS, V15, P561, DOI 10.1097/00004872-199715050-00013; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Lehmann A, 2014, INT J CLIN PHARM-NET, V36, P55, DOI 10.1007/s11096-013-9865-x; Mahler C, 2012, J EVAL CLIN PRACT, V18, P409, DOI 10.1111/j.1365-2753.2010.01589.x; Mahmoud MIH, 2012, J TAIBAH UNIV MED SC, V7, P92, DOI 10.1016/j.jtumed.2012.11.004; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Meinema JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133560; Mohammad Y, 2016, J EPIDEMIOL GLOB HEA, V6, P157, DOI 10.1016/j.jegh.2015.07.002; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; National Institute for Health and Care Excellence (NICE), 2011, HYP AD DIAGN MAN NIC; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Oliveira AD, 2012, ARQ BRAS CARDIOL, V99, P649, DOI 10.1590/S0066-782X2012005000053; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Phatak HM, 2006, ANN PHARMACOTHER, V40, P1737, DOI 10.1345/aph.1H153; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Saeed AA, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/174135; WHO, 2013, WHODCOWHD20132; World Health Organization, 2003, ADHERENCE LONG TERM	34	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171255	10.1371/journal.pone.0171255	http://dx.doi.org/10.1371/journal.pone.0171255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135324	Green Published, gold			2022-12-26	WOS:000396124700056
J	Baba, SA; Vishwakarma, RA; Ashraf, N				Baba, Shoib Ahmad; Vishwakarma, Ram A.; Ashraf, Nasheeman			Functional Characterization of CsBGlu12, a beta-Glucosidase from Crocus sativus, Provides Insights into Its Role in Abiotic Stress through Accumulation of Antioxidant Flavonols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SCAVENGING ACTIVITY; CELL-SUSPENSION CULTURES; MANIHOT-ESCULENTA CRANTZ; MOLECULAR CHARACTERIZATION; ALKALOID BIOSYNTHESIS; DROUGHT TOLERANCE; ACTIVE-SITE; ARABIDOPSIS; EXPRESSION; GLUCOSYLTRANSFERASE	Glycosylation and deglycosylation are impressive mechanisms that allow plants to regulate the biological activity of an array of secondary metabolites. Although glycosylation improves solubility and renders the metabolites suitable for transport and sequestration, deglycosylation activates them to carry out biological functions. Herein, we report the functional characterization of CsBGlu12, a beta-glucosidase from Crocus sativus. CsBGlu12 has a characteristic glucoside hydrolase 1 family (alpha/beta) 8 triose-phosphate isomerase (TIM) barrel structure with a highly conserved active site. In vitro enzyme activity revealed that CsBGlu12 catalyzes the hydrolysis of flavonol beta-glucosides and cello-oligosaccharides. Site-directed mutagenesis of any of the two conserved catalytic glutamic acid residues (Glu(200) and Glu(414)) of the active site completely abolishes the beta-glucosidase activity. Transcript analysis revealed that Csbglu12 is highly induced in response to UV-B, dehydration, NaCl, methyl jasmonate, and abscisic acid treatments indicating its possible role in plant stress response. Transient overexpression of CsBGlu12 leads to the accumulation of antioxidant flavonols in Nicotiana benthamiana and confers tolerance to abiotic stresses. Antioxidant assays indicated that accumulation of flavonols alleviated the accretion of reactive oxygen species during abiotic stress conditions. beta-Glucosidases are known to play a role in abiotic stresses, particularly dehydration through abscisic acid; however, their role through accumulation of reactive oxygen species (ROS) scavenging flavonols has not been established. Furthermore, only one beta-glucosidase 12 homolog has been characterized so far. Therefore, this work presents an important report on characterization of CsBGlu12 and its role in abiotic stress through ROS scavenging.	[Baba, Shoib Ahmad; Ashraf, Nasheeman] Indian Inst Integrat Med, CSIR, Plant Biotechnol Div, Srinagar 190005, Jammu & Kashmir, India; [Baba, Shoib Ahmad; Ashraf, Nasheeman] Indian Inst Integrat Med, CSIR, Acad Sci & Innovat Res, Canal Rd, Jammu 180001, India; [Vishwakarma, Ram A.] Indian Inst Integrat Med, CSIR, Div Med Chem, Canal Rd, Jammu 180001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Ashraf, N (corresponding author), Indian Inst Integrat Med, Srinagar 190005, Jammu & Kashmir, India.	nashraf@iiim.ac.in	Baba, Shoib/AAA-5264-2022	Baba, Shoib Ahmad/0000-0002-4106-994X	Grant SIMPLE Council of Scientific and Industrial Research and MLP [BSC-0109]; Indian Institute of Integrative Medicine [MLP 3012]	Grant SIMPLE Council of Scientific and Industrial Research and MLP; Indian Institute of Integrative Medicine	This work was supported by Grant SIMPLE (BSC-0109) from the Council of Scientific and Industrial Research and MLP 3012 from Indian Institute of Integrative Medicine. This paper has institutional manuscript number IIIM/1993/2017. The authors declare that they have no conflicts of interest with the contents of this article.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Ashraf N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0423-7; Baba SA, 2015, J PLANT PHYSIOL, V189, P114, DOI 10.1016/j.jplph.2015.11.001; Baba SA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1894-5; Baba SA, 2015, S AFR J BOT, V99, P80, DOI 10.1016/j.sajb.2015.03.194; Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; Cairns JRK, 2015, PLANT SCI, V241, P246, DOI 10.1016/j.plantsci.2015.10.014; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Djilianov D, 2011, PLANT BIOLOGY, V13, P767, DOI 10.1111/j.1438-8677.2010.00436.x; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; GRAHAM TL, 1990, MOL PLANT MICROBE IN, V3, P157, DOI 10.1094/MPMI-3-157; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; HEMSCHEIDT T, 1980, FEBS LETT, V110, P187, DOI 10.1016/0014-5793(80)80069-X; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Jones PR, 2000, RECENT ADV PHYTOCHEM, V34, P191, DOI 10.1016/S0079-9920(00)80008-8; Keresztessy Z, 2001, BIOCHEM J, V353, P199, DOI 10.1042/0264-6021:3530199; KERESZTESSY Z, 1994, ARCH BIOCHEM BIOPHYS, V315, P323, DOI 10.1006/abbi.1994.1507; KLECZKOWSKI K, 1995, CRIT REV PLANT SCI, V14, P283, DOI 10.1080/07352689509382361; Koudounas K, 2015, J EXP BOT, V66, P2093, DOI 10.1093/jxb/erv002; Le Roy J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00735; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; MACKENBROCK U, 1991, Z NATURFORSCH C, V46, P43; Middleton E, 1994, IMPACT PLANT FLAVONO, P619; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nakabayashi R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29518; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Nakajima J, 2004, J BIOMED BIOTECHNOL, P241, DOI 10.1155/S1110724304404045; NISIUS A, 1988, PLANTA, V173, P474, DOI 10.1007/BF00958960; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; Opassiri R, 2010, PLANT SCI, V179, P273, DOI 10.1016/j.plantsci.2010.05.013; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roepke J, 2015, PHYTOCHEMISTRY, V109, P14, DOI 10.1016/j.phytochem.2014.10.028; Roepke J, 2013, CHEMBIOCHEM, V14, P2418, DOI 10.1002/cbic.201300474; Rouyi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096712; Moraga AR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-109; Rubio-Moraga A, 2010, PHYTOCHEMISTRY, V71, P1506, DOI 10.1016/j.phytochem.2010.05.026; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Samappito S, 2002, PLANTA, V216, P64, DOI 10.1007/s00425-002-0872-8; Sansenya S, 2011, ARCH BIOCHEM BIOPHYS, V510, P62, DOI 10.1016/j.abb.2011.04.005; Scarpeci TE, 2008, PLANT GROWTH REGUL, V54, P133, DOI 10.1007/s10725-007-9236-5; SCHUBEL H, 1986, HELV CHIM ACTA, V69, P538, DOI 10.1002/hlca.19860690303; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tohge T, 2005, BIOTECHNOL LETT, V27, P297, DOI 10.1007/s10529-005-0683-7; Trapero A, 2012, PLANT PHYSIOL, V159, P1335, DOI 10.1104/pp.112.198069; Tringali C, 2003, BIOACTIVE COMPOUNDS; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Yoo D, 2013, PLANT SCI, V208, P10, DOI 10.1016/j.plantsci.2013.03.006	65	29	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4700	4713		10.1074/jbc.M116.762161	http://dx.doi.org/10.1074/jbc.M116.762161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154174	Green Published, hybrid			2022-12-26	WOS:000397585100026
J	Paumann-Page, M; Katz, RS; Bellei, M; Schwartz, I; Edenhofer, E; Sevcnikar, B; Soudi, M; Hofbauer, S; Battistuzzi, G; Furtmuller, PG; Obinger, C				Paumann-Page, Martina; Katz, Romy-Sophie; Bellei, Marzia; Schwartz, Irene; Edenhofer, Eva; Sevcnikar, Benjamin; Soudi, Monika; Hofbauer, Stefan; Battistuzzi, Gianantonio; Furtmueller, Paul G.; Obinger, Christian			Pre-steady-state Kinetics Reveal the Substrate Specificity and Mechanism of Halide Oxidation of Truncated Human Peroxidasin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT HEME-BINDING; HUMAN MYELOPEROXIDASE; COLLAGEN-IV; COMPOUND-I; REDOX THERMODYNAMICS; MAMMALIAN PEROXIDASES; BACTERIAL PEROXIDASE; PROSTHETIC GROUP; PROTEIN BONDS; HIGH-SPIN	Human peroxidasin 1 is a homotrimeric multidomain peroxidase that is secreted to the extracellular matrix. The heme enzyme was shown to release hypobromous acid that mediates the formation of specific covalent sulfilimine bonds to reinforce collagen IV in basement membranes. Maturation by proteolytic cleavage is known to activate the enzyme. Here, we present the first multimixing stopped-flow study on a fully functional truncated variant of human peroxidasin 1 comprising four immunoglobulin-like domains and the catalytically active peroxidase domain. The kinetic data unravel the so far unknown substrate specificity and mechanism of halide oxidation of human peroxidasin 1. The heme enzyme is shown to follow the halogenation cycle that is induced by the rapid H2O2-mediated oxidation of the ferric enzyme to the redox intermediate compound I. We demonstrate that chloride cannot act as a two-electron donor of compound I, whereas thiocyanate, iodide, and bromide efficiently restore the ferric resting state. We present all relevant apparent bimolecular rate constants, the spectral signatures of the redox intermediates, and the standard reduction potential of the Fe(III)/Fe(II) couple, and we demonstrate that the prosthetic heme group is post-translationally modified and cross-linked with the protein. These structural features provide the basis of human peroxidasin 1 to act as an effective generator of hypobromous acid, which mediates the formation of covalent cross-links in collagen IV.	[Paumann-Page, Martina; Katz, Romy-Sophie; Schwartz, Irene; Edenhofer, Eva; Sevcnikar, Benjamin; Soudi, Monika; Hofbauer, Stefan; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy; [Bellei, Marzia; Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, I-41125 Modena, Italy	University of Natural Resources & Life Sciences, Vienna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Furtmuller, PG; Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	paul.furtmueller@boku.ac.at; christian.obinger@boku.ac.at	Battistuzzi, Gianantonio/L-7183-2015; Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Hofbauer, Stefan/I-3889-2014	Battistuzzi, Gianantonio/0000-0003-4716-5745; Furtmüller, Paul G./0000-0002-1199-2469; Hofbauer, Stefan/0000-0003-3375-7715; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund [P25538]; Biomolecular Technology of Proteins (BioToP) [FWF W1224]	Austrian Science Fund(Austrian Science Fund (FWF)); Biomolecular Technology of Proteins (BioToP)	This work was supported by Austrian Science Fund Project P25538 and Doctoral Program Biomolecular Technology of Proteins (BioToP) FWF W1224. The authors declare that they have no conflicts of interest with the contents of this article.	ASMUSSEN I, 1979, Clinical Cardiology, V2, P246; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Battistuzzi G, 2002, J AM CHEM SOC, V124, P26, DOI 10.1021/ja017188m; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Colon S, 2016, J BIOL CHEM, V291, P24009, DOI 10.1074/jbc.M116.745935; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Hawkins CL, 2009, FREE RADICAL RES, V43, P1147, DOI 10.3109/10715760903214462; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; Singh PK, 2017, BBA-PROTEINS PROTEOM, V1865, P329, DOI 10.1016/j.bbapap.2016.12.006; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Soudi M, 2012, CHEM BIODIVERS, V9, P1776, DOI 10.1002/cbdv.201100438; Tsuge K, 2000, J HEALTH SCI, V46, P343; VANLEEUWEN FXR, 1987, CRIT REV TOXICOL, V18, P189, DOI 10.3109/10408448709089861; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	38	28	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4583	4592		10.1074/jbc.M117.775213	http://dx.doi.org/10.1074/jbc.M117.775213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154175	Green Published, hybrid			2022-12-26	WOS:000397585100016
J	Su, WP; Foster, SC; Xing, RB; Feistel, K; Olsen, RHJ; Acevedo, SF; Raber, J; Sherman, LS				Su, Weiping; Foster, Scott C.; Xing, Rubing; Feistel, Kerstin; Olsen, Reid H. J.; Acevedo, Summer F.; Raber, Jacob; Sherman, Larry S.			CD44 Transmembrane Receptor and Hyaluronan Regulate Adult Hippocampal Neural Stem Cell Quiescence and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE PROGENITOR MATURATION; DENTATE GYRUS; EXTRACELLULAR-MATRIX; GRANULE CELLS; STATUS EPILEPTICUS; STEM/PROGENITOR CELLS; SYNAPTIC PLASTICITY; IN-VITRO; NEUROGENESIS; BRAIN	Adult neurogenesis in the hippocampal subgranular zone (SGZ) is involved in learning and memory throughout life but declines with aging. Mice lacking the CD44 transmembrane receptor for the glycosaminoglycan hyaluronan (HA) demonstrate a number of neurological disturbances including hippocampal memory deficits, implicating CD44 in the processes underlying hippocampal memory encoding, storage, or retrieval. Here, we found that HA and CD44 play important roles in regulating adult neurogenesis, and we provide evidence that HA contributes to age-related reductions in neural stem cell (NSC) expansion and differentiation in the hippocampus. CD44-expressing NSCs isolated from the mouse SGZ are selfrenewing and capable of differentiating into neurons, astrocytes, and oligodendrocytes. Mice lacking CD44 demonstrate increases in NSC proliferation in the SGZ. This increased proliferation is also observed in NSCs grown in vitro, suggesting that CD44 functions to regulate NSC proliferation in a cell-autonomous manner. HA is synthesized by NSCs and increases in the SGZ with aging. TreatingwildtypebutnotCD44-null NSCs with HAinhibits NSC proliferation. HAdigestion in wild type NSC cultures or in the SGZinducesincreased NSC proliferation, andCD44-nullaswellas HA-disrupted wild type NSCs demonstrate delayed neuronal differentiation. HA therefore signals through CD44 to regulate NSC quiescence and differentiation, and HA accumulation in the SGZ may contribute to reductions in neurogenesis that are linked to age-related decline in spatial memory.	[Su, Weiping; Foster, Scott C.; Xing, Rubing; Feistel, Kerstin; Raber, Jacob; Sherman, Larry S.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, 505 NW 185th Ave, Beaverton, OR 97006 USA; [Feistel, Kerstin] Univ Hohenheim, Inst Zool, Garbenstr 30, D-70593 Stuttgart, Germany; [Olsen, Reid H. J.; Acevedo, Summer F.; Raber, Jacob] Oregon Hlth & Sci Univ, Sch Med, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol & Radiat Med, Portland, OR 97239 USA; [Sherman, Larry S.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon National Primate Research Center; University Hohenheim; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Sherman, LS (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	shermanl@ohsu.edu	su, wei/GZM-3986-2022	Feistel, Kerstin/0000-0003-3397-8972	National Institutes of Health [RR00163, P30-NS061800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS056234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Steven Matsumoto for helpful comments. The Oregon National Primate Research Center was supported by Core Grant RR00163 from the National Institutes of Health. The imaging core at the Oregon National Primate Research Center was supported by Grant P30-NS061800 from the National Institutes of Health.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Arranz AM, 2014, J NEUROSCI, V34, P6164, DOI 10.1523/JNEUROSCI.3458-13.2014; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Barzilay R, 2016, J MOL NEUROSCI, V60, P548, DOI 10.1007/s12031-016-0835-3; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bausch SB, 2006, NEUROSCIENCE, V143, P339, DOI 10.1016/j.neuroscience.2006.07.037; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Cargill R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.006; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; FUXE K, 1994, NEUROSCI LETT, V169, P25, DOI 10.1016/0304-3940(94)90348-4; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; JENKINS HG, 1988, J NEUROCHEM, V51, P1641, DOI 10.1111/j.1471-4159.1988.tb01135.x; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jiruska P, 2013, NEUROBIOL DIS, V54, P492, DOI 10.1016/j.nbd.2013.02.001; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lauren HB, 2013, BRAIN RES, V1516, P33, DOI 10.1016/j.brainres.2013.04.028; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; McRae PA, 2012, EUR J NEUROSCI, V36, P3471, DOI 10.1111/j.1460-9568.2012.08268.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x; Pan Y. W., 2012, PLOS ONE, V7; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165; Raber J, 2014, BEHAV BRAIN RES, V275, P146, DOI 10.1016/j.bbr.2014.09.010; Roszkowska M, 2016, MOL BIOL CELL, V27, P4055, DOI 10.1091/mbc.E16-06-0423; Rotheneichner P, 2013, EPILEPSIA, V54, P40, DOI 10.1111/epi.12274; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Steindler DA, 2012, METHODS MOL BIOL, V814, P9, DOI 10.1007/978-1-61779-452-0_2; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Su WP, 2004, GLIA, V45, P297, DOI 10.1002/glia.10340; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; SUZUKI K, 1965, J NEUROPATH EXP NEUR, V24, P211, DOI 10.1097/00005072-196504000-00004; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	61	44	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4434	4445		10.1074/jbc.M116.774109	http://dx.doi.org/10.1074/jbc.M116.774109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154169	Green Published, hybrid			2022-12-26	WOS:000397585100005
J	Bilotta, GS; Burnside, NG; Turley, MD; Gray, JC; Orr, HG				Bilotta, Gary S.; Burnside, Niall G.; Turley, Matthew D.; Gray, Jeremy C.; Orr, Harriet G.			The effects of run-of-river hydroelectric power schemes on invertebrate community composition in temperate streams and rivers	PLOS ONE			English	Article							MACROINVERTEBRATES; HYDROPOWER; DAMS; IMPACTS; PASSAGE; WORLD	Run-of-river (ROR) hydroelectric power (HEP) schemes are often presumed to be less ecologically damaging than large-scale storage HEP schemes. However, there is currently limited scientific evidence on their ecological impact. The aim of this article is to investigate the effects of ROR HEP schemes on communities of invertebrates in temperate streams and rivers, using a multi-site Before-After, Control-Impact (BACI) study design. The study makes use of routine environmental surveillance data collected as part of long-term national and international monitoring programmes at 22 systematically-selected ROR HEP schemes and 22 systematically-selected paired control sites. Five widely-used family-level invertebrate metrics (richness, evenness, LIFE, E-PSI, WHPT) were analysed using a linear mixed effects model. The analyses showed that there was a statistically significant effect (p<0.05) of ROR HEP construction and operation on the evenness of the invertebrate community. However, no statistically significant effects were detected on the four other metrics of community composition. The implications of these findings are discussed in this article and recommendations are made for best-practice study design for future invertebrate community impact studies.	[Bilotta, Gary S.; Burnside, Niall G.; Turley, Matthew D.] Univ Brighton, Aquat Res Ctr, Sch Environm & Technol, Brighton, E Sussex, England; [Gray, Jeremy C.] Precima Inc, Toronto, ON, Canada; [Orr, Harriet G.] Environm Agcy, Bristol, Avon, England	University of Brighton	Bilotta, GS (corresponding author), Univ Brighton, Aquat Res Ctr, Sch Environm & Technol, Brighton, E Sussex, England.	G.S.Bilotta@brighton.ac.uk	Orr, Harriet/AAP-2665-2020	Burnside, Niall/0000-0002-0416-1608; Orr, Harriet/0000-0001-5021-1074; Bilotta, Gary/0000-0003-1935-9040	Natural Environment Research Council; Environment Agency [NE/M019810/1]; NERC [NE/M019810/1] Funding Source: UKRI; Natural Environment Research Council [NE/M019810/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Environment Agency; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was co-funded by the Natural Environment Research Council (http://www.nerc.ac.uk,/) and the Environment Agency (https://www.gov.uk/government/organisations/environment-agency) under grant reference NE/M019810/1. Only GSB received the funding for this work. The Environment Agency had a role in the original collection of the routine surveillance monitoring data used in this study, though it was not collected specifically for the purposes of this study. The study was designed by GSB and it was his decision to publish the work. HGO (an employee of the Environment Agency funding body) did contribute towards the preparation of the manuscript. JCG is employed by Precima Incorporated. The funder provided support in the form of salaries for authors [JCG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasi T, 2011, RENEW SUST ENERG REV, V15, P2134, DOI 10.1016/j.rser.2010.11.050; Anderson D, 2015, WATER ENVIRON J, V29, P268, DOI 10.1111/wej.12101; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Bilotta GS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154271; Bilotta GS, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-015-0041-x; British Hydropower Association, 2005, GUID UK MIN DEV; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COOK SEK, 1976, ENVIRON POLLUT, V11, P269, DOI 10.1016/0013-9327(76)90067-7; Coutant CC, 2000, T AM FISH SOC, V129, P351, DOI 10.1577/1548-8659(2000)129<0351:FBIRTP>2.0.CO;2; Environment Agency, 2013, TECHNICAL REPORT; Environment Agency, RIV OBSTR DAT ENGL W; Environment Agency, 2009, FRESHW MACR INV SAMP; Extence CA, 2013, RIVER RES APPL, V29, P17, DOI 10.1002/rra.1569; Extence CA, 1999, REGUL RIVER, V15, P543, DOI 10.1002/(SICI)1099-1646(199911/12)15:6&lt;545::AID-RRR561&gt;3.0.CO;2-W; Feld CK, 2014, FRESHWATER BIOL, V59, P233, DOI 10.1111/fwb.12260; Fidler F, 2006, CONSERV BIOL, V20, P1539, DOI 10.1111/j.1523-1739.2006.00525.x; Fthenakis V, 2010, RENEW SUST ENERG REV, V14, P2039, DOI 10.1016/j.rser.2010.03.008; Hutchinson TH, 1998, CHEMOSPHERE, V36, P129, DOI 10.1016/S0045-6535(97)10025-X; International Energy Agency, 2012, WORLD EN OUTL 2012; Kumar A., 2011, IPCC SPECIAL REPORT; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Mekonnen MM, 2015, ENVIRON SCI-WAT RES, V1, P285, DOI [10.1039/c5ew00026b, 10.1039/C5EW00026B]; Moomaw W., 2011, IPCC SPECIAL REPORT; Paish O, 2002, P I MECH ENG A-J POW, V216, P31, DOI 10.1243/095765002760024827; Paisley MF, 2014, RIVER RES APPL, V30, P887, DOI 10.1002/rra.2686; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; Pielou E., 1977, MATH ECOLOGY; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; PRATT JM, 1976, WATER RES, V10, P1019, DOI 10.1016/0043-1354(76)90083-X; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Robson AL, 2013, THESIS; Schilt CR, 2007, APPL ANIM BEHAV SCI, V104, P295, DOI 10.1016/j.applanim.2006.09.004; Stroup WW., 1997, P BIOPH SECT AM STAT, P15; Turley MD, 2016, ECOL INDIC, V70, P151, DOI 10.1016/j.ecolind.2016.05.040; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	38	15	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171634	10.1371/journal.pone.0171634	http://dx.doi.org/10.1371/journal.pone.0171634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158282	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700117
J	Caminha, C; Furtado, V; Pequeno, THC; Ponte, C; Melo, HPM; Oliveira, EA; Andrade, JS				Caminha, Carlos; Furtado, Vasco; Pequeno, Tarcisio H. C.; Ponte, Caio; Melo, Hygor P. M.; Oliveira, Erneson A.; Andrade, Jose S., Jr.			Human mobility in large cities as a proxy for crime	PLOS ONE			English	Article							GROWTH; POPULATION; LAWS	We investigate at the subscale of the neighborhoods of a highly populated city the incidence of property crimes in terms of both the resident and the floating population. Our results show that a relevant allometric relation could only be observed between property crimes and floating population. More precisely, the evidence of a superlinear behavior indicates that a disproportional number of property crimes occurs in regions where an increased flow of people takes place in the city. For comparison, we also found that the number of crimes of peace disturbance only correlates well, and in a superlinear fashion too, with the resident population. Our study raises the interesting possibility that the super-linearity observed in previous studies [Bettencourt et al., Proc. Natl. Acad. Sci. USA 104, 7301 (2007) and Melo et al., Sci. Rep. 4, 6239 (2014)] for homicides versus population at the city scale could have its origin in the fact that the floating population, and not the resident one, should be taken as the relevant variable determining the intrinsic microdynamical behavior of the system.	[Caminha, Carlos; Furtado, Vasco; Pequeno, Tarcisio H. C.; Ponte, Caio; Oliveira, Erneson A.] Univ Fortaleza, Programa Pos Grad Informat Aplicada, Fortaleza, Ceara, Brazil; [Melo, Hygor P. M.] Inst Fed Educ Ciencia & Tecnol Ceara, Dept Ensino, Crateus, Ceara, Brazil; [Melo, Hygor P. M.; Oliveira, Erneson A.; Andrade, Jose S., Jr.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Instituto Federal do Ceara (IFCE); Universidade Federal do Ceara	Caminha, C (corresponding author), Univ Fortaleza, Programa Pos Grad Informat Aplicada, Fortaleza, Ceara, Brazil.	caminha@unifor.br	Furtado, Vasco/AAB-8318-2019; Melo, Hygor Piaget Monteiro/AAY-1792-2020; Andrade, José S/C-5451-2013; Furtado, Vasco/C-3748-2013	Furtado, Vasco/0000-0001-8721-4308; Melo, Hygor Piaget Monteiro/0000-0002-2507-4511; Andrade, José S/0000-0002-5571-7610; Furtado, Vasco/0000-0001-8721-4308	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico; National Institute of Science and Technology for Complex Systems	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); National Institute of Science and Technology for Complex Systems	JSA, CC, VF, THCP, CP, EAO and HPMM have been funded by the Brazilian Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (www.funcap.ce.gov.br). JSA has also been funded by the National Institute of Science and Technology for Complex Systems (www.cbpf.br/inct-sc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/18002; Alves LGA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134862; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150691; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Brantingham P.L., 1981, ENV CRIMINOLOGY, P27; Caminha C., 2012, P 21 INT WORLD WID W; Clarke RV, 1993, ADV CRIMINOLOGICAL T; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Cottineau C, 2016, ARXIV160105664; D'Orsogna MR, 2015, PHYS LIFE REV, V12, P1, DOI 10.1016/j.plrev.2014.11.001; Duranton G., 2013, GROWTH CITIES; Duranton G, 2015, ADV JPN BUS ECON, V4, P107, DOI 10.1007/978-4-431-55390-8_6; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Felson M., 2019, CRIME EVERYDAY LIFE, V6th; Furtado V, 2012, IEEE INTELL SYST, V27, P63, DOI 10.1109/MIS.2012.80; Gallos LK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00454; Giesen K, 2010, J URBAN ECON, V68, P129, DOI 10.1016/j.jue.2010.03.007; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Guedes R, 2014, INT SEC INF C JISIC, P288; Hanley QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149546; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Kiani R., 2015, ANALYSIS, V4; Kinney J. B., 2008, BUILD ENVIRON, V34, P62, DOI [10.2148/benv.34.1.62, DOI 10.2148/BENV.34.1.62]; Kleiber M, 1932, ENE-REV ENFERM, V1, pE9; Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Michael J, 1933, INT LIB PSYCHOL PHIL; Montgomery D.C., 2015, INTRO LINEAR REGRESS; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Rapoport A., 1963, GEN SYSTEMS; Rawlings JO., 2001, APPL REGRESSION ANAL; Roman C., 2005, GEOGRAPHIC INFORM SY, P293, DOI [10.4018/978-1-59140-453-8.ch017, DOI 10.4018/978-1-59140-453-8.CH017]; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Taylor R. B., 1996, PHYS ENV CRIME; Wang T., 2013, LEARNING DETECT PATT, P515; Watson G.S, 1964, SANKHYA A, P359, DOI DOI 10.2307/25049340	47	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171609	10.1371/journal.pone.0171609	http://dx.doi.org/10.1371/journal.pone.0171609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158268	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700111
J	Holder, MK; Blaustein, JD				Holder, Mary K.; Blaustein, Jeffrey D.			Developmental time course and effects of immunostressors that alter hormone-responsive behavior on microglia in the peripubertal and adult female mouse brain	PLOS ONE			English	Article							CONDITIONED AVOIDANCE RESPONSES; ESTROGEN-RECEPTOR-ALPHA; VENTROMEDIAL NUCLEUS; ADOLESCENT PSYCHOPATHOLOGY; ESTRADIOL REPLACEMENT; OVARIECTOMIZED RATS; GENDER DIFFERENCES; OVARIAN HORMONES; IMMUNE CHALLENGE; LORDOSIS REFLEX	In female mice, the experience of being shipped from the breeder facility or a single injection of the bacterial endotoxin, lipopolysaccharide (LPS), during pubertal development alters the behavioral response to estradiol in adulthood as demonstrated by perturbations of estradiol's effects on sexual behavior, cognitive function, as well as its anxiolytic and anti-depressive properties. Microglia, the primary type of immunocompetent cell within the brain, contribute to brain development and respond to stressors with marked and long-lasting morphological and functional changes. Here, we describe the morphology of microglia and their response to shipping and LPS in peripubertal and adult female mice. Peripubertal mice have more microglia with long, thick processes in the hippocampus, amygdala and hypothalamus as compared with adult mice in the absence of an immune challenge. An immune challenge also increases immunoreactivity (IR) of ionized calcium binding adaptor molecule 1 (Iba1), which is constitutively expressed in microglia. In the hippocampus, the age of animal was without effect on the increase in Iba1-IR following shipping from the breeder facility or LPS exposure. In the amygdala, we observed more Iba1-IR following shipping or LPS treatment in peripubertal mice, compared to adult mice. In the hypothalamus, there was a disassociation of the effects of shipping and LPS treatment as LPS treatment, but not shipping, induced an increase in Iba1-IR. Taken together these data indicate that microglial morphologies differ between pubertal and adult mice; moreover, the microglial response to complex stressors is greater in pubertal mice as compared to adult mice.	[Holder, Mary K.; Blaustein, Jeffrey D.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Holder, Mary K.; Blaustein, Jeffrey D.] Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA; [Holder, Mary K.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; Georgia State University	Holder, MK (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA.; Holder, MK (corresponding author), Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA.; Holder, MK (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	mconklin@gsu.edu		Holder, Mary/0000-0003-3585-1094	National Institutes of Mental Health [R21 MH093854]; National Science Foundation [IOS 1050179]; Division Of Integrative Organismal Systems [1050179] Funding Source: National Science Foundation	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Institutes of Mental Health (http://www.nimh.nih.gov/index.shtml) grant R21 MH093854 and National Science Foundation (http://www.nsf.gov/) IOS 1050179 awarded to Jeffrey D. Blaustein. The funding agencies played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Angold A, 2006, CHILD ADOL PSYCH CL, V15, P919, DOI 10.1016/j.chc.2006.05.013; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; CARPENTER AF, 1993, J NEUROPATH EXP NEUR, V52, P601, DOI 10.1097/00005072-199311000-00007; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Dalla C, 2004, EUR J NEUROSCI, V20, P217, DOI 10.1111/j.1460-9568.2004.03443.x; DAVIS PG, 1979, ENDOCRINOLOGY, V104, P898, DOI 10.1210/endo-104-4-898; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; DIAZVELIZ G, 1989, PHYSIOL BEHAV, V46, P397, DOI 10.1016/0031-9384(89)90010-3; DIAZVELIZ G, 1991, PHYSIOL BEHAV, V50, P61, DOI 10.1016/0031-9384(91)90498-D; DiazVeliz G, 1997, PHARMACOL BIOCHEM BE, V58, P637, DOI 10.1016/S0091-3057(97)90004-6; Doorn KJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00084; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Galeeva A, 2001, BEHAV BRAIN RES, V119, P41, DOI 10.1016/S0166-4328(00)00341-7; Gandhi R, 2007, BRAIN BEHAV IMMUN, V21, P477, DOI 10.1016/j.bbi.2006.12.005; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Gibb J, 2008, BRAIN BEHAV IMMUN, V22, P573, DOI 10.1016/j.bbi.2007.12.001; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grant KE, 2004, J CLIN CHILD ADOLESC, V33, P412, DOI 10.1207/s15374424jccp3302_23; Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Holder MK, 2014, FRONT NEUROENDOCRIN, V35, P89, DOI 10.1016/j.yfrne.2013.10.004; Ismail N., 2012, NEUROSCIENCE; Ismail N, 2013, PSYCHONEUROENDOCRINO, V38, P1170, DOI 10.1016/j.psyneuen.2012.11.003; Ismail N, 2011, HORM BEHAV, V59, P565, DOI 10.1016/j.yhbeh.2011.02.010; Korzhevskii D.E., 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Laroche J, 2009, ENDOCRINOLOGY, V150, P3717, DOI 10.1210/en.2009-0099; Laroche J, 2009, ENDOCRINOLOGY, V150, P2351, DOI 10.1210/en.2008-1595; Likhtik E, 2015, TRENDS NEUROSCI, V38, P158, DOI 10.1016/j.tins.2014.12.007; Mohr MA, 2013, P NATL ACAD SCI USA, V110, P4792, DOI 10.1073/pnas.1219443110; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Okada M, 1997, JPN J PHARMACOL, V73, P93, DOI 10.1254/jjp.73.93; Olesen KM, 2011, HORM BEHAV, V60, P318, DOI 10.1016/j.yhbeh.2011.06.005; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patton GC, 1996, J EPIDEMIOL COMMUN H, V50, P661, DOI 10.1136/jech.50.6.661; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Rachman IM, 1998, P NATL ACAD SCI USA, V95, P13941, DOI 10.1073/pnas.95.23.13941; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Schafer D.P., 2012, GLIA; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Soucy G, 2005, J IMMUNOL, V174, P6391, DOI 10.4049/jimmunol.174.10.6391; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; Verney C, 2010, J ANAT, V217, P436, DOI 10.1111/j.1469-7580.2010.01245.x; WONG AKC, 1989, IEEE T SYST MAN CYB, V19, P866, DOI 10.1109/21.35351	59	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171381	10.1371/journal.pone.0171381	http://dx.doi.org/10.1371/journal.pone.0171381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158270	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700071
J	McDermott-Roe, C; Leleu, M; Rowe, GC; Palygin, O; Bukowy, JD; Kuo, J; Rech, M; Hermans-Beijnsberger, S; Schaefer, S; Adami, E; Creemers, EE; Heinig, M; Schroen, B; Arany, Z; Petretto, E; Geurts, AM				McDermott-Roe, Chris; Leleu, Marion; Rowe, Glenn C.; Palygin, Oleg; Bukowy, John D.; Kuo, Judy; Rech, Monika; Hermans-Beijnsberger, Steffie; Schaefer, Sebastian; Adami, Eleonora; Creemers, Esther E.; Heinig, Matthias; Schroen, Blanche; Arany, Zoltan; Petretto, Enrico; Geurts, Aron M.			Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function	PLOS ONE			English	Article							HEART-FAILURE; PGC-1 COACTIVATORS; GENE-EXPRESSION; HUMAN-DISEASE; PROTEIN; DYSFUNCTION; BIOGENESIS; NETWORK; MUSCLE; CELLS	Mitochondrial dysfunction contributes to myriad monogenic and complex pathologies. To understand the underlying mechanisms, it is essential to define the full complement of proteins that modulate mitochondrial function. To identify such proteins, we performed a metaanalysis of publicly available gene expression data. Gene co-expression analysis of a large and heterogeneous compendium of microarray data nominated a sub-population of transcripts that whilst highly correlated with known mitochondrial protein-encoding transcripts (MPETs), are not themselves recognized as generating proteins either localized to the mitochondrion or pertinent to functions therein. To focus the analysis on a medically-important condition with a strong yet incompletely understood mitochondrial component, candidates were cross-referenced with an MPET-enriched module independently generated via genome-wide co-expression network analysis of a human heart failure gene expression dataset. The strongest uncharacterized candidate in the analysis was Leucine Rich Repeat Containing 2 (LRRC2). LRRC2 was found to be localized to the mitochondria in human cells and transcriptionally- regulated by the mitochondrial master regulator Pgc-1 alpha. We report that Lrrc2 transcript abundance correlates with that of beta-MHC, a canonical marker of cardiac hypertrophy in humans and experimentally demonstrated an elevation in Lrrc2 transcript in in vitro and in vivo rodent models of cardiac hypertrophy as well as in patients with dilated cardiomyopathy. RNAi-mediated Lrrc2 knockdown in a rat-derived cardiomyocyte cell line resulted in enhanced expression of canonical hypertrophic biomarkers as well as increased mitochondrial mass in the context of increased Pgc-1 alpha expression. In conclusion, our meta-analysis represents a simple yet powerful springboard for the nomination of putative mitochondrially-pertinent proteins relevant to cardiac function and enabled the identification of LRRC2 as a novel mitochondrially- relevant protein and regulator of the hypertrophic response.	[McDermott-Roe, Chris; Palygin, Oleg; Bukowy, John D.; Kuo, Judy; Geurts, Aron M.] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Leleu, Marion] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Rowe, Glenn C.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Rech, Monika; Hermans-Beijnsberger, Steffie; Schroen, Blanche] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Cardiol, Ctr Heart Failure Res, Maastricht, Netherlands; [Schaefer, Sebastian] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Adami, Eleonora] Max Delbruck Ctr Mol Med, Cardiovasc & Metab Sci, Berlin, Germany; [Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Expt Cardiol, Amsterdam, Netherlands; [Heinig, Matthias] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Arany, Zoltan] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Petretto, Enrico] Imperial Coll London, MRC Clin Sci Ctr, London, England; [Petretto, Enrico] Duke NUS Grad Med Sch, Singapore, Singapore	Medical College of Wisconsin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Alabama System; University of Alabama Birmingham; Maastricht University; National Heart Centre Singapore; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Imperial College London; National University of Singapore	McDermott-Roe, C (corresponding author), Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA.	mcdec@mail.med.upenn.edu	Rowe, Glenn/N-5314-2019; Palygin, Oleg/AAT-3047-2020	Palygin, Oleg/0000-0002-3680-5527; Creemers, Esther/0000-0002-9001-3854; Heinig, Matthias/0000-0002-5612-1720; Adami, Eleonora/0000-0002-1813-6681; Petretto, Enrico/0000-0003-2163-5921; Rowe, Glenn/0000-0002-8195-9605; Schafer, Sebastian/0000-0002-6909-8275	NIH New Innovator Award [OD008396]; Medical Research Council [MC_U120097112] Funding Source: researchfish; MRC [MC_U120097112] Funding Source: UKRI	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH New Innovator Award OD008396 (AMG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Clemente P, 2015, NUCLEIC ACIDS RES, V43, P7398, DOI 10.1093/nar/gkv692; Creemers EE, 2016, CIRC RES, V118, P433, DOI 10.1161/CIRCRESAHA.115.307082; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fahrenbach JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090408; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016; Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Rosello-Lleti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112971; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170458	10.1371/journal.pone.0170458	http://dx.doi.org/10.1371/journal.pone.0170458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158196	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000396161700013
J	Gueguen, J; Piot, MA; Orri, M; Gutierre, A; Le Moan, J; Berthoz, S; Falissard, B; Godart, N				Gueguen, Juliette; Piot, Marie-Aude; Orri, Massimiliano; Gutierre, Andrea; Le Moan, Jocelyne; Berthoz, Sylvie; Falissard, Bruno; Godart, Nathalie			Group Qigong for Adolescent Inpatients with Anorexia Nervosa: Incentives and Barriers	PLOS ONE			English	Article							EATING-DISORDERS; PHYSICAL-ACTIVITY; BODY; PSYCHOTHERAPY; PERCEPTION; MOTIVATION; ALLIANCE; EXERCISE; ANXIETY; ADULTS	Background Qigong is a mind-body intervention focusing on interoceptive awareness that appears to be a promising approach in anorexia nervosa (AN). In 2008, as part of our multidimensional treatment program for adolescent inpatients with AN, we began a weekly qigong workshop that turned out to be popular among our adolescent patients. Moreover psychiatrists perceived clinical benefits that deserved further exploration. Methods and findings A qualitative study therefore sought to obtain a deeper understanding of how young patients with severe AN experience qigong and to determine the incentives and barriers to adherence to qigong, to understanding its meaning, and to applying it in other contexts. Data were collected through 16 individual semi-structured face-to-face interviews and analyzed with the interpretative phenomenological analysis method. Eleven themes emerged from the analysis, categorized in 3 superordinate themes describing the incentives and barriers related to the patients themselves (individual dimension), to others (relational dimension), and to the setting (organizational dimension). Individual dimensions associated with AN (such as excessive exercise and mind-body cleavage) may curb adherence, whereas relational and organizational dimensions appear to provide incentives to join the activity in the first place but may also limit its post-discharge continuation. Once barriers are overcome, patients reported positive effects: satisfaction associated with relaxation and with the experience of mind-body integration. Conclusions Qigong appears to be an interesting therapeutic tool that may potentiate psychotherapy and contribute to the recovery process of patients with AN. Further analysis of the best time window for initiating qigong and of its place in overall management might help to overcome some of the barriers, limit the risks, and maximize its benefits.	[Gueguen, Juliette; Orri, Massimiliano; Berthoz, Sylvie; Falissard, Bruno; Godart, Nathalie] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Paris, France; [Gueguen, Juliette; Piot, Marie-Aude; Orri, Massimiliano; Falissard, Bruno] Univ Paris 05, Paris, France; [Piot, Marie-Aude; Gutierre, Andrea; Le Moan, Jocelyne; Berthoz, Sylvie; Godart, Nathalie] Inst Mutualiste Montsouris, Psychiat Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite	Gueguen, J (corresponding author), Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Paris, France.; Gueguen, J (corresponding author), Univ Paris 05, Paris, France.	juliette.gueguen@inserm.fr	Berthoz Landron, Sylvie/M-4517-2018; Zamora, Cristina Cuesta/E-2864-2016; PIOT, Marie-Aude/AAO-9051-2021; Orri, Massimiliano/S-9220-2019	Zamora, Cristina Cuesta/0000-0003-1121-9561; Piot, Marie-Aude/0000-0001-6776-1611; Orri, Massimiliano/0000-0003-1389-2610; Berthoz, Sylvie/0000-0002-6862-2362				Ainley V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055568; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andres-Perpina S, 2011, EUR CHILD ADOLES PSY, V20, P541, DOI 10.1007/s00787-011-0216-y; [Anonymous], 1960, CARTESIAN MEDITATION; Arlington Va., 2011, DEV EVIDENCE BASED C; Atkinson MJ, 2015, INT J EAT DISORDER, V48, P1024, DOI 10.1002/eat.22416; Boudette Robin, 2006, Eat Disord, V14, P167, DOI 10.1080/10640260500536334; Carei TR, 2010, J ADOLESCENT HEALTH, V46, P346, DOI 10.1016/j.jadohealth.2009.08.007; Coulon N, 2009, ENCEPHALE, V35, P531, DOI 10.1016/j.encep.2008.09.005; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; Eklund M, 2016, SCAND J OCCUP THER, V23, P304, DOI 10.3109/11038128.2016.1143529; Ellis DA, 2012, J PEDIATR PSYCHOL, V37, P75, DOI 10.1093/jpepsy/jsr072; Eshkevari E, 2014, EUR EAT DISORD REV, V22, P383, DOI 10.1002/erv.2305; Espindola CR, 2009, ANN CLIN PSYCHIATRY, V21, P38; Farb N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00763; Fuchs T, 2009, CURR OPIN PSYCHIATR, V22, P570, DOI 10.1097/YCO.0b013e3283318e5c; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Godart N, 2004, Eat Weight Disord, V9, P224; Godart N, 2005, ARCH PEDIATRIE, V12, P1544, DOI 10.1016/j.arcped.2005.02.030; Godart N.T., 2013, OPEN J EPIDEMIOL, V03, P53, DOI [10.4236/ojepi.2013.32009, DOI 10.4236/0JEPI.2013.32009, DOI 10.4236/OJEPI.2013.32009]; Godart N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028249; Griffiths R, 1998, INT J EAT DISORDER, V23, P443; Halmi KA, 2012, INT J EAT DISORDER, V45, P800, DOI 10.1002/eat.22019; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hartmann AS, 2015, BODY IMAGE, V14, P77, DOI 10.1016/j.bodyim.2015.03.013; HAS, 2010, AN MENT PRIS CHARG; Herbert BM, 2012, TOP COGN SCI, V4, P692, DOI 10.1111/j.1756-8765.2012.01189.x; Hillen S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0516-8; Horndasch S, 2015, EUR ARCH PSY CLIN N, V265, P677, DOI 10.1007/s00406-015-0603-3; Hyland ME, 2005, CLIN MED, V5, P361, DOI 10.7861/clinmedicine.5-4-361; Jeammet P, 1984, PSYCHOL FR, V29, P137; Keski-Rahkonen A, 2014, INT J EAT DISORDER, V47, P117, DOI 10.1002/eat.22168; Keyes A, 2015, INT J EAT DISORDER, V48, P46, DOI 10.1002/eat.22354; Kohl M, 2004, ENCEPHALE, V30, P492; Kolnes LJ, 2012, J BODYW MOV THER, V16, P281, DOI 10.1016/j.jbmt.2011.12.005; Lang K, 2015, PSYCHIAT RES, V225, P387, DOI 10.1016/j.psychres.2014.12.008; Laumer U, 1997, PSYCHOTHER PSYCH MED, V47, P170; Lerner MD, 2011, BEHAV THER, V42, P449, DOI 10.1016/j.beth.2010.11.006; Lloyd S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111697; Mason M, 2010, FORUM QUAL SOZIALFOR, V11, pe8; McIver S, 2009, QUAL HEALTH RES, V19, P1234, DOI 10.1177/1049732309343954; Mehta Neeta, 2011, Mens Sana Monogr, V9, P202, DOI 10.4103/0973-1229.77436; National Collaborating Centre for Mental Health (UK), 2004, EAT DIS COR INT TREA; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00484; Pollatos O, 2016, PSYCHIAT RES, V240, P328, DOI 10.1016/j.psychres.2016.04.072; Posadzki P, 2010, COMPLEMENT THER MED, V18, P87, DOI 10.1016/j.ctim.2009.12.002; Sansone Randy A, 2005, Psychiatry (Edgmont), V2, P40; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Shapiro JR, 2008, INT J EAT DISORDER, V41, P728, DOI 10.1002/eat.20552; Shelef K, 2005, J CONSULT CLIN PSYCH, V73, P689, DOI 10.1037/0022-006X.73.4.689; Smink FRE, 2014, INT J EAT DISORDER, V47, P610, DOI 10.1002/eat.22316; Smith J., 2008, DOING SOCIAL PSYCHOL, P229; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tan JOA, 2010, INT J LAW PSYCHIAT, V33, P13, DOI 10.1016/j.ijlp.2009.10.003; Tsang H, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/706892; Vancampfort D, 2014, DISABIL REHABIL, V36, P628, DOI 10.3109/09638288.2013.808271; Vansteelandt K, 2007, BEHAV RES THER, V45, P1717, DOI 10.1016/j.brat.2006.12.005; Vansteenkiste M, 2005, INT J EAT DISORDER, V37, P207, DOI 10.1002/eat.20099; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Wang CW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-8; Yang Y., 2011, J AGING RES, V2011, DOI [10.4061/2011/650210, DOI 10.4061/2011/650210, 10. 4061/2011/650210]; Yuan CS, 2011, TRADITIONAL CHINESE MEDICINE, P1, DOI 10.3109/9781841848433	71	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170885	10.1371/journal.pone.0170885	http://dx.doi.org/10.1371/journal.pone.0170885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152083	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200055
J	Liu, LF; Craig, CM; Tolentino, LL; Choi, O; Morton, J; Rivas, H; Cushman, SW; Engleman, EG; McLaughlin, T				Liu, Li Fen; Craig, Colleen M.; Tolentino, Lorna L.; Choi, Okmi; Morton, John; Rivas, Homero; Cushman, Samuel W.; Engleman, Edgar G.; McLaughlin, Tracey			Adipose tissue macrophages impair preadipocyte differentiation in humans	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOCYTES; INSULIN ACTION; OBESITY; CELLS; EXPRESSION; RISK; MICE	Aim The physiologic mechanisms underlying the relationship between obesity and insulin resistance are not fully understood. Impaired adipocyte differentiation and localized inflammation characterize adipose tissue from obese, insulin-resistant humans. The directionality of this relationship is not known, however. The aim of the current study was to investigate whether adipose tissue inflammation is causally-related to impaired adipocyte differentiation. Methods Abdominal subcutaneous(SAT) and visceral(VAT) adipose tissue was obtained from 20 human participants undergoing bariatric surgery. Preadipocytes were isolated, and cultured in the presence or absence of CD14+ macrophages obtained from the same adipose tissue sample. Adipocyte differentiation was quantified after 14 days via immunofluorescence, Oil-Red O, and adipogenic gene expression. Cytokine secretion by mature adipocytes cultured with or without CD14+ macrophages was quantified. Results Adipocyte differentiation was significantly lower in VAT than SAT by all measures (p<0.001). With macrophage removal, SAT preadipocyte differentiation increased significantly as measured by immunofluorescence and gene expression, whereas VAT preadipocyte differentiation was unchanged. Adipocyte-secreted proinflammatory cytokines were higher and adiponectin lower in media from VAT vs SAT: macrophage removal reduced inflammatory cytokine and increased adiponectin secretion from both SAT and VAT adipocytes. Differentiation of preadipocytes from SAT but not VAT correlated inversely with systemic insulin resistance. Conclusions The current results reveal that proinflammatory immune cells in human SAT are causally-related to impaired preadipocyte differentiation, which in turn is associated with systemic insulin resistance. In VAT, preadipocyte differentiation is poor even in the absence of tissue macrophages, pointing to inherent differences in fat storage potential between the two depots.	[Liu, Li Fen; Craig, Colleen M.; McLaughlin, Tracey] Stanford Univ, Div Endocrinol, Dept Med, Palo Alto, CA 94304 USA; [Tolentino, Lorna L.; Choi, Okmi; Engleman, Edgar G.] Stanford Blood Ctr, Palo Alto, CA USA; [Morton, John; Rivas, Homero] Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; [Cushman, Samuel W.] NIDDK, NIH, Bethesda, MD 20892 USA; [Engleman, Edgar G.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University	Liu, LF (corresponding author), Stanford Univ, Div Endocrinol, Dept Med, Palo Alto, CA 94304 USA.	lifenliu@stanford.edu		craig, colleen/0000-0003-1308-6440	National Institutes of Health/National Institute of Digestive Diseases and Diabetes [R01 DK080436, R01DK071309, DK096038]	National Institutes of Health/National Institute of Digestive Diseases and Diabetes	Grant support for this study was provided by National Institutes of Health/National Institute of Digestive Diseases and Diabetes, R01 DK080436, R01DK071309 and DK096038. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Couturier J, 2012, OBESITY, V20, P253, DOI 10.1038/oby.2011.275; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Liu A, 2009, OBES SURG, V19, P1564, DOI 10.1007/s11695-009-9949-9; Liu LS, 1998, DIABETES, V47, P515, DOI 10.2337/diabetes.47.4.515; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; McLaughlin TM, 2010, OBESITY, V18, P926, DOI 10.1038/oby.2009.380; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; RODBELL M, 1964, J BIOL CHEM, V239, P375; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vidal-Puig Antonio, 2013, Endocrinol Nutr, V60 Suppl 1, P39; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560	33	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170728	10.1371/journal.pone.0170728	http://dx.doi.org/10.1371/journal.pone.0170728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151993	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200038
J	Loomis, Z; Eigenberger, P; Redinius, K; Lisk, C; Karoor, V; Nozik-Grayck, E; Ferguson, SK; Hassell, K; Nuss, R; Stenmark, K; Buehler, P; Irwin, DC				Loomis, Zoe; Eigenberger, Paul; Redinius, Katherine; Lisk, Christina; Karoor, Vijaya; Nozik-Grayck, Eva; Ferguson, Scott K.; Hassell, Kathryn; Nuss, Rachelle; Stenmark, Kurt; Buehler, Paul; Irwin, David C.			Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DAMAGE; HAPTOGLOBIN PRESERVES; RAT LUNGS; HYPERTENSION; INFLAMMATION; PATHOLOGY; DISEASE; INJURY; HEMOPEXIN; HEMOLYSIS	It is now well established that both inherited and acquired forms of hemolytic disease can promote pulmonary vascular disease consequent of free hemoglobin (Hb) induced NO scavenging, elevations in reactive oxygen species and lipid peroxidation. It has recently been reported that oxidative stress can activate NFkB through a toll-like receptor 9 (TLR9) mediated pathway; further, TLR9 can be activated by either nuclear or mitochondrial DNA liberated by stress induced cellular trauma. We hypothesis that Hb induced lipid peroxidation and subsequent endothelial cell trauma is linked to TLR9 activation, resulting in IL-6 mediated pulmonary smooth muscle cell proliferation. We examined the effects of Hb on rat pulmonary artery endothelial and smooth muscle cells (rPAEC and rPASMC, respectively), and then utilized TLR9 and IL6 inhibitors, as well as the Hb and heme binding proteins (haptoglobin (Hp) and hemopexin (Hpx), respectively) to further elucidate the aforementioned mediators. Further, we explored the effects of Hb in vivo utilizing endothelial cell (EC) specific myeloid differentiation primary response gene-88 (MyD88) and TLR9 null mice. Our data show that oxidized Hb induces lipid peroxidation, cellular toxicity (5.5 +/- 1.7 fold; p <= 0.04), increased TLR9 activation (60%; p = 0.01), and up regulated IL6 expression (1.75 +/- 0.3 fold; p = 0.04) in rPAEC. Rat PASMC exhibited a more proliferative state (13 +/- 1%; p = 0.01) when co-cultured with Hb activated rPAEC. These effects were attenuated with the sequestration of Hb or heme by Hp and Hpx as well as with TLR9 an IL-6 inhibition. Moreover, in both EC-MyD88 and TLR9 null mice Hb-infusion resulted in less lung IL-6 expression compared to WT cohorts. These results demonstrate that Hb-induced lipid peroxidation can initiate a modest TLR9 mediated inflammatory response, subsequently generating an activated SMC phenotype.	[Loomis, Zoe; Eigenberger, Paul; Redinius, Katherine; Lisk, Christina; Karoor, Vijaya; Nozik-Grayck, Eva; Ferguson, Scott K.; Stenmark, Kurt; Irwin, David C.] Univ Colorado Denver, Dept Med, Cardiovasc & Pulm Res Lab, Anschutz Med Campus, Aurora, CO 80045 USA; [Hassell, Kathryn; Nuss, Rachelle] Univ Colorado, Denver Sch Med, Div Hematol, Aurora, CO USA; [Hassell, Kathryn; Nuss, Rachelle] Univ Colorado, Denver Sch Med, Colorado Sickle Cell Treatment & Res Ctr, Aurora, CO USA; [Buehler, Paul] US FDA, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Food & Drug Administration (FDA)	Irwin, DC (corresponding author), Univ Colorado Denver, Dept Med, Cardiovasc & Pulm Res Lab, Anschutz Med Campus, Aurora, CO 80045 USA.	David.irwin@ucdenver.edu	stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020; stenmark, kurt/AFI-6776-2022		National Heart, Lung and Blood Institute [1R01HL125642-01A1, 1 R01HL086680-07, 5P01HL014985-38, T32HL007171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125642, P01HL014985, T32HL007171, R01HL086680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grants 1R01HL125642-01A1 (Irwin DC), 1 R01HL086680-07 (Nozik-Grayck E), 5P01HL014985-38(Stenmark KR), and T32HL007171 (Stenmark KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher J. D., 2013, BLOOD; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buehler PW, 2012, AM J PHYSIOL-LUNG C, V303, pL312, DOI 10.1152/ajplung.00074.2012; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Chintagari NR, 2016, AM J RESP CELL MOL B; Chouteau JM, 2011, AM J PHYSIOL-LUNG C, V301, pL892, DOI 10.1152/ajplung.00210.2011; Damm J, 2014, J NEUROIMMUNOL, V277, P105, DOI 10.1016/j.jneuroim.2014.10.007; Deuel JW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.392; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin Mark T, 2005, Hematology Am Soc Hematol Educ Program, P51; Gladwin MT, 2015, BLOOD, V126, P695, DOI 10.1182/blood-2015-06-649491; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gu XL, 2015, FREE RADICAL BIO MED, V83, P149, DOI 10.1016/j.freeradbiomed.2015.02.034; Haase M, 2010, J AM COLL CARDIOL, V55, P2024, DOI 10.1016/j.jacc.2009.12.046; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; Irwin DC, 2015, FREE RADICAL BIO MED, V82, P50, DOI 10.1016/j.freeradbiomed.2015.01.012; Kato G, 2009, BR J HEMATOL, P1; Kato Gregory J, 2008, Hematology Am Soc Hematol Educ Program, P186, DOI 10.1182/asheducation-2008.1.186; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; Kuck JL, 2015, AM J PHYSIOL-LUNG C, V308, pL1078, DOI 10.1152/ajplung.00015.2015; Lisk C, 2013, AM J RESP M IN PRESS; Madathilparambil SV, 2016, SHOCK; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Opitz B, 2009, THROMB HAEMOSTASIS, V102, P1103, DOI 10.1160/TH09-05-0323; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Poulain L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620258; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schaer CA, 2016, AM J RESP CRIT CARE, V193, P1111, DOI 10.1164/rccm.201510-2058OC; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schaer DJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013433; Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, pL962, DOI 10.1152/ajplung.00073.2014; Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Tsuji N., 2015, J AM SOC NEPHROL; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Vaidya B, 2015, J CONTROL RELEASE, V211, P118, DOI 10.1016/j.jconrel.2015.05.287; Vallelian F, 2015, FREE RADICAL BIO MED, V85, P259, DOI 10.1016/j.freeradbiomed.2015.04.023; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Zhu J, 2010, MEDIAT INFLAMM, V2010, P7	45	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171219	10.1371/journal.pone.0171219	http://dx.doi.org/10.1371/journal.pone.0171219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152051	gold, Green Published			2022-12-26	WOS:000396161200106
J	Sadeghi-Bazargani, H; Mohammadi, R; Ayubi, E; Almasi-Hashiani, A; Pakzad, R; Sullman, MJM; Safiri, S				Sadeghi-Bazargani, Homayoun; Mohammadi, Reza; Ayubi, Erfan; Almasi-Hashiani, Amir; Pakzad, Reza; Sullman, Mark J. M.; Safiri, Saeid			Caregiver-related predictors of thermal burn injuries among Iranian children: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; SELECTION	Purpose Burns are a common and preventable cause of injury in children. The aim of this study was to investigate child and caregiver characteristics which may predict childhood burn injuries among Iranian children and to examine whether confounding exists among these predictors. Methods A hospital based case-control study was conducted using 281 burn victims and 273 hospital-based controls, which were matched by age, gender and place of residence (rural/urban). The characteristics of the children and their caregivers were analyzed using crude and adjusted models to test whether these were predictors of childhood burn injuries. Results The age of the caregiver was significantly lower for burn victims than for the controls (P<0.05). Further, the amount of time the caregiver spent outdoors with the child and their economic status had a significant positive association with the odds of a burn injury (P<0.05). A multivariate logistic regression found that Type A behaviour among caregivers was independently associated with the child's odds of suffering a burn injury (OR = 1.12, 95% CI: 1.04-1.21). The research also found that children with ADHD (Inattentive subscale: Crude OR = 2.14, 95% CI: 1.16-3.95, Adjusted OR = 5.65, 95% CI: 2.53-12.61; Hyperactive subscale: Crude OR = 1.73, 95% CI: 1.23-2.41, Adjusted OR = 2.53, 95% CI: 1.65-3.87) also had increased odds of suffering a burn injury. However, several variables were identified as possible negative confounder variables, as the associations were stronger in the multivariate model than in the crude models. Conclusion The caregiver's characteristics which were predictors of burn injuries among Iranian children were: being younger, high socio-economic status, Type A behavioural pattern and spending more time outdoors. In addition, the relationship between a child's ADHD scores and the odds of a burn injury may be negatively confounded by the caregivers predictor variables.	[Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Dept Stat & Epidemiol, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun; Mohammadi, Reza] Karolinska Inst, WHO Collaborating Ctr Community Safety Promot, Stockholm, Sweden; [Ayubi, Erfan] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Sch Publ Hlth, Tehran, Iran; [Almasi-Hashiani, Amir] ACECR, Dept Epidemiol & Reprod Hlth, Reprod Epidemiol Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran; [Pakzad, Reza] Ilam Univ Med Sci, Student Res Comm, Ilam, Iran; [Sullman, Mark J. M.] Cranfield Univ, Driving Res Grp, Cranfield, Beds, England; [Safiri, Saeid] Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Dept Publ Hlth, Sch Nursing & Midwifery, Maragheh, Iran; [Safiri, Saeid] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran	Tabriz University of Medical Science; Karolinska Institutet; Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Cranfield University; Tehran University of Medical Sciences	Safiri, S (corresponding author), Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Dept Publ Hlth, Sch Nursing & Midwifery, Maragheh, Iran.; Safiri, S (corresponding author), Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran.	saeidsafiri@gmail.com	Safiri, Saeid/A-1678-2017; Almasi-Hashiani, Amir/P-3356-2018; Pakzad, Reza/X-7386-2018; Sadeghi-Bazargani, Homayoun/M-5522-2017; Ayubi, Erfan/AAD-3213-2019	Safiri, Saeid/0000-0001-7986-9072; Almasi-Hashiani, Amir/0000-0003-4434-561X; Pakzad, Reza/0000-0001-8133-3664; Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709; Sullman, Mark/0000-0001-7920-6818; Mohammadi, Reza/0000-0003-2294-9316	Tabriz University of Medical Sciences	Tabriz University of Medical Sciences	This study was funded by the Vice Chancellor of Research and Technology of Tabriz University of Medical Sciences, www.tbzmed.ac.ir.	Alaghehbandan R, 2001, BURNS, V27, P115, DOI 10.1016/S0305-4179(00)00083-8; Ansari-Moghaddam A, 2013, EPIDEMIOLOGY; Arshi S, 2006, BURNS, V32, P366, DOI 10.1016/j.burns.2005.10.026; Arshi S, 2007, IRAN J MED SCI, V7, P248; Arshi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049412; Branche C., 2008, WORLD REPORT CHILD I; Chandran A, 2010, EPIDEMIOL REV; Delgado J, 2002, INJ PREV, V8, P38, DOI 10.1136/ip.8.1.38; Deljavan R, 2012, INT J GEN MED, V5, P621, DOI 10.2147/IJGM.S34394; DuPaul G. J., 1998, ADHD RATING SCALE; Forjuoh SN, 2006, BURNS, V32, P529, DOI 10.1016/j.burns.2006.04.002; FORJUOH SN, 1995, J EPIDEMIOL COMMUN H, V49, P189, DOI 10.1136/jech.49.2.189; Howe LD, 2012, INT J EPIDEMIOL; Hutchings H, 2010, CHILD CARE HLTH DEV, V36, P787, DOI 10.1111/j.1365-2214.2010.01106.x; Jewell N, 2003, STAT EPIDEMIOLOGY; Joseph KE, 2002, BURNS, V28, P455, DOI 10.1016/S0305-4179(02)00035-9; Karimi H, 2012, Ann Burns Fire Disasters, V25, P115; Kaslow NJ, 1994, BEHAV ASPECTS PEDIAT, P193; Kohen D E, 2000, Inj Prev, V6, P223, DOI 10.1136/ip.6.3.223; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Ma WJ, 2010, SAFETY SCI, V48, P823, DOI 10.1016/j.ssci.2010.02.021; MATHENY AP, 1986, J PEDIATR PSYCHOL, V11, P163, DOI 10.1093/jpepsy/11.2.163; Mock C, 2008, WHO PLAN BURN PREVEN; Nadjarian B, 1995, J EDUC PSYCHOL, V2, P24; Naghavi M, 2003, POPUL HEALTH METR, V7, P9, DOI DOI 10.1186/1478-7954-7-9; Okoro Philemon E, 2009, Afr J Paediatr Surg, V6, P24, DOI 10.4103/0189-6725.48571; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-83; Petrass L, 2009, FAM COMMUNITY HEALTH, V32, P123, DOI 10.1097/FCH.0b013e3181994740; Rafii MH, 2012, ARCH TRAUMA RES, V1, P27, DOI [10.5812/atr.5295, 10.5812/atr.5383]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sadeghi-Bazargani H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2799-1; Sadeghi-Bazargani H, 2013, BURNS, V39, P1304, DOI 10.1016/j.burns.2013.02.013; Sadeghi-Bazargani H, 2012, BURNS, V38, P319, DOI 10.1016/j.burns.2011.09.025; Shah M, 2013, BURNS, V39, P1474, DOI 10.1016/j.burns.2013.03.022; SHI H, 2013, J APPL MATH, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0076787; Tung KY, 2005, BURNS, V31, pS12, DOI 10.1016/j.burns.2004.10.006; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WHO, 2008, DIS INJ REG EST CAUS; World Health Organization, 2008, WHO LAUNCH NEW DOC B	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170982	10.1371/journal.pone.0170982	http://dx.doi.org/10.1371/journal.pone.0170982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151942	Green Published, gold			2022-12-26	WOS:000396161200064
J	Tang, Y; Shen, PH; Liang, W; Jin, JL; Jiang, XF				Tang, Yu; Shen, Pinghua; Liang, Wei; Jin, Jialin; Jiang, Xiaofei			A putative multi-replicon plasmid co-harboring beta-lactamase genes bla(KPC-2), bla(CTX-M-14) and bla(TEM-1) and trimethoprim resistance gene dfrA25 from a Klebsiella pneumoniae sequence type (ST) 11 strain in China	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH PREVALENCE; INFECTIONS; VIRULENCE	The global emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae poses a major public health threat requiring immediate and aggressive action. Some older generation antibiotics, such as trimethoprim, serve as alternatives for treatment of infections. Here, we determined the complete nucleotide sequence of plasmid pHS091147, which co-harbored the carbapenemase (bla(KPC-2)) and trimethoprim resistance genes (dfrA25) from a Klebsiella pneumoniae sequence type (ST) 11 clone recovered in Shanghai, China. pHS091147 had three replication genes, several plasmid-stability genes and an intact type IV secretion system gene cluster. Besides bla(KPC-2) and dfrA25, pHS091147 carried several other resistance genes, including beta-lactamase genes bla(TEM-1) and bla(CTX-M-14), sulphonamide resistance gene sul1, a quinolone resistance gene remnant (Delta qnrB2), and virulence associated gene iroN. Notably, the multidrug-resistance region was a chimeric structure composed of three subregions, which shared strong sequence homology with several plasmids previously assigned in Genbank. To our knowledge, this is the first report of the co-localization of bla(KPC-2) and dfrA25 on a novel putative multi-replicon plasmid in a Klebsiella pneumoniae ST11 clone.	[Tang, Yu; Liang, Wei; Jiang, Xiaofei] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai, Peoples R China; [Shen, Pinghua] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Lab Med, Sch Med, Shanghai, Peoples R China; [Jin, Jialin] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, XF (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai, Peoples R China.; Jin, JL (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China.	jinjialin2002@126.com; jiangxi2154@aliyun.com			National Natural Science Foundation of China [81071396, 81572031]; Shanghai Natural Science Fund [14ZR1404500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund	Support was provided by the National Natural Science Foundation of China (Grants 81071396 and 81572031), Shanghai Natural Science Fund (No. 14ZR1404500).	Agerso Y, 2006, J ANTIMICROB CHEMOTH, V58, P1044, DOI 10.1093/jac/dkl366; Alvarado A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040438; [Anonymous], 2014, M100S24 CLIN LAB STA, P34; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Bi DX, 2015, J ANTIMICROB CHEMOTH, V70, P2770, DOI 10.1093/jac/dkv204; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P1542, DOI 10.1128/AAC.02332-12; Chen YT, 2014, J ANTIMICROB CHEMOTH, V69, P628, DOI 10.1093/jac/dkt409; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Falagas ME, 2015, INT J ANTIMICROB AG, V46, P231, DOI 10.1016/j.ijantimicag.2015.04.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; He DD, 2015, ANTIMICROB AGENTS CH, V59, P5976, DOI 10.1128/AAC.04920-14; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Peirano G, 2006, J ANTIMICROB CHEMOTH, V58, P305, DOI 10.1093/jac/dkl248; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Quan JJ, 2017, J ANTIMICROB CHEMOTH, V72, P273, DOI 10.1093/jac/dkw372; Sbrana F, 2013, CLIN INFECT DIS, V56, P697, DOI 10.1093/cid/cis969; Shen PH, 2016, BRAZ J INFECT DIS, V20, P384, DOI 10.1016/j.bjid.2016.04.003; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sorsa LJ, 2003, INFECT IMMUN, V71, P3285, DOI 10.1128/IAI.71.6.3285-3293.2003; Wilkowski P, 2016, TRANSPL P, V48, P1576, DOI 10.1016/j.transproceed.2016.01.060; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Xiang DR, 2016, ANTIMICROB AGENTS CH, V60, P1343, DOI 10.1128/AAC.01488-15; Yano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064359; Zhang HN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00239; Zhang T, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00005, 10.3389/fmicb.2016.01830, 10.3389/fmicb.2016.00227]; Zhong YM, 2015, J ANTIMICROB CHEMOTH, V70, P2223, DOI 10.1093/jac/dkv114; Zong Z, 2015, PLASMID, V80, P118, DOI 10.1016/j.plasmid.2015.04.007	33	6	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171339	10.1371/journal.pone.0171339	http://dx.doi.org/10.1371/journal.pone.0171339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152085	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200128
J	Davey, MG; Riley, JS; Andrews, A; Tyminski, A; Limberis, M; Pogoriler, JE; Partridge, E; Olive, A; Hedrick, HL; Flake, AW; Peranteau, WH				Davey, Marcus G.; Riley, John S.; Andrews, Abigail; Tyminski, Alec; Limberis, Maria; Pogoriler, Jennifer E.; Partridge, Emily; Olive, Aliza; Hedrick, Holly L.; Flake, Alan W.; Peranteau, William H.			Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep	PLOS ONE			English	Article							DEVELOPMENTAL-STAGE DETERMINES; IN-UTERO; ANTIGENIC STIMULUS; HEMOPHILIA-B; FACTOR-IX; IMPROVES PHENOTYPE; LENTIVIRAL VECTOR; VIRUS VECTORS; GROWTH-FACTOR; MURINE MODEL	A major limitation to adeno-associated virus (AAV) gene therapy is the generation of host immune responses to viral vector antigens and the transgene product. The ability to induce immune tolerance to foreign protein has the potential to overcome this host immunity. Acquisition and maintenance of tolerance to viral vector antigens and transgene products may also permit repeat administration thereby enhancing therapeutic efficacy. In utero gene transfer (IUGT) takes advantage of the immunologic immaturity of the fetus to induce immune tolerance to foreign antigens. In this large animal study, in utero administration of AAV6.2, AAV8 and AAV9 expressing green fluorescent protein (GFP) to similar to 60 day fetal sheep (term:similar to 150 days) was performed. Transgene expression and postnatal immune tolerance to GFP and viral antigens were assessed. We demonstrate 1) hepatic expression of GFP 1 month following in utero administration of AAV6.2.GFP and AAV8.GFP, 2) in utero recipients of either AAV6.2.GFP or AAV8.GFP fail to mount an anti-GFP antibody response following postnatal GFP challenge and lack inflammatory cellular infiltrates at the intramuscular site of immunization, 3) a serotype specific anti-AAV neutralizing antibody response is elicited following postnatal challenge of in utero recipients of AAV6.2 or AAV8 with the corresponding AAV serotype, and 4) durable hepatic GFP expression was observed up to 6 months after birth in recipients of AAV8.GFP but expression was lost between 1 and 6 months of age in recipients of AAV6.2. GFP. The current study demonstrates, in a preclinical large animal model, the potential of IUGT to achieve host immune tolerance to the viral vector transgene product but also suggests that a single exposure to the vector capsid proteins at the time of IUGT is inadequate to induce tolerance to viral vector antigens.	[Davey, Marcus G.; Riley, John S.; Andrews, Abigail; Tyminski, Alec; Partridge, Emily; Olive, Aliza; Hedrick, Holly L.; Flake, Alan W.; Peranteau, William H.] Childrens Hosp Philadelphia, Ctr Fetal Res, Philadelphia, PA 19104 USA; [Limberis, Maria] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA USA; [Pogoriler, Jennifer E.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Peranteau, WH (corresponding author), Childrens Hosp Philadelphia, Ctr Fetal Res, Philadelphia, PA 19104 USA.	peranteauw@email.chop.edu		Riley, John/0000-0001-6642-690X	National Institute of Health [P30DK047757-16]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study received funding in part from the National Institute of Health (P30DK047757-16) and generous family gifts to The Children's Hospital of Philadelphia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett ALH, 2013, GENE THER, V20, P497, DOI 10.1038/gt.2012.60; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Bouchard S, 2003, J GENE MED, V5, P941, DOI 10.1002/jgm.421; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Burnet FM, 1960, NOBEL LECT NOBEL PRI; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Carlon MS, 2014, HUM GENE THER, V25, P517, DOI 10.1089/hum.2013.196; Corti M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.33; CUMMINGS JN, 1963, AM J OBSTET GYNECOL, V86, P504; Davey MG, 2012, GENE THER, V19, P201, DOI 10.1038/gt.2011.83; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; Endo M, 2010, GENE THER, V17, P61, DOI 10.1038/gt.2009.115; Ferreira V, 2014, HUM GENE THER, V25, P180, DOI 10.1089/hum.2013.169; FLAKE AW, 1995, EXP HEMATOL, V23, P252; FLAKE AW, 1986, SCIENCE, V233, P776, DOI 10.1126/science.2874611; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; Hyatt MA, 2007, ENDOCRINOLOGY, V148, P4754, DOI 10.1210/en.2007-0303; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Joyeux L, 2014, HUM GENE THER METHOD, V25, P197, DOI 10.1089/hgtb.2013.143; Kaeppel C, 2013, NAT MED, V19, P889, DOI 10.1038/nm.3230; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; Loukogeorgakis SP, 2014, EUR J PEDIATR SURG, V24, P237, DOI 10.1055/s-0034-1382260; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McClain LE, 2016, J PEDIATR SURG, V51, P879, DOI 10.1016/j.jpedsurg.2016.02.048; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Osburn B I, 1988, Prog Clin Biol Res, V281, P15; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Peranteau WH, 2009, BIOL BLOOD MARROW TR, V15, P293, DOI 10.1016/j.bbmt.2008.11.034; Porada CD, 1998, HUM GENE THER, V9, P1571, DOI 10.1089/hum.1998.9.11-1571; Roybal JL, 2012, GENE THER, V19, P1085, DOI 10.1038/gt.2011.186; Roybal JL, 2011, GENE THER, V18, P719, DOI 10.1038/gt.2011.23; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; SILVERSTEIN AM, 1964, J EXP MED, V119, P955, DOI 10.1084/jem.119.6.955; SILVERSTEIN AM, 1963, J IMMUNOL, V91, P384; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; SILVERSTEIN AM, 1963, J EXP MED, V117, P799, DOI 10.1084/jem.117.5.799; Smith BK, 2013, HUM GENE THER, V24, P630, DOI 10.1089/hum.2012.250; Stitelman DH, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.40; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Tellez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075142; Themis M, 2005, MOL THER, V12, P763, DOI 10.1016/j.ymthe.2005.07.358; Tran ND, 2001, BLOOD, V97, P3417, DOI 10.1182/blood.V97.11.3417; Vrecenak JD, 2014, BLOOD, V124, P1987, DOI 10.1182/blood-2013-11-537571; Waddington SN, 2004, BLOOD, V104, P2714, DOI 10.1182/blood-2004-02-0627; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Zanjani ED, 1996, INT J HEMATOL, V63, P179	63	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171132	10.1371/journal.pone.0171132	http://dx.doi.org/10.1371/journal.pone.0171132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141818	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500040
J	Myllykoski, M; Kursula, P				Myllykoski, Matti; Kursula, Petri			Structural aspects of nucleotide ligand binding by a bacterial 2H phosphoesterase	PLOS ONE			English	Article							RIBOSE 1,2-CYCLIC PHOSPHATE; ESCHERICHIA-COLI; RNASE-L; MACROMOLECULAR CRYSTALLOGRAPHY; 2',3'-CYCLIC PHOSPHODIESTERASE; CYCLIC PHOSPHODIESTERASE; SOLUTION SCATTERING; MOLECULAR GRAPHICS; CRYSTAL-STRUCTURE; PETRA III	The 2H phosphoesterase family contains enzymes with two His-X-Ser/Thr motifs in the active site. 2H enzymes are found in all kingdoms of life, sharing little sequence identity despite the conserved overall fold and active site. For many 2H enzymes, the physiological function is unknown. Here, we studied the structure of the 2H family member LigT from Escherichia coli both in the apo form and complexed with different active-site ligands, including ATP, 2'-AMP, 3'-AMP, phosphate, and NADP(+). Comparisons to the well-characterized vertebrate myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) highlight specific features of the catalytic cycle and substrate recognition in both enzymes. The role played by the helix alpha 7, unique to CNPases within the 2H family, is apparently taken over by Arg130 in the bacterial enzyme. Other residues and loops lining the active site groove are likely to be important for RNA substrate binding. We visualized conformational changes related to ligand binding, as well as the position of the nucleophilic water molecule. We also present a low-resolution model of E. coli LigT bound to tRNA in solution, and provide a model for RNA binding by LigT, involving flexible loops lining the active site cavity. Taken together, our results both aid in understanding the common features of 2H family enzymes and help highlight the distinct features in the 2H family members, which must result in different reaction mechanisms. Unique aspects in different 2H family members can be observed in ligand recognition and binding, and in the coordination of the nucleophilic water molecule and the reactive phosphate moiety.	[Myllykoski, Matti; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kursula, Petri] Univ Bergen, Dept Biomed, Bergen, Norway	University of Oulu; University of Oulu; University of Bergen	Kursula, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.; Kursula, P (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.; Kursula, P (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	petri.kursula@uib.no	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Myllykoski, Matti/0000-0001-6641-5856	Emil Aaltonen Foundation; Sigrid Juselius Foundation	Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was funded by the Emil Aaltonen Foundation and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arn EA, 1996, J BIOL CHEM, V271, P31145, DOI 10.1074/jbc.271.49.31145; Banerjee S, 2016, CYTOKINE GROWTH F R, V29, P63, DOI 10.1016/j.cytogfr.2016.02.008; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bordeleau E, 2014, BIOORG MED CHEM LETT, V24, P4520, DOI 10.1016/j.bmcl.2014.07.080; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; CULVER GM, 1994, J BIOL CHEM, V269, P24928; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Genschik P, 1997, J BIOL CHEM, V272, P13211, DOI 10.1074/jbc.272.20.13211; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREER CL, 1983, CELL, V33, P899, DOI 10.1016/0092-8674(83)90032-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gusho E, 2014, MBIO, V5, DOI 10.1128/mBio.01312-14; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hilcenko C, 2013, BLOOD, V121, P1028, DOI 10.1182/blood-2012-10-461491; Jackson EK, 2016, HDB EXP PHARM; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato M, 2003, J MOL BIOL, V329, P903, DOI 10.1016/S0022-2836(03)00448-0; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; LIU J, 1986, J BACTERIOL, V165, P1002, DOI 10.1128/jb.165.3.1002-1010.1986; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004; Myllykoski M, 2013, J MOL BIOL, V425, P4307, DOI 10.1016/j.jmb.2013.06.012; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Myllykoski Matti, 2010, BMC Res Notes, V3, P12, DOI 10.1186/1756-0500-3-12; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; Ogden KM, 2015, J VIROL, V89, P6633, DOI 10.1128/JVI.00701-15; Pandey M, 2004, BIOCHEM BIOPH RES CO, V317, P586, DOI 10.1016/j.bbrc.2004.03.083; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Raasakka A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16520; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Remus BS, 2014, RNA, V20, P1697, DOI 10.1261/rna.046797.114; Sakamoto Y, 2005, J MOL BIOL, V346, P789, DOI 10.1016/j.jmb.2004.12.024; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thornbrough JM, 2016, MBIO, V7, DOI 10.1128/mBio.00258-16; TRUJILLO MA, 1987, EUR J BIOCHEM, V169, P167, DOI 10.1111/j.1432-1033.1987.tb13594.x; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; WESTHOF E, 1988, ACTA CRYSTALLOGR A, V44, P112, DOI 10.1107/S010876738700446X; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170355	10.1371/journal.pone.0170355	http://dx.doi.org/10.1371/journal.pone.0170355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141848	Green Published, gold			2022-12-26	WOS:000396129500009
J	Bonfert, T; Friedel, CC				Bonfert, Thomas; Friedel, Caroline C.			Prediction of Poly(A) Sites by Poly(A) Read Mapping	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; ALTERNATIVE POLYADENYLATION; RNA-SEQ; GENE-EXPRESSION; MESSENGER-RNAS; CLEAVAGE; CELLS; LANDSCAPE; QUANTIFICATION; TRANSCRIPTION	RNA-seq reads containing part of the poly(A) tail of transcripts (denoted as poly(A) reads) provide the most direct evidence for the position of poly(A) sites in the genome. However, due to reduced coverage of poly(A) tails by reads, poly(A) reads are not routinely identified during RNA-seq mapping. Nevertheless, recent studies for several herpesviruses successfully employed mapping of poly(A) reads to identify herpesvirus poly(A) sites using different strategies and customized programs. To more easily allow such analyses without requiring additional programs, we integrated poly(A) read mapping and prediction of poly(A) sites into our RNA-seq mapping program ContextMap 2. The implemented approach essentially generalizes previously used poly(A) read mapping approaches and combines them with the context-based approach of ContextMap 2 to take into account information provided by other reads aligned to the same location. Poly(A) read mapping using ContextMap 2 was evaluated on real-life data from the ENCODE project and compared against a competing approach based on transcriptome assembly (KLEAT). This showed high positive predictive value for our approach, evidenced also by the presence of poly(A) signals, and considerably lower runtime than KLEAT. Although sensitivity is low for both methods, we show that this is in part due to a high extent of spurious results in the gold standard set derived from RNAPET data. Sensitivity improves for poly(A) sites of known transcripts or determined with a more specific poly(A) sequencing protocol and increases with read coverage on transcript ends. Finally, we illustrate the usefulness of the approach in a high read coverage scenario by a re-analysis of published data for herpes simplex virus 1. Thus, with current trends towards increasing sequencing depth and read length, poly(A) read mapping will prove to be increasingly useful and can now be performed automatically during RNA-seq mapping with ContextMap 2.	[Bonfert, Thomas; Friedel, Caroline C.] Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany	University of Munich	Friedel, CC (corresponding author), Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany.	caroline.friedel@bio.ifi.lmu.de	Friedel, Caroline/AAG-5017-2019	Friedel, Caroline/0000-0003-3569-4877	Deutsche Forschungsgemeinschaft [FR2938/1-2, FR2938/7-1, CRC 1123 (Z2)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was partially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/) (grants FR2938/1-2, FR2938/7-1, CRC 1123 (Z2)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BIROL I, 2015, PACIFIC S BIOCOMPUTI, V20, P347; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bonfert T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0557-5; Canny SP, 2014, MBIO, V5, DOI 10.1128/mBio.01033-13; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Haenni S, 2012, NUCLEIC ACIDS RES, V40, P6304, DOI 10.1093/nar/gks282; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindner R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052403; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mignone F, 2001, MRNA UNTRANSLATED RE; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Pauws E, 2001, NUCLEIC ACIDS RES, V29, P1690, DOI 10.1093/nar/29.8.1690; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roizman B, 2001, FIELDS VIROLOGY, P2399; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1249; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170914	10.1371/journal.pone.0170914	http://dx.doi.org/10.1371/journal.pone.0170914			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135292	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700031
J	Daneau, G; Aboud, S; Prat, I; Urassa, W; Kestens, L				Daneau, Geraldine; Aboud, Said; Prat, Irena; Urassa, Willy; Kestens, Luc			Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania	PLOS ONE			English	Article							PIMA CD4; SETTINGS; AGREEMENT; THERAPY	Background CD4 T-cell counts are widely used to assess treatment eligibility and to follow-up HIV-infected patients. The World Health Organization prequalification of in vitro diagnostics program conducted a performance evaluation of the FACSPresto (BD Biosciences), a new point-of-care instrument to measure absolute CD4-T cell (CD4) counts and percentages in venous and capillary blood samples from HIV-infected patients. Methods Patients were recruited in Belgium (200 patients) and in Tanzania (247 patients). Venous blood samples were analyzed in two nearby reference laboratories. In addition, nurses/technicians collected a capillary blood sample by finger prick directly into a FACSPresto CD4 cartridge. Assay precision was assessed on fresh blood and on external quality control samples. Trueness (bias) was assessed by comparing results from FACSPresto with the reference (single-platform FACSCalibur). Clinical misclassification was measured at 200, 350 and 500 cells/mu L thresholds. Results Intra-assay precision was < 6%, and inter-assay < 8%. CD4 results from FACSPresto and reference method resulted in regression slopes of 0.99-1.11 using either venous or capillary blood. Correlation was better for venous than for capillary blood (minimum 0.97 vs 0.93 respectively). Capillary blood resulted in a larger bias than venous blood, with 24 and 83 cells/mu L for absolute CD4 counts on capillary blood in Antwerp and Dar es Salaam respectively, vs 12 and 41 cells/mu L on venous blood. Bias on CD4% was < 1% on both venous and capillary blood, and was proportionally better than for absolute CD4 counts. Clinical	[Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium; [Aboud, Said] MUHAS, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Prat, Irena; Urassa, Willy] WHO, Geneva, Switzerland; [Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Muhimbili University of Health & Allied Sciences; World Health Organization; University of Antwerp	Daneau, G; Kestens, L (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium.; Kestens, L (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	gdaneau@itg.be; lkestens@itg.be		Daneau, Geraldine/0000-0002-2570-0893	World Health Organization Prequalification of Diagnostics Programme	World Health Organization Prequalification of Diagnostics Programme	This study was partially funded by the World Health Organization Prequalification of Diagnostics Programme http://www.who.int/diagnostics_laboratory/evaluations/cd4/en/). The funder designed the generic protocol for the evaluation. There was no additional external funding received for this study.	Angira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157939; [Anonymous], 2016, GUID US ANT AG HIV 1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Clinical and Laboratory Standards Institute, 2010, EP09A2IR CLIN LAB ST, P17; Coetzee LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156266; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneau G, 2016, CYTOMETRY B; Daneau G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161891; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Glencross D K, 2001, SADJ, V56, P602; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; Jani I, 2010, POINT OF CARE CD4 IM; Makadzange AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157546; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Scott LE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0396-2; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; UNAIDS, 2014, 90 90 90 AMB TREATM; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; World Health Organization, 2013, 2013 CONS GUID US AN; World Health Organization, 2013, NUMB PEOPL REC ART P; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2015, GLOB SUMM AIDS EP 20	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170248	10.1371/journal.pone.0170248	http://dx.doi.org/10.1371/journal.pone.0170248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129324	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400059
J	Song, I; Ko, SM; Yi, JG; Chee, HK; Kim, JS				Song, Inyoung; Ko, Sung Min; Yi, Jeong Geun; Chee, Hyun Keun; Kim, Jun Seok			Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; VALVULAR HEART-DISEASE; REPLACEMENT; AREA; QUANTIFICATION; CALCIFICATION; REGURGITATION; PREDICTORS; GEOMETRY	Objective This study investigated the morphological and functional characteristics of the aortic valve and the left ventricular (LV) systolic functional parameters and myocardial mass related to the severity of myocardial fibrosis (MF) in patients with severe aortic valve stenosis (AS). Materials and Methods We retrospectively enrolled 81 patients (48 men; mean age: 59 +/- 12 years) with severe AS who underwent transthoracic echocardiography (TTE), cardiac computed tomography (CCT), and cardiovascular magnetic resonance (CMR) within 1 month and subsequent aortic valve surgery. Degree of MF was determined on delayed contrast-enhanced CMR with visual sub-segmental analysis-based quantification and was classified into three groups (no, mild, and severe) for identifying the differences in LV function and characteristics of the aortic valve. One-way ANOVA, Chi-square test or Fisher's exact test were used to compare variables of the three groups. Univariate multinomial logistic regression analysis was performed to determine the association between the severity of MF and variables on imaging modalities. Results Of 81 patients, 34 (42%) had MF (mild, n = 18; severe, n = 16). Aortic valve calcium volume score on CCT, aortic valve area, LV mass index, LV end-diastolic volume index on CMR, presence of mild aortic regurgitation (AR), transaortic mean pressure gradient, and peak velocity on TTE were significantly different among the three groups and were associated with severity of MF on a univariate multinomial logistic regression analysis. Aortic valve calcium grade was different (p = 0.008) among the three groups but not associated with severity of MF (p = 0.375). Conclusions A multi-imaging approach shows that severe AS with MF is significantly associated with more severe calcific AS, higher LV end-diastolic volume, higher LV mass, and higher prevalence of mild AR.	[Song, Inyoung; Ko, Sung Min; Yi, Jeong Geun] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea; [Chee, Hyun Keun; Kim, Jun Seok] Konkuk Univ, Sch Med, Med Ctr, Dept Thorac Surg, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center	Ko, SM (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea.	ksm9723@yahoo.co.kr			Konkuk University	Konkuk University	This work was supported by Konkuk University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Konkuk University.	Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Borer JS, 2002, CIRCULATION, V105, P1837, DOI 10.1161/01.CIR.0000014419.71706.85; Carabello BA, 2012, CIRCULATION, V126, P112, DOI 10.1161/CIRCULATIONAHA.111.079350; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Clavel MA, 2014, J AM COLL CARDIOL, V64, P1202, DOI 10.1016/j.jacc.2014.05.066; Clavel MA, 2013, J AM COLL CARDIOL, V62, P2329, DOI 10.1016/j.jacc.2013.08.1621; Debl K, 2006, HEART, V92, P1447, DOI 10.1136/hrt.2005.079392; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Fine NM, 2013, J MAGN RESON IMAGING, V38, P1369, DOI 10.1002/jmri.24116; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Honda S, 2012, HEART; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Kim EK, 2015, KOREAN J RADIOL, V16, P683, DOI 10.3348/kjr.2015.16.4.683; Klumpp BD, 2009, EUR RADIOL, V19, P1124, DOI 10.1007/s00330-008-1248-7; Koos R, 2004, AM J ROENTGENOL, V183, P1813, DOI 10.2214/ajr.183.6.01831813; KRAYENBUEHL HP, 1979, BRIT HEART J, V41, P204; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Milano AD, 2012, J THORAC CARDIOV SUR, V144, P830, DOI 10.1016/j.jtcvs.2011.11.024; Nigri M, 2009, AM HEART J, V157, P361, DOI 10.1016/j.ahj.2008.09.012; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; NITENBERG A, 1988, J AM COLL CARDIOL, V11, P478, DOI 10.1016/0735-1097(88)91520-3; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Park J, 2014, KOREAN CIRC J, V44, P312, DOI 10.4070/kcj.2014.44.5.312; Pouleur AC, 2007, RADIOLOGY, V244, P745, DOI 10.1148/radiol.2443061127; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Saitoh T, 2012, AM J CARDIOL, V109, P1626, DOI 10.1016/j.amjcard.2012.01.391; Song MG, 2014, ANN THORAC SURG, V97, P1235, DOI 10.1016/j.athoracsur.2013.10.088; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Zhao Y, 2013, INT J CARDIOL, V168, P3560, DOI 10.1016/j.ijcard.2013.05.089; Zilberszac R, 2013, J AM COLL CARDIOL, V61, P1489, DOI 10.1016/j.jacc.2012.11.070	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170939	10.1371/journal.pone.0170939	http://dx.doi.org/10.1371/journal.pone.0170939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129367	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400024
J	Winerdal, M; Urmaliya, V; Winerdal, ME; Fredholm, BB; Winqvist, O; Aring;den, U				Winerdal, Max; Urmaliya, Vijay; Winerdal, Malin E.; Fredholm, Bertil B.; Winqvist, Ola; Aden, Ulrika			Single Dose Caffeine Protects the Neonatal Mouse Brain against Hypoxia Ischemia	PLOS ONE			English	Article								In this randomized blinded study, we investigated caffeine 5 mg/kg treatment given directly after neonatal brain hypoxia ischemia. Brain morphology, behavior and key brain infiltrating immune populations were examined. Caffeine treatment significantly improves outcome when compared to phosphate buffered saline. Flow cytometric analysis of immune responses revealed no persistent immunological alterations. Given its safety caffeine emerges as a candidate for neuroprotective intervention after neonatal brain injury.	[Winerdal, Max; Aden, Ulrika] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Urmaliya, Vijay; Fredholm, Bertil B.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Winerdal, Malin E.; Winqvist, Ola] Karolinska Inst, Dept Med, Stockholm, Sweden; [Urmaliya, Vijay] Janssen Res & Dev, Discovery Sci, Beerse, Belgium	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Johnson & Johnson; Janssen Pharmaceuticals	Winerdal, M (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	max.winerdal@medsci.se		winqvist, Ola/0000-0003-0842-4441	Marianne and Marcus Wallenberg foundation; Swedish Brain Foundation; Swedish Order of Freemasons in Stockholm; Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research	Marianne and Marcus Wallenberg foundation; Swedish Brain Foundation; Swedish Order of Freemasons in Stockholm; Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research	This work was supported by Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research, Marianne and Marcus Wallenberg foundation, Swedish Brain Foundation and Swedish Order of Freemasons in Stockholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden Ulrika, 2011, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-642-13443-2_14; Albertsson AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0153-z; BONA E, 1995, PEDIATR RES, V38, P312, DOI 10.1203/00006450-199509000-00007; Doyle LW, 2010, ANN NEUROL, V68, P734, DOI 10.1002/ana.22098; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hedtjarn M, 2005, NEUROSCI LETT, V373, P16, DOI 10.1016/j.neulet.2004.09.062; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Jacobs SE, 2008, EVID BASED CHILD HLT, V3, P1049, DOI DOI 10.1002/EBCH.293; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Winerdal M, 2016, PURINERG SIGNAL, V12, P89, DOI 10.1007/s11302-015-9482-3	10	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170545	10.1371/journal.pone.0170545	http://dx.doi.org/10.1371/journal.pone.0170545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129361	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400055
J	Vadvalkar, SS; Matsuzaki, S; Eyster, CA; Giorgione, JR; Bockus, LB; Kinter, CS; Kinter, M; Humphries, KM				Vadvalkar, Shraddha S.; Matsuzaki, Satoshi; Eyster, Craig A.; Giorgione, Jennifer R.; Bockus, Lee B.; Kinter, Caroline S.; Kinter, Michael; Humphries, Kenneth M.			Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; PROTEIN ACETYLATION; DEHYDROGENASE; SIRT3; PHOSPHORYLATION; DEACETYLATES; SPECIFICITY; DYSFUNCTION; MECHANISMS; STARVATION	Alterations in mitochondrial function contribute to diabetic cardiomyopathy. We have previously shown that heart mitochondrial proteins are hyperacetylated in OVE26 mice, a transgenic model of type 1 diabetes. However, the universality of this modification and its functional consequences are not well established. In this study, we demonstrate that Akita type 1 diabetic mice exhibit hyperacetylation. Functionally, isolated Akita heart mitochondria have significantly impaired maximal (state 3) respiration with physiological pyruvate (0.1mM) but not with 1.0mM pyruvate. In contrast, pyruvate dehydrogenase activity is significantly decreased regardless of the pyruvate concentration. We found that there is a 70% decrease in the rate of pyruvate transport in Akita heart mitochondria but no decrease in the mitochondrial pyruvate carriers 1 and 2 (MPC1 and MPC2). The potential role of hyperacetylation in mediating this impaired pyruvate uptake was examined. The treatment of control mitochondria with the acetylating agent acetic anhydride inhibits pyruvate uptake and pyruvate- supported respiration in a similar manner to the pyruvate transport inhibitor alpha- cyano4- hydroxycinnamate. A mass spectrometry selective reactive monitoring assay was developed and used to determine that acetylation of lysines 19 and 26 of MPC2 is enhanced in Akita heart mitochondria. Expression of a double acetylation mimic of MPC2(K19Q/ K26Q) in H9c2 cells was sufficient to decrease the maximal cellular oxygen consumption rate. This study supports the conclusion that deficient pyruvate transport activity, mediated in part by acetylation of MPC2, is a contributor to metabolic inflexibility in the diabetic heart.	[Kinter, Caroline S.; Kinter, Michael; Humphries, Kenneth M.] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA; [Bockus, Lee B.; Humphries, Kenneth M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Humphries, KM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kenneth-humphries@omrf.org		Humphries, Kenneth/0000-0002-6167-3175; Kinter, Michael/0000-0001-7409-8918	Oklahoma City Veterans Affairs Medical Center; Development of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	Oklahoma City Veterans Affairs Medical Center; Development of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Q-Exactive Plus system used in this study was purchased by the Oklahoma City Veterans Affairs Medical Center with a grant from the Development of Veterans Affairs to Dr. Arlan Richardson.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; BUECHLER JA, 1989, BIOCHEMISTRY-US, V28, P3018, DOI 10.1021/bi00433a042; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fernandes J, 2015, BIOCHEMISTRY-US, V54, P4008, DOI 10.1021/acs.biochem.5b00375; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fukushima A, 2016, BBA-MOL CELL BIOL L, V1861, P1525, DOI 10.1016/j.bbalip.2016.03.020; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; Liang L, 2015, BIOCHEM BIOPH RES CO, V468, P807, DOI 10.1016/j.bbrc.2015.11.036; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Schummer CM, 2008, AM J PHYSIOL-ENDOC M, V294, pE88, DOI 10.1152/ajpendo.00178.2007; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; Vanderperre B, 2015, CURR OPIN CELL BIOL, V33, P35, DOI 10.1016/j.ceb.2014.10.008; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Willard BB, 2003, ANAL CHEM, V75, P2370, DOI 10.1021/ac034033j; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670	36	31	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4423	4433		10.1074/jbc.M116.753509	http://dx.doi.org/10.1074/jbc.M116.753509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154187	Green Published, hybrid			2022-12-26	WOS:000397585100004
J	Yu, JY; Liang, C; Liu, SL				Yu, Jingyou; Liang, Chen; Liu, Shan-Lu			Interferon-inducible LY6E Protein Promotes HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC SHARED ANTIGEN-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STEM-CELL ANTIGEN-2; DEAMINASE ADAR1; IFITM PROTEINS; T-LYMPHOCYTES; LOCUS-E; VIRUS; TYPE-1; GENE	LY6E is a glycosylphosphatidylinositol-anchored, IFN-inducible protein that regulates T lymphocytes proliferation, differentiation, and development. Single-nucleotide polymorphism rs2572886 in the LY6 family protein locus has been shown to associate with accelerated progression to AIDS. In this study, we show that LY6E promotes HIV, type 1 (HIV-1) infection by enhancing viral entry and gene expression. Knockdown of LY6E in human peripheral blood mononuclear, SupT1, and THP-1 cells diminishes HIV-1 replication. Virion-cell and cell-cell fusion experiments revealed that LY6E promotes membrane fusion of the viral entry step. Interestingly, we find that LTR-driven HIV-1 gene expression is also enhanced by LY6E, suggesting additional roles of LY6E in HIV-1 replication. HIV-1 infection induces LY6E expression in human peripheral blood mononuclear cells, concomitant with increased production of type I IFN and some classical IFN-stimulated genes. Altogether, our results demonstrate that IFN-inducible LY6E promotes HIV-1 entry and replication and highlight a positive regulatory role of IFN-induced proteins in HIV-1 infection. Our work emphasizes the complexity of IFN-mediated signaling in HIV-host interaction and AIDS pathogenesis.	[Yu, Jingyou; Liu, Shan-Lu] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Yu, Jingyou] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Liang, Chen] Lady Davis Inst, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University	Liu, SL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Ctr Microbial Interface Biol, Dept Vet Biosci, Columbus, OH 43210 USA.	liu.6244@osu.edu	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817	National Institutes of Health [R01 AI112381, R21 AI109464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109464, R01AI112381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI112381 and R21 AI109464 (to S.L.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Classon B J, 1998, Dev Immunol, V6, P149, DOI 10.1155/1998/53157; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Feng XB, 2015, CLIN RHEUMATOL, V34, P71, DOI 10.1007/s10067-014-2799-4; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; FREED EO, 1994, NATURE, V369, P107, DOI 10.1038/369107b0; GODFREY DI, 1992, J IMMUNOL, V148, P2006; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; KOSUGI A, 1994, INT IMMUNOL, V6, P1967, DOI 10.1093/intimm/6.12.1967; Kosugi A, 1998, J BIOL CHEM, V273, P12301, DOI 10.1074/jbc.273.20.12301; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li QX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004999; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; MACNEIL I, 1993, J IMMUNOL, V151, P6913; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SAITOH SI, 1995, J IMMUNOL, V155, P5574; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Stier MT, 2012, MAMM GENOME, V23, P250, DOI 10.1007/s00335-011-9368-9; SU B, 1991, J CELL BIOL, V112, P377, DOI 10.1083/jcb.112.3.377; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wetzel MA, 2002, VIROLOGY, V292, P6, DOI 10.1006/viro.2001.1249; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06; Xu X, 2014, J IMMUNOL, V193, P4125, DOI 10.4049/jimmunol.1401249; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	46	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4674	4685		10.1074/jbc.M116.755819	http://dx.doi.org/10.1074/jbc.M116.755819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130445	Green Published, hybrid			2022-12-26	WOS:000397585100024
J	Kumar, U; Quick, WP; Barrios, M; Cruz, PCS; Dingkuhn, M				Kumar, Uttam; Quick, William Paul; Barrios, Marilou; Cruz, Pompe C. Sta; Dingkuhn, Michael			Atmospheric CO2 concentration effects on rice water use and biomass production	PLOS ONE			English	Article							CARBON-DIOXIDE; ELEVATED CO2; STOMATAL CONDUCTANCE; YIELD ENHANCEMENT; ENRICHMENT FACE; TROPICAL RICE; TEMPERATURE; GROWTH; WHEAT; NITROGEN	Numerous studies have addressed effects of rising atmospheric CO2 concentration on rice biomass production and yield but effects on crop water use are less well understood. Irrigated rice evapotranspiration (ET) is composed of floodwater evaporation and canopy transpiration. Crop coefficient Kc (ET over potential ET, or ETo) is crop specific according to FAO, but may decrease as CO2 concentration rises. A sunlit growth chamber experiment was conducted in the Philippines, exposing 1.44-m(2) canopies of IR72 rice to four constant CO2 levels (195, 390, 780 and 1560 ppmv). Crop geometry and management emulated field conditions. In two wet (WS) and two dry (DS) seasons, final aboveground dry weight (agdw) was measured. At 390 ppmv [CO2] (current ambient level), agdw averaged 1744 g m(-2), similar to field although solar radiation was only 61% of ambient. Reduction to 195 ppmv [CO2] reduced agdw to 56 +/- 5% (SE), increase to 780 ppmv increased agdw to 128 +/- 8%, and 1560 ppmv increased agdw to 142 +/- 5%. In 2013WS, crop ET was measured by weighing the water extracted daily from the chambers by the air conditioners controlling air humidity. Chamber ETo was calculated according to FAO and empirically corrected via observed pan evaporation in chamber vs. field. For 390 ppmv [CO2], Kc was about 1 during crop establishment but increased to about 3 at flowering. 195 ppmv CO2 reduced Kc, 780 ppmv increased it, but at 1560 ppmv it declined. Whole-season crop water use was 564 mm (195 ppmv), 719 mm (390 ppmv), 928 mm (780 ppmv) and 803 mm (1560 ppmv). With increasing [CO2], crop water use efficiency (WUE) gradually increased from 1.59 g kg(-1) (195 ppmv) to 2.88 g kg(-1) (1560 ppmv). Transpiration efficiency (TE) measured on flag leaves responded more strongly to [CO2] than WUE. Responses of some morphological traits are also reported. In conclusion, increased CO2 promotes biomass more than water use of irrigated rice, causing increased WUE, but it does not help saving water. Comparability with field conditions is discussed. The results will be used to train crop models.	[Kumar, Uttam; Quick, William Paul; Barrios, Marilou; Dingkuhn, Michael] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Kumar, Uttam; Cruz, Pompe C. Sta] Univ Philippines Los Banos, Crop Sci Cluster, College Los Banos, Laguna, Philippines; [Dingkuhn, Michael] Ctr Cooperat Int Rech Agron Dev Cirad, Montpellier, France	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; CIRAD	Dingkuhn, M (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines.; Dingkuhn, M (corresponding author), Ctr Cooperat Int Rech Agron Dev Cirad, Montpellier, France.	michael.dingkuhn@cirad.fr	Kumar, Uttam/GVT-4765-2022	Kumar, Uttam/0000-0003-3875-541X	Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS); Bill and Melinda Gates Foundation through the C4-Rice project	Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS)(CGIAR); Bill and Melinda Gates Foundation through the C4-Rice project(CGIAR)	This research was supported by the Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS) and the Bill and Melinda Gates Foundation through the C4-Rice project.	Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baker J. T., 1993, J AGR METEOROL, V48, P575, DOI DOI 10.2480/AGRMET.48.575; BAKER JT, 1993, VEGETATIO, V104, P239, DOI 10.1007/BF00048156; BAKER JT, 1990, AGRON J, V82, P834, DOI 10.2134/agronj1990.00021962008200040034x; Bunce JA, 2000, GLOBAL CHANGE BIOL, V6, P371, DOI 10.1046/j.1365-2486.2000.00314.x; Choudhury BU, 2013, AGR WATER MANAGE, V123, P20, DOI 10.1016/j.agwat.2013.03.006; Dingkuhn M, 2015, FIELD CROP RES, V182, P43, DOI 10.1016/j.fcr.2015.05.025; Doorenbos J., 1977, FAO Irrigation and Drainage Paper; GIFFORD RM, 1979, AUST J PLANT PHYSIOL, V6, P367, DOI 10.1071/PP9790367; Grant RF, 2001, AGRON J, V93, P638, DOI 10.2134/agronj2001.933638x; GRiSP (Global Rice Science Partnership). (, 2013, RICE ALMANAC, V4th edition; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; Homma K, 1999, JPN J CROP SCI, V68, P137, DOI 10.1626/jcs.68.137; JONES P, 1985, AGRON J, V77, P242, DOI 10.2134/agronj1985.00021962007700020016x; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Mamta Kumari, 2013, International Journal of Geomatics and Geosciences, V4, P61; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Oue H, 2005, PHYTON-ANN REI BOT A, V45, P117; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Sharma P. K., 1986, Advances in Soil Science, V5, P139; Shih SF, 1982, AM SOC AGR ENG, V25, P701; Shimono H, 2009, ANN BOT-LONDON, V103, P87, DOI 10.1093/aob/mcn209; Shimono H, 2013, GLOBAL CHANGE BIOL, V19, P2444, DOI 10.1111/gcb.12214; Shimono H, 2009, J EXP BOT, V60, P523, DOI 10.1093/jxb/ern288; SIONIT N, 1981, J AGR SCI, V97, P335, DOI 10.1017/S0021859600040764; SIONIT N, 1981, AGRON J, V73, P1023, DOI 10.2134/agronj1981.00021962007300060027x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Wang JY, 2015, CLIMATIC CHANGE, V130, P529, DOI 10.1007/s10584-015-1374-6; Weerakoon WMW, 2000, PLANT SOIL, V220, P99, DOI 10.1023/A:1004786414113; WIGLEY TML, 1983, CLIMATIC CHANGE, V5, P315, DOI 10.1007/BF00140798; Wilson KB, 1999, GLOB CHANGE BIOL, V5, P903, DOI 10.1046/j.1365-2486.1999.00280.x; Yang LX, 2006, FIELD CROP RES, V98, P141, DOI 10.1016/j.fcr.2005.12.014; YOSHIDA S, 1979, SOIL SCI PLANT NUTR, V25, P81, DOI 10.1080/00380768.1979.10433148; Yoshimoto M, 2005, AGR FOREST METEOROL, V133, P226, DOI 10.1016/j.agrformet.2005.09.010; Zhu CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12719; Ziska LH, 1997, AGRON J, V89, P45, DOI 10.2134/agronj1997.00021962008900010007x	37	8	8	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169706	10.1371/journal.pone.0169706	http://dx.doi.org/10.1371/journal.pone.0169706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158204	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700006
J	Winckers, K; Thomassen, S; ten Cate, H; Hackeng, TM				Winckers, Kristien; Thomassen, Stella; ten Cate, Hugo; Hackeng, Tilman M.			Platelet full length TFPI-alpha in healthy volunteers is not affected by sex or hormonal use	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY; RECURRENT VENOUS THROMBOEMBOLISM; PROTEIN-S; COAGULATION INHIBITOR; ORAL-CONTRACEPTIVES; THROMBIN GENERATION; FACTOR-XA; PLASMA; RISK	Background Only 10% of plasma TFPI alpha (TFPI) exists in the full length form, the rest circulates as a C-terminally truncated form. However, blood platelets exclusively contain full length TFPI, which is released at the site of injury upon platelet activation, and which could play an important local regulatory role in thrombin generation and prevention of thrombosis. Methods The anticoagulant activities of full length and truncated TFPI were investigated using thrombin generation assays. Blood samples were obtained from 30 healthy volunteers (10 male subjects, 10 female subjects, and 10 females using oral contraceptives). Platelet TFPI was released in platelet rich plasma and in platelet isolates using convulxin or thrombin, and measured by free TFPI ELISA and thrombin generation assays. Results Full length TFPI and platelet TFPI were much more potent inhibitors of thrombin generation than truncated TFPI, which was virtually inactive. Although mean plasma TFPI antigen levels decreased from men (0.30 nM) to women (0.20 nM) to women using oral contraceptives (0.11 nM), no relevant differences were found in platelet TFPI among those subgroups. Conclusions Platelets release similar amounts of TFPI regardless of plasma TFPI concentrations and is unaffected by sex or oral contraceptive use. We speculate that platelet TFPI is important to prevent systemic coagulation and thrombosis and restrict thrombus formation to the site of the growing platelet plug. The stable contribution of platelet TFPI to the anticoagulant potential in plasma is likely to become particularly relevant under conditions of low plasma TFPI levels in combination of oral contraceptives use.	[Winckers, Kristien; Thomassen, Stella; ten Cate, Hugo; Hackeng, Tilman M.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands; [Winckers, Kristien; ten Cate, Hugo] Maastricht Univ, Med Ctr, CARIM, Dept Internal Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Hackeng, TM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands.	t.hackeng@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	Hackeng, Tilman/0000-0003-0142-0843; Thomassen, Stella/0000-0002-9686-6364; ten Cate, Hugo/0000-0001-7796-4463	Netherlands Heart Foundation, the Netherlands [2007.B138]	Netherlands Heart Foundation, the Netherlands(Netherlands Heart FoundationNetherlands Government)	This study was supported by grants from the Netherlands Heart Foundation, the Netherlands, (grant 2007.B138 to KW).	Ariens RAS, 1999, THROMB HAEMOSTASIS, V81, P203; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1047; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; BROZE GJ, 1994, BLOOD COAGUL FIBRIN, V5, P551; BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90; Castoldi E, 2010, HAEMATOLOGICA; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; Dahm A, 2003, BLOOD, V101, P4387, DOI 10.1182/blood-2002-10-3188; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Harris GM, 1999, AM J HEMATOL, V60, P175, DOI 10.1002/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.3.CO;2-O; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Helmerhorst FM, 1997, THROMB HAEMOSTASIS, V78, P327; Hoke M, 2005, THROMB HAEMOSTASIS, V94, P787, DOI 10.1160/TH05-06-0412; Huang ZF, 1997, BLOOD, V90, P944, DOI 10.1182/blood.V90.3.944.944_944_951; LINDAHL AK, 1991, BLOOD COAGUL FIBRIN, V2, P713, DOI 10.1097/00001721-199112000-00004; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Maroney SA, 2008, TRANSFUS APHER SCI, V38, P9, DOI 10.1016/j.transci.2007.12.001; Maroney SA, 2012, P NATL ACAD SCI USA, V109, P3927, DOI 10.1073/pnas.1119858109; Maurissen LFA, 2010, J THROMB HAEMOST, V8, P750, DOI 10.1111/j.1538-7836.2010.03743.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NOVOTNY WF, 1991, BLOOD, V78, P394; NOVOTNY WF, 1988, BLOOD, V72, P2020; NOVOTNY WF, 1991, BLOOD, V78, P387; Peraramelli S, 2012, THROMB HAEMOSTASIS, V108, P266, DOI 10.1160/TH11-12-0902; Raps M, 2013, THROMB HAEMOSTASIS, V109, P606, DOI 10.1160/TH12-10-0771; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Thomassen MCLGD, 2003, HAEMATOLOGICA, V88, P1150; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Winckers K, 2012, J THROMB HAEMOST, V10, P2208, DOI 10.1111/j.1538-7836.2012.04884.x; Wood JP, 2014, ARTERIOSCL THROM VAS, V34, P169, DOI 10.1161/ATVBAHA.113.302655; Zakai NA, 2010, THROMB HAEMOSTASIS, V104, P207, DOI 10.1160/TH09-10-0693	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0168273	10.1371/journal.pone.0168273	http://dx.doi.org/10.1371/journal.pone.0168273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158181	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700003
J	Levy, I; Olmer, L; Livnat, Y; Yanko, A; Shinar, E				Levy, Itzchak; Olmer, Liraz; Livnat, Yuval; Yanko, Adir; Shinar, Eilat			Attitudes, perceptions and knowledge among men who have sex with men towards the blood donation deferral policy in Israel	PLOS ONE			English	Article							HAD SEX; RISK BEHAVIORS; BENEFITS	Background Men who have sex with men (MSM) are permanently deferred from donating blood in Israel. Pressure to change this policy exists, despite data showing higher prevalence and incidence of HIV in MSM. A survey was conducted to evaluate current knowledge, attitudes, perceptions and compliance if deferral was changed. Study design and methods Anonymous survey was published in a gay-oriented website, collecting demographic information, history of blood donation, attitudes, knowledge and compliance with permanent versus temporary deferral. Responses were analyzed given 1 point for every "yes" response (0-7 points). Student's t-test was applied to compare differences between continuous variables. Correlations were described with the Pearson correlation coefficient. Results Responses from 492 MSM were analyzed. Average age was 31 +/- 9 years. 76% donated blood at least once, mostly for social solidarity (score of 3.2 on 1-5 scale). Tests seeking or protest scores were 1.7 and 1.6, respectively. 66% were unaware of the higher risk of HIV transmission by MSM, or the potential to infect 3 recipients. Knowledge regarding HIV transmission by blood positively correlated with knowledge regarding other routes of HIV transmission (r = 0.11; p = 0.03), age (r = 0.10; p = 0.04), and higher rate of non-compliance with the current deferral policy (OR = 1.9; p = 0.02). Activism for LGBT rights was associated with lower risk for non-adherence (OR = 0.5; p = 0.03). If temporary deferral is introduced 66% will comply with the new policy, but 23% will continue to donate as long as MSM deferral policy is in place. Conclusion A high proportion of MSM do not comply with the current lifetime deferral. This may partially change if temporary deferral is introduced.	[Levy, Itzchak] Sheba Med Ctr, Infect Dis Unit, HIV Unit, Ramat Gan, Israel; [Olmer, Liraz] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Livnat, Yuval; Yanko, Adir] Israeli AIDS Task Force, Tel Aviv, Israel; [Shinar, Eilat] Magen David Adom Natl Blood Serv, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center	Levy, I (corresponding author), Sheba Med Ctr, Infect Dis Unit, HIV Unit, Ramat Gan, Israel.	itsik.levi@sheba.health.gov.il		Levy, Itzchak/0000-0003-4716-1293	ministry of health	ministry of health	This work was funded in part by the ministry of health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2009, TRANSFUSION, V49, P1102, DOI 10.1111/j.1537-2995.2009.02124.x; [Anonymous], PER REP HIV AIDS CAS; [Anonymous], 2008, GENDER DISTRIBUTION; Bani M, 2010, BLOOD TRANSFUS-ITALY, V8, P278, DOI [10.2450/2010.0156-09, 10.2450/2010.0156.09]; Benjamin RJ, 2011, VOX SANG, V101, P339, DOI 10.1111/j.1423-0410.2011.01489.x; Custer B, 2015, TRANSFUSION, V55, P2826, DOI 10.1111/trf.13247; Davison KL, 2013, VOX SANG, V105, P85, DOI 10.1111/vox.12024; Dodd RY, 2016, TRANSFUSION, V56, P2781, DOI 10.1111/trf.13759; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Grenfell P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5604; Lee SS, 2014, BLOOD TRANSFUS-ITALY, V12, P166, DOI 10.2450/2013.0103-13; Lucky TTA, 2014, TRANSFUSION, V54, P1739, DOI 10.1111/trf.12554; O'Brien SF, 2007, TRANSFUS MED REV, V21, P205, DOI 10.1016/j.tmrv.2007.03.002; Pillonel J, 2012, VOX SANG, V102, P13, DOI 10.1111/j.1423-0410.2011.01509.x; Seed CR, 2014, VOX SANG, V106, P14, DOI 10.1111/vox.12093; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; UK Department of Health, 2011, DON SEL CRIT REV; Vamvakas EC, 2009, TRANSFUSION, V49, P1037, DOI 10.1111/j.1537-2995.2009.02175.x; Weinberg I, 2009, VOX SANG, V96, P128, DOI 10.1111/j.1423-0410.2008.01137.x; Wong HTH, 2015, TRANSFUSION, V55, P2175, DOI 10.1111/trf.13106; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	21	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170364	10.1371/journal.pone.0170364	http://dx.doi.org/10.1371/journal.pone.0170364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152072	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200022
J	Pellegrini, GG; Cregor, M; McAndrews, K; Morales, CC; McCabe, LD; McCabe, GP; Peacock, M; Burr, D; Weaver, C; Bellido, T				Pellegrini, Gretel Gisela; Cregor, Meloney; McAndrews, Kevin; Morales, Cynthya Carolina; McCabe, Linda Doyle; McCabe, George P.; Peacock, Munro; Burr, David; Weaver, Connie; Bellido, Teresita			Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age	PLOS ONE			English	Article							OXIDATIVE STRESS; OSTEOBLASTIC DIFFERENTIATION; ACTIVATION; DEFENSE; OSTEOCLASTOGENESIS; 17-BETA-ESTRADIOL; MECHANISMS; EXPRESSION; INDUCERS; PATHWAY	Accumulation of reactive oxygen species (ROS) is an important pathogenic mechanism underling the loss of bone mass and strength with aging and other conditions leading to osteoporosis. The transcription factor erythroid 2-related factor2 (Nrf2) plays a central role in activating the cellular response to ROS. Here, we examined the endogenous response of bone regulated by Nrf2, and its relationship with bone mass and architecture in the male and female murine skeleton. Young (3 month-old) and old (15 month-old) Nrf2 knockout (KO) mice of either sex exhibited the expected reduction in Nrf2 mRNA expression compared to wild type (WT) littermates. Nrf2 deletion did not lead to compensatory increase in Nrf1 or Nrf3, other members of this transcription factor family; and instead, Nrf1 expression was lower in KO mice. Compared to the respective WT littermate controls, female KO mice, young and old, exhibited lower expression of both detoxifying and antioxidant enzymes; young male KO mice, displayed lower expression of detoxifying enzymes but not antioxidant enzymes; and old male KO mice showed no differences in either detoxifying or antioxidant enzymes. Moreover, old male WT mice exhibited lower Nrf2 levels, and consequently lower expression of both detoxifying and antioxidant enzymes, compared to old female WT mice. These endogenous antioxidant responses lead to delayed rate of bone acquisition in female KO mice and higher bone acquisition in male KO mice as quantified by DXA and mu CT, demonstrating that Nrf2 is required for full bone accrual in the female skeleton but unnecessary and even detrimental in the male skeleton. Therefore, Nrf2 regulates the antioxidant endogenous response and bone accrual differently depending on sex and age. These findings suggest that therapeutic interventions that target Nrf2 could be developed to enhance the endogenous antioxidant response in a sex-and age-selective manner.	[Pellegrini, Gretel Gisela; Cregor, Meloney; McAndrews, Kevin; Morales, Cynthya Carolina; Burr, David; Bellido, Teresita] Indiana Univ Purdue Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [McCabe, Linda Doyle; McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Peacock, Munro; Bellido, Teresita] Indiana Univ Purdue Univ, Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Weaver, Connie] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Bellido, Teresita] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Bellido, T (corresponding author), Indiana Univ Purdue Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	tbellido@iupui.edu			National Institutes of Health NIH-NCCAM [R01-AT008754, AT008754-02S1]; Veterans Administration [1 I01 BX002104-01]; Indiana Clinical and Translational Sciences Institute (CTSI)	National Institutes of Health NIH-NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Veterans Administration(US Department of Veterans Affairs); Indiana Clinical and Translational Sciences Institute (CTSI)	This research was supported by the National Institutes of Health NIH-NCCAM (R01-AT008754 and AT008754-02S1), the Veterans Administration (1 I01 BX002104-01 to TB), and the Indiana Clinical and Translational Sciences Institute (CTSI).	Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Almeida M, 2010, MOL ENDOCRINOL; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen CS, 2013, NEUROENDOCRINOLOGY, V97, P232, DOI 10.1159/000342692; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hauge E, 1999, BONE, V25, P389, DOI 10.1016/S8756-3282(99)00194-5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Ibanez L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/726590; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim JH, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.33; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Pacheco-Costa R, 2014, J BIOL CHEM, V289, P8508, DOI 10.1074/jbc.M113.529735; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Sun YX, 2015, BONE, V74, P1, DOI 10.1016/j.bone.2014.12.066; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Warden SJ, 2014, J BONE MINER RES, V29, P1131, DOI 10.1002/jbmr.2143; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.030; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Yu JJ, 2012, J BIOCHEM MOL TOXIC, V26, P264, DOI 10.1002/jbt.21417; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	44	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171161	10.1371/journal.pone.0171161	http://dx.doi.org/10.1371/journal.pone.0171161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152064	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200096
J	Lavu, E; Kave, E; Mosoro, E; Markby, J; Aleksic, E; Gare, J; Elsum, IA; Nano, G; Kaima, P; Dala, N; Gurung, A; Bertagnolio, S; Crowe, SM; Myatt, M; Hearps, AC; Jordan, MR				Lavu, Evelyn; Kave, Ellan; Mosoro, Euodia; Markby, Jessica; Aleksic, Eman; Gare, Janet; Elsum, Imogen A.; Nano, Gideon; Kaima, Petronia; Dala, Nick; Gurung, Anup; Bertagnolio, Silvia; Crowe, Suzanne M.; Myatt, Mark; Hearps, Anna C.; Jordan, Michael R.			High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea	PLOS ONE			English	Article							THERAPY-NAIVE; SURVEILLANCE; IMPACT	Introduction Papua New Guinea is a Pacific Island nation of 7.3 million people with an estimated HIV prevalence of 0.8%. ART initiation and monitoring are guided by clinical staging and CD4 cell counts, when available. Little is known about levels of transmitted HIV drug resistance in recently infected individuals in Papua New Guinea. Methods Surveillance of transmitted HIV drug resistance in a total of 123 individuals recently infected with HIV and aged less than 30 years was implemented in Port Moresby (n = 62) and Mount Hagen (n = 61) during the period May 2013-April 2014. HIV drug resistance testing was performed using dried blood spots. Transmitted HIV drug resistance was defined by the presence of one or more drug resistance mutations as defined by the World Health Organization surveillance drug resistance mutations list. Results The prevalence of non-nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 16.1% (95% CI 8.8%-27.4%) and 8.2% (95% CI 3.2%-18.2%) in Port Moresby and Mount Hagen, respectively. The prevalence of nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 3.2% (95% CI 0.2%-11.7%) and 3.3% (95% CI 0.2%-11.8%) in Port Moresby and Mount Hagen, respectively. No protease inhibitor transmitted HIV drug resistance was observed. Conclusions The level of non-nucleoside reverse transcriptase inhibitor drug resistance in antiretroviral drug naive individuals recently infected with HIV in Port Moresby is amongst the highest reported globally. This alarming level of transmitted HIV drug resistance in a young sexually active population threatens to limit the on-going effective use of NNRTIs as a component of first-line ART in Papua New Guinea. To support the choice of nationally recommended first-line antiretroviral therapy, representative surveillance of HIV drug resistance among antiretroviral therapy initiators in Papua New Guinea should be urgently implemented.	[Lavu, Evelyn; Kave, Ellan; Mosoro, Euodia] Cent Publ Hlth Lab, Port Moresby, Papua N Guinea; [Markby, Jessica; Aleksic, Eman; Gare, Janet; Elsum, Imogen A.; Crowe, Suzanne M.; Hearps, Anna C.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Gare, Janet] Inst Med Res, Goroka, Papua N Guinea; [Nano, Gideon; Dala, Nick] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Kaima, Petronia] Mt Hagen Hosp, Mt Hagen, Papua N Guinea; [Gurung, Anup] World Hlth Org, Port Moresby, Papua N Guinea; [Bertagnolio, Silvia] World Hlth Org, HIV Dept, Geneva, Switzerland; [Myatt, Mark] Brixton Hlth, Llawryglyn, Powys, Wales; [Jordan, Michael R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Burnet Institute; PNG Institute Of Medical Research; World Health Organization; World Health Organization; Tufts Medical Center; Tufts University	Jordan, MR (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA.; Jordan, MR (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	mjordan@tuftsmedicalcenter.org		Elsum, Imogen/0000-0003-4525-0727	Bill and Melinda Gates Foundation [38180]; Global Fund; CFAR [1P30A142853]; Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation; Australian NHMRC Principal Research Fellowship	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Fund; CFAR; Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation; Australian NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding for these surveys was provided by the Bill and Melinda Gates Foundation (38180) awarded to the World Health Organization. Staff required for recruitment from Port Moresby was partially supported by funding from the Global Fund awarded to the Burnet Institute. The authors acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program to the Burnet Institute. MRJ is supported by CFAR grant 1P30A142853 and the Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation. SMC is supported by an Australian NHMRC Principal Research Fellowship. MM was employed by Brixton Health who provided support in the form of salary for MM but Brixton Health did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of MM is articulated in the 'author contributions' section.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; [Anonymous], 2009, 2008 STI HIV AND AID; Avila-Rios S, LANCET HIV IN PRESS; Bansi L, 2010, JAIDS-J ACQ IMM DEF, V53, P633, DOI 10.1097/QAI.0b013e3181c070d2; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Daoni E, 2012, CLIN INFECT DIS, V54, pS303, DOI 10.1093/cid/cir994; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Gare J, 2014, J ANTIMICROB CHEMOTH, V69, P2183, DOI 10.1093/jac/dku089; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kelly A, 2011, ASKIM NA SAVE ASK UN; National Institute for Communicable Diseases Division of the National Health Laboratory Service, 2016, COMMUNICABLE DIS COM, V15, P10; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Phillips A, 2014, LANCET HIV, P2; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rowley CF, 2016, J ANTIMICROB CHEMOTH, V71, P1361, DOI 10.1093/jac/dkv500; StataCorp, 2013, STAT REL 13; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WHO, 2015, HIV DRUG RES SURV GU; WHO, 2012, WHO HIV DRUG RES REP; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2014, SURV HIV DRUG RES AD; World Health Organization, GLOB REP EARL WARN I; World Health Organization, 2012, WHO MAN HIV DRUG RES	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170265	10.1371/journal.pone.0170265	http://dx.doi.org/10.1371/journal.pone.0170265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146591	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700019
J	Torres, DE; Rojas-Martinez, RI; Zavaleta-Mejia, E; Guevara-Fefer, P; Marquez-Guzman, GJ; Perez-Martinez, C				Eduardo Torres, David; Isabel Rojas-Martinez, Reyna; Zavaleta-Mejia, Emma; Guevara-Fefer, Patricia; Judith Marquez-Guzman, G.; Perez-Martinez, Carolina			Cladosporium cladosporioides and Cladosporium pseudocladosporioides as potential new fungal antagonists of Puccinia horiana Henn., the causal agent of chrysanthemum white rust	PLOS ONE			English	Article							PHYLLOPLANE FUNGI; X MORIFOLIUM; IN-VITRO; HYPERPARASITISM; PATHOGENS; UREDINIOSPORES; TENUISSIMUM; INFECTION; FABAE	Puccinia horiana Hennings, the causal agent of chrysanthemum white rust, is a worldwide quarantine organism and one of the most important fungal pathogens of Chrysanthemum x morifolium cultivars, which are used for cut flowers and as potted plants in commercial production regions of the world. It was previously reported to be controlled by Lecanicillium lecanii, Cladosporium sphaerospermum, C. uredinicola and Aphanocladium album, due to their antagonistic and hyperparasitic effects. We report novel antagonist species on Puccinia horiana. Fungi isolated from rust pustules in a commercial greenhouse from Villa Guerrero, Mexico, were identified as Cladosporium cladosporioides and Cladosporium pseudocladosporioides based upon molecular analysis and morphological characters. The antagonism of C. cladosporioides and C. pseudocladosporioides on chrysanthemum white rust was studied using light and electron microscopy in vitro at the host/parasite interface. Cladosporium cladosporioides and C. pseudocladosporioides grew towards the white rust teliospores and colonized the sporogenous cells, but no direct penetration of teliospores was observed; however, the structure and cytoplasm of teliospores were altered. The two Cladosporium spp. were able to grow on media containing laminarin, but not when chitin was used as the sole carbon source; these results suggest that they are able to produce glucanases. Results from the study indicate that both Cladosporium species had potential as biological control agents of chrysanthemum white rust.	[Eduardo Torres, David; Isabel Rojas-Martinez, Reyna; Zavaleta-Mejia, Emma; Perez-Martinez, Carolina] Colegio Postgrad, Inst Fitosanidad, Montecillo, Texcoco, Mexico; [Guevara-Fefer, Patricia] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico; [Judith Marquez-Guzman, G.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Mexico City, DF, Mexico	Colegio de Postgraduados - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rojas-Martinez, RI (corresponding author), Colegio Postgrad, Inst Fitosanidad, Montecillo, Texcoco, Mexico.	rojas@colpos.mx		Torres, David/0000-0003-3711-0548	CONACyT	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The first author (David Eduardo Torres) expresses his appreciation to CONACyT for his Master's scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author (David Eduardo Torres) expresses his appreciation to CONACyT for his Master's scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank M.C. Monica Perez Pacheco from Laboratorio de Desarrollo en Plantas, Departamento de Biologia Comparada, Facultad de Ciencias, UNAM and Biol. Yolanda Hornelas Cruces from Laboratorio de Microscopia Electronica, Instituto de Ciencias del Mar y Limnologia, and UNAM for the facilities for processing material for LR-White and SEM images.	Akiko K, 1977, NIPPON SHOKUBUTSU BY, V43, P145; Alaei H, 2009, J MICROBIOL METH, V76, P136, DOI 10.1016/j.mimet.2008.10.001; Alaei H, 2009, MYCOL RES, V113, P668, DOI 10.1016/j.mycres.2009.02.003; [Anonymous], 2004, Bulletin OEPP, V34, P209, DOI 10.1111/j.1365-2338.2004.00721.x; Assante G, 2004, MYCOL RES, V108, P170, DOI 10.1017/S0953756203008852; Barros ST, 1999, MYCOLOGIST, V13, P3; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; BOLAND GJ, 1988, CAN J PLANT PATHOL, V10, P172, DOI 10.1080/07060668809501750; Bonde MR, 2015, PHYTOPATHOLOGY, V105, P91, DOI 10.1094/PHYTO-09-13-0266-R; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Cook RTA, 2001, PLANT PATHOL, V50, P792, DOI 10.1046/j.1365-3059.2001.00615.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Backer M, 2013, PHYTOPATHOLOGY, V103, P1169, DOI 10.1094/PHYTO-01-13-0007-R; Deising H, 1996, HISTOLOGY ULTRASTRUC, V7, P135; DICKENS JSW, 1990, PLANT PATHOL, V39, P434, DOI 10.1111/j.1365-3059.1990.tb02519.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellsworth KT, 2013, CAN J MICROBIOL, V59, P761, DOI 10.1139/cjm-2013-0639; Falcon L, 2007, ECOLOGIA MOL; FIRMAN ID, 1968, ANN APPL BIOL, V62, P429, DOI 10.1111/j.1744-7348.1968.tb05454.x; FREYTAG S, 1991, PROTOPLASMA, V161, P94, DOI 10.1007/BF01322722; Garcia-Velasco Romulo, 2005, Revista Mexicana de Fitopatologia, V23, P79; HARDER DE, 1986, CAN J BOT, V64, P476, DOI 10.1139/b86-062; Hennings P., 1901, HEDWIGIA, V40, P25; Heuchert B., 2005, Schlechtendalia, P1; Hiratsuka N., 1957, SYDOWIA, V2, P34; Jackson AJ, 1997, BIOL CONTROL, V8, P97, DOI 10.1006/bcon.1996.0481; Kiss L, 2003, PEST MANAG SCI, V59, P475, DOI 10.1002/ps.689; Kohl JJ, 2009, EUR J PLANT PATHOL, V123, P401, DOI 10.1007/s10658-008-9377-z; Littlefield L, 1979, ULTRASTRUCTURE RUST, P277; Mims CW, 2007, CAN J BOT, V85, P76, DOI 10.1139/B06-153; MORGANJONES G, 1990, MYCOTAXON, V39, P185; Moricca S, 2001, PHYTOPATHOLOGY, V91, P457, DOI 10.1094/PHYTO.2001.91.5.457; Moricca S, 2005, RUST DISEASES OF WILLOW AND POPLAR, P213, DOI 10.1079/9780851999999.0213; Moricca Salvatore, 2008, V3, P303, DOI 10.1007/978-1-4020-8571-0_15; O'Keefe G, 2015, PLANT DIS; OMAR M, 1979, T BRIT MYCOL SOC, V72, P225, DOI 10.1016/S0007-1536(79)80036-4; PANDEY RR, 1993, MYCOPATHOLOGIA, V124, P31, DOI 10.1007/BF01103054; Punithalingam E, 1968, CMI DESCRIPTIONS PAT, V176; Rodriguez-Navarro J. A., 1996, Fitopatologia, V31, P122; Ruzin SE, 1999, PLANT MICROTECHNIQUE, P315; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; SHARMA JK, 1980, EUR J FOREST PATHOL, V10, P360; SRIVASTAVA AK, 1985, PHYTOPATHOL Z, V114, P73; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRAQUAIR JA, 1984, CAN J BOT, V62, P181, DOI 10.1139/b84-030; TSUNEDA A, 1979, Canadian Journal of Plant Pathology, V1, P31; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Voigt K, 2001, GENE, V270, P113, DOI 10.1016/S0378-1119(01)00464-4; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; WHIPPS JM, 1993, ANN APPL BIOL, V122, P173, DOI 10.1111/j.1744-7348.1993.tb04025.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06; ZANDVOORT R, 1968, Netherlands Journal of Plant Pathology, V74, P124, DOI 10.1007/BF02309505; Zhan GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111484	55	45	47	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170782	10.1371/journal.pone.0170782	http://dx.doi.org/10.1371/journal.pone.0170782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141830	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500019
J	Lazzarino, AI; Mindell, JS				Lazzarino, Antonio Ivan; Mindell, Jennifer S.			Measuring high-sensitivity cardiac troponin T blood concentration in population surveys	PLOS ONE			English	Article							MENTAL STRESS; ASSOCIATION; ELEVATION; RISK; MORTALITY; ASSAY	Introduction The blood test for high-sensitivity cardiac troponin T (HS-CTnT) has been proposed as a marker of cardiovascular risk in the general population, as it is associated with subsequent incidence of cardiovascular events and mortality. We aimed at evaluating the feasibility of HS-CTnT testing within large nationally-representative population surveys in which blood samples are collected during household visits, shipped using the standard civil postal service, and then frozen for subsequent analyses. Methods The Health Survey for England (HSE) consists of a series of annual surveys beginning in 1991. It is designed to provide regular information on various aspects of the nation's health and risk factors. We measured HS-CTnT in the blood of 200 people from the HSE 2016 wave, then froze and stored their blood samples at -40 degrees C for 5-10 weeks, and then thawed and retested them to appreciate the extent of within-person agreement or test-retest reliability of the two measurements. Results The Cronbach's Alpha (Scale Reliability Coefficient) and the Interclass Correlation Coefficient (two-way mixed-effects model for consistency of agreement at individual level) were 0.97 (95% CI = 0.96-0.99) and 0.95 (95% CI =0.94-0.96) respectively. The time delay from blood withdrawal to analysis and storage (1-4 days) did not affect the results, nor did the freezing time before the retest (5-10 weeks). Conclusion The measurement of HS-CTnT plasma concentration within large nationally-representative surveys such as the Health Survey for England is feasible.	[Lazzarino, Antonio Ivan] London Sch Hyg & Trop Med, London, England; [Lazzarino, Antonio Ivan; Mindell, Jennifer S.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Lazzarino, AI (corresponding author), London Sch Hyg & Trop Med, London, England.; Lazzarino, AI (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	antonio.lazzarino@lshtm.ac.uk	Mindell, Jennifer S/G-2241-2011; Lazzarino, Antonio Ivan/F-9011-2010	Mindell, Jennifer S/0000-0002-7604-6131; Lazzarino, Antonio Ivan/0000-0001-8045-2346	Wellcome Trust Institutional Strategic Support Fund, United Kingdom [105609/Z/14/Z]	Wellcome Trust Institutional Strategic Support Fund, United Kingdom	This research was supported by the Wellcome Trust Institutional Strategic Support Fund (grant code 105609/Z/14/Z), United Kingdom. The funders played no role in any phase of the study.; This research was supported by the Wellcome Trust Institutional Strategic Support Fund (grant code 105609/Z/14/Z awarded to Dr Antonio Ivan Lazzarino), United Kingdom. The funders played no role in any phase of the study. All authors declare no conflict of interest of any kind. All authors have made substantial contribution to the conception and design of the study, the acquisition of data, the interpretation of the results, and the critical review of the article. AIL drafted the article and carried out the data analysis and takes responsibility for the accuracy of the analysis. All authors have approved the final article.	de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Gillis JM, 2013, CLIN CHEM, V59, P442, DOI 10.1373/clinchem.2012.192211; Gimenez MR, 2014, EUR HEART J, V35, P2303, DOI 10.1093/eurheartj/ehu188; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Health and Social Care Information Centre 1 Trevelyan Square, 2013, HLTH SURV ENGL HLTH; Lazzarino AI, 2013, J AM COLL CARDIOL, V62, P1694, DOI 10.1016/j.jacc.2013.05.070; Lazzarino AI, 2016, PREV MED, V93, P46, DOI 10.1016/j.ypmed.2016.09.018; Lazzarino AI, 2015, PSYCHONEUROENDOCRINO, V59, P37, DOI 10.1016/j.psyneuen.2015.05.002; Lazzarino AI, 2015, PREV MED, V77, P150, DOI 10.1016/j.ypmed.2015.05.025; Li AH, 2011, CLIN CHEM LAB MED, V49, P335, DOI 10.1515/CCLM.2011.035; Michel M, 2016, CLIN LAB, V62, P743, DOI 10.7754/Clin.Lab.2015.160123; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; National Institute for Health and Care Excellence (NICE), 2014, MYOC IF AC EARL RUL; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rubin J, 2016, CLIN BIOCHEM, V49, P657, DOI 10.1016/j.clinbiochem.2016.01.024; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171242	10.1371/journal.pone.0171242	http://dx.doi.org/10.1371/journal.pone.0171242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141863	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000396129500052
J	Angelone-Alasaad, S; Biebach, I; Perez, JM; Soriguer, RC; Granados, JE				Angelone-Alasaad, Samer; Biebach, Iris; Perez, Jesus M.; Soriguer, Ramon C.; Granados, Jose E.			Molecular Analyses Reveal Unexpected Genetic Structure in Iberian Ibex Populations	PLOS ONE			English	Article							CAPRA-PYRENAICA MAMMALIA; SPANISH IBEX; ARTIODACTYLA; CONSERVATION; PROGRAM; SPAIN; GOAT	Background Genetic differentiation in historically connected populations could be the result of genetic drift or adaptation, two processes that imply a need for differing strategies in population management. The aim of our study was to use neutral genetic markers to characterize C. pyrenaica populations genetically and examine results in terms of (i) demographic history, (ii) subspecific classification and (iii) the implications for the management of Iberian ibex. Methodology/Principal Findings We used 30 neutral microsatellite markers from 333 Iberian ibex to explore genetic diversity in the three main Iberian ibex populations in Spain corresponding to the two persisting subspecies (victoria and hispanica). Our molecular analyses detected recent genetic bottlenecks in all the studied populations, a finding that coincides with the documented demographic decline in C. pyrenaica in recent decades. Genetic divergence between the two C. pyrenaica subspecies (hispanica and victoriae) was substantial (FST between 0.39 and 0.47). Unexpectedly, we found similarly high genetic differentiation between two populations (Sierra Nevada and Maestrazgo) belonging to the subspecies hispanica. The genetic pattern identified in our study could be the result of strong genetic drift due to the severe genetic bottlenecks in the studied populations, caused in turn by the progressive destruction of natural habitat, disease epidemics and/or uncontrolled hunting. Conclusions Previous Capra pyrenaica conservation decision-making was based on the clear distinction between the two subspecies (victoriae and hispanica); yet our paper raises questions about the usefulness for conservation plans of the distinction between these subspecies.	[Angelone-Alasaad, Samer; Biebach, Iris] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Winterthurerstr 190, Zurich, Switzerland; [Angelone-Alasaad, Samer; Soriguer, Ramon C.] CSIC, Estn Biol Donana, Avda Americo Vespucio S-N, Seville, Spain; [Perez, Jesus M.] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Campus Las Lagunillas S-N, Jaen, Spain; [Granados, Jose E.] Espacio Nat Sierra Nevada, Carretera Antigua de Sierra Nevada,Km 7, Granada, Spain	University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Jaen	Angelone-Alasaad, S (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Winterthurerstr 190, Zurich, Switzerland.; Angelone-Alasaad, S (corresponding author), CSIC, Estn Biol Donana, Avda Americo Vespucio S-N, Seville, Spain.	sameralasaad@hotmail.com	Torres, José Enrique Granados/AAS-5629-2020; Pérez, Jesús/AAA-6324-2019; Casimiro-Soriguer, Ramon/J-1494-2014; Angelone, Samer/G-4727-2013	Torres, José Enrique Granados/0000-0002-9787-9896; Casimiro-Soriguer, Ramon/0000-0002-9165-7766; Angelone, Samer/0000-0003-0868-7276				Acevedo P, 2009, MAMMAL REV, V39, P17, DOI 10.1111/j.1365-2907.2008.00138.x; Acevedo P, 2007, BIODIVERS CONSERV, V16, P3361, DOI 10.1007/s10531-006-9032-y; Acevedo P, 2011, ECOL MODEL, V222, P814, DOI 10.1016/j.ecolmodel.2010.10.006; Alados C.L., 1985, P204; Alasaad S, 2008, PARASITOL RES, V103, P181, DOI 10.1007/s00436-008-0952-1; Allendorf F, 2013, CONSERV GENET, V2nd; Biebach I, 2009, MOL ECOL, V18, P5046, DOI 10.1111/j.1365-294X.2009.04420.x; Bonferroni CE, 1936, TEORIA STAT CLASSI C, V8, P362; Caballero S, 2013, BIOCHEM SYST ECOL, V48, P263, DOI 10.1016/j.bse.2012.12.016; Cabrera A., 1914, FAUNA IBERICA MAMIFE; CABRERA A, 1911, P ZOOL SOC LOND, V66, P963; CLOUET M, 1979, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V115, P269; Cornuet JM, 1996, GENETICS, V144, P2001; Couturier MAJ, 1962, BOUQUETIN ALPES; Crampe J-P, 1991, DOCUMENTS SCI PARC N, V26, P1; Crampe JP, 2015, 33 RENC GEEFSM BALM; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Eizaguirre C, 2014, EVOL APPL, V7, P963, DOI 10.1111/eva.12227; Excoffier L., 2006, ARLEQUIN 3 11 COPYRI; Fandos P, 1991, SERIE TECNICA ICONA; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granados JE, 1997, FOLIA ZOOL, P9; GRODINSKY C, 1987, SMITHSONIAN, V18, P68; Groves C, 2011, UNGULATE TAXONOMY; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Manceau V., 1997, THESIS; Manceau V, 1999, ANIM CONSERV, V2, P33, DOI 10.1111/j.1469-1795.1999.tb00046.x; Mao, 1999, POPGENE VERSION 1 3; Maudet C, 2004, MOL ECOL NOTES, V4, P49, DOI 10.1046/j.1471-8286.2003.00563.x; Moco G, 2006, ORYX, V40, P351, DOI 10.1017/S0030605306000718; NEI M, 1978, GENETICS, V89, P583; Perez JM, 2002, MAMMAL REV, V32, P26, DOI 10.1046/j.1365-2907.2002.00097.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sarasa M, 2012, BIODIVERS CONSERV, V21, P1, DOI 10.1007/s10531-011-0172-3; Seal U. S., 1994, PLAN GEN REST MAN FL; Shackleton DM, 1997, WILD SHEEP GOATS THE; Slatkin M, 1996, THEORETICAL POPULATI, V28, P314; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P4551; [No title captured]	54	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170827	10.1371/journal.pone.0170827	http://dx.doi.org/10.1371/journal.pone.0170827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135293	Green Submitted, gold, Green Published			2022-12-26	WOS:000396124700024
J	N'Diaye, A; Haile, JK; Cory, AT; Clarke, FR; Clarke, JM; Knox, RE; Pozniak, CJ				N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, Fran R.; Clarke, John M.; Knox, Ron E.; Pozniak, Curtis J.			Single Marker and Haplotype-Based Association Analysis of Semolina and Pasta Colour in Elite Durum Wheat Breeding Lines Using a High-Density Consensus Map	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; YELLOW PIGMENT CONTENT; LINKAGE-DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; MOLECULAR MARKERS; NUCLEOTIDE POLYMORPHISMS; LIPOXYGENASE ACTIVITY; GENETIC ASSOCIATION	Association mapping is usually performed by testing the correlation between a single marker and phenotypes. However, because patterns of variation within genomes are inherited as blocks, clustering markers into haplotypes for genome-wide scans could be a worthwhile approach to improve statistical power to detect associations. The availability of high-density molecular data allows the possibility to assess the potential of both approaches to identify marker-trait associations in durum wheat. In the present study, we used single marker-and haplotype-based approaches to identify loci associated with semolina and pasta colour in durum wheat, the main objective being to evaluate the potential benefits of haplotype-based analysis for identifying quantitative trait loci. One hundred sixty-nine durum lines were genotyped using the Illumina 90K Infinium iSelect assay, and 12,234 polymorphic single nucleotide polymorphism (SNP) markers were generated and used to assess the population structure and the linkage disequilibrium (LD) patterns. A total of 8,581 SNPs previously localized to a high-density consensus map were clustered into 406 haplotype blocks based on the average LD distance of 5.3 cM. Combining multiple SNPs into haplotype blocks increased the average polymorphism information content (PIC) from 0.27 per SNP to 0.50 per haplotype. The haplotype-based analysis identified 12 loci associated with grain pigment colour traits, including the five loci identified by the single marker-based analysis. Furthermore, the haplotype-based analysis resulted in an increase of the phenotypic variance explained (50.4% on average) and the allelic effect (33.7% on average) when compared to single marker analysis. The presence of multiple allelic combinations within each haplotype locus offers potential for screening the most favorable haplotype series and may facilitate marker-assisted selection of grain pigment colour in durum wheat. These results suggest a benefit of haplotype-based analysis over single marker analysis to detect loci associated with colour traits in durum wheat.	[N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, John M.; Pozniak, Curtis J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, John M.; Pozniak, Curtis J.] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [Clarke, Fran R.; Knox, Ron E.] Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada	University of Saskatchewan; University of Saskatchewan; Agriculture & Agri Food Canada	N'Diaye, A (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.; N'Diaye, A (corresponding author), Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada.	amidou.ndiaye@usask.ca	Haile, Jemanesh/AAL-7670-2020	Cory, Aron/0000-0002-7215-459X; N'Diaye, Amidou/0000-0001-7769-7801; Knox, Ron/0000-0002-2030-3899	Genome Canada; Western Grains Research Foundation; Province of Saskatchewan; Agriculture and Agri-Food Canada	Genome Canada(Genome Canada); Western Grains Research Foundation; Province of Saskatchewan; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	We gratefully acknowledge funding provided by Genome Canada to the CTAG project, as well as by the Western Grains Research Foundation, the Province of Saskatchewan, and Agriculture and Agri-Food Canada.; We gratefully acknowledge funding provided by Genome Canada to the CTAG project, as well as the by the Western Grains Research Foundation, the Province of Saskatchewan, and Agriculture and Agri-Food Canada. The technical assistance of J. Coulson, Lexie Martin, K. Wiebe and S. Yates is also gratefully acknowledged.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Arbelbide M, 2006, THEOR APPL GENET, V112, P885, DOI 10.1007/s00122-005-0190-1; Bardel C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-24; Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Barton NH, 2000, HEREDITY, V84, P373, DOI 10.1046/j.1365-2540.2000.00683.x; Beattie AD, 2010, CROP SCI, V50, P1649, DOI 10.2135/cropsci2009.06.0334; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Blanchard G, 2010, JMLR WORKSH CONF PRO, V11, P12; Blanco A, 2011, J CEREAL SCI, V54, P255, DOI 10.1016/j.jcs.2011.07.002; Borner A, 1997, THEOR APPL GENET, V95, P1133, DOI 10.1007/s001220050673; Botta V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093379; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Calus MPL, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-11; Campoy JA, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0712-9; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Carrera A, 2007, J CEREAL SCI, V45, P67, DOI 10.1016/j.jcs.2006.07.001; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Cervigni G, 2005, P 7 INT WHEAT C SAGP; Chen YX, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S45; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Clarke FR, 2010, CAN J PLANT SCI, V90, P1, DOI 10.4141/CJPS09035; Clarke JM, 2010, CAN J PLANT SCI, V90, P791, DOI 10.4141/CJPS10091; Clarke JM, 2009, CAN J PLANT SCI, V89, P505, DOI 10.4141/CJPS08168; Clarke JM, 2005, CAN J PLANT SCI, V85, P901, DOI 10.4141/P04-189; Clarke JM, 2005, CAN J PLANT SCI, V85, P651, DOI 10.4141/P04-119; Clarke JM, 2000, CAN J PLANT SCI, V80, P343, DOI 10.4141/P99-108; Clarke JM, 1998, CAN J PLANT SCI, V78, P621, DOI 10.4141/P98-002; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cuyabano BCD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1171; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; De Simone V, 2010, J CEREAL SCI, V52, P121, DOI 10.1016/j.jcs.2010.04.003; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Elouafi I, 2001, HEREDITAS, V135, P255, DOI 10.1111/j.1601-5223.2001.t01-1-00255.x; Escamilla MA, 1999, AM J HUM GENET, V64, P1670, DOI 10.1086/302400; Feng B, 2010, J CEREAL SCI, V52, P387, DOI 10.1016/j.jcs.2010.06.019; Ferdosi MH, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0253-6; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao Q, 2012, GLOBAL JOURNAL OF SC, V12, P1; Garbus I, 2009, J CEREAL SCI, V50, P67, DOI 10.1016/j.jcs.2009.02.008; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gawenda I, 2015, PLANT BREEDING, V134, P28, DOI 10.1111/pbr.12237; Grapes L, 2006, GENETICS, V172, P1955, DOI 10.1534/genetics.105.048686; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Gupta PK, 2014, ADV GENET, V85, P109, DOI 10.1016/B978-0-12-800271-1.00002-0; Haile JK, 2013, GENET RESOUR CROP EV, V60, P853, DOI 10.1007/s10722-012-9880-0; Hamblin MT, 2011, PLANT GENOME-US, V4, P145, DOI 10.3835/plantgenome2011.03.0008; Hao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046444; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Hessler TG, 2002, CROP SCI, V42, P1695, DOI 10.2135/cropsci2002.1695; Hoffman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075707; HOISINGTON D, 1994, LAB PROTOCOLS CIMMYT; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Hou J, 2014, PLANT PHYSIOL, V164, P1918, DOI 10.1104/pp.113.232454; Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jonas D, 2016, J DAIRY SCI, V99, P4537, DOI 10.3168/jds.2015-10433; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kuchel H, 2006, THEOR APPL GENET, V112, P1487, DOI 10.1007/s00122-006-0252-z; Kumagai M, 2013, BIOINFORMATICS, V29, P1806, DOI 10.1093/bioinformatics/btt295; Langewisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094150; Lestari P, 2011, J HERED, V102, P735, DOI 10.1093/jhered/esr094; Li CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/830618; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; Li YH, 2009, MOL BREEDING, V24, P63, DOI 10.1007/s11032-009-9272-0; Lipka AE, 2013, G3-GENES GENOM GENET, V3, P1287, DOI 10.1534/g3.113.006148; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Long AD, 1999, GENOME RES, V9, P720; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Lorenz AJ, 2011, PLOS ONE, V5; Lu YL, 2012, MOL BREEDING, V30, P407, DOI 10.1007/s11032-011-9631-5; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Ma L, 2016, PLANT BIOTECHNOL J, V14, P1269, DOI 10.1111/pbi.12492; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; MacLean CJ, 2000, AM J HUM GENET, V66, P1062, DOI 10.1086/302796; Mago R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0379-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Manna F, 1998, CEREAL RES COMMUN, V26, P23; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mares DJ, 2001, AUST J AGR RES, V52, P1297, DOI 10.1071/AR01048; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; Matthies IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110046; Meuwissen THE, 2000, GENETICS, V155, P421; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Minozzi Giulietta, 2014, BMC Proc, V8, pS4, DOI 10.1186/1753-6561-8-S5-S4; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Muller BU, 2011, HEREDITY, V106, P825, DOI 10.1038/hdy.2010.125; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nachit MM, 2001, THEOR APPL GENET, V102, P177, DOI 10.1007/s001220051633; Pan Y, 2014, SCI REP, V5; Parker GD, 1998, THEOR APPL GENET, V97, P238, DOI 10.1007/s001220050891; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patil RM, 2008, MOL BREEDING, V21, P485, DOI 10.1007/s11032-007-9147-1; Peng ZS, 1999, WHEAT INFORM SERV, V89, P7; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Podlich DW, 2004, CROP SCI, V44, P1560, DOI 10.2135/cropsci2004.1560; Pometti CL, 2014, GENET MOL BIOL, V37, P64, DOI 10.1590/S1415-47572014000100012; Pozniak C, 2012, MOL BREEDING, P1; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prins R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00973; R Core Team, 2021, R LANGUAGE ENV STAT; Racedo J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0829-x; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; Reimer S, 2008, GENOME, V51, P1016, DOI 10.1139/G08-083; Roncallo PF, 2012, EUPHYTICA, V185, P77, DOI 10.1007/s10681-012-0628-x; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sardouie-Nasab S, 2013, MOL BIOL REP, V40, P4661, DOI 10.1007/s11033-013-2561-z; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Sha Qiuying, 2009, BMC Proc, V3 Suppl 7, pS14; Shao GN, 2013, GENOMICS, V101, P157, DOI 10.1016/j.ygeno.2012.11.010; Sneller CH, 2009, CROP SCI, V49, P363, DOI 10.2135/cropsci2008.07.0420; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Tachmazidou I, 2007, PLOS GENET, V3, P1163, DOI 10.1371/journal.pgen.0030111; Tang R, 2009, ANN HUM GENET, V73, P631, DOI 10.1111/j.1469-1809.2009.00543.x; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; TEMPLETON AR, 1987, GENETICS, V117, P343; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TOWNLEYSMITH TF, 1987, CAN J PLANT SCI, V67, P225, DOI 10.4141/cjps87-026; Tsombalova J, 2017, GENET RESOUR CROP EV, V64, P653, DOI 10.1007/s10722-016-0389-9; Tuberosa R, 2014, MOL BREEDING, V34, P1527, DOI 10.1007/s11032-014-0188-y; Van Inghelandt D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-56; Verlotta A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-263; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S6; Weber AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008227; Weir BS., 1996, GENETIC DATA ANAL; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165; Yonemaru J, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct188; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang W, 2008, THEOR APPL GENET, V117, P1361, DOI 10.1007/s00122-008-0869-1; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhang YL, 2009, EUPHYTICA, V165, P435, DOI 10.1007/s10681-008-9744-z; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao LP, 2007, GENET EPIDEMIOL, V31, P154, DOI 10.1002/gepi.20198; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	170	36	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170941	10.1371/journal.pone.0170941	http://dx.doi.org/10.1371/journal.pone.0170941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135299	Green Published, gold			2022-12-26	WOS:000396124700032
J	Adel, M; Yamaguchi, T; Tomita, D; Nakawaki, T; Kim, YI; Hikita, Y; Haga, S; Takahashi, M; Nadim, MA; Kawaguchi, A; Isa, M; El-Kenany, WH; El-Kadi, AA; Park, SB; Ishida, H; Maki, K; Kimura, R				Adel, Mohamed; Yamaguchi, Tetsutaro; Tomita, Daisuke; Nakawaki, Takatoshi; Kim, Yong-Il; Hikita, Yu; Haga, Shugo; Takahashi, Masahiro; Nadim, Mohamed A.; Kawaguchi, Akira; Isa, Mutsumi; El-Kenany, Walid H.; El-Kadi, Abbadi A.; Park, Soo-Byung; Ishida, Hajime; Maki, Koutaro; Kimura, Ryosuke			Contribution of FGFR1 Variants to Craniofacial Variations in East Asians	PLOS ONE			English	Article							RECEPTOR 1 FGFR1; CLEFT-LIP; SYNDROMIC CRANIOSYNOSTOSIS; GROWTH; PALATE; MORPHOLOGY; GENOTYPE; FAMILIES; SKELETAL; PARENTS	FGFR1 plays an important role in the development of the nervous system as well as the regulation of the skeletal development and bone homeostasis. Mutations in FGFR1 genes affect skull development, specifically suture and synchondrosis, resulting in craniosynostosis and facial abnormalities. We examined subjects with normal skull morphology for genetic polymorphisms that might be associated with normal craniofacial variations. Genomic DNA was obtained from 216 Japanese and 227 Korean subjects. Four FGFR1 SNPs, namely, rs881301, rs6996321, rs4647905, and rs13317, were genotyped. These SNPs were tested for association with craniofacial measurements obtained from lateral and posteroanterior cephalometries, in which principle component analysis was performed to compress the data of the craniofacial measurements. We observed that SNPs rs13317 and rs6996321 were correlated with the overall head size and midfacial development, indicating that FGFR1 SNPs played crucial roles in the normal variation of human craniofacial morphology. Subjects with the derived alleles of SNPs rs13317 and rs6996321 had a small face and a facial pattern associated with a retruded midface and relatively wide-set eyes. These facial features were similar to but were milder than those of individuals with Pfeiffer syndrome, which is caused by a dysfunctional mutation in FGFR1.	[Adel, Mohamed; Yamaguchi, Tetsutaro; Tomita, Daisuke; Nakawaki, Takatoshi; Hikita, Yu; Haga, Shugo; Takahashi, Masahiro; Maki, Koutaro] Showa Univ, Dept Orthodont, Tokyo, Japan; [Nadim, Mohamed A.; El-Kadi, Abbadi A.] Suez Canal Univ, Dept Orthodont, Ismailia, Egypt; [Kim, Yong-Il; Park, Soo-Byung] Pusan Natl Univ, Dent Hosp, Dept Orthodont, Dent Res Inst, Yangsan, South Korea; [Kawaguchi, Akira; Isa, Mutsumi; Ishida, Hajime; Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Okinawa, Japan; [El-Kenany, Walid H.] Univ Alexandria, Dept Orthodont, Alexandria, Egypt	Showa University; Egyptian Knowledge Bank (EKB); Suez Canal University; Pusan National University; Pusan National University Hospital; University of the Ryukyus; Egyptian Knowledge Bank (EKB); Alexandria University	Yamaguchi, T (corresponding author), Showa Univ, Dept Orthodont, Tokyo, Japan.; Kimura, R (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Okinawa, Japan.	tyamaguchi@dent.showa-u.ac.jp; rkimura@med.u-ryukyu.ac.jp	Adel, Mohamed/AAR-9153-2020	Yamaguchi, Tetsutaro/0000-0001-9806-7163; Elkadi, Abbadi/0000-0002-6871-1306; Haga, Shugo/0000-0003-0676-7125; Mohamed, Mohamed/0000-0002-9302-0443	Grants-in-Aid for Scientific Research [16K15843] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Albuisson Juliette, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9298; Ali N, 2015, CLEFT PALATE-CRAN J, V52, P506, DOI 10.1597/14-157; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P505, DOI 10.1016/0002-9416(71)90116-3; Bos A, 2003, AM J ORTHOD DENTOFAC, V123, P127, DOI 10.1067/mod.2003.84; Boutros S, 2007, J CRANIOFAC SURG, V18, P146, DOI 10.1097/01.scs.0000248655.53405.a7; Britto JA, 2001, PLAST RECONSTR SURG, V108, P2026, DOI 10.1097/00006534-200112000-00030; Clark Jeremy D, 2016, Am J Ophthalmol Case Rep, V2, P1, DOI 10.1016/j.ajoc.2016.04.001; Coussens AK, 2005, GENOMICS, V85, P563, DOI 10.1016/j.ygeno.2005.02.002; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Dahlberg G, 1940, BMJ-BRIT MED J, V14, P358; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Gomez-Valdes JA, 2013, AM J HUM BIOL, V25, P12, DOI 10.1002/ajhb.22331; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; Harris EF, 2009, ARCH ORAL BIOL, V54, pS107, DOI 10.1016/j.archoralbio.2008.04.010; Hartsfield Jr JK, 2012, GENETIC FACTORS AFFE; Hunemeier T, 2014, AM J HUM BIOL, V26, P164, DOI 10.1002/ajhb.22496; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; MATRAS H, 1977, J MAXILLOFAC SURG, V5, P298, DOI 10.1016/S0301-0503(77)80122-7; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOORE MH, 1995, CLEFT PALATE-CRAN J, V32, P62, DOI 10.1597/1545-1569(1995)032<0062:PSACR>2.3.CO;2; Nalcaci R, 2010, DENTOMAXILLOFAC RAD, V39, P100, DOI 10.1259/dmfr/82724776; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Pruzansky S, 1977, Birth Defects Orig Artic Ser, V13, P3; Rafiqdoost Z, 2014, INT J PEDIATR OTORHI, V78, P731, DOI 10.1016/j.ijporl.2014.01.024; Riley BM, 2007, AM J MED GENET A, V143A, P846, DOI 10.1002/ajmg.a.31673; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Robin NH, 1998, GENEREVIEWS; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Swennen G, 2002, INT J ORAL MAX SURG, V31, P13, DOI 10.1054/ijom.2001.0177; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WARD RE, 1989, CLEFT PALATE J, V26, P318; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yoon YJ, 2001, ANGLE ORTHOD, V71, P396	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170645	10.1371/journal.pone.0170645	http://dx.doi.org/10.1371/journal.pone.0170645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129408	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400050
J	Floros, S; Liakopoulou-Kyriakides, M; Karatasos, K; Papadopoulos, GE				Floros, Stelios; Liakopoulou-Kyriakides, Maria; Karatasos, Kostas; Papadopoulos, Georgios E.			Frequency Dependent Non- Thermal Effects of Oscillating Electric Fields in the Microwave Region on the Properties of a Solvated Lysozyme System: A Molecular Dynamics Study	PLOS ONE			English	Article							HYDROGEN-BOND DYNAMICS; DIELECTRIC-PROPERTIES; COMPUTER-SIMULATIONS; AQUEOUS-SOLUTION; PROTEIN HYDRATION; IONIC SOLUTION; X-RAY; WATER; CONSTANT; RELAXATION	The use of microwaves in every day's applications raises issues regarding the non thermal biological effects of microwaves. In this work we employ molecular dynamics simulations to advance further the dielectric studies of protein solutions in the case of lysozyme, taking into consideration possible frequency dependent changes in the structural and dynamic properties of the system upon application of electric field in the microwave region. The obtained dielectric spectra are identical with those derived in our previous work using the Frohlich-Kirkwood approach in the framework of the linear response theory. Noticeable structural changes in the protein have been observed only at frequencies near its absorption maximum. Concerning C-alpha position fluctuations, different frequencies affected different regions of the protein sequence. Furthermore, the influence of the field on the kinetics of protein-water as well as on the water-water hydrogen bonds in the first hydration shell has been studied; an extension of the Luzar-Chandler kinetic model was deemed necessary for a better fit of the applied field results and for the estimation of more accurate hydrogen bond lifetime values.	[Floros, Stelios; Liakopoulou-Kyriakides, Maria; Karatasos, Kostas] Aristotle Univ Thessaloniki, Dept Chem, Fac Chem Engn, Thessaloniki, Greece; [Papadopoulos, Georgios E.] Univ Thessaly, Dept Biochem & Biotechnol, Fac Hlth Sci, Mezourlo, Larisa, Greece	Aristotle University of Thessaloniki; University of Thessaly	Papadopoulos, GE (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Fac Hlth Sci, Mezourlo, Larisa, Greece.	geopap@bio.uth.gr	Karatasos, Konstantinos/D-1525-2013	Karatasos, Konstantinos/0000-0001-7431-5177; Papadopoulos, Georgios/0000-0002-2742-8467; Liakopoulou-Kyriakides, Maria/0000-0003-4629-8765	Department of Biochemistry & Biotechnology "Biotechnology - Quality Assessment in Nutrition and the Environment [3439]; Applications of Molecular Biology - Genetics - Diagnostic Biomarkers [3817]	Department of Biochemistry & Biotechnology "Biotechnology - Quality Assessment in Nutrition and the Environment; Applications of Molecular Biology - Genetics - Diagnostic Biomarkers	This work has been financially supported partly by the postgraduate courses of the Department of Biochemistry & Biotechnology Biotechnology - Quality Assessment in Nutrition and the Environment (Funding number 3439) and Applications of Molecular Biology - Genetics - Diagnostic Biomarkers (Funding number 3817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAMD US GUID VERS 2; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Bandyopadhyay S, 2005, J AM CHEM SOC, V127, P16660, DOI 10.1021/ja054462u; Barteri M, 2005, BIOPHYS CHEM, V113, P245, DOI 10.1016/j.bpc.2004.09.010; Bonincontro A, 2001, COLLOID SURFACE B, V21, P311, DOI 10.1016/S0927-7765(00)00214-9; Boresch S, 1999, BIOPHYS CHEM, V78, P43, DOI 10.1016/S0301-4622(98)00235-X; Boresch S, 2000, J PHYS CHEM B, V104, P8743, DOI 10.1021/jp0008905; Brace Christopher L., 2010, Critical Reviews in Biomedical Engineering, V38, P65, DOI 10.1615/CritRevBiomedEng.v38.i1.60; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAILLOL JM, 1989, J CHEM PHYS, V91, P5544, DOI 10.1063/1.457557; CAILLOL JM, 1986, J CHEM PHYS, V85, P6645, DOI 10.1063/1.451446; Cametti C, 2011, J PHYS CHEM B, V115, P7144, DOI 10.1021/jp2019389; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; English NJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2515315; English NJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3184794; Floros S, 2015, EUR BIOPHYS J BIOPHY, V44, P599, DOI 10.1007/s00249-015-1052-7; Frohlich H., 1958, THEORY DIELECTRICS, P8; Hayashi Y, 2002, J NON-CRYST SOLIDS, V305, P328, DOI 10.1016/S0022-3093(02)01113-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KING G, 1991, J CHEM PHYS, V95, P4366, DOI 10.1063/1.461760; Kirkwood JG, 1939, J CHEM PHYS, V7, P911, DOI 10.1063/1.1750343; Knocks A, 2001, J PHYS CHEM B, V105, P3635, DOI 10.1021/jp003700z; Kohler F., 1972, THE LIQUID STATE; Loffler G, 1997, J MOL BIOL, V270, P520, DOI 10.1006/jmbi.1997.1130; Luzar A, 1996, PHYS REV LETT, V76, P928, DOI 10.1103/PhysRevLett.76.928; Luzar A, 2000, J CHEM PHYS, V113, P10663, DOI 10.1063/1.1320826; Luzar A, 2000, CHEM PHYS, V258, P267, DOI 10.1016/S0301-0104(00)00163-4; MIURA N, 1994, BIOPOLYMERS, V34, P357, DOI 10.1002/bip.360340307; MULLER JJ, 1992, J APPL CRYSTALLOGR, V25, P181, DOI 10.1107/S0021889891011421; NAKAMURA H, 1988, PROTEIN ENG, V2, P177, DOI 10.1093/protein/2.3.177; Nandi N, 1998, J PHYS CHEM A, V102, P8217, DOI 10.1021/jp983327j; NEUMANN M, 1984, MOL PHYS, V52, P97, DOI 10.1080/00268978400101081; NEUMANN M, 1983, CHEM PHYS LETT, V102, P508, DOI 10.1016/0009-2614(83)87455-7; NEUMANN M, 1986, J CHEM PHYS, V85, P1567, DOI 10.1063/1.451198; NEUMANN M, 1986, MOL PHYS, V57, P97, DOI 10.1080/00268978600100081; NEUMANN M, 1983, CHEM PHYS LETT, V95, P417, DOI 10.1016/0009-2614(83)80585-5; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; PETHIG R, 1992, ANNU REV PHYS CHEM, V43, P177, DOI 10.1146/annurev.physchem.43.1.177; RAPAPORT DC, 1983, MOL PHYS, V50, P1151, DOI 10.1080/00268978300102931; Rosen A, 2007, IEEE MICROW MAG, V8, P70, DOI 10.1109/MMW.2007.289074; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Semenov S, 2009, PHILOS T R SOC A, V367, P3021, DOI 10.1098/rsta.2009.0092; SIMONSON T, 1995, P NATL ACAD SCI USA, V92, P1082, DOI 10.1073/pnas.92.4.1082; SIMONSON T, 1991, BIOPHYS J, V59, P670, DOI 10.1016/S0006-3495(91)82282-2; SMITH PE, 1993, J PHYS CHEM-US, V97, P2009, DOI 10.1021/j100111a046; SOUTH GP, 1972, PROC R SOC LON SER-A, V328, P371, DOI 10.1098/rspa.1972.0083; Suresh SJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162888; Suzuki M, 1996, J PHYS CHEM-US, V100, P7279, DOI 10.1021/jp953331k; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Weingartner H, 2001, J CHEM PHYS, V115, P1463, DOI 10.1063/1.1380205; YANG LQ, 1995, BIOPHYS J, V69, P1519, DOI 10.1016/S0006-3495(95)80022-6	52	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169505	10.1371/journal.pone.0169505	http://dx.doi.org/10.1371/journal.pone.0169505			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129348	Green Submitted, gold, Green Published			2022-12-26	WOS:000396211400068
J	Gebreamlak, B; Dadi, AF; Atnafu, A				Gebreamlak, Bisratemariam; Dadi, Abel Fekadu; Atnafu, Azeb			High Adherence to Iron/Folic Acid Supplementation during Pregnancy Time among Antenatal and Postnatal Care Attendant Mothers in Governmental Health Centers in Akaki Kality Sub City, Addis Ababa, Ethiopia: Hierarchical Negative Binomial Poisson Regression	PLOS ONE			English	Article							IRON SUPPLEMENTATION; FOLIC-ACID; WOMEN	Background Iron deficiency during pregnancy is a risk factor for anemia, preterm delivery, and low birth weight. Iron/Folic Acid supplementation with optimal adherence can effectively prevent anemia in pregnancy. However, studies that address this area of adherence are very limited. Therefore, the current study was conducted to assess the adherence and to identify factors associated with a number of Iron/Folic Acid uptake during pregnancy time among mothers attending antenatal and postnatal care follow up in Akaki kality sub city. Methods Institutional based cross-sectional study was conducted on a sample of 557 pregnant women attending antenatal and postnatal care service. Systematic random sampling was used to select study subjects. The mothers were interviewed and the collected data was cleaned and entered into Epi Info 3.5.1 and analyzed by R version 3.2.0. Hierarchical Negative Binomial Poisson Regression Model was fitted to identify the factors associated with a number of Iron/Folic Acid uptake. Adjusted Incidence rate ratio (IRR) with 95% confidence interval (CI) was computed to assess the strength and significance of the association. Result More than 90% of the mothers were supplemented with at least one Iron/Folic Acid supplement from pill per week during their pregnancy time. Sixty percent of the mothers adhered (took four or more tablets per week) (95% CI, 56%-64.1%). Higher IRR of Iron/Folic Acid supplementation was observed among women: who received health education; which were privately employed; who achieved secondary education; and who believed that Iron/Folic Acid supplements increase blood, whereas mothers who reported a side effect, who were from families with relatively better monthly income, and who took the supplement when sick were more likely to adhere. Conclusion Adherence to Iron/Folic Acid supplement during their pregnancy time among mothers attending antenatal and postnatal care was found to be high. Activities that would address the above mentioned factors were highly recommended to ensure the sustainability of mothers' adherence to the supplement.	[Gebreamlak, Bisratemariam] Teklaymanot Gen Hosp, Addis Ababa, Ethiopia; [Dadi, Abel Fekadu; Atnafu, Azeb] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Dadi, AF (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	Fekten@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020	Dadi, Abel Fekadu/0000-0001-9967-7713				Abdullah H, 2014, ANTENATAL IRON FOLIC, V7; Aguayo VM, 2005, PUBLIC HEALTH NUTR, V8, P33, DOI 10.1079/PHN2004664; [Anonymous], 2012, ETHIOPIA DEMOGRAPHIC; [Anonymous], 2014, RAPID INITIAL ASSESS; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Bin NY, 2014, BMC PREGNANCY CHILDB, V14, P344, DOI [10.1186/1471-2393-14-344, DOI 10.1186/1471-2393-14-344]; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; Dinga LA, 2013, FACTORS ASS ADHERENC; Gathigi LN, 2011, FACTORS INFLUENCING; Gebremedhin S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-607; Haidar J, 2010, S AFR J CLIN NUTR, V23, P132; Khattab M.S., 2011, MED J CAIRO U, V79, P115; Mithra P, 2014, AFR HEALTH SCI, V14, P255, DOI 10.4314/ahs.v14i1.39; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Oriji Vaduneme K, 2011, Niger J Med, V20, P131; Pratim PP, 2003, INT J PREV MED, V4, P1213; Roy MP, 2013, NATL J COMMUNITY MED, V4; Samuel A, 2012, PAN AFRICAN MED J, V20; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Smitasiri S, 2005, NUTR REV, V63, pS81, DOI 10.1301/nr.2005.dec.S81-S86; Taye B, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.43.4894, 10.11604/pamj.2015.20.276.4243]; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Vongvichit P, 2003, J PUBLIC HLTH DEV, p1l; WHO, 2006, IR FOL AC SUPPL INT; World Health Organization, 2012, DAIL IR FOL AC SUPPL; Wulff M, 2003, ACTA OBSTET GYN SCAN, V82, P628, DOI 10.1034/j.1600-0412.2003.00186.x; Zakia M, 2011, MED J CAIRO U, V79, P115	27	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169415	10.1371/journal.pone.0169415	http://dx.doi.org/10.1371/journal.pone.0169415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129344	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400069
J	Li, K; Wei, GY; Cao, YM; Li, D; Li, PH; Zhang, J; Bao, HF; Chen, YL; Fu, YF; Sun, P; Bai, XW; Ma, XQ; Lu, ZJ; Liu, ZX				Li, Kun; Wei, Guoyan; Cao, Yimei; Li, Dong; Li, Pinghua; Zhang, Jing; Bao, Huifang; Chen, Yingli; Fu, Yuanfang; Sun, Pu; Bai, Xingwen; Ma, Xueqing; Lu, Zengjun; Liu, Zaixin			The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine	PLOS ONE			English	Article							AFFERENT LYMPH; EXPRESSION; RESPONSES; ADJUVANT; ANTIGEN; CLEC9A; VIRUS	The chemokine (C motif) receptor 1 (XCR1) and its ligandXCL1 have been intensively studied in the mouse and human immune systems. Here, we determined the molecular characteristics of cattle XCR1 and XCL1 and their distribution among peripheral blood cells. Cattle XCR1 mRNA expression was mainly restricted to CD26(+) CADM1(+) CD205(+) MHCII+ CD11b(-) cells in blood that were otherwise lineage marker negative (lin(-)); these represented a subset of classic dendritic cells (DCs), not plasmacytoid DCs. Some of these DCs expressed CD11a, CD44, CD80 and CD86, but they did not express CD4, CD8, CD163 or CD172a. Cattle XCL1 was expressed in quiescent NK cells and in activated CD8 + T cells. Cattle XCR1(+) DCs migrated chemotactically in response to mouse, but not to human, XCL1. The distribution characters of cattle XCR1 and XCL1 suggested a vital role in regulation of acquired immune responses and indicated a potential for a DC targeted veterinary vaccine in cattle using XCL1 fused antigens.	[Li, Kun; Wei, Guoyan; Cao, Yimei; Li, Dong; Li, Pinghua; Zhang, Jing; Bao, Huifang; Chen, Yingli; Fu, Yuanfang; Sun, Pu; Bai, Xingwen; Ma, Xueqing; Lu, Zengjun; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Lu, ZJ; Liu, ZX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	luzengjun@caas.cn; liuzaixin@caas.cn	Li, Ping/GYV-4914-2022	Li, Kun/0000-0001-8307-634X	National Natural Science Foundation of China [31372422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (31372422).	Auray G, 2016, J IMMUNOL, V11; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Deloizy C, 2016, DEV COMP IMMUNOL, V65, P31, DOI 10.1016/j.dci.2016.06.015; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dutertre CA, 2014, J IMMUNOL, V192, P4697, DOI 10.4049/jimmunol.1302448; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Fossum E, 2015, EUR J IMMUNOL, V45, P624, DOI 10.1002/eji.201445080; Fox JC, 2016, BIOCHEMISTRY-US, V55, P1214, DOI 10.1021/acs.biochem.5b01329; Gliddon DR, 2004, IMMUNOLOGY, V111, P262, DOI 10.1111/j.0019-2805.2004.01820.x; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Gurka S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00035; Hartung E, 2015, J IMMUNOL, V194, P1069, DOI 10.4049/jimmunol.1401903; Howard CJ, 1997, J IMMUNOL, V159, P5372; Li J, 2015, EUR J IMMUNOL, V45, P854, DOI 10.1002/eji.201445127; Reeves RK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109273, DOI 10.1371/JOURNAL.PONE.0109273]; Terhorst D, 2015, J IMMUNOL, V194, P5895, DOI 10.4049/jimmunol.1500564; Tuinstra RL, 2007, BIOCHEMISTRY-US, V46, P2564, DOI 10.1021/bi602365d; Tullett KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87102; Tullett KM, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00239; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551	24	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170575	10.1371/journal.pone.0170575	http://dx.doi.org/10.1371/journal.pone.0170575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129380	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400053
J	Woodhall, SC; Wills, GS; Horner, PJ; Craig, R; Mindell, JS; Murphy, G; McClure, MO; Soldan, K; Nardone, A; Johnson, AM				Woodhall, Sarah C.; Wills, Gillian S.; Horner, Patrick J.; Craig, Rachel; Mindell, Jennifer S.; Murphy, Gary; McClure, Myra O.; Soldan, Kate; Nardone, Anthony; Johnson, Anne M.			Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PELVIC-INFLAMMATORY-DISEASE; NATIONAL SURVEYS; LIFE-STYLES; WOMEN; EPIDEMIOLOGY; ATTITUDES; SEROLOGY; BRITAIN; COHORT	Background Opportunistic chlamydia screening of <25 year-olds was nationally-implemented in England in 2008 but its impact on chlamydia transmission is poorly understood. We undertook a population-based seroprevalence study to explore the impact of screening on cumulative incidence of chlamydia, as measured by C.trachomatis- specific antibody. Methods Anonymised sera from participants in the nationally-representative Health Surveys for England (HSE) were tested for C. trachomatis antibodies using two novel Pgp3 enzymelinked immunosorbent assays (ELISAs) as a marker of past infection. Determinants of being seropositive were explored using logistic regression among 16-44 year-old women and men in 2010 and 2012 (years when sexual behaviour questions were included in the survey) (n = 1,402 women; 1,119 men). Seroprevalence trends among 16-24 year-old women (n = 3,361) were investigated over ten time points from 1994-2012. Results In HSE2010/2012, Pgp3 seroprevalence among 16-44 year-olds was 24.4% (95% CI 22.0 - 27.1) in women and 13.9% (11.8-16.2) in men. Seroprevalence increased with age (up to 33.5% [ 27.5-40.2] in 30-34 year-old women, 18.7% [13.4-25.6] in 35-39 year-old men); years since first sex; number of lifetime sexual partners; and younger age at first sex. 76.7% of seropositive 16-24 year-olds had never been diagnosed with chlamydia. Among 16-24 year-old women, a non-significant decline in seroprevalence was observed from 2008-2012 (prevalence ratio per year: 0.94 [0.84-1.05]). Conclusion Our application of Pgp3 ELISAs demonstrates a high lifetime risk of chlamydia infection among women and a large proportion of undiagnosed infections. A decrease in age-specific cumulative incidence following national implementation of opportunistic chlamydia screening has not yet been demonstrated. We propose these assays be used to assess impact of chlamydia control programmes.	[Woodhall, Sarah C.; Murphy, Gary; Soldan, Kate; Nardone, Anthony] Publ Hlth England, Natl Infect Serv, London, England; [Woodhall, Sarah C.; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Wills, Gillian S.; McClure, Myra O.] Imperial Coll London, Jefferiss Res Trust Labs, Fac Med, St Marys Campus, London, England; [Horner, Patrick J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Craig, Rachel] NatCen Social Res, London, England; [Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London, England	Public Health England; University of London; University College London; Imperial College London; University of Bristol; University of London; University College London	Woodhall, SC (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.; Woodhall, SC; Johnson, AM (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	sarah.woodhall@phe.gov.uk; anne.johnson@ucl.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Johnson, Anne/0000-0003-1330-7100; Horner, Paddy/0000-0003-0411-8332; Nardone, Anthony/0000-0003-1138-0937; Soldan, Kate/0000-0002-0361-3174	Health and Social Care Information Centre; Public Health England; National Institute for Health Research [NF-SI-0508-10244, NF-SI-0513-10078] Funding Source: researchfish	Health and Social Care Information Centre; Public Health England; National Institute for Health Research(National Institute for Health Research (NIHR))	The Health Survey for England was funded by the Health and Social Care Information Centre. Testing of stored sera was funded by the Health Protection Agency (now Public Health England). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen D, 2010, J BACTERIOL, V192, P6017, DOI 10.1128/JB.00847-10; Craig R, 2013, HLTH SURVEY ENGLAND, V2; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Health Protection Agency, 2012, GEN CHLAM TRACH DIAG; Health Protection Agency, 2011, GEN CHLAM TRACH DIAG; Health & Social Care Information Centre, 2009, HLTH SURV ENGL 2008, V2; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386; Horner PJ, 2015, PLOS ONE UNPUB; Hou SP, 2015, INFECT IMMUN, V83, P4701, DOI 10.1128/IAI.00746-15; Johnson AM, 2008, SEX TRANSM INFECT, V84, P79, DOI 10.1136/sti.2007.028472; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Miller WC, 2008, SEX TRANSM INFECT, V84, P82, DOI 10.1136/sti.2007.028662; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; Payne R. A., 2012, Health Statistics Quarterly, P22; Persson K, 2002, BEST PRACT RES CL OB, V16, P801, DOI 10.1053/beog.2002.0321; Prah P, 2014, SEXUALLY TRANSMIT S1, V41; Price MJ, 2014, EPIDEMIOL INFECT, V142, P562, DOI 10.1017/S0950268813001027; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Price MJ, 2012, SEX TRANSM DIS, V39, P608, DOI 10.1097/OLQ.0b013e3182572475; Public Health England, 2014, TABL 8 NUMB RAT SEL; Public Health England, 2014, NAT CHLAM SCREEN PRO; Public Health England, 2015, HLTH PROTECTION REPO, V9; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Stamm WE, 1999, SEXUALLY TRANSMITTED, V3rd; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; UK Clinical Research Network, 2015, 18521 UKCRN; van Aar F, 2014, SEX TRANSM INFECT, V90, P434, DOI 10.1136/sextrans-2013-051074; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; WANG SP, 1974, J INFECT DIS, V130, P388, DOI 10.1093/infdis/130.4.388; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0152810	10.1371/journal.pone.0152810	http://dx.doi.org/10.1371/journal.pone.0152810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129328	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400077
J	Yin, GW; Kistler, S; George, SD; Kuhlmann, N; Garvey, L; Huynh, M; Bagni, RK; Lammers, M; Der, CJ; Campbell, SL				Yin, Guowei; Kistler, Samantha; George, Samuel D.; Kuhlmann, Nora; Garvey, Leslie; Minh Huynh; Bagni, Rachel K.; Lammers, Michael; Der, Channing J.; Campbell, Sharon L.			A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; NUCLEAR-MAGNETIC-RESONANCE; RAS ACTIVATOR SON; K-RAS; BINDING PROTEINS; STRUCTURAL BASIS; H-RAS; ACETYLATION; EFFECTORS; DYNAMICS	The KRAS GTPase plays a critical role in the control of cellular growth. The activity of KRAS is regulated by guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and also post-translational modification. Lysine 104 in KRAScan be modified by ubiquitylation and acetylation, but the role of this residue in intrinsic KRAS function has not been well characterized. We find that lysine 104 is important for GEF recognition, because mutations at this position impaired GEF-mediated nucleotide exchange. Because the KRAS K104Q mutant has recently been employed as an acetylation mimetic, we conducted a series of studies to evaluate its in vitro and cellbased properties. Herein, we found that KRAS K104Q exhibited defects in both GEF-mediated exchange and GAP-mediated GTP hydrolysis, consistent with NMR-detected structural perturbations in localized regions of KRAS important for recognition of these regulatory proteins. Despite the partial defect in both GEF and GAP regulation, KRAS K104Q did not alter steady-state GTP-bound levels or the ability of the oncogenic KRAS G12V mutant to cause morphologic transformation of NIH 3T3 mouse fibroblasts and of WT KRAS to rescue the growth defect of mouse embryonic fibroblasts deficient in all Ras genes. We conclude that the KRAS K104Q mutant retains bothWTand mutant KRAS function, probably due to offsetting defects in recognition of factors that up-regulate (GEF) and down-regulate (GAP) RAS activity.	[Yin, Guowei; Kistler, Samantha; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Eshelman Sch Pharm, Chapel Hill, NC 27699 USA; [Kistler, Samantha] Univ N Carolina, Dept Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27699 USA; [George, Samuel D.; Minh Huynh; Der, Channing J.; Campbell, Sharon L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27699 USA; [George, Samuel D.; Der, Channing J.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27699 USA; [Kuhlmann, Nora; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kuhlmann, Nora; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Garvey, Leslie; Bagni, Rachel K.] Frederick Natl Lab Canc Res, Canc Res Technol Program, NCI RAS Initiat, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Campbell, SL (corresponding author), 120 Mason Farm Rd,CB 7260,3093 Genet Med, Chapel Hill, NC 27599 USA.	campbesl@med.unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022; Lammers, Michael/AAX-1164-2020	campbell, sharon/0000-0003-0311-409X; Yin, Guowei/0000-0003-2669-7160; Der, Channing/0000-0002-7751-2747; Lammers, Michael/0000-0003-4168-4640	National Institutes of Health [R01-GM106227, PO1-CA5104986, P01-CA5104986, R01-CA042978, U01-CA199235]; Deutsche Forschungsgemeinschaft (DFG) [LA2984/3-1]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA042978, U01CA199235, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106227, T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM106227 and PO1-CA5104986 (to S.L.C.) and P01-CA5104986, R01-CA042978, and U01-CA199235 (to C.J.D.) and Heisenberg Program of the Deutsche Forschungsgemeinschaft (DFG) Grant LA2984/3-1 (to M.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Fujimoto H, 2012, J COMPUT CHEM, V33, P239, DOI 10.1002/jcc.21956; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Knyphausen P, 2016, BIOL CHEM, V397, P1071, DOI 10.1515/hsz-2016-0118; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Long D, 2013, ANGEW CHEM INT EDIT, V52, P10771, DOI 10.1002/anie.201305434; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Terada T, 1999, J MOL BIOL, V286, P219, DOI 10.1006/jmbi.1998.2472; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T	42	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4446	4456		10.1074/jbc.M116.762435	http://dx.doi.org/10.1074/jbc.M116.762435			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154176	Green Published, hybrid			2022-12-26	WOS:000397585100006
J	Derbel, O; Heudel, PE; Cropet, C; Meeus, P; Vaz, G; Biron, P; Cassier, P; Decouvelaere, AV; Ranchere-Vince, D; Collard, O; De Laroche, E; Thiesse, P; Farsi, F; Cellier, D; Gilly, FN; Blay, JY; Ray-Coquard, I				Derbel, Olfa; Heudel, Pierre Etienne; Cropet, Claire; Meeus, Pierre; Vaz, Gualter; Biron, Pierre; Cassier, Philippe; Decouvelaere, Anne-Valerie; Ranchere-Vince, Dominique; Collard, Olivier; De Laroche, Eric; Thiesse, Philippe; Farsi, Fadila; Cellier, Dominic; Gilly, Francois-Noel; Blay, Jean-Yves; Ray-Coquard, Isabelle			Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)	PLOS ONE			English	Article							CANCER STATISTICS; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS	Purpose The outcome of sarcoma has been suggested in retrospective and non-exhaustive studies to be better through management by a multidisciplinary team of experts and adherence to clinical practice guidelines (CPGs). The aim of this prospective and exhaustive population based study was to confirm the impact of adherence to CPGs on survival in patients with localized sarcoma. Experimental design Between 2005 and 2007, all evaluable adult patients with a newly diagnosis of localized sarcoma located in Rhone Alpes region (n = 634), including 472 cases of soft-tissue sarcoma (STS), were enrolled. The prognostic impact of adherence to CPGs on progression-free survival (PFS) and overall survival (OS) was assessed by multivariate Cox model in this cohort. Results The median age was 61 years (range 16-92). The most common subtypes were liposarcoma (n = 133, 28%), unclassified sarcoma (n = 98, 20.7%) and leiomyosarcoma (n = 69, 14.6%). In the initial management phase, from diagnosis to adjuvant treatment, the adherence to CPGs for patients with localized STS was 36% overall, corresponding to 56%, 85%, 96% and 84% for initial surgery, radiation therapy, chemotherapy and follow-up, respectively. Adherence to CPGs for surgery was the strongest independent prognostic factor PFS, along with age, gender, grade, and tumor size. For OS, multivariate analysis adherence to CPGs for surgery was a strong independent prognostic factor, with an important interaction with a management in the regional expert centers. Conclusions This study demonstrates impact of CPGs and treatment within an expert center on survival for STS patients in a whole population-based cohort.	[Derbel, Olfa; Heudel, Pierre Etienne; Biron, Pierre; Cassier, Philippe; Cellier, Dominic; Blay, Jean-Yves; Ray-Coquard, Isabelle] Ctr Leon Berard, Dept Med Oncol, Lyon, France; [Cropet, Claire] Ctr Leon Berard, Dept Biostat, Lyon, France; [Meeus, Pierre; Vaz, Gualter] Ctr Leon Berard, Dept Surg, Lyon, France; [Meeus, Pierre; Vaz, Gualter; Ranchere-Vince, Dominique; Collard, Olivier; Blay, Jean-Yves; Ray-Coquard, Isabelle] GSF GETO, Lyon, France; [Vaz, Gualter] Clin IRIS, Dept Orthoped Surg, Lyon, France; [Decouvelaere, Anne-Valerie; Ranchere-Vince, Dominique] Ctr Leon Berard, Dept Pathol, Lyon, France; [Collard, Olivier; De Laroche, Eric] Inst Cancerol Lucien Neuwirth, St Priest En Jarez, France; [Thiesse, Philippe] Ctr Leon Berard, Dept Radiol, Lyon, France; [Farsi, Fadila; Blay, Jean-Yves; Ray-Coquard, Isabelle] Reseau Espace Sante Canc, Rhone Alpes, France; [Gilly, Francois-Noel; Blay, Jean-Yves; Ray-Coquard, Isabelle] Univ Claude Bernard, Lyon, France; [Blay, Jean-Yves; Ray-Coquard, Isabelle] Univ Lyon 1, Lab HESPER EA 7425, Lyon, France	UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Institut de Cancerologie de la Loire; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Derbel, O (corresponding author), Ctr Leon Berard, Dept Med Oncol, Lyon, France.	Olfa.derbel@lyon.unicancer.fr	Blay, Jean-Yves/N-3966-2016	Blay, Jean-Yves/0000-0001-7190-120X; HEUDEL, Pierre/0000-0002-2155-549X				Bauer HCF, 2001, ACTA ORTHOP SCAND, V72, P150, DOI 10.1080/000164701317323408; Bhangu A. A., 2004, Sarcoma, V8, P1, DOI 10.1080/13577140410001679185; Blay JY, 2012, ANN ONCOL, V23, P92, DOI 10.1093/annonc/mds253; Casali PG, 2009, ANN ONCOL, V20, P132, DOI 10.1093/annonc/mdp153; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hebert-Croteau N, 2004, J CLIN ONCOL, V22, P3685, DOI 10.1200/JCO.2004.07.018; Heudel PE, 2013, INT J CLIN ONCOL; Hussein R, 2005, ANN ROY COLL SURG, V87, P171, DOI 10.1308/1478708051658; Jansen-Landheer MLEA, 2009, EJSO-EUR J SURG ONC, V35, P1326, DOI 10.1016/j.ejso.2009.05.002; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Mankin Henry J, 2005, Cancer Control, V12, P5; Misra A, 2009, J PLAST RECONSTR AES, V62, P161, DOI 10.1016/j.bjps.2008.08.018; Paszat Lawrence, 2002, Sarcoma, V6, P19, DOI 10.1080/13577140220127521; Paulson EC, 2008, ANN SURG, V248, P675, DOI 10.1097/SLA.0b013e318187a757; Ray-Coquard I, 2004, ANN ONCOL, V15, P307, DOI 10.1093/annonc/mdh058; Rossi CR, 2013, ANN ONCOL, V24, P1685, DOI 10.1093/annonc/mdt031; Rydholm A, 1997, ACTA ORTHOP SCAND, V68, P4, DOI 10.1080/17453674.1997.11744695; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7	27	49	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0158406	10.1371/journal.pone.0158406	http://dx.doi.org/10.1371/journal.pone.0158406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158190	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700001
J	Mayekar, HV; Kodandaramaiah, U				Mayekar, Harshad Vijay; Kodandaramaiah, Ullasa			Pupal colour plasticity in a tropical butterfly, Mycalesis mineus (Nymphalidae: Satyrinae)	PLOS ONE			English	Article							PAPILIO-MACHAON L; BATTUS-PHILENOR L; SWALLOWTAIL BUTTERFLIES; PIERIS-BRASSICAE; PHENOTYPIC PLASTICITY; INFORMATION CRITERION; ENVIRONMENTAL-CONTROL; BICYCLUS BUTTERFLIES; MODEL SELECTION; LEPIDOPTERA	Lepidopteran insects have provided excellent study systems for understanding adaptive phenotypic plasticity. Although there are a few well-studied examples of adult plasticity among tropical butterflies, our understanding of plasticity of larval and pupal stages is largely restricted to temperate butterflies. The environmental parameters inducing phenotypic plasticity and the selective pressures acting on phenotypes are likely to differ across tropical and temperate climate regimes. We tested the influence of relative humidity (RH), a prominent yet under-appreciated tropical climatic component, along with pupation substrate, larval development time, pupal sex and weight in determining pupal colour in the tropical satyrine butterfly Mycalesis mineus. Pupae of this butterfly are either brown or green or very rarely intermediate. Larvae were reared at high (85%) and low (60%) RH at a constant temperature. Proportions of green and brown pupae were expected to vary across low and high RH and pupation substrates in order to enhance crypsis. Brown pupae were more common at low RH than at high RH, as predicted, and developed faster than green pupae. Pupal colour was correlated with pupation substrate. Choice of pupation substrate differed across RH treatments. It is unclear whether pupal colour influences substrate selection or whether substrate influences pupal colour. Our study underscores the need for further work to understand the basis of pupal plasticity in tropical butterflies.	[Mayekar, Harshad Vijay; Kodandaramaiah, Ullasa] Indian Inst Sci Educ & Res Thiruvananthapuram, ICREEE, Maruthamala PO Vithura, Thiruvananthapuram, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Mayekar, HV (corresponding author), Indian Inst Sci Educ & Res Thiruvananthapuram, ICREEE, Maruthamala PO Vithura, Thiruvananthapuram, Kerala, India.	mayekarharshad@iisertvm.ac.in	Mayekar, Harshad Vijay/AAE-3791-2022	Mayekar, Harshad/0000-0003-4053-5918; Kodandaramaiah, Ullasa/0000-0002-1564-1738	Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; Department of Science and Technology (INSPIRE Faculty Award) [DST/INSPIRE/04/2013/000476]	Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; Department of Science and Technology (INSPIRE Faculty Award)(Department of Science & Technology (India))	This work was supported by the Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; http://www.iisertvm.ac.in, and the Department of Science and Technology (INSPIRE Faculty Award to UK: DST/INSPIRE/04/2013/000476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Agresti A., 2011, CATEGORICAL DATA ANA; Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Andersson S, 1996, P ROY SOC B-BIOL SCI, V263, P843, DOI 10.1098/rspb.1996.0124; ANGERSBACH D, 1975, J INSECT PHYSIOL, V21, P1691, DOI 10.1016/0022-1910(75)90181-X; ANGERSBACH D, 1971, NATURWISSENSCHAFTEN, V58, P571, DOI 10.1007/BF00598731; BAKER RR, 1970, J ZOOL, V162, P43; Bowden S.R., 1979, Entomologist's Gazette, V30, P112; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brakefield P. M., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P337; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Brecher L, 1921, ARCH ENTWICKLUNG ORG, V48, P1, DOI 10.1007/BF02554478; Brisson JA, 2005, EVOLUTION, V59, P1046; Burnham K P, 2003, MODEL SELECT MULTIMO; CLARKE CA, 1972, J ENTOMOL SER A-GEN, V46, P123; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks H. V., 1987, BIOL SURVEY CANADA M, V1, P1; Edmunds M., 1974, DEFENCE ANIMALS; Evans WH, 1927, IDENTIFICATION INDIA; Fox J., 2014, R COMPANION APPL REG; Fox J., 2016, PACKAGE CAR; GARDINER BO, 1974, ROUX ARCH DEV BIOL, V176, P13, DOI 10.1007/BF00577829; Harrison JWH, 1928, P R SOC LOND B-CONTA, V102, P347, DOI 10.1098/rspb.1928.0010; HAZEL W, 1987, HEREDITY, V59, P449, DOI 10.1038/hdy.1987.155; Hazel W, 1998, ECOL ENTOMOL, V23, P41, DOI 10.1046/j.1365-2311.1998.00092.x; HAZEL WN, 1979, ECOL ENTOMOL, V4, P393, DOI 10.1111/j.1365-2311.1979.tb00599.x; HAZEL WN, 1983, ECOL ENTOMOL, V8, P37, DOI 10.1111/j.1365-2311.1983.tb00480.x; Hidaka T., 1959, JAP J EXP MORPH, V13, P1; Hidaka T., 1959, DOBUTSUGAKU ZASSHI, V68, P222; Hiraga S, 2005, J INSECT PHYSIOL, V51, P1033, DOI 10.1016/j.jinsphys.2005.04.018; Hiraga S, 2006, J INSECT PHYSIOL, V52, P826, DOI 10.1016/j.jinsphys.2006.05.002; HONDA K, 1981, APPL ENTOMOL ZOOL, V16, P467, DOI 10.1303/aez.16.467; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ishizaki H., 1956, Memoirs of the College of Science University of Kyoto (B), V23, P11; KAYSER H, 1974, J INSECT PHYSIOL, V20, P2277, DOI 10.1016/0022-1910(74)90050-X; KINGSOLVER JG, 1991, AM NAT, V137, P816, DOI 10.1086/285195; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Majerus M, 1998, MELANISM EVOLUTION A; Mazerolle M.J., 2011, R PACKAGE VERSION, V1; McCullagh P, 1989, GEN LINEAR MODELS; Merrifield F, 1899, T ROY ENT SOC LONDON, V47, P369; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; NYLIN S, 1989, BIOL J LINN SOC, V38, P155, DOI 10.1111/j.1095-8312.1989.tb01571.x; Ohnishi E., 1956, Zoological Magazine Tokyo, V65, P185; Oltmer A., 1968, STEUERUNG MELANINEIN, V160, P401; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Parkash R, 2010, EVOL ECOL, V24, P207, DOI 10.1007/s10682-009-9301-9; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Poulton E. B., 1887, Philosophical Transactions, Vvol. 178, P311, DOI 10.1098/rstb.1887.0014; R Core Team, 2013, R LANG ENV STAT COMP; R Studio Team, 2016, RSTUDIO INT DEV ENV; RAI SN, 1986, J ECOL, V74, P455, DOI 10.2307/2260267; Rajpurohit S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163414; ROFF D, 1983, DIAPAUSE LIFE CYCLE, P253; ROTHSCHILD M, 1975, NATURE, V254, P592, DOI 10.1038/254592a0; Saji K, 2017, BUTTERFLIES INDIA, V2.24; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Sheppard PM, 1958, NAT SEL HERED; SIMS SR, 1983, HEREDITY, V50, P159, DOI 10.1038/hdy.1983.17; SIMS SR, 1983, ECOL ENTOMOL, V8, P95, DOI 10.1111/j.1365-2311.1983.tb00486.x; SINGER MC, 1982, AM NAT, V119, P440, DOI 10.1086/283924; SMITH AG, 1978, PROC R SOC SER B-BIO, V200, P295, DOI 10.1098/rspb.1978.0021; SMITH AG, 1980, PROC R SOC SER B-BIO, V207, P163, DOI 10.1098/rspb.1980.0019; SMITH DAS, 1988, BIOL J LINN SOC, V33, P17, DOI 10.1111/j.1095-8312.1988.tb00444.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WEST DA, 1972, J NEW YORK ENTOMOL S, V80, P205; WEST DA, 1985, PHYSIOL ENTOMOL, V10, P113, DOI 10.1111/j.1365-3032.1985.tb00025.x; West-Eberhard Mary Jane, 2003, pi; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; WIKLUND C, 1991, OIKOS, V60, P241, DOI 10.2307/3544871; WIKLUND C, 1972, NATURWISSENSCHAFTEN, V59, P219, DOI 10.1007/BF00595518; WIKLUND C, 1975, T ROY ENT SOC LONDON, V127, P73; Windig JJ, 1999, HEREDITY, V82, P57, DOI 10.1038/sj.hdy.6884510; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Wood TW., 1867, P ROYAL ENTOMOLOGICA, P98; Wynter Blyth MA, 1957, BUTTERFLIES INDIAN R; Yamamoto K, 2011, J INSECT PHYSIOL, V57, P930, DOI 10.1016/j.jinsphys.2011.04.002	82	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171482	10.1371/journal.pone.0171482	http://dx.doi.org/10.1371/journal.pone.0171482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158254	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700083
J	Ovsyannikova, IG; Schaid, DJ; Larrabee, BR; Haralambieva, IH; Kennedy, RB; Poland, GA				Ovsyannikova, Inna G.; Schaid, Daniel J.; Larrabee, Beth R.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.			A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CLASS-I SUPERTYPES; IMMUNE-RESPONSES; CYTOKINE RESPONSES; SMALLPOX VACCINE; GENETIC-CONTROL; VIRUS; POLYMORPHISMS; ALLELES; CELL	Human antibody response to measles vaccine is highly variable in the population. Host genes contribute to inter-individual antibody response variation. The killer cell immunoglobulin- like receptors (KIR) are recognized to interact with HLA molecules and possibly influence humoral immune response to viral antigens. To expand on and improve our previous work with HLA genes, and to explore the genetic contribution of KIR genes to the inter-individual variability in measles vaccine-induced antibody responses, we performed a large population-based study in 2,506 healthy immunized subjects (ages 11 to 41 years) to identify HLA and KIR associations with measles vaccine-induced neutralizing antibodies. After correcting for the large number of statistical tests of allele effects on measles-specific neutralizing antibody titers, no statistically significant associations were found for either HLA or KIR loci. However, suggestive associations worthy of follow-up in other cohorts include B*57: 01, DQB1*06: 02, and DRB1*15: 05 alleles. Specifically, the B*57: 01 allele (1,040 mIU/mL; p = 0.0002) was suggestive of an association with lower measles antibody titer. In contrast, the DQB1*06: 02 (1,349 mIU/mL; p = 0.0004) and DRB1*15: 05 (2,547 mIU/mL; p = 0.0004) alleles were suggestive of an association with higher measles antibodies. Notably, the associations with KIR genotypes were strongly nonsignificant, suggesting that KIR loci in terms of copy number and haplotypes are not likely to play a major role in antibody response to measles vaccination. These findings refine our knowledge of the role of HLA and KIR alleles in measles vaccine-induced immunity.	[Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55905 USA; [Schaid, Daniel J.; Larrabee, Beth R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967; Larrabee, Beth/0000-0001-9100-563X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI033144, R37AI048793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R37AI048793, R01AI127365] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI033144 and R37AI048793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Aranda-Romo S, 2012, IMMUNOGENETICS, V64, P653, DOI 10.1007/s00251-012-0623-3; Clifford HD, 2012, VACCINE, V30, P6180, DOI 10.1016/j.vaccine.2012.07.063; Clifford HD, 2012, CLIN VACCINE IMMUNOL, V19, P704, DOI 10.1128/CVI.05652-11; Clifford HD, 2012, IMMUNOGENETICS, V64, P219, DOI 10.1007/s00251-011-0574-0; de Wit J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00286; EMBL-EBI, 2016, IPD IMGT HLA DAT; FORTHAL DN, 1993, J INFECT DIS, V168, P1020, DOI 10.1093/infdis/168.4.1020; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Haralambieva IH, 2008, CLIN VACCINE IMMUNOL, V15, P1054, DOI 10.1128/CVI.00008-08; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Johnson KL, 2005, J PROTEOME RES, V4, P2243, DOI 10.1021/pr0501416; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin WHW, 2014, MBIO, V5, DOI 10.1128/mBio.01047-14; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2005, IMMUNOGENETICS, V57, P828, DOI 10.1007/s00251-005-0061-6; Ovsyannikova IG, 2005, IMMUNOGENETICS, V56, P798, DOI 10.1007/s00251-004-0756-0; Ovsyannikova IG, 2004, VACCINE, V22, P1914, DOI 10.1016/j.vaccine.2003.11.016; Ovsyannikova IG, 2004, J VIROL, V78, P42, DOI 10.1128/JVI.78.1.42-51.2004; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Ovsyannikova IG, 2006, CYTOKINE, V36, P173, DOI 10.1016/j.cyto.2006.12.001; Ovsyannikova IG, 2014, HUM GENET, V133, P1083, DOI 10.1007/s00439-014-1449-x; Ovsyannikova IG, 2013, HUM IMMUNOL, V74, P768, DOI 10.1016/j.humimm.2013.01.031; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Ovsyannikova I, 2011, HUM GENET, V130, P547, DOI 10.1007/s00439-011-0977-x; Ovsyannikova IG, 2011, J INFECT DIS, V203, P1546, DOI 10.1093/infdis/jir167; Ovsyannikova IG, 2012, VACCINE, V30, P2146, DOI 10.1016/j.vaccine.2012.01.038; Parham P, 2003, TISSUE ANTIGENS, V62, P194, DOI 10.1034/j.1399-0039.2003.00126.x; Poland GA, 2001, VACCINE, V20, P430, DOI 10.1016/S0264-410X(01)00346-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Vukcevic D, 2015, AM J HUM GENET, V97, P593, DOI 10.1016/j.ajhg.2015.09.005; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Ward BJ, 1999, DIAGN MICR INFEC DIS, V33, P147, DOI 10.1016/S0732-8893(98)00069-8	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171261	10.1371/journal.pone.0171261	http://dx.doi.org/10.1371/journal.pone.0171261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158231	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700047
J	Song, YR; Sullivan, T; Klarmann, K; Gilbert, D; O'Sullivan, TN; Lu, L; Wang, S; Haines, DC; Van Dyke, T; Keller, JR				Song, Yurong; Sullivan, Teresa; Klarmann, Kimberly; Gilbert, Debra; O'Sullivan, T. Norene; Lu, Lucy; Wang, Sophie; Haines, Diana C.; Van Dyke, Terry; Keller, Jonathan R.			RB inactivation in keratin 18 positive thymic epithelial cells promotes non-cell autonomous T cell hyperproliferation in genetically engineered mice	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DELTA-LIKE-1 IN-VITRO; DELTA-LIKE 4; LINEAGE COMMITMENT; CYCLIN D1; EXPRESSION; PRB; MICROENVIRONMENT; PROLIFERATION; HYPERPLASIA	Thymic epithelial cells (TEC), as part of thymic stroma, provide essential growth factors/cytokines and self-antigens to support T cell development and selection. Deletion of Rb family proteins in adult thymic stroma leads to T cell hyperplasia in vivo. To determine whether deletion of Rb specifically in keratin (K) 18 positive TEC was sufficient for thymocyte hyperplasia, we conditionally inactivated Rb and its family members p107 and p130 in K18+ TEC in genetically engineered mice (TgK18GT(121); K18 mice). We found that thymocyte hyperproliferation was induced in mice with Rb inactivation in K18+ TEC, while normal T cell development was maintained; suggesting that inactivation of Rb specifically in K18+ TEC was sufficient and responsible for the phenotype. Transplantation of wild type bone marrow cells into mice with Rb inactivation in K18+ TEC resulted in donor T lymphocyte hyperplasia confirming the non-cell autonomous requirement for Rb proteins in K18+ TEC in regulating T cell proliferation. Our data suggests that thymic epithelial cells play an important role in regulating lymphoid proliferation and thymus size.	[Song, Yurong; Sullivan, Teresa; Klarmann, Kimberly; Gilbert, Debra; O'Sullivan, T. Norene; Lu, Lucy; Wang, Sophie; Van Dyke, Terry; Keller, Jonathan R.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Klarmann, Kimberly; Keller, Jonathan R.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Haines, Diana C.] Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Keller, JR (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA.; Keller, JR (corresponding author), Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.	kellerjo@mail.nih.gov	Keller, Jonathan R./O-6677-2018; Song, Yurong/GRX-9328-2022		Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; National Cancer Institute (NCI) [NCI CA084314, CA046283]; DOD [PC040619, PC050306]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [ZIABC010001] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research, NIH; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part with Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E (https://frederick.cancer.gov/), and in part with research funding from National Cancer Institute (NCI, https://www.cancer.gov/), and NCI CA084314 and CA046283 (https://www.cancer.gov/), DOD PC040619 (http://www.defense.gov/), Prostate Cancer Foundation to TVD (http://www.pcf.org/), and DOD PC050306 to YS (http://www.defense.gov/). The funders including Frederick National Laboratory operated by Leidos Biomedical Research, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsements by the US Government.	Alexandropoulos K, 2012, IMMUNOL RES, V54, P177, DOI 10.1007/s12026-012-8301-y; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Awong G, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-22; Badea TC, 2003, J NEUROSCI, V23, P2314; Billiard F, 2011, EUR J IMMUNOL, V41, P2207, DOI 10.1002/eji.201041343; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carraresi L, 2001, ONCOGENE, V20, P8148, DOI 10.1038/sj.onc.1205007; CHANTRY D, 1989, EUR J IMMUNOL, V19, P783, DOI 10.1002/eji.1830190433; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Danzl NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086129; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Garfin PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149430; Garfin PM, 2013, J EXP MED, V210, P1087, DOI 10.1084/jem.20121716; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; Holmes R, 2009, COLD SPRING HARB PRO; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Magri M, 2009, EUR J IMMUNOL, V39, P1231, DOI 10.1002/eji.200838765; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mulligan GJ, 1998, MOL CELL BIOL, V18, P206, DOI 10.1128/MCB.18.1.206; Nitta T, 2016, CELL MOL LIFE SCI, V73, P1021, DOI 10.1007/s00018-015-2107-8; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Rodriguez-Puebla ML, 2000, AM J PATHOL, V157, P1039, DOI 10.1016/S0002-9440(10)64616-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Song YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080459; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Szabova L, 2012, CANCER RES, V72, P13; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171510	10.1371/journal.pone.0171510	http://dx.doi.org/10.1371/journal.pone.0171510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158249	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700088
J	Zou, J; Semagn, K; Iqbal, M; Chen, H; Asif, M; N'Diaye, A; Navabi, A; Perez-Lara, E; Pozniak, C; Yang, RC; Randhawa, H; Spaner, D				Zou, Jun; Semagn, Kassa; Iqbal, Muhammad; Chen, Hua; Asif, Mohammad; N'Diaye, Amidou; Navabi, Alireza; Perez-Lara, Enid; Pozniak, Curtis; Yang, Rong-Cai; Randhawa, Harpinder; Spaner, Dean			QTLs associated with agronomic traits in the Attila x CDC Go spring wheat population evaluated under conventional management	PLOS ONE			English	Article							WEED-COMPETITIVE ABILITY; MOLECULAR CHARACTERIZATION; CHROMOSOMAL LOCATIONS; GENETIC-ANALYSIS; DWARFING GENES; QUALITY TRAITS; GRAIN-YIELD; VERNALIZATION; EARLINESS; MARKERS	Recently, we investigated the effect of the wheat 90K single nucleotide polymorphic (SNP) array and three gene-specific (Ppd-D1, Vrn-A1 and Rht-B1) markers on quantitative trait loci (QTL) detection in a recombinant inbred lines (RILs) population derived from a cross between two spring wheat (Triticum aestivum L.) cultivars, 'Attila' and 'CDC Go', and evaluated for eight agronomic traits at three environments under organic management. The objectives of the present study were to investigate the effect of conventional management on QTL detection in the same mapping population using the same set of markers as the organic management and compare the results with organic management. Here, we evaluated 167 RILs for number of tillers (tillering), flowering time, maturity, plant height, test weight (grain volume weight), 1000 kernel weight, grain yield, and grain protein content at seven conventionally managed environments from 2008 to 2014. Using inclusive composite interval mapping (ICIM) on phenotypic data averaged across seven environments and a subset of 1203 informative markers (1200 SNPs and 3 gene specific markers), we identified a total of 14 QTLs associated with flowering time (1), maturity (2), plant height (1), grain yield (1), test weight (2), kernel weight (4), tillering (1) and grain protein content (2). Each QTL individually explained from 6.1 to 18.4% of the phenotypic variance. Overall, the QTLs associated with each trait explained from 9.7 to 35.4% of the phenotypic and from 22.1 to 90.8% of the genetic variance. Three chromosomal regions on chromosomes 2D (61-66 cM), 4B (80-82 cM) and 5A (296-297 cM) harbored clusters of QTLs associated with two to three traits. The coincidental region on chromosome 5A harbored QTL clusters for both flowering and maturity time, and mapped about 2 cM proximal to the Vrn-A1 gene, which was in high linkage disequilibrium (0.70 <= r(2) <= 0.75) with SNP markers that mapped within the QTL confidence interval. Six of the 14 QTLs (one for flowering time and plant height each, and two for maturity and kernel weight each) were common between the conventional and organic management systems, which suggests issues in directly utilizing gene discovery results based on conventional management to make in detail selection (decision) for organic management.	[Zou, Jun; Semagn, Kassa; Iqbal, Muhammad; Chen, Hua; Perez-Lara, Enid; Yang, Rong-Cai; Spaner, Dean] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Iqbal, Muhammad] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Asif, Mohammad] Kansas State Univ, Throckmorton Plant Sci Ctr 2004, Dept Agron, Manhattan, KS 66506 USA; [Asif, Mohammad] Kansas Wheat Innovat Ctr, Heartland Plant Innovat, Manhattan, KS USA; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Navabi, Alireza] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Yang, Rong-Cai] Alberta Agr & Forestry, St Edmonton, AB, Canada; [Randhawa, Harpinder] Agr & Agri Food Canada, Lethbridge, AB, Canada	University of Alberta; National Agricultural Research Council - Pakistan; Kansas State University; University of Saskatchewan; University of Saskatchewan; University of Guelph; Agriculture & Agri Food Canada	Spaner, D (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	dspaner@ualberta.ca	Randhawa, Harpinder/AAQ-7207-2021; Semagn, Kassa/S-8858-2017	Semagn, Kassa/0000-0001-6486-5685; N'Diaye, Amidou/0000-0001-7769-7801; Iqbal, Muhammad/0000-0002-7519-6023; Zou, Jun/0000-0003-3271-895X; Spaner, Dean/0000-0002-2088-5104; Perez-Lara, Enid/0000-0002-9672-0226	Alberta Crop Industry Development Fund; Alberta Wheat Commission; Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada; Western Grains Research Foundation; NSERC; Saskatchewan Ministry of Agriculture; Agriculture and Agri-Food Canada; Genome Canada; Genome Prairie; Genome Alberta; Alberta Innovates; Chinese Government; Pakistani Government	Alberta Crop Industry Development Fund; Alberta Wheat Commission; Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada; Western Grains Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Ministry of Agriculture; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Genome Canada(Genome Canada); Genome Prairie; Genome Alberta; Alberta Innovates; Chinese Government; Pakistani Government	The present study was financed by grants to the University of Alberta wheat breeding program from the Alberta Crop Industry Development Fund, the Alberta Wheat Commission, an Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada, Western Grains Research Foundation Endowment and check-off Funds, and an NSERC Discovery Grant to D. Spaner. This work was conducted in part within the project "Canadian Triticum Advancement Through Genomics (CTAG)". We would like to acknowledge CTAG funding provided by the Saskatchewan Ministry of Agriculture, Western Grains Research Foundation, Agriculture and Agri-Food Canada, Genome Canada, Genome Prairie, Genome Alberta and Alberta Innovates. The study was also partly supported by Chinese Government Scholarships to both Jun Zou and Hua Chen, and Pakistani Government Fellowships to Mohammad Asif and Muhammad Iqbal.	Asif M, 2015, CROP SCI, V55, P1129, DOI 10.2135/cropsci2014.01.0080; Babiker EM, 2015, THEOR APPL GENET, V128, P605, DOI 10.1007/s00122-015-2456-6; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Chen F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-199; Chen H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0373-7; CUDNEY DW, 1991, WEED SCI, V39, P175, DOI 10.1017/S0043174500071435; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Elouafi I, 2004, THEOR APPL GENET, V108, P401, DOI 10.1007/s00122-003-1440-8; Entz MH, 2001, CAN J PLANT SCI, V81, P351, DOI 10.4141/P00-089; Evans L., 1998, FEEDING 10 BILLION P; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Iqbal M, 2007, EUPHYTICA, V154, P207, DOI 10.1007/s10681-006-9289-y; Kamran A, 2013, THEOR APPL GENET, V126, P1965, DOI 10.1007/s00122-013-2110-0; Kaut AHEE, 2008, AGRON SUSTAIN DEV, V28, P363, DOI 10.1051/agro:2008017; Kaut AHEE, 2009, J AGR SCI-CAMBRIDGE, V147, P141, DOI 10.1017/S0021859608008319; Letourneau DK, 2008, COMP ORGANIC CONVENT, P430; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li WL, 2002, EUPHYTICA, V125, P357, DOI 10.1023/A:1016069809977; Liu SY, 2016, CROP SCI, V56, P364, DOI 10.2135/cropsci2015.03.0194; Mason H, 2007, RENEW AGR FOOD SYST, V22, P157, DOI 10.1017/S1742170507001688; Mason H, 2007, AGRON J, V99, P1199, DOI 10.2134/agronj2006.0262; Mason HE, 2007, CROP SCI, V47, P1167, DOI 10.2135/cropsci2006.09.0566; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Pearson D, 2011, RENEW AGR FOOD SYST, V26, P171, DOI 10.1017/S1742170510000499; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Perez-Lara E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160623; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; Reid TA, 2011, EUPHYTICA, V177, P253, DOI 10.1007/s10681-010-0257-1; Reid TA, 2009, CAN J PLANT SCI, V89, P591, DOI 10.4141/CJPS08105; Reid TA, 2009, EUPHYTICA, V169, P239, DOI 10.1007/s10681-009-9949-9; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Tadesse W, 2010, CROP SCI, V50, P2240, DOI 10.2135/cropsci2010.02.0102; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Zerner MC, 2008, AGRON J, V100, P1729, DOI 10.2134/agronj2008.0068; Zou J, 2016, CROP SCI	49	24	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171528	10.1371/journal.pone.0171528	http://dx.doi.org/10.1371/journal.pone.0171528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158253	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700092
J	Kassahun, CW; Mekonen, AG				Kassahun, Chanyalew Worku; Mekonen, Alemayehu Gonie			Knowledge, attitude, practices and their associated factors towards diabetes mellitus among non diabetes community members of Bale Zone administrative towns, South East Ethiopia. A cross-sectional study	PLOS ONE			English	Article							AWARENESS	Background Diabetes kills more than 4.9 million adults per year. It becomes rapidly increasing, non-communicable disease-a major threat to global public health particularly in Sub-Saharan Africa. Though previous studies among diabetic patients were focused in health institution, limited knowledge, attitude and practice were seen. There is no study conducted about diabetes related to knowledge, attitudes, practice and associated factors in the community level. Objective of the study The study assessed knowledge, attitude, practices, and its associated factors towards diabetes mellitus among non diabetic community members of Bale Zone, Ethiopia. Methods Community based cross-sectional study was conducted from November 15 to December 15, 2015 among 605 non diabetic community members of Bale Zone administrative towns. Data was collected using pretested structured face-to-face interview after taking informed written consent. Respondents were selected by systematic random sampling. The data was entered into EPI data version 3.1 and analyzed using Statistical package for social sciences version 20. Odds ratio and 95% confidence interval were calculated and P<0.05 was considered statistically significant. Finally, multivariable logistic regression analysis was performed to indicate the independent predictors of knowledge, attitude and practice. Result Response rate of the study was 98.2%. About 52.5% of participants were knowledgeable, 55.9% and 56.6% had good attitude and practice respectively. Earning average monthly family income of <= 500 Ethiopian birr (AOR = 0.4, CI = 0.2, 0.6) and 501-1000 (AOR = 0.4, CI = 0.2, 0.7), heard about diabetes (AOR = 4.4, CI = 1.9, 10.2), had diabetes health education exposure (AOR = 5, CI = 2.5, 9.7) resulted to have good diabetes knowledge. Student, (AOR = 5.1, CI = 2.1,12), government/private employee (AOR = 3, CI = 1.4,6.7), merchant (AOR = 2, CI = 1.1,3.6) and Knowledgeable (AOR = 3, CI = 2.1, 4.7) subjects had positive attitude towards diabetes. Having college and above educational level (AOR = 0.33, CI = 0.16, 0.7), having good attitude towards diabetes (AOR = 2, CI = 1.3, 3) had good practiced. Conclusion Considerable limited knowledge, attitude and practices were seen. A great emphasis on health education regarding symptoms and risk factors modification for diabetes are necessary.	[Kassahun, Chanyalew Worku; Mekonen, Alemayehu Gonie] Madda Walabu Univ, Dept Nursing, Coll Med & Hlth Sci, Bale Goba, Ethiopia	University of Gondar	Kassahun, CW (corresponding author), Madda Walabu Univ, Dept Nursing, Coll Med & Hlth Sci, Bale Goba, Ethiopia.	chanyalewworku@gmail.com	Kassahun, Chanyalew Worku/HHN-6462-2022	Kassahun, Chanyalew Worku/0000-0001-9326-8329				Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Aguiree F., 2013, IDF DIABETES ATLAS, Vsixth, P1; Al-Sarayra L., 2012, Pakistan Journal of Nutrition, V11, P1023; Al-Shafaee MA, 2008, BMC PUBLIC HEALTH, V8, P1; Ambigapathy R, 2003, NCD MALAYSIA, V2, P6, DOI DOI 10.18203/2394-6040.IJC-MPH20183824]; [Anonymous], 2009, INT J PHARM SCI, V1, P96; [Anonymous], 2014, BAL ZON HLTH OFF REP; Asmamaw A, 2015, SCI J PUBLIC HLTH, V3, P199, DOI DOI 10.11648/J.SJPH.20150302.17; Ayesha Motala and Kaushik Ramaiya, 2010, DIABETES HIDDEN SUB; Balla SA, 2014, AM J HLTH RES, V2, P356, DOI DOI 10.11648/j.ajhr.20140206.16; Bani IA, 2015, J DIABETES MELLITUS, V5, P115, DOI [10.4236/jdm.2015.52014, DOI 10.4236/JDM.2015.52014]; Berhane, 2013, PMC, V6, P36; Demaio AR, 2013, BMC PUBLIC HEALTH, V236, P2; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; IDF, 2013, INT DIAB FED DIAB AT, V6th; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kiawi E, 2006, ETHN DIS, V16; Longo Dan L., 2012, HARRISONS PRINCIPLES; Maina WK, 2011, AFR J DIABETES MED, V19, P15; Masood I, 2016, PRIM CARE DIABETES, V10, P3, DOI 10.1016/j.pcd.2015.06.004; Minhat H. S., 2014, World Journal of Medical Sciences, V11, P217; Mohamad S, 2006, PAK J MED SCI, V22, P2; Moira A, 2015, NITTE U J HEAL SCI, V5, P4; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mufunda E, 2012, PAN AFRICA MED J, V13, P1; Mumu SJ, 2014, BMC, P2; Pongmesa T, 2007, COMP DIABETES KNOWLE, V95; Rani PK, 2008, INT ELECT J RURAL RE, P1; Rathod GB., 2014, INT J CURR RES REV, V6, P63; Smeltzer S.C., 2012, BRUNNER SUDDARTHS TX; Sristi S, 2015, INT J DIABETES DEV C, V35, P33, DOI 10.1007/s13410-014-0219-6; Thungathurthi S, 2012, INT J LIFE SCI PHARM, V2, pP16; Ulvi Osman Saleem, 2009, JPMA Journal of the Pakistan Medical Association, V59, P798; Williams K.D., 2010, AFR J PRIM HEALTH CA, V7, P1; World Health Organization, 2005, PREV BLINDN DIAB MEL; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zuhaid Muhammad, 2012, J Ayub Med Coll Abbottabad, V24, P105	37	41	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170040	10.1371/journal.pone.0170040	http://dx.doi.org/10.1371/journal.pone.0170040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152066	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200013
J	Lafarge, T; Bueno, C; Frouin, J; Jacquin, L; Courtois, B; Ahmadi, N				Lafarge, Tanguy; Bueno, Crisanta; Frouin, Julien; Jacquin, Laval; Courtois, Brigitte; Ahmadi, Nourollah			Genome-wide association analysis for heat tolerance at flowering detected a large set of genes involved in adaptation to thermal and other stresses	PLOS ONE			English	Article							TEMPERATURE-INDUCED STERILITY; WALL-ASSOCIATED KINASES; SPIKELET STERILITY; CLIMATE-CHANGE; AIR-TEMPERATURE; RICE PRODUCTION; COMPLEX TRAITS; JAPONICA-RICE; EXPRESSION; ANTHESIS	Fertilization sensitivity to heat in rice is a major issue within climate change scenarios in the tropics. A panel of 167 indica landraces and improved varieties was phenotyped for spikelet sterility (SPKST) under 38 C during anthesis and for several secondary traits potentially affecting panicle micro-climate and thus the fertilization process. The panel was genotyped with an average density of one marker per 29 kb using genotyping by sequencing. Genome-wide association analyses (GWAS) were conducted using three methods based on single marker regression, haplotype regression and simultaneous fitting of all markers, respectively. Fourteen loci significantly associated with SPKST under at least two GWAS methods were detected. A large number of associations was also detected for the secondary traits. Analysis of co-localization of SPKST associated loci with QTLs detected in progenies of bi-parental crosses reported in the literature allowed to narrow-down the position of eight of those QTLs, including the most documented one, qHTSF4.1. Gene families underlying loci associated with SPKST corresponded to functions ranging from sensing abiotic stresses and regulating plant response, such as wall associated kinases and heat shock proteins, to cell division and gametophyte development. Analysis of diversity at the vicinity of loci associated with SPKST within the rice three thousand genomes, revealed widespread distribution of the favourable alleles across 0. sativa genetic groups. However, few accessions assembled the favourable alleles at all loci. Effective donors included the heat tolerant variety N22 and some Indian and Taiwanese varieties. These results provide a basis for breeding for heat tolerance during anthesis and for functional validation of major loci governing this trait.	[Lafarge, Tanguy; Frouin, Julien; Jacquin, Laval; Courtois, Brigitte; Ahmadi, Nourollah] CIRAD, UMR AGAP, Montpellier, France; [Bueno, Crisanta] Int Rice Res Inst, Los Banos, Philippines	CIRAD; Universite de Montpellier; CGIAR; International Rice Research Institute (IRRI)	Ahmadi, N (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	ahmadi@cirad.fr	COURTOIS, Brigitte/A-4004-2009	COURTOIS, Brigitte/0000-0003-2118-7102; AHMADI, Nourollah/0000-0003-0072-6285	CIRAD; IRRI	CIRAD; IRRI	The authors received no specific funding for this work. The work was supported by the core budget of CIRAD and IRRI.	Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Chandel G, 2013, J PLANT BIOCHEM BIOT, V22, P277, DOI 10.1007/s13562-012-0156-8; Charmet G, 1999, THEOR APPL GENET, V99, P1143, DOI 10.1007/s001220051318; Cheng LR, 2012, J INTEGR AGR, V11, P359, DOI 10.1016/S2095-3119(12)60020-3; Chotamonsak C, 2011, ATMOS SCI LETT, V12, P213, DOI 10.1002/asl.313; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Das S, 2014, ENVIRON EXP BOT, V101, P36, DOI 10.1016/j.envexpbot.2014.01.004; Delteil A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0711-x; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Gammulla C, 2014, PROTEOMICS, V10, P3001; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Hasegawa Toshihiro, 2011, Journal of Agricultural Meteorology, V67, P225, DOI 10.2480/agrmet.67.4.3; Hayes Ben, 2013, Methods Mol Biol, V1019, P149, DOI 10.1007/978-1-62703-447-0_6; Hu Y, 2010, PLANT PHYSIOL BIOCH, V70, P33; Jacquin L, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-45; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, CROP SCI, V50, P1633, DOI 10.2135/cropsci2009.09.0516; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Kanneganti Vydehi, 2008, Physiology and Molecular Biology of Plants, V14, P109, DOI 10.1007/s12298-008-0010-6; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Krishnan P, 2007, AGR ECOSYST ENVIRON, V122, P233, DOI 10.1016/j.agee.2007.01.019; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Matsui T, 2001, PLANT PROD SCI, V4, P90, DOI 10.1626/pps.4.90; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Meuwissen THE, 2001, GENETICS, V157, P1819; Nakagawa H., 2002, RICE SCI INNOVATIONS, P635; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Park JB, 2006, INT J INNOVATIONS EN, V1, P1, DOI DOI 10.1038/NATURE04788; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perrier X., 2006, DARWIN SOFTWARE; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Pritchard JK, 2000, GENETICS, V155, P945; Radanielina T, 2013, GENET RESOUR CROP EV, V60, P311, DOI 10.1007/s10722-012-9837-3; Rebolledo MC, 2015, J EXP BOT, V66, P5555, DOI 10.1093/jxb/erv258; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P321, DOI 10.1007/s12192-012-0384-9; SATAKE T, 1978, JPN J CROP SCI, V47, P6, DOI 10.1626/jcs.47.6; Sathishraj R, 2016, FIELD CROP RES, V190, P10, DOI 10.1016/j.fcr.2015.10.012; Shah F, 2011, J AGR SCI; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Tanamachi K, 2016, PLANT PROD SCI, V19, P300, DOI 10.1080/1343943X.2016.1140007; Tian XH, 2010, PLANT PROD SCI, V13, P243, DOI 10.1626/pps.13.243; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Wassmann R, 2009, ADV AGRON, V102, P91, DOI 10.1016/S0065-2113(09)01003-7; Xia M. Y., 2004, HUBEI AGR SCI, V2, P21; Xiao YH, 2011, RICE SCI, V18, P204, DOI 10.1016/S1672-6308(11)60028-0; Xiong DL, 2015, FUNCT PLANT BIOL, V42, P347, DOI 10.1071/FP14166; Ye CR, 2012, PLANT BREEDING, V131, P33, DOI 10.1111/j.1439-0523.2011.01924.x; Ye G, 2005, BMC GENET, V16, P41; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zagorchev L, 2014, SCI WORLD J, DOI 10.1155/2014/764089; Zhang GL, 2009, AGR SCI CHINA, V8, P482, DOI 10.1016/S1671-2927(08)60235-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhi-guo E, 2014, SCI WORLD J; Zou J, 2008, EXPRESSION ANAL 9 HE; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	75	25	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171254	10.1371/journal.pone.0171254	http://dx.doi.org/10.1371/journal.pone.0171254			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152098	Green Published, gold			2022-12-26	WOS:000396161200116
J	Witt, KC; Castillo-Menendez, L; Ding, HT; Espy, N; Zhang, SJ; Kappes, JC; Sodroski, J				Witt, Kristen C.; Castillo-Menendez, Luis; Ding, Haitao; Espy, Nicole; Zhang, Shijian; Kappes, John C.; Sodroski, Joseph			Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs	PLOS ONE			English	Article							CRYO-EM STRUCTURE; HUMAN MONOCLONAL-ANTIBODY; TYPE-1 ENVELOPE; NEUTRALIZING ANTIBODIES; MUTATIONAL ANALYSIS; 3-DIMENSIONAL STRUCTURE; MOLECULAR ARCHITECTURE; V3-SPECIFIC ANTIBODIES; CYTOPLASMIC DOMAIN; DEPENDENT EPITOPE	The entry of human immunodeficiency virus (HIV-1) into host cells is mediated by the viral envelope glycoproteins (Envs), which are derived by the proteolytic cleavage of a trimeric gp160 Env precursor. The mature Env trimer is a major target for entry inhibitors and vaccine-induced neutralizing antibodies. Env interstrain variability, conformational flexibility and heavy glycosylation contribute to evasion of the host immune response, and create challenges for structural characterization and vaccine development. Here we investigate variables associated with reconstitution of the HIV-1 Env precursor into nanodiscs, nanoscale lipid bilayer discs enclosed by membrane scaffolding proteins. We identified detergents, as well as lipids similar in composition to the viral lipidome, that allowed efficient formation of Env-nanodiscs (Env-NDs). Env-NDs were created with the full-length Env precursor and with an Env precursor with the majority of the cytoplasmic tail intact. The self-association of Env-NDs was decreased by glutaraldehyde crosslinking. The Env-NDs exhibited an antigenic profile expected for the HIV-1 Env precursor. Env-NDs were recognized by broadly neutralizing antibodies. Of note, neutralizing antibody epitopes in the gp41 membrane-proximal external region and in the gp120:gp41 interface were well exposed on Env-NDs compared with Env expressed on cell surfaces. Most Env epitopes recognized by non-neutralizing antibodies were masked on the Env-NDs. This antigenic profile was stable for several days, exhibiting a considerably longer half-life than that of Env solubilized in detergents. Negative selection with weak neutralizing antibodies could be used to improve the antigenic profile of the Env-NDs. Finally, we show that lipid adjuvants can be incorporated into Env-NDs. These results indicate that Env-NDs represent a potentially useful platform for investigating the structural, functional and antigenic properties of the HIV-1 Env trimer in a membrane context.	[Witt, Kristen C.; Castillo-Menendez, Luis; Espy, Nicole; Zhang, Shijian; Sodroski, Joseph] Harvard Med Sch, Dept Canc Immunol & Virol, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ding, Haitao; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Birmingham Vet Affairs Med Ctr, Res Serv, Birmingham, AL USA; [Sodroski, Joseph] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Harvard Med Sch, Dept Canc Immunol & Virol, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Sodroski, J (corresponding author), Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu			National Institutes of Health [AI100645, AI24755, AI27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI100645) and by the late William F. McCarty-Cooper to J.S. and by the National Institutes of Health (AI24755 and AI27767) to J.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Akkaladevi N, 2013, PROTEIN SCI, V22, P492, DOI 10.1002/pro.2231; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Alsahafi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122111; Astafieva IV, 1996, J CHROMATOGR A, V740, P215, DOI 10.1016/0021-9673(96)00134-3; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; BIBERFELD P, 1974, J IMMUNOL METHODS, V4, P135, DOI 10.1016/0022-1759(74)90056-8; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BUGGE TH, 1990, J VIROL, V64, P4123, DOI 10.1128/JVI.64.9.4123-4129.1990; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COLLINS JS, 1981, J HISTOCHEM CYTOCHEM, V29, P411, DOI 10.1177/29.3.6787116; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fester T, 2008, J MICROSC-OXFORD, V231, P342, DOI 10.1111/j.1365-2818.2008.01999.x; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Foley B, LAUR1326007 LOS AL N; Frauenfeld J, 2016, NAT METHODS, V13, P345, DOI [10.1038/NMETH.3801, 10.1038/nmeth.3801]; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15; Gogol EP, 2013, PROTEIN SCI, V22, P586, DOI 10.1002/pro.2241; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2013, J VIROL, V87, P1884, DOI 10.1128/JVI.02765-12; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jacob RA, 2015, J VIROL, V89, P5264, DOI 10.1128/JVI.00129-15; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Jumel K, 1996, INT J BIOL MACROMOL, V18, P133, DOI 10.1016/0141-8130(95)01071-8; Justesen BH, 2013, J BIOL CHEM, V288, P26419, DOI 10.1074/jbc.M112.446948; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Korber B.T., 1998, HUMAN RETROVIRUSES A; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Mo HM, 2004, VIROLOGY, V329, P319, DOI 10.1016/j.virol.2004.08.025; Moody MA, 2015, CELL HOST MICROBE, V18, P354, DOI 10.1016/j.chom.2015.08.006; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nakatani-Webster E, 2015, J VIROL METHODS, V226, P15, DOI 10.1016/j.jviromet.2015.09.011; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; ROBINSON JE, 1990, J IMMUNOL METHODS, V132, P63, DOI 10.1016/0022-1759(90)90399-G; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Schiffner T, 2013, J VIROL, V87, P10163, DOI 10.1128/JVI.01161-13; Schiffner T, 2016, J VIROL, V90, P813, DOI 10.1128/JVI.01942-15; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	127	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170672	10.1371/journal.pone.0170672	http://dx.doi.org/10.1371/journal.pone.0170672			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151945	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200033
J	Shnorhavorian, M; Schwartz, SM; Stansfeld, B; Sadler-Riggleman, I; Beck, D; Skinner, MK				Shnorhavorian, Margarett; Schwartz, Stephen M.; Stansfeld, Barbara; Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.			Differential DNA Methylation Regions in Adult Human Sperm following Adolescent Chemotherapy: Potential for Epigenetic Inheritance	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; COPY NUMBER VARIATIONS; TRANSGENERATIONAL INHERITANCE; CANCER SURVIVORS; CHILDHOOD-CANCER; GENETIC-DISEASE; SEQUENCING DATA; ONSET DISEASE; FERTILITY; INFERTILITY	Background The potential that adolescent chemotherapy can impact the epigenetic programming of the germ line to influence later life adult fertility and promote epigenetic inheritance was investigated. Previous studies have demonstrated a number of environmental exposures such as abnormal nutrition and toxicants can promote sperm epigenetic changes that impact offspring. Methods Adult males approximately ten years after pubertal exposure to chemotherapy were compared to adult males with no previous exposure. Sperm were collected to examine differential DNA methylation regions (DMRs) between the exposed and control populations. Gene associations and correlations to genetic mutations (copy number variation) were also investigated. Methods and Findings A signature of statistically significant DMRs was identified in the chemotherapy exposed male sperm. The DMRs, termed epimutations, were found in CpG desert regions of primarily 1 kilobase size. Observations indicate adolescent chemotherapy exposure can promote epigenetic alterations that persist in later life. Conclusions This is the first observation in humans that an early life chemical exposure can permanently reprogram the spermatogenic stem cell epigenome. The germline (i.e., sperm) epimutations identified suggest chemotherapy has the potential to promote epigenetic inheritance to the next generation.	[Shnorhavorian, Margarett; Stansfeld, Barbara] Seattle Childrens Res Inst, Seattle, WA USA; [Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Seattle Children's Hospital; Fred Hutchinson Cancer Center; Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu			NIH Male Reproductive Health Research Award [K12 HD053984]; Childrens Oncology Group [AFLAC 2009-2010]; NIH [ES012974-12]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	NIH Male Reproductive Health Research Award; Childrens Oncology Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by NIH Male Reproductive Health Research Award K12 HD053984 and Childrens Oncology Group- AFLAC 2009-2010 Young Investigator Award grants to Margarett Shnorhavorian and NIH grant (ES012974-12) to MKS.	Andrews S, FASTQC A QUALITY CON; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aston KI, 2015, FERTILITY AND STERIL; Atsem S., 2016, HUM MOL GENET; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; Chan DV, 2012, TOXICOL SCI, V125, P532, DOI 10.1093/toxsci/kfr307; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Daling JR, 2009, CANCER, V115, P1215, DOI 10.1002/cncr.24159; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Donkin I, 2015, CELL METABOLISM; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gapp K, 2014, BIOESSAYS, V36, P491, DOI 10.1002/bies.201300116; Green DM, 2010, J CLIN ONCOL, V28, P2824, DOI 10.1200/JCO.2009.27.2922; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hammond C, 2007, J CLIN ONCOL, V25, P3511, DOI 10.1200/JCO.2007.10.8993; HAWKINS MM, 1991, J NATL CANCER I, V83, P1643, DOI 10.1093/jnci/83.22.1643; Howlader N, 2011, SEER CANCER STATISTI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelly WG, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-6; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Littman AJ, 2009, CANCER CAUSE CONTROL, V20, P1281, DOI 10.1007/s10552-009-9347-6; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mikhail FM, 2014, CURR OPIN PEDIATR, V26, P646, DOI 10.1097/MOP.0000000000000142; Murphy PJ, 2016, METHOD CELL BIOL, V135, P345, DOI 10.1016/bs.mcb.2016.05.002; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Pacchierotti F, 2015, BIOMED RES INT, V2015; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito K, 2005, CANCER-AM CANCER SOC, V104, P521, DOI 10.1002/cncr.21185; Schover LR, 1999, MED PEDIATR ONCOL, V33, P53, DOI 10.1002/(SICI)1096-911X(199907)33:1<53::AID-MPO10>3.0.CO;2-K; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; World Health Organization, 1999, WHO MANUAL FOR THE E; Wyrobek Andrew J, 2005, J Natl Cancer Inst Monogr, P31; Zebrack BJ, 2004, PSYCHO-ONCOL, V13, P689, DOI 10.1002/pon.784	58	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170085	10.1371/journal.pone.0170085	http://dx.doi.org/10.1371/journal.pone.0170085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146567	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700011
J	Sanchez, E; Betriu, A; Arroyo, D; Lopez, C; Hernandez, M; Rius, F; Fernandez, E; Lecube, A				Sanchez, Enric; Betriu, Angels; Arroyo, David; Lopez, Carolina; Hernandez, Marta; Rius, Ferran; Fernandez, Elvira; Lecube, Albert			Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CARDIOVASCULAR-DISEASE; VASCULAR COMPLICATIONS; RISK; PROGRESSION; ACCUMULATION; PENTOSIDINE; MORTALITY; STRESS; MARKER	Advanced glycation end-products (AGEs) are increased and predict mortality in patients with chronic kidney disease (CKD) who are undergoing hemodialysis, irrespective of the presence of type 2 diabetes. However, little information exits about the relationship between AGEs and subclinical atherosclerosis at the early stages of CKD. A case-control study was performed including 87 patients with mild-to-moderate stages of CKD (glomerular filtration rate from 89 to 30 ml/min/per 1.73m(2)) and 87 non-diabetic non-CKD subjects matched by age, gender, body mass index, and waist circumference. Skin autofluorescence (AF), a non-invasive assessment of AGEs, was measured. The presence of atheromatous disease in carotid and femoral arteries was evaluated using vascular ultrasound, and vascular age and SCORE risk were estimated. Patients with mild-to-moderate stages of CKD showed an increase in skin AF compared with control subjects (2.5 +/- 0.6 vs. 2.2 +/- 0.4 AU, p<0.001). A skin AF value >2.0 AU was accompanied by a 3-fold increased risk of detecting the presence of an atheromathous plaque (OR 3.0, 95% CI 1.4(_)6.5, p = 0.006). When vascular age was assessed through skin AF, subjects with CKD were almost 12 years older than control subjects (70.3 +/- 25.5 vs. 58.5 +/- 20.2 years, p = 0.001). Skin AF was negatively correlated with glomerular filtration rate (r = -0.354, p<0.001) and LDL-cholesterol (r = -0.269, p = 0.001), and positively correlated with age (r = 0.472, p<0.001), pulse pressure (r = 0.238, p = 0.002), and SCORE risk (r = 0.451, p<0.001). A stepwise multivariate regression analysis showed that age and glomerular filtration rate independently predicted skin AF (R-2 = 0.289, p<0.001). Skin AF is elevated in patients with mild-to-moderate CKD compared with control subjects. This finding may be independently associated with the glomerular filtration rate and the presence of subclinical atheromatous disease. Therefore, the use of skin AF may help to accurately evaluate the real cardiovascular risk at the early stages of CKD.	[Sanchez, Enric; Lopez, Carolina; Hernandez, Marta; Rius, Ferran; Lecube, Albert] Univ Lleida, Inst Recerca Biomed Lleida IRBLleida, Hosp Univ Arnau Vilanova Lleida, Endocrinol & Nutr Dept, Lleida, Catalonia, Spain; [Betriu, Angels; Arroyo, David; Fernandez, Elvira] Univ Lleida, Unit Detect & Treatment Atherothrombot Dis UDETMA, Hosp Univ Arnau Vilanova Lleida, Nephrol Dept,IRBLleida, Lleida, Catalonia, Spain; [Lecube, Albert] ISCIII, CIBER Diabet & Enfermedades Metab Asociadas CIBE, Madrid, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida; University Hospital Arnau de Vilanova; Instituto de Salud Carlos III	Lecube, A (corresponding author), Univ Lleida, Inst Recerca Biomed Lleida IRBLleida, Hosp Univ Arnau Vilanova Lleida, Endocrinol & Nutr Dept, Lleida, Catalonia, Spain.	alecube@gmail.com	Hernández, Marta/U-9874-2017; Arroyo, David/H-2896-2019; Sánchez, Enric/K-8225-2017; Giráldez, Elvira Dolores Fernández/D-3358-2009; Lecube, Albert/H-3813-2019	Hernández, Marta/0000-0003-1237-298X; Arroyo, David/0000-0003-4652-0311; Sánchez, Enric/0000-0001-7345-1601; Giráldez, Elvira Dolores Fernández/0000-0001-5236-1762; Lecube, Albert/0000-0001-9684-0183; Lopez-Cano, Carolina/0000-0001-7458-5871	Institute de Salud Carlos III ISCIII [14//00008, 14/00008]	Institute de Salud Carlos III ISCIII(Instituto de Salud Carlos III)	This work was supported by grants from de Institute de Salud Carlos III ISCIII (Action Plan 14//00008). This organization had no role in study design, the collection, analysis and interpretation of data, report writing, or the decision to submit the article for publication.; This work was supported by grants from de Instituto de Salud Carlos III ISCIII (Action Plan 14/00008). This organization had no role in study design, the collection, analysis and interpretation of data, report writing, or the decision to submit the article for publication.	Beisswenger PJ, 2013, DIABETES CARE, V36, P3234, DOI 10.2337/dc12-2689; BEISSWENGER PJ, 1995, DIABETES, V44, P824, DOI 10.2337/diabetes.44.7.824; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; den Dekker MAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083084; Friedlander MA, 1996, J CLIN INVEST, V97, P728, DOI 10.1172/JCI118471; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Harvey A, 2015, J MOL CELL CARDIOL, V83, P112, DOI 10.1016/j.yjmcc.2015.04.011; Hunt KJ, 2013, ATHEROSCLEROSIS, V231, P315, DOI 10.1016/j.atherosclerosis.2013.09.027; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Junyent M, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-14; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Luo PL, 2015, MOL MED REP, V11, P4447, DOI 10.3892/mmr.2015.3269; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Murphy D, 2016, ANN INTERN MED; Poulianiti KP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8598253; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Reiniger N, 2010, DIABETES, V59, P2043, DOI 10.2337/db09-1766; Rojas A, 2004, LIFE SCI, V76, P715, DOI 10.1016/j.lfs.2004.09.011; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schroder F, 2006, J VASC SURG, V44, P531, DOI 10.1016/j.jvs.2006.05.016; Shahinian VB, 2013, AM J KIDNEY DIS, V61, P930, DOI 10.1053/j.ajkd.2013.01.018; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tiessen AH, 2014, CLIN CHEM LAB MED, V52, P121, DOI 10.1515/cclm-2012-0825; Ueno H, 2008, METABOLISM, V57, P1452, DOI 10.1016/j.metabol.2008.05.016; Uribarri J, 2003, J AM SOC NEPHROL, V14, P728, DOI 10.1097/01.ASN.0000051593.41395.B9; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147771; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yamagishi S, 2015, INT J CARDIOL, V185, P263, DOI 10.1016/j.ijcard.2015.03.167; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170778	10.1371/journal.pone.0170778	http://dx.doi.org/10.1371/journal.pone.0170778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141808	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500018
J	Huang, F; Cheng, H; Zhang, YT; Ju, YH; Li, YN				Huang, Fei; Cheng, Hang; Zhang, Yu-tong; Ju, Yang-hua; Li, Ya-nan			Early Postnatal Exposure to Cigarette Smoke Leads to Later Airway Inflammation in Asthmatic Mice	PLOS ONE			English	Article							INDUCED PULMONARY INFLAMMATION; EARLY-LIFE EXPOSURE; REGULATORY T-CELLS; TOBACCO-SMOKE; MOUSE MODEL; DISEASE; HYPERRESPONSIVENESS; METAANALYSIS; SYMPTOMS; CHILDREN	Background and objective Asthma is one of the most common airway inflammatory diseases. In most cases, asthma development is related to ubiquitous harmful environmental exposure factors in early-life. Previous studies have indicated that smoking can promote asthma development and increase the difficulty of asthma control. The aim of this study was to determine the effects of early-life CS exposure on ovalbumin (OVA)-sensitized asthmatic mice. Methods Pathological and immunological functions were analyzed in an adult asthma mice model in which mice were sensitized with OVA combined with early-life CS exposure. Results Mice exposed to CS for only 5 weeks demonstrated significantly reduced pulmonary compliance, increased airway inflammation, and augmented cellular and humoral immune responses. In addition, CS inhalation was sufficient to facilitate OVA sensitization and challenge asthmatic development. Meanwhile, CS exposure amplified regulatory T cell-mediated immunity inhibition, but still did not offset the increased effector T cell-mediated inflammatory response. Conclusion Early-life CS exposure is significantly associated with later pulmonary injury and aggravation of T-cell immunologic derangement in asthmatic mice.	[Huang, Fei] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun, Jilin, Peoples R China; [Cheng, Hang; Zhang, Yu-tong; Ju, Yang-hua; Li, Ya-nan] Jilin Univ, Hosp 1, Dept Pediat, Changchun, Jilin, Peoples R China; [Li, Ya-nan] Jilin Univ, Basic Med Coll, Dept Mol Biol, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Li, YN (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun, Jilin, Peoples R China.; Li, YN (corresponding author), Jilin Univ, Basic Med Coll, Dept Mol Biol, Changchun, Peoples R China.	lyanan2008@sina.com			Bethune Program of Jilin University [2015202]; National Natural Science Foundation of China [81200013]	Bethune Program of Jilin University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Bethune Program of Jilin University (No. 2015202) and the National Natural Science Foundation of China (No. 81200013).	Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barrett EG, 2002, AM J RESP CRIT CARE, V165, P1410, DOI 10.1164/rccm.2106029; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Burchiel SW, 2016, INHAL TOXICOL, V28, P61, DOI 10.3109/08958378.2015.1136714; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Chaudhuri R, 2008, ALLERGY, V63, P132, DOI 10.1111/j.1398-9995.2007.01538.x; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; Herbert C, 2013, DIS MODEL MECH, V6, P479, DOI 10.1242/dmm.010728; Hernandez-Alvidrez E, 2013, J ASTHMA, V50, P347, DOI 10.3109/02770903.2013.773009; Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006; Huang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141717; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Khan MA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-11; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochte Lene, 2016, BMC Pediatr, V16, P50, DOI 10.1186/s12887-016-0571-4; Ma CH, 2014, PHYTOTHER RES, V28, P231, DOI 10.1002/ptr.4983; Nakamura K, 2009, ANN ALLERG ASTHMA IM, V102, P288, DOI 10.1016/S1081-1206(10)60333-X; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Orton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112690; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Polosa R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-16; Price D, 2014, ALLERGY ASTHMA IMMUN, V6, P114, DOI 10.4168/aair.2014.6.2.114; Saravia J, 2014, MUCOSAL IMMUNOL, V7, P694, DOI 10.1038/mi.2013.88; Singh SP, 2011, J IMMUNOL, V187, P4542, DOI 10.4049/jimmunol.1101567; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; Stapleton M, 2011, J AM BOARD FAM MED, V24, P313, DOI 10.3122/jabfm.2011.03.100180; Wenzel S E, 2005, Exp Lung Res, V31 Suppl 1, P22; Wenzel SE, 2006, AM J RESP CRIT CARE, V173, P698, DOI 10.1164/rccm.2601007; Wu HX, 2014, BIOCHEM BIOPH RES CO, V450, P110, DOI 10.1016/j.bbrc.2014.05.073; Wu ZX, 2012, AM J PHYSIOL-LUNG C, V302, pL152, DOI 10.1152/ajplung.00071.2011; Wu ZX, 2016, RESP PHYSIOL NEUROBI, V223, P1, DOI 10.1016/j.resp.2015.11.009; Xepapadaki P, 2009, PEDIAT ALLERG IMM-UK, V20, P423, DOI 10.1111/j.1399-3038.2008.00820.x; Yang X, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6470364	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171021	10.1371/journal.pone.0171021	http://dx.doi.org/10.1371/journal.pone.0171021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135326	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700039
J	Itoh, T; Nishinakamura, H; Kumano, K; Takahashi, H; Kodama, S				Itoh, Takeshi; Nishinakamura, Hitomi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta			The Spleen Is an Ideal Site for Inducing Transplanted Islet Graft Expansion in Mice	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; SINGLE-DONOR; INSULIN INDEPENDENCE; STEM-CELLS; AUTOGRAFTS; REVERSAL; ANTIBODY; ORGANS	Alternative islet transplantation sites have the potential to reduce the marginal number of islets required to ameliorate hyperglycemia in recipients with diabetes. Previously, we reported that T cell leukemia homeobox 1 (Tlx1)(+) stem cells in the spleen effectively regenerated into insulin-producing cells in the pancreas of non-obese diabetic mice with endstage disease. Thus, we investigated the spleen as a potential alternative islet transplantation site. Streptozotocin-induced diabetic C57BL/6 mice received syngeneic islets into the portal vein (PV), beneath the kidney capsule (KC), or into the spleen (SP). The marginal number of islets by PV, KC, or SP was 200, 100, and 50, respectively. Some plasma inflammatory cytokine levels in the SP group were significantly lower than those of the PV group after receiving a marginal number of islets, indicating reduced inflammation in the SP group. Insulin contents were increased 280 days after islet transplantation compared with those immediately following transplantation (p< 0.05). Additionally, Tlx1-related genes, including Rrm2b and Pla2g2d, were up-regulated, which indicates that islet grafts expanded in the spleen. The spleen is an ideal candidate for an alternative islet transplantation site because of the resulting reduced inflammation and expansion of the islet graft.	[Itoh, Takeshi; Nishinakamura, Hitomi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta] Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Fukuoka, Japan; [Itoh, Takeshi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta] Fukuoka Univ Hosp, Ctr Regenerat Med, Fukuoka, Japan; [Kumano, Kenjiro] Okayama Univ, Dept Surg Gastroenterol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Takahashi, Hiroyuki] Fukuoka Univ, Dept Surg Gastroenterol, Fac Med, Fukuoka, Japan	Fukuoka University; Fukuoka University; Okayama University; Fukuoka University	Kodama, S (corresponding author), Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Fukuoka, Japan.	skodama@fukuoka-u.ac.jp			Japan Society of the Promotion of Science; Intramural Foundation of Fukuoka University; Grants-in-Aid for Scientific Research [16K09815] Funding Source: KAKEN	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Foundation of Fukuoka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant in Aids for Scientific Research from the Japan Society of the Promotion of Science (HN, TI, and SK) and the Intramural Foundation of Fukuoka University (SK).	Ahearn AJ, 2015, EXPERT REV CLIN IMMU, V11, P59, DOI 10.1586/1744666X.2015.978291; ALDERSON D, 1984, BRIT J SURG, V71, P756, DOI 10.1002/bjs.1800711007; Balamurugan AN, 2014, AM J TRANSPLANT, V14, P2595, DOI 10.1111/ajt.12872; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Bellin MD, 2008, AM J TRANSPLANT, V8, P2463, DOI 10.1111/j.1600-6143.2008.02404.x; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9; Dieguez-Acuna FJ, 2005, MOL CELL PROTEOMICS, V4, P1459, DOI 10.1074/mcp.M500137-MCP200; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; Fiorina P, 2008, DIABETES CARE, V31, P436, DOI 10.2337/dc07-1831; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; GRAY DWR, 1990, SURG GYNECOL OBSTET, V170, P225; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hilling DE, 2014, CELL TRANSPLANT, V23, P921, DOI 10.3727/096368913X666412; ITOH I, 2012, CELL TRANSPLANT, V21, P1371, DOI DOI 10.3727/0963689128640592; Itoh T, 2015, PANCREAS, V44, P166, DOI 10.1097/MPA.0000000000000188; Itoh T, 2014, CELL TRANSPLANT, V23, P153, DOI 10.3727/096368912X658980; KAUFMAN DB, 1990, TRANSPLANTATION, V50, P385, DOI 10.1097/00007890-199009000-00006; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Kodama S, 2004, PEDIATR DIABETES, V5, P38, DOI 10.1111/j.1399-543X.2004.00078.x; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Markmann JF, 2003, ANN SURG, V237, P741, DOI 10.1097/00000658-200306000-00001; Matsumoto S, 2010, CELL TRANSPLANT, V19, P291, DOI 10.3727/096368909X481773; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Robertson SA, 2008, J PEDIATR SURG, V43, P274, DOI 10.1016/j.jpedsurg.2007.10.013; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Sagi B, 2012, STEM CELLS DEV, V21, P814, DOI 10.1089/scd.2011.0551; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2004, AM J TRANSPLANT, V4, P295, DOI 10.1046/j.1600-6143.2003.00375.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smink AM, 2013, DIABETES, V62, P1357, DOI 10.2337/db12-1553; SUTTON R, 1989, DIABETES, V38, P182, DOI 10.2337/diab.38.1.S182; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106	47	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170899	10.1371/journal.pone.0170899	http://dx.doi.org/10.1371/journal.pone.0170899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135283	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700028
J	Sha, J; Wang, P; Zhu, BL; Zhu, MH; Li, XL; Gao, F				Sha, Jie; Wang, Pin; Zhu, Bingliang; Zhu, Minghui; Li, Xueliang; Gao, Feng			Acetic Acid Enhanced Narrow Band Imaging for the Diagnosis of Gastric Intestinal Metaplasia	PLOS ONE			English	Article							MAGNIFICATION CHROMOENDOSCOPY; MAGNIFYING ENDOSCOPY; CANCER; LESIONS; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; ESOPHAGUS; DYSPLASIA; RISK	Gastric intestinal metaplasia (GIM) is a precancerous lesion of the stomach. The detection of GIM using conventional white-light endoscopy (WLE) is difficult. In this study, we determined whether acetic acid-enhanced narrow band imaging (AA-NBI) improves the detection of GIM. A consecutive cohort of 132 individuals aged 40 years or older was subjected to upper gastrointestinal endoscopy using WLE, NBI and AA-NBI. The ability of the three methods to diagnose GIM in patients was compared. Histological assessment (per-patient and per-biopsy) was used for the accuracy assessment. Sixty-six (50.0%) out of the 132 individuals examined were found to have GIM, of which 44 (66.7%) were diagnosed correctly by NBI (sensitivity 66.7% and specificity 68.2%) and 58 (87.9%) were correctly identified by AA-NBI (sensitivity 87.9% and specificity 68.2%), as compared to only 22 (33.3%) by WLE (sensitivity 33.3% and specificity 28.8%). Therefore, the sensitivity of AA-NBI in the diagnosis of GIM was significantly higher than NBI (p<0.05) and WLE (p<0.001). Our study indicates that AA-NBI can improve the accuracy of endoscopy-targeted biopsies for GIM.	[Sha, Jie; Li, Xueliang] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Sha, Jie; Zhu, Bingliang; Zhu, Minghui; Gao, Feng] Jingjiang Peoples Hosp, Dept Gastroenterol, Jingjiang, Jiangsu, Peoples R China; [Wang, Pin] Nanjing Med Univ, Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Li, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.; Gao, F (corresponding author), Jingjiang Peoples Hosp, Dept Gastroenterol, Jingjiang, Jiangsu, Peoples R China.	ligakur@aliyun.com; 1036060339@qq.com						An JK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-169; Capelle LG, 2010, DIGEST DIS SCI, V55, P3442, DOI 10.1007/s10620-010-1189-2; CORREA P, 1992, CANCER RES, V52, P6735; Dinis-Ribeiro M, 2003, GASTROINTEST ENDOSC, V57, P498, DOI 10.1067/mge.2003.145; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Guelrud M, 2001, GASTROINTEST ENDOSC, V53, P559, DOI 10.1067/mge.2001.114059; Guo T, 2014, GASTRIC CANCER, V17, P122, DOI 10.1007/s10120-013-0250-1; Kikuste I, 2014, EUR J GASTROEN HEPAT, V26, P704, DOI 10.1097/MEG.0000000000000108; Kono Y, 2014, WORLD J GASTROENTERO, V20, P5092, DOI 10.3748/wjg.v20.i17.5092; Lee BE, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-97; Li Z, 2014, ENDOSCOPY, V46, P282, DOI 10.1055/s-0033-1359215; Lim JH, 2013, GUT LIVER, V7, P41, DOI 10.5009/gnl.2013.7.1.41; Meining A, 2004, ENDOSCOPY, V36, P160, DOI 10.1055/s-2004-814183; Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; NOMURA H, 1980, IGAKU KENKYU, V50, P525; Olliver JR, 2003, BIOMARKERS, V8, P509, DOI 10.1080/13547500310001644961; Pimentel-Nunes P, 2012, ENDOSCOPY, V44, P236, DOI 10.1055/s-0031-1291537; Sakai Y, 2008, GASTROINTEST ENDOSC, V68, P635, DOI 10.1016/j.gie.2008.03.1065; SAUERBRUCH T, 1984, ENDOSCOPY, V16, P101, DOI 10.1055/s-2007-1018546; Savarino E, 2013, WORLD J GASTROENTERO, V19, P2668, DOI 10.3748/wjg.v19.i17.2668; So J, 2013, DIGEST DIS SCI, V58, P3566, DOI 10.1007/s10620-013-2843-2; Taghavi SA, 2009, CAN J GASTROENTEROL, V23, P105, DOI 10.1155/2009/594983; Tanaka K, 2006, J GASTROENTEROL, V41, P332, DOI 10.1007/s00535-005-1760-3; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378	25	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170957	10.1371/journal.pone.0170957	http://dx.doi.org/10.1371/journal.pone.0170957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135297	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700033
J	Russo, J; Lee, JE; Lopez, CM; Anderson, J; Nguyen, TMP; Heck, AM; Wilusz, J; Wilusz, CJ				Russo, Joseph; Lee, Jerome E.; Lopez, Carolina M.; Anderson, John; Nguyen, Thuy-mi P.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.			The CELF1 RNA-Binding Protein Regulates Decay of Signal Recognition Particle mRNAs and Limits Secretion in Mouse Myoblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE; TARGET TRANSCRIPTS; CUG-BP; OVEREXPRESSION; IDENTIFICATION; CELLS; TRANSLATION; DEGRADATION; MECHANISMS; EXPRESSION	We previously identified several mRNAs encoding components of the secretory pathway, including signal recognition particle (SRP) subunit mRNAs, among transcripts associated with theRNA- binding protein CELF1. Through immunoprecipitation of RNAs crosslinked to CELF1 in myoblasts and in vitro binding assays using recombinant CELF1, we now provide evidence that CELF1 directly binds the mRNAs encoding each of the subunits of the SRP. Furthermore, we determined the half-lives of the Srp transcripts in control and CELF1 knockdown myoblasts. Our results indicate CELF1 is a destabilizer of at least five of the six Srp transcripts and that the relative abundance of the SRP proteins is out of balance when CELF1 is depleted. CELF1 knockdown myoblasts exhibit altered secretion of a luciferase reporter protein and are impaired in their ability to migrate and close a wound, consistent with a defect in the secreted extracellular matrix. Importantly, similar defects in wound healing are observed when SRP subunit imbalance is induced by over-expression of SRP68. Our studies support the existence of an RNA regulon containing Srp mRNAs that is controlled by CELF1. One implication is that altered function of CELF1 in myotonic dystrophy may contribute to changes in the extracellular matrix of affected muscle through defects in secretion.	[Russo, Joseph; Lee, Jerome E.; Lopez, Carolina M.; Anderson, John; Nguyen, Thuy-mi P.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Jerome E.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Lee, Jerome E.] ArcherDX, Boulder, CO USA; [Nguyen, Thuy-mi P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Colorado State University; Colorado State University; Mayo Clinic	Wilusz, CJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Wilusz, CJ (corresponding author), Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017	Heck, Adam/0000-0002-2485-759X	National Institutes of Health [AR059247]; National Science Foundation [MCB-1301983]; American Heart Association [10PRE2610140]; National Science Foundation -NRT Award [1450032]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); National Science Foundation -NRT Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (www.niams.nih.gov) through an award to CJW (AR059247) and by the National Science Foundation (www.nsf.gov) through an award to CJW and JW (MCB-1301983). JEL was supported in part by a pre-doctoral fellowship from the American Heart Association (www.heart.org; 10PRE2610140). AH was supported in part through National Science Foundation -NRT Award # 1450032 to Thomas Chen, Carol Wilusz & Asa Ben-Hur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Bauermeister D, 2015, DEV BIOL, V405, P214, DOI 10.1016/j.ydbio.2015.07.005; Beisang D, 2014, GENE, V550, P93, DOI 10.1016/j.gene.2014.08.021; Beisang D, 2012, J BIOL CHEM, V287, P950, DOI 10.1074/jbc.M111.291658; Benveniste O, 2011, PRESSE MED, V40, P249; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; Dori-Bachash M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r114; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Ghirardello A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0335-1; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim SY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002512; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Le Tonqueze O, 2016, GENOM DATA, V8, P97, DOI 10.1016/j.gdata.2016.04.009; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Nielsen FC, 2016, BIOESSAYS; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ohsawa N, 2015, GENES CELLS, V20, P121, DOI 10.1111/gtc.12201; Palumbo MC, 2015, WIRES RNA, V6, P327, DOI 10.1002/wrna.1277; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Ren YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056950; Ren YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040705; ROOTS R, 1976, CANCER RES, V36, P3654; SAWICKI SG, 1971, J CELL BIOL, V50, P746, DOI 10.1083/jcb.50.3.746; SEISER C, 1995, J BIOL CHEM, V270, P29400, DOI 10.1074/jbc.270.49.29400; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun M, 2012, GENOME RES; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; Vlasova-St Louis I, 2013, BBA-GENE REGUL MECH, V1829, P695, DOI 10.1016/j.bbagrm.2013.01.001; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Wang ET, 2015, GENOME RES, V25, P858, DOI 10.1101/gr.184390.114; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Wild K, 2014, RNA BIOL, V11, P1330, DOI 10.1080/15476286.2014.996457; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170680	10.1371/journal.pone.0170680	http://dx.doi.org/10.1371/journal.pone.0170680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129347	gold, Green Published			2022-12-26	WOS:000396211400046
J	Ishii, Y; Hayashi, S; Takamura, N				Ishii, Yumiko; Hayashi, Seiji; Takamura, Noriko			Radiocesium Transfer in Forest Insect Communities after the Fukushima Dai-ichi Nuclear Power Plant Accident	PLOS ONE			English	Article							FRESH-WATER FISH; WOODLAND ECOSYSTEM; RADIONUCLIDES; CS-137; CHERNOBYL; RADIOACTIVITY; INVERTEBRATES; EARTHWORMS; BRYOPHYTES; TRANSPORT	To understand radiocesium transfer in the forest insect food web, we investigated the activity concentrations of radiocesium in forest insects in the Fukushima and Ibaraki Prefectures approximately 1.5-2.5 years after the Fukushima Dai-ichi Nuclear Power Plant. We analyzed 34 species of insects sampled from 4 orders and 4 feeding functional groups (herbivore, carnivore, omnivore, and detritivore) from three sites in each prefecture. Cs-137 activity concentrations were lowest in herbivorous species and were especially high in detritivorous and omnivorous species that feed on forest litter and fungi. Radiocesium activity concentrations in any given species reflected the degree of contamination of that species' primary food sources since radiocesium activity concentrations were found to be the lowest in leaves and grass and the highest in litter, bark, and fungi. This study confirmed that litter and other highly contaminated forest components such as fungi, decaying wood, bryophytes, and lichens serve as sources of Cs-137 transfer into the forest insect community.	[Ishii, Yumiko; Hayashi, Seiji] Natl Inst Environm Studies, Environm Impact Assessment Sect, Fukushima Branch, Fukushima, Japan; [Takamura, Noriko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan	Ishii, Y (corresponding author), Natl Inst Environm Studies, Environm Impact Assessment Sect, Fukushima Branch, Fukushima, Japan.	ischii@gmail.com	Ishii, Yumiko/B-8135-2011	Ishii, Yumiko/0000-0003-2712-5244	research program on Disaster Environment, an internal budget of National Institute for Environmental Studies	research program on Disaster Environment, an internal budget of National Institute for Environmental Studies	This work was financially supported by the research program on Disaster Environment, an internal budget of National Institute for Environmental Studies. The internal budget was originally issued by the Ministry of Environment, Japan (http://www.nies.go.jp/shinsal/index-e.html).	Akimoto S, 2014, ECOL EVOL, V4, P355, DOI 10.1002/ece3.949; Ayabe Y, 2014, J ENVIRON RADIOACTIV, V127, P105, DOI 10.1016/j.jenvrad.2013.10.010; Beresford NA, 2013, SCI TOTAL ENVIRON, V463, P284, DOI 10.1016/j.scitotenv.2013.06.013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; BROWN SL, 1995, ENVIRON POLLUT, V88, P27, DOI 10.1016/0269-7491(95)91045-M; Copplestone D, 1999, SCI TOTAL ENVIRON, V239, P95, DOI 10.1016/S0048-9697(99)00294-6; Dohi T, 2015, J ENVIRON RADIOACTIV, V146, P125, DOI 10.1016/j.jenvrad.2015.04.013; Dragovic S, 2010, ENVIRON MONIT ASSESS, V166, P677, DOI 10.1007/s10661-009-1032-4; Endo I, 2015, J ENVIRON RADIOACTIV, V149, P176, DOI 10.1016/j.jenvrad.2015.07.027; Forest and Forest Product Research Institute, 2012, PREL RES SURV DISTR; Gaso MI, 1995, SCI TOTAL ENVIRON, V173, P41, DOI 10.1016/0048-9697(95)04763-8; GIOVANI C, 1994, SCI TOTAL ENVIRON, V157, P35, DOI 10.1016/0048-9697(94)90563-0; Hasegawa M, 2013, J ENVIRON RADIOACTIV, V126, P8, DOI 10.1016/j.jenvrad.2013.06.006; Hashimoto S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02564; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Koarashi J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06853; Mietelski JW, 2010, J ENVIRON RADIOACTIV, V101, P488, DOI 10.1016/j.jenvrad.2008.04.009; Mietelski JW, 2003, J ENVIRON MONITOR, V5, P296, DOI 10.1039/b212592g; Mietelski JW, 2004, 3 CASE STUDIES, V262, P645; Ministry of Education Culture Sports Science and Technology J, 2011, RES 4 AIRB MON SURV; Moller AP, 2012, ENVIRON POLLUT, V164, P36, DOI 10.1016/j.envpol.2012.01.008; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nishikiori T, 2015, SCI TOTAL ENVIRON, V502, P611, DOI 10.1016/j.scitotenv.2014.09.063; Ohmura Y, 2015, J ENVIRON RADIOACTIV, V141, P38, DOI 10.1016/j.jenvrad.2014.11.014; R Core Team, 2013, R LANG ENV STAT COMP; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; RUDGE SA, 1993, J ENVIRON RADIOACTIV, V19, P199, DOI 10.1016/0265-931X(93)90003-P; Sakai M, 2016, ENVIRON POLLUT, V209, P46, DOI 10.1016/j.envpol.2015.11.025; Shaw G, 2005, J ENVIRON RADIOACTIV, V84, P285, DOI 10.1016/j.jenvrad.2003.09.006; Smith JT, 2005, S-P BKS ENVIRONM SCI, P81; Steiner M, 2002, J ENVIRON RADIOACTIV, V58, P217, DOI 10.1016/S0265-931X(01)00067-4; Sundbom M, 2003, J APPL ECOL, V40, P228, DOI 10.1046/j.1365-2664.2003.00795.x; Toal ME, 2002, J ENVIRON RADIOACTIV, V63, P85, DOI 10.1016/S0265-931X(02)00018-8; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Yoshihara T, 2013, J ENVIRON RADIOACTIV, V115, P60, DOI 10.1016/j.jenvrad.2012.07.002	37	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171133	10.1371/journal.pone.0171133	http://dx.doi.org/10.1371/journal.pone.0171133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125745	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100007
J	Chang, JY; Jung, S; Park, H; Han, MK				Chang, Jun Young; Jung, Seunguk; Park, Hyun; Han, Moon-Ku			Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ORAL ANTICOAGULATION; CARDIOEMBOLIC STROKE; WARFARIN; FREQUENCY; THERAPY; SUBTYPE	Objective We investigated the association between the presence of major vessel occlusion (MVO) and the intensity of the International Normalized Ratio (INR) in cardioembolic high-risk patients taking warfarin. We also evaluated whether the presence of MVO could predict the subtherapeutic range of INR <= 1.7 ensuring safe administration of intravenous thrombolytics. Methods The medical records of 177 cardioembolic stroke patients who were taking warfarin between April, 2008 and March, 2015 were retrospectively analyzed. Logistic regression analysis was performed to calculate the odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between vessel occlusion and intensity of INR. To predict INR <= 1.7, decision tree analysis was performed. Results INR was inversely associated with MVO in an unadjusted model (OR, 0.36; 95% CI, 0.17- 0.76), and in a model adjusted for initial NIHSS score and time from symptom onset to arrival (OR, 0.28; 95% CI, 0.11-0.73). Fifty-two of 58 (89.7%) patients with MVO had an INR <= 1.7, compared with 83 of 119 (69.7%) patients without MVO. Indication for anticoagulation agent use was dichotomized into NVAF and others, and applied to the subgroup of patients with MVO. All patients with NVAF (31/31, 100%) had INR <= 1.7, while 21 of 27 of the other patients (77.8%) had INR <= 1.7. Conclusions Low INR at presentation in cardioembolic stroke patients during anticoagulation treatment was associated with occurrence of major vessel occlusive stroke. Presence of MVO and indications for anticoagulation may be utilized to ensure the feasibility of administration of intravenous thrombolytics.	[Chang, Jun Young; Jung, Seunguk] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Park, Hyun] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurosurg, Chang Won, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Bun Dang Hosp, Dept Neurol, Seongnam, South Korea	Gyeongsang National University; Gyeongsang National University; Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Bun Dang Hosp, Dept Neurol, Seongnam, South Korea.	mkhan@snu.ac.kr		Chang, Jun Young/0000-0003-4880-9258				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arboix A, 2012, CURR CARDIOL REV, V8, P54, DOI 10.2174/157340312801215791; Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730; Bruch TP, 2014, ARQ NEURO-PSIQUIAT, V72, P487, DOI 10.1590/0004-282X20140075; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Ko Y, 2014, J STROKE, V16, P161, DOI 10.5853/jos.2014.16.3.161; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Nakamura A, 2013, STROKE, V44, P3239, DOI 10.1161/STROKEAHA.113.002523; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Rombouts EK, 2009, THROMB HAEMOSTASIS, V101, P552, DOI 10.1160/TH08-09-0626; Rose AJ, 2009, CIRC-CARDIOVASC QUAL, V2, P591, DOI 10.1161/CIRCOUTCOMES.109.862763; Shroff GR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000756; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Xian Y, 2012, JAMA-J AM MED ASSOC, V307, P2600, DOI 10.1001/jama.2012.6756	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170978	10.1371/journal.pone.0170978	http://dx.doi.org/10.1371/journal.pone.0170978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158211	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700022
J	Endesfelder, S; Makki, H; von Haefen, C; Spies, CD; Buhrer, C; Sifringer, M				Endesfelder, Stefanie; Makki, Hanan; von Haefen, Clarissa; Spies, Claudia D.; Buehrer, Christoph; Sifringer, Marco			Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; INDUCED NEUROAPOPTOSIS; HIPPOCAMPAL-NEURONS; ADULT NEUROGENESIS; ANALYSIS REVEALS; SELF-RENEWAL	Dexmedetomidine (DEX) is a highly selective agonist of alpha 2-receptors with sedative, anxiolytic, and analgesic properties. Neuroprotective effects of dexmedetomidine have been reported in various brain injury models. In the present study, we investigated the effects of dexmedetomidine on hippocampal neurogenesis, specifically the proliferation capacity and maturation of neurons and neuronal plasticity following the induction of hyperoxia in neonatal rats. Six-day old sex-matched Wistar rats were exposed to 80% oxygen or room air for 24 h and treated with 1, 5 or 10 mu g/kg of dexmedetomidine or normal saline. A single pretreatment with DEX attenuated the hyperoxia-induced injury in terms of neurogenesis and plasticity. In detail, both the proliferation capacity (PCNA+cells) as well as the expression of neuronal markers (Nestin+, PSA-NCAM+, NeuN+ ells) and transcription factors (SOX2, Tbr1/2, Prox1) were significantly reduced under hyperoxia compared to control. Furthermore, regulators of neuronal plasticity (Nrp1, Nrg1, Syp, and Sema3a/f) were also drastically decreased. A single administration of dexmedetomidine prior to oxygen exposure resulted in a significant up-regulation of expression-profiles compared to hyperoxia. Our results suggest that dexmedetomidine may have neuroprotective effects in an acute hyperoxic model of the neonatal rat.	[Endesfelder, Stefanie; Makki, Hanan; Buehrer, Christoph] Charite, Dept Neonatol, Berlin, Germany; [von Haefen, Clarissa; Spies, Claudia D.; Sifringer, Marco] Charite, Dept Anesthesiol & Intens Care Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Endesfelder, S (corresponding author), Charite, Dept Neonatol, Berlin, Germany.	stefanie.endesfelder@charite.de	Endesfelder, Stefanie/AAA-5534-2022	Endesfelder, Stefanie/0000-0002-4030-7969; Spies, Claudia/0000-0002-1062-0495				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Agarwal A, 2014, CELL REP, V8, P1130, DOI 10.1016/j.celrep.2014.07.026; Ahmed S, 2013, CRIT CARE, V17, DOI 10.1186/cc12707; Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Bendix I, 2012, INT J MOL SCI, V13, P12939, DOI 10.3390/ijms131012939; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buchman AS, 2016, NEUROLOGY, V86, P735, DOI 10.1212/WNL.0000000000002387; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Chrysostomou C, 2014, J PEDIATR-US, V164, P276, DOI 10.1016/j.jpeds.2013.10.002; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Deguchi K, 2015, INT J DEV NEUROSCI, V47, P58, DOI 10.1016/j.ijdevneu.2015.04.164; Deulofeut R, 2007, ACTA PAEDIATR, V96, P990, DOI 10.1111/j.1651-2227.2007.00365.x; Duan X, 2014, ACTA ANAESTH SCAND, V58, P1121, DOI 10.1111/aas.12356; Duerden EG, 2016, ANN NEUROL, V79, P548, DOI 10.1002/ana.24601; Endesfelder S, 2014, FREE RADICAL BIO MED, V67, P221, DOI 10.1016/j.freeradbiomed.2013.09.026; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GALAND P, 1989, CELL TISSUE KINET, V22, P383, DOI 10.1111/j.1365-2184.1989.tb00223.x; Gavazzi I, 2001, CELL TISSUE RES, V305, P275, DOI 10.1007/s004410100365; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Jessberger S, 2009, TRENDS PHARMACOL SCI, V30, P61, DOI 10.1016/j.tips.2008.11.003; Kaindl AM, 2006, CELL DEATH DIFFER, V13, P1097, DOI 10.1038/sj.cdd.4401796; Kato RI, 2014, J ANESTH, V28, P828, DOI 10.1007/s00540-014-1853-3; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Koropouli E, 2014, CURR OPIN NEUROBIOL, V27, P1, DOI 10.1016/j.conb.2014.02.005; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuban KCK, 2016, J PEDIATR-US, V173, P69, DOI 10.1016/j.jpeds.2016.02.048; Lado FA, 2002, EPILEPTIC DISORD, V4, P83; Laudenbach V, 2002, ANESTHESIOLOGY, V96, P134, DOI 10.1097/00000542-200201000-00026; Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093639; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Loi M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00013; Mantz J, 2011, EUR J ANAESTH, V28, P3, DOI 10.1097/EJA.0b013e32833e266d; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McPherson Christopher, 2012, J Pediatr Pharmacol Ther, V17, P351, DOI 10.5863/1551-6776-17.4.351; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Namiki J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/430138; Neu J, 2014, WORLD REV NUTR DIET, V110, P253, DOI 10.1159/000358474; O'Mara Keliana, 2012, J Pediatr Pharmacol Ther, V17, P252, DOI 10.5863/1551-6776-17.3.252; O'Mara K, 2009, ANN PHARMACOTHER, V43, P1707, DOI 10.1345/aph.1M245; Ozsurekci Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2768365; Pan W, 2015, CELL MOL NEUROBIOL; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Patel KN, 2009, PEDIATR EMERG CARE, V25, P133, DOI 10.1097/PEC.0b013e31819a7f75; Perrone S, 2014, CURR PEDIATR REV, V10, P202, DOI 10.2174/1573396309666140101235126; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P110, DOI 10.3109/14767058.2012.664344; Petroz GC, 2006, ANESTHESIOLOGY, V105, P1098, DOI 10.1097/00000542-200612000-00009; Pickard A, 2014, BRIT J ANAESTH, V112, P982, DOI 10.1093/bja/aeu093; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Potts AL, 2009, PEDIATR ANESTH, V19, P1119, DOI 10.1111/j.1460-9592.2009.03133.x; Qian XL, 2015, EUR J PHARMACOL, V746, P206, DOI 10.1016/j.ejphar.2014.11.017; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Revishchin AV, 2008, INT REV CYTOL, V265, P55, DOI 10.1016/S0074-7696(07)65002-5; Role LW, 2007, NATURE, V448, P263, DOI 10.1038/448263a; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Rubenstein J. L. R., 2013, CELLULAR MIGRATION F; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Schwarz Q, 2010, CELL ADHES MIGR, V4, P61, DOI 10.4161/cam.4.1.10207; Siddappa R, 2011, PEDIATR ANESTH, V21, P153, DOI 10.1111/j.1460-9592.2010.03502.x; Sifringer M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/530371; Sifringer M, 2013, DEV NEUROSCI-BASEL, V35, P255, DOI 10.1159/000346723; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stone WL, 2016, FRONT BIOSCI-LANDMRK, V21, P165, DOI 10.2741/4382; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; SZELE FG, 1994, NEUROSCIENCE, V60, P133, DOI 10.1016/0306-4522(94)90209-7; Tachibana K, 2012, PEDIATR ANESTH, V22, P713, DOI 10.1111/j.1460-9592.2012.03810.x; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang XN, 2015, INT J CLIN EXP MED, V8, P17281; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Wu YQ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/562154	106	49	53	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171498	10.1371/journal.pone.0171498	http://dx.doi.org/10.1371/journal.pone.0171498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158247	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700086
J	Kloss, TG; Gonzaga, MO; de Oliveira, LL; Sperber, CF				Kloss, Thiago Gechel; Gonzaga, Marcelo Oliveira; de Oliveira, Leandro Licursi; Sperber, Carlos Frankl			Proximate mechanism of behavioral manipulation of an orb-weaver spider host by a parasitoid wasp	PLOS ONE			English	Article							BUILDING BEHAVIOR; LIFE-HISTORIES; HYMENOPTERA; ARANEAE; ICHNEUMONIDAE; PIMPLINAE; TETRAGNATHIDAE; ARANEIDAE; WEBS	Some ichneumonid wasps induce modifications in the web building behavior of their spider hosts to produce resistant "cocoon" webs. These structures hold and protect the wasp's cocoon during pupa development. The mechanism responsible for host manipulation probably involves the inoculation of psychotropic chemicals by the parasitoid larva during a specific developmental period. Recent studies indicate that some spiders build cocoon webs similar to those normally built immediately before ecdysis, suggesting that this substance might be a molting hormone or a precursor chemical of this hormone. Here, we report that Cyclosa spider species exhibiting modified behavior presented higher 20-OH-ecdysone levels than parasitized spiders acting normally or unparasitized individuals. We suggest that the lack of control that spiders have when constructing modified webs can be triggered by anachronic activation of ecdysis.	[Kloss, Thiago Gechel] Univ Fed Vicosa, Programa Posgrad Entomol, Vicosa, MG, Brazil; [Kloss, Thiago Gechel] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil; [Gonzaga, Marcelo Oliveira] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil; [de Oliveira, Leandro Licursi; Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal do Espirito Santo; Universidade Federal de Uberlandia; Universidade Federal de Vicosa	Kloss, TG (corresponding author), Univ Fed Vicosa, Programa Posgrad Entomol, Vicosa, MG, Brazil.; Kloss, TG (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil.	thiagokloss@yahoo.com.br	Kloss, Thiago Gechel/AAT-8207-2020; Sperber, Carlos Frankl/F-9298-2012; de Oliveira, Leandro Licursi/D-3616-2009; Sperber, Carlos Frankl/AAH-4443-2021; Gonzaga, Marcelo O/A-4805-2013	Kloss, Thiago Gechel/0000-0003-0958-1748; Sperber, Carlos Frankl/0000-0002-0334-7216; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Gonzaga, Marcelo O/0000-0003-0093-1801	MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02104-14, CRA-30058/12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; TGK; MOG; CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140508/2012-0, 300295/2016-2, 309787/2012-2, 306157/2014-4, 403733/2012-0, 445832/2014-2, 573802/2008-4]; Financiadora de Estudos e Projetos; Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao	MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); TGK; MOG; CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao	This work was supported by MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Grant number APQ-02104-14, CRA-30058/12) (http://www.fapemig.br/pt-br/); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/); TGK, MOG, CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant numbers 140508/2012-0, 300295/2016-2,309787/2012-2,306157/2014-4, 403733/2012-0; 445832/2014-2, 573802/2008-4) (http://www.chpq.br/); Financiadora de Estudos e Projetos (www.finep.gov.br); and Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao (www.mcti.gov.br/sisnano). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders offer research grants or money for laboratory equipment maintenance.	Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Biron DG, 2006, INSECT MOL BIOL, V15, P731, DOI 10.1111/j.1365-2583.2006.00671.x; Bonaric J.C., 1987, P111; CADY A, 1993, CAN ENTOMOL, V125, P931, DOI 10.4039/Ent125931-5; Crawley MJ, 2013, R BOOK, P557; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Eberhard WG, 2001, J ARACHNOL, V29, P354, DOI 10.1636/0161-8202(2001)029[0354:UTIWAB]2.0.CO;2; Eberhard WG., 2010, PSYCHE; Eberhard WG, 2013, ANN ENTOMOL SOC AM, V106, P652, DOI 10.1603/AN12147; Eberhard WG, 2010, ANIM BEHAV, V79, P375, DOI 10.1016/j.anbehav.2009.10.033; Gauld I.D., 1991, MEMOIRS AM ENTOMOLOG, V47, P1; Gauld ID, 2006, SYST ENTOMOL, V31, P529, DOI 10.1111/j.1365-3113.2006.00334.x; Gonzaga MO, 2010, ETHOL ECOL EVOL, V22, P151, DOI 10.1080/03949371003707836; Gonzaga MO, 2007, NATURWISSENSCHAFTEN, V94, P223, DOI 10.1007/s00114-006-0177-z; Gonzaga MO, 2015, ACTA OECOL, V69, P113, DOI 10.1016/j.actao.2015.10.001; Gonzaga MO, 2011, ENTOMOL SCI, V14, P220, DOI 10.1111/j.1479-8298.2010.00436.x; Gonzaga MO, 2015, BEHAVIOUR, V152, P181, DOI 10.1163/1568539X-00003238; Haspel G, 2003, J NEUROBIOL, V54, P28; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Kloss TG, 2016, J INSECT BEHAV, V29, P315, DOI 10.1007/s10905-016-9560-6; Kloss TG, 2016, ANIM BEHAV, V111, P289, DOI 10.1016/j.anbehav.2015.11.001; Korenko S, 2014, ECOL ENTOMOL, V39, P30, DOI 10.1111/een.12067; Korenko S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024628; Levi Herbert W., 1999, Bulletin of the Museum of Comparative Zoology, V155, P299; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Matsumoto R, 2007, ENTOMOL SCI, V10, P267, DOI 10.1111/j.1479-8298.2007.00223.x; Matsumoto R, 2009, J INSECT BEHAV, V22, P39, DOI 10.1007/s10905-008-9152-1; Nielsen E., 1923, Entomologiske Meddelelser, V14, P137; Poulin R, 2015, TRENDS PARASITOL, V31, P563, DOI 10.1016/j.pt.2015.07.002; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Schlinger EI, 1987, BIOL ACROCERIDAE DIP, P319; Sobczak JF, 2009, J NAT HIST, V43, P2691, DOI 10.1080/00222930903244010; Takasuka K, 2015, J EXP BIOL, V218, P2326, DOI 10.1242/jeb.122739; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; TRABALON M, 1992, GEN COMP ENDOCR, V88, P128, DOI 10.1016/0016-6480(92)90201-T; Weng JL, 2007, J HYMENOPT RES, V16, P326; Yu DS, 2012, TAXAPAD HOME ICHNEUM; Zhou JH, 2011, J CHROMATOGR B, V879, P2533, DOI 10.1016/j.jchromb.2011.07.006	38	21	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171336	10.1371/journal.pone.0171336	http://dx.doi.org/10.1371/journal.pone.0171336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158280	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700062
J	Nunes, D; Boa-Sorte, N; Grassi, MFR; Taylor, GP; Teixeira, MG; Barreto, ML; Dourado, I; Galvao-Castro, B				Nunes, David; Boa-Sorte, Ney; Rios Grassi, Maria Fernanda; Taylor, Graham P.; Teixeira, Maria Gloria; Barreto, Mauricio L.; Dourado, Ines; Galvao-Castro, Bernardo			HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil	PLOS ONE			English	Article							LYMPHOTROPIC VIRUS TYPE-1; T-CELL LEUKEMIA; SPASTIC PARAPARESIS HAM/TSP; GENERAL-POPULATION; PREGNANT-WOMEN; RISK-FACTORS; INFECTIVE DERMATITIS; NORTHEASTERN BRAZIL; I INFECTION; BAHIA STATE	Background Salvador is the city with the highest number of HTLV-1 infected individuals in Brazil, yet the main route of HTLV-1 transmission is unknown. Objective To investigate the association of syphilis infection as a proxy for sexual transmission of HTLV-1 infection in the general population of this city. Methods A cross sectional population-based study was conducted with 3,451 serum samples obtained by a representative simple random sampling. Data on gender, age, income, and years of education were collected by questionnaire and the presence of HTLV, HIV and Treponema pallidum infection was determined by serology. Logistic regression analysis was used to evaluate the independent effect of the potential explanatory variables to HTLV1 infection and Odds Ratios (OR) and 95% CI were calculated. Results The majority of studied individuals were female (56.4%), had less than 7 years of education (55.3%) and earned two or less minimum wages (52.0%). The overall prevalence of HTLV-1 was 1.48% (51/3,451; 95% CI: 1.10% 1.94%), which increased with age. Only three persons younger than 17 (3/958; 0.31%; CI 95% 0.06-0.91) years were infected by HTLV-1. Among the 45 syphilis positives, 12 (26.7%) were HTLV positive, while among 21 HIV positives, only one (4.8%) was HTLV positive. HTLV-1 infection was found to be associated with syphilis infection (ORADJusTED 36.77; 95% CI 14.96-90.41). Conclusion The data presented herein indicate that horizontal transmission between adults is the main route of HTLV-1 infection in the general population of Salvador and that this is likely to occur through sexual contact.	[Nunes, David; Boa-Sorte, Ney; Rios Grassi, Maria Fernanda; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Ctr Integrat & Interdisciplinar HTLV, Salvador, BA, Brazil; [Rios Grassi, Maria Fernanda; Barreto, Mauricio L.; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz Bahia, Inst Goncalo Moniz, Salvador, BA, Brazil; [Taylor, Graham P.; Dourado, Ines] Imperial Coll Healthcare NHS Trust, Natl Ctr Human Retrovirol, St Marys Hosp, London, England; [Teixeira, Maria Gloria; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil	Escola Bahiana de Medicina e Saude Publica; Imperial College London; Universidade Federal da Bahia	Galvao-Castro, B (corresponding author), Escola Bahiana Med & Saude Publ, Ctr Integrat & Interdisciplinar HTLV, Salvador, BA, Brazil.; Galvao-Castro, B (corresponding author), Fundacao Oswaldo Cruz Bahia, Inst Goncalo Moniz, Salvador, BA, Brazil.	bgalvao@bahiana.edu.br	Dourado, Ines/Q-6535-2016; Grassi, Fernanda/X-7360-2019; Boa-Sorte, Ney A/Q-9902-2018; Boa-Sorte, Ney/AAG-8718-2020; Barreto, Mauricio L/B-1752-2008; Teixeira, Maria Gloria L C/G-4808-2012	Dourado, Ines/0000-0003-1675-2146; Grassi, Fernanda/0000-0002-7356-5569; Boa-Sorte, Ney/0000-0001-7068-3319; Barreto, Mauricio L/0000-0002-0215-4930; Teixeira, Maria Gloria L C/0000-0003-3318-3408	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and by Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Maria da Conceição Chagas de, 2003, Rev. Saúde Pública, V37, P566; Barbosa HS, 1999, J ACQ IMMUN DEF SYND, V21, P65, DOI 10.1097/00126334-199905010-00009; Bittencourt A L, 1998, Rev Inst Med Trop Sao Paulo, V40, P245, DOI 10.1590/S0036-46651998000400008; Bittencourt A, 2009, ACTA ONCOL, V48, P598, DOI 10.1080/02841860802657235; Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016; Brignol S, 2015, CAD SAUDE PUBLICA, V31, P1035, DOI 10.1590/0102-311X00178313; Casseb J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000487; Cooper Joshua M., 2016, Rev. paul. pediatr., V34, P251, DOI 10.1016/j.rppede.2016.06.004; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Demontis MA, 2015, J MED VIROL, V87, P2130, DOI 10.1002/jmv.24264; Dourado I, 1998, J ACQ IMMUN DEF SYND, V19, P426, DOI 10.1097/00042560-199812010-00016; Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Einsiedel L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu023; European Centre for Disease Prevention and Control, 2012, RISK ASS HTLV 1 2 TR; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Mello MAG, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-28; Hanchard B, 2005, CLIN INFECT DIS, V41, P542, DOI 10.1086/432066; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; Hlela C, 2009, AIDS REV, V11, P205; Honarbakhsh S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1002-0; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; KRAMER A, 1995, AM J EPIDEMIOL, V142, P1212; LAGRENADE L, 1990, LANCET, V336, P1345; Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812; Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278; Matsumoto Y, 2011, J OBSTET GYNAECOL RE, V37, P887, DOI 10.1111/j.1447-0756.2010.01461.x; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; Mota Augusto, 2006, Rev. Bras. Hematol. Hemoter., V28, P120, DOI 10.1590/S1516-84842006000200011; Murphy EL, 1996, INT J EPIDEMIOL, V25, P1083, DOI 10.1093/ije/25.5.1083; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; OSAME M, 1986, LANCET, V1, P1031; Paiva A, 2014, REV SOC BRAS MED TRO, V47, P265, DOI 10.1590/0037-8682-0232-2013; Rafatpanah H, 2011, J CLIN VIROL, V52, P172, DOI 10.1016/j.jcv.2011.07.004; RIEDEL DA, 1989, J INFECT DIS, V159, P603, DOI 10.1093/infdis/159.4.603; de Oliveira MDSP, 2012, CLIN INFECT DIS, V54, P1714, DOI 10.1093/cid/cis273; Snelling D, 2007, J BIOSOC SCI, V39, P421, DOI 10.1017/S0021932006001465; STUVER SO, 1993, J INFECT DIS, V167, P57, DOI 10.1093/infdis/167.1.57; Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011; Torii Y, 2013, PEDIATR INFECT DIS J, V32, P699, DOI 10.1097/INF.0b013e3182897c36; TSUJI Y, 1990, PEDIATRICS, V86, P11; UN, 2013, WORLD POP PROSP 2012, P2; Vargens CCL, 2011, J CLIN VIROL, V52, P177, DOI 10.1016/j.jcv.2011.07.016; Venancio SI, 2010, J PEDIAT-BRAZIL, V86, P317, DOI 10.2223/JPED.2016; Venancio SI, 2013, REV SAUDE PUBL, V47, P1205, DOI 10.1590/S0034-8910.2013047004676; Walcott MM, 2014, SEX HEALTH, V11, P42, DOI 10.1071/SH13099; Yamada T, 2014, MICROBIOL IMMUNOL, V58, P427, DOI 10.1111/1348-0421.12165; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	53	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171303	10.1371/journal.pone.0171303	http://dx.doi.org/10.1371/journal.pone.0171303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158226	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700056
J	Fatseas, G; Stapleton, F; Versace, P				Fatseas, George; Stapleton, Fiona; Versace, Patrick			Role of percent peripheral tissue ablated on refractive outcomes following hyperopic LASIK	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CENTRAL CORNEAL THICKNESS; FEMTOSECOND LENTICULE EXTRACTION; PHOTOREFRACTIVE KERATECTOMY; INTRAOCULAR-PRESSURE; MECHANICAL MICROKERATOME; ULTRASOUND PACHYMETRY; TOPOGRAPHIC CHANGES; EXCIMER-LASER; ASTIGMATISM	Objectives To determine the effect of hyperopic laser in situ keratomileusis (H-LASIK) on corneal integrity, by investigating relationships between proportionate corneal tissue ablated and refractive outcomes at 3 months. Methods 18 eyes of 18 subjects treated with H-LASIK by Technolas 217c Excimer Laser were included in the study. Orbscan II Topography System was used to determine corneal volume and pachymetry 3mm temporally (3T). The volume of corneal tissue ablated was determined from the laser nomogram. Univariate associations between age, treatment, corneal volume, overall proportion of tissue removed, proportion of tissue removed at 3T, residual bed thickness at 3T and refractive outcomes 3 months post-LASIK were examined and independent factors associated with refractive outcomes determined using linear regression models. Results At 3 months post-LASIK, the mean difference to expected refractive outcome was -0.20 +/- 0.64 (Range -2.00 to +1.00). In univariate analysis, difference to expected refractive outcome was associated with proportion of tissue removed at 3T (P<0.01, r = -0.605) and total number of pulses (P<0.05, r = -0.574). In multivariable analysis, difference to expected refractive outcome was associated with the proportion of tissue removed at 3T only. Conclusion Subjects undergoing H-LASIK, may present as either over or under-corrected at 3 months. The proportion of tissue removed at 3T was the single significant determinant of this outcome, suggesting unexpected biomechanical alterations resulting in corneal steepening. Future hyperopic LASIK procedures could consider proportionate volume of corneal tissue removed at 3T in addition to laser nomograms to achieve improved refractive outcomes.	[Fatseas, George; Stapleton, Fiona] UNSW Australia, Fac Sci, Sch Optometry & Vis Sci, Kensington, NSW, Australia; [Versace, Patrick] Vis Eye Inst, Bondi Jct, NSW, Australia	University of New South Wales Sydney	Fatseas, G (corresponding author), UNSW Australia, Fac Sci, Sch Optometry & Vis Sci, Kensington, NSW, Australia.	George.fatseas@UNSW.edu.au		Stapleton, Fiona/0000-0002-7203-5443; Fatseas, George/0000-0002-6743-3850				Agudelo LM, 2002, J REFRACT SURG, V18, P472; ANSCHUTZ T, 1994, INT OPHTHALMOL CLIN, V34, P107, DOI 10.1097/00004397-199403440-00010; Antonios R, 2015, J CATARACT REFR SURG, V41, P1602, DOI 10.1016/j.jcrs.2014.11.049; Arbelaez MC, 1999, J REFRACT SURG, V15, P406; Baek TM, 2001, OPHTHALMOLOGY, V108, P317, DOI 10.1016/S0161-6420(00)00502-9; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Brandt James D, 2004, Curr Opin Ophthalmol, V15, P85, DOI 10.1097/00055735-200404000-00004; Carones F, 1999, OPHTHALMOLOGY, V106, P1976, DOI 10.1016/S0161-6420(99)90411-6; Cartwright NEK, 2012, J REFRACT SURG, V28, P419, DOI 10.3928/1081597X-20120518-07; Chen CC, 2002, J CATARACT REFR SURG, V28, P1539, DOI 10.1016/S0886-3350(02)01541-9; Cobo-Soriano R, 2002, J CATARACT REFR SURG, V28, P1530, DOI 10.1016/S0886-3350(02)01367-6; Davidorf JM, 2001, OPHTHALMOLOGY, V108, P1261, DOI 10.1016/S0161-6420(01)00588-7; Dimasi DP, 2010, BRIT J OPHTHALMOL, V94, P971, DOI 10.1136/bjo.2009.162735; Ditzen K, 1998, J CATARACT REFR SURG, V24, P42, DOI 10.1016/S0886-3350(98)80073-4; Erie JC, 2002, OPHTHALMOLOGY, V109, P1447, DOI 10.1016/S0161-6420(02)01106-5; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Feltham Mark H, 2000, Clin Exp Optom, V83, P76; Fiander D C, 1995, J Refract Surg, V11, pS234; Gil-Cazorla R, 2011, AM J OPHTHALMOL, V152, P16, DOI 10.1016/j.ajo.2011.01.009; Gimbel HV, 1998, OPHTHALMOLOGY, V105, P1839, DOI 10.1016/S0161-6420(98)91026-0; Huang D, 1999, J REFRACT SURG, V15, P538; Khaja WA, 2015, CLIN OPHTHALMOL, V9, P1065, DOI 10.2147/OPTH.S81376; Kim T, 2001, CORNEA, V20, P597, DOI 10.1097/00003226-200108000-00008; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Kozak I, 2003, J REFRACT SURG, V19, P149; Leccisotti A, 2014, J CATARACT REFR SURG, V40, P1122, DOI 10.1016/j.jcrs.2013.11.031; Lindstrom R L, 1999, Trans Am Ophthalmol Soc, V97, P241; Lindstrom RL, 1999, T AM OPHTHAL SOC, V97, P55; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Liu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29802; Marshall J. J., 2008, AM SOC CAT REFR SURG; Marsich MM, 2000, CORNEA, V19, P792, DOI 10.1097/00003226-200011000-00007; Miyamoto T, 2003, J CATARACT REFR SURG, V29, P153, DOI 10.1016/S0886-3350(02)01450-5; Modis L, 2001, AM J OPHTHALMOL, V132, P517, DOI 10.1016/S0002-9394(01)01109-6; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Nawa Y, 2003, J CATARACT REFR SURG, V29, P1543, DOI 10.1016/S0886-3350(03)00460-7; PALLIKARIS IG, 1994, J REFRACT CORNEAL S, V10, P498; Paul T, 2008, J CATARACT REFR SURG, V34, P1906, DOI 10.1016/j.jcrs.2008.07.013; Pineda-Fernandez A, 2001, J REFRACT SURG, V17, P670; PINSKY PM, 1991, J BIOMECH, V24, P907, DOI 10.1016/0021-9290(91)90169-N; Rajpal RK, 2015, OPHTHALMOL THER; Randleman JB, 2007, J REFRACT SURG, V23, P98; Rani A, 2002, OPHTHALMOLOGY, V109, P1991, DOI 10.1016/S0161-6420(02)01238-1; Roberts C, 2000, J REFRACT SURG, V16, P407; Roberts C, 2002, J REFRACT SURG, V18, pS589; Rosa DSA, 1999, J REFRACT SURG, V15, pS212; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Settas G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007112.pub3; Van Gelder RN, 2003, AM J OPHTHALMOL, V135, P577, DOI 10.1016/S0002-9394(02)02228-6; Varley GA, 2004, OPHTHALMOLOGY, V111, P1604, DOI 10.1016/j.ophtha.2004.05.016; Wang Z, 1999, OPHTHALMOLOGY, V106, P406, DOI 10.1016/S0161-6420(99)90083-0; WILSON RS, 1982, BRIT J OPHTHALMOL, V66, P513, DOI 10.1136/bjo.66.8.513; Wilson SE, 1998, CORNEA, V17, P459, DOI 10.1097/00003226-199809000-00001; Zadok D, 2002, OPHTHALMOLOGY, V109, P1659, DOI 10.1016/S0161-6420(02)01161-2	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170559	10.1371/journal.pone.0170559	http://dx.doi.org/10.1371/journal.pone.0170559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151939	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200027
J	Lee, MY; Park, C; Ha, SE; Park, PJ; Berent, RM; Jorgensen, BG; Corrigan, RD; Grainger, N; Blair, PJ; Slivano, OJ; Miano, JM; Ward, SM; Smith, TK; Sanders, KM; Ro, S				Lee, Moon Young; Park, Chanjae; Ha, Se Eun; Park, Paul J.; Berent, Robyn M.; Jorgensen, Brian G.; Corrigan, Robert D.; Grainger, Nathan; Blair, Peter J.; Slivano, Orazio J.; Miano, Joseph M.; Ward, Sean M.; Smith, Terence K.; Sanders, Kenton M.; Ro, Seungil			Serum response factor regulates smooth muscle contractility via myotonic dystrophy protein kinases and L-type calcium channels	PLOS ONE			English	Article							INTERSTITIAL-CELLS; IN-VIVO; ICC-MY; WAVES; EXPRESSION; CA(V)1.2; CAJAL; MICE; SRF	Serum response factor (SRF) transcriptionally regulates expression of contractile genes in smooth muscle cells (SMC). Lack or decrease of SRF is directly linked to a phenotypic change of SMC, leading to hypomotility of smooth muscle in the gastrointestinal (GI) tract. However, the molecular mechanism behind SRF-induced hypomotility in GI smooth muscle is largely unknown. We describe here how SRF plays a functional role in the regulation of the SMC contractility via myotonic dystrophy protein kinase (DMPK) and L-type calcium channel CACNA1C. GI SMC expressed Dmpk and Cacnalc genes into multiple alternative transcriptional isoforms. Deficiency of SRF in SMC of Srf knockout (KO) mice led to reduction of SRF-dependent DMPK, which down-regulated the expression of CACNA1C. Reduction of CACNA1C in KO SMC not only decreased intracellular Ca2+ spikes but also disrupted their coupling between cells resulting in decreased contractility. The role of SRF in the regulation of SMC phenotype and function provides new insight into how SMC lose their contractility leading to hypomotility in pathophysiological conditions within the GI tract.	[Lee, Moon Young; Park, Chanjae; Ha, Se Eun; Park, Paul J.; Berent, Robyn M.; Jorgensen, Brian G.; Corrigan, Robert D.; Grainger, Nathan; Blair, Peter J.; Ward, Sean M.; Smith, Terence K.; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Lee, Moon Young] Wonkwang Univ, Dept Physiol, Wonkwang Digest Dis Res Inst, Sch Med, Iksan, Chonbuk, South Korea; [Lee, Moon Young] Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Chonbuk, South Korea; [Slivano, Orazio J.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University; Wonkwang University; University of Rochester	Ro, S (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	sro@medicine.nevada.edu	Miano, Joseph/L-5634-2018	Miano, Joseph/0000-0001-7522-3207; Grainger, Nathan/0000-0002-3954-7041; Grainger, Nathan/0000-0002-9956-9592; Ro, Seungil/0000-0003-0861-8334	National Institute of Diabetes and Digestive and Kidney Diseases [DK094886, DK103055]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103055, P01DK041315, R01DK094886, R01DK091336] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grants, DK094886 and DK103055, to SR.	Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; DROOGMANS G, 1986, PFLUG ARCH EUR J PHY, V406, P259, DOI 10.1007/BF00640911; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Hennig GW, 2002, J PHYSIOL-LONDON, V543, P233, DOI 10.1113/jphysiol.2002.018986; Hirst GDS, 2002, J PHYSIOL-LONDON, V540, P1003, DOI 10.1113/jphysiol.2001.013672; Huizinga JD, 2002, GASTROENTEROLOGY, V123, P1627, DOI 10.1053/gast.2002.36549; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kaliman P, 2008, CELL SIGNAL, V20, P1935, DOI 10.1016/j.cellsig.2008.05.005; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; Mack CP, 1999, CIRC RES, V84, P852; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Park C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.353; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Timchenko L, 2013, INT J BIOCHEM CELL B, V45, P2280, DOI 10.1016/j.biocel.2013.06.010; Ueda H, 2000, PROG HISTOCHEM CYTO, V35, P187, DOI 10.1016/S0079-6336(00)80002-9; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; Vogalis F, 1991, AM J PHYS 1, V260, P34, DOI [10.1093/emboj/cdg583, DOI 10.1093/EMBOJ/CDG583]; Ward SM, 2000, J NEUROSCI, V20, P1393; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666	33	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171262	10.1371/journal.pone.0171262	http://dx.doi.org/10.1371/journal.pone.0171262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152551	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200119
J	Li, Y; Zhao, L; Gu, BY; Cai, JJ; Lv, YY; Yu, LK				Li, Yan; Zhao, Li; Gu, Boya; Cai, Jiajia; Lv, Yuanyuan; Yu, Laikang			Aerobic exercise regulates Rho/cofilin pathways to rescue synaptic loss in aged rats	PLOS ONE			English	Article							SPATIAL-LEARNING DEFICITS; MONKEY PREFRONTAL-CORTEX; ENVIRONMENTAL ENRICHMENT; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MODERATE EXERCISE; FORCED EXERCISE; PYRAMIDAL CELLS; NEURON NUMBER; PLASTICITY	Purpose The role of exercise to prevent or reverse aging-induced cognitive decline has been widely reported. This neuroprotection is associated with changes in the synaptic structure plasticity. However, the mechanisms of exercise-induced synaptic plasticity in the aging brain are still unclear. Thus, the aim of the present study is to investigate the aging-related alterations of Rho-GTPase and the modulatory influences of exercise training. Methods Young and old rats were used in this study. Old rats were subjected to different schedules of aerobic exercise (12 m/min, 60 min/d, 3d/w or 5d/w) or kept sedentary for 12 w. After 12 w of aerobic exercise, the synapse density in the cortex and hippocampus was detected with immunofluorescent staining using synaptophysin as a marker. The total protein levels of RhoA, Rac1, Cdc42 and cofilin in the cortex and hippocampus were detected with Western Blot. The activities of RhoA, Rac1 and Cdc42 were determined using a pull down assay. Results We found that synapse loss occurred in aging rats. However, the change of expression and activity of RhoA, Rac1 and Cdc42 was different in the cortex and hippocampus. In the cortex, the expression and activity of Rac1 and Cdc42 was greatly increased with aging, whereas there were no changes in the expression and activity of RhoA. In the hippocampus, the expression and activity of Rac1 and Cdc42 was greatly decreased and there were no changes in the expression and activity of RhoA. As a major downstream substrate of the Rho GTPase family, the increased expression of cofilin was only observed in the cortex. High frequency exercise ameliorated all aging-related changes in the cortex and hippocampus. Conclusions These data suggest that aerobic exercise reverses synapse loss in the cortex and hippocampus in aging rats, which might be related to the regulation of Rho GTPases.	[Li, Yan; Zhao, Li; Cai, Jiajia; Yu, Laikang] Beijing Sport Univ, Dept Exercise Physiol, Beijing, Peoples R China; [Gu, Boya; Lv, Yuanyuan] Beijing Sport Univ, Key Lab Phys Fitness & Exercise, Minist Educ, Beijing, Peoples R China	Beijing Sport University; Beijing Sport University	Zhao, L (corresponding author), Beijing Sport Univ, Dept Exercise Physiol, Beijing, Peoples R China.	zhaolispring@126.com		Yu, Laikang/0000-0001-7649-5095	National Natural Science Foundation of China [31271278, 31571229]; Chinese Universities Scientific Fund [2015ZX002, 2015ZD009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work was supported by National Natural Science Foundation of China www.nsfc.gov.cn (31271278, 31571229), and the Chinese Universities Scientific Fund www.bsu.edu.cn (2015ZX002, 2015ZD009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; [Anonymous], 2010, TRENDS COGN SCI, V14, P365, DOI [10.1016/j.tics.2010.05.003, DOI 10.1016/J.TICS.2010.05.003]; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang YM, 2005, CEREB CORTEX, V15, P409, DOI 10.1093/cercor/bhh144; Chen C, 2012, INT J BIOCHEM CELL B, V44, P447, DOI 10.1016/j.biocel.2011.11.022; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Ferreira AFB, 2010, BRAIN RES, V1361, P31, DOI 10.1016/j.brainres.2010.09.045; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Huesa G, 2010, J ALZHEIMERS DIS, V19, P37, DOI 10.3233/JAD-2010-1203; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Larson MJ, 2013, SUBST ABUS, V34, P179, DOI 10.1080/08897077.2012.746255; Li Yan, 2013, J BEIJING SPORT U, V36, P44; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke J, 2010, BRAIN RES REV, V62, P212, DOI 10.1016/j.brainresrev.2009.12.002; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; Maloney MT, 2008, ADF COFILIN ACTIN DY; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Niederost B, 2002, J NEUROSCI, V22, P10368; Peters A, 2008, NEUROSCIENCE, V152, P970, DOI 10.1016/j.neuroscience.2007.07.014; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; Real CC, 2010, BRAIN RES, V1363, P63, DOI 10.1016/j.brainres.2010.09.060; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shamy JL, 2011, CEREB CORTEX, V21, P1559, DOI 10.1093/cercor/bhq210; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234; [赵丽 Zhao Li], 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P5357; 赵丽, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P2134	49	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171491	10.1371/journal.pone.0171491	http://dx.doi.org/10.1371/journal.pone.0171491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152068	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200148
J	Mroczkowska, A; Zmudzki, J; Marszalek, N; Orczykowska-Kotyna, M; Komorowska, I; Nowak, A; Grzesiak, A; Czyzewska-Dors, E; Dors, A; Pejsak, Z; Hryniewicz, W; Wyszomirski, T; Empel, J				Mroczkowska, Aneta; Zmudzki, Jacek; Marszalek, Natalia; Orczykowska-Kotyna, Monika; Komorowska, Iga; Nowak, Agnieszka; Grzesiak, Anna; Czyzewska-Dors, Ewelina; Dors, Arkadiusz; Pejsak, Zygmunt; Hryniewicz, Waleria; Wyszomirski, Tomasz; Empel, Joanna			Livestock-associated Staphylococcus aureus on Polish pig farms	PLOS ONE			English	Article							METHICILLIN-RESISTANT; GENETIC DIVERSITY; MULTIPLEX PCR; MRSA CC398; ST398; HUMANS; COLONIZATION; PREVALENCE; SWINE; RISK	Background Livestock-associated Staphylococcus aureus (LA-SA) draws increasing attention due to its particular ability to colonize farm animals and be transmitted to people, which in turn leads to its spread in the environment. The aim of the study was to determine the dissemination of LA-SA on pig farms selected throughout Poland, characterize the population structure of identified S. aureus, and assess the prevalence of LA-SA carriage amongst farmers and veterinarians being in contact with pigs. Methods and findings The study was conducted on 123 pig farms (89 farrow-to-finish and 34 nucleus herds), located in 15 out of 16 provinces of Poland. Human and pig nasal swabs, as well as dust samples were analyzed. S. aureus was detected on 79 (64.2%) farms from 14 provinces. Amongst these farms LA-SA-positive farms dominated (71/79, 89.9%, 95% CI [81.0%, 95.5%]). The prevalence of LA-MRSA-positive farms was lower than LA-MSSA-positive (36.6% of LA-SA-positive farms, 95% CI [25.5%, 48.9%] vs. 74.6%, 95% CI [62.9%, 84.2%]). In total, 190 S. aureus isolates were identified: 72 (38%) MRSA and 118 (62%) methicillin-susceptible S. aureus (MSSA), of which 174 (92%) isolates were classified to three livestock-associated lineages: CC398 (73%), CC9 (13%), and CC30/ST433 (6%). All CC398 isolates belonged to the animal clade. Four LA-MRSA clones were detected: ST433-IVa(2B) clone (n = 8, 11%), described to the best of our knowledge for the first time, and three ST398 clones (n = 64, 89%) with the most prevalent being ST398-V(5C2&5)c, followed by ST398-V(5C2), and ST398-IVa(2B). Nasal carriage of LA-SA by pig farmers was estimated at 13.2% (38/283), CC398 carriage at 12.7% (36/283) and ST398-MRSA carriage at 3.2% (9/283), whereas by veterinarians at 21.1% (8/38), 18.4% (7/38) and 10.5% (4/38), respectively. Conclusions The prevalence of LA-MRSA-positive pig farms in Poland has increased considerably since 2008, when the first MRSA EU baseline survey was conducted in Europe. On Polish pig farms CC398 of the animal clade predominates, this being also reflected in the prevalence of CC398 nasal carriage in farmers and veterinarians. However, finding a new ST433-IVa (2B) clone provides evidence for the continuing evolution of LA-MRSA and argues for further monitoring of S. aureus in farm animals.	[Mroczkowska, Aneta; Marszalek, Natalia; Orczykowska-Kotyna, Monika; Komorowska, Iga; Hryniewicz, Waleria; Empel, Joanna] Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland; [Zmudzki, Jacek; Nowak, Agnieszka; Grzesiak, Anna; Czyzewska-Dors, Ewelina; Dors, Arkadiusz; Pejsak, Zygmunt] Natl Inst Vet Res, Dept Swine Dis, Pulawy, Poland; [Hryniewicz, Waleria] Ctr Qual Control Microbiol, Warsaw, Poland; [Wyszomirski, Tomasz] Univ Warsaw, Biol & Chem Res Ctr, Fac Biol, Warsaw, Poland	National Medicines Institute Lekow (NIL); National Veterinary Institute - National Research Institute; University of Warsaw	Empel, J (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	jempel@cls.edu.pl	Dors, Arkadiusz/AHE-7159-2022; Dors, Arkadiusz/M-1508-2019; Orczykowska-Kotyna, Monika/X-6004-2018; Wyszomirski, Tomasz/V-8605-2018; Orczykowska-Kotyna, Monika/N-5008-2019	Dors, Arkadiusz/0000-0003-0270-2914; Dors, Arkadiusz/0000-0003-0270-2914; Wyszomirski, Tomasz/0000-0001-8385-2919; Orczykowska-Kotyna, Monika/0000-0002-5382-5343; Mroczkowska, Aneta/0000-0001-8529-5095; Empel, Joanna/0000-0002-1127-4053	Ministry of Science and Higher Education, Poland [5767/B/P01/2010/39]; Ministry of Science and Higher Education, Poland; European Commission [CONCORD-HEALTH-F3-2008-222718]; EU European Regional Development Fund under the Innovative Economy Operational Program; Wellcome Trust	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); EU European Regional Development Fund under the Innovative Economy Operational Program; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was financially supported by the Ministry of Science and Higher Education, Poland, decision number 5767/B/P01/2010/39. The work performed at National Medicines Institute was partially supported by the Mikrobank 2 Programme from the Ministry of Science and Higher Education, Poland. NM was supported by the fellowship from a project CONCORD-HEALTH-F3-2008-222718 from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this study, performed by TW, was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within a project co-financed by the EU European Regional Development Fund under the Innovative Economy Operational Program, 2007-2013.; We gratefully acknowledge the use of the S. aureus MLST database which was located at Imperial College London and funded by the Wellcome Trust.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Aspiroz C, 2010, EMERG INFECT DIS, V16, P157, DOI 10.3201/eid1601.090694; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Brandt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054425; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dahms C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0053-3; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Dors A, 2013, POL J VET SCI, V16, P707, DOI 10.2478/pjvs-2013-0100; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST,, 2019, BREAKPOINT TABLES IN; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Habrun B, 2011, ACTA VET HUNG, V59, P419, DOI 10.1556/AVet.2011.028; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Kumagai R, 2007, VET MICROBIOL, V122, P190, DOI 10.1016/j.vetmic.2007.01.008; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lim SK, 2012, VET MICROBIOL, V155, P88, DOI 10.1016/j.vetmic.2011.08.011; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marszalek N, 1 METHICILLIN RESIST; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Moreno LZ, 2016, MEM I OSWALDO CRUZ, V111, P659, DOI 10.1590/0074-02760160276; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; SAS Institute, 2014, SAS STAT 13 2 US GUI; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; van Cleef BAGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127190; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	69	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170745	10.1371/journal.pone.0170745	http://dx.doi.org/10.1371/journal.pone.0170745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151984	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200039
J	Nelson, N; Szekeres, K; Iclozan, C; Rivera, IO; McGill, A; Johnson, G; Nwogu, O; Ghansah, T				Nelson, Nadine; Szekeres, Karoly; Iclozan, Cristina; Rivera, Ivannie Ortiz; McGill, Andrew; Johnson, Gbemisola; Nwogu, Onyekachi; Ghansah, Tomar			Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer	PLOS ONE			English	Article							CASEIN KINASE-II; PROTEASOME ACTIVITY; FLAVONOID APIGENIN; SUPPRESSOR-CELLS; DENDRITIC CELLS; GENE; PHOSPHORYLATION; GROWTH; IDENTIFICATION; IMMUNOTHERAPY	Pancreatic cancer (PC) evades immune destruction by favoring the development of regulatory T cells (Tregs) that inhibit effector T cells. The transcription factor Ikaros is critical for lymphocyte development, especially T cells. We have previously shown that downregulation of Ikaros occurs as a result of its protein degradation by the ubiquitin-proteasome system in our Panc02 tumor-bearing (TB) mouse model. Mechanistically, we observed a deregulation in the balance between Casein Kinase II (CK2) and protein phosphatase 1 (PP1), which suggested that increased CK2 activity is responsible for regulating Ikaros' stability in our model. We also showed that this loss of Ikaros expression is associated with a significant decrease in CD4(+) and CD8(+) T cell percentages but increased CD4(+) CD25+ Tregs in TB mice. In this study, we evaluated the effects of the dietary flavonoid apigenin (API), on Ikaros expression and T cell immune responses. Treatment of splenocytes from naive mice with (API) stabilized Ikaros expression and prevented Ikaros downregulation in the presence of murine Panc02 cells in vitro, similar to the proteasome inhibitor MG132. In vivo treatment of TB mice with apigenin (TB-API) improved survival, reduced tumor weights and prevented splenomegaly. API treatment also restored protein expression of some Ikaros isoforms, which may be attributed to its moderate inhibition of CK2 activity from splenocytes of TBAPI mice. This partial restoration of Ikaros expression was accompanied by a significant increase in CD4(+) and CD8(+) T cell percentages and a reduction in Treg percentages in TBAPI mice. In addition, CD8(+) T cells from TB-API mice produced more IFN-gamma. and their splenocytes were better able to prime allogeneic CD8(+) T cell responses compared to TB mice. These results provide further evidence that Ikaros is regulated by CK2 in our pancreatic cancer model. More importantly, our findings suggest that API may be a possible therapeutic agent for stabilizing Ikaros expression and function to maintain T cell homeostasis in murine PC.	[Nelson, Nadine; Szekeres, Karoly; Iclozan, Cristina; Rivera, Ivannie Ortiz; McGill, Andrew; Johnson, Gbemisola; Nwogu, Onyekachi; Ghansah, Tomar] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Ghansah, Tomar] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Ghansah, T (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.; Ghansah, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Tghansah@health.usf.edu		Nwogu, Onyekachi/0000-0003-3602-7857	National Cancer Institute, Center to Reduce Cancer Health Disparities, [1R21 CA179668-01A1]; NATIONAL CANCER INSTITUTE [R21CA179668] Funding Source: NIH RePORTER	National Cancer Institute, Center to Reduce Cancer Health Disparities,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute, Center to Reduce Cancer Health Disparities, 1R21 CA179668-01A1 grants awarded to TG. The graduate training support was from the Florida Education Fund McKnight Dissertation Completion Fellowship awarded to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; Bazhin AV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25736; BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Cao MD, 2004, CELL BIOL INT, V28, P223, DOI 10.1016/j.cellbi.2003.12.006; Capece D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068080; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; Chen D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1797; CORBETT TH, 1984, CANCER RES, V44, P717; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Ghanekar SA, 2001, CLIN DIAGN LAB IMMUN, V8, P628, DOI 10.1128/CDLI.8.3.628-631.2001; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Ghansah T, 2013, CANCER IMMUNOL IMMUN, V62, P1083, DOI 10.1007/s00262-013-1407-9; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hadrup S, 2013, CANCER MICROENVIRON, V6, P123, DOI 10.1007/s12307-012-0127-6; Hamacher R, 2007, ONCOL REP, V18, P695; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kim HJ, 2014, CANCER IMMUNOL RES, V2, P91, DOI 10.1158/2326-6066.CIR-13-0216; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nelson N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115546; Nelson N, 2012, JOVE-J VIS EXP, DOI 10.3791/3875; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Patel D, 2007, INT J ONCOL, V30, P233; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Qin ZH, 2003, CANCER RES, V63, P4095; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Seldin DC, 2008, MOL CELL BIOCHEM, V316, P141, DOI 10.1007/s11010-008-9811-8; Shevach EM, 2011, ADV IMMUNOL, V112, P137, DOI 10.1016/B978-0-12-387827-4.00004-8; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Song Chunhua, 2011, World J Biol Chem, V2, P126, DOI 10.4331/wjbc.v2.i6.126; Strouch MJ, 2009, PANCREAS, V38, P409, DOI 10.1097/MPA.0b013e318193a074; Sun L, 1999, CLIN CANCER RES, V5, P2112; Ujiki MB, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-76; Urban JA, 2009, J IMMUNOL, V182, P3955, DOI 10.4049/jimmunol.0802869; Wang HJ, 2014, PEDIATR BLOOD CANCER, V61, P2230, DOI 10.1002/pbc.25221; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xianjun Y, TRANSLATIONAL MED, P2161; Yamamoto T, 2012, PANCREAS, V41, P409, DOI 10.1097/MPA.0b013e3182373a66; Yoon MS, 2006, MOL PHARMACOL, V70, P1033, DOI 10.1124/mol.106.024547	58	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170197	10.1371/journal.pone.0170197	http://dx.doi.org/10.1371/journal.pone.0170197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152014	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200017
J	Quiroz-Zarate, A; Harshfield, BJ; Hu, R; Knoblauch, N; Beck, AH; Hankinson, SE; Carey, V; Tamimi, RM; Hunter, DJ; Quackenbush, J; Hazra, A				Quiroz-Zarate, Alejandro; Harshfield, Benjamin J.; Hu, Rong; Knoblauch, Nick; Beck, Andrew H.; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Hunter, David J.; Quackenbush, John; Hazra, Aditi			Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue	PLOS ONE			English	Article							CANCER RISK; SUSCEPTIBILITY; ASSOCIATION; VARIANTS; ALLELES; OVARIAN; GENES	We investigate 71 single nucleotide polymorphisms (SNPs) identified in meta-analytic studies of genome-wide association studies (GWAS) of breast cancer, the majority of which are located in intergenic or intronic regions. To explore regulatory impacts of these variants we conducted expression quantitative loci (eQTL) analyses on tissue samples from 376 invasive postmenopausal breast cancer cases in the Nurses' Health Study (NHS) diagnosed from 1990-2004. Expression analysis was conducted on all formalin-fixed paraffin-embedded (FFPE) tissue samples (and on 264 adjacent normal samples) using the Affymetrix Human Transcriptome Array. Significance and ranking of associations between tumor receptor status and expression variation was preserved between NHS FFPE and TCGA fresh-frozen sample sets (Spearman r = 0.85, p<10<^>-10 for 17 of the 21 Oncotype DX recurrence signature genes). At an FDR threshold of 10%, we identified 27 trans-eQTLs associated with expression variation in 217 distinct genes. SNP-gene associations can be explored using an open-source interactive browser distributed in a Bioconductor package. Using a new a procedure for testing hypotheses relating SNP content to expression patterns in gene sets, defined as molecular function pathways, we find that loci on 6q14 and 6q25 affect various gene sets and molecular pathways (FDR < 10%). Although the ultimate biological interpretation of the GWAS-identified variants remains to be uncovered, this study validates the utility of expression analysis of this FFPE expression set for more detailed integrative analyses.	[Quiroz-Zarate, Alejandro] ArcBio LLC, Cambridge, MA USA; [Harshfield, Benjamin J.; Hu, Rong; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Quackenbush, John] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Harshfield, Benjamin J.; Hu, Rong; Knoblauch, Nick; Beck, Andrew H.; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Quackenbush, John; Hazra, Aditi] Harvard Med Sch, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Knoblauch, Nick; Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Hunter, David J.; Hazra, Aditi] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Hunter, David J.; Hazra, Aditi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA; [Quackenbush, John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hazra, Aditi] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Hazra, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ahazra@bwh.harvard.edu		Knoblauch, Nicholas/0000-0002-2890-6520; Quackenbush, John/0000-0002-2702-5879	National Cancer Institute GAME-ON DRIVE initiative [U19 CA148065, U24 CA180996, CA148065-01]; Susan G. Komen for the Cure [SAC110014]; NATIONAL CANCER INSTITUTE [U24CA180996] Funding Source: NIH RePORTER	National Cancer Institute GAME-ON DRIVE initiative; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute GAME-ON DRIVE initiative U19 CM 48065, U24 CM 80996, CA148065-01 and by Susan G. Komen for the Cure - SAC110014.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Arbustini E, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atanassov BS, 2005, GENE CHROMOSOME CANC, V44, P429, DOI 10.1002/gcc.20255; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Camp NJ, 2016, CANCER RES, V76, P1916, DOI 10.1158/0008-5472.CAN-15-1629; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; CHURCHILL GA, 1994, GENETICS, V138, P963; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; EASTON DF, 2007, NATURE; Ghoussaini M, 2016, AM J HUM GENET, V99, P903, DOI 10.1016/j.ajhg.2016.07.017; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Guo YW, 2016, CARBOHYD POLYM, V145, P13, DOI 10.1016/j.carbpol.2016.03.016; Han YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165559; Horne HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160316; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kar SP, 2016, CANCER DISCOV, V6, P1052, DOI 10.1158/2159-8290.CD-15-1227; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lawrenson K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12675; Li Q, 2014, HUM MOL GENET; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lin WY, 2014, HUM MOL GENET; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McAllister KA, 2002, CANCER RES, V62, P990; Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morimatsu M, 1998, CANCER RES, V58, P3441; Muranen TA, 2016, GENET MED; Muranen TA, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0758-5; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; de Garibay GR, 2014, HUM MUTAT, V35, P53, DOI 10.1002/humu.22456; Seo JH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0363; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Veeraraghavan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5577; Wang L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000115; Wang YR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0422-x; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Zeng C, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0718-0; Zhang X, 2012, BRIT J CANCER, V106, P1335, DOI 10.1038/bjc.2012.76	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170181	10.1371/journal.pone.0170181	http://dx.doi.org/10.1371/journal.pone.0170181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152060	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200015
J	Tsai, KF; Liou, JM; Chen, MJ; Chen, CC; Kuo, SH; Lai, IR; Yeh, KH; Lin, MT; Wang, HP; Cheng, AL; Lin, JT; Shun, CT; Wu, MS				Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Kuo, Sung-Hsin; Lai, I-Rue; Yeh, Kun-Huei; Lin, Ming-Tsan; Wang, Hsiu-Po; Cheng, Ann-Lii; Lin, Jaw-Town; Shun, Chia-Tung; Wu, Ming-Shiang		Taiwan Gastrointestinal Dis	Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer	PLOS ONE			English	Article							ATROPHIC GASTRITIS; INFECTION; TESTS; RISK; EPIDEMIOLOGY; CHEMOTHERAPY; POPULATION; CARCINOMAS; ACCURACY; STOMACH	Background Whether the characteristics and prognosis of gastric cancer (GC) are different in patients with and without Helicobacter pylori (HP) remains controversial. The definitions of HP status in patients with atrophic gastritis but negative tests for HP are heterogeneous. We aimed to assess the impact of HP on the prognosis of GC using different definitions. Methods From 1998 Nov to 2011 Jul, five hundred and sixty-seven consecutive patients with GC were included. HP status was determined by serology and histology. Patients with any positive test were defined as HP infection. Patients without HP infection whose serum pepsinogen (PG) I <70 ng/dl and PG I/II ratio <3.0 were defined as atrophic gastritis and they were categorized into model 1: HP positive; model 2: HP negative; and model 3: exclusion of these patients. Results We found four characteristics of HP negative GC in comparison to HP positive GC: (1) higher proportion of the proximal tumor location (24.0%, P = 0.004), (2) more diffuse histologic type (56.1%, p = 0.008), (3) younger disease onset (58.02 years, p = 0.008) and (4) more stage IV disease (40.6%, p = 0.03). Patients with negative HP had worse overall survival (24.0% vs. 35.8%, p = 0.035). In Cox regression models, the negative HP status is an independent poor prognostic factor (HR: 1.34, CI:1.04-1.71, p = 0.019) in model 1, especially in stage I, II and III patients (HR: 1.62; CI:1.05-2.51, p = 0.026). Conclusion We found the distinct characteristics of HP negative GC. The prognosis of HP negative GC was poor.	[Tsai, Kun-Feng] China Med Univ, An Nan Hosp, Gastroenterol & Hepatol Sect, Dept Internal Med, Tainan, Taiwan; [Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Kuo, Sung-Hsin; Lai, I-Rue; Yeh, Kun-Huei; Lin, Ming-Tsan; Wang, Hsiu-Po; Cheng, Ann-Lii; Lin, Jaw-Town; Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Kuo, Sung-Hsin; Yeh, Kun-Huei; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei, Taiwan; [Lai, I-Rue; Lin, Ming-Tsan] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Lin, Ming-Tsan] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ, Dept Pathol & Forens Med, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan	China Medical University Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Wu, MS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.; Wu, MS (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.; Shun, CT (corresponding author), Natl Taiwan Univ, Dept Pathol & Forens Med, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan.	ctshun@ntu.edu.tw; mingshiang@ntu.edu.tw	Shun, Chia-Tung/M-1400-2019; Yeh, Kun-Huei/HGD-3316-2022	Chen, Mei-Jyh/0000-0003-3284-004X; LIN, MING-TSAN/0000-0001-7313-7057; Cheng, Ann-Lii/0000-0002-9152-6512; Kuo, Sung-Hsin/0000-0003-0054-887X; SHUN, CHIA-TUNG/0000-0002-0468-4468; Wu, Ming-Shiang/0000-0002-1940-6428; YEH, Kun-Huei/0000-0002-7306-174X; LIOU, JYH-MING/0000-0002-7945-5408; Lai, I-Rue/0000-0002-3444-8255	Ministry of Science and Technology, Executive Yuan, ROC, Taiwan [MOST 103-2314-B-002-154-MY2]	Ministry of Science and Technology, Executive Yuan, ROC, Taiwan	The study was funded by the Ministry of Science and Technology, Executive Yuan, ROC, Taiwan (Grant Number: MOST 103-2314-B-002-154-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi IK, 2012, CANCER CHEMOTH PHARM, V70, P555, DOI 10.1007/s00280-012-1944-5; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Feldman M, 1996, GASTROENTEROLOGY, V110, P1043, DOI 10.1053/gast.1996.v110.pm8612992; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Gatta L, 2006, GUT, V55, P457, DOI 10.1136/gut.2005.078626; Graziano F, 2004, CLIN CANCER RES, V10, P2784, DOI 10.1158/1078-0432.CCR-03-0320; Guilford P, 2010, GASTRIC CANCER, V13, P1, DOI 10.1007/s10120-009-0531-x; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P416, DOI 10.1016/j.cgh.2006.01.019; Hansen S, 2007, GUT, V56, P918, DOI 10.1136/gut.2006.114504; Hur H, 2012, J KOREAN SURG SOC, V83, P203, DOI 10.4174/jkss.2012.83.4.203; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakinoki R, 2009, DIGEST DIS SCI, V54, P614, DOI 10.1007/s10620-008-0389-5; Kamineni A, 1999, CANCER CAUSE CONTROL, V10, P77, DOI 10.1023/A:1008849014992; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kang SY, 2012, INT J CANCER, V130, P948, DOI 10.1002/ijc.26081; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P1671, DOI 10.1111/jgh.12605; Lee SR, 2012, J KOREAN SURG SOC, V82, P211, DOI 10.4174/jkss.2012.82.4.211; Lee YC, 2016, GASTROENTEROLOGY, V150, P1113, DOI 10.1053/j.gastro.2016.01.028; Li GH, 2013, J SURG ONCOL, V108, P421, DOI 10.1002/jso.23417; Marrelli D, 2009, CANCER, V115, P2071, DOI 10.1002/cncr.24253; Matsuo T, 2011, HELICOBACTER, V16, P415, DOI 10.1111/j.1523-5378.2011.00889.x; Meimarakis G, 2006, LANCET ONCOL, V7, P211, DOI 10.1016/S1470-2045(06)70586-1; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Mizoue T, 2000, INT J EPIDEMIOL, V29, P232, DOI 10.1093/ije/29.2.232; Mohri Y, 2012, CLIN ONCOL-UK, V24, P610, DOI 10.1016/j.clon.2011.11.002; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Nardone G, 2005, ALIMENT PHARM THER, V22, P1139, DOI 10.1111/j.1365-2036.2005.02734.x; Ono S, 2012, DIGESTION, V86, P59, DOI 10.1159/000339176; Qiu HB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-374; Sampieri CL, 2013, J CANCER RES THER, V9, P356, DOI 10.4103/0973-1482.119302; Schlansky B, 2011, AM J GASTROENTEROL, V106, P1978, DOI 10.1038/ajg.2011.213; Shiao YH, 1999, INT J CANCER, V82, P59, DOI 10.1002/(SICI)1097-0215(19990702)82:1<59::AID-IJC11>3.3.CO;2-U; Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaira D, 2000, ALIMENT PHARM THER, V14, P13, DOI 10.1046/j.1365-2036.2000.00096.x; vanLoon AJM, 1997, CANCER LETT, V114, P259, DOI 10.1016/S0304-3835(97)04677-6; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Wang ZW, 2012, INT J MOL SCI, V13, P13308, DOI 10.3390/ijms131013308; Wu MS, 2000, GENE CHROMOSOME CANC, V27, P403, DOI 10.1002/(SICI)1098-2264(200004)27:4<403::AID-GCC10>3.3.CO;2-T; Wu MS, 1997, GASTROENTEROLOGY, V112, P1457, DOI 10.1016/S0016-5085(97)70071-4; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; Xia HHX, 2002, ALIMENT PHARM THERAP, V16, P521, DOI 10.1046/j.1365-2036.2002.01176.x; Yoon H, 2011, HELICOBACTER, V16, P382, DOI 10.1111/j.1523-5378.2011.00859.x	43	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170942	10.1371/journal.pone.0170942	http://dx.doi.org/10.1371/journal.pone.0170942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152027	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200060
J	Verdugo, M; Encinar, JR; Costa-Fernandez, JM; Menendez-Miranda, M; Bouzas-Ramos, D; Bravo, M; Quiroz, W				Verdugo, Marcelo; Ruiz Encinar, Jorge; Manuel Costa-Fernandez, Jose; Menendez-Miranda, Mario; Bouzas-Ramos, Diego; Bravo, Manuel; Quiroz, Waldo			Study of conformational changes and protein aggregation of bovine serum albumin in presence of Sb(III) and Sb(V)	PLOS ONE			English	Article							PARTICULATE MATTER; ANTIMONY; GLUTATHIONE; METAL; REDOX; FLUORESCENCE; PLASMA; FIBRILLATION; ENVIRONMENT; SPECIATION	\Antimony is a metalloid that affects biological functions in humans due to a mechanism still not understood. There is no doubt that the toxicity and physicochemical properties of Sb are strongly related with its chemical state. In this paper, the interaction between Sb(III) and Sb (V) with bovine serum albumin (BSA) was investigated in vitro by fluorescence spectroscopy, and circular dichroism (CD) under simulated physiological conditions. Moreover, the coupling of the separation technique, asymmetric flow field-flow fractionation, with elemental mass spectrometry to understand the interaction of Sb(V) and Sb(III) with the BSA was also used. Our results showed a different behaviour of Sb(III) vs. Sb(V) regarding their effects on the interaction with the BSA. The effects in terms of protein aggregates and conformational changes were higher in the presence of Sb(III) compared to Sb(V) which may explain the differences in toxicity between both Sb species in vivo. Obtained results demonstrated the protective effect of GSH that modifies the degree of interaction between the Sb species with BSA. Interestingly, in our experiments it was possible to detect an interaction between BSA and Sb species, which may be related with the presence of labile complex between the Sb and a protein for the first time.	[Verdugo, Marcelo; Bravo, Manuel; Quiroz, Waldo] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Verdugo, Marcelo; Ruiz Encinar, Jorge; Manuel Costa-Fernandez, Jose; Menendez-Miranda, Mario; Bouzas-Ramos, Diego] Univ Oviedo, Dept Phys & Analyt Chem, Fac Chem, Oviedo, Spain	Pontificia Universidad Catolica de Valparaiso; University of Oviedo	Quiroz, W (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	waldo.quiroz@pucv.cl	COSTA-FERNANDEZ, JOSE/AAN-2527-2020; COSTA-FERNANDEZ, JOSE MANUEL/R-9141-2017; Verdugo, Marcelo/U-9363-2018	COSTA-FERNANDEZ, JOSE/0000-0002-8671-5300; COSTA-FERNANDEZ, JOSE MANUEL/0000-0002-8671-5300; Bravo, Manuel/0000-0002-4548-6265; Verdugo, Marcelo/0000-0002-1537-0560; Bouzas-Ramos, Diego/0000-0002-8063-9589; Ruiz Encinar, Jorge/0000-0001-6245-5770; Menendez-Miranda, Mario/0000-0002-2992-1351	FONDECYT [1150528]; Spanish Ministry of Education [MINECO-13-CTQ2013-49032-C2-1-R]; Principado de Asturias [FC-15-GRUPIN14-092]; CONICYT [21120558]; Principado de Asturias (Spain) [BP14-137, BP12-046]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Ministry of Education(Spanish Government); Principado de Asturias(Principality of Asturias); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Principado de Asturias (Spain)(Principality of Asturias)	The authors gratefully acknowledge financial support from FONDECYT (project 1150528) and the Spanish Ministry of Education (MINECO-13-CTQ2013-49032-C2-1-R) and Principado de Asturias (FC-15-GRUPIN14-092). Agilent Technologies Foundation is also acknowledged. M. Verdugo also thanks to CONICYT (project 21120558) for doctoral and research-travel fellowships. Diego Bouzas-Ramos and Mario Menendez-Miranda acknowledge the Ph.D. grants (BP14-137 and BP12-046, respectively) from Principado de Asturias (Spain).	Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Ajmal MR, 2017, INT J BIOL MACROMOL, V94, P301, DOI 10.1016/j.ijbiomac.2016.10.025; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Anraku M, 2013, BBA-GEN SUBJECTS, V1830, P5465, DOI 10.1016/j.bbagen.2013.04.036; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Burford N, 2005, J INORG BIOCHEM, V99, P1992, DOI 10.1016/j.jinorgbio.2005.06.019; Chai Y, 2005, J INORG BIOCHEM, V99, P2257, DOI 10.1016/j.jinorgbio.2005.08.015; Chen MM, 2015, J LUMIN, V158, P116, DOI 10.1016/j.jlumin.2014.09.021; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; Cooper Ross G, 2009, Indian J Occup Environ Med, V13, P3, DOI 10.4103/0019-5278.50716; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Demicheli C, 2002, BBA-GEN SUBJECTS, V1570, P192, DOI 10.1016/S0304-4165(02)00198-8; Fernandez SD, 2012, ANAL CHEM, V84, P5851, DOI 10.1021/ac3009516; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Filella M, 2002, EARTH-SCI REV, V59, P265, DOI 10.1016/S0012-8252(02)00089-2; Furuta N, 2005, J ENVIRON MONITOR, V7, P1155, DOI 10.1039/b513988k; Galano A, 2011, RSC ADV, V1, P1763, DOI 10.1039/c1ra00474c; Giugliarelli A, 2015, J PHYS CHEM B, V119, P13009, DOI 10.1021/acs.jpcb.5b07487; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; Hernandez LE, 2015, J EXP BOT, V66, P2901, DOI 10.1093/jxb/erv063; Housaindokht MR, 2001, B KOR CHEM SOC, V22, P145; Hubbard R. E., 2001, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0003011.PUB2; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lopez S, 2015, PLOS ONE, V10; Loukianov AS, 2007, ATLA-ALTERN LAB ANIM, V35, P123, DOI 10.1177/026119290703500116; Mayo JC, 2003, BBA-GEN SUBJECTS, V1620, P139, DOI 10.1016/S0304-4165(02)00527-5; Menendez-Miranda M, 2014, ANAL CHIM ACTA, V839, P8, DOI 10.1016/j.aca.2014.06.034; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Murayama K, 2004, BIOCHEMISTRY-US, V43, P11526, DOI 10.1021/bi0489154; Navarra G, 2009, J INORG BIOCHEM, V103, P1729, DOI 10.1016/j.jinorgbio.2009.09.023; Navea S, 2002, ANAL CHEM, V74, P6031, DOI 10.1021/ac025914d; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; Othmer K., 2001, ENCY CHEM TECHNOLOGY, V4th; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peacock AFA, 2009, ANGEW CHEM INT EDIT, V48, P7371, DOI 10.1002/anie.200902166; Quiroz W, 2013, MICROCHEM J, V110, P266, DOI 10.1016/j.microc.2013.04.006; Quiroz W, 2013, TALANTA, V115, P902, DOI 10.1016/j.talanta.2013.06.052; Quiroz W, 2009, J ENVIRON MONITOR, V11, P1051, DOI 10.1039/b815838j; Alvarez-Idaboy JR, 2012, J PHYS CHEM B, V116, P9316, DOI 10.1021/jp303116n; Rolinski OJ, 2010, BIOSENS BIOELECTRON, V25, P2249, DOI 10.1016/j.bios.2010.03.005; Sarmiento-Gonzalez A, 2008, ANAL CHEM, V80, P8702, DOI 10.1021/ac801029p; Smichowski P, 2004, J ENVIRON MONITOR, V6, P286, DOI 10.1039/b312446k; Smichowski P, 2008, APPL SPECTROSC REV, V43, P22, DOI 10.1080/05704920701645886; Sun HZ, 2000, EUR J BIOCHEM, V267, P5450, DOI 10.1046/j.1432-1327.2000.01605.x; Tamas MJ, 2014, BIOMOLECULES, V4, P252, DOI 10.3390/biom4010252; Telpoukhovskaia MA, 2013, CHEM SOC REV, V42, P1836, DOI 10.1039/c2cs35236b; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Verdugo M, 2016, J TOXICOL SCI, V41, P783, DOI 10.2131/jts.41.783; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; von Uexkull O, 2005, J CLEAN PROD, V13, P19, DOI 10.1016/j.jclepro.2003.10.008; Wijayanti HB, 2014, COMPR REV FOOD SCI F, V13, P1235, DOI 10.1111/1541-4337.12105; Wu LZ, 2008, J MOL STRUCT, V877, P44, DOI 10.1016/j.molstruc.2007.07.013; Zheng YH, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-31; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919; Zotov AV, 2003, GEOCHIM COSMOCHIM AC, V67, P1821, DOI 10.1016/S0016-7037(02)01281-4	58	13	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170869	10.1371/journal.pone.0170869	http://dx.doi.org/10.1371/journal.pone.0170869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151990	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200051
J	Suarez-Bregua, P; Torres-Nunez, E; Saxena, A; Guerreiro, P; Braasch, I; Prober, DA; Moran, P; Cerda-Reverter, JM; Du, SJ; Adrio, F; Power, DM; Canario, AVM; Postlethwait, JH; Bronner, ME; Canestro, C; Rotllant, J				Suarez-Bregua, Paula; Torres-Nunez, Eva; Saxena, Ankur; Guerreiro, Pedro; Braasch, Ingo; Prober, David A.; Moran, Paloma; Miguel Cerda-Reverter, Jose; Du, Shao Jun; Adrio, Fatima; Power, Deborah M.; Canario, Adelino V. M.; Postlethwait, John H.; Bronner, Marianne E.; Canestro, Cristian; Rotllant, Josep			Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway	FASEB JOURNAL			English	Article						runx; phosphate; calcium; hypothalamus; fgf23	BASS DICENTRARCHUS-LABRAX; WHOLE-GENOME DUPLICATION; PHOSPHATE HOMEOSTASIS; SKELETAL MINERALIZATION; CONSERVED SYNTENY; TELEOST FISH; ZEBRAFISH; RECEPTOR; CALCIUM; GENE	Regulation of bone development, growth, and remodeling traditionally has been thought to depend on endocrine and autocrine/paracrine modulators. Recently, however, brain-derived signals have emerged as key regulators of bone metabolism, although their mechanisms of action have been poorly understood. We reveal the existence of an ancient parathyroid hormone (Pth)4 in zebrafish that was secondarily lost in the eutherian mammals' lineage, including humans, and that is specifically expressed in neurons of the hypothalamus and appears to be a central neural regulator of bone development and mineral homeostasis. Transgenic fish lines enabled mapping of axonal projections leading from the hypothalamus to the brainstem and spinal cord. Targeted laser ablation demonstrated an essential role for of pth4-expressing neurons in larval bone mineralization. Moreover, we show that Runx2 is a direct regulator of pth4 expression and that Pth4 can activate cAMP signaling mediated by Pth receptors. Finally, gain-of-function experiments show that Pth4 can alter calcium/phosphorus levels and affect expression of genes involved in phosphate homeostasis. Based on our discovery and characterization of Pth4, we propose a model for evolution of bone homeostasis in the context of the vertebrate transition from an aquatic to a terrestrial lifestyle.	[Suarez-Bregua, Paula; Torres-Nunez, Eva; Rotllant, Josep] Inst Marine Res, Spanish Natl Res Council, IIM CSIC, Vigo, Spain; [Saxena, Ankur; Prober, David A.] CALTECH, Pasadena, CA 91125 USA; [Saxena, Ankur] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Guerreiro, Pedro; Power, Deborah M.; Canario, Adelino V. M.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Moran, Paloma] Univ Vigo, Dept Biochem Genet & Immunol, Vigo, Spain; [Miguel Cerda-Reverter, Jose] IATS, CSIC, Castellon de La Plana, Spain; [Du, Shao Jun] Univ Maryland, Dept Mol & Cellular Biol, Baltimore, MD 21201 USA; [Adrio, Fatima] Univ Santiago de Compostela, Dept Cell Biol, Santiago De Compostela, Spain; [Canestro, Cristian] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Dept Genet Microbiol & Estadist, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); California Institute of Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidade do Algarve; University of Oregon; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University System of Maryland; University of Maryland Baltimore; Universidade de Santiago de Compostela; University of Barcelona	Rotllant, J (corresponding author), Inst Marine Res, Spanish Natl Res Council, IIM CSIC, Vigo, Spain.	rotllant@iim.csic.es	Morán, Paloma/J-6877-2014; Braasch, Ingo/A-6948-2010; Cañestro, Cristian/L-9661-2014; Suarez-Bregua, Paula/A-5124-2019; Power, Deborah M/D-3333-2011; Canario, Adelino/C-7942-2009; Guerreiro, P. M./A-2539-2009; Adrio, Fatima/ABD-6556-2021; Cerda-Reverter, Jose Miguel/K-4934-2014; Rotllant, Josep/K-1146-2014	Morán, Paloma/0000-0002-3644-8507; Braasch, Ingo/0000-0003-4766-611X; Cañestro, Cristian/0000-0003-4623-8105; Power, Deborah M/0000-0003-1366-0246; Canario, Adelino/0000-0002-6244-6468; Adrio, Fatima/0000-0002-3196-7682; Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Rotllant, Josep/0000-0001-5331-807X; Saxena, Ankur/0000-0001-8646-2887; Bronner, Marianne/0000-0003-4274-1862	Spanish Economy and Competitiveness Ministry Project [ALG2011-23581, AGL2014-52473R]; Portuguese Foundation for Science and Technology [PTDC/BIA-ANM/4225/2012-phos-fate]; U. S. National Institutes of Health/Office of the Director Grant [R01OD011116, R01 RR020833]; Generalitat de Catalunya [SGR2014-290]; Spanish Economy and Competitiveness Ministry [BFU2010-14875]; Science and Innovation Ministry [AGL2010-22247-C03-01]; Campus do Mar Ph.D. grant; Xunta de Galicia (Santiago, Spain) [AGL2014-52473R]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-ANM/4225/2012] Funding Source: FCT; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS094390, R01NS095824, R01NS070911] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	Spanish Economy and Competitiveness Ministry Project; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); U. S. National Institutes of Health/Office of the Director Grant; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Economy and Competitiveness Ministry(Spanish Government); Science and Innovation Ministry; Campus do Mar Ph.D. grant; Xunta de Galicia (Santiago, Spain)(Xunta de Galicia); Fundação para a Ciência e a Tecnologia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Yi-lin Yan (University of Oregon) for providing the tip39 (PTH2) expression vector; Prof. N. Lawson (University of Massachusetts Medical School, Worcester, MA, USA) and Prof. K. Kawakami (National Institute of Genetics, Mishima, Japan) for providing the iTol2 constructs; D.A.P. for the hcrt: tdTomato line and Prof. K. M. Kwan (University Of Utah, Salt Lake City, UT, USA) for the bactin2: H2A-mCherry line; Ines Pazos and Jesus Mendez [Scientific and Technological Research Assistance Centre (CACTI), University of Vigo] for their advice and assistance with the confocal microscope; Ruben Chamorro and Rosa Ceinos (IIM-CSIC) for their help in handling and care of the fish and David Guede and Jose R. Caeiro (University of Santiago de Compostela, Santiago, Spain) for their advice and assistance with the micro-CT SkyScan. This work was funded by the Spanish Economy and Competitiveness Ministry Project ALG2011-23581 and AGL2014-52473R (to J. R.); the Portuguese Foundation for Science and Technology (Project PTDC/BIA-ANM/4225/2012-phos-fate; to P.G.); U. S. National Institutes of Health/Office of the Director Grant R01OD011116 (alias R01 RR020833; to J.H.P.); Generalitat de Catalunya (Grant SGR2014-290) and the Spanish Economy and Competitiveness Ministry (Project BFU2010-14875; to C.C.). Partial funding was obtained from Science and Innovation Ministry (AGL2010-22247-C03-01; to J.M.C.-R.), a Campus do Mar Ph.D. grant, and Xunta de Galicia (Santiago, Spain; Project AGL2014-52473R) (to P.S.B.). C.C. and J.R. are co-senior authors.	Abbink W, 2006, J EXP BIOL, V209, P3550, DOI 10.1242/jeb.02399; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Anjos L, 2013, GEN COMP ENDOCR, V191, P102, DOI 10.1016/j.ygcen.2013.05.014; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Bhattacharya P, 2011, J ENDOCRINOL, V211, P187, DOI 10.1530/JOE-10-0439; Blair HC, 2008, BIOL REV, V83, P401, DOI 10.1111/j.1469-185X.2008.00048.x; Canario AVM, 2006, FEBS LETT, V580, P291, DOI 10.1016/j.febslet.2005.12.023; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cariestro C., 2012, POLYPLOIDY GENOME EV, P309, DOI DOI 10.1007/978-3-642-31442-1_16; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catchen JM, 2011, METHOD CELL BIOL, V104, P259, DOI 10.1016/B978-0-12-374814-0.00015-X; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cerda-Reverter JM, 2000, J COMP NEUROL, V426, P197, DOI 10.1002/1096-9861(20001016)426:2<197::AID-CNE3>3.0.CO;2-3; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Christov M, 2013, SEMIN NEPHROL, V33, P143, DOI 10.1016/j.semnephrol.2012.12.015; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Galitzer H, 2008, CURR OPIN NEPHROL HY, V17, P363, DOI 10.1097/MNH.0b013e328303e172; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gensure RC, 2004, ENDOCRINOLOGY, V145, P1634, DOI 10.1210/en.2003-0964; Graham C, 2003, AM J PHYSIOL-RENAL, V284, pF727, DOI 10.1152/ajprenal.00356.2002; Guerreiro PM, 2007, AM J PHYSIOL-REG I, V292, pR679, DOI 10.1152/ajpregu.00480.2006; Guerreiro PM, 2010, AM J PHYSIOL-REG I, V299, pR603, DOI 10.1152/ajpregu.00509.2009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hoare SRJ, 2000, ENDOCRINOLOGY, V141, P3080, DOI 10.1210/en.141.9.3080; Hori M, 2011, ENDOCRINOLOGY, V152, P4, DOI 10.1210/en.2010-0800; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Kalev-Zylinska ML, 2003, DEV DYNAM, V228, P323, DOI 10.1002/dvdy.10388; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Khanal RC, 2008, CLIN EXP PHARMACOL P, V35, P1277, DOI 10.1111/j.1440-1681.2008.05053.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P301; Lewis-McCrea LM, 2010, J APPL ICHTHYOL, V26, P334, DOI 10.1111/j.1439-0426.2010.01431.x; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; On JSW, 2015, MOL BIOL EVOL, V32, P2048, DOI 10.1093/molbev/msv087; Penido MGMG, 2012, PEDIATR NEPHROL, V27, P2039, DOI 10.1007/s00467-012-2175-z; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro PLC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-373; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quiros-Gonzalez I, 2014, ARCH BIOCHEM BIOPHYS, V561, P130, DOI 10.1016/j.abb.2014.06.005; Radanovic T, 2005, AM J PHYSIOL-GASTR L, V288, pG496, DOI 10.1152/ajpgi.00167.2004; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rotllant J, 2006, CELL TISSUE RES, V323, P333, DOI 10.1007/s00441-005-0070-7; Rotllant J, 2005, REGUL PEPTIDES, V132, P33, DOI 10.1016/j.regpep.2005.08.004; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Rubin DA, 1999, J BIOL CHEM, V274, P23035, DOI 10.1074/jbc.274.33.23035; Sanchez E, 2009, J EXP BIOL, V212, P3901, DOI 10.1242/jeb.035121; Sanchez E, 2009, AM J PHYSIOL-REG I, V296, pR1293, DOI 10.1152/ajpregu.90948.2008; Saxena A, 2013, ELIFE, V2, DOI 10.7554/eLife.00336; Suzuki N, 2011, BONE, V48, P1186, DOI 10.1016/j.bone.2011.02.004; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; van der Velden YU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073997; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yan YL, 2012, J ENDOCRINOL, V214, P421, DOI 10.1530/JOE-12-0110; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	69	11	12	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					569	583		10.1096/fj.201600815R	http://dx.doi.org/10.1096/fj.201600815R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148780	Green Published, Green Submitted			2022-12-26	WOS:000394235400012
J	Canedo, EO; Santiago, GS; Zurlo, LF; Ribas, CR; Carvalho, RP; Alves, GP; Carvalho, MCS; Souza, B				Canedo-Junior, Ernesto Oliveira; Santiago, Graziele Silva; Zurlo, Luana Fonseca; Ribas, Carla Rodrigues; Carvalho, Rafaela Pereira; Alves, Guilherme Pereira; Silva Carvalho, Mariana Comanucci; Souza, Brigida			Isolated and Community Contexts Produce Distinct Responses by Host Plants to the Presence of Ant-Aphid Interaction: Plant Productivity and Seed Viability	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; EXTRAFLORAL NECTARIES; MUTUALISM; DISPERSAL; TRANSMISSION; DIVERSITY; DAMAGE; L.	Ant-aphid interactions may affect host plants in several ways, however, most studies measure only the amount of fruit and seed produced, and do not test seed viability. Therefore, the aim of this study was to assess the effects of the presence of ant-aphid interactions upon host plant productivity and seed viability in two different contexts: isolated and within an arthropod community. For this purpose we tested the hypothesis that in both isolated and community contexts, the presence of an ant-aphid interaction will have a positive effect on fruit and seed production, seed biomass and rate of seed germination, and a negative effect on abnormal seedling rates, in comparison to plants without ants. We performed a field mesocosm experiment containing five treatments: Ant-aphid, Aphid, Community, Ant-free community and Control. We counted fruits and seeds produced by each treatment, and conducted experiments for seed biomass and germinability. We found that in the community context the presence of an ant-aphid interaction negatively affected fruit and seed production. We think this may be because aphid attendance by tending-ants promotes aphid damage to the host plant, but without an affect on seed weight and viability. On the other hand, when isolated, the presence of an ant-aphid interaction positively affected fruit and seed production. These positive effects are related to the cleaning services offered to aphids by tending-ants, which prevent the development of saprophytic fungi on the surface of leaves, which would cause a decrease in photosynthetic rates. Our study is important because we evaluated some parameters of plant fitness that have not been addressed very well by other studies involving the effects of ant-aphid interactions mainly on plants with short life cycles. Lastly, our context dependent approach sheds new light on how ecological interactions can vary among different methods of crop management.	[Canedo-Junior, Ernesto Oliveira; Santiago, Graziele Silva; Zurlo, Luana Fonseca; Ribas, Carla Rodrigues; Carvalho, Rafaela Pereira; Alves, Guilherme Pereira; Silva Carvalho, Mariana Comanucci] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Formigas, Lavras, MG, Brazil; [Canedo-Junior, Ernesto Oliveira; Souza, Brigida] Univ Fed Lavras, Dept Entomol, Programa Posgrad Entomol, Lavras, MG, Brazil; [Zurlo, Luana Fonseca] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Subterran, Lavras, MG, Brazil; [Carvalho, Rafaela Pereira] Univ Fed Lavras, Dept Biol, Lab Melhoramento Plantas Visando Resistencia Pato, Setor Genet & Melhoramento Plantas, Lavras, MG, Brazil; [Silva Carvalho, Mariana Comanucci] Univ Fed Lavras, Dept Zootecnia, Nucleo Estudos Manejo Animais Selvagens, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras	Canedo, EO (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Formigas, Lavras, MG, Brazil.; Canedo, EO (corresponding author), Univ Fed Lavras, Dept Entomol, Programa Posgrad Entomol, Lavras, MG, Brazil.	canedojr.e.o@gmail.com	Ribas, Carla/AAY-8673-2020; SOUZA, BRIGIDA/AAP-8928-2021	Ribas, Carla/0000-0002-9781-0450; Canedo Junior, Ernesto/0000-0002-9012-0051	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CRA - PPM - 00243/14]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was partially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) - CRA - PPM - 00243/14. (http://www.fapemig.br/ptbr/) to CRR. Dr Carla Ribas received a grant from (Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) CRA - PPM - 00243/14 (http://www.fapemig.br/ptbr/) WO to CRR. Scholarships were received by the following authors: (GSS) - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); (EOCJ and GPA) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); and (MCSC and LFZ) - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld L, 2006, ENVIRON ENTOMOL, V35, P31, DOI 10.1603/0046-225X-35.1.31; BACH CE, 1991, OECOLOGIA, V87, P233, DOI 10.1007/BF00325261; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECERRA JXI, 1989, OIKOS, V55, P276, DOI 10.2307/3565432; Billick I, 2007, ANN ENTOMOL SOC AM, V100, P887, DOI 10.1603/0013-8746(2007)100[887:AIAAFE]2.0.CO;2; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Brasil. Ministerio da Agricultura Pecuaria e Abastecimento, 2009, REGR AN SEM; Delabie Jacques H. C., 2001, Neotropical Entomology, V30, P501, DOI 10.1590/S1519-566X2001000400001; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Delfino M.A., 2000, Zoologica Baetica, V11, P3; DIXON AFG, 1977, ANNU REV ECOL SYST, V8, P329, DOI 10.1146/annurev.es.08.110177.001553; Embrapa, 2013, CAT CULT FEIJ COM; Eriksson O, 1999, ACTA OECOL, V20, P61, DOI 10.1016/S1146-609X(99)80016-2; Gardiner MM, 2005, ECOLOGICAL APPL, V19, P143; Harrington R, 2007, APHID CROP PESTS; Hill DS., 1997, EC IMPORTANCE INSECT; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Jha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043510; Kaminski Lucas A., 2009, Oecologia Brasiliensis, V13, P27; Katayama N, 2010, APPL ENTOMOL ZOOL, V45, P505, DOI 10.1303/aez.2010.505; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; Keen NT, 2000, ANNU REV PHYTOPATHOL, V38, P31, DOI 10.1146/annurev.phyto.38.1.31; Kindlmann P, 2007, OECOLOGIA, V152, P625, DOI 10.1007/s00442-007-0684-4; Lach L, 2010, ANT ECOLOGY, P1; Lemessa D, 2015, LANDSCAPE ECOL, V30, P167, DOI 10.1007/s10980-014-0115-y; LeVan KE, 2015, ECOLOGY, V96, P1620, DOI 10.1890/14-0058.1; Lovett-Doust L., 1988, PLANT REPROD ECOLOGY; McPhee KE, 2008, USDA TECHNICAL B, P199; Minarro M, 2010, ECOL ENTOMOL, V35, P206, DOI 10.1111/j.1365-2311.2010.01173.x; Moraes GJ, 2005, REV USP, V64; Moreira VSS, 2005, NEOTROP ENTOMOL, V34, P881, DOI 10.1590/S1519-566X2005000600002; Moreira X, 2012, P ROY SOC B-BIOL SCI, V279, P4464, DOI 10.1098/rspb.2012.0893; Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Offenberg J, 2001, BEHAV ECOL SOCIOBIOL, V49, P304, DOI 10.1007/s002650000303; Ohgushi T, 2008, ENTOMOL EXP APPL, V128, P217, DOI 10.1111/j.1570-7458.2008.00705.x; Olff H, 1998, TREE, V7; Oliver TH, 2007, P ROY SOC B-BIOL SCI, V274, P3127, DOI 10.1098/rspb.2007.1251; Pascov C, 2015, OECOLOGIA, V179, P1123, DOI 10.1007/s00442-015-3400-9; R Core Team, 2021, R LANGUAGE ENV STAT; Rando J.S.S, 2010, Rev. bras. plantas med., V12, P239, DOI 10.1590/S1516-05722010000200018; Raven P.H., 2007, BIOL VEGETAL; Renault CK, 2005, ECOL RES, V20, P71, DOI 10.1007/s11284-004-0015-8; Rice KB, 2013, FLA ENTOMOL, V96, P929, DOI 10.1653/024.096.0329; Rosario-Martinez HD, 2015, ANAL INTERACTIONS FI; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; Schulze E-D., 2005, PLANT ECOL; Schumacher E, 2009, J APPL ENTOMOL, V133, P33, DOI 10.1111/j.1439-0418.2008.01315.x; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B., 2008, MUTUALISM ANTS THEIR; Stadler B, 2005, ANN REV ECOLOGY EVOL, V36; Stutz S, 2011, BIOL CONTROL, V57, P37, DOI 10.1016/j.biocontrol.2011.01.001; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Styrsky JD, 2010, ECOL ENTOMOL, V35, P190, DOI 10.1111/j.1365-2311.2009.01172.x; Suzuki N, 2004, ECOL RES, V19, P275, DOI 10.1111/j.1440-1703.2004.00636.x; Tansley AG., 1993, INTRO PLANT ECOLOGY; Tegelaar K, 2012, OIKOS, V121, P61, DOI 10.1111/j.1600-0706.2011.19387.x; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Tokunaga E, 2008, POPUL ECOL, V50, P45, DOI 10.1007/s10144-007-0065-1; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Pijl L, 1982, PRINCIPLES DISPERSAL, V3; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wu D, 2014, J ECON ENTOMOL, V107, P1758, DOI 10.1603/EC14162; Wu H, 2013, APPL SOIL ECOL, V70, P9, DOI 10.1016/j.apsoil.2013.04.004; Zhang S, 2012, BASIC APPL ECOL, V13, P116, DOI 10.1016/j.baae.2012.02.002	67	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170915	10.1371/journal.pone.0170915	http://dx.doi.org/10.1371/journal.pone.0170915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141849	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500025
J	Fonsah, JY; Njamnshi, AK; Kouanfack, C; Qiu, F; Njamnshi, DM; Tagny, CT; Nchindap, E; Kenmogne, L; Mbanya, D; Heaton, R; Kanmogne, GD				Fonsah, Julius Y.; Njamnshi, Alfred K.; Kouanfack, Charles; Qiu, Fang; Njamnshi, Dora M.; Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora; Heaton, Robert; Kanmogne, Georgette D.			Adherence to Antiretroviral Therapy (ART) in Yaounde-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects	PLOS ONE			English	Article							ANRS 12110/ESTHER TRIAL; NONADHERENCE; PATTERNS; AFRICA; IMPACT; ADULTS; TIME	Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART coverage among HIV-infected Cameroonians increased from 0% in 2003 to 22% in 2014. However, the success of current HIV treatment programs depends not only on access to ART, but also on retention in care and good treatment adherence. This is necessary to achieve viral suppression, prevent virologic failure, and reduce viral transmission and HIV/AIDS-related deaths. Previous studies in Cameroon showed poor adherence, treatment interruption, and loss to follow-up among HIV+ subjects on ART, but the factors that influence ART adherence are not well known. In the current cross-sectional study, patient/self-reported questionnaires and pharmacy medication refill data were used to quantify ART adherence and determine the factors associated with increased risk of non-adherence among HIV-infected Cameroonians. We demonstrated that drug side-effects, low CD4 cell counts and higher viral loads are associated with increased risk of non-adherence, and compared to females, males were more likely to forego ART because of side effects (p< 0.05). Univariate logistic regression analysis demonstrated that subjects with opportunistic infections (on antibiotics) had 2.42-times higher odds of having been non-adherent (p< 0.001). Multivariable analysis controlling for ART regimen, age, gender, and education showed that subjects with opportunistic infections had 3.1-times higher odds of having been non-adherent (p< 0.0003), with significantly longer periods of non-adherence, compared to subjects without opportunistic infections (p = 0.02). We further showed that compared to younger subjects (<= 40 years), older subjects (>40 years) were less likely to be non-adherent (p< 0.01) and had shorter non-adherent periods (p< 0.0001). The presence of depression symptoms correlated with non-adherence to ART during antibiotic treatment (r = 0.53, p = 0.04), and was associated with lower CD4 cell counts (p = 0.04) and longer non-adherent periods (p = 0.04). Change in ART regimen was significantly associated with increased likelihood of non-adherence and increased duration of the non-adherence period. Addressing these underlying risk factors could improve ART adherence, retention in care and treatment outcomes for HIV/AIDS patients in Cameroon.	[Fonsah, Julius Y.; Njamnshi, Alfred K.] Yaounde Cent Hosp, Dept Neurol, Yaounde, Cameroon; [Fonsah, Julius Y.; Njamnshi, Alfred K.; Kouanfack, Charles; Tagny, Claude T.; Mbanya, Dora] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Kouanfack, Charles; Njamnshi, Dora M.] Yaounde Cent Hosp, HIV Day Care Serv, Yaounde, Cameroon; [Qiu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora] Univ Yaounde, Teaching Hosp, Yaounde, Cameroon; [Heaton, Robert] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Kanmogne, Georgette D.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Yaounde I; University of Nebraska System; University of Nebraska Medical Center; University of Yaounde I; University of California System; University of California San Diego; University of Nebraska System; University of Nebraska Medical Center	Kanmogne, GD (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	gkanmogne@unmc.edu			NIMH [RO1 MH094160]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH094160] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH RO1 MH094160.	Abah Isaac Okoh, 2016, J Int Assoc Provid AIDS Care, V15, P77, DOI 10.1177/2325957414539197; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; [Anonymous], 2015, GLOB HLTH OBS IND ES; Badiee J, 2012, AIDS PATIENT CARE ST, V26, P388, DOI 10.1089/apc.2011.0447; Bank W, 2016, ANT THER COV PEOPL A; Barroso J, 2001, QUAL HEALTH RES, V11, P491, DOI 10.1177/104973201129119271; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Bragard I, 2013, CANCER RADIOTHER, V17, P731, DOI 10.1016/j.canrad.2013.05.014; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chkhartishvili Nikoloz, 2014, J Int AIDS Soc, V17, P18885, DOI 10.7448/IAS.17.1.18885; Corbiere M, 2011, CLIN J PAIN, V27, P62, DOI 10.1097/AJP.0b013e3181eef903; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cunningham S, 2008, J CAN ACAD CHILD ADO, V17, P137; Denison JA, 2015, AIDS, V29, P361, DOI 10.1097/QAD.0000000000000543; Duran S, 2001, HIV Clin Trials, V2, P38; Ehlers Valerie J., 2015, Curationis, V38, P1, DOI [10.4102/curationis.v38i1.1255, 10.4102/CURATIONIS.V38I1.1255]; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Fogarty L, 2002, PATIENT EDUC COUNS, V46, P93, DOI 10.1016/S0738-3991(01)00219-1; Fokam J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129210, 10.137]; Gaynes BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140001; Gonzalez-Serna A, 2014, J ANTIMICROB CHEMOTH, V69, P2202, DOI 10.1093/jac/dku112; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Hsu J., 1996, MULTIPLE COMP THEORY; Johnson MO, 2009, J GEN INTERN MED, V24, P247, DOI 10.1007/s11606-008-0854-z; Kanmogne GD, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-60; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; Kindzeka ME., 2013, SHORTAGE ARVS HITS C; Kouanfack C, 2008, JAIDS-J ACQ IMM DEF, V48, P216, DOI 10.1097/QAI.0b013e3181743955; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Lahlou-Laforet K, 2015, J AFFECT DISORDERS, V184, P256, DOI 10.1016/j.jad.2015.05.056; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Legrand F, 2007, J SPORT EXERCISE PSY, V29, P348, DOI 10.1123/jsep.29.3.348; Marcotte D, 2014, CIENC SAUDE COLETIVA, V19, P785, DOI 10.1590/1413-81232014193.16072013; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Meresse M, 2013, ANTIVIR THER, V18, P29, DOI 10.3851/IMP2535; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Muya Aisa N, 2015, J Int Assoc Provid AIDS Care, V14, P163, DOI 10.1177/2325957414539193; NACC, 2010, IMP HIV AIDS CAM 202; NACC, 2014, RAPP NAT SUIV DECL P; Newman J, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/725713; Pefura-Yone EW, 2013, J INFECT PUBLIC HEAL, V6, P307, DOI 10.1016/j.jiph.2013.02.003; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Saberi P, 2015, AIDS PATIENT CARE ST, V29, P111, DOI 10.1089/apc.2014.0255; Safren SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104178; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; UNAIDS, 2014, 2014 PROGR REP GLOB; UNAIDS, 2013, ACC ANT THER AFR STA; UNAIDS, 2015, FACT SHEET 2015 GLOB; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; World Health Organization, 2015, CONGUID UANT DRU	61	54	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170893	10.1371/journal.pone.0170893	http://dx.doi.org/10.1371/journal.pone.0170893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141867	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500024
J	Goncalves, B; Coutinho, D; Santos, S; Lago-Penas, C; Jimenez, S; Sampaio, J				Goncalves, Bruno; Coutinho, Diogo; Santos, Sara; Lago-Penas, Carlos; Jimenez, Sergio; Sampaio, Jaime			Exploring Team Passing Networks and Player Movement Dynamics in Youth Association Football	PLOS ONE			English	Article							TACTICAL BEHAVIOR; LOSING TEAMS; SUB-PHASE; PERFORMANCE; SOCCER; STATISTICS; SPORT; CYTOSCAPE; POSITION; METRICS	Understanding how youth football players base their game interactions may constitute a solid criterion for fine-tuning the training process and, ultimately, to achieve better individual and team performances during competition. The present study aims to explore how passing networks and positioning variables can be linked to the match outcome in youth elite association football. The participants included 44 male elite players from under-15 and under-17 age groups. A passing network approach within positioning-derived variables was computed to identify the contributions of individual players for the overall team behaviour outcome during a simulated match. Results suggested that lower team passing dependency for a given player (expressed by lower betweenness network centrality scores) and high intra-team well-connected passing relations (expressed by higher closeness network centrality scores) were related to better outcomes. The correlation between the dyads' positioning regularity and the passing density showed a most likely higher correlation in under-15 (moderate effect), indicating a possible more dependence of the ball position rather than in the under-17 teams (small/unclear effects). Overall, this study emphasizes the potential of coupling notational analyses with spatial-temporal relations to produce a more functional and holistic understanding of teams' sports performance. Also, the social network analysis allowed to reveal novel key determinants of collective performance.	[Goncalves, Bruno; Coutinho, Diogo; Santos, Sara; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal; [Lago-Penas, Carlos] Univ Vigo, Fac Educ & Sport, Pontevedra, Spain; [Jimenez, Sergio] Univ Europea Madrid, Fac Ciencias Actividad Fis & Deporte, Madrid, Spain	University of Tras-os-Montes & Alto Douro; Universidade de Vigo; European University of Madrid	Goncalves, B (corresponding author), Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal.	air.bruno.23@gmail.com	Jiménez, Sergio L./AAD-2148-2020; Sampaio, Jaime/B-7392-2008; Santos, Sara/N-8806-2018; Gonçalves, Bruno/M-5361-2013; Coutinho, D./H-7313-2016; LAGO-PENAS, CARLOS/E-3957-2016	Jiménez, Sergio L./0000-0002-5069-6099; Sampaio, Jaime/0000-0003-2335-9991; Santos, Sara/0000-0002-4090-5790; Gonçalves, Bruno/0000-0001-7874-4104; Coutinho, D./0000-0001-6605-9505; LAGO-PENAS, CARLOS/0000-0002-1626-2035	Portuguese Foundation for Science and Technology (FCT); European Social Fund (ESF) under the Human Potential Operating Program (POPH) [SFRH/BD/86044/2012]; project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM) [NORTE-01-0145-FEDER-000026]; Fundo Europeu de Desenvolvimento Regional (FEDER); NORTE	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund (ESF) under the Human Potential Operating Program (POPH); project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); NORTE	This work was supported by the Portuguese Foundation for Science and Technology (FCT) and European Social Fund (ESF), through a Doctoral grant endorsed to the first author (SFRH/BD/86044/2012) under the Human Potential Operating Program (POPH); and through the project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01-0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020.	Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283; Carling C, 2009, PERFORMANCE ASSESSME; Carling C., 2005, HDB SOCCER MATCH ANA; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Cintia P, 2015, 2015 IEEE INT C DAT; Clemente FM, 2015, J HUM KINET, V45, P123, DOI 10.1515/hukin-2015-0013; Clemente Filipe Manuel, 2014, Motriz: rev. educ. fis., V20, P262, DOI 10.1590/S1980-65742014000300004; Clemente FM, 2013, J HUM KINET, V36, P179, DOI 10.2478/hukin-2013-0018; Clemente FM, 2016, INTRO SOCIAL NETWORK, P1; Cotta C, 2013, J SYST SCI COMPLEX, V26, P21, DOI 10.1007/s11424-013-2291-2; Cummings T., 1987, HUMAN SIDE ADV MANUF, P37; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Duarte R, 2012, J SPORT SCI, V30, P871, DOI 10.1080/02640414.2012.675081; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Evans MB, 2015, SCAND J MED SCI SPOR, V25, pE139, DOI 10.1111/sms.12235; Fewell JH, 2012, PLOS ONE, V7; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Fonseca S, 2012, HUM MOVEMENT SCI; Franks I., 2007, ESSENTIALS PERFORMAN, DOI 10.4324/9780203938065; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gama J, 2016, S AFR J RES SPORT PH, V38, P75; Gama J, 2014, INT J PERF ANAL SPOR, V14, P692, DOI 10.1080/24748668.2014.11868752; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B., 2016, J STRENGTH COND RES; Goncalves BV, 2014, J SPORT SCI, V32, P191, DOI 10.1080/02640414.2013.816761; Grund TU, 2016, AM BEHAV SCI, V60, P1260, DOI 10.1177/0002764216643133; Grund TU, 2012, SOC NETWORKS, V34, P682, DOI 10.1016/j.socnet.2012.08.004; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hopkins W. G., 2007, SPORTSCIENCE SPREADS; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hughes M, 2005, J SPORT SCI, V23, P509, DOI 10.1080/02640410410001716779; Johnston RJ, 2014, J STRENGTH COND RES, V28, P1649, DOI 10.1519/JSC.0000000000000323; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Kozlowski SWJ., 2013, HDB PSYCHOL IND ORG, V2, P412; Lago-Penas C, 2011, J HUM KINET, V27, P137; Lago-Penas C, 2010, J SPORT SCI MED, V9, P288; Lopez-Pena J., 2012, SPORTS PHYS, P517, DOI DOI 10.1016/J.HUMOV.2017.08.022; Lusher D, 2010, MEAS PHYS EDUC EXERC, V14, P211, DOI 10.1080/1091367X.2010.495559; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Memmert D, 2017, SPORTS MED, V47, P1, DOI 10.1007/s40279-016-0562-5; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; O'Donoghue P, 2010, RES METHODS SPORTS P; Phillips E, 2010, SPORTS MED, V40, P271, DOI 10.2165/11319430-000000000-00000; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ramos-Villagrasa PJ, 2012, EUR J WORK ORGAN PSY, V21, P778, DOI 10.1080/1359432X.2012.669525; Rein R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3108-2; Ric A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyd.2016.01513; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; Unnithan V, 2012, J SPORT SCI, V30, P1719, DOI 10.1080/02640414.2012.731515; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	58	51	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171156	10.1371/journal.pone.0171156	http://dx.doi.org/10.1371/journal.pone.0171156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141823	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500046
J	Stremmel, W; Schmidt, KV; Schuhmann, V; Kratzer, F; Garbade, SF; Langhans, CD; Fricker, G; Okun, JG				Stremmel, Wolfgang; Schmidt, Kathrin V.; Schuhmann, Vera; Kratzer, Frank; Garbade, Sven F.; Langhans, Claus-Dieter; Fricker, Gert; Okun, Juergen G.			Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; ULCERATIVE-COLITIS; GUT MICROBIOTA; POLYMORPHISMS; MANAGEMENT; METABOLISM; URINE; RISK	Elevated serum trimethylamine-N-oxide (TMAO) was previously reported to be associated with an elevated risk for cardiovascular events. TMAO originates from the microbiota-dependent breakdown of food-derived phosphatidylcholine (PC) to trimethylamine (TMA), which is oxidized by hepatic flavin-containing monooxygenases to TMAO. Our aim was to investigate the predominant site of absorption of the bacterial PC-breakdown product TMA. A healthy human proband was exposed to 6.9 g native phosphatidylcholine, either without concomitant treatment or during application with the topical antibiotic rifaximin, or exposed only to 6.9 g of a delayed-release PC formulation. Plasma and urine concentrations of TMA and TMAO were determined by electrospray ionization tandem mass spectrometry (plasma) and gas chromatography-mass spectrometry (urine). Native PC administration without concomitant treatment resulted in peak plasma TMAO levels of 43 +/- 8 mu M at 12 h post-ingestion, which was reduced by concomitant rifaximin treatment to 22 +/- 8 mu M (p < 0.05). TMAO levels observed after delayed-release PC administration were 20 +/- 3 mu M (p < 0.001). Accordingly, the peak urinary concentration at 24 h post-exposure dropped from 252 +/- 33 to 185 +/- 31 mmol/mmol creatinine after rifaximin treatment. In contrast, delayed-release PC resulted in even more suppressed urinary TMAO levels after the initial 12-h observation period (143 +/- 18 mmol/mmol creatinine) and thereafter remained within the control range (24 h: 97 +/- 9 mmol/mmol creatinine, p < 0.001 24 h vs. 12 h), indicating a lack of substrate absorption in distal intestine and large bowel. Our results showed that the microbiota in the small intestine generated the PC breakdown product TMA. The resulting TMAO, as a cardiovascular risk factor, was suppressed by topical-acting antibiotics or when PC was presented in an intestinally delayed release preparation.	[Stremmel, Wolfgang] Univ Clin Heidelberg, Dept Gastroenterol, Heidelberg, Germany; [Schmidt, Kathrin V.; Schuhmann, Vera; Kratzer, Frank; Garbade, Sven F.; Langhans, Claus-Dieter; Okun, Juergen G.] Univ Clin Heidelberg, Dept Pediat, Heidelberg, Germany; [Fricker, Gert] Ruprecht Karls Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Stremmel, W (corresponding author), Univ Clin Heidelberg, Dept Gastroenterol, Heidelberg, Germany.	wolfgang.stremmel@med.uni-heidelberg.de	Garbade, Sven F/S-2804-2016; Garbade, Sven F/O-4615-2019; Garbade, Sven Friedrich/HGA-2325-2022	Garbade, Sven F/0000-0002-7420-4757; Garbade, Sven F/0000-0002-7420-4757; Stremmel, Wolfgang/0000-0002-8545-1753				Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; Cashman JR, 2000, DRUG METAB DISPOS, V28, P169; Chalmers RA, 2006, J INHERIT METAB DIS, V29, P162, DOI 10.1007/s10545-006-0158-6; Cheng G, 2004, WORLD J GASTROENTERO, V10, P1769; Johnson DW, 2008, J MASS SPECTROM, V43, P495, DOI 10.1002/jms.1339; Karner M, 2014, AM J GASTROENTEROL, V109, P1041, DOI 10.1038/ajg.2014.104; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Mills GA, 1999, J CHROMATOGR B, V723, P281, DOI 10.1016/S0378-4347(98)00542-8; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1; Sitaraman R, 2013, J MED MICROBIOL, V62, P948, DOI 10.1099/jmm.0.053587-0; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Team C, 2016, LANG ENV STAT COMP; Vas G, 2004, J MASS SPECTROM, V39, P233, DOI 10.1002/jms.606; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	17	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170742	10.1371/journal.pone.0170742	http://dx.doi.org/10.1371/journal.pone.0170742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129384	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400041
J	Kumazoe, M; Nakamura, Y; Yamashita, M; Suzuki, T; Takamatsu, K; Huang, Y; Bae, J; Yamashita, S; Murata, M; Yamada, S; Shinoda, Y; Yamaguchi, W; Toyoda, Y; Tachibana, H				Kumazoe, Motofumi; Nakamura, Yuki; Yamashita, Mai; Suzuki, Takashi; Takamatsu, Kanako; Huang, Yuhui; Bae, Jaehoon; Yamashita, Shuya; Murata, Motoki; Yamada, Shuhei; Shinoda, Yuki; Yamaguchi, Wataru; Toyoda, Yui; Tachibana, Hirofumi			Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							67-KDA LAMININ RECEPTOR; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE ACCUMULATION; COMMON POLYMORPHISM; METABOLIC SYNDROME; RAT-LIVER; INFLAMMATION; OBESITY	Toll-like receptor 4 (TLR4) plays an essential role in innate immunity through inflammatory cytokine induction. Recent studies demonstrated that the abnormal activation of TLR4 has a pivotal role in obesity-induced inflammation, which is associated with several diseases, including hyperinsulinemia, hypertriglyceridemia, and cardiovascular disease. Here we demonstrate that (-)-epigallocatechin-3-O-gallate, a natural agonist of the 67-kDa laminin receptor (67LR), suppressed TLR4 expression through E3 ubiquitin-protein ring finger protein 216 (RNF216) up-regulation. Our data indicate cyclic GMP mediates 67LR agonist-dependent RNF216 up-regulation. Moreover, we show that the highly absorbent 67LR agonist (-)-epigallocatechin- 3-O-(3-O-methyl)-gallate (EGCG3"Me) significantly attenuated TLR4 expression in the adipose tissue. EGCG3"Me completely inhibited the high-fat/high-sucrose (HF/HS)-induced up-regulation of tumor necrosis factor alpha in adipose tissue and serum monocyte chemoattractant protein-1 increase. Furthermore, this agonist intake prevented HF/HS-induced hyperinsulinemia and hypertriglyceridemia. Taken together, 67LR presents an attractive target for the relief of obesity-induced inflammation.	[Kumazoe, Motofumi; Nakamura, Yuki; Yamashita, Mai; Suzuki, Takashi; Takamatsu, Kanako; Huang, Yuhui; Bae, Jaehoon; Yamashita, Shuya; Murata, Motoki; Yamada, Shuhei; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Shinoda, Yuki; Yamaguchi, Wataru; Toyoda, Yui] Asahi Soft Drinks Co Ltd, Prod Res Dev Lab, Ibaraki 3020106, Japan	Kyushu University; Asahi Group Holdings Ltd.	Tachibana, H (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [22228002, 15H02448]; JSPS KAKENHI Grant [15K18821]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 22228002 and 15H02448 (to H. T.), Grant-in-Aid for JSPS Fellows (to M. K.) (postdoctoral researcher (PD)), and JSPS KAKENHI Grant 15K18821. The authors declare that they have no conflicts of interest with the contents of this article.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Boden G, 2013, OBESITY, V21, P1208, DOI 10.1002/oby.20134; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Byun EB, 2012, BIOCHEM BIOPH RES CO, V426, P480, DOI 10.1016/j.bbrc.2012.08.096; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Fernandez ML, 2008, J AM COLL NUTR, V27, P1, DOI 10.1080/07315724.2008.10719668; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Hotston M, 2008, ASIAN J ANDROL, V10, P905, DOI 10.1111/j.1745-7262.2008.00380.x; Iida Y, 2014, MOL MED REP, V10, P1383, DOI 10.3892/mmr.2014.2389; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Jovinge S, 1998, METABOLISM, V47, P113, DOI 10.1016/S0026-0495(98)90203-7; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim HS, 2004, ANTICANCER RES, V24, P747; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10130; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kumazoe M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09474; Kumazoe M, 2013, FEBS LETT, V587, P3052, DOI 10.1016/j.febslet.2013.07.041; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Lai HL, 2007, PEDIATR NEPHROL, V22, P1751, DOI 10.1007/s00467-007-0533-z; Li JL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-161; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Medina EA, 2002, METABOLISM, V51, P1104, DOI 10.1053/meta.2002.34699; Merial C, 2000, AM J PHYSIOL-CELL PH, V279, pC1100, DOI 10.1152/ajpcell.2000.279.4.C1100; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b; Suzuki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02749; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	50	40	43	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4077	4088		10.1074/jbc.M116.755959	http://dx.doi.org/10.1074/jbc.M116.755959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28154178	hybrid, Green Published			2022-12-26	WOS:000395837100011
J	Li, Z; Kitanishi, K; Twahir, UT; Cracan, V; Chapman, D; Warncke, K; Banerjee, R				Li, Zhu; Kitanishi, Kenichi; Twahir, Umar T.; Cracan, Valentin; Chapman, Derrell; Warncke, Kurt; Banerjee, Ruma			Cofactor Editing by the G-protein Metallochaperone Domain Regulates the Radical B-12 Enzyme IcmF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRINOID-ADENOSYLTRANSFERASE PDUO; METHYLMALONYL-COA MUTASE; COENZYME B-12; SALMONELLA-ENTERICA; SUBSTRATE-SPECIFICITY; LACTOBACILLUS-REUTERI; COMPLEMENTATION GROUP; MECHANISM; ATP; MEAB	IcmF is a 5 '-deoxyadenosylcobalamin (AdoCbl)-dependent enzyme that catalyzes the carbon skeleton rearrangement of isobutyryl-CoA to butyryl-CoA. It is a bifunctional protein resulting from the fusion of a G-protein chaperone with GTPase activity and the cofactor-and substrate-binding mutase domains with isomerase activity. IcmF is prone to inactivation during catalytic turnover, thus setting up its dependence on a cofactor repair system. Herein, we demonstrate that the GTPase activity of IcmF powers the ejection of the inactive cob(II) alamin cofactor and requires the presence of an acceptor protein, adenosyltransferase, for receiving it. Adenosyltransferase in turn converts cob(II) alamin to AdoCbl in the presence of ATP and a reductant. The repaired cofactor is then reloaded onto IcmF in a GTPase-gated step. The mechanistic details of cofactor loading and offloading from the AdoCbl-dependent IcmF are distinct from those of the better characterized and homologous methylmalonyl-CoA mutase/ G-protein chaperone system.	[Li, Zhu; Kitanishi, Kenichi; Cracan, Valentin; Chapman, Derrell; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Twahir, Umar T.; Warncke, Kurt] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Kitanishi, Kenichi] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Cracan, Valentin] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of Michigan System; University of Michigan; Emory University; Ibaraki University; Harvard University; Massachusetts General Hospital	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kitanishi, Kenichi/I-3323-2014	Kitanishi, Kenichi/0000-0002-2110-8104; Cracan, Valentin/0000-0002-3280-0593; Li, Zhu/0000-0003-1536-9401	National Institutes of Health Grant [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK45776. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bauer CB, 2001, BIOCHEMISTRY-US, V40, P361, DOI 10.1021/bi002145o; Brunold TC, 2009, COORDIN CHEM REV, V253, P779, DOI 10.1016/j.ccr.2008.09.013; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Dong SL, 1999, J AM CHEM SOC, V121, P7063, DOI 10.1021/ja982753f; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jost M, 2015, J BIOL CHEM, V290, P26882, DOI 10.1074/jbc.M115.676890; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kitanishi K, 2015, J BIOL CHEM, V290, P20466, DOI 10.1074/jbc.M115.646299; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Liptak MD, 2009, J PHYS CHEM B, V113, P5245, DOI 10.1021/jp810136d; Lofgren M, 2013, J BIOL CHEM, V288, P30980, DOI 10.1074/jbc.M113.499970; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; Mera PE, 2007, BIOCHEMISTRY-US, V46, P13829, DOI 10.1021/bi701622j; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; Pallares IG, 2016, J AM CHEM SOC, V138, P3694, DOI 10.1021/jacs.5b11708; Park K, 2008, BIOCHEMISTRY-US, V47, P9007, DOI 10.1021/bi800419e; Park K, 2015, ANGEW CHEM INT EDIT, V54, P7158, DOI 10.1002/anie.201501930; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WOLFLE K, 1986, EUR J BIOCHEM, V156, P545, DOI 10.1111/j.1432-1033.1986.tb09614.x; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l	41	4	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3977	3987		10.1074/jbc.M117.775957	http://dx.doi.org/10.1074/jbc.M117.775957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130442	Green Published, hybrid			2022-12-26	WOS:000395837100003
J	Endo, F; Tabata, T; Sadato, D; Kawamura, M; Ando, N; Oboki, K; Ukaji, M; Kobayashi, K; Kobayashi, Y; Ikeda, T; Shibasaki, F				Endo, Fumiko; Tabata, Tsutomu; Sadato, Daichi; Kawamura, Machiko; Ando, Noriyuki; Oboki, Keisuke; Ukaji, Masako; Kobayashi, Kaoru; Kobayashi, Yukuharu; Ikeda, Tomoaki; Shibasaki, Futoshi			Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; HPV-16/18 AS04-ADJUVANTED VACCINE; LONG-TERM; CERVICAL-CANCER; YOUNG-WOMEN; HPV VACCINE; FOLLOW-UP; IMMUNOGENICITY; RESPONSES; EFFICACY	lmmunochromatography (IC) is widely used to detect target molecules in biological fluids. Since this method can be performed without a special technique or device, IC is a convenient way to assess the existence of antibodies or pathogens such as viruses and bacteria, simply and quickly. In this study, we established an IC method to detect serum antibodies against oncogenic human papillomavirus (HPV)-16 and HPV-18 L1 proteins using recombinant L1 proteins produced by silkworms as antigens. Infection of oncogenic HPVs is a major risk factor of cervical cancer, which is one of the most common cancers in women worldwide. We first measured blood sera of two groups by magnetic beads enzyme -linked immunosorbent assay (MB-ELISA). For the first group, sera were collected prospectively from young women who planned to receive HPV vaccination. The second group consisted of children under 20 years of age, non -vaccinated healthy women, vaccinated healthy women, dysplasia, cervical intraepithelial neoplasia III, and cervical cancer patients. We confirmed that standard vaccination doses significantly increased serum HPV antibody concentrations, and the level was sustained at least more than 30 months after vaccination. In contrast, an increase in antibody concentration was not observed in patients with precancerous cervical changes and cervical cancer. We next measured the samples in both groups using the IC method we originally developed, and found that the measurement values of IC highly correlated with those of MB-ELISA. The simple and quick IC method would be a useful tool for rapid monitoring of L1 specific antibody levels in a non-laboratory environment. With less than one drop of serum, our IC can easily detect serum HPV-16/-18 antibodies within 15 minutes, without the need for electronic devices or techniques.	[Endo, Fumiko; Sadato, Daichi; Oboki, Keisuke; Ukaji, Masako; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kami Kitazawa, Tokyo, Japan; [Tabata, Tsutomu; Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Fac Med, 2-174 Edobashi, Tsu, Mie, Japan; [Sadato, Daichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba, Japan; [Kawamura, Machiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pediat, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo, Japan; [Ando, Noriyuki] Josei Kokoro Clin, Arakawa Ku, 1-1-9 Machiya, Tokyo, Japan; [Kobayashi, Kaoru; Kobayashi, Yukuharu] ADTEC Co LTD, 1693-6 Yokkaichi, Usa City, Oita, Japan; [Kawamura, Machiko] Saitama Canc Ctr, Dept Hematol, 780 Komuro, Ina, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; Mie University; Tokyo University of Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital	Oboki, K; Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kami Kitazawa, Tokyo, Japan.	ooboki-ks@igakuken.or.jp; shibasaki-ft@igakuken.or.jp	Oboki, Keisuke/AAR-1813-2020	Oboki, Keisuke/0000-0001-7011-6234; Sadato, Daichi/0000-0002-3873-8268; Kawamura, Machiko/0000-0002-6138-1690	Japan Society for the Promotion of Science KAKENHI [JP23659314, JP23650620, JP26640096]; Tokyo Metropolitan Government	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Metropolitan Government(Tokyo Metropolitan Government)	This work was supported by grants from the Japan Society for the Promotion of Science KAKENHI, grant numbers JP23659314 (FS), JP23650620 and JP26640096 (FE) and by some part of the special grant from Tokyo Metropolitan Government (FS). The funder provided support in the form of salaries for authors (FE, KO, MU), but did not have any additional role in the study design,	Angioli R, 2016, CRIT REV ONCOL HEMAT, V102, P65, DOI 10.1016/j.critrevonc.2016.03.020; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Bierl C, 2005, GYNECOL ONCOL, V99, pS262, DOI 10.1016/j.ygyno.2005.07.100; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2011, HUM VACCINES, V7, P230, DOI 10.4161/hv.7.2.13948; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117; Ferris D, 2014, PEDIATRICS, V134, pE657, DOI 10.1542/peds.2013-4144; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Handisurya A, 2016, BRIT J CANCER, V114, P409, DOI 10.1038/bjc.2015.462; Herrero R, 2015, LANCET ONCOL, V16, pE206, DOI 10.1016/S1470-2045(14)70481-4; Hestbech MS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007921; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kollmann TR, 2016, TRENDS IMMUNOL, V37, P523, DOI 10.1016/j.it.2016.05.005; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Maeda S., 1989, INVERTEBRATE CELL SY, P167; Marais DJ, 2001, J MED VIROL, V65, P149, DOI 10.1002/jmv.2014; Marin AC, 2015, WORLD J GASTROENTERO, V21, P11273, DOI 10.3748/wjg.v21.i40.11273; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nakano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128351; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Naud PS, 2014, HUM VACC IMMUNOTHER, V10, P2147, DOI 10.4161/hv.29532; Nygard M, 2015, CLIN VACCINE IMMUNOL, V22, P943, DOI 10.1128/CVI.00133-15; Pagliusi SR, 2007, DIS MARKERS, V23, P283, DOI 10.1155/2007/591826; Peirson L, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-35; Pellegrino P, 2015, VACCINE, V33, P3444, DOI 10.1016/j.vaccine.2015.05.041; Pollock KGJ, 2014, BRIT J CANCER, V111, P1824, DOI 10.1038/bjc.2014.479; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Ruiz Wanda, 2005, J Immune Based Ther Vaccines, V3, P2, DOI 10.1186/1476-8518-3-2; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Suzuki T, 1997, J GEN VIROL, V78, P3073, DOI 10.1099/0022-1317-78-12-3073; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinberg A, 2012, J INFECT DIS, V206, P1309, DOI 10.1093/infdis/jis489; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171314	10.1371/journal.pone.0171314	http://dx.doi.org/10.1371/journal.pone.0171314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158224	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700059
J	Meli, P; Holl, KD; Benayas, JMR; Jones, HP; Jones, PC; Montoya, D; Mateos, DM				Meli, Paula; Holl, Karen D.; Rey Benayas, Jose Maria; Jones, Holly P.; Jones, Peter C.; Montoya, Daniel; Mateos, David Moreno			A global review of past land use, climate, and active vs. passive restoration effects on forest recovery	PLOS ONE			English	Article							ABOVEGROUND BIOMASS ACCUMULATION; ECOSYSTEM SERVICES; ECOLOGICAL RESTORATION; NATURAL REGENERATION; SPECIES COMPOSITION; TROPICAL FOREST; CARBON STORAGE; RAPID RECOVERY; TRADE-OFF; BIODIVERSITY	Global forest restoration targets have been set, yet policy makers and land managers lack guiding principles on how to invest limited resources to achieve them. We conducted a meta-analysis of 166 studies in naturally regenerating and actively restored forests worldwide to answer: (1) To what extent do floral and faunal abundance and diversity and biogeochemical functions recover? (2) Does recovery vary as a function of past land use, time since restoration, forest region, or precipitation? (3) Does active restoration result in more complete or faster recovery than passive restoration? Overall, forests showed a high level of recovery, but the time to recovery depended on the metric type measured, past land use, and region. Abundance recovered quickly and completely, whereas diversity recovered slower in tropical than in temperate forests. Biogeochemical functions recovered more slowly after agriculture than after logging or mining. Formerly logged sites were mostly passively restored and generally recovered quickly. Mined sites were nearly always actively restored using a combination of planting and either soil amendments or recontouring topography, which resulted in rapid recovery of the metrics evaluated. Actively restoring former agricultural land, primarily by planting trees, did not result in consistently faster or more complete recovery than passively restored sites. Our results suggest that simply ending the land use is sufficient for forests to recover in many cases, but more studies are needed that directly compare the value added of active versus passive restoration strategies in the same system. Investments in active restoration should be evaluated relative to the past land use, the natural resilience of the system, and the specific objectives of each project.	[Meli, Paula] Nat & Ecosistemas Mexicanos AC, Mexico City, DF, Mexico; [Meli, Paula; Rey Benayas, Jose Maria; Mateos, David Moreno] Fdn Int Restaurac Ecosistemas, Madrid, Spain; [Holl, Karen D.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Rey Benayas, Jose Maria] Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain; [Jones, Holly P.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Jones, Holly P.] Northern Illinois Univ, Inst Study Environm Sustainabil & Energy, De Kalb, IL USA; [Jones, Peter C.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Montoya, Daniel] CNRS, Stn Ecol Expt, Ctr Biodivers Theory & Modeling, Moulis, France; [Montoya, Daniel] Ctr INRA Dijon, Dijon, France; [Montoya, Daniel] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Mateos, David Moreno] Basque Ctr Climate Change, Bilbao, Spain; [Mateos, David Moreno] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Meli, Paula] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil	University of California System; University of California Santa Cruz; Universidad de Alcala; Northern Illinois University; Northern Illinois University; Northern Illinois University; Centre National de la Recherche Scientifique (CNRS); INRAE; University of Bristol; Basque Centre for Climate Change (BC3); Basque Foundation for Science; Universidade de Sao Paulo	Meli, P (corresponding author), Nat & Ecosistemas Mexicanos AC, Mexico City, DF, Mexico.; Meli, P (corresponding author), Fdn Int Restaurac Ecosistemas, Madrid, Spain.; Meli, P (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil.	paula@naturamexicana.org.mx	Montoya, Daniel/L-2266-2019; , 0000-0001-5390-7552/G-1872-2018	Montoya, Daniel/0000-0002-5521-5282; , 0000-0001-5390-7552/0000-0001-5390-7552; Jones, Holly/0000-0002-5512-9958	National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation [DBI-1052875]; German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); sDiv; Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG) [FZT 118]; 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature; Department for International Development (DFID); Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); sDiv; Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG)(German Research Foundation (DFG)); 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature; Department for International Development (DFID); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) with funding received from the National Science Foundation DBI-1052875; by the German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); by sDiv, the Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG FZT 118); and by a grant to the Fundacion Internacional para la Restauracion de Ecosistemas from 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature. The KNOW-FOR program is funded by the Department for International Development (DFID).	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alexander S, 2011, RESTOR ECOL, V19, P683, DOI 10.1111/j.1526-100X.2011.00822.x; [Anonymous], 2012, RESTOR ECOL; Barto K, 2013, MUMIN MULTIMODEL INF; Belote RT, 2012, ECOL APPL, V22, P502, DOI 10.1890/11-0925.1; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; Brancalion PHS, 2016, BIOTROPICA, V48, P856, DOI 10.1111/btp.12383; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burton JI, 2013, ECOL APPL, V23, P1297, DOI 10.1890/12-1472.1; Chazdon R.L., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CBO9781107415324.004; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; Cole LES, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4906; Convention on Biological Diversity, 2016, STRAT PLAN BIOD 2011; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Curran M, 2014, ECOL APPL, V24, P617, DOI 10.1890/13-0243.1; Dodson EK, 2012, CAN J FOREST RES, V42, P345, DOI [10.1139/x11-188, 10.1139/X11-188]; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gibb H, 2013, J APPL ECOL, V50, P449, DOI 10.1111/1365-2664.12054; Graham SA, 2005, WETLANDS, V25, P594, DOI 10.1672/0277-5212(2005)025[0594:FAAOSP]2.0.CO;2; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2014, FOREST ECOL MANAG, V319, P36, DOI 10.1016/j.foreco.2014.01.024; Holl KD, 2013, OECOLOGIA, V173, P569, DOI 10.1007/s00442-013-2632-9; Holl KD, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P411; Holl KD, 2002, J APPL ECOL, V39, P960, DOI 10.1046/j.1365-2664.2002.00767.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Knoke T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6612; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lajeunesse MJ, 2003, ECOL LETT, V6, P448, DOI 10.1046/j.1461-0248.2003.00448.x; Le HD, 2012, J RURAL STUD, V28, P5, DOI 10.1016/j.jrurstud.2011.07.006; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lu N, 2014, LANDSCAPE ECOL, V29, P1697, DOI 10.1007/s10980-014-0101-4; Marin-Spiotta Erika, 2008, P22, DOI 10.1007/978-0-387-33642-8_2; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Meli P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093507; Minnemayer S, 2011, WORLD OPPORTUNITY; Montoya D, 2012, TRENDS ECOL EVOL, V27, P666, DOI 10.1016/j.tree.2012.07.004; Moreno-Mateos D, 2015, J APPL ECOL, V52, P1528, DOI 10.1111/1365-2664.12518; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; Mundry R, 2011, BEHAV ECOL SOCIOBIOL, V65, P57, DOI 10.1007/s00265-010-1040-y; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; NAKAGOSHI N, 1990, VEGETATIO, V87, P73, DOI 10.1007/BF00045657; Norden N, 2015, P NATL ACAD SCI USA, V112, P8013, DOI 10.1073/pnas.1500403112; Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009; Pinheiro J, R PACKAGE VERSION; Plieninger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098355; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Sampaio AB, 2007, RESTOR ECOL, V15, P462, DOI 10.1111/j.1526-100X.2007.00242.x; Schwenk WS, 2012, ECOL APPL, V22, P1612, DOI 10.1890/11-0864.1; Shoo LP, 2013, RESTOR ECOL, V21, P670, DOI 10.1111/rec.12048; Society for Ecology Restoration Science & Policy Working Group, 2009, SER PRIM EC REST 200; Stanturf JA, 2014, FOREST ECOL MANAG, V331, P292, DOI 10.1016/j.foreco.2014.07.029; Suganuma MS, 2014, COMMUNITY ECOL, V15, P27, DOI [10.1556/COMEC.15.2014.1.3, 10.1556/ComEc.15.2014.1.3]; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang MC, 1998, PSYCHOL METHODS, V3, P46, DOI 10.1037/1082-989X.3.1.46; Whisenant S.G., 1999, REPAIRING DAMAGED WI, DOI [10.1017/CBO9780511612565, DOI 10.1017/CBO9780511612565]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zuur Alain F., 2009, P1	64	190	193	19	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171368	10.1371/journal.pone.0171368	http://dx.doi.org/10.1371/journal.pone.0171368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158256	Green Published, gold			2022-12-26	WOS:000396161700068
J	Sakaki, M; Ebihara, Y; Okamura, K; Nakabayashi, K; Igarashi, A; Matsumoto, K; Hata, K; Kobayashi, Y; Maehara, K				Sakaki, Mizuho; Ebihara, Yukiko; Okamura, Kohji; Nakabayashi, Kazuhiko; Igarashi, Arisa; Matsumoto, Kenji; Hata, Kenichiro; Kobayashi, Yoshiro; Maehara, Kayoko			Potential roles of DNA methylation in the initiation and establishment of replicative senescence revealed by array-based methylome and transcriptome analyses	PLOS ONE			English	Article							CELLULAR SENESCENCE; HETEROCHROMATIN FORMATION; HUMAN FIBROBLASTS; GENE-EXPRESSION; CELLS; DEMETHYLATION; P53; CANCER; PROTEINS; PATHWAY	Cellular senescence is classified into two groups: replicative and premature senescence. Gene expression and epigenetic changes are reported to differ between these two groups and cell types. Normal human diploid fibroblast TIG-3 cells have often been used in cellular senescence research; however, their epigenetic profiles are still not fully understood. To elucidate how cellular senescence is epigenetically regulated in TIG-3 cells, we analyzed the gene expression and DNA methylation profiles of three types of senescent cells, namely, replicatively senescent, ras-induced senescent (RIS), and non-permissive temperatureinduced senescent SVts8 cells, using gene expression and DNA methylation microarrays. The expression of genes involved in the cell cycle and immune response was commonly either down-or up-regulated in the three types of senescent cells, respectively. The altered DNA methylation patterns were observed in replicatively senescent cells, but not in prematurely senescent cells. Interestingly, hypomethylated CpG sites detected on non-CpG island regions ("open sea") were enriched in immune response-related genes that had non-CpG island promoters. The integrated analysis of gene expression and methylation in replicatively senescent cells demonstrated that differentially expressed 867 genes, including cell cycle-and immune response-related genes, were associated with DNA methylation changes in CpG sites close to the transcription start sites (TSSs). Furthermore, several miRNAs regulated in part through DNA methylation were found to affect the expression of their targeted genes. Taken together, these results indicate that the epigenetic changes of DNA methylation regulate the expression of a certain portion of genes and partly contribute to the introduction and establishment of replicative senescence.	[Sakaki, Mizuho; Ebihara, Yukiko; Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Sakaki, Mizuho; Kobayashi, Yoshiro] Toho Univ, Grad Sch Sci, Dept Biomol Sci, Funabashi, Chiba, Japan; [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Setagaya Ku, Tokyo, Japan; [Igarashi, Arisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, Tokyo, Japan; [Maehara, Kayoko] Kio Univ, Grad Sch Hlth Sci, Dept Nutr, Nara, Japan	National Center for Child Health & Development - Japan; Toho University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Maehara, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan.	sakaki-m@ncchd.go.jp; yoshiro@biomol.sci.toho-u.ac.jp; k.maehara@kio.ac.jp		Igarashi, Arisa/0000-0001-7206-3105	Takeda Science Foundation; Kio University; National Research Institute for Child Health and Development [24-3]; JSPS [15K19439]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kio University; National Research Institute for Child Health and Development; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Takeda Science Foundation (http://www.takeda-sci.or.jp/) to KMae, a grant from Kio University (http://www.kio.ac.jp/) to KMae, grant 24-3 from the National Research Institute for Child Health and Development to KN and KMat, and Grant-in-Aid for Young Scientists (B 15K19439) from JSPS KAKENHI to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/17142; Asuthkar S, 2012, ONCOTARGET, V3, P1439; Ayala-Ortega E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2273-6; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; BAUMANN H, 1991, J BIOL CHEM, V266, P20424; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Disayabutr S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158367; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Kaneda A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002359; Koch CM, 2013, METHODS MOL BIOL, V1048, P309, DOI 10.1007/978-1-62703-556-9_20; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li CW, 2016, ONCOTARGET, V7, P8556, DOI 10.18632/oncotarget.7388; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oliveira NFP, 2009, J CLIN PERIODONTOL, V36, P719, DOI 10.1111/j.1600-051X.2009.01446.x; Overhoff MG, 2014, NUCLEIC ACIDS RES, V42, P1606, DOI 10.1093/nar/gkt1096; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Price ME, 2013, EPIGENETICS CHROMATI, V6, P4; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rusiecki JA, 2013, FRONT PSYCHIATRY, V4, P1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Taguchi YH, 2012, AGING DIS, V3, P301; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Truong TP, 2015, J CLIN EXP HEMATOP, V55, P1, DOI 10.3960/jslrt.55.1; TSUYAMA N, 1991, CELL STRUCT FUNCT, V16, P55, DOI 10.1247/csf.16.55; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu Z, 2015, J IMMUNOL RES, V2015, DOI [10.1155/2015/471342, 10.1155/2015/412515]; Yin HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep18824; Zhang WJ, 2014, FREE RADICAL RES, V48, P550, DOI 10.3109/10715762.2014.893580; Zhang ZH, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2016.2628205	69	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171431	10.1371/journal.pone.0171431	http://dx.doi.org/10.1371/journal.pone.0171431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158250	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700079
J	Li, BY; Yang, YM; Liu, Y; Sun, J; Ye, Y; Liu, XN; Liu, HX; Sun, ZQ; Li, M; Cui, J; Sun, DJ; Gao, YH				Li, Bing-Yun; Yang, Yan-Mei; Liu, Yang; Sun, Jing; Ye, Yan; Liu, Xiao-Na; Liu, Hong-Xu; Sun, Zhen-Qi; Li, Mang; Cui, Jing; Sun, Dian-Jun; Gao, Yan-Hui			Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENTAL FLUOROSIS; RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; OSTEOCLAST DIFFERENTIATION; G/T POLYMORPHISM; BONE-FORMATION; RECEPTOR; EXPRESSION; ACTIVATION	Objective Prolactin (PRL) has been reported to be associated with increased bone turnover, and increased bone turnover is also a feature of skeletal fluorosis (SF). Autocrine/paracrine production of PRL is regulated by the extrapituitary promoter and a polymorphism in the extrapituitary PRL promoter at - 1149 (rs1341239) is associated with disturbances of bone metabolism in other diseases. Here, we have investigated the possibility that the rs1341239 polymorphism is associated with SF, which results from the consumption of brick tea. Design We conducted a cross-sectional study in Sinkiang, Qinghai, Inner Mongolia in China. Demography survey questionnaires were completed and physical examination and X-ray diagnoses were used to diagnose SF. Brick tea water fluoride intake (IF) and urinary fluoride (UF) were tested by an F-ion selective electrode method. A Sequenom MassARRAY system was used to determine PRL gene polymorphisms. Results Subjects who were younger than 45 years of age and carried the T allele had a significantly decreased risk of SF [OR = 0.279 (95% CI, 0.094 -0.824)]compared to those carrying the homozygous G allele. This phenomenon was only observed in Kazakh subjects [OR = 0.127 (95% CI, 0.025-0.646)]. Kazakh females who carried T alleles has a decreased risk of SF [OR = 0.410 (95% CI, 0.199-0.847)]. For Kazakh subjects which IF is less than 3.5 mg/d, a decreased risk of SF was observed among the participants who carried T alleles [OR = 0.118 (95% CI, 0.029-0.472)]. Overall, subjects with 1.6-3.2 mg/L UF and carried T alleles had a significantly decreased risk of SF [OR = 0.476 (95% CI, 0.237-0.955)] compared to homozygous G allele carriers. This phenomenon was only observed in Kazakh subjects [OR = 0.324 (95% CI, 0.114-0.923)]. Conclusions Our results suggested that the PRL rs1341239 T allele decreases the risk of brick tea SF.	[Sun, Dian-Jun; Gao, Yan-Hui] Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol, Educ Bur Heilongjiang Prov, Harbin, Heilongjiang Pr, Peoples R China; Minist Hlth 23618504, Harbin, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention	Sun, DJ; Gao, YH (corresponding author), Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol, Educ Bur Heilongjiang Prov, Harbin, Heilongjiang Pr, Peoples R China.	hrbmusdj@163.com; gaoyh411@163.com			National Natural Science Foundation of China [81673110, 81172605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (No. 81673110) to Yan-Mei Yang and National Natural Science Foundation of China (No. 81172605) to Yan-Hui Gao. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, GBB199652005 MIN HLT; [Anonymous], 2006, WST892006 MIN HLTH P; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; Ba Y, 2011, BIOL TRACE ELEM RES, V143, P87, DOI 10.1007/s12011-010-8848-1; BatailleSimoneau N, 1996, BIOCHEM BIOPH RES CO, V229, P323, DOI 10.1006/bbrc.1996.1800; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao J, 1997, FOOD CHEM TOXICOL, V35, P827, DOI 10.1016/S0278-6915(97)00049-5; Cao J, 2003, FOOD CHEM TOXICOL, V41, P535, DOI 10.1016/S0278-6915(02)00285-5; Cao Jin, 2003, Wei Sheng Yan Jiu, V32, P141; Clement-Lacroix P, 1999, ENDOCRINOLOGY, V140, P96, DOI 10.1210/en.140.1.96; Coss D, 2000, AM J PHYSIOL-ENDOC M, V279, pE1216, DOI 10.1152/ajpendo.2000.279.6.E1216; CROSS NA, 1995, J BONE MINER RES, V10, P1312; Dawson Deborah V, 2010, J Evid Based Dent Pract, V10, P96, DOI 10.1016/j.jebdp.2010.02.007; Escobar-Garcia D, 2016, COMMUNITY DENT ORAL, V44, P162, DOI 10.1111/cdoe.12201; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Fan ZP, 2016, J EPIDEMIOL, V26, P57, DOI 10.2188/jea.JE20150037; Fojtikova M, 2007, ANN RHEUM DIS, V66, P706, DOI 10.1136/ard.2006.061788; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Jin C, 2003, ECOTOX ENVIRON SAFE, V56, P222, DOI 10.1016/S0147-6513(03)00065-4; KRISHNAMACHARI KAVR, 1986, PROG FOOD NUTR SCI, V10, P279; Kumar JV, 1998, AM J PUBLIC HEALTH, V88, P1866, DOI 10.2105/AJPH.88.12.1866; Lee YH, 2015, CLIN RHEUMATOL, V34, P683, DOI 10.1007/s10067-015-2904-3; Lee YC, 2009, ARTHRITIS RHEUM, V60, P1250, DOI 10.1002/art.24468; MABELYA L, 1994, COMMUNITY DENT ORAL, V22, P415, DOI 10.1111/j.1600-0528.1994.tb00789.x; Ministry of Health of the People's Republic of China, 2008, 1922008 WST MIN HLTH; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Organization. WH, 2010, FLUORIDE DRINKING WA; PELLEGRINI I, 1992, MOL ENDOCRINOL, V6, P1023, DOI 10.1210/me.6.7.1023; Ray Katrina, 2014, Nat Rev Rheumatol, V10, P382, DOI 10.1038/nrrheum.2014.83; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; SCHLECHTE JA, 1995, BAILLIERE CLIN ENDOC, V9, P359, DOI 10.1016/S0950-351X(95)80386-6; Seriwatanachai D, 2008, BONE, V42, P535, DOI 10.1016/j.bone.2007.11.008; Sowers MF, 1996, JAMA-J AM MED ASSOC, V276, P549, DOI 10.1001/jama.276.7.549; Stevens A, 2001, ARTHRITIS RHEUM-US, V44, P2358, DOI 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K; [孙殿军 SUN Dian-jun], 2008, [中国地方病学杂志, Chinese Journal of Endemiology], V27, P513; Thomas T, 2010, B ACAD NAT MED PARIS, V194, P1493, DOI 10.1016/S0001-4079(19)32179-X; Tzeng SJ, 1997, MOL REPROD DEV, V48, P45, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;45::AID-MRD6&gt;3.0.CO;2-P; Velkeniers B, 1998, CELL MOL LIFE SCI, V54, P1102, DOI 10.1007/s000180050239; Vieira APGF, 2005, CALCIFIED TISSUE INT, V76, P17, DOI 10.1007/s00223-004-0075-3; Wang C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001564; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280; Wythe SE, 2014, CALCIFIED TISSUE INT, V94, P98, DOI 10.1007/s00223-013-9764-0	48	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171011	10.1371/journal.pone.0171011	http://dx.doi.org/10.1371/journal.pone.0171011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152004	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200071
J	Park, J; Kwon, YW; Ham, S; Hong, CP; Seo, S; Choe, MK; Shin, SI; Lee, CS; Kim, HS; Roh, TY				Park, Jihwan; Kwon, Yoo-Wook; Ham, Seokjin; Hong, Chang-Pyo; Seo, Seonghye; Choe, Moon Kyung; Shin, So-I; Lee, Choon-Soo; Kim, Hyo-Soo; Roh, Tae-Young			Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts	PLOS ONE			English	Article							BREAST-CANCER CELLS; HUMAN SOMATIC-CELLS; HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; IPS CELLS; EXPRESSION SIGNATURES; IMPRINTED GENES; DEFINED FACTORS; HUMAN GENOME; T-CELLS	Background The generation of induced pluripotent stem cell (iPSC), a substitute for embryonic stem cell (ESC), requires the proper orchestration of a transcription program at the chromatin level. Our recent approach for the induction of pluripotent stem cells from fibroblasts using protein extracts from mouse ESCs could overcome the potential tumorigenicity risks associated with random retroviral integration. Here, we examine the epigenetic modifications and the transcriptome of two types of iPSC and of partially reprogrammed iPSCs (iPSCp) generated independently from adult cardiac and skin fibroblasts to assess any perturbations of the transcription program during reprogramming. Results The comparative dissection of the transcription profiles and histone modification patterns at lysines 4 and 27 of histone H3 of the iPSC, iPSCp, ESC, and somatic cells revealed that the iPSC was almost completely comparable to the ESC, regardless of their origins, whereas the genes of the iPSCp were dysregulated to a larger extent. Regardless of the origins of the somatic cells, the fibroblasts induced using the ESC protein extracts appear to be completely reprogrammed into pluripotent cells, although they show unshared marginal differences in their gene expression programs, which may not affect the maintenance of stemness. A comparative investigation of the iPSCp generated by unwanted reprogramming showed that the two groups of genes on the pathway from somatic cells to iPSC might function as sequential reprogramming-competent early and late responders to the induction stimulus. Moreover, some of the divergent genes expressed only in the iPSCp were associated with many tumor-related pathways. Conclusions Faithful transcriptional reprogramming should follow epigenetic alterations to generate induced pluripotent stem cells from somatic cells. This genome-wide comparison enabled us to define the early and late responder genes during the cell reprogramming process to iPSC. Our results indicate that the cellular responsiveness to external stimuli should be predetermined and sequentially orchestrated through the tight modulation of the chromatin environment during cell reprogramming to prevent unexpected reprogramming.	[Park, Jihwan; Ham, Seokjin; Hong, Chang-Pyo; Seo, Seonghye; Choe, Moon Kyung; Shin, So-I; Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Kwon, Yoo-Wook; Lee, Choon-Soo; Kim, Hyo-Soo] Seoul Natl Univ, Natl Res Lab Stem Cell Niche, Coll Med, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH)	Roh, TY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.; Roh, TY (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea.	tyroh@postech.edu	Hong, Chang Pyo/AGR-6554-2022; Ham, SeokJin/A-2948-2012; Hong, Chang Pyo/I-6813-2019	Ham, SeokJin/0000-0002-6950-2848; Roh, Tae-Young/0000-0001-5833-0844	National Research Foundation of Korea [NRF-2015M3A9B4051044, 2011-0030049, NRF-2014M3C9A3064548]; BK21 PLUS fellowship program - Ministry of Education, Korea [10Z20130012243]	National Research Foundation of Korea(National Research Foundation of Korea); BK21 PLUS fellowship program - Ministry of Education, Korea	This work was supported by grants from the National Research Foundation of Korea (NRF-2015M3A9B4051044, 2011-0030049, and NRF-2014M3C9A3064548 to TYR) and BK21 PLUS fellowship program funded by the Ministry of Education, Korea (10Z20130012243 to JP, SH, and SIS).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bae Jae-Bum, 2013, Genomics & Informatics, V11, P7, DOI 10.5808/GI.2013.11.1.7; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Choe MK, 2012, BIOCHEM BIOPH RES CO, V418, P475, DOI 10.1016/j.bbrc.2012.01.042; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hong Chang Pyo, 2012, Genomics & Informatics, V10, P145, DOI 10.5808/GI.2012.10.3.145; Jin J, 2011, J PROTEOME RES, V10, P977, DOI 10.1021/pr100624f; Kang L, 2011, CELL RES, V21, P546, DOI 10.1038/cr.2010.164; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yavartanoo Maryam, 2013, Genomics & Informatics, V11, P2, DOI 10.5808/GI.2013.11.1.2; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171300	10.1371/journal.pone.0171300	http://dx.doi.org/10.1371/journal.pone.0171300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152015	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200123
J	Martin-Espinosa, N; Diez-Fernandez, A; Sanchez-Lopez, M; Rivero-Merino, I; Lucas-De La Cruz, L; Solera-Martinez, M; Martinez-Vizcaino, V				Martin-Espinosa, Noelia; Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Rivero-Merino, Irene; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat; Martinez-Vizcaino, Vicente		Movi-Kids Grp	Prevalence of high blood pressure and association with obesity in Spanish schoolchildren aged 4-6 years old	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; SECULAR TRENDS; PULSE PRESSURE; RISK-FACTORS; US CHILDREN; ADOLESCENTS; OVERWEIGHT; ADIPOSITY	Background The prevalence of high blood pressure in children is increasing worldwide, largely, but not entirely, driven by the concurrent childhood obesity epidemic. The aims of this study were to examine the prevalence of prehypertension and hypertension in 4-to-6-year-old Spanish schoolchildren, and to evaluate the association between different blood pressure (BP) components with different adiposity indicators. Methods Cross-sectional study including a sample of 1.604 schoolchildren aged 4-to-6-years belonging to 21 schools from the provinces of Ciudad Real and Cuenca, Spain. We measured height, weight, body mass index (BMI), fat mass percentage (%FM), triceps skinfold thickness (TST), waist circumference (WC), systolic and diastolic BP, mean arterial pressure and pulse pressure. Results The estimates of prevalence of prehypertension and hypertension were 12.3% and 18.2%, respectively. In both sexes, adiposity indicators were positively and significantly associated with all BP components (p< 0.001), thus schoolchildren in the higher adiposity categories had significantly higher BP levels (p< 0.001). Conclusions Our results show a high prevalence of high blood pressure in Spanish children. Moreover, high levels of adiposity are associated with high blood pressure in early childhood, which support that it could be related to cardiovascular risk later in life.	[Martin-Espinosa, Noelia] Univ Castilla La Mancha, Fac Nursing, Toledo, Spain; [Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Diez-Fernandez, Ana; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat] Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain; [Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Fac Educ, Ciudad Real, Spain; [Rivero-Merino, Irene] Hosp Gen Univ, Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Martinez-Vizcaino, V (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	Vicente.Martinez@uclm.es	Diez-Fernandez, Ana/Z-3348-2019; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; mota, jorge/B-2980-2013; Suárez Gómez, María/GOH-3088-2022; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Notario Pacheco, Blanca/G-2583-2016; Arias Palencia, Natalia Maria/Q-5070-2017	Diez-Fernandez, Ana/0000-0002-7673-986X; mota, jorge/0000-0001-7571-9181; Suárez Gómez, María/0000-0002-4806-106X; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Notario Pacheco, Blanca/0000-0001-8406-6952; Alvarez-Bueno, Celia/0000-0002-6176-1618; Martin Espinosa, Noelia Maria/0000-0002-1298-6976; Sanchez Lopez, Mairena/0000-0002-0217-0623; Arias Palencia, Natalia Maria/0000-0001-5004-3197; Cerrillo Urbina, Alberto Jose/0000-0001-5854-069X	Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds [FIS PI12/02400, FIS PI12/00761]; Research Network on Preventative Activities and Health Promotion [RD12/ 0005/0009]	Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds (FIS PI12/02400 and FIS PI12/00761). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref. - RD12/ 0005/0009).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aguirrea CJ, 2012, ATEN PRIM, V44, P16; Almas A, 2011, AM J HYPERTENS, V24, P876, DOI 10.1038/ajh.2011.67; [Anonymous], 1995, AN ESP PEDIATR, V43, P11; Crispim PAA, 2014, ARQ BRAS CARDIOL, V102, P39, DOI 10.5935/abc.20130227; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Chandramohan G, 2012, J AM SOC HYPERTENS, V6, P277, DOI 10.1016/j.jash.2012.05.002; Chen B, 2011, ASIA PAC J CLIN NUTR, V20, P557; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2007, J HUM HYPERTENS, V21, P120, DOI 10.1038/sj.jhh.1002125; Chiolero A, 2009, CIRCULATION, V119, P558, DOI 10.1161/CIRCULATIONAHA.108.796276; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; de Hoog MLA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-136; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Drozdz D, 2009, PEDIATR NEPHROL, V24, P1735, DOI 10.1007/s00467-009-1207-9; Eisenmann JC, 2005, J HUM HYPERTENS, V19, P675, DOI 10.1038/sj.jhh.1001882; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flores-Huerta S, 2009, ARCH MED RES, V40, P208, DOI 10.1016/j.arcmed.2009.02.009; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Garcia AG, 2015, NUTR HOSP, V32, P1476, DOI 10.3305/nh.2015.32.4.9508; Jimenez EG, 2011, NUTR HOSP, V26, P1004, DOI [10.3305/nh.2011.26.5.5003, 10.1590/S0212-16112011000500013]; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Kelishadi R, 2006, EUR J CARDIOV PREV R, V13, P956, DOI 10.1097/01.hjr.0000219109.17791.b6; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; Serrano MDM, 2013, REV ESP CARDIOL, V66, P110, DOI [10.1016/j.recesp.2012.08.007, 10.1016/j.rec.2012.08.007]; Martin S, 2005, CLIN INVEST ARTERIOS, V17, P112; Martinez-Vizcaino V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1512-0; Martinez-Vizcaino V, 2012, PUBLIC HEALTH NUTR, V15, P2170, DOI 10.1017/S1368980012003473; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Miqueleiz E, 2014, EUR J CLIN NUTR, V68, P209, DOI 10.1038/ejcn.2013.255; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ostrowska-Nawarycz L, 2007, KARDIOL POL, V65, P1079; Perez-Farinos N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/163687; Peters H, 2012, J HYPERTENS, V30, P1708, DOI 10.1097/HJH.0b013e3283562a6b; Plachta-Danielzik S, 2008, BRIT J NUTR, V100, P208, DOI 10.1017/S0007114508882980; Rademacher ER, 2009, J HYPERTENS, V27, P1766, DOI 10.1097/HJH.0b013e32832e8cfa; Raj M, 2007, NATL MED J INDIA, V20, P288; Safar ME, 2001, CURR OPIN NEPHROL HY, V10, P257, DOI 10.1097/00041552-200103000-00015; Salvadori M, 2008, PEDIATRICS, V122, pE821, DOI 10.1542/peds.2008-0951; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Xi B, 2016, AM J HYPERTENS, V29, P217, DOI 10.1093/ajh/hpv091; Yang QH, 2012, PEDIATRICS, V130, P611, DOI 10.1542/peds.2011-3870; Zachariah JP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000725	45	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170926	10.1371/journal.pone.0170926	http://dx.doi.org/10.1371/journal.pone.0170926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141860	Green Published, gold			2022-12-26	WOS:000396129500026
J	Mokgatle, MM; Madiba, S				Mokgatle, Mathildah Mpata; Madiba, Sphiwe			High Acceptability of HIV Self-Testing among Technical Vocational Education and Training College Students in Gauteng and North West Province: What Are the Implications for the Scale Up in South Africa?	PLOS ONE			English	Article								Background Although HIV self-testing (HIVST) is globally accepted as an important complement to existing HIV testing approaches, South Africa has lagged behind in its adoption. As a result, data on the acceptability and uptake of HIVST testing is limited. The study investigated the acceptability of HIVST among students in Technical Vocational Education and Training (TVET) colleges in two provinces in South Africa. Methods A cross-sectional survey using a self-administered structured questionnaire was used to collect data among 3,662 students recruited from 13 TVET colleges. Results The mean age of the students was 21.9 years. The majority (80.9%) were sexually active; while 66.1% reported that they had one sexual partner, and 33.9% had two or more sexual partners in the past year, and66.5% used condoms during the last sexual act. Three-quarters tested for HIV in the past year but less than half knew about HIVST prior to the survey. The acceptability of HIVST was high; about three-quarters showed a willingness to purchase a self-test kit and a majority would self-test with partners. Acceptability of HIVST was associated with being sexually active (OR = 1.73, p = 0.02, confidence interval (CI): 1.08- 2.75), having ever been tested for HIV (OR = 1.74, p = 0.001, CI: 1.26-2.38), and having multiple sexual partners (OR = 0.61, p = 0.01, CI: 0.42-0.88). Three-quarters would confirm test results at a local health facility. In terms of counselling, telephone hotlines were acceptable to only 39.9%, and less than half felt that test-kit leaflets would provide sufficient information to self-test. Interpretations The high acceptability of HIVST among the students calls for extensive planning and preparation for the scaling up of HIVST in South Africa. In addition, campaigns similar to those conducted to promote HIV counselling and testing (HCT) should be considered to educate communities about HIVST.	[Mokgatle, Mathildah Mpata] Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Biostat, Ga Rankuwa, South Africa; [Madiba, Sphiwe] Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Ga Rankuwa, South Africa	Sefako Makgatho Health Sciences University; Sefako Makgatho Health Sciences University	Mokgatle, MM (corresponding author), Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Biostat, Ga Rankuwa, South Africa.	mathilda_mokgatle@embanet.com	Mokgatle, Mathildah Mpata/GQH-2926-2022; Madiba, Sphiwe/ABC-5750-2020	Mokgatle, Mathildah Mpata/0000-0001-5807-8212; Madiba, Sphiwe/0000-0002-3735-1248	University of Limpopo;  [MREC/H/46/2014: IR]	University of Limpopo; 	This work was supported by University of Limpopo; MREC/H/46/2014: IR.	Abiodun Olumide, 2014, BMC Res Notes, V7, P639, DOI 10.1186/1756-0500-7-639; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Asante KO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-17; Brown AN, 2014, AIDS BEHAV, V18, pS445, DOI 10.1007/s10461-014-0831-y; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cosser M., 2011, FURTHER ED TRAINING; Djibuti M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1760-z; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Gardner J, 2012, S AFR J BIOETH LAW, V5, P15; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kumwenda M, 2014, AIDS BEHAV, V18, pS396, DOI 10.1007/s10461-014-0817-9; Leon N, 2010, SAMJ S AFR MED J, V100, P220, DOI 10.7196/SAMJ.4043; Madiba S, 2015, WORLD J AIDS, V5, P208; Madiba S, 2015, BMC PUBLIC HEALTH, V15, P1; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Myers JE, 2013, AIDS, V27, P1687, DOI 10.1097/QAD.0b013e32835fd7a0; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai N, 2014, AIDS RES TREATMENT, V2014; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Perez GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152653; Powell L, 2014, 7 EXPLORING VALUE CA, P126; Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755; Richter ML, 2012, S AFR J HIV MED, P186, DOI 10.7196/SAJHIVMED.858; SANAC, 2011, HIV AIDS STI NAT STR; Smith J., 2009, THESIS ROWAN U; Tsegay G, 2013, BMC PUBLIC HLTH, V13, P1; van Dyk AC, 2013, AJAR-AFR J AIDS RES, V12, P41, DOI 10.2989/16085906.2013.815413; van Rooyen H, 2015, J INT AIDS SOC, V18; WHO, 2015, CONSOLIDATED GUIDELI	33	35	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0169765	10.1371/journal.pone.0169765	http://dx.doi.org/10.1371/journal.pone.0169765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141858	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129500005
J	Belay, E; Hayes, BJ; Blau, CA; Torok-Storb, B				Belay, Eyayu; Hayes, Brian J.; Blau, C. Anthony; Torok-Storb, Beverly			Human Cord Blood and Bone Marrow CD34+Cells Generate Macrophages That Support Erythroid Islands	PLOS ONE			English	Article							ERYTHROBLASTIC ISLANDS; DEFINITIVE ERYTHROPOIESIS; FUNCTIONAL-CHARACTERIZATION; PERIPHERAL-BLOOD; PROTEIN EMP; CELLS; PROLIFERATION; EXPRESSION; ENUCLEATION; HOMEOSTASIS	Recently, we developed a small molecule responsive hyperactive Mpl-based Cell Growth Switch (CGS) that drives erythropoiesis associated with macrophages in the absence of exogenous cytokines. Here, we compare the physical, cellular and molecular interaction between the macrophages and erythroid cells in CGS expanded CD34+ cells harvested from cord blood, marrow or G-CSF-mobilized peripheral blood. Results indicated that macrophage based erythroid islands could be generated from cord blood and marrow CD34+ cells but not from G-CSF-mobilized CD34+ cells. Additional studies suggest that the deficiency resides with the G-CSF-mobilized CD34+ derived monocytes. Gene expression and proteomics studies of the in vitro generated erythroid islands detected the expression of erythroblast macrophage protein (EMP), intercellular adhesion molecule 4 (ICAM-4), CD163 and DNASE2. 78% of the erythroblasts in contact with macrophages reached the pre reticulocyte orthochromatic stage of differentiation within 14 days of culture. The addition of conditioned medium from cultures of CD146+ marrow fibroblasts resulted in a 700-fold increase in total cell number and a 90-fold increase in erythroid cell number. This novel CD34+ cell derived erythroid island may serve as a platform to explore the molecular basis of red cell maturation and production under normal, stress and pathological conditions.	[Belay, Eyayu; Hayes, Brian J.; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Blau, C. Anthony] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Belay, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	ebelay@fhcrc.org		Hayes, Brian J/0000-0002-0930-0160	National Institutes of Health [P30 DK56465, U01 HL099993, UO1 HL099993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants P30 DK56465, U01 HL099993, B.T.S and Supplement for E. Belay NHLBI / U01 HL099993.; This work was supported by the National Institutes of Health grants P30 DK56465, UO1 HL099993, B.T.S and Supplement for E. Belay NHLBI / U01 HL099993	ALLEN TD, 1982, DIFFERENTIATION, V21, P86, DOI 10.1111/j.1432-0436.1982.tb01201.x; Belay E, 2015, BLOOD, V125, P1025, DOI 10.1182/blood-2014-02-555318; Bessis M, 1958, REV HEMATOLOGIE, V13; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chasis JA, 2006, CURR OPIN HEMATOL, V13, P137, DOI 10.1097/01.moh.0000219657.57915.30; Choi HS, 2013, STEM CELL RES, V10, P442, DOI 10.1016/j.scr.2013.02.003; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eymard N, 2015, J MATH BIOL, V70, P71, DOI 10.1007/s00285-014-0758-y; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fischer S, 2012, J THEOR BIOL, V298, P92, DOI 10.1016/j.jtbi.2012.01.002; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Graf L, 2001, BIOL BLOOD MARROW TR, V7, P486, DOI 10.1053/bbmt.2001.v7.pm11669215; HANSPAL M, 1994, BLOOD, V84, P3494; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Iwata M, 2014, STEM CELLS DEV, V23, P729, DOI 10.1089/scd.2013.0300; Jacobsen RN, 2014, EXP HEMATOL, V42, P547, DOI 10.1016/j.exphem.2014.03.009; Kalfa TA, 2011, BLOOD, V117, P748, DOI 10.1182/blood-2010-11-316448; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; Migliaccio G, 2010, CELL TRANSPLANT, V19, P453, DOI 10.3727/096368909X485049; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Mohandas N, 2010, TRANSFUS CLIN BIOL, V17, P110, DOI 10.1016/j.tracli.2010.05.009; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pishesha N, 2014, P NATL ACAD SCI USA, V111, P4103, DOI 10.1073/pnas.1401598111; Porcu S, 2011, MOL CELL BIOL, V31, P4144, DOI 10.1128/MCB.05532-11; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Ribeil JA, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/394295, DOI 10.1155/2013/394295PMID:23606813]; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Soni S, 2008, BLOOD CELL MOL DIS, V41, P141, DOI 10.1016/j.bcmd.2008.03.008; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; Spring FA, 2001, BLOOD, V98, P458, DOI 10.1182/blood.V98.2.458; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; Xue L, 2014, DEVELOPMENT, V141, P2245, DOI 10.1242/dev.103960; Zhang DL, 2011, BLOOD, V118, P2868, DOI 10.1182/blood-2011-01-330241	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171096	10.1371/journal.pone.0171096	http://dx.doi.org/10.1371/journal.pone.0171096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135323	Green Submitted, gold, Green Published			2022-12-26	WOS:000396124700049
J	Kuusk, S; Sorlie, M; Valjamae, P				Kuusk, Silja; Sorlie, Morten; Valjamae, Priit			Human Chitotriosidase Is an Endo-Processive Enzyme	PLOS ONE			English	Article							HUMAN MACROPHAGE CHITINASE; SERRATIA-MARCESCENS 2170; SUBSTRATE DEGRADATION; ASPERGILLUS-FUMIGATUS; BETA-GLUCOSIDASES; PRODUCT BINDING; HYDROLYSIS; RESOLUTION; PURIFICATION; EXPRESSION	Human chitotriosidase (HCHT) is involved in immune response to chitin-containing pathogens in humans. The enzyme is able to degrade chitooligosaccharides as well as crystalline chitin. The catalytic domain of HCHT is connected to the carbohydrate binding module (CBM) through a flexible hinge region. In humans, two active isoforms of HCHT are found-the full length enzyme and its truncated version lacking CBM and the hinge region. The active site architecture of HCHT is reminiscent to that of the reducing-end exo-acting processive chitinase ChiA from bacterium Serratia marcescens (SmChiA). However, the presence of flexible hinge region and occurrence of two active isoforms are reminiscent to that of non-processive endo-chitinase from S. marcescens, SmChiC. Although the studies on soluble chitin derivatives suggest the endo-character of HCHT, the mode of action of the enzyme on crystalline chitin is not known. Here, we made a thorough characterization of HCHT in terms of the mode of action, processivity, binding, and rate constants for the catalysis and dissociation using a-chitin as substrate. HCHT efficiently released the end-label from reducing-end labelled chitin and had also high probability (95%) of endo-mode initiation of processive run. These results qualify HCHT as an endo-processive enzyme. Processivity and the rate constant of dissociation of HCHT were found to be in-between those, characteristic to processive exo-enzymes, like SmChiA and randomly acting non-processive endoenzymes, like SmChiC. Apart from increasing the affinity for chitin, CBM had no major effect on kinetic properties of HCHT.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	University of Tartu; Norwegian University of Life Sciences	Kuusk, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia.	silja.kuusk@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism [EMP171]; Estonian Research Council [PUT1024]; Norwegian Research Council [221576]	Norwegian Financial Mechanism; Estonian Research Council(Estonian Research Council); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by the Norwegian Financial Mechanism, grant EMP171. PV and SK were supported by the Estonian Research Council, grant PUT1024. MS was supported by Norwegian Research Council, grant 221576.	Aguilera B, 2003, J BIOL CHEM, V278, P40911, DOI 10.1074/jbc.M301804200; Artieda M, 2007, CARDIOLOGY, V108, P297, DOI 10.1159/000099099; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Bargagli E, 2007, RESPIRATION, V74, P548, DOI 10.1159/000100555; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cruys-Bagger N, 2016, J PHYS CHEM B, V120, P5591, DOI 10.1021/acs.jpcb.6b01877; Di Rosa M, 2016, IMMUNOBIOLOGY, V221, P399, DOI 10.1016/j.imbio.2015.11.014; Di Rosa M, 2014, BONE, V61, P55, DOI 10.1016/j.bone.2014.01.005; Eide KB, 2016, BBA-PROTEINS PROTEOM, V1864, P242, DOI 10.1016/j.bbapap.2015.11.007; Eide KB, 2013, FEBS LETT, V587, P3508, DOI 10.1016/j.febslet.2013.09.004; Eide KB, 2013, THERMOCHIM ACTA, V565, P146, DOI 10.1016/j.tca.2013.04.022; Eide KB, 2012, BIOCHEMISTRY-US, V51, P487, DOI 10.1021/bi2015585; Elmonem Mohamed A, 2016, Enzyme Res, V2016, P2682680, DOI 10.1155/2016/2682680; Fadel F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154190; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Gavala ML, 2013, CLIN EXP ALLERGY, V43, P187, DOI 10.1111/cea.12032; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Iyer A, 2009, CLIN IMMUNOL, V131, P501, DOI 10.1016/j.clim.2009.02.003; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Koch BEV, 2015, GLYCOBIOLOGY, V25, P469, DOI 10.1093/glycob/cwv005; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0690-z; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malaguarnera L, 2006, GUT, V55, P1313, DOI 10.1136/gut.2005.075697; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Moroz OV, 2015, ACTA CRYSTALLOGR F, V71, P114, DOI 10.1107/S2053230X14027307; Nutt A, 1998, EUR J BIOCHEM, V258, P200, DOI 10.1046/j.1432-1327.1998.2580200.x; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Sawant S, 2016, J MOL CATAL B-ENZYM, V133, P161, DOI 10.1016/j.molcatb.2016.08.010; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stockinger LW, 2015, BBA-PROTEINS PROTEOM, V1854, P1494, DOI 10.1016/j.bbapap.2015.06.008; Synstad B, 2008, BIOSCI BIOTECH BIOCH, V72, P715, DOI 10.1271/bbb.70594; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Ujita M, 2003, BIOSCI BIOTECH BIOCH, V67, P2402, DOI 10.1271/bbb.67.2402; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17296	62	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171042	10.1371/journal.pone.0171042	http://dx.doi.org/10.1371/journal.pone.0171042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129403	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000396211400009
J	O'Farrell, AC; Evans, R; Silvola, JMU; Miller, IS; Conroy, E; Hector, S; Cary, M; Murray, DW; Jarzabek, MA; Maratha, A; Alamanou, M; Udupi, GM; Shiels, L; Pallaud, C; Saraste, A; Liljenback, H; Jauhiainen, M; Oikonen, V; Ducret, A; Cutler, P; McAuliffe, FM; Rousseau, JA; Lecomte, R; Gascon, S; Arany, Z; Ky, B; Force, T; Knuuti, J; Gallagher, WM; Roivainen, A; Byrne, AT				O'Farrell, Alice C.; Evans, Rhys; Silvola, Johanna M. U.; Miller, Ian S.; Conroy, Emer; Hector, Suzanne; Cary, Maurice; Murray, David W.; Jarzabek, Monika A.; Maratha, Ashwini; Alamanou, Marina; Udupi, Girish Mallya; Shiels, Liam; Pallaud, Celine; Saraste, Antti; Liljenback, Heidi; Jauhiainen, Matti; Oikonen, Vesa; Ducret, Axel; Cutler, Paul; McAuliffe, Fionnuala M.; Rousseau, Jacques A.; Lecomte, Roger; Gascon, Suzanne; Arany, Zoltan; Ky, Bonnie; Force, Thomas; Knuuti, Juhani; Gallagher, William M.; Roivainen, Anne; Byrne, Annette T.			A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; MYOCARDIAL-METABOLISM; BLOOD-PRESSURE; CARDIOTOXICITY; HEART; CARDIOMYOCYTES; CANCER; MITOCHONDRIA	Sunitinib is a tyrosine kinase inhibitor approved for the treatment of multiple solid tumors. However, cardiotoxicity is of increasing concern, with a need to develop rational mechanism driven approaches for the early detection of cardiac dysfunction. We sought to interrogate changes in cardiac energy substrate usage during sunitinib treatment, hypothesising that these changes could represent a strategy for the early detection of cardiotoxicity. Balb/CJ mice or Sprague-Dawley rats were treated orally for 4 weeks with 40 or 20 mg/kg/day sunitinib. Cardiac positron emission tomography (PET) was implemented to investigate alterations in myocardial glucose and oxidative metabolism. Following treatment, blood pressure increased, and left ventricular ejection fraction decreased. Cardiac [F-18]-fluorodeoxyglucose (FDG)-PET revealed increased glucose uptake after 48 hours. [C-11] Acetate-PET showed decreased myocardial perfusion following treatment. Electron microscopy revealed significant lipid accumulation in the myocardium. Proteomic analyses indicated that oxidative metabolism, fatty acid beta-oxidation and mitochondrial dysfunction were among the top myocardial signalling pathways perturbed. Sunitinib treatment results in an increased reliance on glycolysis, increased myocardial lipid deposition and perturbed mitochondrial function, indicative of a fundamental energy crisis resulting in compromised myocardial energy metabolism and function. Our findings suggest that a cardiac PET strategy may represent a rational approach to non-invasively monitor metabolic pathway remodeling following sunitinib treatment.	[O'Farrell, Alice C.; Evans, Rhys; Hector, Suzanne; Alamanou, Marina; Saraste, Antti; Oikonen, Vesa; Byrne, Annette T.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; [Silvola, Johanna M. U.; Murray, David W.; Cutler, Paul; McAuliffe, Fionnuala M.] Turku Univ Hosp, Turku PET Ctr, Turku, Finland; [Silvola, Johanna M. U.; Hector, Suzanne; Jarzabek, Monika A.; Shiels, Liam; Jauhiainen, Matti; Cutler, Paul] Abo Akad Univ, Turku, Finland; [Miller, Ian S.; Murray, David W.; Maratha, Ashwini; Saraste, Antti; Liljenback, Heidi] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Miller, Ian S.; Cary, Maurice; Shiels, Liam; Liljenback, Heidi] Roche Innovat Ctr Basel, F Hoffman Roche, Basel, Switzerland; [Conroy, Emer; Jarzabek, Monika A.] Pathol Experts GmbH, Basel, Switzerland; [Cary, Maurice; Maratha, Ashwini; Ky, Bonnie; Force, Thomas; Knuuti, Juhani] Oncomark Ltd, Dublin, Ireland; [Cary, Maurice; Cutler, Paul; Ky, Bonnie; Knuuti, Juhani] Heart Ctr Turku Univ Hosp, Turku, Finland; [Silvola, Johanna M. U.; Maratha, Ashwini] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Conroy, Emer; Shiels, Liam] Univ Coll, Sch Med, UCD Obstet & Gynaecol, Dublin, Ireland; [Conroy, Emer; Shiels, Liam; Pallaud, Celine; Rousseau, Jacques A.] Univ Sherbrooke, Quebec City, PQ, Canada; [Hector, Suzanne; McAuliffe, Fionnuala M.] Hosp Univ Penn, Dept Med, Philadelphia, PA USA; [Hector, Suzanne] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Conroy, Emer; Murray, David W.; Arany, Zoltan; Gallagher, William M.] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	Royal College of Surgeons - Ireland; University of Turku; Abo Akademi University; University College Dublin; Roche Holding; Finland National Institute for Health & Welfare; University College Dublin; University of Sherbrooke; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; University of Turku	Byrne, AT (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland.	annettebyrne@rcsi.ie	Knuuti, Juhani/AAA-7472-2019; Conroy, Emer/T-2878-2019	Knuuti, Juhani/0000-0003-3156-9593; Jarzabek, Monika/0000-0001-7008-4797; Miller, Ian/0000-0003-2118-6345; Oikonen, Vesa/0000-0002-1947-0219; Conroy, Emer/0000-0002-6158-229X; Byrne, Annette/0000-0003-0287-8899; O'Farrell, Alice C/0000-0002-6732-2966; Roivainen, Anne/0000-0002-4006-7977; Gallagher, William/0000-0002-4307-5999; Liljenback, Heidi/0000-0001-9372-1584	AngioTox; European Commission FP7 Industry Academia Pathways; Partnerships Marie Curie Award [251528]; British Association of Cancer Research; Oncomark Ltd; Pathology Experts GmBH; Roche Innovation Center Basel; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119234, R01HL133290] Funding Source: NIH RePORTER	AngioTox; European Commission FP7 Industry Academia Pathways; Partnerships Marie Curie Award; British Association of Cancer Research; Oncomark Ltd; Pathology Experts GmBH; Roche Innovation Center Basel; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by AngioTox [www.angiotox.com], a European Commission FP7 Industry Academia Pathways and Partnerships Marie Curie Award (Grant Agreement 251528). Oncomark Ltd, Pathology Experts GmBH and Roche Innovation Center Basel are partner organizations within AngioTox and thus received funding towards salaries and consumables supporting this work. The specific roles of industry co-authors are described in the 'author contributions' section. ACOF received a Travel Fellowship of 2000 pound from the British Association of Cancer Research for travel costs incurred whilst undertaking work at the Turku PET Center, Turku, Finland.	Azizi M, 2008, NEW ENGL J MED, V358, P95, DOI 10.1056/NEJMc072330; Bello CL, 2009, CLIN CANCER RES, V15, P7045, DOI 10.1158/1078-0432.CCR-09-1521; Berardi R, 2013, CRIT REV ONCOL HEMAT, V88, P75, DOI 10.1016/j.critrevonc.2013.02.007; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; Bordun KA, 2015, AM J PHYSIOL-HEART C, V309, pH692, DOI 10.1152/ajpheart.00172.2015; Bry M, 2010, CIRCULATION, V122, P1725, DOI 10.1161/CIRCULATIONAHA.110.957332; Chintalgattu V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005066; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clinicaltrials.gov, 2014, LIST RES SEARCH SUN; Doherty KR, 2013, TOXICOL APPL PHARM, V272, P245, DOI 10.1016/j.taap.2013.04.027; Ewer MS, 2008, J CLIN ONCOL, V26, P1201, DOI 10.1200/JCO.2007.14.8742; Ewer MS, 2014, EUR J CANCER, V50, P2162, DOI 10.1016/j.ejca.2014.05.013; [FDA www.FDA.gov], 2013, SUT MED GUID; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; French KJ, 2010, TOXICOL PATHOL, V38, P691, DOI 10.1177/0192623310373775; Greineder CF, 2011, CURR HYPERTENS REP, V13, P436, DOI 10.1007/s11906-011-0225-8; Hahn VS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000665; Harvey PA, 2015, CARDIOVASC RES, V107, P66, DOI 10.1093/cvr/cvv152; Hasinoff BB, 2008, MOL PHARMACOL, V74, P1722, DOI 10.1124/mol.108.050104; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Hundley WG, 2011, HEMONC TODAY; Ibrahim EM, 2013, INT J CLIN ONCOL, V18, P1060, DOI 10.1007/s10147-012-0497-2; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Ky B, 2013, CIRC RES, V113, P754, DOI 10.1161/CIRCRESAHA.113.300218; McFalls EO, 2002, AM J PHYSIOL-HEART C, V282, pH205, DOI 10.1152/ajpheart.2002.282.1.H205; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mookadam F, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00259; Morissette P, 2015, J PHARM TOXICOL METH; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Naya M, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-013-9244-y; Peterson LR, 2010, CIRC-CARDIOVASC IMAG, V3, P211, DOI 10.1161/CIRCIMAGING.109.860593; Pfizer, 2013, HIGHL PRESCR INF; Prisco D, 2014, INTERN EMERG MED, V9, P359, DOI 10.1007/s11739-014-1064-9; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Rees ML, 2015, BIOCHEM BIOPH RES CO, V459, P430, DOI 10.1016/j.bbrc.2015.02.122; Stortecky S, 2010, CURR OPIN ONCOL, V22, P312, DOI 10.1097/CCO.0b013e32833ab6f1; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Timmer SAJ, 2013, EUR HEART J-CARD IMG, V14, P95, DOI 10.1093/ehjci/jes242; Toubert ME, 2011, THYROID, V21, P451, DOI 10.1089/thy.2010.0270; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Witteles RM, 2012, J CLIN ONCOL, V30, P1916, DOI 10.1200/JCO.2011.40.4012; Zhong M, 2013, J NUCL MED, V54, P609, DOI 10.2967/jnumed.112.108092	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169964	10.1371/journal.pone.0169964	http://dx.doi.org/10.1371/journal.pone.0169964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129334	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400067
J	Huang, Q; Merriman, CF; Zhang, H; Fu, D				Huang, Qiong; Merriman, Chengfeng; Zhang, Hao; Fu, Dax			Coupling of Insulin Secretion and Display of a Granule-resident Zinc Transporter ZnT8 on the Surface of Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; GLUCOSE-HOMEOSTASIS; EXPRESSION; AUTOANTIGEN	The islet-specific zinc transporter ZnT8 mediates zinc enrichment in the insulin secretory granules of the pancreatic beta cell. This granular zinc transporter is also a major self-antigen found in type 1 diabetes patients. It is not clear whether ZnT8 can be displayed on the cell surface and how insulin secretion may regulate the level of ZnT8 exposure to extracellular immune surveillance. Here we report specific antibody binding to the extracellular surface of rat insulinoma INS-1E cells that stably expressed a tagged human zinc transporter ZnT8. Flow cytometry analysis after fluorescent antibody labeling revealed strong correlations among the levels of ZnT8 expression, its display on the cell surface, and glucose-stimulated insulin secretion (GSIS). Glucose stimulation increased the surface display of endogenous ZnT8 from a basal level to 32.5% of the housekeeping Na+/K+ ATPase on the cell surface, thereby providing direct evidence for a GSIS-dependent surface exposure of the ZnT8 self-antigen. Moreover, the variation in tagged-ZnT8 expression and surface labeling enabled sorting of heterogeneous beta cells to subpopulations that exhibited marked differences in GSIS with parallel changes in endogenous ZnT8 expression. The abundant surface display of endogenous ZnT8 and its coupling to GSIS demonstrated the potential of ZnT8 as a surface bio-marker for tracking and isolating functional beta cells in mixed cell populations.	[Huang, Qiong; Merriman, Chengfeng; Zhang, Hao; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961; Fu, Dax/0000-0002-2663-1316	National Institutes of Health shared instrumentation Grant [S10OD016374, S10OD016315, S10RR13777001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374, S10OD016315] Funding Source: NIH RePORTER	National Institutes of Health shared instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Zeiss confocal microscope was funded through National Institutes of Health shared instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was funded through National Institutes of Health Grants S10OD016315 and S10RR13777001.	Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; El Muayed M, 2010, J ENDOCRINOL, V206, P159, DOI 10.1677/JOE-09-0420; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005679; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hamel Y, 2016, J AUTOIMMUN, V73, P54, DOI 10.1016/j.jaut.2016.06.003; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; Mauvals F.X., 2016, F1000RES, DOI 10.12688/f1000research.7411.1; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Petersen AB, 2011, APMIS, V119, P93, DOI 10.1111/j.1600-0463.2010.02698.x; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Vo YP, 2004, BIOCHEM BIOPH RES CO, V324, P1004, DOI 10.1016/j.bbrc.2004.09.147; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Yu C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9083103	38	24	25	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4034	4043		10.1074/jbc.M116.772152	http://dx.doi.org/10.1074/jbc.M116.772152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28130446	hybrid, Green Published			2022-12-26	WOS:000395837100007
J	Li, J; Xu, HZ; Pan, W; Wu, B				Li, Juan; Xu, Hanzhang; Pan, Wei; Wu, Bei			Association between tooth loss and cognitive decline: A 13-year longitudinal study of Chinese older adults	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; REPORTED ORAL-HEALTH; TERM PERIODONTAL MAINTENANCE; ALZHEIMERS-DISEASE; DENTITION STATUS; DENTAL-HEALTH; DEMENTIA; IMPAIRMENT; COMMUNITY; LIFE	Objectives To examine the association between the number of teeth remaining and cognitive decline among Chinese older adults over a 13-year period. Design A large national longitudinal survey of Chinese older adults Setting The Chinese Longitudinal Healthy Longevity Survey (CLHLS) (1998-2011). Participants A total of 8,153 eligible participants aged 60+ interviewed in up to six waves. Measurements Cognitive function and teeth number were measured at each interview. Cognitive function was measured by the Mini-Mental Status Examination (MMSE). Number of natural teeth was self-reported. Individuals with severe cognitive impairment were excluded. Covariates included demographic characteristics, adult socioeconomic status characteristics, childhood socioeconomic status, health conditions, and health behaviors. Linear mixed models were applied in the analysis. Results The mean teeth number at baseline was 17.5(SD = 0.1), and the mean of baseline cognitive function was 27.3(SD = 0.0). Cognitive function declined over time (beta = -0.19, P <.001) after controlling covariates. But, regardless of time, more teeth were associated with better cognitive function (beta = 0.01, P <.001). The interaction of teeth number and time was significant (beta = 0.01, P <.001), suggesting that the participants who had more teeth showed a slower pace of cognitive decline over time than those with fewer teeth after controlling for other covariates. Conclusion This study showed that tooth loss was associated with cognitive decline among Chinese older adults. Further studies are needed to examine the linkages between cognitive decline and oral health status using clinical examination data.	[Li, Juan] Second Mil Med Univ, Sch Nursing, Shanghai, Peoples R China; [Li, Juan; Xu, Hanzhang; Pan, Wei] Duke Univ, Sch Nursing, Durham, NC 27706 USA; [Xu, Hanzhang] Duke Global Hlth Inst, Durham, NC USA; [Wu, Bei] NYU, Rory Meyers Coll Nursing, New York, NY 10010 USA	Naval Medical University; Duke University; Duke University; New York University	Wu, B (corresponding author), NYU, Rory Meyers Coll Nursing, New York, NY 10010 USA.	bei.wu@nyu.edu	Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X				Al-Shammari KF, 2005, J PERIODONTOL, V76, P1910, DOI 10.1902/jop.2005.76.11.1910; [Anonymous], 2001, MISSING DATA; Arrive E, 2012, COMMUNITY DENT ORAL, V40, P230, DOI 10.1111/j.1600-0528.2011.00650.x; Batty GD, 2013, EUR PSYCHIAT, V28, P49, DOI 10.1016/j.eurpsy.2011.07.005; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Carrillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0100476; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Chen HY, 2015, INT J MED SCI, V12, P502, DOI 10.7150/ijms.11911; De Cicco V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148715; Ding D, 2015, ALZHEIMERS DEMENT, V11, P300, DOI 10.1016/j.jalz.2013.11.002; DOUGLASS CW, 1991, J PUBLIC HEALTH DENT, V51, P220, DOI 10.1111/j.1752-7325.1991.tb02218.x; [高宝迪 Gao Baodi], 2011, [实用口腔医学杂志, Journal of Practical Stomatology], V27, P279; Gao SJ, 2014, AM J GERIAT PSYCHIAT, V22, P670, DOI 10.1016/j.jagp.2013.02.015; Gatz Margaret, 2006, Alzheimers Dement, V2, P110, DOI 10.1016/j.jalz.2006.01.002; Gu D.-N., 2008, J FUNCTIONAL MAT, V1, P1; Han WJ, 2015, ARCH GERONTOL GERIAT, V60, P168, DOI 10.1016/j.archger.2014.09.001; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P439, DOI 10.1016/j.jalz.2013.09.008; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kaye EK, 2010, J AM GERIATR SOC, V58, P713, DOI 10.1111/j.1532-5415.2010.02788.x; Kim JM, 2007, INT J GERIATR PSYCH, V22, P850, DOI 10.1002/gps.1750; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Krall E, 1998, J AM DENT ASSOC, V129, P1261, DOI 10.14219/jada.archive.1998.0423; Langa KM, 2014, JAMA-J AM MED ASSOC, V312, P2551, DOI 10.1001/jama.2014.13806; Luo Y, 2005, J GERONTOL B-PSYCHOL, V60, pS93, DOI 10.1093/geronb/60.2.S93; Martinez-Canut P, 2015, J CLIN PERIODONTOL, V42, P1115, DOI 10.1111/jcpe.12475; Meng Q, 2010, UNIVERSAL COVERAGE H; Miyake S, 2012, ARCH ORAL BIOL, V57, P1491, DOI 10.1016/j.archoralbio.2012.06.008; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Paganini-Hill A, 2012, J AM GERIATR SOC, V60, P1556, DOI 10.1111/j.1532-5415.2012.04064.x; Pink C, 2015, J CLIN PERIODONTOL; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Prevention CC for DC and, 2007, CHIN 3 OR EP SURV OU; Qi XQ, 2008, 3 NATL ORAL HLTH SUR; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Shimazaki Y, 2001, J DENT RES, V80, P340, DOI 10.1177/00220345010800010801; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spencer RJ, 2013, EXP AGING RES, V39, P382, DOI 10.1080/0361073X.2013.808109; Starr JM, 2010, CURR OPIN CLIN NUTR, V13, P19, DOI 10.1097/MCO.0b013e328333aa37; Stein PS, 2010, J DENT RES, V89, P473, DOI 10.1177/0022034509357881; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Stewart R, 2015, ASS ORAL HLTH RISK D, P100; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Stewart R, 2015, J AM GERIATR SOC, V63, P100, DOI 10.1111/jgs.13194; Stewart R, 2013, J AM GERIATR SOC, V61, P177, DOI 10.1111/jgs.12094; Thomson WM, 2004, COMMUNITY DENT ORAL, V32, P345, DOI 10.1111/j.1600-0528.2004.00173.x; Thorstensson H, 2010, GERODONTOLOGY, V27, P19, DOI 10.1111/j.1741-2358.2009.00297.x; Trzepacz PT, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0103-3; Tsakos G, 2004, J AM GERIATR SOC, V324; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Watts Amber, 2008, Neuropsychiatr Dis Treat, V4, P865; Wen M, 2011, DEMOGRAPHY, V48, P153, DOI 10.1007/s13524-010-0003-2; Wu B, 2007, AM J PUBLIC HEALTH, V97, P2216, DOI 10.2105/AJPH.2007.109934; Wu B, 2011, J AGING HEALTH, V23, P267, DOI 10.1177/0898264310382135; Yi Z, 2008, RELIABILITY AGE REPO, P61; Yin ZX, 2012, AGE AGEING, V41, P600, DOI 10.1093/ageing/afs033; Zhang ZM, 2010, SOC SCI MED, V71, P941, DOI 10.1016/j.socscimed.2010.05.013; Zimmer Z, 2010, DEMOGRAPHY, V47, P537	61	42	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171404	10.1371/journal.pone.0171404	http://dx.doi.org/10.1371/journal.pone.0171404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158261	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700074
J	Liu, XY; Behrman, JR; Stein, AD; Adair, LS; Bhargava, SK; Borja, JB; da Silveira, MF; Horta, BL; Martorell, R; Norris, SA; Richter, LM; Sachdev, HS				Liu, Xiaoying; Behrman, Jere R.; Stein, Aryeh D.; Adair, Linda S.; Bhargava, Santosh K.; Borja, Judith B.; da Silveira, Mariangela Freitas; Horta, Bernardo L.; Martorell, Reynaldo; Norris, Shane A.; Richter, Linda M.; Sachdev, Harshpal S.			Prenatal care and child growth and schooling in four low- and medium-income countries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; BIRTH-WEIGHT; COHORT PROFILE; ANTENATAL CARE; NUTRITION; OUTCOMES; HEALTH; PATTERNS; IMPACT; MORTALITY	Background The effectiveness of prenatal care for improving birth and subsequent child outcomes in low-income countries remains controversial, with much of the evidence to date coming from high-income countries and focused on early-life outcomes. We examined associations between prenatal care visits and birth weight, height-for-age at 24 months and attained schooling in four low- and middle-income countries. Methods We pooled data from prospective birth-cohort studies from Brazil, Guatemala, Philippines and South Africa. We created a prenatal care utilization index based on the number and timing of prenatal visits. Associations were examined between this index and birth weight, height-for-age at 24 months, and highest attained schooling grade until adulthood. Results Among 7203 individuals in the analysis, 68.9% (Philippines) to 96.7% (South Africa) had at least one prenatal care visit, with most having at least four visits. Over 40% of Brazilians and Guatemalans had their first prenatal visit in the first trimester, but fewer Filipinos (13.9%) and South Africans (19.8%) did so. Prenatal care utilization was not significantly associated with birth weight (p>0.05 in pooled data). Each unit increase in the prenatal care utilization index was associated with 0.09 (95% CI 0.04 to 0.15) higher height-for-age z-score at 24 months and with 0.26 (95% CI 0.17 to 0.35) higher schooling grades attained. Although there was some heterogeneity and greater imprecision across sites, the results were qualitatively similar among the four different populations. Conclusions While not related to birth weight, prenatal care utilization was associated with important outcomes later in life, specifically higher height-for-age at 24 months and higher attained school grades. These results suggest the relevance of prenatal care visits for human capital outcomes important over the lifecycle.	[Liu, Xiaoying; Behrman, Jere R.] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Stein, Aryeh D.; Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Stein, Aryeh D.; Norris, Shane A.; Richter, Linda M.] Univ Witwatersrand, Med Res Council Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Adair, Linda S.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA; [Bhargava, Santosh K.] SL Jain Hosp, Dept Pediat, Delhi, India; [Borja, Judith B.] Univ San Carlos, USC Off Populat Studies Fdn Inc, Cebu, Philippines; [Borja, Judith B.] Univ San Carlos, Dept Nutr & Dietet, Cebu, Philippines; [da Silveira, Mariangela Freitas; Horta, Bernardo L.] Univ Fed Pelotas, Fac Med, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa; [Sachdev, Harshpal S.] Sitaram Bhartia Inst Sci & Res, Dept Pediat & Clin Epidemiol, New Delhi, India	University of Pennsylvania; Emory University; Rollins School Public Health; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of San Carlos; University of San Carlos; Universidade Federal de Pelotas; University of Witwatersrand; Sitaram Bhartia Institute of Science & Research	Liu, XY (corresponding author), Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.	xiaoyliu@sas.upenn.edu	Stein, Aryeh D/J-9831-2012; Silveira, Mariangela F/L-6868-2013; Horta, Bernardo/A-7604-2008; Norris, Shane/C-4664-2014; Martorell, Reynaldo/I-2539-2012; Behrman, Jere R/A-9734-2009	Silveira, Mariangela F/0000-0002-3551-9713; Horta, Bernardo/0000-0001-9843-412X; Norris, Shane/0000-0001-7124-3788; Liu, Xiaoying/0000-0001-9897-1291; Sachdev, Harshpal Singh/0000-0002-4956-9391; Stein, Aryeh/0000-0003-1138-6458	Grand Challenges Canada Grant [0072-03]; Bill & Melinda Gates Foundation Global Health Grant [OPP1032713]; Eunice Shriver Kennedy National Institute of Child Health and Development [R01 HD070993, HD070993]; Wellcome Trust (UK); Bill & Melinda Gates Foundation [OPP1032713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD070993] Funding Source: NIH RePORTER	Grand Challenges Canada Grant; Bill & Melinda Gates Foundation Global Health Grant; Eunice Shriver Kennedy National Institute of Child Health and Development; Wellcome Trust (UK)(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Grand Challenges Canada Grant 0072-03 (http://www.grandchallenges ca/), Bill & Melinda Gates Foundation Global Health Grant OPP1032713 (http://www.gatesfoundaton org/) and Eunice Shriver Kennedy National Institute of Child Health and Development Grant R01 HD070993 (https://www.nichd.nih.gov/Pages/index.aspx). COHORTS has received support from the Wellcome Trust (UK), the Bill & Melinda Gates Foundation. Funding for the individual cohorts was as follows: Guatemala (US National Institutes of Health; US National Science Foundation); Pelotas (Wellcome Trust); Birth To Twenty (Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, Mellon Foundation, Anglo American Chairman's Fund, University of the Witwatersrand); Cebu (US National Institutes of Health). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Grant sponsors: Grand Challenges Canada Grant 0072-03, Bill & Melinda Gates Foundation Global Health Grant OPP1032713 and Eunice Shriver Kennedy National Institute of Child Health and Development Grant R01 HD070993. COHORTS has received supports from the Wellcome Trust (UK), the Bill & Melinda Gates Foundation. Funding for the individual cohorts was as follows: Guatemala (US National Institutes of Health; US National Science Foundation); Pelotas (Wellcome Trust); Birth To Twenty (Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, Mellon Foundation, Anglo American Chairman's Fund, University of the Witwatersrand); Cebu (US National Institutes of Health).	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Alderman H, 2006, WORLD BANK RES OBSER, V21, P25, DOI 10.1093/wbro/lkj001; Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; [Anonymous], 1988, HDB DEV EC, DOI DOI 10.1016/S1573-4471(88)01016-2; Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Becker G. S., 2009, TREATISE FAMILY; Behrman JR, 2010, HBK ECON, V5, P4883, DOI 10.1016/B978-0-444-52944-2.00011-2; Behrman JR, 2009, AM J CLIN NUTR, V90, P1372, DOI 10.3945/ajcn.2009.27524; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Chamberlain C, 2013, COCHRANE DB SYST REV, P10; Christian P, 2012, J NUTR, V142, p173S, DOI 10.3945/jn.111.149898; Conley D, 2001, J HEALTH SOC BEHAV, V42, P450, DOI 10.2307/3090189; Conley D, 2006, ECON HUM BIOL, V4, P151, DOI 10.1016/j.ehb.2005.12.001; Conway KS, 2005, J HEALTH ECON, V24, P489, DOI 10.1016/j.jhealeco.2004.09.012; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Gajate-Garrido G, 2013, ECON DEV CULT CHANGE, V62, P95, DOI 10.1086/671716; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Glewwe Paul, 2006, HDB EC ED, V2, P945, DOI [10.1016/S1574-0692(06)02016-2, DOI 10.1016/S1574-0692(06)02016-2]; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; GROSSMAN M, 1990, J POLIT ECON, V98, P983, DOI 10.1086/261716; GUILKEY DK, 1989, J DEV EC, V30; Haas JD, 1996, NUTR REV, V54, pS41, DOI 10.1111/j.1753-4887.1996.tb03869.x; Habibov NN, 2011, ECON HUM BIOL, V9, P56, DOI 10.1016/j.ehb.2010.08.003; Haider BA, 2013, BMJ-BRIT MED J, P346; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hoddinott J, 2013, AM J CLIN NUTR; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Hollowell J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-13; HUNTINGTON J, 1994, NEW ENGL J MED, V331, P1303, DOI 10.1056/NEJM199411103311910; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Kirkham C, 2005, AM FAM PHYSICIAN, V71, P1307; Krueger Paul M., 2000, Journal of the American Osteopathic Association, V100, P485; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Noonan K, 2013, MATERN CHILD HLTH J, V17, P189, DOI 10.1007/s10995-012-0966-2; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Ramakrishna T, 1999, PHYSIOL RES, V48, P175; Ramakrishnan U, 2014, MATERNAL NUTR INTERV; REYNES JF, 1985, J SOUTHE ASIAN STUD, V16, P292, DOI 10.1017/S0022463400008468; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; SCHULTZ TW, 1961, AM ECON REV, V51, P1; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; SHWARTZ S, 1962, AM J OBSTET GYNECOL, V83, P591, DOI 10.1016/S0002-9378(16)35888-4; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; United Nations Department of Economic, 2008, MILL DEV GOALS REP 2; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2010, PEDIATRICS; von Hippel PT, 2009, SOCIOL METHODOL, V39, P265, DOI 10.1111/j.1467-9531.2009.01215.x; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WONG EL, 1987, SOC SCI MED, V24, P927, DOI 10.1016/0277-9536(87)90286-3; Woodhouse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091292	69	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171299	10.1371/journal.pone.0171299	http://dx.doi.org/10.1371/journal.pone.0171299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158229	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700055
J	Siland, JE; Geelhoed, B; van Gelder, IC; van der Harst, P; Rienstra, M				Siland, Joylene E.; Geelhoed, Bastiaan; van Gelder, Isabelle C.; van der Harst, Pim; Rienstra, Michiel			Telomere length and incident atrial fibrillation - data of the PREVEND cohort	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; RISK; PREVALENCE; MORTALITY; STROKE; POPULATION; LEUKOCYTES; PREDICTOR; FIBROSIS	Background The incidence of atrial fibrillation (AF) increases with age. Telomere length is considered a marker of biological ageing. We investigated the association between leukocyte telomere length and incident AF in the Dutch Prevention of Renal and Vascular End-stage Disease (PREVEND) study. Methods We included 7775 individuals without prevalent AF, and with leukocyte telomere length measured. Mean telomere length was determined by a monochrome multiplex quantitative polymerase chain reaction-based assay. Results Mean age of our cohort was 49 +/- 13 years, and 50% were men. During a mean follow-up of 11.4 +/- 2.9 years incident AF was detected in 367 (4.7%) individuals. Telomere length was shorter in individuals developing incident AF compared to those without AF (p = 0.013). Incident AF was inversely related to the telomere length. In the quartile with the longest telomere length 68 (3.5%) individuals developed AF, in the shortest telomere length quartile 100 (5.1%) individuals (p = 0.032). Telomere length was associated with incident AF in the second shortest telomere length quartile using the longest telomere length quartile as reference (hazard ratio 1.64; 95% CI 1.02-2.66; p = 0.043). After including age or AF risk factors, the relation between telomere length and incident AF was no longer significant. We found a significant interaction of age, male sex, systolic blood pressure, BMI, heart failure, and myocardial infarction with telomere length for the association with incident AF. Conclusions We found that shorter leukocyte telomere length is not independently associated with incident AF in a community-based cohort.	[Siland, Joylene E.; Geelhoed, Bastiaan; van Gelder, Isabelle C.; van der Harst, Pim; Rienstra, Michiel] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	University of Groningen	Rienstra, M (corresponding author), Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	m.rienstra@umcg.nl		Siland, Joylene/0000-0003-4404-1245; Rienstra, Michiel/0000-0002-2581-070X	Dutch Kidney Foundation [E0.13]; National Institutes of Health [2R01LM010098]; Netherlands organization for health research and development (NWO-Groot grant) [175.010.2007.006]; ZonMw [90.700.441]; Dutch Inter University Cardiology Institute Netherlands (ICIN); Netherlands Heart Foundation [NHS20108280]; Netherlands Organization for Scientific Research [016.136.055]	Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands organization for health research and development (NWO-Groot grant); ZonMw(Netherlands Organization for Health Research and Development); Dutch Inter University Cardiology Institute Netherlands (ICIN); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The PREVEND study is supported by the Dutch Kidney Foundation (grant E0.13), the National Institutes of Health (grant 2R01LM010098), The Netherlands organization for health research and development (NWO-Groot grant 175.010.2007.006, ZonMw grant 90.700.441), and the Dutch Inter University Cardiology Institute Netherlands (ICIN), and the Netherlands Heart Foundation (grant NHS20108280). Dr. M. Rienstra is supported by a grant from the Netherlands Organization for Scientific Research (Veni grant 016.136.055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ANDERSON KR, 1979, J PATHOL, V128, P79, DOI 10.1002/path.1711280205; Angel N, 2015, J CARDIOVASC ELECTR, V26, P1352, DOI 10.1111/jce.12773; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Carlquist JF, 2016, HEART RHYTHM, V13, P21, DOI 10.1016/j.hrthm.2015.07.032; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Dewland TA, 2013, ANN INTERN MED, V159, P721, DOI 10.7326/0003-4819-159-11-201312030-00004; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; FLEGEL KM, 1987, LANCET, V1, P526; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gates PE, 2003, EUR HEART J, V24, P2213, DOI 10.1016/j.ehj.2003.09.026; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huzen J, 2014, J INTERN MED, V275, P155, DOI 10.1111/joim.12149; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Lin CY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002192; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Lubitz SA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000126; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Roberts JD, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1026, DOI 10.1161/CIRCEP.114.001781; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Stuveling EM, 2004, ATHEROSCLEROSIS, V172, P107, DOI 10.1016/S0021-9150(03)00252-1; Thong T, 2004, IEEE T BIO-MED ENG, V51, P561, DOI 10.1109/TBME.2003.821030; Van de Veire NR, 2006, INT J CARDIOVAS IMAG, V22, P633, DOI 10.1007/s10554-006-9082-y; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171545	10.1371/journal.pone.0171545	http://dx.doi.org/10.1371/journal.pone.0171545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158257	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700096
J	Song, H; Wang, PF; Li, CS; Han, SY; Zhao, CZ; Xia, H; Bi, YP; Guo, BZ; Zhang, XY; Wang, XJ				Song, Hui; Wang, Pengfei; Li, Changsheng; Han, Suoyi; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Guo, Baozhu; Zhang, Xinyou; Wang, Xingjun			Comparative analysis of NBS-LRR genes and their response to Aspergillus flavus in Arachis	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; CULTIVATED PEANUT; EVOLUTION; BLAST; EXPRESSION; HYPOGAEA; DURANENSIS	Studies have demonstrated that nucleotide-binding site-leucine-rich repeat (NBS-LRR) genes respond to pathogen attack in plants. Characterization of NBS-LRR genes in peanut is not well documented. The newly released whole genome sequences of Arachis duranensis and Arachis ipaensis have allowed a global analysis of this important gene family in peanut to be conducted. In this study, we identified 393 (AdNBS) and 437 (AiNBS) NBS-LRR genes from A. duranensis and A. ipaensis, respectively, using bioinformatics approaches. Full-length sequences of 278 AdNBS and 303 AiNBS were identified. Fifty-one orthologous, four AdNBS paralogous, and six AiNBS paralogous gene pairs were predicted. All paralogous gene pairs were located in the same chromosomes, indicating that tandem duplication was the most likely mechanism forming these paralogs. The paralogs mainly underwent purifying selection, but most LRR 8 domains underwent positive selection. More gene clusters were found in A. ipaensis than in A. duranensis, possibly owing to tandem duplication events occurring more frequently in A. ipaensis. The expression profile of NBS-LRR genes was different between A. duranensis and A. hypogaea after Aspergillus flavus infection. The up-regulated expression of NBS-LRR in A. duranensis was continuous, while these genes responded to the pathogen temporally in A. hypogaea.	[Song, Hui; Wang, Pengfei; Li, Changsheng; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Wang, Xingjun] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Song, Hui; Wang, Pengfei; Li, Changsheng; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Wang, Xingjun] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Li, Changsheng; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Han, Suoyi; Zhang, Xinyou] Henan Acad Agr Sci, Zhengzhou, Peoples R China; [Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA	Shandong Academy of Agricultural Sciences; Shandong Normal University; Henan Academy of Agricultural Sciences; United States Department of Agriculture (USDA)	Wang, XJ (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China.; Wang, XJ (corresponding author), Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China.; Wang, XJ (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China.; Zhang, XY (corresponding author), Henan Acad Agr Sci, Zhengzhou, Peoples R China.	haasz@sohu.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022		National High Tech Project [2013AA102602]; NSFC [31500217]; Genetically Modified Organisms Breeding Major Project [2013ZX08010-004]; Shandong Provincial Natural Science Foundation [ZR2015YL061]; Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shandong Province Germplasm Innovation and Utilization Project	National High Tech Project(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Project; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shandong Province Germplasm Innovation and Utilization Project	This study was supported by grants from National High Tech Project (2013AA102602), NSFC (31500217), Genetically Modified Organisms Breeding Major Project (2013ZX08010-004), Shandong Provincial Natural Science Foundation (ZR2015YL061), Young Talents Training Program of Shandong Academy of Agricultural Sciences and Shandong Province Germplasm Innovation and Utilization Project.	Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Ashfield T, 2012, PLANT PHYSIOL, V159, P336, DOI 10.1104/pp.112.195040; Ben C, 2013, NEW PHYTOL, V199, P758, DOI 10.1111/nph.12299; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bertioli DJ, 2003, MOL GENET GENOMICS, V270, P34, DOI 10.1007/s00438-003-0893-4; Borhan MH, 2010, MOL PLANT PATHOL, V11, P283, DOI 10.1111/j.1364-3703.2009.00599.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0305-6; Chen NWG, 2010, NEW PHYTOL, V187, P941, DOI 10.1111/j.1469-8137.2010.03337.x; Cheng SP, 2015, FORESTS, V6, P839, DOI 10.3390/f6030839; Christie N, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01238; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Feng S, 2012, COMP FUNCT GENOM, V7, P1; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fukuoka S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04550; Gu LJ, 2015, MOL GENET GENOMICS, V290, P727, DOI 10.1007/s00438-014-0948-8; HERBERT T T, 1981, Peanut Science, V8, P45, DOI 10.3146/i0095-3679-8-1-12; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KEEN NT, 1991, THEOR APPL GENET, V81, P133, DOI 10.1007/BF00226123; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li CJ, 2013, PHYSIOL MOL PLANT P, V84, P70, DOI 10.1016/j.pmpp.2013.07.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Michelotto MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128811; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Ramos ML, 2006, MOL GENET GENOMICS, V275, P578, DOI 10.1007/s00438-006-0114-z; Ratnaparkhe MB, 2011, NEW PHYTOL, V192, P164, DOI 10.1111/j.1469-8137.2011.03800.x; Samoluk SS, 2014, GENETIC RESOURCES CR, V61, P1; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Shao ZQ, 2016, PLANT PHYSIOL; Simpson C. E., 2001, Peanut Science, V28, P114, DOI 10.3146/i0095-3679-28-2-12; Song H, 2015, GENET MOL RES, V14, P16024, DOI 10.4238/2015.December.7.16; Song H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35245; Song H, 2014, CHINESE SCI BULL, V59, P1129, DOI 10.1007/s11434-014-0155-3; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Xia H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-517; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yang SM, 2008, P NATL ACAD SCI USA, V105, P12164, DOI 10.1073/pnas.0802518105; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Yuksel B, 2005, MOL GENET GENOMICS, V274, P248, DOI 10.1007/s00438-005-0022-7; Zhang HL, 2015, J PHYTOPATHOL, V163, P212, DOI 10.1111/jph.12311; Zhang XH, 2015, PLANT J, V84, P20, DOI 10.1111/tpj.12955; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	63	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171181	10.1371/journal.pone.0171181	http://dx.doi.org/10.1371/journal.pone.0171181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158222	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700036
J	Tan, SY; Chowdhury, S; Polak, N; Gorrell, MD; Weninger, W				Tan, Sioh-Yang; Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.; Weninger, Wolfgang			Fibroblast activation protein is dispensable in the anti-influenza immune response in mice	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; TUMOR-ASSOCIATED FIBROBLASTS; INTEGRAL MEMBRANE PROTEASE; MALIGNANT MELANOMA-CELLS; T-CELLS; STROMAL CELLS; DENDRITIC CELLS; VIRUS-INFECTION; ALPHA; EXPRESSION	Fibroblast activation protein alpha (FAP) is a unique dual peptidase of the S9B serine protease family, being capable of both dipeptidyl peptidase and endopeptidase activities. FAP is expressed at low level in healthy adult organs including the pancreas, cervix, uterus, submaxillary gland and the skin, and highly upregulated in embryogenesis, chronic inflammation and tissue remodelling. It is also expressed by cancer-associated stromal fibroblasts in more than 90% of epithelial tumours. FAP has enzymatic and non-enzymatic functions in the growth, immunosuppression, invasion and cell signalling of tumour cells. FAP deficient mice are fertile and viable with no gross abnormality, but little data exist on the role of FAP in the immune system. FAP is upregulated in association with microbial stimulation and chronic inflammation, but its function in infection remains unknown. We showed that major populations of immune cells including CD4(+) and CD8(+) T cells, B cells, dendritic cells and neutrophils are generated and maintained normally in FAP knockout mice. Upon intranasal challenge with influenza virus, FAP mRNA was increased in the lungs and lung-draining lymph nodes. Nonetheless, FAP deficient mice showed similar pathologic kinetics to wildtype controls, and were capable of supporting normal anti-influenza T and B cell responses. There was no evidence of compensatory upregulation of other DPP4 family members in influenza-infected FAP-deficient mice. FAP appears to be dispensable in anti-influenza adaptive immunity.	[Tan, Sioh-Yang; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW, Australia; [Tan, Sioh-Yang; Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.; Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.] Centenary Inst Canc Med & Cell Biol, Mol Hepatol Lab, Newtown, NSW, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Tan, SY (corresponding author), Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW, Australia.; Tan, SY (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	tansiohy@gmail.com	Gorrell, Mark/AAX-6394-2021; Gorrell, Mark Douglas/H-7231-2019	Gorrell, Mark Douglas/0000-0002-0528-2604	Australian National Health and Medical Research Council [APP1030145, APP512282]; National Institutes of Health [BAA-NIAID-DAIT-HHSN272201100018C]; Rebecca L. Cooper Medical Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rebecca L. Cooper Medical Research Foundation	This work was supported by project grants from the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au) (APP1030145 to W.W., APP512282 to MDG), a contract from the National Institutes of Health (https://www.niaid.nih.gov/Pages/default.aspx) (BAA-NIAID-DAIT-HHSN272201100018C to W.W.), and the Rebecca L. Cooper Medical Research Foundation (http://www.cooperfoundation.org.au) (MDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; AOYAMA A, 1990, P NATL ACAD SCI USA, V87, P8296, DOI 10.1073/pnas.87.21.8296; Arnold JN, 2014, CANCER IMMUNOL RES, V2, P121, DOI 10.1158/2326-6066.CIR-13-0150; Baird SK, 2015, APOPTOSIS, V20, P1483, DOI 10.1007/s10495-015-1166-5; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brokopp CE, 2011, EUR HEART J, V32, P2713, DOI 10.1093/eurheartj/ehq519; Chowdhury S, 2013, WORLD J GASTROENTERO, V19, P2883, DOI 10.3748/wjg.v19.i19.2883; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Cooksley CD, 2005, CANCER-AM CANCER SOC, V104, P618, DOI 10.1002/cncr.21203; Coppage AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151269; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dunshee DR, 2016, J BIOL CHEM, V291, P5986, DOI 10.1074/jbc.M115.710582; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fan MH, 2016, J BIOL CHEM, V291, P8070, DOI 10.1074/jbc.M115.701433; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Guo J, 2015, INT J CLIN EXP PATHO, V8, P10014; Hamson EJ, 2014, PROTEOM CLIN APPL, V8, P454, DOI 10.1002/prca.201300095; Huang SC, 2011, J DRUG TARGET, V19, P487, DOI 10.3109/1061186X.2010.511225; Jacob M, 2012, CURR MOL MED, V12, P1220, DOI 10.2174/156652412803833607; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kelly T, 2012, INT REV CEL MOL BIO, V297, P83, DOI 10.1016/B978-0-12-394308-8.00003-0; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Koczorowska MM, 2016, MOL ONCOL, V10, P40, DOI 10.1016/j.molonc.2015.08.001; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1877; MONSKY WL, 1994, CANCER RES, V54, P5702; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Osborne B, 2014, BBA-PROTEINS PROTEOM, V1844, P1248, DOI 10.1016/j.bbapap.2014.03.015; Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Ramirez-Montagut T, 2004, ONCOGENE, V23, P5435, DOI 10.1038/sj.onc.1207730; RETTIG WJ, 1993, CANCER RES, V53, P3327; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Rovedatti L, 2011, INFLAMM BOWEL DIS, V17, P1251, DOI 10.1002/ibd.21446; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schreiber H, 2010, SCIENCE, V330, P761, DOI 10.1126/science.1198345; Schuberth PC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-187; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; Sun SX, 2002, PROTEIN EXPRES PURIF, V24, P274, DOI 10.1006/prep.2001.1572; Tan SY, 2012, IMMUNOL CELL BIOL, V90, P722, DOI 10.1038/icb.2011.104; Teichgraber V, 2015, ADV MED SCI-POLAND, V60, P264, DOI 10.1016/j.advms.2015.04.006; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Waumans Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00387; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; Yan SL, 2012, EUR J IMMUNOL, V42, P533, DOI 10.1002/eji.201041038; Yan SL, 2003, EUR J IMMUNOL, V33, P1519, DOI 10.1002/eji.200323469; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang YD, 2016, ONCOTARGET; Zhen EY, 2016, BIOCHEM J, V473, P605, DOI 10.1042/BJ20151085	75	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171194	10.1371/journal.pone.0171194	http://dx.doi.org/10.1371/journal.pone.0171194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158223	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700041
J	Wang, X; Li, YS; Zhang, J; Zhang, QW; Liu, XX; Li, Z				Wang, Xiu; Li, Yisong; Zhang, Jing; Zhang, Qingwen; Liu, Xiaoxia; Li, Zhen			De novo characterization of microRNAs in oriental fruit moth Grapholita molesta and selection of reference genes for normalization of microRNA expression	PLOS ONE			English	Article							REAL-TIME; SMALL RNA; HELICOVERPA-ARMIGERA; RT-PCR; LEPIDOPTERA-TORTRICIDAE; PHOTOPERIODIC DIAPAUSE; FUNCTIONAL-ANALYSIS; ECDYSONE RECEPTOR; FAT-BODY; QRT-PCR	MicroRNAs (miRNAs) are a group of endogenous non-coding small RNAs that have critical regulatory functions in almost all known biological processes at the post-transcriptional level in a variety of organisms. The oriental fruit moth Grapholita molesta is one of the most serious pests in orchards worldwide and threatens the production of Rosacea fruits. In this study, a de novo small RNA library constructed from mixed stages of G. molesta was sequenced through Illumina sequencing platform and a total of 536 mature miRNAs consisting of 291 conserved and 245 novel miRNAs were identified. Most of the conserved and novel miRNAs were detected with moderate abundance. The miRNAs in the same cluster normally showed correlated expressional profiles. A comparative analysis of the 79 conserved miRNA families within 31 arthropod species indicated that these miRNA families were more conserved among insects and within orders of closer phylogenetic relationships. The KEGG pathway analysis and network prediction of target genes indicated that the complex composed of miRNAs, clock genes and developmental regulation genes may play vital roles to regulate the developmental circadian rhythm of G. molesta. Furthermore, based on the sRNA library of G. molesta, suitable reference genes were selected and validated for study of miRNA transcriptional profile in G. molesta under two biotic and six abiotic experimental conditions. This study systematically documented the miRNA profile in G. molesta, which could lay a foundation for further understanding of the regulatory roles of miRNAs in the development and metabolism in this pest and might also suggest clues to the development of genetic-based techniques for agricultural pest control.	[Wang, Xiu; Li, Yisong; Zhang, Jing; Zhang, Qingwen; Liu, Xiaoxia; Li, Zhen] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Li, Yisong] Shihezi Univ, Dept Plant Protect, Shihezi, Peoples R China	China Agricultural University; Shihezi University	Liu, XX; Li, Z (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	liuxiaoxia611@cau.edu.cn; lizhencau@cau.edu.cn			Chinese Universities Scientific Fund [2014XJ018]; Modern Agro-industry Technology Research System Grants [CARS-29-08]	Chinese Universities Scientific Fund; Modern Agro-industry Technology Research System Grants	This study was supported by Chinese Universities Scientific Fund (No. 2014XJ018) and Modern Agro-industry Technology Research System Grants (No. CARS-29-08). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Andrews SV, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0107-z; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Biryukova I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-557; Blenkiron C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122203; Boisen MK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2030-2; Cao JJ, 2015, COMP BIOCHEM PHYS B, V190, P54, DOI 10.1016/j.cbpb.2015.08.008; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Chang ZX, 2016, INSECT SCI, V23, P452, DOI 10.1111/1744-7917.12343; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Choi IK, 2012, DEV COMP IMMUNOL, V37, P50, DOI 10.1016/j.dci.2011.12.008; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Gharbi S, 2015, CELL J, V17, P494; Greenberg JK, 2012, GENES BRAIN BEHAV, V11, P660, DOI 10.1111/j.1601-183X.2012.00782.x; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; He J, 2016, P NATL ACAD SCI USA, V113, P584, DOI 10.1073/pnas.1521098113; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jayachandran B, 2013, J INVERTEBR PATHOL, V114, P151, DOI 10.1016/j.jip.2013.07.004; Jiang JH, 2013, INSECT BIOCHEM MOLEC, V43, P692, DOI 10.1016/j.ibmb.2013.05.002; Jin H, 2012, GENE DEV, V26, P1427, DOI 10.1101/gad.192872.112; Kagias K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-222; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanga LHB, 2003, PEST MANAG SCI, V59, P921, DOI 10.1002/ps.702; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kim K, 2014, CELL REP, V7, P2066, DOI 10.1016/j.celrep.2014.05.025; Kirk H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-12; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Li GW, 2016, ARCH INSECT BIOCHEM, V91, P67, DOI 10.1002/arch.21309; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Liang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078787; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Liu SP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-88; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Long QX, 2017, METHODS MOL BIOL, V1540, P211, DOI 10.1007/978-1-4939-6700-1_17; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Macedo LMF, 2016, INSECT MOL BIOL, V25, P216, DOI 10.1111/imb.12214; Mahdipour M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0075-8; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meuti ME, 2013, INTEGR COMP BIOL, V53, P131, DOI 10.1093/icb/ict023; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Nelson C, 2014, MOL CELL, V56, P376, DOI 10.1016/j.molcel.2014.09.011; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ninova M, 2014, GENOME BIOL EVOL, V6, P2459, DOI 10.1093/gbe/evu183; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ragupathy R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39373; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; Rubio M, 2013, J INSECT PHYSIOL, V59, P1089, DOI 10.1016/j.jinsphys.2013.09.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sun KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002515; Surridge AK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-62; Tollerup KE, 2012, J ECON ENTOMOL, V105, P1712, DOI 10.1603/EC11419; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168166; Yang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098164; Yang YT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00086; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhang XF, 2015, INSECT BIOCHEM MOLEC, V62, P11, DOI 10.1016/j.ibmb.2014.08.006; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhang YL, 2015, GENE, V557, P215, DOI 10.1016/j.gene.2014.12.038; Zhou GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103041; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4; Zhu X, 2015, INT J MOL SCI, V16, P8310, DOI 10.3390/ijms16048310	98	12	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171120	10.1371/journal.pone.0171120	http://dx.doi.org/10.1371/journal.pone.0171120			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158242	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700030
J	Jeong, S; Oh, JM; Oh, KH; Kim, IW				Jeong, Sohyun; Oh, Jung Mi; Oh, Kook-Hwan; Kim, In-Wha			Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; ADYNAMIC BONE; HIP FRACTURE; INCREASED RISK; PTH; OSTEODYSTROPHY; OSTEOPOROSIS	Mineral and bone disorder (MBD) is observed universally in patients with chronic kidney disease (CKD). Detrimental MBD-related skeletal changes include increased prevalence of fracture, cardiovascular disease, and mortality. MicroRNAs (miRNAs) have been identified as useful biomarkers in various diseases, and the aim of this study was to identify miRNAs associated with parathyroid hormone level in peritoneal dialysis (PD) patients. Fifty-two PD patients were enrolled and grouped by their intact parathyroid hormone (iPTH) level; 11 patients had low iPTH (<150 pg/mL) and 41 patients had high iPTH (>= 150 pg/mL). Total RNA was extracted from whole blood samples. Total RNA from 15 patients (7 and 8 patients in the low and high iPTH groups, respectively) underwent miRNA microarray analysis, and three differentially upregulated (>2-fold change) miRNAs previously associated with human disease were selected for real-time quantitative PCR (qPCR) analysis. Interaction analyses between miRNAs and genes were performed by using TargetScan and the KEGG pathway database. Microarray results revealed 165 miRNAs were differentially expressed between patients with high iPTH levels and low iPTH levels. Of those miRNAs, 81 were upregulated and 84 were downregulated in patients with high iPTH levels. Expression levels of miR-1299, miR-3680-5p, and miR-548b-5p (previously associated with human disease) in 52 patients were analyzed by using qPCR. MiR-3680-5p was differentially expressed in low and high iPTH patients (P < 0.05). The predicted target genes of miR-3680-5p were USP6, USP32, USP46, and DLT, which are involved in the ubiquitin proteolysis pathway. This pathway has roles in PTH and parathyroid hormone related protein degradation and proteolysis. The mechanisms involved in the associations among low PTH, adynamic bone disease, miR-3680-5p, and the target genes should be explored further in order to elucidate their roles in CKD-MBD development.	[Jeong, Sohyun; Oh, Jung Mi; Kim, In-Wha] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Jeong, Sohyun; Oh, Jung Mi; Kim, In-Wha] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Oh, Kook-Hwan] Seoul Natl Univ Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, IW (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea.	khoh@snu.ac.kr; iwkim2@hanmail.net	Jeong, Sohyun/ABC-4625-2020	Jeong, Sohyun/0000-0003-3805-4349	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2055734]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2055734). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; ANDRESS DL, 1989, KIDNEY INT, V36, P471, DOI 10.1038/ki.1989.219; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Barreto FC, 2006, KIDNEY INT, V69, P1852, DOI 10.1038/sj.ki.5000311; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Brandenburg VM, 2008, CLIN KIDNEY J, V1, P135, DOI 10.1093/ndtplus/sfn040; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cannata-Andia JB, 2013, J NEPHROL, V26, P73, DOI 10.5301/jn.5000212; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Coen G, 1996, NEPHROL DIAL TRANSPL, V11, P813, DOI 10.1093/oxfordjournals.ndt.a027404; Dooley AC, 2008, AM J KIDNEY DIS, V51, P38, DOI 10.1053/j.ajkd.2007.08.019; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Frazao JM, 2009, CURR OPIN NEPHROL HY, V18, P303, DOI 10.1097/MNH.0b013e32832c4df0; Garrett G, 2013, CLIN J AM SOC NEPHRO, V8, P299, DOI 10.2215/CJN.09580911; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hackl M, 2016, MOL CELL ENDOCRINOL, V432, P93, DOI 10.1016/j.mce.2015.10.015; Holmes David, 2015, Nat Rev Endocrinol, V11, P445, DOI 10.1038/nrendo.2015.104; Hutchison A J, 1996, Perit Dial Int, V16 Suppl 1, pS295; Ingsathit A, 2010, NEPHROL DIAL TRANSPL, V25, P1567, DOI 10.1093/ndt/gfp669; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Jean G, 2013, NEPHROL THER, V9, P154, DOI 10.1016/j.nephro.2013.02.006; Kalantar-Zadeh K, 2010, KIDNEY INT, V78, pS10, DOI 10.1038/ki.2010.189; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524519; LLACH F, 2000, KIDNEY, P2103; Lobao R, 2004, CLIN NEPHROL, V62, P432; London G, 2010, CLIN NEPHROL, V74, P423, DOI 10.2379/CN106512; Malluche HH, 2006, CLIN NEPHROL, V65, P235; Malluche HH, 2004, NEPHROL DIAL TRANSPL, V19, pI9, DOI 10.1093/ndt/gfh1002; Meng QL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-37; Nickolas TL, 2006, J AM SOC NEPHROL, V17, P3223, DOI 10.1681/ASN.2005111194; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Parfitt AM, 2003, CURR OPIN NEPHROL HY, V12, P387, DOI 10.1097/00041552-200307000-00007; Picton ML, 2000, KIDNEY INT, V58, P1440, DOI 10.1046/j.1523-1755.2000.00306.x; SHERRARD DJ, 1993, KIDNEY INT, V43, P436, DOI 10.1038/ki.1993.64; Shilo V, 2016, CURR OPIN NEPHROL HY, V25, P271, DOI 10.1097/MNH.0000000000000227; Souberbielle JCP, 2010, KIDNEY INT, V77, P93, DOI 10.1038/ki.2009.374; Sprague SM, 2000, SEMIN DIALYSIS, V13, P152, DOI 10.1046/j.1525-139x.2000.00042.x; Stehman-Breen CO, 1999, AM J KIDNEY DIS, V33, P941, DOI 10.1016/S0272-6386(99)70430-0; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; United States Renal Data System, 2014, DIS NIOHNIODADAK; Warnes G.R., 2006, R NEWS, V6, P64; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu HQ, 2016, BIOMED PHARMACOTHER, V83, P792, DOI 10.1016/j.biopha.2016.07.037	56	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170535	10.1371/journal.pone.0170535	http://dx.doi.org/10.1371/journal.pone.0170535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152049	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200025
J	Uuskula, A; Raag, M; Marsh, K; Talu, A; Vorobjov, S; Jarlais, DD				Uuskula, Anneli; Raag, Mait; Marsh, Kristina; Talu, Ave; Vorobjov, Sigrid; Jarlais, Don Des			HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic	PLOS ONE			English	Article							SYRINGE EXCHANGE; RISK BEHAVIORS; HEPATITIS-C; INFECTION; PREVENTION; SEROPREVALENCE; INTERVENTION; ADHERENCE	Introduction New injectors / younger drug users are an important population to target for intervention because they are often at especially high risk of HIV and HCV infection. We examined HIV prevalence and gender differences in HIV prevalence and risk behavior among new injection-drug-users in Tallinn, Estonia. Methods Respondent driven sampling (RDS) interview surveys and HIV testing were conducted in Tallinn in 2009, 2011 and 2013. We classified "new injectors" as persons who reported their first injection as occurring within three years of the study interview. Recruiting trees of the three individual RDS studies were joined to form one RDS dataset and RDS estimates for prevalence and means were derived. Bootstrap tests were used to compare data from men and women, HIV infected and uninfected. Results Among 110 new injectors (34 women and 76 men) the mean age was 24.5 (SD 7.5) years; 63% reported injecting mainly fentanyl, 34% injecting mainly amphetamine, 36% sharing syringes, 89% were sexually active, and, of these, 88% did not always use condoms in the last 6 months. HIV prevalence was 18% (95% CI 8-28%) (41% (95% CI 19-63%) among female and 7% (95% CI 2-12%) among male new injectors). Based on self-reports, 8.1% of all new injectors (and 22% of female new injectors) were HIV positive before starting to inject drugs. 40% of HIV infected reported receiving antiretroviral therapy. In multivariable analysis, gender (male: OR 0.12, 95% CI 0.03-0.45), main drug injected (fentanyl: OR 6.7, 95% CI 1.3-35.7) and syringe sharing (distributive: OR 0.11, 95% CI 0.02-0.55; and receptive: OR 3.7, 95% CI 1.0-13.5) were associated with the HIV seropositivity. Conclusions New injectors exhibit high-risk behavior and correspondingly high HIV prevalence. Sexual transmission of HIV infection, including before injection initiation, is likely to be a significant contributor to HIV risk among female new injectors. This highlights the need to identify and target new injectors and their partners with gender specific interventions in addition to interventions to reduce initiation into injecting and ensuring provision of ART to HIV positive new injectors.	[Uuskula, Anneli; Raag, Mait; Marsh, Kristina; Talu, Ave] Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia; [Vorobjov, Sigrid] Natl Inst Hlth Dev, Tallinn, Estonia; [Jarlais, Don Des] Mt Sinai Beth Israel Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY USA	University of Tartu; National Institute for Health Development - Estonia	Uuskula, A (corresponding author), Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia.	anneli.uuskula@ut.ee	Uusküla, Anneli/H-3303-2015; Talu, Ave/D-7677-2014	Uusküla, Anneli/0000-0002-4036-3856; Talu, Ave/0000-0003-3543-483X	National Institutes of Health, USA [R01A1083035, 1DP1DA039542]; Estonian Ministry of Education and Research [IUT34-17]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant # R01A1083035 and 1DP1DA039542 from the National Institutes of Health, USA, and by grant # IUT34-17 from the Estonian Ministry of Education and Research.	[Anonymous], 1992, BMJ, V304, P809; [Anonymous], 2011, GUID MON PREGN; [Anonymous], 2014, R LANG ENV STAT COMP; Atkinson John, 2011, Afr J Drug Alcohol Stud, V10, P1; Azim T, 2015, INT J DRUG POLICY, V26, pS16, DOI 10.1016/j.drugpo.2014.09.003; Cedarbaum ER, 2016, DRUG ALCOHOL DEPEN, V158, P102, DOI 10.1016/j.drugalcdep.2015.11.011; Des Jarlais DC, 1999, J ACQ IMMUN DEF SYND, V20, P67, DOI 10.1097/00042560-199901010-00010; Des Jarlais DC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-54; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; European Centre for Disease Prevention and Control (ECDC), 2009, HIV AIDS SURV EUR; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Frajzyngier V, 2007, DRUG ALCOHOL DEPEN, V89, P145, DOI 10.1016/j.drugalcdep.2006.12.021; Fuller CM, 2003, JAIDS, V32, P86, DOI 10.1097/00126334-200301010-00013; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Gyarmathy VA, 2009, EUR ADDICT RES, V15, P163, DOI 10.1159/000220344; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Handcock M.S., 2012, RDS RESPONDENT DRIVE; Handcock M. S., 2014, RDS ANAL SOFTWARE AN; Harocopos A, 2009, INT J DRUG POLICY, V20, P317, DOI 10.1016/j.drugpo.2008.06.003; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; HIV in Estonia, 2016, NARR REP GLOB AIDS R; Johnson M, 2013, ANTIVIR THER, V18, P19, DOI 10.3851/IMP2637; Jolley E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001465; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Montgomery SB, 2002, AM J DRUG ALCOHOL AB, V28, P453, DOI 10.1081/ADA-120006736; Munoz F, 2015, AIDS BEHAV, V19, P199, DOI 10.1007/s10461-014-0815-y; Neaigus A, 1996, J ACQ IMMUN DEF SYND, V11, P499, DOI 10.1097/00042560-199604150-00011; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; Riehman KS, 2004, J URBAN HEALTH, V81, P249, DOI 10.1093/jurban/jth111; Robbins CL, 2010, INT J STD AIDS, V21, P489, DOI 10.1258/ijsa.2010.010097; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Uuskula A, 2015, AIDS CARE, V27, P105, DOI 10.1080/09540121.2014.940271; Uuskula A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-517; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014; Uuskula A, 2010, J URBAN HEALTH, V87, P304, DOI 10.1007/s11524-009-9427-7; Valdiserri R, 2014, AM J PUBLIC HEALTH, V104, P816, DOI 10.2105/AJPH.2013.301812; Vorobjov S, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-3; Wilson TE, 2007, INT J STD AIDS, V18, P389, DOI 10.1258/095646207781024900; Wood E, 2008, HIV MED, V9, P503, DOI 10.1111/j.1468-1293.2008.00582.x	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170956	10.1371/journal.pone.0170956	http://dx.doi.org/10.1371/journal.pone.0170956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152026	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200061
J	Kim, EK; Kim, KA; Lee, CY; Shim, HS				Kim, Eun Kyung; Kim, Kyung A.; Lee, Chang Young; Shim, Hyo Sup			The frequency and clinical impact of HER2 alterations in lung adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; GENE COPY NUMBER; PHASE-II TRIAL; PROTEIN EXPRESSION; ACQUIRED-RESISTANCE; KINASE MUTATIONS; BREAST-CANCER; AMPLIFICATION; TRASTUZUMAB	Human epidermal growth factor receptor 2 (HER2 or ErbB2) can be overexpressed, amplified and/or mutated in malignant tumors, and is a candidate for therapeutic targeting. However, molecular associations and clinical significances of these alterations were controversial in lung cancer. In this study, we investigated the frequency and clinicopathological significance of HER2 dysregulation in patients with lung adenocarcinoma. HER2 protein overexpression, gene amplification, and gene mutation were evaluated by immunohistochemistry (IHC), silver in situ hybridization, and direct sequencing, respectively. The H-scoring method and American Society of Clinical Oncology/College of American Pathologists breast cancer guidelines were used to interpret IHC results. Genetic analyses of EGFR and KRAS mutations, and of ALK and ROS1 rearrangements, were also performed. Of the 321 adenocarcinoma patients identified, HER2 overexpression (Hscore >= 200) and gene amplification were found in 6 (1.9%) and 46 (14.3%), respectively. HER2 overexpression was correlated with papillary predominant histology; furthermore, it indicated poor overall survival and was an independent prognostic factor. HER2 amplification was associated with pleural invasion and showed a tendency towards shorter overall and disease-free survival. High-level gene amplification (HER2/CEP17 ratio >= 5 or copy number >= 10) was a poor prognostic factor for disease-free survival. HER2 mutations were detected in 6.7% (7 of 104) of driver oncogene-negative adenocarcinomas. Our study suggests that HER2 overexpression or amplification is a poor prognostic factor in lung adenocarcinoma, although the frequency of such events is low. Since molecular targeted agents are being tested in clinical trials, awareness of the specific HER2 status can influence the prognostic stratification and treatment of patients with molecularly defined subsets of lung adenocarcinoma.	[Kim, Eun Kyung; Kim, Kyung A.; Shim, Hyo Sup] Yonsei Univ, Coll Med, Dept Pathol, Severance Hosp, Seoul, South Korea; [Lee, Chang Young] Yonsei Univ, Coll Med, Dept Cardiovasc & Thorac Surg, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shim, HS (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Severance Hosp, Seoul, South Korea.	shimhs@yuhs.ac	Shim, Hyo Sup/ABI-6190-2020; Kim, Eun-Kyung/E-5211-2017	Shim, Hyo Sup/0000-0002-5718-3624; Kim, Eun-Kyung/0000-0002-3368-5013	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015R1C1A1A01051935]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (http://www.nrf.re.kr/; NRF-2015R1C1A1A01051935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2010, J THORAC ONCOL, V5, P1536, DOI 10.1097/JTO.0b013e3181ea510a; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Bang YJ, 2010, LANCET, V376, P1302; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Clamon G, 2005, CANCER-AM CANCER SOC, V103, P1670, DOI 10.1002/cncr.20950; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Edge SB, 2010, AJCC CANC STAGING MA, P251; Gatzemeier U, 2004, ANN ONCOL, V15, P19, DOI 10.1093/annonc/mdh031; Heinmoller P, 2003, CLIN CANCER RES, V9, P5238; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hirsch FR, 2002, BRIT J CANCER, V86, P1449, DOI 10.1038/sj.bjc.6600286; Kobyakov DS, 2014, B EXP BIOL MED+, V157, P789, DOI 10.1007/s10517-014-2668-9; Korrapati V, 2001, Clin Lung Cancer, V2, P216, DOI 10.3816/CLC.2001.n.006; Langer CJ, 2004, J CLIN ONCOL, V22, P1180, DOI 10.1200/JCO.2004.04.105; Lara Primo N Jr, 2004, Clin Lung Cancer, V5, P231; Li BW, 2016, ACTA ASTRONAUT, V127, P579, DOI 10.1016/j.actaastro.2016.06.048; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Liu LX, 2010, J THORAC ONCOL, V5, P1922, DOI 10.1097/JTO.0b013e3181f26266; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Pellegrini C, 2003, CLIN CANCER RES, V9, P3645; Planchard D, 2015, ANN ONCOL, V26, P2073, DOI 10.1093/annonc/mdv319; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Travis WD., 2015, WHO CLASSIFICATION T; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshizawa A, 2014, LUNG CANCER, V85, P373, DOI 10.1016/j.lungcan.2014.06.007	32	48	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171280	10.1371/journal.pone.0171280	http://dx.doi.org/10.1371/journal.pone.0171280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146588	gold, Green Published, Green Submitted			2022-12-26	WOS:000396131700029
J	Kovacs, CJ; Perrtree, RM; Cox, TM				Kovacs, Carolyn J.; Perrtree, Robin M.; Cox, Tara M.			Social Differentiation in Common Bottlenose Dolphins (Tursiops truncatus) that Engage in Human-Related Foraging Behaviors	PLOS ONE			English	Article							SARASOTA BAY; ASSOCIATION; TRANSMISSION; PATTERNS; ECOLOGY; CATCH	Both natural and human-related foraging strategies by the common bottlenose dolphin (Tursiops truncatus) have resulted in social segregation in several areas of the world. Bottlenose dolphins near Savannah, Georgia beg at an unprecedented rate and also forage behind commercial shrimp trawlers, providing an opportunity to study the social ramifications of two human-related foraging behaviors within the same group of animals. Dolphins were photo-identified via surveys conducted throughout estuarine waterways around Savannah in the summers of 2009-2011. Mean half-weight indices (HWI) were calculated for each foraging class, and community division by modularity was used to cluster animals based on association indices. Pairs of trawler dolphins had a higher mean HWI (0.20 +/- 0.07) than pairs of non-trawler dolphins (0.04 +/- 0.02) or mixed pairs (0.02 +/- 0.02). In contrast, pairs of beggars, non-beggars, and mixed pairs all had similar means, with HWI between 0.05 +/- 0.07. Community division by modularity produced a useful division (0.307) with 6 clusters. Clusters were predominately divided according to trawler status; however, beggars and non-beggars were mixed throughout clusters. Both the mean HWI and social clusters revealed that the social structure of common bottlenose dolphins near Savannah, Georgia was differentiated based on trawler status but not beg status. This finding may indicate that foraging in association with trawlers is a socially learned behavior, while the mechanisms for the propagation of begging are less clear. This study highlights the importance of taking into account the social parameters of a foraging behavior, such as how group size or competition for resources may affect how the behavior spreads. The positive or negative ramifications of homophily may influence whether the behaviors are exhibited by individuals within the same social clusters and should be considered in future studies examining social relationships and foraging behaviors.	[Kovacs, Carolyn J.; Perrtree, Robin M.; Cox, Tara M.] Savannah State Univ, Marine Sci Program, Dept Marine & Environm Sci, Savannah, GA 31404 USA; [Kovacs, Carolyn J.] Univ S Florida, Sea Mester, Sarasota, FL USA	University System of Georgia; Savannah State University; State University System of Florida; University of South Florida	Perrtree, RM; Cox, TM (corresponding author), Savannah State Univ, Marine Sci Program, Dept Marine & Environm Sci, Savannah, GA 31404 USA.	perrtreer@savannahstate.edu; coxt@savannahstate.edu			NSF GK12 [0841372]; NSF EDGE [GE0-0194680]; NOM Office of Education's Educational Partnership Program [NA050AR4811017]; Department of Education, Title VII [P382G090003]; Oak Foundation	NSF GK12(National Science Foundation (NSF)); NSF EDGE; NOM Office of Education's Educational Partnership Program; Department of Education, Title VII; Oak Foundation	Boat time was provided by the Marine Sciences Program at Savannah State University (www.savannahstate.eduu/marinesciences) CJK RMP TMC. Support was provided by NSF GK12 (www.gk-12.org; award 0841372) CJK; NSF EDGE (www.nsf.gov; award GE0-0194680) TMC RMP; the NOM Office of Education's Educational Partnership Program (http://www.epp.noaa.gov; award NA050AR4811017) RMP; Department of Education, Title VII (http://www.ed.gov/; award P382G090003) CJK RMP TMC; and the Oak Foundation (http://oakfnd.org/) TMC RMP.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Baird RM, 1992, OECOLOGIA, P89125; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broadhurst M.K., 1998, MAR FISH REV, V60, P9; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Donaldson R, 2012, ANIM CONSERV; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; Finn Hugh, 2008, Pacific Conservation Biology, V14, P215; Fleming KH, 2004, THESIS; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GIRALDEAU LA, 1984, AM NAT, V124, P72, DOI 10.1086/284252; Gonzalvo J, 2008, J EXP MAR BIOL ECOL, V367, P47, DOI 10.1016/j.jembe.2008.08.013; Gubbins Cara, 2002, Aquatic Mammals, V28, P24; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Kovacs C, 2014, AQUAT MAMM, V40, P81, DOI 10.1578/AM.40.1.2014.81; Lopez BD, 2008, BEHAV ECOL SOCIOBIOL, V62, P887, DOI 10.1007/s00265-007-0512-1; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowacek DP, 2002, BEHAVIOUR, V139, P1125, DOI 10.1163/15685390260437290; Pace DS, 2011, BEHAV ECOL, V22, P276; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Perrtree RM, 2011, THESIS; Perrtree RM, 2014, MAR MAMMAL SCI, V30, P1320, DOI 10.1111/mms.12114; Powell JR, 2011, MAR MAMMAL SCI, V27, P111, DOI 10.1111/j.1748-7692.2010.00401.x; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rossbach KA, 1999, CAN J ZOOL, V77, P581, DOI 10.1139/cjz-77-4-581; Samuels Amy, 2004, Journal of Cetacean Research and Management, V6, P69; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Svane I, 2005, FISH RES, V76, P317, DOI 10.1016/j.fishres.2005.07.012; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Urian KW, 1999, NMESSEFSC425 NOAA; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	41	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170151	10.1371/journal.pone.0170151	http://dx.doi.org/10.1371/journal.pone.0170151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146563	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700014
J	Hartmann, AK; Nuel, G				Hartmann, Alexander K.; Nuel, Gregory			Using Triplet Ordering Preferences for Estimating Causal Effects in the Analysis of Gene Expression Data	PLOS ONE			English	Article							OBSERVATIONAL DATA; REGULATORY NETWORKS	Triplet ordering preferences are used to perform Monte Carlo sampling of the posterior causal orderings originating from the analysis of gene-expression experiments involving observation as well as, usually few, interventions, like knock-outs. The performance of this sampling approach is compared to a previously used sampling via pairwise ordering preference as well as to the sampling of the full posterior distribution. For a fair comparison, the latter approach is restricted to twice the numerical effort of the triplet-based approach. This is done for artificially generated causal, i.e.,directed acyclic graphs (DAGs)and for actual experimental data taken from the ROSETTA challenge. The sampling using the triplets ordering turns out to be superior to both other approaches.	[Hartmann, Alexander K.] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany; [Nuel, Gregory] Univ Paris 06, LPMA, CNRS 7599, Paris, France	Carl von Ossietzky Universitat Oldenburg; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Hartmann, AK (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany.	alexander.hartmann@uni-oldenburg.de		Hartmann, Alexander/0000-0001-6865-5474	Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" - Deutsche Forschungsgemeinschaft (DFG); Foundation Sciences Mathematiques de Paris (FSMP); DFG [INST 184/108-1 FUGG]; ministry of Science and Culture (MWK) of the Lower Saxony State [INST 184/108-1 FUGG]	Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Foundation Sciences Mathematiques de Paris (FSMP); DFG(German Research Foundation (DFG)); ministry of Science and Culture (MWK) of the Lower Saxony State	A visit of GN to the University of Oldenburg, during which the project was set up, was supported by the Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" funded by the Deutsche Forschungsgemeinschaft (DFG). AKH is grateful to the Foundation Sciences Mathematiques de Paris (FSMP) for providing financial support for a three month (February to April 2016) visit at the LPTMA of the Universite Pierre et Marie Curie during which this project was mainly conducted. The simulations were performed on the HERO cluster of the University of Oldenburg jointly funded by the DFG (INST 184/108-1 FUGG) and the ministry of Science and Culture (MWK) of the Lower Saxony State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A visit of GN to the University of Oldenburg, during which the project was set up, was supported by the Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" funded by the Deutsche Forschungsgemeinschaft (DFG). AKH is grateful to the Foundation Sciences Mathmatiques de Paris (FSMP) for providing financial support for a three month (February to April 2016) visit at the LPTMA of the Universite Pierre et Marie Curie during which this project mainly conducted.; The simulations were performed on the HERO cluster of the University of Oldenburg jointly funded by the DFG (INST 184/108-1 FUGG) and the ministry of Science and Culture (MWK) of the Lower Saxony State.	CRITCHLOW DE, 1991, J MATH PSYCHOL, V35, P294, DOI 10.1016/0022-2496(91)90050-4; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Hartmann AK, 2015, BIG PRACTICAL GUIDE, DOI [DOI 10.1142/9019, 10.1142/9019]; Hauser A, 2015, J R STAT SOC B, V77, P291, DOI 10.1111/rssb.12071; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jayavelu ND, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0768-9; Joe H, 1993, CELL, V102, P109; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Nuel G, 2014, QUAL TECHNOL QUANT M, V11, P23, DOI 10.1080/16843703.2014.11673323; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J.., 2009, CAUSALITY; Rau A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-111; Wang JX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt147; Wang YQ, 2012, BRIEF BIOINFORM, V13, P162, DOI 10.1093/bib/bbr032; Wu HL, 2014, J AM STAT ASSOC, V109, P700, DOI 10.1080/01621459.2013.859617; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170514	10.1371/journal.pone.0170514	http://dx.doi.org/10.1371/journal.pone.0170514			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141825	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000396129500011
J	Xu, ZR; Yang, W; You, KM; Li, W; Kim, YI				Xu, Zirui; Yang, Wei; You, Kaiming; Li, Wei; Kim, Young-Il			Vehicle autonomous localization in local area of coal mine tunnel based on vision sensors and ultrasonic sensors	PLOS ONE			English	Article							SYSTEM; ENVIRONMENT; ROBOT	This paper presents a vehicle autonomous localization method in local area of coal mine tunnel based on vision sensors and ultrasonic sensors. Barcode tags are deployed in pairs on both sides of the tunnel walls at certain intervals as artificial landmarks. The barcode coding is designed based on UPC-A code. The global coordinates of the upper left inner corner point of the feature frame of each barcode tag deployed in the tunnel are uniquely represented by the barcode. Two on-board vision sensors are used to recognize each pair of barcode tags on both sides of the tunnel walls. The distance between the upper left inner corner point of the feature frame of each barcode tag and the vehicle center point can be determined by using a visual distance projection model. The on-board ultrasonic sensors are used to measure the distance from the vehicle center point to the left side of the tunnel walls. Once the spatial geometric relationship between the barcode tags and the vehicle center point is established, the 3D coordinates of the vehicle center point in the tunnel's global coordinate system can be calculated. Experiments on a straight corridor and an underground tunnel have shown that the proposed vehicle autonomous localization method is not only able to quickly recognize the barcode tags affixed to the tunnel walls, but also has relatively small average localization errors in the vehicle center point's plane and vertical coordinates to meet autonomous unmanned vehicle positioning requirements in local area of coal mine tunnel.	[Xu, Zirui; Yang, Wei; You, Kaiming] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Li, Wei] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing, Peoples R China; [Kim, Young-Il] Elect & Telecommun Res Inst, Daejeon, South Korea	Beijing Jiaotong University; Beijing Jiaotong University; Electronics & Telecommunications Research Institute - Korea (ETRI)	Yang, W (corresponding author), Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	wyang@bjtu.edu.cn			Natural Science Foundation of China [51474015]; Key projects of national key Research and Development program [2016YFC0801806]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key projects of national key Research and Development program	This work was supported by the Natural Science Foundation of China under Grant (51474015, 51474015) and the Key projects of national key Research and Development program (2016YFC0801806).	Ahmad R, 2015, INDIACOM; Asmaa L, 2014, 2014 3 IEEE INT C IN; Bansal S, 2013, IJCA, V66; Brown C, 2012, ENG MIN J, V213, P30; Chauhan AS, 2014, 2014 4 INT C COMM SY; Chen KC, 2010, IEEE T VEH TECHNOL, V59, P3261, DOI 10.1109/TVT.2010.2052079; Chen XH, 2014, INT J CONTROL AUTOM, V12, P1313, DOI [10.1007/s12555-013-0076-y, 10.1007/s12555-013-0021-0]; Cheng GL, 2012, PHYSCS PROC, V24, P534, DOI 10.1016/j.phpro.2012.02.078; Cossairt O, 2013, IEEE T IMAGE PROCESS, V22, P447, DOI 10.1109/TIP.2012.2216538; Dirami A, 2013, SIGNAL PROCESS, V93, P139, DOI 10.1016/j.sigpro.2012.07.010; Fabijanska A, 2010, 2010 P 6 INT C PERSP; Fiala M ., 2005, 2005 IEEE COMP SOC C; Forooshani Arghavan Emami, 2013, IEEE Communications Surveys & Tutorials, V15, P1524, DOI 10.1109/SURV.2013.031413.00130; Fu M, 2014, 17 INT IEEE C INT TR; Hirata S, 2009, IEEE INT CONF ROBOT, P3454; Huh S, 2011, CONTR AUT SYST ICCAS; Jun O., 1988, IEEE T SYST MAN CY-S, P62; Karakaya M, 2014, ACM T SENSOR NETWORK, V10, DOI 10.1145/2529999; Lee D, 2013, UB ROB AMB INT URAI; Li W, 2011, IECON 2011 37 ANN C; Liu LA, 2010, IEEE T VEH TECHNOL, V59, P3562, DOI 10.1109/TVT.2009.2031454; Mehta SS, 2008, COMPUT ELECTRON AGR, V63, P28, DOI 10.1016/j.compag.2008.01.013; Niu X, 2007, IEEE GLOBECOM 2007 I; Olson Edwin, 2011, 2011 IEEE International Conference on Robotics and Automation, P3400; Razzak MI, 2010, IJCC, V8; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Sasmito AP, 2013, TUNN UNDERGR SP TECH, V34, P82, DOI 10.1016/j.tust.2012.09.006; Straw AD, 2010, J ROYAL SOC INTERFAC; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Trivun D, 2015, IND TECHN ICIT 2015; Usha D, 2014, IJCA, V87; Wang H, 2010, IEEE J SEL AREA COMM, V28, P1127, DOI 10.1109/JSAC.2010.100917; Wang J., 2014, INT J COAL SCI TECHN, V1, P253, DOI [DOI 10.1007/S40789-014-0017-2, 10.1007/s40789-014-0017-2]; You KM, 2015, SENSORS-BASEL, V15, P25103, DOI 10.3390/s151025103; Zhang L, 2015, SENSORS-BASEL, V15, P19937, DOI 10.3390/s150819937; Zhang Y, 2014, SENSORS-BASEL, V14, P13149, DOI 10.3390/s140713149; Zhou Y, 2007, P 2007 IEEE INT C RO	37	12	14	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171012	10.1371/journal.pone.0171012	http://dx.doi.org/10.1371/journal.pone.0171012			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141829	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129500033
J	Saldana, RS; Schrem, H; Barthold, M; Kaltenborn, A				Saldana, Ricardo Salinas; Schrem, Harald; Barthold, Marc; Kaltenborn, Alexander			Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients	PLOS ONE			English	Article							DISEASE SCORE; HEPATITIS-B; SERUM SODIUM; MELD-SCORE; SURVIVAL; ALLOCATION; CIRRHOSIS; FAILURE; GERMANY; INDEX	Background Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on liver transplant waiting-lists. Methods 818 consecutive patients on the liver transplant waiting-list included to calculate the MELD, MESO Index, MELD-Na, UKELD, iMELD, refitMELD, refitMELD-Na, upMELD and PELDscores. Prognostic abilities for 90-day mortality were investigated applying Receiver-operating-characteristic-curve analysis. Independent risk factors for 90-day mortality were identified with multivariable binary logistic regression modelling. Methodological quality of the underlying development studies was assessed with a systematic assessment tool. Results 74 patients (9%) died on the liver transplant waiting list within 90 days after listing. All but one scores, refitMELD-Na, had acceptable prognostic performance with areas under the ROC-curves (AUROCs)>0.700. The iMELD performed best (AUROC = 0.798). In pediatric cases, the PELD-score just failed to reach the acceptable threshold with an AUROC = 0.699. All scores reached a mean quality score of 72.3%. Highest quality scores could be achieved by the UKELD and PELD-scores. Studies specifically lack statistical validity and model evaluation. Conclusions Inferior quality assessment of prognostic models does not necessarily imply inferior prognostic abilities. The iMELD might be a more reliable tool representing urgency of transplantation than the MELD-score. PELD-score is assumedly not accurate enough to allow graft allocation decision in pediatric liver transplantation.	[Saldana, Ricardo Salinas; Schrem, Harald; Barthold, Marc; Kaltenborn, Alexander] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany; [Schrem, Harald] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Hosp Westerstede, Dept Trauma & Orthoped Surg, Westerstede, Germany	Hannover Medical School; Hannover Medical School	Kaltenborn, A (corresponding author), Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany.; Kaltenborn, A (corresponding author), Fed Armed Forces Hosp Westerstede, Dept Trauma & Orthoped Surg, Westerstede, Germany.	kaltenborn.alexander@mh-hannover.de			German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EUROTRANSPLANT MANUA, V1, P13; Barber K, 2011, TRANSPLANTATION, V92, P469, DOI 10.1097/TP.0b013e318225db4d; Cai CJ, 2008, CHINESE MED J-PEKING, V121, P2065, DOI 10.1097/00029330-200810020-00023; Collins GS, 2015, BRIT J SURG, V102, P148, DOI 10.1002/bjs.9736; German Medical Association, 2013, DTSCH ARZTEBL, V110; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huo TI, 2007, LIVER INT, V27, P498, DOI 10.1111/j.1478-3231.2007.01445.x; Jacob M, 2005, LIVER TRANSPLANT, V11, P814, DOI 10.1002/lt.20456; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lee WC, 2011, J VIRAL HEPATITIS, V18, P193, DOI 10.1111/j.1365-2893.2010.01295.x; Leise MD, 2011, GASTROENTEROLOGY, V140, P1952, DOI 10.1053/j.gastro.2011.02.017; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720; Schlitt HJ, 2011, Z GASTROENTEROL, V49, P30, DOI 10.1055/s-0029-1245946; Schrem H, 2013, NATURE, V498, P37, DOI 10.1038/498037b; Schrem H, 2012, ANN TRANSPL, V17, P5; Schrem H, 2012, LANGENBECK ARCH SURG, V397, P717, DOI 10.1007/s00423-011-0881-9; Seehofer D, 2013, CHIRURG, V84, P391, DOI 10.1007/s00104-012-2413-8; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Sun LJ, 2010, J GASTROEN HEPATOL, V25, P583, DOI 10.1111/j.1440-1746.2009.06089.x; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	27	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170499	10.1371/journal.pone.0170499	http://dx.doi.org/10.1371/journal.pone.0170499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129338	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400056
J	Zeng, WP; Zhang, R; Li, R; Luo, JF; Hu, XF				Zeng, Wen-ping; Zhang, Rui; Li, Ran; Luo, Jin-fang; Hu, Xiao-feng			Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MAJOR RISK-FACTOR; MYOCARDIAL-INFARCTION; T-786C POLYMORPHISM; 5'-FLANKING REGION; CLINICAL-OUTCOMES; GROWTH-FACTOR; BARE-METAL; PREDICTORS; MUTATION	Background and aim Many studies have reported that genetic variants correlate with higher risk for coronary artery disease (CAD) or in-stent restenosis (ISR) after bare metal stent (BMS) implantation. However, there is limited data assessing the impact of these variants on ISR in patients treated with drug-eluting stent (DES). The purpose of this study was to investigate the effects of genetic risk factors on ISR in Chinese Han patients treated with DES. Methods A total of 425 patients with a diagnosis of CAD who underwent successful revascularization in native coronary arteries with DES were included in this retrospective study. Genotyping was performed on six single nucleotide polymorphisms (SNPs) in the endothelial nitric oxide synthase gene (eNOS), the angiotensin converting enzyme gene (ACE), the angiotensin II type 1 receptor gene (AT1R), the transforming growth factor beta gene (TGF-beta), and the vascular endothelial growth factor gene (VEGF). Quantitative coronary angiography (QCA) was performed during the follow-up period to detect ISR. Logistic regression models were used to test for association. Results Fifty-four patients (12.7%) developed ISR during the follow-up period. Of the six analyzed SNPs, the frequency of the C allele of T786C polymorphism in eNOS was significantly higher in the ISR group (22.2%) compared to the non-ISR group (12.7%) (p<0.01). In the ISR group, the frequency of the TT, TC, and CC genotypes was 61.1%, 33.3%, and 5.6%, respectively, and in the non-ISR group, the frequencies were 76.8%, 21.0%, and 2.2%, respectively. The multivariable analysis adjusted for potential confounders and revealed that the T786C polymorphism increased the risk of ISR in both additive and dominant models with odds ratios of 1.870 (95% confidence interval [CI]: 1.079-3.240, p = 0.03) and 2.045 (95% CI: 1.056-3.958, p = 0.03), respectively. Conclusion The eNOS T786C polymorphism was associated with ISR in Chinese Han patients treated with DES. Genotyping may be helpful to identify patients with higher risks of ISR after DES implantation.	[Zeng, Wen-ping; Hu, Xiao-feng] Zhejiang Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Rui; Li, Ran; Luo, Jin-fang] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Hu, XF (corresponding author), Zhejiang Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China.	ncdx2006hu@126.com			Health Bureau of Zhejiang Province [2014KYB002]	Health Bureau of Zhejiang Province	This work is supported by grants from Health Bureau of Zhejiang Province (2014KYB002) (Wen-ping Zeng), http://www.zjwst.gov.cn/. Author Contribution of WPZ: preparation of the manuscript, data analysis and funding acquisition.	Amant C, 1997, CIRCULATION, V96, P56; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chung IM, 2002, J AM COLL CARDIOL, V40, P2072, DOI 10.1016/S0735-1097(02)02598-6; Doshi AA, 2010, J CARD FAIL, V16, P314, DOI 10.1016/j.cardfail.2009.12.013; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Han Y, 2010, PHARMACOLOGY, V85, P211, DOI 10.1159/000275135; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; James SK, 2009, NEW ENGL J MED, V360, P1933, DOI 10.1056/NEJMoa0809902; Jo I, 2006, CLIN CHIM ACTA, V365, P86, DOI 10.1016/j.cca.2005.07.029; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jorgensen E, 2001, J AM COLL CARDIOL, V38, P1434, DOI 10.1016/S0735-1097(01)01580-7; Katsaros KM, 2014, EUROINTERVENTION, V10, P224, DOI 10.4244/EIJV10I2A36; Kim IJ, 2007, THROMB RES, V119, P579, DOI 10.1016/j.thromres.2006.06.005; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Li YT, 2015, IEEE GLOB COMM CONF, DOI [10.1109/GLOCOM.2015.7417288, 10.1109/GLOCOM.2015.7417682]; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Liu DX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003413; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; Fragoso JM, 2015, EXP MOL PATHOL, V98, P13, DOI 10.1016/j.yexmp.2014.11.007; Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629; Morris DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037878; Nakano M, 2013, EUR HEART J, V34, P3304, DOI 10.1093/eurheartj/eht241; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Osadnik T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150500; Pallero MA, 2010, J VASC RES, V47, P309, DOI 10.1159/000265565; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Rai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113363; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Shibata M, 2001, HISTOCHEM CELL BIOL, V116, P471, DOI 10.1007/s00418-001-0336-4; Shuvalova YA, 2012, MOL CELL BIOCHEM, V370, P241, DOI 10.1007/s11010-012-1419-3; Souza-Costa DC, 2007, ATHEROSCLEROSIS, V193, P438, DOI 10.1016/j.atherosclerosis.2006.07.020; Suzuki T, 2002, INT J CARDIOL, V86, P71, DOI 10.1016/S0167-5273(02)00192-4; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wijpkema JS, 2006, PHARMACOGENET GENOM, V16, P331, DOI 10.1097/01.fpc.0000205001.07054.fa; Xu JX, 2015, ANGIOLOGY, V66, P652, DOI 10.1177/0003319714547946	43	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170964	10.1371/journal.pone.0170964	http://dx.doi.org/10.1371/journal.pone.0170964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129392	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400019
J	Dahl-Halvarsson, M; Pokrzywa, M; Rauthan, M; Pilon, M; Tajsharghi, H				Dahl-Halvarsson, Martin; Pokrzywa, Malgorzata; Rauthan, Manish; Pilon, Marc; Tajsharghi, Homa			Myosin Storage Myopathy in C. elegans and Human Cultured Muscle Cells	PLOS ONE			English	Article							HYALINE BODY MYOPATHY; ONSET DISTAL MYOPATHY; HEAVY-CHAIN; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS; MYH7 MUTATION; ROD; MECHANISMS; DOMAIN	Myosin storage myopathy is a protein aggregate myopathy associated with the characteristic subsarcolemmal accumulation of myosin heavy chain in muscle fibers. Despite similar histological findings, the clinical severity and age of onset are highly variable, ranging from no weakness to severe impairment of ambulation, and usually childhood-onset to onset later in life. Mutations located in the distal end of the tail of slow/beta-cardiac myosin heavy chain are associated with myosin storage myopathy. Four missense mutations (L1793P, R1845W, E1883K and H1901L), two of which have been reported in several unrelated families, are located within or closed to the assembly competence domain. This location is critical for the proper assembly of sarcomeric myosin rod filaments. To assess the mechanisms leading to protein aggregation in myosin storage myopathy and to evaluate the impact of these mutations on myosin assembly and muscle function, we expressed mutated myosin proteins in cultured human muscle cells and in the nematode Caenorhabditis elegans. While L1793P mutant myosin protein efficiently incorporated into the sarcomeric thick filaments, R1845W and H1901L mutants were prone to formation of myosin aggregates without assembly into striated sarcomeric thick filaments in cultured muscle cells. In C. elegans, mutant alleles of the myosin heavy chain gene unc-54 corresponding to R1845W, E1883K and H1901L, were as effective as the wild-type myosin gene in rescuing the null mutant worms, indicating that they retain functionality. Taken together, our results suggest that the basis for the pathogenic effect of the R1845W and H1901L mutations are primarily structural rather than functional. Further analyses are needed to identify the primary trigger for the histological changes seen in muscle biopsies of patients with L1793P and E1883K mutations.	[Dahl-Halvarsson, Martin; Pokrzywa, Malgorzata] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Rauthan, Manish; Pilon, Marc] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Tajsharghi, Homa] Univ Skovde, Sch Hlth & Educ, Div Biomed & Publ Hlth, Skovde, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Skovde	Tajsharghi, H (corresponding author), Univ Skovde, Sch Hlth & Educ, Div Biomed & Publ Hlth, Skovde, Sweden.	homa.tajsharghi@his.se	Pilon, Marc/AAY-4082-2020; Pokrzywa, Małgorzata/GQA-6257-2022	Pilon, Marc/0000-0003-3919-2882; Halvarsson, Martin/0000-0003-4312-0363	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Swedish Research Council (H.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072396; Armel TZ, 2010, J MOL CELL CARDIOL, V48, P1007, DOI 10.1016/j.yjmcc.2009.10.011; Armel TZ, 2010, BIOCHEM BIOPH RES CO, V391, P352, DOI 10.1016/j.bbrc.2009.11.062; Armel TZ, 2009, P NATL ACAD SCI USA, V106, P6291, DOI 10.1073/pnas.0900107106; Bohlega S, 2004, NEUROLOGY, V62, P1518, DOI 10.1212/01.WNL.0000123255.92062.37; BRENNER S, 1974, GENETICS, V77, P71; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; Dubourg O, 2011, J NEUROL, V258, P1157, DOI 10.1007/s00415-011-5900-9; Dye DE, 2006, NEUROMUSCULAR DISORD, V16, P357, DOI 10.1016/j.nmd.2006.03.011; Kiphuth IC, 2010, FORTSCHR NEUROL PSYC, V78, P219, DOI 10.1055/s-0029-1245145; Laing NG, 2005, NEUROLOGY, V64, P527, DOI 10.1212/01.WNL.0000150581.37514.30; Lamont PJ, 2014, HUM MUTAT, V35, P868, DOI 10.1002/humu.22553; Lamont PJ, 2006, J NEUROL NEUROSUR PS, V77, P208, DOI 10.1136/jnnp.2005.073825; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Muelas N, 2010, NEUROLOGY, V75, P732, DOI 10.1212/WNL.0b013e3181eee4d5; Pegoraro E, 2007, NEUROMUSCULAR DISORD, V17, P321, DOI 10.1016/j.nmd.2007.01.010; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shingde MV, 2006, NEUROMUSCULAR DISORD, V16, P882, DOI 10.1016/j.nmd.2006.09.001; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Tajsharghi H, 2005, ANN NEUROL, V58, P442, DOI 10.1002/ana.20594; Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693; Tajsharghi H, 2007, NEUROLOGY, V68, P962, DOI 10.1212/01.wnl.0000257131.13438.2c; Tajsharghi H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/s00401-012-1024-2; Udd B, 2009, Neuromuscul Disord, V19, P429, DOI 10.1016/j.nmd.2009.04.002; Uro-Coste E, 2009, NEUROMUSCULAR DISORD, V19, P163, DOI 10.1016/j.nmd.2008.11.012; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Voit T, 2001, NEUROMUSCULAR DISORD, V11, P11, DOI 10.1016/S0960-8966(00)00158-9; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170613	10.1371/journal.pone.0170613	http://dx.doi.org/10.1371/journal.pone.0170613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125727	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100086
J	Zheng, HM; Wang, XX; Guo, PF; Ge, WZ; Yan, QF; Gao, WQ; Xi, YM; Yang, XH				Zheng, Huimei; Wang, Xuexiang; Guo, Pengfei; Ge, Wanzhong; Yan, Qinfeng; Gao, Weiqiang; Xi, Yongmei; Yang, Xiaohang			Premature remodeling of fat body and fat mobilization triggered by platelet-derived growth factor/VEGF receptor in Drosophila	FASEB JOURNAL			English	Article						CD117/c-kit; lipid metabolism; ecdysone; Rac1; fat cell	PROGRAMMED CELL-DEATH; PDGF/VEGF RECEPTOR; LIPID DROPLETS; ADIPOSE-TISSUE; MATRIX METALLOPROTEINASES; ECDYSONE RECEPTOR; RHO-GTPASES; STEM-CELL; C-KIT; MELANOGASTER	In Drosophila, fat-body remodeling accompanied with fat mobilization is an ecdysone-induced dynamic process that only occurs during metamorphosis. Here, we show that the activated Drosophila platelet-derived growth factor/VEGF receptor (PVR) is sufficient to induce shape changes in the fat body, from thin layers of tightly conjugated polygonal cells to clusters of disaggregated round-shaped cells. These morphologic changes are reminiscent of those seen during early pupation upon initiation of fat-body remodeling. Activation of PVR also triggers an early onset of lipolysis and mobilization of internal storage, as revealed by the appearance of small lipid droplets and up-regulated lipolysis-related genes. We found that PVR displays a dynamic expression pattern in the fat body and peaks at the larval-prepupal transition under the control of ecdysone signaling. Removal of PVR, although it does not prevent ecdysone-induced fat-body remodeling, causes ecdysone signaling to be up-regulated. Our data reveal that PVR is active in a dual-secured mechanism that involves an ecdysone-induced fat-body remodeling pathway and a reinforced PVR pathway for effective lipid mobilization. Ectopic expression of activated c-kit-the mouse homolog of PVR in the Drosophila fat body-also results in a similar phenotype. This may suggest a novel function of c-kit as it relates to lipid metabolism in mammals.-Zheng, H., Wang, X., Guo, P., Ge, W., Yan, Q., Gao, W., Xi, Y., Yang, X. Premature remodeling of fat body and fat mobilization triggered by platelet-derived growth factor/VEGF receptor in Drosophila.	[Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Sch Med, Womens Hosp, Div Human Reprod & Dev Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Inst Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Wang, Xuexiang; Yan, Qinfeng] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Weiqiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Gao, Weiqiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China; [Yang, Xiaohang] Zhejiang Univ, Univ Toronto, Joint Inst Genet & Genom Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Toronto; Zhejiang University	Xi, YM; Yang, XH (corresponding author), Zhejiang Univ, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	xyyongm@zju.edu.cn; xhyang@zju.edu.cn	Gao, Wei/GXH-0380-2022; Guo, Peng/GWC-0572-2022; 席, 咏梅/AAE-1909-2022; guo, peng/AAG-4052-2019	ZHENG, HUIMEI/0000-0001-7129-8412; Ge, Wanzhong/0000-0003-1334-2723	National Key Basic Research Program of China (973 Program) [2012CB966801]; National Natural Science Foundation of China [31371319]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank P. Rorth (National University of Singapore, Singapore), C. Tong (Zhejiang University), the Bloomington Drosophila Stock Center (Indiana University, Bloomington, IN, USA), Vijaya Development Resource Centre and the Tsinghua Fly Center for providing fly stocks. The authors also thank H. Zhu (Jiao Tong University) for providing the c-kit plasmid, and R. Yang (Jiao Tong University School of Medicine) for suggestions. This study was supported by grants from the National Key Basic Research Program of China (973 Program; 2012CB966801) and National Natural Science Foundation of China (31371319).	ABEL T, 1993, DEVELOPMENT, V119, P623; Aguila JR, 2013, J EXP BIOL, V216, P399, DOI 10.1242/jeb.078311; Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Asha H, 2003, GENETICS, V163, P203; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Bond ND, 2011, DEV BIOL, V360, P286, DOI 10.1016/j.ydbio.2011.09.015; Bond ND, 2010, COMP BIOCHEM PHYS A, V157, P398, DOI [10.1016/J.cbpa.2010.08.025, 10.1016/j.cbpa.2010.08.025]; Britton JS, 1998, DEVELOPMENT, V125, P2149; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Corless CL, 2002, AM J PATHOL, V160, P1567, DOI 10.1016/S0002-9440(10)61103-0; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gavert N, 2013, CANCER RES, V73, P5754, DOI 10.1158/0008-5472.CAN-13-0576; Ge WZ, 2015, GENETICS, V200, P255, DOI 10.1534/genetics.115.174748; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KE, 2007, MECH DEVELOP, V124, P441, DOI 10.1016/j.mod.2007.03.003; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; HOSHIZAKI DK, 1994, DEV BIOL, V163, P133, DOI 10.1006/dbio.1994.1129; HOSHIZAKI DK, 2005, COMPLETE MOL INSECT, V2, P315; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; LOCKETT TJ, 1989, DEV BIOL, V134, P430, DOI 10.1016/0012-1606(89)90115-2; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Patnaik MM, 2007, CURR CANCER DRUG TAR, V7, P492; Pignoni F, 1997, DEVELOPMENT, V124, P271; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tan WJ, 2015, MODERN PATHOL, V28, P352, DOI 10.1038/modpathol.2014.111; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exger.2004.12.008; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81; Yamada M, 2000, DEVELOPMENT, V127, P5083; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	79	7	10	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1964	1975		10.1096/fj.201601127R	http://dx.doi.org/10.1096/fj.201601127R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126734				2022-12-26	WOS:000399195500018
J	Hoffman, H; Rice, C; Skordalakes, E				Hoffman, Hunter; Rice, Cory; Skordalakes, Emmanuel			Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA RECOGNITION; BINDING; TERT; TETRAHYMENA; TEMPLATE; ENZYME; GENE	Naturally occurring mutations in the ribonucleoprotein reverse transcriptase, telomerase, are associated with the bone marrow failure syndromes dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis. However, the mechanism by which these mutations impact telomerase function remains unknown. Here we present the structure of the human telomerase C-terminal extension (or thumb domain) determined by the method of single-wavelength anomalous diffraction to 2.31 angstrom resolution. We also used direct telomerase activity and nucleic acid binding assays to explain how naturally occurring mutations within this portion of telomerase contribute to human disease. The single mutations localize within three highly conserved regions of the telomerase thumb domain referred to as motifs E-I (thumb loop and helix), E-II, and E-III (the FVYL pocket, comprising the hydrophobic residues Phe-1012, Val-1025, Tyr-1089, and Leu-1092). Biochemical data show that the mutations associated with dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis disrupt the binding between the protein subunit reverse transcriptase of the telomerase and its nucleic acid substrates leading to loss of telomerase activity and processivity. Collectively our data show that although these mutations do not alter the overall stability or expression of telomerase reverse transcriptase, these rare genetic disorders are associated with an impaired telomerase holoenzyme that is unable to correctly assemble with its nucleic acid substrates, leading to incomplete telomere extension and telomere attrition, which are hallmarks of these diseases.	[Hoffman, Hunter; Rice, Cory; Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA; [Rice, Cory; Skordalakes, Emmanuel] Univ Penn, Perelman Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine	Skordalakes, E (corresponding author), Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA.; Skordalakes, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA.	skorda@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833; Rice, Cory/0000-0003-2270-030X	National Institutes of Health [R01CA201312]; Wistar Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [R01CA201312, T32CA009171, P30CA010815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA201312 and Wistar Cancer Center Support Grant P30 CA10815. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Bryan C, 2015, STRUCTURE, V23, P1934, DOI 10.1016/j.str.2015.08.006; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Cristofari G, 2007, NAT METHODS, V4, P851, DOI 10.1038/NMETH1099; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dokal I, 1996, BRIT J HAEMATOL, V92, P775, DOI 10.1046/j.1365-2141.1996.355881.x; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Harkisheimer M, 2013, STRUCTURE, V21, P1870, DOI 10.1016/j.str.2013.08.013; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Jansson LI, 2015, NAT STRUCT MOL BIOL, V22, P883, DOI 10.1038/nsmb.3101; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Mason M, 2011, CURR OPIN STRUC BIOL, V21, P92, DOI 10.1016/j.sbi.2010.11.005; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Palmer H.M., 2000, J ANTIMICROB CHEMOTH, V45, P413, DOI [10.1093/jac/45.3.413, DOI 10.1093/JAC/45.3.413]; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Tomlinson CG, 2016, BIOCHIMIE, V128, P114, DOI 10.1016/j.biochi.2016.07.010; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	40	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4593	4601		10.1074/jbc.M116.771204	http://dx.doi.org/10.1074/jbc.M116.771204			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154186	hybrid, Green Published			2022-12-26	WOS:000397585100017
J	Xu, F; Dong, F; Wang, P; Cao, HY; Li, CY; Li, PY; Pang, XH; Zhang, YZ; Chen, XL				Xu, Fei; Dong, Fang; Wang, Peng; Cao, Hai-Yan; Li, Chun-Yang; Li, Ping-Yi; Pang, Xiu-Hua; Zhang, Yu-Zhong; Chen, Xiu-Lan			Novel Molecular Insights into the Catalytic Mechanism of Marine Bacterial Alginate Lyase AlyGC from Polysaccharide Lyase Family 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PECTATE LYASE; PSEUDOMONAS-AERUGINOSA; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; MAJOR SOURCES; URONIC-ACID; EVOLUTION; OLIGOSACCHARIDES; ADAPTATION	Alginate lyases that degrade alginate via a beta-elimination reaction fall into seven polysaccharide lyase (PL) families. Although the structures and catalytic mechanisms of alginate lyases in the other PL families have been clarified, those in family PL6 have yet to be revealed. Here, the crystal structure of AlyGC, a PL6 alginate lyase from marine bacterium Glaciecola chathamensis S18K6(T), was solved, and its catalytic mechanism was illustrated. AlyGC is a homodimeric enzyme and adopts a structure distinct from other alginate lyases. Each monomer contains a catalytic N-terminal domain and a functionally unknown C-terminal domain. A combined structural and mutational analysis using the structures of AlyGC and of an inactive mutant R241A in complex with an alginate tetrasaccharide indicates that conformational changes occur in AlyGC when a substrate is bound and that the two active centers in AlyGC may not bind substrates simultaneously. The C-terminal domain is shown to be essential for the dimerization and the catalytic activity of AlyGC. Residues Tyr(130), Arg(187), His(242), Arg(265), and Tyr(304) in the active center are also important for the activity of AlyGC. In catalysis, Lys(220) and Arg(241) function as the Bronsted base and acid, respectively, and a Ca2+ in the active center neutralizes the negative charge of the C5 carboxyl group of the substrate. Finally, based on our data, we propose a metal ion assisted catalytic mechanism of AlyGC for alginate cleavage with a state change mode, which provides a better understanding for polysaccharide lyases and alginate degradation.	[Xu, Fei; Dong, Fang; Wang, Peng; Cao, Hai-Yan; Li, Chun-Yang; Li, Ping-Yi; Pang, Xiu-Hua; Zhang, Yu-Zhong; Chen, Xiu-Lan] Shandong Univ, Inst Marine Sci & Technol, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Yu-Zhong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266000, Peoples R China	Shandong University; Qingdao National Laboratory for Marine Science & Technology	Chen, XL (corresponding author), Shandong Univ, Inst Marine Sci & Technol, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	cxl0423@sdu.edu.cn	xu, fei/AAU-4859-2020; WANG, Peng/GSN-5263-2022	Li, Chun-Yang/0000-0002-1151-4897; Zhang, Yu-Zhong/0000-0002-2017-1005	National Science Foundation of China [31290230, 31290231, 41676180, 31670038]; Program of Shandong for Taishan Scholars Grant [TS20090803]; National Postdoctoral Program for Innovative Talents Grant [BX201600095]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shandong for Taishan Scholars Grant; National Postdoctoral Program for Innovative Talents Grant	This work was supported by National Science Foundation of China Grants 31290230, 31290231, 41676180, and 31670038, Program of Shandong for Taishan Scholars Grant TS20090803, and National Postdoctoral Program for Innovative Talents Grant BX201600095. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alahuhta M, 2011, ACTA CRYSTALLOGR F, V67, P1498, DOI 10.1107/S1744309111038449; BROWN BJ, 1991, CARBOHYD RES, V211, P91, DOI 10.1016/0008-6215(91)84148-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; DOUBET RS, 1984, APPL ENVIRON MICROB, V47, P699, DOI 10.1128/AEM.47.4.699-703.1984; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Ducruix A., 1999, CRYSTALLIZATION NUCL, P391; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00523; Hatch RA, 1998, ANTIMICROB AGENTS CH, V42, P974, DOI 10.1128/AAC.42.4.974; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Islan GA, 2013, MACROMOL BIOSCI, V13, P1238, DOI 10.1002/mabi.201300134; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li LY, 2011, CARBOHYD RES, V346, P794, DOI 10.1016/j.carres.2011.01.023; Li SY, 2016, J BIOCHEM, V159, P77, DOI 10.1093/jb/mvv076; MAKI H, 1993, J GEN MICROBIOL, V139, P987, DOI 10.1099/00221287-139-5-987; Matsuyama H, 2006, INT J SYST EVOL MICR, V56, P2883, DOI 10.1099/ijs.0.64413-0; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; NAKADA HI, 1967, J BIOL CHEM, V242, P845; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; PREISS J, 1962, J BIOL CHEM, V237, P309; Qin QL, 2014, ENVIRON MICROBIOL, V16, P1642, DOI 10.1111/1462-2920.12318; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Thompson JE, 2010, J BIOL CHEM, V285, P23963, DOI 10.1074/jbc.M110.127571; Wang P, 2015, MOL MICROBIOL, V98, P289, DOI 10.1111/mmi.13119; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Zhu BW, 2015, BIOENGINEERED, V6, P125, DOI 10.1080/21655979.2015.1030543	47	63	66	8	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4457	4468		10.1074/jbc.M116.766030	http://dx.doi.org/10.1074/jbc.M116.766030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154171	Green Published, hybrid			2022-12-26	WOS:000397585100007
J	Wernly, B; Lichtenauer, M; Franz, M; Kabisch, B; Muessig, J; Masyuk, M; Hoppe, UC; Kelm, M; Jung, C				Wernly, Bernhard; Lichtenauer, Michael; Franz, Marcus; Kabisch, Bjoern; Muessig, Johanna; Masyuk, Maryna; Hoppe, Uta C.; Kelm, Malte; Jung, Christian			Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance	PLOS ONE			English	Article							CHRONIC HEALTH EVALUATION; CHRONIC HEART-FAILURE; HEPATIC-DYSFUNCTION; ACUTE PHYSIOLOGY; FUNCTION ABNORMALITIES; CARDIOGENIC-SHOCK; MORTALITY; MICROCIRCULATION; TRANSPLANTATION; MORBIDITY	Purpose MELD-XI, an adapted version of Model for End-stage Liver Disease (MELD) score excluding INR, was reported to predict outcomes e.g. in patients with acute heart failure. We aimed to evaluate MELD-XI in critically ill patients admitted to an intensive care unit (ICU) for prognostic relevance. Methods A total of 4381 medical patients (66 +/- 14 years, 2862 male) admitted to a German ICU between 2004 and 2009 were included and retrospectively investigated. Admission diagnoses were e.g. myocardial infarction (n = 2034), sepsis (n = 694) and heart failure (n = 688). We divided our patients in two cohorts basing on their MELD-XI score and evaluated the MELD-XI score for its prognostic relevance regarding short-term and long-term survival. Optimal cut-offs were calculated by means of the Youden-Index. Results Patients with a MELD-XI score > 12 had pronounced laboratory signs of organ failure and more comorbidities. MELD-XI > 12 was associated with an increase in short-term (27% vs 6%; HR 4.82, 95% CI 3.93-5.93; p<0.001) and long-term (HR 3.69, 95% CI 3.20-4.25; p<0.001) mortality. In a univariate Cox regression analysis for all patients MELD-XI was associated with increased long-term mortality (changes per score point: HR 1.06, 95% CI 1.05-1.07; p<0.001) and remained to be associated with increased mortality after correction in a multivariate regression analysis for renal failure, liver failure, lactate concentration, blood glucose concentration, oxygenation and white blood count (HR 1.04, 95% CI 1.03-1.06; p<0.001). Optimal cutoff for the overall cohort was 11 and varied remarkably depending on the admission diagnosis: myocardial infarction (9), pulmonary embolism (9), cardiopulmonary resuscitation (17) and pneumonia (17). We performed ROC-analysis and compared the AUC: SAPS2 (0.78, 95% CI 0.76-0.80; p<0.0001) and APACHE (0.76, 95% CI 0.74-0.78; p<0.003) score were superior to MELD-XI (0.71, 95% CI 0.68-0.73) for prediction of mortality. Conclusions The easily calculable MELD-XI score is a robust and reliable tool to predict both intra-ICU and long-term mortality in critically ill medical patients admitted to an ICU. Optimal cut-off values for MELD-XI scores seem to depend on the primary disease and need to be validated in future prospective studies. Compared to SAPS2 and APACHE score, MELD-XI lacks precision but might have comparable and even additive value, as it is easily available and independent of subjective values.	[Wernly, Bernhard; Lichtenauer, Michael; Hoppe, Uta C.] Paracelsus Med Univ Salzburg, Clin Internal Med 2, Dept Cardiol, Salzburg, Austria; [Franz, Marcus; Kabisch, Bjoern] Jena Univ Hosp, Dept Cardiol, Clin Internal Med 1, Jena, Germany; [Muessig, Johanna; Masyuk, Maryna; Kelm, Malte; Jung, Christian] Univ Duesseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany	Paracelsus Private Medical University; Friedrich Schiller University of Jena	Jung, C (corresponding author), Univ Duesseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany.	christian.jung@med.uni-duesseldorf.de	Jung, Christian/AAN-4537-2021; Lichtenauer, Michael/H-5139-2019; Franz, Marcus/ABA-4688-2021; Wernly, Bernhard/AAA-8529-2020	Jung, Christian/0000-0001-8325-250X; Lichtenauer, Michael/0000-0001-8403-3931; Franz, Marcus/0000-0001-6543-4684; Wernly, Bernhard/0000-0003-4024-0220; Masyuk, Maryna/0000-0003-2856-6893				Abe Satoshi, 2014, PLoS One, V9, pe100618, DOI 10.1371/journal.pone.0100618; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Assenza GE, 2013, HEART, V99, P491, DOI 10.1136/heartjnl-2012-303347; Bannier K, 2015, J DIABETES COMPLICAT, V29, P1130, DOI 10.1016/j.jdiacomp.2015.08.010; Batin P, 1995, EUR HEART J, V16, P1613, DOI 10.1093/oxfordjournals.eurheartj.a060785; Cannito S, 2014, HISTOL HISTOPATHOL, V29, P33, DOI 10.14670/HH-29.33; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; Fu QW, 2016, CLIN MED RES, V14, P15, DOI 10.3121/cmr.2015.1282; Fujita B, 2015, CLIN BIOCHEM, V48, P1048, DOI 10.1016/j.clinbiochem.2015.07.011; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grimm JC, 2015, ANN THORAC SURG, V100, P1737, DOI 10.1016/j.athoracsur.2015.07.026; HAWKER F, 1991, ANAESTH INTENS CARE, V19, P165, DOI 10.1177/0310057X9101900203; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heuman DM, 2007, LIVER TRANSPLANT, V13, P30, DOI 10.1002/lt.20906; Inohara T, 2014, INT J CARDIOL, V176, P571, DOI 10.1016/j.ijcard.2014.08.052; Jung C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1312-7; Jung C, 2016, CLIN RES CARDIOL, V105, P196, DOI 10.1007/s00392-015-0906-4; Jung C, 2015, CLIN HEMORHEOL MICRO, V61, P213, DOI 10.3233/CH-151994; Jung C, 2015, CLIN RES CARDIOL, V104, P679, DOI 10.1007/s00392-015-0833-4; Jung C, 2010, CRIT CARE, V14, DOI 10.1186/cc9244; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kim MS, 2013, J AM COLL CARDIOL, V61, P2253, DOI 10.1016/j.jacc.2012.12.056; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KUBO SH, 1987, ARCH INTERN MED, V147, P1227, DOI 10.1001/archinte.147.7.1227; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lim H Sern, 2015, EUR HEART J-ACUTE CA; Markgraf R, 2001, CRIT CARE, V5, P31, DOI 10.1186/cc975; Matthews JC, 2010, CIRCULATION, V121, P214, DOI 10.1161/CIRCULATIONAHA.108.838656; McCaughan GW, 2016, INTERN MED J, V46, P404, DOI 10.1111/imj.13025; Murata M, 2016, INT J CARDIOL, V203, P682, DOI 10.1016/j.ijcard.2015.10.181; Pisani Margaret A, 2009, J Intensive Care Med, V24, P83, DOI 10.1177/0885066608329942; Roth C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1242-4; SHOREY J, 1969, AM J PHYSIOL, V216, P1441, DOI 10.1152/ajplegacy.1969.216.6.1441; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; Wu AH, 2013, AM J CARDIOL, V111, P1192, DOI 10.1016/j.amjcard.2012.12.048; Zheng H, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-7	40	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170987	10.1371/journal.pone.0170987	http://dx.doi.org/10.1371/journal.pone.0170987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151948	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200067
J	Matsuo, T; Miyata, Y; Asai, A; Sagara, Y; Furusato, B; Fukuoka, J; Sakai, H				Matsuo, Tomohiro; Miyata, Yasuyoshi; Asai, Akihiro; Sagara, Yuji; Furusato, Bungo; Fukuoka, Junya; Sakai, Hideki			Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer	PLOS ONE			English	Article							GROWTH FACTOR-A; EPIGALLOCATECHIN-3-GALLATE EGCG; HEME OXYGENASE-1; BREAST-CANCER; CELL-PROLIFERATION; VEGF INDUCTION; EXPRESSION; HUR; APOPTOSIS; CONSUMPTION	Green tea polyphenol (GTP) suppresses carcinogenesis and aggressiveness in many types of malignancies including bladder cancer. However, the mechanistic basis of these effects is not well understood. This was investigated in the present study using a mouse model of chemically induced bladder cancer. C3H/He mice (8 weeks old; n = 46) were treated with 0.05% N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) solution for 14-24 weeks. Mice in the BBN + GTP group (n = 47) were also treated with 0.5% GTP solution over the same period. Tumor cell proliferation and microvessel density were evaluated along with immunohistochemical analysis of human antigen (Hu)R, vascular endothelial growth factor (VEGF)-A, cyclooxygenase (COX)-2, and hemeoxygenase (H0)-1 expression. Cytoplasmic HuR expression in cancer cells was higher at 14 and 24 weeks in the BBN than in the control group and was associated with increased invasion of tumor cells in muscle. However, these effects were not observed in the BBN + GTP group. A multivariate analysis of GTP intake and cytoplasmic HuR expression revealed that GTP was independently associated with COX-2 and HO-1 expression, while cytoplasmic HuR expression was associated with COX 2 and VEGF-A levels. Expression of COX-2 and HO-1 was associated with cell proliferation and that of VEGF-A and HO-1 was associated with angiogenesis. Nuclear HuR expression was not associated with any parameters such as carcinogenesis, muscle invasion, and GTP intake. These results indicate that GTP intake can suppress tumor progression and malignant behavior in an animal model of bladder cancer. We also speculate that GTP directly and indirectly suppresses tumor cell proliferation and angiogenesis via HuR-related pathways in bladder cancer.	[Matsuo, Tomohiro; Miyata, Yasuyoshi; Asai, Akihiro; Sagara, Yuji; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki, Japan; [Furusato, Bungo; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan	Nagasaki University; Nagasaki University	Miyata, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki, Japan.	int.doc.miya@m3.dion.ne.jp	Fukuoka, Junya/AAT-2924-2021	Fukuoka, Junya/0000-0002-2496-3050; Furusato, Bungo/0000-0003-4614-9882; Matsuo, Tomohiro/0000-0002-9508-0319				Ahn WS, 2003, DNA CELL BIOL, V22, P217, DOI 10.1089/104454903321655846; Annabi B, 2007, LEUKEMIA RES, V31, P1277, DOI 10.1016/j.leukres.2006.10.001; Ashughyan Vahagn R, 2006, Rev Urol, V8, P8; Bernardo C, 2014, ANTICANCER RES, V34, P735; Bettuzzi S, 2006, CANCER RES, V30, P207; Caporali A, 2004, CARCINOGENESIS, V25, P2217, DOI 10.1093/carcin/bgh235; Ding GQ, 2016, AM J TRANSL RES, V8, P578; Espina C, 2015, CANCER EPIDEMIOL, V39, pS84, DOI 10.1016/j.canep.2015.03.017; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Giaginis C, 2015, TUMOR BIOL, V36, P315, DOI 10.1007/s13277-014-2637-y; Gu JW, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-9; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Inoue M, 2001, CANCER LETT, V167, P175, DOI 10.1016/S0304-3835(01)00486-4; Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3&lt;255::AID-IJC1&gt;3.0.CO;2-W; Jimbo M, 2015, ONCOTARGET, V6, P27312, DOI 10.18632/oncotarget.4743; Jung YD, 2001, BRIT J CANCER, V84, P844, DOI 10.1054/bjoc.2000.1691; Kuwano Y, 2009, MOL CELL BIOL, V29, P2622, DOI 10.1128/MCB.01495-08; Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Lim SJ, 2009, CANCER RES TREAT, V41, P87, DOI 10.4143/crt.2009.41.2.87; Lu Q., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/201462, DOI 10.1155/2012/201462]; Matsuo T, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.019; Meyer J, 2015, CANCER EPIDEM BIOMAR, V24, P1516, DOI 10.1158/1055-9965.EPI-15-0415; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Miyata Y, 2003, CLIN CANCER RES, V9, P1741; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Miyata Y, 2014, TRANSL RES, V164, P468, DOI 10.1016/j.trsl.2014.06.010; Miyata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059095; Philips BJ, 2009, BIOMED RES-TOKYO, V30, P207, DOI 10.2220/biomedres.30.207; Qin J, 2007, BIOCHEM BIOPH RES CO, V354, P852, DOI 10.1016/j.bbrc.2007.01.003; Riegsecker S, 2013, LIFE SCI, V93, P307, DOI 10.1016/j.lfs.2013.07.006; Sagara Y, 2010, CANCER EPIDEMIOL, V34, P350, DOI 10.1016/j.canep.2010.03.001; Saito Y, 2014, J GASTROENTEROL, V49, P692, DOI 10.1007/s00535-013-0799-9; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Sartippour MR, 2002, J NUTR, V132, P2307, DOI 10.1093/jn/132.8.2307; Shi JL, 2015, ONCOL REP, V33, P2972, DOI 10.3892/or.2015.3889; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang X, 2013, UROL INT, V90, P10, DOI 10.1159/000342804; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wu WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09051; Zhang SY, 2014, NUTR CANCER, V66, P315, DOI 10.1080/01635581.2014.868909; Zhu KW, 2016, TUMOR BIOL, V37, P4373, DOI 10.1007/s13277-015-4187-3	45	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171091	10.1371/journal.pone.0171091	http://dx.doi.org/10.1371/journal.pone.0171091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141864	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500037
J	Porte, B; Chatelain, C; Hardouin, J; Derambure, C; Zerdoumi, Y; Hauchecorne, M; Dupre, N; Bekri, S; Gonzalez, B; Marret, S; Cosette, P; Leroux, P				Porte, Baptiste; Chatelain, Clemence; Hardouin, Julie; Derambure, Celine; Zerdoumi, Yasmine; Hauchecorne, Michele; Dupre, Nicolas; Bekri, Soumeya; Gonzalez, Bruno; Marret, Stephane; Cosette, Pascal; Leroux, Philippe			Proteomic and transcriptomic study of brain microvessels in neonatal and adult mice	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CEREBRAL-BLOOD-FLOW; LARGE GENE LISTS; PREMATURE-INFANTS; ENERGY-METABOLISM; GERMINAL MATRIX; INTRAVENTRICULAR HEMORRHAGE; PRETERM INFANTS; DATA SUBMISSION; MOUSE-BRAIN	Infants born before 29 weeks gestation incur a major risk of preterm encephalopathy and subependymal/intracerebral/intraventricular haemorrhage. In mice, an ontogenic window of haemorrhage risk was recorded up to 5 days after birth in serpinel knock-out animals. Using proteome and transcriptome approaches in mouse forebrain microvessels, we previously described the remodelling of extracellular matrix and integrins likely strengthening the vascular wall between postnatal day 5 (P5) and P10. Haemorrhage is the ultimate outcome of vessel damage (i.e., during ischaemia), although discreet vessel insults may be involved in the aetiology of preterm encephalopathy. In this study, we examined proteins identified by mass spectrometry and segregating in gene ontology pathways in forebrain microvessels in P5, P10, and adult wild type mice. In parallel, comparative transcript levels were obtained using RNA hybridization microarrays and enriched biological pathways were extracted from genes exhibiting at least a two-fold change in expression. Five major biological functions were observed in those genes detected both as proteins and mRNA expression undergoing at least a two-fold change in expression in one or more age comparisons: energy metabolism, protein metabolism, antioxidant function, ion exchanges, and transport. Adult micro vessels exhibited the highest protein and mRNA expression levels for a majority of genes. Energy metabolism enriched gene ontology pathways pointed to the preferential occurrence of glycolysis in P5 microvessels cells versus P10 and adult preparations enriched in aerobic oxidative enzymes. Age-dependent levels of RNA coding transport proteins at the plasma membrane and mitochondria strengthened our findings based on protein data. The data suggest that immature microvessels have fewer energy supply alternatives to glycolysis than mature structures. In the context of high energy demand, this constraint might account for vascular damage and maintenance of the high bleeding occurrence in specific areas in immature brain.	[Porte, Baptiste; Chatelain, Clemence; Zerdoumi, Yasmine; Hauchecorne, Michele; Dupre, Nicolas; Bekri, Soumeya; Gonzalez, Bruno; Marret, Stephane; Leroux, Philippe] Normandie Univ, UNIROUEN, INSERM, U1245,IRIB, Rouen, France; [Hardouin, Julie; Cosette, Pascal] Normandie Univ, UNIROUEN, UMR 6270, CNRS,IRIB, Mont St Aignan, France; [Hardouin, Julie; Cosette, Pascal] Normandie Univ, UNIROUEN, Prote Facil PISSARO, IRIB, Mont St Aignan, France; [Derambure, Celine] Normandie Univ, UNIROUEN, UMR S905, INSERM,IRIB, Rouen, France; [Bekri, Soumeya] Rouen Univ Hosp, Metab Biochem Dept, Rouen, France; [Marret, Stephane] Rouen Univ Hosp, Neonatal Pediat & Intens Care Dept, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Rouen	Leroux, P (corresponding author), Normandie Univ, UNIROUEN, INSERM, U1245,IRIB, Rouen, France.	philippe.leroux@univ-rouen.fr	Dupre, Nicolas/Y-1828-2019; Porte, Baptiste/L-7381-2017; Gonzalez, Bruno/E-6103-2016; Leroux, Philippe/M-2002-2018	Gonzalez, Bruno/0000-0002-7176-1320; Porte, Baptiste/0000-0003-3728-6308; Cosette, Pascal/0000-0002-7588-0167; Bekri, Soumeya/0000-0001-6184-7270; Derambure, celine/0000-0002-6722-5955; Marret, Stephane/0000-0002-2858-148X; Hardouin, Julie/0000-0003-4588-9811	INSERM [UMR-5905, UMR-1079]; Region Haute Normandie [ERI28]; CNRS [UMR-6270]; IRIB of PISSARO; European FEDER grant [33245]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Haute Normandie(Region Normandie); CNRS(Centre National de la Recherche Scientifique (CNRS)); IRIB of PISSARO; European FEDER grant	Support was provided by: INSERM and Region Haute Normandie funding of ERI28; INSERM funding of UMR-5905; INSERM funding of UMR-1079; CNRS funding of UMR-6270; IRIB funding of PISSARO proteomics facility; and European FEDER grant 33245.	Adle-Biassette H, 2007, PEDIATR RES, V61, P54, DOI 10.1203/01.pdr.0000250040.61888.61; Ancel PY, 2005, AM J OBSTET GYNECOL, V193, P178, DOI 10.1016/j.ajog.2004.11.057; Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Ballabh P, 2007, NAT MED, V13, P477, DOI 10.1038/nm1558; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Baud O, 2003, J COMP NEUROL, V465, P445, DOI 10.1002/cne.10853; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fyfe KL, 2014, SLEEP MED REV, V18, P299, DOI 10.1016/j.smrv.2013.06.002; Giedt RJ, 2012, ANN BIOMED ENG, V40, P1903, DOI 10.1007/s10439-012-0568-6; Guo SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052665; Haruda FD, 2001, PEDIATRICS, V108, P1050, DOI 10.1542/peds.108.4.1050; Henry VJ, 2013, NEUROBIOL DIS, V50, P201, DOI 10.1016/j.nbd.2012.10.020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illsinger S, 2011, J PERINAT MED, V39, P587, DOI [10.1515/jpm.2011.063, 10.1515/JPM.2011.063]; Ivanov Anton, 2011, Front Neuroenergetics, V3, P2, DOI 10.3389/fnene.2011.00002; Ivanov AI, 2014, J CEREBR BLOOD F MET, V34, P397, DOI 10.1038/jcbfm.2013.222; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasischke K, 2011, FRONT NEUROENERGETIC, V3, P1; Kratzer I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-25; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lecointre M, 2014, J CEREB BLOOD FLOW M; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Leroux P, 2014, J NEUROPATH EXP NEUR, V73, P387, DOI 10.1097/NEN.0000000000000062; Licht T, 2015, J CLIN INVEST, V125, P1319, DOI 10.1172/JCI79401; Marin-Padilla M, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00038; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; OLDENDORF WH, 1975, P SOC EXP BIOL MED, V149, P736; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Perrone S, 2015, J MATERN-FETAL NEO M, V28, P2291, DOI 10.3109/14767058.2013.796170; Porte B, 2016, J CEREB BLOOD FLOW M; Salmina AB, 2015, INT J BIOCHEM CELL B, V64, P174, DOI 10.1016/j.biocel.2015.04.005; Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; TUOR UI, 1994, AM J PHYSIOL-HEART C, V267, pH2220, DOI 10.1152/ajpheart.1994.267.6.H2220; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005	51	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171048	10.1371/journal.pone.0171048	http://dx.doi.org/10.1371/journal.pone.0171048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141873	Green Published, gold			2022-12-26	WOS:000396129500036
J	Ullah, A; Chen, W; Khan, MA; Sun, HG				Ullah, Asmat; Chen, Wen; Khan, Mushtaq Ahmad; Sun, HongGuang			A New Variational Approach for Multiplicative Noise and Blur Removal	PLOS ONE			English	Article							FAST ALGORITHM; MODEL; MINIMIZATION; IMAGES	This paper proposes a new variational model for jointmultiplicative denoising and deblurring. It combines a total generalized variation filter (which has been proved to be able to reduce the blocky-effects by being aware of high-order smoothness) and shearlet transform (that effectively preserves anisotropic image features such as sharp edges, curves and so on). The new model takes the advantage of both regularizers since it is able to minimize the staircase effects while preserving sharp edges, textures and other fine image details. The existence and uniqueness of a solution to the proposed variational model is also discussed. The resulting energy functional is then solved by using alternating direction method of multipliers. Numerical experiments showing that the proposed model achieves satisfactory restoration results, both visually and quantitatively in handling the blur (motion, Gaussian, disk, and Moffat) and multiplicative noise (Gaussian, Gamma, or Rayleigh) reduction. A comparison with other recent methods in this field is provided as well. The proposed model can also be applied for restoring both single and multi-channel images contaminated with multiplicative noise, and permit cross-channel blurs when the underlying image has more than one channel. Numerical tests on color images are conducted to demonstrate the effectiveness of the proposed model.	[Ullah, Asmat; Chen, Wen; Khan, Mushtaq Ahmad; Sun, HongGuang] Hohai Univ, Ctr Numer Simulat Software Engn & Sci, State Key Lab Hydrol Water Resources & Hydraul En, Coll Mech & Mat, Nanjing 210098, Jiangsu, Peoples R China	Hohai University	Ullah, A; Chen, W (corresponding author), Hohai Univ, Ctr Numer Simulat Software Engn & Sci, State Key Lab Hydrol Water Resources & Hydraul En, Coll Mech & Mat, Nanjing 210098, Jiangsu, Peoples R China.	asmatullah@hhu.edu.cn; chenwen@hhu.edu.cn	Ullah, Md Asmat/GYU-9827-2022; Heisenberg, X/K-9096-2015	Ullah, Md Asmat/0000-0003-4308-4200; 	National Science Funds of China [11572111, 11372097]; 111 Project [B12032]	National Science Funds of China; 111 Project(Ministry of Education, China - 111 Project)	The work described in this paper was supported by the National Science Funds of China (Grant Nos. 11572111, 11372097) and the 111 Project (Grant No. B12032), Dr. Wen Chen.	Aubert G, 2000, MATH PROBLEMS IMAGE, P147; Aubert G, 2008, SIAM J APPL MATH, V68, P925, DOI 10.1137/060671814; Bioucas D, 2009, P IEEE INT C IM PROC; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Bredies K., 2012, RECOVERING PIECEWISE; Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; Candes E, 1999, PHILOS T LONDON ROYA, P357; Candes E, 2006, MULTISCALE MODELING, V05; Chambolle A, 2008, INTRO TOTAL VARIATIO, V4, P2278; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Chen K, 2007, J SCI COMPUT, V33, P115, DOI 10.1007/s10915-007-9145-9; Chen YJ, 2014, IEEE SIGNAL PROC LET, V21, P1370, DOI 10.1109/LSP.2014.2337274; Chumchob N, 2013, INT J COMPUT MATH, V90, P140, DOI 10.1080/00207160.2012.709625; Deng W., 2012, TR1214 CAAM RIC U; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Dong YQ, 2013, SIAM J IMAGING SCI, V6, P1598, DOI 10.1137/120870621; Durand S, 2009, MULTIPLICATIVE NOISE, P282; Easley G, 2008, APPL COMPUT HARMON A, V25, P25, DOI 10.1016/j.acha.2007.09.003; Feng WS, 2014, IEEE T IMAGE PROCESS, V23, P1831, DOI 10.1109/TIP.2014.2308432; Glowinski R, 2003, COMPUT PHYS COMMUN, V152, P242, DOI 10.1016/S0010-4655(02)00823-8; GOODMAN JW, 1976, J OPT SOC AM, V66, P1145, DOI 10.1364/JOSA.66.001145; Guang Xial, 2013, MATH PROBL ENG, V2013; Hauser S., 2014, FAST FINITE SHEARLET; He BS, 2002, MATH PROGRAM, V92, P103, DOI 10.1007/s101070100280; He CY, 2015, J INEQUAL APPL, DOI 10.1186/s13660-015-0596-5; Hirakawa K, 2006, IEEE T IMAGE PROCESS, V15, P2730, DOI 10.1109/TIP.2006.877352; Huang LL, 2010, EURASIP J IMAGE VIDE, DOI 10.1155/2010/250768; Huang YM, 2009, SIAM J IMAGING SCI, V2, P20, DOI 10.1137/080712593; Huang YM, 2013, COMMUN COMPUT PHYS, V13, P1066, DOI 10.4208/cicp.310811.090312a; Jin ZM, 2010, J MATH ANAL APPL, V362, P415, DOI 10.1016/j.jmaa.2009.08.036; Knoll F, 2011, MAGN RESON MED, V65, P480, DOI 10.1002/mrm.22595; Labate D., 2005, INT SOC OPTICS PHOTO; Le T, 2007, J MATH IMAGING VIS, V27, P257, DOI 10.1007/s10851-007-0652-y; Liu GJ, 2009, SIGNAL PROCESS, V89, P2233, DOI 10.1016/j.sigpro.2009.04.042; Liu PD, 2014, SPRING CANC RES, P1, DOI [10.1007/978-3-319-05026-3_1, 10.1155/2014/545049]; Longa Z, DENOISING IMAGES MUL; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Marquina A, 2000, SIAM J SCI COMPUT, V22, P387, DOI 10.1137/S1064827599351751; MUNSON DC, 1989, IEEE T ACOUST SPEECH, V37, P2131, DOI 10.1109/29.45556; Osher S., 2005, SIMULATION, V02, P460; Rudin L, 2003, GEOMETRIC LEVEL SET METHODS IN IMAGING, VISION AND GRAPHICS, P103, DOI 10.1007/0-387-21810-6_6; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Sciacchitano F, 2015, SIAM J IMAGING SCI, V8, P1894, DOI 10.1137/140997816; Shen JH, 2003, PHYSICA D, V175, P241, DOI 10.1016/S0167-2789(02)00734-0; Sheng C, 2005, TOTAL VARIATION BASE, V36, P245; Shi BL, 2012, J VIS COMMUN IMAGE R, V23, P126, DOI 10.1016/j.jvcir.2011.08.003; Shi JN, 2008, SIAM J IMAGING SCI, V1, P294, DOI 10.1137/070689954; Steidl G, 2010, J MATH IMAGING VIS, V36, P168, DOI 10.1007/s10851-009-0179-5; Wang F, 2013, INT J COMPUT MATH, V90, P48, DOI 10.1080/00207160.2012.688821; Wu Y., 2015, MATH PROBL ENG, Va01, P1, DOI DOI 10.1155/2015/395973; Xiao Y, 2011, PATTERN RECOGN, V44, P1708, DOI 10.1016/j.patcog.2011.02.002; Yang JF, 2009, SIAM J IMAGING SCI, V2, P569, DOI 10.1137/080730421; You YL, 2000, IEEE T IMAGE PROCESS, V9, P1723, DOI 10.1109/83.869184; Zhao XL, 2014, SIAM J IMAGING SCI, V7, P456, DOI 10.1137/13092472X	57	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0161787	10.1371/journal.pone.0161787	http://dx.doi.org/10.1371/journal.pone.0161787			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141802	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500001
J	Atkilt, HS; Turago, MG; Tegegne, BS				Atkilt, Helen Siyoum; Turago, Muluken Gizaw; Tegegne, Balewgizie Sileshi			Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study	PLOS ONE			English	Article								Background Diabetic ketoacidosis (DKA) is one of the most serious acute complications of type 1 diabetes (T1D) and the leading cause of morbidity and mortality in children with T1D. This study was aimed at assessing the prevalence and associated factors of DKA in children with newly diagnosed T1D in Addis Ababa. Methods A hospital based cross-sectional study was conducted in selected hospitals in Addis Ababa. Children below the age of 12 years with DKA who were admitted to the pediatric ward in the selected hospitals between January 2009 and December 2014 and the residence of Addis Ababa were included. DKA was defined as children below the age of 12 years who have blood glucose level >= 250mg/dl, ketonuria, and ketonemia and diagnosed being T1D patient for the first time. Descriptive statistics was performed using frequency distribution, mean, median, tables, and graphs. Logistic regression analysis was used to identify independent factors associated with the prevalence of DKA in children with newly diagnosed T1D. Results Of 395 DKA patients who were hospitalized during the five-year period, 142(35.8%) pre-sented with DKA at first diagnosis of diabetes. On the other hand 253 (64.2%) children with DKA had longstanding T1D. Independent factors associated with DKA include: Age category 2-4.49years, 7-9.49 years and >= 9.5years (Adjusted odd ratio (AOR) = 3.14[1.21,8.06]), 3.44(1.39,8.49) and 4.02(1.68,9.60), respectively); parents' knowledge on the sign and symptoms of DKA (AOR = 0.51[0.27, 0.95]); sign and symptoms of DKA before the onset of DKA (AOR = 0.35[0.21, 0.59]) and infection prior to DKA onset (AOR = 3.45[1.97, 6.04]). Conclusions The overall proportion of children diagnosed with DKA and new onset of T1D in Addis Ababa was high. In particular, children between 9-12 years of age and children whose parents did not know the sign and symptoms of DKA had a high risk of DKA at primary diag-nosis of T1D.	[Atkilt, Helen Siyoum] Bole Hlth Ctr, Addis Ababa, Ethiopia; [Turago, Muluken Gizaw] Univ Addis Ababa, Sch Publ Hlth, Dept Prevent Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Tegegne, Balewgizie Sileshi] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia	Addis Ababa University; Haramaya University	Atkilt, HS (corresponding author), Bole Hlth Ctr, Addis Ababa, Ethiopia.	helux24@gmail.com	Tegegne, Balewgizie Sileshi/K-6117-2016	Tegegne, Balewgizie Sileshi/0000-0001-9420-0043				Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Fantahun B., 2008, ETHIOP J PEDIAT CHIL, V4, P1; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Federation ID, 2013, IDF DIABETES ATLAS; Ibekwe MU, 2011, PEDIAT ONCALL, V8, P99; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Majaliwa E S, 2010, East Afr Med J, V87, P167; Marigliano M, 2013, EUR J ENDOCRINOL, V168, P107, DOI 10.1530/EJE-12-0541; Mbugua PK, 2005, E AFR MED J, V82; Murunga AN, 2013, TROP MED INT HEALTH, V18, P1357, DOI 10.1111/tmi.12195; Onyiriuka AN, 2013, J DIABETES METABOLIC, V12, P1; Razavi Zahra, 2010, Oman Med J, V25, P114, DOI 10.5001/omj.2010.31; Reddy Y, 2013, S AFR J CHILD HEALTH, V7, P46, DOI 10.7196/SAJCH.500; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, pd4092, DOI DOI 10.1136/BMJ.D4092; Van Zyl DG, 2008, S AFR FAM PRACT, V50, P35, DOI 10.1080/20786204.2008.10873664; Wilson J. F, 2010, ANN INTERN MED, V152, DOI DOI 10.7326/0003-4819-152-1-201001050-01001; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909; Zeitler P, 2015, PEDIATR DIABETES, V16, P392, DOI 10.1111/pedi.12239	19	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0169666	10.1371/journal.pone.0169666	http://dx.doi.org/10.1371/journal.pone.0169666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135278	Green Submitted, gold, Green Published			2022-12-26	WOS:000396124700004
J	Braune, K; Volkmer, I; Staege, MS				Braune, Katarina; Volkmer, Ines; Staege, Martin S.			Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; I-TASSER SERVER; ALSTROM-SYNDROME; PROTEIN-STRUCTURE; EXPRESSION; DISEASE; LINES; GENE; PREDICTION; CHILDHOOD	The Alstrom syndrome gene (ALMS1) is one of the largest disease associated genes identified today in the human genome and is implicated in cell cycle control, ciliogenesis, endosome recycling and intracellular transport mechanisms. ALMS1 mutations cause Alstrom syndrome, a rare genetic disorder. However, its function is not completely understood. DNA microarray analysis suggested that ALMS1 might be differentially expressed between Hodgkin lymphoma (HL) cells and normal tissues. By using reverse transcription-polymerase chain reaction (RT-PCR) we detected low but variable expression of ALMS1 in HL cell lines with highest expression in KM-H2 cells. Immunofluorescence indicated centrosomal accumulation of ALMS1 protein in HL cells. Knock-down of ALMS1 in KM-H2 cells had no impact on viability or cytotoxic drug sensitivity of these cells. Sequencing of RT-PCR products from HL cell lines identified three variable regions in ALMS1 transcripts that affect exons 2, 13, and 23. One of these variants was characterized by splicing out of exon 13. The other variants are characterized by two alternative 5 prime ends or alternative 3 prime ends. Structure prediction of the corresponding RNAs and proteins suggest that the different transcript variants might affect post-transcriptional regulation and ligand binding.	[Braune, Katarina; Volkmer, Ines; Staege, Martin S.] Martin Luther Univ Halle Wittenberg, Dept Pediat, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Pediat, Halle, Saale, Germany.	martin.staege@medizin.uni-halle.de	Braune, Katarina/AAC-1690-2019; Staege, Martin S/B-8885-2008; Staege, Martin/AAX-8994-2021	Braune, Katarina/0000-0001-6590-245X; Staege, Martin/0000-0003-3765-7068				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Satta M, 2015, APPL CLIN GENET, V8, P171, DOI 10.2147/TACG.S56612; Arya LS, 2005, INDIAN PEDIATR, V42, P1115; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Feuerborn A, 2006, LEUKEMIA LYMPHOMA, V47, P1932, DOI 10.1080/10428190600667721; Giefing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084928; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hoennscheidt C, 2009, SCAND J IMMUNOL, V70, P216, DOI 10.1111/j.1365-3083.2009.02286.x; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; KAMESAKI H, 1986, BLOOD, V68, P285; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Kochert K, 2011, ONCOGENE, V30, P1831, DOI 10.1038/onc.2010.544; Li G, 2007, PLOS GENET, V5, P3; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Liu TY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-32; Liu Y, 2014, LEUKEMIA, V28, P2248, DOI 10.1038/leu.2014.201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall JD, 2007, HUM MUTAT, V28, P1114, DOI 10.1002/humu.20577; Marshall JD, 2011, CURR GENOMICS, V12, P225, DOI 10.2174/138920211795677912; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Mauz-Korholz C, 2015, J CLIN ONCOL, V33, P2975, DOI 10.1200/JCO.2014.59.4853; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Orlov Yuriy L., 2007, In Silico Biology, V7, P241; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Purvis TL, 2010, GENE, V460, P20, DOI 10.1016/j.gene.2010.03.015; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	46	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170694	10.1371/journal.pone.0170694	http://dx.doi.org/10.1371/journal.pone.0170694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135309	Green Submitted, Green Published, gold			2022-12-26	WOS:000396124700018
J	Korenromp, EL; Wi, T; Resch, S; Stover, J; Broutet, N				Korenromp, Eline L.; Wi, Teodora; Resch, Stephen; Stover, John; Broutet, Nathalie			Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS INFECTIONS; HUMAN-PAPILLOMAVIRUS VACCINATION; MIDDLE-INCOME COUNTRIES; NONGONOCOCCAL URETHRITIS; MYCOPLASMA-GENITALIUM; SYNDROMIC MANAGEMENT; CHLAMYDIA-TRACHOMATIS; DISCHARGE SYNDROMES; CERVICAL-CANCER; SOUTH-AFRICA	Introduction In 2016 the World Health Assembly adopted the global strategy on Sexually Transmitted Infections (STI) 2016-2021 aiming to reduce curable STIs by 90% by 2030. We costed scaling -up priority interventions to coverage targets. Methods Strategy-targeted declines in Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum and Trichomonas vaginalis were applied to WHO -estimated regional burdens at 2012. Syndromic case management was costed for these curable STIs, symptomatic Herpes Simplex Virus 2 (HSV-2), and non-STI vaginal syndromes, with incrementally expanding etiologic diagnosis. Service unit costs were multiplied with clinic attendances and people targeted for screening or prevention, by income tier. Human papilloma virus (HPV) vaccination and screening were costed for coverage increasing to 60% of 10-year-old girls for vaccination, and 60% of women 30-49 years for twice -lifetime screening (including clinical follow-up for positive screens), by 2021. Results Strategy implementation will cost an estimated US$ 18.1 billion over 2016-2021 in 117 low and middle -income countries. Cost drivers are HPV vaccination ($3.26 billion) and screening ($3.69 billion), adolescent chlamydia screening ($2.54 billion), and antenatal syphilis screening ($1.4 billion). Clinical management of 18 million genital ulcers, 29-39 million urethral discharges and 42-53 million vaginal discharges annually will cost $3.0 billion, including $818 million for service delivery and $1.4 billion for gonorrhea and chlamydia testing. Global costs increase from $2.6 billion to $ 4.0 billion over 2016-2021, driven by HPV services scale -up, despite vaccine price reduction. Sub-Saharan Africa, bearing 40% of curable STI burdens, covers 44% of global service needs and 30% of cost, the Western Pacific 15% of burden/need and 26% of cost, South-East Asia 20% of burden/need and 18% of cost. Conclusions Costs of global STI control depend on price trends for HPV vaccines and chlamydia tests. Middle-income and especially low-income countries need increased investment, innovative financing, and synergizing with other health programs.	[Korenromp, Eline L.; Stover, John] Avenir Hlth, Geneva, Switzerland; [Korenromp, Eline L.; Stover, John] Avenir Hlth, Glastonbury, CT 06033 USA; [Wi, Teodora; Broutet, Nathalie] WHO, Geneva, Switzerland; [Resch, Stephen] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.; Korenromp, EL (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.	ekorenromp@avenirhealth.org						Alami K, 2002, East Mediterr Health J, V8, P794; [Anonymous], 2016, GUIDELINES TREATMENT; [Anonymous], 2015, WORLD POP PROSP 2015; Atun R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009656; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Bennani A, 2017, PLOS ONE UNPUB   JAN; Bollinger L, 2014, BACKGROUND PAPER UPD; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Campos NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164000; Campos NG, 2015, INT J CANCER, V137, P2208, DOI 10.1002/ijc.29594; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Novaes HMD, 2015, VACCINE, V33, pA135, DOI 10.1016/j.vaccine.2014.12.031; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; Horner P, 2013, SEX TRANSM INFECT, V89, pA23, DOI 10.1136/sextrans-2013-051184.0073; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Korenromp E, 2016, 21 INT AIDS SOC C JU; Korenromp EL, 2002, SEX TRANSM DIS, V29, P228, DOI 10.1097/00007435-200204000-00008; Korenromp EL, 2017, SEX TRANSM IN PRESS; Kularatne R, 2016, 17 IUSTI WORLD C MAY; Lewis DA, 2013, SEX TRANSM INFECT, V89, P523, DOI 10.1136/sextrans-2013-051049; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mahiane A G, TRENDS ADULT CHLA MY; Marrazzo JM, 2011, ANAEROBE, V17, P186, DOI 10.1016/j.anaerobe.2011.03.016; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Ng A, 2016, INT J STD AIDS, V27, P63, DOI 10.1177/0956462415571372; Pepin J, 2001, B WORLD HEALTH ORGAN, V79, P118; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Price MA, 2003, SEX TRANSM DIS, V30, P516, DOI 10.1097/00007435-200306000-00009; Rietmeijer KC, 2016, 17 IUSTI WORLD C MAY; Ryan CA, 1998, SEX TRANSM INFECT, V74, pS95; Samarawickrema NA, 2015, INT J STD AIDS, V26, P733, DOI 10.1177/0956462414552813; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sena AC, 2014, EXPERT REV ANTI-INFE, V12, P673, DOI 10.1586/14787210.2014.887440; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; STIGMA, 2019, GUID MAN SEX TRANSM; Stop TB Partnership UNOPS., 2015, THE PARADIGM SHIFT 2; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Stover J, 2014, JAIDS-J ACQ IMM DEF, V66, pS170, DOI 10.1097/QAI.0000000000000174; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Takuva S, 2014, SEX TRANSM DIS, V41, P706, DOI 10.1097/OLQ.0000000000000204; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS153, DOI 10.1097/01.olq.0000235177.30718.84; UNAIDS, 2015, UNAIDS STRAT 2016 20; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD POP PROSP 2012; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2015, GLOB TECHN STRAT MAL; Wi T, 2015, WORLD STI HIV C JOIN; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; WONG ES, 1988, J INFECT DIS, V158, P1098, DOI 10.1093/infdis/158.5.1098; World Health Organisation,, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2014, REP GLOB SEX TANSM I; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2012, INV CAS EL MOTH TO C; World Health Organization, 2007, 592006A5911 WHO WHA; World Health Organization, 2015, PROGR REP IMPL GLOB; World Health Organization, 2016, GUID TREATM CHALM TR; World Health Organization, 2015, WHOHTMTB201522; World Health Organization, 2012, GLOB ACT PLAN CONTR; World Health Organization, 2011, METH SURV MON COGN S	68	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170773	10.1371/journal.pone.0170773	http://dx.doi.org/10.1371/journal.pone.0170773			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129372	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400037
J	Pillai, SG; Zhu, PX; Siddappa, CM; Adams, DL; Li, SH; Makarova, OV; Amstutz, P; Nunley, R; Tang, CM; Watson, MA; Aft, RL				Pillai, Sreeraj G.; Zhu, Peixuan; Siddappa, Chidananda M.; Adams, Daniel L.; Li, Shuhong; Makarova, Olga V.; Amstutz, Pete; Nunley, Ryan; Tang, Cha-Mei; Watson, Mark A.; Aft, Rebecca L.			Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EXPRESSION; THERAPY; RELAPSE; SYSTEM; RISK; CTC	Purpose Molecular characterization of disseminated tumor cells (DTCs) in the bone marrow (BM) of breast cancer (BC) patients has been hindered by their rarity. To enrich for these cells using an antigen-independent methodology, we have evaluated a size-based microfiltration device in combination with several downstream biomarker assays. Methods BM aspirates were collected from healthy volunteers or BC patients. Healthy BM was mixed with a specified number of BC cells to calculate recovery and fold enrichment by microfiltration. Specimens were pre-filtered using a 70 pm mesh sieve and the effluent filtered through CellSieve microfilters. Captured cells were analyzed by immunocytochemistry (ICC), FISH for HER-2/neu gene amplification status, and RNA in situ hybridization (RISH). Cells eluted from the filter were used for RNA isolation and subsequent qRT-PCR analysis for DTC biomarker gene expression. Results Filtering an average of 14x106 nucleated BM cells yielded approximately 17-21x103 residual BM cells. In the BC cell spiking experiments, an average of 87% (range 84-92%) of tumor cells were recovered with approximately 170- to 400-fold enrichment. Captured BC cells from patients co-stained for cytokeratin and EpCAM, but not CD45 by ICC. RNA yields from 4 ml of patient BM after filtration averaged 135ng per 10 million BM cells filtered with an average RNA Integrity Number (RIN) of 5.3. DTC-associated gene expression was detected by both qRT-PCR and RISH in filtered spiked or BC patient specimens but, not in control filtered normal BM. Conclusions We have tested a microfiltration technique for enrichment of BM DTCs. DTC capture efficiency was shown to range from 84.3% to 92.1% with up to 400-fold enrichment using model BC cell lines. In patients, recovered DTCs can be identified and distinguished from normal BM cells using multiple antibody-, DNA-, and RNA-based biomarker assays.	[Pillai, Sreeraj G.; Siddappa, Chidananda M.; Aft, Rebecca L.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Zhu, Peixuan; Li, Shuhong] Creatv MicroTech Inc, Rockville, MD USA; [Adams, Daniel L.] Creatv MicroTech Inc, Monmouth Jct, NJ USA; [Makarova, Olga V.] Creatv MicroTech Inc, Chicago, IL USA; [Amstutz, Pete; Tang, Cha-Mei] Creatv MicroTech Inc, Potomac, MD USA; [Nunley, Ryan] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Watson, Mark A.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Aft, Rebecca L.] John Cochran Vet Adm Hosp, St Louis, MO 63106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Aft, RL (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.; Aft, RL (corresponding author), John Cochran Vet Adm Hosp, St Louis, MO 63106 USA.	aftr@wustl.edu	Pillai, Sreeraj G/M-2369-2013; mudalagiriyappa siddappa, chidananda/B-7851-2015	Pillai, Sreeraj G/0000-0002-0285-0813; mudalagiriyappa siddappa, chidananda/0000-0002-6942-6793	NIH [R01CA172623]; Maryland Technology Development Corporation (TEDCO) MTTCF award; U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency (DARPA) [W911NF-14-C-0098]; Creatv Microtech Inc.; NATIONAL CANCER INSTITUTE [R01CA172623] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Technology Development Corporation (TEDCO) MTTCF award; U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Creatv Microtech Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Grant NIH R01CA172623 (RA and MAW) and a Maryland Technology Development Corporation (TEDCO) MTTCF award and the U.S. Army Research Office (ARO) and the Defense Advanced Research Projects Agency (DARPA) (W911NF-14-C-0098). The content of the information does not necessarily reflect the position or the policy of the US Government. Creatv Microtech Inc. provided support in the form of salaries for authors PZ, DLA, SL, OVM, PA, and CMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DL, 2016, RSC ADV, V6, P6405, DOI 10.1039/c5ra21524b; Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Adams DL, 2015, CYTOM PART A, V87A, P137, DOI 10.1002/cyto.a.22613; Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324; Banys-Paluchowski M, 2016, CRIT REV ONCOL HEMAT, V97, P22, DOI 10.1016/j.critrevonc.2015.10.010; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Dolfus C, 2015, CHINESE J CANCER RES, V27, P479, DOI 10.3978/j.issn.1000-9604.2015.09.01; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; Ferreira MM, 2016, MOL ONCOL, V10, P374, DOI 10.1016/j.molonc.2016.01.007; Gabriel MT, 2016, CLIN CHEM, V62, P571, DOI 10.1373/clinchem.2015.249706; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gruber I, 2014, BREAST CANCER RES TR, V144, P353, DOI 10.1007/s10549-014-2853-6; Hartkopf AD, 2016, CANCER RES TREAT, V48, P115, DOI 10.4143/crt.2014.287; Hartkopf AD, 2014, EUR J CANCER, V50, P2550, DOI 10.1016/j.ejca.2014.06.025; Jager BAS, 2015, TRANSL ONCOL, V8, P509, DOI 10.1016/j.tranon.2015.11.009; Janni W., 2016, CLIN CANC RES; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Kasimir-Bauer S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26355; Kasimir-Bauer S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0679-3; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Krishnamurthy S, 2013, CANCER MED-US, V2, P226, DOI 10.1002/cam4.70; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Magbanua MJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141166; Makarova OV, 2016, MAT SCI ENG C-MATER, V66, P193, DOI 10.1016/j.msec.2016.04.075; Moller EK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00320; Naume B, 2014, J CLIN ONCOL, V32, P3848, DOI 10.1200/JCO.2014.56.9327; Pantel K, 2014, BONEKEY REP, V3; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Rack B, 2012, ARCH GYNECOL OBSTET, V285, P485, DOI 10.1007/s00404-011-1954-2; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ross JS, 2009, AM J CLIN PATHOL, V132, P237, DOI 10.1309/AJCPJI7DEOLKCS6F; Schindlbeck C, 2016, J CANC RES CLIN ONCO; Schindlbeck C, 2016, J CANCER RES CLIN, V29, P1; Schindlbeck C, 2008, CLIN EXP METASTAS, V25, P233, DOI 10.1007/s10585-007-9137-z; Schindlbeck C, 2013, J CANCER RES CLIN, V139, P1055, DOI 10.1007/s00432-013-1418-0; Siddappa CM, 2013, BREAST CANCER RES TR, V137, P45, DOI 10.1007/s10549-012-2279-y; Tachtsidis A, 2016, CLIN EXPT METASTASIS, P1; van Beem Rachel T, 2008, EuroIntervention, V4, P133; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Yoshioka T, 2011, INT ORTHOP, V35, P823, DOI 10.1007/s00264-010-1048-y	44	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170761	10.1371/journal.pone.0170761	http://dx.doi.org/10.1371/journal.pone.0170761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129357	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400038
J	Sengvilaipaseuth, O; Phommasone, K; de Lamballerie, X; Vongsouvath, M; Phonemixay, O; Blacksell, SD; Mayxay, M; Keomany, S; Souvannasing, P; Newton, PN; Dubot-Peres, A				Sengvilaipaseuth, Onanong; Phommasone, Koukeo; de Lamballerie, Xavier; Vongsouvath, Manivanh; Phonemixay, Ooyanong; Blacksell, Stuart D.; Mayxay, Mayfong; Keomany, Sommay; Souvannasing, Phoutthalavanh; Newton, Paul N.; Dubot-Peres, Audrey			Temperature of a Dengue Rapid Diagnostic Test under Tropical Climatic Conditions: A Follow Up Study	PLOS ONE			English	Article							HEAT-STABILITY; LAOS; INFECTION; ACCURACY; ASSAYS; FEVER; IGG; NS1	The Dengue Duo Rapid Diagnostic Test (SD Dengue RDT) has good specificity and sensitivity for dengue diagnosis in rural tropical areas. In a previous study, using four control sera, we demonstrated that that the diagnostic accuracy of these RDTs remains stable after longterm storage at high temperatures. We extended this study by testing sera from 119 febrile patients collected between July-November 2012 at Salavan Provincial Hospital (southern Laos) with RDTs stored for 6 months at 4 degrees C, 35 degrees and in a hut (miniature traditional house) at Lao ambient temperatures. The dengue NS1 antigen results from RDTs stored at 35 degrees C and in the hut demonstrated 100% agreement with those stored at 4 degrees C. However, lower positive percent agreements, with broad 95% CI, were observed for the tests: IgM, 60% (14.7-94.7) and 40% (5.3-85.3) for RDTs store at 35 degrees C and in the hut, compared to those stored at 4 degrees C, respectively. This study strenghtens the evidence of the robustness of the NS1 antigen detection RDT for the diagnosis of dengue after storage at tropical temperatures.	[Sengvilaipaseuth, Onanong; Phommasone, Koukeo; Vongsouvath, Manivanh; Phonemixay, Ooyanong; Blacksell, Stuart D.; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [de Lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, UMR EPV, EHESP, IRD 190,Inserm 1207, Marseille, France; [de Lamballerie, Xavier] Publ Hosp Marseille, AP HM, Inst Hosp Univ Mediterranee Infect, Marseille, France; [Blacksell, Stuart D.; Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Blacksell, Stuart D.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Keomany, Sommay; Souvannasing, Phoutthalavanh] Salavan Prov Hosp, Salavan Prov Hlth Dept, Vapi, Salavan Provinc, Laos	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Dubot-Peres, A (corresponding author), Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos.; Dubot-Peres, A (corresponding author), Aix Marseille Univ, UMR EPV, EHESP, IRD 190,Inserm 1207, Marseille, France.; Dubot-Peres, A (corresponding author), Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	audrey@tropmedres.ac	Blacksell, Stuart/D-5530-2018	Blacksell, Stuart/0000-0001-6576-726X; Newton, Paul/0000-0002-4608-6431	Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs	Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs	This work was supported by the Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs. Standard Diagnostics has no role in the planning, analysis, writing or decision to publish this paper.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Dubot-Peres A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002360; Food U., 2007, STAT GUID REP RES ST; Learmonth KM, 2011, T ROY SOC TROP MED H, V105, P388, DOI 10.1016/j.trstmh.2011.04.005; Mayxay M, 2015, AM J TROP MED HYG, V93, P517, DOI 10.4269/ajtmh.14-0772; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mikhail AFW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-169; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14; Peyerl-Hoffmann G, 2004, CLIN MICROBIOL INFEC, V10, P181, DOI 10.1111/j.1198-743x.2003.00854.x; Phommasone K, 2015, AM J TROP MED HYG, V93, P33, DOI 10.4269/ajtmh.15-0142; StataCorp L, 2007, STAT DAT AN STAT SOF; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170359	10.1371/journal.pone.0170359	http://dx.doi.org/10.1371/journal.pone.0170359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129346	Green Submitted, gold, Green Published			2022-12-26	WOS:000396211400058
J	Wagner, BD; Sontag, MK; Harris, JK; Miller, JI; Morrow, L; Robertson, CE; Stephens, M; Poindexter, BB; Abman, SH; Mourani, PM				Wagner, Brandie D.; Sontag, Marci K.; Harris, J. Kirk; Miller, Joshua I.; Morrow, Lindsey; Robertson, Charles E.; Stephens, Mark; Poindexter, Brenda B.; Abman, Steven H.; Mourani, Peter M.			Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; INFLAMMATION; PREVENTION; DIVERSITY; EXPOSURE; RISK	Preterm birth exposes the developing lung to an environment with direct exposure to bacteria, often facilitated by endotracheal intubation. Despite evidence linking bacterial infections to the pathogenesis of bronchopulmonary dysplasia (BPD), systematic studies of airway microbiota are limited. The objective was to identify specific patterns of the early respiratory tract microbiome from tracheal aspirates of mechanically ventilated preterm infants that are associated with the development and severity of BPD. Infants with gestational age <= 34 weeks, and birth weight 500-1250g were prospectively enrolled. Mechanically ventilated infants had tracheal aspirate samples collected at enrollment, 7, 14, and 21 days of age. BPD was determined by modified NIH criteria with oxygen reduction tests; infants without BPD were excluded due to low numbers. Aspirates were processed for bacterial identification by 16S rRNA sequencing, and bacterial load by qPCR. Cross-sectional analysis was performed using 7 day samples and longitudinal analysis was performed from subjects with at least 2 aspirates. Microbiome analysis was performed on tracheal aspirates from 152 infants (51, 49, and 52 with mild, moderate, and severe BPD, respectively). Seventy-nine of the infants were included in the cross-sectional analysis and 94 in the longitudinal. Shannon Diversity, bacterial load, and relative abundance of individual taxa were not strongly associated with BPD status. Longitudinal analysis revealed that preterm infants who eventually developed severe BPD exhibited greater bacterial community turnover with age, acquired less Staphylococcus in the first days after birth, and had higher initial relative abundance of Ureaplasma. In conclusion, longitudinal changes in the airway microbial communities of mechanically ventilated preterm infants may be associated with BPD severity, whereas cross-sectional analysis of airway ecology at 7 days of age did not reveal an association with BPD severity. Further evaluation is necessary to determine whether the observed longitudinal changes are causal or in response to clinical management or other factors that lead to BPD.	[Wagner, Brandie D.; Morrow, Lindsey] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat, Aurora, CO USA; [Wagner, Brandie D.; Harris, J. Kirk; Stephens, Mark; Abman, Steven H.] Univ Colorado, Dept Pediat, Sect Pulm, Aurora, CO USA; [Sontag, Marci K.; Miller, Joshua I.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Infect Dis Sect, Dept Med, Aurora, CO USA; [Poindexter, Brenda B.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Abman, Steven H.; Mourani, Peter M.] Univ Colorado, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80309 USA; [Mourani, Peter M.] Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO 80309 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mourani, PM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80309 USA.; Mourani, PM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO 80309 USA.	peter.mourani@childrenscolorado.org		Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121; Wagner, brandie/0000-0002-2745-0103; Sontag, Marci/0000-0003-2501-652X	Gerber Foundation; National Institute of Health/National Center Research Resources [K23RR021921]; National Institute of Health National Heart Lung Blood Institute [R01 HL085703]; National Institute of Health/National Center for Advancing Translational Sciences [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Gerber Foundation; National Institute of Health/National Center Research Resources; National Institute of Health National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health/National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by: Gerber Foundation, http://www.gerberfoundation.org; National Institute of Health/National Center Research Resources K23RR021921; National Institute of Health National Heart Lung Blood Institute R01 HL085703; National Institute of Health/National Center for Advancing Translational Sciences Grant Number UL1 TR000154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baier R John, 2003, BMC Pediatr, V3, P10, DOI 10.1186/1471-2431-3-10; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chuang GS, 2008, J AM ACAD DERMATOL, V59, P167, DOI 10.1016/j.jaad.2008.02.017; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Groneck P, 2001, PEDIATR PULM, V31, P331, DOI 10.1002/ppul.1055; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hiergeist A, 2016, INT J MED MICROBIOL, V306, P334, DOI 10.1016/j.ijmm.2016.03.005; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Jobe AH, 2001, RESP RES, V2, P27, DOI 10.1186/rr35; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; JONSSON B, 1994, ACTA PAEDIATR, V83, P927, DOI 10.1111/j.1651-2227.1994.tb13174.x; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kemp MW, 2016, AM J REPROD IMMUNOL; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Lyon AJ, 1998, ARCH DIS CHILD-FETAL, V78, pF10, DOI 10.1136/fn.78.1.F10; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC; Mourani PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025959; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pettigrew MM, 2011, J CLIN MICROBIOL, V49, P3750, DOI 10.1128/JCM.01186-11; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101	49	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170120	10.1371/journal.pone.0170120	http://dx.doi.org/10.1371/journal.pone.0170120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129336	gold, Green Submitted, Green Published			2022-12-26	WOS:000396211400062
J	Guan, Y; Wang, XD; Wong, MH; Sun, GP; An, TC; Guo, J; Zhang, GX				Guan, Ying; Wang, Xiaodong; Wong, Minghung; Sun, Guoping; An, Taicheng; Guo, Jun; Zhang, Guoxia			Evaluation of Genotoxic and Mutagenic Activity of Organic Extracts from Drinking Water Sources	PLOS ONE			English	Article							PEARL RIVER DELTA; ORGANOCHLORINE PESTICIDES OCPS; HOSPITAL WASTE-WATER; RISK-ASSESSMENT; SURFACE WATERS; SOS CHROMOTEST; SOUTH CHINA; SALMONELLA; SEDIMENTS; ESTUARY	An increasing number of industrial, agricultural and commercial chemicals in the aquatic environment lead to various deleterious effects on organisms, which is becoming a serious global health concern. In this study, the Ames test and SOS/umu test were conducted to investigate the potential genotoxicity and mutagenicity caused by organic extracts from drinking water sources. Organic content of source water was extracted with XAD-2 resin column and organic solvents. Four doses of the extract equivalent to 0.25, 0.5, 1 and 2L of source water were tested for toxicity. All the water samples were collected from six different locations in Guangdong province. The results of the Ames test and SOS/umu test showed that all the organic extracts from the water samples could induce different levels of DNA damage and mutagenic potentials at the dose of 2 L in the absence of S9 mix, which demonstrated the existence of genotoxicity and mutagenicity. Additionally, we found that Salmonella typhimurium strain TA98 was more sensitive for the mutagen. Correlation analysis between genotoxicity, Organochlorine Pesticides (OCPs) and Polycyclic Aromatic Hydrocarbons (PAHs) showed that most individual OCPs were frame shift toxicants in drinking water sources, and there was no correlation with total OCPs and PAHs.	[Guan, Ying; Zhang, Guoxia] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaodong] Jiangxi Acad Forestry, Nanchang, Jiangxi, Peoples R China; [Wong, Minghung] Hong Kong Baptist Univ, Croucher Inst Environm Sci, Hong Kong, Hong Kong, Peoples R China; [Wong, Minghung] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Sun, Guoping; Guo, Jun] Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Sun, Guoping; Guo, Jun] Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [An, Taicheng] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochemist, Protect, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Hong Kong Baptist University; Hong Kong Baptist University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Zhang, GX (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	guoxiazhang@126.com	Wong, Ming Hung/AAC-6507-2022	Wong, Ming Hung/0000-0001-5615-471X; Zhang, guo-xia Zhang/0000-0003-2530-3238	National Science Foundation of China [NSFC31500076]; Science and Technology Planning Project of Guangdong Province [2012B030800011]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201517]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; School of Public Health and Tropical Medicine of Southern Medical University, China	This work was supported by the National Science Foundation of China (NSFC31500076), www.nsfc.gov.cn; Science and Technology Planning Project of Guangdong Province (2012B030800011), www.gdstc.gov.cn; Grant from School of Public Health and Tropical Medicine of Southern Medical University, China (Grant No. GW201517), www.fimmu.com.	Aleem A, 2005, ECOTOX ENVIRON SAFE, V61, P404, DOI 10.1016/j.ecoenv.2004.09.001; de Lima ROA, 2007, MUTAT RES-GEN TOX EN, V626, P53, DOI 10.1016/j.mrgentox.2006.08.002; An TC, 2011, J ENVIRON MONITOR, V13, P1457, DOI 10.1039/c0em00542h; Arnaldos M, 2014, WATER RES C, V70C, P458; Chen GS, 2004, MUTAT RES-REV MUTAT, V567, P151, DOI 10.1016/j.mrrev.2004.08.005; Claxton LD, 1998, MUTAT RES-REV MUTAT, V410, P237, DOI 10.1016/S1383-5742(98)00008-8; Fang D, 2001, ENV MONIT CHINA, V17, P2; FILIPIC M, 1995, MUTAT RES-GENET TOX, V342, P1, DOI 10.1016/0165-1218(95)90084-5; Giuliani F, 1996, MUTAT RES-GENET TOX, V368, P49, DOI 10.1016/S0165-1218(96)90039-7; Guo LL, 2008, ENVIRON POLLUT, V152, P604, DOI 10.1016/j.envpol.2007.06.067; Guo Y, 2009, ENVIRON POLLUT, V157, P1753, DOI 10.1016/j.envpol.2008.12.026; Hartmann A, 1999, ARCH ENVIRON CON TOX, V36, P115, DOI 10.1007/s002449900449; Huang Q, 2014, ENVIRON MONIT ASSESS, V186, P247, DOI 10.1007/s10661-013-3370-5; ISO, 2000, 138292000 ISO; Jolibois B, 2003, CHEMOSPHERE, V51, P539, DOI 10.1016/S0045-6535(02)00867-6; LEGAULT R, 1994, ENVIRON TOXIC WATER, V9, P45, DOI 10.1002/tox.2530090107; Leite ACL, 2005, MUTAT RES-GEN TOX EN, V588, P166, DOI 10.1016/j.mrgentox.2005.10.006; Li HZ, 2011, CHEMOSPHERE, V82, P1373, DOI 10.1016/j.chemosphere.2010.11.074; Li YQ, 2006, J ENVIRON SCI-CHINA, V18, P983, DOI 10.1016/S1001-0742(06)60026-0; Liu XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144729; Luo QY, 2014, INT J CLIN EXP MED, V7, P4260; Maertens RM, 2008, ENVIRON SCI TECHNOL, V42, P1754, DOI 10.1021/es702448x; Mai BX, 2001, APPL GEOCHEM, V16, P1429; MEIER JR, 1985, J WATER POLLUT CON F, V57, P999; Gana JM, 2008, J HAZARD MATER, V155, P403, DOI 10.1016/j.jhazmat.2007.11.080; Ohe T, 2004, MUTAT RES-REV MUTAT, V567, P109, DOI 10.1016/j.mrrev.2004.08.003; Pan E, 2014, JUANGSU ZHONGHUA LIU, V35, P1105; Park JH, 2000, MUTAT RES-GEN TOX EN, V466, P173, DOI 10.1016/S1383-5718(00)00017-6; Penders EJM, 2003, UMU COMET ASSAY QUAL; Pereira Tda S, 2007, MUTAT RES, V629, P71, DOI [10.1016/j.mrgentox.2006.12.008, DOI 10.1016/J.MRGENTOX.2006.12.008]; PROBST GS, 1981, ENVIRON MUTAGEN, V3, P11, DOI 10.1002/em.2860030103; Qiao M, 2010, J ENVIRON MONITOR, V12, P1666, DOI 10.1039/c002019b; RAPPAPORT SM, 1979, ENVIRON SCI TECHNOL, V13, P957, DOI 10.1021/es60156a004; Rosenkranz HS, 1999, MUTAT RES-FUND MOL M, V431, P31, DOI 10.1016/S0027-5107(99)00155-4; Shen L, 2003, CHEMOSPHERE, V52, P1641, DOI 10.1016/S0045-6535(03)00504-6; SIMMON VF, 1979, J NATL CANCER I, V62, P893; Steger-Hartmann T, 1999, ECOTOX ENVIRON SAFE, V42, P274, DOI 10.1006/eesa.1998.1759; Sun HW, 2014, ENVIRON SCI POLLUT R, V21, P10083, DOI 10.1007/s11356-014-3031-4; Tang F, 1999, CHINA WATER WASTEWAT, V15, P20; Thomas KV, 2002, CHEMOSPHERE, V49, P247, DOI 10.1016/S0045-6535(02)00316-8; Vahl HH, 1997, MUTAT RES-GEN TOX EN, V394, P81, DOI 10.1016/S1383-5718(97)00129-0; Wang YP, 2001, CHINA PUBLIC HLTH, V17, P131; Waters M D, 1982, Basic Life Sci, V21, P275; Wei S, 2006, MAR POLLUT BULL, V52, P1682, DOI 10.1016/j.marpolbul.2006.06.009; White PA, 1998, MUTAT RES-REV MUTAT, V410, P223, DOI 10.1016/S1383-5742(98)00002-7; Wu JY, 2005, MAR POLLUT BULL, V50, P1661, DOI 10.1016/j.marpolbul.2005.07.001; Wu JY, 2008, ENVIRON MONIT ASSESS, V98, P225; [杨婉玲 Yang Wanling], 2015, [生态环境学报, Ecology and Environmental Sciences], V24, P831; Zhao ZH, 2010, MUTAT RES-GEN TOX EN, V696, P62, DOI 10.1016/j.mrgentox.2009.12.013; Zhou SH, 2005, 2005 REPORT STATE EN	50	13	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170454	10.1371/journal.pone.0170454	http://dx.doi.org/10.1371/journal.pone.0170454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125725	gold, Green Submitted, Green Published			2022-12-26	WOS:000396176100107
J	Fraile, JM; Manchado, E; Lujambio, A; Quesada, V; Campos-Iglesias, D; Webb, TR; Lowe, SW; Lopez-Otin, C; Freije, JMP				Fraile, Julia M.; Manchado, Eusebio; Lujambio, Amaia; Quesada, Victor; Campos-Iglesias, Diana; Webb, Thomas R.; Lowe, Scott W.; Lopez-Otin, Carlos; Freije, Jose M. P.			USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC LETHAL INTERACTIONS; UBIQUITIN-SPECIFIC PROTEASES; PRE-MESSENGER-RNA; THERAPEUTIC TARGET; MEK INHIBITION; RAS ONCOGENE; LUNG-CANCER; ADDICTION; CELLS; SPLICEOSOME	KRAS is the most frequently mutated oncogene in human cancer, but its therapeutic targeting remains challenging. Here, we report a synthetic lethal screen with a library of deubiquitinases and identify USP39, which encodes an essential splicing factor, as a critical gene for the viability of KRAS-dependent cells. We show that splicing fidelity inhibitors decrease preferentially the proliferation rate of KRAS-active cells. Moreover, depletion of DHX38, encoding an USP39-interacting splicing factor, also reduces the viability of these cells. In agreement with these results, USP39 depletion caused a significant reduction in pre-mRNA splicing efficiency, as demonstrated through RNAseq experiments. Furthermore, we show that USP39 is up-regulated in lung and colon carcinomas and its expression correlates with KRAS levels and poor clinical outcome. Accordingly, our work provides critical information for the development of splicing-directed antitumor treatments and supports the potential of USP39-targeting strategies as the basis of new anticancer therapies.	[Fraile, Julia M.; Quesada, Victor; Campos-Iglesias, Diana; Lopez-Otin, Carlos; Freije, Jose M. P.] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Fraile, Julia M.; Quesada, Victor; Lopez-Otin, Carlos; Freije, Jose M. P.] Ctr Invest Biomed Red Canc, Madrid, Spain; [Manchado, Eusebio; Lujambio, Amaia; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Webb, Thomas R.] SRI Int, Div Biosci, Menlo Pk, CA 94025 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Memorial Sloan Kettering Cancer Center; SRI International	Freije, JMP (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	jmpf@uniovi.es	López-Otín, Carlos/AAB-2106-2020; Quesada, Víctor/B-6557-2014; Freije, José M.P./A-6535-2008	López-Otín, Carlos/0000-0001-6964-1904; Quesada, Víctor/0000-0002-8398-3457; Freije, José M.P./0000-0002-4688-8266; Campos-Iglesias, Diana/0000-0002-7679-229X; Lujambio, Amaia/0000-0002-2798-1481	Principado de Asturias, Spain; National Institutes of Health Grant [CA140474]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP; NATIONAL CANCER INSTITUTE [R01CA140474] Funding Source: NIH RePORTER	Principado de Asturias, Spain; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III (CIBERONC, Plan Feder); Fundacion EDP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBERONC, Plan Feder), Fundacion EDP, and Principado de Asturias, Spain. The discovery and synthesis of sudemycin D1 and D6 were supported in part by National Institutes of Health Grant CA140474, the American Lebanese Syrian Associated Charities (ALSAC), and St. Jude Children's Research Hospital. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Costa-Cabral S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149099; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fraile JM, 2016, ONCOTARGET, V7, P74427, DOI 10.18632/oncotarget.12769; Fraile JM, 2013, ONCOTARGET, V4, P1919, DOI 10.18632/oncotarget.1303; Freije JMP, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00025; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hadjivassiliou H, 2014, RNA, V20, P656, DOI 10.1261/rna.042838.113; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/NCHEMBIO.1455, 10.1038/nchembio.1455]; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Pringle LM, 2012, ONCOGENE, V31, P3525, DOI 10.1038/onc.2011.520; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; 杨晓杰, 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P109	63	27	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4164	4175		10.1074/jbc.M116.762757	http://dx.doi.org/10.1074/jbc.M116.762757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28154181	Green Published, hybrid			2022-12-26	WOS:000404672500003
J	Baipluthong, B; Anekthananon, T; Munsakul, W; Jirajariyavej, S; Asavapiriyanont, S; Hancharoenkit, U; Roongpisuthipong, A; Pattanasin, S; Martin, M; Guntamala, L; Lolekha, R				Baipluthong, Benjamas; Anekthananon, Thanomsak; Munsakul, Warangkana; Jirajariyavej, Supunnee; Asavapiriyanont, Suvanna; Hancharoenkit, Ubonsri; Roongpisuthipong, Anuvat; Pattanasin, Sarika; Martin, Michael; Guntamala, Lisa; Lolekha, Rangsima			Implementation and assessment of a prevention with positives intervention among people living with HIV at five hospitals in Thailand	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; SEXUAL-BEHAVIOR; VIRAL LOAD; CARE; WOMEN; RISK; POPULATION; INDICATORS; PHYSICIAN	Background We implemented a hospital-based prevention with positives (PwP) intervention among people living with HIV (PLHIV) that included HIV transmission risk screening, short HIV prevention messages, family planning, HIV disclosure counseling, and partner HIV testing at five hospitals in Thailand. We assessed changes in sexual risk behaviors among PLHIV who received the PwP services at the hospitals. Methods From January 2008-March 2009, we systematically selected a subset of PLHIV receiving care at the five hospitals to offer participation in the PwP intervention. We collected demographic, risk behavior, and laboratory data using a standardized questionnaire. We analyzed data from PLHIV who completed at least four visits, using generalized estimating equations to identify baseline participant characteristics that were associated with adopting sexual practices less likely to be associated with HIV transmission during follow-up. Results A total of 830 PLHIV were interviewed and 756 (91.1%) completed four visits. The median age of these 756 participants was 37 years, 400 (52.9%) were women, and 475 (62.8%) had a steady partner. At baseline, 353 (74.3%) of the steady partners had been tested for HIV and 132 (37.4%) had tested negative. Among the 756 PLHIV, 427 (56.5%) reported having sex in the 3 months before enrollment and 413 (54.6%) in the 3 months before the fourth visit. The proportion reporting having vaginal or anal sex without a condom decreased from 20.8% at baseline to 5.1% at the fourth visit (p<0.001). Factors associated (p<0.05) with abstinence or 100% condom use at follow-up visits included: completing >= two visits, being diagnosed with HIV for longer than 3 months, and receiving HIV prevention messages from a doctor (versus a nurse or counselor). Conclusion Safe sex behaviors increased among PLHIV receiving PwP services, suggesting that expansion of hospital-based PwP services may reduce the number of new HIV infections in Thailand.	[Baipluthong, Benjamas; Pattanasin, Sarika; Martin, Michael; Lolekha, Rangsima] US Ctr Dis Control & Prevent, Div Global HIV & TB, Nonthaburi, Thailand; [Anekthananon, Thanomsak; Roongpisuthipong, Anuvat] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand; [Munsakul, Warangkana] Navamindharadhiraj Univ, Vajira Hosp, Fac Med, Bangkok, Thailand; [Jirajariyavej, Supunnee] Taksin Hosp, HIV Clin, Bangkok, Thailand; [Asavapiriyanont, Suvanna] Rajavithi Hosp, Obstet & Gynecol Unit, Bangkok, Thailand; [Hancharoenkit, Ubonsri] Wiang Pa Pao Hosp, HIV Clin, Chiang Rai, Thailand; [Guntamala, Lisa] Thailand Minist Publ Hlth, Dept Dis Control, Bur AIDS TB & STIs, Nonthaburi, Thailand	Mahidol University; Rajavithi Hospital; Ministry of Public Health - Thailand	Lolekha, R (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Nonthaburi, Thailand.	hpu8@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through CDC [3U19GH000004-03]	President's Emergency Plan for AIDS Relief (PEPFAR) through CDC	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through CDC under the terms of 3U19GH000004-03.	Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Asavapiriyanont S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-373; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baipluthong B, 2011, 10 INT C AIDS AS PAC; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fitzgerald DW, 2004, AIDS PATIENT CARE ST, V18, P658, DOI 10.1089/apc.2004.18.658; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Gilliam PP, 2009, J ASSOC NURSE AIDS C, V20, P92, DOI 10.1016/j.jana.2008.11.001; Guntamala L, 2011, 10 INT C AIDS AS PAC; Jones DL, 2006, AIDS CARE, V18, P629, DOI 10.1080/09540120500415371; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kidder DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057215; King-Spooner S, 1999, INT J STD AIDS, V10, P141, DOI 10.1258/0956462991913763; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Kuzoe-Liengme Bayi, 2010, Rev Med Suisse, V6, P714; Llabre MM, 2006, AIDS PATIENT CARE ST, V20, P701, DOI 10.1089/apc.2006.20.701; Lolekha R, 2008, GUIDELINES SETTING P; MacNeil JM, 1999, AIDS CARE, V11, P537, DOI 10.1080/09540129947695; Mark KE, 2007, J WOMENS HEALTH, V16, P1200, DOI 10.1089/jwh.2006.0238; Medley A, 2015, JAIDS-J ACQ IMM DEF, V68, pS286, DOI 10.1097/QAI.0000000000000520; MoH, 2014, NATL GUIDELINES MANA, V1st, P8; Munsakul W, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0123-2; Ngure K, 2009, AIDS, V23, pS89, DOI 10.1097/01.aids.0000363781.50580.03; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tunthanathip P, 2009, SEX TRANSM INFECT, V85, P36, DOI 10.1136/sti.2008.032532; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson IB, 2000, J ACQ IMMUN DEF SYND, V25, P417, DOI 10.1097/00126334-200012150-00006; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107652	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170558	10.1371/journal.pone.0170558	http://dx.doi.org/10.1371/journal.pone.0170558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158210	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700014
J	Patel, HN; Carroll, I; Lopez, R; Sankararaman, S; Etienne, C; Kodigala, SR; Paul, MR; Postma, HWC				Patel, Hirai N.; Carroll, Ian; Lopez, Rodolfo, Jr.; Sankararaman, Sandeep; Etienne, Charles; Kodigala, Subba Ramaiah; Paul, Mark R.; Postma, Henk W. Ch.			DNA-graphene interactions during translocation through nanogaps	PLOS ONE			English	Article							SOLID-STATE NANOPORES	We study how double-stranded DNA translocates through graphene nanogaps. Nanogaps are fabricated with a novel capillary-force induced graphene nanogap formation technique. DNA translocation signatures for nanogaps are qualitatively different from those obtained with circular nanopores, owing to the distinct shape of the gaps discussed here. Translocation time and conductance values vary by similar to 100%, which we suggest are caused by local gap width variations. We also observe exponentially relaxing current traces. We suggest that slow relaxation of the graphene membrane following DNA translocation may be responsible. We conclude that DNA-graphene interactions are important, and need to be considered for graphene-nanogap based devices. This work further opens up new avenues for direct read of single molecule activitities, and possibly sequencing.	[Patel, Hirai N.; Carroll, Ian; Lopez, Rodolfo, Jr.; Sankararaman, Sandeep; Etienne, Charles; Kodigala, Subba Ramaiah; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Paul, Mark R.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA	California State University System; California State University Northridge; Virginia Polytechnic Institute & State University	Postma, HWC (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Postma, Henk W.Ch./A-8770-2014; Paul, Mark/E-3567-2014; Patel, Hiral/AAC-8251-2021	Paul, Mark/0000-0002-0701-1955; Postma, Henk/0000-0003-4349-9406	National Science Foundation, USA [DMR-1034937]; National Science Foundation [DMR-1034937]	National Science Foundation, USA(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	H.W.Ch.P. gratefully acknowledges support from the National Science Foundation, USA, under award number DMR-1034937.; We acknowledge support from the National Science Foundation under award DMR-1034937. We thank Richard Kaner and Jaime Torres for discussions. We thank Cees Dekker and Greg Schneider for useful discussions and their hospitality while helping us learn their wedge-transfer technique.	Amorim RG, 2016, J PHYS CHEM C, V120, P19384, DOI 10.1021/acs.jpcc.6b04683; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Bundschuh R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208104; Fennouri A, 2012, ACS NANO, V6, P9672, DOI 10.1021/nn3031047; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; He H, 2008, J PHYS CHEM C, V112, P3456, DOI 10.1021/jp7115142; He YH, 2011, ADV FUNCT MATER, V21, P2674, DOI 10.1002/adfm.201002530; Heerema SJ, 2016, NAT NANOTECHNOL, V11, P127, DOI [10.1038/NNANO.2015.307, 10.1038/nnano.2015.307]; Held R, 1998, PHYSICA E, V2, P748, DOI 10.1016/S1386-9477(98)00153-2; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]; Kuan AT, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921620; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Muthukumar M, 2015, PHYS TODAY, V68, P40, DOI 10.1063/PT.3.2881; Paul MR, 2006, NANOTECHNOLOGY, V17, P4502, DOI 10.1088/0957-4484/17/17/037; Paul MR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.235501; Plesa C, 2016, NAT NANOTECHNOL, V11, P1093, DOI [10.1038/nnano.2016.153, 10.1038/NNANO.2016.153]; Postma HWC, 2010, NANO LETT, V10, P420, DOI 10.1021/nl9029237; Postma HWC, 2012, DAQ DATA ACQUISITION; Prasongkit J, 2011, NANO LETT, V11, P1941, DOI 10.1021/nl200147x; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Schneider GF, 2010, NANO LETT, V10, P1912, DOI 10.1021/nl1008037; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Wang HM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291110; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wei XD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205407; Yanagi I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05000; Zacharia R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155406; Zhao Q, 2007, NANO LETT, V7, P1680, DOI 10.1021/nl070668c	34	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171505	10.1371/journal.pone.0171505	http://dx.doi.org/10.1371/journal.pone.0171505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158244	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700087
J	Zhou, C; Wu, FR; Lu, LH; Wei, LP; Pai, E; Yao, Y; Song, YC				Zhou, Chao; Wu, Fangrui; Lu, Lianghao; Wei, Liping; Pai, Eric; Yao, Yuan; Song, Yongcheng			Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1	PLOS ONE			English	Article							LSD1; CANCER; LEUKEMIA; POTENT; METHYLATION	Post-translational modifications of histone play important roles in gene transcription. Aberrant methylation of histone lysine sidechains have been often found in cancer. Lysine specific demethylase 1 (LSD1), which can demethylate histone H3 lysine 4 (H3K4) and other proteins, has recently been found to be a drug target for acute myeloid leukemia. To understand structure activity/selectivity relationships of LSD1 inhibitors, several series of cyclopropylamine and related compounds were synthesized and tested for their activities against LSD1 and related monoamine oxidase (MAO) A and B. Several cyclopropylamine containing compounds were found to be highly potent and selective inhibitors of LSD1. A novel series cyclopropylimine compounds also exhibited strong inhibitory activity against LSD1. Structure activity relationships (SAR) of these compounds are discussed. Docking studies were performed to provide possible binding models of a representative compound in LSD1 and MAO-A. Moreover, these modeling studies can rationalize the observed SARs and selectivity.	[Zhou, Chao; Wu, Fangrui; Lu, Lianghao; Wei, Liping; Pai, Eric; Yao, Yuan; Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, 1 Baylor Pl, Houston, TX 77030 USA	Baylor College of Medicine	Song, YC (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Pl, Houston, TX 77030 USA.	ysong@bcm.edu	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		Cancer Prevention and Research Institute of Texas (CPRIT) [RP150129, RP140469]; National Institute of Neurological Disorders and Stroke (NINDS/NIH) [R01NS080963]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080963] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institute of Neurological Disorders and Stroke (NINDS/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants RP150129 and RP140469 from Cancer Prevention and Research Institute of Texas (CPRIT) and a grant (R01NS080963) from National Institute of Neurological Disorders and Stroke (NINDS/NIH) to Y.S.	Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Feng ZZ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0252-7; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hitchin JR, 2013, MEDCHEMCOMM, V4, P1513, DOI 10.1039/c3md00226h; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kutz CJ, 2014, MEDCHEMCOMM, V5, P1863, DOI 10.1039/c4md00283k; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Mould DP, 2015, MED RES REV, V35, P586, DOI 10.1002/med.21334; Neelamegam R, 2012, ACS CHEM NEUROSCI, V3, P120, DOI 10.1021/cn200104y; Prusevich P, 2014, ACS CHEM BIOL, V9, P1284, DOI 10.1021/cb500018s; Schrodinger LLC, 2016, SCHROD SUIT VERS 201; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Song YC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0279-9; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wu FR, 2016, J MED CHEM, V59, P253, DOI 10.1021/acs.jmedchem.5b01361; Zheng YC, 2013, J MED CHEM, V56, P8543, DOI 10.1021/jm401002r	28	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170301	10.1371/journal.pone.0170301	http://dx.doi.org/10.1371/journal.pone.0170301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158205	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700010
J	Gao, XL; Wu, JS; Cao, MX; Gao, SY; Cen, X; Jiang, YP; Wang, SS; Tang, YJ; Chen, QM; Liang, XH; Tang, YL				Gao, Xiao-lei; Wu, Jia-shun; Cao, Min-xin; Gao, Shi-yu; Cen, Xiao; Jiang, Ya-ping; Wang, Sha-sha; Tang, Ya-jie; Chen, Qian-ming; Liang, Xin-hua; Tang, Yaling			Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma	PLOS ONE			English	Article							CANCER-CELL INVASION; GLAND TUMORS; MIGRATION; METASTASIS; EXPRESSION; LUNG; DISSEMINATION; TRANSITIONS; PROGRESSION; EPITHELIUM	Collective invasion of cells plays a fundamental role in tissue growth, wound healing, immune response and cancer metastasis. This paper aimed to investigate cytokeratin-14 (CK14) expression and analyze its association with collective invasion in the invasive front of salivary adenoid cystic carcinoma (SACC) to uncover the role of collective invasion in SACC. Here, in the clinical data of 121 patients with SACC, the positive expression of CK14 was observed in 35/121(28.93%) of the invasive front of SACC. CK14 expression in the invasive front, local regional recurrence and distant metastasis were independent and significant prognostic factors in SACC patients. Then, we found that in an ex vivo 3D culture assay, CK14 siRNA receded the collective invasion, and in 2D monolayer culture, CK14 overexpression induced a collective SACC cell migration. These data indicated that the presence of characterized CK14+ cells in the invasive front of SACC promoted collective cell invasion of SACC and may be a biomarker of SACC with a worse prognosis.	[Gao, Xiao-lei; Wu, Jia-shun; Cao, Min-xin; Gao, Shi-yu; Cen, Xiao; Jiang, Ya-ping; Wang, Sha-sha; Chen, Qian-ming; Liang, Xin-hua; Tang, Yaling] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Peoples R China; [Tang, Ya-jie] Hubei Univ Technol, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China; [Liang, Xin-hua] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Peoples R China; [Tang, Yaling] Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu, Peoples R China	Sichuan University; Hubei University of Technology; Sichuan University; Sichuan University	Liang, XH; Tang, YL (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Peoples R China.; Liang, XH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Peoples R China.; Tang, YL (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu, Peoples R China.	lxh88866@scu.edu.cn; tangyaling@scu.edu.cn		Cen, Xiao/0000-0002-3959-1608	National Natural Science Foundation of China [81572650, 81372891, 81672672, 81361120399, 81621062]; Fundamental Research Funds of the Central Universities of China; State Key Laboratory of Oral Diseases Special Funded Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the Central Universities of China; State Key Laboratory of Oral Diseases Special Funded Projects	This study was supported by the National Natural Science Foundation of China (nos. 81572650, 81372891, 81672672, 81361120399, and 81621062); Fundamental Research Funds of the Central Universities of China (2015); State Key Laboratory of Oral Diseases Special Funded Projects 2016.	Bleaken BM, 2016, MOL BIOL CELL, V27, P451, DOI 10.1091/mbc.E15-09-0615; Chapnick DA, 2014, MOL BIOL CELL, V25, P1586, DOI 10.1091/mbc.E14-01-0697; Cheung KJ, 2016, SCIENCE, V352, P167, DOI 10.1126/science.aaf6546; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2014, CURR OPIN CELL BIOL, V30, P99, DOI 10.1016/j.ceb.2014.07.003; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GOLDBLATT LI, 1987, CANCER-AM CANCER SOC, V60, P74, DOI 10.1002/1097-0142(19870701)60:1<74::AID-CNCR2820600113>3.0.CO;2-B; Graves ML, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0670-4; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hart IR, 2009, J PATHOL, V219, P275, DOI 10.1002/path.2616; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Perez DED, 2006, ORAL ONCOL, V42, P139, DOI 10.1016/j.oraloncology.2005.06.024; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI [10.1146/annurev.cellbio.042308.113231, DOI 10.1146/ANNUREV.CELLBIO.042308.113231]; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; SEIFERT G, 1992, CANCER-AM CANCER SOC, V70, P379, DOI 10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C; Senft E, 2015, INT J ORAL SCI, V7, P18, DOI 10.1038/ijos.2014.28; SEQUEIROS SG, 2005, ACTA OTORRINOLARINGO, V56, P361; Southgate J, 1999, HISTOL HISTOPATHOL, V14, P657, DOI 10.14670/HH-14.657; Tang YL, 2015, ONCOTARGET, V6, P9031, DOI 10.18632/oncotarget.3320; Tang YL, 2014, ONCOTARGET, V5, P1491, DOI 10.18632/oncotarget.1606; Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubokawa F, 2002, PATHOL INT, V52, P286, DOI 10.1046/j.1440-1827.2002.01353.x; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wu JS, 2017, FUTURE ONCOL; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	33	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171341	10.1371/journal.pone.0171341	http://dx.doi.org/10.1371/journal.pone.0171341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152077	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200129
J	Kumar, A; Pandey, V; Singh, M; Pandey, D; Saharan, MS; Marla, SS				Kumar, Anil; Pandey, Vishakha; Singh, Manoj; Pandey, Dinesh; Saharan, M. S.; Marla, Soma S.			Draft genome sequence of Karnal bunt pathogen (Tilletia indica) of wheat provides insights into the pathogenic mechanisms of quarantined fungus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSPOSABLE ELEMENTS; ABC TRANSPORTERS; GENE PREDICTION; WEB SERVER; RNA GENES; EUKARYOTES; DATABASE; ANNOTATION; AUGUSTUS	Karnal bunt disease in wheat is caused by hemibiotrophic fungus, Tilletia indica that has been placed as quarantine pest in more than 70 countries. Despite its economic importance, little knowledge about the molecular components of fungal pathogenesis is known. In this study, first time the genome sequence of T. indica has been deciphered for unraveling the effectors' functions of molecular pathogenesis of Karnal bunt disease. The T. indica genome was sequenced employing hybrid approach of PacBio Single Molecule Real Time (SMRT) and Illumina HiSEQ 2000 sequencing platforms. The genome was assembled into 10,957 contigs (N50 contig length 3 kb) with total size of 26.7 Mb and GC content of 53.99%. The number of predicted putative genes were 11,535, which were annotated with Gene Ontology databases. Functional annotation of Karnal bunt pathogen genome and classification of identified effectors into protein families revealed interesting functions related to pathogenesis. Search for effectors' genes using pathogen host interaction database identified 135 genes. The T. indica genome sequence and putative genes involved in molecular pathogenesis would further help in devising novel and effective disease management strategies including development of resistant wheat genotypes, novel biomarkers for pathogen detection and new targets for fungicide development.	[Kumar, Anil; Pandey, Vishakha; Singh, Manoj; Pandey, Dinesh] GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India; [Saharan, M. S.] Indian Agr Res Inst, Div Plant Pathol, New Delhi, India; [Marla, Soma S.] Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi, India	Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Kumar, A (corresponding author), GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India.	ak_gupta2k@rediffmail.com	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022; Saharan, Mahender/AAI-9831-2020		Department of Biotechnology (Govt. of India), New Delhi [BT/PR/14987/AGR/2/914/2015]; G.B. Pant University of Agriculture and Technology, Pantnagar; Department of Biotechnology	Department of Biotechnology (Govt. of India), New Delhi(Department of Biotechnology (DBT) India); G.B. Pant University of Agriculture and Technology, Pantnagar; Department of Biotechnology	This work is funded by Department of Biotechnology (Govt. of India), New Delhi (BT/PR/14987/AGR/2/914/2015) and G.B. Pant University of Agriculture and Technology, Pantnagar.; This work is funded by G.B. Pant University of Agriculture and Technology, Pantnagar and Department of Biotechnology (Govt. of India), New Delhi (BT/PR/14987/AGR/2/914/2015). The support provided by Director of Experiment Station, G.B. Pant University of Agriculture and Technology, Pantnagar is thankfully acknowleged. The authors also acknowledge Department of Biotechnology, for providing fellowship to Vishakha Pandey as a DBT-JRF and Mr. Ashwani Kumar Mishra for the Next generation sequencing and assembly of the genome.	ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; [陈红伟 Chen Hongwei], 2014, [生物技术通报, Biotechnology Bulletin], P25; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deWaard MA, 1997, PESTIC SCI, V51, P271, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;271::AID-PS642&gt;3.0.CO;2-#; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fuentus DG, 1986, CAN J BOT, V8, P1712; Gao SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-627; Gill K. S., 1993, Karnal bunt and wheat production.; GOATES BJ, 1988, PHYTOPATHOLOGY, V78, P1434, DOI 10.1094/Phyto-78-1434; Gupta A. K., 2011, J PROTEOMIC BIOINFOR, V4, P160, DOI DOI 10.4172//JPB.1000185; Hood ME, 2005, GENETICS, V170, P1081, DOI 10.1534/genetics.105.042564; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kumar S., 2016, MOL BIOL EVOLUTION; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mitra M, 1931, ANN APPL BIOL, V18, P178, DOI 10.1111/j.1744-7348.1931.tb02294.x; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Que YX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-996; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Roohparvar R, 2007, FUNGAL GENET BIOL, V44, P378, DOI 10.1016/j.fgb.2006.09.007; Rush CM, 2005, PLANT DIS, V89, P212, DOI 10.1094/PD-89-0212; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh D. V., 2005, Indian Phytopathology, V58, P1; Smit A, 1996, REPEATMASKER OPEN 30; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; WARHAM EJ, 1986, TROP PEST MANAGE, V32, P229; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yang S, 2009, STRUCTURAL BIOINFORM, P561; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	42	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171323	10.1371/journal.pone.0171323	http://dx.doi.org/10.1371/journal.pone.0171323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152050	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200127
J	Lacoste, B; Raymond, VA; Cassim, S; Lapierre, P; Bilodeau, M				Lacoste, Benoit; Raymond, Valerie-Ann; Cassim, Shamir; Lapierre, Pascal; Bilodeau, Marc			Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; IN-VIVO; EXPRESSION DEFINES; EP-CAM; EPCAM; ACTIVATION; ADHESION; CARCINOGENESIS; TRANSFORMATION; POPULATION	There are limited numbers of models to study hepatocellular carcinoma (HCC) in vivo in immunocompetent hosts. In an effort to develop a cell line with improved tumorigenicity, we derived a new cell line from Hepa1-6 cells through an in vivo passage in C57BL/6 mice. The resulting Dt81Hepa1-6 cell line showed enhanced tumorigenicity compared to Hepa16 with more frequent (28 +/- 12 vs. 0 +/- 0 lesions at 21 days) and more rapid tumor development (21 (100%) vs. 70 days (10%)) in C57BL/6 mice. The minimal Dt81Hepa1-6 cell number required to obtain visible tumors was 100,000 cells. The Dt81Hepa1-6 cell line showed high hepatotropism with subcutaneous injection leading to liver tumors without development of tumors in lungs or spleen. In vitro, Dt81Hepa1-6 cells showed increased anchorage-independent growth (34.7 +/- 6.8 vs. 12.3 +/- 3.3 colonies; P<0.05) and increased EpCAM (8.7 +/- 1.1 folds; P<0.01) and beta-catenin (5.4 +/- 1.0 folds; P<0.01) expression. A significant proportion of Dt81Hepa1-6 cells expressed EpCAM compared to Hepa1-6 (34.8 +/- 1.1% vs 0.9 +/- 0.13%; P<0.001). Enriched EpCAM(+) Dt81Hepa1-6 cells led to higher tumor load than EpCAM -Dt81Hepa1-6 cells (1093 +/- 74 vs 473 +/- 100 tumors; P<0.01). The in vivo selected Dt81Hepa1-6 cell line shows high liver specificity and increased tumorigenicity compared to Hepa1-6 cells. These properties are associated with increased expression of EpCAM and beta-catenin confirming that EpCAM(+) HCC cells comprise a subset with characteristics of tumor-initiating cells with stem/progenitor cell features. The Dt81Hepa1-6 cell line with its cancer stem cell-like properties will be a useful tool for the study of hepatocellular carcinoma in vivo.	[Lacoste, Benoit; Raymond, Valerie-Ann; Cassim, Shamir; Lapierre, Pascal; Bilodeau, Marc] CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada; [Lapierre, Pascal; Bilodeau, Marc] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Bilodeau, M (corresponding author), CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada.	marc.bilodeau@umontreal.ca	Bilodeau, Marc/L-2822-2017; Lapierre, Pascal/ABD-2247-2021	Lapierre, Pascal/0000-0002-2753-3566; Cassim, Shamir/0000-0003-1072-5868				Blonski W, 2010, WORLD J GASTROENTERO, V16, P3603, DOI 10.3748/wjg.v16.i29.3603; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Boterberg T, 2001, Methods Mol Med, V58, P33, DOI 10.1385/1-59259-137-X:033; Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chen Y, 2012, INT J BIOL SCI, V8, P992, DOI 10.7150/ijbs.4454; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ethier C, 2003, AM J PHYSIOL-GASTR L, V285, pG298, DOI 10.1152/ajpgi.00040.2003; Figueiredo ML, 2010, HEPATOLOGY, V52, P634, DOI 10.1002/hep.23682; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Qian YW, 2012, GASTROENTEROLOGY, V142, P1547, DOI 10.1053/j.gastro.2012.02.042; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SUGDEN B, 1977, J VIROL, V23, P503, DOI 10.1128/JVI.23.3.503-508.1977; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Takata M, 2007, CELL COMMUN ADHES, V14, P157, DOI 10.1080/15419060701557859; Vineis P, 2010, CARCINOGENESIS, V31, P1703, DOI 10.1093/carcin/bgq087; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; Whiteside TL, 2011, B CANCER, V98, pE25, DOI 10.1684/bdc.2010.1294; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Xie C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040607; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Zhou JJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-112	43	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171215	10.1371/journal.pone.0171215	http://dx.doi.org/10.1371/journal.pone.0171215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152020	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200105
J	Mosites, E; Sammons, M; Otiang, E; Eng, A; Noecker, C; Manor, O; Hilton, S; Thumbi, SM; Onyango, C; Garland-Lewis, G; Call, DR; Njenga, MK; Wasserheit, JN; Zambriski, JA; Walson, JL; Palmer, GH; Montgomery, J; Borenstein, E; Omore, R; Rabinowitz, PM				Mosites, Emily; Sammons, Matt; Otiang, Elkanah; Eng, Alexander; Noecker, Cecilia; Manor, Ohad; Hilton, Sarah; Thumbi, Samuel M.; Onyango, Clayton; Garland-Lewis, Gemina; Call, Douglas R.; Njenga, M. Kariuki; Wasserheit, Judith N.; Zambriski, Jennifer A.; Walson, Judd L.; Palmer, Guy H.; Montgomery, Joel; Borenstein, Elhanan; Omore, Richard; Rabinowitz, Peter M.			Microbiome sharing between children, livestock and household surfaces in western Kenya	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; COMMUNITIES; IMPACT; AGE	The gut microbiome community structure and development are associated with several health outcomes in young children. To determine the household influences of gut microbiome structure, we assessed microbial sharing within households in western Kenya by sequencing 16S rRNA libraries of fecal samples from children and cattle, cloacal swabs from chickens, and swabs of household surfaces. Among the 156 households studied, children within the same household significantly shared their gut microbiome with each other, although we did not find significant sharing of gut microbiome across host species or household surfaces. Higher gut microbiome diversity among children was associated with lower wealth status and involvement in livestock feeding chores. Although more research is necessary to identify further drivers of microbiota development, these results suggest that the household should be considered as a unit. Livestock activities, health and microbiome perturbations among an individual child may have implications for other children in the household.	[Mosites, Emily; Garland-Lewis, Gemina; Rabinowitz, Peter M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Mosites, Emily; Sammons, Matt; Thumbi, Samuel M.; Call, Douglas R.; Njenga, M. Kariuki; Zambriski, Jennifer A.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Otiang, Elkanah; Onyango, Clayton; Omore, Richard] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Eng, Alexander; Noecker, Cecilia; Manor, Ohad; Hilton, Sarah; Borenstein, Elhanan] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wasserheit, Judith N.; Walson, Judd L.; Rabinowitz, Peter M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Wasserheit, Judith N.; Walson, Judd L.] Univ Washington, Dept Med, Seattle, WA USA; [Wasserheit, Judith N.; Walson, Judd L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Montgomery, Joel] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rabinowitz, Peter M.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington State University; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; The Santa Fe Institute; University of Washington; University of Washington Seattle	Garland-Lewis, G (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gemina@uw.edu	Walson, Judd/R-7269-2019; Mwangi, Thumbi/L-2216-2019; Noecker, Cecilia/AAF-3859-2020; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Mwangi, Thumbi/0000-0002-5754-0556; Hilton, Sarah/0000-0001-9278-3644; Noecker, Cecilia/0000-0003-1417-2383; Mosites, Emily/0000-0002-2968-9564	Bill and Melinda Gates Foundation: Grand Challenges Explorations [OPP1098757]; NIH post-doctoral fellowship [NIH T32 AI07025]; Washington State University, College of Veterinary Medicine, Summer Research Scholars Program; UW Center for One Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation: Grand Challenges Explorations(Bill & Melinda Gates Foundation); NIH post-doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State University, College of Veterinary Medicine, Summer Research Scholars Program; UW Center for One Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation: Grand Challenges Explorations Grant Number OPP1098757. http://gcgh.grandchallenges.org/about. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from an NIH post-doctoral fellowship (NIH T32 AI07025) for author EM. https://researchtraining.nih.gov/programs/training-grants/T32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Washington State University, College of Veterinary Medicine, Summer Research Scholars Program (internal) provided support for author MS. http://www.vetmed.wsu.edu/research/student-research/research-scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UW Center for One Health Research (internal, supplemental) also provided support. http.//deohs.washington.edu/cohr/. Author PR is the director of the Center for One Health Research and played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Supplemental funding was provided by the Center only to complete additional data analysis.	Althani A., 2015, J CELLULAR PHYSL; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Bendtsen KM, 2015, INFLUENCE YOUNG MI C; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chong CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13338; D'Argenio V, 2015, CLIN CHIM ACTA, V451, P97, DOI 10.1016/j.cca.2015.01.003; Dai J, 2015, BIORESOURCE TECHNOL, V175, P23, DOI 10.1016/j.biortech.2014.10.049; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2; Hedin CR, 2014, GUT; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Knip M, 2016, NATURE REV ENDOCRINO; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludvigsen J, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00016; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Moeller AH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500997; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oakley BB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00011; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Probst M, 2015, APPL MICROBIOL BIOT, V99, P3029, DOI 10.1007/s00253-015-6414-7; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ruiz-Calderon JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501061; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Seppanen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062662; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Tung J., 2015, ELIFE, V4; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13	44	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171017	10.1371/journal.pone.0171017	http://dx.doi.org/10.1371/journal.pone.0171017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152044	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200073
J	Rogers, NT; Marshall, A; Roberts, CH; Demakakos, P; Steptoe, A; Scholes, S				Rogers, Nina T.; Marshall, Alan; Roberts, Chrissy H.; Demakakos, Panayotes; Steptoe, Andrew; Scholes, Shaun			Physical activity and trajectories of frailty among older adults: Evidence from the English Longitudinal Study of Ageing	PLOS ONE			English	Article							BODY-COMPOSITION; ELDERLY-PEOPLE; DISABILITY; EXERCISE; AGE; METAANALYSIS; AMERICANS; LIFE; HOME; US	Background Frail older adults are heavy users of health and social care. In order to reduce the costs associated with frailty in older age groups, safe and cost-effective strategies are required that will reduce the incidence and severity of frailty. Objective We investigated whether self-reported intensity of physical activity (sedentary, mild, moderate or vigorous) performed at least once a week can significantly reduce trajectories of frailty in older adults who are classified as non-frail at baseline (Rockwood's Frailty Index [FI] <= 0.25). Methods Multi-level growth curve modelling was used to assess trajectories of frailty in 8649 non-frail adults aged 50 and over and according to baseline self-reported intensity of physical activity. Frailty was measured in five-year age cohorts based on age at baseline (50-54; 55-59; 60-64; 65-69; 70-74; 75-79; 80+) on up to 6 occasions, providing an average of 10 years of follow-up. All models were adjusted for baseline sex, education, wealth, cohabitation, smoking, and alcohol consumption. Results Compared with the sedentary reference group, mild physical activity was insufficient to significantly slow the progression of frailty, moderate physical activity reduced the progression of frailty in some age groups (particularly ages 65 and above) and vigorous activity significantly reduced the trajectory of frailty progression in all older adults. Conclusion Healthy non-frail older adults require higher intensities of physical activity for continued improvement in frailty trajectories.	[Rogers, Nina T.; Demakakos, Panayotes; Steptoe, Andrew; Scholes, Shaun] UCL, Dept Epidemiol & Publ Hlth, London, England; [Marshall, Alan] Univ St Andrews, Dept Geog & Sustainable Dev, Irvine Bldg, St Andrews, Fife, Scotland; [Roberts, Chrissy H.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London, England	University of London; University College London; University of St Andrews; University of London; London School of Hygiene & Tropical Medicine	Rogers, NT (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	n.rogers@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019	Marshall, Alan/0000-0003-0971-829X; Roberts, Chrissy h./0000-0003-1064-5980; Rogers, Nina/0000-0003-1857-2122; Demakakos, Panayotes/0000-0002-7663-2122; Scholes, Shaun/0000-0002-7865-5264	National Institute on Aging in the United States [2R01AG7644-01A1, 2R01AG017644, 2R01AG764401A1]; UK government departments; ESRC [ES/K007394/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK government departments; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. The data were made available through the UK Data Archive. The English Longitudinal Study of Ageing (ELSA) was developed by a team of researchers based at University College London, the Institute of Fiscal Studies and the National Centre for Social Research.The work was supported by the National Institute on Aging in the United States (grants 2RO1AG764401A1 and 2RO1AG017644) and a consortium of UK government departments. The funders had no role in the study design; in the collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the paper for publication. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here.	Binder EF, 2005, J GERONTOL A-BIOL, V60, P1425, DOI 10.1093/gerona/60.11.1425; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cooper C, 2016, AGE AGEING, V45, P148, DOI [10.1093/ageing/afu148, 10.1093/ageing/afv154]; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Department of Health, 2011, START ACT STAY ACT R; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Henry KD, 1999, PHYS THER, V79, P270, DOI 10.1093/ptj/79.3.270; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS; Marshall A, 2015, J EPIDEMIOL COMMUN H, V69, P316, DOI 10.1136/jech-2014-204655; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Peterson MJ, 2009, J GERONTOL A-BIOL, V64, P61, DOI 10.1093/gerona/gln001; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Samper-Ternent R, 2012, J AGING HEALTH, V24, P641, DOI 10.1177/0898264311428490; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; Smith L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007423; Soong J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008456; Sourial N, 2012, J GERONTOL A-BIOL, V67, P1197, DOI 10.1093/gerona/gls084; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P647, DOI 10.1016/j.jclinepi.2009.08.007; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Tribess S, REV ASS MED BRAS, V58, P341; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102	32	72	72	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170878	10.1371/journal.pone.0170878	http://dx.doi.org/10.1371/journal.pone.0170878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152084	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396161200054
J	Tanveer, A; Hayat, T; Alsaedi, A; Ahmad, B				Tanveer, Anum; Hayat, T.; Alsaedi, A.; Ahmad, B.			Numerical simulation for peristalsis of Carreau-Yasuda nanofluid in curved channel with mixed convection and porous space	PLOS ONE			English	Article							TAPERED ASYMMETRIC CHANNEL; RADIAL MAGNETIC-FIELD; CHEMICAL-REACTION; PSEUDOPLASTIC NANOFLUID; HEAT-TRANSFER; MASS-TRANSFER; FLOW; FLUID; TRANSPORT; VELOCITY	Main theme of present investigation is to model and analyze the peristaltic activity of Carraeu-Yasuda nanofluid saturating porous space in a curved channel. Unlike the traditional approach, the porous medium effects are characterized by employing modified Darcy's law for Carreau-Yasuda fluid. To our knowledge this is first attempt in this direction for Carreau-Yasuda fluid. Heat and mass transfer are further considered. Simultaneous effects of heat and mass transfer are examined in presence of mixed convection, viscous dissipation and thermal radiation. The compliant characteristics for channel walls are taken into account. The resulting complex mathematical system has been discussed for small Reynolds number and large wavelength concepts. Numerical approximation to solutions are thus plotted in graphs and the physical description is presented. It is concluded that larger porosity in a medium cause an enhancement in fluid velocity and reduction in concentration.	[Tanveer, Anum; Hayat, T.] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.; Ahmad, B.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	anum@math.qau.edu.pk	Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013; Ahmad, Bashir/B-1977-2012	Alsaedi, Ahmed/0000-0003-3452-8922; Ahmad, Bashir/0000-0001-5350-2977				Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Ali N, 2016, INT J HEAT MASS TRAN, V94, P500, DOI 10.1016/j.ijheatmasstransfer.2015.11.066; Annimasun I. L., ALEX ENG J; [Anonymous], [No title captured]; Babu MJ, 2016, INT J ENG RES AFR, V25, P58, DOI 10.4028/www.scientific.net/JERA.25.58; Bhatti MM, 2016, J MOL LIQ, V218, P240, DOI 10.1016/j.molliq.2016.02.066; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Buongiorno J., 2005, P ICAPP 05 SEOUL, V5, P15; Chamkha A.J., 2016, J MAGN MAGN MATER, V406, P266, DOI [10.1016/j.jmmm.2016.01.039, DOI 10.1016/J.JMMM.2016.01.039]; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; Hayat T, 2016, J MOL LIQ, V223, P469, DOI 10.1016/j.molliq.2016.08.067; Hayat T, 2016, J MOL LIQ, V221, P434, DOI 10.1016/j.molliq.2016.05.072; Hayat T, 2016, J MOL LIQ, V220, P693, DOI 10.1016/j.molliq.2016.04.123; Hayat T, 2016, J MAGN MAGN MATER, V412, P207, DOI 10.1016/j.jmmm.2016.03.046; Hayat T, 2016, J MAGN MAGN MATER, V408, P168, DOI 10.1016/j.jmmm.2016.02.044; Hayat T, 2016, INT J HEAT MASS TRAN, V96, P474, DOI 10.1016/j.ijheatmasstransfer.2016.01.055; Hayat T, 2016, J MAGN MAGN MATER, V407, P321, DOI 10.1016/j.jmmm.2016.02.020; Hayat T, 2014, APPL BIONICS BIOMECH, V11, P221, DOI 10.1155/2014/385821; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156995; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148002; Hayat T, 2016, J MAGN MAGN MATER, V403, P47, DOI 10.1016/j.jmmm.2015.11.078; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Hina S, 2016, INT J HEAT MASS TRAN, V101, P156, DOI 10.1016/j.ijheatmasstransfer.2016.05.034; Kothandapani M, 2015, INT J HEAT MASS TRAN, V81, P234, DOI 10.1016/j.ijheatmasstransfer.2014.09.062; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Narla VK, 2015, PROCEDIA ENGINEER, V127, P869, DOI 10.1016/j.proeng.2015.11.424; Raju CSK, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16267-3; Raju C.S.K., J MOL LIQ; Raju C.S. K., J MAGN MAGN MAT; Selimefendigil F, 2016, INT J HEAT MASS TRAN, V98, P40, DOI 10.1016/j.ijheatmasstransfer.2016.02.092; Selimefendigil F, 2016, J THERM SCI ENG APPL, V8, DOI 10.1115/1.4032760; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Thiel GP, 2016, J HEAT TRANS-T ASME, V138, DOI 10.1115/1.4034055; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170029	10.1371/journal.pone.0170029	http://dx.doi.org/10.1371/journal.pone.0170029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151968	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200012
J	Wu, LL; Ouyang, Q; Wang, HL				Wu, Lili; Ouyang, Qi; Wang, Hongli			Robust network topologies for generating oscillations with temperature-independent periods	PLOS ONE			English	Article							ARABIDOPSIS CIRCADIAN CLOCK; ESCHERICHIA-COLI; THERMAL ROBUSTNESS; MOLECULAR-BASES; FEEDBACK LOOPS; COMPENSATION; DROSOPHILA; RHYTHMS; MODEL; TIME	Nearly all living systems feature a temperature-independent oscillation period in circadian clocks. This ubiquitous property occurs at the system level and is rooted in the network architecture of the clock machinery. To investigate the mechanism of this prominent property of the circadian clock and provide general guidance for generating robust genetic oscillators with temperature-compensated oscillations, we theoretically explored the design principle and core network topologies preferred by oscillations with a temperature-independent period. By enumerating all topologies of genetic regulatory circuits with three genes, we obtained four network motifs, namely, a delayed negative feedback oscillator, repressilator, activator-inhibitor oscillator and substrate-depletion oscillator; hybrids of these motifs constitute the vast majority of target network topologies. These motifs are biased in their capacities for achieving oscillations and the temperature sensitivity of the period. The delayed negative feedback oscillator and repressilator are more robust for oscillations, whereas the activator-inhibitor and substrate-depletion oscillators are superior for maintaining a temperature-independent oscillation period. These results suggest that thermally robust oscillation can be more plausibly achieved by hybridizing these two categories of network motifs. Antagonistic balance and temperature insulation mechanisms for achieving temperature compensation are typically found in these topologies with temperature robustness. In the temperature insulation approach, the oscillation period relies on very few parameters, and these parameters are influenced only slightly by temperature. This approach prevents the temperature from affecting the oscillation period and generates circadian rhythms that are robust against environmental perturbations.	[Wu, Lili; Ouyang, Qi; Wang, Hongli] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China; [Ouyang, Qi; Wang, Hongli] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [Ouyang, Qi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Wang, HL (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China.	hlwang@pku.edu.cn			Ministry of Science and Technology of China [2015CB910301, 2012AA02A702]; National Natural Science Foundation of China [11174013, 11434001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by Ministry of Science and Technology of China (2015CB910301 to H.W. and 2012AA02A702 to Q.O.) and National Natural Science Foundation of China grants (11174013 to H.W. and 11434001 to Q.O.).	Alon U., 2006, INTRO SYSTEMS BIOL D; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bodenstein C, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/3/036011; Bodenstein C, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/056007; Cassone VM, 2014, FRONT NEUROENDOCRIN, V35, P76, DOI 10.1016/j.yfrne.2013.10.002; Castillo-Hair Sebastian M, 2015, Syst Synth Biol, V9, P125, DOI 10.1007/s11693-015-9178-6; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Denlinger D. L., 2001, INSECT TIMING CIRCAD; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; Hatakeyama TS, 2012, P NATL ACAD SCI USA, V109, P8109, DOI 10.1073/pnas.1120711109; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hong CI, 1997, CHRONOBIOL INT, V14, P521, DOI 10.3109/07420529709001473; Hussain F, 2014, P NATL ACAD SCI USA, V111, P972, DOI 10.1073/pnas.1316298111; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Iman R.L, 1980, LATIN HYPERCUBE SAMP; Kidd PB, 2015, P NATL ACAD SCI USA, V112, pE6284, DOI 10.1073/pnas.1511215112; Kurosawa G, 2005, J THEOR BIOL, V233, P453, DOI 10.1016/j.jtbi.2004.10.012; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lim WA, 2013, MOL CELL, V49, P202, DOI 10.1016/j.molcel.2012.12.020; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marland E, 2002, COMPUTATIONAL CELL B; McClung CR, 2007, P NATL ACAD SCI USA, V104, P16727, DOI 10.1073/pnas.0708757104; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Ruoff P, 2005, J THEOR BIOL, V237, P41, DOI 10.1016/j.jtbi.2005.03.030; Ruoff P, 2003, BIOPHYS CHEM, V106, P179, DOI 10.1016/S0301-4622(03)00191-1; Ruoff P, 1997, CHRONOBIOL INT, V14, P499, DOI 10.3109/07420529709001471; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; RUOFF P, 1992, J INTERDISCIPL CYCLE, V23, P92, DOI 10.1080/09291019209360133; Ruoff P, 2007, FEBS J, V274, P940, DOI 10.1111/j.1742-4658.2007.05641.x; Shah NA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002085; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimizu H, 2014, CELL, V157, P1160, DOI 10.1016/j.cell.2014.03.050; Takeuchi T, 2007, J THEOR BIOL, V246, P195, DOI 10.1016/j.jtbi.2006.12.028; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; YAN L, 2012, PLOS ONE, V0007; Yun HS, 1996, BIOTECHNOL BIOENG, V52, P615, DOI 10.1002/(SICI)1097-0290(19961205)52:5<615::AID-BIT9>3.0.CO;2-M	55	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171263	10.1371/journal.pone.0171263	http://dx.doi.org/10.1371/journal.pone.0171263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152061	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200120
J	Zhu, Y; Kawaguchi, K; Kiyama, R				Zhu, Yun; Kawaguchi, Kayoko; Kiyama, Ryoiti			Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; DNA MICROARRAY; ENTEROLACTONE; LIGNANS; ENTERODIOL; RISK; METABOLITES; CHEMICALS; PHYTOESTROGENS	Mammalian lignans or enterolignans are metabolites of plant lignans, an important category of phytochemicals. Although they are known to be associated with estrogenic activity, cell signaling pathways leading to specific cell functions, and especially the differences among lignans, have not been explored. We examined the estrogenic activity of enterolignans and their precursor plant lignans and cell signaling pathways for some cell functions, cell cycle and chemokine secretion. We used DNA microarray-based gene expression profiling in human breast cancer MCF-7 cells to examine the similarities, as well as the differences, among enterolignans, enterolactone and enterodiol, and their precursors, matairesinol, pinoresinol and sesamin. The profiles showed moderate to high levels of correlation (Rvalues: 0.44 to 0.81) with that of estrogen (17 beta-estradiol or E-2). Significant correlations were observed among lignans (Rvalues: 0.77 to 0.97), and the correlations were higher for cell functions related to enzymes, signaling, proliferation and transport. All the enterolignans/ precursors examined showed activation of the Erk1/2 and PI3KIAkt pathways, indicating the involvement of rapid signaling through the non-genomic estrogen signaling pathway. However, when their effects on specific cell functions, cell cycle progression and chemokine (MCP-1) secretion were examined, positive effects were observed only for enterolactone, suggesting that signals are given in certain directions at a position closer to cell functions. We hypothesized that, while estrogen signaling is initiated by the enterolignans/precursors examined, their signals are differentially and directionally modulated later in the pathways, resulting in the differences at the cell function level.	[Zhu, Yun; Kawaguchi, Kayoko; Kiyama, Ryoiti] Natl Inst Adv Ind Sci & Technol, Adv Biomeasurements Res Grp, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan; [Zhu, Yun] Scinet Co, Minato Ku, 4-21-12 Takanawa, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kiyama, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Adv Biomeasurements Res Grp, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	kiyama.r@aist.go.jp			Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers); Knowledge Cluster Initiative program; Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan; Scinet Company	Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers); Knowledge Cluster Initiative program; Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scinet Company	This research has been supported partly by a Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers), a Knowledge Cluster Initiative program, a grant from Kyushu Sangyo University for promoting basic technologies, and a Grant-in-Aid for Basic Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders and Scinet Company provided support in the form of salaries for authors [YZ and KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Aehle E, 2011, PHYTOCHEMISTRY, V72, P2396, DOI 10.1016/j.phytochem.2011.08.013; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Azrad M, 2013, J MED FOOD, V16, P357, DOI 10.1089/jmf.2012.0159; Buck K, 2011, J CLIN ONCOL, V29, P3730, DOI 10.1200/JCO.2011.34.6478; Buck K, 2010, AM J CLIN NUTR, V92, P141, DOI 10.3945/ajcn.2009.28573; Carreau C, 2008, J STEROID BIOCHEM, V110, P176, DOI 10.1016/j.jsbmb.2008.03.032; Clavel T, 2005, APPL ENVIRON MICROB, V71, P6077, DOI 10.1128/AEM.71.10.6077-6085.2005; Clavel T, 2006, NUTR RES REV, V19, P187, DOI 10.1017/S0954422407249704; Damdimopoulou P, 2011, J NUTR, V141, P1583, DOI 10.3945/jn.111.140277; Dar AA, 2013, BIOORG CHEM, V50, P1, DOI 10.1016/j.bioorg.2013.06.009; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dong S, 2013, J AGR FOOD CHEM, V61, P128, DOI 10.1021/jf304546a; Dong S, 2012, MICROBIOL RES, V167, P231, DOI 10.1016/j.micres.2011.09.003; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Frankenfeld CL, 2014, J NUTR, V144, P1445, DOI 10.3945/jn.114.190512; Inoue A, 2007, TOXICOL IN VITRO, V21, P741, DOI 10.1016/j.tiv.2007.01.014; Jansen GHE, 2005, ARCH BIOCHEM BIOPHYS, V435, P74, DOI 10.1016/j.abb.2004.12.015; Jin JS, 2013, MOLECULES, V18, P1122, DOI 10.3390/molecules18011122; Kivama R., 2016, ENV BIOTECH IN PRESS; Kiyama R, 2016, TRENDS FOOD SCI TECH, V54, P186, DOI 10.1016/j.tifs.2016.06.007; Kiyama R, 2014, ENVIRON TECHNOL INNO, V1-2, P16, DOI 10.1016/j.eti.2014.09.001; Kiyama R, 2015, ENVIRON INT, V83, P11, DOI 10.1016/j.envint.2015.05.012; Kiyama R, 2014, CELL MOL LIFE SCI, V71, P2065, DOI 10.1007/s00018-013-1544-5; Kuijsten A, 2006, CANCER EPIDEM BIOMAR, V15, P1132, DOI 10.1158/1055-9965.EPI-05-0991; Lampe JW, 2006, J AOAC INT, V89, P1174; Li S, 2016, CELL MOL IM IN PRESS; Mabrok HB, 2012, CARCINOGENESIS, V33, P203, DOI 10.1093/carcin/bgr256; Martynowicz H, 2014, ADV CLIN EXP MED, V23, P319, DOI 10.17219/acem/37123; Miguel V, 2014, DRUG METAB DISPOS, V42, P943, DOI 10.1124/dmd.113.055970; MOUSAVI Y, 1992, J STEROID BIOCHEM, V41, P615, DOI 10.1016/0960-0760(92)90393-W; Nishihara T, 2000, J HEALTH SCI, V46, P282; Penalvo JL, 2012, J NUTR, V142, P751, DOI 10.3945/jn.111.150516; Penttinen P, 2007, ENDOCRINOLOGY, V148, P4875, DOI 10.1210/en.2007-0289; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Raffaelli B, 2002, J CHROMATOGR B, V777, P29, DOI 10.1016/S1570-0232(02)00092-2; Reger MK, 2016, EUR J NUTR, V55, P1029, DOI 10.1007/s00394-015-0917-y; Saarinen NM, 2007, MOL NUTR FOOD RES, V51, P857, DOI 10.1002/mnfr.200600240; SATHYAMOORTHY N, 1994, CANCER RES, V54, P957; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; Sonestedt E, 2010, NUTR RES, V30, P667, DOI 10.1016/j.nutres.2010.09.010; Takic MM, 2016, FOOD FUNCT, V7, P1217, DOI [10.1039/c5fo01346a, 10.1039/C5FO01346A]; Tanji Masao, 2004, Current Pharmacogenomics, V2, P255, DOI 10.2174/1570160043377529; Terasaka S, 2004, ENVIRON HEALTH PERSP, V112, P773, DOI 10.1289/ehp.6753; Touillaud MS, 2007, JNCI-J NATL CANCER I, V99, P475, DOI 10.1093/jnci/djk096; van der Schouw YT, 2000, NUTR METAB CARDIOVAS, V10, P154; Wang LQ, 2002, J CHROMATOGR B, V777, P289, DOI 10.1016/S1570-0232(02)00281-7; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580	48	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171390	10.1371/journal.pone.0171390	http://dx.doi.org/10.1371/journal.pone.0171390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152041	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200137
J	Migani, V; Ekesi, S; Merkel, K; Hoffmeister, T				Migani, Valentina; Ekesi, Sunday; Merkel, Katharina; Hoffmeister, Thomas			At Lunch with a Killer: The Effect of Weaver Ants on Host-Parasitoid Interactions on Mango	PLOS ONE			English	Article							BACTROCERA-INVADENS DIPTERA; FRUIT-FLIES DIPTERA; OECOPHYLLA-LONGINODA; FORAGING BEHAVIOR; PREDATION RISK; FOPIUS-ARISANUS; OVIPOSITION BEHAVIOR; PATCH EXPLOITATION; CERATITIS-COSYRA; TEPHRITIDAE	Predator-prey interactions can affect the behaviour of the species involved, with consequences for population distribution and competitive interactions. Under predation pressure, potential prey may adopt evasive strategies. These responses can be costly and could impact population growth. As some prey species may be more affected than others, predation pressure could also alter the dynamics among species within communities. In field cages and small observation cages, we studied the interactions between a generalist predator, the African weaver ant, Oecophylla longinoda, two species of fruit flies that are primary pests of mango fruits, Ceratitis cosyra and Bactrocera dorsalis, and their two exotic parasitoids, Fopius arisanus and Diachasmimorpha longicaudata. In all experiments, either a single individual (observation cage experiments) or groups of individuals (field cage experiments) of a single species were exposed to foraging in the presence or absence of weaver ants. Weaver ant presence reduced the number of eggs laid by 75 and 50 percent in B. dorsalis and C. cosyra respectively. Similarly, parasitoid reproductive success was negatively affected by ant presence, with success of parasitism reduced by around 50 percent for both F. arisanus and D. longicaudata. The negative effect of weaver ants on both flies and parasitoids was mainly due to indirect predation effects. Encounters with weaver ant workers increased the leaving tendency in flies and parasitoids, thus reduced the time spent foraging on mango fruits. Parasitoids were impacted more strongly than fruit flies. We discuss how weaver ant predation pressure may affect the population dynamics of the fruit flies, and, in turn, how the alteration of host dynamics could impact parasitoid foraging behaviour and success.	[Migani, Valentina; Merkel, Katharina; Hoffmeister, Thomas] Univ Bremen, Inst Ecol, Fac Biol Chem, Bremen, Germany; [Ekesi, Sunday] ICIPE, Nairobi, Kenya; [Merkel, Katharina] Queensland Univ Technol, Brisbane, Qld, Australia	University of Bremen; International Centre of Insect Physiology & Ecology (ICIPE); Queensland University of Technology (QUT)	Migani, V (corresponding author), Univ Bremen, Inst Ecol, Fac Biol Chem, Bremen, Germany.	migani@uni-bremen.de	Migani, Valentina/AAF-9746-2020; Ekesi, Sunday/P-8944-2019; Hoffmeister, Thomas S./AAH-7796-2020; Hoffmeister, Thomas S/E-2804-2013	Hoffmeister, Thomas S./0000-0003-2840-7278; Hoffmeister, Thomas S/0000-0003-2840-7278	German Ministry for Economic Cooperation and Development (BMZ project) [10.7860.9-001.00]	German Ministry for Economic Cooperation and Development (BMZ project)	This research was supported by funds from the German Ministry for Economic Cooperation and Development (BMZ project No: 10.7860.9-001.00).	Adandonon A, 2009, INT J PEST MANAGE, V55, P285, DOI 10.1080/09670870902878418; Appiah EF, 2014, BIOL CONTROL, V79, P49, DOI 10.1016/j.biocontrol.2014.08.004; Balagawi S, 2005, AUST J ENTOMOL, V44, P97, DOI 10.1111/j.1440-6055.2005.00459.x; Barzman MS, 2001, J ANIM ECOL, V70, P237, DOI 10.1046/j.1365-2656.2001.00483.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blake CA, 2014, BEHAV ECOL, V25, P871, DOI 10.1093/beheco/aru041; BROWN JS, 1992, ANN ZOOL FENN, V29, P301; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Davies NB, 2012, INTRO BEHAV ECOLOGY; DEJEAN A, 1990, PHYSIOL ENTOMOL, V15, P393, DOI 10.1111/j.1365-3032.1990.tb00528.x; Ekesi S, 2006, B ENTOMOL RES, V96, P379, DOI 10.1079/BER2006442; Ekesi S, 2007, B ENTOMOL RES, V96, P279; Ekesi S, 2009, J ECON ENTOMOL, V102, P981, DOI 10.1603/029.102.0317; Field SA, 1998, ETHOLOGY, V104, P323, DOI 10.1111/j.1439-0310.1998.tb00072.x; HACCOU P, 1991, J ANIM ECOL, V60, P93, DOI 10.2307/5447; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Heimpel GE, 1997, OECOLOGIA, V110, P346, DOI 10.1007/s004420050168; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; Holldobler B., 1990, pi; Houtman R, 1998, EVOL ECOL, V12, P251, DOI 10.1023/A:1006544031697; Hubner G, 1996, J INSECT BEHAV, V9, P143, DOI 10.1007/BF02213729; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; Kolss M, 2006, BEHAV ECOL SOCIOBIOL, V61, P291, DOI 10.1007/s00265-006-0259-0; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; MACKAUER M, 1993, OECOLOGIA, V94, P339, DOI 10.1007/BF00317107; Martinez-Ferrer MT, 2003, BIOL CONTROL, V26, P279, DOI 10.1016/S1049-9644(02)00158-5; Messelink GJ, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P191; Messing RH, 1997, ENTOMOL EXP APPL, V82, P147, DOI 10.1023/A:1002900111900; Mohamed SA, 2010, BIOCONTROL SCI TECHN, V20, P183, DOI 10.1080/09583150903447794; Montoya P, 2003, BIOCONTROL SCI TECHN, V13, P683, DOI 10.1080/09583150310001606273; Noldus LPJJ, 1991, OBSERVER; Outreman Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P208, DOI 10.1007/s00265-004-0895-1; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peng RK, 1999, INT J PEST MANAGE, V45, P189, DOI 10.1080/096708799227789; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Core Team, 2021, R LANGUAGE ENV STAT; ROITBERG BD, 1990, BEHAVIOUR, V114, P65, DOI 10.1163/156853990X00059; Roitberg BD, 2010, BEHAV ECOL SOCIOBIOL, V64, P627, DOI 10.1007/s00265-009-0880-9; Rwomushana I, 2009, ENTOMOL EXP APPL, V133, P27, DOI 10.1111/j.1570-7458.2009.00897.x; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Sinzogan AAC, 2008, INT J PEST MANAGE, V54, P241, DOI 10.1080/09670870802014940; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thiel A, 2004, BEHAV ECOL, V15, P419, DOI 10.1093/beheco/arh030; van Alphen J.J.M., 1986, P23; Van Mele P, 2007, J ECON ENTOMOL, V100, P695, DOI 10.1603/0022-0493(2007)100[695:EOAAWA]2.0.CO;2; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vayssieres J- F, 2011, INT J BIOL CHEM SCI, V5, P790, DOI DOI 10.4314/IJBCS.V5I2.72153; Volkl W, 1997, ANIM BEHAV, V54, P349, DOI 10.1006/anbe.1996.0462; VOLKL W, 1994, OIKOS, V70, P149, DOI 10.2307/3545710; Wang XG, 2003, J INSECT BEHAV, V16, P593, DOI 10.1023/B:JOIR.0000007698.01714.56; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; WEISSER WW, 1994, EVOL ECOL, V8, P587, DOI 10.1007/BF01237843; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wielgoss A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2144; WOOSTER D, 1995, OIKOS, V73, P3, DOI 10.2307/3545718	61	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170101	10.1371/journal.pone.0170101	http://dx.doi.org/10.1371/journal.pone.0170101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146561	gold, Green Submitted, Green Published			2022-12-26	WOS:000396131700012
J	Hou, LK; Ma, YS; Han, Y; Lu, GX; Luo, P; Chang, ZY; Xie, RT; Yang, HQ; Chai, L; Cai, MX; Wu, TM; Yu, F; Qin, SS; Lv, ZW; Wu, CY; Fu, D				Hou, Li-Kun; Ma, Yu-Shui; Han, Yang; Lu, Gai-Xia; Luo, Pei; Chang, Zheng-Yan; Xie, Ru-Ting; Yang, Hui-Qiong; Chai, Li; Cai, Ming-Xiang; Wu, Ting-Miao; Yu, Fei; Qin, Shan-Shan; Lv, Zhong-Wei; Wu, Chun-Yan; Fu, Da			Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy	PLOS ONE			English	Article							AMERICAN SOCIETY; THERAPY; MIR-33A; METASTASIS; GENOMICS	Objective This study aims to explore the expression pattern and prognostic significance of miR-33a in non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy. Methods MiR-33aexpression in NSCLC was analyzed in silico using the GEO database and was subsequently confirmed by quantitative RT-PCR in 147 NSCLC biopsies. Among these, 32 of these biopsies were paired with adjacent non-neoplastic tissues. The survival analysis of NSCLC by Kaplan-Meier estimates was stratified based on miR-33a expression. In addition, multivariate survival analysis in corresponding groups of NSCLC patients was conducted by Cox proportional hazards regression model. Results The in silico analysis of miR-33a expression in NSCLC resulted to its down-regulation in different tumor types. The expression level of miR-33a was lower in each grade of NSCLC tumor biopsies than in normal lung tissues. Univariate and multivariate survival analysis further established that low miR-33a expression was an important risk factor for overall survival and disease free survival in NSCLC patients. Conclusion Our study implied that miR-33a expression levels may have an essential role in NSCLC progression, and could act as a specific and sensitive biomarker for NSCLC patients who have undergone adjuvant chemotherapy.	[Hou, Li-Kun; Wu, Chun-Yan] Tongji Univ, Shanghai Pulm Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Ma, Yu-Shui] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Coll Chem & Mol Engn, Shanghai, Peoples R China; [Ma, Yu-Shui; Lu, Gai-Xia; Chai, Li; Cai, Ming-Xiang; Wu, Ting-Miao; Yu, Fei; Qin, Shan-Shan; Lv, Zhong-Wei] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Sch Med, Shanghai, Peoples R China; [Han, Yang] Inner Mongolia Med Univ, Dept Radiol, Dept Translat Med Ctr, Cent Hosp Baotou, Hohhot, Inner Mongolia, Peoples R China; [Han, Yang] Inner Mongolia Med Univ, Med Imaging Res Inst, Cent Hosp Baotou, Hohhot, Inner Mongolia, Peoples R China; [Luo, Pei] Hunan Agr Univ, Fac Vet, Coll Vet Med, Changsha, Hunan, Peoples R China; [Chang, Zheng-Yan; Xie, Ru-Ting; Yang, Hui-Qiong] Tongji Univ, Sch Med, Dept Pathol, Shanghai Peoples Hosp 10, Shanghai, Peoples R China; [Fu, Da] Tongji Univ, Cent Lab Med Res, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China	Tongji University; East China Normal University; Tongji University; Inner Mongolia Medical University; Inner Mongolia Medical University; Hunan Agricultural University; Tongji University; Tongji University	Wu, CY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China.; Fu, D (corresponding author), Tongji Univ, Cent Lab Med Res, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China.	chunyan_wu2015@126.com; fu800da900@126.com	han, yang/GRS-2388-2022; ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022		National Natural Science Foundation of China [81372175, 81301993, 81472202, 81302065]; Shanghai health and family planning commission projects [201540228, 201440398]; Shanghai Natural Science Foundation [16ZR1428900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai health and family planning commission projects; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This study was supported in part by grants from the National Natural Science Foundation of China (81372175, 81301993, 81472202, and 81302065), Shanghai health and family planning commission projects (201540228 and 201440398) and Shanghai Natural Science Foundation (16ZR1428900).	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cykert S, 2010, JAMA-J AM MED ASSOC, V303, P2368, DOI 10.1001/jama.2010.793; Database resources of the National Center for Biotechnology Information, 2015, NUCL ACIDS RES; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI 10.1056/NEJMoa1214271; Han Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134682; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Klopfleisch R, 2015, VET J LONDON ENGLAND; Li X., 2011, J NANOMATER, V2011, P1, DOI [DOI 10.1155/2011/382068, DOI 10.1155/2011/270974]; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rodrigues G, 2015, PRACT RADIAT ONCOL, V5, P149, DOI 10.1016/j.prro.2015.02.013; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang H, 2014, J CLIN INVEST, V124, P4489, DOI 10.1172/JCI75284; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13677; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang CZ, 2015, INVEST NEW DRUG, V33, P1, DOI 10.1007/s10637-014-0156-8; Zhou Jun, 2015, IEEE T CIRCUITS SYST, VI, P1, DOI DOI 10.1016/J.BMCL.2015.01.016; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12	39	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170431	10.1371/journal.pone.0170431	http://dx.doi.org/10.1371/journal.pone.0170431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141816	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500010
J	Kowall, B; Rathmann, W; Stang, A; Bongaerts, B; Kuss, O; Herder, C; Roden, M; Quante, A; Holle, R; Huth, C; Peters, A; Meisinger, C				Kowall, Bernd; Rathmann, Wolfgang; Stang, Andreas; Bongaerts, Brenda; Kuss, Oliver; Herder, Christian; Roden, Michael; Quante, Anne; Holle, Rolf; Huth, Cornelia; Peters, Annette; Meisinger, Christa			Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; GERMAN POPULATION; TYPE-2; ADULTS; PREVALENCE; MELLITUS; PEOPLE; PREVENTION; PREDICTION	Objective Early detection of diabetes and prediabetic states is beneficial for patients, but may be delayed by patients A being overly optimistic about their own health. Therefore, we assessed how persons without known diabetes perceive their risk of having or developing diabetes, and we identified factors associated with perception of diabetes risk. Research design and methods 1,953 participants without previously known diabetes from the population-based, German KORA FF4 Study (59.1 years, 47.8% men) had an oral glucose tolerance test. They estimated their probability of having undiagnosed diabetes mellitus (UDM) on a six category scale, and assessed whether they were at risk of developing diabetes in the future. We cross-tabulated glycemic status with risk perception, and fitted robust Poisson regression models to identify determinants of diabetes risk perception. Results 74% (95% CI: 65-82) of persons with UDM believed that their probability of having undetected diabetes was low or very low. 72% (95% CI: 69-75) of persons with prediabetes believed that they were not at risk of developing diabetes. In people with prediabetes, seeing oneself at risk of diabetes was associated with self-rated poor general health (prevalence ratio (PR) = 3.1 (95% CI: 1.4-6.8), parental diabetes (PR = 2.6, 1.9-3.4), high educational level (PR = 1.9 (1.4-2.5)), lower age (PR = 0.7, 0.6-0.8, per 1 standard deviation increase), female sex (PR = 1.2, 0.9-1.5) and obesity (PR = 1.5, 1.2-2.0). Conclusions People with undiagnosed diabetes or prediabetes considerably underestimate their probability of having or developing diabetes. Contrary to associations with actual diabetes risk, perceived diabetes risk was lower in men, lower educated and older persons.	[Kowall, Bernd; Stang, Andreas] Univ Duisburg Essen, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany; [Rathmann, Wolfgang; Bongaerts, Brenda; Kuss, Oliver] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rathmann, Wolfgang; Bongaerts, Brenda; Kuss, Oliver; Herder, Christian; Roden, Michael; Holle, Rolf; Huth, Cornelia; Peters, Annette; Meisinger, Christa] German Ctr Diabet Res DZD, Munich, Germany; [Stang, Andreas] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Talbot Bldg, Boston, MA USA; [Herder, Christian; Roden, Michael] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Roden, Michael] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Quante, Anne] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Quante, Anne] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Huth, Cornelia; Peters, Annette; Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany	University of Duisburg Essen; Deutsches Diabetes-Zentrum (DDZ); Boston University; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kowall, B (corresponding author), Univ Duisburg Essen, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany.	bernd.kowall@uk-essen.de	Huth, Cornelia/B-5350-2014; Peters, Annette/A-6117-2011; Roden, Michael/AAD-3843-2019; Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014	Huth, Cornelia/0000-0003-2421-433X; Peters, Annette/0000-0001-6645-0985; Holle, Rolf/0000-0001-5395-2695; 	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG) [RA 459/3-1]; German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research; Helmholtz Zentrum Munchen; German Research Center for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria; German Diabetes Foundation	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria; German Diabetes Foundation	This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW) and the German Federal Ministry of Health (BMG). The diabetes part of the KORA F4 study was funded by a grant from the German Research Foundation (DFG; RA 459/3-1). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Science and Research (Berlin, Germany) and by the State of Bavaria. The diabetes part of the KORA FF4 study was funded by a grant from the German Diabetes Foundation to WR and C Herder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MC, 2008, PATIENT EDUC COUNS, V73, P307, DOI 10.1016/j.pec.2008.06.009; Adriaanse MC, 2003, DIABETIC MED, V20, P210, DOI 10.1046/j.1464-5491.2003.00901.x; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bodemer N, 2014, MED DECIS MAKING, V34, P615, DOI 10.1177/0272989X14526305; Boer H, 1996, PREDICTING HLTH BEHA, P95, DOI [10.1080/13548506.2011.579983, DOI 10.1080/13548506.2011.579983]; Colagiuri S, 2009, CURR OPIN ENDOCRINOL, V16, P95, DOI 10.1097/MED.0b013e328329302f; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Genuth S, 2003, DIABETES CARE, V26, P3160; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Godino JG, 2014, DIABETES RES CLIN PR, V106, P412, DOI 10.1016/j.diabres.2014.10.004; Guess ND, 2015, PRIM CARE DIABETES, V9, P407, DOI 10.1016/j.pcd.2015.04.005; Heidemann C, 2015, DIABETIC MED; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hivert MF, 2009, DIABETES CARE, V32, P1820, DOI 10.2337/dc09-0720; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koksal Burcu, 2015, Open Access Maced J Med Sci, V3, P380, DOI 10.3889/oamjms.2015.093; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Olafsdottir E, 2016, ACTA OPHTHALMOL, V94, P232, DOI 10.1111/aos.12954; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Reyes-Velazquez Wanda, 2015, Diabetes Spectr, V28, P5, DOI 10.2337/diaspect.28.1.5; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tiller D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2210-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valdes S, 2009, REV ESP CARDIOL, V62, P528, DOI 10.1016/S0300-8932(09)71033-4; WEINSTEIN ND, 1982, J BEHAV MED, V5, P441, DOI 10.1007/BF00845372	34	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171152	10.1371/journal.pone.0171152	http://dx.doi.org/10.1371/journal.pone.0171152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141837	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500045
J	Ge, CZ; Wang, RQ; Chai, YC; Wang, HQ; Kan, MM; Liu, J				Ge, Changzi; Wang, Renqing; Chai, Yanchao; Wang, Haiqing; Kan, Manman; Liu, Jian			High Colonization Possibility of Some Species of Weeds in Suaeda salsa Community: From an Ecological Stoichiometry Perspective	PLOS ONE			English	Article							YELLOW-RIVER ESTUARY; PLANT SPARTINA-ALTERNIFLORA; ORGANIC-CARBON DYNAMICS; N P STOICHIOMETRY; PHOSPHORUS STOICHIOMETRY; NUTRIENT LIMITATION; COASTAL WETLAND; LEAF NITROGEN; SEEDLING EMERGENCE; INTERTIDAL ZONE	Suaeda salsa community is a vegetation type in saline-alkali areas. Weed invasion and colonization in S. salsa communities lead to fragmentationsof S. salsa communities. The colonization of invaded weeds in S. salsa communities is related to community succession of saline-alkali zones. The fragmented S. salsa community may be restored if the mechanism of invaded weed colonization in S. salsa communities is clearly elucidated. Thus, we studied the ecological stoichiometric characteristics of soils and plants in a salt marsh to explain the high colonization possibility of invaded weeds in S. salsa communities. In October 2014, soils and plants were collected from Dongfeng Salt Marsh, Jiaozhou Bay, Shandong Province, China. The ratio of Ex-N/Ex-P in soil was less than 13, which suggests a relative nitrogen limitation for the primary production in the zone. The minimum phosphorus content in plants was higher than 1 mg g(-1), whereas the maximum nitrogen content in plants was less than 13 mg g(-1). These results imply that phosphorus was abundant, whereas nitrogen was deficient in the area. The plants in the salt marsh may be limited by nitrogen. Given the relatively lower nitrogen contents in Cyperus glomeratus, Echinochloa crusgalli, and Aster subulatus than that in S. salsa, these three species exhibited higher competitiveness than S. salsa did when nitrogen was limited in primary production. These weed species may colonize highly in S. salsa communities. Moreover, nitrogen fertilization might be effective to maintain S. salsa community in Dongfeng Salt Marsh, whereas its effects on controlling weeds colonization in S. salsa communities need more studies to verify.	[Ge, Changzi; Wang, Renqing] Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan, Peoples R China; [Ge, Changzi; Chai, Yanchao; Wang, Haiqing; Kan, Manman] Shandong Univ, Marine Coll, Weihai, Peoples R China; [Liu, Jian] Shandong Univ, Inst Environm Res, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, RQ (corresponding author), Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan, Peoples R China.	wrq@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	Science & Technology Project of Shandong Province [2010GHZ0801, 2012GSF11609, 2014GSF117042]; Independent Innovation Foundation of Shandong University [2011DX008]; National Natural Science Foundation of China [31200426]; China Postdoctoral Science Foundation [2013M541905]; Science & Technology Project of Shenzhen [JCYJ2014041811549187]	Science & Technology Project of Shandong Province; Independent Innovation Foundation of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science & Technology Project of Shenzhen	The work used in this study was jointly funded by the Science & Technology Project of Shandong Province (Nos. 2010GHZ0801, 2012GSF11609 and 2014GSF117042), Independent Innovation Foundation of Shandong University (No. 2011DX008), National Natural Science Foundation of China (No. 31200426), China Postdoctoral Science Foundation (No. 2013M541905), the Science & Technology Project of Shenzhen (No. JCYJ2014041811549187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2015, ESTUAR COAST SHELF S, V163, P265, DOI 10.1016/j.ecss.2014.12.035; Bott T, 2008, NEW PHYTOL, V180, P631, DOI 10.1111/j.1469-8137.2008.02575.x; Chen XinWei, 2016, Research of Environmental Sciences, V29, P538; [崔保山 CUI BaoShan], 2008, [生态学报, Acta Ecologica Sinica], V28, P1408; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fang Yong, 2008, Journal of Northeast Forestry University, V36, P89; Figueroa-Espinoza B, 2014, ATMOSFERA, V27, P77, DOI 10.1016/S0187-6236(14)71102-6; Gao YC, 2014, CHEMOSPHERE, V117, P486, DOI 10.1016/j.chemosphere.2014.08.070; Glasby TM, 2015, AQUAT BOT, V120, P251, DOI 10.1016/j.aquabot.2014.09.003; Goloran JB, 2015, ECOL INDIC, V57, P32, DOI 10.1016/j.ecolind.2015.04.018; Guo XH, 2015, APPL SOIL ECOL, V95, P1, DOI 10.1016/j.apsoil.2015.05.010; Gusewell S, 2003, FUNCT ECOL, V17, P754, DOI 10.1111/j.1365-2435.2003.00784.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hu Wei-Fang, 2014, Chinese Journal of Plant Ecology, V38, P1041, DOI 10.3724/SP.J.1258.2014.00098; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Huang LD, 2015, ESTUAR COAST SHELF S, V157, P93, DOI 10.1016/j.ecss.2014.09.027; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Li Zheng, 2012, Chinese Journal of Plant Ecology, V36, P1054, DOI 10.3724/SP.J.1258.2012.01054; [林威鹏 Lin Weipeng], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1593; Liu SJ, 2012, PROCEDIA ENVIRON SCI, V16, P293, DOI 10.1016/j.proenv.2012.10.041; Ma J. S., 2013, CHECKLIST CHINESE IN; Ma MingRui, 2014, China Environmental Science, V34, P1531; Ma RenTian, 2016, Acta Pedologica Sinica, V53, P1170; [毛培利 MAO Peili], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1214; [莫良玉 Mo Liangyu], 2002, [生态学报, Acta Ecologica Sinica], V22, P118; Mou XJ, 2011, J ENVIRON SCI, V23, P958, DOI 10.1016/S1001-0742(10)60530-X; Roth T, 2013, AGR ECOSYST ENVIRON, V178, P121, DOI 10.1016/j.agee.2013.07.002; Song J, 2008, AQUAT BOT, V88, P331, DOI 10.1016/j.aquabot.2007.11.004; Sun PP, 2015, EUR J SOIL BIOL, V70, P58, DOI 10.1016/j.ejsobi.2015.07.004; Sun ZG, 2016, ECOL ENG, V93, P175, DOI 10.1016/j.ecoleng.2016.05.024; Sun ZG, 2015, CATENA, V126, P43, DOI 10.1016/j.catena.2014.10.037; Sun ZG, 2014, J ENVIRON MANAGE, V135, P27, DOI 10.1016/j.jenvman.2014.01.017; [谭向峰 Tan Xiangfeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P5998; Wang Mei, 2014, China Environmental Science, V34, P720; [王顺忠 Wang Shunzhong], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P550; WASSEN MJ, 1995, J VEG SCI, V6, P5, DOI 10.2307/3236250; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Xi NX, 2014, SOIL BIOL BIOCHEM, V71, P40, DOI 10.1016/j.soilbio.2014.01.008; Xu SJ, 2015, BIOCHEM SYST ECOL, V62, P58, DOI 10.1016/j.bse.2015.07.037; Yang W, 2013, ECOL ENG, V61, P50, DOI 10.1016/j.ecoleng.2013.09.056; Zeng QC, 2016, CATENA, V147, P481, DOI 10.1016/j.catena.2016.07.047; Zhan SX, 2017, ENVIRON EXP BOT, V134, P21, DOI 10.1016/j.envexpbot.2016.10.014; Zhang Ren-yi, 2014, Huanjing Kexue, V35, P1131; Zhang YH, 2010, ATMOS ENVIRON, V44, P4588, DOI 10.1016/j.atmosenv.2010.08.012; Zhang YH, 2010, SOIL BIOL BIOCHEM, V42, P1712, DOI 10.1016/j.soilbio.2010.06.006; Zhao LY, 2008, TIANJING AGR SCI, V14, P56; [赵振勇 Zhao Zhenyong], 2013, [中国沙漠, Journal of Desert Research], V33, P1420; Zhou Fanqi, 2014, Hupo Kexue, V26, P401	50	2	2	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170401	10.1371/journal.pone.0170401	http://dx.doi.org/10.1371/journal.pone.0170401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135313	Green Published, gold, Green Submitted			2022-12-26	WOS:000396124700013
J	Raimi, KT; Stern, PC; Maki, A				Raimi, Kaitlin T.; Stern, Paul C.; Maki, Alexander			The Promise and Limitations of Using Analogies to Improve Decision-Relevant Understanding of Climate Change	PLOS ONE			English	Article							FRAMEWORK; MODELS; BELIEF	To make informed choices about how to address climate change, members of the public must develop ways to consider established facts of climate science and the uncertainties about its future trajectories, in addition to the risks attendant to various responses, including non-response, to climate change. One method suggested for educating the public about these issues is the use of simple mental models, or analogies comparing climate change to familiar domains such as medical decision making, disaster preparedness, or courtroom trials. Two studies were conducted using online participants in the U.S.A. to test the use of analogies to highlight seven key decision-relevant elements of climate change, including uncertainties about when and where serious damage may occur, its unprecedented and progressive nature, and tradeoffs in limiting climate change. An internal meta-analysis was then conducted to estimate overall effect sizes across the two studies. Analogies were not found to inform knowledge about climate literacy facts. However, results suggested that people found the medical analogy helpful and that it led people-especially political conservatives-to better recognize several decision-relevant attributes of climate change. These effects were weak, perhaps reflecting a well-documented and overwhelming effect of political ideology on climate change communication and education efforts in the U.S.A. The potential of analogies and similar education tools to improve understanding and communication in a polarized political environment are discussed.	[Raimi, Kaitlin T.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Stern, Paul C.] US Natl Acad Sci Engn & Med, Board Environm Change & Soc, Washington, DC USA; [Stern, Paul C.] Norwegian Univ Sci & Technol, Trondheim, Norway; [Maki, Alexander] Vanderbilt Univ, Vanderbilt Inst Energy & Environm, 221 Kirkland Hall, Nashville, TN 37235 USA; [Maki, Alexander] Vanderbilt Univ, Vanderbilt Climate Change Res Network, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Michigan System; University of Michigan; National Academies of Sciences, Engineering & Medicine; Norwegian University of Science & Technology (NTNU); Vanderbilt University; Vanderbilt University	Raimi, KT (corresponding author), Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA.	kraimi@umich.edu	Raimi, Kaitlin T/N-1872-2013	Raimi, Kaitlin T/0000-0002-3301-9520	Climate Change Research Network	Climate Change Research Network	These studies were funded by the Climate Change Research Network. Funders approved the initial study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WASHINGTON POST; Belluck P., 2016, NY TIMES; Bessette DL, 2014, ENVIRON SCI TECHNOL, V48, P1401, DOI 10.1021/es4036286; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Broockman D, 2016, SCIENCE, V352, P220, DOI 10.1126/science.aad9713; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Clifford S., 2015, RES POLITICS, V2, DOI [10.1177/2053168015622072, DOI 10.1177/2053168015622072]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; Feldman L, 2014, J COMMUN, V64, P590, DOI 10.1111/jcom.12108; Gentner D., 2013, OXFORD HDB COGNITIVE, P668; Guy S, 2014, EUR J SOC PSYCHOL, V44, P421, DOI 10.1002/ejsp.2039; Hamilton L. C., 2014, ENVIRON POLIT, P1, DOI [10.1080/09644016.2014.976485, DOI 10.1080/09644016.2014.976485]; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244; Lewandowsky S, 2012, NATURE CLIMATE CHANG, V2, P1; Maibach EW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/091003; McCright AM, 2016, ENERGY RES SOC SCI, V21, P180, DOI 10.1016/j.erss.2016.08.003; McCright AM, 2016, TOP COGN SCI, V8, P76, DOI 10.1111/tops.12171; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Nordhaus William D., 2013, CLIM CASINO; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Pielke R.A., 2010, CLIMATE FIX WHAT SCI; Schulz K., 2015, NEW YORKER, DOI [10.7312/asme16957-009, DOI 10.7312/ASME16957-009]; Sifferlin A., 2016, TIME; Sopory P, 2002, HUM COMMUN RES, V28, P382, DOI 10.1093/hcr/28.3.382; StataCorp, 2015, STATA STATISTICAL SO; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Stern PC, 2015, SOC RES, V82, P581; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093	34	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171130	10.1371/journal.pone.0171130	http://dx.doi.org/10.1371/journal.pone.0171130			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135337	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700051
J	Lee, J; Shin, JS; Lee, YJ; Kim, MR; Choi, A; Lee, JH; Shin, KM; Shin, BC; Cho, JH; Ha, IH				Lee, Jinho; Shin, Joon-Shik; Lee, Yoon Jae; Kim, Me-riong; Choi, Areum; Lee, Jun-Hwan; Shin, Kyung-Min; Shin, Byung-Cheul; Cho, Jae-Heung; Ha, In-Hyuk			Long-Term Course of Failed Back Surgery Syndrome (FBSS) Patients Receiving Integrative Korean Medicine Treatment: A 1 Year Prospective Observational Multicenter Study	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; RANDOMIZED CONTROLLED-TRIAL; NEUROPATHIC PAIN; TRADITIONAL MEDICINE; HEALTH SURVEY; MANAGEMENT; QUALITY; COMPLEMENTARY; ACUPUNCTURE; HERNIATION	Background With increase of spine surgeries, failed back surgery syndrome (FBSS) prevalence is also rising. While complementary and alternative medicine (CAM) is commonly used for low back pain (LBP), there are no studies reporting use of integrative Korean medicine in FBSS patients. Methods Patients with pain continuing after back surgery or recurring within 1 year and visual analogue scale (VAS) of LBP or leg pain of >= 6 (total n = 120) were recruited at 2 hospital sites from November 2011 to September 2014. Weekly sessions of integrative Korean medicine treatment were conducted for 16 weeks (herbal medicine, acupuncture/electroacupuncture, pharmacopuncture/bee venom pharmacopuncture, and Chuna manual therapy) with additional follow-ups at 24 weeks and 1 year. Outcome measures included VAS of LBP and leg pain (primary outcome), Oswestry Disability Index (ODI), Short-Form 36 (SF-36), medical use, and patient global impression of change (PGIC). Results VAS of LBP and leg pain improved at 6 months (LBP from 6.1 +/- 2.0 at baseline to 2.9 +/- 2.3; and leg pain from 5.4 +/- 2.6 to 2.4 +/- 2.5, respectively). Eighty patients (66.7%) showed improvement of 50% or more in main pain of LBP or leg pain from baseline. Disability and quality of life also improved at 6 months (ODI from 41.3 +/- 12.3 at baseline to 23.6 +/- 13.6; and SF-36 from 42.8 +/- 14.5 to 62.7 +/- 16.8). At 1 year follow-up, conventional medical management use decreased, improvement in pain and disability was maintained, and 79.2% reported improvement of PGIC. Conclusions Despite limitations as an observational study, integrative Korean medicine treatment showed positive results in pain, function, and quality of life of FBSS patients.	[Lee, Jinho; Shin, Joon-Shik; Lee, Yoon Jae; Kim, Me-riong; Choi, Areum; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Lee, Jun-Hwan; Shin, Kyung-Min] Korea Inst Oriental Med, Div Clin Res, Daejeon, South Korea; [Lee, Jun-Hwan] Univ Sci & Technol, Korean Med Life Sci, Campus Korea Inst Oriental Med, Daejeon, South Korea; [Shin, Kyung-Min] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Yangsan, South Korea; [Cho, Jae-Heung] Kyung Hee Univ, Dept Korean Rehabil Med, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM); University of Science & Technology (UST); Pusan National University; Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Shin, Kyung-Min/AAO-9382-2020; Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; Lee, Jinho/0000-0003-0672-6892; HA, IN-HYUK/0000-0002-5020-6723	Korea Institute of Oriental Medicine [K16123]	Korea Institute of Oriental Medicine	This study was supported by a grant from the Korea Institute of Oriental Medicine (K16123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Korea Institute of Oriental Medicine (K16123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Ki Byung Park for his help in statistical analysis.	[Anonymous], 1991, GUIDE CLIN TRIALS, P565; Brox JI, 2006, PAIN, V122, P145, DOI 10.1016/j.pain.2006.01.027; Brunelli B, 2004, J NEUROL SCI, V218, P59, DOI 10.1016/j.jns.2003.10.013; Chung HJ, 2010, J ETHNOPHARMACOL, V130, P450, DOI 10.1016/j.jep.2010.05.020; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Deyo RA, 2009, EUR SPINE J, V18, pS331, DOI 10.1007/s00586-009-0908-x; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Eldabe S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-189; Evidence-based Korean Medicine Clinical Practice Guideline Development Committee for Lumbar Herniated Intervertebral Disc(Korea Institute of Oriental Medicine and the Society of Korean Medicine Rehabilitation), 2014, KOREAN MEDICINE CLIN; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fritzell P, 2003, EUR SPINE J, V12, P178, DOI 10.1007/s00586-002-0493-8; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Han CW, 2004, TOHOKU J EXP MED, V203, P189, DOI 10.1620/tjem.203.189; Hussain A, 2014, PAIN PRACT, V14, P64, DOI 10.1111/papr.12035; Jeon CH, 2006, J KOREAN MED SCI, V21, P1092, DOI 10.3346/jkms.2006.21.6.1092; Kim JK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/730907; Kim Tae, 2011, Open Neuroimag J, V5, P136, DOI 10.2174/1874440001105010136; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Kvachadze I, 2015, Georgian Med News, P102; Lee MS, 2008, J PAIN, V9, P289, DOI 10.1016/j.jpain.2007.11.012; Manca A, 2008, EUR J PAIN, V12, P1047, DOI 10.1016/j.ejpain.2008.01.014; Moon TW, 2013, CHIN J INTEGR MED, V19, P228, DOI 10.1007/s11655-012-1238-0; National Center for Health Statistics, 1997, NAT HOSP DISCH SURV, V13; NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008; Park JJ, 2010, COMPLEMENT THER MED, V18, P78, DOI 10.1016/j.ctim.2010.02.003; Park YG, 2013, J ETHNOPHARMACOL, V149, P816, DOI 10.1016/j.jep.2013.08.008; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Rahimzadeh P, 2014, PAIN PHYSICIAN, V17, pE75; Rigoard P, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-376; Robinson N, 2012, EUR J INTEGR MED, V4, pE363, DOI 10.1016/j.eujim.2012.10.001; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; Shin JS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005801; Shin JS, 2016, SPINE PHILA PA 1976; Shin YS, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0956-1; Stevens L, 2007, J ALTERN COMPLEM MED, V13, P481, DOI 10.1089/acm.2007.6263; Taylor RS, 2012, BRIT J PAIN, V6, P174, DOI 10.1177/2049463712470887; TURK DC, 1993, PAIN, V53, P3, DOI 10.1016/0304-3959(93)90049-U; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Wilkinson HA., 1991, FAILED BACK SYNDROME; World Health Organization, 2005, US WHO UMC SYST STAN	43	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170972	10.1371/journal.pone.0170972	http://dx.doi.org/10.1371/journal.pone.0170972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129399	gold, Green Published, Green Submitted			2022-12-26	WOS:000396211400015
J	Tung, YC; Chang, GM; Chang, HY; Yu, TH				Tung, Yu-Chi; Chang, Guann-Ming; Chang, Hsien-Yen; Yu, Tsung-Hsien			Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIAN; EMERGENCY-DEPARTMENT; CHEST-PAIN; OUTCOMES; RISK; ASSOCIATION; TAIWAN; CONTINUITY; ADMISSIONS; MANAGEMENT	Background Thirty-day readmission rates after acute myocardial infarction (AMI) and heart failure are important patient outcome metrics. Early post-discharge physician follow-up has been promoted as a method of reducing 30-day readmission rates. However, the relationships between early post-discharge follow-up and 30-day readmission for AMI and heart failure are inconclusive. We used nationwide population-based data to examine associations between 7-day physician follow-up and 30-day readmission, and further associations of 7-day same physician (during the index hospitalization and at follow-up) and cardiologist follow- up with 30-day readmission for non-ST-segment-elevation myocardial infarction (NSTEMI) or heart failure. Methods We analyzed all patients 18 years or older with NSTEMI and heart failure and discharged from hospitals in 2010 in Taiwan through Taiwan's National Health Insurance Research Database. Cox proportional hazard models with robust sandwich variance estimates and propensity score weighting were performed after adjustment for patient and hospital characteristics to test associations between 7-day physician follow-up and 30-day readmission. Results The study population for NSTEMI and heart failure included 5,008 and 13,577 patients, respectively. Early physician follow-up was associated with a lower hazard ratio of readmission compared with no early physician follow-up for patients with NSTEMI (hazard ratio [HR], 0.47; 95% confidence interval [CI], 0.39-0.57), and for patients with heart failure (HR, 0.54; 95% CI, 0.48-0.60). Same physician follow-up was associated with a reduced hazard ratio of readmission compared with different physician follow-up for patients with NSTEMI (HR, 0.56; 95% CI, 0.48-0.65), and for patients with heart failure (HR, 0.69; 95% CI, 0.62-0.76). Conclusions For each condition, patients who have an outpatient visit with a physician within 7 days of discharge have a lower risk of 30- day readmission. Moreover, patients who have an outpatient visit with the same physician within 7 days of discharge have a much lower risk of 30-day readmission.	[Tung, Yu-Chi] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei, Taiwan; [Chang, Guann-Ming] Cardinal Tien Hosp, Dept Family Med, New Taipei, Taiwan; [Chang, Guann-Ming] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Chang, Hsien-Yen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Yu, Tsung-Hsien] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	National Taiwan University; Fu Jen Catholic University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Taipei University of Nursing & Health Science (NTUNHS)	Yu, TH (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	ericthyu@ntu.edu.tw	Chang, Hsien-Yen/E-4627-2014; Tung, Yu-Chi/V-1036-2019	Chang, Hsien-Yen/0000-0002-7997-4822; Tung, Yu-Chi/0000-0001-9031-8749; CHANG, HAO-YUAN/0000-0001-5810-7562; Yu, Tsung-Hsien/0000-0002-6874-989X	Taiwan Ministry of Science and Technology [MOST 103-2410-H-002-209-MY2, MOST 105-2410-H-002-220-MY2]	Taiwan Ministry of Science and Technology	Taiwan Ministry of Science and Technology provides the financial support (MOST 103-2410-H-002-209-MY2 and MOST 105-2410-H-002-220-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Andersson C, 2014, J AM COLL CARDIOL, V64, P247, DOI 10.1016/j.jacc.2014.04.042; Centers for Medicare and Medicaid Services, 2015, OUTC MEAS 2015; Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; Chang HY, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1585; Chang HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP958, DOI 10.1177/1010539512471073; Chiu HY, 2016, TAIWAN J PUBLIC HLTH, V35, P66; Ciccone MM, 2010, VASC HEALTH RISK MAN, V6, P297; Coleman EA, 2007, J HOSP MED, V2, P287, DOI 10.1002/jhm.276; Czarnecki A, 2014, AM HEART J, V168, P289, DOI 10.1016/j.ahj.2014.05.016; Czarnecki A, 2013, CIRCULATION, V127, P1386, DOI 10.1161/CIRCULATIONAHA.112.000737; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Field TS, 2015, J GEN INTERN MED, V30, P565, DOI 10.1007/s11606-014-3106-4; Geronimus AT, 1996, J AM STAT ASSOC, V91, P529, DOI 10.2307/2291645; Glickman SW, 2012, AM HEART J, V163, P372, DOI 10.1016/j.ahj.2011.10.021; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hess CN, 2013, CIRCULATION, V128, P1206, DOI 10.1161/CIRCULATIONAHA.113.004569; Huang IC, 2005, HEALTH SERV RES, V40, P253, DOI 10.1111/j.1475-6773.2005.00352.x; Institute of Medicine, 2007, REW PROV PERF AL INC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lee KK, 2016, MED CARE, V54, P365, DOI 10.1097/MLR.0000000000000492; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062492; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McAlister FA, 2013, CAN MED ASSOC J, V185, pE681, DOI 10.1503/cmaj.130048; Medicare Payment Advisory Commission, 2007, PROM GREAT EFF MED R; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Roux AVD, 2004, EPIDEMIOL REV, V26, P104, DOI 10.1093/epirev/mxh006; Ryan J, 2013, AM J MED, V126, P989, DOI 10.1016/j.amjmed.2013.06.027; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tung YC, 2015, CIRC-CARDIOVASC QUAL, V8, P30, DOI 10.1161/CIRCOUTCOMES.114.001086; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang G, 2015, REV PROPENSITY SCORE; Yeung DF, 2012, CAN MED ASSOC J, V184, pE765, DOI 10.1503/cmaj.111958; Yu TH, 2015, INT J QUAL HEALTH C, V27, P361, DOI 10.1093/intqhc/mzv050; Zhang YT, 2014, AM J MANAG CARE, V20, pE498	45	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170061	10.1371/journal.pone.0170061	http://dx.doi.org/10.1371/journal.pone.0170061			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129332	Green Submitted, gold, Green Published			2022-12-26	WOS:000396211400064
J	Lin, IH; Chen, YF; Hsu, MT				Lin, I-Hsuan; Chen, Yi-Fan; Hsu, Ming-Ta			Correlated 5-Hydroxymethylcytosine (5hmC) and Gene Expression Profiles Underpin Gene and Organ-Specific Epigenetic Regulation in Adult Mouse Brain and Liver	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA DEMETHYLATION; GENOMIC FEATURES; BASE-RESOLUTION; DYNAMICS; CANCER; DIFFERENTIATION; METHYLATION; NEURONS; TRANSCRIPTION	Background DNA methylation is an epigenetic mechanism essential for gene regulation and vital for mammalian development. 5-hydroxymethylcytosine (5hmC) is the first oxidative product of the TET-mediated 5-methylcytosine (5mC) demethylation pathway. Aside from being a key intermediate in cytosine demethylation, 5hmC may have potential regulatory functions with emerging importance in mammalian biology. Methods Here, we investigate the global 5hmC enrichment in five brain structures, including cerebellum, cerebral cortex, hippocampus, hypothalamus and thalamus, as well as liver tissues from female and male adult mice by using chemical capture-based technique coupled with next-generation sequencing. At the same time, we carried out total RNA sequencing (RNAseq) to analyze the transcriptomes of brain regions and liver tissues. Results Our results reveal preferential 5hmC enrichment in the gene bodies of expressed genes, and 5hmC levels of many protein-coding genes are positively correlated with RNA expression intensity. However, more than 75% of genes with low or no 5hmC enrichment are genes encode for mitochondrial proteins and ribosomal proteins despite being actively transcribed, implying different transcriptional regulation mechanisms of these housekeeping genes. Brain regions developed from the same embryonic structures have more similar 5hmC profiles. Also, the genic 5hmC enrichment pattern is highly tissue-specific, and 5hmC marks genes involving in tissue-specific biological processes. Sex chromosomes are mostly depleted of 5hmC, and the X inactive specific transcript (Xist) gene located on the X chromosome is the only gene to show sex-specific 5hmC enrichment. Conclusions This is the first report of the whole-genome 5hmC methylome of five major brain structures and liver tissues in mice of both sexes. This study offers a comprehensive resource for future work of mammalian cytosine methylation dynamics. Our findings offer additional evidence that suggests 5hmC is an active epigenetic mark stably maintained after the global reprogramming event during early embryonic development.	[Lin, I-Hsuan; Chen, Yi-Fan] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei, Taiwan; [Lin, I-Hsuan] Taipei Med Univ, Ctr Translat Med, Taipei, Taiwan; [Chen, Yi-Fan] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biomed Informat, Taipei, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei, Taiwan.	mth@ym.edu.tw	Chen, Yi-Fan/AAP-1427-2020; Lin, I-Hsuan/N-6501-2013	Chen, Yi-Fan/0000-0002-0793-8769; Lin, I-Hsuan/0000-0002-6207-1299	Ministry of Education; National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan [MOST 104-2319-B-010-001]	Ministry of Education; National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan. The Core Facility of VYM Genome Research Center is supported by the National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan (MOST 104-2319-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Greco CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12418; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lunnon K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0871-x; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mariani Christopher J, 2013, Cancers (Basel), V5, P786, DOI 10.3390/cancers5030786; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Pfeifer GP, 2014, CELL TISSUE RES, V356, P631, DOI 10.1007/s00441-014-1896-7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shi XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153100; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; Tekpli X, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0070-8; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vasanthakumar A, 2015, CANCER GENET-NY, V208, P167, DOI 10.1016/j.cancergen.2015.02.009; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wu H, 2015, NAT STRUCT MOL BIOL, V22, P1, DOI 10.1038/nsmb.3071; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang Q, 2013, J BIOMED NANOTECHNOL, V9, P1607, DOI 10.1166/jbn.2013.1713; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang LY, 2016, JPN J CLIN ONCOL, V46, P427, DOI 10.1093/jjco/hyw002	62	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170779	10.1371/journal.pone.0170779	http://dx.doi.org/10.1371/journal.pone.0170779			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125731	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100053
J	Straubinger, J; Boldt, K; Kuret, A; Deng, L; Krattenmacher, D; Bork, N; Desch, M; Feil, R; Feil, S; Nemer, M; Ueffing, M; Ruth, P; Just, S; Lukowski, R				Straubinger, Julia; Boldt, Karsten; Kuret, Anna; Deng, Lisa; Krattenmacher, Diana; Bork, Nadja; Desch, Matthias; Feil, Robert; Feil, Susanne; Nemer, Mona; Ueffing, Marius; Ruth, Peter; Just, Steffen; Lukowski, Robert			Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4-negative mouse hearts	FASEB JOURNAL			English	Article						BNP; cGMP; CRP4; Crip1; cardiac hypertrophy	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN-T; KINASE-I; DILATED CARDIOMYOPATHY; NATRIURETIC PEPTIDES; NEOINTIMA FORMATION; ALPHA-TROPOMYOSIN; GENE; MUTATIONS; EXPRESSION	LIM domain proteins have been identified as essential modulators of cardiac biology and pathology; however, it is unclear which role the cysteine-rich LIM-only protein (CRP)4 plays in these processes. In studying CRP4 mutant mice, we found that their hearts developed normally, but lack of CRP4 exaggerated multiple parameters of the cardiac stress response to the neurohormone angiotensin II (Ang II). Aiming to dissect the molecular details, we found a link between CRP4 and the cardioprotective cGMP pathway, as well as a multiprotein complex comprising well-known hypertrophy-associated factors. Significant enrichment of the cysteine-rich intestinal protein (CRIP)1 in murine hearts lacking CRP4, as well as severe cardiac defects and premature death of CRIP1 and CRP4 morphant zebrafish embryos, further support the notion that depleting CRP4 is incompatible with a proper cardiac development and function. Together, amplified Ang II signaling identified CRP4 as a novel antiremodeling factor regulated, at least to some extent, by cardiac cGMP.-Straubinger, J., Boldt, K., Kuret, A., Deng, L., Krattenmacher, D., Bork, N., Desch, M., Feil, R., Feil, S., Nemer, M., Ueffing, M., Ruth, P., Just, S., Lukowski, R. Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4 negative mouse hearts.	[Straubinger, Julia; Kuret, Anna; Deng, Lisa; Bork, Nadja; Desch, Matthias; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Mol Biol Retinal Degenerat, Tubingen, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Med Proteome Ctr, Tubingen, Germany; [Feil, Robert; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Krattenmacher, Diana; Just, Steffen] Univ Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany; [Nemer, Mona] Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada; [Bork, Nadja] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Desch, Matthias] Madonnen Apotheke, Vienna, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ulm University; University of Ottawa; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lukowski, R (corresponding author), Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany.	robert.lukowski@uni-tuebingen.de	Feil, Robert/B-8918-2014; Feil, Susanne/AAF-7032-2019	Feil, Robert/0000-0002-7335-4841; 	Deutsche Forschungsgemeinschaft (DFG); DFG; cGMP Signaling in Cell Growth and Survival; Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); cGMP Signaling in Cell Growth and Survival; Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung	The authors thank Clement Kabagema-Bilan, Michael Glaser, and Katrin Junger (all from the Institute of Pharmacy, University of Tubingen) for excellent technical help. The authors also thank Franz Hofmann (Institute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany) for helpful discussions. Work the authors' laboratories is supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (to R.L. and P.R.); the DFG Research Unit 2060, "cGMP Signaling in Cell Growth and Survival"; and by the Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung (to R.L.). The authors declare no conflicts of interest.	Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Boldt K, 2009, METHOD CELL BIOL, V91, P143, DOI 10.1016/S0091-679X(08)91009-8; Bos JM, 2006, MOL GENET METAB, V88, P78, DOI 10.1016/j.ymgme.2005.10.008; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; Cheung AKL, 2011, P NATL ACAD SCI USA, V108, P8390, DOI 10.1073/pnas.1101747108; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Girolami F, 2014, CIRC-CARDIOVASC GENE, V7, P741, DOI 10.1161/CIRCGENETICS.113.000486; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Henderson JR, 1999, DEV DYNAM, V214, P229, DOI 10.1002/(SICI)1097-0177(199903)214:3<229::AID-AJA6>3.3.CO;2-J; Hu XQ, 2011, J CELL MOL MED, V15, P1865, DOI 10.1111/j.1582-4934.2010.01182.x; Huang XP, 1999, CIRC RES, V84, P1; Huber A, 2000, J BIOL CHEM, V275, P5504, DOI 10.1074/jbc.275.8.5504; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KAPLAN ML, 1994, AM J PHYSIOL, V267, pH1167, DOI 10.1152/ajpheart.1994.267.3.H1167; Karim MA, 1996, GENOMICS, V31, P167, DOI 10.1006/geno.1996.0028; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kessler M, 2015, EXPERT OPIN DRUG DIS, V10, P1231, DOI 10.1517/17460441.2015.1078788; Kim JD, 2014, MOL CELLS, V37, P406, DOI 10.14348/molcells.2014.0072; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kishimoto I, 2009, CURR CARDIOL REV, V5, P45, DOI 10.2174/157340309787048068; Klaiber M, 2010, BASIC RES CARDIOL, V105, P583, DOI 10.1007/s00395-010-0098-z; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kuhn C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0262-8; Kuhn Michaela, 2009, V191, P47, DOI 10.1007/978-3-540-68964-5_4; Lee DI, 2010, BASIC RES CARDIOL, V105, P337, DOI 10.1007/s00395-010-0084-5; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Liu Y, 1998, CIRC RES, V82, P1145, DOI 10.1161/01.RES.82.11.1145; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Ma YL, 2016, CELL SIGNAL, V28, P585, DOI 10.1016/j.cellsig.2016.02.019; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Meder B, 2011, BIOCHEM BIOPH RES CO, V408, P218, DOI 10.1016/j.bbrc.2011.03.121; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; OKANO I, 1993, FEBS LETT, V333, P51, DOI 10.1016/0014-5793(93)80373-3; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Sagave JF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-80; Schluter KD, 2008, PHARMACOL THERAPEUT, V119, P311, DOI 10.1016/j.pharmthera.2008.05.010; Schmidtko A, 2008, J NEUROSCI, V28, P1320, DOI 10.1523/JNEUROSCI.5037-07.2008; Song DW, 2015, BIOCHEM BIOPH RES CO, V463, P975, DOI 10.1016/j.bbrc.2015.06.045; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Straubinger J, 2015, J PHARMACOL EXP THER, V354, P406, DOI 10.1124/jpet.115.226092; Sun XJ, 2008, CIRC RES, V102, P831, DOI 10.1161/CIRCRESAHA.107.166488; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Texier Y, 2014, MOL CELL PROTEOMICS, V13, P1382, DOI 10.1074/mcp.O113.033233; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Thoonen R, 2015, CIRC-HEART FAIL, V8, P1115, DOI 10.1161/CIRCHEARTFAILURE.115.002308; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V349, P709, DOI 10.1016/j.bbrc.2006.08.106; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; Wang G, 2015, J PHYSIOL-LONDON, V593, P3013, DOI 10.1113/JP270033; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Wei J, 2005, CIRC RES, V97, P1323, DOI 10.1161/01.RES.0000194331.76925.5c; Wei TC, 2011, GENE EXPR PATTERNS, V11, P384, DOI 10.1016/j.gep.2011.05.001; Wells QS, 2011, CARDIOGENETICS, V1, P45, DOI 10.4081/cardiogenetics.2011.e10; Yamamoto R, 2007, CIRC J, V71, P1958, DOI 10.1253/circj.71.1958; Yu TS, 2002, MECH DEVELOP, V116, P187, DOI 10.1016/S0925-4773(02)00139-9; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200	75	9	9	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1620	1638		10.1096/fj.201601186	http://dx.doi.org/10.1096/fj.201601186			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28138039				2022-12-26	WOS:000398504300028
J	Demberg, LM; Winkler, J; Wilde, C; Simon, KU; Schon, J; Rothemund, S; Schoneberg, T; Promel, S; Liebscher, I				Demberg, Lilian M.; Winkler, Jana; Wilde, Caroline; Simon, Kay-Uwe; Schoen, Julia; Rothemund, Sven; Schoeneberg, Torsten; Proemel, Simone; Liebscher, Ines			Activation of Adhesion G Protein-coupled Receptors AGONIST SPECIFICITY OF STACHEL SEQUENCE-DERIVED PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERED AGONIST; PROTEOLYTIC SITE; CLEAVAGE; GPR126; DOMAIN; MOTIF; GPCR; MECHANISMS	Members of the adhesion G protein-coupled receptor (aGPCR) family carry an agonistic sequence within their large ectodomains. Peptides derived from this region, called the Stachel sequence, can activate the respective receptor. As the conserved core region of the Stachel sequence is highly similar between aGPCRs, the agonist specificity of Stachel sequencederived peptides was tested between family members using cell culture-based second messenger assays. Stachel peptides derived from aGPCRs of subfamily VI (GPR110/ADGRF1, GPR116/ADGRF5) and subfamily VIII (GPR64/ADGRG2, GPR126/ADGRG6) are able to activate more than one member of the respective subfamily supporting their evolutionary relationship and defining them as pharmacological receptor subtypes. Extended functional analyses of the Stachel sequences and derived peptides revealed agonist promiscuity, not only within, but also between aGPCR subfamilies. For example, the Stachelderived peptide of GPR110 (subfamily VI) can activate GPR64 and GPR126 (both subfamily VIII). Our results indicate that key residues in the Stachel sequence are very similar between aGPCRs allowing for agonist promiscuity of several Stachel-derived peptides. Therefore, aGPCRs appear to be pharmacologically more closely related than previously thought. Our findings have direct implications for many aGPCR studies, as potential functional overlap has to be considered for in vitro and in vivo studies. However, it also offers the possibility of a broader use of more potent peptides when the original Stachel sequence is less effective.	[Demberg, Lilian M.; Winkler, Jana; Wilde, Caroline; Simon, Kay-Uwe; Schoen, Julia; Schoeneberg, Torsten; Proemel, Simone; Liebscher, Ines] Univ Leipzig, Fac Med, Mol Biochem, Rudolf Schonheimer Inst Biochem, D-04103 Leipzig, Germany; [Rothemund, Sven] Univ Leipzig, Fac Med, Core Unit Peptide Technol, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Promel, S; Liebscher, I (corresponding author), Univ Leipzig, Fac Med, Mol Biochem, Rudolf Schonheimer Inst Biochem, D-04103 Leipzig, Germany.	simone.proemel@medizin.uni-leipzig.de; ines.liebscher@medizin.uni-leipzig.de	Liebscher, Ines/AAX-7478-2020	Liebscher, Ines/0000-0003-4480-8987; Promel, Simone/0000-0001-7800-7323; Wilde, Caroline/0000-0003-4548-1760	Deutsche Forschungsgemeinschaft [FOR2149]; BMBF (IFB AdipositasDiseases Leipzig) [ADI-K767]; European Social Fund; Free State of Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (IFB AdipositasDiseases Leipzig)(Federal Ministry of Education & Research (BMBF)); European Social Fund(European Social Fund (ESF)); Free State of Saxony	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR2149, BMBF (IFB AdipositasDiseases Leipzig) Grant ADI-K767, the European Social Fund, and the Free State of Saxony. The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Coster M, 2012, FASEB J, V26, P3273, DOI 10.1096/fj.12-203737; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liebscher I, 2016, HANDB EXP PHARMACOL, V234, P111, DOI 10.1007/978-3-319-41523-9_6; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liebscher I, 2013, BIOL CHEM, V394, P937, DOI 10.1515/hsz-2013-0109; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Muller A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005624; Okayama H., 1992, BIOTECHNOLOGY, V24, P270; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220	32	59	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4383	4394		10.1074/jbc.M116.763656	http://dx.doi.org/10.1074/jbc.M116.763656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154189	hybrid, Green Published			2022-12-26	WOS:000397585100001
J	Xia, J; Cui, JQ; He, X; Liu, YY; Yao, KC; Cao, SJ; Han, XF; Huang, Y				Xia, Jing; Cui, Jia-Qi; He, Xiao; Liu, Yue-Yue; Yao, Ke-Chang; Cao, San-Jie; Han, Xin-Feng; Huang, Yong			Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016	PLOS ONE			English	Article							HEMAGGLUTININ GENE; RECEPTOR-BINDING; VACCINE STRAIN; ACID; IDENTIFICATION; SELECTION; CLONING; FLOCKS	H9N2 avian influenza virus (AIV) has caused significant losses in chicken flocks throughout china in recent years. There is a limited understanding of the genetic and antigenic characteristics of the H9N2 virus isolated in chickens in southwestern China. In this study a total of 12 field strains were isolated from tissue samples from diseased chickens between 2013 and 2016. Phylogenetic analysis of the Hemagglutinin (HA) and Neuraminidase (NA) nucleotide sequences from the 12 field isolates and other reference strains showed that most of the isolates in the past four years could be clustered into a major branch (HA-branch A and NA-branch I) in the Clade h9.4.2 lineages. These sequences are accompanied by nine and seven new amino acids mutations in the HA and NA proteins, respectively, when compared with those previous to 2013. In addition, four new isolates were grouped into a minor branch (HA-branch B) in the Clade h9.4.2 lineages and two potential N-glycosylation sites were observed due to amino acid mutations in the HA protein. Three antigenic groups (1-3), which had low antigenic relatedness with two commonly used vaccines in China, were identified among the 12 isolates by antigenMap analysis. Immunoprotection testing showed that those two vaccines could efficiently prevent the shedding of branch A viruses but not branch B viruses. In conclusion, these results indicate the genotype of branch B may become epidemic in the next few years and that a new vaccine should be developed for the prevention of H9N2 AIV.	[Xia, Jing; Cui, Jia-Qi; He, Xiao; Liu, Yue-Yue; Yao, Ke-Chang; Cao, San-Jie; Han, Xin-Feng; Huang, Yong] Sichuan Agr Univ, Coll Vet Med, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Huang, Y (corresponding author), Sichuan Agr Univ, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	hyong601@163.com						Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Chen F, 2012, VIRUS GENES, V45, P69, DOI 10.1007/s11262-012-0742-9; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Ge FF, 2016, ARCH VIROL, V161, P1437, DOI 10.1007/s00705-016-2767-1; Goto H, 2016, J VIROLOGY; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hassan KE, 2016, POULTRY SCI, V95, P1271, DOI 10.3382/ps/pew068; He J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P708, DOI 10.3760/cma.j.issn.0254-6450.2016.05.025; Huang YY, 2010, VIRUS RES, V151, P26, DOI 10.1016/j.virusres.2010.03.010; Huang YW, 2015, J MED VIROL, V87, P1641, DOI 10.1002/jmv.24231; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Lee CW, 2009, COMP IMMUNOL MICROB, V32, P301, DOI 10.1016/j.cimid.2008.01.007; Lee DH, 2013, CLIN EXP VACCINE RES, V2, P26, DOI 10.7774/cevr.2013.2.1.26; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li Qiuchun, 2010, Weishengwu Xuebao, V50, P1545; Liu Lin-Yu, 2014, Bing Du Xue Bao, V30, P109; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Marinova-Petkova A, 2016, AVIAN DIS, V60, P108, DOI 10.1637/11136-050815-Reg; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Okamatsu M, 2008, ARCH VIROL, V153, P2189, DOI 10.1007/s00705-008-0243-2; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Qi XF, 2016, VET RES, V47, DOI 10.1186/s13567-016-0322-4; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Shanmuganatham K, 2013, EMERGING INFECT DIS, V19; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Sun YP, 2015, PROTEIN CELL, V6, P18, DOI 10.1007/s13238-014-0111-7; Sun YP, 2012, VET MICROBIOL, V156, P193, DOI 10.1016/j.vetmic.2011.10.003; Sun YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015537; Wan ZM, 2014, J VIROL, V88, P3898, DOI 10.1128/JVI.03440-13; Wei YD, 2016, VET MICROBIOL, V182, P1, DOI 10.1016/j.vetmic.2015.10.031; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wu ZQ, 2010, POULTRY SCI, V89, P1136, DOI 10.3382/ps.2010-00695; Xia J, 2016, INFECTION GENETICS E; Xu T, 2015, J GEN VIROL, V96, P2939, DOI 10.1099/jgv.0.000238; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020; Zhu YB, 2015, VET MICROBIOL, V178, P144, DOI 10.1016/j.vetmic.2015.04.012; Zou NL, 2010, VIRUS GENES, V41, P202, DOI 10.1007/s11262-010-0500-9	42	20	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171564	10.1371/journal.pone.0171564	http://dx.doi.org/10.1371/journal.pone.0171564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158271	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700100
J	Nlooto, M				Nlooto, Manimbulu			Comorbidities of HIV infection and health care seeking behavior among HIV infected patients attending public sector healthcare facilities in KwaZulu-Natal: A cross sectional study	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; ALTERNATIVE MEDICINE; DRUG INTERACTIONS; COMPLEMENTARY; POPULATION; DISEASE; PEOPLE	Background HIV-infected people may present with co-infections, comorbidities, and side effects associated with antiretroviral therapy. This study explored the prevalence of comorbid health problems and determined the extent of the use of traditional medicine for treatment of coinfections, comorbidities of HIV infection and side effects. Methods A cross sectional study, using researcher-administered questionnaires, was carried out among HIV-infected patients in eight public sector healthcare facilities in KwaZulu-Natal between April and October 1024. Self-reports of comorbidities, co-infections and side effects were analyzed with respect to factors such as age, gender, race, and health care seeking behavior including the use of traditional medicine. Cross-tabulations were conducted to test the association between factors and the use of traditional medicine, using Pearson chi-squared (chi(2)) test. Simple and multiple logistic regression models tested the association of the use of traditional medicine with age, gender, race, side effects and comorbidities. Odds ratios with 95% confidence intervals were estimated. Missing values were handled, defined and treated as missing values in the final analysis. Results Overall, 29.5% (n = 516) of the survey participants reported having other comorbidities and or co-infections besides their HIV condition. Same participants reported two or more comorbidities. Almost forty percent of participants (208/531, 39.17%) reported having hypertension as the most noninfectious comorbidity while 21.65% of participants (115/531) had tuberculosis accounting for the most infectious comorbidity. Almost eight percent of participants (142/1748, 8.12%) reported using traditional medicine after starting with cART. Sixty out of 142 participants (60/142, 42.25%) on cART resorted to the use of traditional medicine for the management of comorbidities and or co-infections of their HIV infection. Overall, 311 out of 1748 participants (17.80%) complained of ARVs related side-effects. Forty-five percent of those with side-effects (141/311, 45.34%) reported taking various types of medicines for treating side-effects, with 90.07% of them (127/141) using medicines prescribed by bio-medically trained doctors or by pharmacy personnel as over-the -counter medicines, p<0. 001. Very few participants (14/141, 9.93%) resorted to the use of traditional medicine for treating side effects associated with antiretroviral therapy with no significant difference (p=0.293). In a multiple logistic regression, after adjusting for age, gender, race and side-effects due to antiretroviral therapy, odds for using traditional medicine were almost two times higher [odds ratio = 1.884, 95% Confidence Interval 1.317-2.695] with those participants having comorbidities and co-infections, with a significant difference p-value<0.001. Conclusions Comorbidities, co-infections and side effects are prevalent among HIV-infected patients attending public sector healthcare facilities. Odds of using traditional medicine were almost two times higher and significantly associated with the presence of comorbidities and co-infections than for other factors. The presence of such comorbid health problems does not explain the increased use of traditional medicine among HIV-infected patients on antiretroviral therapy. Findings from this study should be interpreted cautiously as they cannot be generalized to the entire population of HIV-infected patients in KwaZulu-Natal. Studies on safety and efficacy of herbal traditional medicines are needed for beneficiation of the minority of patients who still resort to them for co-treatment with combination antiretroviral therapy.	[Nlooto, Manimbulu] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa	University of Kwazulu Natal	Nlooto, M (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa.	Nlooto@ukzn.ac.za			DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal; Victor Daitz Information Gateway; Victor Daitz Foundation; University of KwaZulu-Natal	DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal; Victor Daitz Information Gateway; Victor Daitz Foundation; University of KwaZulu-Natal	The author received running expenses from the College of Health Sciences and a stipend from the DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal, during the time this study was conducted. Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070326; Bajunirwe F, 2013, ANTIRETROVIRAL TREAT, P39; Bessong PO, 2008, T ROY SOC TROP MED H, V102, P209, DOI 10.1016/j.trstmh.2007.11.009; Boyer S, 2011, HLTH POLICY PLANNING; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Chinggwaru W, 2006, EUR J INTEGR MED; Cichello S., 2014, AUSTR J HERBAL MED, V26, P100; Deebii N, 2015, J BIOSCIENCES MED, V4, P54; Fasinu PS, 2016, CURR DRUG METAB, V17, P52, DOI 10.2174/1389200216666151103115053; Fasinu PS, 2013, PHARM BIOL, V51, P1499, DOI 10.3109/13880209.2013.796393; Grundy C., 2005, WHO GLOBAL ATLAS TRA; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Gustafsson M, 2010, COSTS ILLITERACY S A; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; Hasan SS, 2011, MED PRIN PRACT, V20, P265, DOI 10.1159/000321274; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Littlewood RA, 2008, AIDS CARE, V20, P1002, DOI 10.1080/09540120701767216; Machin D, 2011, SAMPLE SIZE TABLES C; Mbatha N, 2012, SAMJ S AFR MED J, V102, P129, DOI 10.7196/SAMJ.5295; McInerney PA, 2008, NURS HEALTH SCI, V10, P266, DOI 10.1111/j.1442-2018.2008.00410.x; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; National Department of Health Republic of South Africa, 2014, NAT CONS GUID PREV M; Nlooto M, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1101-5; PageShafer K, 1996, ANN EPIDEMIOL, V6, P420, DOI 10.1016/S1047-2797(96)00064-6; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; Reed R., 2012, HORIZ ENFERM, V1, P81; Simbayi L, 2014, S AFRICAN NATL HIV P; Souhami RL, 1997, LANCET, V350, P911, DOI 10.1016/S0140-6736(97)02307-6; UNAIDS, 2014, HIV AIDS EST; Venter F, 2012, S AFRICAN HLTH REV, V2012, P37; WHO (The World Health Organization), 2008, TRADITIONAL MED; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	34	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170983	10.1371/journal.pone.0170983	http://dx.doi.org/10.1371/journal.pone.0170983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151951	gold, Green Published			2022-12-26	WOS:000396161200065
J	Paraiso, LF; Goncalves-e-Oliveira, AFM; Cunha, LM; Neto, OPD; Pacheco, AG; Araujo, KBG; Garrote, RD; Neto, MB; Penha-Silva, N				Paraiso, Lara Ferreira; Mayrink Goncalves-e-Oliveira, Ana Flavia; Cunha, Lucas Moreira; de Almeida Neto, Omar Pereira; Pacheco, Adriana Garcia; Goncalves Araujo, Karinne Beatriz; Garrote-Filho, Rio da Silva; Bernardino Neto, Morun; Penha-Silva, Nilson			Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers	PLOS ONE			English	Article							RED-BLOOD-CELLS; INDUCED OXIDATIVE STRESS; PHYSICAL-EXERCISE; MULTIVARIATE ANALYSES; EXHAUSTIVE EXERCISE; SKELETAL-MUSCLE; FLUIDITY; DAMAGE; RELEVANCE; FRAGILITY	This study aimed to evaluate the influence of acute and chronic exercise on erythrocyte membrane stability and various blood indices in a population consisting of five national-level male swimmers, over 18 weeks of training. The evaluations were made at the beginning and end of the 1st, 7th, 13th and 18th weeks, when volume and training intensity have changed. The effects manifested at the beginning of those weeks were considered due to chronic adaptations, while the effects observed at the end of the weeks were considered due to acute manifestations of the exercise load of that week. Acute changes resulting from the exercise comprised increases in creatine kinase activity (CK) and leukocyte count (Leu), and decrease in hematocrit (Ht) and mean corpuscular volume (MCV), at the end of the first week; increase in the activities of CK and lactate dehydrogenase (LDH), in the uric acid (UA) concentration and Leu count, at the end of the seventh week; increases in CK and LDH activities and in the mean corpuscular hemoglobin concentration (MCHC), at the end of the 13th week; and decrease in the value of the osmotic stability index 1/H-50 and increases in the CK activity and platelets (Plt) count, at the end of the 18th week. Chronic changes due to training comprised increase in the values of 1/H-50, CK, LDH, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), serum iron (Fe), MCV and Plt. Although acute training has resulted in decrease in the osmotic stability of erythrocytes, possibly associated with exacerbation of the oxidative processes during intense exercise, chronic training over 18 weeks resulted in increased osmotic stability of erythrocytes, possibly by modulation in the membrane cholesterol content by low and high density lipoproteins.	[Paraiso, Lara Ferreira; Mayrink Goncalves-e-Oliveira, Ana Flavia; Cunha, Lucas Moreira; Pacheco, Adriana Garcia; Goncalves Araujo, Karinne Beatriz; Garrote-Filho, Rio da Silva; Penha-Silva, Nilson] Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil; [de Almeida Neto, Omar Pereira] Univ Fed Goias, Dept Hlth Sci, Jatai, Go, Brazil; [Bernardino Neto, Morun] Univ Sao Paulo, Dept Basic & Environm Sci, Sao Paulo, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Goias; Universidade de Sao Paulo	Penha-Silva, N (corresponding author), Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil.	nspenha@ufu.br	Neto, Morun Bernardino/L-7381-2015; Penha-Silva, Nilson/E-5730-2010; de Almeida Neto, Omar Pereira/AAJ-1704-2021; Garrote Filho, Mario da Silva/U-3043-2017	Neto, Morun Bernardino/0000-0003-4292-7800; Penha-Silva, Nilson/0000-0002-8205-6213; Garrote Filho, Mario da Silva/0000-0003-2332-6567	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG [PPM-00485-12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES [PE-PNPD AUX2718/2011]; Conselho Nacional de Pesquisa e Desenvolvimento, CNPq [307705/2012-9, 306608/2015-4]; FAPEMIG [PPM-00485-12]; CAPES [PE-PNPD AUX2718/2011]; CNPq [306608/2015-4]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG (PPM-00485-12); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES (PE-PNPD AUX2718/2011); Conselho Nacional de Pesquisa e Desenvolvimento, CNPq (307705/2012-9 and 306608/2015-4). The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank FAPEMIG (PPM-00485-12), CAPES (PE-PNPD AUX2718/2011) and CNPq (306608/2015-4) for the financial support that enabled the development of this study.	Aguilo A., 2000, Biofactors, V11, P27; Ashton T, 1998, EUR J APPL PHYSIOL O, V77, P498, DOI 10.1007/s004210050366; BALABAN EP, 1992, CLIN SPORT MED, V11, P313; Neto MB, 2013, BIORHEOLOGY, V50, P305, DOI 10.3233/BIR-130641; Berzosa C, 2011, EUR J APPL PHYSIOL, V111, P1127, DOI 10.1007/s00421-010-1738-6; Bishop C., 1964, RED BLOOD CELL; Bloomer RJ, 2007, INT J SPORTS MED, V28, P21, DOI 10.1055/s-2006-924140; Bloomer RJ, 2008, GENDER MED, V5, P218, DOI 10.1016/j.genm.2008.07.002; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Brun JF, 2007, SCI SPORT, V22, P251, DOI 10.1016/j.scispo.2007.09.010; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Brun JF, 2002, CLIN HEMORHEOL MICRO, V26, P155; Brzeszczynska J, 2008, APPL PHYSIOL NUTR ME, V33, P1223, DOI 10.1139/H08-125; Cazzola R, 2003, EUR J CLIN INVEST, V33, P924, DOI 10.1046/j.1365-2362.2003.01227.x; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; de Arvelos LR, 2013, J MEMBRANE BIOL, V246, P231, DOI 10.1007/s00232-013-9524-0; de Freitas MV, 2008, TOXICOL IN VITRO, V22, P219, DOI 10.1016/j.tiv.2007.07.010; de Freitas MV, 2014, HEMATOLOGY, V19, P424, DOI 10.1179/1607845413Y.0000000145; de Freitas MV, 2010, J MEMBRANE BIOL, V233, P127, DOI 10.1007/s00232-010-9232-y; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Lemos GSD, 2011, CELL BIOCHEM BIOPHYS, V61, P531, DOI 10.1007/s12013-011-9235-z; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Goto C, 2007, AM J HYPERTENS, V20, P825, DOI 10.1016/j.amjhyper.2007.02.014; Gwozdzinski K, 2013, SCI WORLD J, DOI 10.1155/2013/168376; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Jackson MJ, 2000, HDB OXIDANTS ANTIOXI, P57, DOI DOI 10.1016/B978-044482650-3/50002-X; JAIN NC, 1973, CORNELL VET, V63, P411; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; KAMADA T, 1993, J APPL PHYSIOL, V74, P354, DOI 10.1152/jappl.1993.74.1.354; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Kayatekin BM, 2010, BIOL SPORT, V27, P99, DOI 10.5604/20831862.913075; Klinken SP, 2002, INT J BIOCHEM CELL B, V34, P1513, DOI 10.1016/S1357-2725(02)00087-0; Knez WL, 2007, MED SCI SPORT EXER, V39, P283, DOI 10.1249/01.mss.0000246999.09718.0c; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Li JX, 1999, EUR J APPL PHYSIOL, V80, P113, DOI 10.1007/s004210050566; Netto RDM, 2014, PARASITOL RES, V113, P863, DOI 10.1007/s00436-013-3717-4; MASSALDI HA, 1988, BIOPHYS J, V54, P301, DOI 10.1016/S0006-3495(88)82960-6; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NAGASAWA T, 1976, TOHOKU J EXP MED, V120, P277; Paraiso LF, 2014, INT J SPORTS MED, V35, P1072, DOI 10.1055/s-0034-1371834; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Robinson Y, 2006, MED SCI SPORT EXER, V38, P480, DOI 10.1249/01.mss.0000188448.40218.4c; Santos-Silva A, 2001, CLIN CHIM ACTA, V306, P119, DOI 10.1016/S0009-8981(01)00406-5; Senturk UK, 2005, J APPL PHYSIOL, V99, P1434, DOI 10.1152/japplphysiol.01392.2004; SHIGA T, 1990, CRIT REV ONCOL HEMAT, V10, P9, DOI 10.1016/1040-8428(90)90020-S; SHIRAKI K, 1977, JPN J PHYSIOL, V27, P413; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; SJODIN B, 1990, SPORTS MED, V10, P236; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; SMITH JA, 1995, EUR J APPL PHYSIOL O, V70, P427, DOI 10.1007/BF00618494; Spodaryk K, 2002, PHYSIOL BEHAV, V75, P201, DOI 10.1016/S0031-9384(01)00640-0; SPODARYK K, 1990, MECH AGEING DEV, V55, P199, DOI 10.1016/0047-6374(90)90027-D; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Tozzi-Ciancarelli MG, 2002, EUR J APPL PHYSIOL, V86, P266, DOI 10.1007/s00421-001-0542-8; Tsuda K, 2003, CLIN EXP PHARMACOL P, V30, P382, DOI 10.1046/j.1440-1681.2003.03846.x; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; Walski T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/162102	62	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171318	10.1371/journal.pone.0171318	http://dx.doi.org/10.1371/journal.pone.0171318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151958	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200126
J	Pavkov-Keller, T; Steiner, K; Faber, M; Tengg, M; Schwab, H; Gruber-Khadjawi, M; Gruber, K				Pavkov-Keller, Tea; Steiner, Kerstin; Faber, Mario; Tengg, Martin; Schwab, Helmut; Gruber-Khadjawi, Mandana; Gruber, Karl			Crystal Structure and Catalytic Mechanism of CouO, a Versatile C-Methyltransferase from Streptomyces rishiriensis	PLOS ONE			English	Article							PROTEIN; METHYLATION; DISCOVERY; FEATURES	Friedel-Crafts alkylation of aromatic systems is a classic reaction in organic chemistry, for which regiospecific mono-alkylation, however, is generally difficult to achieve. In nature, methyltransferases catalyze the addition of methyl groups to a wide range of biomolecules thereby modulating the physico-chemical properties of these compounds. Specifically, S-adenosyl- L-methionine dependent C-methyltransferases possess a high potential to serve as biocatalysts in environmentally benign organic syntheses. Here, we report on the high resolution crystal structure of CouO, a C-methyltransferase from Streptomyces rishiriensis involved in the biosynthesis of the antibiotic coumermycin A1. Through molecular docking calculations, site-directed mutagenesis and the comparison with homologous enzymes we identified His120 and Arg121 as key functional residues for the enzymatic activity of this group of C-methyltransferases. The elucidation of the atomic structure and the insight into the catalytic mechanism provide the basis for the (semi)-rational engineering of the enzyme in order to increase the substrate scope as well as to facilitate the acceptance of SAM-analogues as alternative cofactors.	[Pavkov-Keller, Tea; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Pavkov-Keller, Tea; Steiner, Kerstin; Tengg, Martin; Schwab, Helmut; Gruber-Khadjawi, Mandana; Gruber, Karl] Austrian Ctr Ind Biotechnol GmbH, ACIB, Graz, Austria; [Faber, Mario; Tengg, Martin; Schwab, Helmut] Graz Univ Technol, Inst Mol Biotechnol, Graz, Austria; [Faber, Mario; Gruber-Khadjawi, Mandana] Graz Univ Technol, Inst Organ Chem, Graz, Austria	University of Graz; Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Gruber, K (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.; Gruber, K (corresponding author), Austrian Ctr Ind Biotechnol GmbH, ACIB, Graz, Austria.	karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022; Pavkov-Keller, Tea/K-9234-2015	Gruber, Karl/0000-0002-3485-9740; Pavkov-Keller, Tea/0000-0001-7871-6680	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program; Austrian Science Fund (FWF) [P24135]; Austrian Science Fund (FWF) [P 24135] Funding Source: researchfish	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by the Federal Ministry of Science, Research and Economy (BMWFW, http://www.bmwfw.gv.at/), the Federal Ministry of Traffic, Innovation and Technology (bmvit, https://www.bmvit.gv.at/), the Styrian Business Promotion Agency (SFG, https://www.sfg.at/), the Standortagentur Tirol (https://www.standort-tirol.at), the Government of Lower Austria (http://www.noe.gv.at/) and Business Agency Vienna (https://wirtschattsagentur.at/) through the COMET Funding Program managed by the Austrian Research Promotion Agency (FFG, https://www.ffg.at/). MGK. and KG. acknowledge financial support from the Austrian Science Fund (FWF, https://www.fwf.ac.at/) through project P24135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai YN, 2014, ACTA CRYSTALLOGR D, V70, P2085, DOI 10.1107/S1399004714011559; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Lyskowski A, 2012, ACTA CRYSTALLOGR F, V68, P698, DOI 10.1107/S1744309112017137; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P14969, DOI 10.1021/bi051599o; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Siegrist J, 2015, CHEMBIOCHEM, V16, P2576, DOI 10.1002/cbic.201500410; Stecher H, 2009, ANGEW CHEM INT EDIT, V48, P9546, DOI 10.1002/anie.200905095; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; Tengg M, 2016, CHEMCATCHEM, V8, P1354, DOI 10.1002/cctc.201501306; Tengg M, 2012, J MOL CATAL B-ENZYM, V84, P2, DOI 10.1016/j.molcatb.2012.03.016; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wessjohann L, 2014, CASCADE BIOCATALYSIS: INTEGRATING STEREOSELECTIVE AND ENVIRONMENTALLY FRIENDLY REACTIONS, P393; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171056	10.1371/journal.pone.0171056	http://dx.doi.org/10.1371/journal.pone.0171056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152088	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200080
J	Wu, JL; Ravikumar, P; Nguyen, KT; Hsia, CCW; Hong, Y				Wu, Jinglei; Ravikumar, Priya; Nguyen, Kytai T.; Hsia, Connie C. W.; Hong, Yi			Lung protection by inhalation of exogenous solubilized extracellular matrix	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-DEATH; MACROPHAGE PHENOTYPE; DE-CELLULARIZATION; IN-VITRO; HYPEROXIA; HYDROGEL; TISSUE; INJURY; DAMAGE	Decellularized extracellular matrix (ECM) contains complex tissue-specific components that work in concert to promote tissue repair and constructive remodeling and has been used experimentally and clinically to accelerate epithelial wound repair, leading us to hypothesize that lung-derived ECM could mitigate acute lung injury. To explore the therapeutic potential of ECM for noninvasive delivery to the lung, we decellularized and solubilized porcine lung ECM, then characterized the composition, concentration, particle size and stability of the preparation. The ECM preparation at 3.2 mg/mL with average particle size <3 mu m was tested in vitro on human A549 lung epithelial cells exposed to 95% O-2 for 24 hours, and in vivo by tracheal instillation or nebulization into the lungs of rats exposed intermittently or continuously to 90% O-2 for a cumulative 72 hours. Our results showed that the preparation was enriched in collagen, reduced in glycosaminoglycans, and contained various bioactive molecules. Particle size was concentration-dependent. Compared to the respective controls treated with cell culture medium in vitro or saline in vivo, ECM inhalation normalized cell survival and alveolar morphology, and reduced hyperoxia-induced apoptosis and oxidative damage. This proof-of-concept study established the methodology, feasibility and therapeutic potential of exogenous solubilized ECM for pulmonary cytoprotection, possibly as an adjunct or potentiator of conventional therapy.	[Wu, Jinglei; Nguyen, Kytai T.; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Wu, Jinglei; Nguyen, Kytai T.; Hsia, Connie C. W.; Hong, Yi] Joint Grad Program Biomed Engn Univ Texas Arlingt, Dallas, TX USA; [Ravikumar, Priya; Hsia, Connie C. W.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Pulm & Crit Care Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hong, Y (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.; Hsia, CCW; Hong, Y (corresponding author), Joint Grad Program Biomed Engn Univ Texas Arlingt, Dallas, TX USA.; Hsia, CCW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Pulm & Crit Care Med, Dallas, TX 75390 USA.	Connie.Hsia@utsouthwestern.edu; yihong@uta.edu	Hong, Yi/AAA-8971-2022; Wu, Jinglei/AFW-1416-2022; Wu, Jinglei/AFW-1414-2022	Wu, Jinglei/0000-0001-9549-3992; Wu, Jinglei/0000-0001-9549-3992; Hong, Yi/0000-0002-5846-2596	University of Texas at Arlington; National Heart, Lung and Blood Institute [R01 HL40070, U01 HL111146]; Mentored Clinical and Translational Research Scholar Award from the National Center for Advancing Translational Science of the National Institutes of Health [KL2TR001103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040070, R01HL134373, U01HL111146] Funding Source: NIH RePORTER	University of Texas at Arlington; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mentored Clinical and Translational Research Scholar Award from the National Center for Advancing Translational Science of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the support from a new faculty start-up fund (YH) at the University of Texas at Arlington, and the National Heart, Lung and Blood Institute grants R01 HL40070 (CCH) and U01 HL111146 (CCH and KTN). RP is the recipient of a Mentored Clinical and Translational Research Scholar Award (KL2TR001103) from the National Center for Advancing Translational Science of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Cepkova Magda, 2006, J Intensive Care Med, V21, P119, DOI 10.1177/0885066606287045; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Franek WR, 2004, FREE RADICAL BIO MED, V37, P1670, DOI 10.1016/j.freeradbiomed.2004.08.007; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; HEREMANS A, 1988, J BIOL CHEM, V263, P4731; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Jeffords ME, 2015, ACS APPL MATER INTER, V7, P11053, DOI 10.1021/acsami.5b03195; Jensen T, 2012, TISSUE ENG PART C-ME, V18, P632, DOI [10.1089/ten.tec.2011.0584, 10.1089/ten.TEC.2011.0584]; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039; Liu FF, 2013, TOXICOLOGY, V304, P158, DOI 10.1016/j.tox.2012.12.020; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Manni ML, 2011, TISSUE ENG PT A, V17, P2795, DOI 10.1089/ten.tea.2011.0023; Mendez JJ, 2014, TISSUE ENG PT A, V20, P1735, DOI [10.1089/ten.tea.2013.0647, 10.1089/ten.TEA.2013.0647]; Merna N, 2015, TISSUE ENG PT A, V21, P2195, DOI [10.1089/ten.TEA.2014.0337, 10.1089/ten.tea.2014.0337]; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Okamoto T, 2013, J THORAC CARDIOV SUR, V145, P1108, DOI 10.1016/j.jtcvs.2012.04.006; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Ravikumar P, 2016, NANOMED-NANOTECHNOL, V12, P811, DOI 10.1016/j.nano.2015.10.004; Ravikumar P, 2014, AM J PHYSIOL-LUNG C, V307, pL566, DOI 10.1152/ajplung.00306.2013; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Struber M, 2007, J THORAC CARDIOV SUR, V133, P1620, DOI 10.1016/j.jtcvs.2006.12.057; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Wallis JM, 2012, TISSUE ENG PART C-ME, V18, P420, DOI [10.1089/ten.tec.2011.0567, 10.1089/ten.TEC.2011.0567]; Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; Wu JL, 2015, ACTA BIOMATER, V16, P49, DOI 10.1016/j.actbio.2015.01.027; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007; Xu D, 2006, AM J PHYSIOL-LUNG C, V291, pL966, DOI 10.1152/ajplung.00045.2006; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171165	10.1371/journal.pone.0171165	http://dx.doi.org/10.1371/journal.pone.0171165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151947	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200098
J	McDougal, L; Atmavilas, Y; Hay, K; Silverman, JG; Tarigopula, UK; Raj, A				McDougal, Lotus; Atmavilas, Yamini; Hay, Katherine; Silverman, Jay G.; Tarigopula, Usha K.; Raj, Anita			Making the continuum of care work for mothers and infants: Does gender equity matter? Findings from a quasi-experimental study in Bihar, India	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; MIDDLE-INCOME COUNTRIES; QUALITY-OF-CARE; NEONATAL-MORTALITY; PREVENTIVE INTERVENTIONS; REPRODUCTIVE HEALTH; CHILD MARRIAGE; NEWBORN HEALTH; UTTAR-PRADESH; IMPACT	Background Improvements in continuum of care (CoC) utilization are needed to address inadequate reductions in neonatal and infant mortality in India and elsewhere. This study examines the effect of Ananya, a health system training and community outreach intervention, on reproductive, maternal and newborn health continuum of care (RMNH CoC) utilization in Bihar, India, and explores whether that effect is moderated by gender equity factors (child marriage, restricted mobility and low decision-making control). Methods A two-armed quasi-experimental design compared districts in Bihar that did/did not implement Ananya. Cross-sections of married women aged 15-49 with a 0-5 month old child were surveyed at baseline and two year follow-up (baseline n = 7191 and follow-up n = 6143; response rates 88.9% and 90.7%, respectively). Difference-in-difference analyses assessed program impact on RMNH CoC co-coverage, defined by 9 health services/behaviors for the index pregnancy (e.g.,antenatal care, skin-to-skin care). Three-way interactions assessed gender equity as a moderator of Ananya's impact. Findings Participants reported low RMNH CoC co-coverage at baseline (on average 3.2 and 3.0 of the 9 RMNH services/behaviors for Ananya and control groups, respectively). The Ananya group showed a significantly greater increase in RMNH CoC co-coverage (. 41 services) compared with the control group over time (p< 0.001), with the primary drivers being increases in clean cord care, skin-to-skin care and postpartum contraceptive use. Gender equity interaction analyses revealed diminished intervention effects on antenatal care, skilled birth attendance and exclusive breastfeeding for women married as minors. Conclusion Ananya improved RMNH CoC co-coverage among these recent mothers, largely through positive health behavior changes. Child marriage attenuated Ananya's impact on utilization of key health services and behaviors. Supporting the health system with training and community outreach can be beneficial to RMNH CoC utilization; additional support is needed to adequately address the unique issues faced by women married as minors.	[McDougal, Lotus; Silverman, Jay G.; Raj, Anita] Univ Calif San Diego, Dept Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth,Sch Med, San Diego, CA 92103 USA; [Atmavilas, Yamini; Hay, Katherine; Tarigopula, Usha K.] Bill & Melinda Gates Fdn, New Delhi, India	University of California System; University of California San Diego	McDougal, L (corresponding author), Univ Calif San Diego, Dept Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth,Sch Med, San Diego, CA 92103 USA.	lmcdouga@ucsd.edu	Hay, Katherine/ABB-7795-2021		Bill and Melinda Gates Foundation (BMGF); BMGF [OPP1163682]; Sambodhi Research and Communications Private Limited [UCSD 2016-3182]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); BMGF; Sambodhi Research and Communications Private Limited	This manuscript and the Ananya Program and data collection were supported by the Bill and Melinda Gates Foundation (BMGF www.gatesfoundation.org). LM, JGS and AR received funding from BMGF directly [OPP1163682] and via Sambodhi Research and Communications Private Limited [UCSD 2016-3182]. KH, YA and UKT are BMGF staff who participated in the development of this study and the generation of this manuscript, and are recognized as coauthors. In their roles with BMGF, they were involved with the design and conduct of the Ananya Program and evaluation study design from which data for this study were obtained. They provided some oversight of data collection and management, and gave input into analyses included in this manuscript. They assisted with the interpretation of this paper and reviewed and approved this final manuscript.	Agrawal PK, 2012, J EPIDEMIOL COMMUN H, V66, P755, DOI 10.1136/jech-2011-200362; Anand S, 2010, INT J HEALTH CARE Q, V23, P718, DOI 10.1108/09526861011081859; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, SEMIN PERINATOL, V34, P434, DOI 10.1053/j.semperi.2010.09.002; Black R., 2013, LANCET; Borkum E, 2014, MIDLINE FINDINGS EVA; Countdown to 2015, 2015, 9789280648140 WHO; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; IIPS and MoHFW, 2016, NATL FAMILY HLTH SUR; Jejeebhoy SJ, 2014, STUD FAMILY PLANN, V45, P183, DOI 10.1111/j.1728-4465.2014.00384.x; Kamiya Y, 2013, SOC SCI MED, V83, P34, DOI 10.1016/j.socscimed.2013.01.035; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Kraft JM, 2014, J HEALTH COMMUN, V19, P122, DOI 10.1080/10810730.2014.918216; Kumar GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-357; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S5; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S2; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lassi ZS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub2; Lawn JE, 2011, INT J EPIDEMIOL, V40, P525, DOI 10.1093/ije/dyq172; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; McCurdy RJ, 2011, ACTA OBSTET GYN SCAN, V90, P779, DOI 10.1111/j.1600-0412.2011.01133.x; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; National Family Health Survey (NFHS-3), 2007, NAT FAM HLTH SURV NF, VI; National Health Mission MoHFW Government of India, 2015, STAT WIS INF; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Peterman A., 2015, IFPRI - Discussion Papers; Raj A, 2014, INT J GYNECOL OBSTET, V124, P86, DOI 10.1016/j.ijgo.2013.07.027; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Scott VK, 2015, STUD FAMILY PLANN, V46, P241, DOI 10.1111/j.1728-4465.2015.00028.x; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Singh A, 2013, MATERN CHILD HLTH J, V17, P493, DOI 10.1007/s10995-012-1023-x; Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971; Singh S, 2012, ADDING IT COSTS BENE; Smith K, 2011, MEASUREMENT LEARNING; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0942-8; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Victora C, 2015, LANCET; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; Wendt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120404; WHO, 2009, WHO UNICEF JOINT STA; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2010, NEWBORN CHILD HLTH; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	58	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171002	10.1371/journal.pone.0171002	http://dx.doi.org/10.1371/journal.pone.0171002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146586	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700025
J	Ramzan, M; Bilal, M; Chung, JD				Ramzan, Muhammad; Bilal, Muhammad; Chung, Jae Dong			Radiative Flow of Powell-Eyring MagnetoNanofluid over a Stretching Cylinder with Chemical Reaction and Double Stratification near a Stagnation Point	PLOS ONE			English	Article							CONVECTIVE BOUNDARY-CONDITION; POROUS-MEDIUM; THERMAL-RADIATION; FLUID-FLOW; LAYER-FLOW; MHD FLOW; NANOFLUID; SORET; PLATE; SHEET	This exploration addresses MHD stagnation point Powell Eyring nanofluid flow with double stratification. The effects of thermal radiation and chemical reaction are added in temperature and nanoparticle concentration fields respectively. Furthermore, appropriate transformations are betrothed to obtain nonlinear differential equations from the system of partial differential equations and an analytical solution of system of coupled differential equations is obtained by means of the renowned Homotopy Analysis method. Through graphical illustrations, momentum, energy and concentration distributions are conversed for different prominent parameters. Comparison in limiting case is also part of present study to validate the obtained results. It is witnessed that nanoparticle concentration is diminishing function of chemical reaction parameter. Moreover, mounting values of thermal and solutal stratification lowers the temperature and concentration fields respectively.	[Ramzan, Muhammad] Bahria Univ, Dept Comp Sci, Islamabad Campus, Islamabad 44000, Pakistan; [Bilal, Muhammad] Capital Univ Sci & Technol, Fac Comp, Dept Math, Islamabad, Pakistan; [Chung, Jae Dong] Sejong Univ, Dept Mech Engn, Seoul 143747, South Korea	Capital University of Science & Technology; Sejong University	Ramzan, M (corresponding author), Bahria Univ, Dept Comp Sci, Islamabad Campus, Islamabad 44000, Pakistan.	mramzan@bahria.edu.pk	Ramzan, M./AAH-9959-2020	Ramzan, M./0000-0002-9523-5800	World Class 300 Project of the SMBA (Korea) [S2367878]	World Class 300 Project of the SMBA (Korea)	This work was supported by the World Class 300 Project (No. S2367878) of the SMBA (Korea).	Abbas Z, 2016, ENERGY, V95, P12, DOI 10.1016/j.energy.2015.11.039; Abbasi FM, 2016, J MAGN MAGN MATER, V404, P159, DOI 10.1016/j.jmmm.2015.11.090; Akbar NS, 2015, J MAGN MAGN MATER, V382, P355, DOI 10.1016/j.jmmm.2015.01.088; Dogonchi AS, 2016, J MOL LIQ, V220, P592, DOI 10.1016/j.molliq.2016.05.022; Hayat T, 2016, APPL MATH MECH-ENGL, V37, P919, DOI 10.1007/s10483-016-2093-9; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156955; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152555; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133831; Hayat T, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000501; Hayat T., 2016, THERMAL SCI; Hayat T, 2017, J AEROSPACE ENG, V30, DOI 10.1061/(ASCE)AS.1943-5525.0000674; Hayat T, 2017, THERM SCI, V21, P849, DOI 10.2298/TSCI141106052H; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145332; Hayat T, 2016, INT J HEAT MASS TRAN, V92, P100, DOI 10.1016/j.ijheatmasstransfer.2015.08.013; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127646; Hussain T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103719; Hussanan A, 2016, J TEKNOL, V78, P121; Hussanan A, 2015, MAEJO INT J SCI TECH, V9, P224; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Kaladhar K, 2017, COMPUT APPL MATH, V36, P611, DOI 10.1007/s40314-015-0248-x; Khan NA, 2015, INT J CHEM REACT ENG, V13, DOI 10.1515/ijcre-2014-0090; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Powell RE, 1944, NATURE, V154, P427, DOI 10.1038/154427a0; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14024-4; Qasim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083930; Ramzan M, 2016, J MOL LIQ, V221, P394, DOI 10.1016/j.molliq.2016.05.091; Ramzan M, 2016, ALEX ENG J, V55, P311, DOI 10.1016/j.aej.2015.09.012; Ramzan M, 2016, J MOL LIQ, V215, P212, DOI 10.1016/j.molliq.2015.12.036; Ramzan M, 2015, AIP ADV, V5, DOI 10.1063/1.4921312; Ramzan M, 2015, J CENT SOUTH UNIV, V22, P707, DOI 10.1007/s11771-015-2574-y; Ramzan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124699; Shehzad SA, 2015, J CENT SOUTH UNIV, V22, P360, DOI 10.1007/s11771-015-2530-x; Sk MT, 2016, APPL THERM ENG, V104, P758, DOI 10.1016/j.applthermaleng.2016.05.129	33	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170790	10.1371/journal.pone.0170790	http://dx.doi.org/10.1371/journal.pone.0170790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129356	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400034
J	Shukla, P; Mansoori, MN; Kakaji, M; Shukla, M; Gupta, SK; Singh, D				Shukla, Priyanka; Mansoori, Mohd Nizam; Kakaji, Manisha; Shukla, Manoj; Gupta, Sushil Kumar; Singh, Divya			Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; T-CELLS; OSTEOCLAST DIFFERENTIATION; TR1 CELLS; B-CELLS; INFLAMMATION; OSTEOBLAST; TH17; PROLIFERATION; ACTIVATION	A growing understanding of the bone remodeling process suggests that inflammation significantly contributes to the pathogenesis of osteoporosis. T cells and various cytokines contribute majorly to the estrogen deficiency-induced bone loss. Recent studies have identified the IL-12 cytokine family as consisting of pro-inflammatory IL-12 and IL-23 and the anti-inflammatory IL-27 and IL-35 cytokines. IL-27 exerts protective effects in autoimmune diseases like experimental autoimmune encephalomyelitis; however, its role in the pathogenesis of osteoporosisremains to be determined. In this report, we study the effect of IL-27 supplementation on ovariectomized estrogen-deficient mice on various immune and skeletal parameters. IL-27 treatment in ovariectomized mice suppressed Th17 cell differentiation by inhibiting transcription factor ROR gamma t. Supplementation of IL-27 activates Egr-2 to induce IL-10 producing Tr1 cells. IL-27 treatment prevented the loss of trabecular micro-architecture and preserved corticalboneparameters. IL-27 also in hibite do steoblastapoptosis through increased Egr-2 expression, which induces antiapoptotic factors like MCL-1. IL-27 suppressed osteoclastogenesis in an Egr-2-dependentmannerthat up-regulates Id2, the repressor of the receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Additionally, these results were corroborated in female osteoporotic subjects where we found decreased serum IL-27 levels along with reduced Egr-2 expression. Our study forms a strong basis for using humanized IL-27 toward the treatment of post-menopausal osteoporosis.	[Shukla, Priyanka; Mansoori, Mohd Nizam; Singh, Divya] Cent Drug Res Inst, CSIR, Div Endocrinol, BS 10-1,Sect 10, Lucknow 226031, Cdri, India; [Shukla, Priyanka; Mansoori, Mohd Nizam; Singh, Divya] Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, BS 10-1,Sect 10, Lucknow 226031, Cdri, India; [Kakaji, Manisha; Shukla, Manoj; Gupta, Sushil Kumar] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Pgi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Sanjay Gandhi Postgraduate Institute of Medical Sciences	Singh, D (corresponding author), Cent Drug Res Inst, CSIR, Div Endocrinol, BS 10-1,Sect 10, Lucknow 226031, Cdri, India.; Singh, D (corresponding author), Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, BS 10-1,Sect 10, Lucknow 226031, Cdri, India.	divya_singh@cdri.res.in			Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI) [BSC0201]; Department of Biotechnology, India [102/IFD/SAN/3486/2014-15]; CDRI [9424]; Council of Scientific and Industrial Research; University Grant Commission	Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology, India(Department of Biotechnology (DBT) India); CDRI; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India)	This work was supported in part by Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI) Grant BSC0201, Department of Biotechnology, India, Grants 102/IFD/SAN/3486/2014-15 (dated Nov. 25, 2014), CDRI Communication no. 9424, and the Council of Scientific and Industrial Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of support from University Grant Commission for fellowship.; Recipient of support from Council of Scientific and Industrial Research for fellowship.	Adamopoulos IE, 2013, CYTOKINE GROWTH F R, V24, P115, DOI 10.1016/j.cytogfr.2012.10.001; Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009; Kalliolias GD, 2010, ARTHRITIS RHEUM-US, V62, P402, DOI 10.1002/art.27200; Kamiya S, 2007, J BONE MINER METAB, V25, P277, DOI 10.1007/s00774-007-0766-8; Kim HJ, 2012, BONE, V51, P643, DOI 10.1016/j.bone.2012.07.015; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Liu H, 2011, J INTERF CYTOK RES, V31, P459, DOI 10.1089/jir.2010.0115; Mansoori MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep33680; Moon SJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.89; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Okamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7329; Park JS, 2012, IMMUNOLOGY, V137, P326, DOI 10.1111/j.1365-2567.2012.03622.x; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tyagi AM, 2012, OSTEOPOROSIS INT, V23, P1151, DOI 10.1007/s00198-011-1650-x; Tyagi AM, 2014, J BONE MINER RES, V29, P1981, DOI 10.1002/jbmr.2228; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Vasanthakumar A, 2013, EUR J IMMUNOL, V43, P882, DOI 10.1002/eji.201343479; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	37	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4686	4699		10.1074/jbc.M116.764779	http://dx.doi.org/10.1074/jbc.M116.764779			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28130449	Green Published, hybrid			2022-12-26	WOS:000397585100025
J	Huang, KS; Wang, SH; Chuah, SK; Rau, KM; Lin, YH; Hsieh, MC; Shih, LH; Chen, YH				Huang, Kun-Siang; Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Shih, Li-Hsueh; Chen, Yen-Hao			The effects of hospice-shared care for gastric cancer patients	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; PALLIATIVE CARE; LIFE; END; TAIWAN; IMPACT; EXPENDITURE; OUTCOMES; JAPAN	Background Hospice care has been proved to result in changes to the medical behaviors of terminally ill patients. The aim of this study was to evaluate the effects and medical behavior changes of hospice-shared care intervention among terminally ill gastric cancer patients. Methods A total of 174 patients who died of gastric cancer between 2012 and 2014 were identified. These patients were divided into two groups: a hospice-shared care group (n = 93) and a control group (n = 81). Results Among the 174 patients, 84% had advanced stage (stage III or stage IV) cancer. The females and the patients cared by medical oncologists had a higher percentage of hospice-shared care than the males (71% vs 44%, p = 0.001) and those cared by other physicians (63% vs 41%, p = 0.004). Compared to the control group, the hospice-shared care group underwent lower incidence of life sustaining or aggressive medical treatments, including intensive care unit admission (2% vs 26%, p<0.001), intubation (1% vs 27%, p<0.001), cardiopulmonary- cerebral resuscitation (0% vs 11%, p = 0.001), ventilator use (1% vs 27%, p< 0.001), inotropic agent use (8% vs 46%, p< 0.001), total or partial parenteral nutrition use (38% vs. 58%, p = 0.029), and blood transfusion (45% vs 74%, p< 0.001). Besides, the hospice- shared care group had a higher percentage of palliative treatments than the control group, including signed Do-Not-Resuscitate (DNR) orders (95% vs 37%, p< 0.001), receiving home hospice care (16% vs 1%, p< 0.001), and indicating home as the realistically preferred place of death (41% vs 19%, p = 0.001). The hospice ward admission rate in the hospice-shared care group increased from 30% to 53% from 2012 to 2014. Conclusion The use of hospice-shared care for gastric cancer patients could increase the rate of signed DNR orders, decrease the use of life sustaining and aggressive/palliative treatments, and improve quality of life.	[Huang, Kun-Siang] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Kun-Siang; Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Chen, Yen-Hao] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Shih-Ho; Lin, Yu-Hung] Kaohsiung Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Shih, Li-Hsueh; Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Gastr Canc Team, Kaohsiung, Taiwan; [Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Rau, Kun-Ming; Hsieh, Meng-Che; Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Shih, Li-Hsueh] Kaohsiung Chang Gung Mem Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Hosp Care Team, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Gastr Canc Team, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Hosp Care Team, Kaohsiung, Taiwan.	alex8701125@gmail.com						Bai Yana, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P306, DOI 10.3760/cma.j.issn.0254-6450.2016.03.002; Chuang R-B, 2005, TAIWAN J HOSPICE PAL, V10, P5; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Everett SM, 1997, GUT, V41, P142, DOI 10.1136/gut.41.2.142; Gwilliam B, 2001, Int J Palliat Nurs, V7, P474; Hong JH, 2013, CANCER RES TREAT, V45, P270, DOI 10.4143/crt.2013.45.4.270; Izadi Azar, 2016, Asian Pac J Cancer Prev, V17, P3007; Kang SC, 2012, J CHIN MED ASSOC, V75, P221, DOI 10.1016/j.jcma.2012.04.005; Lai YL, 1997, SUPPORT CARE CANCER, V5, P348, DOI 10.1007/s005200050090; Lin WY, 2014, SUPPORT CARE CANCER, V22, P1907, DOI 10.1007/s00520-014-2168-5; Liu CN, 2002, J FORMOS MED ASSOC, V101, P552; Loke SS, 2011, J PALLIAT MED, V14, P683, DOI 10.1089/jpm.2010.0331; Loke SS, 2011, CANCER NURS, V34, pE21, DOI 10.1097/NCC.0b013e3181ff78b6; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; MAEHARA Y, 1992, BRIT J SURG, V79, P245, DOI 10.1002/bjs.1800790320; Masuda Y, 2006, J PALLIAT MED, V9, P152, DOI 10.1089/jpm.2006.9.152; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Okada K, 2012, ENDOSCOPY, V44, P122, DOI 10.1055/s-0031-1291486; Rosania R, 2015, GASTROINTEST TUMORS, V2, P178, DOI 10.1159/000445188; Sato K, 2008, SUPPORT CARE CANCER, V16, P113, DOI 10.1007/s00520-007-0332-x; Torelli GF, 1999, NUTRITION, V15, P665, DOI 10.1016/S0899-9007(99)00118-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tse DMW, 2007, PALLIATIVE MED, V21, P425, DOI 10.1177/0269216307079825; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Wu LF, 2016, SUPPORT CARE CANCER, V24, P53, DOI 10.1007/s00520-015-2741-6; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M	28	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171365	10.1371/journal.pone.0171365	http://dx.doi.org/10.1371/journal.pone.0171365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158232	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700065
J	Landry, J; Martinov, T; Mengistu, H; Dhanwada, J; Benck, CJ; Kline, J; Boo, B; Swanson, L; Tonc, E; Daughters, R; Fife, BT; Chatterjea, D				Landry, Jasmine; Martinov, Tijana; Mengistu, Hanna; Dhanwada, Jyothi; Benck, Charles J.; Kline, Jaclyn; Boo, Beebie; Swanson, Linnea; Tonc, Elena; Daughters, Randy; Fife, Brian T.; Chatterjea, Devavani			Repeated hapten exposure induces persistent tactile sensitivity in mice modeling localized provoked vulvodynia	PLOS ONE			English	Article							MAST-CELL PROGENITORS; TUMOR-NECROSIS-FACTOR; VULVAR VESTIBULITIS; MOUSE MODEL; IGE; HYPERSENSITIVITY; HYPERINNERVATION; RECRUITMENT; EXPRESSION; ETIOLOGY	Background Vulvodynia is a remarkably prevalent chronic pain condition of unknown etiology. Epidemiologic studies associate the risk of vulvodynia with a history of atopic disease. We used an established model of hapten-driven contact hypersensitivity to investigate the underlying mechanisms of allergy-provoked prolonged sensitivity to pressure. Methods We sensitized female ND4 Swiss mice to the hapten oxazolone on their flanks, and subsequently challenged them four days later with oxazolone or vehicle for ten consecutive days on the labia. We evaluated labiar sensitivity to touch, local mast cell accumulation, and hyperinnervation after ten challenges. Results Oxazolone-challenged mice developed significant tactile sensitivity that persisted for over three weeks after labiar allergen exposures ceased. Allergic sites were characterized by mast cell accumulation, sensory hyper-innervation and infiltration of regulatory CD4(+)CD25(+)FoxP3(+)T cells as well as localized early increases in transcripts encoding Nerve Growth Factor and nerve-mast cell synapse marker Cell Adhesion Molecule 1. Local depletion of mast cells by intra-labiar administration of secretagogue compound 48/80 led to a reduction in both nerve density and tactile sensitivity. Conclusions Mast cells regulate allergy-provoked persistent sensitivity to touch. Mast cell-targeted therapeutic strategies may provide novel means to manage and limit chronic pain conditions associated with atopic disease.	[Landry, Jasmine; Mengistu, Hanna; Dhanwada, Jyothi; Benck, Charles J.; Kline, Jaclyn; Boo, Beebie; Swanson, Linnea; Tonc, Elena; Daughters, Randy; Chatterjea, Devavani] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Martinov, Tijana; Fife, Brian T.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	Macalester College; University of Minnesota System; University of Minnesota Twin Cities	Chatterjea, D (corresponding author), Macalester Coll, Dept Biol, St Paul, MN 55105 USA.	chatterjead@macalester.edu	Martinov, Tijana/AFU-5047-2022; Landry, Jasmine/AAI-8246-2021; Fife, Brian/D-2042-2013	Landry, Jasmine/0000-0002-3242-9878; Kline, Jaclyn/0000-0002-6897-5520; Fife, Brian/0000-0001-9826-5637; Martinov, Tijana/0000-0002-6027-3380	National Institutes of Health [NIH R15 NS067536-01A1, NIH R15 AI113620-01A1]; National Vulvodynia Association; Macalester College; Arnold and Mabel Beckman Foundation; Howard Hughes Medical Research Institute; National Institute of Health [R01AI106791]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI113620, T35AI118620, R01AI106791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Vulvodynia Association; Macalester College; Arnold and Mabel Beckman Foundation; Howard Hughes Medical Research Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support includes National Institutes of Health grants NIH R15 NS067536-01A1 and NIH R15 AI113620-01A1 (awarded to DC; https://www.nih.gov), a National Vulvodynia Association research grant (awarded to DC; http://www.nva.org), and internal awards from Macalester College. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CJB and JD received stipends from intra-mural programs supported by science education grants to Macalester College from the Arnold and Mabel Beckman Foundation (CJB) and the Howard Hughes Medical Research Institute (HM, JD). TM and BTF are supported by National Institute of Health grant R01AI106791.	Akopians AL, 2015, SEMIN REPROD MED, V33, P239, DOI 10.1055/s-0035-1554919; Almarestani L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-56; Babula O, 2004, AM J OBSTET GYNECOL, V190, P663, DOI 10.1016/j.ajog.2003.09.031; Bax HJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00229; Benck CJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53638; Bomstein J, 2008, INT J GYNECOL PATHOL, V27, P136, DOI 10.1097/pgp.0b013e318140021b; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Chakrabarty A, 2011, NEUROSCI LETT, V495, P67, DOI 10.1016/j.neulet.2011.03.043; Chatterjea D, 2015, MOL IMMUNOL, V63, P38, DOI 10.1016/j.molimm.2014.03.001; Chatterjea D, 2012, BIOCHEM BIOPH RES CO, V425, P237, DOI 10.1016/j.bbrc.2012.07.074; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Falsetta ML, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.002; Farage MA, 2011, CURR PROBL DERMATOL, V40, P9, DOI 10.1159/000321042; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Foster DC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.038; Foster DC, 1997, OBSTET GYNECOL, V89, P291, DOI 10.1016/S0029-7844(96)00447-4; Giesecke J, 2004, OBSTET GYNECOL, V104, P126, DOI 10.1097/01.AOG.0000129238.49397.4e; Gimenez-Rivera V, 2016, J IMMUNOL; Goetsch MF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.028; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Hagiyama M, 2013, BRIT J DERMATOL, V168, P771, DOI 10.1111/bjd.12108; Harlow BL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.033; Harlow BL, 2009, ANN EPIDEMIOL, V19, P771, DOI 10.1016/j.annepidem.2009.06.006; Harlow BL, 2005, AM J EPIDEMIOL, V161, P871, DOI 10.1093/aje/kwi108; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Jones TG, 2010, J IMMUNOL, V185, P1804, DOI 10.4049/jimmunol.1001146; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewendorf AI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00140; Martinov T, 2013, JOVE-J VIS EXP, DOI 10.3791/51212; Martinov T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078673; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Nguyen RHN, 2009, J REPROD MED, V54, P385; Nyirjesy P, 2001, SEX TRANSM INFECT, V77, P53, DOI 10.1136/sti.77.1.53; Piovezan AP, 2004, BRIT J PHARMACOL, V141, P755, DOI 10.1038/sj.bjp.0705663; Pukall CF, 2016, J SEX MED, V13, P291, DOI 10.1016/j.jsxm.2015.12.021; Reed BD, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.012; Regauer S, 2015, APMIS, V123, P452, DOI 10.1111/apm.12372; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Sadownik LA, 2014, INT J WOMENS HEALTH, V6, P437, DOI 10.2147/IJWH.S37660; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tommola P, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1098; Wesselmann U, 2014, PAIN, V155, P1696, DOI 10.1016/j.pain.2014.05.010; Xiang Z, 2000, CLIN EXP ALLERGY, V30, P1379, DOI 10.1046/j.1365-2222.2000.00906.x; Yoneshige A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00075; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169672	10.1371/journal.pone.0169672	http://dx.doi.org/10.1371/journal.pone.0169672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158195	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700004
J	Carbia, C; Cadaveira, F; Caamano-Isorna, F; Rodriguez-Holguin, S; Corral, M				Carbia, Carina; Cadaveira, Fernando; Caamano-Isorna, Francisco; Rodriguez-Holguin, Socorro; Corral, Montse			Binge drinking during adolescence and young adulthood is associated with deficits in verbal episodic memory	PLOS ONE			English	Article							ALCOHOL-USE; HIPPOCAMPAL FUNCTION; WEEKEND ALCOHOLISM; ETHANOL EXPOSURE; PERSISTENT LOSS; LEARNING TEST; NEUROGENESIS; BRAIN; PERFORMANCE; CONSUMPTION	Binge drinking (BD), a harmful pattern of alcohol consumption, is common during adolescence. Young adults with alcohol use disorders exhibit hippocampal alterations and episodic memory deficits. However, it is not known how these difficulties progress in community BD adolescents. Our objective was to analyze the relationship between BD trajectory and verbal episodic memory during the developmental period spanning from adolescence and to early adulthood. An initial sample of 155 male and female first-year university students with no other risk factors were followed over six years. Participants were classified as stable nonBDs, stable BDs and ex-BDs according to the third AUDIT item. At baseline, participants comprised 36 male/40 female non-BDs (18.58 years), 40 male/39 female BDs (18.87 years), and at the third follow-up, they comprised 8 cf/8 9 stable non-BDs (25.49 years), 2 male/2 female stable BDs (25.40) and 8 male/12 female ex-BDs (24.97 years). Episodic memory was assessed four times with the Logical Memory subtest (WMS-III) and the Rey Auditory Verbal Learning Test (RAVLT). Generalized linear mixed models were applied. The results showed that, relative to non-BDs, stable BDs presented difficulties in immediate and delayed recall in the Logical Memory subtest. These difficulties remained stable over time. The short-term ex-BDs continued to display difficulties in immediate and delayed recall in the Logical Memory subtest, but long-term ex-BDs did not. The effects were not influenced by age of alcohol onset, frequency of cannabis use, tobacco use or psychopathological distress. In conclusion, BD during adolescence and young adulthood is associated with episodic memory deficits. Abandoning the BD pattern may lead to partial recovery. These findings are consistent with the vulnerability of the adolescent hippocampus to the neurotoxic effects of alcohol.	[Carbia, Carina; Cadaveira, Fernando; Rodriguez-Holguin, Socorro; Corral, Montse] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Caamano-Isorna, Francisco] Univ Santiago de Compostela, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Dept Prevent Med, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela	Carbia, C (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain.	carina.carbia@usc.es	Cadaveira, Fernando/ABE-7827-2021; Varela, Montserrat Corral/AEP-7949-2022; Cadaveira, Fernando/C-5981-2011; Holguín, Socorro Rodríguez/D-1800-2010; Caamano-Isorna, Francisco/AAL-3770-2020; Varela, Montserrat Corral/A-6384-2012	Cadaveira, Fernando/0000-0001-6198-1541; Varela, Montserrat Corral/0000-0003-3068-3415; Cadaveira, Fernando/0000-0001-6198-1541; Holguín, Socorro Rodríguez/0000-0003-1502-987X; Carbia, Carina/0000-0001-7921-8966; Caamano-Isorna, Francisco/0000-0001-8995-3673	Spanish Ministerio de Ciencia e Innovacion [EDU2008-03400, PSI2011-22575]; Spanish Ministerio de Educacion [FPU13/04569]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Educacion(Spanish Government)	The study was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (EDU2008-03400; PSI2011-22575). Carina Carbia was supported by the FPU program (FPU13/04569) of the Spanish Ministerio de Educacion.	Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Brown H., APPL MIXED MODELS ME; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brown SA, 2004, ANN NY ACAD SCI, V1021, P234, DOI 10.1196/annals.1308.028; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Caamano-Isorna F, 2008, J STUD ALCOHOL DRUGS, V69, P308, DOI 10.15288/jsad.2008.69.308; Chin VS, 2010, ALCOHOL, V44, P3, DOI 10.1016/j.alcohol.2009.10.015; Consonni M, 2015, J NEUROPSYCHOL, V242, DOI [10.1080/13854040590947461, DOI 10.1080/13854040590947461]; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; Degoratis LR, 1983, SCL90R; Doallo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096380; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Garcioa-Moreno L M, 2009, NEUROPSICOLOGIA NEUR, V9, P75; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Hanson KL, 2011, PSYCHOL ADDICT BEHAV, V25, P127, DOI 10.1037/a0022350; Hanson KL, 2010, AM J DRUG ALCOHOL AB, V36, P161, DOI 10.3109/00952991003736397; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; He J, 2007, PHARMACOL BIOCHEM BE, V86, P327, DOI 10.1016/j.pbb.2006.11.003; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Howell NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074164; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lundervold AJ, 2015, J ATTEN DISORD; Marshall EJ, 2014, ALCOHOL ALCOHOLISM, V49, P160, DOI 10.1093/alcalc/agt180; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Garcia-Moreno L, 2008, ADICCIONES, V20, P271, DOI 10.20882/adicciones.269; Mitrushina M., 2005, HDB NORMATIVE DATA N; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; Nguyen-Louie TT, 2016, ALCOHOL CLIN EXP RES, V40, p303A, DOI 10.1111/acer.13160; Nixon K, 2010, CURR OPIN PSYCHIATR, V23, P227, DOI 10.1097/YCO.0b013e32833864fe; Nixon K, 2010, ALCOHOL, V44, P39, DOI 10.1016/j.alcohol.2009.11.001; Oliveira ACA, 2015, J PSYCHOPHARMACOL, V29, P712, DOI 10.1177/0269881115581960; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Parada M, 2011, ALCOHOL CLIN EXP RES, V35, P1475, DOI 10.1111/j.1530-0277.2011.01484.x; Pascual M, 2014, ALCOHOL ALCOHOLISM, V49, P187, DOI 10.1093/alcalc/agt164; R Core Team, 2013, R LANG ENV STAT COMP; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rouleau I, 2001, BRAIN COGNITION, V46, P244, DOI 10.1016/S0278-2626(01)80076-2; Salas-Gomez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166834; Sanhueza C, 2011, PSICOTHEMA, V23, P209; Sawrie SM, 2001, EPILEPSIA, V42, P651, DOI 10.1046/j.1528-1157.2001.30200.x; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SHIMAMURA AP, 1995, J COGNITIVE NEUROSCI, V7, P144, DOI 10.1162/jocn.1995.7.2.144; Shing YL, 2010, NEUROSCI BIOBEHAV R, V34, P1080, DOI 10.1016/j.neubiorev.2009.11.002; Silveri MM, 2016, NEUROSCI BIOBEHAV R, V70, P244, DOI 10.1016/j.neubiorev.2016.06.042; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sneider JT, 2013, J ADDICT RES THER S7; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Squeglia LM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0689-y; Squeglia Lindsay M, 2012, Psychopharmacology (Berl), V220, P529, DOI 10.1007/s00213-011-2500-4; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355, https://doi.org/10.1037/0894-4105.8.3.355]; Substance Abuse and Mental Health, 2013, USITC PUBL; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vargas WM, 2014, J NEUROSCI, V34, P14777, DOI 10.1523/JNEUROSCI.3189-13.2014; Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P218, DOI 10.1017/S1355617713001410; Woodard JL, 1999, J CLIN EXP NEUROPSYC, V21, P553, DOI 10.1076/jcen.21.4.553.878	81	43	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171393	10.1371/journal.pone.0171393	http://dx.doi.org/10.1371/journal.pone.0171393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152062	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161200139
J	Elaish, M; Ngunjiri, JM; Ali, A; Xia, M; Ibrahim, M; Jang, H; Hiremath, J; Dhakal, S; Helmy, YA; Jiang, X; Renukaradhya, GJ; Lee, CW				Elaish, Mohamed; Ngunjiri, John M.; Ali, Ahmed; Xia, Ming; Ibrahim, Mahmoud; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Helmy, Yosra A.; Jiang, Xi; Renukaradhya, Gourapura J.; Lee, Chang-Won			Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; IMPROVED CROSS-PROTECTION; INFECTED-CELL SURFACE; A VIRUS; M2 PROTEIN; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODY; FUSION PROTEIN; EPITOPE; H5	The current inactivated influenza vaccines provide satisfactory protection against homologous viruses but limited cross-protection against antigenically divergent strains. Consequently, there is a need to develop more broadly protective vaccines. The highly conserved extracellular domain of the matrix protein 2 (M2e) has shown promising results as one of the components of a universal influenza vaccine in different animal models. As an approach to overcome the limited, strain specific, protective efficacy of inactivated influenza vaccine (IIV), a combination of recombinant M2e expressed on the surface of norovirus P particle (M2eP) and IIV was tested in chickens. Co-immunization of birds with both vaccines did not affect the production of M2e-specific IgG antibodies compared to the group vaccinated with M2eP alone. However, the co-immunized birds developed significantly higher pre-challenge hemagglutination inhibition antibody titers against the homologous IIV antigen and heterologous challenge virus. These combined vaccine groups also had cross reactive antibody responses against different viruses (H5, H6, and H7 subtypes) compared to the IIV alone vaccinated group. Upon intranasal challenge with homologous and heterologous viruses, the combined vaccine groups showed greater reduction in viral shedding in tracheal swabs compared to those groups receiving IIV alone. Moreover, M2eP antisera from vaccinated birds were able to bind to the native M2 expressed on the surface of whole virus particles and infected cells, and inhibit virus replication in vitro. Our results support the potential benefit of supplementing IIV with M2eP, to expand the vaccine cross protective efficacy.	[Elaish, Mohamed; Ngunjiri, John M.; Ali, Ahmed; Ibrahim, Mahmoud; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Helmy, Yosra A.; Renukaradhya, Gourapura J.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Elaish, Mohamed; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Renukaradhya, Gourapura J.; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Xia, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Ali, Ahmed] Beni Suef Univ, Fac Vet Med, Poultry Dis Dept, Bani Suwayf, Egypt; [Ibrahim, Mahmoud] Univ Sadat City, Fac Vet Med, Dept Birds & Rabbit Med, Menoufia, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); University of Sadat City	Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	lee.2854@osu.edu	Elaish, Mohamed/AAT-4642-2020; Helmy, Yosra A./I-9426-2019; Dhakal, Santosh/J-2906-2019; Ngunjiri, John/AAB-3798-2021; Xia, Ming/AAY-7154-2021; Jang, Hyesun/AAG-7814-2021; Ali, Ahmed/B-5108-2013	Helmy, Yosra A./0000-0003-1470-5418; Dhakal, Santosh/0000-0002-4494-8608; Ngunjiri, John/0000-0002-2131-1698; Ali, Ahmed/0000-0002-2576-2031; Elaish, Mohamed/0000-0003-3628-5856; Ibrahim, Mahmoud/0000-0002-8259-7706; Jang, Hyesun/0000-0002-8142-8222	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Ohio Agricultural Research and Development Center, The Ohio State University; Egyptian Ministry of Higher Education	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture and funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. Mohamed Elaish is supported by a PhD scholarship from the Egyptian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babapoor S, 2011, INFLUENZA RES TREAT, V2011; Chande C, 1996, Indian J Pathol Microbiol, V39, P27; Dabaghian M, 2014, VET MICROBIOL, V174, P116, DOI 10.1016/j.vetmic.2014.09.009; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Deng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126650; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ebrahimi SM, 2010, MOL BIOL REP, V37, P2877, DOI 10.1007/s11033-009-9846-2; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Elaish M, 2015, VACCINE, V33, P4901, DOI 10.1016/j.vaccine.2015.07.049; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gabbard J, 2009, PROTEIN ENG DES SEL, V22, P189, DOI 10.1093/protein/gzn070; Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; HUGHEY PG, 1995, VIROLOGY, V212, P411, DOI 10.1006/viro.1995.1498; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156603; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kapczynski DR, 2009, CURR TOP MICROBIOL, V333, P133, DOI 10.1007/978-3-540-92165-3_6; Kim MC, 2014, VACCINE; Kim MC, 2014, MOL THER, V22, P1364, DOI 10.1038/mt.2014.33; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Layton SL, 2009, POULTRY SCI, V88, P2244, DOI 10.3382/ps.2009-00251; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; 박형록, 2013, [Journal of Preventive Veterinary Medicine, 예방수의학회지], V37, P169; Lee YN, 2015, IMMUNE NETW, V15, P213, DOI 10.4110/in.2015.15.5.213; Lee YN, 2015, ANTIVIR RES, V122, P82, DOI 10.1016/j.antiviral.2015.08.001; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park JK, 2014, VET MICROBIOL, V169, P211, DOI 10.1016/j.vetmic.2014.01.001; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; RYANPOIRIER KA, 1991, J VIROL, V65, P389, DOI 10.1128/JVI.65.1.389-395.1991; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Song BM, 2016, VACCINE, V34, P678, DOI 10.1016/j.vaccine.2015.11.074; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stepanova LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119520; Swayne DE, 1999, AVIAN PATHOL, V28, P245, DOI 10.1080/03079459994731; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2012, NANOMEDICINE-UK, V7, P889, DOI [10.2217/nnm.12.62, 10.2217/NNM.12.62]; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Tumpey TM, 2005, J CLIN MICROBIOL, V43, P676, DOI 10.1128/JCM.43.2.676-683.2005; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P6095, DOI 10.1016/j.vaccine.2008.11.037; Xia M, 2011, VACCINE, V29, P7670, DOI 10.1016/j.vaccine.2011.07.139; Yong CY, 2015, INT J NANOMED, V10, P2751, DOI 10.2147/IJN.S77405; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985; ZEBEDEE SL, 1989, P NATL ACAD SCI USA, V86, P1061, DOI 10.1073/pnas.86.3.1061; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang XT, 2011, INTERVIROLOGY, V54, P290, DOI 10.1159/000319440; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	61	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171174	10.1371/journal.pone.0171174	http://dx.doi.org/10.1371/journal.pone.0171174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151964	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200099
J	Engelmann, I; Dewilde, A; Lazrek, M; Batteux, M; Hamissi, A; Yakoub-Agha, I; Hober, D				Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Yakoub-Agha, Ibrahim; Hober, Didier			In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients	PLOS ONE			English	Article							RESPIRATORY-TRACT; ENTEROVIRAL RNA; VIRAL-INFECTION; MYOCARDIUM; REPLICATION; PATHOGENESIS; VIRUS; ADULT	Several species of the genus Enterovirus cause persistent infections in humans. Human rhinovirus (HRV) infections are generally self-limiting but occasionally persistent infections have been described. This study aimed to identify persistent HRV infections and investigate the clinical and virologic characteristics of patients with persistent infections. From January 2012 to March 2015, 3714 respiratory specimens from 2608 patients were tested for respiratory viruses by using a multiplex reverse transcription-polymerase chain reaction. A retrospective study was performed. Patients with at least two specimens positive for HRV/enterovirus taken 45 days or longer apart were identified and the HRV/enteroviruses were typed. Patients with persistent infection were compared to patients with reinfection and patients with cleared infection. Phylogenetic analysis of the viral protein(VP)4/VP2 region was performed. 18 patients with persistent HRV/enterovirus infection were identified. Minimum median duration of persistence was 92 days (range 50-455 days). All but one patients with persistence were immunosuppressed. Immunosuppression and hematologic disorders were more frequent in patients with persistence (n = 18) than in patients with reinfection (n = 33) and with cleared infection (n = 25) (p = 0.003 and p = 0.001, respectively). In conclusion, this retrospective study identified HRV persistence in vivo which occurred mainly in immunosuppressed patients.	[Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Hober, Didier] Univ Lille, Lab Virol EA 3610, Fac Med, Lille, France; [Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Hober, Didier] CHU Lille, Lille, France; [Yakoub-Agha, Ibrahim] CHU Lille, Malad Sang, Lille, France; [Yakoub-Agha, Ibrahim] Univ Lille, Fac Med, Lille, France; [Yakoub-Agha, Ibrahim] INSERM, U995, LIRIC, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Engelmann, I (corresponding author), Univ Lille, Lab Virol EA 3610, Fac Med, Lille, France.; Engelmann, I (corresponding author), CHU Lille, Lille, France.	ilka.engelmann@chru-lille.fr	Yakoub-Agha, Ibrahim/R-7872-2018	Yakoub-Agha, Ibrahim/0000-0003-4524-8782	Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2 [3610]; Centre Hospitalier Regional et Universitaire de Lille	Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2; Centre Hospitalier Regional et Universitaire de Lille	This work was supported by Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2 (Equipe d'accueil 3610) and Centre Hospitalier Regional et Universitaire de Lille. The funding sources had no involvement in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2015, EUR J CLIN INVEST, V45, P918, DOI 10.1111/eci.12485; Alidjinou EK, 2014, DISCOV MED, V18, P273; Andreoletti L, 2000, J INFECT DIS, V182, P1222, DOI 10.1086/315818; Engelmann I, 2013, AM J RESP CRIT CARE, V188, P1165, DOI 10.1164/rccm.201303-0585LE; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Flight WG, 2013, J CLIN MICROBIOL, V51, P3893, DOI 10.1128/JCM.01604-13; Fujioka S, 2000, J AM COLL CARDIOL, V36, P1920, DOI 10.1016/S0735-1097(00)00955-4; Fujioka S, 2004, AM J CARDIOL, V94, P602, DOI 10.1016/j.amjcard.2004.05.023; Goffard A, 2014, J CLIN VIROL, V60, P147, DOI 10.1016/j.jcv.2014.02.005; Hober D, 2013, CURR OPIN INFECT DIS, V26, P263, DOI 10.1097/QCO.0b013e3283608300; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Julien J, 1999, J NEUROL, V246, P472, DOI 10.1007/s004150050386; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Pathak AK, 2013, BONE MARROW TRANSPL, V48, P747, DOI 10.1038/bmt.2012.226; Pauschinger M, 1999, CIRCULATION, V99, P889, DOI 10.1161/01.CIR.99.7.889; Peltola V, 2013, CLIN MICROBIOL INFEC, V19, pE322, DOI 10.1111/1469-0691.12193; Piralla A, 2015, J CLIN VIROL, V67, P38, DOI 10.1016/j.jcv.2015.03.022; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Royston L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010016; Satoh M, 2004, LAB INVEST, V84, P173, DOI 10.1038/labinvest.3700031; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163; WHY HJF, 1994, CIRCULATION, V89, P2582, DOI 10.1161/01.CIR.89.6.2582; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170774	10.1371/journal.pone.0170774	http://dx.doi.org/10.1371/journal.pone.0170774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151988	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200043
J	Silva, LAF; Couto, MIV; Magliaro, FCL; Tsuji, RK; Bento, RF; de Carvalho, ACM; Matas, CG				Fagundes Silva, Liliane Aparecida; Vieira Couto, Maria Ines; Magliaro, Fernanda C. L.; Tsuji, Robinson Koji; Bento, Ricardo Ferreira; Martinho de Carvalho, Ana Claudia; Matas, Carla Gentile			Cortical maturation in children with cochlear implants: Correlation between electrophysio-logical and behavioral measurement	PLOS ONE			English	Article							CENTRAL AUDITORY DEVELOPMENT; EVOKED POTENTIALS; SPEECH-PERCEPTION; NORMAL-HEARING; OUTCOMES; INFANTS; LANGUAGE; LATENCY; AGE; REORGANIZATION	Central auditory pathway maturation in children depends on auditory sensory stimulation. The objective of the present study was to monitor the cortical maturation of children with cochlear implants using electrophysiological and auditory skills measurements. The study was longitudinal and consisted of 30 subjects, 15 (8 girls and 7 boys) of whom had a cochlear implant, with a mean age at activation time of 36.4 months (minimum, 17 months; maximum, 66 months), and 15 of whom were normal-hearing children who were matched based on gender and chronological age. The auditory and speech skills of the children with cochlear implants were evaluated using GASP, IT-MAIS and MUSS measures. Both groups underwent electrophysiological evaluation using long-latency auditory evoked potentials. Each child was evaluated at three and nine months after cochlear implant activation, with the same time interval adopted for the hearing children. The results showed improvements in auditory and speech skills as measured by IT-MAIS and MUSS. Similarly, the long-latency auditory evoked potential evaluation revealed a decrease in P1 component latency; however, the latency remained significantly longer than that of the hearing children, even after nine months of cochlear implant use. It was observed that a shorter P1 latency corresponded to more evident development of auditory skills. Regarding auditory behavior, it was observed that children who could master the auditory skill of discrimination showed better results in other evaluations, both behavioral and electrophysiological, than those who had mastered only the speech-detection skill. Therefore, cochlear implant auditory stimulation facilitated auditory pathway maturation, which decreased the latency of the P1 component and advanced the development of auditory and speech skills. The analysis of the long-latency auditory evoked potentials revealed that the P1 component was an important biomarker of auditory development during the rehabilitation process.	[Fagundes Silva, Liliane Aparecida; Martinho de Carvalho, Ana Claudia; Matas, Carla Gentile] FMUSP, Dept Phys Speech & Occupat, Sao Paulo, SP, Brazil; [Vieira Couto, Maria Ines; Magliaro, Fernanda C. L.; Tsuji, Robinson Koji; Bento, Ricardo Ferreira] FMUSP, Dept Otorhinolaryngol, Clin Hosp, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Silva, LAF (corresponding author), FMUSP, Dept Phys Speech & Occupat, Sao Paulo, SP, Brazil.	liliane.fagundes@usp.br	Silva, Liliane Aparecida Fagundes/D-6320-2015; Magliaro, Fernanda C Leite/A-9225-2013; MATAS, CARLA GENTILE/K-4806-2016	Magliaro, Fernanda C Leite/0000-0003-0627-4320; MATAS, CARLA GENTILE/0000-0002-9408-7172				Agrawal D, 2013, NEUROIMAGE-CLIN, V2, P229, DOI 10.1016/j.nicl.2013.01.001; Alvarenga KD, 2013, CODAS, V25, P521, DOI 10.1590/S2317-17822014000100004; Alvarenga KF, 2012, INT J PEDIATR OTORHI, V76, P1332, DOI 10.1016/j.ijporl.2012.06.001; Anderson I, 2004, INT J PEDIATR OTORHI, V68, P425, DOI 10.1016/j.ijporl.2003.11.013; Bauer PW, 2006, ARCH OTOLARYNGOL, V132, P1133, DOI 10.1001/archotol.132.10.1133; Bento RF, 2004, REV BRAS OTORRINOLAR, V70, P632; Bevilacqua M C, 1996, TOPICOS FONOAUDIOLOG, P411; Bevilacqua MC, 2011, TRATADO AUDIOLOGIA, P407; Bevilacqua MC, 2010, TRATADO FONOAUDILOGI, P220; Bhatnagar SC., 2004, NEUROCIENCIA ESTUDO, P185; Biever A., 2007, SOUND FDN EARLY AMPL, P43; Boechat EM, 2010, PLASTICIDADE AMPLIFI, P160; Cardon G, 2013, INT J AUDIOL, V52, P577, DOI 10.3109/14992027.2013.799786; Castiquini E AT, 1998, THESIS; Chen XQ, 2010, ACTA OTO-LARYNGOL, V130, P263, DOI 10.3109/00016480903150528; Clark GM, 2003, AIP SER MOD AC SIG, P160; Dinces E, 2009, INT J PEDIATR OTORHI, V73, P843, DOI 10.1016/j.ijporl.2009.03.002; Dorman MF, 2007, J COMMUN DISORD, V40, P284, DOI 10.1016/j.jcomdis.2007.03.007; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Erber N., 1982, AUDITORY TRAINING; Silva LAF, 2014, BRAZ J OTORHINOLAR, V80, P131, DOI 10.5935/1808-8694.20140028; Silva LAF, 2013, CODAS, V25, P595, DOI 10.1590/S2317-17822013.05000009; Fallon JB, 2008, HEARING RES, V238, P110, DOI 10.1016/j.heares.2007.08.004; Fallon JB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065008; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2007, Audiol Med, V5, P262, DOI 10.1080/16513860701659404; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; Gordon KA, 2005, HEARING RES, V204, P78, DOI 10.1016/j.heares.2005.01.003; Jang JH, 2010, CLIN EXP OTORHINOLAR, V3, P194, DOI 10.3342/ceo.2010.3.4.194; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Kileny PR, 1997, OTOLARYNG HEAD NECK, V117, P161, DOI 10.1016/S0194-5998(97)70169-4; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kubo T, 2008, ORL-J OTO-RHIN-LARYN, V70, P224, DOI 10.1159/000130869; Lesinski-Schiedat A, 2004, Cochlear Implants Int, V5, P146, DOI 10.1179/cim.2004.5.4.146; Martines F, 2013, INT J PEDIATR OTORHI, V77, P707, DOI 10.1016/j.ijporl.2013.01.023; Maurer J, 2002, LARYNGOSCOPE, V112, P2220, DOI 10.1097/00005537-200212000-00017; Melo Tatiana Mendes de, 2012, J Soc Bras Fonoaudiol, V24, P390; Moog JS, 2010, OTOL NEUROTOL, V31, P1315, DOI 10.1097/MAO.0b013e3181eb3226; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Moret Adriane Lima Mortari, 2007, Pró-Fono R. Atual. Cient., V19, P295, DOI 10.1590/S0104-56872007000300008; Nascimento LT, PROPOSTA AVALIAC LIN; Nikolopoulos TP, 1999, INT J PEDIATR OTORHI, V49, pS189; Northen J., 2005, AUDICAO INFANCIA, V., P3; Ouellet C, 1999, J NEUROLINGUIST, V12, P271, DOI 10.1016/S0911-6044(99)00018-4; Pinto Elaine Soares Monteiro, 2008, Rev. Bras. Otorrinolaringol., V74, P91, DOI 10.1590/S0034-72992008000100015; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Robbins AM, CONVERSION IT MAIS S; Robbins AM, 1990, MEANINGFUL USE SPEEC; SHALLOP JK, 1993, EAR HEARING, V14, P58, DOI 10.1097/00003446-199302000-00008; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma A, 2004, ARCH OTOLARYNGOL, V130, P511, DOI 10.1001/archotol.130.5.511; Sharma A, 2002, NEUROREPORT, V13, P1365, DOI 10.1097/00001756-200207190-00030; Sharma A., 2007, AUDIOL MED, V5, P218, DOI DOI 10.1080/16513860701659479; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma Anu, 2006, Adv Otorhinolaryngol, V64, P66, DOI 10.1159/000094646; Sharma Anu, 2005, J Am Acad Audiol, V16, P564, DOI 10.3766/jaaa.16.8.5; Sharma A, 2011, INT J AUDIOL, V50, P98, DOI 10.3109/14992027.2010.542492; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Tanamati LF, 2011, INT ARCH OTORHINOLAR, V15, P365; Thai-Van H, 2010, ACTA OTO-LARYNGOL, V130, P333, DOI 10.3109/00016480903258024; Ventura LMP, 2008, THESIS; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Yucel E, 2009, INT J PEDIATR OTORHI, V73, P1043, DOI 10.1016/j.ijporl.2009.04.009; Zimmerman-Phillips S., 1997, INFANT TODDLER MEANI	69	11	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171177	10.1371/journal.pone.0171177	http://dx.doi.org/10.1371/journal.pone.0171177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151961	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200100
J	Gunawardena, S; Kapilananda, GMG; Samarakoon, D; Maddevithana, S; Wijesundera, S; Goonaratne, LV; Karunaweera, ND				Gunawardena, Sharmini; Kapilananda, G. M. G.; Samarakoon, Dilhani; Maddevithana, Sashika; Wijesundera, Sulochana; Goonaratne, Lallindra V.; Karunaweera, Nadira D.			Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka	PLOS ONE			English	Article							METHEMOGLOBIN REDUCTION TEST; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; X-CHROMOSOME; PRIMAQUINE; VARIANTS; GENE; DAPSONE; MUTATIONS; HEMOLYSIS; PROVINCE	Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme deficiency is known to offer protection against malaria and an increased selection of mutant genes in malaria endemic regions is expected. However, anti-malarial drugs such as primaquine can cause haemolytic anaemia in persons with G6PD deficiency. We studied the extent of G6PD deficiency in selected persons attending Teaching Hospitals of Anuradhapura and Kurunegala, two previously high malaria endemic districts in Sri Lanka. A total of 2059 filter-paper blood spots collected between November 2013 and June 2014 were analysed for phenotypic G6PD deficiency using the modified WST-8/1-methoxy PMS method. Each assay was conducted with a set of controls and the colour development assessed visually as well as with a microplate reader at OD 450-630 nm. Overall, 142/1018 (13.95%) and 83/1041 (7.97%) were G6PD deficient in Anuradhapura and Kurunegala districts respectively. The G6PD prevalence was significantly greater in Anuradhapura when compared to Kurunegala (P<0.0001). Surprisingly, females were equally affected as males in each district: 35/313 (11.18%) males and 107/705 (15.18%) females were affected in Anuradhapura (P = 0.089); 25/313 (7.99%) males and 58/728 (7.97%) females were affected in Kurunegala (P = 0.991). Prevalence was greater among females in Anuradhapura than in Kurunegala (P<0.05), while no such difference was observed between the males (P>0.05). Severe deficiency (<10% normal) was seen among 28/1018 (2.75%) in Anuradhapura (7 males; 21 females) and 17/1041 (1.63%) in Kurunegala (7 males; 10 females). Enzyme activity between 10-30% was observed among 114/1018 (11.20%; 28 males; 86 females) in Anuradhapura while it was 66/1041 (6.34%; 18 males; 48 females) in Kurunegala. Screening and educational programmes for G6PD deficiency are warranted in these high risk areas irrespective of gender for the prevention of disease states related to this condition.	[Gunawardena, Sharmini; Kapilananda, G. M. G.; Samarakoon, Dilhani; Maddevithana, Sashika; Karunaweera, Nadira D.] Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka; [Wijesundera, Sulochana] Univ Colombo, Dept Biochem, Fac Med, Colombo, Sri Lanka; [Goonaratne, Lallindra V.] Univ Colombo, Dept Pathol, Fac Med, Colombo, Sri Lanka	University of Colombo; University of Colombo; University of Colombo	Gunawardena, S (corresponding author), Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka.	sharmini@parasit.cmb.ac.lk		Karunaweera, Nadira/0000-0003-3985-1817	National Science Foundation, Sri Lanka [RG/2011/HS/09]	National Science Foundation, Sri Lanka(National Science Foundation (NSF))	The work was supported by National Science Foundation, Sri Lanka, Grant No: RG/2011/HS/09, http://www.nsf.ac.lk/.	ABEYARATNE K P, 1968, Ceylon Medical Journal, V13, P134; ABEYARATNE KP, 1976, AM J PHYS ANTHROPOL, V44, P135, DOI 10.1002/ajpa.1330440119; [Anonymous], ANTIMALARIA CAMP; Arai M, 2006, ACTA MED OKAYAMA, V60, P127; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1992, ANNU REV MED, V43, P47, DOI 10.1146/annurev.me.43.020192.000403; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; De Niz M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-210; Denic S, 2007, HUM BIOL, V79, P145, DOI 10.1353/hub.2007.0030; Dewasurendra RL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0603-9; Espino FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148172; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Fernando P, 2011, 100 YEARS MALARIA CO; Fernando P., 2014, J COLL COMMUNITY PHY, V19, P27, DOI DOI 10.4038/JCCPSL.V19I1.7624; Fernando V.N, 2020, INT J SCI RES, V9, P1310; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; GILLES HM, 1967, LANCET, V1, P138; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Kuwahata M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-223; Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Luzzatto L, ONLINE METABOLIC MOL; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mal E. R., 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1000402, DOI 10.1371/JOURNAL.PMED.1000402]; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; NAGARATNAM N, 1969, INDIAN J MED RES, V57, P569; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017; Ranawaka RR, 2008, LEPROSY REV, V79, P436; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sandakumari GVN, 2015, GALLE MED J, V20, P36; Saunders MA, 2002, GENETICS, V162, P1849; Senaratne R, 2016, LANCET, V388, P1038, DOI 10.1016/S0140-6736(16)31572-0; Shanks GD, 2001, CLIN INFECT DIS, V33, P1968, DOI 10.1086/324081; Silva Kalinga Tudor, 2014, DECOLONISATION DEV D; Singh A. K., 2013, African Journal of Agricultural Research, V8, P6634; Sugathadasa R, 2006, J DIAGNOSTIC PATHOLO, V5, P30; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; WHO Working Group, 1989, B WORLD HEALTH ORGAN, V67, P601; World Health Organization, WHO MULT THER MDT; World Health Organization, 2015, GUID TREATM MAL, Vthird; Wozel G, 2014, ARCH DERMATOL RES, V306, P103, DOI 10.1007/s00403-013-1409-7	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171208	10.1371/journal.pone.0171208	http://dx.doi.org/10.1371/journal.pone.0171208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152025	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200104
J	Mastropasqua, R; Toto, L; Borrelli, E; Di Antonio, L; Mattei, PA; Senatore, A; Di Nicola, M; Mariotti, C				Mastropasqua, Rodolfo; Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; Mattei, Peter A.; Senatore, Alfonso; Di Nicola, Marta; Mariotti, Cesare			Optical Coherence Tomography Angiography Findings in Stargardt Disease	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; CHOROIDAL THICKNESS; GEOGRAPHIC ATROPHY; VASCULAR LAYERS; LIPOFUSCIN; AUTOFLUORESCENCE; PROGRESSION; SEQUENCE; EYES	Background to assess vessel density of superficial capillary plexus (SCP), deep capillary plexus (DCP) and choriocapillaris (CC) in advanced Stargardt disease (STGD) using optical coherence tomography angiography (OCTA) and correlate these findings with macular function using pattern electroretinogram (PERG) and multifocal electroretinogram (mfERG). Methods Twelve patients (24 eyes) with advanced STGD underwent vessel densities and macular thickness measurements using OCTA. A control group of 24 healthy controls (24 eyes) was chosen for comparison. In the STGD group correlation between vessel density and macular thickness and between macular function and morphologic parameters were evaluated. Results Whole parafoveal vessel density (VD) of SCP was significantly lower in STGD group compared to the control group (p<0.05). Foveal VD and whole parafoveal VD of the DCP were significantly lower in STGD group compared to the controls (p<0.05). CC was significantly decreased in STGD compared to controls (p<0.05). Foveal macular thickness (MT), full parafoveal MT, and inner limiting membrane (ILM)-inner plexiform layer (IPL) parafoveal MT thickness were decreased in STGD eyes compared to controls (p<0.001). PERG and mfERG were both significantly reduced in STGD compared to controls (p<0.001). A direct correlation was found between full parafoveal MT and vessel density in the STGD group. Conclusions Patients with advanced STGD showed a reduction of SCP, DCP and CC compared to healthy eyes related to a reduction of total and ILM-IPL macular thickness. These results suggest that both retinal capillaris plexuses and choriocapillaris reduction occur in STDG along with inner and outer retinal thinning.	[Mastropasqua, Rodolfo] NHS Fdn Trust, Moorfields Eye Hosp, London, England; [Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; Mattei, Peter A.; Senatore, Alfonso] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy; [Di Nicola, Marta] Univ G dAnnunzio, Dept Expt & Clin Sci, Lab Biostat, Chieti, Italy; [Mariotti, Cesare] Univ Marche, Dept Surg & Biomed Sci, Ophthalmol Clin, Ancona, Italy	Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Marche Polytechnic University	Toto, L (corresponding author), Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy.	l.toto@unich.it	Senatore, Alfonso/T-3105-2019; Mastropasqua, Rodolfo/AAC-6453-2022; Borrelli, Enrico/AAR-3693-2020; Toto, Lisa/K-3473-2018	Senatore, Alfonso/0000-0002-8190-8269; Borrelli, Enrico/0000-0003-2815-5031; Toto, Lisa/0000-0001-5311-5184; DI NICOLA, MARTA/0000-0003-1748-1931				Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Adhi M, 2015, AM J OPHTHALMOL, V160, P1276, DOI 10.1016/j.ajo.2015.08.025; Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; Alten F1, 2016, GRAEFES ARCH CLIN EX, V18; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Battaglia Parodi M, 2016, BR J OPHTHALMOL; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; Fujinami K, 2015, OPHTHALMOLOGY, V122, P326, DOI 10.1016/j.ophtha.2014.08.012; Genead MA, 2009, INVEST OPHTH VIS SCI, V50, P5867, DOI 10.1167/iovs.09-3611; Giani A, 2012, INVEST OPHTH VIS SCI, V53, P3999, DOI 10.1167/iovs.11-9258; Gomes NL, 2009, INVEST OPHTH VIS SCI, V50, P3953, DOI 10.1167/iovs.08-2657; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Lambertus S, 2015, OPHTHALMOLOGY, V122, P335, DOI 10.1016/j.ophtha.2014.08.032; Lee JY, 2013, INVEST OPHTH VIS SCI, V54, P7812, DOI 10.1167/iovs.13-12284; Lenassi E, 2009, BRIT J OPHTHALMOL, V93, P1600, DOI 10.1136/bjo.2009.158725; McBain VA, 2012, AM J OPHTHALMOL, V154, P146, DOI 10.1016/j.ajo.2012.01.019; Nunes RP, 2015, OSLI RETINA, V46, P814, DOI 10.3928/23258160-20150909-05; Smith RT, 2009, INVEST OPHTH VIS SCI, V50, P3907, DOI 10.1167/iovs.08-2448; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Testa F, 2012, INVEST OPHTH VIS SCI, V53, P4409, DOI 10.1167/iovs.11-8201; Toto L, 2016, RETINA; Toto L, 2016, INVEST OPHTH VIS SCI, V57, pOCT268, DOI 10.1167/iovs.15-18872; Waheed NK, 2016, DEV OPHTHALMOL, V56, P91, DOI 10.1159/000442784; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Westeneng-van Haaften SC, 2012, OPHTHALMOLOGY, V119, P1199, DOI 10.1016/j.ophtha.2012.01.005; Yeoh J, 2010, GRAEF ARCH CLIN EXP, V248, P1719, DOI 10.1007/s00417-010-1437-3	37	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170343	10.1371/journal.pone.0170343	http://dx.doi.org/10.1371/journal.pone.0170343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151966	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200020
J	Poh, AH; Moghavvemi, M; Leong, CS; Lau, YL; Ghandari, AS; Apau, A; Adikan, FRM				Poh, Abdul Halim; Moghavvemi, Mahmoud; Leong, Cherng Shii; Lau, Yee Ling; Ghandari, Alireza Safdari; Apau, Alexlee; Adikan, Faisal Rafiq Mahamd			Collective behavior quantification on human odor effects against female Aedes aegypti mosquitoes-Open source development	PLOS ONE			English	Article							TRACKING; MOVEMENT	Classifying and quantifying mosquito activity includes a plethora of categories, ranging from measuring flight speeds, repellency, feeding rates, and specific behaviors such as home entry, swooping and resting, among others. Entomologists have been progressing more toward using machine vision for efficiency for this endeavor. Digital methods have been used to study the behavior of insects in labs, for instance via three-dimensional tracking with specialized cameras to observe the reaction of mosquitoes towards human odor, heat and CO2, although virtually none was reported for several important fields, such as repellency studies which have a significant need for a proper response quantification. However, tracking mosquitoes individually is a challenge and only limited number of specimens can be studied. Although tracking large numbers of individual insects is hailed as one of the characteristics of an ideal automated image-based tracking system especially in 3D, it also is a costly method, often requiring specialized hardware and limited access to the algorithms used for mapping the specimens. The method proposed contributes towards (a) unlimited open source use, (b) a low-cost setup, (c) complete guide for any entomologist to adapt in terms of hardware and software, (d) simple to use, and (e) a lightweight data output for collective behavior analysis of mosquitoes. The setup is demonstrated by testing a simple response of mosquitoes in the presence of human odor versus control, one session with continuous human presence as a stimuli and the other with periodic presence. A group of female Aedes aegypti (Linnaeus) mosquitoes are released into a white-background chamber with a transparent acrylic panel on one side. The video feed of the mosquitoes are processed using filtered contours in a threshold-adjustable video. The mosquitoes in the chamber are mapped on the raster where the coordinates of each mosquito are recorded with the corresponding timestamp. The average distance of the blobs within the frames against time forms a spectra where behavioral patterns can be observed directly, whether any collective effect is observed. With this method, 3D tracking will not be required and a more straightforward data output can be obtained.	[Poh, Abdul Halim; Moghavvemi, Mahmoud; Ghandari, Alireza Safdari; Apau, Alexlee; Adikan, Faisal Rafiq Mahamd] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Poh, Abdul Halim; Moghavvemi, Mahmoud; Ghandari, Alireza Safdari; Apau, Alexlee] Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud] Univ Sci & Culture, Tehran, Iran; [Leong, Cherng Shii; Lau, Yee Ling] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Moghavvemi, M (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Sci & Culture, Tehran, Iran.	mahmoud@um.edu.my	Moghavvemi, Mahmoud/B-8912-2010; ADIKAN, FAISAL RAFIQ MAHAMD/B-8038-2010; Lau, Yee Ling/C-6996-2009	Moghavvemi, Mahmoud/0000-0001-6447-4203; Lau, Yee Ling/0000-0002-2037-2165	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS) [FP003-2014B, HIR UM.00000005/HIR. C1]	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS)	This study was supported by Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS, grant number FP003-2014B), website: https://jpt.mohe.gov.my/menupenyelidik.php (authors who received funding: Prof Dr. Mahmoud Moghawemi (MM), role: study design, decision to publish and preparation of manuscript) and Malaysia's High Impact Research Grant (HIR UM.00000005/HIR. C1), website: http://hir.um.edu.my/ (authors who received funding: Prof Dr Faisal Rafiq Mahamd Adikan (FRMA), role: preparation of manuscript).	Angarita-Jaimes NC, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0974; Attanasi A, 2015, IEEE T PATTERN ANAL, V37, P2451, DOI 10.1109/TPAMI.2015.2414427; Bezerra-Silva PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150008; Bibbs CS, 2016, J MED ENTOMOL, V53, P480, DOI 10.1093/jme/tjv200; Bradski G., 2008, LEARNING OPENCV COMP; Butail S, 2011, ENG MED BIOL SOC EMB; Butail S, 2012, J R SOC INTERFACE, V9, P2624, DOI 10.1098/rsif.2012.0150; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chambers EW, 2013, MED VET ENTOMOL, V27, P332, DOI 10.1111/j.1365-2915.2012.01065.x; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P250; Cheng XE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132101; Cheng XE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129657; Crall JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136487; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Enayati AA, 2007, COCHRANE DATABASE SY, V2; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Hoffmann WC, 2010, J AM MOSQUITO CONTR, V26, P167, DOI 10.2987/09-0008.1; Jacoby DMP, 2016, TRENDS ECOL EVOL, V31, P301, DOI 10.1016/j.tree.2016.01.011; Khan B, 2015, INT C NEUR INF PROC; Lee SC, 2006, ATMOS ENVIRON, V40, P2128, DOI 10.1016/j.atmosenv.2005.11.047; Manoukis NC, 2009, J MED ENTOMOL, V46, P227, DOI 10.1603/033.046.0207; Mullen ER, 2016, OPT EXPRESS, V24, P1828, DOI 10.1364/OE.24.011828; Nguyen NM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004667; Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; Webster B, 2015, J CHEM ECOL, V41, P59, DOI 10.1007/s10886-014-0542-x; Wilkinson DA, 2014, J INSECT PHYSIOL, V71, P114, DOI 10.1016/j.jinsphys.2014.10.005; World Health Organization, 2013, GUID EFF TEST SPAT R; Wotodjo AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126187; Yokoi S., 1975, COMPUT GRAPHICS IMAG, V4, P63, DOI DOI 10.1016/0146-664X(75)90022-2; Zou D, 2009, COMP VIS 2009 IEEE 1	37	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171555	10.1371/journal.pone.0171555	http://dx.doi.org/10.1371/journal.pone.0171555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152031	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161200155
J	Ptaszek, A; Ptaszek, P; Dziubinski, M; Grzesik, NM; Liszka-Skoczylas, M				Ptaszek, Anna; Ptaszek, Pawel; Dziubinski, Marek; Grzesik, N. Miroslaw; Liszka-Skoczylas, Marta			The effect of structural properties on rheological behaviour of starches in binary dimethyl sulfoxide-water solutions	PLOS ONE			English	Article							SHEAR-THICKENING BEHAVIOR; WAXY MAIZE STARCHES; LIGHT-SCATTERING; AQUEOUS-SOLUTION; COMPLEX FLUIDS; DMSO; AMYLOSE; AMYLOPECTIN; VISCOSITY; DYNAMICS	This research study analysed the rheological properties of potato amylose and potato amylopectin in binary solutions of the following water and dimethyl sulfoxide concentrations: 90% DMSO (1), 80% DMSO (2) and 50% DMSO (3), with preparation methodology involving the dissolution at the temperature of 98 degrees C. The studies of dynamic light scattering on the biopolymer coils and the determination of main relaxation times of the solutions were carried out. For the amylose solutions, the fast relaxation phenomena are predominant. The results of the quality tests of the hysteresis loop showed, that the amylose solutions in the solvents (1) and (2) are rheologically stable and shear-thickened. The amylose solutions in solvents (3) reveal oscillatory alterations of viscosity in the time. Amylopectin solutions are characterized by 80% share of slow relaxation phenomena, very low diffusion coefficients and hydrodynamic radii in the range of 2000 nm. The amylopectin solutions are rheologically unstable.	[Ptaszek, Anna; Ptaszek, Pawel; Liszka-Skoczylas, Marta] Agr Univ Krakow, Fac Food Technol, Dept Engn & Machinery Food Ind, Ul Balicka 122, Krakow, Poland; [Dziubinski, Marek] Tech Univ Lodz, Fac Proc & Environm Engn, Dept Chem Engn, Ul Wolczanska 175, Lodz, Poland; [Grzesik, N. Miroslaw] Polish Acad Sci, Inst Chem Engn, Ul Baltycka 5, Gliwice, Poland	Agricultural University Krakow; Lodz University of Technology; Polish Academy of Sciences; Institute of Chemical Engineering of the Polish Academy of Sciences	Ptaszek, A (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Engn & Machinery Food Ind, Ul Balicka 122, Krakow, Poland.	a.ptaszek@ur.krakow.pl	Dziubinski, Marek/P-4524-2019; Ptaszek, Anna/AAF-6615-2019; Ptaszek, Anna/E-4082-2016; Ptaszek, Anna/AAH-1094-2020; Ptaszek, Pawel/K-8177-2017	Dziubinski, Marek/0000-0002-7765-1106; Ptaszek, Anna/0000-0002-2252-7650; Ptaszek, Anna/0000-0002-2252-7650; Ptaszek, Pawel/0000-0003-3190-3547; Grzesik, Miroslaw/0000-0002-9289-2581; Liszka-Skoczylas, Marta/0000-0001-7281-3711	NCN [N N312 171339]	NCN	This work was supported by NCN grant no. N N312 171339.	ABERLE T, 1994, STARCH-STARKE, V46, P329, DOI 10.1002/star.19940460903; Aberle T, 1997, STARCH-STARKE, V49, P215, DOI 10.1002/star.19970490602; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Bello-Perez LA, 1998, J CEREAL SCI, V27, P267, DOI 10.1006/jcrs.1998.0186; Chakraborty S, 2005, CARBOHYD POLYM, V60, P475, DOI 10.1016/j.carbpol.2005.03.011; Chamberlain EK, 1999, CARBOHYD POLYM, V40, P251, DOI 10.1016/S0144-8617(99)00060-0; Cheetham NWH, 1998, CARBOHYD POLYM, V35, P287, DOI 10.1016/S0144-8617(97)00151-3; Das DK, 2016, BIOPHYS CHEM, V216, P31, DOI 10.1016/j.bpc.2016.06.002; de Vasconcelos CL, 2000, CARBOHYD POLYM, V41, P181, DOI 10.1016/S0144-8617(99)00078-8; DEKEE D, 1980, CHEM ENG COMMUN, V6, P273, DOI 10.1080/00986448008912535; Dintzis FR, 1996, CEREAL CHEM, V73, P638; DINTZIS FR, 1995, J RHEOL, V39, P1399, DOI 10.1122/1.550643; Divers T, 2007, CARBOHYD POLYM, V68, P136, DOI 10.1016/j.carbpol.2006.07.026; Eliasson A. -C., 2004, STARCH FOOD STRUCTUR; Ghosh A, 2001, CHEM ENG SCI, V56, P5635, DOI 10.1016/S0009-2509(01)00159-2; Ghosh R, 2011, J PHYS CHEM B, V115, P7612, DOI 10.1021/jp110549h; Ghosh S, 2014, RSC ADV, V4, P14378, DOI 10.1039/c4ra00719k; Han JA, 2004, CARBOHYD POLYM, V55, P265, DOI 10.1016/j.carbpol.2003.09.007; Heineck ME, 2008, POLYMER, V49, P4386, DOI 10.1016/j.polymer.2008.07.062; Honerkamp J, 1990, CONTINUUM MECHANICS, V2, P17, DOI [10.1007/BF01170953, DOI 10.1007/BF01170953]; JORDAN RC, 1980, MACROMOLECULES, V13, P491, DOI 10.1021/ma60075a006; Kapoor B, 2000, CARBOHYD POLYM, V42, P323, DOI 10.1016/S0144-8617(99)00188-5; Kapoor B, 2001, CARBOHYD POLYM, V44, P217, DOI 10.1016/S0144-8617(00)00218-6; Lee JH, 2014, FOOD HYDROCOLLOID, V35, P115, DOI 10.1016/j.foodhyd.2013.05.003; Macosko CW, 1994, VISCOUS LIQUID RHEOL; Mewis J, 2009, ADV COLLOID INTERFAC, V147-48, P214, DOI 10.1016/j.cis.2008.09.005; Millard MM, 1997, CEREAL CHEM, V74, P687, DOI 10.1094/CCHEM.1997.74.5.687; Ptaszek A, 2014, STARCH-STARKE, V66, P326, DOI 10.1002/star.201300113; Ptaszek A, 2012, J FOOD ENG, V111, P272, DOI 10.1016/j.jfoodeng.2012.02.022; Ptaszek P, 2011, STARCH-STARKE, V63, P181, DOI 10.1002/star.201000100; Quemada D, 1998, EUR PHYS J-APPL PHYS, V3, P309, DOI 10.1051/epjap:1998234; Quemada D, 1999, EUR PHYS J-APPL PHYS, V5, P191, DOI 10.1051/epjap:1999128; Quemada D, 1998, EUR PHYS J-APPL PHYS, V2, P175, DOI 10.1051/epjap:1998170; Radosta S, 2001, BIOMACROMOLECULES, V2, P970, DOI 10.1021/bm0100662; Roy S, 2011, J PHYS CHEM B, V115, P685, DOI 10.1021/jp109622h; Schuster HG, 2005, DETERMINISTIC CHAOS: AN INTRODUCTION, 4TH EDITION, P1, DOI 10.1002/3527604804; Teraoka Iwao, 2002, POLYM SOLUTIONS INTR; Yang C, 2006, CARBOHYD POLYM, V64, P190, DOI 10.1016/j.carbpol.2005.11.017; Yang Ch, 2006, CARBOHYD POLYM, V64, P227, DOI [10.1016/j.cis.2008.09.005, DOI 10.1016/J.CIS.2008.09.005]; Yu SF, 2014, CZECH J FOOD SCI, V32, P514, DOI 10.17221/394/2013-CJFS	40	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171109	10.1371/journal.pone.0171109	http://dx.doi.org/10.1371/journal.pone.0171109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152071	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200091
J	Strumylaite, L; Kregzdyte, R; Poskiene, L; Bogusevicius, A; Pranys, D; Norkute, R				Strumylaite, Loreta; Kregzdyte, Rima; Poskiene, Lina; Bogusevicius, Algirdas; Pranys, Darius; Norkute, Roberta			Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ESTROGEN-RECEPTOR; ACTIVE SMOKING; CIGARETTE-SMOKING; CADMIUM EXPOSURE; ALPHA; POPULATION; EXPRESSION; METALS; JAPAN	Tobacco smoking is inconsistently associated with breast cancer. Although some studies suggest that breast cancer risk is related to passive smoking, little is known about the association with breast cancer by tumor hormone receptor status. We aimed to explore the association between lifetime passive smoking and risk of breast cancer subtypes defined by estrogen receptor and progesterone receptor status among non-smoking Caucasian women. A hospital-based case-control study was performed in 585 cases and 1170 controls aged 28-90 years. Information on lifetime passive smoking and other factors was collected via a self-administered questionnaire. Logistic regression was used for analyses restricted to the 449 cases and 930 controls who had never smoked actively. All statistical tests were two-sided. Adjusted odds ratio of breast cancer was 1.01 (95% confidence interval (CI): 0.72-1.41) in women who experienced exposure to passive smoking at work, 1.88 (95% CI: 1.38-2.55) in women who had exposure at home, and 2.80 (95% CI: 1.84-4.25) in women who were exposed at home and at work, all compared with never exposed regularly. Increased risk was associated with longer exposure: women exposed <= 20 years and > 20 years had 1.27 (95% CI: 0.97-1.66) and 2.64 (95% CI: 1.87-3.74) times higher risk of breast cancer compared with never exposed (P-trend < 0.001). The association of passive smoking with hormone receptor-positive breast cancer did not differ from that with hormone receptor-negative breast cancer (P-heterogeneity > 0.05). There was evidence of interaction between passive smoking intensity and menopausal status in both overall group (P = 0.02) and hormone receptor-positive breast cancer group (P < 0.05). In Caucasian women, lifetime exposure to passive smoking is associated with the risk of breast cancer independent of tumor hormone receptor status with the strongest association in postmenopausal women.	[Strumylaite, Loreta; Kregzdyte, Rima] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania; [Poskiene, Lina; Pranys, Darius] Lithuanian Univ Hlth Sci, Med Acad, Dept Pathol Anat, Kaunas, Lithuania; [Bogusevicius, Algirdas] Lithuanian Univ Hlth Sci, Med Acad, Dept Surg, Kaunas, Lithuania; [Norkute, Roberta] Lithuanian Univ Hlth Sci, Med Acad, Dept Obstet & Gynecol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Strumylaite, L (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania.	loreta.strumylaite@lsmuni.lt						Ahern TP, 2009, CANCER CAUSE CONTROL, V20, P1837, DOI 10.1007/s10552-009-9376-1; Anderson LN, 2012, AM J EPIDEMIOL, V175, P289, DOI 10.1093/aje/kwr324; Bjerkaas E, 2015, PREV MED, V73, P125, DOI 10.1016/j.ypmed.2015.01.004; Borgerding M.F., 2000, MASSACHUSETTS BENCHM; Chen C, 2014, CHIN J CANCER, V33, P306, DOI 10.5732/cjc.013.10248; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Chen ZH, 2015, ASIA-PAC J PUBLIC HE, V27, pNP58, DOI 10.1177/1010539513481493; Conlon MSC, 2010, CANCER EPIDEMIOL, V34, P142, DOI 10.1016/j.canep.2010.02.001; DAKO, 1996, REF IMM BREAST CANC, P9; Dossus L, 2014, INT J CANCER, V134, P1871, DOI 10.1002/ijc.28508; Gao CM, 2013, ASIAN PAC J CANCER P, V14, P993, DOI 10.7314/APJCP.2013.14.2.993; Gram IT, 2015, AM J EPIDEMIOL, V182, P917, DOI 10.1093/aje/kwv092; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; IARC, LIST CLASS CANC SIT, V1-123; IARC, 2017, AG CLASS IARC MON, V1e117; International Agency for Research on Cancer (IARC), 2004, IARC MONOGRAPHS EVAL; International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Larsson SC, 2015, AM J EPIDEMIOL, V182, P375, DOI 10.1093/aje/kwv085; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; Li B, 2015, PLOS ONE; Li L, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-167; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Liu Longjian, 2000, Asian Pac J Cancer Prev, V1, P131; Luo J, 2011, BMJ; Macacu A, 2015, BREAST CANCER RES TR, V154, P213, DOI 10.1007/s10549-015-3628-4; Martin MB, 2007, ENDOCRINOLOGY, V148, P4676, DOI 10.1210/en.2007-0208; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Nagata C, 2013, BREAST CANCER RES TR, V138, P235, DOI 10.1007/s10549-013-2414-4; Nishino Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-65; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Rosenberg L, 2013, CANCER CAUSE CONTROL, V24, P2207, DOI 10.1007/s10552-013-0298-6; Shrubsole MJ, 2004, INT J CANCER, V110, P605, DOI 10.1002/ijc.20168; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Strumylaite L, 2008, MEDICINA-LITHUANIA, V44, P415, DOI 10.3390/medicina44060054; Strumylaite L, 2014, BREAST CANCER RES TR, V145, P225, DOI 10.1007/s10549-014-2918-6; Strumylaite L, 2013, ASIAN PAC J CANCER P, V14, P2777, DOI 10.7314/APJCP.2013.14.5.2777; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Tong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097498; Wada K, 2015, CANCER SCI, V106, P455, DOI 10.1111/cas.12619; Yang Y., 2013, PLOS ONE	55	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171198	10.1371/journal.pone.0171198	http://dx.doi.org/10.1371/journal.pone.0171198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151962	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161200101
J	Yu, SH; Huang, CY				Yu, Shu-Han; Huang, Cheng-Ya			Improving posture-motor dual-task with a supraposture-focus strategy in young and elderly adults	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; OLDER-ADULTS; VISUAL FEEDBACK; EXTERNAL FOCUS; HEALTHY-YOUNG; REACTION-TIME; WALKING; PERFORMANCE; ATTENTION; RESOURCES	In a postural-suprapostural task, appropriate prioritization is necessary to achieve task goals and maintain postural stability. A "posture-first" principle is typically favored by elderly people in order to secure stance stability, but this comes at the cost of reduced suprapostural performance. Using a postural-suprapostural task with a motor suprapostural goal, this study investigated differences between young and older adults in dual-task cost across varying task prioritization paradigms. Eighteen healthy young (mean age: 24.8 +/- 5.2 years) and 18 older (mean age: 68.8 +/- 3.7 years) adults executed a designated force-matching task from a stabilometer board using either a stabilometer stance (posture-focus strategy) or force-matching (supraposture-focus strategy) as the primary task. The dual-task effect (DTE: % change in dual-task condition; positive value: dual-task benefit, negative value: dual-task cost) of force-matching error and reaction time (RT), posture error, and approximate entropy (ApEn) of stabilometer movement were measured. When using the supraposture-focus strategy, young adults exhibited larger DTE values in each behavioral parameter than when using the posture-focus strategy. The older adults using the supraposture-focus strategy also attained larger DTE values for posture error, stabilometer movement ApEn, and force-matching error than when using the posture-focus strategy. These results suggest that the supraposture-focus strategy exerted an increased dual-task benefit for posturemotor dual-tasking in both healthy young and elderly adults. The present findings imply that the older adults should make use of the supraposture-focus strategy for fall prevention during dual-task execution.	[Yu, Shu-Han; Huang, Cheng-Ya] Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan; [Huang, Cheng-Ya] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan.; Huang, CY (corresponding author), Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan.	rcyhuang@ntu.edu.tw		Yu, Shu-Han/0000-0002-9522-1740; HUANG, CHENG-YA/0000-0001-6946-2105	Ministry of Science and Technology, R.O.C. Taiwan [MOST 103-2314-B-002-007-MY3]	Ministry of Science and Technology, R.O.C. Taiwan	This research was supported by a grant from the Ministry of Science and Technology, R.O.C. Taiwan, under grant no. MOST 103-2314-B-002-007-MY3.	Abellaneda S, 2009, J APPL PHYSIOL, V106, P169, DOI 10.1152/japplphysiol.90577.2008; [Anonymous], 2011, J SPORTS SCI, V29, P539, DOI [10.1080/02640414.2010.544046, DOI 10.1080/02640414.2010.544046]; BARRETT G, 1985, ELECTROEN CLIN NEURO, V60, P276, DOI 10.1016/0013-4694(85)90042-2; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Beurskens R, 2016, NEURAL PLAST, V2016, DOI [10.1155/2016/8032180, DOI 10.1155/2016/8032180]; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; Borel L, 2014, NEUROPHYSIOL CLIN, V44, P95, DOI 10.1016/j.neucli.2013.10.129; Chen FC, 2015, NEUROSCI LETT, V605, P69, DOI 10.1016/j.neulet.2015.08.016; Critchley K, 2014, EUR J APPL PHYSIOL, V114, P1925, DOI 10.1007/s00421-014-2916-8; Deviterne D, 2005, BRAIN RES BULL, V64, P487, DOI 10.1016/j.brainresbull.2004.10.007; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Endrass T, 2012, BIOL PSYCHOL, V89, P426, DOI 10.1016/j.biopsycho.2011.12.005; Hartley AA, 2001, PSYCHOL AGING, V16, P47, DOI 10.1037//0882-7974.16.1.47; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Jehu DA, 2015, INT J NEUROSCI, V125, P100, DOI 10.3109/00207454.2014.907573; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laessoe U, 2008, HUM MOVEMENT SCI, V27, P496, DOI 10.1016/j.humov.2007.12.001; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lion A, 2014, INT J NEUROSCI, V124, P558, DOI 10.3109/00207454.2013.864288; Marone JR, 2014, GAIT POSTURE, V40, P243, DOI 10.1016/j.gaitpost.2014.04.188; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Mitra S, 2004, HUM MOVEMENT SCI, V23, P1, DOI 10.1016/j.humov.2004.03.003; Mitra S, 2004, J EXP PSYCHOL HUMAN, V30, P28, DOI 10.1037/0096-1523.30.1.28; NAVON D, 1984, PSYCHOL REV, V91, P216, DOI 10.1037/0033-295X.91.2.216; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Polskaia N, 2015, GAIT POSTURE, V41, P454, DOI 10.1016/j.gaitpost.2014.11.009; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; Sherafat S, 2014, J MANIP PHYSIOL THER, V37, P170, DOI 10.1016/j.jmpt.2014.02.003; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sosnoff JJ, 2006, J GERONTOL B-PSYCHOL, V61, pP117, DOI 10.1093/geronb/61.2.P117; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; Therrien AS, 2010, EXP BRAIN RES, V201, P673, DOI 10.1007/s00221-009-2084-y; TOMBERG C, 1991, ELECTROEN CLIN NEURO, V81, P269, DOI 10.1016/0168-5597(91)90013-N; Tomporowski PD, 2014, J AGING PHYS ACTIV, V22, P557, DOI [10.1123/JAPA.2012-0241, 10.1123/japa.2012-0241]; Tsang PS, 2013, Q J EXP PSYCHOL, V66, P1517, DOI 10.1080/17470218.2012.752019; Tsang PS, 1996, ACTA PSYCHOL, V91, P175, DOI 10.1016/0001-6918(94)00055-7; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Vieluf S, 2013, EXP BRAIN RES, V224, P107, DOI 10.1007/s00221-012-3292-4; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott MH, 2000, J GERONTOL A-BIOL, V55, pM424, DOI 10.1093/gerona/55.8.M424; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; Zaepffel M, 2012, PSYCHOPHYSIOLOGY, V49, P17, DOI 10.1111/j.1469-8986.2011.01277.x; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	56	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170687	10.1371/journal.pone.0170687	http://dx.doi.org/10.1371/journal.pone.0170687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151943	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200034
J	Angulo, DF; Amarilla, LD; Anton, AM; Sosa, V				Angulo, Diego F.; Amarilla, Leonardo D.; Anton, Ana M.; Sosa, Victoria			Colonization in North American Arid Lands: The Journey of Agarito (Berberis trifoliolata) Revealed by Multilocus Molecular Data and Packrat Midden Fossil Remains	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; CHIHUAHUAN DESERT; LATE PLEISTOCENE; NEOGENE VICARIANCE; NEUTRALITY TESTS; CLIMATIC-CHANGE; SPECIES GROUP; WARM DESERTS; PHYLOGEOGRAPHY; PLANT	Here we conduct research to understand the evolutionary history of a shrubby species known as Agarito (Berberis trifoliolata), an endemic species to the Chihuahuan Desert. We identify genetic signatures based on plastid DNA and AFLP markers and perform niche modelling and spatial connectivity analyses as well as niche modelling based on records in packrats to elucidate whether orogenic events such as mountain range uplift in the Miocene or the contraction/expansion dynamics of vegetation in response to climate oscillations in the Pliocene/Pleistocene had an effect on evolutionary processes in Agarito. Our results of current niche modelling and palaeomodelling showed that the area currently occupied by Berberis trifoliolata is substantially larger than it was during the Last Interglacial period and the Last Glacial Maximum. Agarito was probably confined to small areas in the Northeastern and gradually expanded its distribution just after the Last Glacial Maximum when the weather in the Chihuahuan Desert and adjacent regions became progressively warmer and drier. The most contracted range was predicted for the Interglacial period. Populations remained in stable areas during the Last Glacial Maximum and expanded at the beginning of the Holocene. Most genetic variation occured in populations from the Sierra Madre Oriental. Two groups of haplotypes were identified: the Mexican Plateau populations and certain Northeastern populations. Haplogroups were spatially connected during the Last Glacial Maximum and separated during interglacial periods. The most important prediction of packrat middens palaeomodelling lies in the Mexican Plateau, a finding congruent with current and past niche modelling predictions for agarito and genetic results. Our results corroborate that these climate changes in the Pliocene/Pleistocene affected the evolutionary history of agarito. The journey of agarito in the Chihuahuan Desert has been dynamic, expanding and contracting its distribution range and currently occupying the largest area in its history.	[Angulo, Diego F.; Sosa, Victoria] Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico; [Amarilla, Leonardo D.; Anton, Ana M.] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina	Instituto de Ecologia - Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Angulo, DF (corresponding author), Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico.		Sosa, Victoria/A-5798-2013; Angulo, Diego F./B-3152-2015	Sosa, Victoria/0000-0002-0584-1672; Angulo, Diego F./0000-0002-5678-4946	CONACyT [106060, 204519]; Instituto Multidisciplinario de Biologia Vegetal; CONICET-Universidad Nacional de Cordoba; CONACyT-MINCyT [MX/11/08]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Multidisciplinario de Biologia Vegetal; CONICET-Universidad Nacional de Cordoba(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONACyT-MINCyT	This research was supported by CONACyT, grant no. 106060 to VS, and grant no. 204519 to DFA, by the Institute Multidisciplinario de Biologia Vegetal, CONICET-Universidad Nacional de Cordoba (to AMA), and by a grant from CONACyT-MINCyT (Bilateral project MX/11/08) to AMA and VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE M, 1985, SOUTHWEST NAT, V30, P533, DOI 10.2307/3671047; Angulo DF, 2014, BOTANY, V92, P195, DOI 10.1139/cjb-2013-0213; Angulo DF, 2014, BOT SCI, V92, P141, DOI 10.17129/botsci.46; [Anonymous], 2004, K 1 COUPLED GCM MIRO; ARCHER S, 1989, AM NAT, V134, P545, DOI 10.1086/284996; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; Axelrod D. I., 1950, CARNEGIE I WASHINGTO, V590, P215; AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; Axelrod DI, 1979, ARID LAND PLANT RESO, P3; Bonetti MF, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3229; BOX TW, 1969, J RANGE MANAGE, V22, P373, DOI 10.2307/3895845; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Calvino-Cancela M, 2012, J BIOGEOGR, V39, P1996, DOI 10.1111/j.1365-2699.2012.02732.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Dorsey RJ, 2007, GEOLOGY, V35, P57, DOI 10.1130/G23139A.1; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Dregne HE, 1984, DESERTS ARID LANDS, P145; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fehlberg SD, 2009, MOL PHYLOGENET EVOL, V50, P326, DOI 10.1016/j.ympev.2008.11.011; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3, DOI [DOI 10.1007/BF02908211, 10.1007/BF02908211]; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Graham MR, 2013, MOL PHYLOGENET EVOL, V69, P502, DOI 10.1016/j.ympev.2013.07.028; Graham RW, 1987, N AM ADJACENT OCEANS; Gugger PF, 2013, MOL ECOL, V22, P3598, DOI 10.1111/mec.12317; Guo YP, 2012, BMC EVOL BIOL, V12; Hafner DJ, 2011, PALAEOGEOGR PALAEOCL, P239; Hammer O, 2022, SOFTWARE NATURAL HIS; Henrickson J., 1986, 2 S RES CHIH DES REG, P20; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holmgren CA, 2007, J QUATERNARY SCI, V22, P141, DOI 10.1002/jqs.1023; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Hunter KL, 2001, GLOBAL ECOL BIOGEOGR, V10, P521, DOI 10.1046/j.1466-822X.2001.00254.x; Inoue K, 2015, MOL ECOL, V24, P1910, DOI 10.1111/mec.13156; JAEGER EC, 1957, N AM DESERTS; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jezkova T, 2016, ECOGRAPHY, V39, P437, DOI 10.1111/ecog.01464; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mackay William P., 1992, Psyche (Cambridge), V99, P169, DOI 10.1155/1992/82014; MCPHERSON GR, 1988, AM MIDL NAT, V120, P391, DOI 10.2307/2426011; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Metcalfe S, 2002, QUATERNARY RES, V57, P91, DOI 10.1006/qres.2001.2292; Metcalfe SE, 2006, ANN MO BOT GARD, V93, P258, DOI 10.3417/0026-6493(2006)93[258:LQEOTN]2.0.CO;2; Metcalfe SE, 2000, QUATERNARY SCI REV, V19, P699, DOI 10.1016/S0277-3791(99)00022-0; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Moore MJ, 2006, MOL PHYLOGENET EVOL, V39, P668, DOI 10.1016/j.ympev.2006.01.020; Morafka D. J, 1989, YB LOUISIANA STATE U, P23; Morafka D. J, 1977, BIOGEOGRAPHICA, V9, P1; Musgrove M, 2001, GEOL SOC AM BULL, V113, P1532, DOI 10.1130/0016-7606(2001)113<1532:GOLPTH>2.0.CO;2; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nei M., 1987, MOL EVOLUTIONARY GEN; NEILSON RP, 1986, SCIENCE, V232, P27, DOI 10.1126/science.232.4746.27; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez JL, 2000, REV PALAEOBOT PALYNO, V110, P247, DOI 10.1016/S0034-6667(00)00015-4; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Rebernig CA, 2010, MOL PHYLOGENET EVOL, V54, P594, DOI 10.1016/j.ympev.2009.10.010; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P145, DOI 10.1006/mpev.2000.0841; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rudolf PO, 1974, SEED WOODY PLANTS US, P247; Schmidt Jr R. H., 1986, 2 S RES CHIH DES REG, P40; SCHMIDT RH, 1979, J ARID ENVIRON, V2, P243, DOI 10.1016/S0140-1963(18)31774-9; Schneider S, 1999, GENETICS, V152, P1079; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SHREVE F., 1942, BOT REV, V8, P195, DOI 10.1007/BF02882228; Sosa V, 2009, J BIOGEOGR, V36, P18, DOI 10.1111/j.1365-2699.2008.01957.x; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Surina B, 2014, MOL ECOL, V23, P2861, DOI 10.1111/mec.12779; TAJIMA F, 1989, GENETICS, V123, P597; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; TOOMEY RS, 1993, GLOBAL PLANET CHANGE, V7, P299, DOI 10.1016/0921-8181(93)90003-7; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Van Devender TR, 1978, NATL PARK SERV T P 3, V3, P85; VANDEVENDER TR, 1977, SCIENCE, V198, P189, DOI 10.1126/science.198.4313.189; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; WEBB SD, 1977, ANNU REV ECOL SYST, V8, P355, DOI 10.1146/annurev.es.08.110177.002035; WELLS PV, 1966, SCIENCE, V153, P970, DOI 10.1126/science.153.3739.970; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wroblewska A, 2013, BOT J LINN SOC, V173, P64, DOI 10.1111/boj.12073; Zink RM, 2001, CONDOR, V103, P1, DOI 10.1650/0010-5422(2001)103[0001:CPOSAB]2.0.CO;2	105	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0168933	10.1371/journal.pone.0168933	http://dx.doi.org/10.1371/journal.pone.0168933			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146559	Green Published, Green Submitted, gold			2022-12-26	WOS:000396131700003
J	Doherty, A; Jackson, D; Hammerla, N; Plotz, T; Olivier, P; Granat, MH; White, T; van Hees, VT; Trenell, MI; Owen, CG; Preece, SJ; Gillions, R; Sheard, S; Peakman, T; Brage, S; Wareham, NJ				Doherty, Aiden; Jackson, Dan; Hammerla, Nils; Plotz, Thomas; Olivier, Patrick; Granat, Malcolm H.; White, Tom; van Hees, Vincent T.; Trenell, Michael I.; Owen, Christoper G.; Preece, Stephen J.; Gillions, Rob; Sheard, Simon; Peakman, Tim; Brage, Soren; Wareham, Nicholas J.			Large Scale Population Assessment of Physical Activity Using Wrist Worn Accelerometers: The UK Biobank Study	PLOS ONE			English	Article								Background Physical activity has not been objectively measured in prospective cohorts with sufficiently large numbers to reliably detect associations with multiple health outcomes. Technological advances now make this possible. We describe the methods used to collect and analyse accelerometer measured physical activity in over 100,000 participants of the UK Biobank study, and report variation by age, sex, day, time of day, and season. Methods Participants were approached by email to wear a wrist-worn accelerometer for seven days that was posted to them. Physical activity information was extracted from 100Hz raw triaxial acceleration data after calibration, removal of gravity and sensor noise, and identification of wear / non-wear episodes. We report age-and sex-specific wear-time compliance and accelerometer measured physical activity, overall and by hour-of-day, week-weekend day and season. Results 103,712 datasets were received (44.8% response), with a median wear-time of 6.9 days (IQR: 6.5 - 7.0). 96,600 participants (93.3%) provided valid data for physical activity analyses. Vector magnitude, a proxy for overall physical activity, was 7.5% (2.35mg) lower per decade of age (Cohen's d = 0.9). Women had a higher vector magnitude than men, apart from those aged 45-54yrs. There were major differences in vector magnitude by time of day (d = 0.66). Vector magnitude differences between week and weekend days (d = 0.12 for men, d = 0.09 for women) and between seasons (d = 0.27 for men, d = 0.15 for women) were small. Conclusions It is feasible to collect and analyse objective physical activity data in large studies. The summary measure of overall physical activity is lower in older participants and age-related differences in activity are most prominent in the afternoon and evening. This work lays the foundation for studies of physical activity and its health consequences. Our summary variables are part of the UK Biobank dataset and can be used by researchers as exposures, confounding factors or outcome variables in future analyses.	[Doherty, Aiden] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, BHF Ctr Res Excellence, Oxford, England; [Doherty, Aiden] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England; [Jackson, Dan; Hammerla, Nils; Plotz, Thomas; Olivier, Patrick] Newcastle Univ, Open Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Granat, Malcolm H.; Preece, Stephen J.] Univ Salford, Sch Hlth Sci, Manchester, Lancs, England; [White, Tom; Brage, Soren; Wareham, Nicholas J.] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [van Hees, Vincent T.; Trenell, Michael I.] Newcastle Univ, Inst Cellular Med, MoveLab, Newcastle Upon Tyne, Tyne & Wear, England; [Owen, Christoper G.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Gillions, Rob; Sheard, Simon; Peakman, Tim] UK Biobank, Stockport, Lancs, England	University of Oxford; University of Oxford; Newcastle University - UK; University of Salford; University of Cambridge; Newcastle University - UK; St Georges University London	Doherty, A (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, BHF Ctr Res Excellence, Big Data Inst, Oxford, England.; Doherty, A (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England.	aiden.doherty@ndph.ox.ac.uk	Olivier, Patrick/B-2909-2011; OLIVIER, PATRICK/V-5367-2019; Brage, Soren/C-6415-2013	Olivier, Patrick/0000-0003-2841-7580; Brage, Soren/0000-0002-1265-7355; Trenell, Michael/0000-0001-8253-5620; van Hees, Vincent/0000-0003-0182-9008; White, Thomas/0000-0001-8456-0803; Doherty, Aiden/0000-0003-1840-0451; Jackson, Daniel/0000-0002-6349-5026; Owen, Christopher/0000-0003-1135-5977; Sheard, Simon/0000-0002-8925-8280; Granat, Malcolm/0000-0002-0722-2760	Wellcome Trust; Medical Research Council; British Heart Foundation Centre of Research Excellence at Oxford [RE/13/1/30181]; Li Ka Shing Foundation; UK Medical Research Council [MC_UU_12015/1, MC_UU_12015/3]; RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE) [EP/G066019/1]; EPSRC Centre for Doctoral Training in Digital Civics [EP/L016176/1]; National Institute for Health Research [SRF-2011-04-017]; EPSRC [EP/M023001/1] Funding Source: UKRI; ESRC [ES/K007688/1] Funding Source: UKRI; MRC [MC_U106179473, MR/L016354/1, MC_UU_12015/3, G0700718, MC_UU_12015/1] Funding Source: UKRI; Economic and Social Research Council [ES/K007688/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M023001/1] Funding Source: researchfish; Medical Research Council [MR/L016354/1, MC_UU_12015/1, MC_U106179473, MC_U106179471, MC_qA137853, G0700718, MC_UU_12015/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; Alzheimer&quot;s Society [189] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Centre of Research Excellence at Oxford; Li Ka Shing Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE); EPSRC Centre for Doctoral Training in Digital Civics(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society	The UK Biobank Activity Project and the collection of activity data from participants was funded by the Wellcome Trust (https://wellcome.ac.uk/) and the Medical Research Council (http://www.mrc.ac.uk/). The analysis was supported by the British Heart Foundation Centre of Research Excellence at Oxford (http://www.cardioscience.ox.ac.uk/bhf-centre-of-research-excellence) [grant number RE/13/1/30181 to AD], the Li Ka Shing Foundation (http://www.lksf.org/) [to AD], the UK Medical Research Council (http://www.mrc.ac.uk/) [grant numbers MC_UU_12015/1 and MC_UU_12015/3 to NW and SB], the RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE) (http://www.rcuk.ac.uk/) [EP/G066019/1 to NH], the EPSRC Centre for Doctoral Training in Digital Civics (https://www.epsrc.ac.uk/)[EP/L016176/1 to DJ], and the National Institute for Health Research (http://www.nihr.ac.uk/) [SRF-2011-04-017 to MIT]. The MRC and Wellcome Trust played a key role in the decision to establish UK Biobank, and the accelerometer data collection. No funding bodies had any role in the analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Chief Medical Officers of England Scotland Wales and Northern Ireland, 2011, START ACT STAY ACT R; Colley RC, 2011, HLTH REP, V22, P7; Craig RJM, 2008, HLTH SURVEY ENGLAND; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Hammerla Nils Y, 2013, P 2013 INT S WEARABL, P65; Ladha C, 2013, 3 INT C AMB MON PHYS, P69; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Sartini C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1976-y; Steene-Johannessen J, 2016, MED SCI SPORT EXER, P48; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; White T, 2016, PLOS ONE IN PRESS; Wijndaele K, 2015, MED SCI SPORTS EXERC; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P447, DOI 10.1123/jpah.2013-0464	22	393	394	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169649	10.1371/journal.pone.0169649	http://dx.doi.org/10.1371/journal.pone.0169649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146576	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000396131700009
J	Eriksen, VR; Rasmussen, MB; Hahn, GH; Greisen, G				Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo; Hahn, Gitte Holst; Greisen, Gorm			Dopamine therapy does not affect cerebral autoregulation during hypotension in newborn piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; ARTERIAL-BLOOD-PRESSURE; PRETERM INFANTS; LASER-DOPPLER; FLOW; HEMODYNAMICS; PERFUSION; BRAIN	Background Hypotensive neonates who have been treated with dopamine have poorer neurodevelopmental outcome than those who have not been treated with dopamine. We speculate that dopamine stimulates adrenoceptors on cerebral arteries causing cerebral vasoconstriction. This vasoconstriction might lead to a rightward shift of the cerebral autoregulatory curve; consequently, infants treated with dopamine would have a higher risk of low cerebral blood flow at a blood pressure that is otherwise considered "safe". Methods In anaesthetized piglets, perfusion of the brain, monitored with laser-doppler flowmetry, and cerebral venous saturation was measured at different levels of hypotension. Each piglet was studied in two phases: a phase with stepwise decreases in MAP and a phase with stepwise increases in MAP. We randomized the order of the two phases, whether dopamine was given in the first or second phase, and the infusion rate of dopamine (10, 25, or 40 mu g/kg/min). In/deflation of a balloon catheter, placed in vena cava, induced different levels of hypotension. At each level of hypotension, fluctuations in MAP were induced by in/deflations of a balloon catheter in descending aorta. Results During measurements, PaCO(2)and arterial saturation were stable. MAP levels ranged between 14 and 82 mmHg. Cerebral autoregulation (CA) capacity was calculated as the ratio between %-change in cerebrovascular resistance and %-change in MAP induced by the in/deflation of the arterial balloon. A breakpoint in CA capacity was identified at a MAP of 38 +/- 18 mmHg without dopamine and at 44 +/- 18, 31 +/- 14, and 24 +/- 14 mmHg with dopamine infusion rates of 10, 25, and 40 mu g/kg/min (p = 0.057). Neither the index of steady-state cerebral perfusion nor cerebral venous saturation were affected by dopamine infusion. Conclusion Dopamine infusion tended to improve CA capacity at low blood pressures while an index of steady-state cerebral blood flow and cerebral venous saturation were unaffected by dopamine infusion. Thus, dopamine does not appear to impair CA in newborn piglets.	[Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo; Hahn, Gitte Holst; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark; [Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hahn, Gitte Holst] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Eriksen, VR (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark.	vibeke.eriksen@dadlnet.dk	Greisen, Gorm/AAA-6463-2022; Hahn, Gitte/AAN-4967-2020	Greisen, Gorm/0000-0001-8042-3262; Eriksen, Vibeke/0000-0002-8544-8626	Lundbeck Foundation; University of Copenhagen; Lundbeck Foundation [R77-2010-7200, R151-2013-14782] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	The Lundbeck Foundation and University of Copenhagen financially supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tawil KI, 2012, PEDIATR NEUROL, V46, P149, DOI 10.1016/j.pediatrneurol.2011.12.008; Amenta F, 2000, CLIN EXP HYPERTENS, V22, P277, DOI 10.1081/CEH-100100077; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Barrington KJ, 2008, SEMIN FETAL NEONAT M, V13, P16, DOI 10.1016/j.siny.2007.09.002; Batton B, 2016, ARCH DIS CHILD-FETAL, V101, pF201, DOI 10.1136/archdischild-2015-308899; Bishai JM, 2003, J PHYSIOL-LONDON, V546, P869, DOI 10.1113/jphysiol.2002.025270; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Dempsey EM, 2009, ARCH DIS CHILD-FETAL, V94, pF241, DOI 10.1136/adc.2007.124263; Eriksen VR, 2014, ACTA PAEDIATR, V103, P1221, DOI 10.1111/apa.12817; Fanaroff AA, 2006, SEMIN PERINATOL, V30, P151, DOI 10.1053/j.semperi.2006.04.006; Fanaroff JM, 2006, PEDIATRICS, V117, P1131, DOI 10.1542/peds.2005-1230; FERRARA JJ, 1995, ANN SURG, V221, P531, DOI 10.1097/00000658-199505000-00011; GRAHAM DI, 1979, STROKE, V10, P724, DOI 10.1161/01.STR.10.6.724; Hahn GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063069; Hahn GH, 2012, ACTA PAEDIATR, V101, P736, DOI 10.1111/j.1651-2227.2012.02666.x; Kissack CM, 2005, J CEREBR BLOOD F MET, V25, P545, DOI 10.1038/sj.jcbfm.9600046; LOW JA, 1993, ACTA PAEDIATR, V82, P433, DOI 10.1111/j.1651-2227.1993.tb12717.x; Meek JH, 1999, ARCH DIS CHILD-FETAL, V81, pF15, DOI 10.1136/fn.81.1.F15; MIALLALLEN VM, 1987, ARCH DIS CHILD, V62, P1068, DOI 10.1136/adc.62.10.1068; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Nachar RA, 2011, PEDIATR RES, V70, P473, DOI 10.1203/PDR.0b013e31822e178e; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pellicer A, 2005, PEDIATRICS, V115, P1501, DOI 10.1542/peds.2004-1396; Rios DR, 2014, J PEDIATR-US, V165, P697, DOI 10.1016/j.jpeds.2014.06.009; Sassano-Higgins S, 2011, J PERINATOL, V31, P647, DOI 10.1038/jp.2011.2; SERI I, 1984, J PEDIATR-US, V105, P489, DOI 10.1016/S0022-3476(84)80035-9; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; TODA N, 1983, EXPERIENTIA, V39, P1131, DOI 10.1007/BF01943144; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170738	10.1371/journal.pone.0170738	http://dx.doi.org/10.1371/journal.pone.0170738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141842	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129500017
J	Su, T; Zhang, HF				Su, Ting; Zhang, Haifeng			Electrical Study of Trapped Charges in Copper-Doped Zinc Oxide Films by Scanning Probe Microscopy for Nonvolatile Memory Applications	PLOS ONE			English	Article							THIN-FILMS; ELECTRONIC CHARACTERIZATION; EPITAXIAL-GROWTH; ZNO FILMS; FORCE; CU; MICROSTRUCTURE	Charge trapping properties of electrons and holes in copper-doped zinc oxide (ZnO:Cu) films have been studied by scanning probe microscopy. We investigated the surface potential dependence on the voltage and duration applied to the copper-doped ZnO films by Kelvin probe force microscopy. It is found that the Fermi Level of the 8 at.% Cu-doped ZnO films shifted by 0.53 eV comparing to undoped ZnO films. This shift indicates significant change in the electronic structure and energy balance in Cu-doped ZnO films. The Fermi Level (work function) of zinc oxide films can be tuned by Cu doping, which are important for developing this functional material. In addition, Kelvin probe force microscopy measurements demonstrate that the nature of contact at Pt-coated tip/ZnO: Cu interface is changed from Schottky contact to Ohmic contact by increasing sufficient amount of Cu ions. The charge trapping property of the ZnO films enhance greatly by Cu doping (similar to 10 at.%). The improved stable bipolar charge trapping properties indicate that copper-doped ZnO films are promising for nonvolatile memory applications.	[Su, Ting] Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China; [Su, Ting] Fudan Univ, Dept Phys, Shanghai, Peoples R China; [Zhang, Haifeng] Jiamusi Univ, Dept Phys, Jiamusi, Peoples R China	Fudan University; Fudan University; Jiamusi University	Su, T (corresponding author), Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China.; Su, T (corresponding author), Fudan Univ, Dept Phys, Shanghai, Peoples R China.	14110190063@fudan.edu.cn						Ando M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4901946; Barth C, 2011, ADV MATER, V23, P477, DOI 10.1002/adma.201002270; Chen CC, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768921; Chen XQ, 1999, J VAC SCI TECHNOL B, V17, P1930, DOI 10.1116/1.590851; Dai W, 2014, RSC ADV, V4, P31969, DOI 10.1039/c4ra04249b; DINGLE R, 1969, PHYS REV LETT, V23, P579, DOI 10.1103/PhysRevLett.23.579; Faraji N, 2016, ADV ELECTRON MATER, V2, DOI 10.1002/aelm.201600138; Guo DY, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890524; Jin CM, 2005, MAT SCI ENG B-SOLID, V117, P348, DOI 10.1016/j.mseb.2004.12.003; Kalinin SV, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125411; Kim Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3046786; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Maragliano C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04203; Melitz W, 2011, SURF SCI REP, V66, P1, DOI 10.1016/j.surfrep.2010.10.001; Min CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432398; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Musumeci C, 2014, MATER TODAY, V17, P504, DOI 10.1016/j.mattod.2014.05.010; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Palermo V, 2006, ADV MATER, V18, P145, DOI 10.1002/adma.200501394; Recker MC, 2014, J APPL PHYS, V115, DOI 10.1063/1.4885439; Shi YM, 2010, ACS NANO, V4, P2689, DOI 10.1021/nn1005478; Singh S, 2007, J PHYS D APPL PHYS, V40, P6312, DOI 10.1088/0022-3727/40/20/S15; Snure M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749487; Tiwari A, 2004, J APPL PHYS, V96, P3827, DOI 10.1063/1.1783591; Tiwari A, 2002, J MATER RES, V17, P2480, DOI 10.1557/JMR.2002.0361; Tiwari A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857481; Wang XB, 2005, J PHYS D APPL PHYS, V38, P4104, DOI 10.1088/0022-3727/38/22/014; Wen L, 2015, SURF COAT TECH, V284, P85, DOI 10.1016/j.surfcoat.2015.06.084; Younas M, 2015, RSC ADV, V5, P55648, DOI 10.1039/c5ra09002d	29	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171050	10.1371/journal.pone.0171050	http://dx.doi.org/10.1371/journal.pone.0171050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135335	Green Published, Green Submitted, gold			2022-12-26	WOS:000396124700042
J	Cai, KP; Xu, H; Guan, H; Zhu, WL; Jiang, JY; Cui, Y; Zhang, JC; Liu, T; Wen, W				Cai, Kunpeng; Xu, Hong; Guan, Hao; Zhu, Wanlin; Jiang, Jiyang; Cui, Yue; Zhang, Jicong; Liu, Tao; Wen, Wei			Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; REDUCED CORTICAL FEATURES; MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; CEREBRAL-CORTEX; HIPPOCAMPUS; AD; AMYGDALA; SYSTEM	Identifying Alzheimer's disease (AD) at its early stage is of major interest in AD research. Previous studies have suggested that abnormalities in regional sulcal width and global sulcal index (g-SI) are characteristics of patients with early-stage AD. In this study, we investigated sulcal width and three other common neuroimaging morphological measures (cortical thickness, cortical volume, and subcortical volume) to identify early-stage AD. These measures were evaluated in 150 participants, including 75 normal controls (NC) and 75 patients with early-stage AD. The global sulcal index (g-SI) and the width of five individual sulci (the superior frontal, intra-parietal, superior temporal, central, and Sylvian fissure) were extracted from 3D T1-weighted images. The discriminative performances of the other three traditional neuroimaging morphological measures were also examined. Information Gain (IG) was used to select a subset of features to provide significant information for separating NC and early-stage AD subjects. Based on the four modalities of the individual measures, i.e.,sulcal measures, cortical thickness, cortical volume, subcortical volume, and combinations of these individual measures, three types of classifiers (Naive Bayes, Logistic Regression and Support Vector Machine) were applied to compare the classification performances. We observed that sulcal measures were either superior than or equal to the other measures used for classification. Specifically, the g- SI and the width of the Sylvian fissure were two of the most sensitive sulcal measures and could be useful neuroanatomical markers for detecting early-stage AD. There were no significant differences between the three classifiers that we tested when using the same neuroanatomical features.	[Cai, Kunpeng; Xu, Hong] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China; [Cai, Kunpeng; Guan, Hao; Zhu, Wanlin; Zhang, Jicong; Liu, Tao] Beihang Univ, Int Res Inst Multidisciplinary Sci, Beijing, Peoples R China; [Guan, Hao; Zhang, Jicong; Liu, Tao] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Zhu, Wanlin; Jiang, Jiyang; Wen, Wei] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Jiang, Jiyang; Wen, Wei] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Cui, Yue] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Cui, Yue] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Liu, Tao] Beijing Key Lab Rehabil Engn Elderly, Beijing, Peoples R China	Beihang University; Beihang University; Beihang University; University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, T (corresponding author), Beihang Univ, Int Res Inst Multidisciplinary Sci, Beijing, Peoples R China.; Liu, T (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China.; Liu, T (corresponding author), Beijing Key Lab Rehabil Engn Elderly, Beijing, Peoples R China.	tao.liu@buaa.edu.cn	Jiang, Jiyang/AAD-6296-2019	Jiang, Jiyang/0000-0002-2147-6302; Wen, Wei/0000-0003-2753-3870; Liu, Tao/0000-0002-7783-3073	Natural Science Foundation of China [81401476, 61301005]; National Key Research and Development Program of China [2016YFF0201002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This research received support from the Natural Science Foundation of China (http://www.nsfc .gov.cn/, Grant No. 81401476 and Grant No. 61301005) and the National Key Research and Development Program of China (Grant No. 2016YFF0201002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Bubitzky W, 2007, FUNDAMENTALS DATA MI, Vxxii; Bunea F, 2011, NEUROIMAGE, V55, P1519, DOI 10.1016/j.neuroimage.2010.12.028; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Cohen NJ, 2010, MEMORY AMNESIA HIPPO, pXiii; Cui Y, 2012, NEUROIMAGE, V60, P894, DOI 10.1016/j.neuroimage.2012.01.084; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eskildsen SF, 2015, NEUROBIOL AGING, V36, pS23, DOI 10.1016/j.neurobiolaging.2014.04.034; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016; Hall M., 2009, ACM SIGKDD; Hamelin L, 2015, NEUROBIOL AGING, V36, P2932, DOI 10.1016/j.neurobiolaging.2015.04.019; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kochunov P, 2012, NEUROINFORMATICS, V10, P81, DOI 10.1007/s12021-011-9127-9; Kodaz H, 2009, EXPERT SYST APPL, V36, P3086, DOI 10.1016/j.eswa.2008.01.026; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Liu T, 2013, NEUROIMAGE, V83, P12, DOI 10.1016/j.neuroimage.2013.06.058; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Liu T, 2010, NEUROIMAGE, V51, P19, DOI 10.1016/j.neuroimage.2010.02.016; Liu TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031001; Mangin J, 1995, 14 INT C 14 INT C; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miller MI, 2014, NEUROBIOL AGING, V36; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Ota K, 2016, J ALZHEIMERS DIS, V52, P1385, DOI 10.3233/JAD-160145; Park H, 2013, NEUROSCI LETT, V550, P17, DOI 10.1016/j.neulet.2013.06.042; Park H, 2012, NEUROSCI LETT, V529, P123, DOI 10.1016/j.neulet.2012.09.011; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Penttilae J, 2009, J PSYCHIATR NEUROSCI, V34, P127; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Rogan Shannon, 2002, Am J Alzheimers Dis Other Demen, V17, P11, DOI 10.1177/153331750201700106; Savio A, 2009, LECT NOTES COMPUT SC, V5788, P641, DOI 10.1007/978-3-642-04394-9_78; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; Teipel SJ, 2006, J NEUROL, V253, P794, DOI 10.1007/s00415-006-0120-4; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu L, 2003, MACH LEARN P 20 INT; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	60	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170875	10.1371/journal.pone.0170875	http://dx.doi.org/10.1371/journal.pone.0170875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129351	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400029
J	Ehrmann, W; Schmiedl, G; Beuscher, S; Krueger, S				Ehrmann, Werner; Schmiedl, Gerhard; Beuscher, Sarah; Krueger, Stefan			Intensity of African Humid Periods Estimated from Saharan Dust Fluxes	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; LAST GLACIAL MAXIMUM; LATE-QUATERNARY; SURFACE SEDIMENTS; CLAY-MINERALS; AEGEAN SEA; SIMULATED CLIMATE; NORTHERN AFRICA; MODERN HUMANS; HOLOCENE	North Africa experienced dramatic changes in hydrology and vegetation during the late Quaternary driven by insolation-induced shifts of the tropical rain belt and further modulated by millennial-scale droughts and vegetation-climate feedbacks. While most past proxy and modelling studies concentrated on the temporal and spatial dynamics of the last African humid period, little is known about the intensities and characteristics of pre-Holocene humid periods. Here we present a high-resolution record of fine-grained eastern Saharan dust from the Eastern Mediterranean Sea spanning the last 180 kyr, which is based on the clay mineral composition of the marine sediments, especially the kaolinite/chlorite ratio. Minimum aeolian kaolinite transport occurred during the African Humid Periods because kaolinite deflation was hampered by increased humidity and vegetation cover. Instead, kaolinite weathering from kaolinite-bearing Cenozoic rocks was stored in lake basins, river beds and soils during these periods. During the subsequent dry phases, fine-grained dust was mobilised from the desiccated lakes, rivers and soils resulting in maximum aeolian uptake and transport of kaolinite. The kaolinite transport decreased again when these sediment sources exhausted. We conclude that the amount of clay-sized dust blown out of the Sahara into the Eastern Mediterranean Sea is proportional to the intensity of the kaolinite weathering and accumulation in soils and lake sediments, and thus to the strength of the preceding humid period. These humid periods provided the windows for the migration of modern humans out of Africa, as postulated previously. The strongest humid period occurred during the Eemian and was followed by two weaker phases centred at ca. 100 ka and ca. 80 ka.	[Ehrmann, Werner; Beuscher, Sarah; Krueger, Stefan] Univ Leipzig, Inst Geol & Geophys, Talstr 35, Leipzig, Germany; [Schmiedl, Gerhard] Univ Hamburg, Ctr Erdsyst Forsch & Nachhaltigkeit, Bundesstr 55, Hamburg, Germany	Leipzig University; University of Hamburg	Ehrmann, W (corresponding author), Univ Leipzig, Inst Geol & Geophys, Talstr 35, Leipzig, Germany.	ehrmann@rz.uni-leipzig.de	Schmiedl, Gerhard/E-6644-2017	Schmiedl, Gerhard/0000-0002-2177-6858	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); DFG; University of Leipzig	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Leipzig	We thank the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for providing financial support to carry out the project, and also acknowledge the support of the DFG and the University of Leipzig within the programme of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Baumhauer R., 2004, ERDE, V135, P289; BISCAYE PE, 1965, GEOL SOC AM BULL, V76, P803, DOI 10.1130/0016-7606(1965)76[803:MASORD]2.0.CO;2; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Bolle MP, 2000, ECLOGAE GEOL HELV, V93, P33; Bout-Roumazeilles V, 2007, QUATERNARY SCI REV, V26, P3197, DOI 10.1016/j.quascirev.2007.07.015; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Brooks K, 2005, PALAEOGEOGR PALAEOCL, V216, P235, DOI 10.1016/j.palaeo.2004.10.005; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Bullard J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033928; Bullard JE, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002061; Caquineau S, 1998, GEOPHYS RES LETT, V25, P983, DOI 10.1029/98GL00569; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; CHESTER R, 1977, MAR GEOL, V24, P201, DOI 10.1016/0025-3227(77)90028-7; Claussen M, 2013, NAT GEOSCI, V6, P954, DOI [10.1038/ngeo1962, 10.1038/NGEO1962]; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; Coulthard TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074834; Crouvi O, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052145; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ehrmann W, 2007, PALAEOGEOGR PALAEOCL, V249, P36, DOI 10.1016/j.palaeo.2007.01.004; Ehrmann W, 2007, INT J EARTH SCI, V96, P769, DOI 10.1007/s00531-006-0119-1; Ehrmann W, 2016, CLIM PAST, V12, P713, DOI 10.5194/cp-12-713-2016; Ehrmann W, 2013, GLOBAL PLANET CHANGE, V107, P186, DOI 10.1016/j.gloplacha.2013.05.010; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Felix-Henningsen P, 2000, CATENA, V41, P43, DOI 10.1016/S0341-8162(00)00108-9; Foucault A, 2000, PALAEOGEOGR PALAEOCL, V158, P311, DOI 10.1016/S0031-0182(00)00056-0; Gallego-Torres D, 2010, PALAEOGEOGR PALAEOCL, V293, P76, DOI 10.1016/j.palaeo.2010.05.001; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Grant KM, 2016, QUATERNARY SCI REV, V140, P125, DOI 10.1016/j.quascirev.2016.03.026; Hamann Y, 2008, MAR GEOL, V248, P97, DOI 10.1016/j.margeo.2007.10.009; Hamann Y, 2009, QUATERNARY RES, V71, P453, DOI 10.1016/j.yqres.2009.01.001; Hieke W, 1997, MITTELMEER 1998 99 C, P99; HILLAIREMARCEL C, 1986, QUATERNARY RES, V25, P312, DOI 10.1016/0033-5894(86)90004-9; Jennings RP, 2015, QUATERN INT, V382, P181, DOI 10.1016/j.quaint.2015.01.006; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; KELLER J, 1978, GEOL SOC AM BULL, V89, P591, DOI 10.1130/0016-7606(1978)89<591:EVAITM>2.0.CO;2; Kohfeld K., 2001, EARTH-SCI REV, V54, P114, DOI DOI 10.1016/S0012-8252(01)00042-3; Kraml M., 1997, THESIS; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Krom MD, 1999, MAR GEOL, V155, P319, DOI 10.1016/S0025-3227(98)00130-3; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; McTainsh G, 2013, TREATISE GEOMORPHOLO, P23; Mikolajewicz U, 2011, CLIM PAST, V7, P161, DOI 10.5194/cp-7-161-2011; Moreno A, 2002, QUATERNARY RES, V58, P318, DOI 10.1006/qres.2002.2383; Mulitza S, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001637; Narcisi B, 1999, GLOBAL PLANET CHANGE, V21, P31, DOI 10.1016/S0921-8181(99)00006-5; NIHLEN T, 1995, Z GEOMORPHOL, V39, P341; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Pachur H.J., 2001, NOVA ACTA LEOPOLDINA, VNF88, P109; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Parton A, 2015, QUATERN INT, V382, P82, DOI 10.1016/j.quaint.2015.01.005; PYE K, 1992, EARTH SURF PROCESSES, V17, P271, DOI 10.1002/esp.3290170306; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renssen H, 2006, QUATERN INT, V150, P95, DOI 10.1016/j.quaint.2005.01.001; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Scerri EML, 2014, QUATERNARY SCI REV, V101, P207, DOI 10.1016/j.quascirev.2014.07.019; Scheuvens D, 2013, EARTH-SCI REV, V116, P170, DOI 10.1016/j.earscirev.2012.08.005; Schmiedl G, 1998, PALEOCEANOGRAPHY, V13, P447, DOI 10.1029/98PA01864; Shanahan TM, 2015, NAT GEOSCI, V8, P140, DOI [10.1038/ngeo2329, 10.1038/NGEO2329]; Stanley DJ, 1996, J COASTAL RES, V12, P911; Stuut JB, 2009, QUATERN INT, V198, P234, DOI 10.1016/j.quaint.2008.10.007; Tegen I, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000963; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Trauth MH, 2003, EARTH PLANET SC LETT, V206, P297, DOI 10.1016/S0012-821X(02)01105-6; VENKATARATHNAM K, 1971, MAR GEOL, V11, P261, DOI 10.1016/0025-3227(71)90028-4; Washington R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025827; WEAVER CE, 1977, SEDIMENT GEOL, V17, pR9, DOI 10.1016/0037-0738(77)90062-8; Weldeab S, 2003, PALAEOGEOGR PALAEOCL, V191, P169, DOI 10.1016/S0031-0182(02)00711-3; Weldeab S, 2002, CHEM GEOL, V186, P139, DOI 10.1016/S0009-2541(01)00415-6; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Wulf S, 2004, QUATERN INT, V122, P7, DOI 10.1016/j.quaint.2004.01.028	86	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170989	10.1371/journal.pone.0170989	http://dx.doi.org/10.1371/journal.pone.0170989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129378	Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400014
J	Voros, J; Marton, O; Schmidt, BR; Gal, JT; Jelic, D				Voros, Judit; Marton, Orsolya; Schmidt, Benedikt R.; Gal, Julia Tunde; Jelic, Dusan			Surveying Europe's Only Cave-Dwelling Chordate Species (Proteus anguinus) Using Environmental DNA	PLOS ONE			English	Article							GROUNDWATER BIODIVERSITY; EUPROCTUS-ASPER; EDNA; CONSERVATION; PROTEIDAE; SALAMANDER; EVOLUTION; RICHNESS; TOOL	In surveillance of subterranean fauna, especially in the case of rare or elusive aquatic species, traditional techniques used for epigean species are often not feasible. We developed a non-invasive survey method based on environmental DNA (eDNA) to detect the presence of the red-listed cave-dwelling amphibian, Proteus anguinus, in the caves of the Dinaric Karst. We tested the method in fifteen caves in Croatia, from which the species was previously recorded or expected to occur. We successfully confirmed the presence of P. anguinus from ten caves and detected the species for the first time in five others. Using a hierarchical occupancy model we compared the availability and detection probability of eDNA of two water sampling methods, filtration and precipitation. The statistical analysis showed that both availability and detection probability depended on the method and estimates for both probabilities were higher using filter samples than for precipitation samples. Combining reliable field and laboratory methods with robust statistical modeling will give the best estimates of species occurrence.	[Voros, Judit; Gal, Julia Tunde] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Voros, Judit] Hungarian Nat Hist Museum, Mol Taxon Lab, Budapest, Hungary; [Marton, Orsolya] Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary; [Schmidt, Benedikt R.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmidt, Benedikt R.] Koordinat Stelle Amphibien & Reptilienschutz Schw, Neuchatel, Switzerland; [Jelic, Dusan] Croatian Inst Biodivers, Zagreb, Croatia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Zurich; University of Zagreb	Voros, J (corresponding author), Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary.; Voros, J (corresponding author), Hungarian Nat Hist Museum, Mol Taxon Lab, Budapest, Hungary.	voros.judit@nhmus.hu	Jelić, Dušan/Q-3779-2017; Schmidt, Benedikt R./B-8491-2008	Jelić, Dušan/0000-0003-2790-1522; Schmidt, Benedikt R./0000-0002-4023-1001; Voros, Judit/0000-0001-9707-1443	MAVA Foundation; Zoological Society of London; Krka National Park; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences [BO/00579/14/8]	MAVA Foundation; Zoological Society of London; Krka National Park; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	DJ was supported by the MAVA Foundation, Zoological Society of London and Krka National Park. JV was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences (BO/00579/14/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arntzen JW, 2009, IUCN RED LIST THREAT; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bendik NF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-201; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Bozic V, 2014, ILLUSTRATED HIST SPE; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; curcic BPM, 2008, MONOGRAPHS, V12, P35; Deharveng L, 2009, FRESHWATER BIOL, V54, P709, DOI 10.1111/j.1365-2427.2008.01972.x; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dumas P, 1998, BEHAV PROCESS, V43, P107, DOI 10.1016/S0376-6357(98)00002-3; DURAND JP, 1987, BEHAV PROCESS, V15, P285, DOI 10.1016/0376-6357(87)90013-1; DURAND JP, 1981, J THERM BIOL, V6, P53, DOI 10.1016/0306-4565(81)90044-9; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fitzinger LJ, 1850, SITZ BER AKAD WISS M, V5, P291; Gal JT, 2013, THESIS SZENT ISTVAN; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herder J., 2014, ENV DNA A REV POSSIB; Hervant F, 2001, J EXP BIOL, V204, P269; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; HOLSINGER JR, 1993, J NAT HIST, V27, P821, DOI 10.1080/00222939300770501; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Jelic D., 2012, RED BOOK AMPHIBIANS; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kletecki Eduard, 1996, Memoires de Biospeologie, V23, P227; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kovacevic T., 1984, 9 YUG C SPEL, P539; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; MARMONIER P, 1993, TRENDS ECOL EVOL, V8, P392, DOI 10.1016/0169-5347(93)90039-R; Matocec Sanja Gottstein, 2002, Natura Croatica, V11, P1; Parzefall J, 1993, HDB REPTILIEN AMPHIB, V4, P57; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, APPL ENV DNA INVENTO, V2012-3146; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Romero A., 2009, CAVE BIOL LIFE DARKN; Romero A, 2011, AM SCI, V99, P144, DOI 10.1511/2011.89.144; Rouch R, 1997, INT REV GES HYDROBIO, V82, P121, DOI 10.1002/iroh.19970820202; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Schlegel P, 1997, J PHYSIOLOGY-PARIS, V91, P75, DOI 10.1016/S0928-4257(97)88941-3; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Schneider K, 2004, J CAVE KARST STUD, V66, P39; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Sket B, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P309; Sket B, 1999, BIODIVERS CONSERV, V8, P1319, DOI 10.1023/A:1008916601121; Sket B, 1997, J BIOGEOGR, V24, P263, DOI 10.1046/j.1365-2699.1997.00103.x; Soares D, 2013, BIOSCIENCE, V63, P274, DOI 10.1525/bio.2013.63.4.7; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; UIBLEIN F, 1992, BEHAV PROCESS, V28, P33, DOI 10.1016/0376-6357(92)90046-G; Voituron Y, 2011, BIOL LETTERS, V7, P105, DOI 10.1098/rsbl.2010.0539	66	48	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170945	10.1371/journal.pone.0170945	http://dx.doi.org/10.1371/journal.pone.0170945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129383	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000396211400022
J	Yang, FM; Du, J; Zhang, H; Ruan, GR; Xiang, JF; Wang, LX; Sun, HX; Guan, AJ; Shen, G; Liu, Y; Guo, XM; Li, Q; Tang, YL				Yang, Fengmin; Du, Jie; Zhang, Hong; Ruan, Guorui; Xiang, Junfeng; Wang, Lixia; Sun, Hongxia; Guan, Aijiao; Shen, Gang; Liu, Yan; Guo, Xiaomeng; Li, Qian; Tang, Yalin			Serum Metabolomics of Burkitt Lymphoma Mouse Models	PLOS ONE			English	Article							CHOLINE PHOSPHOLIPID-METABOLISM; MAGNETIC-RESONANCE-SPECTROSCOPY; H-1-NMR SPECTROSCOPY; NMR-SPECTROSCOPY; CELL CARCINOMA; CANCER; CLASSIFICATION; PROFILES; BIOLOGY; URINE	Burkitt lymphoma (BL) is a rare and highly aggressive type of non-Hodgkin lymphoma. The mortality rate of BL patients is very high due to the rapid growth rate and frequent systemic spread of the disease. A better understanding of the pathogenesis, more sensitive diagnostic tools and effective treatment methods for BL are essential. Metabolomics, an important aspect of systems biology, allows the comprehensive analysis of global, dynamic and endogenous biological metabolites based on their nuclear magnetic resonance (NMR) and mass spectrometry (MS). It has already been used to investigate the pathogenesis and discover new biomarkers for disease diagnosis and prognosis. In this study, we analyzed differences of serum metabolites in BL mice and normal mice by NMR-based metabolomics. We found that metabolites associated with energy metabolism, amino acid metabolism, fatty acid metabolism and choline phospholipid metabolism were altered in BL mice. The diagnostic potential of the metabolite differences was investigated in this study. Glutamate, glycerol and choline had a high diagnostic accuracy; in contrast, isoleucine, leucine, pyruvate, lysine, a-ketoglutarate, betaine, glycine, creatine, serine, lactate, tyrosine, phenylalanine, histidine and formate enabled the accurate differentiation of BL mice from normal mice. The discovery of abnormal metabolism and relevant differential metabolites may provide useful clues for developing novel, noninvasive approaches for the diagnosis and prognosis of BL based on these potential biomarkers.	[Yang, Fengmin; Zhang, Hong; Xiang, Junfeng; Wang, Lixia; Sun, Hongxia; Guan, Aijiao; Shen, Gang; Liu, Yan; Guo, Xiaomeng; Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Natl Lab Mol Sci,Ctr Mol Sci, Beijing, Peoples R China; [Du, Jie] JOINN Labs Inc, Beijing, Peoples R China; [Ruan, Guorui] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Ruan, Guorui] Peking Univ, Inst Hematol, Beijing, Peoples R China; [Li, Qian; Tang, Yalin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Peking University; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q; Tang, YL (corresponding author), Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Natl Lab Mol Sci,Ctr Mol Sci, Beijing, Peoples R China.; Li, Q; Tang, YL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	qianlee@iccas.ac.cn; tangyl@iccas.ac.cn		sun, hong xia/0000-0002-4487-1823	General Program of the National Natural Science Foundation of China [21472197]; Major National Basic Research Projects (973) [2013CB733701]; National Natural Science Foundation of China [21305145]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA09030307]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Projects (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the General Program of the National Natural Science Foundation of China (Grant Number 21472197), the Major National Basic Research Projects (973) (Grant Number 2013CB733701), the National Natural Science Foundation of China (Grant Number 21305145) and "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Number XDA09030307). Funding for open access charge: General Program of the National Natural Science Foundation of China (Grant Number 21472197).; This work was supported by the Major National Basic Research Projects (973) (Grant Number 2013CB733701), the General Program of the National Natural Science Foundation of China (Grant Number 21472197), the National Natural Science Foundation of China (Grant Number 21305145) and "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Number XDA09030307). Funding for open access charge comes from General Program of the National Natural Science Foundation of China (Grant Number 21472197).	Aboagye EO, 1999, CANCER RES, V59, P80; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; AlaKorpela M, 1995, PROG NUCL MAG RES SP, V27, P475, DOI 10.1016/0079-6565(95)01013-0; Baracos VE, 2006, J NUTR, V136, p237S, DOI 10.1093/jn/136.1.237S; Beckwith-Hall BM, 2003, ANALYST, V128, P814, DOI 10.1039/b302360p; Bornkamm GW, 2009, INT J CANCER, V124, P1745, DOI 10.1002/ijc.24223; Braziel RM, 2001, BLOOD, V97, P3713, DOI 10.1182/blood.V97.12.3713; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chen WL, 2016, CANC CELL; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; GRIBBESTAD IS, 1993, ANTICANCER RES, V13, P1973; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; HARRIS NL, 1994, BLOOD, V84, P1361; Holmes E, 1998, NMR BIOMED, V11, P235, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO;2-V; Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Jouret F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163021; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; LAZO PA, 1981, FEBS LETT, V135, P229, DOI 10.1016/0014-5793(81)80788-0; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pirhaji L, 2016, NAT METHODS, V13, P770, DOI [10.1038/NMETH.3940, 10.1038/nmeth.3940]; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Ronen SM, 2001, BREAST CANCER RES, V3, P36, DOI 10.1186/bcr268; Soeters PB, 1997, BAILLIERE CLIN ENDOC, V11, P659, DOI 10.1016/S0950-351X(97)80942-1; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tang HR, 2004, ANAL BIOCHEM, V325, P260, DOI 10.1016/j.ab.2003.10.033; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wadhera A, 2013, J CANCER RES THER, V9, P751, DOI 10.4103/0973-1482.126488; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Weber T, 2016, EUR J NUCL MED MOL I, V43, P489, DOI 10.1007/s00259-015-3175-6; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeng J, 2014, J PROTEOME RES, V13, P3420, DOI 10.1021/pr500390y; Zhang L, 2008, CANCER LETT, V269, P26, DOI 10.1016/j.canlet.2008.04.024; Zheng H, 2016, ONCOTARGET, V7, P59189, DOI 10.18632/oncotarget.10830; Zira AN, 2010, J PROTEOME RES, V9, P4038, DOI 10.1021/pr100226m	54	11	11	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170896	10.1371/journal.pone.0170896	http://dx.doi.org/10.1371/journal.pone.0170896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129369	gold, Green Submitted, Green Published			2022-12-26	WOS:000396211400028
J	Shimoshige, H; Nakajima, Y; Kobayashi, H; Yanagisawa, K; Nagaoka, Y; Shimamura, S; Mizuki, T; Inoue, A; Maekawa, T				Shimoshige, Hirokazu; Nakajima, Yoshikata; Kobayashi, Hideki; Yanagisawa, Keiichi; Nagaoka, Yutaka; Shimamura, Shigeru; Mizuki, Toru; Inoue, Akira; Maekawa, Toru			Formation of Core-Shell Nanoparticles Composed of Magnetite and Samarium Oxide in Magnetospirillum magneticum Strain RSS-1	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; MAGNETOTACTIC BACTERIA; MAGNETOSOME FORMATION; BIOGENIC MAGNETITE; NANOCRYSTALS; ADSORPTION; BIOMINERALIZATION; GRYPHISWALDENSE; ACCUMULATION; SEDIMENTS	Magnetotactic bacteria (MTB) synthesize magnetosomes composed of membrane-enveloped magnetite (Fe3O4) or greigite (Fe3S4) particles in the cells. Recently, several studies have shown some possibilities of controlling the biomineralization process and altering the magnetic properties of magnetosomes by adding some transition metals to the culture media under various environmental conditions. Here, we successfully grow Magnetospirillum magneticum strain RSS-1, which are isolated from a freshwater environment, and find that synthesis of magnetosomes are encouraged in RSS-1 in the presence of samarium and that each core magnetic crystal composed of magnetite is covered with a thin layer of samarium oxide (Sm2O3). The present results show some possibilities of magnetic recovery of transition metals and synthesis of some novel structures composed of magnetic particles and transition metals utilizing MTB.	[Shimoshige, Hirokazu; Nakajima, Yoshikata; Yanagisawa, Keiichi; Nagaoka, Yutaka; Mizuki, Toru; Inoue, Akira; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan; [Nakajima, Yoshikata; Mizuki, Toru; Inoue, Akira; Maekawa, Toru] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan; [Kobayashi, Hideki; Shimamura, Shigeru] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa, Japan	Toyo University; Toyo University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Maekawa, T (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.; Maekawa, T (corresponding author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan.	maekawa@toyo.jp	Nakajima, Yoshikata/Y-8403-2019	Nakajima, Yoshikata/0000-0002-0302-7386; Shimoshige, Hirokazu/0000-0002-0583-6160; Mizuki, Toru/0000-0003-2744-881X	Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]; Grants-in-Aid for Scientific Research [15K18056] Funding Source: KAKEN	Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by S1101017, grant for the Program for the Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, http://www.mext.go.jp/en/.	ANDRES Y, 1993, APPL MICROBIOL BIOT, V39, P413, DOI 10.1007/BF00192103; BAYER ME, 1991, J BACTERIOL, V173, P141, DOI 10.1128/jb.173.1.141-149.1991; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1994, MICROSC RES TECHNIQ, V27, P389, DOI 10.1002/jemt.1070270505; BAZYLINSKI DA, 1993, ARCH MICROBIOL, V160, P35; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; Charilaou M, 2016, J APPL PHYS, V109; Cotton S.A., 2006, LANTHANIDE ACTINIDE; De Silva CR, 2009, J AM CHEM SOC, V131, P6336, DOI 10.1021/ja9014277; Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gehring AU, 2011, GEOPHYS J INT, V187, P1215, DOI 10.1111/j.1365-246X.2011.05175.x; Hammond C.R., 2000, ELEMENTS HDB CHEM PH, V81st ed.; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Jabeen F, 2015, ANAL CHEM, V87, P4726, DOI 10.1021/ac504818s; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Keim CN, 2009, FEMS MICROBIOL LETT, V292, P250, DOI 10.1111/j.1574-6968.2009.01499.x; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kundu S, 2009, BIOMATERIALS, V30, P4211, DOI 10.1016/j.biomaterials.2009.04.039; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JH, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0355; Li JH, 2013, GEOCHEM GEOPHY GEOSY, V14, P3887, DOI 10.1002/ggge.20228; Li JH, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004384; Liang X, 2006, ADV FUNCT MATER, V16, P1805, DOI 10.1002/adfm.200500884; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Liu T, 2003, LANGMUIR, V19, P7569, DOI 10.1021/la034350l; MANN S, 1990, ADV MICROB PHYSIOL, V31, P125; Miyazaki S, 2003, NUCLEIC ACIDS RES, V31, P13, DOI 10.1093/nar/gkg088; MOSKOWITZ BM, 1993, EARTH PLANET SC LETT, V120, P283, DOI 10.1016/0012-821X(93)90245-5; Ngwenya BT, 2010, ENVIRON SCI TECHNOL, V44, P650, DOI 10.1021/es9014234; Pan YX, 2005, EARTH PLANET SC LETT, V237, P311, DOI 10.1016/j.epsl.2005.06.029; Pang XC, 2016, SCIENCE, V353, P1268, DOI 10.1126/science.aad8279; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Posfai M, 1998, AM MINERAL, V83, P1469, DOI 10.2138/am-1998-11-1235; Prozorov T, 2014, EUR J MINERAL, V26, P457, DOI 10.1127/0935-1221/2014/0026-2388; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shimoshige H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127481; Song HP, 2008, CHEMOSPHERE, V72, P616, DOI 10.1016/j.chemosphere.2008.02.064; Song HP, 2007, CHINESE J CHEM ENG, V15, P847, DOI 10.1016/S1004-9541(08)60013-0; SOROKIN PP, 1979, IBM J RES DEV, V23, P476, DOI 10.1147/rd.235.0476; SPARKS NHC, 1986, FEMS MICROBIOL LETT, V37, P305, DOI 10.1016/0378-1097(86)90424-6; Staniland S, 2008, NAT NANOTECHNOL, V3, P158, DOI 10.1038/nnano.2008.35; Sun JB, 2010, NANOTOXICOLOGY, V4, P271, DOI 10.3109/17435391003690531; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Tanaka M, 2012, EUR J MINERAL, V22, P11919; Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; TOWE KM, 1981, EARTH PLANET SC LETT, V52, P213, DOI 10.1016/0012-821X(81)90222-3; Tsuruta T, 2006, COLLOID SURFACE B, V52, P117, DOI 10.1016/j.colsurfb.2006.04.014; Wang YH, 2011, DESALINATION, V270, P258, DOI 10.1016/j.desal.2010.11.053; Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x; Xie J, 2009, NANO RES, V2, P261, DOI [10.1007/s12274-009-9025-8, 10.1007/S12274-009-9025-8]; Xu H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1016/J.CECA.2015.02.006; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X; Yang D, 2015, ANGEW CHEM INT EDIT, V54, P12091, DOI 10.1002/anie.201504676	60	11	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170932	10.1371/journal.pone.0170932	http://dx.doi.org/10.1371/journal.pone.0170932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125741	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100021
J	Jhan, JR; Andrechek, ER				Jhan, J-R; Andrechek, E. R.			Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis	ONCOGENE			English	Article							TRASTUZUMAB RESISTANCE; TRANSCRIPTION FACTORS; ADJUVANT BEVACIZUMAB; MOLECULAR PORTRAITS; TARGETED THERAPIES; LUNG-CANCER; IN-VITRO; INHIBITION; MODELS; CONTRIBUTES	Current therapeutic outcomes for breast cancer underscore the complexity of treating a heterogeneous disease. Indeed, studies have shown that differences in gene expression among patients with the same subtype of breast cancer are correlated with the response to treatment. This strongly suggests that there is an urgent need to treat breast cancer with a personalized approach. Here we employed cell signaling pathway signatures to predict pathway activity in subtypes of MMTV-Myc mammary tumors. We then split tumors into subsets and developed individualized combinatorial treatments for two subtypes with distinct pathway activation patterns. Elevation of the EGFR, RAS and TGF beta pathways was observed in one subtype whereas these pathways were not predicted to be active in the other subtype that had high predicted activity of the Myc, Stat3 and Akt pathways. In a proof-of-principle experiment, treatment of these two subtypes with targeted therapies inhibited tumor growth only in the subtype of tumor where the therapy was designed to be active. We then analyzed gene expression profiles of human breast cancer patients and patientderived xenograft (PDX) samples to predict pathway activity, and validated our approach of developing individualized treatments in mice with PDX tumors. Importantly, our combinatorial therapy resulted in tumor regression, including regression in PDX samples from triple-negative breast cancer. Together our data is a proof-of-principle experiment that demonstrates that cell signaling pathway signature-guided treatment for breast cancer is viable.	[Jhan, J-R; Andrechek, E. R.] Michigan State Univ, Dept Physiol, 2194 Biomed Phys Sci Bldg,567 Wilson Rd, E Lansing, MI 48824 USA	Michigan State University	Andrechek, ER (corresponding author), Michigan State Univ, Dept Physiol, 2194 Biomed Phys Sci Bldg,567 Wilson Rd, E Lansing, MI 48824 USA.	andrech1@msu.edu			Susan Komen Career Catalyst [KG110510]; NIH [R011CA160514]	Susan Komen Career Catalyst; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Andrechek laboratory for helpful discussions. Funding for this project was provided by grants from Susan Komen Career Catalyst (KG110510) and NIH R011CA160514 to ERA.	Alok J., 2004, BIOINFORMATICS, V20, P3246; Andrechek ER, 2015, ONCOGENE, V34, P217, DOI 10.1038/onc.2013.540; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bear HD, 2015, LANCET ONCOL, V16, P1037, DOI 10.1016/S1470-2045(15)00041-8; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertucci F, 2016, LANCET ONCOL, V17, P600, DOI 10.1016/S1470-2045(16)00011-5; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; DaCosta BS, 2004, MOL PHARM, V65, P744, DOI DOI 10.1124/M0L.65.3.744; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Eo HS, 2012, MOL CELLS, V34, P393, DOI 10.1007/s10059-012-0177-0; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Hoefflin R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11845; Hollern DP, 2013, ONCOGENE, V32, P1296, DOI 10.1038/onc.2012.142; Hollern DP, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3672; Hollern DP, 2014, MOL CELL BIOL, V34, P3229, DOI 10.1128/MCB.00737-14; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Morrow PK, 2011, J CLIN ONCOL, V29, P3126, DOI 10.1200/JCO.2010.32.2321; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Xia WL, 2007, CANCER RES, V67, P1170, DOI 10.1158/0008-5472.CAN-06-2101; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; 2007, CLIN CANCER RES, V13, P4429, DOI DOI 10.1158/1078-0432.CCR-06-3045	56	10	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3553	3561		10.1038/onc.2016.503	http://dx.doi.org/10.1038/onc.2016.503			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28135251				2022-12-26	WOS:000403878600005
J	Henriques, FS; Sertie, RAL; Franco, FO; Knobl, P; Neves, RX; Andreotti, S; Lima, FB; Guilherme, A; Seelaender, M; Batista, ML				Henriques, Felipe Santos; Laurato Sertie, Rogerio Antonio; Franco, Felipe Oliveira; Knobl, Pamela; Neves, Rodrigo Xavier; Andreotti, Sandra; Lima, Fabio Bessa; Guilherme, Adilson; Seelaender, Marilia; Batista, Miguel Luiz, Jr.			Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome	FASEB JOURNAL			English	Article						de novo lipogenesis; lipolysis; inflammation; adipose tissue	ADIPOSE-TISSUE LIPOLYSIS; INSULIN-RESISTANCE; FAT; BIOMARKERS; METABOLISM; LIPASES; OBESITY; MICE	Cancer cachexia is a multifactorial syndrome characterized by body weight loss, atrophy of adipose tissue (AT) and systemic inflammation. However, there is limited information regarding the mechanisms of immunometabolic response in AT from cancer cachexia. Male Wistar rats were inoculated with 2 3 107 of Walker 256 tumor cells [tumor bearing (TB) rats]. The mesenteric AT (MeAT) was collected on d 0, 4, 7 (early stage), and 14 (cachexia stage) after tumor cell injection. Surgical biopsies for MeAT were obtained from patients who had gastrointestinal cancer with cachexia. Lipolysis showed an early decrease in glycerol release in TB d 4 (TB4) rats in relation to the control, followed by a 6-fold increase in TB14 rats, whereas de novo lipogenesis was markedly lower in the incorporation of glucose into fatty acids in TB14 rats during the development of cachexia. CD11b and CD68 were positive in TB7 and TB14 rats, respectively. In addition, we found cachexia stage results similar to those of animals in MeAT from patients: an increased presence of CD68(+), iNOS2(+), TNF alpha(+), and HSL+ cells. In summary, translational analysis of MeAT from patients and an animal model of cancer cachexia enabled us to identify early disruption in Adl turnover and subsequent inflammatory response during the development of cancer cachexia.-Henriques, F. S., Serti ' e, R. A. L., Franco, F. O., Knobl, P., Neves, R. X., Andreotti, S., Lima, F. B., Guilherme, A., Seelaender, M., Batista, M. L., Jr. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome.	[Henriques, Felipe Santos; Franco, Felipe Oliveira; Knobl, Pamela; Batista, Miguel Luiz, Jr.] Univ Mogi das Cruzes, Integrated Grp Biotechnol, Lab Adipose Tissue Biol, Sao Paulo, Brazil; [Henriques, Felipe Santos] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA USA; [Laurato Sertie, Rogerio Antonio; Andreotti, Sandra; Lima, Fabio Bessa; Guilherme, Adilson] Univ Sao Paulo, Inst Biomed Sci, Physiol Lab, Sao Paulo, Brazil; [Neves, Rodrigo Xavier; Seelaender, Marilia] Univ Sao Paulo, Inst Biomed Sci, Canc Metab Res Grp, Sao Paulo, Brazil	Universidade de Mogi das Cruzes; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Sao Paulo; Universidade de Sao Paulo	Batista, ML (corresponding author), Ave Doutor Candido Xavier de Almeida Souza 200, BR-08780911 Mogi Das Cruzes, SP, Brazil.	migueljr4@me.com	Batista Jr., Miguel Luiz/E-7748-2015; Seelaender, Marilia Cerqueira Leite/B-9101-2011; Lima, Fabio/L-5634-2019; de Oliveira Franco, Felipe/AAP-3905-2020; Henriques, Felipe/I-6312-2015	Batista Jr., Miguel Luiz/0000-0001-7022-5131; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Lima, Fabio/0000-0003-0573-9544; Henriques, Felipe/0000-0002-9245-7141; Franco, Felipe/0000-0002-4185-223X	Sao Paulo Research Foundation (FAPESP) [2010/51078-1, 2012/500790-0, 2015/19259-0]; CNPq [311966/2015-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was sponsored by Sao Paulo Research Foundation (FAPESP) Grants: 2010/51078-1 (to M. L. B.), 2012/500790-0 (to M. S.), and 2015/19259-0 (to M. L. B.) and CNPq 311966/2015-2 (to M. L. B.). The authors thank Dr. Jose Pinhata Otoch and Dr. Paulo S. M. de Alcantara and team for their excellent support and assistance in clinical data management and acquisition. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of FAPESP. The authors declare no conflicts of interest.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; [Anonymous], 2011, CURR PROB CANCER, V35, P58, DOI 10.1016/j.currproblcancer.2011.01.001; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Batista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023; Batista ML, 2012, J ENDOCRINOL, V215, P363, DOI 10.1530/JOE-12-0307; Batista ML, 2016, J CACHEXIA SARCOPENI, V7, P37, DOI 10.1002/jcsm.12037; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Borges-Silva CN, 2005, J PINEAL RES, V39, P178, DOI 10.1111/j.1600-079X.2005.00241.x; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; de Matos-Neto EM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00629; Ebadi M, 2014, NUTRIENTS, V6, P5280, DOI 10.3390/nu6115280; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Franco FD, 2017, J ENDOCRINOL, V232, P493, DOI 10.1530/JOE-16-0305; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Kliewer KL, 2015, CANCER BIOL THER, V16, P886, DOI 10.4161/15384047.2014.987075; Kwon SJ, 2011, J GASTRIC CANCER, V11, P78, DOI 10.5230/jgc.2011.11.2.78; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Neves RX, 2016, J CACHEXIA SARCOPENI, V7, P193, DOI 10.1002/jcsm.12041; Penafuerte CA, 2016, BRIT J CANCER, V114, P680, DOI 10.1038/bjc.2016.3; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Seelaender M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/536954; Tsoli M, 2016, SEMIN CELL DEV BIOL, V54, P68, DOI 10.1016/j.semcdb.2015.10.039; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; WEX T, 1995, FEBS LETT, V374, P341, DOI 10.1016/0014-5793(95)01139-6	32	12	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1976	1986		10.1096/fj.201601151R	http://dx.doi.org/10.1096/fj.201601151R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28138038				2022-12-26	WOS:000399195500019
J	Uchida, H; Matsumura, S; Okada, S; Suzuki, T; Minami, T; Ito, S				Uchida, Hitoshi; Matsumura, Shinji; Okada, Shunpei; Suzuki, Tsutomu; Minami, Toshiaki; Ito, Seiji			RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury	FASEB JOURNAL			English	Article						tactile allodynia; posttranscriptional regulation; dorsal root ganglion; adenosine deaminase	MESSENGER-RNA; ENDONUCLEASE V; SEROTONIN 2C; RECEPTOR; NEURONS; SYSTEM; BRAIN; ACTIVATION; MECHANISMS; EXPRESSION	Transcriptional and post-translational regulations are important in peripheral nerve injury-induced neuropathic pain, but little is known about the role of post-transcriptional modification. Our objective was to determine the possible effect of adenosine deaminase acting on RNA (ADAR) enzymes, which catalyze post-transcriptional RNA editing, in tactile allodynia, a hallmark of neuropathic pain. Seven days after L5 spinal nerve transection (SNT) in adultmice, we found an increase in ADAR2 expression and a decrease in ADAR3 expression in the injured, but not in the uninjured, dorsal root ganglions (DRGs). These changes were accompanied by elevated levels of editing at the D site of the serotonin (5-hydroxytryptamine) 2C receptor (5-HT2CR), at the I/V site of coatomer protein complex subunit alpha(COPA), and at the R/G site of AMPA receptor subunit GluA2 in the injured DRG. Compared to Adar2(+/+)/Gria2(R/R) littermate controls, Adar2(+/+)/Gria2(R/R) mice completely lacked the increased editing of 5-HT2CR, COPA, and GluA2 transcripts in the injured DRG and showed attenuated tactile allodynia after SNT. Furthermore, the antidepressant fluoxetine inhibited neuropathic allodynia after injury and reduced the COPAI/V site editing in the injured DRG. These findings suggest that ADAR2 is a mediator of injury-induced tactile allodynia and thus a potential therapeutic target for the treatment of neuropathic pain.-Uchida, H., Matsumura, S., Okada, S., Suzuki, T., Minami, T., Ito, S. RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.	[Uchida, Hitoshi; Matsumura, Shinji; Ito, Seiji] Kansai Med Univ, Dept Med Chem, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan; [Okada, Shunpei; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Osaka, Japan; [Uchida, Hitoshi] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan	Kansai Medical University; University of Tokyo; Osaka Medical College; Niigata University	Ito, S (corresponding author), Kansai Med Univ, Dept Med Chem, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	ito@hirakata.kmu.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; ito, Seiji/0000-0002-0942-1624	Japan Society for the Promotion of Science [22390063, 11J09224, 24590735]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Prof. Peter H. Seeburg and Dr. Miyoko Higuchi (Max Planck Institute for Medical Research, Heidelberg, Germany) for providing Adar2<SUP>+/+/</SUP>Gria2<SUP>R/R</SUP> and Adar2<SUP>-/-</SUP>/Gria2<SUP>R/R</SUP> mice. This work was supported by Grants-in-Aid for Scientific Research 22390063 (to S.I.), 11J09224 (to H.U.), and 24590735 (to S.M.) from the Japan Society for the Promotion of Science. H.U. is a research fellow of the Japan Society for the Promotion of Science. The authors declare no conflicts of interest.	Balik A, 2013, NUCLEIC ACIDS RES, V41, P1124, DOI 10.1093/nar/gks1045; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; Hang PNT, 2008, NEUROSCI RES, V61, P398, DOI 10.1016/j.neures.2008.04.007; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hulse RP, 2014, NEUROBIOL DIS, V71, P245, DOI 10.1016/j.nbd.2014.08.012; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Joseph DJ, 2011, DEV NEUROBIOL, V71, P818, DOI 10.1002/dneu.20906; LaBuda CJ, 2005, J NEUROSCI METH, V144, P175, DOI 10.1016/j.jneumeth.2004.11.008; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; Navarrett S, 2012, NEUROSCI LETT, V506, P74, DOI 10.1016/j.neulet.2011.10.052; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Persson AK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-7; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Sakurai M, 2011, METHODS MOL BIOL, V718, P89, DOI 10.1007/978-1-61779-018-8_5; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Schmidt HD, 2015, MOL PSYCHIATR, V20, P1460, DOI 10.1038/mp.2014.134; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Wei J, 2014, ACTA NEUROCHIR, V156, P1135, DOI 10.1007/s00701-014-2004-1; Wu SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629048	49	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1847	1855		10.1096/fj.201600950R	http://dx.doi.org/10.1096/fj.201600950R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126736				2022-12-26	WOS:000399195500008
J	Wang, YD; Wang, Y; Ma, LL; Nie, M; Ju, JY; Liu, M; Deng, YX; Yao, B; Gui, T; Li, XY; Guo, C; Ma, C; Tan, RX; Zhao, Q				Wang, Yadong; Wang, Ying; Ma, Lingling; Nie, Min; Ju, Junyi; Liu, Ming; Deng, Yexuan; Yao, Bing; Gui, Tao; Li, Xinyu; Guo, Chan; Ma, Chi; Tan, Renxiang; Zhao, Quan			Heterochromatin Protein 1 gamma Is a Novel Epigenetic Repressor of Human Embryonic epsilon-Globin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FETAL; DNA METHYLATION; GAMMA-GLOBIN; HEMOGLOBIN; TRIMETHYLATION; MECHANISMS; INTEGRITY; DISEASE; MOUSE; CELLS	Production of hemoglobin during development is tightly regulated. For example, expression from the human beta-globin gene locus, comprising beta, delta, epsilon, and gamma globin genes, switches from beta-globin to epsilon-globin during embryonic development and then from beta-globin to beta-globin after birth. Expression of human beta-globin in mice has been shown to ameliorate anemia caused by beta-globin mutations, including those causing beta-thalassemia and sickle cell disease, raising the prospect that reactivation of beta-globin expression could be used in managing these conditions in humans. Although the human globin genes are known to be regulated by a variety of multiprotein complexes containing enzymes that catalyze epigenetic modifications, the exact mechanisms controlling beta-globin gene silencing remain elusive. Here we found that the heterochromatin protein HP1 gamma, a multifunctional chromatin-and DNA-binding protein with roles in transcriptional activation and elongation, represses epsilon-globin expression by interacting with a histone-modifying enzyme, lysine methyltransferase SUV4-20h2. Silencing of HP1 gamma expression markedly decreased repressive histone marks and the multimethylation of histone H3 lysine 9 and H4 lysine 20, leading to a significant decrease in DNA methylation at the proximal promoter of the epsilon-globin gene and greatly increased epsilon-globin expression. In addition, using chromatin immunoprecipitation, we showed that SUV4-20h2 facilitates the deposition of HP1 gamma on the epsilon-globin-proximal promoter. Thus, these data indicate that HP1 gamma is a novel epigenetic repressor of epsilon-globin gene expression and provide a potential strategy for targeted therapies for beta-thalassemia and sickle cell disease.	[Wang, Yadong; Wang, Ying; Ma, Lingling; Nie, Min; Ju, Junyi; Liu, Ming; Deng, Yexuan; Yao, Bing; Gui, Tao; Li, Xinyu; Guo, Chan; Ma, Chi; Tan, Renxiang; Zhao, Quan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University	Zhao, Q (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011; Xinyu, Li/AAG-1655-2021	Zhao, Quan/0000-0002-8533-1938; Xinyu, Li/0000-0003-3694-4188; ju, junyi/0000-0002-9141-2363	National Natural Science Foundation of China (NFSC) [31470750, 31270811, 81421091, 2015M571736, 2016M590442]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants NSFC 31470750 and 31270811 (to Q. Z.), 81421091 (to R. T.), 2015M571736 (to J. J.), and 2016M590442 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bian CJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05606; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Cui SY, 2015, BLOOD, V125, P1477, DOI 10.1182/blood-2014-10-605022; Fathallah H, 2008, BLOOD CELL MOL DIS, V40, P166, DOI 10.1016/j.bcmd.2007.08.001; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hahn M, 2013, GENE DEV, V27, P859, DOI 10.1101/gad.210377.112; He ZN, 2002, P NATL ACAD SCI USA, V99, P10635, DOI 10.1073/pnas.162269099; Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014; Lavelle D, 2006, BLOOD CELL MOL DIS, V36, P269, DOI 10.1016/j.bcmd.2006.01.004; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Miyagi S, 2014, STEM CELL REP, V2, P145, DOI 10.1016/j.stemcr.2013.12.008; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Russell JE, 1998, BLOOD, V92, P3057, DOI 10.1182/blood.V92.9.3057.421k57_3057_3063; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; STAMATOYANNOPOULOS JA, 1992, ANNU REV MED, V43, P497; Suzuki M, 2014, MOL CELL BIOL, V34, P3560, DOI 10.1128/MCB.00714-14; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Wang YY, 2016, 2016 INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY, ENVIRONMENT AND INFORMATION ENGINEERING (SEEIE 2016), P4; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xu Z, 2012, HAEMATOL-HEMATOL J, V97, P1632, DOI 10.3324/haematol.2012.061937; Zhao QL, 2009, CPGPS 2009: GLOBAL NAVIGATION SATELLITE SYSTEM: TECHNOLOGY INNOVATION AND APPLICATION, PROCEEDINGS, P5	30	3	3	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4811	4817		10.1074/jbc.M116.768515	http://dx.doi.org/10.1074/jbc.M116.768515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28154185	Green Published, hybrid			2022-12-26	WOS:000397590400006
J	Ohoka, N; Okuhira, K; Ito, M; Nagai, K; Shibata, N; Hattori, T; Ujikawa, O; Shimokawa, K; Sano, O; Koyama, R; Fujita, H; Teratani, M; Matsumoto, H; Imaeda, Y; Nara, H; Cho, N; Naito, M				Ohoka, Nobumichi; Okuhira, Keiichiro; Ito, Masahiro; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Ujikawa, Osamu; Shimokawa, Kenichiro; Sano, Osamu; Koyama, Ryokichi; Fujita, Hisashi; Teratani, Mika; Matsumoto, Hirokazu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko			In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; SMALL-MOLECULE PROTACS; CELL-DEATH; UBIQUITIN LIGASE; IAP PROTEINS; DEGRADATION; CANCER; TARGET; CIAP1; ESTROGEN	Many diseases, especially cancers, result from aberrant or overexpression of pathogenic proteins. Specific inhibitors against these proteins have shown remarkable therapeutic effects, but these are limited mainly to enzymes. An alternative approach that may have utility in drug development relies on selective degradation of pathogenic proteins via small chimeric molecules linking an E3 ubiquitin ligase to the targeted protein for proteasomal degradation. To this end, we recently developed a protein knockdown system based on hybrid small molecule SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers) that recruit inhibitor of the apoptosis protein (IAP) ubiquitin ligases to specifically degrade targeted proteins. Here, we extend our previous study to show a proof of concept of the SNIPER technology in vivo. By incorporating a high affinity IAP ligand, we developed a novel SNIPER against estrogen receptor alpha(ER alpha), SNIPER(ER)-87, that has a potent protein knockdown activity. The SNIPER(ER) reduced ER alpha levels in tumor xenografts and suppressed the growth of ER alpha-positive breast tumors in mice. Mechanistically, it preferentially recruits X-linked IAP (XIAP) rather than cellular IAP1, to degrade ER alpha via the ubiquitin-proteasome pathway. With this IAP ligand, potent SNIPERs against other pathogenic proteins, BCR-ABL, bromodo-main- containing protein 4 (BRD4), and phosphodiesterase-4 (PDE4) could also be developed. These results indicate that forced ubiquitylation by SNIPERs is a useful method to achieve efficient protein knockdown with potential therapeutic activities and could also be applied to study the role of ubiquitylation in many cellular processes.	[Ohoka, Nobumichi; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Ito, Masahiro; Nagai, Katsunori; Ujikawa, Osamu; Shimokawa, Kenichiro; Nara, Hiroshi; Cho, Nobuo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Med Chem Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Sano, Osamu; Koyama, Ryokichi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Fujita, Hisashi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Teratani, Mika; Matsumoto, Hirokazu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Technol Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Imaeda, Yasuhiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Okuhira, Keiichiro] Univ Tokushima, Grad Sch, Inst Biomed Sci, 1-78-1 Shomachi, Tokushima 7708505, Japan	National Institute of Health Sciences - Japan; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Tokushima University	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp		SHIBATA, NORIHITO/0000-0001-5792-8510; Shimokawa, Kenichiro/0000-0003-1982-0407; , Hiroshi/0000-0001-6770-2750	Japan Society for the Promotion of Science KAKENHI [26860049, 16H05090, 16K15121]; Japan Agency for Medical Research and Development [15ak0101029h1402, 16ak0101029j1403, 16cm0106124j0001]; Ministry of Health and Labor Welfare, Japan; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health and Labor Welfare, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 26860049 (to N. O.) and 16H05090 and 16K15121 (to M. N.), Japan Agency for Medical Research and Development Grants 15ak0101029h1402 and 16ak0101029j1403 (to M. N.) and 16cm0106124j0001 (to N. O.), the Ministry of Health and Labor Welfare, Japan (to M. N.), and Takeda Science Foundation (to N. O.). M. I., K. N., O. U., K. S., O. S., R. K., H. F., M. T., H. M., Y. I., H. N., and N. C. are employees of Takeda Pharmaceutical Co., Ltd. The authors filed a patent for the novel compounds described in this paper.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Demizu Y, 2012, BIOORG MED CHEM LETT, V22, P1793, DOI 10.1016/j.bmcl.2011.11.086; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Honsho M, 2016, BBA-MOL CELL RES, V1863, P984, DOI 10.1016/j.bbamcr.2015.09.032; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Itoh Y, 2010, J AM CHEM SOC, V132, P5820, DOI 10.1021/ja100691p; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Ohoka N, 2016, CURR CANCER DRUG TAR, V16, P136, DOI 10.2174/1568009616666151112122502; Okuhira K, 2013, CANCER SCI, V104, P1492, DOI 10.1111/cas.12272; Okuhira K, 2011, FEBS LETT, V585, P1147, DOI 10.1016/j.febslet.2011.03.019; Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007; Pedersen J, 2014, TRENDS MOL MED, V20, P652, DOI 10.1016/j.molmed.2014.09.006; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sekine K, 2008, J BIOL CHEM, V283, P8961, DOI 10.1074/jbc.M709525200; Shibata N, 2015, J BIOL CHEM, V290, P28428, DOI 10.1074/jbc.M115.670901; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	40	140	155	3	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4556	4570		10.1074/jbc.M116.768853	http://dx.doi.org/10.1074/jbc.M116.768853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28154167	Green Published, hybrid			2022-12-26	WOS:000397585100014
J	Moynihan, R; Sims, R; Hersch, J; Thomas, R; Glasziou, P; McCaffery, K				Moynihan, Ray; Sims, Rebecca; Hersch, Jolyn; Thomas, Rae; Glasziou, Paul; McCaffery, Kirsten			Communicating about overdiagnosis: Learning from community focus groups on osteoporosis	PLOS ONE			English	Article							OVERTREATMENT	Background Overdiagnosis is considered a risk associated with the diagnosis of osteoporosis-as many people diagnosed won't experience harm from the condition. As yet there's little evidence on community understanding of overdiagnosis outside cancer-where it is an established risk of some screening programs-or effective ways to communicate about it. We examined community understanding around overdiagnosis of osteoporosis, to optimise communication strategies about this problem. Methods and findings Using a qualitative design we recruited a community sample of women, 50-80 years, from the Gold Coast community around Bond University, Australia, using random digit dialing, and conducted 5 focus groups with 41 women. A discussion guide and 4-part presentation were developed and piloted, with independent review from a consumer and clinical experts. Initial discussion had 4 segments: osteoporosis; bone density vs. other risk factors; medication; and overdiagnosis. The second half included the 4 short presentations and discussions on each. Analysis used Framework Analysis method. Initially participants described osteoporosis as bone degeneration causing some fear, demonstrated imprecise understanding of overdiagnosis, had a view osteoporosis couldn't be overdiagnosed as bone scans provided "clear cut" results, expressed belief in early diagnosis, and interest in prevention strategies enabling control. Following presentations, participants expressed some understanding of overdiagnosis, preference for describing osteoporosis as a "risk factor" not "disease", concern about a poor risk-benefit ratio for medications, and surprise and unease the definition of osteoporosis decided bone density of young women was "normal", without age adjustment. Limitations include English-speaking backgrounds of the sample and complex materials. Conclusions Our findings suggest a gap between community expectations and how experts sometimes arbitrarily set low diagnostic thresholds which label those at risk as "diseased". Optimal communication about overdiagnosis could build on community scepticism about treatments, encouraging weighing up benefits and harms of tests and diagnoses, and framing this information as positively adding to knowledge.	[Moynihan, Ray; Sims, Rebecca; Thomas, Rae; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [Hersch, Jolyn; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	Bond University; University of Sydney	Moynihan, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia.	raymoynihan@bond.edu.au	, beccie/AAM-3770-2021; Moynihan, Ray/ABC-3010-2020; Glasziou, Paul/A-7832-2008; McCaffery, Kirsten/K-7945-2019; Hersch, Jolyn/H-7153-2013	, beccie/0000-0002-3885-1199; Glasziou, Paul/0000-0001-7564-073X; McCaffery, Kirsten/0000-0003-2696-5006; Hersch, Jolyn/0000-0001-5225-6639; Sims, Rebecca/0000-0002-1604-8354	Bond University; National Health and Medical Research Council [1112509, 1029241]; National Health and Medical Research Council Screening and Test Evaluation Program grant [633033]	Bond University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Screening and Test Evaluation Program grant	The focus groups research was funded by an un-numbered grant from the Bond University, Vice-Chancellor's Research Grants scheme. JH is supported by a National Health and Medical Research Council Early Career Fellowship (#1112509). RT and RM were supported by a National Health and Medical Research Council Screening and Test Evaluation Program grant (#633033). KM was supported by a National Health and Medical Research Council fellowship (#1029241). Bond University's website is www.bond.edu.au. The National Health and Medical Research Council website is: https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MJA OPEN S1, V2; Australian Institute of Health and Welfare, 2014, EST PREV OST; Caro J, 2015, EBHC C 2015; Carter SM, 2016, J MED ETHICS, P1; Fenton JJ, 2016, JAMA INTERN MED, V176, P391, DOI 10.1001/jamainternmed.2015.6020; Herndon MB, 2007, HEALTH AFFAIR, V26, P1702, DOI 10.1377/hlthaff.26.6.1702; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McClung MR, 2015, J BONE MINER RES, V30, P1754, DOI 10.1002/jbmr.2686; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125165; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; Rader T., SHOULD I TAKE ALENDR; Reid IR, 2011, SKELETAL RADIOL, V40, P1191, DOI 10.1007/s00256-011-1164-9; Reventlow SD, 2006, SOC SCI MED, V62, P2720, DOI 10.1016/j.socscimed.2005.11.009; RUBIN SM, 1992, ANN INTERN MED, V116, P990, DOI 10.7326/0003-4819-116-12-990; Schleifer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052552; Simmonds R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010337; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Welch GH, 2011, OVER DIAGNOSED MAKIN; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; WHO Study Group, 1994, ASS FRACT RISK ITS A	29	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170142	10.1371/journal.pone.0170142	http://dx.doi.org/10.1371/journal.pone.0170142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158214	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700009
J	Frietze, KM; Pascale, JM; Moreno, B; Chackerian, B; Peabody, DS				Frietze, Kathryn M.; Pascale, Juan M.; Moreno, Brechla; Chackerian, Bryce; Peabody, David S.			Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses	PLOS ONE			English	Article							DENGUE VIRUS-INFECTIONS; ENVELOPE GLYCOPROTEIN; IDENTIFICATION; PROTEIN; EPITOPE; PARTICLES; SELECTION; FUSION	Identifying the targets of antibody responses during infection is important for designing vaccines, developing diagnostic and prognostic tools, and understanding pathogenesis. We developed a novel deep sequence-coupled biopanning approach capable of identifying the protein epitopes of antibodies present in human polyclonal serum. Here, we report the adaptation of this approach for the identification of pathogen-specific epitopes recognized by antibodies elicited during acute infection. As a proof-of-principle, we applied this approach to assessing antibodies to Dengue virus (DENV). Using a panel of sera from patients with acute secondary DENV infection, we panned a DENV antigen fragment library displayed on the surface of bacteriophage MS2 virus-like particles and characterized the population of affinity-selected peptide epitopes by deep sequence analysis. Although there was considerable variation in the responses of individuals, we found several epitopes within the Envelope glycoprotein and Non-Structural Protein 1 that were commonly enriched. This report establishes a novel approach for characterizing pathogen-specific antibody responses in human sera, and has future utility in identifying novel diagnostic and vaccine targets.	[Frietze, Kathryn M.; Chackerian, Bryce; Peabody, David S.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, MSC08 4660,1 Univ New Mexico, Albuquerque, NM 87131 USA; [Pascale, Juan M.; Moreno, Brechla] Gorgas Mem Inst Hlth Studies, Ave Justo Arosemena & Calle 35, Panama City, Panama	University of New Mexico; Instituto Conmemorativo Gorgas de Estudios de la Salud	Frietze, KM (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, MSC08 4660,1 Univ New Mexico, Albuquerque, NM 87131 USA.	kfrietze@salud.unm.edu		Frietze, Kathryn/0000-0002-1428-8899	National Institutes of Health [R01 AI 083305]; National Research System from the Panamanian National Council of Science and Technology (SENACYT); NIH [UL1TR00449]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research System from the Panamanian National Council of Science and Technology (SENACYT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R01 AI 083305) to BC. Dr. Pascale is supported by the National Research System from the Panamanian National Council of Science and Technology (SENACYT). This work was partially supported by a Pilot Project Grant from the NIH-funded University of New Mexico Clinical and Translational Science Center Grant Number: UL1TR00449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Crossey E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132560; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Frietze KM, 2016, CANCER IMMUNOL RES, V4, P157, DOI 10.1158/2326-6066.CIR-15-0165; Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x; INNIS BL, 1989, AM J TROP MED HYG, V40, P676, DOI 10.4269/ajtmh.1989.40.676; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Larman HB, 2013, J AUTOIMMUN, V43, P1, DOI 10.1016/j.jaut.2013.01.013; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357; O'Rourke JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111198; Omokoko MD, 2014, AM J TROP MED HYG, V91, P146, DOI 10.4269/ajtmh.13-0624; Ord RL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-326; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; da Silva ANMR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007425; Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	25	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171511	10.1371/journal.pone.0171511	http://dx.doi.org/10.1371/journal.pone.0171511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152075	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161200152
J	Fu, LY; Koganti, PP; Wang, J; Wang, L; Wang, CL; Yao, JB				Fu, Liyuan; Koganti, Prasanthi P.; Wang, Jian; Wang, Lei; Wang, Cheng-Lun; Yao, Jianbo			Lhx8 interacts with a novel germ cell-specific nuclear factor containing an Nbl1 domain in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							LIM HOMEOBOX GENE; PROTEIN; EXPRESSION; FOLLICULOGENESIS; IDENTIFICATION; BOREALIN; L3/LHX8; CLONING	Lhx8 is an important transcription factor that is preferentially expressed in germ cells. Lhx8 null mice are infertile due to lack of oocytes and impairment of the transition from primordial follicles to primary follicles. Lhx8 deficiency also affects the expression of many important oocyte-specific genes. In this study, we report the characterization of rainbow trout lhx8 genes and identification of a novel germ cell-specific nuclear factor that interacts with Lhx8. Two lhx8 genes, lhx8a and lhx8b, were identified, encoding proteins of 344 and 361 amino acids, respectively. The two proteins share 83% sequence identity and both transcripts are specifically expressed in the ovary. Quantitative real time PCR analysis demonstrated that both genes are expressed highly in pre-vitellogenic ovaries as well as in early stage embryos. Using a yeast two-hybrid screening system, a novel protein (Borealin-2) interacting with Lhx8 was identified. The interaction between either Lhx8a or Lhx8b and Borealin-2 was further confirmed by a bimolecular fluorescence complementation (BiFC) assay. Borealin-2 is a protein of 255 amino acids containing an Nbl1 domain, and its mRNA expression is restricted to the ovary and testis. A GFP reporter assay revealed that Borealin-2 is a nuclear protein. Collectively, results indicate that both Lhx8a and Lhx8b function through interaction with Borealin-2, which may play an important role during oogenesis and early embryogenesis in rainbow trout.	[Fu, Liyuan; Koganti, Prasanthi P.; Wang, Jian; Wang, Lei; Wang, Cheng-Lun; Yao, Jianbo] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA	West Virginia University	Yao, JB (corresponding author), West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu	Wang, Jian/M-4594-2018; Koganti, Prasanthi/ABB-2730-2020	Koganti, Prasanthi/0000-0002-5452-389X	USDA-ARS [58-1930-0-059]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the USDA-ARS Cooperative Agreement No. 58-1930-0-059 (JY). It is published with the approval of the director of the West Virginia Agricultural and Forestry Experiment Station as scientific paper No. 3297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 1984, TETRAPLOIDY EVOLUTIO, P55; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Cho H, 2014, J APPL MATH, DOI 10.1155/2014/951214; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Fang W, 2009, AGR SCI CHINA, V8, P1503, DOI 10.1016/S1671-2927(08)60365-X; Fu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164671; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Inoue M, 2006, ANAT EMBRYOL, V211, P247, DOI 10.1007/s00429-006-0078-0; Miller John, 2004, Methods Mol Biol, V261, P247; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Qiu GF, 2008, MOL REPROD DEV, V75, P723, DOI 10.1002/mrd.20827; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ramachandra RK, 2007, MOL REPROD DEV, V74, P502, DOI 10.1002/mrd.20628; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2014, MOL REPROD DEV, V81, P1136, DOI 10.1002/mrd.22433; Wang L, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-86; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Zhang QJ, 2009, MOL BIOL REP, V36, P603, DOI 10.1007/s11033-008-9220-9; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170760	10.1371/journal.pone.0170760	http://dx.doi.org/10.1371/journal.pone.0170760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151980	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200042
J	Schmukler, E; Wolfson, E; Elazar, Z; Kloog, Y; Pinkas-Kramarski, R				Schmukler, Eran; Wolfson, Eya; Elazar, Zvulun; Kloog, Yoel; Pinkas-Kramarski, Ronit			Continuous treatment with FTS confers resistance to apoptosis and affects autophagy	PLOS ONE			English	Article							AURORA KINASE; TUMOR-GROWTH; RAS; INHIBITION; DEATH; DEGRADATION; MECHANISMS	High percentage of human cancers involves alteration or mutation in Ras proteins, including the most aggressive malignancies, such as lung, colon and pancreatic cancers. FTS (Salirasib) is a farnesylcysteine mimetic, which acts as a functional Ras inhibitor, and was shown to exert anti-tumorigenic effects in vitro and in vivo. Previously, we have demonstrated that short-term treatment with FTS also induces protective autophagy in several cancer cell lines. Drug resistance is frequently observed in cancer cells exposed to prolonged treatment, and is considered a major cause for therapy inefficiency. Therefore, in the present study, we examined the effect of a prolonged treatment with FTS on drug resistance of HCT-116 human colon cancer cells, and the involvement of autophagy in this process. We found that cells grown in the presence of FTS for 6 months have become resistant to FTSinduced cell growth inhibition and cell death. Furthermore, we discovered that the resistant cells exhibit altered autophagy, reduced apoptosis and changes in Ras-related signaling pathways following treatment with FTS. Moreover we found that while FTS induces an apoptosis-related cleavage of p62, the FTS-resistant cells were more resistant to apoptosis and p62 cleavage.	[Schmukler, Eran; Wolfson, Eya; Kloog, Yoel; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel; [Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel	Tel Aviv University; Weizmann Institute of Science	Pinkas-Kramarski, R (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Israel Science Foundation [848/12]; Israel Cancer Association; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (grant No. 848/12), the Israel Cancer Association and by the Kauffman Prostate Cancer Research Fund.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; Halaschek-Wiener J, 2000, MOL MED, V6, P693, DOI 10.1007/BF03402049; He W, 2013, AM J TRANSL RES, V5, P359; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang ZH, 2014, ONCOL REP, V31, P1249, DOI 10.3892/or.2014.2986; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Schmukler E, 2014, ONCOTARGET, V5, P173, DOI 10.18632/oncotarget.1500; Schmukler E, 2013, ONCOTARGET, V4, P145; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Wolfson E, 2015, BIOL CELL, V107, P130, DOI 10.1111/boc.201400087; Yuan CX, 2015, DRUG DES DEV THER, V9, P487, DOI 10.2147/DDDT.S74127; Zeng RX, 2014, CELL BIOL INT, V38, P1221, DOI 10.1002/cbin.10311	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171351	10.1371/journal.pone.0171351	http://dx.doi.org/10.1371/journal.pone.0171351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151959	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161200131
J	Yamagishi, T; Yamaguchi, H; Suzuki, S; Horie, Y; Tatarazako, N				Yamagishi, Takahiro; Yamaguchi, Haruyo; Suzuki, Shigekatsu; Horie, Yoshifumi; Tatarazako, Norihisa			Cell reproductive patterns in the green alga Pseudokirchneriella subcapitata (=Selenastrum capricornutum) and their variations under exposure to the typical toxicants potassium dichromate and 3,5-DCP	PLOS ONE			English	Article							ANKISTRODESMUS-GRACILIS; COLONY FORMATION; FLOW-CYTOMETRY; LIFE-CYCLE; SCENEDESMUS; CHLORELLA; TOXICITY; COPPER; DIVISION; CADMIUM	Pseudokirchneriella subcapitata is a sickle-shaped freshwater green microalga that is normally found in unicellular form. Currently, it is the best known and most frequently used species of ecotoxicological bioindicator because of its high growth rate and sensitivity to toxicants. However, despite this organism's, our knowledge of its cell biology for example, the patterns of nuclear and cytoplasmic division in the mitotic stage is limited. Although it has been reported that P. subcapitata proliferates by popularity forming four daughter cells (autospores) through multiple fission after two nuclear divisions, here, we report two additional reproductive patterns by which two autospores are formed by binary fission ("twoautospore type") and eight autospores are formed by multiple fission ("eight-autospore type"). Moreover, we found that cell reproductive patterns differed markedly with the culture conditions or with exposure to either of two typical toxicants, potassium dichromate (K2Cr2O7) and 3,5-dichlorophenol (3,5-DCP). The eight-autospore type occurred at the highest frequency in the early phase of culture, but it disappeared under 3,5-DCP at 2.0 mg/L. Under 0.3 mg/L K2CrO7 (Cr(VI)) the eight-autospore type took substantially longer to appear than in control culture. The two-autospore type occurred only in the late phase of culture. To our knowledge, this is the first detailed evaluation of the reproductive patterns of P. subcapitata, which changed dramatically in the presence of toxicants. These findings suggest that observation of the reproductive patterns of P. subcapitata will help to elucidate different cell reactions to toxicants.	[Yamagishi, Takahiro; Horie, Yoshifumi; Tatarazako, Norihisa] Natl Inst Environm Studies, Risk Assessment Sci Collaborat Off, Ctr Hlth & Environm Risk Res, Ecotox Reference Lab, Tsukuba, Ibaraki, Japan; [Yamaguchi, Haruyo; Suzuki, Shigekatsu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan	Tatarazako, N (corresponding author), Natl Inst Environm Studies, Risk Assessment Sci Collaborat Off, Ctr Hlth & Environm Risk Res, Ecotox Reference Lab, Tsukuba, Ibaraki, Japan.	tatarazako.norihisa@nies.go.jp	Horie, Yoshifumi/AAT-1955-2021; Yoshifumi, Horie/Y-1627-2019	Yoshifumi, Horie/0000-0002-4558-8624				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, OECD GUID TEST CHEM; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bisova K, 2003, FOLIA MICROBIOL, V48, P805, DOI 10.1007/BF02931518; Bisova K, 2014, J EXP BOT, V65, P2585, DOI 10.1093/jxb/ert466; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cid A, 1996, CYTOMETRY, V25, P32, DOI 10.1002/(SICI)1097-0320(19960901)25:1<32::AID-CYTO4>3.3.CO;2-A; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franklin NM, 2002, ENVIRON TOXICOL CHEM, V21, P2412, DOI 10.1897/1551-5028(2002)021<2412:TOMMTA>2.0.CO;2; Franklin NM, 2001, ENVIRON TOXICOL CHEM, V20, P160, DOI [10.1002/etc.5620200118, 10.1897/1551-5028(2001)020&lt;0160:DOFCBA&gt;2.0.CO;2]; GRIFFITH.DJ, 1967, PLANTA, V75, P161, DOI 10.1007/BF00387131; Hanstveit AO, 1982, 147SC5WG5 ISOTC NED; HESSEN DO, 1993, ARCH HYDROBIOL, V127, P129; Hindak F., 1990, BIOL PRACE, V36, P1; KOBAYASHI M, 1977, BOT MAG TOKYO, V90, P211, DOI 10.1007/BF02488358; KOBAYASHI M, 1974, PLANT CELL PHYSIOL, V15, P1017; Komarek J., 1983, BINNENGEWASSER, V16, P1; Komarek J., 1969, STUDIES PHYCOLOGY, P262; Komarkova-Legnerova J., 1969, STUDIES IN PHYCOLOGY, P75; Krienitz L, 2011, J PHYCOL, V47, P880, DOI 10.1111/j.1529-8817.2011.01010.x; Kumar S., 2016, MEGA7 MOL EVOLUTIONA; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Le Faucheur S, 2005, ENVIRON TOXICOL CHEM, V24, P1731, DOI 10.1897/04-394R.1; Lurling M, 2000, OIKOS, V88, P111, DOI 10.1034/j.1600-0706.2000.880113.x; Lurling M, 1996, DAPHNIA, V108, P432; Machado MD, 2014, AQUAT TOXICOL, V147, P1, DOI 10.1016/j.aquatox.2013.11.017; MARVAN P, 1984, ALGOL STUD, V37, P363; MORIMURA Y, 1959, PLANT CELL PHYSIOL, V1, P49; Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7; Nygaard G, 1987, OPERA BOT, V90, P1; PFAU J, 1972, BER DEUT BOT GES, V85, P409; SETLIK I, 1972, Algological Studies, V7, P172; STAUBER JL, 1990, MAR BIOL, V105, P519, DOI 10.1007/BF01316323; TRAINOR FR, 1970, ANN NY ACAD SCI, V175, P749, DOI 10.1111/j.1749-6632.1970.tb45189.x; Vitova M, 2005, FOLIA MICROBIOL, V50, P141, DOI 10.1007/BF02931463; Wilde KL, 2006, ARCH ENVIRON CON TOX, V51, P174, DOI 10.1007/s00244-004-0256-0	36	23	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171259	10.1371/journal.pone.0171259	http://dx.doi.org/10.1371/journal.pone.0171259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152022	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161200118
J	Girard, O; Brocherie, F; Morin, JB; Racinais, S; Millet, GP; Periard, JD				Girard, Olivier; Brocherie, Franck; Morin, Jean-Benoit; Racinais, Sebastien; Millet, Gregoire P.; Periard, Julien D.			Mechanical Alterations Associated with Repeated Treadmill Sprinting under Heat Stress	PLOS ONE			English	Article							GROUND REACTION FORCE; MASS MODEL; RUNNING SPEED; TEAM SPORT; PERFORMANCE; FREQUENCY; EXERCISE; FATIGUE; TEMPERATURE; STIFFNESS	Purpose Examine the mechanical alterations associated with repeated treadmill sprinting performed in HOT ( 38 degrees C) and CON ( 25 degrees C) conditions. Methods Eleven recreationally active males performed a 30-min warm-up followed by three sets of five 5-s sprints with 25-s recovery and 3-min between sets in each environment. Constantvelocity running for 1-min at 10 and 20 km.h(-1) was also performed prior to and following sprinting. Results Mean skin (37.2 +/- 0.7 vs. 32.7 +/- 0.8 E C; P< 0.001) and core (38.9 +/- 0.2 vs. 38.8 +/- 0.3 degrees C; P< 0.05) temperatures, together with thermal comfort (P< 0.001) were higher following repeated sprinting in HOT vs. CON. Step frequency and vertical stiffness were lower (-2.6 +/- 1.6% and -5.5 +/- 5.5%; both P< 0.001) and contact time (+ 3.2 +/- 2.4%; P< 0.01) higher in HOT for the mean of sets 1-3 compared to CON. Running distance per sprint decreased from set 1 to 3 (-7.0 +/- 6.4%; P< 0.001), with a tendency for shorter distance covered in HOT vs. CON (-2.7 +/- 3.4%; P = 0.06). Mean vertical (-2.6 +/- 5.5%; P< 0.01), horizontal (-9.1 +/- 4.4%; P< 0.001) and resultant ground reaction forces (-3.0 +/- 2.8%; P< 0.01) along with vertical stiffness (-12.9 +/- 2.3%; P< 0.001) and leg stiffness (-8.4 +/- 2.7%; P< 0.01) decreased from set 1 to 3, independently of conditions. Propulsive power decreased from set 1 to 3 (-16.9 +/- 2.4%; P< 0.001), with lower propulsive power values in set 2 (-6.6%; P< 0.05) in HOT vs. CON. No changes in constant-velocity running patterns occurred between conditions, or from pre-to-post repeated-sprint exercise. Conclusions Thermal strain alters step frequency and vertical stiffness during repeated sprinting; however without exacerbating mechanical alterations. The absence of changes in constantvelocity running patterns suggests a strong link between fatigue-induced velocity decrements during sprinting and mechanical alterations.	[Girard, Olivier; Racinais, Sebastien; Periard, Julien D.] Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar; [Girard, Olivier; Brocherie, Franck; Millet, Gregoire P.] Univ Lausanne, Inst Sports Sci, ISSUL, Lausanne, Switzerland; [Brocherie, Franck] French Inst Sport INSEP, Lab Sport Expertise & Performance EA 7370, Res Dept, Paris, France; [Morin, Jean-Benoit] Univ Cote Azur, LAMHESS, Nice, France	Aspetar Orthopaedic & Sports Medicine Hospital; University of Lausanne; UDICE-French Research Universities; Universite Cote d'Azur	Girard, O (corresponding author), Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar.; Girard, O (corresponding author), Univ Lausanne, Inst Sports Sci, ISSUL, Lausanne, Switzerland.	oliv.girard@gmail.com	Racinais, Sebastien/N-3052-2019; Millet, Gregoire P/F-4104-2012	Millet, Gregoire P/0000-0001-8081-4423; girard, olivier/0000-0002-4797-182X; Brocherie, Franck/0000-0002-0808-7986; Morin, Jean-Benoit/0000-0003-3808-6762; Periard, Julien/0000-0002-6266-4246	QNRF [NPRP 4 - 760 - 3 - 217, NPRP 4-760-3-217]; Aspire Zone Foundation Research Grant [AF/C/ASP1905/11]	QNRF(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Aspire Zone Foundation Research Grant	This project was funded by QNRF (NPRP 4 - 760 - 3 - 217) and Aspire Zone Foundation Research Grant (AF/C/ASP1905/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is based on research funded by QNRF (NPRP 4-760-3-217).	Arampatzis A, 2000, J BIOMECH, V33, P457, DOI 10.1016/S0021-9290(99)00187-6; Bedford T, 1936, WARMTH FACTOR COMFOR, P102; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brocherie F, 2016, MED SCI SPORT EXER, V48, P1570, DOI 10.1249/MSS.0000000000000937; Brughelli M, 2011, J STRENGTH COND RES, V25, P933, DOI 10.1519/JSC.0b013e3181c64308; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; Christian RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00115; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Girard O, 2015, SCAND J MED SCI SPOR, V25, P79, DOI 10.1111/sms.12437; Girard O, 2016, J SCI MED S IN PRESS; Girard O, 2014, BR J SPORTS MED S1, V48, pi52, DOI DOI 10.1136/BJSPORTS-2013-093286; Girard O, 2016, INT J SPORT PHYSIOL, V11, P432, DOI 10.1123/ijspp.2015-0145; Girard O, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00097; Girard O, 2013, EUR J APPL PHYSIOL, V113, P359, DOI 10.1007/s00421-012-2444-3; Girard O, 2011, EUR J APPL PHYSIOL, V111, P125, DOI 10.1007/s00421-010-1638-9; Hobara H, 2012, INT J SPORTS MED, V33, P310, DOI 10.1055/s-0031-1291232; Hunter JP, 2005, J APPL BIOMECH, V21, P31, DOI 10.1123/jab.21.1.31; Kawamori N, 2013, J STRENGTH COND RES, V27, P568, DOI 10.1519/JSC.0b013e318257805a; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Maughan RJ, 2012, EUR J APPL PHYSIOL, V112, P2313, DOI 10.1007/s00421-011-2206-7; Morin JB, 2010, J BIOMECH, V43, P1970, DOI 10.1016/j.jbiomech.2010.03.012; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P1419, DOI 10.1007/s00421-011-2103-0; Morin JB, 2011, J BIOMECH, V44, P2719, DOI 10.1016/j.jbiomech.2011.07.020; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nummela A, 2007, INT J SPORTS MED, V28, P655, DOI 10.1055/s-2007-964896; Periard JD, 2014, MUSCLE NERVE, V50, P822, DOI 10.1002/mus.24228; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Racinais S, 2008, J PHYSIOL-LONDON, V586, P4751, DOI 10.1113/jphysiol.2008.157420; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Schimpchen J, 2016, J SPORT SCI, V34, P519, DOI 10.1080/02640414.2015.1112023; Serpiello FR, 2011, EUR J APPL PHYSIOL, V111, P669, DOI 10.1007/s00421-010-1687-0; Slawinski J, 2008, J STRENGTH COND RES, V22, P930, DOI 10.1519/JSC.0b013e31816a4475; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; Weyand PG, 2010, J APPL PHYSIOL, V108, P950, DOI 10.1152/japplphysiol.00947.2009; Zadpoor AA, 2012, P I MECH ENG H, V226, P579, DOI 10.1177/0954411912447021	42	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170679	10.1371/journal.pone.0170679	http://dx.doi.org/10.1371/journal.pone.0170679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146582	gold, Green Published			2022-12-26	WOS:000396131700023
J	Chen, XQ; Li, Y; Blankson, S; Liu, M; Huang, DP; Redmond, HP; Huang, J; Wang, JH; Wang, J				Chen, Xuqin; Li, Yan; Blankson, Siobhan; Liu, Min; Huang, Danping; Redmond, H. Paul; Huang, Jing; Wang, Jiang Huai; Wang, Jian			B7-H3 Augments Inflammatory Responses and Exacerbates Brain Damage via Amplifying NF-kappa B p65 and MAPK p38 Activation during Experimental Pneumococcal Meningitis	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; RECEPTOR 2; PROGNOSTIC-FACTORS; CELL ACTIVATION; IMMUNE-RESPONSE; INNATE IMMUNITY; UNITED-STATES; CUTTING EDGE; T-CELLS	The costimulatory protein B7-H3 has been shown to play a contributory role in the development and progression of experimental pneumococcal meningitis by augmentation of the innate immunity-associated inflammatory response via a TLR2-dependent manner. This study aimed to clarify the component(s) of TLR2-mediated signal transduction pathways responsible for B7-H3-augmented inflammatory response and subsequent brain damage during experimental pneumococcal meningitis. Administration of B7-H3 did not augment expression of TLR2 and other TLR2 upstream components, but led to an enhanced formation of MyD88-IRAK immunocomplex in the brain of S. pneumoniae-infected mice. Furthermore, B7-H3 substantially augmented S. pneumoniae-induced activation of TLR2 downstream NF-kappa B p65 and MAPK p38 pathways in the brain of S. pneumoniae-infected mice. Notably, blockage of NF-kappa B p65 and/or MAPK p38 with their specific inhibitors strongly attenuated B7-H3-amplified inflammatory response with significantly reduced proinflammatory cytokine and chemokine production, and markedly ameliorated B7-H3-exacerbated disruption of blood-brain barrier and severity of disease status in S. pneumoniae-infected mice. These results indicate that targeting NF-kappa B p65 and/or MAPK p38 may represent a promising therapeutic option for amelioration of overwhelming inflammatory response-associated brain injury frequently observed during pneumococcal meningitis.	[Chen, Xuqin; Li, Yan; Liu, Min; Huang, Danping; Huang, Jing] Soochow Univ, Childrens Hosp, Dept Neurol, Suzhou, Peoples R China; [Chen, Xuqin; Wang, Jian] Soochow Univ, Pediat Res Inst, Suzhou, Peoples R China; [Blankson, Siobhan; Redmond, H. Paul; Wang, Jiang Huai] Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland	Soochow University - China; Soochow University - China; University College Cork	Wang, J (corresponding author), Soochow Univ, Pediat Res Inst, Suzhou, Peoples R China.; Wang, JH (corresponding author), Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland.	jh.wang@ucc.ie; wj196312@gmail.com			National Natural Science Foundation of China [81273242, 81272143]; Natural Science Foundation of Jiangsu Province [BK20161227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (Grants 81273242 and 81272143) and the Natural Science Foundation of Jiangsu Province (Grant BK20161227).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen XQ, 2015, EXP THER MED, V9, P1984, DOI 10.3892/etm.2015.2333; Chen XQ, 2012, J IMMUNOL, V189, P347, DOI 10.4049/jimmunol.1103715; Chen XQ, 2009, J MOL NEUROSCI, V37, P86, DOI 10.1007/s12031-008-9133-z; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Echchannaoui H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-25; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Ferlazzo G, 2002, EUR J IMMUNOL, V32, P3092, DOI 10.1002/1521-4141(200211)32:11<3092::AID-IMMU3092>3.0.CO;2-0; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2006, PROG NEUROBIOL, V80, P269, DOI 10.1016/j.pneurobio.2006.11.008; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; MacNeil JR, 2015, PEDIATRICS, V135, pE305, DOI 10.1542/peds.2014-2035; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Wang JH, 2002, J BIOL CHEM, V277, P36068, DOI 10.1074/jbc.M205584200; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171146	10.1371/journal.pone.0171146	http://dx.doi.org/10.1371/journal.pone.0171146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141831	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129500043
J	Hardy, DS; Stallings, DT; Garvin, JT; Xu, HY; Racette, SB				Hardy, Dale S.; Stallings, Devita T.; Garvin, Jane T.; Xu, Hongyan; Racette, Susan B.			Best anthropometric discriminators of incident type 2 diabetes among white and black adults: A longitudinal ARIC study	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; RISK-FACTORS; BMI; PREDICTION; INDEXES; FAT	Objective To determine which anthropometric measures are the strongest discriminators of incident type 2 diabetes (T2DM) among White and Black males and females in a large U.S. cohort. Methods We used Atherosclerosis Risk in Communities study data from 12,121 participants aged 45-64 years without diabetes at baseline who were followed for over 11 years. Anthropometric measures included a body shape index (ABSI), body adiposity index (BAI), body mass index (BMI), waist circumference (WC), waist to hip ratio (WHR), waist to height ratio (WHtR), and waist to hip to height ratio (WHHR). All anthropometric measures were repeated at each visit and converted to Z-scores. Hazard ratios and 95% confidence intervals adjusted for age were calculated using repeated measures Cox proportional hazard regression analysis. Akaike Information Criteria was used to select best-fit models. The magnitude of the hazard ratio effect sizes and the Harrell's C-indexes were used to rank the highest associations and discriminators, respectively. Results There were 1,359 incident diabetes cases. Higher values of all anthropometric measures increased the risk for development of T2DM (p < 0.0001) except ABSI, which was not significant in White and Black males. Statistically significant hazard ratios ranged from 1.26-1.63 for males and 1.15-1.88 for females. In general, the largest hazard ratios were those that corresponded to the highest Harrell's C-Index and lowest Akaike Information Criteria values. Among White and Black males and females, BMI, WC, WHR, and WHtR were comparable in discriminating cases from non-cases of T2DM. ABSI, BAI, and WHHR were inferior discriminators of incident T2DM across all race-gender groups. Conclusions BMI, the most commonly used anthropometric measure, and three anthropometric measures that included waist circumference (i.e., WC, WHR, WHtR) were the best anthropometric discriminators of incident T2DM across all race- gender groups in the ARIC cohort.	[Hardy, Dale S.] Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA; [Stallings, Devita T.] St Louis Univ, Sch Nursing, St Louis, MO 63103 USA; [Garvin, Jane T.] Augusta Univ, Coll Nursing, Augusta, GA USA; [Xu, Hongyan] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Racette, Susan B.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA; [Racette, Susan B.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University System of Georgia; Augusta University; Saint Louis University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Washington University (WUSTL); Washington University (WUSTL)	Hardy, DS (corresponding author), Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA.	dhardy@augusta.edu	Racette, Susan B/GLS-6669-2022; Racette, Susan/GXV-8800-2022	Racette, Susan B/0000-0002-6932-1887; Garvin, Jane/0000-0001-6023-3269; Hardy, Dale/0000-0001-8778-5661	NIH/NHLBI [1K01HL127278-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL127278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by a career development grant sponsored by the NIH/NHLBI (Grant ID: 1K01HL127278-01A1).	Adegbija O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009185; Adegbija O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123788; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; ARIC Investigators, 2016, ATH RISK COMM STUD P; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bi X, 2015, EUR J CLIN NUTR, V69, P329, DOI 10.1038/ejcn.2014.227; BioLINCC: National Heart Lung and Blood Institute, 2015, WEB ACC NHLBI BIOSP; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; CDC, 2020, AD OB PREV MAPS; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Hardy DS, 2016, J DIABETES; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Hartwig S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009266; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Hofso Dag, 2009, Diabetes Res Clin Pract, V86, pe9, DOI 10.1016/j.diabres.2009.06.016; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Katzmarzyk PT, 2013, OBESITY, V21, P2221, DOI 10.1002/oby.20519; KAYE SA, 1991, J CLIN EPIDEMIOL, V44, P329, DOI 10.1016/0895-4356(91)90044-A; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; MacKay MF, 2009, DIABETES CARE, V32, P956, DOI 10.2337/dc08-1663; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Motamed N, 2016, METAB SYNDR RELAT D, V14, P249, DOI 10.1089/met.2015.0133; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Perry AC, 2000, J APPL PHYSIOL, V89, P636, DOI 10.1152/jappl.2000.89.2.636; Salkind N., 2007, ENCY MEASUREMENT STA; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0168282	10.1371/journal.pone.0168282	http://dx.doi.org/10.1371/journal.pone.0168282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141847	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129500002
J	El Missiry, M; Hjorth-Hansen, H; Richter, J; Olson-Stromberg, U; Stenke, L; Porkka, K; Kreutzman, A; Mustjoki, S				El Missiry, Mohamed; Hjorth-Hansen, Henrik; Richter, Johan; Olson-Stromberg, Ulla; Stenke, Leif; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu			Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC-PHASE; STEM-CELLS; IMATINIB; DASATINIB; NILOTINIB; CML; RECOMMENDATIONS; HYDROXYUREA; MANAGEMENT; QUIESCENT	In chronic myeloid leukemia (CML), early treatment prediction is important to identify patients with inferior overall outcomes. We examined the feasibility of using reductions in BCR-ABL1 transcript levels after 1 month of tyrosine kinase inhibitor (TKI) treatment to predict therapy response. Fifty-two first-line TKI-treated CML patients were included (imatinib n = 26, dasatinib n = 21, nilotinib n = 5), and BCR-ABL1 transcript levels were measured at diagnosis (dg) and 1, 3, 6, 12, 18, 24, and 36 months. The fold change of the BCR-ABL1 transcripts at 1 month compared to initial BCR-ABL1 transcript levels was used to indicate early therapy response. In our cohort, 21% of patients had no decrease in BCR-ABL1 transcript levels after 1 month and were classified as poor responders. Surprisingly, these patients had lower BCR-ABL1 transcript levels at dg compared to responders (31% vs. 48%, p = 0.0083). Poor responders also significantly more often had enlarged spleen (55% vs. 15%; p< 0.01) and a higher percentage of Ph+ CD34+CD38- cells in the bone marrow (91% vs. 75%, p< 0.05). The major molecular response rates were inferior in the poor responders (at 12m 18% vs. 64%, p< 0.01; 18m 27% vs. 75%, p< 0.01; 24m 55% vs. 87%, p< 0.01). In conclusion, early treatment response analysis defines a biologically distinct patient subgroup with inferior long-term outcomes.	[El Missiry, Mohamed; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu] Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland; [El Missiry, Mohamed; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu] Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland; [Hjorth-Hansen, Henrik] St Olavs Hosp, Dept Hematol, Trondheim, Norway; [Hjorth-Hansen, Henrik] Norwegian Univ Sci & Technol NTNU, St Olavs Hosp, Dept Canc Res & Mol Med, Trondheim, Norway; [Richter, Johan] Skane Univ Hosp, Dept Hematol & Vasc Disorders, Lund, Sweden; [Olson-Stromberg, Ulla] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden; [Stenke, Leif] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Stenke, Leif] Karolinska Inst, Stockholm, Sweden; [Mustjoki, Satu] Univ Helsinki, Dept Clin Chem, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Lund University; Skane University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Helsinki	Mustjoki, S (corresponding author), Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland.; Mustjoki, S (corresponding author), Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland.; Mustjoki, S (corresponding author), Univ Helsinki, Dept Clin Chem, Helsinki, Finland.	satu.mustjoki@helsinki.fi	Mustjoki, Satu/AAD-9974-2020; Kreutzman, Anna/V-5769-2019; Porkka, Kimmo/O-2323-2016	Mustjoki, Satu/0000-0002-0816-8241; Kreutzman, Anna/0000-0002-5587-8844; Porkka, Kimmo/0000-0003-4112-5902	Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; Cancer Foundation Finland sr [160102, 100118, 110101] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; Cancer Foundation Finland sr	This work was supported by the Academy of Finland (SM, http://www.aka.fi/en/); the Finnish Cancer Societies (SM, https://www.cancersociety.fi/); Sigrid Juselius Foundation (AK, SM, http://www.sigridjuselius.fi/foundation); Finnish Cancer Institute (SM); Signe and Ane Gyllenberg Foundation (SM, http://gyllenbergs.fi/en/); Otto A. Malm Foundation (MEM, http://en.ottomalm.fi.kotisivukone.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Personnel at the Hematology Research Unit Helsinki are acknowledged for their expert clinical and technical assistance. This work was supported by the Academy of Finland, the Finnish Cancer Societies, the Sigrid Juselius Foundation, the Finnish Cancer Institute, the Signe and Ane Gyllenberg Foundation, and the Otto A. Malm Foundation.	Agarwal MB, 2014, INDIAN J MED PAEDIAT, V35, P10, DOI 10.4103/0971-5851.133704; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bonecker Simone, 2015, Rev. Bras. Hematol. Hemoter., V37, P142, DOI 10.1016/j.bjhh.2014.08.003; Branford S, 2014, BLOOD, V124, P511, DOI 10.1182/blood-2014-03-566323; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes JE, 2010, J CLIN ONCOL, V28, P392, DOI 10.1200/JCO.2009.25.4896; Crews LA, 2012, CURR HEMATOL MALIG R, V7, P125, DOI 10.1007/s11899-012-0121-6; Fabbro D, 2012, NAT CHEM BIOL, V8, P228, DOI 10.1038/nchembio.900; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hanfstein B, 2014, LEUKEMIA, V28, P1988, DOI 10.1038/leu.2014.153; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hasford J, 1996, BONE MARROW TRANSPL, V17, pS49; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hjorth-Hansen H, 2014, EUR J HAEMATOL; Hoffbrand AV, 2011, POSTGRADUATE HEMATOL; Huet S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106250; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; KOLITZ JE, 1992, SEMIN ONCOL, V19, P27; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Mustjoki S, 2013, LEUKEMIA, V27, P1520, DOI 10.1038/leu.2013.19; Mustjoki S, 2010, LEUKEMIA, V24, P219, DOI 10.1038/leu.2009.190; Neelakantan P, 2013, BLOOD, V121, P2739, DOI 10.1182/blood-2012-11-466037; Pavey T, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16420; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Signorovitch J, 2014, CANCER TREAT REV, V40, P285, DOI 10.1016/j.ctrv.2013.09.004; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171041	10.1371/journal.pone.0171041	http://dx.doi.org/10.1371/journal.pone.0171041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135325	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000396124700041
J	Nandan, D; Thomas, SA; Nguyen, A; Moon, KM; Foster, LJ; Reiner, NE				Nandan, Devki; Thomas, Sneha A.; Nguyen, Anne; Moon, Kyung-Mee; Foster, Leonard J.; Reiner, Neil E.			Comprehensive Identification of mRNABinding Proteins of Leishmania donovani by Interactome Capture	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; RNA-BINDING PROTEINS; GENE-EXPRESSION; COMPARATIVE GENOMICS; TRYPANOSOMA-BRUCEI; MESSENGER-RNAS; NUCLEIC-ACIDS; CROSS-LINKING; PROTEOME; HSP70	Leishmania are unicellular eukaryotes responsible for leishmaniasis in humans. Like other trypanosomatids, leishmania regulate protein coding gene expression almost exclusively at the post-transcriptional level with the help of RNA binding proteins (RBPs). Due to the pres-ence of polycystronic transcription units, leishmania do not regulate RNA polymerase II-dependent transcription initiation. Recent evidence suggests that the main control points in gene expression are mRNA degradation and translation. Protein-RNA interactions are involved in every aspect of RNA biology, such as mRNA splicing, polyadenylation, localiza-tion, degradation, and translation. A detailed picture of these interactions would likely prove to be highly informative in understanding leishmania biology and virulence. We developed a strategy involving covalent UV cross-linking of RBPs to mRNA in vivo, followed by interac-tome capture using oligo(dT) magnetic beads to define comprehensively the mRNA interactome of growing L. donovani amastigotes. The protein mass spectrometry analysis of captured proteins identified 79 mRNA interacting proteins which withstood very stringent washing conditions. Strikingly, we found that 49 of these mRNA interacting proteins had no orthologs or homologs in the human genome. Consequently, these may represent high quality candidates for selective drug targeting leading to novel therapeutics. These results show that this unbiased, systematic strategy has the promise to be applicable to study the mRNA interactome during various biological settings such as metabolic changes, stress (low pH environment, oxidative stress and nutrient deprivation) or drug treatment.	[Nandan, Devki; Thomas, Sneha A.; Nguyen, Anne; Reiner, Neil E.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	nreiner@mail.ubc.ca			MOP [125879]; NER [77688]; Canadian Institutes for Health Research	MOP; NER; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Grants MOP 125879 to NER and 77688 to LJF from the Canadian Institutes for Health Research. The funding agencies had no role in design, collection, analysis, or interpretation of data; neither were they involved in writing the manuscript; or in the decision to submit the manuscript for publication.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beck S, 2015, MOL CELL PROTEOMICS, V14, P2014, DOI 10.1074/mcp.M114.047407; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Collingridge PW, 2010, PARASITOLOGY, V137, P1467, DOI 10.1017/S0031182010000259; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Keene JD, 2007, COLD SH Q B, V72, P157; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mittal N, 2013, MOL BIOCHEM PARASIT, V187, P21, DOI 10.1016/j.molbiopara.2012.11.001; Najafabadi HS, 2013, NUCLEIC ACIDS RES, V41, P8591, DOI 10.1093/nar/gkt647; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Nandan D, 2007, BIOCHEM BIOPH RES CO, V364, P601, DOI 10.1016/j.bbrc.2007.10.065; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Preusser C, 2012, INT J MED MICROBIOL, V302, P221, DOI 10.1016/j.ijmm.2012.07.004; Ramirez CA, 2013, J PROTEOMICS, V94, P124, DOI 10.1016/j.jprot.2013.09.008; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Reichel M, 2016, PLANT CELL, V28, P2435, DOI 10.1105/tpc.16.00562; Scherrer T, 2014, INVESTIGATIONS IN YEAST FUNCTIONAL GENOMICS AND MOLECULAR BIOLOGY, P233, DOI 10.1371/journal.pone.0015499; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Singh R, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0072-z; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2013, BBA-MOL CELL RES, V1833, P2673, DOI 10.1016/j.bbamcr.2013.06.017; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200	61	41	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170068	10.1371/journal.pone.0170068	http://dx.doi.org/10.1371/journal.pone.0170068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135300	gold, Green Submitted, Green Published			2022-12-26	WOS:000396124700008
J	De Serres, G; Skowronski, DM; Ward, BJ; Gardam, M; Lemieux, C; Yassi, A; Patrick, DM; Krajden, M; Loeb, M; Collignon, P; Carrat, F				De Serres, Gaston; Skowronski, Danuta M.; Ward, Brian J.; Gardam, Michael; Lemieux, Camille; Yassi, Annalee; Patrick, David M.; Krajden, Mel; Loeb, Mark; Collignon, Peter; Carrat, Fabrice			Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement	PLOS ONE			English	Article							LONG-TERM-CARE; ELDERLY-PEOPLE; SURVEILLANCE NETWORK; UNITED-STATES; HOME STAFF; MORTALITY; VIRUS; ILLNESS; PREVENTION; MORBIDITY	Background Four cluster randomized controlled trials (cRCTs) conducted in long-term care facilities (LTCFs) have reported reductions in patient risk through increased healthcare worker (HCW) influenza vaccination. This evidence has led to expansive policies of enforcement that include all staff of acute care hospitals and other healthcare settings beyond LTCFs. We critique and quantify the cRCT evidence for indirect patient benefit underpinning policies of mandatory HCW influenza vaccination. Methods Plausibility of the four cRCT findings attributing indirect patient benefits to HCW influenza vaccination was assessed by comparing percentage reductions in patient risk reported by the cRCTs to predicted values. Plausibly predicted values were derived according to the basic mathematical principle of dilution, taking into account HCW influenza vaccine coverage and the specificity of patient outcomes for influenza. Accordingly, predicted values were calculated as a function of relevant compound probabilities including vaccine efficacy (ranging 40-60% in HCWs and favourably assuming the same indirect protection conferred through them to patients) x change in proportionate HCW influenza vaccine coverage (as reported by each cRCT) x percentage of a given patient outcome (e.g. influenza-like illness (ILI) or all-cause mortality) plausibly due to influenza virus. The number needed to vaccinate (NNV) for HCWs to indirectly prevent patient death was recalibrated based on real patient data of hospital-acquired influenza, with adjustment for potential under-detection (5.2-fold), and using favourable assumptions of HCW-attributable risk (ranging 60-80%). Results In attributing patient benefit to increased HCW influenza vaccine coverage, each cRCT was found to violate the basic mathematical principle of dilution by reporting greater percentage reductions with less influenza-specific patient outcomes (i.e., all-cause mortality > ILI > laboratory-confirmed influenza) and/or patient mortality reductions exceeding even favourably-derived predicted values by at least 6- to 15-fold. If extrapolated to all LTCF and hospital staff in the United States, the prior cRCT-claimed NNV of 8 would implausibly mean >200,000 and >675,000 patient deaths, respectively, could be prevented annually by HCW influenza vaccination, inconceivably exceeding total US population mortality estimates due to seasonal influenza each year, or during the 1918 pandemic, respectively. More realistic recalibration based on actual patient data instead shows that at least 6000 to 32,000 hospital workers would need to be vaccinated before a single patient death could potentially be averted. Conclusions The four cRCTs underpinning policies of enforced HCW influenza vaccination attribute implausibly large reductions in patient risk to HCW vaccination, casting serious doubts on their validity. The impression that unvaccinated HCWs place their patients at great influenza peril is exaggerated. Instead, the HCW-attributable risk and vaccine-preventable fraction both remain unknown and the NNV to achieve patient benefit still requires better understanding. Although current scientific data are inadequate to support the ethical implementation of enforced HCW influenza vaccination, they do not refute approaches to support voluntary vaccination or other more broadly protective practices, such as staying home or masking when acutely ill.	[De Serres, Gaston] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [De Serres, Gaston] Univ Laval, Quebec City, PQ, Canada; [Skowronski, Danuta M.; Patrick, David M.; Krajden, Mel] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Skowronski, Danuta M.; Yassi, Annalee; Patrick, David M.; Krajden, Mel] Univ British Columbia, Vancouver, BC, Canada; [Ward, Brian J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Gardam, Michael; Lemieux, Camille] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Loeb, Mark] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Collignon, Peter] Australian Natl Univ, Acton, Australia; [Collignon, Peter] Canberra Hosp, Garran, ACT, Australia; [Carrat, Fabrice] Inst Pierre Louis Epidemiol & Sante Publ, Inst Natl Sante & Rech Med, Paris, France; [Carrat, Fabrice] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, Paris, France	Institut national de sante publique du Quebec (INSPQ); Laval University; University of British Columbia; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Australian National University; Australian National University; Canberra Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	De Serres, G (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.; De Serres, G (corresponding author), Univ Laval, Quebec City, PQ, Canada.	gaston.deserres@inspq.qc.ca	Collignon, Peter/U-4846-2019; Carrat, Fabrice/AAU-8480-2020	Carrat, Fabrice/0000-0002-8672-7918; Collignon, Peter/0000-0001-8648-9203	Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada; Ontario Nurses' Association	Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada; Ontario Nurses' Association	Funding support in the form of wages for Dr. Gaston De Serres was provided foremost by the Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada and in part by the Ontario Nurses' Association. Coauthors were supported by their respective institutions and no other external funding was provided. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2014, CLIN INFECT DIS, V58, P50, DOI 10.1093/cid/cit580; American Health Care association, 2011, STAT LONG TERM HLTH; Andrews N., 2014, EUROSURVEILLANCE, V19, P20851; [Anonymous], 2014, INFLUENZA COVERAGE B; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Benet T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-30; Bodewes R, 2012, VACCINE, V30, P7407, DOI 10.1016/j.vaccine.2012.04.086; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Carrat F, 2006, EPIDEMIOL INFECT, V134, P63, DOI 10.1017/S0950268805005479; Centers for Disease Control and Prevention (CDC), 2011, MMWR MORB MORTAL WKL, V60, P8; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; Coleman BL, 2011, INFLUENZA OTHER RESP, V5, P404, DOI 10.1111/j.1750-2659.2011.00245.x; Cowling BJ, 2016, VACCINE, V34, P61, DOI 10.1016/j.vaccine.2015.11.016; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; Elliot AJ, 2006, EURO SURVEILL, V11, ppii=651; Enserink R, 2011, J AM GERIATR SOC, V59, P2301, DOI 10.1111/j.1532-5415.2011.03715.x; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Harris Katherine M., 2011, Morbidity and Mortality Weekly Report, V60, P1073; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Health Protection Agency, 2006, HPA NAT INFL SEAS SU; Health Protection Agency, 2005, HPA NAT INFL SEAS SU; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Jhung MA, 2014, AM J INFECT CONTROL, V42, P7, DOI 10.1016/j.ajic.2013.06.018; Ksienski DS, 2014, CAN J PUBLIC HEALTH, V105, pE312, DOI 10.17269/cjph.105.4346; Kuster SP, 2013, EMERG INFECT DIS, V19, P606, DOI 10.3201/eid1904.111812; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Mereckiene J, 2014, EUROSURVEILLANCE, V19, P29, DOI 10.2807/1560-7917.ES2014.19.16.20780; Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Oshitani H, 2000, INFECT CONT HOSP EP, V21, P728, DOI 10.1086/501725; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paget W J, 2005, Euro Surveill, V10, P107, DOI 10.2807/esm.10.04.00529-en; Pebody R, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/ESE.18.05.20389-EN; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Public Health Toronto, 2015, TOR 2015 INFL UPD; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Regis C, 2010, 20 EUR C CLIN MICR I; Regis C, 2008, BEH, V34, P308; Ridgway JP, 2015, CLIN INFECT DIS, V60, P1591, DOI 10.1093/cid/civ163; Riphagen-Dalhuisen J, 2013, EUROSURVEILLANCE, V18, P10, DOI 10.2807/1560-7917.ES2013.18.26.20512; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P148; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086555; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2012, CAN MED ASS J; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P889, DOI 10.1086/656211; Taylor G, 2014, INFECT CONT HOSP EP, V35, P169, DOI 10.1086/674858; Thomas RE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub5; Thomas RE, 2014, VACCINE, V32, P2143, DOI 10.1016/j.vaccine.2014.02.059; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub4; Thomas RE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub3; Thompson MG, 2016, VACCINE, V34, P981, DOI 10.1016/j.vaccine.2015.10.119; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Turnberg W, 2010, AM J INFECT CONTROL, V38, P486, DOI 10.1016/j.ajic.2009.12.006; United States Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P28; United States Centers for Disease Control and Prevention, 2015, EST SEAS INFL ASS DE; United States Department of Health and Human Services, GREAT PAND US 1918 1; Valenciano M, 2016, EURO SURVEILL, V21; Van Buynder PG, 2013, VACCINE, V31, P6122, DOI 10.1016/j.vaccine.2013.07.059; van den Dool C, 2009, VACCINE, V27, P6261, DOI 10.1016/j.vaccine.2009.07.104; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Vanhems P, 2011, ARCH INTERN MED, V171, P151, DOI 10.1001/archinternmed.2010.500; Wendelboe AM, 2011, INFECT CONT HOSP EP, V32, P990, DOI 10.1086/661916; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P207	76	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0163586	10.1371/journal.pone.0163586	http://dx.doi.org/10.1371/journal.pone.0163586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129360	Green Published, Green Submitted, gold			2022-12-26	WOS:000396211400076
J	Ghadimi, S; Mohtasebi, M; Moghaddam, HA; Grebe, R; Gity, M; Wallois, F				Ghadimi, Sona; Mohtasebi, Mehrana; Moghaddam, Hamid Abrishami; Grebe, Reinhard; Gity, Masoumeh; Wallois, Fabrice			A Neonatal Bimodal MR-CT Head Template	PLOS ONE			English	Article							IMAGE REGISTRATION; AUTOMATIC SEGMENTATION; SPATIOTEMPORAL ATLAS; BRAIN; CONSTRUCTION; INFANT; NORMALIZATION; PROBABILITY; NEWBORNS; FONTANEL	Neonatal MR templates are appropriate for brain structural analysis and spatial normalization. However, they do not provide the essential accurate details of cranial bones and fontanels-sutures. Distinctly, CT images provide the best contrast for bone definition and fontanels- sutures. In this paper, we present, for the first time, an approach to create a fully registered bimodal MR-CT head template for neonates with a gestational age of 39 to 42 weeks. Such a template is essential for structural and functional brain studies, which require precise geometry of the head including cranial bones and fontanels- sutures. Due to the special characteristics of the problem (which requires inter-subject inter-modality registration), a two-step intensity-based registration method is proposed to globally and locally align CT images with an available MR template. By applying groupwise registration, the new neonatal CT template is then created in full alignment with the MR template to build a bimodal MR-CT template. The mutual information value between the CT and the MR template is 1.17 which shows their perfect correspondence in the bimodal template. Moreover, the average mutual information value between normalized images and the CT template proposed in this study is 1.24 +/- 0.07. Comparing this value with the one reported in a previously published approach (0.63 +/- 0.07) demonstrates the better generalization properties of the new created template and the superiority of the proposed method for the creation of CT template in the standard space provided by MR neonatal head template. The neonatal bimodal MR-CT head template is freely downloadable from https://www.u-picardie.fr/labo/GRAMFC.	[Ghadimi, Sona; Mohtasebi, Mehrana; Moghaddam, Hamid Abrishami] KN Toosi Univ Technol, Fac Elect Engn, Tehran, Iran; [Ghadimi, Sona; Moghaddam, Hamid Abrishami; Grebe, Reinhard; Wallois, Fabrice] Univ Picardie Jules Verne, Fac Med, INSERM, UMR 1105, Amiens, France; [Gity, Masoumeh] Univ Tehran Med Sci, Tehran, Iran; [Wallois, Fabrice] Ctr Hosp Univ Amiens, INSERM, UMR 1105, Amiens, France	K. N. Toosi University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Tehran University of Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Moghaddam, HA (corresponding author), KN Toosi Univ Technol, Fac Elect Engn, Tehran, Iran.	hamid.abrishami@u-picardie.fr	Mohtasebi, Mehrana/AAB-7110-2019; Mohtasebi, Mehrana/AAX-7672-2020; Abrishami Moghaddam, Hamid/AAW-9288-2021	Mohtasebi, Mehrana/0000-0002-4689-990X; Ghadimi, Sona/0000-0001-8612-4757	EGIDE France; CISSC Iran [961/93-9-2]	EGIDE France; CISSC Iran	This work was partially supported by EGIDE France and CISSC Iran under the grant number 961/93-9-2 (Jundi Shapour scientific collaboration program).	Aljabar P, 2008, NEUROIMAGE, V39, P348, DOI 10.1016/j.neuroimage.2007.07.067; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Christensen GE, 2001, IEEE T MED IMAGING, V20, P568, DOI 10.1109/42.932742; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cunningham ML, 2007, CURR OPIN PEDIATR, V19, P645, DOI 10.1097/MOP.0b013e3282f1581a; De Nigris D, 2012, IEEE T MED IMAGING, V31, P2343, DOI 10.1109/TMI.2012.2218116; Dehaes M, 2013, HUM BRAIN MAPP, V34, P878, DOI 10.1002/hbm.21483; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gallagher ER, 2013, CONT PEDIAT, V30, P12; Gargiulo P, 2015, CLIN NEUROPHYSIOL, V126, P1703, DOI 10.1016/j.clinph.2014.12.002; Ghadimi S, 2016, IEEE J BIOMED HEALTH, V20, P563, DOI 10.1109/JBHI.2015.2391991; Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054; Hartkens T., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P565; Heinrich MP, 2012, MED IMAGE ANAL, V16, P1423, DOI 10.1016/j.media.2012.05.008; Holden M, 2000, IEEE T MED IMAGING, V19, P94, DOI 10.1109/42.836369; Hsu LY, 2001, IMAGE VISION COMPUT, V19, P75, DOI 10.1016/S0262-8856(00)00058-5; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Jafarian N, 2014, SIGNAL IMAGE VIDEO P, V8, P377, DOI 10.1007/s11760-012-0300-x; Jia HJ, 2010, NEUROIMAGE, V51, P1057, DOI 10.1016/j.neuroimage.2010.03.010; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kazemi K, ENG MED BIOL SOC 200, P3892; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; Kikinis R, 1996, IEEE T VIS COMPUT GR, V2, P232, DOI 10.1109/2945.537306; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kuijf Hugo J., 2013, Multimodal Brain Image Analysis. Third International Workshop, MBIA 2013. Held in Conjunction with MICCAI 2013. Proceedings: LNCS 8159, P119, DOI 10.1007/978-3-319-02126-3_12; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Law W, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P350, DOI 10.1109/ISIMP.2004.1434072; Lemieux L, 1998, Med Image Anal, V2, P227, DOI 10.1016/S1361-8415(98)80021-2; Leroy F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027128; Lew S, 2013, NEUROIMAGE, V76, P282, DOI 10.1016/j.neuroimage.2013.03.017; Loeckx D, 2010, IEEE T MED IMAGING, V29, P19, DOI 10.1109/TMI.2009.2021843; Meyer J, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P1118; Momeni M, 2015, CURR MED IMAGING, V11, P38, DOI 10.2174/157340561101150423104958; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Roche-Labarbe N, 2008, HUM BRAIN MAPP, V29, P167, DOI 10.1002/hbm.20376; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rutherford M., 2002, MRI NEONATAL BRAIN; Sabuncu MR, 2009, IEEE T MED IMAGING, V28, P1473, DOI 10.1109/TMI.2009.2017942; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Shi F, 2010, NEUROIMAGE, V51, P684, DOI 10.1016/j.neuroimage.2010.02.025; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; van den Elsen P.A., 1994, P SOC PHOTO-OPT INS, V2359, P227; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang Q, 2009, SPIE MED IMAGING 200; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483; Xie ZY, 2004, IEEE T VIS COMPUT GR, V10, P85, DOI 10.1109/TVCG.2004.1260760; Yasuda M, 1998, AM J PSYCHIAT, V155, P779	61	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0166112	10.1371/journal.pone.0166112	http://dx.doi.org/10.1371/journal.pone.0166112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129340	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400075
J	Xu, G; Liang, XF; Yao, SB; Chen, DW; Li, ZW				Xu, Gang; Liang, Xifeng; Yao, Shuanbao; Chen, Dawei; Li, Zhiwei			Multi-Objective Aerodynamic Optimization of the Streamlined Shape of High-Speed Trains Based on the Kriging Model	PLOS ONE			English	Article							FLOW	Minimizing the aerodynamic drag and the lift of the train coach remains a key issue for highspeed trains. With the development of computing technology and computational fluid dynamics (CFD) in the engineering field, CFD has been successfully applied to the design process of high-speed trains. However, developing a new streamlined shape for high-speed trains with excellent aerodynamic performance requires huge computational costs. Furthermore, relationships between multiple design variables and the aerodynamic loads are seldom obtained. In the present study, the Kriging surrogate model is used to perform a multi objective optimization of the streamlined shape of high-speed trains, where the drag and the lift of the train coach are the optimization objectives. To improve the prediction accuracy of the Kriging model, the cross-validation method is used to construct the optimal Kriging model. The optimization results show that the two objectives are efficiently optimized, indicating that the optimization strategy used in the present study can greatly improve the optimization efficiency and meet the engineering requirements.	[Xu, Gang; Liang, Xifeng; Li, Zhiwei] Cent S Univ, Minist Educ, Key Lab Rail Traff Safety, Changsha, Hunan, Peoples R China; [Xu, Gang; Liang, Xifeng; Li, Zhiwei] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Xu, Gang; Yao, Shuanbao; Chen, Dawei] CSR Qingdao Sifang Co Ltd, Qingdao, Peoples R China	Central South University; Central South University	Li, ZW (corresponding author), Cent S Univ, Minist Educ, Key Lab Rail Traff Safety, Changsha, Hunan, Peoples R China.; Li, ZW (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	lzhw1205@163.com			National Basic Research Program of China (973 Program) [2011CB711101]; CRRC QINGDAO SIFANG CO., LTD	National Basic Research Program of China (973 Program)(National Basic Research Program of China); CRRC QINGDAO SIFANG CO., LTD	The funding of National Basic Research Program of China (973 Program, No. 2011CB711101, http://program.most.gov.cn/) provided full support for the study design, data collection and analysis, the research materials, the manuscript preparation and publication. CRRC QINGDAO SIFANG CO., LTD provided support in the form of salaries for authors [G. Xu, S. B. Yao, D. W. Chen], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker C, 2010, J WIND ENG IND AEROD, V98, P277, DOI 10.1016/j.jweia.2009.11.002; Baker CJ, 2004, J WIND ENG IND AEROD, V92, P547, DOI 10.1016/j.jweia.2004.03.002; CHIU TW, 1992, J WIND ENG IND AEROD, V45, P47, DOI 10.1016/0167-6105(92)90005-U; COPLEY JM, 1987, J WIND ENG IND AEROD, V26, P21, DOI 10.1016/0167-6105(87)90034-1; Cui K., 2012, P 1 INT WORKSH HIGH, V148, P187; Hemida H, 2010, COMPUT FLUIDS, V39, P1944, DOI 10.1016/j.compfluid.2010.06.026; Hemida H, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4001447; Krajnovic S., 2009, AERODYNAMICS HEAVY V, P197; Ku YC, 2010, STRUCT MULTIDISCIP O, V42, P965, DOI 10.1007/s00158-010-0550-6; Lee J, 2008, STRUCT MULTIDISCIP O, V35, P79, DOI 10.1007/s00158-007-0111-9; [李明 Li Ming], 2013, [铁道学报, Journal of the China Railway Society], V35, P14; Liao Yanping, 2012, Journal of Mechanical Engineering, V48, P132, DOI 10.3901/JME.2012.13.132; Liu JL, 2013, CHIN SCI TECHNOL, V43, P689; Raghunathan RS, 2002, PROG AEROSP SCI, V38, P469, DOI 10.1016/S0376-0421(02)00029-5; Schetz JA, 2001, ANNU REV FLUID MECH, V33, P371, DOI 10.1146/annurev.fluid.33.1.371; Sun ZX, 2010, SCI CHINA TECHNOL SC, V53, P3356, DOI 10.1007/s11431-010-4163-5; Tian H., 2007, AERODYNAMICS TRAIN M; Tian HQ, 2009, J CENT SOUTH UNIV T, V16, P166, DOI 10.1007/s11771-009-0028-0; Tian HQ, 2003, ELECT DRIVE LOCOMOTI, P40; Vytla VV, 2010, AIAA APPL AERODYNAMI, V15, P25; [王英学 Wang Yingxue], 2004, [西南交通大学学报, Journal of Southwest Jiaotong University], V39, P20; Yang GW, 2012, SCI CHINA TECHNOL SC, V55, P1923, DOI 10.1007/s11431-012-4863-0; Yao SB, 2012, SCI CHINA TECHNOL SC, V55, P3118, DOI 10.1007/s11431-012-4934-2; Yu Mengge, 2014, Journal of Mechanical Engineering, V50, P122, DOI 10.3901/JME.2014.24.122	24	19	19	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170803	10.1371/journal.pone.0170803	http://dx.doi.org/10.1371/journal.pone.0170803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129365	Green Published, gold, Green Submitted			2022-12-26	WOS:000396211400033
J	Hojland, DH; Kristensen, M				Hojland, Dorte H.; Kristensen, Michael			Analysis of Differentially Expressed Genes Related to Resistance in Spinosad- and Neonicotinoid-Resistant Musca domestica L. (Diptera: Muscidae) Strains	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; INSECTICIDE RESISTANCE; HOUSE-FLIES; CROSS-RESISTANCE; NATURAL-PRODUCTS; CYTOCHROMES P450; POPULATIONS; FAMILY; SUSCEPTIBILITY; TRANSFERASES	Background The housefly is a global pest that has developed resistance to most insecticides applied against it. Resistance of the spinosad-resistant strain 791 spin and the neonicotinoid-resistant 766b strain is believed to be due to metabolism. We investigate differentially expressed genes in these two resistant strains related to metabolism in comparison with an insecticide-susceptible reference strain. Results Genes involved in metabolism of xenobiotics were primarily up-regulated in resistant flies with some differences between resistant strains. The cyp4g98 and cyp6g4 genes proved interesting in terms of neonicotinoid resistance, while cyp4d9 was overexpressed in 791spin compared to spinosad-susceptible strains. GSTs, ESTs and UGTs were mostly overexpressed, but not to the same degree as P450s. We present a comprehensive and comparative picture of gene expression in three housefly strains differing significantly in their response to insecticides. High differential expression of P450s and genes coding for cuticle protein indicates a combination of factors involved in metabolic neonicotinoid and spinosad resistance. Conclusion Resistance in these strains is apparently not linked to the alteration of a single gene but is composed of several changes including differential expression of genes encoding metabolic detoxification enzymes.	[Hojland, Dorte H.; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Slagelse, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	mikr@agro.au.dk	Kristensen, Michael/F-5536-2016	Kristensen, Michael/0000-0001-7332-3490	Innovation Fund Denmark [0603-00516B]	Innovation Fund Denmark	This work was supported by the Innovation Fund Denmark. Grant 0603-00516B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; BULL DL, 1972, J AGR FOOD CHEM, V20, P561, DOI 10.1021/jf60181a061; CARINO F, 1992, ACS SYM SER, V505, P31; Chao SL, 1997, PESTIC BIOCHEM PHYS, V58, P77; Coelho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117328; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Epis S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07435; FEYEREISEN R, 1989, P NATL ACAD SCI USA, V86, P1465, DOI 10.1073/pnas.86.5.1465; ffrench-Constant R, 2006, BIOESSAYS, V28, P6, DOI 10.1002/bies.20354; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gao Q, 2012, PESTIC BIOCHEM PHYS, V104, P252, DOI 10.1016/j.pestbp.2012.09.006; Geng Hua, 2004, Acta Genetica Sinica, V31, P1344; GEORGHIOU GP, 1990, ACS SYM SER, V421, P18; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103689; Hojland DH, 2014, PEST MANAG SCI, V70, P1114, DOI 10.1002/ps.3655; Hojland DH, 2014, PEST MANAG SCI, V70, P1237, DOI 10.1002/ps.3681; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085965; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kasai S, 2000, PESTIC BIOCHEM PHYS, V68, P34, DOI 10.1006/pest.2000.2492; Kavi LAK, 2014, PESTIC BIOCHEM PHYS, V109, P64, DOI 10.1016/j.pestbp.2014.01.006; Keiding J, 1986, VECTOR CONTROL SERIE; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2005, J ECON ENTOMOL, V98, P1341, DOI 10.1603/0022-0493-98.4.1341; Kristensen M, 2004, J ECON ENTOMOL, V97, P1042, DOI 10.1603/0022-0493(2004)097[1042:SOSIMD]2.0.CO;2; Kristensen M, 2001, PEST MANAG SCI, V57, P82, DOI 10.1002/1526-4998(200101)57:1<82::AID-PS251>3.0.CO;2-8; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Kristensen M, 2006, PEST MANAG SCI, V62, P738, DOI 10.1002/ps.1231; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Mahmood K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151434; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Meisel RP, 2015, TRANSCRIPTOME DIFFER; Mitchell CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093489; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Orr N, 2009, PESTIC BIOCHEM PHYS, V95, P1, DOI 10.1016/j.pestbp.2009.04.009; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Scott H.G., 1962, FLIES PUBLIC HLTH IM; Scott JG, 2008, J PESTIC SCI, V33, P221, DOI 10.1584/jpestics.R08-04; Scott JG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0466-3; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shi J, 2011, PEST MANAG SCI, V67, P335, DOI 10.1002/ps.2073; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Ware G., 2004, PESTICIDE BOOK MEIST; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008	63	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170935	10.1371/journal.pone.0170935	http://dx.doi.org/10.1371/journal.pone.0170935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125739	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100019
